Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCA7 ABCX ENSG00000064687 "ATP binding cassette subfamily A member 7" Q8IZY2 19 1039997-1065572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Phagocytosis, Transport" Translocase "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.4;pituitary gland: 28.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Bipolar cells: 70.6;Cone photoreceptor cells: 175.2;Extravillous trophoblasts: 303.3;Rod photoreceptor cells: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 20.4;HMC-1: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA041564 Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" "Golgi apparatus, Plasma membrane" "Cell Junctions" "HPA041564: AB_2677550" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (7.26e-4)" "prognostic favorable (1.12e-4)" "unprognostic (8.88e-2)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (4.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "unprognostic (1.51e-3)" "unprognostic (3.68e-2)" "unprognostic (8.99e-3)" "unprognostic (2.08e-2)" "unprognostic (3.66e-1)" "unprognostic (7.88e-2)" "unprognostic (7.85e-2)" 4.4 3.0 3.4 5.5 3.9 27.4 3.3 4.0 6.1 3.2 11.5 3.8 2.3 1.2 0.2 7.6 2.1 2.1 3.1 3.6 3.7 6.4 4.2 9.5 8.5 5.8 4.5 0.5 7.7 2.7 28.7 1.2 5.3 5.3 1.2 25.5 8.6 1.1 3.8 5.9 10.1 0.5 3.0 26.6 3.8 1.7 4.1 10.0 5.7 0.3 3.2 2.3 2.8 3.2 4.7 6.4 0.5 4.4 7.2 2.2 7.3 0.8 1.0 0.4 0.6 5.2 2.8 13.9 5.6 1.3 0.6 8.0 1.3 6.2 0.4 10.2 2.5 6.7 20.4 5.6 1.8 3.9 40.3 3.8 1.8 0.9 1.2 4.4 1.4 7.7 10.2 6.9 1.3 2.2 4.3 2.2 0.9 3.3 2.5 3.1 0.8 11.6 3.8 6.0 0.3 1.3 8.2 1.9 1.2 1.1 4.6 7.1 2.2 0.4 1.6 3.7 0.8 9.9 6.6 5.7 2.1 7.4 2.0 2.8 1.4 5.9 1.8 1.2 1.1 0.6 0.9 1.2 2.1 0.9 0.8 1.5 3.3 1.1 1.3 7.3 0.4 1.3 3.4 3.9 4.0 6.1 3.6 3.7 5.8 4.5 5.3 3.0 4.1 3.2 4.1 73.7 21.9 8.5 13.2 3.3 0.8 10.7 5.2 70.6 4.8 2.2 6.0 4.3 14.0 5.5 175.2 4.6 9.1 14.7 1.9 2.7 7.3 8.9 1.4 2.9 3.5 13.3 12.9 2.5 303.3 1.5 5.6 6.9 10.1 2.0 2.5 4.9 7.9 15.2 11.5 4.7 16.2 12.6 7.5 4.8 0.0 12.7 0.0 4.7 19.6 13.1 9.2 1.5 2.4 7.0 9.6 0.0 12.0 1.5 1.7 1.3 17.5 149.1 0.0 2.7 2.7 0.7 2.0 6.6 3.4 25.7 12.6 1.0 5.3 1.9 ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209772-219218994 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: AB_2683578" "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 10.2 8.7 4.3 3.4 3.9 10.4 7.6 3.2 4.6 7.7 4.4 6.5 6.9 8.4 8.2 11.4 9.6 7.1 8.5 4.0 5.1 5.2 15.9 5.9 1.9 4.4 4.2 12.9 5.7 4.8 6.0 3.1 6.2 8.0 3.3 3.0 6.2 8.6 30.4 6.8 6.3 7.9 4.1 3.9 7.9 18.0 5.7 2.6 10.7 9.8 2.9 14.9 7.9 5.0 0.3 22.9 4.7 28.8 30.8 11.1 27.6 8.5 7.9 9.2 9.2 35.5 5.0 0.3 42.8 8.6 5.0 49.1 0.6 3.6 3.0 15.0 4.7 36.3 24.9 65.8 37.0 0.0 12.0 16.3 4.2 6.2 0.1 13.9 16.3 4.8 31.4 4.4 6.3 12.0 2.3 0.1 7.2 53.6 9.2 12.3 14.3 1.6 5.1 0.4 16.6 17.8 17.6 41.4 18.7 17.4 12.4 0.8 7.5 12.5 0.5 16.9 10.3 11.2 9.6 0.1 14.0 0.4 17.0 0.7 0.4 0.0 0.7 0.4 0.2 1.0 0.5 0.2 0.3 0.8 1.2 0.8 0.0 0.4 0.3 2.3 0.5 1.0 4.3 3.9 3.2 4.6 4.0 5.1 4.4 4.2 6.2 4.1 5.7 5.0 0.2 0.0 0.0 14.7 0.3 0.3 0.0 0.5 1.2 1.0 0.2 0.0 0.2 0.0 1.3 0.0 0.0 0.2 0.2 0.1 0.0 0.8 1.2 0.3 0.6 0.4 0.0 1.3 12.9 0.0 0.1 0.7 5.1 0.2 0.0 0.5 0.0 0.4 0.1 0.0 10.9 0.3 0.0 0.3 0.4 1.0 0.3 0.3 0.0 3.7 0.0 0.3 0.0 13.6 5.6 0.3 0.0 0.4 0.5 0.0 0.5 0.2 2.2 0.8 0.0 0.4 0.3 1.0 0.3 2.8 0.3 0.3 0.1 0.4 0.2 0.1 ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019835-95301475 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 41.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 51.3;granulocytes: 53.9;Microglial cells: 203.3" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HEL: 245.7;HMC-1: 256.3;RPTEC TERT1: 69.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002476 Enhanced Supported "Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane" "Nucleoli, Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favorable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 2.2 1.3 2.5 6.1 2.3 4.1 6.9 2.5 2.5 4.9 7.2 9.2 4.9 3.4 18.8 2.0 10.2 6.1 2.0 2.3 5.4 18.0 1.3 7.6 3.9 4.3 3.7 3.7 3.3 22.5 1.4 2.1 4.6 41.1 8.5 0.9 1.5 5.5 5.3 2.9 5.4 6.3 4.9 4.1 5.2 4.7 3.2 3.9 7.7 1.7 6.3 15.4 1.8 5.1 18.5 31.7 5.3 9.4 9.5 12.3 1.3 14.4 14.3 12.6 10.9 43.8 13.2 10.2 9.3 19.5 9.0 24.0 7.9 7.1 15.8 30.7 12.1 245.7 8.8 8.8 19.2 28.6 256.3 9.4 3.2 9.1 18.5 17.9 16.4 11.3 25.8 0.4 17.1 5.9 5.4 4.6 6.2 22.3 7.9 7.7 14.3 26.9 69.3 40.4 12.5 9.3 4.8 1.2 10.1 5.9 0.0 15.1 27.0 13.3 8.6 11.2 17.3 0.1 0.0 4.0 25.4 16.0 6.6 0.2 0.5 0.2 1.3 0.6 1.1 1.4 1.0 1.5 1.8 1.6 0.6 1.5 0.3 1.9 2.3 0.3 1.5 1.3 2.5 2.3 2.5 2.5 2.3 5.4 4.3 3.7 4.6 4.9 3.2 5.1 4.6 9.6 32.7 28.4 5.8 4.2 7.0 7.3 4.0 0.1 0.6 0.6 4.5 8.6 9.1 23.9 22.9 0.1 2.0 2.7 0.0 6.9 3.8 4.2 11.3 19.8 0.0 51.3 13.6 3.1 0.4 5.7 6.1 6.0 53.9 9.5 2.9 0.6 4.5 0.0 10.3 4.0 0.0 2.5 8.1 2.0 6.8 10.7 1.8 203.3 13.5 0.5 4.1 16.1 2.5 2.9 8.3 1.9 8.3 27.1 0.5 26.4 4.7 0.8 0.0 8.2 3.1 0.9 8.3 3.4 7.5 0.3 6.4 17.3 9.2 4.5 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "pancreas: 20.1;pituitary gland: 34.4" "Group enriched" "Detected in some" 4 "Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" No NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: AB_2677947" "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 0.4 2.8 2.6 0.0 3.7 0.0 1.8 3.9 5.2 3.5 0.0 0.7 0.5 2.6 1.4 0.1 0.6 0.0 1.6 3.1 1.4 0.5 0.1 5.0 0.0 3.3 2.7 0.4 20.1 0.2 34.4 0.4 3.3 2.1 0.3 2.2 0.0 1.5 1.5 0.2 1.0 0.2 0.6 0.1 6.1 0.4 1.2 0.0 3.4 0.6 0.0 0.4 1.3 3.5 0.0 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.7 3.9 5.2 3.1 1.4 3.3 2.7 3.3 0.6 1.2 3.5 0.3 0.0 0.0 19.6 0.3 0.0 0.1 0.0 0.0 39.0 5.3 3.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.5 17.9 0.3 22.0 0.0 48.2 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.3 0.1 0.0 39.3 0.7 0.0 0.3 0.5 0.0 0.0 0.1 0.0 3.7 0.0 1.9 0.0 39.2 7.6 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.3 0.0 0.7 2.0 0.1 0.8 0.0 0.1 0.0 0.1 2.6 0.1 0.2 ABCG1 ABC8 ENSG00000160179 "ATP binding cassette subfamily G member 1" P45844 21 42199689-42297244 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 35.5;neutrophil: 36.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 36.6" "Cell line enhanced" "Detected in many" "hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031470, HPA031471" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "HPA031470: AB_10599188, HPA031471: AB_10600201" "unprognostic (2.89e-2)" "unprognostic (2.53e-2)" "unprognostic (9.96e-2)" "unprognostic (4.20e-3)" "unprognostic (2.87e-1)" "unprognostic (3.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (3.66e-3)" "unprognostic (6.37e-2)" "prognostic favorable (7.16e-6)" "unprognostic (1.40e-2)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.42e-2)" 17.2 37.7 18.3 12.1 25.5 8.1 15.2 14.4 20.2 8.1 20.0 14.1 17.5 4.9 3.9 4.1 6.3 13.8 10.5 15.5 17.0 10.2 6.3 29.4 18.1 12.0 19.9 6.3 5.3 24.4 10.7 13.7 13.3 6.2 15.0 29.1 16.1 7.0 19.6 16.8 22.0 4.0 12.2 31.2 15.9 1.1 20.3 18.9 8.5 6.2 12.1 12.9 5.0 24.7 0.0 6.0 4.6 2.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 3.1 1.9 0.8 0.0 0.7 0.9 0.0 8.8 0.0 8.5 0.5 10.2 19.2 0.0 17.4 0.0 0.4 2.0 25.5 0.1 3.9 0.0 18.2 38.4 0.0 0.1 0.0 33.2 31.5 0.2 1.4 54.9 10.3 0.4 0.0 25.8 0.0 2.8 22.3 5.8 3.7 13.5 0.0 0.4 5.7 0.9 11.8 0.0 4.7 0.1 0.0 13.1 4.2 0.0 0.1 3.3 0.5 1.7 1.7 35.5 3.0 0.5 5.6 5.5 6.1 6.0 1.1 7.0 5.8 5.0 36.6 7.4 0.3 2.5 7.4 2.1 18.3 25.5 14.4 20.2 15.5 17.0 12.0 19.9 13.3 12.2 20.3 24.7 38.2 6.4 8.2 0.3 21.3 8.9 6.9 3.2 5.7 48.4 4.1 6.9 9.5 4.3 5.9 25.8 50.1 7.0 7.0 33.4 3.9 2.6 4.5 21.6 6.3 33.8 3.5 5.7 13.2 1.2 1.8 7.5 11.2 45.3 0.0 1.2 42.8 0.6 16.0 11.8 17.8 12.1 8.2 44.5 23.4 7.6 0.3 20.9 3.6 7.5 4.3 16.1 3.1 43.2 40.6 2.3 8.3 1.9 4.0 3.0 36.6 1.1 4.5 122.6 6.6 1.6 3.5 0.6 0.5 1.0 6.7 63.1 21.4 10.4 1.1 9.1 ACAP1 "CENTB1, KIAA0050" ENSG00000072818 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 1" Q15027 17 7336529-7351477 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0" "Cell type enriched" "Detected in many" 6 "Late spermatids: 3430.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075570 Approved Approved "Golgi apparatus" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA075570: AB_2732295" "unprognostic (1.20e-2)" "prognostic favorable (3.66e-4)" "unprognostic (2.49e-1)" "prognostic favorable (2.97e-5)" "unprognostic (4.43e-4)" "prognostic favorable (4.17e-5)" "unprognostic (5.66e-3)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (2.48e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.14e-1)" "unprognostic (5.58e-2)" "unprognostic (2.90e-1)" "unprognostic (8.61e-3)" 5.6 1.1 0.4 18.9 0.5 41.0 2.1 0.5 0.8 2.3 0.5 7.4 4.1 1.5 0.3 4.2 4.0 3.6 2.1 0.3 0.4 4.6 5.2 16.1 39.5 0.6 0.5 0.9 1.2 0.1 1.3 0.5 0.6 3.8 2.1 0.2 3.6 0.4 0.9 2.5 43.3 0.9 0.5 96.0 5.0 0.8 0.8 25.8 5.2 0.8 22.6 4.3 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 23.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 8.8 0.1 0.0 0.1 11.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 42.4 0.0 29.4 0.0 0.0 14.5 37.9 0.4 0.0 0.0 15.1 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.9 0.0 0.0 0.1 0.0 0.0 9.1 8.2 10.9 0.1 24.9 0.0 28.8 7.9 30.8 29.6 2.4 33.3 20.2 31.5 32.1 13.7 21.3 26.7 27.5 22.6 32.5 0.4 17.3 39.0 22.3 0.4 0.5 0.5 0.8 0.3 0.4 0.6 0.5 0.6 0.5 0.8 0.6 3.8 9.6 5.5 1.6 150.9 8.3 7.6 25.1 2.8 15.8 7.0 8.1 32.9 7.2 12.3 5.5 18.8 3.9 160.7 2.0 7.9 3.9 498.1 8.3 5.4 5.0 3.6 22.9 0.3 3.7 3.2 8.0 5.6 3.4 40.5 1.8 7.1 5.3 7.5 0.0 1.9 2.7 8.2 26.2 39.5 3430.7 20.2 27.9 24.9 2.8 38.3 11.7 332.7 0.5 1.0 5.5 0.0 15.4 68.0 4.6 1.3 3.8 44.6 20.4 19.7 7.5 8.1 15.6 10.5 1.5 7.4 4.4 268.3 0.9 1.6 3.5 ACAP3 "CENTB5, KIAA1716" ENSG00000131584 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 3" Q96P50 1 1292390-1309609 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 148.3;Cone photoreceptor cells: 104.3;Rod photoreceptor cells: 201.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049317, HPA058381" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 45: Intestine - Brush border" "Cluster 25: RPMI-8226 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Golgi apparatus" "HPA049317: AB_2680710, HPA058381: AB_2683699" "unprognostic (5.92e-2)" "unprognostic (1.55e-1)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (7.94e-2)" "unprognostic (3.77e-3)" "unprognostic (2.98e-3)" "unprognostic (1.01e-3)" "unprognostic (1.29e-2)" "unprognostic (8.05e-2)" "unprognostic (1.56e-3)" "unprognostic (5.35e-3)" "unprognostic (3.70e-2)" "unprognostic (6.76e-3)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" 14.1 17.1 40.9 2.9 48.0 9.0 10.1 46.1 62.4 23.0 27.9 21.2 6.0 16.3 2.5 32.4 14.2 3.5 26.7 47.7 32.9 17.3 20.6 12.8 3.1 35.1 33.6 16.4 13.3 2.7 40.2 2.9 34.0 17.3 2.1 12.1 14.5 5.0 17.4 33.5 13.7 3.7 35.0 16.3 16.4 6.5 41.7 4.8 10.7 5.7 2.3 19.6 25.3 43.9 9.7 10.5 5.2 8.5 11.8 8.1 5.2 23.7 7.6 6.7 5.0 13.2 8.1 10.5 12.1 13.2 6.7 22.0 4.7 6.3 1.7 11.8 21.1 4.5 43.7 25.2 8.3 9.1 10.8 6.0 5.0 5.7 3.5 6.4 3.2 12.7 12.5 14.2 7.6 12.9 19.1 13.9 5.1 12.8 24.6 18.7 10.9 40.7 4.1 5.1 36.4 25.9 14.1 9.2 22.8 4.4 9.4 7.1 10.7 12.4 8.9 10.3 8.4 11.5 8.6 9.0 17.0 23.6 5.5 0.0 0.2 0.3 0.2 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.1 40.9 48.0 46.1 62.4 47.7 32.9 35.1 33.6 34.0 35.0 41.7 43.9 10.0 0.0 4.7 20.5 11.0 32.1 5.8 7.0 12.5 148.3 15.4 11.9 23.4 14.3 5.6 1.8 104.3 9.0 9.3 22.2 3.9 9.4 3.5 4.3 18.3 8.8 32.3 12.6 48.2 5.1 8.8 16.0 39.3 8.0 0.0 8.2 13.2 17.3 7.2 53.8 31.7 14.4 8.2 17.9 15.5 9.0 15.2 11.2 8.8 15.0 11.9 18.9 12.3 80.9 44.4 12.7 13.7 13.2 11.1 6.1 12.6 7.8 6.9 201.6 6.6 12.9 15.2 3.9 15.2 23.5 34.2 10.1 10.4 12.2 16.8 9.9 ACBD3 "GCP60, GOCAP1, GOLPH1, PAP7" ENSG00000182827 "Acyl-CoA binding domain containing 3" Q9H3P7 1 226144679-226186741 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015594 Approved Supported "Golgi apparatus" NA NA 29000 "Cluster 37: B-cells - Transcription" "Cluster 46: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" "HPA015594: AB_1844491" "unprognostic (1.82e-3)" "unprognostic (1.53e-2)" "unprognostic (7.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.85e-1)" "unprognostic (5.34e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.66e-3)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-3)" "unprognostic (2.54e-3)" 21.6 16.9 11.6 20.4 12.4 25.9 24.4 13.1 13.0 27.6 16.6 23.2 17.5 22.8 20.6 30.8 17.8 23.5 21.4 10.9 13.7 20.2 24.3 22.4 21.3 12.6 13.9 23.2 22.7 28.0 14.6 31.7 12.9 22.8 25.4 16.1 24.1 16.4 21.5 19.3 17.5 21.7 13.1 17.8 31.7 18.8 13.1 18.0 28.8 20.3 25.7 26.9 20.2 13.5 43.7 29.3 24.3 15.1 73.6 65.4 47.2 53.7 55.7 31.5 40.3 38.0 53.2 46.3 48.0 69.7 28.5 33.5 34.6 35.2 43.9 19.4 40.4 22.5 30.3 34.8 47.2 36.5 26.7 48.7 46.0 39.1 51.1 44.7 36.6 22.2 42.6 32.0 51.3 22.1 27.2 28.5 36.1 72.5 38.0 25.0 53.3 47.1 29.4 39.2 27.6 39.8 47.8 52.7 53.0 34.0 54.2 41.5 46.2 31.4 22.0 76.7 51.5 60.4 67.4 57.3 37.3 24.2 52.8 2.1 1.4 1.4 0.9 1.8 1.6 5.0 1.3 0.9 1.0 4.4 1.4 1.3 1.5 1.0 1.5 1.4 1.7 0.7 11.6 12.4 13.1 13.0 10.9 13.7 12.6 13.9 12.9 13.1 13.1 13.5 53.5 67.3 41.5 14.0 50.4 52.0 63.4 17.9 38.7 35.1 50.6 37.2 35.7 27.1 37.9 35.0 56.3 45.3 44.2 46.1 15.6 25.0 24.0 56.6 84.0 47.6 43.5 10.7 29.8 34.7 60.7 55.8 50.4 85.8 24.6 29.8 28.2 52.0 37.9 26.9 31.3 71.9 28.5 25.1 51.0 7.3 40.7 39.4 49.8 20.6 18.0 52.1 18.6 27.6 29.2 39.0 28.4 32.7 87.3 61.7 26.7 32.1 26.9 39.4 32.9 46.6 51.4 72.1 55.8 46.7 77.7 62.4 34.0 33.1 35.6 98.3 ACCS "ACS, PHACS" ENSG00000110455 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive)" Q96QU6 11 44065925-44084237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018873, HPA021654" Approved Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA018873: AB_1855273, HPA021654: AB_1855274" "unprognostic (3.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.98e-1)" "unprognostic (1.86e-1)" "unprognostic (7.86e-3)" "unprognostic (2.01e-2)" "unprognostic (1.40e-1)" "unprognostic (7.57e-3)" "unprognostic (1.41e-1)" "unprognostic (3.38e-2)" "prognostic favorable (4.25e-4)" "unprognostic (6.51e-2)" "unprognostic (3.07e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-1)" "unprognostic (5.63e-3)" "unprognostic (1.92e-2)" 11.4 17.0 1.8 3.7 1.5 10.0 11.2 1.5 2.0 11.1 7.2 8.3 5.4 14.2 8.1 5.5 15.4 10.1 5.8 1.9 2.2 10.4 18.9 9.7 5.5 2.0 1.8 9.8 11.0 2.8 11.0 2.6 1.8 10.9 6.9 1.0 10.3 6.3 3.1 7.8 10.3 6.3 1.5 14.0 10.4 6.5 2.3 4.1 12.7 2.4 6.4 9.1 8.3 2.0 4.0 8.8 0.0 1.0 2.3 4.1 0.0 2.1 2.7 1.9 2.0 0.7 5.6 1.5 1.6 4.7 0.0 6.7 2.4 0.5 1.0 0.5 2.6 6.3 3.3 0.1 4.4 0.0 0.0 4.6 8.2 2.4 1.1 2.6 3.5 0.0 5.0 0.0 5.8 3.0 0.0 2.5 3.4 5.1 1.3 5.5 0.0 0.0 4.8 2.6 1.1 3.5 2.1 1.1 2.5 2.2 8.6 3.8 3.8 2.2 2.3 3.5 1.1 0.0 0.0 0.2 5.3 0.0 2.3 0.9 3.1 5.6 0.8 3.1 0.7 1.1 0.7 1.3 4.4 1.4 1.1 0.7 0.0 0.9 2.5 3.3 1.2 2.0 1.8 1.5 1.5 2.0 1.9 2.2 2.0 1.8 1.8 1.5 2.3 2.0 12.2 12.8 22.7 11.8 4.6 2.7 2.7 4.0 6.8 1.9 8.6 10.2 4.0 7.2 8.9 9.2 0.0 3.1 4.0 6.4 0.0 2.3 2.1 8.6 3.9 7.0 7.2 3.4 3.4 4.2 0.4 6.9 13.7 5.0 9.5 11.0 8.2 9.7 6.1 0.0 3.3 8.2 4.1 7.0 5.5 4.4 9.6 9.0 0.0 5.6 9.4 2.6 7.2 4.5 6.6 2.9 8.0 7.5 2.5 2.1 16.6 6.5 7.4 1.0 0.0 3.7 4.7 0.7 2.4 2.4 2.3 1.9 3.3 9.2 6.4 2.1 ACHE YT ENSG00000087085 "Acetylcholinesterase (Cartwright blood group)" P22303 7 100889994-100896974 "Blood group antigen proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter degradation" "Blood group antigen, Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 98.2;skeletal muscle: 163.2;tongue: 48.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 86.2;Erythroid cells: 37.7;Exocrine glandular cells: 39.7;Horizontal cells: 55.5;Paneth cells: 118.3;Proximal enterocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.9;CACO-2: 13.0;K-562: 13.9;Karpas-707: 19.7;U-2 OS: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027098 Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 990000 "Cluster 80: Striated muscle - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA027098: AB_2672111" "unprognostic (2.23e-1)" "unprognostic (9.44e-2)" "unprognostic (2.71e-2)" "unprognostic (5.80e-3)" "prognostic unfavorable (5.27e-4)" "unprognostic (2.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.36e-2)" "unprognostic (2.48e-2)" "unprognostic (8.92e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.88e-5)" "unprognostic (2.95e-1)" "unprognostic (2.59e-2)" "unprognostic (9.28e-2)" "unprognostic (8.38e-2)" 1.4 4.7 20.9 2.2 16.8 7.9 2.0 37.1 32.5 5.0 0.0 7.6 4.9 2.6 0.2 2.3 3.2 1.3 12.5 8.0 98.2 8.8 4.1 4.4 3.5 66.1 54.2 4.6 4.3 4.7 8.3 0.7 72.7 8.1 1.8 5.7 7.1 1.6 163.2 1.3 9.1 0.5 26.2 3.5 2.4 3.9 58.1 3.6 2.3 48.0 1.5 1.4 3.7 10.5 0.0 0.2 0.2 0.2 0.3 0.0 7.9 0.3 0.0 0.1 0.2 13.0 0.1 0.0 0.6 0.0 1.2 0.6 2.0 0.1 0.0 4.6 0.5 0.2 0.1 0.2 0.1 0.0 0.4 0.5 0.1 0.1 0.0 0.0 0.0 0.1 13.9 19.7 0.1 4.3 0.0 0.2 1.1 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.8 1.5 0.1 0.8 0.0 2.9 0.0 0.0 0.2 0.5 6.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 16.8 37.1 32.5 8.0 98.2 66.1 54.2 72.7 26.2 58.1 10.5 0.5 0.0 0.0 3.3 0.5 0.8 20.9 0.9 6.2 13.5 2.9 1.1 6.4 5.7 0.4 0.0 0.0 8.2 0.9 86.2 0.0 10.5 0.0 0.5 1.5 2.1 3.5 37.7 4.7 39.7 2.6 3.0 1.5 2.4 0.0 7.4 2.2 0.4 0.8 55.5 9.7 12.0 0.0 0.3 6.6 0.4 0.6 1.7 1.8 1.0 4.6 11.4 0.0 8.5 0.8 20.1 118.3 0.7 1.8 20.4 45.6 1.1 0.1 6.8 0.0 13.5 4.9 4.1 8.0 1.7 1.0 7.1 0.6 1.4 4.6 15.2 ACSL4 "ACS4, FACL4, LACS4, MRX63, MRX68" ENSG00000068366 "Acyl-CoA synthetase long chain family member 4" O60488 X 109624244-109733403 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 184.3;Glandular and luminal cells: 208.8;granulocytes: 633.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 360.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000286, HPA005552" Supported Approved "Golgi apparatus,Mitochondria" NA NA 16000 "Cluster 2: Granulocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" Mitochondria "HPA000286: AB_2665966, HPA005552: AB_1078774" "unprognostic (9.13e-2)" "unprognostic (3.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.61e-1)" "unprognostic (2.55e-1)" "unprognostic (2.94e-2)" "unprognostic (5.32e-2)" "unprognostic (4.14e-3)" "unprognostic (1.92e-1)" "unprognostic (9.45e-2)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (4.78e-1)" "unprognostic (3.29e-2)" "prognostic favorable (5.73e-4)" 44.2 40.6 11.9 38.8 14.1 16.2 19.8 13.2 14.8 48.2 5.6 12.7 15.4 19.2 17.7 15.8 13.4 29.2 29.4 16.5 23.7 46.4 13.9 39.0 24.6 17.6 20.8 14.9 11.9 19.8 9.2 21.4 21.3 13.4 13.6 24.7 10.6 15.2 42.6 9.9 13.4 22.0 13.7 22.2 19.3 26.8 14.6 20.3 18.6 16.9 18.5 68.0 10.6 18.9 67.3 21.3 24.2 28.3 97.8 61.6 20.3 94.0 107.6 91.0 97.4 21.1 45.0 46.2 35.4 71.7 100.9 19.4 22.4 92.0 143.0 15.7 23.3 181.4 26.6 223.3 44.8 44.8 360.0 51.4 36.7 103.6 74.0 50.2 71.8 25.5 5.6 54.2 100.7 4.7 40.7 60.7 31.6 15.2 37.2 26.4 45.4 39.6 136.3 20.9 15.2 12.3 109.3 0.4 63.2 49.0 1.9 45.8 128.5 81.1 22.6 129.3 85.9 28.1 31.7 41.2 139.7 97.8 52.2 32.5 10.9 35.0 4.2 15.5 3.2 3.3 3.9 3.5 10.6 3.1 3.0 3.8 29.6 4.0 19.4 4.0 6.7 6.5 11.9 14.1 13.2 14.8 16.5 23.7 17.6 20.8 21.3 13.7 14.6 18.9 27.9 76.9 184.3 29.0 19.5 22.3 25.7 20.0 81.4 44.2 7.3 8.1 37.2 15.7 40.1 73.5 2.1 7.3 18.3 0.8 50.9 27.7 1.4 79.5 27.0 29.8 7.7 26.1 76.7 25.4 36.9 46.0 7.1 208.8 633.8 151.6 18.2 44.2 23.9 6.7 78.3 5.7 2.0 64.9 59.1 4.9 5.6 67.8 16.0 57.1 70.4 10.9 8.2 71.4 116.4 32.3 3.0 10.1 36.1 19.4 0.7 12.4 12.2 16.7 0.0 20.0 27.9 3.7 5.3 10.1 8.1 31.6 25.2 34.9 2.7 18.4 ADAMTSL5 THSD6 ENSG00000185761 "ADAMTS like 5" 19 1505022-1513604 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 33.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 9.8;Cardiomyocytes: 9.6;Leydig cells: 19.3;Peritubular cells: 18.0;Proximal enterocytes: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 20.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044050 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 39: CACO-2 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA044050: AB_10962625" "unprognostic (1.71e-1)" "unprognostic (1.32e-1)" "unprognostic (5.85e-2)" "unprognostic (2.45e-1)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" "unprognostic (1.17e-2)" "unprognostic (1.77e-2)" "unprognostic (1.89e-1)" "unprognostic (2.79e-2)" "unprognostic (2.89e-3)" "unprognostic (1.52e-1)" "unprognostic (5.03e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-3)" 1.8 1.5 1.7 0.7 2.2 0.3 2.2 2.3 2.0 33.0 8.3 3.2 9.8 19.8 5.0 15.1 9.5 0.5 20.7 1.8 0.4 1.5 4.2 1.4 0.6 0.8 1.0 1.3 1.0 1.4 2.6 4.2 0.6 4.5 1.1 0.9 3.9 3.3 15.1 2.1 8.4 12.5 0.2 0.8 1.4 3.6 1.6 0.2 1.5 5.9 1.5 3.8 22.5 1.4 8.1 3.5 0.1 0.1 4.1 3.0 3.8 14.7 9.8 5.6 8.1 20.7 4.0 0.0 3.6 12.3 1.6 6.7 3.5 4.2 4.2 7.9 0.4 1.7 11.0 3.8 4.6 0.2 10.2 1.8 4.6 1.3 3.5 7.4 0.0 2.5 5.0 9.8 0.6 7.5 0.4 0.4 0.1 2.3 1.8 0.2 0.8 2.1 4.5 0.0 0.1 0.3 3.5 0.4 4.4 1.9 9.2 3.0 0.9 0.0 5.4 10.9 0.6 6.2 4.2 1.0 0.1 0.8 2.4 0.2 0.0 0.4 1.4 0.5 0.9 0.0 1.6 1.1 0.0 0.0 2.0 1.3 0.1 0.0 0.9 0.0 0.5 0.5 1.7 2.2 2.3 2.0 1.8 0.4 0.8 1.0 0.6 0.2 1.6 1.4 0.2 0.0 1.1 3.6 0.3 0.4 2.4 9.8 6.2 0.3 1.9 0.8 9.6 0.0 3.4 0.0 0.0 0.8 0.7 0.6 0.0 0.6 0.6 0.3 4.5 0.4 0.0 0.0 0.1 1.7 2.1 5.8 1.1 0.4 0.0 0.5 0.0 1.8 0.3 0.0 0.1 1.8 4.1 0.0 0.4 2.6 19.3 0.4 1.8 1.0 0.0 3.7 0.0 0.0 0.1 7.0 1.5 18.0 1.8 2.7 12.5 0.5 1.3 2.1 0.0 0.9 3.3 0.6 1.9 8.4 0.4 0.7 1.2 0.3 1.6 3.5 ADAT2 "DEADC1, dJ20N2.1, TAD2" ENSG00000189007 "Adenosine deaminase tRNA specific 2" Q7Z6V5 6 143422832-143450695 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035479 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 18: Non-specific - Mitochondria" "Cluster 32: U-937 - Innate immune response" "Cluster 32: Non-specific - Translation" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA035479: AB_10611672" "unprognostic (2.24e-1)" "unprognostic (3.07e-3)" "unprognostic (1.55e-1)" "unprognostic (8.20e-2)" "unprognostic (3.05e-2)" "unprognostic (8.58e-2)" "unprognostic (1.07e-3)" "unprognostic (3.31e-2)" "unprognostic (1.34e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-2)" "unprognostic (9.28e-5)" "unprognostic (4.88e-2)" "unprognostic (6.96e-2)" "unprognostic (7.29e-2)" "unprognostic (4.08e-2)" 6.8 8.8 1.4 3.1 1.3 5.4 6.3 1.9 1.5 6.3 1.8 7.8 3.1 4.8 1.4 10.3 6.1 1.2 3.4 1.3 1.2 7.7 12.0 8.5 4.2 1.2 1.2 5.8 10.5 1.5 6.6 1.1 1.3 7.3 4.1 1.4 5.4 1.1 3.1 8.9 8.8 1.7 1.0 10.7 8.9 2.8 1.5 1.9 8.6 0.7 3.5 6.5 7.9 1.4 1.8 1.6 2.2 7.2 1.7 5.3 2.7 2.6 1.1 1.6 2.2 4.0 4.4 7.0 2.7 1.7 1.7 5.8 4.3 4.1 3.4 3.5 9.2 10.4 7.3 8.3 2.1 15.0 4.6 2.4 6.0 3.2 6.3 1.8 3.7 6.5 11.3 5.4 2.7 2.5 6.0 7.6 2.5 2.6 2.8 7.0 5.7 5.6 3.0 1.9 4.7 3.1 2.1 6.0 1.8 1.2 2.4 5.0 3.4 2.6 1.9 5.6 4.8 5.9 4.2 4.9 2.7 13.0 2.8 0.0 0.2 0.0 0.6 0.3 0.8 0.5 0.5 0.5 0.6 0.3 0.7 1.0 0.1 0.4 0.0 0.6 1.3 0.4 1.4 1.3 1.9 1.5 1.3 1.2 1.2 1.2 1.3 1.0 1.5 1.4 4.6 6.4 12.9 8.8 6.9 6.6 4.3 4.1 6.2 3.7 5.6 6.3 4.0 5.7 4.1 1.8 0.0 2.4 11.9 4.3 3.9 5.6 1.2 2.7 11.1 4.8 4.2 14.9 11.2 4.1 2.6 5.3 12.2 5.9 7.6 7.1 3.9 5.2 4.9 1.7 10.4 6.0 4.1 4.3 6.1 1.6 6.8 5.3 5.4 7.5 2.1 1.9 8.2 12.5 4.2 6.6 2.4 3.4 4.2 6.8 1.6 1.4 2.1 4.3 0.0 5.1 5.1 2.4 5.6 9.8 9.2 0.8 8.9 6.2 8.8 4.5 ADCY6 AC6 ENSG00000174233 "Adenylate cyclase 6" O43306 12 48766194-48789089 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 68.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018365 Approved Approved "Golgi apparatus" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB018365: AB_2257941" "unprognostic (1.18e-2)" "unprognostic (2.20e-2)" "unprognostic (6.89e-2)" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (3.68e-2)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-3)" "unprognostic (5.10e-3)" "unprognostic (1.09e-1)" "unprognostic (3.09e-1)" "unprognostic (2.48e-2)" 43.2 15.0 8.9 6.1 7.9 1.3 23.7 5.0 9.2 19.3 10.3 26.3 18.7 20.7 19.0 10.3 17.1 13.9 57.2 8.0 11.2 21.1 9.6 13.5 3.9 5.5 5.4 22.3 22.3 20.7 14.6 14.5 6.6 16.3 20.3 5.7 33.5 16.5 12.1 15.3 21.4 13.6 1.9 4.8 25.1 4.0 14.4 2.8 17.9 12.7 3.2 12.3 12.8 6.4 14.0 25.9 30.2 18.9 32.0 15.9 32.0 16.7 17.1 19.8 13.8 45.7 45.3 0.0 37.2 15.3 8.2 10.9 9.2 11.6 7.9 0.1 13.4 12.5 37.8 8.4 17.6 0.0 10.1 20.0 13.6 17.1 6.5 37.9 18.7 0.8 1.7 4.5 15.6 23.1 0.0 0.5 10.3 21.6 12.3 4.6 11.4 7.7 23.4 41.5 4.5 18.4 17.2 68.0 15.2 13.3 53.3 3.5 21.1 18.3 13.1 9.7 7.4 7.0 3.7 0.4 16.9 0.0 8.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.9 7.9 5.0 9.2 8.0 11.2 5.5 5.4 6.6 1.9 14.4 6.4 11.6 0.0 6.4 18.3 0.6 2.7 3.3 7.5 4.0 10.1 22.7 15.0 8.2 7.2 9.8 18.4 20.9 7.4 0.4 38.8 0.0 5.8 0.8 6.8 8.0 8.1 8.4 0.0 17.5 4.0 2.7 7.6 14.3 11.3 1.3 14.6 5.0 7.7 2.5 10.1 18.8 24.9 8.2 0.6 2.8 1.1 11.5 0.7 7.2 7.5 0.6 3.4 0.0 15.1 7.0 9.5 30.3 9.4 0.3 6.3 26.0 2.8 5.8 9.3 19.7 9.5 26.6 1.9 1.7 3.6 2.0 5.1 0.8 13.9 23.7 9.3 ADGRF3 "GPR113, hGPCR37, PGR23" ENSG00000173567 "Adhesion G protein-coupled receptor F3" Q8IZF5 2 26308173-26346817 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enhanced" "Detected in some" "Astrocytes: 11.4;Early spermatids: 12.0;Late spermatids: 28.0;Microglial cells: 5.6;Oligodendrocytes: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 1.4;U-937: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA044500 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" Cytosol "HPA044500: AB_10794290" "unprognostic (9.58e-3)" "unprognostic (2.13e-2)" "unprognostic (4.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (6.68e-4)" "unprognostic (8.98e-3)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" "unprognostic (9.66e-4)" "unprognostic (2.29e-1)" "unprognostic (8.09e-2)" "unprognostic (3.53e-2)" "unprognostic (2.58e-1)" "unprognostic (4.08e-2)" "unprognostic (8.70e-5)" 0.1 0.1 0.5 0.4 0.3 0.4 0.0 1.0 0.6 0.0 0.5 0.1 0.5 0.1 0.0 0.2 0.1 0.1 0.0 0.4 0.4 0.8 0.1 0.1 0.5 0.6 0.3 0.2 0.8 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.3 0.3 0.2 0.5 0.4 0.4 0.2 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.5 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.2 0.0 1.0 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.3 0.7 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.0 1.4 0.4 0.9 0.0 0.0 0.8 0.7 0.3 0.0 1.1 0.8 0.4 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.7 0.7 1.2 0.0 1.4 0.1 0.0 0.0 0.4 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.3 1.0 0.6 0.4 0.4 0.6 0.3 0.4 0.3 0.4 0.4 0.4 0.0 0.0 11.4 1.3 0.0 0.3 0.0 0.0 0.9 0.3 0.4 0.7 0.0 0.0 0.0 2.1 0.1 0.8 0.0 0.0 0.1 12.0 0.9 1.1 0.2 0.0 0.0 3.4 0.0 0.1 0.2 0.5 0.8 0.0 0.2 0.0 0.2 0.1 1.7 4.1 0.1 0.0 0.0 0.0 28.0 0.0 0.5 0.0 5.6 0.3 0.2 0.0 3.0 6.3 0.1 0.0 0.0 2.7 0.1 0.4 0.1 0.0 1.2 0.0 0.2 0.3 1.5 0.4 0.1 0.0 0.1 0.9 0.2 0.2 0.1 ADI1 "APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL" ENSG00000182551 "Acireductone dioxygenase 1" Q9BV57 2 3497366-3519531 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 590.7" "Cell type enhanced" "Detected in all" "Distal tubular cells: 888.3;Hepatocytes: 1234.6;Proximal tubular cells: 1546.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035403, HPA035404" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 130000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Golgi apparatus" "HPA035403: AB_10603576, HPA035404: AB_2674611" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (2.60e-2)" "unprognostic (1.75e-1)" "unprognostic (3.65e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-3)" "unprognostic (4.23e-3)" "unprognostic (2.36e-3)" "unprognostic (4.00e-3)" "unprognostic (2.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.90e-2)" "unprognostic (1.56e-1)" "unprognostic (9.94e-2)" "unprognostic (6.76e-2)" "unprognostic (8.74e-2)" 55.1 76.9 31.1 28.0 32.6 31.7 50.4 31.7 42.1 54.2 43.3 58.3 105.2 45.6 43.3 48.2 45.2 66.7 146.4 32.0 31.0 200.2 590.7 44.6 30.1 33.0 32.2 50.0 34.9 49.6 33.5 41.3 33.6 101.1 52.3 17.1 53.6 55.9 121.1 35.7 68.9 37.9 31.6 57.2 82.4 16.7 31.6 26.9 36.5 56.0 34.5 57.9 36.5 34.7 46.5 64.5 55.9 50.2 187.5 85.0 91.9 95.6 124.1 102.7 74.5 86.9 59.2 22.1 143.4 109.5 21.4 45.1 62.9 49.0 59.2 39.5 131.4 67.6 42.2 184.1 165.4 71.2 151.3 91.4 72.3 55.0 63.7 45.3 75.8 36.1 51.8 45.3 87.4 137.8 25.6 147.1 44.4 131.9 86.4 27.1 31.3 128.2 90.2 83.3 57.0 54.0 53.0 75.0 37.2 36.8 55.6 95.5 54.1 75.9 29.0 35.9 56.6 35.4 91.6 88.7 58.6 115.5 41.0 87.6 134.3 336.9 28.5 126.5 31.8 66.8 67.4 26.7 127.7 53.4 79.3 25.6 59.4 54.5 117.4 186.3 67.4 189.0 31.1 32.6 31.7 42.1 32.0 31.0 33.0 32.2 33.6 31.6 31.6 34.7 44.8 67.3 111.1 25.1 73.1 76.0 154.5 107.8 92.2 9.2 103.0 88.9 275.8 338.8 109.5 152.6 14.6 395.0 80.6 140.1 888.3 157.2 8.8 65.9 116.3 61.6 57.2 123.1 9.4 87.2 247.1 129.1 66.3 116.3 41.8 75.1 207.8 1234.6 263.2 8.4 15.0 146.1 236.0 168.8 67.6 23.8 137.0 90.0 204.5 7.5 108.2 197.2 40.2 5.5 19.0 79.7 272.5 210.3 97.4 143.6 409.8 1546.8 38.0 15.3 164.3 45.5 109.3 5.3 11.3 113.6 76.9 381.4 53.0 120.8 147.2 156.9 AFP "FETA, HPAFP" ENSG00000081051 "Alpha fetoprotein" P02771 4 73431138-73456174 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "liver: 3.7" "Group enriched" "Detected in some" 10 "Hepatocytes: 107.5;Proximal tubular cells: 101.6" "Cancer enriched" "Detected in some" 4 "liver cancer: 208.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 192 "Hep G2: 2165.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA010607, HPA023600, CAB024283, CAB025339" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 3010000 150000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Cytosol "CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769" "unprognostic (4.69e-1)" "unprognostic (1.87e-1)" "unprognostic (3.34e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-3)" "unprognostic (2.95e-2)" "unprognostic (3.35e-1)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-6)" "unprognostic (1.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.14e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2165.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 9.7 5.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 2.7 2.8 0.3 0.0 0.1 0.0 0.1 2.5 107.5 2.3 0.0 0.1 0.1 0.0 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 101.6 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 1.5 0.2 0.1 0.2 0.0 AFTPH "FLJ20080, FLJ23793, MGC33965, Nbla10388" ENSG00000119844 Aftiphilin Q6ULP2 2 64524305-64593005 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034990, HPA034991" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Cytosol "Golgi apparatus, Vesicles" "HPA034990: AB_2674398, HPA034991: AB_10603577" "unprognostic (7.30e-2)" "unprognostic (4.72e-2)" "unprognostic (9.16e-2)" "unprognostic (8.54e-2)" "unprognostic (3.24e-1)" "unprognostic (4.25e-2)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" "unprognostic (1.52e-1)" "unprognostic (8.44e-2)" "unprognostic (3.42e-2)" "unprognostic (4.65e-2)" "prognostic favorable (2.37e-5)" "prognostic favorable (8.44e-4)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.83e-4)" 15.9 20.2 24.6 21.1 24.9 21.3 32.4 31.2 38.4 22.5 28.3 30.5 23.1 18.8 43.7 29.6 22.9 21.9 12.0 25.3 25.6 56.1 33.6 21.9 37.2 24.6 24.6 19.3 31.6 38.0 25.1 15.0 24.5 34.5 33.7 36.8 28.9 18.6 15.4 33.2 24.5 17.3 24.8 26.4 33.7 24.6 25.4 29.3 25.3 12.9 41.4 25.5 22.4 26.2 29.8 19.3 14.1 17.1 17.8 15.1 23.4 16.7 24.9 26.9 20.1 22.4 21.9 43.9 16.0 20.7 31.1 23.5 24.6 23.3 34.8 42.8 13.5 21.0 12.0 26.5 18.8 40.5 34.5 7.5 48.6 17.4 39.6 19.8 21.4 21.8 16.0 38.7 16.8 16.9 21.9 49.1 13.0 55.9 14.3 17.7 22.6 28.8 48.9 31.5 25.9 13.1 17.7 39.9 35.7 18.0 24.0 30.6 18.5 20.0 23.0 17.0 18.8 43.3 27.8 66.7 15.1 45.3 22.6 40.5 9.3 16.6 7.4 9.3 8.7 21.8 9.3 9.1 12.2 20.3 8.8 6.9 16.3 7.1 14.7 15.8 12.8 5.9 24.6 24.9 31.2 38.4 25.3 25.6 24.6 24.6 24.5 24.8 25.4 26.2 24.6 25.6 39.7 43.1 75.4 122.6 29.6 21.5 55.8 24.2 43.8 23.0 16.0 40.0 33.6 20.2 20.9 13.8 40.5 60.7 37.2 25.5 34.8 44.6 17.8 27.1 46.6 52.0 72.1 25.7 12.4 23.6 35.2 55.9 46.9 17.8 17.5 36.8 20.8 37.0 62.9 40.3 20.3 45.2 77.9 55.1 15.8 52.1 23.2 65.6 60.8 35.0 26.8 52.3 67.0 27.3 43.0 20.7 60.5 42.6 29.0 70.5 40.2 32.9 26.3 25.3 21.2 43.1 21.9 59.0 123.5 27.2 36.5 10.2 40.3 46.1 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129967-161274061 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 51.3" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 407.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.5;HEL: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: AB_2682101, HPA060525: AB_2684306" "unprognostic (5.69e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 4.8 2.1 14.7 1.8 30.5 5.2 4.5 24.6 22.5 7.2 5.6 6.4 1.2 7.8 2.2 3.7 6.1 4.2 2.6 14.9 22.7 6.0 0.8 6.7 0.9 47.1 26.3 7.4 2.1 0.3 11.4 8.7 34.3 3.6 2.1 2.2 2.7 2.4 1.0 2.3 2.6 4.7 25.5 4.6 2.3 2.8 28.6 1.3 4.1 1.0 1.0 3.0 5.0 51.3 0.5 1.0 25.5 5.1 4.7 9.5 1.1 0.9 0.3 1.9 3.2 1.5 4.6 0.7 1.8 4.2 11.8 0.5 4.8 4.0 1.8 2.9 8.1 19.4 4.9 0.1 3.7 0.2 2.8 11.4 1.9 5.0 2.7 9.1 6.1 3.1 9.8 8.9 2.4 0.0 1.4 2.2 6.2 0.0 9.7 0.0 1.1 0.5 5.6 0.4 14.8 5.6 4.0 2.1 1.1 9.9 1.1 1.2 6.8 2.6 3.3 1.8 4.4 0.7 1.0 0.0 9.9 1.0 1.6 0.0 1.8 0.0 3.4 1.5 1.1 0.2 1.6 2.1 1.0 0.5 0.8 1.2 0.3 2.9 1.3 0.8 1.7 1.3 14.7 30.5 24.6 22.5 14.9 22.7 47.1 26.3 34.3 25.5 28.6 51.3 12.0 3.2 5.5 7.5 4.5 3.2 5.5 9.7 6.2 2.4 3.5 2.7 5.6 5.7 6.9 5.5 0.0 20.3 31.1 6.1 0.0 5.2 52.1 23.8 12.5 13.5 1.8 31.5 87.9 8.2 12.0 17.8 4.6 5.1 11.4 20.6 10.4 0.2 18.2 0.0 95.8 0.7 10.2 7.2 16.4 72.8 5.9 17.0 3.6 23.4 9.4 4.0 9.2 56.3 407.6 5.5 18.7 8.6 15.7 1.3 0.0 0.6 21.4 1.2 19.7 5.3 6.9 4.9 2.8 1.1 2.6 22.2 14.1 3.7 1.4 3.6 AGTRAP ATRAP ENSG00000177674 "Angiotensin II receptor associated protein" Q6RW13 1 11736084-11754802 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 446.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 196.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044120 Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" Vesicles "Golgi apparatus" "HPA044120: AB_10960748" "unprognostic (1.08e-3)" "unprognostic (2.98e-3)" "unprognostic (6.10e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (6.57e-7)" "unprognostic (4.44e-2)" "unprognostic (7.96e-2)" "unprognostic (4.31e-2)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (1.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (2.33e-3)" "unprognostic (5.89e-2)" 44.1 50.3 26.6 30.2 28.5 132.3 44.3 27.1 32.4 34.6 44.0 29.3 11.2 24.7 47.7 53.6 48.3 25.2 37.0 24.5 30.5 65.8 29.5 62.3 23.4 37.3 28.8 26.9 67.3 25.7 31.2 22.0 31.3 79.1 9.3 3.4 39.0 21.0 54.3 38.8 25.7 20.3 28.4 83.4 33.7 24.7 31.8 11.3 40.8 12.4 13.3 43.9 43.3 31.1 55.9 66.7 16.7 36.9 27.5 34.9 30.5 28.6 49.0 34.8 30.2 42.0 129.7 5.4 126.7 35.4 87.3 45.8 27.9 135.3 10.7 3.1 61.5 1.6 38.4 51.8 84.9 27.6 64.3 34.6 105.4 112.9 59.2 42.4 46.9 17.3 73.8 52.8 19.8 44.6 13.7 80.9 29.7 24.0 67.3 4.6 15.0 27.5 56.7 5.2 14.6 22.0 52.5 26.4 48.4 22.3 59.8 57.4 26.0 44.1 30.8 70.3 30.9 19.6 24.2 33.3 111.7 196.1 20.7 483.4 844.2 694.6 185.7 442.7 90.4 47.0 66.9 109.8 312.2 38.2 72.0 93.5 756.8 73.0 385.2 25.5 90.8 577.4 26.6 28.5 27.1 32.4 24.5 30.5 37.3 28.8 31.3 28.4 31.8 31.1 46.2 22.4 27.4 3.9 12.1 11.6 30.7 112.4 16.5 1.0 54.8 56.0 12.0 32.9 41.6 36.8 6.2 15.7 60.1 6.9 9.8 95.5 20.6 75.3 30.8 36.1 7.2 21.0 0.2 446.7 92.4 45.3 11.2 41.1 88.0 19.1 42.1 7.7 118.3 3.3 0.2 12.3 20.3 143.5 18.9 23.4 37.9 97.8 28.4 1.9 107.4 19.4 122.6 0.5 7.0 96.9 22.5 27.1 8.6 66.5 8.6 55.3 78.5 5.6 13.1 13.0 23.8 3.5 36.1 34.4 13.5 13.1 45.0 50.4 18.2 25.2 AHSG "A2HS, FETUA, HSGA" ENSG00000145192 "Alpha 2-HS glycoprotein" P02765 3 186613060-186621318 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Mineral balance" "Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4302 "liver: 5817.6" "Cell type enriched" "Detected in some" 38 "Hepatocytes: 1242.5" "Cancer enriched" "Detected in some" 284 "liver cancer: 1231.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 78 "Hep G2: 2287.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001524, HPA001525, CAB026209" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 864000000000 110000000000 "Cluster 48: NK-cells - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849" "unprognostic (6.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (3.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (7.47e-3)" "unprognostic (3.05e-1)" "unprognostic (5.27e-2)" "unprognostic (8.64e-2)" "unprognostic (3.99e-7)" "unprognostic (5.21e-2)" "unprognostic (5.21e-2)" "unprognostic (1.04e-1)" 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 1.3 5817.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.9 1.0 2287.3 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 3.5 0.0 0.0 1.1 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.2 0.0 0.1 3.9 0.2 4.3 0.2 0.1 0.9 0.0 32.0 0.6 0.6 2.4 0.1 0.0 0.1 0.0 0.0 28.2 1242.5 1.3 0.0 0.1 0.0 0.0 32.4 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 2.0 0.0 0.0 0.1 AIG1 "AIG-1, dJ95L4.1, FLJ10485" ENSG00000146416 "Androgen induced 1" Q9NVV5 6 143060496-143341058 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 235.8" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 245.4;Proximal tubular cells: 261.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060766 Approved Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA060766: AB_2684356" "unprognostic (2.70e-2)" "prognostic unfavorable (3.26e-6)" "unprognostic (4.27e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (5.34e-2)" "prognostic unfavorable (3.25e-7)" "unprognostic (1.91e-2)" "unprognostic (8.75e-3)" "unprognostic (2.17e-1)" "unprognostic (5.53e-2)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" "unprognostic (2.74e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.11e-2)" "unprognostic (2.75e-1)" 42.0 29.8 43.7 10.4 44.6 31.6 30.0 43.3 46.1 17.6 48.2 23.0 46.6 14.4 33.0 34.1 34.4 24.5 54.1 44.1 49.1 102.0 235.8 19.9 10.7 45.0 43.4 34.7 31.0 31.0 36.6 11.9 46.4 22.7 18.8 33.9 19.8 24.1 23.7 16.8 45.9 15.2 47.1 20.1 20.8 15.7 51.0 6.8 42.9 32.5 14.8 29.4 26.1 52.5 32.6 25.2 20.6 56.9 29.7 22.3 7.6 28.3 57.1 26.8 61.9 37.5 81.5 20.0 40.5 66.1 41.7 42.0 26.5 79.2 64.2 67.2 63.0 5.6 35.6 157.3 40.8 46.0 2.7 32.9 76.7 35.7 129.6 88.2 10.9 30.8 4.0 67.6 59.3 45.6 14.2 9.8 40.8 37.4 27.6 20.2 61.6 36.6 100.6 77.6 75.5 42.4 35.5 33.2 17.2 36.0 31.7 96.0 3.0 25.2 27.8 22.7 33.4 99.6 95.1 2.1 59.7 9.5 26.9 12.0 6.2 9.6 6.6 29.3 15.1 9.6 12.4 10.6 33.0 5.6 13.1 10.0 11.3 11.8 35.4 2.9 9.7 9.2 43.7 44.6 43.3 46.1 44.1 49.1 45.0 43.4 46.4 47.1 51.0 52.5 40.8 16.0 27.7 114.9 22.0 25.0 51.8 82.5 27.9 68.3 69.9 65.4 73.7 72.9 66.9 51.5 25.0 79.6 8.6 12.6 52.8 60.3 22.4 99.8 25.9 32.8 39.5 29.3 204.3 31.5 10.5 42.2 26.0 83.1 36.8 90.9 36.8 229.6 32.7 53.8 245.4 33.3 59.0 40.1 42.3 7.0 32.0 37.2 55.2 100.2 18.2 74.3 8.2 105.1 172.9 25.8 65.2 38.4 47.7 35.3 232.9 261.5 69.1 36.9 32.9 41.7 50.8 5.6 17.3 53.1 45.7 108.1 18.5 61.5 42.4 53.2 AJUBA "JUB, MGC15563" ENSG00000129474 "Ajuba LIM protein" Q96IF1 14 22971177-22982551 "Cancer-related genes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 61.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 47.5;Basal squamous epithelial cells: 35.3;Pancreatic endocrine cells: 33.8;Prostatic glandular cells: 34.2;Sertoli cells: 32.9;Suprabasal keratinocytes: 49.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 217.0;hTCEpi: 222.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006171 Approved Approved "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 11: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Golgi apparatus" "HPA006171: AB_1852044" "unprognostic (1.15e-1)" "unprognostic (2.99e-2)" "unprognostic (2.39e-1)" "unprognostic (1.24e-3)" "unprognostic (9.81e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-3)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.47e-1)" "unprognostic (3.19e-3)" "unprognostic (2.94e-1)" "unprognostic (2.68e-1)" "unprognostic (9.35e-3)" "unprognostic (2.07e-1)" 4.8 3.0 2.3 1.4 1.8 0.5 6.7 2.0 2.2 14.4 9.2 3.2 1.5 12.1 8.5 18.3 7.5 4.9 6.3 2.2 1.5 17.7 43.4 15.2 2.6 2.5 2.1 12.2 11.6 7.2 2.0 19.3 1.6 10.6 2.5 3.7 8.2 15.9 1.9 61.7 1.9 8.4 2.2 3.8 4.2 5.5 1.9 8.2 10.9 2.3 5.5 7.6 15.5 2.7 46.9 54.1 71.0 27.6 6.8 12.2 57.4 44.9 58.5 102.6 91.4 116.0 47.3 1.2 45.5 92.9 70.8 146.2 54.9 217.0 124.6 4.5 5.0 3.5 90.8 131.4 78.9 4.9 3.1 38.9 222.3 42.9 164.3 72.7 40.0 8.3 1.9 2.8 96.2 37.3 4.5 5.7 4.5 86.6 73.9 12.7 59.0 1.2 103.9 71.3 0.2 6.2 135.5 39.4 8.8 57.4 55.3 4.5 36.1 44.2 88.4 7.3 43.6 0.4 1.3 0.5 7.0 4.2 20.6 0.7 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.5 0.1 0.2 0.3 0.2 0.5 0.5 0.2 0.2 0.0 0.1 2.3 1.8 2.0 2.2 2.2 1.5 2.5 2.1 1.6 2.2 1.9 2.7 2.1 19.2 6.4 0.7 0.0 47.5 13.0 27.6 35.3 0.1 3.7 9.7 4.5 20.0 10.2 7.3 0.0 10.0 0.1 0.3 5.9 14.3 5.8 13.0 2.5 4.0 0.0 0.0 0.0 14.9 9.8 3.4 0.0 4.4 0.0 12.8 2.5 17.1 1.7 0.0 0.0 0.4 2.0 0.0 2.2 5.0 3.7 0.6 3.6 0.0 0.0 8.1 0.0 0.5 0.0 33.8 0.1 0.7 1.2 34.2 0.3 21.0 8.3 0.2 32.9 2.7 14.0 7.0 2.7 14.2 49.6 4.0 0.5 1.6 0.8 18.0 AKAP9 "AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO" ENSG00000127914 "A-kinase anchoring protein 9" Q99996 7 91940840-92110673 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 2230.9;Rod photoreceptor cells: 1279.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008548, CAB012909, HPA026109" Supported Enhanced "Golgi apparatus,Vesicles,Centrosome" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 54: Non-specific - Microtubule organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "Vesicles, Centrosome" "CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688" "unprognostic (9.57e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (5.97e-3)" "unprognostic (1.20e-1)" "unprognostic (1.47e-1)" "unprognostic (4.75e-2)" "unprognostic (1.31e-2)" "unprognostic (1.28e-1)" "unprognostic (6.59e-2)" "unprognostic (7.59e-2)" "unprognostic (6.32e-2)" "prognostic favorable (2.10e-6)" "unprognostic (8.89e-2)" "unprognostic (1.73e-1)" "unprognostic (7.77e-2)" "unprognostic (3.96e-2)" 7.1 8.3 8.6 6.2 9.0 8.6 11.0 15.3 14.1 6.5 15.5 16.0 16.5 6.4 3.9 7.9 8.4 10.4 6.5 8.6 11.0 13.2 16.2 7.8 5.8 8.8 9.6 11.9 9.5 12.7 8.6 5.4 9.0 7.5 14.6 31.4 9.6 3.8 16.2 6.8 18.6 4.0 7.7 5.0 9.4 4.1 11.9 9.3 9.3 10.0 5.3 5.5 7.2 9.7 11.7 8.1 9.6 5.8 11.6 11.3 6.2 8.7 6.3 4.9 5.9 10.3 8.0 9.2 12.5 7.3 7.5 8.3 10.5 5.6 9.2 9.8 8.2 10.9 11.6 7.3 4.0 18.5 9.6 6.2 6.2 9.1 8.8 7.7 10.3 10.6 19.3 13.0 7.4 14.1 10.4 7.0 8.3 6.5 8.4 7.6 18.2 6.2 4.9 11.5 13.3 11.0 19.0 16.9 10.1 11.1 5.1 9.8 17.5 9.5 11.2 14.5 12.6 7.3 13.0 13.6 6.2 7.8 9.4 1.1 0.6 0.9 1.3 0.6 0.9 1.9 1.1 1.1 0.4 1.6 1.2 1.0 0.7 1.2 0.6 3.2 1.0 0.2 8.6 9.0 15.3 14.1 8.6 11.0 8.8 9.6 9.0 7.7 11.9 9.7 123.3 525.6 357.0 141.3 143.3 103.5 126.5 112.6 170.8 273.5 165.4 150.9 253.2 297.4 208.4 176.6 2230.9 141.4 201.5 293.4 101.8 131.0 22.5 392.3 157.7 115.9 185.1 129.4 142.6 92.6 81.9 123.5 152.9 185.0 136.6 386.1 98.2 153.5 57.2 360.1 182.6 350.8 136.3 78.3 88.4 17.5 173.4 101.6 58.7 115.2 121.5 155.7 119.4 169.9 187.1 102.4 218.9 135.8 193.5 91.4 298.5 47.2 506.3 1279.6 138.1 206.1 116.1 83.0 129.0 87.3 111.8 333.8 145.7 135.8 171.4 97.6 AKR1E2 "AKR1CL2, AKRDC1, htAKR, HTSP1, MGC10612" ENSG00000165568 "Aldo-keto reductase family 1 member E2" Q96JD6 10 4786629-4848062 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 19.0" "Group enriched" "Detected in some" 5 "Early spermatids: 153.8;Late spermatids: 174.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 12.3;RT4: 10.4;U-2197: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037821, HPA037822" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA037821: AB_2675687, HPA037822: AB_10671722" "unprognostic (2.33e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (8.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (7.42e-3)" "unprognostic (7.47e-2)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (3.06e-2)" "unprognostic (2.74e-1)" "unprognostic (2.04e-2)" "unprognostic (1.62e-4)" "unprognostic (5.62e-2)" 2.0 0.8 1.7 0.7 1.8 2.1 3.1 1.5 2.3 1.8 0.0 1.3 1.4 1.1 0.9 1.4 1.0 1.3 1.9 2.0 2.4 0.9 0.5 2.0 0.8 1.6 2.0 0.7 2.1 1.0 0.5 1.8 2.7 0.9 1.2 3.5 1.1 1.8 1.5 1.2 1.0 2.1 0.5 1.2 1.5 19.0 1.6 0.7 3.3 0.8 0.5 1.1 1.3 1.6 0.5 5.9 2.2 1.0 0.0 0.0 0.1 2.3 0.2 0.1 0.1 9.0 0.8 0.0 0.0 6.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 1.1 6.2 1.1 0.0 0.0 6.5 12.3 5.6 0.0 0.0 5.4 0.7 0.0 2.2 6.9 4.4 0.0 0.0 0.0 1.6 10.4 0.0 4.8 8.2 2.4 4.7 2.4 4.6 2.6 4.1 0.0 2.0 19.5 0.0 2.8 0.0 0.0 0.1 0.0 1.4 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.7 1.8 1.5 2.3 2.0 2.4 1.6 2.0 2.7 0.5 1.6 1.6 0.9 0.0 0.0 1.6 0.2 0.0 0.1 0.5 0.6 0.2 1.1 0.6 0.8 0.0 0.6 1.8 0.0 0.1 0.1 0.0 0.0 0.3 153.8 0.5 0.7 1.4 0.0 1.3 7.1 0.0 0.0 2.2 0.0 0.6 0.0 0.6 2.2 0.0 1.2 1.7 8.9 0.1 0.0 0.6 0.6 174.2 2.8 0.8 3.6 5.6 0.6 0.3 0.0 9.0 0.0 0.1 0.1 1.5 0.0 0.2 0.0 0.5 0.3 1.2 0.0 0.8 1.2 32.0 10.0 0.7 0.1 0.0 0.2 0.2 0.1 0.5 AKR7A2 AFAR ENSG00000053371 "Aldo-keto reductase family 7 member A2" O43488 1 19303965-19312144 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 711.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB032587, CAB032841, HPA064638" Enhanced Supported "Golgi apparatus,Cytosol" NA NA 950000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Golgi apparatus" "CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307" "unprognostic (1.06e-1)" "unprognostic (3.48e-2)" "unprognostic (7.23e-2)" "unprognostic (5.76e-2)" "unprognostic (9.92e-2)" "unprognostic (1.09e-1)" "unprognostic (1.14e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (5.11e-2)" "unprognostic (7.11e-2)" "prognostic favorable (2.67e-4)" "unprognostic (3.72e-2)" "unprognostic (8.53e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.59e-4)" 33.3 67.9 45.3 17.5 48.0 25.0 33.8 47.4 44.2 57.2 66.2 46.4 81.1 34.7 22.4 47.8 48.4 29.1 39.1 45.9 46.1 76.7 62.7 24.6 25.3 48.8 49.4 45.7 47.9 32.7 32.6 19.0 44.9 31.6 27.5 16.0 31.4 27.7 55.4 37.1 56.8 22.6 49.2 28.3 42.7 33.1 48.2 31.3 28.6 39.6 20.5 29.6 38.5 54.1 65.3 40.2 43.3 40.2 67.0 64.7 28.8 47.6 57.6 65.0 58.2 51.5 53.6 46.8 49.6 64.2 36.6 50.8 48.7 71.5 30.5 37.5 77.4 29.4 37.5 83.3 51.9 32.9 22.9 64.8 55.5 50.0 30.6 61.5 55.8 60.2 43.6 42.6 67.7 64.9 64.2 31.9 12.4 90.8 50.1 66.7 54.0 83.2 64.2 28.3 80.9 30.2 51.8 46.1 84.6 24.6 91.9 112.7 44.2 40.6 42.7 44.0 36.2 51.4 34.8 57.9 87.6 74.4 58.5 0.7 82.2 40.6 61.4 69.7 71.7 63.8 54.4 54.2 113.5 57.6 61.7 54.1 9.5 69.4 54.1 98.8 78.9 73.7 45.3 48.0 47.4 44.2 45.9 46.1 48.8 49.4 44.9 49.2 48.2 54.1 47.6 16.0 22.3 15.3 42.6 24.3 73.2 56.4 37.5 33.1 94.6 98.8 27.7 98.7 31.7 77.3 6.2 167.5 52.8 95.0 254.3 64.0 94.6 85.8 35.8 35.3 99.7 33.4 8.6 36.2 99.8 67.9 44.9 33.4 10.2 62.5 43.2 90.6 104.6 21.9 7.5 97.9 46.8 58.4 34.2 57.6 77.3 47.6 53.4 5.6 64.6 128.7 63.8 5.5 9.2 39.4 131.5 67.7 36.3 39.3 273.8 711.5 61.0 30.1 46.0 57.8 54.4 56.3 24.9 76.0 34.1 102.6 40.4 88.4 136.4 62.3 AKR7A3 ENSG00000162482 "Aldo-keto reductase family 7 member A3" O95154 1 19282573-19288770 "Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 248.9;liver: 154.6;pancreas: 288.4;stomach 1: 224.4" "Group enriched" "Detected in many" 5 "Gastric mucus-secreting cells: 348.1;Proximal enterocytes: 1132.3;Proximal tubular cells: 766.6" "Cancer enhanced" "Detected in many" "liver cancer: 36.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 15.9;SK-BR-3: 25.0" HPA064638 Supported "Golgi apparatus,Cytosol" NA NA 1900000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Golgi apparatus" "HPA064638: AB_2685307" "unprognostic (7.78e-2)" "unprognostic (5.07e-2)" "unprognostic (6.08e-2)" "unprognostic (1.61e-1)" "unprognostic (1.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (7.70e-3)" "unprognostic (2.72e-1)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.80e-7)" "unprognostic (4.53e-2)" "unprognostic (5.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.35e-1)" 1.6 4.0 2.3 2.6 2.4 0.3 4.2 2.8 3.2 2.3 16.7 29.2 248.9 1.4 0.4 1.8 1.8 38.0 0.6 3.3 2.6 71.1 154.6 1.0 0.4 2.7 2.9 2.6 288.4 0.3 2.2 0.2 2.6 1.9 17.4 1.5 3.5 0.3 0.4 2.6 144.8 1.4 2.5 1.3 224.4 2.1 2.9 0.1 1.8 0.1 0.2 1.0 1.6 2.6 0.5 0.0 0.5 0.3 0.5 0.2 1.8 0.1 0.1 0.2 0.1 0.5 1.9 0.2 0.3 0.4 0.0 0.8 0.0 0.0 0.0 0.2 0.5 0.2 0.7 0.8 0.2 0.2 0.2 0.3 0.3 0.3 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.7 0.5 1.7 0.3 15.9 0.6 0.7 0.1 1.6 0.0 0.1 0.9 1.4 0.3 25.0 0.6 0.1 4.1 0.5 0.4 0.3 0.2 0.9 0.3 1.2 0.3 0.3 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 2.4 2.8 3.2 3.3 2.6 2.7 2.9 2.6 2.5 2.9 2.6 0.4 0.0 0.0 7.5 3.3 0.8 0.7 0.2 0.6 1.0 13.8 9.5 0.8 140.2 0.3 29.5 0.0 0.5 0.5 133.3 119.3 3.9 3.5 0.5 0.4 0.8 20.8 11.2 4.1 31.8 0.3 0.5 348.1 0.4 4.5 0.9 4.2 119.0 0.3 0.0 3.6 87.6 4.1 3.5 0.0 4.7 0.3 4.4 0.0 1.9 0.1 3.6 0.0 2.5 1.9 18.3 125.0 0.4 0.8 1.2 1132.3 766.6 3.2 1.1 0.0 0.7 0.4 1.8 1.1 1.1 0.6 0.5 3.0 0.7 130.2 0.4 AL049629.2 ENSG00000284969 "Novel protein" 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Ductal cells: 9.1;Exocrine glandular cells: 14.4;Pancreatic endocrine cells: 44.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.8;HUVEC TERT2: 55.1;TIME: 66.2;U-2197: 57.6" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 2.5 0.7 1.5 2.3 1.4 1.5 1.1 1.5 1.6 0.5 2.5 0.7 1.4 1.3 1.8 1.2 0.6 2.1 1.1 1.4 1.7 1.6 0.8 1.7 0.3 1.8 2.0 0.6 0.7 1.0 1.5 1.8 0.5 0.7 0.6 2.4 0.7 3.5 0.3 0.3 0.6 1.8 0.5 2.9 1.1 1.8 0.2 0.8 1.1 1.4 2.3 2.1 1.3 3.3 0.2 2.4 3.4 7.9 0.1 18.5 8.4 2.3 2.2 0.1 9.6 0.0 2.3 12.5 1.1 2.2 0.3 42.8 4.0 2.0 0.4 0.3 7.1 0.8 0.8 0.4 1.2 3.0 2.7 1.0 14.7 1.9 55.1 0.3 0.5 7.4 15.4 1.0 1.8 0.8 0.5 1.3 24.8 0.4 1.5 1.3 4.9 2.2 0.0 0.3 2.0 3.4 7.3 0.2 1.0 0.0 66.2 7.0 2.7 57.6 7.4 3.8 3.7 0.3 16.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 1.4 1.5 1.6 1.4 1.7 1.8 2.0 1.8 1.8 1.8 2.1 0.5 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.7 0.2 2.1 0.0 0.0 0.0 14.4 0.0 0.2 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 AL132671.2 ENSG00000282218 "Novel protein, GOPC-ROS1 readthrough" 6 117318211-117573571 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "Alveolar cells type 2: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "U-138 MG: 8.9" "Low region specificity" "Detected in all" HPA019477 Uncertain Approved "Golgi apparatus" NA NA "Cluster 10: BJ & FHDF - ECM organization" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA019477: AB_1849890" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136295.1 ENSG00000254692 "Novel protein" 14 24189157-24213473 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.4;granulocytes: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 8.1" HPA059249 Approved Approved "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 43: THP-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.45e-2)" 1.7 3.0 0.6 2.1 0.7 2.0 0.8 0.7 1.5 1.2 0.5 1.3 2.5 1.0 0.2 0.8 1.1 0.4 1.7 0.6 0.8 1.7 0.8 1.1 1.4 0.8 0.6 0.9 1.4 0.5 0.5 0.7 0.7 0.8 0.9 1.3 0.8 0.6 1.9 1.3 2.2 0.6 0.5 0.8 1.3 1.0 0.8 1.6 0.8 0.0 0.4 0.8 0.7 0.7 1.5 1.4 2.4 0.9 2.2 1.3 1.9 1.4 2.0 1.0 2.2 1.0 5.1 1.5 0.2 1.8 2.9 1.5 1.5 0.8 3.2 2.4 0.0 0.9 0.8 1.2 0.4 4.3 2.5 0.5 0.8 1.2 0.0 3.5 0.7 1.3 0.1 4.3 1.7 1.2 1.1 0.0 2.1 0.7 0.0 1.7 1.9 0.0 1.9 1.1 0.2 1.0 8.1 2.7 3.4 2.8 2.0 3.4 4.4 0.2 1.0 1.3 2.1 3.4 2.6 3.6 0.5 0.9 0.8 0.0 0.1 0.5 0.2 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.3 0.1 0.6 0.7 0.7 1.5 0.6 0.8 0.8 0.6 0.7 0.5 0.8 0.7 0.0 6.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ALB ENSG00000163631 Albumin P02768 4 73397114-73421482 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 135 "liver: 212494.0" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 65190.0" "Cancer enriched" "Detected in many" 384 "liver cancer: 14213.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 38 "Hep G2: 4500.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB006262, HPA031024, HPA031025" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus" "Secreted to blood" NA NA 40000000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "Endoplasmic reticulum" "CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704" "unprognostic (1.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.73e-1)" "unprognostic (2.60e-1)" "unprognostic (4.44e-1)" "unprognostic (2.46e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-2)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.84e-2)" "unprognostic (5.37e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.87e-4)" "unprognostic (7.23e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" 8.3 3.7 0.9 0.0 1.0 0.0 5.9 0.6 1.3 1.9 0.6 2.5 0.0 1.8 15.4 2.6 4.3 3.8 8.2 0.7 0.9 465.2 212494.0 6.7 1.3 0.7 0.8 2.5 1569.1 1.0 3.4 4.5 0.7 2.2 0.1 0.5 2.1 0.1 1.9 3.3 2.3 0.0 0.7 37.0 10.1 3.6 1.0 0.3 3.6 0.1 1.4 0.9 1.7 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 18.8 0.6 0.0 0.0 1.6 0.0 0.0 0.1 0.6 0.0 31.7 2.1 4500.0 0.0 117.1 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 17.0 0.2 0.0 0.1 2.0 0.0 4.0 0.0 0.1 2.1 95.1 0.0 0.0 3.2 0.0 0.0 52.3 0.0 0.0 0.0 0.0 0.0 13.5 0.0 1.4 0.1 0.1 7.0 0.6 32.9 0.1 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.6 1.3 0.7 0.9 0.7 0.8 0.7 0.7 1.0 0.8 0.1 0.0 0.0 1.0 187.5 0.0 0.0 0.0 0.0 0.0 43.4 18.9 0.1 13788.8 0.0 38.6 0.0 1.4 0.6 0.1 72.4 5.3 2.5 0.2 0.1 65.5 1.8 1133.8 0.2 273.8 11.1 0.5 4.6 0.0 0.0 0.1 1252.5 65190.0 8.5 0.0 0.2 0.0 0.0 1764.5 0.0 0.1 0.0 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.1 160.6 0.0 0.0 0.0 0.2 0.0 686.5 0.0 0.0 0.0 0.0 1.1 0.2 1.3 0.0 0.1 21.2 77.1 0.1 0.0 0.1 ALG2 "CDG1I, CDGIi, FLJ14511, hALPG2, NET38" ENSG00000119523 "ALG2 alpha-1,3/1,6-mannosyltransferase" Q9H553 9 99216425-99221942 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041512, HPA041601" Approved Approved "Golgi apparatus" NA No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA041512: AB_10794380, HPA041601: AB_10794302" "unprognostic (8.86e-3)" "unprognostic (4.39e-1)" "unprognostic (2.37e-1)" "prognostic favorable (8.44e-5)" "unprognostic (9.21e-3)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.06e-2)" "unprognostic (5.94e-2)" "unprognostic (3.31e-1)" "unprognostic (3.66e-1)" "unprognostic (2.99e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.28e-7)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-2)" "unprognostic (4.81e-1)" 17.7 38.2 13.4 19.4 14.6 23.0 27.1 16.6 18.4 35.1 19.8 24.9 21.9 23.8 74.0 15.1 29.5 26.2 13.4 14.5 15.0 34.3 47.4 24.3 20.8 14.7 16.1 30.2 42.0 37.0 21.8 29.9 15.1 32.8 27.3 15.0 37.9 34.5 15.3 17.9 20.5 24.2 14.8 17.9 25.0 19.2 14.7 16.7 42.3 13.5 27.5 31.7 10.9 16.9 22.9 28.7 22.7 34.4 82.6 52.7 42.0 46.7 75.3 45.6 39.3 34.9 31.2 24.6 18.8 54.3 60.0 85.3 37.9 49.1 45.7 35.2 16.2 14.4 23.7 54.0 99.7 28.2 26.2 61.9 65.2 37.7 72.8 45.8 52.3 15.1 23.2 56.2 44.7 47.8 12.9 29.8 27.6 75.0 39.6 14.0 43.4 38.1 65.2 31.1 22.5 19.3 33.5 63.8 61.6 33.5 24.4 23.3 38.8 31.4 27.9 40.9 28.6 45.8 28.0 10.5 58.6 20.5 16.3 38.7 35.5 22.0 33.7 28.2 49.2 30.8 32.0 33.9 45.1 26.3 27.7 27.4 9.3 38.0 28.4 79.9 38.3 36.0 13.4 14.6 16.6 18.4 14.5 15.0 14.7 16.1 15.1 14.8 14.7 16.9 12.6 12.8 22.9 6.8 22.1 23.3 26.8 56.2 10.2 11.3 22.6 16.6 6.9 32.9 35.8 23.9 2.1 50.3 30.2 20.0 21.5 36.1 28.7 16.9 30.9 19.8 12.5 12.0 8.1 35.2 34.2 30.4 15.3 26.4 7.6 14.1 21.8 55.5 28.1 10.1 8.3 26.3 38.7 25.8 45.4 20.3 26.8 23.0 21.4 10.3 64.2 15.5 15.5 9.5 9.7 31.9 16.0 25.2 47.0 37.3 18.7 36.6 33.1 8.3 6.6 17.2 18.2 22.6 24.6 15.0 23.7 89.2 16.6 25.6 20.8 31.3 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 236.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favorable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavorable (5.69e-4)" 33.4 40.1 23.7 21.4 21.8 32.6 29.2 18.1 23.5 34.2 17.8 51.1 22.3 45.3 5.2 25.9 43.1 21.6 68.6 20.4 23.4 29.9 33.6 28.8 25.1 23.2 23.7 33.5 36.0 26.6 39.8 17.4 29.5 31.7 10.6 26.5 36.4 25.1 236.6 28.1 31.0 22.0 19.3 26.8 33.6 51.3 26.7 22.2 29.8 98.7 15.8 43.0 29.6 27.4 90.3 86.4 27.8 47.0 37.0 25.0 30.1 41.1 41.8 56.8 51.5 96.1 19.9 53.9 65.4 35.9 29.4 56.2 40.9 33.6 26.8 71.3 74.0 35.4 47.7 41.8 32.5 27.4 53.0 24.3 23.1 41.8 24.7 33.9 31.8 35.3 45.0 20.4 29.8 60.6 60.1 28.6 24.9 28.3 44.4 57.6 56.0 89.0 14.4 31.0 32.5 47.6 44.8 27.2 41.7 90.9 31.4 20.9 38.3 55.8 44.1 87.8 78.0 32.0 25.1 32.2 100.6 38.8 39.0 3.6 7.4 20.4 13.0 7.8 11.9 6.8 13.3 16.1 9.0 10.0 9.5 9.5 4.3 7.2 11.6 5.7 7.4 6.7 23.7 21.8 18.1 23.5 20.4 23.4 23.2 23.7 29.5 19.3 26.7 27.4 37.2 35.3 33.3 17.9 41.1 64.6 29.0 26.8 19.4 80.3 48.7 40.3 93.5 28.6 24.4 27.6 39.6 33.0 59.0 44.9 84.1 27.4 58.9 53.9 36.5 36.6 60.9 24.0 17.0 31.4 44.8 42.4 18.3 36.7 40.7 25.2 35.7 65.2 33.5 119.5 18.1 45.0 22.4 45.3 56.9 42.5 41.0 36.4 49.8 7.5 36.3 76.3 57.7 9.0 24.0 32.8 38.7 51.9 21.1 35.3 47.6 115.2 46.4 58.9 19.7 39.4 47.3 118.7 117.3 20.3 56.0 31.5 48.3 32.7 39.1 28.6 ALX1 CART1 ENSG00000180318 "ALX homeobox 1" Q15699 12 85280220-85301784 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 3.9;kidney: 6.1" "Cell type enriched" "Detected in some" 5 "Melanocytes: 32.0" "Cancer enriched" "Detected in some" 10 "melanoma: 16.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001598, HPA018905" Uncertain Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies" "Nucleoplasm, Golgi apparatus" "HPA001598: AB_1078400, HPA018905: AB_1844783" "unprognostic (4.92e-3)" "unprognostic (8.09e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-1)" "unprognostic (6.24e-2)" "unprognostic (2.05e-2)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-5)" "unprognostic (8.97e-2)" "unprognostic (1.43e-1)" 0.2 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.3 1.0 0.4 0.0 0.0 0.7 3.9 0.0 2.3 0.0 0.0 0.2 0.3 6.1 0.0 0.0 0.0 0.2 0.2 1.6 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.2 1.9 0.9 0.0 1.6 0.0 0.3 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.8 0.0 0.4 0.3 0.2 0.0 6.0 0.0 0.0 0.7 0.7 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 3.6 0.0 10.4 0.5 0.0 0.0 23.3 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 9.3 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 2.7 5.8 0.0 0.0 29.5 4.1 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 2.2 0.2 1.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 AMBP "EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI" ENSG00000106927 "Alpha-1-microglobulin/bikunin precursor" P02760 9 114060127-114078328 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "liver: 10947.9" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 10517.4" "Cancer enriched" "Detected in many" 115 "liver cancer: 2620.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 173 "Hep G2: 1398.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001497, CAB069436, HPA075585" Approved Approved "Golgi apparatus,Vesicles,Cytosol" "Secreted to blood" NA NA 47000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Golgi apparatus, Cytosol" "CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: " "unprognostic (6.92e-2)" "unprognostic (3.61e-1)" "unprognostic (4.95e-3)" "prognostic favorable (1.20e-4)" "unprognostic (9.79e-2)" "unprognostic (2.90e-1)" "unprognostic (1.04e-3)" "unprognostic (7.59e-2)" "unprognostic (2.83e-2)" "unprognostic (2.04e-1)" "unprognostic (2.14e-1)" "unprognostic (7.84e-2)" "unprognostic (4.36e-2)" "unprognostic (2.89e-3)" "unprognostic (4.66e-2)" "unprognostic (2.97e-3)" "unprognostic (9.45e-3)" 0.7 0.2 0.1 0.0 0.1 0.0 6.4 0.3 0.4 0.2 0.3 0.3 2.3 0.1 0.4 0.3 0.4 160.4 0.5 0.1 0.1 11.0 10947.9 0.3 0.0 0.1 0.1 0.2 125.3 0.0 0.2 0.4 0.1 0.2 0.5 0.2 0.1 0.0 0.2 0.3 0.7 0.0 0.1 3.1 2.6 1.0 0.1 0.1 0.4 0.0 0.2 0.1 0.2 0.0 0.0 6.7 0.1 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 1.8 0.0 1.8 2.1 0.2 0.9 0.5 0.0 0.0 0.0 3.2 0.0 3.0 1.0 1398.1 0.0 5.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.1 0.3 0.0 0.9 3.1 0.0 0.2 8.1 0.4 5.9 0.6 1.7 0.0 2.8 1.1 0.0 0.1 0.0 0.2 1.0 0.0 0.8 0.0 0.4 1.0 0.3 1.5 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.0 19.1 1.5 0.6 0.0 2.2 0.0 1.9 0.4 0.2 2585.0 0.6 1.8 0.0 0.1 0.0 0.6 3.9 216.5 30.4 0.2 0.1 10.0 2.4 219.2 0.1 28.2 0.8 0.1 0.0 1.0 0.0 0.0 181.3 10517.4 0.7 0.0 0.1 1.6 0.0 243.7 0.5 59.4 0.6 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 14.9 1.7 0.0 0.0 0.6 0.6 13.7 0.0 0.0 0.0 0.0 0.5 0.6 0.2 1.1 0.4 1.4 14.3 0.0 1.2 0.3 AMFR "gp78, RNF45" ENSG00000159461 "Autocrine motility factor receptor" Q9UKV5 16 56361452-56425545 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 154.5;Hepatocytes: 166.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026381, HPA029018, HPA077835" Approved Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 54: Non-specific - Microtubule organization" "Cluster 6: T47d - Mammary gland" "Cluster 2: Hepatocytes - Metabolism" "Endoplasmic reticulum, Golgi apparatus" "CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856" "unprognostic (1.72e-2)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (2.43e-2)" "unprognostic (3.60e-3)" "unprognostic (6.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.26e-3)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (4.16e-2)" "unprognostic (5.52e-3)" "unprognostic (1.45e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (2.28e-1)" 29.6 53.1 49.7 22.8 58.0 36.9 27.5 56.6 48.0 34.4 78.5 29.1 47.5 33.6 51.5 44.2 31.7 29.2 32.1 50.2 56.7 64.8 75.4 27.1 40.2 62.1 58.4 40.1 29.2 70.6 24.2 41.0 62.6 28.0 25.0 57.6 25.6 37.4 159.4 24.9 36.0 33.9 65.3 26.9 24.6 83.7 57.2 20.6 33.8 56.5 43.5 25.8 29.4 75.7 55.5 75.2 32.4 59.2 98.2 54.7 28.4 56.8 71.2 77.0 60.1 66.4 49.4 142.0 65.3 79.1 45.2 50.3 49.9 45.1 72.9 31.7 51.2 40.9 29.2 73.4 85.7 33.2 45.6 64.1 64.3 61.7 73.1 53.6 45.6 41.0 45.7 18.8 56.9 33.7 50.7 35.8 15.3 28.2 51.1 57.0 64.8 53.6 47.9 57.0 32.2 24.6 135.6 47.3 45.5 30.3 142.3 35.0 59.4 72.3 39.4 36.9 39.7 40.7 38.5 75.8 52.7 23.4 33.7 37.1 10.0 14.4 7.9 12.5 11.2 21.7 9.9 8.3 9.9 17.9 10.1 10.9 12.5 14.2 17.9 13.2 11.4 5.5 49.7 58.0 56.6 48.0 50.2 56.7 62.1 58.4 62.6 65.3 57.2 75.7 25.7 9.6 9.0 23.8 34.0 25.7 18.1 11.0 10.8 17.7 58.9 23.0 19.9 28.6 11.7 99.3 39.6 27.5 17.4 53.6 25.4 20.8 154.5 16.4 26.4 23.5 24.7 29.0 20.5 43.0 6.8 31.9 8.6 32.4 8.8 31.8 38.9 166.4 17.0 32.0 23.7 23.6 12.2 69.1 33.2 118.7 41.0 25.5 30.2 23.4 25.5 50.1 10.3 27.6 31.5 35.6 25.3 34.3 12.0 36.0 53.4 54.3 9.2 43.3 13.1 29.4 24.1 30.5 11.7 12.0 20.9 24.4 17.1 34.1 22.9 29.7 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079959 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 62.6;Enteroendocrine cells: 60.4;Glandular and luminal cells: 72.8;Granulosa cells: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 192.0;fHDF/TERT166: 183.2;hTERT-RPE1: 312.2;LHCN-M2: 179.2;RT4: 251.9;U-2 OS: 149.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" NA Yes 390000 "Cluster 32: T-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: AB_2684078" "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 10.8 19.8 4.5 7.0 4.9 3.5 22.8 3.6 5.4 20.3 2.3 39.4 3.3 30.7 7.9 4.0 36.4 19.3 5.6 3.2 8.8 7.7 4.6 20.0 12.4 9.1 37.9 28.7 3.6 6.4 5.3 13.2 19.6 11.3 9.0 25.7 4.5 11.0 1.1 4.4 12.6 34.3 4.3 17.4 5.5 10.7 13.1 2.8 4.2 2.2 7.6 22.6 14.3 3.9 44.4 105.5 6.3 0.2 2.5 0.2 17.2 14.8 39.3 4.7 3.8 0.3 192.0 0.0 47.6 183.2 117.0 64.8 0.0 117.6 5.5 8.6 0.7 0.0 11.0 0.1 3.8 1.2 1.7 0.9 20.1 122.6 59.5 312.2 15.0 0.9 8.5 0.0 179.2 2.1 3.6 0.1 4.5 21.2 27.1 0.3 46.5 0.1 52.3 251.9 18.8 0.0 76.2 9.0 0.5 3.4 11.2 1.0 4.1 2.6 149.9 1.7 121.3 1.9 0.4 0.2 10.0 3.4 2.8 0.0 0.1 0.0 4.4 0.2 6.0 3.7 6.8 6.9 0.7 1.6 15.3 12.1 0.1 8.6 0.0 8.8 4.4 4.7 4.5 4.9 3.6 5.4 3.2 8.8 9.1 37.9 19.6 4.3 13.1 3.9 7.2 9.6 3.1 1.0 3.6 2.4 13.1 39.4 15.4 62.6 10.8 37.7 1.6 1.5 4.9 1.8 0.0 1.0 12.4 0.4 1.9 5.3 1.4 31.5 6.0 12.7 60.4 5.7 2.6 19.3 28.1 11.1 0.5 72.8 7.0 76.8 32.2 1.2 4.8 0.0 0.2 3.1 2.0 3.5 1.1 2.3 2.5 7.2 1.8 1.9 5.3 15.6 2.1 0.0 0.1 40.4 1.5 0.7 3.8 10.7 0.0 0.1 2.9 4.9 0.0 3.2 27.7 0.7 2.4 2.5 0.4 8.5 7.6 12.8 0.3 33.9 ANAPC10 "APC10, DKFZP564L0562, DOC1" ENSG00000164162 "Anaphase promoting complex subunit 10" Q9UM13 4 144831908-145098541 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044547 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus" "HPA044547: AB_2678979" "unprognostic (2.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.04e-1)" "unprognostic (5.88e-2)" "unprognostic (2.66e-3)" "unprognostic (1.02e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (8.22e-4)" "unprognostic (2.80e-2)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (7.81e-2)" "unprognostic (1.70e-1)" "unprognostic (5.55e-2)" 11.4 9.4 7.7 6.1 8.2 10.1 14.3 9.6 11.2 11.0 7.9 9.1 4.4 11.6 13.3 7.7 10.7 7.7 13.9 7.9 8.5 12.9 13.6 9.8 10.3 8.3 8.9 11.9 7.5 9.0 7.5 12.3 8.3 8.9 9.8 9.2 8.1 9.2 14.9 8.2 6.6 11.8 8.5 8.4 7.4 19.0 8.4 13.8 11.8 15.1 10.7 11.0 9.0 9.1 14.3 7.8 20.0 7.8 19.5 21.2 13.0 17.1 16.9 21.6 15.7 18.9 18.6 19.6 11.1 11.8 15.6 8.4 17.6 22.6 23.1 19.0 14.0 12.1 6.0 15.6 24.5 23.9 13.7 17.2 15.9 17.7 28.8 18.0 17.1 23.0 32.2 28.2 22.8 10.3 40.5 29.1 14.1 17.0 15.7 20.5 15.5 11.8 24.1 9.0 14.0 10.4 11.1 10.4 23.1 18.6 9.4 19.7 15.6 14.7 8.9 13.7 21.7 22.3 25.2 31.3 19.2 30.2 18.7 25.5 7.8 9.7 13.0 10.3 13.4 15.1 13.5 13.2 11.5 12.4 13.4 13.7 2.2 16.4 9.6 15.6 18.1 7.4 7.7 8.2 9.6 11.2 7.9 8.5 8.3 8.9 8.3 8.5 8.4 9.1 30.7 12.8 17.0 31.3 16.7 16.3 22.0 61.6 10.8 9.9 16.9 26.0 14.8 4.3 34.3 14.7 0.0 38.9 20.2 7.6 46.9 25.8 83.3 26.4 21.0 22.2 3.0 8.6 61.2 26.1 35.8 20.7 9.2 15.6 26.0 15.3 19.6 15.6 35.1 5.0 58.0 13.0 40.7 12.7 18.2 22.8 33.8 17.6 10.6 36.5 27.8 19.0 22.6 55.8 62.3 27.3 15.5 27.1 10.5 26.9 14.3 49.8 27.6 9.8 32.9 21.0 36.2 126.8 41.5 14.2 19.9 29.6 19.5 26.1 13.7 29.4 ANGPTL2 "ARP2, HARP" ENSG00000136859 "Angiopoietin like 2" Q9UKU9 9 127087348-127122635 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 47.4;Endothelial cells: 34.6;Fibroblasts: 99.7;Oligodendrocyte precursor cells: 35.2;Skeletal myocytes: 39.3;Smooth muscle cells: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 140.4;ASC TERT1: 94.9;BJ hTERT+: 205.9;HSkMC: 98.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040933, HPA041299" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 2510000 2200000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA040933: AB_10795530, HPA041299: AB_10794552" "unprognostic (5.46e-2)" "unprognostic (4.96e-3)" "unprognostic (1.11e-2)" "unprognostic (2.07e-2)" "unprognostic (8.79e-2)" "unprognostic (3.13e-2)" "unprognostic (1.79e-2)" "unprognostic (2.04e-2)" "unprognostic (3.31e-1)" "unprognostic (1.17e-3)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (3.32e-5)" "unprognostic (1.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.45e-2)" "unprognostic (4.15e-2)" 109.5 11.5 6.1 33.5 12.9 0.2 71.2 15.1 8.6 67.7 12.4 76.5 15.1 72.9 13.7 21.7 31.4 67.0 69.2 6.9 9.4 13.4 14.8 22.5 8.1 12.0 12.4 44.2 5.5 4.1 3.4 21.4 11.7 24.7 17.9 0.9 18.0 27.1 57.6 29.2 27.8 63.4 9.9 49.2 28.9 4.4 12.6 4.7 15.7 36.6 8.9 59.4 49.1 15.4 0.0 0.0 17.4 0.0 140.4 94.9 9.4 8.1 205.9 9.2 8.5 0.0 0.0 0.0 7.0 21.4 1.8 0.1 1.7 0.0 4.8 0.1 0.0 0.0 0.1 0.5 30.3 0.1 0.0 98.2 0.0 20.0 0.0 28.7 27.6 2.3 0.0 0.1 6.3 0.0 0.2 4.3 18.4 0.0 1.0 16.5 27.3 1.6 2.2 0.0 9.3 10.1 0.0 0.0 0.0 3.3 0.0 0.0 8.8 35.5 4.5 50.4 0.0 0.0 0.1 0.0 37.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 12.9 15.1 8.6 6.9 9.4 12.0 12.4 11.7 9.9 12.6 15.4 47.4 9.6 2.4 1.0 0.1 14.3 7.0 0.2 3.4 14.4 0.6 6.6 16.6 0.0 0.1 0.0 2.1 1.0 0.5 0.1 0.0 0.2 1.6 1.4 20.2 34.6 0.0 0.0 0.6 0.0 0.8 99.7 1.1 1.0 0.0 2.9 5.0 0.0 1.4 0.0 1.5 0.0 0.0 0.0 17.4 1.5 20.8 0.8 7.2 1.9 0.0 1.9 0.0 35.2 19.2 1.2 0.0 6.4 0.0 1.7 0.0 2.4 1.6 0.8 0.0 39.3 43.5 1.0 0.0 1.4 11.1 2.6 1.7 1.1 0.0 0.6 ANGPTL8 "C19orf80, RIFL, TD26" ENSG00000130173 "Angiopoietin like 8" Q6UXH0 19 11237450-11241943 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid metabolism" Hormone "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 409.8" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 151.2" "Cancer enriched" "Detected in some" 37 "liver cancer: 84.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "Hep G2: 37.0;MCF7: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA042131 Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 836000 350000 "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" Nucleoplasm "HPA042131: AB_10794413" "unprognostic (2.37e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (1.31e-2)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (3.73e-1)" "unprognostic (2.80e-1)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.84e-6)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (4.57e-1)" "unprognostic (1.75e-2)" 35.7 0.8 1.1 0.2 1.0 0.1 22.5 0.1 1.7 1.2 0.0 1.4 0.4 0.9 1.6 0.3 0.8 0.4 1.8 0.9 0.6 4.0 409.8 0.4 0.1 0.7 0.6 1.1 0.9 0.0 0.3 0.1 0.5 0.8 0.0 0.1 1.3 0.1 0.8 0.9 1.2 0.1 0.3 0.4 0.7 0.5 1.1 0.0 1.0 0.0 0.0 1.1 1.0 0.9 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 1.3 37.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 21.2 0.0 0.7 0.2 0.0 0.0 0.1 0.4 1.0 0.0 0.3 0.0 0.3 0.4 0.9 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.1 1.7 0.9 0.6 0.7 0.6 0.5 0.3 1.1 0.9 0.6 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.4 0.2 0.8 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 2.7 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 4.6 151.2 0.1 0.0 0.0 0.0 0.0 4.4 0.0 1.9 0.9 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.0 0.1 ANKRD26 "KIAA1074, THC2" ENSG00000107890 "Ankyrin repeat domain 26" Q9UPS8 10 26973793-27100494 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 130.6;Cone photoreceptor cells: 200.1;Excitatory neurons: 136.8;Inhibitory neurons: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA040654, HPA041460" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "HPA040654: AB_10795370, HPA041460: AB_10795120" "unprognostic (1.92e-1)" "unprognostic (3.41e-1)" "unprognostic (2.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.02e-1)" "unprognostic (2.09e-2)" "unprognostic (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (4.08e-2)" "unprognostic (1.53e-2)" "unprognostic (1.03e-2)" "unprognostic (2.53e-3)" "unprognostic (5.35e-2)" "unprognostic (1.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.99e-1)" 2.3 2.6 4.7 1.6 5.4 1.5 3.8 5.9 8.6 3.9 5.0 2.5 1.7 3.3 3.0 2.0 3.0 2.0 4.1 4.4 4.0 2.7 2.8 1.9 3.5 4.7 3.8 4.0 2.6 4.0 4.6 3.2 2.7 2.6 2.8 10.0 2.3 2.5 6.7 2.5 2.0 2.5 2.8 2.5 2.2 4.0 4.9 3.1 2.7 7.5 2.2 2.2 2.7 5.8 7.7 5.4 9.8 3.7 6.1 6.7 3.4 10.1 3.7 9.2 8.5 5.2 5.1 17.9 3.1 4.7 6.5 8.1 9.6 4.7 11.0 7.4 7.2 1.1 7.9 7.9 4.5 4.5 1.2 4.7 2.9 9.5 3.2 7.5 8.4 5.5 14.8 4.8 9.3 4.3 5.5 2.8 3.9 2.8 3.5 6.6 13.8 4.3 5.7 3.1 8.5 4.7 9.6 2.0 8.1 7.1 8.5 3.1 7.6 7.7 5.2 9.9 5.7 1.9 2.6 11.7 7.3 9.9 3.5 1.0 0.2 0.2 0.2 0.1 0.7 1.2 0.4 0.4 0.3 0.6 1.6 0.5 0.1 1.6 0.1 2.1 0.4 0.2 4.7 5.4 5.9 8.6 4.4 4.0 4.7 3.8 2.7 2.8 4.9 5.8 19.5 22.4 28.8 130.6 14.3 4.2 7.6 9.0 8.6 77.8 13.5 17.7 70.9 7.2 19.4 3.7 200.1 24.8 8.6 8.3 5.9 14.5 19.0 47.7 38.6 20.4 20.9 6.3 136.8 13.1 13.1 21.3 8.2 16.5 5.1 43.5 13.6 8.3 11.9 79.1 185.9 9.3 10.2 5.7 5.4 6.4 30.4 11.8 3.6 45.0 12.4 45.0 18.6 87.0 67.2 11.3 4.2 27.1 7.8 5.3 12.1 5.6 49.5 117.9 32.9 30.1 15.6 60.7 57.2 8.9 8.0 13.7 12.9 46.1 14.6 5.0 ANKRD40 MGC15396 ENSG00000154945 "Ankyrin repeat domain 40" Q6AI12 17 50693198-50707914 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 164.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021668, HPA021759, HPA074884" Uncertain Approved "Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 39: CACO-2 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "Nucleoli fibrillar center, Cytosol" "HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: " "unprognostic (2.73e-1)" "unprognostic (1.82e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (4.99e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (7.02e-4)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.84e-2)" "unprognostic (1.53e-1)" "unprognostic (4.77e-2)" "unprognostic (1.00e-2)" "unprognostic (9.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" 42.8 19.7 126.7 15.5 163.3 7.8 25.7 130.4 159.3 20.6 63.4 32.0 11.8 23.8 13.7 18.4 19.4 16.2 27.6 98.5 115.4 17.8 17.8 22.5 16.6 150.3 152.4 20.6 19.4 26.9 10.8 23.1 142.2 18.3 16.3 20.7 15.0 24.7 107.0 14.4 16.3 27.9 141.3 20.5 18.7 10.3 135.2 16.9 16.9 84.0 14.4 25.3 16.9 164.8 41.1 38.6 34.2 34.6 48.2 39.8 29.9 36.2 39.5 41.3 38.7 82.6 20.5 43.3 49.2 46.4 44.3 22.8 49.3 29.4 66.8 40.0 31.7 59.1 25.1 40.7 26.4 41.6 24.0 34.3 29.5 40.3 50.1 30.2 32.9 35.1 34.0 42.3 34.4 32.0 52.2 15.1 38.0 33.0 36.1 35.2 61.9 30.8 32.5 34.8 18.1 50.5 20.2 27.2 39.6 59.1 31.4 27.4 40.4 55.8 44.1 29.2 46.7 44.3 43.4 38.3 30.6 15.9 46.4 7.4 7.0 3.1 10.9 11.2 12.5 9.8 12.0 12.3 7.1 9.2 11.1 13.4 1.8 10.7 12.3 14.2 9.3 4.6 126.7 163.3 130.4 159.3 98.5 115.4 150.3 152.4 142.2 141.3 135.2 164.8 39.0 16.0 11.4 11.4 13.9 45.0 24.2 6.1 11.4 14.3 19.8 11.7 31.7 12.8 4.9 18.4 4.2 14.9 19.9 13.5 27.4 16.6 1.8 10.4 20.3 31.4 6.0 7.4 16.0 17.5 18.9 19.6 5.6 16.1 9.5 14.3 32.9 21.9 19.0 35.3 15.6 12.3 6.1 32.4 25.1 3.1 34.2 16.3 26.6 11.2 13.2 19.6 8.2 12.1 32.2 19.9 8.4 37.6 4.5 30.5 9.6 24.8 5.0 12.0 46.0 39.1 27.3 17.5 21.1 10.4 33.2 10.7 15.7 9.7 12.8 24.1 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493979-94499578 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: AB_2680279" "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavorable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favorable (6.16e-4)" 7.8 6.8 8.3 12.7 8.9 25.2 13.1 11.1 11.4 9.7 8.2 10.8 11.4 10.4 18.3 9.5 8.5 8.4 5.3 8.3 8.4 7.8 8.6 7.5 20.8 8.2 7.7 12.6 13.4 9.3 8.9 12.1 8.0 10.9 13.6 11.8 10.7 10.8 5.8 10.2 16.2 8.8 7.8 15.6 12.7 5.4 9.3 17.1 14.2 7.3 20.8 7.9 8.5 9.5 8.9 4.4 11.0 9.4 10.2 12.0 13.5 13.3 12.0 14.9 17.1 20.7 18.4 23.4 20.9 8.5 12.5 20.5 14.0 9.8 12.2 17.9 12.1 18.9 16.8 7.8 11.1 17.8 15.8 9.1 23.1 10.7 14.9 10.4 11.3 20.9 18.4 14.4 9.4 6.1 19.8 32.8 6.3 17.5 9.8 14.9 11.3 12.0 12.9 9.2 10.5 10.9 10.2 9.8 8.7 18.4 18.0 12.9 7.5 13.0 9.3 13.8 7.2 7.6 20.0 24.6 4.4 21.8 7.4 77.8 23.1 23.9 21.9 19.5 23.7 34.1 23.4 19.4 18.4 28.8 28.4 25.9 42.7 27.2 15.8 30.5 31.4 17.8 8.3 8.9 11.1 11.4 8.3 8.4 8.2 7.7 8.0 7.8 9.3 9.5 20.5 12.8 9.3 11.1 43.2 5.6 10.0 15.1 14.2 16.3 14.0 11.3 9.1 24.3 15.4 25.8 14.6 31.1 36.1 27.8 21.5 20.3 10.1 11.9 18.1 15.4 13.3 40.0 11.1 23.0 13.8 16.5 27.0 15.1 21.5 18.7 16.4 18.8 14.3 11.8 9.5 23.6 8.2 28.5 8.4 3.7 35.8 18.5 10.6 8.4 28.1 21.8 57.7 5.5 12.7 22.8 35.2 23.7 28.0 11.3 45.3 19.3 8.1 14.4 26.3 11.3 18.4 21.0 19.9 11.6 6.8 28.0 36.5 9.8 22.0 5.8 ANO9 "PIG5, TMEM16J, TP53I5" ENSG00000185101 "Anoctamin 9" A1A5B4 11 417933-442011 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.2;skin 1: 27.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.0;Intestinal goblet cells: 50.5;Paneth cells: 50.5;Proximal enterocytes: 87.7;Undifferentiated cells: 45.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 26.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 48 "B-cells: 2.1;NK-cells: 4.1;T-cells: 8.2" "Cell line enhanced" "Detected in some" "BEWO: 9.2;CAPAN-2: 29.5;HaCaT: 16.8;RPMI-8226: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039948, HPA040112" Approved Uncertain "Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA039948: AB_2676765, HPA040112: " "unprognostic (3.62e-3)" "unprognostic (2.83e-2)" "unprognostic (4.68e-2)" "unprognostic (1.62e-1)" "unprognostic (1.41e-2)" "unprognostic (8.93e-2)" "unprognostic (6.98e-2)" "unprognostic (8.94e-3)" "unprognostic (1.39e-1)" "unprognostic (2.28e-3)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (1.91e-2)" "unprognostic (1.18e-2)" "unprognostic (2.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (8.81e-4)" 0.7 0.1 0.0 7.0 0.0 2.2 1.7 0.0 0.0 1.1 0.2 16.0 34.2 0.5 7.0 6.3 1.2 2.0 0.1 0.0 0.0 3.7 0.3 2.9 12.0 0.0 0.0 0.1 6.5 0.7 1.3 0.1 0.0 2.9 9.1 0.0 3.0 0.7 0.0 27.8 30.0 0.8 0.0 4.7 7.0 0.2 0.0 9.0 2.4 0.1 8.7 2.4 3.4 0.0 2.7 0.6 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 3.1 29.5 1.9 1.4 0.0 0.1 16.8 0.0 7.0 0.0 2.1 0.0 0.0 0.6 5.1 0.0 0.4 0.0 0.0 5.6 0.0 1.2 0.1 0.0 4.5 0.1 1.9 0.0 3.8 0.5 0.1 0.0 6.0 0.0 0.1 0.0 20.6 5.1 4.4 1.6 0.0 0.3 7.3 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 5.5 2.1 6.5 3.3 0.0 0.8 3.7 2.8 0.0 4.1 0.0 0.0 8.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.7 0.3 9.1 5.2 4.6 15.3 6.2 0.0 5.5 3.9 2.4 8.6 9.1 3.7 0.0 0.3 3.0 81.0 0.0 10.5 0.8 4.9 1.0 0.8 15.5 0.0 0.3 6.5 3.7 0.6 29.0 11.0 0.0 0.0 0.7 0.3 0.4 0.0 0.2 50.5 14.2 0.3 1.9 0.1 0.0 1.2 3.6 0.0 1.3 0.0 0.0 0.0 0.0 9.0 50.5 0.0 5.0 2.7 87.7 3.7 9.2 0.0 0.0 0.1 1.0 0.2 0.2 7.0 6.3 0.1 12.8 0.0 45.2 5.7 AOC3 "HPAO, VAP-1, VAP1" ENSG00000131471 "Amine oxidase copper containing 3" Q16853 17 42851184-42858130 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 422.8" "Group enriched" "Detected in many" 4 "Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "ASC diff: 307.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA000980, CAB025797" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted - unknown location" NA NA 240000000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "Golgi apparatus" "CAB025797: , HPA000980: AB_1078170" "unprognostic (2.20e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (2.64e-1)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (4.00e-2)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (5.61e-2)" "unprognostic (1.67e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (6.98e-4)" 422.8 48.4 2.6 31.9 3.2 1.4 169.2 2.5 4.2 52.8 2.7 210.8 17.3 95.1 33.5 88.0 84.8 50.7 50.2 2.9 2.5 24.1 19.1 218.6 12.4 2.5 2.5 26.5 12.0 8.4 5.4 28.0 2.6 59.1 41.0 1.7 14.7 103.6 17.8 24.6 57.6 144.8 2.3 21.4 66.6 12.8 2.4 5.9 28.2 22.9 3.9 142.1 50.9 2.5 0.1 1.5 0.2 1.0 307.5 0.3 5.0 0.3 0.1 0.2 0.8 0.9 0.0 0.7 0.7 0.1 0.2 0.5 0.8 0.2 0.8 1.5 5.7 0.4 0.5 18.4 0.8 0.3 1.0 3.3 1.0 0.3 0.8 0.0 0.2 2.2 0.3 1.7 0.6 0.2 0.2 1.4 0.7 0.1 0.4 0.7 0.8 3.0 0.1 2.2 0.3 0.4 0.0 0.2 2.0 2.2 0.1 0.1 0.0 0.3 2.7 1.2 0.4 4.8 5.9 0.6 0.4 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 3.2 2.5 4.2 2.9 2.5 2.5 2.5 2.6 2.3 2.4 2.5 58.2 3.2 6.0 0.0 0.5 2.9 0.1 0.0 2.2 0.0 1.1 2.2 9.5 0.0 1.9 0.0 0.0 0.1 0.4 0.1 0.0 0.2 4.5 0.8 2.3 12.3 0.0 0.0 0.4 0.2 0.1 11.3 0.0 1.4 1.3 2.1 20.7 0.2 1.4 0.0 0.3 0.1 0.0 1.4 2.7 2.6 3.4 0.9 3.6 3.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 74.9 0.0 0.4 0.1 1.4 1.0 0.4 118.3 2.6 93.0 1.1 1.3 0.7 1.8 0.3 0.6 74.6 0.1 0.3 AP1AR "2C18, C4orf16, gamma-BAR, PRO0971" ENSG00000138660 "Adaptor related protein complex 1 associated regulatory protein" Q63HQ0 4 112231740-112273110 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035863, HPA058115" Approved Supported "Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA035863: AB_10672098, HPA058115: AB_2683610" "unprognostic (1.11e-1)" "unprognostic (1.99e-1)" "unprognostic (2.49e-3)" "unprognostic (9.14e-2)" "unprognostic (2.19e-1)" "unprognostic (9.16e-2)" "unprognostic (1.86e-2)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (2.45e-1)" "unprognostic (2.69e-2)" "unprognostic (6.15e-2)" "prognostic favorable (4.05e-7)" "unprognostic (2.50e-2)" "unprognostic (1.36e-1)" "unprognostic (2.10e-3)" "prognostic favorable (7.79e-4)" 9.0 15.7 6.4 12.6 7.6 3.7 16.9 9.4 9.7 8.4 5.7 18.0 22.2 11.3 8.2 13.3 6.5 12.8 7.9 8.7 8.4 22.1 20.5 9.1 12.1 6.2 7.2 11.6 8.3 40.9 4.8 12.0 6.5 9.0 16.3 7.6 12.1 10.0 7.4 14.2 23.8 9.8 5.9 13.2 13.0 14.5 7.6 10.9 10.8 7.5 12.1 13.0 9.9 7.9 20.7 10.1 24.5 23.8 20.7 15.2 22.3 18.9 45.9 13.6 16.2 10.0 39.0 46.0 15.3 12.7 16.2 9.2 24.4 14.5 23.2 53.1 13.3 15.5 13.6 32.8 31.9 38.0 23.9 16.9 32.3 11.9 33.7 11.1 21.2 24.2 16.7 38.5 13.5 19.6 34.7 23.5 18.2 47.0 10.8 30.0 26.2 23.5 26.4 14.5 24.5 32.1 12.7 45.2 34.5 12.2 14.9 12.8 19.0 18.1 23.1 27.4 15.2 34.5 68.0 56.2 19.0 14.4 16.3 6.7 7.4 2.6 4.0 10.0 5.6 6.8 6.3 6.4 9.5 5.9 8.5 8.9 1.1 9.0 8.4 4.4 7.5 5.2 6.4 7.6 9.4 9.7 8.7 8.4 6.2 7.2 6.5 5.9 7.6 7.9 21.3 9.6 19.5 9.4 12.9 21.0 8.9 7.0 22.2 8.9 34.2 22.7 20.5 17.2 14.9 16.5 2.1 5.5 14.5 38.4 11.7 9.8 91.7 21.3 17.2 17.7 31.7 6.3 24.8 10.1 3.8 15.2 18.3 29.5 6.3 8.2 9.3 27.3 15.7 10.1 20.6 16.0 6.1 20.1 16.5 59.9 4.7 17.4 23.2 15.0 12.0 12.3 1.0 13.6 16.3 12.7 24.0 10.1 6.8 13.1 24.9 28.6 16.0 8.0 0.0 16.0 20.4 9.6 12.2 28.2 31.3 3.1 12.5 15.2 20.8 14.7 AP1B1 "ADTB1, AP105A, BAM22, CLAPB2" ENSG00000100280 "Adaptor related protein complex 1 subunit beta 1" Q10567 22 29327680-29388583 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 138.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065226, HPA068520" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 660000 "Cluster 39: Non-specific - mRNA processing" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 15: RT4 - Unknown function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" "Vesicles, Cytosol" "HPA065226: AB_2685438, HPA068520: AB_2685998" "unprognostic (1.78e-1)" "prognostic favorable (4.81e-4)" "unprognostic (2.40e-1)" "unprognostic (2.21e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (4.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-3)" "unprognostic (1.60e-1)" "prognostic favorable (7.24e-6)" "unprognostic (1.85e-2)" "unprognostic (3.78e-2)" "unprognostic (2.94e-2)" "unprognostic (3.76e-2)" 30.7 46.7 38.0 47.2 38.3 45.8 26.4 37.3 45.2 22.8 35.6 34.9 43.3 22.7 12.1 63.0 23.5 30.4 23.9 36.1 40.8 34.8 34.8 30.1 57.8 44.2 44.6 17.5 38.3 67.0 39.2 44.8 43.7 38.3 30.1 35.3 40.3 25.9 24.5 47.2 45.6 27.1 41.4 52.6 40.9 24.7 52.7 34.2 29.6 20.5 54.4 39.4 32.2 48.8 84.6 47.5 49.3 50.2 37.0 27.0 60.0 59.8 65.5 71.2 68.2 74.4 33.2 46.1 37.2 68.4 33.0 74.6 71.5 97.6 45.2 58.2 102.0 79.1 60.8 42.0 38.9 114.1 99.9 38.6 36.0 67.5 55.0 33.0 98.7 17.2 54.6 54.9 48.3 93.7 45.5 36.8 37.3 124.8 53.3 89.0 54.3 119.9 50.2 194.5 75.9 52.2 74.0 82.5 36.4 33.5 66.7 49.5 84.6 79.1 48.8 46.0 62.1 60.4 32.5 84.6 56.1 48.1 46.7 0.0 29.3 5.7 9.2 29.2 9.1 16.2 6.3 7.9 28.7 18.2 4.9 5.2 3.0 7.2 31.7 9.0 8.8 24.2 38.0 38.3 37.3 45.2 36.1 40.8 44.2 44.6 43.7 41.4 52.7 48.8 17.8 12.8 16.4 27.7 53.0 7.1 9.3 16.7 16.5 26.3 26.2 20.8 16.1 21.5 16.4 22.0 39.6 52.3 15.1 69.6 23.5 41.2 7.5 16.4 11.6 19.8 21.6 40.0 24.1 40.7 30.1 12.1 33.6 30.1 5.1 13.2 35.3 34.3 138.9 45.4 25.6 24.9 18.3 95.5 24.2 13.1 11.8 65.7 12.4 51.5 29.8 28.4 9.2 16.1 14.0 65.9 33.2 12.4 28.5 17.5 51.2 30.1 14.5 42.1 6.6 17.8 12.7 23.5 17.6 33.0 9.1 68.3 17.0 39.6 36.2 18.1 AP1S1 "AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2" ENSG00000106367 "Adaptor related protein complex 1 subunit sigma 1" P61966 7 101154456-101161596 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Ichthyosis, Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060945 Supported Supported "Golgi apparatus,Vesicles" NA Yes "Cluster 28: Myeloid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus, Vesicles" "HPA060945: AB_2684393" "unprognostic (1.98e-2)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.98e-3)" "unprognostic (8.70e-3)" "unprognostic (7.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.76e-1)" "unprognostic (7.79e-2)" "unprognostic (1.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.81e-2)" "unprognostic (2.14e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" 14.4 24.6 72.2 13.9 75.7 5.8 17.2 43.7 82.6 18.3 34.6 28.6 39.0 16.9 17.0 34.2 13.8 12.8 11.8 85.2 59.6 41.2 36.2 14.7 11.9 53.6 51.9 13.5 21.9 22.8 31.0 15.9 53.4 22.2 22.4 14.6 20.3 9.3 6.4 39.2 30.3 12.7 46.1 20.2 22.0 16.4 62.5 19.1 15.2 8.5 13.6 20.1 19.5 62.7 121.0 87.3 63.3 118.4 42.8 70.4 138.2 76.8 51.1 50.8 52.8 47.3 147.5 24.9 127.5 84.6 97.1 59.0 35.3 116.0 45.6 57.0 56.6 16.8 52.0 61.4 54.2 46.8 87.7 79.1 91.0 49.4 20.6 76.7 76.8 54.1 56.7 103.2 129.9 292.1 40.4 107.8 97.8 177.0 188.2 24.9 27.2 54.6 127.8 88.8 47.5 157.7 40.4 121.1 151.4 101.6 50.7 46.8 79.0 74.1 132.3 27.6 55.2 21.4 51.4 48.4 195.2 50.1 152.9 0.5 3.3 0.3 2.3 3.1 2.2 2.6 3.2 2.5 4.6 2.0 1.9 1.8 1.2 1.3 1.8 5.0 3.3 2.4 72.2 75.7 43.7 82.6 85.2 59.6 53.6 51.9 53.4 46.1 62.5 62.7 34.4 6.4 0.0 2.3 17.9 38.7 29.7 173.0 46.7 30.7 54.8 49.0 1.1 45.8 72.9 55.2 8.4 170.7 19.8 88.4 344.4 128.2 2.5 28.8 34.2 36.7 90.3 16.2 21.2 111.7 101.3 27.7 42.8 31.9 5.7 85.3 28.9 43.0 95.2 30.3 10.3 96.5 116.0 24.8 21.6 3.4 35.1 27.3 53.4 7.5 58.0 34.1 17.5 2.5 9.8 183.3 86.1 21.8 17.4 34.9 241.3 304.8 34.9 22.3 19.7 11.4 38.4 13.1 70.9 51.4 45.5 60.5 19.5 157.4 119.9 38.2 AP1S2 "MRX59, MRXS5, PGS, SIGMA1B" ENSG00000182287 "Adaptor related protein complex 1 subunit sigma 2" P56377 X 15825806-15854931 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "epididymis: 663.3" "Cell type enhanced" "Detected in all" "Hofbauer cells: 259.8;Kupffer cells: 392.6;Langerhans cells: 609.2;Macrophages: 362.7;monocytes: 630.0" "Group enriched" "Detected in all" 4 "endometrial cancer: 13.1;glioma: 22.0;melanoma: 49.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 326.8;intermediate monocyte: 325.0;myeloid DC: 221.1;non-classical monocyte: 175.4;plasmacytoid DC: 82.2" "Group enriched" "Detected in all" 5 "dendritic cells: 221.1;monocytes: 326.8" "Cell line enhanced" "Detected in all" "Karpas-707: 298.0;SK-MEL-30: 442.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049894, HPA060945" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Vesicles" "HPA049894: AB_2680939, HPA060945: AB_2684393" "prognostic favorable (9.86e-4)" "unprognostic (4.62e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" "unprognostic (2.47e-3)" "unprognostic (3.85e-1)" "unprognostic (2.03e-3)" "unprognostic (5.76e-2)" "unprognostic (1.43e-2)" "prognostic favorable (5.53e-6)" "unprognostic (1.85e-2)" "unprognostic (5.61e-2)" "unprognostic (5.08e-2)" "unprognostic (6.35e-2)" "unprognostic (3.13e-1)" "unprognostic (9.34e-2)" "unprognostic (6.47e-2)" 28.3 21.4 24.6 36.7 28.4 38.3 15.0 32.0 36.9 31.6 27.3 42.1 11.9 52.2 663.3 21.4 13.5 20.1 74.8 25.1 48.0 13.1 15.9 25.8 33.2 42.7 35.8 8.8 7.8 16.7 19.4 42.0 47.0 11.6 22.0 43.7 9.5 30.5 70.1 14.0 20.1 76.3 34.4 43.0 19.5 23.4 29.6 28.7 12.5 93.7 28.8 26.1 12.7 33.8 12.0 14.2 130.1 78.4 29.5 19.1 5.0 47.1 22.7 31.1 41.1 9.6 11.1 22.6 183.0 72.6 50.4 16.1 31.7 10.8 57.0 30.1 64.9 15.3 16.7 14.7 24.2 63.1 16.9 12.2 11.2 36.0 33.1 50.4 78.1 19.1 14.3 298.0 72.4 8.7 12.9 39.5 171.0 6.4 42.5 29.5 116.7 50.6 37.4 2.5 14.8 69.2 18.4 4.8 442.2 84.1 52.7 69.2 43.9 67.8 21.2 92.5 41.9 25.5 58.7 37.3 33.6 28.0 159.7 50.9 326.8 34.6 21.1 325.0 24.8 30.8 25.5 20.6 221.1 28.0 18.5 18.1 52.8 27.9 175.4 82.2 38.1 228.0 24.6 28.4 32.0 36.9 25.1 48.0 42.7 35.8 47.0 34.4 29.6 33.8 130.8 3.2 13.1 37.2 77.0 55.2 12.7 9.1 8.6 34.7 12.0 11.4 195.6 12.8 3.2 9.2 12.5 5.3 114.2 9.2 33.2 13.7 5.1 50.4 32.6 166.3 26.9 32.6 15.1 6.4 18.9 38.0 7.7 78.0 78.6 15.6 147.4 8.6 259.8 11.8 73.2 8.4 12.2 392.6 609.2 17.5 17.4 362.7 149.4 31.9 630.0 21.1 62.8 19.1 85.0 10.3 14.0 7.2 26.0 19.0 6.5 9.0 1.6 39.3 39.5 26.7 39.1 55.7 28.8 10.6 51.6 5.6 58.3 4.0 8.5 6.7 AP3B1 "ADTB3A, HPS2" ENSG00000132842 "Adaptor related protein complex 3 subunit beta 1" O00203 5 78002326-78294698 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 231.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038737, HPA045458" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 38000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Golgi apparatus" "HPA038737: AB_10670788, HPA045458: AB_2679333" "unprognostic (9.14e-2)" "unprognostic (2.02e-1)" "prognostic favorable (1.37e-5)" "unprognostic (8.17e-2)" "unprognostic (2.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-3)" "unprognostic (7.47e-3)" "unprognostic (4.51e-1)" "unprognostic (9.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.97e-2)" "prognostic favorable (7.97e-6)" "unprognostic (1.65e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (3.39e-2)" 21.5 21.5 21.1 19.6 26.1 21.9 21.3 22.3 26.4 20.7 23.0 24.1 19.8 17.8 53.9 30.8 15.8 15.9 19.0 19.6 23.4 30.3 15.9 17.2 22.5 23.4 24.4 13.0 24.9 29.3 40.4 19.6 24.5 16.9 28.3 8.8 26.4 16.4 15.8 22.5 20.8 20.5 23.3 21.6 23.0 13.2 23.6 23.2 27.2 13.0 24.8 20.1 21.9 26.5 51.3 40.3 45.4 63.1 53.2 64.5 39.5 56.3 66.1 50.1 67.5 31.4 44.1 53.7 32.5 69.4 41.7 36.6 45.0 94.1 62.7 61.7 31.7 37.4 33.9 55.5 31.1 33.7 47.1 46.2 34.0 42.3 42.5 47.7 64.1 10.9 27.3 34.3 86.9 31.6 43.4 52.2 24.1 37.4 23.9 45.2 80.2 74.4 72.7 47.5 16.0 25.7 52.3 33.7 49.7 37.1 40.9 55.6 65.0 37.4 29.1 45.4 57.4 26.3 43.3 36.3 48.5 48.5 48.4 18.3 12.6 11.3 9.6 12.5 10.6 31.3 8.0 10.0 17.2 40.1 6.6 8.8 15.4 9.6 17.3 14.2 10.4 8.1 21.1 26.1 22.3 26.4 19.6 23.4 23.4 24.4 24.5 23.3 23.6 26.5 31.6 44.8 33.7 82.3 59.0 15.8 22.1 28.1 22.8 16.2 18.8 14.1 29.0 10.0 37.5 31.3 22.9 30.9 37.1 36.9 25.4 35.8 12.0 27.7 38.8 33.3 19.2 27.3 59.7 38.0 38.7 32.0 35.2 40.8 32.9 26.1 23.2 17.0 39.5 20.2 57.3 34.1 26.4 41.9 24.8 20.2 15.8 47.3 26.6 118.0 66.5 21.5 32.0 86.5 231.0 43.5 25.0 16.6 44.0 20.7 30.0 27.2 29.8 27.5 26.3 36.2 28.5 16.1 10.1 28.9 23.4 29.8 39.9 31.2 28.0 22.2 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 subunit beta 2" Q13367 15 82659281-82710112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.7;pituitary gland: 18.8;retina: 33.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 27.1;Excitatory neurons: 61.7;Inhibitory neurons: 56.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 22.8;Rod photoreceptor cells: 58.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.5;NTERA-2: 9.5;RT4: 17.3;SCLC-21H: 29.0;SH-SY5Y: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 0.7 4.5 15.3 0.9 18.6 1.1 1.4 15.5 20.7 0.9 0.0 1.1 0.7 1.1 2.3 0.7 0.9 0.4 0.2 19.6 5.5 0.6 0.2 0.3 0.5 15.6 5.4 1.2 2.1 12.7 18.8 0.6 13.2 1.4 0.6 33.0 0.9 1.4 0.3 0.9 0.9 1.3 1.1 0.7 1.1 6.2 4.7 1.0 2.1 0.4 1.3 0.8 0.6 11.3 0.2 0.4 9.5 3.2 1.6 0.2 5.7 0.5 0.0 0.8 0.2 0.4 0.4 0.8 4.9 0.2 1.8 0.9 1.0 0.0 0.2 3.2 0.7 0.3 0.4 0.2 0.3 0.4 1.8 1.0 1.1 0.1 0.7 0.1 0.0 2.8 1.0 0.7 0.1 2.5 0.3 0.5 9.5 0.1 0.1 0.3 0.0 0.2 0.0 17.3 29.0 17.5 3.2 1.4 2.4 1.0 0.2 1.9 0.2 0.3 0.9 0.4 1.3 1.6 8.8 0.7 2.2 0.5 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.2 0.9 0.1 0.1 0.4 0.0 0.1 15.3 18.6 15.5 20.7 19.6 5.5 15.6 5.4 13.2 1.1 4.7 11.3 0.1 0.0 1.1 20.9 0.1 0.4 2.1 0.6 1.2 18.4 1.5 2.3 0.8 0.0 0.1 0.0 27.1 0.1 0.2 0.1 0.0 0.2 8.0 0.2 0.6 0.1 13.9 0.0 61.7 0.4 0.1 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 13.5 56.9 0.5 6.1 0.0 0.6 5.4 0.9 0.1 0.0 4.7 0.0 4.1 0.0 44.7 22.8 0.0 0.1 0.4 1.2 0.7 0.0 0.4 0.0 58.6 0.0 1.3 0.7 9.8 3.1 0.7 0.1 0.0 0.1 0.2 0.0 0.6 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 subunit beta 1" Q2VPB7 11 65773898-65780976 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 44.0" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "neutrophil: 25.0" "Lineage enriched" "Detected in many" 14 "granulocytes: 25.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: AB_2685550, HPA067880: AB_2685914" "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 8.3 4.8 3.2 6.9 2.6 44.0 6.6 5.8 3.6 5.4 1.3 6.0 5.7 7.1 2.0 10.2 5.2 3.1 5.0 3.6 1.2 5.7 5.8 8.7 4.7 3.9 1.5 2.9 10.3 6.4 3.5 3.8 3.0 5.0 3.0 2.5 7.0 4.5 9.6 9.1 6.8 3.2 1.1 10.0 6.0 2.5 1.8 4.8 4.9 3.4 4.3 6.6 5.1 1.6 12.8 9.8 2.8 14.3 8.6 4.1 16.4 5.3 6.2 6.1 4.7 7.7 6.0 7.8 9.4 6.3 12.4 15.8 8.7 4.3 2.9 12.1 10.1 7.0 12.0 3.8 5.8 9.9 13.3 7.0 10.1 4.0 2.9 6.0 5.2 13.6 15.6 9.7 3.6 9.2 5.5 10.5 4.6 4.4 10.1 17.3 0.5 16.8 5.9 15.8 2.7 5.4 4.1 2.6 26.0 3.7 4.4 14.1 7.6 10.2 8.6 13.6 6.0 10.0 11.2 8.1 7.5 8.5 10.5 1.1 1.7 0.6 0.5 1.0 0.2 0.3 0.2 0.2 0.5 0.3 0.3 0.2 25.0 0.4 1.3 0.3 0.2 0.8 3.2 2.6 5.8 3.6 3.6 1.2 3.9 1.5 3.0 1.1 1.8 1.6 2.0 0.0 8.8 6.2 3.9 2.4 12.3 4.3 7.4 5.0 4.2 2.0 1.6 2.8 3.7 7.3 14.6 7.6 5.9 12.8 1.9 8.9 1.4 6.3 2.9 3.0 3.0 0.0 3.6 13.6 18.2 2.9 6.6 10.7 2.5 5.3 1.4 7.1 14.0 11.8 3.2 3.8 6.1 12.4 2.1 0.7 0.6 11.6 7.2 3.7 17.8 3.0 6.2 1.0 2.2 9.4 6.9 3.8 3.6 5.6 10.1 8.8 2.9 8.0 0.0 3.7 3.0 0.6 4.7 6.0 2.3 34.9 4.3 2.0 4.5 10.0 APAF1 "APAF-1, CED4" ENSG00000120868 "Apoptotic peptidase activating factor 1" O14727 12 98645290-98735433 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 32.0" "Cell type enhanced" "Detected in many" "monocytes: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 71.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031373, CAB069399" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 43: THP-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB069399: AB_1611908, HPA031373: AB_10602230" "unprognostic (1.32e-1)" "unprognostic (5.12e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.21e-1)" "unprognostic (3.94e-1)" "unprognostic (8.21e-3)" "unprognostic (2.03e-3)" "unprognostic (1.35e-1)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (5.63e-2)" "unprognostic (6.04e-2)" "unprognostic (9.93e-3)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.07e-2)" 4.5 2.8 2.4 8.9 2.8 32.0 5.0 2.5 2.7 5.5 1.2 8.5 5.1 5.5 3.5 3.2 4.0 7.3 2.6 2.8 1.3 3.7 4.7 6.7 9.4 2.3 1.2 7.7 4.0 2.8 3.1 7.6 2.2 3.9 9.6 5.8 4.6 3.4 3.4 5.7 7.1 5.0 1.9 9.7 6.6 3.1 2.2 7.7 4.7 3.1 8.8 5.8 3.9 4.3 6.8 8.7 30.3 11.6 9.4 18.2 8.3 17.3 12.1 11.7 11.6 6.3 4.8 9.8 4.5 12.7 4.4 11.3 20.2 11.4 13.9 7.3 8.0 18.5 9.6 7.7 3.5 18.6 22.7 7.5 3.5 12.1 5.5 14.1 19.6 7.3 9.1 5.2 18.7 1.8 9.4 19.0 8.1 7.5 5.8 11.9 22.8 3.1 7.1 11.5 4.1 7.4 13.5 5.3 4.6 18.6 9.2 25.7 17.7 7.5 6.6 9.0 5.4 3.5 7.1 11.5 3.3 25.4 11.5 16.8 18.1 17.0 4.0 8.0 3.1 5.5 2.8 2.3 14.3 6.2 2.9 1.9 71.1 2.9 8.5 10.4 2.1 3.9 2.4 2.8 2.5 2.7 2.8 1.3 2.3 1.2 2.2 1.9 2.2 4.3 11.7 12.8 8.2 10.4 13.8 3.8 5.7 8.7 8.6 5.8 6.4 6.5 1.5 1.5 7.8 7.3 14.6 3.8 21.4 22.3 0.0 9.4 0.7 5.9 11.6 11.1 12.0 7.6 12.8 8.0 8.0 9.1 14.8 8.7 6.3 18.6 13.2 6.7 12.3 5.0 13.8 18.9 4.1 34.7 25.3 1.3 5.9 34.1 10.6 30.9 54.6 2.7 20.6 14.1 11.2 19.7 20.3 5.3 8.9 8.7 9.2 2.7 8.9 9.8 0.0 6.9 8.1 6.9 10.0 8.7 3.3 1.9 14.6 4.3 13.3 15.0 APBA1 "D9S411E, MINT1, X11" ENSG00000107282 "Amyloid beta precursor protein binding family A member 1" Q02410 9 69427532-69672371 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5" "Group enriched" "Detected in many" 7 "Astrocytes: 53.5;Excitatory neurons: 130.3;Horizontal cells: 69.0;Inhibitory neurons: 181.6;Microglial cells: 78.7;Oligodendrocyte precursor cells: 141.3;Oligodendrocytes: 106.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.2;BJ hTERT+: 6.0;HAP1: 17.2;SCLC-21H: 6.5;TIME: 7.8;U-138 MG: 6.9;U-266/70: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061287 Supported "Golgi apparatus" NA NA "Cluster 65: Brain - Ion transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA061287: AB_2684467" "unprognostic (4.02e-2)" "unprognostic (4.64e-2)" "unprognostic (7.29e-2)" "unprognostic (8.94e-3)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (4.21e-3)" "unprognostic (8.49e-3)" "unprognostic (2.22e-1)" "unprognostic (2.33e-1)" "unprognostic (2.46e-5)" "unprognostic (1.60e-1)" "unprognostic (3.09e-2)" "unprognostic (4.99e-3)" "unprognostic (3.14e-2)" "unprognostic (2.28e-1)" "unprognostic (4.66e-3)" 2.9 1.2 14.1 0.7 13.1 0.0 2.5 0.0 16.5 3.6 0.0 2.9 0.6 4.1 0.1 1.8 2.5 1.3 3.0 16.0 9.5 2.2 11.9 1.4 0.6 15.1 13.8 5.3 1.9 6.8 6.3 1.4 16.1 1.9 1.9 3.2 2.9 1.1 2.0 3.9 1.8 0.8 0.0 3.8 2.0 2.8 7.9 0.2 2.0 0.6 0.3 2.8 3.6 0.9 0.0 0.0 0.6 0.0 3.1 2.2 0.1 7.2 6.0 0.1 0.1 0.0 0.0 0.0 3.2 3.0 0.0 0.1 17.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.0 2.9 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 2.5 6.5 4.2 0.4 0.9 0.1 0.2 0.0 0.0 7.8 6.9 0.8 0.0 0.5 7.1 3.3 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 13.1 0.0 16.5 16.0 9.5 15.1 13.8 16.1 0.0 7.9 0.9 1.0 0.0 0.0 53.5 0.0 1.8 1.2 0.2 0.0 15.4 2.0 2.2 4.9 0.0 0.2 0.0 4.2 0.8 0.0 3.7 0.0 0.1 0.3 0.9 1.7 1.4 4.2 0.0 130.3 0.0 0.6 1.7 0.0 1.0 0.0 1.3 3.3 5.8 3.1 69.0 181.6 1.6 0.0 3.7 1.4 0.6 2.5 1.4 0.0 78.7 1.0 3.2 0.0 141.3 106.2 0.2 0.4 10.9 0.0 0.6 0.0 0.4 0.1 9.1 0.0 1.6 2.3 1.1 1.3 0.5 2.4 0.4 0.5 6.0 1.2 0.4 APBA2 "D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L" ENSG00000034053 "Amyloid beta precursor protein binding family A member 2" Q99767 15 28884483-29118315 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;lymphoid tissue: 10.7" "Cell type enhanced" "Detected in many" "Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1" "Cancer enhanced" "Detected in many" "glioma: 17.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6" "Lineage enriched" "Detected in many" 4 "T-cells: 5.6" "Cell line enhanced" "Detected in some" "HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037065, HPA058796, HPA070376" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "CAB037065: AB_477178, HPA058796: , HPA070376: " "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.42e-1)" "unprognostic (5.96e-2)" "unprognostic (1.41e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-1)" "unprognostic (8.19e-2)" "unprognostic (4.71e-2)" "unprognostic (9.25e-2)" "unprognostic (4.21e-5)" "unprognostic (1.98e-2)" "unprognostic (4.74e-2)" "unprognostic (7.63e-3)" "unprognostic (4.28e-1)" 1.0 1.6 4.3 0.7 4.4 0.7 0.9 8.7 8.4 2.9 0.0 1.3 0.4 1.2 0.4 1.7 1.6 0.3 0.4 8.0 2.5 0.9 0.9 3.3 0.6 3.3 2.4 1.1 5.9 0.0 7.6 0.1 2.4 2.5 0.2 1.1 0.4 0.1 0.1 1.0 4.9 0.0 2.2 10.7 1.4 5.7 3.0 1.4 2.7 0.0 0.7 1.3 1.5 4.9 0.0 1.6 0.7 3.7 0.0 0.0 0.0 0.9 1.4 0.1 0.5 0.0 0.0 0.0 3.5 0.0 2.3 0.0 0.5 0.0 0.0 0.0 3.1 8.4 0.0 0.1 3.1 0.0 0.2 0.4 2.5 0.4 0.0 0.4 4.4 1.8 5.0 0.2 0.0 0.5 0.2 2.4 1.1 0.0 3.3 0.0 0.4 0.2 0.0 0.0 5.4 20.0 0.0 0.0 0.2 0.1 0.0 1.0 4.4 0.0 4.4 0.0 0.9 0.0 0.1 0.0 0.1 14.9 1.7 0.0 0.0 0.0 0.9 0.0 0.2 0.0 1.5 3.3 0.0 0.0 5.4 5.6 0.1 1.3 0.0 0.0 0.0 2.0 4.3 4.4 8.7 8.4 8.0 2.5 3.3 2.4 2.4 2.2 3.0 4.9 0.5 0.0 0.6 53.2 1.8 0.4 0.2 0.0 0.0 21.5 1.9 2.3 1.4 0.0 0.1 0.0 0.0 0.1 36.5 0.1 1.9 1.8 18.9 2.9 6.4 1.2 0.0 2.1 142.7 5.8 0.2 2.2 0.0 2.1 0.0 1.9 3.6 0.5 1.2 89.2 106.1 0.3 0.0 1.6 0.4 10.4 1.8 0.8 3.6 33.7 1.9 1.3 63.8 97.0 74.1 3.3 0.0 3.8 12.3 0.1 0.0 0.3 0.2 4.5 0.0 0.4 2.1 1.6 14.5 0.4 0.3 0.1 30.7 10.6 0.0 0.1 APC "DP2, DP2.5, DP3, PPP1R46" ENSG00000134982 "APC regulator of WNT signaling pathway" P25054 5 112707498-112846239 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.8" "Cell type enhanced" "Detected in many" "Astrocytes: 536.4;Bipolar cells: 196.9;Excitatory neurons: 165.8;Inhibitory neurons: 236.4;Oligodendrocyte precursor cells: 196.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013349, HPA013362" Supported Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA013349: AB_1844913, HPA013362: " "unprognostic (4.80e-2)" "unprognostic (1.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (7.09e-3)" "unprognostic (1.62e-1)" "unprognostic (8.10e-3)" "unprognostic (2.35e-1)" "unprognostic (4.85e-3)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-2)" "unprognostic (1.07e-1)" "unprognostic (3.35e-1)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" 6.9 4.6 28.4 6.2 26.0 9.1 5.7 23.1 31.0 5.7 0.1 6.7 6.2 5.6 3.3 7.7 4.3 4.9 7.2 52.8 27.4 6.2 5.7 6.2 5.6 32.1 30.7 6.6 4.1 8.5 3.9 5.1 39.0 5.2 6.2 20.0 3.8 4.1 8.5 5.7 8.5 7.5 16.0 6.1 5.0 5.1 37.9 8.5 5.9 11.8 5.9 5.4 3.6 20.9 11.3 10.1 16.8 12.2 13.4 11.3 6.7 17.9 8.5 9.7 11.5 8.2 8.9 22.0 17.0 23.1 15.5 9.0 17.4 14.6 15.9 13.2 12.2 16.8 14.9 6.2 6.6 8.4 8.6 9.3 9.8 16.6 10.8 6.8 13.6 10.2 20.9 7.2 14.3 7.8 9.6 4.2 6.0 6.1 3.6 8.1 20.8 10.7 8.9 14.1 17.0 10.1 16.9 6.5 7.1 6.8 9.1 6.7 22.8 19.6 9.5 19.5 13.6 5.6 9.5 8.2 10.8 15.3 11.2 11.8 2.5 4.9 2.9 1.3 2.4 2.8 1.5 1.9 2.1 3.1 2.4 2.4 11.4 2.9 2.4 2.7 1.5 1.0 28.4 26.0 23.1 31.0 52.8 27.4 32.1 30.7 39.0 16.0 37.9 20.9 40.6 51.3 23.6 536.4 21.9 11.2 8.9 10.1 19.9 196.9 13.1 14.9 56.6 18.6 20.1 0.0 66.7 5.4 28.9 28.6 0.0 18.7 10.5 20.1 27.6 31.2 27.5 17.4 165.8 19.5 6.5 25.9 19.4 29.7 19.0 28.7 26.7 13.9 16.3 79.1 236.4 17.2 2.0 18.9 12.4 5.5 17.7 27.8 17.8 85.3 30.7 23.4 23.7 196.6 150.8 20.3 34.7 19.5 22.9 10.4 37.2 5.1 18.0 41.5 39.5 44.1 34.0 19.2 30.4 26.5 11.6 2.9 22.4 27.1 16.0 8.9 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879792 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 1201.6" "Group enriched" "Detected in many" 4 "Bipolar cells: 147.1;Horizontal cells: 161.5;Oligodendrocytes: 461.3" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 81.6;AN3-CA: 162.9;HMC-1: 76.0;SCLC-21H: 87.2;SH-SY5Y: 89.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 6400000 "Cluster 11: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavorable (2.65e-5)" 3.0 31.5 417.1 3.1 718.0 0.4 1.4 680.9 552.4 3.1 218.6 4.4 1.8 3.1 1.3 1.5 2.7 5.5 10.8 438.3 465.8 4.9 0.6 1.9 1.4 783.2 627.4 1.4 75.0 22.3 151.4 0.9 710.7 2.1 2.2 56.3 1.8 1.9 0.5 1.1 2.1 3.2 605.9 0.5 28.1 13.1 598.3 0.8 1.5 0.5 1.5 1.2 2.1 1201.6 4.4 40.0 81.6 162.9 7.1 3.2 10.4 5.6 3.5 7.8 1.1 7.3 6.3 0.8 66.5 21.0 27.7 2.2 26.1 2.6 5.2 48.9 3.7 0.3 10.6 5.2 2.0 0.2 76.0 3.6 1.8 3.2 0.1 28.8 3.1 6.1 2.7 1.2 25.0 8.3 0.2 0.3 3.9 16.5 16.5 7.2 0.4 1.1 1.4 1.1 87.2 89.3 23.1 3.8 0.8 23.9 20.8 4.3 1.3 61.3 28.8 32.9 4.3 2.4 1.6 0.3 42.3 1.1 33.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 417.1 718.0 680.9 552.4 438.3 465.8 783.2 627.4 710.7 605.9 598.3 1201.6 2.5 6.4 0.0 12.4 0.6 1.3 2.6 0.7 1.2 147.1 0.4 1.1 6.2 1.5 0.2 0.0 12.5 0.3 0.3 0.4 0.0 2.0 27.6 1.3 1.2 2.8 34.9 0.0 55.5 4.2 6.4 2.8 10.2 3.2 0.0 0.1 0.7 0.4 0.4 161.5 46.8 1.1 2.0 0.3 1.6 15.8 1.2 1.1 5.4 12.2 0.0 14.6 0.0 19.1 461.3 3.1 0.1 0.0 0.4 1.9 0.0 0.1 0.2 38.6 0.0 1.9 1.8 14.5 28.7 0.1 0.6 0.4 0.5 0.1 0.2 1.3 APOH "B2G1, BG" ENSG00000091583 "Apolipoprotein H" P02749 17 66212033-66256525 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 563 "liver: 17965.3" "Cell type enriched" "Detected in some" 41 "Hepatocytes: 7680.6" "Cancer enriched" "Detected in many" 232 "liver cancer: 2878.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "Hep G2: 1253.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001654, HPA003732, CAB022214" Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 247000000000 41000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.39e-7)" "unprognostic (1.26e-1)" "unprognostic (5.99e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (1.10e-6)" "unprognostic (1.26e-2)" "unprognostic (5.76e-2)" 0.9 0.3 0.0 0.1 0.1 0.4 0.2 0.1 0.2 0.2 0.3 0.8 2.5 0.1 1.0 0.2 0.8 2.8 0.6 0.2 0.0 31.9 17965.3 5.6 0.3 0.2 0.1 0.2 10.9 0.0 0.2 0.4 0.1 0.2 0.7 0.2 0.1 0.3 0.1 0.2 1.0 0.0 0.1 4.3 3.8 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 33.5 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 60.8 0.0 1.4 0.1 0.0 1.7 1.1 0.0 0.0 0.0 0.4 0.0 2.6 1.4 1253.3 0.0 6.4 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.4 0.5 0.2 0.0 0.2 0.1 0.6 31.5 0.0 0.8 6.4 0.1 0.0 0.9 0.4 0.0 3.4 0.1 0.2 0.0 0.0 0.0 1.7 0.2 0.1 0.1 0.0 0.8 0.1 2.9 15.3 2.4 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.0 12.3 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 183.0 0.6 0.0 0.0 0.0 0.0 0.2 3.9 0.8 0.2 0.2 0.0 5.2 0.0 109.7 0.2 2.3 0.6 0.0 0.0 0.1 0.0 0.0 120.0 7680.6 0.5 0.0 0.2 0.4 0.0 182.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.8 0.0 0.0 0.0 0.4 25.6 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 8.8 0.0 0.8 0.0 APOM "G3a, NG20" ENSG00000204444 "Apolipoprotein M" O95445 6 31652416-31658210 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 390.7" "Group enriched" "Detected in many" 8 "Hepatocytes: 665.9;Proximal tubular cells: 681.1" "Cancer enriched" "Detected in all" 13 "liver cancer: 185.9" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 12 "Hep G2: 38.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034086, HPA051006" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 7400000000 8200000000 "Cluster 34: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "CAB034086: AB_1119033, HPA051006: AB_2681307" "unprognostic (2.76e-3)" "unprognostic (1.69e-2)" "unprognostic (8.66e-2)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (3.78e-1)" "unprognostic (1.97e-2)" "unprognostic (1.80e-1)" "unprognostic (6.04e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (7.28e-2)" "unprognostic (5.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.30e-1)" "unprognostic (3.20e-2)" 4.9 5.3 0.6 0.1 0.6 2.5 5.2 1.0 0.9 3.7 0.5 3.8 0.6 3.9 1.0 4.1 4.1 0.5 3.5 0.6 0.7 93.7 390.7 2.6 0.6 0.7 0.7 6.2 6.0 0.7 4.7 0.1 0.7 3.8 0.4 0.4 3.5 0.5 7.2 6.4 9.0 0.4 0.7 4.1 5.3 16.0 0.6 1.2 5.5 0.6 1.1 3.3 3.3 0.8 0.5 0.3 0.6 0.7 0.6 0.8 0.0 0.4 1.1 0.4 0.9 3.2 1.0 1.4 0.2 1.1 0.2 0.6 0.4 0.6 0.8 0.8 0.7 0.8 0.3 38.2 1.3 1.7 0.1 1.2 0.4 0.3 1.0 0.5 0.3 0.9 1.2 0.4 1.1 1.1 1.1 0.9 0.5 0.6 0.2 0.8 0.4 1.5 1.1 0.6 0.5 0.2 0.4 0.0 0.5 0.2 1.5 1.2 0.4 0.2 0.1 0.3 0.3 1.1 1.2 1.5 0.2 1.8 0.1 3.0 0.6 0.6 0.3 0.3 0.5 1.1 0.4 0.3 0.5 0.5 0.5 0.6 0.4 0.3 0.7 0.3 0.7 0.3 0.6 0.6 1.0 0.9 0.6 0.7 0.7 0.7 0.7 0.7 0.6 0.8 1.5 0.0 7.4 2.3 9.0 6.4 6.7 6.7 9.1 1.5 6.6 12.4 1.6 12.8 3.0 14.7 4.2 2.0 1.6 4.1 76.3 4.3 60.2 5.2 3.1 2.0 4.2 11.4 0.3 6.9 0.9 4.3 5.1 1.6 5.1 1.8 8.9 665.9 5.4 0.0 0.4 4.9 2.0 14.5 4.2 38.4 9.3 6.1 5.4 0.0 2.5 14.6 1.0 0.5 1.3 6.4 4.9 6.4 7.4 4.2 81.4 681.1 4.6 2.5 0.0 6.2 3.1 33.1 6.6 5.3 6.5 1.2 5.6 4.6 6.5 6.1 APP AD1 ENSG00000142192 "Amyloid beta precursor protein" P05067 21 25880550-26171128 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 870.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 38.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000157, HPA001462" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 26000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" Vesicles "CAB000157: AB_323833, HPA001462: AB_1078185" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (3.69e-3)" "unprognostic (2.54e-1)" "unprognostic (8.22e-2)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "unprognostic (4.28e-2)" "unprognostic (5.35e-2)" "prognostic favorable (2.79e-6)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" "unprognostic (5.23e-2)" "unprognostic (2.08e-3)" 249.9 498.0 413.0 157.4 457.6 134.4 447.5 413.1 572.4 264.2 396.8 357.2 226.4 281.1 293.3 178.6 308.1 350.8 389.0 456.2 405.3 532.5 298.2 279.4 78.9 425.0 481.9 306.2 323.5 278.6 155.4 451.9 448.7 260.6 328.5 209.3 270.7 343.6 107.5 218.6 200.3 379.9 419.7 154.4 213.5 165.6 426.4 159.2 469.9 176.0 78.2 304.9 151.7 523.5 388.7 489.9 538.4 448.5 707.7 869.8 559.8 757.1 1029.2 386.6 449.3 286.4 941.0 0.9 848.3 614.8 505.1 255.6 326.4 921.6 324.4 14.7 253.1 0.8 275.6 204.1 688.0 372.0 19.6 790.4 990.7 456.8 823.0 1584.3 1750.7 158.6 0.8 39.0 614.5 433.1 6.5 4.0 416.2 644.9 418.6 241.2 505.2 325.3 1283.3 270.1 267.3 385.6 824.0 549.0 393.4 720.0 482.4 400.1 1837.1 850.8 350.2 310.4 371.6 232.3 3.1 4.8 690.4 1.6 836.3 1.1 7.5 0.0 0.2 2.2 0.3 0.8 2.2 0.7 5.6 2.2 2.3 0.6 1.5 0.5 1.6 38.1 0.6 3.3 413.0 457.6 413.1 572.4 456.2 405.3 425.0 481.9 448.7 419.7 426.4 523.5 330.2 109.0 39.6 70.5 47.6 181.6 215.6 449.0 306.7 45.2 280.3 199.6 143.2 296.0 214.0 502.1 29.2 472.6 180.7 395.2 56.7 398.7 46.1 78.8 162.2 416.0 162.6 29.2 481.6 180.4 141.2 309.5 164.7 110.7 8.2 100.3 539.7 125.7 76.3 84.1 525.5 303.1 256.3 61.6 79.9 61.8 242.6 69.9 161.9 189.3 89.9 329.9 4.1 423.2 870.8 205.4 223.1 296.8 24.0 187.5 95.2 165.8 164.7 24.5 118.3 336.5 198.5 38.3 86.9 85.9 106.1 552.1 27.0 111.4 283.5 133.6 ARCN1 COPD ENSG00000095139 "Archain 1" P48444 11 118572390-118603033 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037573, HPA044874" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 140000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "Golgi apparatus, Cytosol" "HPA037573: AB_10696938, HPA044874: AB_2679126" "unprognostic (1.46e-2)" "unprognostic (4.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.20e-1)" "unprognostic (9.99e-2)" "unprognostic (2.30e-2)" "prognostic unfavorable (2.97e-5)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-3)" "unprognostic (9.39e-2)" "unprognostic (3.56e-2)" "unprognostic (7.99e-2)" "unprognostic (9.20e-2)" "unprognostic (4.14e-3)" "unprognostic (5.56e-3)" 75.4 67.7 47.5 53.8 51.0 30.4 67.5 52.0 60.5 78.0 61.2 65.0 59.2 69.2 111.1 72.5 60.5 51.6 75.6 46.8 50.9 58.3 91.6 62.6 53.2 51.2 51.3 65.5 119.7 61.9 88.7 54.7 51.1 68.8 67.1 39.2 79.6 64.5 51.1 60.9 64.9 71.0 50.0 57.9 71.8 46.2 50.5 58.8 65.2 55.0 62.2 66.4 60.9 57.2 90.9 72.6 135.3 98.9 174.0 172.7 66.6 244.8 208.5 102.4 120.7 239.4 116.6 96.4 199.7 275.7 148.0 123.7 160.5 139.5 151.5 128.0 66.3 211.6 56.7 151.4 197.1 140.4 121.8 157.8 117.6 175.0 168.7 149.3 162.2 95.0 106.8 139.2 201.3 157.0 123.2 130.8 85.3 207.7 92.4 107.9 134.2 147.4 137.3 107.0 88.3 86.6 130.2 129.0 70.1 132.5 155.9 111.4 144.0 129.4 65.1 118.4 109.5 79.9 78.5 147.6 74.3 122.6 161.4 118.1 49.8 50.7 52.7 59.8 69.0 39.5 51.7 51.3 54.0 35.4 48.0 44.7 41.5 64.5 64.5 44.9 53.9 55.8 47.5 51.0 52.0 60.5 46.8 50.9 51.2 51.3 51.1 50.0 50.5 57.2 43.6 35.3 47.9 12.4 32.2 31.6 38.5 31.5 23.9 22.4 39.4 27.9 46.5 24.3 41.9 31.3 4.2 17.2 45.6 68.4 9.8 34.3 11.1 38.4 72.2 43.1 40.2 14.9 15.4 37.8 36.1 44.9 39.3 50.4 39.3 31.9 31.4 55.7 30.3 18.5 17.7 80.2 22.4 36.0 37.6 8.5 48.1 35.3 23.2 11.2 49.0 17.3 26.8 17.1 20.2 46.9 35.8 41.3 68.3 51.5 56.2 30.5 46.2 13.6 19.7 52.7 45.7 44.8 47.6 30.4 34.7 30.2 38.4 43.9 42.6 51.6 ARFGAP1 "ARF1GAP, bA261N11.3, FLJ10767" ENSG00000101199 "ADP ribosylation factor GTPase activating protein 1" Q8N6T3 20 63272785-63289790 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051019, HPA056273" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 71: Testis - DNA repair" "Cluster 39: CACO-2 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus, Vesicles" Cytosol "HPA051019: AB_2681313, HPA056273: AB_2683084" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (1.27e-1)" "unprognostic (3.93e-1)" "unprognostic (1.38e-1)" "unprognostic (1.24e-1)" "unprognostic (1.57e-3)" "unprognostic (7.76e-2)" "unprognostic (8.86e-3)" "unprognostic (8.62e-2)" "prognostic favorable (4.57e-4)" "unprognostic (3.23e-2)" "prognostic unfavorable (3.48e-7)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (4.34e-2)" "unprognostic (2.86e-1)" 12.9 16.7 13.1 15.5 14.3 12.1 13.0 13.1 20.6 19.1 8.4 19.1 13.1 20.8 8.6 15.8 16.1 16.8 14.1 14.4 11.0 15.9 17.8 16.1 16.1 14.1 12.0 17.7 28.3 11.8 63.9 15.4 14.2 20.1 9.5 11.7 18.4 13.4 14.1 19.1 18.1 12.5 9.1 20.5 18.5 24.2 12.5 14.2 17.9 7.5 11.3 16.5 14.9 15.9 32.6 60.2 25.6 30.6 30.3 32.5 51.2 46.4 36.5 90.7 45.5 145.2 35.2 24.5 41.7 55.4 41.5 43.2 23.5 73.8 28.5 15.8 26.7 19.4 64.7 128.4 46.2 28.8 38.4 28.5 46.9 44.0 24.9 30.5 32.9 25.5 34.9 27.8 25.1 53.2 52.9 28.0 34.5 34.3 51.9 29.7 36.8 23.6 22.3 38.8 27.3 29.9 55.1 58.7 59.2 20.7 42.8 36.4 42.8 56.0 77.3 35.0 37.6 28.4 20.2 26.5 56.9 20.0 35.3 4.8 5.7 6.4 5.6 7.1 6.4 3.0 3.1 5.3 5.7 4.2 3.0 3.0 2.4 4.7 9.5 4.2 4.1 6.0 13.1 14.3 13.1 20.6 14.4 11.0 14.1 12.0 14.2 9.1 12.5 15.9 12.6 22.4 30.7 34.9 11.2 10.1 6.0 8.6 4.0 26.6 17.6 14.4 12.4 11.5 14.4 12.9 33.3 12.5 15.4 37.6 9.8 12.2 15.9 11.0 17.1 14.2 24.5 9.5 14.5 15.4 24.9 16.3 50.4 14.9 15.9 30.6 13.6 23.3 14.9 21.9 14.9 40.4 2.0 14.4 11.5 23.3 12.5 13.5 12.4 5.6 12.3 11.8 15.5 18.6 24.8 28.2 18.3 9.8 17.8 11.6 17.4 11.5 18.8 20.1 6.6 11.1 14.9 21.3 7.4 6.7 8.5 15.2 10.3 16.8 24.0 9.2 ARFGAP2 "FLJ14576, IRZ, Zfp289, ZNF289" ENSG00000149182 "ADP ribosylation factor GTPase activating protein 2" Q8N6H7 11 47164299-47177125 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016649, HPA018152" Enhanced Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA016649: AB_1844980, HPA018152: AB_1844979" "unprognostic (1.69e-2)" "unprognostic (9.11e-2)" "unprognostic (5.91e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-2)" "unprognostic (1.12e-1)" "unprognostic (4.81e-3)" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.41e-1)" "unprognostic (3.42e-2)" "unprognostic (7.00e-2)" "prognostic favorable (7.65e-7)" "unprognostic (2.05e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" "unprognostic (9.20e-2)" 38.0 51.4 62.1 36.3 63.9 82.2 41.7 63.2 68.3 42.3 57.2 49.4 40.0 43.3 35.5 60.8 49.3 32.1 58.7 62.5 60.1 47.6 76.8 40.7 51.9 65.1 61.8 44.6 69.7 48.2 38.7 39.9 61.8 51.4 39.4 38.9 56.1 41.7 115.9 78.7 43.8 38.8 60.6 51.2 55.7 30.7 63.1 49.8 47.4 81.4 50.5 44.7 43.3 70.3 55.7 36.4 54.9 43.3 45.9 37.3 51.6 51.2 48.1 64.1 48.4 41.3 45.3 91.3 32.4 58.7 40.8 82.3 47.2 74.6 40.3 45.0 46.1 77.6 85.5 50.8 53.7 107.0 84.4 56.7 82.3 33.3 71.1 46.1 60.4 65.6 111.8 67.8 58.5 102.5 50.8 87.8 43.6 98.3 48.4 78.8 94.8 116.8 60.3 79.3 53.0 47.0 58.7 81.7 38.8 26.1 126.8 78.8 48.7 55.2 43.3 50.5 68.6 58.6 60.7 78.3 38.6 81.2 56.4 108.5 69.1 92.8 74.0 77.3 66.6 59.0 57.1 66.2 65.9 63.1 63.0 63.4 41.8 69.2 98.4 35.4 71.8 108.1 62.1 63.9 63.2 68.3 62.5 60.1 65.1 61.8 61.8 60.6 63.1 70.3 23.8 35.3 45.9 25.1 46.5 22.2 31.4 22.1 29.6 73.6 30.9 25.8 13.0 20.0 41.2 31.3 114.7 64.3 40.7 38.6 25.4 38.7 2.7 20.3 26.4 29.8 45.4 47.1 16.2 36.6 47.1 29.7 34.1 27.0 60.8 44.9 31.1 44.0 36.8 74.0 15.1 35.0 38.7 33.6 25.4 6.6 34.2 28.6 28.4 15.9 58.1 51.1 71.1 13.0 23.7 39.2 45.0 26.4 31.7 26.4 41.0 26.3 34.1 115.4 39.5 33.0 28.0 24.7 35.9 30.3 26.7 91.8 43.7 40.3 36.3 34.0 ARFGAP3 ARFGAP1 ENSG00000242247 "ADP ribosylation factor GTPase activating protein 3" Q9NP61 22 42796502-42858106 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000638 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "Golgi apparatus" "HPA000638: AB_1078188" "unprognostic (3.29e-2)" "unprognostic (6.08e-2)" "unprognostic (3.22e-1)" "prognostic favorable (8.97e-6)" "unprognostic (5.83e-2)" "unprognostic (8.85e-3)" "unprognostic (5.00e-3)" "unprognostic (1.00e-1)" "unprognostic (2.05e-1)" "unprognostic (1.31e-1)" "unprognostic (9.06e-3)" "unprognostic (1.67e-1)" "unprognostic (1.87e-1)" "unprognostic (2.52e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (2.65e-4)" "unprognostic (1.73e-1)" 30.1 88.9 16.5 34.1 17.4 47.8 30.9 19.5 20.4 56.1 23.2 26.9 36.5 32.2 53.3 22.1 22.9 36.6 23.6 17.9 20.6 53.2 49.2 32.3 28.1 20.5 18.7 20.7 85.8 38.0 38.1 34.8 20.3 64.7 30.6 35.5 68.5 40.2 31.3 20.7 51.1 30.8 19.0 26.0 43.2 49.5 19.6 25.9 61.3 21.8 32.6 45.2 23.4 21.0 59.6 19.3 41.1 24.7 57.2 94.1 17.3 111.8 76.4 50.5 60.9 23.5 32.8 30.1 24.5 102.9 41.8 14.4 18.7 33.0 54.7 18.5 25.4 35.7 27.6 37.4 79.6 31.9 53.2 42.0 57.6 42.6 75.9 71.9 52.4 27.4 16.1 132.0 89.6 15.7 49.4 17.5 6.7 32.7 23.2 31.1 92.3 38.3 80.7 27.5 14.6 9.0 54.3 21.5 46.0 30.6 22.7 24.4 67.0 58.7 42.5 52.1 30.7 94.7 48.2 33.1 41.9 34.0 46.7 86.2 33.2 36.8 45.1 44.4 58.8 27.1 29.7 39.8 32.5 26.1 19.2 27.2 50.8 49.4 50.9 53.1 28.8 30.1 16.5 17.4 19.5 20.4 17.9 20.6 20.5 18.7 20.3 19.0 19.6 21.0 40.8 38.5 54.8 27.4 41.7 26.6 86.9 43.0 19.9 42.8 43.1 29.5 26.5 37.1 62.1 57.0 18.8 18.8 67.3 36.4 66.5 65.9 19.1 60.5 89.9 42.4 49.1 17.5 26.1 64.3 23.7 58.1 30.1 96.3 65.9 28.4 30.4 37.3 28.7 33.7 28.8 53.0 46.8 21.7 89.3 15.0 48.1 68.2 69.4 35.6 33.7 40.5 38.1 43.7 40.0 83.0 15.6 45.5 110.0 121.5 70.9 62.9 65.5 33.7 39.5 80.0 65.5 178.7 67.6 14.6 26.7 59.9 49.6 39.0 22.7 86.7 ARFGEF1 "ARFGEP1, BIG1, DKFZP434L057, p200" ENSG00000066777 "ADP ribosylation factor guanine nucleotide exchange factor 1" Q9Y6D6 8 67173511-67343781 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023399, HPA023822" Supported Supported Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA023399: AB_1844981, HPA023822: AB_1844982" "prognostic unfavorable (8.76e-4)" "unprognostic (1.62e-1)" "unprognostic (4.60e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (4.52e-1)" "unprognostic (5.38e-2)" "unprognostic (4.67e-2)" "unprognostic (2.13e-3)" "unprognostic (1.31e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (1.62e-1)" "unprognostic (1.61e-2)" 11.4 10.3 5.6 14.6 5.3 27.5 13.6 8.2 6.8 14.2 10.1 19.2 16.9 10.5 11.0 15.2 11.8 12.5 9.6 4.6 5.5 22.8 15.2 13.8 15.4 6.2 6.5 10.3 17.5 28.0 5.4 14.4 6.7 13.0 17.2 36.5 14.8 12.1 12.8 13.7 17.5 10.8 5.2 13.8 19.6 28.3 6.4 22.2 22.4 14.0 17.2 19.7 7.9 7.3 31.8 20.4 19.3 7.3 21.9 29.8 22.5 21.4 24.3 21.7 22.0 12.6 30.0 23.9 8.9 27.6 26.2 22.2 23.5 30.4 26.6 28.3 16.0 40.2 12.0 13.5 18.6 20.9 37.3 18.4 21.6 19.2 31.8 22.3 31.5 24.6 24.5 25.3 25.5 7.2 48.1 9.7 42.5 34.5 18.5 22.4 13.9 4.8 35.8 58.2 7.6 14.9 14.1 33.9 19.5 29.5 58.5 18.3 38.6 14.4 19.3 19.5 16.4 20.4 22.6 17.5 23.6 20.8 14.2 6.1 1.6 4.3 2.8 2.3 3.6 1.2 1.8 2.3 1.6 1.3 3.0 2.6 5.1 2.5 0.9 2.2 3.9 0.9 5.6 5.3 8.2 6.8 4.6 5.5 6.2 6.5 6.7 5.2 6.4 7.3 38.5 44.8 23.1 73.1 32.7 23.7 34.0 23.8 19.9 36.8 32.7 18.9 33.1 18.6 31.9 38.6 139.7 20.0 47.0 43.2 11.7 29.7 25.4 42.5 34.7 28.5 29.4 16.2 119.0 25.6 15.4 22.9 57.6 53.0 15.2 40.0 23.2 19.6 15.8 43.7 146.3 27.9 14.2 31.3 20.4 36.0 40.0 35.2 17.8 105.9 47.1 22.9 46.4 151.8 126.6 40.1 25.7 30.1 29.8 38.2 30.8 24.7 33.9 100.8 6.6 23.6 26.5 69.4 50.7 26.0 29.5 24.9 42.4 32.1 28.0 60.4 ARFGEF2 BIG2 ENSG00000124198 "ADP ribosylation factor guanine nucleotide exchange factor 2" Q9Y6D5 20 48921711-49036693 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 81.5" "Cell type enhanced" "Detected in all" "Excitatory neurons: 102.6;Inhibitory neurons: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026078, CAB026382" Supported Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Vesicles, Cytosol" "CAB026382: , HPA026078: AB_1844983" "unprognostic (1.50e-2)" "unprognostic (9.56e-3)" "unprognostic (4.14e-2)" "unprognostic (4.94e-3)" "unprognostic (5.30e-2)" "unprognostic (6.94e-2)" "unprognostic (1.57e-2)" "unprognostic (2.99e-1)" "unprognostic (8.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.12e-2)" "unprognostic (1.11e-1)" "prognostic favorable (6.15e-7)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (2.85e-1)" "unprognostic (3.90e-2)" 9.1 20.2 2.8 8.7 4.1 10.4 15.8 1.9 5.8 11.5 7.9 14.2 13.7 9.0 5.9 11.0 7.5 8.5 13.4 4.5 3.9 15.3 12.4 7.8 9.8 2.6 3.2 7.7 19.2 81.5 8.7 9.2 3.5 10.6 15.7 6.8 11.0 9.7 11.8 11.1 10.9 9.5 1.9 10.4 16.2 13.6 3.5 11.3 23.8 18.2 14.2 11.1 8.2 5.0 18.3 16.5 8.9 5.1 18.0 14.8 21.8 15.5 19.5 36.6 19.0 37.1 19.8 25.5 22.1 19.7 33.8 21.0 18.6 23.6 33.8 9.0 7.6 17.5 17.9 25.4 19.7 22.6 19.7 15.0 21.6 23.9 27.6 12.7 28.4 11.7 15.0 22.3 20.8 6.3 13.0 6.8 8.3 20.5 17.4 14.0 25.5 30.3 13.6 23.4 7.1 9.0 42.6 66.0 23.4 10.3 26.6 18.6 34.5 35.6 16.5 18.2 13.1 35.9 35.0 18.7 23.4 10.7 11.6 1.1 0.6 0.2 0.5 0.4 0.6 0.5 0.5 0.4 0.7 0.9 0.8 0.7 0.3 0.3 0.3 0.9 0.1 0.3 2.8 4.1 1.9 5.8 4.5 3.9 2.6 3.2 3.5 1.9 3.5 5.0 16.6 19.2 26.0 37.2 21.2 11.3 12.2 11.0 11.4 15.3 27.7 14.7 40.7 17.2 20.0 11.0 14.6 10.5 14.7 30.4 1.9 10.9 16.6 19.5 17.1 19.5 12.5 14.3 102.6 13.3 10.0 12.6 16.3 24.7 15.2 11.0 20.7 27.8 10.8 11.8 96.7 23.3 8.2 15.7 13.9 24.6 10.2 17.8 10.6 60.9 15.6 5.4 10.3 43.2 57.0 15.5 21.6 11.3 29.0 24.1 18.6 11.5 17.2 16.1 6.6 14.2 12.5 32.6 20.4 17.5 15.5 30.0 13.2 16.6 21.0 21.2 ARFIP1 HSU52521 ENSG00000164144 "ADP ribosylation factor interacting protein 1" P53367 4 152779937-152918463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005080, HPA037375, HPA063759" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Vesicles" Nucleoplasm "CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.75e-5)" "unprognostic (1.49e-3)" "unprognostic (4.32e-1)" "unprognostic (1.24e-1)" "unprognostic (3.54e-2)" "unprognostic (5.34e-1)" "unprognostic (1.03e-2)" "unprognostic (3.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-2)" "prognostic favorable (2.83e-10)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (7.02e-2)" "unprognostic (4.22e-3)" 16.8 14.8 7.9 15.8 8.7 3.7 23.4 9.9 10.8 22.5 9.9 28.1 23.2 21.7 20.5 20.9 18.5 19.9 10.2 7.3 9.3 19.8 15.4 16.8 15.1 9.3 8.0 17.6 10.5 22.4 10.5 18.0 9.5 21.1 27.8 20.2 13.7 17.2 6.6 17.3 21.3 19.8 9.4 18.3 22.7 12.1 8.3 12.0 20.1 10.4 14.8 23.5 15.2 11.4 25.8 18.4 25.1 25.7 37.2 37.9 30.6 29.5 40.5 28.7 26.9 21.3 51.3 20.6 9.9 40.5 22.7 18.1 26.3 29.1 35.3 16.9 16.2 20.0 18.0 20.5 26.1 38.2 41.7 26.6 30.9 24.8 23.8 30.7 26.4 11.8 23.5 43.3 39.8 28.6 22.7 19.8 21.8 29.9 18.5 12.6 14.7 19.2 50.7 32.1 32.8 26.0 22.1 40.7 30.2 23.5 37.7 19.6 17.3 27.8 20.1 26.8 21.4 48.2 42.8 28.1 35.3 38.2 40.0 31.5 27.3 42.2 14.5 31.1 14.6 19.0 11.2 12.2 24.8 17.7 8.7 11.8 81.6 29.1 30.7 3.1 18.5 18.7 7.9 8.7 9.9 10.8 7.3 9.3 9.3 8.0 9.5 9.4 8.3 11.4 28.5 6.4 31.8 40.5 20.3 29.6 18.4 30.7 34.1 17.2 26.2 19.7 10.2 20.0 29.1 38.6 0.0 28.6 15.6 40.9 27.4 27.4 46.3 42.2 33.0 23.8 38.9 12.0 44.5 18.3 27.0 28.8 40.2 50.7 22.8 14.2 17.2 19.8 22.1 18.5 42.8 39.1 34.6 23.8 18.0 21.6 22.4 24.5 21.4 89.9 19.5 35.9 23.7 76.4 75.6 24.4 28.2 21.8 11.8 23.6 23.8 34.2 31.9 24.2 32.9 20.6 27.8 31.7 29.5 31.9 34.0 43.9 17.7 89.2 31.7 30.3 ARFIP2 POR1 ENSG00000132254 "ADP ribosylation factor interacting protein 2" P53365 11 6474683-6481479 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032985, HPA038156" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "CAB032985: AB_2058811, HPA038156: AB_10697243" "unprognostic (2.32e-1)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "prognostic favorable (2.00e-5)" "unprognostic (8.44e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-3)" "unprognostic (2.50e-1)" "unprognostic (2.96e-1)" "unprognostic (1.76e-1)" "unprognostic (5.70e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.53e-4)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (2.32e-2)" "unprognostic (9.48e-3)" 19.8 29.3 31.7 18.6 32.3 22.8 50.7 32.5 35.2 36.3 36.2 36.8 32.9 27.2 34.0 31.4 39.3 23.9 17.9 32.1 31.4 27.0 34.6 24.4 22.4 31.2 31.4 29.4 49.4 46.4 40.7 29.7 31.9 46.6 48.1 28.3 57.7 28.2 15.2 32.8 30.7 27.4 30.9 20.7 50.4 18.3 31.8 25.7 36.9 16.1 32.0 29.2 24.4 33.1 50.4 64.8 38.9 38.5 59.1 53.9 56.1 40.3 107.0 86.2 101.8 62.1 80.3 39.9 16.5 79.3 49.8 68.0 49.4 84.1 70.0 30.9 86.5 22.3 87.7 60.4 71.3 36.2 42.8 60.0 65.7 43.0 98.3 64.2 55.9 38.3 35.3 45.0 55.8 98.9 41.9 41.6 67.2 119.0 71.9 31.7 22.6 37.1 61.9 50.4 50.8 63.2 48.7 204.9 25.9 36.3 86.9 33.0 36.8 35.4 35.7 39.1 30.3 67.3 32.5 24.3 65.4 22.0 43.9 13.0 15.6 9.9 17.9 10.9 17.8 12.1 16.7 14.5 21.3 13.8 16.7 17.1 6.1 21.1 6.7 16.6 18.9 13.9 31.7 32.3 32.5 35.2 32.1 31.4 31.2 31.4 31.9 30.9 31.8 33.1 14.8 6.4 6.4 4.6 20.7 28.0 49.3 48.9 16.5 32.6 59.8 45.1 4.3 40.0 30.5 12.9 29.2 80.1 24.3 56.0 58.7 62.7 31.7 28.1 20.1 19.6 63.0 21.8 8.4 85.4 65.8 23.1 62.2 37.2 31.8 30.3 20.3 21.1 28.1 21.9 7.8 126.6 32.6 10.1 16.4 43.3 20.5 14.4 24.9 5.6 25.2 35.4 18.6 6.6 7.6 59.9 63.4 24.5 28.0 73.3 65.2 34.4 34.7 32.3 26.3 21.6 23.3 41.0 26.2 26.2 32.1 112.5 16.9 40.9 52.6 64.7 ARFRP1 "ARL18, ARP, Arp1" ENSG00000101246 "ADP ribosylation factor related protein 1" Q13795 20 63698642-63708025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047028, HPA050634" Approved Supported "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA047028: AB_2679908, HPA050634: AB_2681196" "unprognostic (6.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.95e-2)" "unprognostic (6.03e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.70e-2)" "unprognostic (2.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.53e-2)" "unprognostic (5.58e-2)" "unprognostic (3.93e-2)" "unprognostic (1.72e-2)" "unprognostic (5.48e-2)" "unprognostic (3.39e-1)" 26.8 27.8 23.4 14.0 23.4 10.0 25.0 22.8 29.1 31.8 22.4 29.3 18.9 29.3 5.3 36.2 27.9 8.8 41.0 22.7 22.7 34.1 36.5 26.0 17.8 23.1 23.2 29.3 24.4 12.6 25.1 11.6 23.1 32.4 8.4 5.5 22.4 16.0 31.8 22.9 27.2 10.1 22.7 42.0 24.6 20.1 24.5 17.7 25.6 15.5 11.2 29.5 28.3 23.9 26.5 31.9 10.1 10.6 10.0 10.8 14.6 31.8 21.1 67.7 24.6 60.0 22.4 32.4 21.6 18.8 27.3 35.8 11.0 35.5 11.9 11.3 16.5 23.8 36.1 52.2 34.7 27.3 21.5 15.1 45.2 17.8 21.6 17.9 25.1 30.5 36.0 24.1 16.9 14.9 54.0 37.7 15.8 19.5 46.7 42.3 14.0 33.4 14.5 21.7 16.9 17.3 32.3 46.5 11.4 6.1 20.5 34.8 20.0 39.6 15.9 14.9 32.6 24.9 11.1 25.1 26.5 17.9 22.8 44.3 30.9 23.5 41.5 31.6 34.7 32.6 37.5 39.8 28.3 33.7 46.8 41.5 15.7 37.6 34.7 49.2 32.3 36.5 23.4 23.4 22.8 29.1 22.7 22.7 23.1 23.2 23.1 22.7 24.5 23.9 40.7 12.8 11.9 12.4 25.9 13.9 25.5 26.1 19.4 44.6 20.8 28.7 34.0 8.6 15.8 25.8 20.9 42.2 28.0 48.9 39.2 31.2 12.8 13.5 27.0 34.3 26.4 25.7 10.6 20.4 25.5 31.6 18.3 10.7 24.7 28.4 24.3 18.4 36.9 37.0 10.6 31.6 18.3 20.7 15.3 10.5 23.9 24.1 24.9 5.6 41.0 40.8 29.9 4.0 11.9 51.6 34.6 29.7 23.4 22.9 52.4 33.4 12.3 42.3 19.7 21.8 35.1 44.5 32.7 22.4 14.2 30.2 30.7 35.7 33.1 17.0 ARHGAP15 BM046 ENSG00000075884 "Rho GTPase activating protein 15" Q53QZ3 2 143091362-143768352 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 79.8;lymphoid tissue: 75.2" "Cell type enhanced" "Detected in many" "B-cells: 126.3;Early spermatids: 132.3;granulocytes: 88.5;Microglial cells: 250.1;NK-cells: 89.6;T-cells: 149.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 59.4;HEL: 75.8;HL-60: 124.3;MOLT-4: 82.0;NB-4: 100.4;THP-1: 131.0;U-698: 89.5;U-937: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032125 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA 38000 "Cluster 5: Granulocytes - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 43: THP-1 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "Golgi apparatus, Vesicles" Nucleoplasm "HPA032125: AB_10671370" "unprognostic (1.59e-2)" "unprognostic (2.40e-3)" "unprognostic (8.63e-2)" "unprognostic (2.19e-2)" "unprognostic (2.99e-1)" "unprognostic (6.62e-3)" "unprognostic (6.14e-2)" "unprognostic (2.18e-3)" "unprognostic (1.32e-2)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (4.40e-2)" "unprognostic (2.12e-2)" "unprognostic (4.58e-2)" "unprognostic (6.94e-2)" 6.9 5.9 1.4 27.1 1.3 79.8 7.6 2.3 2.3 4.1 1.9 7.3 6.8 2.6 9.7 4.0 2.8 11.4 5.6 1.2 2.2 4.4 10.2 9.8 59.3 3.0 1.9 1.8 1.3 1.7 1.0 4.0 2.7 4.3 7.7 1.3 4.2 5.1 1.2 2.0 15.1 3.9 1.9 44.9 7.5 7.4 2.1 75.2 4.5 2.2 46.3 11.4 4.3 4.0 0.3 0.1 4.9 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 59.4 0.2 0.1 0.1 0.1 0.2 0.1 0.3 14.6 0.0 75.8 0.5 0.1 0.0 124.3 1.2 0.0 0.0 0.2 0.2 0.1 0.0 47.0 0.3 4.4 0.0 0.1 82.0 100.4 0.3 0.0 0.1 44.7 0.6 22.7 0.0 0.1 0.2 0.4 0.3 0.2 1.0 0.1 4.5 131.0 0.6 0.4 1.2 0.1 0.2 1.0 0.3 89.5 0.7 63.9 3.9 181.8 32.0 140.1 97.7 34.3 161.6 94.3 172.8 125.7 56.3 86.2 119.0 101.7 207.2 121.4 40.5 54.3 147.7 99.9 1.4 1.3 2.3 2.3 1.2 2.2 3.0 1.9 2.7 1.9 2.1 4.0 8.2 0.0 9.6 2.0 126.3 5.6 0.1 0.0 0.0 0.3 1.8 2.0 3.9 1.5 2.5 0.0 0.0 0.2 78.9 0.3 0.0 0.1 132.3 1.8 2.3 4.3 0.0 26.3 12.2 0.0 0.3 9.7 8.6 3.5 88.5 0.0 8.6 0.8 21.3 1.7 6.8 0.0 0.0 39.9 30.9 17.5 14.9 43.0 8.8 250.1 34.9 0.4 89.6 20.6 3.2 0.0 0.0 3.4 65.8 0.2 0.0 0.7 2.2 0.3 46.0 2.7 31.6 68.4 1.2 0.4 4.5 0.3 149.2 0.1 0.2 0.2 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 240.6;Excitatory neurons: 403.4;Inhibitory neurons: 239.7;Oligodendrocyte precursor cells: 170.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 26.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 36.6;RT4: 39.5;SK-BR-3: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544" "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.7 7.5 2.6 3.4 8.2 2.1 10.3 0.0 26.6 11.9 0.0 14.1 21.1 8.1 9.0 26.3 13.3 7.6 4.3 15.1 0.0 7.0 5.0 5.8 1.6 0.0 0.0 10.9 15.2 10.7 6.1 8.6 0.0 6.4 15.8 33.5 15.8 4.2 7.6 20.1 20.6 5.9 0.0 3.0 12.0 10.7 0.0 10.5 3.8 4.3 6.9 9.4 17.1 5.1 12.2 6.4 19.7 0.1 6.3 6.3 14.2 4.5 6.3 2.8 3.4 14.9 24.7 0.1 6.7 8.7 14.1 27.2 9.0 11.4 5.4 0.0 3.1 0.2 3.4 5.6 3.1 0.0 0.0 6.1 14.4 2.7 16.3 6.2 3.5 10.2 0.6 0.2 4.9 9.5 10.2 0.2 5.4 36.6 6.8 24.9 5.9 2.5 3.0 39.5 19.3 7.9 6.8 42.3 8.0 7.5 21.9 3.9 6.6 9.9 5.2 5.9 8.9 0.3 0.0 0.1 4.3 27.4 6.4 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.7 0.1 0.3 0.1 0.1 2.6 8.2 0.0 26.6 15.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.3 6.4 16.8 240.6 3.4 18.2 12.7 29.1 16.5 31.6 36.5 17.1 4.3 14.3 46.6 11.0 123.0 23.1 4.8 48.7 1.9 8.3 19.0 27.7 10.0 5.6 40.7 2.5 403.4 27.2 4.2 14.1 35.2 25.4 1.3 9.8 5.0 16.2 6.5 18.5 239.7 61.9 20.3 4.1 4.2 12.3 6.8 5.7 16.0 103.0 2.9 113.6 0.0 170.9 95.0 24.5 44.2 13.2 1.5 22.7 52.7 9.9 61.6 37.9 19.7 19.4 9.5 8.6 9.6 55.4 31.1 28.5 2.0 4.0 54.0 59.5 ARHGEF10L "FLJ10521, KIAA1626" ENSG00000074964 "Rho guanine nucleotide exchange factor 10 like" Q9HCE6 1 17539698-17697874 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 41 "classical monocyte: 18.8;intermediate monocyte: 18.0;myeloid DC: 13.4;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 48 "dendritic cells: 13.4;monocytes: 18.8" "Cell line enhanced" "Detected in many" "Hep G2: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026426, HPA026440, HPA028115" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus, Vesicles, Cytosol" "HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285" "unprognostic (4.34e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "prognostic favorable (8.13e-5)" "unprognostic (3.61e-2)" "unprognostic (7.90e-2)" "unprognostic (2.10e-2)" "unprognostic (1.75e-3)" "unprognostic (1.94e-3)" "unprognostic (5.83e-2)" "prognostic favorable (5.65e-4)" "unprognostic (4.11e-2)" "unprognostic (1.66e-1)" "unprognostic (8.17e-2)" "unprognostic (5.21e-3)" 22.2 10.5 11.9 11.4 10.9 1.7 16.5 38.7 11.4 24.2 13.8 29.4 15.9 16.2 4.6 28.1 16.0 11.9 30.2 10.3 12.2 32.5 87.5 13.0 4.5 19.4 18.5 10.4 43.9 17.0 7.9 5.9 19.4 18.4 12.9 4.0 25.9 19.5 66.2 40.9 21.7 8.7 10.9 9.7 20.8 3.7 17.7 1.6 18.0 35.5 4.3 24.6 21.7 9.3 8.0 9.1 11.3 3.9 19.1 6.3 7.6 5.4 10.6 6.3 5.3 9.5 23.6 0.0 9.8 10.2 8.8 6.0 1.6 2.9 1.2 0.2 2.9 0.0 9.5 26.9 4.2 0.0 0.0 8.5 5.5 3.9 1.1 12.7 1.2 0.0 0.0 0.2 17.8 7.7 0.0 0.2 4.9 12.2 0.0 0.0 4.5 3.0 13.4 16.4 16.5 12.2 4.2 2.9 12.3 3.2 11.0 9.5 0.0 5.5 6.5 6.5 2.3 0.0 2.5 0.0 8.5 0.2 3.0 0.0 18.8 0.0 0.0 18.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.3 0.0 4.8 0.0 0.0 7.6 11.9 10.9 38.7 11.4 10.3 12.2 19.4 18.5 19.4 10.9 17.7 9.3 1.3 3.2 7.4 82.6 1.0 5.7 5.3 7.2 5.2 16.1 13.7 12.3 36.4 20.0 13.9 31.3 2.1 0.7 0.1 41.6 9.8 19.8 15.9 3.4 4.2 2.1 37.8 2.7 16.7 20.3 0.6 8.5 17.9 6.5 0.0 3.9 2.5 43.7 26.0 10.1 23.8 45.5 8.2 8.6 26.4 8.9 5.0 18.6 3.6 19.7 9.6 14.6 0.0 24.6 7.1 11.7 24.9 6.8 0.2 5.9 13.6 18.3 9.4 5.4 13.1 10.8 18.3 11.9 1.6 8.0 8.7 1.0 0.6 0.3 46.1 12.1 ARL1 ARFL1 ENSG00000120805 "ADP ribosylation factor like GTPase 1" P40616 12 101393116-101407772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062656, HPA073012" Approved Supported "Golgi apparatus" NA NA 13000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 1: Thyroid gland - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA062656: AB_2684821, HPA073012: AB_2686564" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.61e-4)" "unprognostic (6.41e-2)" "unprognostic (3.15e-2)" "unprognostic (2.62e-3)" "unprognostic (1.69e-1)" "unprognostic (1.97e-1)" "unprognostic (4.82e-2)" "unprognostic (2.28e-1)" "unprognostic (4.54e-2)" "unprognostic (1.04e-2)" "unprognostic (1.21e-1)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (3.46e-2)" 46.4 66.0 25.3 40.0 27.0 16.5 62.5 26.6 31.6 86.5 41.8 56.6 48.0 51.3 71.2 49.1 50.1 43.6 65.5 27.1 33.6 76.6 68.6 36.6 33.2 30.1 29.3 65.2 44.6 92.6 59.1 51.5 31.9 73.4 60.5 48.7 73.9 69.1 51.9 27.8 43.2 59.7 28.5 28.9 57.5 32.8 28.0 32.8 84.7 56.7 48.7 53.0 35.9 27.7 64.9 61.2 58.8 51.6 162.0 161.5 77.8 129.2 155.2 85.9 81.9 71.4 46.9 58.4 77.3 150.7 76.4 44.3 67.1 88.6 98.0 47.0 51.5 54.9 32.9 110.7 120.2 63.7 40.2 97.7 77.1 85.6 135.7 146.1 93.1 39.7 74.1 33.5 113.3 76.1 55.4 63.4 56.6 93.9 82.5 40.8 58.8 67.1 130.5 128.6 38.8 25.5 62.1 80.5 104.2 82.6 136.0 43.5 70.4 65.1 37.3 88.5 56.4 55.5 59.5 58.9 93.3 47.4 71.5 50.4 25.3 18.2 21.8 30.7 32.5 30.1 25.8 28.4 32.8 28.8 25.6 20.1 2.5 23.7 34.2 39.6 34.1 24.6 25.3 27.0 26.6 31.6 27.1 33.6 30.1 29.3 31.9 28.5 28.0 27.7 57.0 41.7 46.7 13.4 39.4 51.2 71.4 175.5 38.7 42.1 65.1 64.4 75.2 41.5 119.1 69.9 18.8 102.6 30.5 42.3 125.2 97.0 90.2 54.8 68.4 44.6 47.5 24.6 14.5 64.3 119.4 88.4 36.2 60.6 37.4 37.4 36.8 50.2 65.8 32.0 19.5 125.6 75.3 27.7 31.9 31.8 78.6 31.6 55.2 6.5 39.6 81.9 25.7 12.5 15.8 62.1 52.2 71.1 79.3 117.2 70.4 131.3 100.0 48.9 46.0 51.2 75.7 134.6 86.1 46.2 55.4 135.3 28.8 54.6 65.7 100.1 ARL15 "ARFRP2, FLJ20051" ENSG00000185305 "ADP ribosylation factor like GTPase 15" Q9NXU5 5 53883942-54310582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 441.6;Inhibitory neurons: 285.2;Microglial cells: 408.5;Oligodendrocyte precursor cells: 184.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044604, HPA063820" Uncertain Approved "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Plasma membrane, Cell Junctions" "HPA044604: AB_10960542, HPA063820: AB_2685131" "unprognostic (2.18e-1)" "unprognostic (4.32e-2)" "unprognostic (1.82e-2)" "unprognostic (2.41e-2)" "unprognostic (1.08e-1)" "unprognostic (3.70e-1)" "unprognostic (8.52e-3)" "unprognostic (1.16e-2)" "unprognostic (3.05e-2)" "unprognostic (6.56e-2)" "unprognostic (4.26e-3)" "unprognostic (3.86e-1)" "unprognostic (2.48e-3)" "unprognostic (1.35e-1)" "unprognostic (9.15e-2)" "unprognostic (5.60e-2)" "unprognostic (1.08e-1)" 14.0 12.5 6.6 5.6 7.5 1.9 13.0 5.6 10.0 17.7 7.2 10.6 11.9 16.0 7.6 9.8 8.2 14.5 14.0 8.5 7.1 17.9 9.8 7.6 6.3 5.8 6.2 5.7 5.0 3.2 8.5 22.3 6.0 10.0 10.9 7.6 10.5 6.8 3.3 11.3 9.9 16.6 6.1 8.2 8.3 9.3 6.8 10.6 8.4 11.7 8.0 13.6 8.8 6.2 3.2 5.5 8.5 15.6 7.0 7.8 11.8 10.2 15.1 9.4 20.7 21.1 8.0 32.0 14.9 9.1 11.0 7.7 13.2 14.1 12.4 3.2 13.9 36.9 7.1 2.8 2.5 4.5 43.8 10.0 10.1 15.8 9.5 14.2 20.8 7.0 32.4 5.3 6.5 7.7 7.5 4.3 3.0 1.6 3.9 6.2 10.4 0.8 12.8 30.3 11.3 7.1 13.1 6.7 7.9 15.6 8.6 4.7 11.4 5.7 9.6 5.4 6.7 1.8 1.7 34.8 9.9 10.6 9.5 1.1 1.8 2.2 1.3 1.4 0.7 1.0 0.9 0.9 2.4 0.7 0.9 0.7 3.5 0.7 1.2 0.3 2.3 1.2 6.6 7.5 5.6 10.0 8.5 7.1 5.8 6.2 6.0 6.1 6.8 6.2 44.5 3.2 7.7 33.6 6.5 9.7 7.9 5.8 8.0 5.1 4.8 5.8 7.5 5.7 4.5 12.9 14.6 52.5 5.2 7.5 21.5 3.2 3.4 4.1 6.9 35.1 20.9 8.6 441.6 4.9 4.9 8.5 6.6 5.1 2.5 3.2 26.0 4.9 8.4 1.7 285.2 7.6 18.3 8.7 8.7 1.5 4.4 12.5 1.8 408.5 5.0 3.2 6.2 184.5 104.7 6.9 7.6 3.8 4.7 5.4 5.7 10.0 3.9 3.0 6.6 3.6 5.3 1.0 3.5 5.9 10.1 42.7 8.9 24.4 7.1 8.4 ARL2 ARFL2 ENSG00000213465 "ADP ribosylation factor like GTPase 2" P36404 11 65014160-65022184 "FDA approved drug targets, Predicted intracellular proteins" "Cell cycle" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 430.8;Late spermatids: 1125.1;Proximal tubular cells: 505.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044610 Supported Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol" "HPA044610: AB_10964207" "unprognostic (9.23e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (1.61e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-3)" "unprognostic (2.34e-1)" "unprognostic (9.85e-3)" "unprognostic (6.43e-2)" "unprognostic (6.87e-3)" "prognostic favorable (7.70e-4)" "unprognostic (2.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (1.24e-2)" 124.8 93.7 161.5 40.6 190.2 51.3 112.0 172.4 200.2 106.3 132.3 123.1 52.7 121.2 28.2 67.2 94.6 48.0 169.1 157.0 168.7 138.5 22.5 90.4 37.7 171.5 167.9 95.7 75.3 65.3 68.5 56.1 167.2 84.7 32.9 43.5 67.9 66.6 214.2 95.8 73.4 60.9 171.4 63.4 85.2 116.1 167.4 33.5 85.7 158.1 29.0 112.2 93.5 184.4 162.0 257.0 76.5 115.8 207.4 156.5 70.5 82.5 181.7 111.2 109.1 72.8 110.0 62.1 144.5 112.7 168.1 101.4 82.9 140.0 53.1 65.5 130.6 61.9 109.2 111.9 157.8 77.9 54.9 123.7 114.6 92.6 204.4 160.5 150.4 74.0 152.8 110.1 76.4 194.1 63.1 174.5 120.3 77.7 208.6 33.4 81.6 152.9 120.9 70.6 143.3 79.3 66.4 67.6 225.8 74.4 72.3 94.3 109.2 205.9 68.6 164.7 82.1 37.9 57.6 38.5 97.2 112.5 171.3 46.5 78.2 72.5 120.4 80.2 130.9 163.1 110.0 116.9 101.7 149.0 123.5 137.2 10.2 83.3 48.2 140.1 79.0 136.9 161.5 190.2 172.4 200.2 157.0 168.7 171.5 167.9 167.2 171.4 167.4 184.4 179.1 22.4 43.6 0.0 42.7 81.4 94.4 118.4 63.7 70.2 66.8 83.9 103.2 51.5 66.4 82.8 29.2 179.7 40.0 110.0 268.0 142.0 430.8 42.2 59.0 148.0 83.3 69.4 0.0 76.0 193.5 107.0 29.6 50.7 95.7 71.5 137.4 19.7 98.3 69.0 0.0 68.4 83.4 49.7 73.5 1125.1 71.7 49.5 177.9 0.0 100.6 208.4 55.6 0.0 0.0 68.3 115.7 71.1 16.5 79.9 162.4 505.5 47.0 48.9 65.7 74.2 109.7 126.5 79.4 56.3 82.8 107.3 40.0 65.7 98.0 75.9 ARL4D ARF4L ENSG00000175906 "ADP ribosylation factor like GTPase 4D" P49703 17 43398993-43401137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 224.3;Early spermatids: 220.8;Rod photoreceptor cells: 259.6;Squamous epithelial cells: 223.4;Suprabasal keratinocytes: 254.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 32.3;naive B-cell: 36.1" "Lineage enriched" "Detected in all" 4 "B-cells: 36.1" "Cell line enhanced" "Detected in many" "HHSteC: 57.1;hTCEpi: 76.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 8.7;cerebral cortex: 8.8;hippocampal formation: 5.7;olfactory bulb: 4.2;spinal cord: 5.4" HPA060379 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 77: Retina - Visual perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" Vesicles "Golgi apparatus" "HPA060379: AB_2684269" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (2.34e-2)" "prognostic favorable (1.16e-5)" "unprognostic (7.71e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.47e-1)" "unprognostic (4.59e-2)" "unprognostic (4.45e-1)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (7.87e-2)" "unprognostic (2.00e-3)" "unprognostic (3.49e-2)" "unprognostic (6.48e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (9.25e-4)" 21.0 4.3 7.9 2.2 8.7 0.9 7.2 9.1 11.6 29.3 12.6 27.9 2.0 20.2 4.7 82.2 22.1 7.3 12.7 8.1 7.1 30.5 56.4 16.2 1.6 5.6 5.7 9.7 2.2 8.1 21.6 7.7 5.7 11.0 3.5 85.1 16.9 15.2 1.9 44.9 6.0 14.8 5.4 16.7 7.6 32.1 5.7 1.6 38.3 3.4 3.0 28.5 39.5 9.3 8.7 10.9 6.7 5.2 12.5 17.2 3.1 21.0 21.5 14.6 18.8 9.7 37.7 0.1 10.3 22.6 10.0 23.4 4.5 32.0 10.0 1.9 7.5 0.7 8.7 22.5 57.1 2.4 2.1 19.2 76.1 21.3 45.8 13.2 6.3 2.3 1.4 0.4 14.3 0.5 5.4 5.0 7.1 0.8 10.1 9.1 1.5 1.0 24.9 18.8 7.9 5.6 16.5 0.4 15.8 14.4 30.6 8.5 1.3 21.0 6.7 27.2 6.4 2.1 1.1 0.0 25.8 1.9 7.1 0.1 2.8 2.1 5.1 4.3 3.2 32.3 4.2 4.7 8.4 36.1 4.6 5.2 0.0 2.1 1.4 2.5 1.0 4.6 7.9 8.7 9.1 11.6 8.1 7.1 5.6 5.7 5.7 5.4 5.7 9.3 28.8 0.0 1.7 0.7 37.9 224.3 41.4 142.2 132.1 155.5 35.3 60.6 12.7 5.7 49.5 132.4 116.7 39.9 37.4 1.5 76.3 2.3 220.8 55.5 33.3 32.2 11.9 4.0 9.1 1.8 24.1 52.3 5.6 69.6 0.0 20.7 22.9 29.7 8.1 16.8 9.3 5.4 26.4 4.1 77.9 55.3 15.8 16.6 26.6 1.0 1.4 70.1 2.1 2.5 1.3 3.7 0.9 22.6 1.4 9.5 0.3 17.6 7.6 259.6 13.1 11.1 45.1 25.0 9.2 223.4 254.6 105.5 31.7 19.3 4.6 78.1 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "thyroid cancer: 88.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349" "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favorable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 34.9 58.9 30.8 24.4 33.0 14.7 32.2 35.4 35.7 45.0 27.6 31.5 20.2 40.9 105.3 18.1 27.7 34.0 51.0 34.1 38.7 37.2 24.6 29.5 21.8 34.5 33.7 38.3 57.4 103.6 47.7 45.4 34.8 44.5 21.8 19.0 59.6 46.7 30.7 11.9 21.5 36.3 35.4 41.3 29.7 12.9 35.5 20.1 49.9 63.6 21.5 31.9 22.5 37.7 26.4 18.8 48.8 23.9 109.4 118.3 10.0 56.5 54.3 23.2 68.3 20.7 21.5 9.5 31.7 64.7 50.8 5.0 34.9 20.2 28.7 21.6 23.2 18.7 64.9 30.2 85.2 18.2 41.5 67.0 27.4 30.9 30.3 65.1 47.6 11.6 15.2 78.9 67.4 10.9 15.0 0.8 24.4 49.5 4.3 19.1 62.2 8.9 36.0 10.1 22.1 18.9 28.3 1.5 63.9 67.7 19.2 19.0 67.5 29.8 18.9 70.8 11.2 69.7 20.9 0.1 50.4 14.5 25.5 43.6 15.3 13.6 14.6 15.8 18.3 15.0 14.0 12.4 15.8 9.8 15.2 10.6 5.6 13.7 16.8 25.8 9.0 14.4 30.8 33.0 35.4 35.7 34.1 38.7 34.5 33.7 34.8 35.4 35.5 37.7 67.4 44.8 36.1 16.3 61.1 37.9 81.2 40.6 42.7 63.1 70.9 42.3 114.6 50.1 48.4 75.4 58.4 55.3 61.1 20.4 37.2 53.9 0.6 42.2 80.9 69.2 82.4 25.6 35.9 30.6 27.4 85.8 33.1 78.8 79.1 45.5 58.2 48.6 50.7 62.2 41.8 67.6 40.7 52.5 84.9 2.8 64.7 72.3 97.8 18.7 27.2 86.6 34.0 28.6 31.0 30.6 22.1 72.6 122.6 75.2 20.1 43.1 25.1 13.3 32.9 57.1 73.2 2.5 0.4 24.6 21.5 114.9 58.0 70.2 32.1 81.2 ARR3 ARRX ENSG00000120500 "Arrestin 3" P36575 X 70268305-70281840 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 170 "retina: 392.2" "Cell type enriched" "Detected in some" 8 "Cone photoreceptor cells: 1538.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA063129 Enhanced Approved "Golgi apparatus" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 2: Karpas-707 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA063129: AB_2732696" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.70e-2)" "unprognostic (5.37e-2)" "unprognostic (2.82e-1)" "unprognostic (1.37e-2)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.02e-3)" "unprognostic (2.77e-7)" "unprognostic (8.64e-2)" "unprognostic (6.53e-2)" "unprognostic (6.06e-2)" "unprognostic (1.43e-1)" 0.2 0.3 0.1 0.5 0.2 0.5 0.0 0.0 0.1 0.0 0.6 0.3 0.6 0.3 0.0 0.2 0.1 0.4 0.4 0.1 0.1 0.1 0.0 0.2 0.9 0.4 0.3 0.3 0.4 0.0 0.0 0.3 0.3 0.3 0.2 392.2 0.3 0.0 0.3 2.3 0.9 0.0 0.1 0.5 0.4 0.2 0.3 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.1 0.2 1.2 0.8 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.2 0.4 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.5 1.2 0.1 0.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.1 2.2 0.0 0.2 0.4 0.2 0.3 0.2 0.2 0.4 0.2 0.0 0.0 0.5 0.1 0.3 0.2 0.0 0.0 0.7 0.0 0.1 0.9 0.5 0.7 0.5 0.0 0.5 0.3 0.3 0.5 0.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.4 0.3 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.3 0.0 0.0 0.0 1538.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.2 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 68.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 172.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARSA ENSG00000100299 "Arylsulfatase A" P15289 22 50622754-50628173 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 127.5;Plasma cells: 132.0;Proximal enterocytes: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 80.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005554, CAB025183" Enhanced Uncertain "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 5600000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" Cytosol "CAB025183: , HPA005554: AB_1078220" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "prognostic favorable (2.96e-5)" "unprognostic (4.66e-2)" "unprognostic (4.40e-1)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.61e-2)" "unprognostic (2.16e-1)" "unprognostic (4.47e-2)" "unprognostic (2.76e-1)" "unprognostic (9.90e-2)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (7.73e-3)" 28.8 25.1 14.4 15.6 18.0 18.4 27.2 16.8 21.8 21.3 27.5 31.3 30.8 22.4 8.6 28.1 25.1 15.7 33.0 14.9 15.2 31.4 42.8 29.1 19.8 20.0 15.9 11.3 46.7 11.7 34.7 10.9 19.1 28.9 8.2 4.4 39.6 16.2 25.3 17.5 33.8 6.5 16.3 44.5 30.3 54.0 19.4 9.8 32.3 5.1 9.5 23.9 24.7 21.0 8.5 11.0 5.3 10.9 41.8 21.8 13.5 13.0 15.9 5.7 9.3 3.3 12.9 5.3 8.2 22.9 10.8 12.8 1.2 12.3 1.0 2.7 8.0 3.4 14.3 12.5 28.3 5.2 32.7 26.0 24.4 9.5 6.3 19.9 12.8 11.5 3.5 80.4 12.1 9.6 4.6 5.8 1.7 9.0 11.2 4.0 0.4 26.7 9.9 13.5 2.5 8.2 18.2 17.2 10.1 5.1 7.7 6.6 22.1 3.8 15.1 14.9 4.1 18.4 1.9 4.5 11.7 4.3 13.6 10.4 27.7 36.1 17.3 33.3 15.1 10.4 12.4 14.2 22.7 12.5 7.3 10.0 60.4 8.9 43.2 32.1 18.2 16.3 14.4 18.0 16.8 21.8 14.9 15.2 20.0 15.9 19.1 16.3 19.4 21.0 22.8 6.4 12.9 24.5 22.2 4.7 14.0 23.8 18.8 5.3 18.9 13.1 8.0 27.1 15.5 12.9 4.2 11.5 14.0 85.4 1.9 29.4 62.4 24.4 10.3 13.4 36.7 9.7 9.4 21.3 19.9 19.6 41.3 21.3 6.3 15.3 8.2 28.6 36.8 6.7 8.6 30.6 14.2 29.0 9.5 127.5 10.8 29.2 17.8 10.3 28.7 10.3 8.2 8.0 11.9 24.2 75.2 6.0 132.0 10.8 93.9 22.7 21.2 7.2 0.0 6.6 9.9 48.3 4.1 18.3 5.5 13.3 17.2 7.2 25.0 16.1 ARSB ENSG00000113273 "Arylsulfatase B" P15848 5 78777209-78986087 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 40.8;Excitatory neurons: 37.4;Inhibitory neurons: 42.5;Microglial cells: 40.3;Oligodendrocyte precursor cells: 71.4;Oligodendrocytes: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 25.6" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 25.6;monocytes: 8.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037770, HPA037771" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" "HPA037770: AB_10671719, HPA037771: AB_10671720" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.97e-2)" "unprognostic (1.09e-2)" "unprognostic (7.34e-2)" "unprognostic (2.65e-1)" "unprognostic (8.69e-3)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (7.20e-2)" "unprognostic (1.74e-1)" "unprognostic (3.59e-2)" "unprognostic (2.48e-2)" "unprognostic (9.57e-3)" "unprognostic (9.88e-2)" "unprognostic (6.54e-3)" "prognostic unfavorable (3.42e-4)" 6.9 4.5 3.9 8.1 3.9 8.1 2.6 3.1 4.6 5.3 4.2 5.5 3.1 6.4 3.5 4.8 2.9 7.3 8.3 4.7 3.6 21.3 7.6 7.0 5.4 4.6 5.3 2.2 4.6 6.6 2.5 11.5 4.0 5.0 8.2 6.7 3.1 6.6 3.8 2.1 3.6 14.1 4.3 5.2 3.9 2.6 5.2 2.6 4.2 4.3 4.8 8.0 2.3 5.0 5.0 11.3 18.6 6.3 41.9 16.4 16.7 29.2 23.0 18.9 23.0 9.9 8.4 6.5 31.5 25.5 29.0 3.9 7.0 7.4 18.5 55.6 6.2 9.2 11.2 40.1 9.7 10.5 10.4 19.4 2.4 19.7 6.5 15.6 22.4 3.9 2.0 12.9 19.6 9.2 5.8 19.3 5.6 1.1 6.7 7.7 10.9 5.9 12.0 6.2 6.8 15.9 20.3 6.2 12.1 12.7 6.9 26.2 16.2 17.5 10.4 7.6 26.4 14.8 28.0 7.2 21.6 21.4 40.3 19.0 8.3 25.6 1.0 6.7 0.6 2.0 0.4 0.4 7.8 1.3 0.3 0.5 4.6 0.2 5.6 5.7 0.7 2.7 3.9 3.9 3.1 4.6 4.7 3.6 4.6 5.3 4.0 4.3 5.2 5.0 3.9 0.0 2.0 40.8 5.1 0.8 1.4 1.3 0.6 3.7 1.6 1.0 7.2 1.5 0.7 3.7 6.2 2.2 5.5 1.4 3.9 3.7 0.5 1.9 7.2 4.5 1.2 16.2 37.4 9.2 5.1 6.6 2.6 9.0 0.0 6.3 13.6 3.8 16.7 6.7 42.5 6.0 0.0 25.2 14.3 0.5 4.4 15.9 14.2 40.3 16.1 3.6 2.1 71.4 56.2 4.0 3.0 3.8 8.1 2.2 0.5 18.8 2.5 2.7 6.6 5.0 4.4 2.2 3.1 0.7 1.3 2.6 3.4 1.6 2.2 1.3 ARSI "FLJ16069, SPG66" ENSG00000183876 "Arylsulfatase family member I" Q5FYB1 5 150296343-150339307 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 12.1;Fibroblasts: 10.8;Melanocytes: 21.4;Smooth muscle cells: 6.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 15.7;HaCaT: 31.4;Hep G2: 19.9;hTEC/SVTERT24-B: 30.9;U-87 MG: 39.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA038386, HPA038398" Uncertain Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA038386: AB_10669781, HPA038398: AB_2675995" "unprognostic (6.08e-2)" "unprognostic (1.70e-2)" "unprognostic (9.41e-3)" "unprognostic (4.77e-3)" "unprognostic (1.54e-3)" "unprognostic (2.83e-3)" "unprognostic (2.76e-1)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.06e-1)" "unprognostic (5.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.26e-1)" "unprognostic (3.39e-7)" "unprognostic (7.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.19e-4)" 1.2 0.3 1.6 2.3 2.6 0.6 0.4 2.5 2.1 2.7 0.7 1.6 0.6 3.1 0.6 1.8 2.1 1.1 1.3 1.4 1.8 0.7 0.4 4.5 0.3 3.6 2.4 0.4 0.4 0.6 1.0 2.8 3.9 1.7 0.4 0.4 0.5 0.8 0.8 4.8 0.7 2.8 2.6 0.8 0.8 0.4 2.8 0.3 0.2 0.5 0.4 3.8 2.7 5.5 1.0 3.8 1.1 0.0 0.0 0.8 0.0 8.1 12.1 15.7 11.5 1.1 1.8 0.0 3.1 11.5 1.3 31.4 0.2 5.3 5.6 0.0 0.1 0.0 0.4 19.9 1.5 0.0 0.0 0.8 3.4 30.9 0.9 10.7 0.2 0.0 0.0 0.2 2.5 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.2 0.0 6.7 0.9 1.3 11.2 0.0 0.0 0.0 0.3 10.2 0.3 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.6 2.5 2.1 1.4 1.8 3.6 2.4 3.9 2.6 2.8 5.5 0.1 0.0 0.0 0.3 0.0 12.1 0.0 2.4 0.0 0.1 0.1 0.4 1.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 1.1 10.8 0.0 0.0 4.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.1 0.0 0.8 0.2 0.6 0.0 21.4 0.0 0.0 3.9 0.0 0.0 2.5 0.4 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.3 0.0 1.8 6.6 0.1 0.9 0.9 4.7 1.4 1.1 0.0 0.0 0.0 ARSL "ARSE, CDPX, CDPX1" ENSG00000157399 "Arylsulfatase L" P51690 X 2934521-2968475 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.6;liver: 86.3;pancreas: 105.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "liver cancer: 34.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6" "Low region specificity" "Detected in all" "HPA060518, HPA070651" Approved Supported "Golgi apparatus" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA060518: AB_2684301, HPA070651: AB_2732160" "unprognostic (2.07e-1)" "unprognostic (6.60e-3)" "prognostic favorable (8.95e-4)" "unprognostic (8.74e-3)" "unprognostic (1.14e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-1)" "unprognostic (8.27e-2)" "unprognostic (5.45e-2)" "unprognostic (2.25e-1)" "unprognostic (2.27e-1)" "unprognostic (2.37e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (1.28e-1)" "unprognostic (5.94e-2)" "unprognostic (4.76e-2)" 0.4 0.7 2.6 2.2 2.7 0.3 1.1 2.1 2.8 1.7 4.5 20.8 17.9 3.2 2.2 0.4 4.1 8.2 1.0 2.8 2.6 36.6 86.3 2.7 0.1 2.8 2.8 7.1 105.2 0.0 0.7 0.7 2.9 0.5 16.7 0.3 1.3 2.9 0.2 0.2 13.6 1.9 2.4 0.0 2.9 0.4 2.6 0.0 0.2 0.3 0.1 0.5 1.6 2.3 4.5 68.9 8.2 0.0 3.3 4.0 1.3 3.9 6.4 4.0 4.0 42.7 0.0 0.0 13.7 0.1 30.8 0.0 0.0 0.9 2.3 0.0 4.5 0.0 0.0 64.1 1.8 0.0 0.1 9.6 0.0 3.8 0.0 7.3 3.8 0.0 0.0 0.1 10.5 0.1 0.0 0.0 33.6 2.4 0.2 2.8 1.1 0.3 7.1 0.0 0.1 0.2 0.0 0.0 2.6 13.7 0.0 0.2 5.0 0.1 0.2 0.0 7.4 0.0 0.0 0.1 9.1 0.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 2.1 2.8 2.8 2.6 2.8 2.8 2.9 2.4 2.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ASB13 "FLJ13134, MGC19879" ENSG00000196372 "Ankyrin repeat and SOCS box containing 13" Q8WXK3 10 5638867-5666595 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 45.0;Hepatocytes: 55.9;Proximal enterocytes: 41.1;Proximal tubular cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 13.6;monocytes: 12.9;T-cells: 4.1" "Cell line enhanced" "Detected in many" "Daudi: 66.7;RPMI-8226: 68.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048293, HPA061742" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Golgi apparatus" "HPA048293: AB_2680344, HPA061742: AB_2684599" "unprognostic (3.64e-2)" "unprognostic (3.60e-1)" "unprognostic (7.39e-2)" "unprognostic (2.21e-2)" "unprognostic (4.83e-2)" "unprognostic (2.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.87e-1)" "unprognostic (6.93e-2)" "unprognostic (3.42e-2)" "unprognostic (4.58e-3)" "unprognostic (1.16e-2)" "unprognostic (3.03e-1)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" 11.2 19.7 4.9 7.2 4.9 3.5 15.9 6.3 7.0 10.1 5.5 14.4 25.4 9.2 1.8 10.3 12.8 7.6 8.9 3.7 4.5 21.3 44.0 6.5 18.2 5.9 5.9 14.8 10.7 4.8 8.2 3.3 5.9 9.6 6.6 6.7 8.9 6.5 11.9 11.9 25.4 5.7 5.2 9.7 8.7 3.3 8.4 3.8 6.2 10.1 12.9 11.7 9.1 4.8 10.6 13.7 5.5 24.6 21.5 5.8 9.5 1.9 4.1 6.1 7.0 11.4 19.4 66.7 16.2 3.9 2.2 17.3 12.2 13.6 0.8 3.4 24.0 10.0 7.7 8.5 14.4 8.5 0.9 9.6 20.7 3.2 5.3 6.1 5.0 18.0 12.1 1.3 1.7 7.6 11.0 7.8 12.0 28.6 8.0 4.5 0.8 68.8 7.9 16.3 11.5 27.2 12.9 8.7 21.5 1.6 25.9 10.6 2.1 3.5 6.2 14.6 5.7 3.6 8.6 44.0 10.8 22.9 2.8 0.0 12.9 0.3 1.5 8.3 2.6 1.8 3.9 1.7 13.6 2.4 4.1 2.0 0.4 1.2 6.6 0.4 1.2 7.5 4.9 4.9 6.3 7.0 3.7 4.5 5.9 5.9 5.9 5.2 8.4 4.8 4.7 0.0 5.8 9.1 1.7 1.7 1.9 2.5 2.2 45.0 8.8 7.4 7.8 8.6 4.7 1.8 18.8 5.8 0.4 21.3 5.9 5.3 2.7 3.2 7.9 5.3 4.2 1.7 6.7 4.5 1.6 9.1 1.5 2.3 3.8 20.1 5.3 55.9 7.0 16.8 13.3 5.7 4.1 12.6 2.6 0.7 13.4 7.3 8.8 6.5 7.0 8.5 0.0 7.1 8.1 4.5 12.6 21.4 0.4 3.3 41.1 39.5 4.9 14.2 6.6 7.2 10.7 0.2 1.6 5.7 1.7 2.1 2.1 16.5 12.4 1.5 ASB7 ENSG00000183475 "Ankyrin repeat and SOCS box containing 7" Q9H672 15 100602589-100651701 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003300 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Golgi apparatus, Vesicles" Nucleoplasm "HPA003300: AB_1845071" "unprognostic (1.38e-1)" "unprognostic (3.48e-2)" "unprognostic (3.91e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" 4.6 3.6 4.2 4.5 4.7 12.8 5.1 4.9 4.6 5.2 5.6 6.8 4.6 5.3 6.5 4.6 5.7 3.8 3.9 4.2 4.1 6.7 6.8 4.9 6.3 4.5 4.3 5.7 3.5 6.7 3.1 4.3 4.2 4.7 6.3 4.9 4.5 4.3 3.1 4.4 4.4 6.0 4.2 5.9 4.3 6.8 4.9 7.0 6.2 4.7 6.3 5.1 3.5 5.0 6.7 14.5 6.6 7.9 8.6 9.2 7.5 7.2 13.0 11.8 12.3 8.8 13.2 10.9 6.4 9.2 11.6 14.5 9.2 9.4 12.2 7.6 9.8 14.4 9.0 8.8 13.0 8.6 12.3 8.9 10.3 9.6 15.8 11.4 11.0 11.7 8.6 8.9 6.8 7.2 6.7 8.7 6.3 14.9 6.9 9.0 14.1 9.2 11.8 14.8 6.5 9.2 11.1 10.8 15.0 12.5 7.6 10.7 8.4 10.3 9.5 7.3 10.2 10.6 23.5 10.4 8.0 7.8 8.3 1.2 5.8 10.2 5.2 4.7 4.2 4.3 4.5 6.4 5.1 4.2 6.2 4.4 5.2 4.3 3.1 3.3 5.7 4.8 4.2 4.7 4.9 4.6 4.2 4.1 4.5 4.3 4.2 4.2 4.9 5.0 4.6 0.0 5.4 14.7 6.6 6.5 2.3 3.5 13.1 4.9 6.2 4.1 3.4 12.8 6.4 3.7 6.2 3.8 9.9 12.9 1.9 5.7 4.0 8.1 8.3 6.7 8.4 3.0 20.6 4.9 3.0 4.0 7.1 8.1 10.8 7.3 4.2 8.0 6.0 13.5 15.0 6.2 4.1 7.8 4.3 2.1 5.0 5.2 3.6 20.6 7.8 3.1 6.2 16.6 17.4 6.5 9.7 5.3 4.9 5.5 5.4 7.1 10.3 5.0 0.0 4.3 4.3 9.9 8.2 10.8 4.5 5.9 8.2 6.7 5.8 5.6 ASCC3 "ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH" ENSG00000112249 "Activating signal cointegrator 1 complex subunit 3" Q8N3C0 6 100508194-100881372 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 166.0;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031608, HPA031609, HPA031610" Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Golgi apparatus" "HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526" "unprognostic (6.79e-2)" "unprognostic (1.46e-2)" "unprognostic (2.96e-3)" "unprognostic (1.12e-1)" "unprognostic (9.70e-3)" "unprognostic (4.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.14e-2)" "unprognostic (4.02e-1)" "unprognostic (3.34e-1)" "unprognostic (5.08e-3)" "unprognostic (1.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-1)" "unprognostic (1.55e-2)" 6.0 6.6 4.1 10.0 5.3 11.2 9.2 6.6 4.2 10.2 7.7 9.3 8.2 7.9 8.5 8.4 5.8 7.5 6.5 3.9 5.2 5.0 12.5 7.1 10.1 4.7 4.3 5.9 6.4 10.7 6.2 12.9 5.1 9.2 11.3 5.7 6.3 8.1 6.0 7.2 8.5 8.5 4.7 8.3 8.6 8.6 4.6 12.7 7.2 5.4 11.0 14.8 7.4 6.0 16.8 21.1 30.1 18.6 32.9 41.7 48.0 71.5 45.5 24.1 27.6 43.3 13.0 52.1 14.4 48.3 19.0 37.6 26.2 63.5 38.7 35.2 23.2 38.7 36.0 27.8 30.1 41.0 28.5 38.1 31.7 35.4 44.2 22.6 45.1 20.5 47.1 23.0 67.3 16.5 21.1 12.7 15.9 31.8 16.4 24.7 23.3 18.7 23.7 46.6 20.2 15.3 30.1 26.7 12.5 53.3 14.7 23.2 64.2 26.9 20.6 23.3 30.4 9.9 11.3 46.4 19.4 30.6 29.0 6.2 2.7 1.8 4.3 4.3 5.2 4.2 3.8 4.0 2.9 5.7 4.3 4.2 0.2 4.4 3.8 6.4 3.1 1.4 4.1 5.3 6.6 4.2 3.9 5.2 4.7 4.3 5.1 4.7 4.6 6.0 32.7 32.1 24.9 58.1 45.4 25.5 41.3 33.3 19.4 27.0 24.1 24.0 32.0 20.0 37.7 3.7 22.9 24.4 49.0 17.3 11.7 23.1 11.3 30.1 77.3 25.2 13.8 20.8 166.0 25.1 66.3 32.2 46.9 35.0 22.1 29.9 10.4 30.3 17.7 28.6 166.2 22.8 22.4 17.2 12.5 3.7 23.0 27.5 5.4 103.0 26.2 14.6 29.9 150.8 132.3 28.6 14.4 17.3 66.4 66.9 17.5 10.6 32.0 31.1 6.6 39.6 30.0 50.2 30.3 38.2 27.4 38.0 43.7 42.6 23.5 65.4 ASH1L "ASH1, ASH1L1, huASH1, KMT2H" ENSG00000116539 "ASH1 like histone lysine methyltransferase" Q9NR48 1 155335268-155563162 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004806 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus" "HPA004806: AB_1845087" "unprognostic (2.98e-1)" "unprognostic (3.15e-2)" "unprognostic (1.10e-1)" "unprognostic (1.70e-2)" "unprognostic (2.05e-2)" "unprognostic (4.75e-2)" "unprognostic (1.42e-1)" "unprognostic (1.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (6.84e-2)" "prognostic favorable (3.80e-4)" "unprognostic (2.95e-1)" "unprognostic (1.62e-1)" "unprognostic (2.45e-2)" "unprognostic (1.94e-1)" 14.1 12.8 21.3 8.5 23.4 11.9 16.8 27.0 25.7 14.4 14.8 13.0 9.7 14.4 20.8 9.2 11.4 9.0 12.6 23.8 19.2 13.9 10.0 10.3 10.9 18.7 19.8 21.3 9.9 18.2 8.4 10.3 18.9 15.7 11.5 26.2 14.8 15.4 30.3 20.4 10.2 12.7 19.3 10.5 11.9 6.8 20.7 12.1 15.8 24.3 9.7 11.7 10.0 23.4 17.2 12.3 9.5 9.4 28.0 22.8 9.6 14.7 13.5 8.3 6.5 10.5 12.3 5.4 14.2 17.0 5.4 19.2 13.6 12.6 13.6 7.6 8.9 8.0 13.2 9.8 14.5 8.8 6.6 16.2 18.0 13.6 15.0 17.1 11.0 6.0 12.3 8.3 18.8 19.0 6.4 8.8 8.3 28.8 13.1 6.1 18.5 10.4 18.6 16.0 9.1 14.3 20.1 25.9 12.9 9.3 16.6 26.6 17.4 13.6 15.8 13.4 17.9 8.0 5.3 8.9 10.7 9.1 13.1 1.0 0.4 0.8 0.7 0.2 0.5 0.9 0.5 0.5 0.2 0.8 0.8 0.5 1.0 0.6 0.1 0.7 0.9 0.2 21.3 23.4 27.0 25.7 23.8 19.2 18.7 19.8 18.9 19.3 20.7 23.4 96.5 60.9 103.2 171.7 108.3 103.9 97.4 52.9 109.3 147.6 75.9 58.3 107.8 50.1 82.7 51.5 202.3 53.6 83.3 76.2 17.6 41.5 25.9 72.0 107.4 77.6 67.5 46.7 220.6 39.8 25.2 93.7 101.4 87.9 81.1 72.3 63.1 39.0 24.6 114.4 211.8 59.0 26.4 42.1 106.9 22.8 102.2 69.1 53.4 203.3 85.2 68.4 89.6 190.5 265.0 37.5 64.8 118.8 110.1 112.0 68.9 31.0 47.1 116.7 98.6 134.4 104.6 85.6 56.1 80.9 112.0 76.2 98.7 87.3 60.2 111.6 ASIC1 "ACCN2, BNaC2, hBNaC2" ENSG00000110881 "Acid sensing ion channel subunit 1" P78348 12 50057548-50083611 "Predicted membrane proteins" "Calcium transport, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Cell type enhanced" "Detected in some" "Astrocytes: 31.3;Inhibitory neurons: 16.4;Oligodendrocyte precursor cells: 64.8;Oligodendrocytes: 11.2" "Cancer enhanced" "Detected in many" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 34.8;SH-SY5Y: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058870 Supported "Golgi apparatus,Plasma membrane" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus, Plasma membrane" "HPA058870: AB_2683841" "unprognostic (5.32e-3)" "unprognostic (1.70e-1)" "unprognostic (4.00e-2)" "unprognostic (3.56e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-3)" "unprognostic (2.92e-3)" "unprognostic (3.00e-2)" "unprognostic (1.72e-1)" "unprognostic (9.37e-2)" "unprognostic (2.34e-2)" "unprognostic (2.86e-3)" "unprognostic (6.97e-7)" "unprognostic (7.19e-2)" "unprognostic (3.73e-1)" "unprognostic (2.78e-3)" "unprognostic (8.27e-5)" 1.6 0.7 19.3 0.9 22.2 0.1 1.6 14.4 19.8 3.2 6.4 6.3 0.8 1.9 0.0 2.3 3.0 2.5 2.6 18.2 21.0 0.7 0.2 0.6 0.4 18.0 24.9 1.1 0.5 5.0 0.8 0.6 15.9 2.8 1.2 1.0 3.5 1.9 0.3 0.9 2.5 2.3 13.7 0.3 2.8 0.7 23.7 1.5 0.5 0.0 0.2 1.9 1.7 13.8 3.3 7.2 8.7 19.7 2.7 4.2 4.9 2.2 6.1 4.0 4.0 4.8 2.3 2.1 4.7 1.1 2.4 3.2 8.7 7.7 2.3 1.9 25.1 6.2 9.0 3.2 3.8 9.5 22.7 10.7 3.7 0.4 1.0 34.8 0.5 22.8 4.3 0.0 3.3 4.0 8.8 18.3 3.9 6.9 12.5 9.3 8.5 4.0 2.0 0.1 13.4 27.4 5.3 1.8 3.2 1.4 11.0 6.5 0.3 4.1 12.8 2.5 1.2 0.1 0.0 0.0 5.1 7.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 22.2 14.4 19.8 18.2 21.0 18.0 24.9 15.9 13.7 23.7 13.8 0.3 0.0 0.0 31.3 0.0 0.0 0.4 0.5 0.0 2.8 2.0 2.8 0.9 0.0 2.1 1.8 0.0 0.4 0.1 0.1 0.0 0.2 0.1 0.0 0.7 0.1 0.0 0.0 7.0 0.0 0.9 3.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 3.3 16.4 0.1 0.0 0.0 0.3 0.0 1.5 0.1 0.0 1.9 0.0 1.4 0.0 64.8 11.2 0.2 0.0 1.2 0.2 0.5 0.0 3.2 6.0 0.5 0.0 1.3 0.7 0.1 0.9 2.3 0.0 0.3 0.9 0.4 0.0 0.2 ASIC4 "ACCN4, BNAC4" ENSG00000072182 "Acid sensing ion channel subunit family member 4" Q96FT7 2 219514170-219538772 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 10.7;pituitary gland: 22.0;retina: 6.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 223.4;Cone photoreceptor cells: 173.0" "Cancer enriched" "Detected in single" 38 "glioma: 8.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 21.2;HMC-1: 6.2;K-562: 12.1;SH-SY5Y: 5.2" "Region enhanced" "Detected in many" "basal ganglia: 73.2" "Low region specificity" "Detected in many" HPA036042 Approved "Golgi apparatus" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 1: K-562 - Erythropoiesis" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "HPA036042: AB_10672998" "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.55e-1)" "unprognostic (1.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.74e-2)" "unprognostic (3.04e-2)" "unprognostic (2.54e-1)" "unprognostic (6.53e-2)" "unprognostic (1.90e-2)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (7.80e-8)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (5.51e-1)" "unprognostic (2.48e-2)" 0.1 1.1 6.1 0.0 4.2 0.0 0.0 4.1 8.4 0.4 2.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 3.9 4.9 0.0 0.0 0.1 0.0 5.5 8.4 0.0 0.0 0.0 22.0 0.0 4.4 0.1 0.0 6.4 0.0 0.1 0.0 0.1 0.0 0.0 5.7 0.0 0.0 1.3 10.7 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 4.2 4.1 8.4 3.9 4.9 5.5 8.4 4.4 5.7 10.7 3.9 0.1 0.0 0.0 0.3 0.0 0.1 1.6 0.1 0.0 223.4 0.9 1.0 1.1 0.0 0.0 0.0 173.0 2.5 0.0 0.7 0.0 0.0 6.1 0.0 0.9 0.4 0.0 0.0 0.3 0.4 1.0 0.9 0.0 0.3 17.8 0.4 0.0 0.0 0.1 0.0 11.6 0.6 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 10.0 0.0 39.2 0.4 0.0 2.5 0.4 0.1 1.1 1.3 0.2 0.0 12.8 0.0 3.1 0.6 0.3 0.6 0.0 0.3 2.9 0.4 0.5 0.9 0.3 ASTN1 ASTN ENSG00000152092 "Astrotactin 1" O14525 1 176857302-177164973 "Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 14.9;brain: 29.8;retina: 14.0" "Group enriched" "Detected in some" 6 "Astrocytes: 191.3;Excitatory neurons: 218.7;Inhibitory neurons: 275.6;Oligodendrocyte precursor cells: 280.0" "Cancer enriched" "Detected in some" 14 "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.8;NTERA-2: 4.4;SCLC-21H: 2.7;U-2 OS: 3.4;U-266/84: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074112 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 65: Brain - Ion transport" "Cluster 16: U-266 - Nucleosome" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA074112: AB_2686662" "unprognostic (4.41e-3)" "unprognostic (1.48e-2)" "unprognostic (4.03e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (2.03e-4)" "unprognostic (3.86e-3)" "unprognostic (1.08e-1)" "unprognostic (4.36e-1)" "unprognostic (1.67e-3)" "unprognostic (1.98e-1)" "unprognostic (6.77e-2)" "unprognostic (4.74e-3)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (1.16e-1)" 0.8 14.9 22.9 0.4 27.1 0.0 0.7 3.0 29.8 0.4 0.0 0.5 0.3 0.9 3.3 0.0 1.6 0.6 0.5 28.5 23.3 0.1 0.2 0.2 0.1 6.1 10.7 5.7 0.5 0.1 9.0 0.3 7.5 1.0 0.3 14.0 0.9 1.6 0.1 0.1 0.3 0.9 11.5 2.2 0.3 0.7 22.7 0.0 0.0 0.3 0.3 0.0 0.4 11.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 27.1 3.0 29.8 28.5 23.3 6.1 10.7 7.5 11.5 22.7 11.5 0.0 0.0 0.0 191.3 0.0 0.1 0.0 0.0 0.0 7.9 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.8 0.3 0.2 0.0 0.0 218.7 0.0 0.1 0.7 0.0 0.2 0.0 4.0 5.0 0.0 0.5 23.5 275.6 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 25.3 0.0 0.8 0.0 280.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.7 4.4 1.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 ATAT1 "C6orf134, Em:AB023049.7, FLJ13158, MEC17" ENSG00000137343 "Alpha tubulin acetyltransferase 1" Q5SQI0 6 30626842-30646823 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 87.6;Late spermatids: 42.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 8.0;AN3-CA: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046816, HPA050999" Approved Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Cluster 46: Basophils - DNA binding" "Cluster 71: Testis - DNA repair" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Golgi apparatus, Cytosol" "HPA046816: AB_2679822, HPA050999: AB_2681303" "unprognostic (3.98e-1)" "unprognostic (3.18e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-2)" "unprognostic (8.86e-2)" "unprognostic (8.18e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.49e-2)" "unprognostic (5.39e-2)" "unprognostic (2.37e-2)" "unprognostic (1.29e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (7.78e-5)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.35e-4)" 5.3 6.0 2.3 0.6 2.9 0.6 7.6 1.8 3.3 12.4 0.9 8.6 0.5 9.7 3.6 7.6 9.8 0.7 5.5 2.6 3.3 11.3 7.6 5.8 0.6 2.3 2.7 13.4 6.0 0.2 21.3 0.4 2.5 13.5 0.6 2.5 7.7 0.3 4.9 6.6 7.8 0.7 1.9 5.6 7.4 13.5 2.5 0.7 9.3 0.0 0.7 9.2 8.4 3.1 1.4 0.7 8.0 5.3 0.9 0.7 0.6 0.3 0.0 0.2 0.4 2.3 1.4 0.1 1.1 1.1 2.2 1.5 2.5 0.9 0.0 1.0 4.2 0.1 0.1 2.6 0.4 0.5 1.1 1.4 0.5 0.3 0.0 1.0 0.5 3.8 1.5 0.0 1.3 1.5 1.0 0.3 0.4 2.2 0.0 1.0 0.1 0.4 1.3 2.4 0.3 3.2 0.6 0.6 0.4 0.0 2.9 0.4 1.0 3.0 1.3 0.0 0.5 0.9 2.5 0.8 1.6 3.4 2.1 0.5 0.4 0.3 0.1 0.3 0.1 0.5 0.2 0.1 0.4 0.2 0.4 0.4 0.3 0.1 0.2 0.5 0.1 0.1 2.3 2.9 1.8 3.3 2.6 3.3 2.3 2.7 2.5 1.9 2.5 3.1 6.2 0.0 1.5 14.7 6.4 5.6 14.0 16.9 14.2 9.0 9.4 11.4 1.9 5.7 8.6 14.7 10.4 11.9 4.1 7.6 7.9 11.9 87.6 9.0 7.7 7.9 18.0 3.0 7.8 4.5 6.3 6.9 8.2 8.0 1.3 16.0 3.3 2.9 6.1 1.7 11.4 8.9 14.2 1.6 3.1 42.4 4.1 3.1 0.0 5.6 9.1 12.5 6.2 16.6 13.1 9.3 10.8 8.6 4.1 11.6 9.7 5.4 10.8 10.7 6.6 8.0 7.8 12.4 11.8 8.0 5.4 8.9 4.7 6.1 11.1 15.3 ATP11A "ATPIH, ATPIS, KIAA1021" ENSG00000068650 "ATPase phospholipid transporting 11A" P98196 13 112690329-112887168 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035583, HPA035584" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Vesicles "Golgi apparatus" "HPA035583: AB_10671106, HPA035584: AB_10672096" "unprognostic (1.67e-1)" "unprognostic (5.06e-3)" "unprognostic (1.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.58e-2)" "unprognostic (8.84e-2)" "unprognostic (5.87e-3)" "unprognostic (1.80e-2)" "unprognostic (6.97e-2)" "unprognostic (1.54e-3)" "unprognostic (3.93e-2)" "unprognostic (4.23e-1)" "prognostic favorable (7.44e-4)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.26e-2)" "unprognostic (7.40e-3)" 10.2 10.4 12.3 8.9 22.0 18.2 6.1 18.3 16.8 13.0 5.7 4.4 9.9 10.1 5.8 7.0 8.7 15.0 21.4 9.7 12.5 12.7 10.1 39.5 5.8 25.3 22.2 6.5 12.4 23.1 16.2 10.1 22.9 4.3 3.2 14.9 9.0 3.9 13.1 8.9 8.3 9.1 15.7 8.9 5.3 8.9 21.9 8.2 13.9 17.3 6.1 6.5 5.9 40.2 28.0 14.0 17.5 20.5 8.7 11.7 30.9 13.0 7.6 10.9 8.8 44.5 31.5 14.1 15.5 11.0 14.0 23.2 15.8 10.8 10.5 14.2 14.9 16.3 11.9 23.3 13.6 30.8 25.5 7.9 8.2 13.2 8.0 8.8 29.0 12.6 11.4 2.3 7.7 10.5 14.1 19.4 7.5 31.8 9.9 12.2 7.1 8.1 59.3 6.4 27.8 7.7 12.7 16.3 10.7 22.4 6.2 40.4 19.2 0.0 23.3 14.1 9.9 7.4 15.5 5.9 4.8 28.3 12.2 0.0 1.1 1.7 0.4 1.6 0.3 0.6 0.2 0.2 0.6 1.8 0.3 0.2 3.1 0.0 1.5 0.5 0.0 0.3 12.3 22.0 18.3 16.8 9.7 12.5 25.3 22.2 22.9 15.7 21.9 40.2 25.6 218.0 215.0 22.2 11.3 10.8 3.4 4.9 1.2 42.0 5.2 3.7 42.3 31.5 29.4 16.5 235.6 1.7 7.0 2.4 5.9 32.7 0.9 51.2 24.2 34.2 12.0 3.8 35.0 11.4 32.2 16.5 8.6 176.3 12.0 62.2 27.1 16.5 20.7 13.5 32.5 3.5 14.2 33.6 16.9 1.9 11.1 29.3 10.6 48.7 36.9 11.0 6.2 33.7 138.3 24.3 6.1 4.9 7.7 7.7 10.5 15.7 13.3 44.8 0.0 9.5 12.8 4.0 10.1 6.3 9.7 8.6 8.4 8.7 5.9 3.9 ATP2C1 "ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1" ENSG00000017260 "ATPase secretory pathway Ca2+ transporting 1" P98194 3 130850595-131016712 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 162.6;Excitatory neurons: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010207, HPA035116, HPA069684" Supported Supported "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169" "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.06e-6)" "unprognostic (7.66e-2)" "unprognostic (6.52e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.44e-2)" "prognostic favorable (1.55e-4)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "unprognostic (3.06e-1)" 32.2 32.7 34.0 25.3 36.6 38.6 32.9 31.8 42.8 33.4 76.9 36.5 23.9 30.9 28.0 23.6 37.2 27.2 31.9 40.7 38.6 44.7 28.5 51.4 21.9 37.0 38.9 28.8 22.6 78.0 22.7 32.7 40.3 85.8 35.9 59.4 29.2 25.2 28.1 31.9 26.9 31.0 33.6 19.5 31.5 25.2 48.8 36.2 35.0 21.1 26.2 31.6 18.1 48.6 133.1 51.1 49.9 48.5 136.7 110.0 53.9 141.2 186.8 69.4 87.0 83.5 106.3 47.6 95.6 134.4 96.4 153.6 95.1 77.9 100.8 104.4 34.2 127.2 51.5 39.0 87.2 51.2 148.4 86.8 76.6 73.2 82.2 126.3 74.6 59.3 37.3 84.1 86.7 59.0 50.6 40.9 57.0 71.7 54.8 36.3 49.9 75.6 127.5 87.7 76.7 45.9 121.4 37.8 72.8 70.8 55.7 41.7 102.6 73.3 40.8 95.5 65.8 54.6 71.1 69.9 75.8 38.0 62.6 30.6 8.9 15.9 7.4 7.6 7.0 5.6 7.3 6.6 9.5 3.6 4.9 4.9 4.3 11.5 9.6 8.2 9.3 6.5 34.0 36.6 31.8 42.8 40.7 38.6 37.0 38.9 40.3 33.6 48.8 48.6 30.2 38.5 53.0 162.6 17.4 39.4 34.5 34.8 26.7 25.9 34.4 22.4 30.2 35.8 41.1 46.0 20.9 16.3 15.5 39.0 5.9 35.3 17.5 26.9 34.1 27.8 35.6 23.3 172.5 38.0 27.6 25.9 33.1 55.8 28.5 28.2 26.7 27.4 27.7 82.4 136.5 32.4 36.7 26.2 34.8 18.9 16.1 39.5 21.4 128.4 20.5 26.4 19.6 148.3 154.3 51.1 27.5 14.7 18.5 69.0 16.3 19.8 52.7 33.4 6.6 27.7 25.9 16.2 14.1 24.7 52.8 17.6 19.5 17.3 31.2 36.9 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522582 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 130.7" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 294.0;Rod photoreceptor cells: 403.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 58: Brain - Synaptic function" "Cluster 2: Karpas-707 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favorable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (6.90e-4)" 17.7 28.2 30.6 18.0 35.2 21.5 16.3 16.8 42.7 13.4 0.0 22.1 34.6 20.9 19.6 17.4 17.1 22.7 18.9 43.6 44.1 37.4 21.0 24.1 13.1 25.6 26.2 20.0 17.4 86.0 39.0 21.2 34.6 17.4 20.5 130.7 13.5 18.6 59.3 28.1 24.3 21.5 12.1 21.8 16.3 18.7 30.9 15.2 30.3 25.3 14.9 11.9 12.8 27.2 18.4 37.0 22.1 40.1 36.5 31.7 12.9 12.7 23.3 26.4 34.2 23.9 39.9 3.4 22.6 26.2 36.2 38.7 34.5 21.5 30.4 28.3 36.2 29.2 27.3 19.0 22.7 12.8 50.9 23.5 30.3 42.4 18.0 32.6 18.9 13.2 108.0 111.3 39.7 15.8 5.1 11.3 14.3 23.9 0.4 0.2 23.0 51.2 30.2 14.4 60.9 32.0 19.7 17.7 37.1 28.8 43.0 19.0 11.4 22.3 0.9 33.0 15.3 45.0 66.1 6.8 29.7 0.2 26.5 21.6 14.5 11.2 1.0 4.4 1.6 4.7 0.7 0.2 12.2 7.3 1.2 0.9 18.7 0.1 3.3 6.2 3.7 6.6 30.6 35.2 16.8 42.7 43.6 44.1 25.6 26.2 34.6 12.1 30.9 27.2 20.0 19.2 48.0 47.0 23.0 19.8 56.7 15.7 32.5 164.8 15.7 16.5 21.1 28.6 18.3 14.7 294.0 34.3 16.7 46.2 11.7 16.3 4.0 32.8 27.4 22.2 84.9 45.8 125.0 18.5 15.7 31.0 23.4 74.0 24.1 74.5 16.4 37.8 53.8 95.9 112.3 27.3 12.2 37.8 29.2 3.9 17.4 42.8 40.9 38.4 17.7 59.3 3.1 61.3 80.5 24.2 37.6 23.7 13.8 32.7 56.9 32.5 11.4 403.4 6.6 39.4 32.3 38.8 18.2 21.7 20.2 99.9 6.9 35.0 24.5 14.9 ATP7A MNK ENSG00000165240 "ATPase copper transporting alpha" Q04656 X 77910656-78050395 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ionocytes: 61.1;Microglial cells: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012887, HPA048107" Approved Supported "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 31: Skin - Epidermis development" "Cluster 2: Karpas-707 - Immune response" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA012887: AB_1845205, HPA048107: AB_2680266" "unprognostic (3.14e-2)" "unprognostic (3.48e-1)" "unprognostic (4.90e-2)" "unprognostic (1.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-3)" "unprognostic (2.59e-2)" "unprognostic (3.17e-2)" "unprognostic (2.47e-1)" "unprognostic (2.30e-2)" "unprognostic (1.14e-1)" "prognostic favorable (8.38e-4)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (3.69e-1)" "unprognostic (2.52e-1)" 3.0 4.3 1.2 3.6 1.7 5.9 6.3 2.3 2.1 3.9 1.6 3.4 3.9 3.6 5.0 4.9 3.5 3.6 2.5 1.3 2.1 4.4 2.3 4.5 4.1 2.1 2.1 3.6 2.4 7.3 2.5 4.0 3.8 5.3 3.4 3.0 5.1 3.4 1.8 11.1 3.4 3.2 1.1 4.7 5.5 1.6 1.6 4.7 4.6 2.9 4.6 3.9 2.8 2.9 3.2 8.3 5.4 5.5 5.0 5.3 0.9 4.8 6.6 2.8 5.7 1.0 3.6 4.7 6.9 4.8 3.3 3.8 7.1 3.9 5.2 7.0 4.8 2.4 7.8 0.8 6.3 4.1 4.1 5.6 1.6 5.9 1.8 6.5 7.3 4.7 19.6 17.4 5.2 2.8 4.6 1.4 1.5 11.2 1.7 3.7 9.0 15.8 4.6 8.8 1.6 20.4 11.9 2.8 6.0 3.3 2.2 1.3 9.4 3.7 3.6 5.2 1.9 5.6 10.7 5.2 6.0 2.5 5.7 7.1 1.5 4.5 1.8 1.5 0.9 1.8 1.2 1.2 1.0 1.4 1.4 2.1 8.1 1.2 1.9 1.0 0.4 1.0 1.2 1.7 2.3 2.1 1.3 2.1 2.1 2.1 3.8 1.1 1.6 2.9 14.3 0.0 8.4 15.7 12.6 7.4 5.1 5.8 13.1 6.4 17.3 10.0 5.1 1.5 8.2 9.2 4.2 2.0 15.0 4.5 1.9 5.6 0.5 5.3 9.2 9.7 4.8 22.5 11.1 13.6 2.2 9.4 20.4 8.8 9.5 6.4 14.6 3.6 14.3 1.7 12.5 4.8 61.1 11.7 6.7 1.1 7.2 12.6 19.6 44.0 5.5 4.4 11.3 37.7 35.0 6.2 4.1 9.8 10.5 4.8 4.1 5.5 10.2 4.1 32.9 10.3 8.7 1.8 5.4 20.5 16.6 2.2 13.8 6.7 5.2 6.6 ATP7B WND ENSG00000123191 "ATPase copper transporting beta" P35670 13 51930436-52012125 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA009137, HPA013187" Supported Supported "Golgi apparatus" NA NA "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 36: HEL - Hemostasis" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA009137: AB_2668214, HPA013187: AB_1845206" "unprognostic (1.13e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (3.49e-1)" "unprognostic (5.51e-2)" "unprognostic (1.55e-2)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (8.29e-2)" "unprognostic (1.17e-1)" "unprognostic (3.26e-3)" "unprognostic (4.66e-2)" "unprognostic (3.54e-1)" "unprognostic (6.21e-3)" "unprognostic (1.40e-1)" 3.6 0.9 1.3 0.6 1.2 2.2 1.7 2.0 2.1 1.8 0.8 2.9 10.6 1.5 0.1 0.7 2.0 7.0 2.1 2.5 1.4 2.2 8.6 1.4 0.3 0.8 1.2 1.9 2.0 6.4 1.2 7.1 1.1 2.0 2.7 3.7 3.0 0.9 1.1 1.0 6.0 1.7 0.5 0.4 4.4 8.4 1.7 0.7 1.2 1.8 0.2 1.6 1.2 0.7 0.8 2.8 5.2 4.5 1.0 0.8 32.8 1.5 0.5 1.6 1.2 21.1 0.1 0.1 0.6 2.7 3.6 0.3 4.0 4.4 1.0 0.4 7.5 53.0 0.5 14.7 1.4 0.6 11.8 1.9 4.7 0.2 2.0 2.1 3.7 3.7 14.4 0.2 1.5 1.0 0.2 0.9 1.7 6.6 1.8 2.0 1.4 0.0 22.5 3.4 3.3 2.2 1.9 2.8 1.8 5.5 8.0 0.5 2.0 0.3 1.7 2.8 0.6 0.6 0.7 0.2 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 2.0 2.1 2.5 1.4 0.8 1.2 1.1 0.5 1.7 0.7 5.4 6.4 0.0 10.7 0.9 0.4 0.7 1.7 0.0 3.1 2.3 1.8 2.1 4.3 5.2 1.8 22.9 14.3 1.8 6.6 0.0 1.6 30.2 2.4 1.3 2.7 2.4 4.2 24.5 1.0 5.5 2.1 9.2 4.2 0.0 13.3 3.9 23.6 2.3 0.0 25.4 3.4 4.1 0.8 0.3 74.2 2.1 0.2 1.8 15.0 0.2 0.2 0.0 12.1 4.3 2.0 3.0 0.7 0.2 1.3 11.4 2.2 4.3 6.1 6.6 1.0 1.4 2.2 1.7 0.7 0.4 4.5 0.2 0.4 5.0 1.2 ATR "FRP1, MEC1, SCKL, SCKL1" ENSG00000175054 "ATR serine/threonine kinase" Q13535 3 142449007-142578733 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054320 Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 15: NK-cells - Transcription" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Golgi apparatus" "HPA054320: AB_2682448" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" "unprognostic (2.90e-1)" "unprognostic (4.23e-2)" "unprognostic (2.25e-2)" "unprognostic (6.42e-2)" "prognostic unfavorable (8.39e-5)" "unprognostic (3.44e-1)" "unprognostic (1.67e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.94e-1)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-1)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" 3.0 8.6 0.7 4.1 1.1 1.2 3.2 0.9 1.4 3.8 3.7 2.7 1.7 3.3 2.3 3.1 3.3 3.4 2.3 1.2 1.9 3.7 3.6 2.9 4.8 1.5 1.2 2.7 3.8 5.2 3.7 3.1 1.4 3.0 2.9 2.9 3.5 2.5 2.9 2.7 3.1 3.2 1.0 4.2 2.8 5.2 1.2 4.9 5.0 1.4 4.6 4.1 2.7 1.2 28.6 13.2 7.1 7.0 9.6 13.6 8.8 14.8 8.4 10.1 9.7 6.4 6.8 19.9 14.6 10.1 14.6 16.1 10.9 12.8 15.0 7.5 7.9 11.9 8.2 4.1 4.2 20.5 5.3 9.8 4.8 9.5 10.3 5.8 11.6 8.7 8.2 7.5 9.6 7.5 13.9 2.6 7.3 15.6 9.6 11.8 12.5 13.5 6.3 11.1 5.2 5.1 28.6 8.3 8.0 7.8 12.0 5.4 14.6 10.5 4.9 12.3 15.2 10.8 7.4 18.5 13.8 6.5 8.5 0.0 0.3 0.0 0.5 0.4 1.0 0.1 0.3 0.5 0.7 0.3 0.4 0.4 0.0 1.3 0.2 0.2 0.4 0.2 0.7 1.1 0.9 1.4 1.2 1.9 1.5 1.2 1.4 1.0 1.2 1.2 11.5 6.4 10.6 39.2 22.4 4.0 7.2 8.8 14.2 14.1 9.2 6.5 7.6 5.7 10.1 3.7 37.5 7.7 14.9 3.5 0.0 5.9 16.4 18.8 18.6 10.2 7.7 14.5 93.0 4.9 3.6 8.3 14.8 10.3 1.3 16.3 7.9 7.3 6.4 8.4 94.4 4.8 14.2 9.4 4.0 8.7 6.5 12.8 10.6 73.1 12.0 6.0 9.2 65.4 71.9 6.4 1.8 7.2 23.1 8.1 1.9 6.5 25.4 23.6 0.0 14.6 9.8 50.1 18.5 14.7 4.5 5.1 15.1 13.8 7.6 6.1 B2M ENSG00000166710 Beta-2-microglobulin P61769 15 44711487-44718851 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Immunity "Amyloidosis, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 31919.3;NK-cells: 24726.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002572, HPA006361" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1790000000 2100000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 3: Monocytes - Immune response regulation" "Golgi apparatus, Plasma membrane" Cytosol "CAB002572: AB_563434, HPA006361: AB_1078278" "unprognostic (9.45e-2)" "unprognostic (5.63e-2)" "unprognostic (3.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.18e-1)" "unprognostic (4.82e-2)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (2.44e-3)" "unprognostic (2.02e-2)" "unprognostic (4.77e-2)" "unprognostic (2.39e-1)" "unprognostic (5.25e-2)" "unprognostic (1.97e-2)" "unprognostic (2.17e-2)" 3160.2 3214.7 697.6 5686.5 705.1 7839.2 2606.9 711.8 1145.0 2539.9 789.6 5139.0 5180.7 2192.2 1735.6 2283.9 1648.3 4948.8 2327.2 651.0 769.9 2462.6 6206.2 6159.2 9311.8 889.5 763.2 1945.7 1310.9 1940.5 318.4 3502.0 815.3 2345.0 5593.5 139.3 5657.1 1784.5 931.7 3015.6 5693.3 2545.3 838.3 7896.1 4878.2 615.6 771.9 4217.4 2340.8 2026.5 5333.4 5753.1 549.4 909.5 1735.4 378.9 226.0 633.6 4348.7 4719.4 1662.5 2045.5 4961.9 3609.7 6561.4 425.3 5417.9 554.8 2567.9 1948.8 2410.2 2537.0 497.2 878.7 1226.2 4762.2 435.9 2956.9 2263.6 600.3 3609.3 2074.5 3328.6 2735.9 609.8 1075.7 1044.4 2442.6 1884.1 965.4 611.9 3649.1 2195.5 476.9 1518.4 3213.8 206.5 629.8 1014.3 2240.2 1926.6 4789.2 2425.5 3486.4 254.1 179.1 1288.4 1571.2 1338.5 394.3 655.3 6180.6 2548.7 4531.4 676.5 5389.2 2193.3 4771.7 7118.6 1683.1 5384.6 3783.6 2567.3 48105.4 18117.1 33178.9 20639.1 17775.0 20836.8 15768.0 23783.0 22245.1 9978.8 11988.4 17122.9 22791.8 50453.6 18779.6 19034.9 12052.6 29659.1 56957.2 697.6 705.1 711.8 1145.0 651.0 769.9 889.5 763.2 815.3 838.3 771.9 909.5 12048.3 3387.8 3505.1 28.7 8472.8 7843.7 3197.1 8420.8 1628.8 33.3 2399.5 2015.2 1068.8 3593.1 5347.4 2100.3 27.1 1354.6 14028.8 8753.6 1038.9 13898.6 43.1 2073.7 2414.0 8385.6 2266.0 2087.2 7.3 9034.5 4397.5 3691.1 1981.7 2282.2 3029.5 1270.6 6835.7 3832.6 11985.7 5.0 22.0 5982.6 8701.4 12536.8 14507.0 158.8 3018.0 10687.9 6744.8 368.2 31919.3 322.0 24726.3 95.0 129.2 10115.7 7085.6 1688.8 11026.6 5300.4 18327.7 3122.5 8367.9 52.5 4016.7 2055.2 4107.1 64.2 72.1 1541.4 8619.8 804.8 14266.2 3229.8 3063.4 8248.6 B3GALNT2 MGC39558 ENSG00000162885 "Beta-1,3-N-acetylgalactosaminyltransferase 2" Q8NCR0 1 235447190-235504452 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 252.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007846, HPA050662" Approved Uncertain "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA007846: , HPA050662: AB_2681209" "unprognostic (5.50e-2)" "unprognostic (3.16e-3)" "unprognostic (6.60e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (7.59e-3)" "unprognostic (1.96e-2)" "unprognostic (3.39e-2)" "unprognostic (3.38e-1)" "unprognostic (7.19e-3)" "unprognostic (2.89e-1)" "unprognostic (1.99e-1)" "unprognostic (5.52e-2)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (8.34e-3)" 4.7 5.4 2.3 2.8 2.2 1.6 4.0 2.5 2.4 5.3 5.7 8.1 3.2 7.3 4.8 8.9 5.5 5.3 6.1 2.4 2.6 3.3 3.2 3.4 2.2 2.4 2.7 5.1 22.3 6.7 3.8 4.3 2.3 7.3 5.3 3.9 6.0 6.6 23.3 6.2 5.1 10.6 2.3 2.7 8.9 5.9 2.5 3.6 7.3 16.7 3.4 7.9 5.4 2.2 15.0 10.4 11.1 16.2 14.2 15.7 21.6 14.1 11.8 9.8 10.0 7.7 13.1 8.2 15.3 15.5 7.0 17.3 21.3 14.8 12.5 14.5 11.7 5.8 12.7 9.3 10.0 17.9 4.3 9.9 9.5 10.4 21.5 7.0 14.1 19.2 10.9 10.9 9.2 7.3 10.0 8.8 15.7 7.9 3.1 10.6 19.9 18.8 6.4 21.1 14.2 16.8 23.7 7.8 12.2 3.9 18.5 15.6 13.1 9.7 13.3 16.6 18.1 11.3 14.8 5.0 6.7 12.1 21.7 1.1 1.1 0.5 0.6 1.6 0.8 0.6 0.6 0.7 2.3 0.5 0.5 0.9 0.2 1.2 1.4 1.9 0.3 0.4 2.3 2.2 2.5 2.4 2.4 2.6 2.4 2.7 2.3 2.3 2.5 2.2 9.6 9.6 5.0 38.8 7.8 31.2 39.0 15.1 36.5 33.1 8.9 6.7 6.7 1.5 9.5 5.5 252.3 20.3 14.6 5.2 0.0 6.9 26.7 20.2 14.8 7.0 9.0 5.0 38.4 7.2 7.0 11.5 10.7 19.9 5.7 11.9 4.6 4.7 3.9 28.6 56.2 6.2 4.1 3.0 16.3 7.3 10.5 6.9 1.8 23.4 11.5 11.2 7.2 29.1 21.7 9.2 5.4 16.1 14.0 27.6 9.7 2.3 8.1 18.4 0.0 21.0 20.5 35.8 40.3 28.5 29.7 22.4 9.0 17.6 7.0 33.1 B3GNT7 beta3GnT7 ENSG00000156966 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7" Q8NFL0 2 231395710-231401164 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 71.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 272.8;Intestinal goblet cells: 145.2;Paneth cells: 126.4;Undifferentiated cells: 354.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 32.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.5;HEL: 15.6;THP-1: 14.0;WM-115: 23.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA013881, HPA035625, HPA035626" Enhanced Approved "Golgi apparatus,Mitotic spindle,Cytosol" "Intracellular and membrane" Yes NA 3600000 "Cluster 40: NK-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "Mitotic spindle, Cytosol" "HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-3)" "unprognostic (1.46e-2)" "unprognostic (1.28e-2)" "unprognostic (2.69e-1)" "unprognostic (1.36e-1)" "unprognostic (2.31e-2)" "unprognostic (6.18e-2)" "unprognostic (5.82e-2)" "unprognostic (2.17e-2)" "unprognostic (7.77e-2)" "unprognostic (4.27e-3)" "unprognostic (6.96e-2)" "unprognostic (1.18e-1)" "prognostic favorable (6.00e-4)" "unprognostic (3.57e-1)" 3.1 12.9 5.9 2.8 5.1 14.2 3.8 4.0 5.8 2.5 4.6 56.2 25.2 1.9 6.8 2.9 4.6 14.0 4.7 5.6 6.5 2.2 1.2 15.3 1.6 6.0 7.0 16.7 25.4 14.3 8.8 5.4 5.3 3.2 71.2 2.1 7.5 4.4 0.4 5.0 28.4 2.3 4.3 5.1 35.6 1.3 7.3 2.4 8.4 0.3 1.5 3.7 0.6 5.4 0.7 2.8 0.3 0.6 0.1 0.2 1.0 0.2 1.1 0.1 0.1 1.4 19.5 2.2 5.8 0.3 0.2 5.1 0.2 0.0 0.1 0.3 0.5 15.6 0.5 0.9 0.1 0.1 0.8 0.1 1.4 0.2 0.3 1.1 0.2 0.4 0.5 0.4 0.1 0.9 0.2 0.7 6.3 7.7 3.3 0.3 0.1 0.4 0.6 1.7 0.5 0.8 0.3 1.7 0.7 6.9 0.6 14.0 0.2 0.4 0.4 0.2 0.2 2.3 0.9 0.7 0.3 0.2 23.7 0.7 0.1 0.7 2.9 0.5 0.5 9.9 0.1 0.4 6.5 7.0 0.1 0.7 0.2 32.1 0.6 3.1 0.2 1.0 5.9 5.1 4.0 5.8 5.6 6.5 6.0 7.0 5.3 4.3 7.3 5.4 0.9 41.7 30.2 0.3 8.7 2.3 1.7 8.7 0.0 0.4 5.2 2.5 1.1 95.8 29.7 1.8 2.1 0.6 61.7 272.8 0.0 16.1 0.4 13.3 2.2 4.7 103.0 0.4 0.5 84.3 64.9 2.3 51.5 18.5 9.5 17.3 3.3 0.2 11.2 0.0 0.4 145.2 18.3 10.1 38.6 1.2 1.5 9.7 3.6 0.0 2.9 0.5 10.3 55.3 0.2 69.8 126.4 8.2 5.5 11.6 93.2 0.4 82.2 1.8 0.0 0.5 2.3 0.9 1.4 0.0 2.7 2.1 10.0 0.4 354.6 16.2 B3GNT9 MGC4655 ENSG00000237172 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9" Q6UX72 16 67148104-67150998 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 12.9;Leydig cells: 11.5;Peritubular cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052743, HPA062734" Approved Approved "Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "Nucleoli fibrillar center" "HPA052743: AB_2681934, HPA062734: AB_2684854" "unprognostic (2.56e-2)" "unprognostic (2.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.07e-1)" "unprognostic (6.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.28e-2)" "unprognostic (3.01e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (4.96e-3)" "unprognostic (7.56e-3)" 7.7 8.4 7.1 4.2 8.0 0.2 5.7 7.5 6.8 15.0 8.4 7.6 3.2 13.4 7.3 5.2 13.7 6.8 13.8 7.1 8.0 7.4 2.5 9.0 2.9 8.7 9.7 15.0 3.5 21.8 20.5 7.9 8.7 11.8 3.3 1.4 9.0 14.8 1.9 5.9 5.6 7.8 9.3 5.6 6.1 6.0 7.7 1.5 18.7 2.1 2.5 11.7 8.9 11.1 4.9 8.8 0.7 0.9 27.7 28.6 1.0 22.5 36.2 14.4 18.5 4.0 0.8 0.6 1.5 34.9 6.0 11.1 0.3 1.0 7.8 7.6 3.2 0.7 9.7 3.5 22.3 0.6 0.5 23.7 8.3 14.0 0.4 35.8 2.0 0.5 1.0 2.7 22.6 2.6 2.6 1.2 5.4 3.8 7.7 7.4 12.9 4.4 2.3 6.0 5.0 11.2 50.9 0.2 0.8 4.3 1.3 3.9 4.6 25.6 1.1 25.9 10.2 3.2 2.4 0.8 31.9 1.3 12.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.1 8.0 7.5 6.8 7.1 8.0 8.7 9.7 8.7 9.3 7.7 11.1 1.2 6.4 5.0 1.0 1.2 3.2 2.8 2.4 9.6 1.6 3.2 2.3 2.6 5.7 2.4 3.7 0.0 0.3 0.1 0.4 0.0 1.3 5.3 2.5 7.6 2.0 2.4 0.0 0.4 1.7 0.5 12.9 2.6 2.2 0.0 3.0 6.4 0.1 1.8 0.0 1.3 0.9 2.0 0.6 3.3 6.9 11.5 0.4 1.8 0.0 0.1 0.9 0.0 1.0 2.3 0.9 0.1 13.5 4.7 2.4 0.1 0.9 4.2 0.3 6.6 3.2 6.6 4.4 2.8 2.7 4.1 0.8 1.5 2.9 0.8 1.3 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 459939-563509 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 61.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.2 7.0 0.5 3.2 0.7 2.1 1.3 0.0 1.0 7.4 1.0 18.4 1.0 6.2 2.7 7.5 3.7 2.2 23.9 0.5 0.0 4.6 0.1 5.2 0.1 0.0 0.0 0.4 2.6 16.9 9.3 0.1 0.0 2.0 12.5 0.1 4.8 0.7 1.5 14.8 2.0 2.2 0.0 0.3 61.0 8.0 0.0 2.3 2.3 0.1 0.7 1.4 5.6 0.7 0.0 0.0 0.3 1.2 0.0 0.0 33.5 0.0 0.0 0.0 0.0 8.0 6.6 0.0 0.9 0.0 0.7 3.6 8.0 1.1 0.1 13.2 12.5 0.0 0.0 1.8 0.0 0.1 5.3 0.0 5.3 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.4 0.0 0.1 14.8 10.5 0.6 0.5 5.0 0.0 7.1 6.8 3.8 2.7 0.8 0.3 1.0 4.9 0.8 2.9 0.0 0.0 2.7 0.2 0.9 0.0 0.0 0.0 0.0 9.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 7.0 1.3 0.3 7.5 6.0 3.4 0.0 0.6 2.9 0.6 15.1 1.5 6.2 9.2 0.0 0.0 0.6 81.1 0.0 12.0 26.3 20.4 4.8 0.6 10.3 0.0 32.6 4.8 0.1 1.6 128.0 47.4 0.0 0.1 0.0 0.1 0.7 0.0 5.2 18.6 2.0 0.0 1.1 89.2 0.0 0.5 0.0 2.8 0.6 0.0 0.0 1.0 3.6 16.6 33.4 0.0 0.2 12.7 1.9 0.2 9.1 0.2 0.0 0.2 0.8 2.8 1.3 0.9 17.3 0.0 1.5 1.9 26.1 14.4 B4GALT1 "beta4Gal-T1, GGTB2" ENSG00000086062 "Beta-1,4-galactosyltransferase 1" P15291 9 33104082-33167356 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 215.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 346.6;SiHa: 635.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010806, HPA010807" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 97000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 20: HeLa - Mitochondria" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" "HPA010806: AB_1078255, HPA010807: AB_1078254" "unprognostic (7.57e-2)" "unprognostic (1.24e-2)" "unprognostic (2.09e-1)" "prognostic favorable (6.85e-7)" "unprognostic (1.83e-2)" "unprognostic (9.94e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-3)" "unprognostic (2.78e-1)" "unprognostic (7.93e-3)" "unprognostic (4.98e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.46e-2)" 52.4 39.2 5.6 43.9 5.1 80.2 91.1 7.3 6.4 64.9 17.9 38.0 21.9 35.7 35.7 49.7 49.3 47.8 55.4 5.4 6.8 42.1 89.4 50.1 33.3 8.6 6.4 77.4 43.9 77.1 21.2 52.9 7.7 38.8 34.3 26.2 70.3 34.0 30.9 35.8 28.1 55.2 8.1 39.7 52.1 38.3 8.3 26.8 60.8 16.7 41.2 79.4 44.9 9.4 99.1 71.8 13.1 18.1 64.9 113.7 235.9 100.6 125.7 59.5 58.8 44.0 112.1 37.8 62.4 147.3 77.2 51.9 13.7 124.5 59.4 346.6 13.6 21.6 277.6 34.1 127.4 17.9 35.0 128.0 218.1 68.0 82.2 127.6 64.0 11.5 24.9 45.5 57.0 86.1 16.3 35.4 8.1 54.1 21.8 21.0 12.2 25.1 177.0 84.6 9.8 12.7 635.5 122.2 25.8 40.4 154.8 32.3 59.9 42.2 49.4 137.2 39.8 7.6 17.9 23.3 131.0 24.2 15.8 30.6 33.2 20.3 45.2 30.5 59.2 87.1 30.4 40.7 23.3 69.9 17.9 23.3 96.5 72.4 24.8 215.3 22.0 24.0 5.6 5.1 7.3 6.4 5.4 6.8 8.6 6.4 7.7 8.1 8.3 9.4 104.4 86.6 71.9 3.3 112.0 141.9 53.0 59.2 75.7 3.8 215.8 66.7 37.2 88.6 59.5 167.3 20.9 94.9 206.2 146.1 15.6 78.2 21.9 108.6 39.7 60.6 8.4 12.8 4.1 125.9 155.8 99.9 80.0 163.7 36.8 19.6 91.1 195.4 53.9 0.0 4.5 64.0 24.4 82.3 333.3 11.1 50.7 129.0 96.0 33.7 31.3 7.7 39.1 3.0 1.0 157.8 57.4 44.4 116.4 89.0 23.9 57.7 33.8 40.1 52.6 80.0 50.8 6.4 13.8 86.1 108.4 173.9 92.7 33.9 41.6 93.2 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" NA NA 3100000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Vesicles" "HPA007620: AB_2667879, HPA047739: AB_2680141" "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavorable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 29.0 19.0 61.4 13.0 55.0 6.6 24.6 48.0 70.1 28.4 44.0 43.7 12.5 31.0 9.6 32.4 20.0 14.9 40.8 58.4 51.6 24.6 38.8 19.6 5.9 53.6 53.6 19.6 51.5 14.2 24.7 10.1 53.0 31.2 10.2 8.9 27.3 23.8 61.0 32.8 15.2 26.3 52.6 12.0 22.4 22.6 55.2 3.1 14.3 33.2 6.8 37.0 26.8 52.6 61.6 38.4 45.3 76.0 51.3 54.5 37.8 54.2 55.9 54.8 50.9 30.4 51.4 38.4 31.6 112.3 52.5 39.9 36.8 72.8 14.0 39.6 80.2 23.2 37.8 66.9 43.2 20.6 0.8 47.0 79.1 39.3 71.4 55.3 65.5 15.9 51.7 25.3 46.7 45.3 15.3 18.6 65.6 35.7 56.7 44.3 48.2 62.7 33.9 29.3 72.7 58.5 31.1 89.4 38.5 16.9 38.6 17.5 39.3 90.8 102.4 63.8 78.5 7.6 17.8 15.9 40.4 16.9 64.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 61.4 55.0 48.0 70.1 58.4 51.6 53.6 53.6 53.0 52.6 55.2 52.6 9.7 0.0 8.8 7.5 2.2 7.8 10.3 10.8 1.8 13.3 15.0 18.9 14.0 7.2 7.4 14.7 4.2 2.0 1.2 10.2 1.9 13.3 16.4 6.2 16.2 10.4 16.3 1.3 8.0 20.6 8.0 15.2 13.7 8.7 0.0 23.8 6.1 18.7 2.3 18.5 5.6 22.6 2.0 1.0 3.3 6.7 16.4 1.5 3.6 1.0 1.6 15.0 0.0 5.0 9.8 27.3 6.1 12.4 5.0 25.9 6.4 8.8 4.4 12.2 6.6 9.8 14.3 6.2 15.6 7.6 12.6 0.5 1.7 21.1 15.3 16.1 B4GALT3 beta4Gal-T3 ENSG00000158850 "Beta-1,4-galactosyltransferase 3" O60512 1 161171310-161177968 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 114.8;Syncytiotrophoblasts: 114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 246.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010793 Approved Supported "Golgi apparatus,Cytosol" NA NA 130000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" Cytosol "HPA010793: AB_1078256" "unprognostic (5.67e-3)" "unprognostic (7.68e-3)" "unprognostic (1.20e-2)" "unprognostic (8.15e-3)" "unprognostic (3.91e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.87e-5)" "unprognostic (3.11e-2)" "unprognostic (3.13e-1)" "unprognostic (4.64e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (7.12e-7)" "unprognostic (1.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" 28.4 21.9 20.0 16.0 20.5 19.0 21.6 17.9 21.1 21.8 18.6 19.4 17.2 14.7 18.3 25.1 19.0 14.4 24.9 20.5 22.0 27.7 22.5 25.1 23.4 18.4 19.3 29.0 34.0 21.9 32.5 21.7 19.1 21.8 17.5 8.0 32.3 12.3 24.6 24.6 18.6 10.6 18.2 31.2 27.6 19.4 22.9 16.9 21.9 16.3 20.7 23.7 21.4 19.3 35.2 22.3 32.8 43.6 47.5 24.7 52.5 19.2 34.7 39.6 36.3 44.8 68.4 32.2 54.2 22.1 37.8 34.3 34.9 21.7 22.8 34.1 42.5 18.6 14.2 35.8 34.1 37.0 48.6 33.7 31.1 36.5 39.6 47.0 45.2 41.3 60.3 69.3 32.2 35.4 24.1 34.4 40.9 70.3 48.0 28.5 18.2 79.4 33.5 20.9 46.6 54.7 19.7 50.4 41.7 44.2 50.7 64.8 18.9 19.5 35.4 22.4 57.7 246.6 146.5 43.0 28.5 31.2 32.0 10.7 14.9 12.6 27.0 17.2 24.3 26.2 25.9 26.0 18.0 21.2 25.0 23.2 9.7 25.9 23.3 37.4 43.1 21.0 20.0 20.5 17.9 21.1 20.5 22.0 18.4 19.3 19.1 18.2 22.9 19.3 18.1 19.2 20.0 1.6 34.7 38.5 36.6 26.2 19.9 17.3 32.8 19.9 10.2 15.7 17.7 25.8 2.1 44.8 30.3 15.3 5.9 28.7 10.1 8.2 7.8 24.4 28.8 34.5 6.2 22.9 91.7 24.7 15.3 10.9 9.5 21.0 27.8 13.2 29.7 26.9 7.1 20.7 26.4 16.6 17.9 5.7 9.6 16.2 23.2 4.7 10.2 9.4 47.4 5.0 4.5 31.4 20.0 7.2 114.8 46.1 19.0 20.9 12.4 8.6 26.3 11.1 24.7 14.9 46.9 21.7 41.9 114.2 29.5 11.8 22.7 51.4 B4GALT4 beta4Gal-T4 ENSG00000121578 "Beta-1,4-galactosyltransferase 4" O60513 3 119211732-119240946 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 76.0" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 123.6;Urothelial cells: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 125.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046819, HPA063546" Approved Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA046819: AB_2679824, HPA063546: AB_2685036" "unprognostic (4.07e-2)" "unprognostic (1.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.14e-3)" "unprognostic (4.59e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (6.30e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-1)" "unprognostic (6.10e-3)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" 12.4 9.1 6.8 10.7 8.4 20.1 11.1 6.5 8.1 16.4 8.7 30.6 28.6 14.8 76.0 17.7 21.8 33.2 12.9 7.0 6.9 24.1 16.6 9.9 9.9 6.9 6.7 18.4 19.5 15.1 18.2 25.7 6.9 13.7 35.2 9.9 12.2 14.7 6.3 14.1 32.5 13.6 7.0 9.4 29.3 8.3 7.5 7.4 16.4 6.5 11.5 37.6 10.5 7.2 60.1 100.3 12.8 9.8 36.0 31.1 65.3 125.8 54.4 54.4 56.2 65.4 18.3 11.8 23.9 61.3 32.2 78.6 20.7 15.0 59.9 23.5 6.8 15.1 20.3 31.7 25.3 8.9 15.7 21.2 21.4 23.0 19.3 21.6 5.8 8.0 11.2 11.7 25.5 18.4 5.3 10.7 17.6 34.0 27.2 4.9 11.8 4.7 31.2 60.3 10.9 24.0 29.4 14.6 27.9 28.2 30.2 5.7 4.9 27.3 24.0 15.2 13.5 27.2 21.5 16.1 23.5 10.1 23.5 20.1 4.1 8.3 13.3 5.2 7.3 4.2 7.3 7.9 5.5 3.2 13.6 7.1 2.5 14.8 5.0 3.4 2.7 5.7 6.8 8.4 6.5 8.1 7.0 6.9 6.9 6.7 6.9 7.0 7.5 7.2 8.5 0.0 9.4 7.2 17.1 10.7 22.2 48.9 12.0 10.8 14.9 12.4 9.2 61.5 69.1 7.3 4.2 36.2 46.0 43.2 1.9 30.7 2.1 40.1 16.9 8.4 13.8 7.8 11.9 33.2 123.6 24.0 36.2 74.5 13.3 35.0 3.9 10.8 14.4 18.5 11.1 78.7 16.2 9.8 14.8 2.4 14.9 14.9 14.2 6.5 10.9 22.2 39.1 10.6 10.2 40.5 50.2 28.2 27.4 30.7 59.3 22.6 52.6 10.2 19.7 13.9 16.9 1.7 8.4 14.0 10.5 52.3 23.1 20.0 23.6 171.6 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375848-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 158.0;salivary gland: 131.4;vagina: 72.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 128.5;Breast glandular cells: 50.4;Squamous epithelial cells: 136.4;Suprabasal keratinocytes: 82.5;Urothelial cells: 84.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 163.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.8;hippocampal formation: 1.7" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.3 0.0 0.1 1.3 0.3 0.0 14.9 1.1 0.3 24.2 5.5 7.0 17.9 0.1 0.2 158.0 16.7 4.7 0.2 0.3 0.4 5.4 0.0 0.3 0.7 3.0 1.6 0.0 10.3 0.3 1.7 3.6 3.2 4.8 4.9 0.2 131.4 0.6 2.2 34.8 13.0 0.2 1.8 0.0 6.4 2.4 0.4 0.4 0.3 39.3 8.8 0.4 72.2 2.9 23.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 0.0 1.0 20.9 0.0 5.1 0.0 163.7 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.1 0.0 3.9 0.0 6.2 0.0 0.0 0.0 20.6 0.9 0.0 0.0 39.8 0.0 0.3 0.2 0.0 0.0 19.4 0.1 0.4 3.8 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.3 0.3 0.4 3.0 1.6 3.2 1.8 0.4 2.9 0.2 0.0 1.1 0.3 0.5 43.1 128.5 8.7 3.4 0.6 50.4 16.9 0.5 4.3 8.0 0.0 0.0 13.4 0.8 29.4 7.9 23.7 7.2 11.3 0.6 1.2 1.8 0.0 1.8 0.7 5.8 2.7 6.6 4.6 0.0 0.0 0.0 0.2 1.9 0.0 0.3 13.4 0.0 0.3 2.2 1.6 0.0 0.7 10.6 0.0 0.1 0.7 0.0 0.0 0.3 6.2 29.8 0.4 0.9 25.6 34.0 3.4 11.8 0.3 0.0 0.6 1.7 0.1 5.3 136.4 82.5 4.2 1.7 0.0 19.4 84.8 BDKRB2 BK-2 ENSG00000168398 "Bradykinin receptor B2" P30411 14 96204679-96244166 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 41.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 19.3;Endothelial cells: 18.2;Fibroblasts: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 49.2;BJ hTERT+: 94.5;U-87 MG: 39.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA003551, HPA050841" Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "Golgi apparatus, Vesicles" "HPA003551: , HPA050841: AB_2681254" "unprognostic (1.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (8.79e-3)" "unprognostic (2.68e-2)" "unprognostic (1.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.84e-2)" "unprognostic (3.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-3)" "unprognostic (3.11e-2)" "unprognostic (9.40e-2)" "unprognostic (9.90e-2)" "unprognostic (1.49e-2)" 14.0 1.4 0.8 5.5 1.0 0.0 5.8 3.8 1.1 15.6 0.9 12.4 7.9 6.7 2.4 17.2 7.2 20.8 1.2 0.9 0.8 13.4 0.7 2.5 0.3 4.9 1.3 1.0 9.4 0.9 0.8 1.3 5.0 4.8 12.2 0.0 3.5 6.2 0.9 5.4 9.7 10.2 1.0 0.1 4.9 0.2 1.5 0.9 3.6 1.8 1.7 41.1 15.4 1.2 1.7 6.1 0.1 11.0 16.2 49.2 0.0 5.5 94.5 3.2 3.7 0.3 10.4 0.0 0.2 8.7 3.7 14.8 0.0 2.4 2.8 1.2 0.1 0.0 1.1 0.0 7.8 0.0 0.0 15.1 7.5 9.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.1 0.1 20.4 0.0 0.0 2.2 0.0 3.2 0.0 3.4 1.1 1.8 15.6 0.1 2.1 1.0 0.0 0.0 0.3 0.3 3.3 0.1 0.2 0.0 0.0 39.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 1.0 3.8 1.1 0.9 0.8 4.9 1.3 5.0 1.0 1.5 1.2 8.2 3.2 3.1 0.0 0.0 9.2 0.7 5.3 6.8 0.0 0.2 0.5 0.6 10.0 11.6 9.2 0.0 1.2 0.0 19.3 7.9 11.5 0.0 7.5 16.1 18.2 7.1 0.0 1.8 3.8 3.6 25.8 1.1 4.6 0.0 0.0 3.3 0.2 0.2 0.0 0.4 7.2 8.2 0.0 15.2 0.0 0.9 0.4 5.4 0.0 0.0 0.0 0.0 1.0 1.9 6.9 6.2 1.2 0.0 1.0 10.6 0.2 12.5 0.0 0.0 4.5 1.2 0.0 0.0 15.3 5.8 4.0 0.3 0.1 0.9 2.9 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;pancreas: 23.8;pituitary gland: 19.6" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 143.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Group enriched" "Detected in some" 7 "HeLa: 56.6;SH-SY5Y: 129.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002899 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.9 3.2 15.3 0.4 14.9 4.0 1.7 16.4 27.2 3.4 0.0 1.2 2.6 2.4 0.8 1.0 6.0 1.2 2.6 22.0 5.1 1.0 0.7 1.4 0.5 6.4 1.5 4.8 23.8 4.6 19.6 1.6 6.6 4.1 0.2 2.1 1.5 1.3 0.7 1.2 2.7 0.8 1.0 5.8 1.2 2.8 3.2 1.0 1.0 0.1 0.5 1.5 1.3 11.9 0.8 3.3 1.8 11.1 0.0 0.0 0.3 0.3 0.0 0.5 0.1 0.0 1.1 0.3 0.5 0.5 2.5 0.4 0.5 0.0 0.0 0.0 1.1 5.1 56.6 0.0 0.1 0.2 0.3 0.3 0.2 0.9 1.2 0.0 0.1 0.7 0.6 0.1 0.0 4.4 0.4 1.6 1.3 0.3 1.9 0.1 0.3 7.0 0.0 0.2 2.9 129.7 3.0 0.1 3.0 0.0 0.9 13.7 0.0 0.4 3.8 0.1 0.0 0.0 0.0 0.2 9.2 2.5 0.3 0.8 0.1 3.4 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.4 0.0 0.1 15.3 14.9 16.4 27.2 22.0 5.1 6.4 1.5 6.6 1.0 3.2 11.9 0.8 0.0 0.6 18.6 0.3 2.4 1.8 0.3 0.0 3.7 0.5 1.1 2.3 0.0 0.7 0.0 0.0 0.1 0.2 0.3 0.0 1.4 0.4 0.1 0.1 0.6 0.0 0.0 18.4 8.0 0.2 1.5 0.0 0.1 9.5 0.1 1.4 0.0 0.3 143.0 10.9 0.0 0.0 0.0 0.8 0.8 1.8 0.3 1.8 4.7 1.1 0.8 0.0 15.6 0.8 2.9 1.1 6.8 0.3 1.6 2.7 0.1 0.1 2.3 0.0 1.7 0.7 0.9 1.5 0.3 2.0 0.1 0.3 0.4 0.4 0.4 BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 36.2 38.2 26.8 29.4 28.2 18.0 35.5 26.5 27.6 43.2 33.2 37.0 29.1 37.0 37.3 30.1 38.8 27.5 34.3 25.6 27.1 40.4 53.5 35.4 32.9 31.0 28.5 53.6 79.9 39.9 56.0 29.8 28.0 43.4 29.8 17.1 52.9 41.6 22.5 36.1 39.4 31.3 27.5 39.4 43.1 33.0 27.5 28.2 37.5 23.4 35.7 37.4 33.2 30.1 46.2 37.6 22.0 27.3 66.5 58.3 31.8 48.1 62.8 50.6 51.5 47.3 43.4 40.5 22.9 87.7 36.4 42.1 25.6 44.0 38.3 31.6 27.7 37.5 21.5 48.2 61.4 43.2 70.2 66.2 58.1 29.8 79.6 58.7 34.7 28.2 55.7 41.3 32.7 25.0 31.7 27.3 33.6 66.8 42.3 32.6 32.6 27.7 41.8 20.3 23.9 29.0 42.9 68.5 47.7 31.5 35.2 33.6 38.6 39.0 18.0 16.0 24.0 72.2 35.9 35.6 52.7 35.6 36.4 58.5 19.0 66.0 28.4 27.5 34.1 31.9 32.5 29.1 19.0 25.0 37.4 29.6 43.5 27.9 25.8 22.1 27.4 32.5 26.8 28.2 26.5 27.6 25.6 27.1 31.0 28.5 28.0 27.5 27.5 30.1 9.8 12.8 17.0 3.9 23.0 9.3 16.8 12.8 16.5 6.8 21.3 19.0 14.5 15.7 10.7 14.7 8.4 15.8 16.9 24.4 21.5 12.8 58.8 8.6 13.2 10.6 7.8 12.0 3.6 23.4 28.2 19.4 20.9 10.1 38.0 10.2 18.2 39.3 22.7 3.3 4.4 23.1 14.2 16.4 12.7 142.9 22.1 18.4 7.2 2.8 14.8 9.1 10.3 4.0 4.7 18.6 26.1 18.8 68.3 29.2 39.2 28.7 12.6 10.4 6.6 12.8 15.9 47.2 21.8 11.9 11.6 26.3 19.4 8.9 17.1 29.3 BGN "DSPG1, SLRR1A" ENSG00000182492 Biglycan P21810 X 153494980-153509546 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Aortic aneurysm, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 795.8" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 223.5;Peritubular cells: 782.7;Sertoli cells: 1485.7;Smooth muscle cells: 401.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 312.6;BJ hTERT+: 400.8;fHDF/TERT166: 568.9;HSkMC: 283.9;hTEC/SVTERT24-B: 235.2;HUVEC TERT2: 561.2;U-138 MG: 249.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003157, CAB003678" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" NA NA 3300000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "Endoplasmic reticulum" "CAB003678: AB_425325, HPA003157: AB_1078282" "unprognostic (1.74e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-3)" "unprognostic (3.60e-1)" "unprognostic (5.42e-2)" "unprognostic (3.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.22e-2)" "unprognostic (1.76e-3)" "unprognostic (1.30e-2)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (6.00e-8)" "unprognostic (7.05e-3)" "unprognostic (2.40e-2)" "unprognostic (5.66e-2)" "unprognostic (2.57e-3)" 165.8 213.0 54.1 93.1 57.6 0.3 118.0 51.2 91.5 371.0 69.5 69.3 22.0 234.4 83.7 45.8 143.7 326.1 795.8 56.1 48.7 396.5 347.9 477.3 42.4 50.6 50.8 94.9 67.9 26.6 144.1 199.1 53.2 184.2 24.8 1.1 107.7 135.5 32.4 118.9 48.8 213.2 45.5 352.1 51.6 69.9 64.6 15.9 250.0 46.7 35.9 126.8 180.0 65.4 0.0 0.0 29.7 0.1 31.5 70.5 1.1 312.6 400.8 56.7 18.6 39.5 0.0 0.0 56.9 568.9 2.0 0.1 0.0 0.0 10.2 0.0 0.0 0.0 0.6 3.9 27.0 0.0 0.2 283.9 2.2 235.2 10.7 29.0 561.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.5 0.3 0.2 0.0 0.1 0.0 0.6 0.4 0.0 0.0 1.1 11.8 1.3 0.0 120.0 249.5 2.3 1.0 1.5 0.9 0.1 0.0 0.1 0.3 114.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 57.6 51.2 91.5 56.1 48.7 50.6 50.8 53.2 45.5 64.6 65.4 30.5 3.2 5.6 5.9 0.6 104.1 1.3 7.3 5.7 0.2 1.2 5.6 16.1 4.3 2.5 9.2 0.0 15.5 0.7 0.0 1.9 2.7 1.8 1.4 28.3 45.2 0.0 5.3 0.1 0.2 50.0 180.0 7.7 1.1 3.8 8.4 223.5 1.6 4.4 3.3 0.1 0.0 0.0 4.0 43.6 13.5 147.9 3.0 35.6 25.3 2.0 0.1 0.0 20.6 0.0 1.2 0.0 782.7 0.0 3.0 0.0 0.8 1.6 0.2 1485.7 3.1 401.3 0.8 1.2 1.8 54.1 56.9 3.0 7.7 0.0 1.6 BHLHA15 "BHLHB8, MIST1" ENSG00000180535 "Basic helix-loop-helix family member a15" Q7RTS1 7 98211439-98215457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "pancreas: 502.8;salivary gland: 145.9" "Cell type enriched" "Detected in single" 25 "Plasma cells: 12.6" "Cancer enriched" "Detected in many" 4 "prostate cancer: 16.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Karpas-707: 53.5;RPMI-8226: 72.0;U-266/70: 67.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034083, HPA047834" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 25: Pancreas - Digestion" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Golgi apparatus" "CAB034083: AB_2065216, HPA047834: AB_2680172" "unprognostic (2.80e-2)" "unprognostic (9.45e-3)" "unprognostic (8.10e-2)" "unprognostic (6.66e-2)" "unprognostic (4.33e-3)" "unprognostic (1.10e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (3.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (3.70e-4)" "unprognostic (3.36e-1)" "unprognostic (1.94e-1)" "unprognostic (2.95e-1)" "unprognostic (8.25e-3)" 0.1 0.1 0.8 3.6 0.6 0.3 1.5 0.1 2.0 1.9 0.1 4.0 4.0 0.1 0.8 0.9 0.1 0.7 0.2 1.3 0.9 0.6 5.2 0.9 3.8 0.6 0.5 0.4 502.8 0.1 1.5 0.1 0.6 8.5 1.5 0.0 145.9 3.9 0.2 0.6 3.4 0.0 1.0 5.0 31.3 0.2 1.5 0.7 1.9 0.0 4.7 2.5 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.3 0.1 0.8 0.9 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.6 6.7 5.9 0.0 0.1 0.0 0.4 0.4 0.2 0.0 0.2 0.0 0.0 53.5 0.0 0.9 0.0 0.0 0.8 6.2 0.8 0.4 0.0 72.0 0.3 0.0 4.3 1.2 0.0 11.2 0.0 0.0 0.7 0.1 0.0 0.0 0.7 0.1 0.1 67.6 5.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.6 0.1 2.0 1.3 0.9 0.6 0.5 0.6 1.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 BICD2 KIAA0699 ENSG00000185963 "BICD cargo adaptor 2" Q8TD16 9 92711363-92764833 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 63.4" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 83.6;Squamous epithelial cells: 103.2;Suprabasal keratinocytes: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023013, HPA024452" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Golgi apparatus, Plasma membrane, Cytosol" "HPA023013: AB_1845352, HPA024452: AB_1845353" "unprognostic (9.99e-3)" "unprognostic (1.98e-1)" "unprognostic (7.84e-3)" "unprognostic (2.81e-2)" "unprognostic (4.33e-2)" "unprognostic (2.86e-1)" "unprognostic (2.37e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (6.54e-3)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.39e-4)" "unprognostic (1.25e-1)" "unprognostic (2.26e-1)" "unprognostic (3.95e-1)" "unprognostic (1.39e-2)" 15.4 10.6 11.4 13.5 10.0 12.0 10.9 10.9 10.5 20.8 7.8 18.5 4.6 15.5 6.0 47.0 12.8 9.4 19.8 11.1 8.6 9.1 8.5 16.0 14.7 11.0 9.8 12.5 8.9 17.7 6.0 10.4 10.3 11.3 5.0 6.5 14.6 13.1 22.3 63.4 10.4 13.7 10.5 17.3 9.5 9.4 10.0 13.8 10.0 15.3 16.8 15.2 30.9 12.3 32.6 26.5 19.2 19.8 36.6 25.1 27.1 30.8 22.2 17.2 13.6 15.6 14.4 36.3 19.5 34.4 22.0 99.4 21.8 49.1 19.4 17.4 23.5 19.2 25.6 21.7 21.8 26.9 30.0 25.8 67.1 28.8 22.0 20.4 26.0 15.4 19.3 27.5 38.1 21.4 25.6 16.7 13.3 23.8 32.0 27.8 41.8 19.3 27.8 27.0 13.4 20.7 21.7 19.9 14.3 19.2 8.2 12.3 34.9 31.8 21.1 53.9 33.9 22.5 17.5 31.9 26.9 16.3 28.4 1.6 3.4 4.4 1.2 3.6 1.2 1.8 1.4 1.6 3.8 2.0 1.3 1.2 7.5 1.1 5.9 3.2 0.9 1.7 11.4 10.0 10.9 10.5 11.1 8.6 11.0 9.8 10.3 10.5 10.0 12.3 21.7 28.9 12.7 14.7 27.6 73.7 17.1 19.2 83.6 12.8 11.4 10.2 54.5 8.6 16.2 7.3 6.2 8.5 26.1 3.4 3.9 10.1 6.5 21.3 26.7 26.4 10.8 16.0 16.2 5.1 6.5 26.0 5.6 21.1 24.1 13.0 19.2 7.5 14.2 15.2 14.0 1.9 12.2 32.4 30.2 7.6 21.1 40.7 16.0 19.7 38.9 22.0 7.2 9.5 18.5 8.5 3.6 33.4 22.1 18.7 0.8 6.7 14.0 6.4 19.7 23.0 33.1 9.7 8.4 103.2 130.8 7.3 17.2 13.8 3.6 20.3 BIRC6 BRUCE ENSG00000115760 "Baculoviral IAP repeat containing 6" Q9NR09 2 32357028-32618899 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 9.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 9.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074409, HPA074738" Approved Supported "Golgi apparatus,Vesicles,Mitotic spindle" Yes No "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus, Vesicles" "Mitotic spindle" "HPA074409: , HPA074738: AB_2686710" "unprognostic (3.38e-2)" "unprognostic (8.13e-3)" "unprognostic (8.88e-2)" "unprognostic (7.06e-3)" "unprognostic (6.69e-3)" "unprognostic (9.01e-2)" "unprognostic (4.51e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (4.49e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-2)" "unprognostic (1.30e-1)" "unprognostic (4.61e-1)" "unprognostic (7.32e-2)" "unprognostic (3.37e-1)" 4.6 4.7 3.1 6.7 9.7 11.3 8.9 13.9 5.7 7.7 6.3 7.6 5.0 6.8 5.2 5.3 6.2 5.8 4.9 4.6 3.7 7.6 8.9 5.4 9.6 6.4 5.5 12.0 14.7 10.9 2.9 6.9 7.3 6.2 7.5 15.5 5.5 5.9 6.1 6.7 5.4 6.1 4.4 8.5 7.1 6.8 5.6 14.7 11.4 8.8 9.7 7.2 3.1 16.3 21.7 17.8 16.1 7.9 14.9 19.1 11.3 10.8 14.1 11.0 11.3 14.2 5.7 23.6 7.3 19.7 13.2 10.1 22.9 15.1 13.9 18.8 10.5 31.2 11.3 10.7 7.9 32.4 11.9 12.4 6.9 18.0 16.2 10.1 17.7 5.4 25.6 10.0 11.9 9.3 15.5 7.5 11.7 9.2 10.5 14.6 26.6 8.2 9.2 23.4 11.7 18.4 18.6 10.8 8.2 12.5 6.4 11.5 28.7 13.0 13.3 9.1 15.3 13.9 20.0 30.6 10.1 15.1 8.7 9.7 0.9 0.6 1.3 0.7 1.8 0.8 1.0 1.2 0.7 1.8 1.1 1.4 1.5 1.6 1.5 1.6 1.0 0.5 3.1 9.7 13.9 5.7 4.6 3.7 6.4 5.5 7.3 4.4 5.6 16.3 53.9 32.1 30.5 239.3 74.8 46.0 28.6 34.7 41.5 60.8 40.0 23.4 45.8 38.6 42.7 36.8 191.8 35.0 93.4 70.1 1.9 26.9 45.9 39.3 58.0 49.8 32.5 34.3 272.0 31.2 22.0 39.7 68.3 63.1 29.9 52.1 45.7 47.5 29.8 69.0 291.3 43.3 26.4 54.7 60.0 17.6 45.4 59.1 23.2 202.4 67.2 34.9 64.9 231.8 361.3 34.3 30.3 59.0 70.9 46.4 48.5 22.6 30.6 88.2 39.5 56.0 49.1 53.7 46.2 49.7 54.8 38.0 72.4 52.8 45.3 44.0 BLOC1S3 "BLOS3, HPS8" ENSG00000189114 "Biogenesis of lysosomal organelles complex 1 subunit 3" Q6QNY0 19 45178784-45216933 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050111, HPA070609" Approved Approved "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA050111: AB_2681019, HPA070609: " "unprognostic (1.17e-1)" "unprognostic (3.97e-2)" "unprognostic (6.94e-3)" "unprognostic (6.26e-2)" "unprognostic (3.14e-1)" "unprognostic (3.04e-2)" "unprognostic (1.75e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-1)" "unprognostic (9.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.89e-9)" "unprognostic (1.92e-2)" "unprognostic (1.93e-1)" "unprognostic (3.29e-1)" "prognostic favorable (6.86e-4)" 6.7 6.3 7.8 5.9 7.8 12.4 5.7 7.0 8.2 5.7 4.4 5.7 5.3 5.6 5.9 6.4 4.7 3.2 5.2 7.5 6.4 5.7 7.8 5.5 7.6 9.3 8.0 5.6 6.1 4.8 4.4 3.9 8.4 5.7 4.3 3.3 5.6 4.5 4.4 13.2 6.7 4.1 6.8 11.0 7.6 7.2 8.1 4.7 4.7 3.4 7.5 6.6 5.9 9.2 10.4 11.6 3.2 8.1 10.8 7.3 9.7 5.1 8.2 9.5 9.8 7.0 6.6 9.0 12.2 11.9 10.8 16.0 8.5 11.6 6.8 7.9 17.3 12.3 5.5 8.0 15.4 6.0 19.5 10.8 16.3 12.3 17.3 5.4 10.6 5.9 13.2 18.2 5.6 17.8 6.2 9.2 1.8 14.9 14.5 8.9 4.3 7.5 7.0 13.2 6.3 6.0 13.6 22.8 5.1 5.6 9.4 11.1 5.7 9.7 5.5 10.4 8.2 12.7 14.0 6.1 10.6 11.1 7.5 51.1 34.4 30.2 37.4 42.8 31.0 18.4 31.6 28.3 21.4 24.8 25.5 25.5 35.2 24.2 39.9 18.5 29.8 17.8 7.8 7.8 7.0 8.2 7.5 6.4 9.3 8.0 8.4 6.8 8.1 9.2 3.4 0.0 1.7 1.0 5.4 12.7 2.6 1.7 2.2 5.7 4.2 3.2 2.3 1.5 1.5 3.7 0.0 3.7 5.9 4.6 1.9 4.4 17.7 1.9 3.2 5.2 7.2 1.7 2.7 3.7 4.0 3.2 2.0 2.7 8.2 3.0 6.1 6.3 6.1 5.0 2.8 5.0 0.0 8.8 8.9 39.3 6.2 4.7 3.6 1.0 6.8 3.4 11.3 3.5 2.9 5.1 3.2 7.9 4.0 4.9 4.6 4.2 1.7 2.0 0.0 1.9 3.1 1.5 5.1 2.7 13.9 4.5 6.7 3.0 4.1 1.9 BLZF1 JEM-1 ENSG00000117475 "Basic leucine zipper nuclear factor 1" Q9H2G9 1 169367970-169396540 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 85.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025703, HPA027331, HPA067113" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: AB_2685781" "unprognostic (5.25e-2)" "unprognostic (9.03e-2)" "unprognostic (9.31e-3)" "unprognostic (1.48e-2)" "unprognostic (4.66e-1)" "unprognostic (4.00e-1)" "unprognostic (2.34e-2)" "unprognostic (4.52e-3)" "unprognostic (1.07e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-3)" "unprognostic (4.86e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (3.28e-1)" "unprognostic (3.06e-2)" "unprognostic (7.53e-2)" "unprognostic (2.18e-1)" 14.9 13.1 8.2 12.5 10.3 25.6 19.4 11.3 10.3 14.6 9.4 13.9 12.3 15.6 14.3 32.4 11.3 16.3 16.0 8.9 9.0 17.0 14.9 13.0 11.8 9.9 9.4 14.5 9.5 15.1 8.7 18.2 9.7 15.6 15.6 22.8 12.7 16.0 11.3 18.0 12.7 17.9 9.7 12.5 13.1 35.0 9.3 13.7 18.7 11.0 16.2 16.6 14.7 14.3 52.8 16.6 16.5 13.6 24.9 37.6 26.2 46.6 32.0 48.1 52.5 19.5 33.3 7.5 26.8 31.6 30.7 38.6 16.6 30.3 37.4 16.8 16.1 13.7 20.0 13.6 26.4 27.2 18.9 27.6 36.9 35.8 31.7 27.3 25.1 14.9 25.6 20.0 46.0 10.8 12.1 12.7 19.9 38.2 25.2 6.8 26.0 16.6 48.1 17.5 9.3 30.6 30.3 41.3 36.9 28.3 44.8 20.4 30.5 28.9 22.5 26.7 39.6 20.4 26.1 19.5 22.1 11.7 44.6 85.6 12.2 51.5 12.2 16.2 16.0 11.3 15.0 14.1 10.8 10.4 13.2 14.4 25.1 19.8 15.8 8.2 23.9 10.9 8.2 10.3 11.3 10.3 8.9 9.0 9.9 9.4 9.7 9.7 9.3 14.3 14.7 22.4 16.4 34.9 11.7 18.4 46.7 22.6 16.5 14.3 18.0 12.1 29.6 11.5 24.4 11.0 14.6 18.3 15.2 18.2 23.5 24.2 131.4 28.0 18.6 11.9 12.6 16.0 30.2 13.2 17.3 18.7 22.4 28.5 26.0 12.3 12.5 4.8 14.3 33.7 32.8 11.7 14.2 10.7 6.8 72.8 14.6 11.6 14.2 17.8 10.3 21.2 17.5 30.2 57.8 36.7 11.6 17.7 13.9 17.0 15.4 22.4 31.6 27.9 0.0 23.0 21.7 84.9 25.8 16.7 15.6 20.1 18.8 17.1 11.6 65.3 BORCS6 "C17orf59, FLJ20014" ENSG00000196544 "BLOC-1 related complex subunit 6" Q96GS4 17 8188345-8190180 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045415, HPA060791" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 11000 "Cluster 2: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Vesicles" "HPA045415: AB_10964575, HPA060791: AB_2684367" "unprognostic (2.11e-1)" "unprognostic (7.22e-3)" "unprognostic (3.25e-2)" "prognostic favorable (2.78e-4)" "unprognostic (3.84e-2)" "unprognostic (9.91e-3)" "unprognostic (7.51e-2)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" "unprognostic (6.93e-2)" "prognostic favorable (2.60e-4)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (2.18e-2)" "unprognostic (4.38e-2)" "unprognostic (3.28e-1)" "unprognostic (3.10e-2)" 6.4 8.4 9.8 5.0 9.9 4.2 5.7 10.1 10.4 5.7 7.9 8.3 7.2 6.6 3.7 10.9 5.2 2.3 10.1 9.1 8.9 7.7 8.0 5.4 6.7 11.8 10.0 4.1 14.4 6.1 4.7 4.0 10.7 6.2 2.7 3.1 6.2 4.9 15.0 12.5 8.6 2.8 9.8 11.6 8.2 5.5 9.9 5.3 5.7 6.0 4.9 7.1 6.5 10.8 6.3 7.5 2.5 5.1 5.3 3.9 10.0 4.6 5.1 4.4 4.7 4.2 4.2 5.9 9.9 3.7 4.2 9.2 3.9 5.4 1.5 17.8 16.3 4.5 7.0 6.5 6.0 2.7 9.5 4.0 5.7 4.0 4.6 3.9 7.2 8.6 5.1 12.0 2.7 6.7 9.0 7.7 1.8 4.0 8.3 10.6 3.2 8.9 6.1 3.5 3.0 6.9 4.7 3.5 4.2 2.5 5.1 4.2 5.8 2.7 2.4 4.2 5.0 18.0 8.8 2.7 3.9 9.5 3.3 46.4 18.6 50.7 27.8 18.7 22.7 23.5 23.4 29.6 20.9 23.3 22.0 24.9 17.0 28.5 23.1 18.3 23.5 21.4 9.8 9.9 10.1 10.4 9.1 8.9 11.8 10.0 10.7 9.8 9.9 10.8 13.5 9.6 6.4 0.0 21.6 0.0 2.6 0.0 14.2 23.1 9.0 9.5 0.0 11.5 0.6 5.5 6.2 20.4 22.3 12.2 7.9 9.7 2.4 5.6 3.8 10.9 1.2 11.4 0.0 17.7 12.0 4.4 4.1 5.7 3.8 5.2 12.5 9.4 20.9 18.5 0.0 8.6 0.0 21.1 0.0 3.2 5.9 21.5 0.0 0.0 25.6 23.8 45.3 0.0 0.0 11.3 18.3 6.8 18.5 3.5 29.8 10.3 0.0 19.7 32.9 4.3 6.7 9.0 1.3 17.3 0.0 6.2 18.7 9.4 7.5 1.5 BPNT2 "FLJ20421, gPAPP, IMPA3, IMPAD1" ENSG00000104331 "3'(2'), 5'-bisphosphate nucleotidase 2" Q9NX62 8 56957931-56993867 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 22.6;Cardiomyocytes: 53.8;Cytotrophoblasts: 18.0;dendritic cells: 16.2;Extravillous trophoblasts: 91.8;Hofbauer cells: 26.6;Syncytiotrophoblasts: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 480000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 37.6 37.3 14.8 16.1 19.9 12.4 19.3 19.2 19.8 25.5 8.9 17.4 13.3 21.9 16.2 19.1 13.4 16.5 29.4 16.0 17.9 23.4 36.2 17.2 12.3 17.2 17.6 11.8 19.6 35.6 13.7 24.9 17.7 31.0 17.6 19.7 21.9 23.6 37.4 14.3 12.7 25.7 15.3 15.5 16.9 16.5 18.0 15.4 27.1 30.1 13.3 22.4 12.2 29.3 42.4 34.5 26.0 26.9 78.2 53.3 35.7 62.9 60.9 44.1 38.3 17.4 29.2 26.3 47.0 67.3 31.2 33.7 31.8 42.5 65.0 36.4 22.7 51.4 23.0 31.2 48.5 33.0 35.1 43.2 41.6 39.7 63.9 40.8 59.5 24.3 22.5 46.1 48.9 22.1 40.6 19.8 19.2 48.1 12.7 27.9 23.4 29.7 46.0 24.9 10.1 28.1 35.3 42.9 36.3 27.1 38.4 23.9 50.1 59.3 34.2 59.2 45.8 47.5 42.5 27.8 81.0 27.0 37.3 1.8 0.9 0.5 0.9 0.6 0.7 0.7 0.6 0.5 0.7 0.9 0.6 1.1 2.5 3.2 2.6 1.0 0.4 0.3 14.8 19.9 19.2 19.8 16.0 17.9 17.2 17.6 17.7 15.3 18.0 29.3 22.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 18.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 91.8 14.4 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 33.8 1.8 0.0 0.0 0.0 BROX "C1orf58, FLJ32421" ENSG00000162819 "BRO1 domain and CAAX motif containing" Q5VW32 1 222712553-222735196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031445 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 270000 "Cluster 38: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA031445: AB_10602697" "unprognostic (1.27e-1)" "unprognostic (4.32e-1)" "unprognostic (3.43e-2)" "unprognostic (4.60e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-1)" "unprognostic (3.31e-2)" "unprognostic (2.83e-2)" "unprognostic (2.52e-2)" "unprognostic (6.72e-2)" "unprognostic (4.27e-2)" "unprognostic (2.53e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.56e-2)" "unprognostic (1.83e-2)" "unprognostic (2.50e-2)" 17.4 14.5 19.3 18.1 21.9 40.8 23.3 21.0 21.6 17.5 14.1 25.9 21.6 17.3 15.3 27.7 18.5 19.2 16.5 16.6 20.7 22.3 16.9 20.1 19.0 23.2 18.2 21.6 14.8 26.2 8.9 20.5 23.3 17.3 24.9 16.3 16.6 17.8 26.7 23.2 27.5 17.7 22.7 20.9 24.9 12.8 20.2 14.4 26.5 20.5 22.1 16.4 13.5 33.6 56.6 34.2 20.1 17.5 28.6 30.2 38.8 38.2 47.6 30.6 34.8 19.0 71.6 18.7 44.1 47.2 16.5 48.2 22.9 36.5 46.1 23.2 20.4 28.2 34.8 19.2 32.2 32.2 25.4 26.8 34.8 38.4 44.8 34.5 28.3 11.9 43.0 24.8 38.0 17.4 13.7 16.7 25.3 46.0 39.8 14.4 61.2 42.3 36.3 55.6 22.5 35.3 41.7 46.3 28.8 18.9 57.1 32.5 40.7 42.1 23.9 43.6 43.5 18.4 33.8 16.7 34.0 26.8 39.0 75.4 28.0 36.6 21.3 42.1 24.1 15.9 27.0 21.8 26.1 14.4 17.8 22.6 52.7 28.4 44.1 14.4 27.2 18.6 19.3 21.9 21.0 21.6 16.6 20.7 23.2 18.2 23.3 22.7 20.2 33.6 35.7 73.7 46.5 15.7 30.4 48.6 32.3 32.2 27.3 16.3 42.1 23.9 35.9 30.0 38.3 51.5 8.4 29.7 49.1 56.2 56.7 40.0 20.8 43.2 30.9 29.0 31.8 73.0 17.1 32.5 32.6 29.7 35.7 54.2 16.4 26.3 31.8 28.4 36.6 35.3 20.1 50.1 32.6 65.5 33.1 23.7 24.2 50.8 49.8 12.2 52.4 31.0 42.2 25.1 27.3 54.5 44.6 32.0 23.2 47.8 48.4 58.8 67.8 20.8 52.6 27.4 26.8 29.9 27.4 40.4 46.7 51.6 40.5 35.1 41.0 56.4 BRSK2 "C11orf7, PEN11B, STK29" ENSG00000174672 "BR serine/threonine kinase 2" Q8IWQ3 11 1389899-1462689 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 37.8;pancreas: 104.2" "Cell type enhanced" "Detected in some" "Astrocytes: 22.9;Bipolar cells: 87.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 35.5;Horizontal cells: 69.0;Inhibitory neurons: 23.5;Rod photoreceptor cells: 28.6" "Cancer enhanced" "Detected in many" "glioma: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.8;AN3-CA: 17.3;CACO-2: 14.4;HAP1: 13.3;NTERA-2: 27.2;SCLC-21H: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073690 Approved "Golgi apparatus" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "HPA073690: " "unprognostic (5.47e-2)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.05e-2)" "unprognostic (3.63e-1)" "unprognostic (6.42e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.17e-7)" "unprognostic (3.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.49e-3)" "unprognostic (1.86e-1)" 1.1 2.4 11.5 0.2 16.0 0.1 0.7 29.2 37.8 2.1 0.0 2.8 0.5 1.0 0.0 0.8 2.0 0.7 1.0 20.5 2.1 0.5 0.2 0.4 0.1 7.9 3.6 0.9 104.2 2.2 15.6 0.6 8.6 1.4 0.1 17.4 0.4 0.2 0.4 0.3 1.5 0.1 0.5 0.6 1.9 9.0 5.0 0.1 1.0 0.2 0.0 0.8 1.1 17.6 0.1 7.2 15.8 17.3 0.3 0.5 0.0 0.2 0.2 1.3 0.5 14.4 0.9 0.0 2.4 0.2 0.2 0.0 13.3 0.1 1.0 1.7 6.2 0.0 0.0 0.2 0.7 0.0 0.6 0.2 0.0 0.0 1.6 0.3 0.0 0.5 0.2 0.1 0.3 1.7 0.0 0.0 27.2 5.1 2.2 0.0 0.0 0.0 0.2 0.2 62.0 9.0 3.3 0.2 4.7 0.3 0.3 0.8 0.3 1.4 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 16.0 29.2 37.8 20.5 2.1 7.9 3.6 8.6 0.5 5.0 17.6 0.4 0.0 0.0 22.9 0.1 0.3 0.1 0.0 0.0 87.9 0.1 0.1 2.1 0.0 0.0 0.0 35.5 0.0 0.2 0.1 0.0 0.1 0.5 0.2 0.4 0.6 0.0 0.0 35.5 1.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.2 69.0 23.5 0.2 0.0 0.0 0.0 0.7 0.9 0.1 0.0 6.5 0.0 20.7 0.0 20.1 20.6 0.3 0.0 1.2 0.0 0.2 0.0 0.1 0.0 28.6 6.6 0.9 6.0 0.9 1.7 0.1 0.0 0.0 0.6 0.1 0.1 0.0 BSDC1 "FLJ10276, RP4-811H24.7" ENSG00000160058 "BSD domain containing 1" Q9NW68 1 32364633-32394731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 37.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 37.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031358, HPA031360" Approved Supported "Golgi apparatus,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "Plasma membrane" "HPA031358: AB_2673841, HPA031360: AB_10601120" "unprognostic (1.42e-1)" "unprognostic (8.97e-2)" "unprognostic (2.91e-2)" "unprognostic (3.86e-2)" "unprognostic (2.48e-1)" "prognostic favorable (8.82e-5)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (9.56e-3)" "unprognostic (5.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.92e-3)" "unprognostic (2.68e-1)" "unprognostic (2.37e-1)" "unprognostic (2.07e-1)" 36.8 63.0 28.0 17.4 29.4 77.1 37.8 31.7 30.6 38.7 27.3 35.9 25.4 35.3 24.9 36.7 35.3 23.3 35.9 28.9 27.2 38.7 73.2 33.7 22.4 32.5 27.8 54.5 56.0 42.3 46.5 22.1 28.8 41.0 22.5 21.7 45.0 24.3 36.7 47.5 34.8 20.7 28.1 35.8 41.0 51.3 28.4 19.5 37.9 16.3 21.8 33.2 36.5 35.9 24.3 16.2 32.8 25.2 38.6 29.6 25.6 23.0 43.9 39.8 41.0 18.1 19.9 17.8 27.0 41.3 22.6 26.1 23.4 21.6 25.6 33.4 33.3 14.2 35.5 22.1 33.2 17.6 24.7 35.5 46.4 30.7 23.2 47.8 24.8 28.0 36.4 30.8 22.3 10.7 18.7 10.3 20.8 14.1 19.0 18.8 18.8 24.7 22.6 19.5 34.6 25.0 22.1 22.7 25.2 37.7 21.4 13.9 30.1 22.1 19.8 28.3 22.6 42.2 41.6 15.9 25.8 22.3 13.5 37.4 5.1 18.3 6.2 5.9 6.1 7.0 5.5 5.2 4.9 8.3 6.0 5.6 8.4 6.1 5.0 6.5 7.3 6.2 28.0 29.4 31.7 30.6 28.9 27.2 32.5 27.8 28.8 28.1 28.4 35.9 24.6 32.1 18.6 23.5 42.8 28.4 56.6 31.5 25.6 53.6 38.9 26.7 19.4 55.8 21.9 25.8 83.4 51.1 38.8 59.3 19.6 37.8 88.9 23.7 26.3 35.2 40.1 76.0 25.6 44.1 31.0 32.7 27.0 34.4 21.0 36.1 50.0 56.7 20.0 85.8 31.6 47.8 28.5 25.8 13.1 100.7 54.7 20.1 32.0 25.3 28.0 30.3 57.7 29.1 35.0 45.6 40.0 47.4 32.1 58.4 63.9 28.0 18.4 69.8 39.5 33.1 38.1 42.9 45.9 21.2 25.9 96.5 34.6 60.5 39.3 57.2 BST2 "CD317, tetherin" ENSG00000130303 "Bone marrow stromal cell antigen 2" Q10589 19 17402939-17405630 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 694.2" "Cell type enhanced" "Detected in many" "Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA017060, HPA073472" Enhanced Supported "Golgi apparatus,Vesicles" NA NA 260000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Vesicles" "HPA017060: AB_1845467, HPA073472: " "prognostic favorable (6.69e-4)" "unprognostic (1.75e-1)" "unprognostic (8.42e-3)" "unprognostic (8.93e-3)" "unprognostic (4.87e-2)" "unprognostic (2.25e-1)" "unprognostic (2.26e-1)" "unprognostic (1.07e-1)" "unprognostic (3.25e-1)" "unprognostic (6.46e-2)" "unprognostic (6.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.56e-9)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" 226.0 509.8 86.7 95.6 87.6 103.7 152.9 84.0 125.7 93.4 81.7 94.1 47.4 58.7 59.5 40.3 248.0 109.4 111.2 85.1 84.5 160.1 227.8 141.4 128.0 101.5 85.9 694.2 26.3 13.8 56.8 203.0 88.4 88.6 33.3 2.0 77.7 105.2 46.1 24.8 109.1 76.0 97.0 238.5 84.1 35.4 91.1 123.5 54.0 50.8 65.8 82.9 88.6 90.8 327.0 0.5 0.9 145.6 0.0 1.0 49.6 1.3 24.9 459.5 615.0 150.5 286.1 252.2 338.2 197.6 14.6 1.3 212.9 23.9 14.3 279.1 1.8 3.6 525.7 149.8 256.7 120.1 304.7 1.3 0.0 153.0 0.1 4.4 119.0 6.0 146.3 603.4 0.0 89.5 57.7 208.6 158.0 0.1 407.9 105.5 0.8 530.7 110.1 1.5 0.6 1.4 325.5 12.3 410.5 12.3 243.1 166.3 1.5 1.9 11.4 0.5 3.3 308.3 439.3 168.0 1.3 470.8 2.2 229.7 345.3 125.3 171.4 385.5 163.0 115.2 143.2 160.0 283.8 146.5 114.8 132.6 113.3 353.2 359.3 421.7 143.3 367.9 86.7 87.6 84.0 125.7 85.1 84.5 101.5 85.9 88.4 97.0 91.1 90.8 1193.2 57.7 13.6 4.9 90.7 33.1 19.6 255.7 48.9 0.2 86.2 168.5 7.0 50.1 68.5 49.7 0.0 7.8 184.2 1.5 37.2 18.7 10.7 27.8 11.2 420.2 1.2 74.0 0.0 1.2 61.5 152.4 14.8 50.1 227.8 260.9 455.8 211.1 388.9 0.0 0.0 2.8 28.5 189.4 187.6 12.0 346.7 220.4 74.7 32.8 214.5 1.3 211.2 0.5 0.3 3.3 4.8 419.4 192.8 10.3 3.7 1.3 27.4 2.1 164.3 30.7 146.3 1.3 1.2 15.5 26.1 13.1 135.8 490.6 5.0 28.6 BTG4 "APRO3, PC3B" ENSG00000137707 "BTG anti-proliferation factor 4" Q9NY30 11 111467526-111512354 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 26.4" "Group enriched" "Detected in some" 6 "Early spermatids: 61.3;Late spermatids: 80.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.3;Karpas-707: 4.5;U-266/70: 3.1;U-266/84: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057157 Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "Endoplasmic reticulum, Golgi apparatus" "HPA057157: AB_2683354" "unprognostic (1.58e-1)" "unprognostic (2.68e-3)" "unprognostic (3.20e-2)" "unprognostic (2.80e-4)" "unprognostic (1.42e-2)" "unprognostic (3.14e-1)" "unprognostic (9.39e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 5.2 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.7 1.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 26.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.2 3.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.5 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.2 3.1 1.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 1.0 0.5 0.4 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 80.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 10.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261338-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 107.7;Proximal enterocytes: 162.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 222.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012411, HPA012748" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Golgi apparatus" Vesicles "HPA012411: , HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 25.0 17.6 8.9 20.7 12.2 4.7 21.0 12.1 12.7 23.3 8.2 29.2 53.8 39.2 7.3 15.5 22.2 17.6 31.5 9.7 10.5 17.0 87.4 24.1 15.5 14.4 11.6 19.3 27.3 7.3 14.5 16.1 12.5 22.9 17.4 3.0 34.0 17.6 13.7 15.4 59.4 32.6 11.0 20.8 23.6 14.6 12.8 6.4 17.0 15.2 16.7 22.3 19.4 15.2 44.8 45.5 26.4 51.6 62.1 62.5 29.7 105.4 67.5 51.8 53.1 96.2 26.9 20.1 31.7 131.3 47.2 49.4 39.1 47.4 33.2 22.1 23.1 21.4 44.8 65.3 50.1 18.3 68.7 52.1 34.6 78.8 32.0 31.0 21.2 10.6 37.9 32.2 44.6 55.7 4.5 26.4 44.2 72.1 53.8 8.2 44.8 104.1 23.9 21.1 17.3 31.8 33.3 27.1 222.8 21.8 25.6 15.3 23.3 80.8 50.2 103.3 47.3 39.4 41.4 18.8 65.1 14.1 79.9 16.7 12.1 12.6 14.0 19.0 9.4 26.7 7.9 8.9 19.5 35.7 7.3 7.7 1.8 9.9 14.1 26.7 8.4 12.6 8.9 12.2 12.1 12.7 9.7 10.5 14.4 11.6 12.5 11.0 12.8 15.2 6.8 9.6 3.6 3.3 25.5 14.0 12.2 11.7 9.6 4.8 8.2 8.9 10.4 11.5 6.9 9.2 2.1 11.9 12.4 36.2 1.9 21.9 3.5 5.3 17.8 6.6 4.8 9.1 4.1 31.5 30.7 21.1 18.3 6.8 45.0 5.0 9.3 107.7 15.8 0.0 4.2 50.0 6.1 12.9 23.5 7.1 14.0 12.3 28.4 5.6 14.9 6.8 18.6 6.6 8.5 26.9 16.6 16.1 67.0 13.0 162.5 10.6 9.4 2.9 13.1 11.2 20.2 20.7 27.1 9.6 11.2 10.5 6.5 9.6 15.5 10.6 C12orf40 FLJ40126 ENSG00000180116 "Chromosome 12 open reading frame 40" Q86WS4 12 39626167-39908300 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 8.7" "Cell type enhanced" "Detected in some" "Early spermatids: 11.5;Late spermatids: 5.2;Spermatocytes: 33.2;Spermatogonia: 7.6" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "K-562: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA039032 Approved "Golgi apparatus,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Cytosol "HPA039032: AB_2676316" "unprognostic (1.75e-1)" "unprognostic (2.76e-6)" "unprognostic (3.45e-1)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 7.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 C12orf43 "Custos, FLJ12448" ENSG00000157895 "Chromosome 12 open reading frame 43" Q96C57 12 121000486-121016502 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046148, HPA061739" Uncertain Supported "Nucleoli,Golgi apparatus" NA NA "Cluster 30: Non-specific - Translation" "Cluster 65: Brain - Ion transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoli "Golgi apparatus" "HPA046148: AB_10965169, HPA061739: AB_2684597" "unprognostic (1.51e-1)" "unprognostic (5.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.75e-2)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (6.44e-4)" "unprognostic (3.53e-1)" "unprognostic (5.02e-2)" "unprognostic (2.54e-1)" "unprognostic (1.95e-1)" "unprognostic (2.45e-3)" "unprognostic (9.70e-2)" "unprognostic (2.49e-1)" "unprognostic (2.28e-1)" "unprognostic (1.36e-1)" 9.8 8.1 11.7 6.9 11.9 7.4 9.3 8.8 13.6 7.8 7.2 11.2 5.0 9.5 4.4 7.2 9.0 5.1 7.4 12.3 9.5 8.2 10.5 6.7 8.7 10.9 9.6 11.2 7.5 9.0 7.4 7.2 10.8 7.7 5.3 6.0 8.7 6.2 7.2 6.7 6.7 8.4 8.6 7.8 8.2 6.1 9.4 7.2 6.4 5.9 7.4 9.6 7.0 10.4 14.2 31.4 16.2 12.8 14.0 11.0 17.8 17.2 17.5 28.3 17.9 22.8 13.0 26.2 17.2 16.8 15.0 15.7 19.2 26.3 16.8 31.6 21.4 21.1 12.4 17.1 16.7 28.1 16.2 12.9 13.6 26.0 16.4 17.9 16.4 27.0 25.5 6.7 15.1 23.3 30.9 22.0 28.8 11.1 23.2 27.4 19.0 19.8 17.5 20.8 22.0 14.0 23.0 9.9 18.6 13.4 27.0 13.1 15.9 15.6 18.7 12.8 18.4 12.3 19.1 20.5 20.5 16.5 23.6 5.7 15.6 9.0 23.8 21.3 21.8 23.8 23.5 23.2 16.1 19.0 27.5 23.6 2.2 18.4 18.5 13.3 23.8 20.6 11.7 11.9 8.8 13.6 12.3 9.5 10.9 9.6 10.8 8.6 9.4 10.4 16.1 25.6 18.1 3.3 17.3 8.8 16.4 12.2 6.8 19.6 12.4 12.4 7.0 11.5 9.6 18.4 20.9 24.3 13.9 8.6 23.5 16.5 5.9 9.8 17.1 16.0 2.4 10.7 6.8 18.5 22.3 16.3 8.2 10.1 14.5 22.3 12.5 11.7 16.7 16.8 6.4 9.5 10.2 10.4 7.3 13.8 13.7 13.2 14.2 3.7 21.7 18.8 24.7 4.0 4.8 15.6 12.3 12.8 11.3 13.8 5.3 16.7 16.3 15.7 19.7 19.6 16.9 16.3 16.4 12.7 7.7 13.7 17.6 16.0 10.9 14.0 C15orf40 MGC29937 ENSG00000169609 "Chromosome 15 open reading frame 40" Q8WUR7 15 82988441-83011641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041947, HPA042980" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 7: Kidney - Transmembrane transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus" "HPA041947: , HPA042980: AB_10964298" "unprognostic (8.30e-3)" "unprognostic (2.56e-2)" "unprognostic (3.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.17e-2)" "unprognostic (3.04e-2)" "unprognostic (8.65e-2)" "unprognostic (2.20e-2)" "unprognostic (8.55e-3)" "unprognostic (7.71e-2)" "prognostic favorable (4.35e-4)" "unprognostic (2.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (2.51e-2)" 13.4 13.5 8.3 10.1 8.1 13.9 13.2 12.4 10.8 11.0 6.1 12.4 13.7 9.2 19.8 12.1 9.0 6.5 8.1 8.1 6.7 19.1 13.0 8.2 13.5 8.1 6.3 10.5 12.4 9.7 9.3 7.6 7.6 9.4 8.2 10.2 12.4 5.8 12.4 14.7 12.9 6.1 4.2 11.9 11.2 13.9 7.0 10.7 10.3 6.7 11.2 10.1 10.7 15.3 16.8 19.7 12.8 17.4 15.9 14.4 11.6 10.1 16.0 9.7 10.9 13.7 26.6 16.6 13.4 7.6 23.8 29.5 28.5 20.2 10.9 32.1 19.0 15.7 26.4 15.9 15.3 26.6 15.6 12.1 28.8 16.1 18.1 12.8 16.8 43.6 22.1 26.6 9.3 15.7 22.6 14.3 21.4 23.8 12.5 30.5 17.3 22.7 16.7 23.5 29.7 18.2 26.0 20.4 40.8 16.2 23.3 15.4 10.4 20.0 29.1 15.5 17.7 25.4 42.0 31.8 26.0 26.4 22.4 58.0 20.9 31.2 28.1 22.0 31.4 46.7 29.7 29.5 21.2 38.8 34.7 29.9 20.6 42.2 21.4 29.6 41.1 20.5 8.3 8.1 12.4 10.8 8.1 6.7 8.1 6.3 7.6 4.2 7.0 15.3 27.3 28.9 32.5 16.6 41.1 12.0 27.8 45.2 51.2 28.9 33.6 41.0 11.6 38.6 46.2 25.8 12.5 46.6 22.3 42.3 93.9 47.3 36.7 30.0 21.1 27.2 28.8 32.4 11.6 56.1 30.0 29.9 32.1 19.0 27.8 33.7 26.0 37.7 30.0 30.3 14.3 26.4 34.6 28.4 12.0 30.8 33.2 28.0 26.6 8.4 42.7 32.1 63.8 11.6 19.9 62.7 29.6 36.1 41.2 26.7 77.6 127.3 51.2 30.1 19.7 28.6 25.9 107.3 66.8 46.5 15.3 35.6 39.3 39.9 29.9 26.3 C17orf75 "NJMU-R1, SRI2" ENSG00000108666 "Chromosome 17 open reading frame 75" Q9HAS0 17 32324565-32350023 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004061, HPA075333" Approved Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus, Cytosol" "HPA004061: AB_1078337, HPA075333: " "unprognostic (4.21e-2)" "unprognostic (2.49e-2)" "unprognostic (3.32e-2)" "unprognostic (2.28e-1)" "unprognostic (1.51e-1)" "unprognostic (4.73e-2)" "unprognostic (1.07e-3)" "unprognostic (6.36e-2)" "unprognostic (3.29e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.92e-2)" "unprognostic (7.80e-2)" "prognostic favorable (1.33e-4)" "unprognostic (3.09e-1)" "unprognostic (1.29e-1)" "unprognostic (4.27e-2)" "unprognostic (5.60e-2)" 8.1 15.9 10.9 10.4 11.4 7.5 13.2 12.1 13.5 8.9 12.3 11.7 13.3 12.4 18.7 8.7 15.0 7.0 19.4 10.8 11.7 21.3 14.5 8.7 12.9 11.2 10.9 16.1 13.2 27.8 13.4 10.4 11.8 11.6 12.6 26.1 12.2 10.6 17.5 7.2 10.8 10.4 10.5 9.5 12.9 26.3 11.1 16.0 14.1 14.3 13.2 9.6 8.2 11.2 39.2 33.4 51.0 15.5 13.3 14.5 27.9 25.5 22.4 34.3 29.1 18.2 14.9 23.5 28.6 18.2 52.6 42.5 32.8 27.6 46.6 18.0 37.9 18.7 39.8 39.5 26.6 26.3 14.1 13.4 33.0 25.2 17.4 28.6 25.3 43.6 38.9 31.8 22.8 29.2 76.5 26.9 37.7 23.9 14.7 50.1 31.5 44.0 21.4 18.2 50.4 44.3 21.1 19.1 62.7 37.2 50.4 16.8 19.8 18.8 35.4 9.3 42.4 42.5 51.0 82.9 15.3 23.0 5.7 34.6 12.4 16.4 17.6 12.0 20.1 18.2 16.9 18.3 16.1 19.9 18.2 17.0 3.2 19.0 17.1 12.8 19.6 15.4 10.9 11.4 12.1 13.5 10.8 11.7 11.2 10.9 11.8 10.5 11.1 11.2 12.6 12.8 30.7 7.2 13.8 5.9 13.4 27.8 12.5 25.0 11.3 13.5 25.8 8.6 19.3 14.7 8.4 31.8 10.7 3.8 43.0 16.2 10.0 17.2 8.8 10.5 12.6 13.5 11.1 13.8 18.0 9.8 9.7 10.5 11.4 18.3 6.4 11.0 9.7 32.0 15.0 8.0 28.5 7.5 3.7 6.3 7.5 7.8 5.4 2.8 6.7 17.5 11.3 10.1 8.7 11.8 3.2 8.2 14.0 6.4 6.9 29.9 29.9 23.0 39.5 9.7 13.1 88.0 31.8 12.0 6.1 16.3 15.1 10.5 8.4 8.2 C19orf18 MGC41906 ENSG00000177025 "Chromosome 19 open reading frame 18" Q8NEA5 19 57958437-57974534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.4" "Cell type enriched" "Detected in many" 5 "Early spermatids: 131.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.0;HEK 293: 3.0;RT4: 2.0;U-266/84: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014527, HPA079195" Approved Approved "Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 77: Retina - Visual perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Golgi apparatus" "HPA014527: AB_1845612, HPA079195: " "unprognostic (5.38e-2)" "unprognostic (6.36e-3)" "unprognostic (3.70e-2)" "prognostic favorable (5.07e-4)" "unprognostic (4.85e-2)" "unprognostic (9.50e-2)" "unprognostic (2.75e-1)" "unprognostic (5.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.64e-1)" "unprognostic (4.08e-5)" "unprognostic (1.11e-2)" "unprognostic (8.75e-5)" "unprognostic (1.53e-1)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (1.05e-3)" 1.3 1.9 2.8 0.4 3.8 0.6 2.6 2.8 8.1 1.5 6.5 2.0 0.8 1.3 4.0 0.6 2.3 1.2 4.8 3.0 3.1 2.5 1.8 1.0 0.6 4.2 4.3 1.8 1.1 0.9 3.9 0.8 3.9 3.3 0.8 5.1 1.2 1.3 3.5 1.3 1.2 0.9 3.6 1.2 1.1 12.4 3.7 0.6 1.7 0.6 0.7 1.6 0.9 3.6 0.1 0.0 0.8 2.0 0.4 0.6 0.6 1.0 0.2 0.2 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.0 0.0 0.0 0.6 0.0 3.0 0.1 0.0 0.7 0.7 0.0 0.5 0.7 1.2 0.0 0.2 0.7 0.1 0.4 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.0 0.5 0.5 2.0 0.8 0.2 0.4 0.0 0.3 0.6 0.7 0.6 0.4 0.1 0.2 0.2 0.2 0.4 1.8 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.1 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 2.8 3.8 2.8 8.1 3.0 3.1 4.2 4.3 3.9 3.6 3.7 3.6 1.9 3.2 2.2 17.9 0.8 0.4 0.3 0.6 0.0 0.9 2.2 1.8 3.6 1.5 2.1 0.0 0.0 0.5 0.6 0.8 0.0 2.0 131.6 5.7 0.9 2.1 0.0 2.7 2.5 0.2 0.6 0.7 0.0 1.4 0.0 0.7 4.6 1.9 0.4 0.0 3.2 1.9 0.0 0.8 1.4 24.2 2.1 0.4 1.8 1.0 0.6 1.5 0.0 8.5 8.0 1.0 0.3 0.7 0.2 0.6 0.5 0.3 4.0 3.4 6.6 0.9 1.2 5.3 2.2 0.2 0.6 0.3 0.6 1.2 1.1 0.5 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 98.0" "Cell type enhanced" "Detected in many" "Kupffer cells: 90.1;Langerhans cells: 33.4;Macrophages: 59.2;monocytes: 86.7;Plasma cells: 24.7;Spermatocytes: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 20 "classical monocyte: 282.3;eosinophil: 169.4;intermediate monocyte: 312.5;myeloid DC: 162.2;neutrophil: 230.1;non-classical monocyte: 392.8" "Group enriched" "Detected in all" 20 "dendritic cells: 162.2;granulocytes: 230.1;monocytes: 392.8" "Cell line enriched" "Detected in some" 4 "U-937: 50.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 3.6 1.0 3.5 11.2 3.9 98.0 1.2 4.2 4.5 2.1 3.5 1.8 1.7 1.0 2.7 1.0 2.3 2.9 0.9 3.4 4.1 1.2 3.2 6.1 5.2 5.2 4.3 2.0 1.7 0.4 0.8 1.8 5.2 1.3 1.2 0.7 0.9 0.9 2.7 0.5 2.3 3.4 4.6 21.7 1.6 11.1 4.0 3.2 0.5 1.5 3.0 4.6 1.6 6.0 2.4 0.1 0.2 0.4 2.2 1.2 0.2 0.4 0.1 0.4 0.9 0.2 0.4 5.9 0.5 0.0 0.2 0.2 0.3 0.3 0.3 2.7 0.6 0.3 0.0 0.0 1.6 3.9 0.6 6.0 0.7 1.0 0.3 0.1 0.1 0.6 0.3 12.2 0.2 2.2 0.2 9.3 0.5 0.4 0.4 4.5 0.0 3.1 0.0 0.2 0.3 0.1 1.2 0.0 0.9 0.1 0.2 8.7 0.0 0.1 0.0 1.1 0.1 7.3 3.7 1.7 0.0 50.9 0.0 7.8 282.3 169.4 0.6 312.5 1.6 13.0 0.8 0.8 162.2 8.5 4.9 1.5 230.1 8.0 392.8 3.6 2.3 157.7 3.5 3.9 4.2 4.5 3.4 4.1 5.2 4.3 5.2 4.6 4.0 6.0 0.3 0.0 1.8 1.6 10.6 0.8 0.4 2.1 1.2 0.1 0.6 0.5 1.1 0.0 1.7 1.8 2.1 1.0 0.7 0.3 0.0 0.1 3.7 0.9 0.3 1.1 0.0 4.8 0.9 1.3 0.9 1.6 4.1 1.0 2.5 0.3 0.4 1.1 22.3 0.0 0.9 0.6 2.0 90.1 33.4 6.1 0.9 59.2 1.8 0.0 86.7 3.1 4.1 0.0 3.1 0.1 3.5 0.7 24.7 0.3 0.2 0.7 5.1 1.1 6.6 0.5 0.6 28.5 19.2 0.3 0.9 0.7 2.1 0.1 0.6 0.6 C1orf162 MGC24133 ENSG00000143110 "Chromosome 1 open reading frame 162" Q8NEQ5 1 111473792-111478512 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 115.0;lymphoid tissue: 134.5" "Cell type enhanced" "Detected in many" "granulocytes: 182.3;Hofbauer cells: 195.3;Kupffer cells: 797.4;Langerhans cells: 226.7;Macrophages: 413.5;monocytes: 278.6;NK-cells: 355.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "HDLM-2: 141.3;HL-60: 70.4;NB-4: 40.3;THP-1: 55.2;U-937: 117.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA026988 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Golgi apparatus" "HPA026988: AB_10600887" "unprognostic (8.79e-2)" "unprognostic (5.18e-3)" "unprognostic (1.14e-2)" "unprognostic (2.11e-1)" "unprognostic (5.20e-2)" "unprognostic (5.96e-2)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (3.14e-6)" "unprognostic (1.29e-2)" "unprognostic (3.15e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-1)" 45.4 23.6 16.3 70.8 16.2 115.0 22.3 17.2 29.0 13.2 19.6 15.8 7.3 11.5 6.3 9.8 22.5 31.2 18.1 16.3 18.4 12.5 41.9 85.7 70.4 20.6 17.3 9.4 9.4 4.8 9.1 15.2 19.7 11.7 17.9 9.5 11.2 6.6 10.1 7.8 21.2 37.6 16.7 134.5 12.5 7.6 23.3 27.7 10.0 7.4 55.9 25.1 10.8 21.4 0.3 0.1 0.5 1.1 0.4 0.6 0.6 0.9 0.1 0.3 0.3 0.2 0.4 0.5 0.5 0.2 0.1 0.2 0.8 0.5 0.6 141.3 0.4 0.4 0.5 0.0 0.4 70.4 11.1 0.0 2.6 0.8 0.9 1.0 2.0 0.7 0.5 0.4 0.5 0.5 0.6 40.3 0.2 0.7 0.8 0.1 0.7 0.1 0.3 0.1 0.5 0.2 0.5 0.6 0.8 0.6 0.3 55.2 0.0 0.8 1.0 0.7 0.6 0.6 0.1 0.6 0.3 117.9 1.2 1114.1 1026.8 1294.8 166.6 1529.2 47.6 231.0 206.5 97.3 1021.6 296.4 318.0 193.6 143.3 536.7 1173.4 302.8 66.7 1189.5 16.3 16.2 17.2 29.0 16.3 18.4 20.6 17.3 19.7 16.7 23.3 21.4 4.4 22.4 43.9 8.1 84.1 7.9 0.7 0.4 0.6 4.0 2.2 5.2 3.8 10.0 4.5 7.3 2.1 1.0 103.4 0.6 0.0 0.2 36.7 0.8 0.9 8.1 1.8 23.5 9.2 0.2 2.0 3.2 0.5 1.0 182.3 0.9 15.7 8.9 195.3 0.0 13.0 0.0 0.0 797.4 226.7 90.7 2.8 413.5 12.4 12.2 278.6 0.2 355.3 6.0 7.7 0.2 0.0 0.7 4.2 0.8 0.9 1.0 0.9 4.2 32.9 2.4 2.9 2.4 2.0 0.2 6.5 1.6 59.8 0.3 0.7 0.3 C1orf189 ENSG00000163263 "Chromosome 1 open reading frame 189" Q5VU69 1 154199085-154206333 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 30.5;testis: 19.7" "Cell type enhanced" "Detected in some" "Early spermatids: 88.7;Endometrial ciliated cells: 30.7;Late spermatids: 19.6;Respiratory ciliated cells: 25.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045779 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Golgi apparatus, Plasma membrane" "HPA045779: AB_2679448" "unprognostic (8.23e-3)" "unprognostic (5.55e-3)" "unprognostic (2.39e-2)" "unprognostic (2.01e-3)" "unprognostic (2.50e-3)" "unprognostic (2.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.24e-2)" "unprognostic (8.78e-3)" "unprognostic (1.36e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (3.75e-2)" "unprognostic (2.06e-1)" "unprognostic (9.79e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.2 0.1 0.3 0.5 0.1 0.4 0.4 1.6 0.6 0.0 0.0 0.5 0.3 0.1 30.5 0.0 0.1 0.3 0.4 0.1 0.3 1.8 0.1 1.6 3.4 0.1 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.1 0.0 0.9 0.0 0.1 19.7 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.2 0.3 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.4 0.2 0.4 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.3 0.5 0.1 0.1 0.5 0.2 0.5 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.3 0.0 0.4 0.2 0.2 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.4 0.4 0.3 0.4 1.6 3.4 1.2 0.9 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.7 30.7 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 19.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 25.1 0.0 0.0 0.0 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 C1QTNF2 CTRP2 ENSG00000145861 "C1q and TNF related 2" Q9BXJ5 5 160347754-160370641 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Fibroblasts: 23.7;Leydig cells: 23.3;Peritubular cells: 29.7;Skeletal myocytes: 16.9;Smooth muscle cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "basophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "RH-30: 34.4;U-138 MG: 15.1;U-2 OS: 8.3;WM-115: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061290 Uncertain Approved "Golgi apparatus,Centrosome" "Secreted to blood" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Centrosome" "HPA061290: AB_2684468" "unprognostic (2.28e-2)" "unprognostic (5.61e-2)" "unprognostic (4.09e-2)" "unprognostic (4.53e-2)" "unprognostic (8.92e-3)" "unprognostic (6.20e-2)" "unprognostic (1.46e-1)" "unprognostic (1.94e-1)" "unprognostic (5.91e-2)" "unprognostic (8.33e-2)" "unprognostic (3.23e-2)" "unprognostic (8.32e-2)" "unprognostic (2.11e-5)" "unprognostic (5.40e-5)" "unprognostic (1.14e-1)" "unprognostic (6.75e-2)" "unprognostic (1.10e-2)" 2.8 0.6 0.9 0.7 0.9 0.1 1.9 1.2 1.3 4.7 0.1 2.5 1.2 3.3 1.1 1.4 2.3 1.8 3.9 0.9 0.8 0.6 0.4 2.4 0.3 0.3 1.3 1.3 0.3 0.2 0.5 0.8 0.2 1.9 1.1 0.2 1.3 1.0 1.9 1.4 2.3 1.8 0.2 0.6 2.0 1.8 2.5 0.1 2.1 2.1 0.3 2.1 2.6 0.8 0.3 0.0 0.5 0.1 0.0 0.0 0.0 3.9 5.3 0.9 3.3 0.1 0.9 0.0 0.1 1.4 0.6 0.2 0.1 0.4 0.2 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 34.4 0.0 0.0 0.2 0.0 0.8 1.0 0.1 0.2 0.1 0.4 0.1 0.2 15.1 8.3 1.5 4.4 0.1 0.0 0.0 0.5 0.0 6.8 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.9 0.9 1.2 1.3 0.9 0.8 0.3 1.3 0.2 0.2 2.5 0.8 2.0 0.0 0.0 0.0 0.0 6.5 0.2 0.2 0.6 0.8 0.3 0.4 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.9 0.1 0.0 0.1 1.0 4.2 0.0 0.0 0.6 0.2 0.3 23.7 0.5 0.2 0.0 0.2 1.1 0.0 1.1 0.0 6.2 0.1 0.0 0.0 6.2 0.4 23.3 0.5 5.4 1.0 0.6 0.1 0.0 1.0 0.3 0.1 0.1 29.7 0.0 0.1 0.0 0.0 0.0 0.8 0.0 16.9 22.8 0.1 0.5 0.6 3.8 0.8 0.3 2.1 0.1 0.3 C1QTNF3 "2310005P21Rik, Corcs, Cors, Cors-26, CTRP3" ENSG00000082196 "C1q and TNF related 3" Q9BXJ4 5 34017858-34043213 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.4;salivary gland: 52.0" "Cell type enhanced" "Detected in many" "Early spermatids: 161.6;Fibroblasts: 61.5;Late spermatids: 387.6;Muller glia cells: 227.2;Skeletal myocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 211 "U-266/84: 810.2" "HPA064996, HPA066011" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 44100000 24000000 "Cluster 37: Intestine - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA064996: AB_2685399, HPA066011: AB_2685597" "unprognostic (7.71e-2)" "unprognostic (2.81e-3)" "unprognostic (5.83e-2)" "unprognostic (6.58e-2)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-3)" "unprognostic (5.18e-2)" "unprognostic (1.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (4.89e-3)" "unprognostic (1.80e-1)" "unprognostic (9.38e-3)" "unprognostic (2.35e-1)" 7.3 0.5 4.1 1.7 5.0 0.6 6.8 6.8 4.0 3.6 2.6 11.2 3.5 2.7 1.0 33.4 3.0 5.9 0.9 3.9 7.0 4.8 1.1 4.1 0.8 5.3 4.3 1.4 1.7 0.3 1.3 0.6 4.5 2.2 10.0 23.7 52.0 4.9 2.2 2.3 8.9 23.3 5.8 0.7 10.7 11.4 4.2 1.0 1.6 9.9 0.4 13.2 3.6 5.1 0.7 0.1 0.2 0.3 0.0 0.1 0.3 0.2 0.1 0.2 0.1 0.0 0.2 0.2 0.9 0.2 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.2 0.7 0.8 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.8 3.2 0.0 0.0 0.0 1.1 0.1 0.0 0.1 0.2 0.2 1.6 0.0 0.1 0.6 0.1 0.0 3.8 0.6 0.1 1.0 0.0 1.0 0.9 810.2 1.3 0.0 0.8 3.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.1 5.0 6.8 4.0 3.9 7.0 5.3 4.3 4.5 5.8 4.2 5.1 2.3 3.2 2.0 0.0 2.0 5.7 0.6 0.4 1.8 5.1 3.0 2.3 1.0 8.6 0.8 3.7 0.0 0.9 1.5 0.7 1.9 1.2 161.6 2.6 1.0 7.2 1.8 1.3 0.0 1.4 0.5 61.5 1.5 2.6 0.0 1.8 0.4 1.3 1.3 8.4 0.0 1.4 2.0 0.6 9.6 387.6 1.8 1.1 7.2 0.0 0.3 227.2 1.0 0.0 0.0 0.5 1.5 2.6 0.2 0.8 0.8 2.1 1.2 11.9 0.0 77.5 4.5 6.2 2.0 1.1 5.8 0.4 1.3 1.0 2.0 0.5 C1QTNF4 "CTRP4, ZACRP4" ENSG00000172247 "C1q and TNF related 4" Q9BXJ3 11 47589667-47594411 "Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0;pituitary gland: 17.1" "Cell type enhanced" "Detected in many" "Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0" "Group enriched" "Detected in some" 4 "glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "REH: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041032 Approved Uncertain "Golgi apparatus,Vesicles" "Secreted in brain" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 14: REH - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus, Vesicles" "HPA041032: AB_10671170" "unprognostic (1.84e-3)" "unprognostic (1.58e-1)" "unprognostic (8.98e-4)" "unprognostic (8.19e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-3)" "unprognostic (6.78e-2)" "unprognostic (6.11e-2)" "unprognostic (6.35e-2)" "unprognostic (4.00e-1)" "unprognostic (4.91e-4)" "unprognostic (1.22e-1)" "unprognostic (8.22e-6)" "unprognostic (6.02e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (6.28e-2)" 1.7 1.5 7.9 0.0 33.0 1.1 2.2 13.2 17.6 5.3 0.0 3.9 0.1 5.8 0.0 0.5 4.2 0.0 1.0 7.5 1.1 1.4 0.9 0.7 0.0 6.0 4.9 12.0 0.4 0.7 17.1 0.0 2.1 2.8 0.0 0.1 1.1 0.1 0.9 1.8 1.5 0.1 1.0 1.0 1.5 5.8 6.7 0.0 1.5 0.0 0.0 1.3 2.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 33.0 13.2 17.6 7.5 1.1 6.0 4.9 2.1 1.0 6.7 3.4 2.4 0.0 0.0 18.9 0.0 2.4 6.5 0.2 0.0 15.8 1.3 25.8 0.7 1.5 0.3 3.7 16.7 1.3 0.1 0.2 3.9 0.1 11.3 0.8 21.2 4.5 0.0 2.5 15.5 0.2 2.7 20.7 0.5 0.6 0.0 31.3 2.5 0.2 3.3 5.0 17.8 0.1 0.0 0.3 3.0 51.7 46.0 0.7 10.6 4.7 0.0 54.5 0.0 5.0 8.0 0.1 0.1 38.4 0.0 4.3 0.1 0.6 0.6 24.7 26.3 12.8 8.5 13.5 44.5 0.3 1.8 3.6 0.6 39.0 0.2 2.4 C2orf50 FLJ25143 ENSG00000150873 "Chromosome 2 open reading frame 50" Q96LR7 2 11133128-11151317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 5.7;fallopian tube: 7.4" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 8.4;Endometrial ciliated cells: 21.5;Excitatory neurons: 9.7;Respiratory ciliated cells: 27.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.0" "HPA062894, HPA067681" Enhanced Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" Cytosol "HPA062894: AB_2684897, HPA067681: " "unprognostic (6.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.53e-4)" "unprognostic (1.92e-3)" "unprognostic (3.35e-2)" "unprognostic (6.19e-2)" "unprognostic (3.55e-1)" "unprognostic (1.31e-1)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (2.00e-2)" "unprognostic (2.45e-1)" "unprognostic (3.97e-4)" "unprognostic (7.03e-2)" "unprognostic (2.92e-1)" "unprognostic (8.25e-3)" "unprognostic (7.36e-2)" 0.1 0.2 1.5 0.2 1.8 0.5 0.2 0.4 1.6 0.4 5.7 0.1 0.3 0.3 0.2 0.1 7.4 0.1 0.0 1.3 1.4 0.2 0.1 0.6 0.3 1.8 1.9 0.3 0.2 0.1 0.7 0.1 0.5 0.2 0.2 1.5 0.3 0.1 0.2 0.4 0.1 0.1 1.0 0.3 0.2 0.3 1.0 0.2 0.2 0.0 0.1 0.1 0.0 1.0 0.1 0.5 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.0 0.2 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.3 0.0 0.7 0.1 0.3 0.2 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.3 0.1 0.6 0.2 0.2 0.2 0.1 0.1 1.5 1.8 0.4 1.6 1.3 1.4 1.8 1.9 0.5 1.0 1.0 1.0 0.0 0.0 1.8 0.7 0.5 0.0 0.5 0.5 0.0 0.4 0.4 0.5 0.4 0.0 3.5 0.0 8.4 0.0 0.1 0.0 0.0 0.3 0.2 21.5 0.4 0.0 0.0 0.0 9.7 0.2 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.0 2.0 0.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.9 0.0 2.5 0.4 0.2 0.0 1.5 0.0 0.1 0.0 0.2 27.1 3.0 0.0 1.0 0.5 0.5 1.4 0.0 0.0 0.0 0.3 0.9 0.0 0.1 C2orf80 "GONDA1, LOC389073" ENSG00000188674 "Chromosome 2 open reading frame 80" Q0P641 2 208165343-208190030 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 31.8" "Group enriched" "Detected in some" 8 "Excitatory neurons: 25.8;Inhibitory neurons: 11.7;Oligodendrocyte precursor cells: 31.7" "Cancer enriched" "Detected in single" 41 "glioma: 11.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 3.2;neutrophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Cell line enhanced" "Detected in single" "NTERA-2: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042639 Approved "Golgi apparatus" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA042639: AB_10794915" "unprognostic (6.36e-2)" "unprognostic (2.12e-1)" "unprognostic (2.95e-1)" "unprognostic (3.05e-1)" "unprognostic (1.83e-1)" "unprognostic (2.98e-2)" 0.0 0.1 21.0 0.4 26.5 1.1 0.0 6.3 31.8 0.0 7.4 0.2 0.2 0.1 0.0 0.9 0.1 0.2 0.1 27.2 20.5 0.1 0.3 0.0 0.2 11.6 13.3 0.2 0.0 0.1 1.0 0.1 13.9 0.2 0.2 1.4 0.3 0.4 0.3 0.4 0.3 0.1 11.0 0.1 0.2 0.6 17.0 0.0 0.1 0.0 0.0 0.0 0.0 15.1 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.4 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.5 1.7 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.3 3.2 0.6 0.5 0.3 0.4 0.2 0.5 0.3 0.3 0.2 0.7 0.3 0.3 4.6 0.5 0.3 0.8 0.1 0.1 21.0 26.5 6.3 31.8 27.2 20.5 11.6 13.3 13.9 11.0 17.0 15.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.8 0.0 1.0 0.0 31.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4BPB C4BP ENSG00000123843 "Complement component 4 binding protein beta" P20851 1 207088860-207099993 "Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 471.3" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 597.6" "Cancer enriched" "Detected in many" 19 "liver cancer: 83.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 16 "CACO-2: 116.4;HeLa: 46.2;Hep G2: 151.6;OE19: 57.1" "Not detected" "Not detected" "HPA000925, HPA051620" Approved Uncertain "Golgi apparatus" "Secreted to blood" NA NA 265000000000 1100000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 39: CACO-2 - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA000925: , HPA051620: AB_2681554" "unprognostic (1.73e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-1)" "unprognostic (2.07e-3)" "unprognostic (1.72e-1)" "unprognostic (2.54e-2)" "unprognostic (4.58e-3)" "unprognostic (9.49e-2)" "unprognostic (1.37e-1)" "unprognostic (4.25e-1)" "unprognostic (6.39e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (8.25e-2)" 3.0 0.1 0.0 3.4 0.0 0.0 1.8 0.0 0.1 2.8 0.0 3.6 3.8 0.1 0.0 0.2 0.5 3.1 0.1 0.0 0.0 0.4 471.3 1.5 0.4 0.0 0.0 44.2 9.1 0.0 0.0 6.2 0.1 0.0 1.8 0.0 0.5 0.0 0.1 0.2 4.4 0.6 0.0 0.4 8.4 0.7 0.0 0.1 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.4 5.8 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 46.2 151.6 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 12.8 2.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 7.3 2.2 0.5 54.3 3.2 0.0 0.0 1.0 0.2 10.2 1.9 11.4 4.1 0.7 0.1 0.8 1.8 8.0 0.1 88.8 0.3 3.4 5.6 0.8 0.0 0.3 9.7 597.6 2.1 0.0 0.2 5.6 0.0 13.1 0.3 2.8 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 69.2 15.9 0.0 0.1 0.2 4.3 0.0 2.2 0.0 0.0 1.1 0.4 0.1 0.4 0.0 0.0 0.1 1.1 143.8 4.8 0.1 C4orf33 FLJ33703 ENSG00000151470 "Chromosome 4 open reading frame 33" Q8N1A6 4 129093317-129116640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA061199 Uncertain Approved "Nuclear bodies,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "Nuclear bodies" "HPA061199: AB_2684450" "unprognostic (7.27e-2)" "unprognostic (8.84e-2)" "unprognostic (3.50e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (4.07e-2)" "unprognostic (5.82e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (1.34e-2)" "unprognostic (3.55e-2)" "unprognostic (5.14e-2)" "prognostic favorable (3.04e-4)" "unprognostic (2.09e-2)" "unprognostic (2.54e-1)" "unprognostic (9.89e-2)" "prognostic favorable (2.49e-5)" 7.8 10.3 4.6 6.4 5.2 16.1 9.5 11.6 5.6 5.5 3.9 20.5 17.0 4.8 9.4 9.1 8.4 9.2 5.8 4.7 5.4 14.2 9.9 8.4 6.5 6.3 6.5 11.1 9.4 6.0 12.2 9.4 7.0 4.6 16.7 13.4 6.7 4.1 2.6 6.8 15.1 5.7 6.2 7.9 16.2 5.6 5.5 8.9 12.0 2.7 5.8 9.9 5.8 7.0 7.7 4.3 9.7 9.8 7.8 7.5 15.7 7.2 10.0 8.4 10.8 2.2 36.1 6.4 17.8 10.4 13.0 4.8 11.2 11.5 6.8 38.3 8.6 15.7 11.4 3.0 9.5 7.8 16.0 7.6 10.2 10.0 4.0 15.5 6.9 22.9 20.5 26.9 8.6 3.1 12.7 6.2 0.5 16.2 5.4 5.3 10.3 8.3 23.7 8.7 12.4 2.8 5.5 13.1 8.7 2.2 12.2 5.9 5.0 7.4 2.7 5.5 5.8 14.4 6.8 11.3 15.4 20.4 6.4 18.7 11.7 30.3 3.3 11.6 2.5 5.6 2.6 4.0 11.8 2.7 2.7 4.3 5.7 9.3 12.3 6.4 4.8 4.9 4.6 5.2 11.6 5.6 4.7 5.4 6.3 6.5 7.0 6.2 5.5 7.0 10.7 6.4 14.1 11.8 9.2 10.5 7.4 22.9 10.8 15.1 13.4 8.3 4.2 18.6 16.3 12.9 8.4 21.5 19.8 24.7 50.9 10.4 6.9 34.8 7.4 7.9 4.9 8.2 12.8 9.3 18.9 8.3 18.8 17.5 14.5 5.9 8.6 5.2 14.2 1.7 11.2 14.7 22.4 18.1 16.7 3.0 2.1 18.6 12.4 10.3 13.3 11.8 7.2 12.1 21.5 8.1 17.9 2.2 9.6 2.7 25.6 30.9 36.9 11.5 0.0 5.0 12.9 4.6 5.4 13.5 9.2 18.9 12.2 15.5 16.4 8.9 C5AR1 "C5A, C5AR, C5R1, CD88" ENSG00000197405 "Complement C5a receptor 1" P21730 19 47290023-47322066 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 125.5;lymphoid tissue: 84.8" "Group enriched" "Detected in many" 4 "Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 394.0" "Group enriched" "Detected in many" 42 "granulocytes: 394.0;monocytes: 115.9" "Cell line enhanced" "Detected in some" "A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB002720, HPA014520, HPA048012" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" Vesicles "CAB002720: , HPA014520: AB_1846337, HPA048012: " "unprognostic (5.95e-2)" "prognostic favorable (4.71e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-1)" "unprognostic (4.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-2)" "unprognostic (4.41e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (9.55e-4)" "unprognostic (2.02e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.96e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.82e-2)" "unprognostic (6.54e-2)" 72.7 18.2 3.3 84.8 3.1 125.5 8.5 2.4 9.0 11.8 21.6 9.8 2.5 7.5 1.4 8.3 23.9 38.8 11.7 3.9 8.2 9.7 18.0 43.1 11.5 8.9 6.9 5.0 8.9 4.8 51.8 31.8 8.4 5.3 4.2 4.4 5.1 2.5 1.9 2.3 5.8 28.1 5.7 38.2 7.2 2.6 10.5 7.1 3.6 5.8 4.3 37.1 4.6 11.6 1.0 3.9 0.1 0.1 0.7 0.2 0.6 0.7 0.5 0.2 0.1 0.2 4.1 0.3 0.7 0.9 0.4 1.4 0.2 0.5 0.2 0.7 0.5 0.1 3.8 0.6 0.4 1.5 4.7 0.3 2.2 0.4 0.3 0.6 0.0 0.2 0.2 1.7 0.1 1.1 0.2 2.5 1.2 0.2 0.3 0.2 0.1 0.3 1.3 0.9 0.0 0.0 0.3 0.3 0.6 0.5 0.2 2.2 0.0 0.1 2.1 0.3 0.1 0.2 0.3 0.3 6.2 6.5 0.2 41.6 53.8 38.8 0.4 80.4 0.3 0.4 0.3 0.2 6.1 0.6 0.3 0.3 394.0 0.5 115.9 1.1 0.3 19.3 3.3 3.1 2.4 9.0 3.9 8.2 8.9 6.9 8.4 5.7 10.5 11.6 4.4 3.2 20.8 0.0 5.1 5.1 1.0 3.4 2.8 1.0 2.1 4.4 2.9 1.5 15.3 1.8 2.1 0.8 1.5 1.6 3.9 0.0 1.3 17.3 1.8 6.3 0.0 0.4 1.5 0.0 1.5 5.3 1.1 4.6 25.2 0.1 2.9 8.3 130.9 0.0 0.6 0.8 4.1 228.3 122.4 1.3 0.6 446.7 5.4 5.6 56.3 0.2 0.0 1.0 0.3 0.1 0.1 0.0 4.9 0.5 0.7 1.3 40.7 4.3 13.1 4.1 2.8 0.5 0.9 1.4 3.0 1.5 3.3 0.0 1.3 0.5 C5orf15 "HTGN29, KCT2" ENSG00000113583 "Chromosome 5 open reading frame 15" Q8NC54 5 133955510-133968674 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011951, HPA039165" Uncertain Approved "Golgi apparatus" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA011951: AB_2668584, HPA039165: AB_10795580" "unprognostic (2.25e-1)" "unprognostic (3.01e-1)" "unprognostic (2.07e-1)" "unprognostic (4.91e-2)" "unprognostic (1.81e-1)" "unprognostic (2.26e-3)" "unprognostic (1.01e-2)" "unprognostic (7.72e-2)" "unprognostic (2.62e-2)" "unprognostic (7.54e-2)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (9.07e-3)" "unprognostic (5.18e-2)" "unprognostic (1.34e-1)" "unprognostic (1.66e-1)" "unprognostic (2.14e-2)" 35.4 49.5 15.5 35.6 16.2 18.6 44.7 16.6 22.9 38.5 24.8 32.4 48.7 35.4 34.4 24.0 48.0 41.3 40.7 15.5 17.1 73.6 80.3 39.9 47.5 16.7 16.6 36.6 26.3 44.7 19.9 58.9 17.2 39.6 33.1 24.5 30.9 25.1 22.3 30.7 48.6 30.5 17.4 37.3 48.8 26.6 15.9 33.9 53.1 22.6 37.0 46.4 19.0 21.3 70.4 51.5 70.5 81.3 101.9 115.9 85.9 71.3 95.4 107.2 178.7 49.9 204.1 49.5 127.4 87.3 108.4 51.1 57.7 104.0 125.6 56.3 87.7 18.7 34.2 63.9 96.1 30.8 79.8 102.2 62.7 84.7 44.7 152.5 45.9 31.3 39.7 57.4 86.7 44.7 35.9 57.9 39.0 34.1 30.8 34.0 72.3 73.8 175.0 53.9 62.8 47.0 71.9 24.2 117.1 126.0 74.9 91.7 42.4 95.6 88.4 39.2 71.8 42.9 44.1 30.3 113.3 72.9 143.6 19.5 31.6 16.8 14.6 34.6 13.7 22.8 16.6 16.0 37.0 24.3 21.1 17.1 16.3 22.0 34.2 26.7 17.3 29.4 15.5 16.2 16.6 22.9 15.5 17.1 16.7 16.6 17.2 17.4 15.9 21.3 18.6 25.6 33.2 12.7 32.3 30.7 39.8 85.7 33.6 22.0 41.3 22.1 17.9 51.5 54.1 49.7 10.4 83.6 19.6 27.1 17.6 73.7 45.6 68.4 34.2 21.2 37.2 17.1 17.1 46.8 71.9 61.1 25.0 32.2 15.2 31.5 23.9 48.5 55.7 5.0 15.6 30.4 81.4 32.8 57.7 7.0 51.3 34.0 64.0 21.5 97.1 27.6 19.6 37.2 35.3 47.9 24.1 39.1 28.8 33.5 51.5 71.8 125.5 26.9 26.3 30.6 36.3 46.8 29.1 23.3 32.5 58.0 21.5 80.6 21.2 22.8 C6orf132 bA7K24.2 ENSG00000188112 "Chromosome 6 open reading frame 132" Q5T0Z8 6 42101119-42142620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 157.0;skin 1: 73.6" "Cell type enhanced" "Detected in many" "Late spermatids: 163.8;Pancreatic endocrine cells: 219.9;Prostatic glandular cells: 144.6;Urothelial cells: 226.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 57.8;CACO-2: 52.0;CAPAN-2: 44.0;OE19: 181.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA044588 Enhanced Approved "Golgi apparatus,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus, Cytosol" "HPA044588: AB_10794293" "unprognostic (7.09e-2)" "unprognostic (8.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.24e-3)" "unprognostic (1.60e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (6.78e-2)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (4.90e-4)" "unprognostic (1.31e-1)" "unprognostic (4.26e-3)" "unprognostic (1.04e-2)" "unprognostic (5.53e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" 3.7 1.0 0.4 2.2 0.4 1.0 8.7 0.6 0.7 31.7 0.3 14.1 33.4 1.0 0.1 157.0 5.8 6.6 1.8 0.4 0.1 14.9 0.5 5.8 0.3 0.4 0.1 0.2 18.0 2.5 1.7 1.5 0.4 12.1 11.7 0.9 47.1 2.3 0.9 73.6 20.7 0.5 0.0 0.1 36.2 0.7 0.3 0.7 10.7 0.3 13.9 9.9 54.9 0.6 57.8 0.5 0.0 0.1 0.3 6.1 29.0 2.9 4.4 7.6 7.6 52.0 44.0 0.0 5.4 5.4 0.1 37.5 0.1 17.3 5.2 5.1 7.2 2.8 5.0 12.1 2.0 0.0 0.2 4.0 30.4 5.9 8.8 3.1 0.0 0.3 1.7 0.5 1.7 20.4 0.4 0.3 3.6 181.7 1.5 0.1 0.0 0.3 6.2 25.5 3.0 0.1 4.7 35.2 0.1 4.1 25.2 0.3 0.8 0.4 3.5 13.5 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.5 0.2 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.5 0.1 0.0 0.3 0.0 0.1 0.4 0.4 0.6 0.7 0.4 0.1 0.4 0.1 0.4 0.0 0.3 0.6 0.8 44.8 16.6 0.3 0.2 52.5 88.6 31.8 19.4 0.8 41.7 19.8 5.1 45.8 63.1 51.5 20.9 12.4 1.2 89.9 0.0 57.9 22.2 91.9 9.4 2.8 7.3 0.0 0.5 134.7 1.0 9.2 57.1 135.8 1.3 18.3 1.4 0.0 0.8 5.0 0.5 41.3 38.7 1.2 6.8 163.8 0.6 1.5 12.4 0.0 3.8 0.5 4.1 0.5 0.2 219.9 66.8 1.5 0.3 144.6 102.7 7.7 92.1 7.9 0.0 7.9 4.9 4.9 9.1 81.4 82.0 4.1 1.5 45.4 43.7 226.0 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330955-68819023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;fallopian tube: 9.1;parathyroid gland: 7.4" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 396.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.3;HEK 293: 2.3;LHCN-M2: 2.7;RH-30: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 2.7 0.3 4.0 0.2 5.4 0.5 0.7 3.6 3.9 2.1 2.0 0.2 0.2 0.6 0.6 1.0 9.1 0.6 0.7 6.2 3.8 0.4 0.2 2.5 0.2 6.4 10.2 0.4 1.1 7.4 1.7 0.3 4.6 2.1 0.3 1.0 0.6 1.0 0.3 0.9 0.2 0.1 4.0 0.2 0.8 0.7 6.7 0.8 0.4 0.9 0.2 0.4 0.2 6.1 0.1 0.0 0.3 0.1 0.6 1.0 0.1 0.9 2.3 0.3 0.3 0.1 0.2 0.1 0.3 0.5 0.1 0.1 0.1 0.3 0.1 0.0 2.3 0.3 0.5 0.2 0.1 0.0 0.2 0.1 0.3 0.4 0.8 0.1 0.0 0.3 0.1 0.4 2.7 0.3 0.0 0.2 1.0 0.0 0.0 0.1 2.7 0.0 0.2 0.2 0.5 0.0 0.1 0.1 0.0 0.2 1.4 0.1 0.0 0.4 0.2 1.6 0.0 0.4 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.3 0.2 0.3 0.5 0.2 0.1 0.4 0.1 0.1 4.0 5.4 3.6 3.9 6.2 3.8 6.4 10.2 4.6 4.0 6.7 6.1 0.2 16.0 18.7 9.4 0.0 1.7 0.8 0.2 0.0 1.5 0.2 0.0 1.2 0.0 3.9 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.5 26.4 0.7 0.5 0.0 0.0 79.2 0.0 0.3 1.9 0.0 4.3 1.3 0.1 0.0 0.0 0.3 0.0 396.6 0.1 0.0 0.0 1.2 1.3 0.3 0.4 1.8 3.7 0.1 0.0 0.0 9.5 10.1 0.5 0.0 0.4 0.0 0.8 0.0 0.0 20.8 0.7 0.0 0.6 1.7 0.6 0.4 0.1 0.9 0.4 0.4 0.2 0.0 0.4 C9orf64 MGC10999 ENSG00000165118 "Chromosome 9 open reading frame 64" Q5T6V5 9 83938311-83956986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054903, HPA066190" Uncertain Approved "Golgi apparatus" NA NA 9400 "Cluster 15: NK-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA054903: AB_2682636, HPA066190: AB_2685633" "unprognostic (2.07e-1)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (1.04e-1)" "unprognostic (4.00e-3)" "unprognostic (2.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-1)" "prognostic favorable (4.23e-4)" "unprognostic (1.49e-2)" "unprognostic (3.89e-1)" "unprognostic (1.63e-2)" "unprognostic (8.48e-3)" 8.1 9.2 4.7 8.4 5.6 2.3 7.9 5.1 5.6 8.9 11.0 7.9 23.6 10.2 11.3 5.9 11.4 6.3 8.4 4.8 5.8 13.5 24.5 8.8 8.4 5.7 6.0 10.9 6.1 14.0 4.6 8.0 5.7 8.8 8.2 5.5 6.6 8.7 7.7 4.3 22.1 10.4 5.3 6.6 9.7 8.2 5.5 10.0 16.1 7.1 8.1 7.7 4.9 6.7 23.4 19.7 0.3 0.1 9.9 13.4 23.7 15.0 4.3 14.2 15.8 17.9 20.5 0.1 12.5 16.9 5.7 14.2 0.0 0.5 18.4 25.2 13.1 10.4 25.6 34.9 22.8 0.0 30.1 15.4 19.8 13.6 0.0 3.2 9.3 0.1 25.3 0.3 17.4 23.0 4.9 0.8 18.7 14.8 9.6 0.1 29.9 1.1 11.4 3.7 19.2 18.9 27.0 6.4 21.1 0.3 8.4 20.1 2.9 1.7 20.0 31.7 4.4 6.3 0.3 0.9 13.1 0.8 10.2 7.0 10.4 9.8 6.5 11.8 6.2 2.4 4.9 6.6 11.9 3.3 5.3 6.3 4.2 12.6 12.9 8.3 5.8 4.6 4.7 5.6 5.1 5.6 4.8 5.8 5.7 6.0 5.7 5.3 5.5 6.7 6.5 12.8 10.8 2.0 3.6 2.2 4.5 5.2 4.0 4.3 5.5 4.2 5.4 4.3 3.3 3.7 4.2 12.7 4.1 6.2 11.7 11.6 6.7 11.1 9.0 5.4 4.2 3.4 2.6 8.7 19.4 8.5 8.6 8.4 9.5 6.0 4.6 24.7 12.3 3.3 2.9 7.2 14.2 12.8 4.6 2.9 8.1 8.7 1.8 1.9 13.2 11.9 7.2 3.0 3.8 10.6 10.4 10.9 3.6 3.7 22.1 17.3 6.5 7.3 0.0 11.3 6.7 9.6 5.5 3.7 1.4 4.4 4.2 10.7 10.5 3.0 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 112.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Cluster 15: NK-cells - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: AB_2681229, HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 7.5 6.6 7.5 6.4 9.0 6.0 8.9 8.2 7.8 9.2 5.0 7.8 11.9 7.3 5.7 9.9 6.5 6.8 6.2 7.0 7.2 7.1 7.9 5.0 8.7 8.5 7.6 9.5 7.8 4.9 5.9 8.4 8.2 7.2 7.5 6.3 8.9 5.0 8.7 11.2 8.2 6.3 6.5 6.7 6.8 5.4 8.2 8.5 8.5 8.4 8.0 9.8 8.4 12.9 11.6 7.5 12.6 10.4 12.7 23.4 12.8 13.8 22.0 11.1 11.0 1.5 6.4 18.5 6.9 12.1 11.7 20.1 13.4 13.6 15.4 12.9 6.5 11.3 10.3 9.5 13.9 16.7 8.5 19.2 18.2 11.4 25.2 17.5 13.8 17.1 13.8 11.8 14.5 5.7 20.4 11.8 11.6 17.8 17.6 11.6 22.4 0.5 16.3 16.7 10.1 13.9 7.0 17.8 25.0 13.8 6.0 9.6 12.1 10.2 13.3 23.7 10.6 12.0 21.7 8.5 14.0 12.6 6.5 15.1 6.6 10.6 9.9 7.5 10.5 8.7 8.4 8.5 7.3 8.6 10.2 10.8 7.6 13.0 6.8 10.5 8.4 7.4 7.5 9.0 8.2 7.8 7.0 7.2 8.5 7.6 8.2 6.5 8.2 12.9 19.2 6.4 17.0 35.6 15.7 7.6 13.6 12.8 25.6 10.9 13.9 22.9 14.0 8.6 12.6 5.5 8.4 20.3 18.4 25.2 21.5 14.2 10.8 9.4 19.7 15.0 6.6 8.2 27.4 19.9 19.0 14.1 19.9 10.8 18.4 13.7 18.5 9.7 14.8 5.0 19.2 23.4 10.2 16.1 8.9 7.5 20.8 15.2 3.6 24.4 17.7 12.5 33.0 44.2 112.1 17.8 30.6 13.2 9.5 12.7 29.3 22.8 8.4 13.0 13.1 19.3 17.3 20.6 14.6 23.2 9.8 10.8 16.2 21.9 16.8 27.0 CACNB3 CACNLB3 ENSG00000167535 "Calcium voltage-gated channel auxiliary subunit beta 3" P54284 12 48813794-48828941 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.2" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.8" "Lineage enriched" "Detected in single" 10 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 75.9;U-937: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059515 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus, Vesicles" "HPA059515: AB_2684047" "unprognostic (1.77e-2)" "unprognostic (4.84e-2)" "unprognostic (2.16e-3)" "unprognostic (2.12e-2)" "unprognostic (8.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.06e-1)" "unprognostic (3.60e-2)" "unprognostic (3.27e-2)" "unprognostic (2.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.04e-1)" "unprognostic (5.44e-3)" "unprognostic (6.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" 10.1 3.9 67.9 2.8 69.9 1.3 9.0 56.8 84.2 33.7 44.1 18.1 4.1 31.1 8.5 21.5 19.6 7.2 8.4 72.6 56.7 12.4 1.9 11.8 1.8 50.2 56.2 43.7 4.5 5.1 12.3 5.8 53.4 13.7 8.2 4.7 13.0 9.1 2.8 11.5 10.8 23.1 49.9 6.1 9.2 8.6 59.6 7.6 9.6 5.9 4.1 14.5 20.2 58.7 17.3 13.2 21.1 46.1 26.8 18.0 12.9 16.8 39.4 25.6 14.5 4.5 13.4 2.2 21.5 30.7 4.4 17.2 21.6 19.5 10.1 18.4 5.9 8.5 11.7 0.6 11.0 1.7 9.1 11.7 10.6 10.2 5.5 75.9 31.1 18.6 1.2 7.2 16.9 42.6 22.1 2.2 13.3 18.1 10.9 24.0 5.0 6.6 19.9 31.6 32.9 31.8 5.5 37.1 12.0 18.6 25.2 7.7 27.3 15.5 21.7 7.7 9.5 7.1 3.5 0.7 12.9 109.9 5.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.6 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.8 0.2 67.9 69.9 56.8 84.2 72.6 56.7 50.2 56.2 53.4 49.9 59.6 58.7 5.6 3.2 4.3 1.0 0.5 2.9 3.2 5.9 4.0 3.2 8.7 5.7 2.8 1.5 5.1 1.8 4.2 0.8 2.1 12.6 1.9 9.5 1.0 10.0 22.0 5.9 10.2 0.8 15.1 4.3 10.4 7.9 6.1 7.1 1.3 12.0 3.6 0.2 1.6 0.0 4.5 9.5 16.2 0.6 2.9 2.7 13.4 2.4 1.8 3.7 3.7 1.0 2.1 2.0 1.1 10.4 4.6 10.9 1.3 2.9 8.7 0.7 9.4 1.0 0.0 1.5 12.2 1.6 8.1 9.6 5.1 1.1 3.5 6.1 14.4 1.9 CALHM5 "C6orf188, dJ493F7.3, FAM26E, MGC45451" ENSG00000178033 "Calcium homeostasis modulator family member 5" Q8N5C1 6 116511639-116524788 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 10.6;Endothelial cells: 2.6;Fibroblasts: 2.0;Granulosa cells: 2.6;Smooth muscle cells: 3.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.3;fHDF/TERT166: 5.6;HUVEC TERT2: 5.6;LHCN-M2: 5.9;TIME: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034969, HPA034970" Uncertain Approved "Golgi apparatus" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "HPA034969: AB_10670299, HPA034970: AB_2674390" "unprognostic (2.71e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-2)" "unprognostic (1.01e-1)" "unprognostic (1.36e-1)" "unprognostic (3.92e-1)" "unprognostic (1.93e-2)" "unprognostic (5.37e-2)" "unprognostic (4.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.06e-1)" "unprognostic (9.16e-2)" "unprognostic (1.24e-7)" "unprognostic (1.16e-2)" "unprognostic (2.98e-2)" "unprognostic (7.69e-2)" "unprognostic (6.65e-3)" 3.3 0.5 0.6 1.1 0.7 0.0 1.6 0.5 0.6 1.3 0.7 1.5 0.6 1.3 0.6 1.2 0.9 1.5 2.3 0.6 0.5 1.9 0.5 1.7 0.9 0.6 0.5 0.5 0.1 0.5 0.3 4.4 0.6 0.9 1.0 0.0 0.6 0.7 1.6 1.0 0.9 2.1 0.5 1.7 0.6 0.7 0.8 0.1 0.8 2.5 0.5 1.4 1.2 0.6 0.0 0.0 4.5 0.0 2.7 4.3 0.0 3.6 5.3 1.4 3.8 0.2 0.0 0.0 0.3 5.6 3.8 0.0 0.0 0.0 1.5 0.0 0.2 0.8 0.0 0.0 0.6 0.0 0.0 2.6 0.0 3.4 0.0 1.0 5.6 0.0 0.0 1.0 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 8.9 2.5 0.8 0.3 0.2 0.0 0.0 0.0 2.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.5 0.6 0.6 0.5 0.6 0.5 0.6 0.5 0.8 0.6 10.6 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.6 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206079 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 91.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 184.3;non-classical monocyte: 216.9" "Lineage enriched" "Detected in many" 7 "monocytes: 216.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 5.2 5.1 2.9 14.5 2.9 4.5 3.1 3.9 3.8 9.2 12.6 70.1 91.9 3.3 1.4 2.1 19.3 18.7 1.2 3.1 2.7 29.1 15.0 5.1 3.9 2.8 2.7 1.7 7.0 0.9 3.5 5.4 2.9 6.2 64.7 4.3 2.2 4.4 3.4 4.8 76.0 7.3 2.4 5.9 15.6 3.3 3.0 4.5 1.6 0.7 4.0 3.5 2.3 3.3 3.4 11.6 7.9 4.8 1.6 1.7 5.7 2.2 2.3 4.8 3.0 22.1 29.8 3.7 3.0 1.9 3.7 15.1 18.2 2.8 2.0 3.3 16.9 6.7 21.6 7.9 3.5 5.8 14.7 1.6 4.4 1.8 3.4 3.0 5.9 10.8 6.2 3.9 0.7 10.2 14.5 12.6 8.5 24.1 3.4 30.1 8.1 8.2 1.3 6.0 4.4 4.3 3.5 3.2 9.9 3.1 2.8 12.6 3.5 5.0 4.5 9.2 8.7 14.4 9.4 10.0 3.3 14.9 2.2 0.1 43.7 0.2 0.1 184.3 0.6 0.6 0.6 0.2 29.1 0.1 0.5 0.3 21.3 0.0 216.9 1.4 0.4 18.3 2.9 2.9 3.9 3.8 3.1 2.7 2.8 2.7 2.9 2.4 3.0 3.3 1.3 0.0 1.5 3.3 0.7 1.5 0.8 2.8 1.8 11.1 0.4 0.1 0.3 12.8 15.8 3.7 0.0 0.5 0.3 49.2 0.0 2.5 6.5 9.4 0.6 6.4 7.7 1.3 3.8 4.3 0.5 3.2 31.6 0.4 0.0 0.4 5.0 8.1 3.9 8.4 4.0 17.1 0.0 11.7 1.5 0.5 3.7 8.1 0.0 4.7 3.9 2.0 2.1 3.0 3.4 3.0 39.3 6.8 2.4 1.1 36.2 25.4 107.8 3.1 0.0 1.1 0.7 0.0 0.4 1.3 2.0 0.1 1.2 0.1 21.1 1.1 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269358-67319953 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 5900000 "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 18.4 23.1 19.6 19.9 21.4 22.6 25.9 25.3 21.8 21.4 15.9 19.8 19.5 21.2 27.8 22.5 19.2 18.3 12.6 20.9 21.7 24.3 27.4 16.8 27.5 18.8 19.0 25.0 18.7 28.3 19.3 23.2 21.2 22.4 20.6 37.5 16.5 20.0 9.9 29.3 18.5 21.6 19.5 19.1 18.2 27.8 19.5 38.8 26.0 11.4 30.8 23.3 19.3 19.5 62.1 62.6 93.1 66.6 69.7 54.3 62.4 60.2 51.6 62.0 54.2 58.4 34.5 132.9 51.0 60.6 38.9 57.8 101.1 68.3 70.6 50.8 60.5 75.1 46.5 55.7 45.7 89.5 40.9 51.5 51.0 56.8 51.9 75.8 58.7 63.9 60.4 72.3 67.7 61.0 81.6 60.3 98.8 47.4 43.1 78.4 79.8 56.3 57.3 103.9 95.2 47.3 74.9 68.0 49.9 77.8 73.2 40.7 50.3 49.0 31.5 34.1 46.1 23.5 31.1 111.5 58.3 52.2 51.4 9.3 6.4 7.4 14.0 7.4 17.0 10.9 16.8 15.3 10.0 14.7 17.7 14.9 2.7 19.0 14.0 8.6 19.3 5.7 19.6 21.4 25.3 21.8 20.9 21.7 18.8 19.0 21.2 19.5 19.5 19.5 37.6 60.9 36.3 38.5 61.2 58.1 50.2 51.6 57.5 92.4 51.4 40.6 17.0 42.9 42.0 44.1 116.7 37.4 61.5 47.3 13.7 30.7 3.9 45.2 53.9 44.6 45.4 34.9 48.8 28.6 42.7 47.7 41.3 51.1 7.6 71.0 40.4 49.8 31.3 87.5 61.7 50.4 34.6 42.4 52.4 11.0 69.0 35.9 33.8 32.8 54.6 53.8 48.4 49.8 63.5 35.2 28.6 60.9 55.1 56.6 59.8 32.3 55.3 115.3 26.3 52.1 50.7 82.5 47.7 47.1 63.9 44.6 59.3 66.4 46.5 64.2 CANT1 "SCAN-1, SHAPY" ENSG00000171302 "Calcium activated nucleotidase 1" Q8WVQ1 17 78991716-79009867 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 139.5;Intestinal goblet cells: 155.6;Syncytiotrophoblasts: 101.5;Undifferentiated cells: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 445.4;T-47d: 282.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019627, HPA019639, HPA022818" Enhanced Supported "Golgi apparatus" NA Yes 3300000 "Cluster 52: Eosinophils - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971" "unprognostic (1.98e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-2)" "unprognostic (5.36e-2)" "unprognostic (2.13e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.41e-4)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.21e-4)" "unprognostic (7.04e-2)" "unprognostic (5.06e-2)" "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" 15.8 23.9 10.4 24.7 12.4 19.1 25.4 13.6 11.3 32.3 13.8 89.2 51.9 17.4 8.7 44.8 18.2 25.2 17.0 11.1 12.6 16.1 17.3 16.4 15.2 14.6 14.5 14.6 19.6 24.5 17.5 25.9 13.9 71.8 82.8 7.4 62.7 32.4 14.9 14.9 55.5 15.5 13.8 26.5 51.1 20.7 14.5 14.7 13.9 12.4 15.1 16.7 21.7 17.8 106.5 112.1 31.9 46.3 29.7 35.2 38.9 66.0 51.3 66.7 55.9 53.8 99.6 25.3 36.1 46.1 83.0 53.7 27.1 49.8 68.4 43.0 46.4 33.7 34.1 45.9 25.0 33.0 51.6 33.7 32.4 62.7 34.2 40.9 116.1 42.5 42.3 43.2 46.4 58.4 50.2 19.8 22.1 445.4 103.1 27.6 51.8 29.8 29.8 53.5 45.6 45.4 33.9 227.2 50.2 50.3 282.6 38.6 56.6 101.9 90.5 46.4 83.1 48.9 43.8 24.3 64.4 24.9 65.3 6.3 4.0 8.7 5.5 4.4 5.7 3.9 4.3 4.8 3.8 2.5 4.1 4.1 17.4 3.1 3.0 2.7 3.6 4.6 10.4 12.4 13.6 11.3 11.1 12.6 14.6 14.5 13.9 13.8 14.5 17.8 12.6 28.9 20.6 5.9 11.8 16.6 15.3 16.8 6.8 6.4 49.9 16.3 13.3 14.3 15.1 12.9 14.6 36.6 8.9 139.5 3.9 34.7 14.0 10.7 13.1 16.3 51.0 15.2 4.1 28.8 39.4 13.5 38.2 19.0 5.7 20.0 41.7 14.4 24.9 5.0 5.2 155.6 16.2 12.4 9.5 15.7 11.8 14.2 14.2 3.7 18.1 8.1 11.3 5.0 10.2 37.7 55.8 7.5 16.6 33.4 39.4 6.7 9.7 8.7 6.6 9.5 13.3 23.9 5.8 12.0 13.1 101.5 11.1 11.3 100.2 19.4 CAPN9 "GC36, nCL-4" ENSG00000135773 "Calpain 9" O14815 1 230747384-230802003 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 22.2;stomach 1: 60.3" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 25.6;Gastric mucus-secreting cells: 93.8;Intestinal goblet cells: 71.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 7.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "OE19: 10.7;SCLC-21H: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020398, CAB033483, HPA062050" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 4: Stomach - Digestion" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "Golgi apparatus" "CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: " "unprognostic (2.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.60e-2)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.49e-2)" "unprognostic (3.36e-2)" "unprognostic (2.30e-2)" "unprognostic (4.61e-2)" "unprognostic (3.44e-2)" "unprognostic (9.10e-2)" "unprognostic (1.60e-1)" "unprognostic (5.97e-5)" "unprognostic (1.51e-1)" "unprognostic (2.08e-1)" "unprognostic (4.60e-2)" "unprognostic (2.16e-1)" 0.0 0.6 1.4 0.9 2.2 0.0 0.4 1.3 1.2 0.4 0.0 13.7 6.6 0.2 0.5 0.2 2.5 0.6 0.4 1.1 1.4 0.0 0.0 7.5 0.0 2.1 1.7 0.6 0.2 1.0 0.0 0.0 1.8 0.6 22.2 5.0 11.3 0.1 0.2 0.1 11.7 0.5 1.9 0.0 60.3 0.2 1.7 0.1 0.1 0.1 0.0 2.0 0.1 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.5 10.7 0.0 0.4 0.0 0.0 0.0 0.1 14.7 0.0 0.0 0.4 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 1.3 1.2 1.1 1.4 2.1 1.7 1.8 1.9 1.7 3.4 0.0 25.6 3.0 0.3 0.1 0.0 0.6 0.7 0.0 0.0 0.6 0.3 6.0 0.0 3.2 0.0 0.0 0.1 0.0 4.1 0.0 0.2 5.2 1.5 0.1 0.1 3.0 0.0 0.4 0.2 0.0 0.4 93.8 0.5 2.5 0.1 0.0 0.0 0.1 0.0 0.4 71.8 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.6 1.7 5.0 0.0 0.2 0.5 3.3 0.1 8.2 1.7 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.1 1.5 CASP10 "FLICE-2, MCH4" ENSG00000003400 "Caspase 10" Q92851 2 201182898-201229406 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 71.3;NK-cells: 44.3;Paneth cells: 44.5;Plasma cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 25.3" "Low region specificity" "Detected in all" "CAB003780, HPA017059" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 1: K-562 - Erythropoiesis" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "CAB003780: AB_289592, HPA017059: AB_1846040" "unprognostic (4.01e-2)" "unprognostic (8.24e-2)" "unprognostic (4.80e-1)" "unprognostic (1.28e-3)" "unprognostic (4.74e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.68e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.05e-7)" "unprognostic (3.23e-2)" "unprognostic (2.19e-2)" "unprognostic (4.49e-2)" "unprognostic (1.38e-2)" 8.8 2.4 5.7 9.2 5.5 19.5 6.5 4.5 5.8 4.0 4.4 13.2 21.8 3.3 6.2 8.8 5.4 7.4 6.7 4.7 5.1 8.1 6.2 11.5 8.9 6.0 5.0 1.6 4.8 2.3 1.3 9.6 5.8 3.9 13.4 1.3 5.4 3.1 4.9 5.7 18.4 5.1 5.6 22.6 10.2 1.2 7.3 8.7 5.3 2.8 10.4 9.0 5.1 5.4 4.4 3.5 0.3 0.4 0.1 0.3 7.5 0.7 4.6 0.4 1.8 4.6 9.8 0.5 7.0 2.5 1.7 2.9 0.2 2.3 1.3 2.1 4.8 12.2 4.0 15.1 1.6 8.3 12.7 0.5 2.0 5.3 0.4 0.3 25.3 5.1 14.9 17.4 0.4 0.3 15.9 7.8 0.6 6.0 2.4 8.8 0.5 18.4 8.7 6.2 0.2 0.1 4.1 0.2 1.9 3.0 0.2 7.8 10.0 0.4 0.8 3.4 0.2 18.7 12.1 0.5 4.5 6.3 0.2 5.9 11.7 0.7 6.4 16.5 5.6 8.2 5.2 3.6 6.5 7.7 7.2 6.4 2.1 8.5 19.3 6.6 1.2 7.2 5.7 5.5 4.5 5.8 4.7 5.1 6.0 5.0 5.8 5.6 7.3 5.4 20.7 19.2 10.0 0.3 15.8 6.0 2.7 10.6 5.2 0.0 1.3 0.9 1.8 8.6 9.4 9.2 0.0 1.1 20.5 71.3 1.9 16.2 1.2 7.7 7.4 29.7 2.4 14.9 0.3 10.4 0.7 4.2 26.5 12.0 7.6 0.8 26.4 7.1 9.4 0.0 0.5 21.6 4.1 26.6 17.5 0.0 0.6 16.2 7.2 33.7 22.0 0.5 44.3 0.0 0.9 8.6 44.5 0.0 49.7 2.5 26.1 8.7 24.4 0.4 0.0 2.9 2.2 0.1 0.1 6.6 4.5 0.4 12.9 4.1 16.4 10.3 CAV1 CAV ENSG00000105974 "Caveolin 1" Q03135 7 116524994-116561179 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 14.6;memory B-cell: 5.1" "Group enriched" "Detected in many" 57 "B-cells: 5.1;granulocytes: 14.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 122.1" "CAB003791, HPA049326" Enhanced Supported "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "CAB003791: AB_562068, HPA049326: AB_2680714" "unprognostic (5.98e-2)" "unprognostic (1.35e-3)" "unprognostic (3.35e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-3)" "unprognostic (2.35e-3)" "unprognostic (8.07e-2)" "prognostic unfavorable (7.17e-5)" "unprognostic (1.31e-1)" "unprognostic (2.25e-1)" "unprognostic (1.79e-3)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.65e-3)" "unprognostic (2.72e-1)" "unprognostic (7.40e-2)" "unprognostic (6.14e-3)" 621.1 17.4 12.7 44.7 15.3 0.6 284.5 14.3 21.6 267.0 11.8 298.8 32.3 190.9 72.5 135.1 152.5 148.2 276.5 12.2 13.9 18.4 26.6 592.0 30.3 15.1 13.4 137.4 24.6 21.4 6.8 449.2 14.6 110.3 93.6 31.4 58.0 175.5 102.9 104.9 89.4 274.2 14.3 199.1 120.8 25.8 16.1 25.2 168.4 184.6 20.3 202.0 124.1 16.2 458.7 344.3 9.5 3.7 1406.6 2140.5 20.6 1055.8 2371.6 566.0 591.2 3.0 652.4 0.1 365.8 1228.5 494.8 828.2 2.2 2333.7 840.3 36.0 19.5 0.4 128.7 0.3 196.9 0.1 2.1 736.9 481.6 805.7 536.0 539.0 1749.9 0.2 0.3 23.4 2372.1 45.2 0.5 0.8 33.7 1.2 173.9 5.2 25.2 251.0 317.0 2.0 1.0 0.6 328.3 20.1 52.3 137.8 1.6 3.9 1349.3 1894.8 212.4 730.6 298.9 96.8 15.8 1.9 758.4 0.9 701.0 14.6 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 12.7 15.3 14.3 21.6 12.2 13.9 15.1 13.4 14.6 14.3 16.1 16.2 2160.5 3557.7 123.0 0.0 15.8 1375.3 392.0 534.8 316.4 8.3 17.9 190.8 286.6 107.2 342.0 7.3 2.1 64.3 7.0 0.3 5.9 76.8 2.6 17.5 102.3 1024.0 1.8 16.0 0.4 0.7 449.5 326.8 1.5 21.3 13.9 6.3 450.5 5.2 15.0 0.0 0.5 7.0 20.3 11.0 187.1 13.4 377.2 10.7 439.4 19.7 3.7 249.0 0.0 1.0 1.3 43.1 0.1 565.4 56.2 512.7 0.7 0.3 30.6 7.7 558.8 152.4 751.4 2.1 5.7 39.4 610.9 117.0 16.7 59.7 2.4 93.3 CAVIN4 "cavin-4, MURC" ENSG00000170681 "Caveolae associated protein 4" Q5BKX8 9 100578079-100588389 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 276.1;tongue: 92.4" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.9;Granulosa cells: 1.8;Pancreatic endocrine cells: 1.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 8.9;SCLC-21H: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020973, HPA020987, HPA021021" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082" "unprognostic (9.54e-5)" "unprognostic (1.68e-2)" "unprognostic (2.50e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (4.56e-3)" "unprognostic (1.14e-4)" "unprognostic (3.36e-2)" "unprognostic (2.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (4.02e-1)" "unprognostic (1.74e-8)" "unprognostic (1.14e-1)" "unprognostic (3.39e-1)" "unprognostic (3.68e-3)" "unprognostic (1.55e-3)" 0.2 0.1 1.6 0.2 2.9 0.1 0.1 2.0 5.6 0.4 0.4 0.4 0.0 0.5 0.1 4.3 0.1 0.3 45.9 1.7 2.5 0.2 0.2 0.4 0.1 2.7 2.7 0.2 0.1 0.0 0.2 0.3 2.7 4.5 0.1 0.3 2.4 0.1 276.1 0.2 0.1 0.3 1.8 0.1 0.3 3.7 2.7 0.4 0.5 92.4 0.1 0.3 0.2 3.5 0.5 0.3 6.1 2.2 1.4 2.0 4.3 1.1 0.9 0.8 1.0 0.0 0.4 0.2 0.3 0.6 2.1 0.3 3.1 0.1 1.7 1.4 2.0 0.1 1.0 0.0 0.4 0.2 0.4 5.0 0.3 0.8 0.5 1.5 1.1 1.5 0.2 0.2 3.9 0.1 1.8 0.3 8.9 1.0 0.7 2.6 5.8 0.0 0.8 0.3 13.2 3.4 0.2 0.2 1.1 4.1 0.1 0.2 1.1 1.5 1.2 1.0 1.0 0.3 1.1 0.6 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.9 2.0 5.6 1.7 2.5 2.7 2.7 2.7 1.8 2.7 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.7 0.0 1.2 1.8 0.3 0.0 0.0 0.0 0.5 0.4 0.5 0.0 1.9 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 CCAR1 "CARP-1, CARP1, FLJ10590" ENSG00000060339 "Cell division cycle and apoptosis regulator 1" Q8IX12 10 68721012-68792377 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007856, HPA048513" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Golgi apparatus" "HPA007856: AB_1078415, HPA048513: AB_2680424" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.86e-1)" "unprognostic (5.15e-3)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.41e-5)" "unprognostic (1.10e-1)" "unprognostic (3.25e-2)" "prognostic favorable (4.05e-5)" "unprognostic (2.89e-2)" "unprognostic (3.21e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.67e-1)" "unprognostic (2.36e-1)" "unprognostic (2.24e-1)" "unprognostic (1.41e-2)" 17.4 21.4 14.4 20.2 16.0 23.4 17.2 21.1 25.4 15.9 15.2 17.9 16.8 16.7 16.1 20.1 14.5 16.5 15.6 13.6 17.0 18.4 19.1 15.9 30.3 16.9 14.9 19.9 20.4 15.9 14.5 21.7 16.4 17.3 22.2 20.9 18.5 13.5 20.6 23.9 19.4 16.0 13.2 21.5 17.8 14.3 16.8 29.8 18.2 17.9 28.7 21.7 17.0 19.2 64.0 64.8 73.9 49.7 31.4 30.3 57.7 56.0 47.4 59.3 40.0 87.2 50.8 74.7 29.9 39.1 29.8 49.3 78.4 44.3 64.8 51.5 48.2 60.1 46.1 54.5 35.7 96.2 67.5 30.5 54.2 50.1 61.7 36.7 48.5 37.5 83.5 46.8 58.8 46.5 64.2 60.7 74.1 49.7 58.4 74.2 44.1 44.7 52.5 48.6 42.7 36.9 55.1 89.1 57.1 57.6 60.6 58.9 48.1 36.8 46.3 40.1 61.4 32.2 45.5 78.5 30.8 63.8 35.6 6.1 14.6 14.3 16.3 13.0 14.6 14.2 11.3 15.8 21.0 17.3 13.5 14.3 3.3 10.6 15.5 13.1 18.4 11.3 14.4 16.0 21.1 25.4 13.6 17.0 16.9 14.9 16.4 13.2 16.8 19.2 50.5 35.3 85.5 61.4 69.2 37.0 49.6 54.7 66.0 51.0 36.1 40.0 65.5 41.5 49.0 46.0 58.4 73.1 62.9 44.1 23.5 68.0 28.8 55.2 68.5 54.0 46.1 61.2 49.7 78.1 83.8 49.2 45.3 62.2 67.2 76.8 39.3 40.4 49.2 55.5 51.2 55.1 30.5 47.4 36.3 14.5 53.7 49.8 21.4 41.2 65.4 36.5 66.9 47.7 66.1 77.7 34.2 50.4 61.0 45.3 36.0 18.3 49.1 68.7 65.7 53.2 62.3 128.7 77.2 50.4 37.4 109.5 61.3 83.2 67.2 49.4 CCDC110 "CT52, KM-HN-1, MGC33607" ENSG00000168491 "Coiled-coil domain containing 110" Q8TBZ0 4 185445182-185471752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "pancreas: 30.7;testis: 100.0" "Cell type enhanced" "Detected in many" "Early spermatids: 796.2;Late spermatids: 175.5;Spermatocytes: 552.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 8.4;U-266/70: 5.3;U-266/84: 8.8;U-87 MG: 4.0" "Low region specificity" "Detected in many" HPA078808 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA078808: " "unprognostic (1.18e-1)" "unprognostic (7.26e-3)" "unprognostic (5.42e-2)" "unprognostic (9.84e-4)" "unprognostic (3.72e-2)" "unprognostic (3.08e-3)" "unprognostic (1.95e-5)" "unprognostic (4.92e-2)" "unprognostic (5.81e-2)" "unprognostic (9.94e-3)" "unprognostic (1.43e-1)" "unprognostic (2.64e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (1.21e-2)" "unprognostic (1.21e-2)" 0.6 1.0 1.8 1.0 3.4 0.0 3.6 2.6 2.1 2.6 1.6 1.8 0.9 1.4 5.1 1.8 2.9 1.2 1.1 1.2 1.2 2.5 0.8 0.9 1.2 2.0 1.6 4.5 30.7 2.0 2.9 0.8 2.4 2.2 1.9 7.9 6.2 2.0 2.1 1.1 0.8 1.4 0.8 0.6 2.5 100.0 1.7 0.4 7.7 0.9 0.7 1.3 0.5 0.9 0.4 0.0 0.2 0.1 2.2 2.4 0.1 0.0 0.0 0.0 0.2 0.0 1.7 2.7 0.3 0.0 2.3 0.3 1.7 0.0 0.2 1.0 1.7 0.0 0.2 0.0 1.1 0.0 0.0 0.6 0.0 1.0 0.0 1.4 0.8 0.7 0.2 0.2 2.9 0.7 0.0 0.0 0.2 0.3 1.3 0.1 0.0 0.4 0.6 0.0 8.4 1.5 0.0 0.9 0.7 0.4 3.8 0.0 0.5 0.3 0.7 0.1 0.1 5.3 8.8 0.0 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.4 2.6 2.1 1.2 1.2 2.0 1.6 2.4 0.8 1.7 0.9 0.4 0.0 0.0 0.7 0.9 0.3 0.4 0.3 1.8 0.5 2.9 4.7 4.2 0.0 0.0 1.8 0.0 0.1 0.0 0.3 1.9 2.6 796.2 1.8 0.2 1.2 0.0 0.0 3.5 3.5 0.1 2.1 0.5 1.0 0.0 0.2 2.2 0.5 0.1 0.0 1.3 1.1 4.1 0.0 0.3 175.5 7.2 0.9 3.6 1.9 0.1 3.1 1.0 0.5 1.8 2.2 0.3 6.0 9.3 0.4 0.0 2.3 4.4 5.3 0.0 1.7 2.5 552.8 6.1 1.5 0.4 0.0 0.3 0.7 1.1 0.1 CCDC126 FLJ23031 ENSG00000169193 "Coiled-coil domain containing 126" Q96EE4 7 23597382-23644708 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.6" "Group enriched" "Detected in all" 18 "Early spermatids: 642.3;Late spermatids: 490.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "basophil: 479.0" "Lineage enriched" "Detected in all" 23 "granulocytes: 479.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010969, HPA026883" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 39000000 "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA010969: , HPA026883: AB_1846131" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (5.96e-3)" "unprognostic (1.16e-2)" "unprognostic (3.90e-1)" "unprognostic (9.30e-2)" "unprognostic (1.42e-2)" "unprognostic (3.44e-2)" "unprognostic (3.29e-2)" "unprognostic (7.35e-3)" "unprognostic (5.90e-2)" "unprognostic (1.20e-1)" "unprognostic (1.62e-1)" "unprognostic (3.28e-1)" 6.5 7.5 3.7 4.5 4.1 7.6 8.4 6.5 4.9 6.6 2.5 5.2 8.6 7.2 4.8 5.9 6.4 5.9 5.0 3.6 4.6 7.2 11.6 6.1 8.9 5.0 5.2 6.8 8.4 11.7 4.3 4.5 4.5 5.5 6.1 8.4 5.4 5.5 7.1 4.8 7.0 6.2 4.6 6.3 6.5 34.6 4.7 5.4 9.4 10.0 8.8 6.3 4.4 4.1 6.0 4.1 8.9 11.3 14.6 8.1 20.4 7.4 7.3 6.2 9.0 4.3 1.9 12.8 11.3 6.2 11.8 3.4 3.9 3.5 8.1 2.7 5.1 2.2 1.6 5.6 5.8 5.9 10.9 8.7 10.0 2.0 1.9 5.2 8.4 5.3 5.2 3.5 7.6 2.8 4.1 7.1 4.2 7.9 5.1 2.7 14.0 3.9 6.5 2.7 5.4 10.2 7.6 7.2 5.6 13.8 6.1 5.4 10.2 3.7 6.5 8.4 5.9 9.9 10.5 9.2 4.1 8.5 20.2 479.0 18.0 86.7 14.7 17.0 17.6 20.7 15.8 17.0 15.6 19.3 19.2 15.0 35.2 16.8 17.1 3.2 19.3 15.6 3.7 4.1 6.5 4.9 3.6 4.6 5.0 5.2 4.5 4.6 4.7 4.1 17.3 6.4 8.1 12.7 12.8 19.1 7.9 8.0 13.6 14.1 15.4 10.7 9.0 12.8 8.2 12.9 8.4 10.2 9.3 7.3 7.9 10.1 642.3 11.1 9.0 10.8 15.0 4.8 14.0 9.1 6.8 11.5 13.3 9.5 7.0 3.7 10.8 15.2 6.9 8.4 17.4 8.7 16.2 7.9 9.6 490.0 11.5 9.5 14.2 12.2 11.4 7.7 14.4 18.6 20.1 10.4 7.3 14.3 12.8 8.3 8.4 8.9 14.6 14.1 13.1 12.0 12.9 31.1 26.3 12.1 23.7 20.2 11.3 29.2 5.9 6.9 CCDC136 "DKFZP434G156, KIAA1793, NAG6" ENSG00000128596 "Coiled-coil domain containing 136" Q96JN2 7 128790757-128822132 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 87.6;retina: 52.5;testis: 185.7" "Group enriched" "Detected in many" 4 "Early spermatids: 780.2;Late spermatids: 2032.0" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-87 MG: 30.5;U-937: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010646, HPA071015" Enhanced Approved Approved "Nuclear membrane,Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "Nuclear membrane, Plasma membrane" "HPA010646: , HPA071015: AB_2686334" "unprognostic (2.07e-2)" "unprognostic (2.32e-2)" "unprognostic (1.29e-4)" "unprognostic (4.65e-2)" "unprognostic (4.52e-1)" "unprognostic (2.16e-1)" "unprognostic (1.66e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-4)" "unprognostic (2.58e-2)" "unprognostic (8.44e-3)" "unprognostic (4.35e-1)" "unprognostic (1.18e-4)" "unprognostic (5.27e-3)" "unprognostic (4.85e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" 1.8 3.7 37.2 1.9 24.4 0.8 1.7 42.7 39.9 5.2 6.2 20.1 1.6 9.3 2.2 1.7 3.3 2.2 5.7 24.2 34.7 0.7 0.3 1.1 2.7 30.5 54.2 2.8 0.8 1.6 6.4 1.4 26.3 12.1 3.1 52.5 1.6 13.6 4.4 0.9 4.8 11.6 34.9 1.5 4.6 185.7 87.6 5.2 1.3 4.0 1.7 13.1 3.9 30.6 1.1 1.5 11.7 7.9 6.3 5.4 2.0 4.7 6.0 4.6 4.3 1.8 1.0 6.5 0.5 6.2 18.4 2.5 7.8 0.9 4.3 17.2 7.7 10.7 3.1 0.0 2.2 1.5 22.2 6.0 0.8 5.0 0.4 4.1 2.7 10.0 4.0 6.0 1.9 2.3 8.0 3.4 16.3 0.1 5.1 19.5 2.3 2.9 0.3 2.4 7.4 20.4 2.9 3.3 5.1 4.1 0.3 3.1 2.4 7.4 4.2 3.7 3.5 3.4 1.6 6.1 30.5 46.2 1.9 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 37.2 24.4 42.7 39.9 24.2 34.7 30.5 54.2 26.3 34.9 87.6 30.6 1.6 0.0 0.5 11.4 1.1 0.5 0.9 0.1 1.8 306.0 0.6 3.8 7.5 1.5 0.7 0.0 98.0 0.1 2.2 0.0 0.0 0.7 780.2 0.3 2.2 2.0 0.0 0.4 23.3 1.5 0.3 2.6 1.5 0.1 0.0 1.9 1.1 0.0 6.8 40.4 48.0 0.1 0.0 0.6 1.6 2032.0 18.0 2.3 0.0 10.3 0.7 22.5 2.1 28.6 13.3 0.6 0.1 7.5 1.1 0.9 0.0 0.2 2.0 20.7 6.6 1.6 6.1 321.9 17.2 0.1 0.4 0.4 3.4 0.3 0.0 0.3 CCDC154 "C16orf29, LOC645811" ENSG00000197599 "Coiled-coil domain containing 154" 16 1434383-1444556 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 11.6" "Cell type enriched" "Detected in some" 4 "Early spermatids: 51.6" "Cancer enhanced" "Detected in many" "prostate cancer: 4.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.5;NB-4: 4.7;SCLC-21H: 33.2;U-266/70: 5.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.9" "HPA041158, HPA043535, HPA048237" Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 43: Testis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Plasma membrane" "Golgi apparatus" "HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323" "unprognostic (2.40e-1)" "unprognostic (1.42e-2)" "unprognostic (5.97e-4)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (5.76e-3)" "unprognostic (7.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (4.19e-5)" "unprognostic (2.35e-2)" "unprognostic (8.02e-6)" "unprognostic (9.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (9.35e-5)" 0.6 0.8 1.5 0.9 1.7 1.0 0.8 1.7 2.2 1.9 0.5 1.2 1.4 1.0 0.3 0.4 1.9 0.5 0.7 1.4 1.3 2.3 0.7 0.8 1.4 1.8 1.4 1.5 1.2 0.1 3.8 0.4 1.6 1.5 0.1 0.8 0.7 0.4 0.8 1.5 1.2 0.2 0.9 2.2 2.0 11.6 1.5 0.4 2.8 0.1 0.4 0.8 0.9 2.4 9.5 0.4 0.3 0.6 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.3 0.8 0.1 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.4 0.3 0.1 0.5 0.1 0.3 0.1 0.0 0.1 0.0 0.1 1.2 0.5 0.0 0.7 0.0 4.7 0.2 0.0 0.1 2.8 0.1 0.2 0.0 0.2 33.2 0.5 0.1 0.2 1.4 0.1 1.0 2.4 0.0 0.4 0.1 0.4 0.0 5.8 1.6 0.1 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.7 1.7 2.2 1.4 1.3 1.8 1.4 1.6 0.9 1.5 2.4 0.2 0.0 0.0 9.8 1.4 0.0 0.5 0.2 0.0 3.2 0.5 0.6 0.6 1.5 0.1 3.7 8.4 0.0 0.4 0.1 0.0 0.1 51.6 0.3 0.3 0.1 0.0 0.0 3.9 0.4 0.0 0.3 1.1 0.3 1.3 1.5 0.4 0.2 0.8 6.7 4.8 0.5 0.0 0.3 0.8 11.1 1.5 0.6 1.8 7.5 0.8 2.4 0.0 2.0 3.8 0.0 0.0 0.4 0.0 0.1 0.2 0.2 0.8 4.2 0.0 0.3 0.6 10.1 1.2 0.0 0.4 0.0 0.7 0.4 0.0 0.2 CCDC170 "bA282P11.1, C6orf97, FLJ23305" ENSG00000120262 "Coiled-coil domain containing 170" Q8IYT3 6 151494017-151621193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "fallopian tube: 33.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 236.6;Late spermatids: 82.6;Respiratory ciliated cells: 379.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MCF7: 10.4;T-47d: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027114, HPA027185" Enhanced Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "Cell Junctions" "HPA027114: AB_2732435, HPA027185: AB_2672151" "unprognostic (7.46e-2)" "unprognostic (3.54e-2)" "unprognostic (6.93e-2)" "prognostic favorable (3.64e-4)" "unprognostic (2.13e-1)" "unprognostic (8.79e-3)" "unprognostic (2.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.56e-2)" "unprognostic (1.40e-2)" "unprognostic (3.93e-2)" "unprognostic (2.17e-1)" "unprognostic (5.21e-2)" 3.0 4.2 1.5 1.3 1.4 0.1 3.7 0.9 0.7 3.0 8.0 0.7 2.5 3.6 0.4 0.4 33.4 1.3 0.8 1.3 1.8 0.8 1.3 4.1 1.4 3.6 4.9 5.6 0.1 0.1 0.2 1.4 3.1 0.4 0.6 0.2 0.2 0.4 0.3 0.2 1.1 0.9 3.2 2.2 1.7 2.7 1.7 0.3 5.6 0.1 0.6 1.1 0.5 2.8 0.0 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.1 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.1 5.9 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.1 6.2 0.0 2.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.8 0.1 2.8 0.1 0.0 0.6 1.5 1.4 0.9 0.7 1.3 1.8 3.6 4.9 3.1 3.2 1.7 2.8 1.2 3.2 1.5 7.5 0.4 0.6 0.3 6.5 1.2 0.3 27.3 8.9 0.7 0.0 39.5 0.0 22.9 0.1 0.4 1.1 0.0 0.3 53.0 236.6 23.6 1.2 0.0 0.0 5.5 1.1 0.4 5.2 3.1 14.1 3.8 3.5 1.1 1.5 11.9 0.0 5.9 0.0 12.2 17.5 11.3 82.6 7.2 16.8 0.0 0.0 11.0 2.5 0.0 3.0 0.8 2.7 5.8 0.0 0.1 0.9 0.5 5.8 379.4 1.0 0.0 0.4 6.5 19.1 1.1 0.2 1.0 0.0 1.2 14.0 0.3 0.5 CCDC186 "C10orf118, CCCP-1, FLJ10188, FLJ35301, golgin104" ENSG00000165813 "Coiled-coil domain containing 186" Q7Z3E2 10 114120862-114174232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 49.3" "Group enriched" "Detected in all" 4 "dendritic cells: 49.3;granulocytes: 26.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014569, HPA018019" Approved Approved "Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA014569: AB_2066352, HPA018019: AB_1845513" "unprognostic (1.66e-2)" "unprognostic (1.76e-2)" "unprognostic (9.14e-2)" "unprognostic (2.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.85e-3)" "unprognostic (2.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.06e-1)" "unprognostic (3.20e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "prognostic favorable (7.65e-8)" "unprognostic (8.45e-3)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" 7.4 7.3 2.8 9.0 3.3 32.8 12.5 8.6 5.4 8.5 9.2 12.4 15.4 7.5 9.6 12.5 8.2 6.8 9.4 2.8 5.9 14.9 7.2 10.8 9.1 3.4 2.9 8.0 21.1 13.1 7.1 9.4 3.7 15.1 11.9 14.1 15.6 9.2 7.1 12.6 16.1 6.2 2.5 11.0 16.7 16.6 4.8 12.0 14.7 9.2 10.2 7.7 6.8 4.3 17.9 6.1 6.0 6.9 6.8 7.9 7.8 11.0 13.2 5.1 8.1 11.2 18.3 4.2 7.0 9.1 6.3 14.1 7.1 9.8 9.8 21.9 7.3 3.3 7.0 6.6 6.3 9.6 14.6 5.9 11.1 6.0 16.9 12.6 7.7 11.1 6.1 13.5 6.0 6.5 8.8 5.3 3.5 10.6 3.9 8.4 20.7 6.6 9.0 10.9 4.2 4.4 9.7 13.4 6.6 9.7 8.6 4.1 11.2 3.9 7.8 3.9 9.3 7.6 13.3 8.4 4.1 0.1 3.0 26.5 3.3 11.7 8.6 3.8 8.5 7.9 6.6 7.8 4.0 8.6 6.4 6.4 19.9 5.8 3.7 49.3 8.7 2.6 2.8 3.3 8.6 5.4 2.8 5.9 3.4 2.9 3.7 2.5 4.8 4.3 63.2 141.1 85.7 23.8 46.7 0.0 79.5 0.0 63.2 63.8 73.5 49.0 57.4 38.6 57.6 77.3 62.6 94.9 174.6 107.1 66.5 78.2 221.9 98.4 40.6 41.3 64.6 33.1 53.0 70.7 40.7 43.7 48.9 108.9 24.7 28.1 21.0 20.9 21.4 107.7 49.9 78.9 0.0 25.0 0.0 143.6 50.1 37.1 0.0 33.7 40.0 31.7 70.0 25.6 27.7 74.9 89.9 44.4 77.8 94.8 91.4 84.0 64.1 74.0 26.3 61.7 28.3 83.7 69.2 56.1 0.0 113.6 62.1 32.5 53.7 120.3 CCDC25 FLJ10853 ENSG00000147419 "Coiled-coil domain containing 25" Q86WR0 8 27733316-27772653 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023256 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Golgi apparatus" Cytosol "HPA023256: AB_2072067" "unprognostic (1.43e-1)" "unprognostic (5.48e-2)" "unprognostic (3.10e-3)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (6.62e-3)" "unprognostic (2.34e-1)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (8.49e-3)" "unprognostic (3.50e-1)" "unprognostic (2.69e-2)" "prognostic favorable (1.11e-7)" "unprognostic (3.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-1)" 14.0 20.9 10.1 11.8 11.4 4.9 17.4 10.5 17.1 10.1 7.3 14.3 35.5 10.4 14.3 14.2 12.9 11.9 12.2 9.9 11.3 22.5 32.3 8.8 14.0 11.1 10.5 10.8 16.3 18.3 7.5 10.6 11.5 11.6 15.7 11.1 13.5 12.0 28.4 10.3 30.8 10.3 11.3 10.5 20.0 10.9 11.9 11.4 18.8 15.2 14.2 11.7 9.4 13.0 50.1 27.9 25.8 24.7 22.8 33.0 17.2 41.0 39.5 24.7 24.0 11.2 17.9 53.6 27.7 20.9 21.2 23.1 23.6 40.0 35.5 20.3 16.4 66.9 23.1 19.3 36.9 23.8 20.8 37.1 25.9 27.1 37.6 28.7 54.0 33.7 32.2 24.6 27.8 19.2 55.3 19.9 37.9 49.4 14.8 18.7 44.4 28.8 32.3 26.7 15.1 41.7 27.5 21.0 42.8 19.0 24.0 13.1 44.6 22.5 33.4 38.9 21.7 24.5 33.8 19.5 35.0 30.8 23.8 20.3 8.9 6.6 15.2 12.6 17.8 19.8 19.6 16.1 11.6 15.5 18.3 19.3 3.2 14.3 13.4 18.1 23.2 10.4 10.1 11.4 10.5 17.1 9.9 11.3 11.1 10.5 11.5 11.3 11.9 13.0 47.5 25.6 38.9 12.4 34.8 21.4 39.6 46.5 55.2 42.6 57.3 61.6 62.5 60.1 44.5 53.3 12.5 77.6 31.2 61.6 109.5 76.9 183.1 46.8 51.0 54.2 26.5 46.7 30.5 134.6 56.0 49.3 63.2 33.3 63.9 39.3 55.0 144.5 44.7 55.5 21.9 58.6 46.8 33.5 27.2 162.9 47.2 27.4 37.4 12.2 44.4 60.2 35.0 12.1 17.7 83.7 51.1 47.4 40.7 55.2 182.1 128.6 53.7 38.9 46.0 44.4 49.1 91.1 59.6 56.7 22.3 42.4 38.7 88.1 71.2 36.0 CCDC68 SE57-1 ENSG00000166510 "Coiled-coil domain containing 68" Q9H2F9 18 54901509-54959461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.8;placenta: 32.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 95.2;Early spermatids: 95.4;Pancreatic endocrine cells: 87.9;Paneth cells: 68.7;Proximal enterocytes: 61.1" "Cancer enhanced" "Detected in many" "stomach cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 10.8;HHSteC: 13.6;HSkMC: 14.9;RT4: 10.5;TIME: 28.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA040865, HPA048197" Supported Approved "Golgi apparatus,Cytosol" No NA "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Cytosol "HPA040865: AB_2677176, HPA048197: AB_2680310" "unprognostic (1.36e-2)" "prognostic unfavorable (4.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.38e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (2.65e-2)" "unprognostic (6.29e-2)" "unprognostic (2.71e-1)" "unprognostic (1.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.28e-4)" "unprognostic (1.77e-2)" "unprognostic (9.71e-2)" "unprognostic (6.12e-2)" "unprognostic (2.38e-1)" 5.5 3.8 1.6 4.1 1.5 0.4 3.4 1.4 2.7 4.2 2.3 18.9 20.2 3.3 0.8 1.8 2.4 5.1 5.7 1.5 3.6 2.8 9.5 13.0 0.8 2.0 2.3 15.7 2.8 0.8 3.6 32.4 2.0 4.2 18.2 0.6 1.8 1.3 1.5 0.9 24.8 2.7 1.2 7.2 14.3 8.8 3.3 0.6 2.6 4.4 1.3 2.3 1.8 1.3 10.8 3.3 0.0 0.0 3.0 8.3 0.0 0.3 4.2 0.6 0.7 5.9 6.2 0.0 7.6 0.0 0.1 0.1 0.7 6.8 0.5 0.0 1.6 0.8 3.6 1.2 13.6 0.0 0.0 14.9 0.0 3.2 0.1 0.0 4.9 0.0 0.0 0.1 0.4 0.8 0.0 0.2 0.0 7.6 3.6 0.3 0.0 0.3 1.2 10.5 0.1 2.5 3.3 1.0 0.1 1.2 0.0 0.0 28.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.6 1.5 1.4 2.7 1.5 3.6 2.0 2.3 2.0 1.2 3.3 1.3 38.5 19.2 10.3 0.3 1.0 0.3 7.4 4.8 1.2 0.1 2.0 1.9 5.5 10.0 13.3 1.8 0.0 2.3 0.3 95.2 1.9 7.2 95.4 15.0 2.5 40.8 6.0 3.6 5.7 35.6 2.7 9.6 38.2 27.1 8.8 2.6 37.5 7.0 0.4 0.0 0.5 21.8 8.2 3.2 1.3 36.7 3.4 0.6 0.0 12.2 1.0 3.3 1.0 0.0 0.1 87.9 68.7 0.7 0.0 32.4 61.1 5.3 4.2 0.2 6.6 0.9 3.0 1.2 2.2 1.1 0.0 6.0 0.4 3.8 20.2 6.4 CCDC69 "DKFZP434C171, FLJ13705" ENSG00000198624 "Coiled-coil domain containing 69" A6NI79 5 151181052-151224093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 351.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 124.5;dendritic cells: 106.9;Granulosa cells: 138.2;NK-cells: 197.8;Plasma cells: 133.6;Theca cells: 132.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 129.2;Daudi: 199.9;U-266/70: 120.5;U-698: 119.1" "Region enhanced" "Detected in some" "cerebellum: 4.8" "Low region specificity" "Detected in all" "HPA043648, HPA052896" Uncertain Approved "Golgi apparatus,Plasma membrane,Actin filaments" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane" "Golgi apparatus, Actin filaments" "HPA043648: AB_10795877, HPA052896: AB_2681983" "prognostic favorable (3.21e-4)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (5.62e-2)" "unprognostic (8.63e-3)" "unprognostic (3.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.00e-1)" "unprognostic (9.29e-2)" "unprognostic (3.85e-2)" "unprognostic (1.55e-2)" "unprognostic (3.67e-1)" "unprognostic (4.31e-2)" "unprognostic (3.69e-1)" "unprognostic (2.93e-1)" "unprognostic (2.01e-1)" 108.9 89.6 6.7 45.8 8.4 46.3 60.5 12.2 7.9 15.2 13.4 138.5 19.6 32.9 13.3 54.1 37.1 19.3 96.9 5.9 8.9 10.7 24.0 39.0 70.4 13.3 13.8 27.1 47.5 32.1 8.5 14.8 13.6 23.0 20.5 1.8 14.4 29.4 351.9 13.3 44.7 45.6 11.3 55.4 37.0 13.2 9.2 37.8 11.6 163.8 66.8 87.7 21.9 7.2 8.0 1.6 0.4 6.4 129.2 13.1 4.2 1.5 13.1 2.6 2.4 2.1 1.1 199.9 6.3 0.5 3.3 1.0 3.0 2.8 0.9 0.1 2.7 27.0 0.0 17.5 21.1 9.9 34.4 33.0 0.2 1.0 0.0 2.5 13.1 0.0 23.7 44.0 0.1 0.6 43.8 23.3 7.5 0.1 15.2 36.0 1.0 12.1 0.5 5.9 0.2 0.8 2.4 3.2 1.7 3.2 2.0 24.0 32.0 1.0 6.1 0.6 1.5 120.5 60.1 119.1 1.4 22.2 0.0 30.9 12.4 13.5 11.3 10.9 10.3 5.4 8.8 10.8 10.0 10.4 6.1 6.6 9.6 14.3 10.3 19.3 8.5 11.5 6.7 8.4 12.2 7.9 5.9 8.9 13.3 13.8 13.6 11.3 9.2 7.2 51.0 12.8 78.4 0.7 68.8 2.5 3.0 3.5 1.2 0.4 4.8 2.4 124.5 1.5 13.5 1.8 0.0 7.3 106.9 0.2 0.0 2.9 0.5 26.8 2.7 58.9 1.8 32.2 1.8 20.0 9.6 18.4 7.1 1.3 34.8 138.2 28.2 39.7 7.3 6.7 2.7 0.0 4.1 64.0 12.2 2.4 5.6 46.5 10.6 11.2 73.5 4.9 197.8 1.0 0.6 8.8 0.1 7.9 133.6 3.6 4.5 3.2 51.3 1.4 13.1 4.7 14.8 1.2 1.0 0.7 1.3 35.4 65.7 132.1 0.9 23.5 CCDC71L "C7orf74, FLJ36031" ENSG00000253276 "Coiled-coil domain containing 71 like" Q8N9Z2 7 106654360-106661158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067925 Approved Approved "Golgi apparatus,Actin filaments,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Actin filaments" Cytosol "HPA067925: AB_2685925" "unprognostic (1.51e-1)" "prognostic unfavorable (9.08e-4)" "unprognostic (7.26e-2)" "unprognostic (1.10e-2)" "unprognostic (1.78e-2)" "unprognostic (1.95e-3)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (2.38e-3)" "unprognostic (6.03e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.53e-6)" "unprognostic (3.34e-2)" "unprognostic (3.72e-1)" "unprognostic (2.26e-1)" "unprognostic (6.35e-2)" 51.5 9.8 2.7 19.6 2.7 15.8 18.7 2.0 2.9 13.1 3.3 14.6 6.5 16.9 2.8 6.8 36.2 10.8 8.2 2.9 3.2 18.1 46.7 22.1 9.6 8.2 2.8 10.1 9.3 5.2 6.4 3.7 3.7 11.2 5.4 1.0 12.6 6.6 5.3 6.2 15.8 7.2 3.3 18.7 16.3 6.9 4.6 14.5 10.2 2.5 8.0 40.0 9.3 3.6 24.8 5.1 7.4 8.9 16.3 15.4 0.0 37.0 47.5 14.2 15.4 0.7 15.3 16.5 12.6 63.3 27.1 2.8 3.6 10.7 11.7 38.7 8.5 2.1 0.9 0.0 25.5 8.4 19.4 13.2 6.4 6.5 3.7 24.1 50.0 9.2 56.0 39.9 17.1 7.1 11.5 13.3 16.0 2.0 17.0 15.4 2.1 3.3 7.3 1.4 3.2 22.1 23.9 8.6 55.9 15.4 3.9 10.1 22.0 31.4 2.9 3.7 14.6 38.4 3.8 13.5 24.3 10.8 35.3 4.9 0.6 1.8 1.1 0.4 0.8 1.3 0.8 0.8 0.4 0.9 0.4 0.6 4.1 0.6 0.7 1.4 1.7 0.5 2.7 2.7 2.0 2.9 2.9 3.2 8.2 2.8 3.7 3.3 4.6 3.6 44.0 3.2 11.6 1.0 9.4 8.2 50.5 2.1 6.8 4.3 39.9 33.0 6.2 18.6 1.6 5.5 2.1 3.0 26.2 12.9 11.7 7.4 1.2 18.7 78.7 21.4 6.6 11.6 1.8 10.7 7.4 47.8 3.6 20.2 12.0 3.3 45.7 34.4 8.1 6.7 2.8 7.3 4.1 10.0 13.9 2.1 21.8 22.5 12.4 1.9 6.5 5.0 10.3 2.5 1.8 13.9 10.1 17.7 4.3 11.0 10.1 4.7 6.8 4.8 0.0 24.5 30.1 7.1 4.9 4.0 5.1 3.3 13.7 3.4 9.5 18.3 CCDC91 "DKFZp779L1558, FLJ11088, p56" ENSG00000123106 "Coiled-coil domain containing 91" Q7Z6B0 12 28133249-28581511 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 18 "Early spermatids: 2093.1;Late spermatids: 7910.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038169 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA038169: AB_10672506" "unprognostic (6.25e-2)" "unprognostic (4.25e-2)" "unprognostic (3.67e-2)" "unprognostic (1.91e-2)" "unprognostic (6.71e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.98e-2)" "unprognostic (2.44e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.69e-4)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "unprognostic (5.85e-2)" "unprognostic (2.38e-1)" 17.5 18.3 15.0 13.0 15.8 12.3 16.1 23.2 29.3 11.5 3.5 14.4 12.1 17.8 17.3 14.3 12.3 14.6 30.9 16.6 12.3 20.2 14.3 12.0 16.4 20.7 13.8 17.7 27.1 30.8 12.1 8.5 20.7 15.1 12.6 27.1 13.6 14.0 41.6 10.2 13.1 13.0 11.1 13.6 17.1 34.5 14.6 21.7 24.6 21.7 13.7 16.6 10.5 20.7 21.2 14.8 13.4 0.4 13.6 12.6 25.1 17.5 18.5 15.1 19.3 8.4 27.6 11.0 14.7 20.9 9.0 23.7 12.3 28.2 22.6 29.7 10.2 36.2 29.4 7.7 21.3 35.0 17.1 12.5 27.6 15.0 43.7 28.5 12.3 19.2 33.4 36.0 14.6 7.6 34.8 29.7 27.5 16.2 13.5 21.1 38.7 18.3 24.6 14.3 11.3 20.4 32.7 10.9 55.4 36.4 21.3 27.3 9.3 31.8 22.1 31.5 10.3 44.4 52.5 30.1 27.6 28.0 18.4 21.8 2.3 3.6 5.1 4.5 6.7 6.7 6.5 7.4 3.4 5.2 7.6 7.0 0.7 7.1 5.9 4.1 8.4 3.4 15.0 15.8 23.2 29.3 16.6 12.3 20.7 13.8 20.7 11.1 14.6 20.7 23.4 38.5 41.0 129.3 47.2 34.9 37.4 49.5 34.7 61.5 42.1 36.8 80.8 20.0 40.8 22.0 45.9 14.0 48.4 26.0 43.0 46.2 2093.1 36.9 19.0 19.7 38.4 19.1 199.3 47.3 16.3 24.8 21.4 26.2 40.4 21.9 11.7 26.7 30.6 45.4 266.0 23.9 28.5 35.0 39.3 7910.6 57.8 39.0 37.4 135.9 35.7 52.0 53.5 152.8 221.0 33.8 25.0 51.9 34.2 33.6 25.5 35.0 54.5 74.9 39.5 28.6 31.7 72.0 39.0 19.9 40.5 16.0 50.6 28.5 18.3 33.6 CCL15 "HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3" ENSG00000275718 "C-C motif chemokine ligand 15" Q16663 17 35996440-36001553 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 83.0;liver: 31.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2" "Cancer enhanced" "Detected in many" "liver cancer: 11.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Hep G2: 35.4;OE19: 28.7" HPA058608 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 3270000 11000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" Vesicles "HPA058608: AB_2683776" "unprognostic (1.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.31e-2)" "unprognostic (1.40e-1)" "unprognostic (8.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" "unprognostic (2.41e-2)" "unprognostic (1.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-2)" "prognostic favorable (3.02e-4)" 0.2 0.4 0.1 7.8 0.1 0.1 0.4 0.1 0.3 0.3 0.0 59.7 37.6 0.1 0.0 0.2 9.6 9.2 0.0 0.1 0.1 10.0 31.6 2.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 83.0 0.0 0.1 0.1 0.0 0.1 62.0 1.4 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 4.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 28.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.5 0.0 0.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.1 7.2 5.0 0.0 0.0 0.0 0.0 262.6 0.0 0.0 0.0 12.2 0.1 0.7 71.8 0.0 0.0 0.7 0.0 0.0 0.0 0.1 8.9 0.0 2.5 40.2 0.1 0.0 0.0 208.3 2.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 380.6 0.0 0.0 0.0 461.4 61.3 76.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 138.2 0.2 CCL2 "GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF" ENSG00000108691 "C-C motif chemokine ligand 2" P13500 17 34255218-34257203 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 756.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1152.5;Ductal cells: 3382.2;Exocrine glandular cells: 919.2;Prostatic glandular cells: 889.0;Skeletal myocytes: 994.7;Smooth muscle cells: 1507.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 7.5;eosinophil: 3.0" "Group enriched" "Detected in many" 6 "granulocytes: 3.0;monocytes: 7.5" "Group enriched" "Detected in many" 4 "BJ hTERT+: 1902.2;HMC-1: 2427.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "midbrain: 9.9;spinal cord: 39.4" "CAB013676, HPA019163" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 323000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" Vesicles "CAB013676: , HPA019163: AB_1846179" "unprognostic (6.43e-2)" "unprognostic (4.14e-2)" "unprognostic (4.78e-2)" "unprognostic (5.57e-2)" "unprognostic (2.37e-3)" "unprognostic (8.64e-2)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.19e-1)" "unprognostic (9.33e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (4.51e-4)" "unprognostic (1.33e-1)" "unprognostic (2.50e-2)" "unprognostic (1.81e-1)" "unprognostic (4.92e-2)" 390.9 129.8 15.6 167.2 15.1 96.5 76.8 14.7 26.8 20.4 24.4 169.5 41.2 30.2 15.0 47.1 85.6 256.5 305.8 16.0 21.1 229.5 161.1 405.1 78.4 32.7 16.5 19.3 141.6 34.6 70.5 39.1 21.9 153.1 103.5 11.5 47.0 45.4 19.6 40.3 80.3 150.7 21.4 73.2 121.2 12.1 43.3 142.7 84.4 47.0 16.6 756.1 36.3 25.3 0.1 15.3 40.4 0.0 110.7 94.5 0.3 116.6 1902.2 243.3 516.8 7.1 0.2 0.3 90.4 27.6 3.8 64.0 4.3 0.1 122.9 0.6 0.9 0.2 13.5 0.0 3.5 0.4 2427.9 105.9 0.0 50.6 2.9 162.6 112.4 0.0 6.5 20.2 0.0 0.0 0.7 19.6 5.8 0.0 0.4 0.6 3.3 20.9 354.7 0.0 0.1 8.1 0.3 6.0 3.3 108.4 4.6 2.5 6.4 129.0 5.7 3.6 0.7 1.2 0.5 0.1 75.7 37.6 84.3 0.0 7.5 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 1.6 15.6 15.1 14.7 26.8 16.0 21.1 32.7 16.5 21.9 21.4 43.3 25.3 218.3 182.7 126.5 2.0 3.6 568.6 866.2 595.3 1152.5 0.1 23.5 50.9 29.5 92.9 120.7 138.0 0.0 2.7 2.2 0.0 0.0 3382.2 0.0 8.4 37.8 577.2 0.0 0.0 0.7 919.2 3.6 840.5 5.6 11.4 353.0 0.1 50.3 0.4 439.1 0.0 0.1 0.0 6.1 8.9 408.5 0.4 12.2 593.1 213.5 8.4 37.8 13.8 0.0 0.0 0.1 781.2 0.0 1.5 2.9 889.0 0.0 67.7 27.7 0.7 131.5 994.7 1507.0 0.4 0.3 13.0 222.8 4.5 44.3 1.7 0.1 40.6 CCN2 "CTGF, IGFBP8" ENSG00000118523 "Cellular communication network factor 2" P29279 6 131948176-131951372 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Cell adhesion, DNA synthesis" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 101.2;Cardiomyocytes: 38.7;Extravillous trophoblasts: 47.1;Fibroblasts: 261.8;Smooth muscle cells: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "naive B-cell: 8.1" "Lineage enriched" "Detected in single" 81 "B-cells: 8.1" "Cell line enhanced" "Detected in many" "EFO-21: 1605.0;HUVEC TERT2: 1377.0;TIME: 2874.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005123, HPA031074, HPA031075" Approved Approved "Golgi apparatus,Vesicles" "Secreted in other tissues" No No 1010000 5900000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Vesicles" "CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248" "unprognostic (2.87e-1)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (5.68e-2)" "unprognostic (9.79e-2)" "unprognostic (1.82e-2)" "unprognostic (3.38e-1)" "unprognostic (4.96e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.27e-3)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.62e-1)" "unprognostic (1.77e-2)" "unprognostic (3.84e-3)" 265.9 107.5 18.9 168.0 18.8 2.0 206.4 16.3 34.0 531.0 31.5 148.8 43.7 418.5 34.4 271.9 243.8 441.4 371.8 25.8 14.2 235.7 82.9 226.3 73.6 18.8 32.1 77.0 194.0 43.0 44.8 198.2 20.2 364.6 136.1 2.4 138.2 154.3 51.8 155.1 151.2 576.3 14.2 569.1 182.6 24.7 20.8 49.5 464.7 61.9 14.9 324.0 102.5 18.2 4.6 7.5 126.8 3.7 279.9 158.5 1.8 373.1 178.2 226.8 119.4 0.2 12.2 0.6 1605.0 482.7 185.0 6.2 4.2 26.4 211.3 2.5 3.5 0.2 55.7 137.3 109.6 0.3 0.5 232.2 5.9 163.9 40.2 340.7 1377.0 0.0 0.4 0.3 650.8 2.5 0.5 1.2 61.8 41.3 21.7 32.6 6.0 0.7 81.9 0.4 0.5 0.8 38.3 62.2 18.3 308.5 6.1 3.1 2874.4 311.6 242.4 397.8 694.0 11.5 1.7 4.1 42.5 0.7 399.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.9 18.8 16.3 34.0 25.8 14.2 18.8 32.1 20.2 14.2 20.8 18.2 101.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 17.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 47.1 261.8 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.4 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 CCNB2 HsT17299 ENSG00000157456 "Cyclin B2" O95067 15 59105126-59125045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "T-reg: 22.7" "Lineage enriched" "Detected in many" 6 "T-cells: 22.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA008873, CAB009575" Enhanced Enhanced "Golgi apparatus,Cytosol" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Golgi apparatus" "CAB009575: AB_2072392, HPA008873: AB_1078604" "unprognostic (2.69e-2)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.96e-2)" "unprognostic (1.77e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.83e-4)" "prognostic unfavorable (4.63e-4)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (4.48e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (3.98e-2)" "unprognostic (4.44e-1)" 1.0 1.1 0.4 12.2 1.1 74.6 2.9 0.7 0.7 2.9 1.1 14.3 14.1 2.6 0.3 16.1 1.1 1.9 0.7 0.6 0.7 1.1 1.4 2.2 33.0 1.3 1.0 0.8 0.7 0.2 0.3 11.4 1.0 1.6 16.8 0.3 2.8 0.4 0.7 9.4 12.0 6.4 0.7 7.1 5.6 69.4 1.1 73.1 1.0 0.4 43.7 3.6 5.6 2.2 132.5 112.1 188.6 47.1 8.5 16.6 97.5 104.8 69.9 165.2 135.6 187.8 81.1 122.1 75.4 71.8 97.2 160.1 181.4 92.6 157.8 124.1 92.4 153.1 127.3 108.1 2.5 118.1 98.6 6.3 12.6 71.4 91.9 32.7 114.1 147.0 163.1 194.5 128.2 96.5 137.9 177.2 138.6 58.5 65.2 157.5 260.0 124.4 53.3 91.9 115.2 75.9 148.9 80.2 97.3 147.9 139.4 120.4 58.5 81.6 134.4 90.5 210.5 84.2 133.2 213.8 53.6 267.1 117.9 0.0 0.1 0.7 0.1 0.0 0.3 2.1 4.6 5.0 3.0 1.7 0.0 0.1 0.8 3.6 0.1 0.1 22.7 2.1 0.4 1.1 0.7 0.7 0.6 0.7 1.3 1.0 1.0 0.7 1.1 2.2 0.3 0.0 0.6 0.0 6.8 4.8 2.8 11.5 1.8 0.2 2.5 3.3 0.5 0.0 3.2 0.0 0.0 67.9 1.6 4.1 0.0 0.7 228.5 5.3 3.1 3.9 3.0 123.6 0.7 0.2 128.3 7.2 7.1 5.9 0.0 29.9 6.1 1.1 29.9 0.0 0.8 10.1 20.3 10.6 3.3 53.5 4.4 7.9 0.0 0.0 2.4 0.2 1.0 0.0 1.4 0.4 1.9 1.9 18.7 2.3 2.1 0.0 1.8 0.3 0.0 1.0 5.7 288.7 32.1 20.3 6.1 16.3 4.4 4.1 23.4 5.0 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047155-77076309 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533" "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 176.7 98.4 182.1 109.8 191.0 222.9 183.6 253.4 218.2 234.8 131.4 182.7 100.0 211.0 249.1 177.9 196.5 150.7 195.7 148.1 171.8 183.8 133.7 144.8 185.2 184.0 185.9 341.6 155.2 145.2 71.1 138.0 188.6 198.9 129.8 213.2 183.0 208.9 225.8 136.4 120.8 195.6 167.5 149.1 149.0 131.7 186.1 229.2 273.5 177.8 238.8 186.6 170.5 220.7 163.3 96.0 305.0 268.6 447.6 406.7 117.0 122.5 298.4 189.9 181.5 119.3 240.6 300.1 183.2 309.4 118.9 83.4 211.7 428.9 300.2 214.0 83.7 180.3 102.1 114.0 438.1 312.0 346.4 320.4 502.6 175.1 426.2 542.6 270.1 154.3 157.2 315.9 273.4 187.7 406.3 292.5 135.2 113.9 59.0 250.7 290.0 126.5 283.5 182.7 387.3 211.8 162.9 247.2 209.2 212.6 141.2 131.6 184.6 231.0 137.0 249.0 170.4 173.7 86.1 310.9 195.4 210.6 153.3 160.7 113.2 236.7 95.6 108.0 131.2 148.2 157.0 142.0 119.5 153.7 165.2 143.8 145.8 109.3 134.0 135.3 149.7 100.0 182.1 191.0 253.4 218.2 148.1 171.8 184.0 185.9 188.6 167.5 186.1 220.7 368.4 173.1 231.3 59.7 606.6 422.9 633.0 489.3 578.8 629.5 550.2 523.5 460.5 323.1 238.7 196.8 68.8 273.7 441.5 258.8 794.3 400.9 71.0 250.5 321.3 405.5 412.3 510.9 125.8 334.3 427.4 510.9 220.2 231.2 278.4 300.9 382.7 121.5 337.0 181.7 150.3 346.6 329.6 685.1 676.5 147.5 604.0 490.4 402.0 77.8 613.0 403.2 390.3 52.3 69.1 515.1 317.6 989.2 500.8 854.8 468.4 596.6 161.4 228.7 552.2 373.3 510.8 200.4 745.5 466.1 394.8 379.5 497.3 326.5 345.9 747.1 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747426-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;intestine: 3.6" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 3.5;Muller glia cells: 4.9;Plasma cells: 4.8;Undifferentiated cells: 4.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "MOLT-4: 25.7" "Low region specificity" "Detected in all" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Cluster 13: T-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: AB_2683086" "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favorable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.2 0.3 1.2 0.9 1.9 0.1 0.2 1.3 1.5 0.5 0.0 2.6 3.6 0.1 0.3 0.1 0.3 0.4 0.3 0.9 0.8 3.1 0.0 0.5 0.8 2.2 1.3 0.2 1.2 0.0 0.6 0.1 1.6 0.9 2.7 1.1 2.6 1.3 0.3 0.3 2.1 0.1 0.9 0.4 2.4 0.7 1.5 1.5 0.4 0.0 0.9 0.9 0.2 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.4 0.0 0.6 25.7 0.1 0.4 1.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.3 1.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 4.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.8 0.1 1.2 1.9 1.3 1.5 0.9 0.8 2.2 1.3 1.6 0.9 1.5 4.3 0.2 0.0 0.5 0.0 0.9 0.1 0.4 0.8 0.0 0.1 0.4 0.1 0.6 0.0 0.4 0.0 0.0 0.4 0.1 3.4 3.9 0.4 2.2 0.4 0.0 0.1 1.2 0.0 0.6 1.5 0.2 0.3 7.1 0.5 1.3 0.0 0.0 0.0 0.1 1.7 0.5 3.5 0.0 0.0 0.0 2.1 0.3 0.4 0.0 0.0 0.0 4.9 0.0 1.0 2.4 1.5 2.3 0.0 4.8 0.6 1.8 0.3 1.0 0.2 0.0 0.1 0.2 0.2 0.7 0.0 0.1 0.0 1.9 0.1 4.2 0.6 CCNJ "bA690P14.1, FLJ10895" ENSG00000107443 "Cyclin J" Q5T5M9 10 96043394-96060870 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 42.1;AN3-CA: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036531, HPA058151" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Nucleoplasm, Golgi apparatus" "HPA036531: AB_10696656, HPA058151: AB_2683623" "unprognostic (1.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (8.61e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (6.65e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-3)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" 3.6 4.5 1.9 4.2 2.4 11.5 3.9 2.9 2.1 3.3 1.7 3.3 4.4 4.3 3.1 2.7 2.8 3.8 2.2 1.7 2.5 2.6 2.5 3.1 4.9 2.5 2.2 2.8 4.3 5.0 2.1 3.5 2.4 3.3 3.6 4.0 2.7 3.1 3.8 2.9 3.6 3.4 2.1 5.0 2.8 4.2 2.4 4.0 3.2 4.0 3.9 4.4 1.8 2.6 9.0 6.6 42.1 42.2 4.2 3.1 6.1 5.6 5.9 7.7 6.9 17.2 3.7 12.3 6.4 5.4 6.5 5.2 27.4 5.9 10.0 6.1 11.8 12.0 5.2 26.0 9.7 12.0 5.4 5.7 8.2 7.5 17.3 7.6 18.8 11.0 17.6 0.2 4.9 8.6 20.9 14.8 23.6 0.8 6.0 24.3 2.0 0.9 9.4 8.1 6.4 22.2 6.2 1.8 12.6 14.1 10.1 13.7 9.1 4.8 11.1 5.6 13.1 2.5 1.0 11.5 5.8 20.5 3.3 0.1 1.7 0.5 0.9 1.4 1.2 0.7 0.8 0.4 2.9 0.7 1.1 1.1 0.1 0.4 1.3 0.6 0.7 0.9 1.9 2.4 2.9 2.1 1.7 2.5 2.5 2.2 2.4 2.1 2.4 2.6 2.6 6.4 3.1 2.3 3.3 1.9 3.1 1.3 2.8 5.1 3.1 2.0 4.0 1.5 2.4 5.5 14.6 1.5 2.1 3.4 3.9 2.9 3.7 2.6 4.8 4.8 4.2 4.2 4.2 2.7 3.0 3.2 2.0 2.5 0.0 4.6 10.4 1.4 3.6 1.7 5.8 3.5 2.0 6.5 4.6 7.6 1.8 5.0 1.8 1.9 2.8 3.1 1.0 5.5 3.7 4.0 1.5 1.9 1.9 4.0 1.4 2.1 4.3 3.2 0.0 4.1 4.0 10.1 6.9 2.3 1.4 1.1 2.2 3.1 3.2 2.9 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 279.2;neutrophil: 296.6" "Group enriched" "Detected in all" 7 "granulocytes: 296.6;monocytes: 84.2" "Cell line enhanced" "Detected in many" "HHSteC: 223.9;Karpas-707: 337.4;U-266/84: 259.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: AB_2668242, HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavorable (5.07e-4)" "prognostic unfavorable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 38.9 37.8 24.0 23.7 27.7 63.8 34.1 23.1 28.4 61.1 36.8 33.3 24.3 26.7 36.1 20.1 22.0 53.8 56.2 24.7 26.9 51.5 66.9 39.3 22.2 18.4 17.3 22.9 84.8 73.3 32.3 27.4 17.7 41.0 33.2 48.2 77.1 42.3 53.0 13.5 25.6 33.5 17.2 28.7 47.5 29.6 27.3 12.2 84.4 35.3 24.2 29.9 9.7 22.9 13.9 47.7 10.9 24.4 173.6 59.3 15.5 30.0 56.4 17.2 26.1 14.4 23.5 20.8 99.5 97.5 33.6 18.7 9.5 25.1 14.4 55.5 14.2 28.1 58.4 12.8 223.9 39.6 84.2 49.5 59.8 35.6 34.4 143.3 65.2 0.8 47.7 337.4 55.1 17.9 0.2 19.3 6.5 54.4 11.8 6.2 17.4 84.8 36.1 10.1 14.0 21.5 35.3 19.5 151.4 35.0 31.0 85.1 65.7 50.8 11.1 38.9 20.4 65.2 259.6 13.0 95.6 77.2 41.0 220.8 59.4 279.2 26.8 50.7 22.5 18.1 16.6 20.7 27.6 13.4 13.9 20.0 296.6 25.7 84.2 4.7 23.0 32.9 24.0 27.7 23.1 28.4 24.7 26.9 18.4 17.3 17.7 17.2 27.3 22.9 92.3 115.4 118.1 0.0 44.6 15.4 30.3 99.2 13.6 68.7 40.2 40.1 14.4 50.1 136.5 88.3 93.8 29.3 42.9 43.7 5.9 60.9 136.2 49.6 41.0 60.1 16.7 25.2 0.0 145.3 23.2 78.6 33.1 62.3 39.1 30.0 76.1 96.1 51.0 85.8 0.0 28.8 114.0 55.9 25.2 216.1 56.5 71.7 48.0 0.0 89.8 72.6 38.1 0.0 0.0 67.6 45.1 116.6 180.8 42.6 29.5 36.7 123.8 128.0 52.6 80.2 48.1 43.3 41.1 11.8 16.6 24.6 41.8 70.0 16.2 21.8 CD1B CD1 ENSG00000158485 "CD1b molecule" P29016 1 158327951-158331531 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 157 "lymphoid tissue: 528.9" "Cell type enriched" "Detected in some" 21 "Langerhans cells: 153.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "myeloid DC: 19.2" "Lineage enriched" "Detected in many" 6 "dendritic cells: 19.2" "Cell line enriched" "Detected in some" 5 "MOLT-4: 587.9" HPA021824 Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus, Vesicles" Cytosol "HPA021824: AB_1846262" "unprognostic (7.72e-3)" "unprognostic (1.55e-4)" "unprognostic (1.66e-5)" "unprognostic (1.04e-2)" "unprognostic (1.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.89e-4)" "unprognostic (2.27e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (9.53e-2)" "unprognostic (3.23e-1)" "unprognostic (3.52e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (3.53e-2)" 0.1 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.6 0.0 0.7 0.1 0.0 0.0 0.1 0.2 1.0 2.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 3.3 0.2 0.1 0.0 1.0 0.7 0.0 0.0 528.9 0.3 0.1 1.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 118.6 0.0 0.0 0.0 0.0 587.9 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.9 153.1 0.2 0.0 7.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 CD1C CD1 ENSG00000158481 "CD1c molecule" P29017 1 158289923-158294774 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 130.4" "Cell type enriched" "Detected in some" 6 "Langerhans cells: 551.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "memory B-cell: 84.1;myeloid DC: 324.9" "Group enriched" "Detected in many" 8 "B-cells: 84.1;dendritic cells: 324.9" "Group enriched" "Detected in some" 10 "JURKAT: 14.8;MOLT-4: 49.4" HPA068359 Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA 200000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus, Vesicles" "Endoplasmic reticulum" "HPA068359: " "unprognostic (2.55e-3)" "prognostic favorable (1.79e-5)" "unprognostic (1.75e-5)" "unprognostic (3.09e-5)" "unprognostic (3.12e-2)" "unprognostic (8.13e-3)" "unprognostic (2.01e-1)" "unprognostic (3.80e-3)" "unprognostic (7.11e-3)" "unprognostic (1.87e-1)" "unprognostic (7.41e-2)" "unprognostic (1.93e-1)" "unprognostic (1.04e-1)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (8.05e-2)" "unprognostic (1.99e-1)" 2.7 0.8 0.0 17.3 0.0 1.1 5.0 0.0 0.2 2.3 0.0 3.4 2.0 2.4 0.6 4.5 1.8 7.7 2.0 0.0 0.0 1.2 4.1 6.5 26.2 0.0 0.0 0.9 0.7 0.6 0.2 0.1 0.0 1.8 9.4 0.0 2.8 1.3 1.0 12.2 12.0 3.1 0.0 23.0 3.7 0.9 0.0 130.4 0.7 1.1 38.2 4.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 49.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.9 0.0 0.6 26.8 0.1 0.1 24.7 0.3 84.1 0.1 0.0 324.9 49.1 0.2 0.0 1.1 4.1 3.7 1.5 0.5 15.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.2 0.0 26.6 13.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 4.1 0.0 0.1 1.5 0.0 0.8 0.0 0.0 0.1 1.4 0.0 0.0 3.8 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 7.1 551.4 4.5 0.0 91.2 19.6 0.0 11.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.5 0.0 0.0 0.2 0.4 0.1 0.3 0.0 7.4 0.0 1.9 0.0 0.0 0.0 CD1E ENSG00000158488 "CD1e molecule" P15812 1 158353696-158357553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 69 "lymphoid tissue: 962.6" "Cell type enriched" "Detected in some" 13 "Langerhans cells: 549.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 14 "myeloid DC: 62.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 62.5" "Cell line enriched" "Detected in some" 43 "MOLT-4: 1276.2" "Not detected" "Not detected" "HPA057769, HPA070634" Uncertain Supported "Nucleoli,Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" Nucleoli "HPA057769: AB_2683522, HPA070634: " "unprognostic (7.94e-3)" "unprognostic (1.85e-5)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "unprognostic (1.54e-3)" "unprognostic (1.24e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (8.55e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (8.50e-2)" "unprognostic (2.45e-1)" 0.7 0.5 0.0 4.4 0.0 0.0 1.8 0.0 0.0 2.1 0.0 2.1 2.2 1.1 0.4 7.9 0.9 4.8 1.0 0.0 0.0 0.8 1.5 3.1 6.4 0.0 0.0 0.6 0.3 0.5 0.1 0.0 0.0 1.1 5.6 0.0 1.5 0.6 0.4 13.9 2.8 0.9 0.0 5.1 4.7 0.5 0.0 962.6 0.8 0.2 9.9 2.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.1 0.0 0.0 0.5 1276.2 0.0 0.3 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 2.5 0.2 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.5 0.0 0.8 8.4 0.0 0.0 0.6 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.8 549.5 0.0 0.0 41.7 8.8 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 7.1 0.1 0.7 0.0 0.0 0.0 CD2 SRBC ENSG00000116824 "CD2 molecule" P06729 1 116754430-116769229 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 249.8" "Group enriched" "Detected in many" 6 "dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 6 "gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2" "Group enriched" "Detected in all" 10 "NK-cells: 1108.0;T-cells: 714.1" "Group enriched" "Detected in some" 25 "HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002430, HPA003883" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "CAB002430: AB_442057, HPA003883: AB_1846263" "prognostic favorable (4.36e-4)" "prognostic favorable (1.47e-4)" "unprognostic (3.34e-3)" "prognostic favorable (1.69e-5)" "unprognostic (1.52e-1)" "prognostic favorable (7.46e-5)" "unprognostic (9.32e-3)" "unprognostic (1.61e-2)" "prognostic favorable (3.97e-5)" "prognostic favorable (7.72e-4)" "unprognostic (4.18e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (4.82e-6)" "unprognostic (6.16e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-2)" "unprognostic (7.63e-3)" 4.6 4.6 0.6 51.3 0.7 11.4 7.6 0.6 1.0 5.8 0.8 13.9 17.2 3.7 2.8 8.4 4.2 16.8 2.6 0.5 0.8 2.5 7.8 21.0 119.6 1.7 0.7 2.8 2.9 0.9 0.7 1.0 1.1 5.2 16.0 0.0 8.6 2.3 1.4 3.5 28.4 4.4 1.0 44.1 24.1 1.8 1.0 249.8 3.8 1.7 79.1 20.8 3.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 224.1 0.0 0.4 0.0 0.0 0.0 0.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 145.8 0.1 0.5 0.0 0.0 166.9 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.8 0.4 0.0 11.3 5.2 1.6 421.8 3.7 403.1 3.8 610.2 714.1 95.4 2.5 316.3 486.2 14.1 1108.0 2.8 21.0 655.2 565.1 0.6 0.7 0.6 1.0 0.5 0.8 1.7 0.7 1.1 1.0 1.0 1.1 5.0 3.2 17.5 0.0 12.3 5.0 0.4 0.0 2.2 0.0 4.0 4.7 2.1 0.0 2.5 3.7 0.0 0.1 158.3 0.2 0.0 0.5 23.5 1.1 1.0 2.9 3.0 24.0 0.0 0.0 0.0 2.5 10.7 0.9 5.1 0.0 8.2 1.5 0.6 0.0 0.0 0.0 0.0 10.9 16.6 7.8 0.6 19.1 1.8 1.0 15.5 0.0 178.2 0.0 0.0 0.0 0.0 0.4 42.3 0.1 0.0 1.7 0.0 0.0 0.0 2.9 4.1 0.3 0.2 0.4 3.7 0.0 476.8 0.0 0.5 0.2 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541073-74546115 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.7;lung: 8.4;lymphoid tissue: 7.3" "Group enriched" "Detected in some" 5 "granulocytes: 15.2;Hofbauer cells: 32.1;Kupffer cells: 26.3;Langerhans cells: 15.3;Macrophages: 36.1;monocytes: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 228.3;non-classical monocyte: 242.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 7.1;HMC-1: 33.1;THP-1: 6.5;U-937: 16.2" "Low region specificity" "Detected in some" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 4.0 1.3 0.7 6.8 1.1 9.7 0.8 0.8 5.5 0.6 1.1 1.3 1.1 0.6 0.1 0.6 0.7 2.0 0.9 0.7 1.4 0.7 1.5 8.4 2.1 1.7 1.8 0.3 0.6 0.4 0.4 2.9 2.1 0.5 1.3 0.0 0.7 0.5 0.3 0.4 1.2 3.1 1.4 7.3 0.7 0.3 2.7 1.0 1.0 0.2 1.1 3.8 0.4 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 3.3 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.9 16.2 0.0 51.8 142.1 7.0 0.7 228.3 0.4 2.7 0.3 0.3 158.8 2.4 0.2 0.2 5.2 43.9 242.7 10.5 0.2 64.6 0.7 1.1 0.8 5.5 0.7 1.4 1.7 1.8 2.1 1.4 2.7 2.2 0.1 0.0 1.3 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.3 0.1 0.0 0.0 15.2 0.0 0.0 0.2 32.1 0.0 0.0 0.0 0.0 26.3 15.3 0.1 0.0 36.1 1.8 1.0 19.6 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 1.3 0.0 0.0 0.0 CD36 "FAT, GP3B, GP4, GPIV, SCARB3" ENSG00000135218 "CD36 molecule" P16671 7 80369575-80679277 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Transport" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 1533.6" "Cell type enhanced" "Detected in many" "Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1" "Group enriched" "Detected in all" 46 "dendritic cells: 507.1;monocytes: 962.6" "Group enriched" "Detected in some" 4 "ASC diff: 322.6;HEL: 158.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "spinal cord: 16.9" "HPA002018, CAB025866, HPA071026" Enhanced Enhanced "Golgi apparatus" NA NA 5300000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170" "unprognostic (7.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.06e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (9.35e-2)" "unprognostic (2.64e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (7.05e-3)" "unprognostic (4.87e-2)" "unprognostic (2.73e-3)" 1533.6 24.6 3.4 51.7 2.5 148.2 540.4 1.6 2.0 11.6 2.7 40.5 113.6 8.7 38.2 19.6 40.5 84.0 540.9 2.6 6.9 7.0 80.8 131.2 18.8 22.0 21.2 4.0 31.2 25.0 2.0 413.3 15.7 5.0 40.9 0.3 31.9 8.6 248.5 28.6 119.7 39.4 14.0 309.9 31.2 7.7 24.0 22.1 69.1 381.6 7.2 22.2 13.4 3.9 0.0 0.0 1.0 0.2 322.6 3.3 0.7 0.9 10.7 0.1 0.1 0.0 0.0 0.1 0.6 1.4 0.3 0.1 4.3 0.5 0.1 0.6 0.4 158.1 0.5 25.7 0.2 0.1 0.1 31.0 12.6 0.1 0.2 7.7 0.9 0.0 5.8 0.0 1.8 0.2 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 0.1 0.9 1.3 0.8 0.6 0.3 2.7 11.1 19.3 0.4 0.5 0.5 0.6 0.3 0.2 0.8 0.4 0.1 54.3 41.8 12.3 962.6 3.7 1.9 270.6 2.1 3.6 0.6 0.6 507.1 0.5 0.8 0.4 15.8 5.9 72.0 128.3 1.5 692.4 3.4 2.5 1.6 2.0 2.6 6.9 22.0 21.2 15.7 14.0 24.0 3.9 3219.2 6.4 63.1 0.0 7.9 7.4 0.2 3.0 0.6 0.2 189.9 24.8 623.1 4.3 9.8 7.3 0.0 10.1 55.0 0.0 0.0 0.2 11.7 5.0 5.9 303.3 0.0 419.5 6.3 0.0 11.1 69.6 1.1 38.4 15.2 0.6 406.2 9.0 1369.8 0.0 2.2 0.6 8.2 153.7 67.3 3.9 0.6 159.6 16.0 17.8 255.2 0.0 7.2 0.5 1.3 0.1 0.0 0.0 4.2 0.8 9.9 0.4 1.2 0.3 696.8 33.1 452.1 4.6 0.7 0.8 4.7 18.3 5.9 1.9 0.2 0.3 CD37 TSPAN26 ENSG00000104894 "CD37 molecule" P11049 19 49335171-49343335 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7" "Cell type enhanced" "Detected in many" "B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002492, HPA032120, HPA032121" Enhanced Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "Plasma membrane" "CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163" "unprognostic (4.30e-3)" "unprognostic (2.39e-3)" "unprognostic (8.85e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.46e-2)" "unprognostic (4.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.23e-2)" "unprognostic (5.34e-2)" "unprognostic (2.23e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-1)" "unprognostic (2.45e-3)" "unprognostic (7.12e-2)" "unprognostic (3.35e-2)" "unprognostic (7.22e-2)" "unprognostic (7.71e-2)" 16.6 7.0 7.5 100.2 7.4 155.2 6.5 9.4 13.7 4.2 5.9 13.9 8.2 3.7 0.7 7.3 5.8 13.9 5.2 6.3 11.4 7.6 6.4 46.9 215.0 17.0 12.0 1.7 3.2 1.8 3.4 15.1 16.5 6.9 3.8 0.3 11.5 2.8 1.9 4.1 116.3 3.9 16.7 235.7 14.8 7.4 15.6 57.5 8.3 2.4 88.0 19.1 5.2 28.7 0.2 0.6 1.5 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 306.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 49.5 0.2 53.1 0.0 0.5 0.0 9.4 290.0 0.0 0.0 0.0 0.0 0.2 0.0 18.5 2.6 16.3 0.0 0.0 0.4 5.8 0.2 0.0 0.0 2.9 0.3 110.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 109.0 0.8 0.3 1.0 0.2 0.0 0.3 0.1 69.4 0.2 81.4 0.1 550.2 658.2 829.6 353.2 601.6 357.4 1511.6 426.3 376.2 449.7 1722.2 435.3 368.6 903.8 321.8 747.8 586.3 467.1 816.2 7.5 7.4 9.4 13.7 6.3 11.4 17.0 12.0 16.5 16.7 15.6 28.7 7.1 9.6 14.3 0.3 1643.9 11.7 1.3 0.1 4.6 12.1 4.6 12.1 1.6 2.8 2.5 1.8 6.2 1.9 489.6 2.2 0.0 0.5 94.2 1.2 1.9 9.7 1.2 67.7 0.1 0.0 2.3 6.9 11.7 1.5 264.6 0.3 11.4 4.1 345.3 0.0 0.2 1.7 0.0 272.0 358.4 221.3 2.8 319.7 28.4 21.5 365.0 1.1 394.4 0.0 0.1 0.0 8.0 0.7 119.8 1.1 0.6 2.9 0.9 6.3 0.0 3.2 5.7 1.1 1.3 2.6 11.8 2.9 390.3 0.9 1.9 1.1 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304730-118316175 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 640.4" "Group enriched" "Detected in many" 7 "dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 26 "gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3" "Group enriched" "Detected in all" 21 "NK-cells: 202.2;T-cells: 501.3" "Group enriched" "Detected in some" 67 "JURKAT: 544.9;MOLT-4: 764.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced Supported "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "Endoplasmic reticulum, Plasma membrane" "Golgi apparatus" "CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favorable (1.72e-4)" "prognostic favorable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favorable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favorable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 6.4 5.6 0.9 85.8 1.1 36.7 6.7 0.9 1.2 7.1 1.3 15.3 22.0 5.8 4.6 9.5 5.4 20.1 3.8 0.7 1.0 3.5 9.7 23.0 209.6 1.8 0.9 3.8 2.2 0.7 1.0 1.6 1.4 6.6 19.3 0.0 11.6 3.0 1.9 5.4 36.4 5.1 1.2 78.9 24.4 1.7 1.3 640.4 5.3 1.6 147.0 24.8 4.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 544.9 0.9 2.0 0.0 0.0 764.9 0.6 0.3 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 1.6 8.0 9.8 0.0 0.6 0.0 16.4 1.8 2.4 490.6 1.3 420.8 1.6 414.4 463.5 1.5 2.1 491.7 501.3 12.2 202.2 2.0 8.6 426.3 333.0 0.9 1.1 0.9 1.2 0.7 1.0 1.8 0.9 1.4 1.2 1.3 1.6 4.9 0.0 8.6 0.0 12.9 5.2 0.3 0.0 0.0 0.0 3.8 4.8 0.3 0.0 0.6 1.8 0.0 0.2 213.6 0.4 0.0 0.2 7.0 0.5 0.9 2.5 0.0 6.9 0.1 0.0 0.0 5.3 24.5 0.9 7.6 0.0 8.9 2.4 0.3 0.0 0.1 0.0 0.0 7.6 8.3 0.2 0.0 12.6 12.4 1.0 8.4 0.0 154.5 0.0 0.1 0.0 1.1 0.0 41.4 0.1 0.2 2.1 0.0 0.0 0.0 1.3 2.7 0.0 0.0 1.6 5.4 0.3 601.4 0.0 0.6 0.3 CD40LG "CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP" ENSG00000102245 "CD40 ligand" P29965 X 136648158-136660390 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 15.5" "Cell type enriched" "Detected in some" 8 "T-cells: 76.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 26.3;MAIT T-cell: 64.1;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.1" "Lineage enriched" "Detected in many" 39 "T-cells: 80.5" "Cell line enriched" "Detected in some" 15 "MOLT-4: 23.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045827, HPA072480" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 776000 20000 "Cluster 32: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus, Plasma membrane" "HPA045827: AB_10959606, HPA072480: " "unprognostic (1.94e-5)" "unprognostic (1.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.27e-3)" "unprognostic (4.71e-2)" "unprognostic (3.56e-5)" "unprognostic (3.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.77e-1)" "unprognostic (2.14e-4)" "unprognostic (1.87e-1)" "unprognostic (1.55e-1)" "unprognostic (6.70e-4)" "unprognostic (2.15e-1)" "unprognostic (5.19e-2)" "unprognostic (2.36e-3)" "unprognostic (2.92e-2)" 0.8 0.3 0.1 7.9 0.0 1.9 1.1 0.2 0.2 0.9 0.2 1.9 1.8 0.3 0.2 1.0 0.4 2.0 0.2 0.1 0.2 0.4 1.0 2.4 15.5 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.2 0.8 3.1 0.0 0.6 0.3 0.1 0.6 3.8 0.6 0.0 4.9 2.0 0.3 0.1 15.5 0.5 0.2 14.8 2.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.3 26.3 0.1 64.1 0.1 80.5 11.7 0.2 0.0 76.1 0.7 1.3 0.8 0.1 0.1 10.5 13.6 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.2 0.6 0.0 2.4 0.0 2.4 1.3 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.0 0.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.6 2.6 0.0 1.3 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.6 4.0 8.9 0.0 2.9 1.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.1 2.0 0.0 76.6 0.0 0.0 0.1 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138882-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 504.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 1650.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000112, CAB000316, HPA005785" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 1200000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavorable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 143.7 42.4 29.2 218.0 33.9 308.1 164.7 63.0 25.1 146.0 16.8 91.1 53.0 200.4 20.1 227.8 69.0 129.7 30.4 33.0 116.5 31.3 31.0 214.1 108.8 114.9 102.3 11.7 263.2 6.0 8.1 74.1 118.3 87.3 111.5 38.0 504.2 57.0 17.1 433.3 60.8 175.8 114.3 83.8 61.5 6.6 62.8 64.2 76.2 27.7 188.7 235.2 193.4 114.9 493.0 448.6 4.3 1.2 252.6 691.5 1.6 962.2 740.3 521.3 288.2 30.4 150.4 0.7 126.5 1350.2 1065.4 820.1 9.9 1013.9 716.4 110.3 6.2 18.9 198.3 0.3 262.3 254.6 1124.3 315.4 778.3 693.2 552.7 1650.0 184.3 0.1 4.0 157.9 518.9 3.0 25.6 166.9 9.8 8.7 136.4 1.4 89.3 7.5 777.4 138.1 2.0 1.4 185.2 5.5 462.8 38.6 25.7 15.1 547.3 646.6 120.0 815.8 1006.0 281.6 327.7 3.7 980.4 145.1 969.8 127.4 403.0 35.4 140.6 257.8 196.5 122.5 210.1 186.5 229.0 90.0 179.7 153.6 92.6 322.3 356.1 79.9 309.7 437.3 29.2 33.9 63.0 25.1 33.0 116.5 114.9 102.3 118.3 114.3 62.8 114.9 41.0 96.1 361.8 54.5 250.1 999.7 297.7 335.3 228.2 0.6 139.6 71.2 8.6 27.1 125.6 20.2 2.1 4.5 257.0 14.0 1.9 992.1 41.3 43.6 395.4 50.9 100.1 94.4 0.4 869.6 3.6 282.2 39.8 196.9 763.2 25.2 13.2 3.6 226.6 0.0 0.4 93.3 30.5 474.3 1934.2 24.3 22.4 523.9 604.7 8.4 594.2 29.6 62.8 0.5 11.2 813.1 10.9 0.4 216.3 386.7 6.0 1.6 18.8 2.0 157.8 197.2 227.9 0.4 0.4 279.3 1024.9 17.9 430.8 1.0 79.1 330.7 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736479 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 1445.2;Prostatic glandular cells: 1678.0;Urothelial cells: 1531.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 3747.5;U-2197: 3049.9" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 58000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favorable (1.39e-10)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 517.4 248.3 284.5 209.6 310.8 198.8 555.9 329.0 365.1 305.5 542.2 255.1 120.7 290.7 971.7 478.9 368.1 475.3 608.3 288.2 359.7 577.4 339.8 553.5 148.8 327.9 340.2 228.5 353.6 706.1 250.3 485.6 340.9 256.8 271.4 130.7 693.6 443.2 529.3 282.8 167.9 380.0 330.5 131.8 422.7 127.7 337.0 167.7 308.1 915.0 288.6 550.5 325.5 315.6 297.2 278.4 77.6 212.0 1697.1 1314.9 46.8 1765.7 1778.5 408.9 451.9 129.7 822.1 23.9 291.5 1802.5 475.5 314.0 141.0 1589.9 561.1 475.5 218.2 31.3 846.7 193.1 483.2 183.4 94.8 631.8 387.2 343.3 1550.6 1104.9 2475.5 109.3 207.9 585.9 2575.4 282.7 79.9 70.3 43.5 541.8 1421.8 30.1 232.1 227.8 1304.4 510.0 54.3 79.5 576.2 243.7 298.2 218.0 187.5 18.1 3747.5 838.6 235.5 3049.9 595.9 273.8 558.8 30.4 734.2 1.3 1556.9 164.9 22.3 209.6 50.9 7.9 64.8 63.9 104.9 56.6 95.4 59.6 68.2 41.4 134.3 92.5 4.8 49.9 298.2 53.5 284.5 310.8 329.0 365.1 288.2 359.7 327.9 340.2 340.9 330.5 337.0 315.6 728.0 272.4 247.2 32.3 39.1 286.0 1103.2 951.4 82.0 51.3 434.9 270.0 315.5 444.7 569.7 242.8 33.3 553.5 29.2 344.6 164.4 1445.2 129.4 94.3 91.6 792.6 166.6 206.0 25.1 618.3 407.2 303.5 109.6 115.6 139.4 88.2 585.0 185.7 486.7 47.1 29.9 112.8 722.2 139.4 374.2 61.6 237.3 88.2 1270.0 54.4 161.7 198.3 26.8 32.6 22.2 1195.7 392.2 204.7 149.7 1678.0 41.7 208.2 1042.5 56.2 276.1 159.1 410.7 130.6 31.2 83.7 284.4 836.6 52.4 139.5 104.9 1531.0 CD68 "DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1" ENSG00000129226 "CD68 molecule" P34810 17 7579491-7582111 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 358.0;lymphoid tissue: 370.7" "Cell type enhanced" "Detected in many" "Hofbauer cells: 1820.4;Kupffer cells: 701.2;Langerhans cells: 341.5;Macrophages: 791.2;Proximal enterocytes: 335.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 3255.5;intermediate monocyte: 3655.9;non-classical monocyte: 3740.6" "Group enriched" "Detected in all" 11 "dendritic cells: 1378.6;monocytes: 3740.6" "Cell line enhanced" "Detected in all" "ASC diff: 472.0;U-87 MG: 751.0" "Low region specificity" "Detected in all" "CAB000051, CAB000066, HPA048982, CAB072861, CAB072862" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" "CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587" "unprognostic (2.16e-2)" "unprognostic (1.47e-2)" "unprognostic (6.46e-2)" "unprognostic (1.49e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.75e-4)" "unprognostic (2.83e-2)" "unprognostic (1.31e-1)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (1.14e-5)" "unprognostic (1.58e-1)" "unprognostic (8.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.65e-2)" 139.6 78.3 10.4 236.1 9.8 266.2 72.6 11.2 33.4 77.8 14.6 88.8 279.5 26.7 9.0 126.4 43.1 161.1 38.9 8.2 26.7 50.6 156.7 358.0 217.3 45.5 31.2 19.4 22.1 14.2 8.9 173.1 36.0 13.1 91.9 4.8 52.6 19.8 23.0 24.8 240.2 79.0 16.1 370.7 87.5 15.2 58.5 44.2 22.7 21.3 84.2 149.3 50.6 31.6 243.4 48.6 3.2 3.5 472.0 177.6 2.1 75.6 203.9 97.8 113.4 10.1 71.3 2.9 84.2 220.8 174.6 10.6 1.2 47.6 65.9 2.2 9.0 38.8 13.2 59.0 42.0 19.2 207.8 57.1 9.8 205.4 150.4 162.6 26.3 4.3 15.7 24.2 95.5 2.2 1.7 17.2 2.8 63.1 36.0 3.3 4.5 144.4 20.9 10.9 1.6 3.0 63.2 31.3 72.1 2.2 1.6 146.1 82.4 123.7 8.0 125.7 100.1 1.4 2.1 1.9 751.0 46.4 64.0 243.5 3255.5 21.4 9.1 3655.9 11.1 80.2 4.1 6.2 817.3 59.0 5.8 5.1 219.4 18.7 3740.6 1378.6 6.5 3324.3 10.4 9.8 11.2 33.4 8.2 26.7 45.5 31.2 36.0 16.1 58.5 31.6 10.4 0.0 19.7 1.3 20.5 15.7 39.0 58.8 3.4 0.2 7.2 9.8 0.0 12.8 53.2 5.5 0.0 8.9 110.3 22.5 5.9 82.1 0.8 8.3 11.3 15.9 4.9 6.6 0.3 156.8 58.1 45.6 29.6 18.7 43.6 0.9 16.4 23.9 1820.4 0.0 0.4 15.8 16.2 701.2 341.5 2.1 6.5 791.2 39.2 5.6 179.2 0.3 7.2 0.0 0.1 121.0 86.1 1.9 8.5 33.3 335.3 50.2 20.6 1.0 26.3 8.7 11.7 0.5 1.2 12.4 14.3 33.4 10.8 0.5 28.9 99.9 CD74 DHLAG ENSG00000019582 "CD74 molecule" P04233 5 150400041-150412969 "Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 5258.9" "Cell type enhanced" "Detected in many" "B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0" "Group enriched" "Detected in all" 6 "B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002506, HPA010592, CAB079994" Enhanced Supported "Golgi apparatus" NA NA 210000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482" "prognostic favorable (1.06e-4)" "unprognostic (1.48e-2)" "unprognostic (4.80e-3)" "prognostic favorable (6.53e-6)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (2.05e-1)" "unprognostic (3.69e-3)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (2.20e-2)" "unprognostic (2.64e-1)" "unprognostic (5.44e-3)" "unprognostic (1.73e-1)" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (4.24e-2)" 1512.1 976.5 338.1 2741.2 301.9 984.3 1157.2 365.5 474.4 1562.8 429.1 992.3 1826.2 593.6 490.6 618.8 1139.0 1477.9 604.0 306.7 506.8 1271.1 1142.0 3786.3 4995.6 598.7 431.8 464.3 392.4 390.6 469.3 305.7 533.4 556.7 1155.8 58.1 1999.3 911.8 307.2 682.4 2438.8 1014.2 514.2 4897.4 1511.5 207.5 514.4 2160.2 853.5 374.2 5258.9 1557.5 483.5 771.8 35.7 0.3 1.5 2.4 2.3 2.5 11.0 0.0 0.0 0.7 0.6 443.0 2171.7 3523.2 124.2 0.0 9.2 9.4 0.0 0.0 0.1 4787.6 0.0 109.1 1.2 250.2 6.6 9.2 6.5 24.5 0.0 0.8 0.0 0.6 0.0 0.0 8.0 1270.7 0.4 0.0 4.2 14.0 5.3 0.0 0.1 3026.0 5.2 2014.2 9.0 133.5 5.1 8.2 5.5 4.7 94.9 19.2 81.2 414.4 5.6 10.3 9.9 9.0 4.5 1443.4 170.7 1978.6 745.9 154.2 678.6 410.8 11041.2 3996.9 808.7 15961.1 899.9 26889.3 688.4 1188.4 23750.6 27930.3 378.9 646.6 839.6 2378.1 8003.3 16940.0 2157.2 17779.7 338.1 301.9 365.5 474.4 306.7 506.8 598.7 431.8 533.4 514.2 514.4 771.8 2080.4 419.9 2160.4 0.7 10167.0 715.9 154.0 762.2 398.4 1.7 220.3 437.5 69.6 401.7 1063.3 502.1 0.0 28.3 3199.0 139.7 117.4 1264.4 10.4 111.3 11.5 1787.6 242.9 562.5 0.7 527.5 32.6 278.6 538.2 85.5 417.2 113.4 514.7 52.5 4361.8 1.7 0.6 475.7 390.6 5201.6 23363.4 31.3 117.1 7290.2 1197.1 137.7 10305.9 16.8 403.7 0.5 1.4 384.2 487.3 17.7 2068.3 174.9 5034.4 815.8 1153.1 10.0 164.3 45.1 146.7 2.8 12.6 170.9 575.8 41.6 790.7 12.9 450.7 743.4 CD83 "BL11, HB15" ENSG00000112149 "CD83 molecule" Q01151 6 14117256-14136918 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 209.6" "Cell type enhanced" "Detected in many" "B-cells: 668.5;Langerhans cells: 1390.2;Macrophages: 539.4;monocytes: 513.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 79.1;HDLM-2: 71.9;U-698: 121.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002509, HPA041454, HPA073595" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Vesicles "Golgi apparatus" "CAB002509: AB_563641, HPA041454: AB_2677489, HPA073595: " "unprognostic (2.22e-3)" "unprognostic (1.92e-2)" "unprognostic (1.22e-1)" "unprognostic (6.39e-2)" "unprognostic (5.83e-2)" "unprognostic (3.02e-2)" "unprognostic (1.00e-2)" "unprognostic (9.05e-3)" "unprognostic (9.05e-2)" "unprognostic (3.91e-2)" "unprognostic (7.37e-2)" "unprognostic (6.68e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.30e-1)" "unprognostic (7.07e-2)" "unprognostic (1.40e-2)" "unprognostic (2.46e-2)" 10.2 19.9 14.7 34.9 13.9 209.6 7.0 16.1 17.9 26.2 23.0 5.2 4.6 7.3 4.0 4.5 5.1 17.0 4.8 15.6 19.2 18.7 14.9 39.9 51.3 20.2 16.6 16.5 4.2 6.6 7.2 9.2 21.0 8.3 9.2 5.0 19.5 13.8 1.3 5.0 11.5 6.9 16.7 20.1 5.7 5.2 21.0 38.0 5.3 2.9 70.2 15.5 15.4 21.6 18.1 0.8 12.7 17.7 18.2 4.2 0.4 5.1 17.6 8.3 14.4 1.3 11.6 79.1 14.6 1.3 16.8 2.0 4.8 5.5 27.0 71.9 7.6 10.6 21.4 2.1 0.6 15.8 16.5 4.8 2.3 8.0 2.6 2.5 0.2 26.4 2.4 0.0 0.8 6.5 12.6 29.7 5.3 3.2 3.7 12.1 28.1 10.9 6.0 17.2 2.8 5.2 1.0 0.6 13.5 7.3 3.0 12.3 0.4 12.8 8.1 1.9 12.0 0.7 0.2 121.5 2.8 21.6 19.7 0.0 3.1 2.0 4.4 19.0 4.8 19.7 4.0 3.7 9.0 31.0 2.8 3.3 2.2 5.0 29.3 3.2 6.2 4.4 14.7 13.9 16.1 17.9 15.6 19.2 20.2 16.6 21.0 16.7 21.0 21.6 41.3 19.2 77.9 5.2 668.5 49.5 16.0 10.0 41.5 4.2 26.5 46.4 30.9 2.8 8.2 11.0 6.2 1.5 100.4 5.4 3.9 0.9 0.9 29.0 24.1 39.1 24.0 3.0 5.6 1.6 2.4 31.1 11.2 74.8 238.8 8.1 2.9 1.1 145.6 1.7 6.1 7.3 4.1 83.0 1390.2 1.9 0.3 539.4 44.4 13.1 513.6 3.5 1.0 2.5 1.3 2.1 0.4 0.0 20.4 26.2 1.7 17.7 4.9 2.7 0.0 17.2 17.0 2.1 10.2 17.2 38.5 2.7 69.2 21.0 11.6 3.5 CD99 MIC2 ENSG00000002586 "CD99 molecule (Xg blood group)" P14209 X 2691187-2741309 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 1614.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000020, HPA035304" Supported Approved "Golgi apparatus" NA NA 62000000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "CAB000020: AB_2076419, HPA035304: AB_10672861" "unprognostic (3.71e-3)" "unprognostic (2.90e-1)" "unprognostic (5.97e-3)" "unprognostic (7.01e-3)" "unprognostic (2.14e-2)" "unprognostic (6.98e-3)" "unprognostic (3.89e-3)" "unprognostic (1.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.87e-7)" "unprognostic (2.11e-2)" "unprognostic (2.18e-1)" "unprognostic (5.37e-2)" "unprognostic (3.61e-2)" 476.3 143.3 132.0 119.2 142.1 105.4 327.7 148.8 135.4 367.4 126.5 353.2 148.5 305.5 132.4 208.8 249.4 264.5 343.7 128.8 247.5 112.7 227.7 256.5 146.6 210.9 178.1 303.0 234.6 46.8 132.9 194.8 216.8 270.3 152.9 15.1 184.2 258.4 163.7 284.7 210.0 226.1 224.4 186.0 209.1 199.6 139.4 562.1 152.6 168.3 129.2 296.3 314.6 227.6 259.4 276.5 308.5 424.8 1217.7 939.2 195.0 681.6 1050.1 419.2 604.8 412.3 179.1 18.3 130.0 929.4 217.5 99.4 124.1 168.4 337.5 350.8 321.2 53.1 179.5 353.4 390.1 81.7 375.0 580.1 204.9 223.7 155.6 271.8 766.4 256.3 66.4 0.9 391.9 191.2 672.3 266.8 107.5 28.6 310.0 118.7 273.2 513.5 240.7 165.4 1.0 141.2 168.7 138.2 432.6 744.9 129.6 229.4 750.2 509.7 86.1 487.1 230.2 1.0 0.8 116.1 338.1 203.1 323.8 23.6 526.0 18.3 1089.2 131.2 620.5 340.1 730.3 961.1 496.5 231.8 267.4 549.7 45.1 377.3 32.3 682.1 833.7 1421.2 132.0 142.1 148.8 135.4 128.8 247.5 210.9 178.1 216.8 224.4 139.4 227.6 297.7 64.1 68.3 20.5 172.0 250.6 207.4 274.4 138.9 5.1 66.9 48.3 86.6 112.9 88.4 71.7 0.0 223.6 507.7 68.4 13.7 145.3 8.8 180.2 279.7 387.7 80.8 136.5 0.9 138.4 189.7 604.7 116.7 188.8 230.4 1614.3 512.9 123.0 799.8 0.0 1.1 150.8 54.9 187.4 579.9 26.4 645.2 342.4 691.9 37.5 175.9 52.0 632.4 1.0 0.9 139.9 158.2 511.2 300.2 385.8 230.9 63.3 117.5 3.2 341.8 231.1 351.9 16.4 56.9 147.9 222.9 123.0 468.9 403.2 262.3 307.0 CDC123 "C10orf7, D123" ENSG00000151465 "Cell division cycle 123" O75794 10 12195965-12250589 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037830, HPA057540" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Golgi apparatus" Cytosol "HPA037830: AB_10671368, HPA057540: AB_2732614" "unprognostic (5.35e-3)" "unprognostic (9.06e-2)" "unprognostic (2.42e-1)" "unprognostic (5.09e-3)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.16e-7)" "unprognostic (2.63e-1)" "unprognostic (2.22e-1)" "unprognostic (3.20e-2)" "unprognostic (2.74e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (5.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.88e-2)" "unprognostic (6.19e-2)" 44.9 40.0 38.1 53.8 44.3 73.5 45.9 40.6 46.1 43.5 39.1 54.1 37.1 39.0 46.9 50.1 42.3 34.0 61.0 41.7 41.5 42.6 55.6 35.8 69.1 40.3 38.4 31.4 29.4 42.3 33.0 50.8 40.5 35.4 58.3 29.7 31.5 39.3 49.7 44.3 39.1 53.4 41.3 45.3 35.4 35.7 40.1 65.2 41.5 52.5 81.1 63.6 34.7 43.7 155.4 187.4 148.3 157.1 125.4 136.3 117.7 137.0 94.2 194.8 205.5 274.0 186.5 259.7 123.5 153.6 116.1 157.7 237.0 223.3 172.0 176.8 206.6 199.3 142.8 266.6 162.1 151.6 159.0 131.3 118.9 214.0 126.5 98.0 206.3 320.6 224.2 114.5 178.6 135.0 208.3 133.8 221.4 223.1 76.3 195.7 111.9 234.0 173.2 86.3 72.3 140.8 139.6 165.4 152.6 120.4 180.7 179.2 200.9 107.7 127.6 167.9 166.6 112.5 233.5 320.7 135.4 155.3 69.7 133.8 99.2 242.2 103.6 117.0 108.1 158.6 114.8 115.0 139.0 170.5 93.5 99.9 233.4 121.1 129.4 116.0 143.5 167.3 38.1 44.3 40.6 46.1 41.7 41.5 40.3 38.4 40.5 41.3 40.1 43.7 48.6 32.1 35.9 18.3 51.5 54.2 49.2 162.1 39.9 28.5 28.0 32.3 56.4 24.3 75.8 35.0 6.2 120.8 55.3 25.1 86.1 91.1 7.9 26.8 39.5 49.7 20.9 36.8 33.2 82.6 138.2 46.3 26.5 26.1 49.4 36.6 34.2 37.6 101.3 26.9 27.9 31.9 105.8 25.9 34.0 10.1 41.7 37.2 46.2 21.5 79.3 43.3 45.3 19.6 23.5 84.3 34.3 45.9 44.2 46.5 30.7 73.0 62.5 29.9 39.5 32.3 59.8 50.2 41.5 46.5 74.0 77.6 51.3 72.4 47.0 50.7 CDC25A ENSG00000164045 "Cell division cycle 25A" P30304 3 48157146-48188417 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3" "Cancer enhanced" "Detected in many" "testis cancer: 19.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005855, HPA008803" Approved "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 43: B-cells - Humoral immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "Golgi apparatus" "HPA005855: AB_1846364, HPA008803: " "unprognostic (1.49e-1)" "unprognostic (8.13e-2)" "unprognostic (1.20e-2)" "unprognostic (1.43e-3)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (7.05e-7)" "unprognostic (1.35e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-3)" "unprognostic (4.41e-2)" "unprognostic (9.09e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-3)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" 0.7 0.9 0.8 3.3 0.8 15.3 1.1 0.7 1.0 0.6 0.7 3.5 2.0 0.6 0.9 2.4 0.2 0.3 0.4 0.8 2.0 0.7 0.8 0.3 4.4 1.1 1.9 2.2 0.7 0.8 0.8 2.6 1.7 0.6 3.9 2.0 0.8 0.6 0.4 0.6 1.8 1.1 0.8 2.0 0.9 13.3 2.0 8.8 1.8 0.3 5.6 0.9 0.9 0.7 22.2 10.7 50.0 27.2 1.7 3.2 34.2 29.9 11.3 36.7 29.6 46.8 11.2 64.9 11.4 8.0 23.4 16.3 86.6 20.6 38.6 21.4 45.1 83.8 19.0 23.1 1.7 59.4 23.4 1.7 3.1 45.8 19.6 4.6 14.1 47.8 67.6 33.6 20.1 11.8 74.8 46.6 73.4 20.2 24.2 33.2 32.9 35.1 9.5 20.7 23.5 28.8 18.6 21.6 9.5 31.7 11.3 41.9 7.2 18.0 27.7 20.3 41.4 16.7 54.2 101.5 13.5 65.2 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.7 1.0 0.8 2.0 1.1 1.9 1.7 0.8 2.0 0.7 0.3 0.0 0.0 1.0 1.1 0.4 0.4 0.8 1.8 0.5 1.2 1.0 111.2 0.0 0.1 0.0 2.1 4.2 0.2 2.4 0.0 0.4 18.3 0.5 0.9 2.7 1.2 8.0 0.2 0.9 7.4 1.5 1.5 1.3 0.0 4.6 1.4 0.3 3.1 0.0 0.5 2.0 0.0 0.6 0.9 31.8 1.5 0.5 0.0 0.0 0.1 1.1 0.0 0.5 0.0 1.1 0.8 1.9 13.0 0.7 0.4 0.4 0.2 0.4 0.0 0.1 2.2 14.5 16.3 4.3 0.0 0.3 0.6 2.4 4.1 0.5 CDH1 "CD324, UVO, uvomorulin" ENSG00000039068 "Cadherin 1" P12830 16 68737292-68835537 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 197.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 451.6;Glandular and luminal cells: 321.0;Pancreatic endocrine cells: 264.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "myeloid DC: 1.7;plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.7" "Cell line enhanced" "Detected in many" "BEWO: 683.3;CACO-2: 241.9;CAPAN-2: 328.1;HaCaT: 318.7;hTCEpi: 217.2;MCF7: 199.6;OE19: 207.2;RT4: 237.7;T-47d: 209.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857" Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA 78000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cell Junctions" "Golgi apparatus" "CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369" "unprognostic (3.95e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-3)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (5.04e-3)" "unprognostic (1.63e-1)" "unprognostic (5.47e-2)" "unprognostic (2.85e-1)" "unprognostic (1.19e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (2.51e-1)" "unprognostic (5.92e-2)" 1.0 0.2 1.5 16.1 2.0 6.5 64.2 0.6 1.9 30.0 19.3 127.5 133.9 9.6 39.5 76.9 51.5 45.7 0.3 1.5 1.3 39.8 97.2 36.8 5.6 2.0 1.3 1.3 84.0 197.8 8.0 60.9 1.3 91.7 131.0 0.1 71.9 41.7 0.3 107.7 127.9 5.1 2.1 10.3 104.2 0.4 2.3 20.1 162.7 0.1 29.0 58.2 38.1 2.7 147.0 14.8 0.0 0.5 0.0 0.0 683.3 0.0 0.0 0.0 0.0 241.9 328.1 0.0 3.1 0.0 0.0 318.7 0.0 156.3 0.0 28.6 3.5 0.1 0.7 48.0 0.0 0.0 0.6 0.0 217.2 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 199.6 0.2 1.0 5.5 207.2 0.8 0.1 0.1 2.1 53.9 237.7 8.5 0.8 1.4 0.2 58.9 91.8 209.2 0.4 0.0 0.4 0.9 0.7 0.6 0.1 0.3 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.2 0.0 4.7 0.0 0.1 1.5 2.0 0.6 1.9 1.5 1.3 2.0 1.3 1.3 2.1 2.3 2.7 0.6 131.4 69.8 0.7 1.4 94.1 130.3 73.8 45.5 0.0 137.6 83.6 0.9 128.7 95.3 163.7 0.0 117.6 2.5 451.6 1.9 129.1 0.1 159.3 29.2 4.4 86.7 9.0 0.7 113.5 29.6 3.4 132.0 321.0 1.3 2.8 0.4 63.4 11.7 0.0 1.4 208.3 75.3 1.2 13.4 0.0 0.3 3.2 53.4 1.0 3.3 0.0 0.0 0.5 32.1 264.6 204.6 0.4 2.2 195.5 159.5 4.5 118.2 0.0 0.0 0.0 7.1 0.1 0.1 100.6 131.6 50.5 2.7 0.0 154.8 251.5 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171748-89195492 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 24.4;skeletal muscle: 57.0" "Cell type enriched" "Detected in some" 13 "Skeletal myocytes: 76.1" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 15 "cerebellum: 24.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RH-30: 145.8" "Region enriched" "Detected in many" 7 "cerebellum: 15.7" "Region enriched" "Detected in some" 17 "cerebellum: 18.7" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" NA NA 870000 "Cluster 80: Striated muscle - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: AB_2686328" "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.0 0.2 0.1 0.0 0.2 0.0 0.0 24.4 0.8 1.3 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 1.3 0.4 0.0 0.1 0.8 0.2 1.4 0.0 0.1 0.7 1.6 0.4 0.0 0.0 0.9 0.0 57.0 0.1 0.0 0.0 0.3 1.2 0.2 0.6 0.1 0.0 0.0 5.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.8 0.7 0.0 0.1 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 31.5 0.1 0.0 0.1 0.0 0.2 0.3 0.0 145.8 0.3 0.0 0.0 0.8 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 24.4 0.8 0.0 0.1 0.1 0.8 1.6 0.3 0.1 0.6 0.2 0.0 2.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 1.0 0.1 1.2 0.0 0.1 0.0 0.3 0.7 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.2 1.8 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.0 76.1 0.4 1.5 5.5 0.0 0.0 0.1 0.2 0.8 0.1 0.1 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880597-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;kidney: 5.7" "Group enriched" "Detected in some" 33 "Excitatory neurons: 307.2;Inhibitory neurons: 459.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 6.8;basal ganglia: 4.3;cerebral cortex: 6.4;hippocampal formation: 5.8" "Immune cell enhanced" "Detected in some" "neutrophil: 4.9" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 4.9" "Cell line enhanced" "Detected in some" "K-562: 7.3;NTERA-2: 10.1;U-698: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved Approved "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.3 0.2 6.8 0.6 4.3 1.9 0.3 0.0 6.4 0.0 0.0 0.4 0.5 0.5 0.6 0.4 0.2 0.4 0.1 5.8 0.0 5.7 0.1 0.3 1.0 0.0 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.5 0.6 1.3 0.2 0.1 0.1 1.0 0.8 0.4 0.0 0.4 0.5 2.2 0.0 0.2 1.0 0.1 1.0 0.3 0.0 0.9 1.9 0.7 0.4 0.6 0.2 0.0 1.2 0.0 0.3 0.1 0.2 0.0 0.7 1.0 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.4 0.6 2.2 0.0 0.0 1.2 0.2 0.3 0.0 0.0 0.0 0.1 0.6 7.3 1.8 0.0 1.3 0.6 0.4 10.1 0.2 0.4 0.2 0.2 0.3 0.3 0.4 2.2 0.2 0.0 0.3 0.3 1.8 0.3 0.7 1.3 0.1 0.7 0.6 0.2 2.0 0.8 4.6 0.6 0.8 0.6 1.2 0.1 0.2 0.1 0.4 0.3 2.3 0.1 0.1 0.1 1.6 0.1 0.3 4.9 0.0 0.7 0.5 0.5 0.6 6.8 4.3 0.0 6.4 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 10.4 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 459.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 11.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDK13 "CDC2L, CDC2L5, CHED, KIAA1791" ENSG00000065883 "Cyclin dependent kinase 13" Q14004 7 39950121-40099580 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 179.0;Oligodendrocyte precursor cells: 171.9;Oligodendrocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059241 Uncertain Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Golgi apparatus, Cytosol" "HPA059241: AB_2683956" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (2.72e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (4.18e-3)" "unprognostic (3.42e-2)" "unprognostic (8.09e-2)" "unprognostic (1.13e-2)" "unprognostic (3.77e-2)" "unprognostic (8.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.21e-1)" "unprognostic (3.33e-2)" "unprognostic (3.53e-1)" "unprognostic (3.53e-2)" 11.4 10.2 8.8 14.6 10.8 28.1 11.1 19.3 9.9 12.8 6.7 11.9 10.5 13.6 14.2 14.7 15.0 12.7 10.4 8.1 10.7 12.7 15.9 12.1 21.7 10.5 8.5 20.1 12.8 17.2 8.0 13.6 8.6 11.2 13.6 19.7 12.9 11.8 11.2 12.0 12.0 12.0 7.2 16.6 12.3 19.0 10.1 19.6 20.6 14.0 20.2 13.4 10.0 14.9 28.4 16.6 28.2 27.0 24.9 24.1 19.3 22.1 23.8 19.8 24.6 17.8 19.1 51.0 12.6 23.4 34.8 33.6 23.4 19.4 29.0 25.3 17.3 22.8 20.0 16.0 23.7 34.8 23.5 14.3 25.5 22.6 30.0 22.6 23.6 23.1 39.0 34.3 20.7 14.7 28.0 24.9 40.8 20.0 19.1 30.5 18.5 20.5 18.5 28.1 20.0 28.8 27.6 59.8 19.9 36.7 24.6 43.0 28.3 27.0 26.0 17.6 30.5 28.3 26.0 41.2 19.8 30.9 35.4 7.8 2.2 4.0 4.1 1.9 2.8 6.4 3.8 3.0 1.3 10.5 3.8 3.9 5.9 4.3 3.1 3.3 3.9 1.3 8.8 10.8 19.3 9.9 8.1 10.7 10.5 8.5 8.6 7.2 10.1 14.9 47.6 44.8 72.0 131.6 49.7 21.4 18.5 15.9 29.0 47.8 36.7 27.7 30.9 25.8 37.1 31.3 70.9 13.7 91.0 23.1 7.9 20.4 13.9 54.3 51.4 30.9 18.7 5.9 179.0 15.4 9.1 31.7 30.1 72.6 17.1 95.5 19.2 23.7 13.2 37.0 166.2 17.6 14.2 23.8 17.4 9.2 26.1 31.6 14.2 145.2 27.9 22.4 53.5 171.9 199.6 28.6 12.9 17.7 50.1 21.8 15.2 12.7 32.8 69.4 6.6 38.5 32.0 36.1 33.4 34.7 26.1 12.2 49.7 56.8 20.1 25.0 CDK15 "ALS2CR7, PFTAIRE2, PFTK2" ENSG00000138395 "Cyclin dependent kinase 15" Q96Q40 2 201790461-201895550 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 15.2;ovary: 6.1" "Group enriched" "Detected in some" 13 "Early spermatids: 27.1;granulocytes: 79.1;Late spermatids: 40.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 2.4" "Group enriched" "Detected in some" 28 "basophil: 1.8;eosinophil: 3.7" "Lineage enriched" "Detected in single" 37 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.6;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 30.9;HMC-1: 58.4;LHCN-M2: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015786 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "Golgi apparatus" "HPA015786: AB_1844780" "unprognostic (2.51e-1)" "unprognostic (2.73e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-1)" "unprognostic (4.79e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.64e-2)" "unprognostic (1.80e-2)" "unprognostic (7.38e-2)" "unprognostic (9.99e-5)" "unprognostic (6.31e-2)" "unprognostic (1.48e-2)" "unprognostic (1.05e-2)" 0.7 0.3 0.0 0.2 0.0 0.0 0.8 2.4 0.4 0.8 0.0 0.5 0.3 0.6 15.2 0.6 0.5 1.9 0.2 0.5 0.0 0.3 0.0 1.0 0.1 0.4 0.1 6.1 0.1 0.2 0.3 0.0 0.4 0.7 0.7 0.0 0.3 0.3 0.9 0.6 0.8 0.4 0.1 0.0 0.7 1.9 0.1 0.2 0.1 0.7 0.1 0.8 0.5 0.3 0.3 0.0 0.0 0.0 1.6 2.8 0.0 5.9 22.6 10.2 20.7 0.0 3.0 0.0 0.0 2.3 0.5 0.0 0.0 0.0 30.9 0.0 0.1 1.9 0.0 0.0 0.3 0.1 58.4 3.4 0.0 2.7 1.5 0.4 0.0 0.0 0.0 0.1 19.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.5 2.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.5 0.0 0.4 0.1 0.4 0.1 0.1 0.3 0.1 0.0 1.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.0 79.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 40.3 0.3 0.1 3.6 1.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.5 0.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 CDR1 "CDR, CDR34, CDR62A" ENSG00000288642 "Cerebellar degeneration related protein 1" P51861 X 140783578-140784366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1331 "brain: 44280.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 140.3;Horizontal cells: 35.3;Muller glia cells: 140.9;Rod photoreceptor cells: 34.1" "Region enhanced" "Detected in all" "cerebellum: 44280.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.9;BJ: 16.0;MOLT-4: 10.6;U-87 MG: 61.7" "Not detected" "Not detected" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" NA NA "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus, Centrosome" Nucleoplasm "HPA073147: AB_2686574" 7.9 3.1 1936.4 0.7 9723.2 0.0 0.0 44280.9 11546.5 0.0 0.0 0.3 0.3 1.2 0.0 2.0 0.6 5.1 5.1 967.3 404.7 0.2 0.0 1.3 0.2 4300.7 2927.3 0.3 10.6 0.0 1.1 8854.8 0.4 0.0 20.8 1.4 0.0 0.4 33.2 0.3 0.0 1798.6 2.4 1.1 0.2 3637.0 0.0 2.2 0.0 0.0 1.7 21870.1 0.0 4.2 8.9 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 10.6 0.0 2.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 2.1 3.7 0.1 0.0 0.0 2.9 0.0 3.0 0.0 0.0 0.0 61.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1936.4 9723.2 44280.9 11546.5 967.3 404.7 4300.7 2927.3 8854.8 1798.6 3637.0 21870.1 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 140.3 0.3 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 1.1 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 35.3 0.7 0.0 0.0 0.0 3.5 0.0 0.0 0.2 0.0 0.0 0.0 140.9 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 34.1 0.0 1.6 1.2 0.0 0.0 0.1 3.1 0.0 0.1 0.1 0.0 0.1 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234200-26278808 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.9;tongue: 65.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 29.0;Oligodendrocytes: 28.8;Spermatocytes: 40.9;Spermatogonia: 34.2;Syncytiotrophoblasts: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.8 3.5 3.9 5.3 8.3 20.8 3.8 5.6 6.7 4.1 3.7 5.4 3.4 3.2 3.2 8.6 2.7 2.7 25.5 4.3 5.9 6.0 5.8 4.7 6.9 7.1 6.8 3.3 5.0 8.8 6.1 3.2 8.9 2.9 6.0 14.1 5.3 2.4 132.9 9.8 5.2 3.7 3.7 6.3 4.7 31.1 7.1 13.6 7.8 65.9 7.8 3.2 6.2 14.3 29.6 12.5 30.2 22.6 7.3 8.9 52.5 18.8 11.5 31.9 28.5 17.4 28.2 34.3 20.1 9.2 14.6 25.5 41.0 14.4 29.9 23.5 20.9 49.7 31.9 19.4 6.6 46.2 43.8 3.8 13.7 24.9 16.4 12.8 14.5 47.7 57.4 39.9 19.2 9.8 38.7 35.2 23.0 17.4 20.8 39.8 31.3 29.7 10.4 5.5 41.4 16.7 24.5 19.8 15.7 21.5 14.5 26.4 14.3 17.1 26.7 19.3 24.7 30.0 48.4 38.9 9.8 65.2 27.5 5.0 6.4 19.2 3.5 6.1 2.8 2.6 2.6 2.7 4.9 1.8 2.2 3.5 0.6 2.3 7.4 2.1 3.6 3.6 3.9 8.3 5.6 6.7 4.3 5.9 7.1 6.8 8.9 3.7 7.1 14.3 1.0 0.0 2.2 3.6 2.7 6.9 4.0 2.5 6.2 11.2 3.7 2.9 29.0 1.5 3.7 5.5 12.5 3.4 5.1 6.9 7.9 1.7 1.0 3.4 2.3 2.0 1.8 16.8 12.8 1.3 3.9 2.3 3.6 4.9 2.5 9.1 1.4 3.1 4.8 0.0 9.9 3.7 2.0 5.0 3.7 2.9 1.5 4.3 1.8 4.7 4.0 1.8 2.1 3.0 28.8 2.7 3.4 0.4 4.4 2.5 2.3 1.1 2.0 11.1 0.0 2.4 2.3 40.9 34.2 8.6 6.1 41.7 3.4 2.3 4.5 4.5 CERT1 "CERT, COL4A3BP, GPBP, STARD11" ENSG00000113163 "Ceramide transporter 1" Q9Y5P4 5 75356345-75512138 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.3;Cardiomyocytes: 37.1;Cytotrophoblasts: 17.7;dendritic cells: 20.2;Extravillous trophoblasts: 16.8;Hofbauer cells: 36.8;Plasma cells: 12.4;Syncytiotrophoblasts: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 132.3;WM-115: 118.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035645, HPA042608" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" Nucleoplasm "HPA035645: AB_10600700, HPA042608: AB_2678075" "unprognostic (2.45e-1)" "unprognostic (7.16e-2)" "unprognostic (6.56e-3)" "unprognostic (1.53e-2)" "unprognostic (2.44e-1)" "unprognostic (9.29e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-1)" "unprognostic (2.51e-1)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.29e-2)" "prognostic favorable (1.24e-5)" "unprognostic (9.12e-2)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (2.91e-1)" 38.1 26.1 12.4 16.5 16.1 27.2 17.6 18.0 15.4 33.9 14.0 20.8 18.7 20.6 15.1 24.9 22.4 23.3 20.8 14.0 15.1 27.9 31.2 24.3 20.3 14.7 17.5 23.1 16.4 26.1 8.0 22.9 16.7 24.3 19.6 18.2 14.0 19.9 28.9 18.7 21.1 18.3 14.7 25.3 23.5 28.8 15.5 21.2 49.9 28.3 22.7 23.7 16.0 17.6 44.9 22.7 21.6 19.0 132.3 36.6 29.0 24.8 30.8 18.8 24.8 34.4 25.3 21.5 52.3 26.9 25.8 26.7 33.4 34.4 28.6 27.1 15.2 18.2 24.4 18.4 33.6 18.2 20.1 27.9 23.8 22.3 24.9 30.5 22.1 28.3 33.0 32.0 25.0 23.0 21.6 13.2 27.9 10.2 16.8 18.0 28.5 20.2 30.5 54.0 16.4 16.5 31.6 21.6 31.8 45.4 21.3 30.5 30.1 12.6 15.1 22.8 20.3 29.1 41.6 24.8 21.4 30.7 118.2 9.6 19.8 16.0 8.2 22.4 7.8 9.1 8.3 7.7 14.5 9.1 7.7 7.8 29.6 7.8 25.4 8.3 13.0 9.0 12.4 16.1 18.0 15.4 14.0 15.1 14.7 17.5 16.7 14.7 15.5 17.6 23.3 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 17.7 20.2 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 16.8 10.5 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 27.8 3.8 0.0 0.0 0.0 CES2 "CE-2, CES2A1, iCE" ENSG00000172831 "Carboxylesterase 2" O00748 16 66934444-66945096 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 703.3;liver: 345.7" "Cell type enhanced" "Detected in all" "Distal enterocytes: 794.4;Hepatocytes: 518.5;Paneth cells: 519.2;Proximal enterocytes: 2529.8;Undifferentiated cells: 499.5" "Cancer enhanced" "Detected in all" "liver cancer: 104.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA018897, HPA074629" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 6400000 "Cluster 44: Non-specific - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "Endoplasmic reticulum, Cytosol" "HPA018897: AB_1846558, HPA074629: " "unprognostic (8.15e-3)" "unprognostic (1.82e-2)" "unprognostic (1.32e-1)" "unprognostic (2.67e-3)" "unprognostic (2.74e-2)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (1.31e-1)" "unprognostic (6.93e-2)" "unprognostic (7.99e-2)" "unprognostic (1.73e-3)" "unprognostic (2.66e-2)" "prognostic favorable (1.50e-5)" "unprognostic (8.01e-2)" "unprognostic (1.53e-1)" "unprognostic (4.14e-2)" "unprognostic (1.38e-1)" 18.8 38.1 21.2 18.1 20.6 6.3 13.5 24.1 23.0 22.0 25.6 191.2 703.3 14.6 14.4 132.7 17.9 19.5 51.4 22.1 20.6 96.5 345.7 15.6 11.9 20.8 20.8 17.0 14.4 38.0 15.7 10.1 20.6 16.7 178.8 16.2 32.9 15.0 33.8 32.7 576.5 19.7 20.0 12.4 41.6 9.3 20.9 13.1 27.9 14.3 20.8 13.7 33.5 20.5 11.6 16.6 18.4 25.9 19.5 17.9 14.5 15.9 25.8 17.6 22.1 17.3 23.5 15.7 14.3 20.9 13.3 35.4 14.2 39.8 15.3 10.7 18.9 14.4 9.6 44.2 26.3 21.6 26.3 25.4 82.5 26.0 46.7 24.6 14.1 11.3 22.2 10.9 35.7 9.1 17.7 21.4 10.8 16.3 18.8 20.9 19.1 19.8 60.7 18.6 11.6 16.0 50.9 12.6 14.5 8.1 21.0 26.5 17.5 22.4 12.6 15.3 11.1 23.3 24.0 18.4 36.7 17.3 17.4 4.1 5.4 1.6 5.1 3.8 4.5 3.0 4.1 5.8 4.5 3.1 4.8 4.5 1.6 4.3 4.1 4.3 3.2 3.1 21.2 20.6 24.1 23.0 22.1 20.6 20.8 20.8 20.6 20.0 20.9 20.5 13.2 32.1 24.6 8.8 18.8 19.5 13.5 32.8 39.3 31.2 12.4 18.3 33.6 115.8 19.8 53.3 20.9 16.1 12.9 794.4 37.2 24.6 2.1 26.9 15.0 14.1 24.1 7.8 7.0 33.8 5.7 15.3 60.6 33.7 27.3 80.7 28.5 518.5 19.6 28.6 9.7 196.0 18.3 37.0 9.6 2.3 18.6 15.3 10.6 10.3 19.5 19.0 21.6 8.0 5.9 51.8 519.2 18.0 8.5 19.1 2529.8 176.0 85.4 24.2 32.9 19.5 15.2 47.2 19.7 116.1 20.5 13.5 13.0 22.1 499.5 16.7 CFAP20DC "C3orf67, FLJ42117, FLJ42930" ENSG00000163689 "CFAP20 domain containing" Q6ZVT6 3 58717365-59050084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "esophagus: 7.9;testis: 22.1" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 1.9;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069696 Approved "Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA069696: AB_2686174" "unprognostic (4.59e-1)" "unprognostic (4.63e-3)" "unprognostic (1.99e-1)" "unprognostic (4.49e-5)" "unprognostic (1.91e-1)" "unprognostic (9.33e-3)" "unprognostic (1.67e-3)" "unprognostic (3.72e-1)" "unprognostic (2.43e-1)" "unprognostic (6.68e-3)" "unprognostic (8.95e-2)" "unprognostic (6.19e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (3.06e-2)" "unprognostic (7.79e-2)" "unprognostic (2.81e-2)" 0.3 1.1 0.5 0.7 0.6 0.2 0.5 0.0 0.7 1.0 0.1 0.5 0.0 0.3 0.3 7.9 2.9 0.5 0.1 0.7 0.4 0.5 1.0 0.4 1.6 0.6 0.7 0.2 0.5 0.7 1.9 1.1 0.4 0.3 0.7 0.4 2.0 0.2 0.0 0.3 0.1 0.3 0.3 0.3 0.4 22.1 0.5 0.5 0.3 0.1 3.2 0.2 2.2 0.3 11.2 1.8 3.0 0.0 1.8 5.7 0.0 5.2 1.7 2.3 1.8 1.0 3.6 11.6 1.7 1.2 0.0 1.1 4.8 2.5 4.0 1.8 0.3 0.0 1.9 0.0 0.9 0.0 0.0 1.1 2.4 4.8 3.9 2.8 4.7 7.6 9.0 0.1 3.1 1.5 0.6 0.0 3.8 3.6 7.7 11.3 0.0 4.8 2.4 0.1 7.8 3.6 1.4 1.1 3.4 5.0 3.5 0.0 0.1 0.2 3.4 5.6 2.4 4.6 10.3 2.3 2.6 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.6 0.0 0.7 0.7 0.4 0.6 0.7 0.4 0.3 0.5 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 CGREF1 CGR11 ENSG00000138028 "Cell growth regulator with EF-hand domain 1" Q99674 2 27098889-27119128 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3;salivary gland: 25.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 12.6;Excitatory neurons: 16.6;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 12.5;Spermatogonia: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 40.1;SK-BR-3: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008241, HPA071103" Uncertain Approved "Golgi apparatus" "Secreted in brain" NA NA 700000 "Cluster 65: Brain - Ion transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA008241: AB_1846605, HPA071103: " "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (8.45e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" "unprognostic (1.92e-1)" "unprognostic (2.57e-1)" "unprognostic (2.27e-1)" "unprognostic (2.52e-3)" "unprognostic (1.05e-1)" "unprognostic (2.30e-2)" "unprognostic (7.24e-4)" "unprognostic (1.20e-2)" 4.2 2.3 20.4 1.0 21.7 1.9 6.3 17.1 28.3 3.5 2.1 2.6 3.9 11.6 1.4 3.5 12.4 3.9 4.9 27.0 18.1 3.8 14.9 1.1 0.5 12.8 12.1 13.9 2.1 0.2 3.3 0.3 12.8 4.2 3.8 3.7 25.3 0.9 6.5 2.3 5.6 5.4 10.2 0.6 11.4 3.8 17.2 0.2 1.8 6.9 0.4 3.7 1.5 16.4 7.6 6.3 0.3 8.1 18.3 6.8 0.7 9.1 0.0 0.8 0.4 1.7 6.2 0.1 2.4 18.2 2.2 0.4 1.4 2.1 0.5 0.7 3.7 0.1 10.4 16.4 16.9 5.3 0.6 4.7 18.1 2.6 2.1 11.6 0.7 1.3 0.2 0.4 1.2 24.0 4.0 6.8 2.1 40.1 16.8 0.3 0.0 0.6 0.1 0.3 17.8 26.6 17.7 78.7 9.4 0.2 25.3 13.3 0.0 0.0 6.9 0.0 0.7 2.3 0.8 0.7 0.0 0.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 21.7 17.1 28.3 27.0 18.1 12.8 12.1 12.8 10.2 17.2 16.4 0.1 0.0 0.0 2.6 0.4 0.6 0.2 0.0 1.8 9.2 9.2 12.6 1.4 0.0 0.0 0.0 4.2 0.0 0.1 0.2 0.0 0.1 1.1 0.3 3.0 0.4 0.0 5.5 16.6 1.5 0.2 3.8 4.6 0.1 0.0 0.4 3.6 5.0 0.4 0.0 15.9 6.8 0.0 0.6 0.7 3.1 4.4 0.2 0.0 1.9 0.0 0.5 0.0 12.5 0.8 2.1 0.0 8.6 1.1 1.8 3.4 4.4 0.0 2.2 0.0 1.7 0.7 3.2 16.2 2.2 0.4 0.1 0.1 3.2 0.9 0.1 CHEK2 "bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53" ENSG00000183765 "Checkpoint kinase 2" O96017 22 28687743-28742422 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatogonia: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001878, CAB002030" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus" "CAB002030: AB_563660, HPA001878: AB_1078514" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (5.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.42e-1)" "unprognostic (3.83e-2)" "unprognostic (1.49e-3)" "unprognostic (5.08e-3)" "unprognostic (3.33e-3)" "unprognostic (9.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (7.80e-9)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (7.27e-2)" "unprognostic (6.79e-3)" 4.5 6.2 2.4 8.8 2.5 15.4 5.8 2.4 3.7 5.0 2.8 8.8 6.3 4.1 7.3 7.2 3.7 4.7 4.2 2.3 2.8 4.5 6.3 4.4 12.1 2.6 2.6 8.2 2.3 1.3 2.7 7.8 2.8 4.1 10.9 0.4 3.2 3.8 1.3 6.7 7.0 4.8 2.6 6.7 4.1 8.5 2.8 9.4 3.3 1.1 12.0 6.8 5.0 2.9 30.7 9.7 31.1 32.4 10.1 42.7 18.7 15.2 19.9 18.7 27.8 29.1 21.8 36.3 13.0 11.5 21.6 32.1 42.7 29.0 25.0 24.6 31.2 45.3 25.5 46.2 9.4 33.4 38.0 18.6 13.5 25.0 23.0 14.1 25.4 29.4 30.5 33.9 19.8 39.2 24.6 61.5 40.6 41.3 21.6 52.6 18.2 42.7 17.1 11.2 17.8 9.7 16.7 31.4 17.4 22.8 22.6 32.2 7.8 17.1 19.4 14.3 9.1 21.8 28.3 65.4 17.1 34.9 21.0 9.9 4.0 1.2 1.1 8.1 2.4 11.9 2.1 2.1 8.2 7.8 4.0 2.6 0.6 3.4 4.1 6.1 2.8 3.6 2.4 2.5 2.4 3.7 2.3 2.8 2.6 2.6 2.8 2.6 2.8 2.9 2.3 9.6 4.8 2.9 5.5 6.4 5.3 8.3 8.6 1.1 3.2 3.9 1.8 0.0 5.0 1.8 0.0 15.4 1.1 3.8 0.0 1.8 7.0 2.9 10.1 3.0 1.2 11.2 2.9 1.4 13.6 12.4 5.1 7.0 3.8 7.4 2.5 1.3 9.7 0.0 1.2 5.3 8.2 2.4 8.5 1.2 6.2 5.1 1.8 2.8 3.9 0.8 6.2 0.0 1.0 1.0 4.7 4.5 11.4 2.7 3.0 3.9 2.9 1.1 0.0 10.2 3.0 6.7 31.2 8.3 2.3 3.4 3.3 5.7 10.0 4.5 CHI3L1 "GP39, YK-40, YKL40" ENSG00000133048 "Chitinase 3 like 1" P36222 1 203178931-203186704 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Inflammatory response" Antimicrobial "Asthma, Cancer-related genes, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 232.4;brain: 239.4;liver: 447.8" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 88.7;Ductal cells: 88.9;Hepatocytes: 61.8;Hofbauer cells: 317.5" "Cancer enriched" "Detected in all" 8 "glioma: 1313.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 495 "neutrophil: 470.4" "Lineage enriched" "Detected in single" 495 "granulocytes: 470.4" "Cell line enhanced" "Detected in some" "ASC diff: 322.9;ASC TERT1: 712.9;HSkMC: 637.0;THP-1: 1068.4;U-138 MG: 303.5;U-87 MG: 303.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 10 "olfactory bulb: 16.0" HPA077365 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 25100000 180000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 15: Liver - Metabolism" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" Vesicles "HPA077365: " "unprognostic (2.11e-3)" "unprognostic (1.21e-1)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.01e-3)" "unprognostic (8.81e-2)" "unprognostic (2.09e-1)" "unprognostic (1.48e-1)" "unprognostic (4.46e-2)" "unprognostic (1.30e-1)" "unprognostic (7.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-2)" "unprognostic (3.43e-2)" "unprognostic (1.14e-2)" "unprognostic (9.39e-3)" 79.8 2.0 58.9 138.9 75.9 232.4 62.8 55.3 94.7 30.5 56.8 6.5 0.4 19.5 1.0 14.4 23.4 3.0 9.8 47.4 129.6 60.9 447.8 38.4 32.4 239.4 112.8 6.6 13.8 0.2 134.5 10.1 135.6 13.7 2.0 50.9 99.4 0.9 21.0 75.6 16.8 6.8 70.0 13.9 9.7 1.0 156.4 12.4 15.0 1.0 36.9 97.8 9.1 70.8 0.8 0.0 0.0 0.3 322.9 712.9 0.0 0.0 0.2 0.0 0.0 75.3 0.2 0.1 1.2 0.4 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 8.3 0.3 0.3 637.0 0.0 1.9 0.3 30.8 0.0 0.0 0.0 1.0 0.2 0.3 0.0 5.8 2.7 0.0 0.0 0.0 0.1 15.4 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.2 0.0 1068.4 0.0 303.5 1.6 0.0 0.4 2.3 41.9 0.3 303.7 1.2 0.2 0.0 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 470.4 0.0 0.9 0.0 0.0 1.3 58.9 75.9 55.3 94.7 47.4 129.6 239.4 112.8 135.6 70.0 156.4 70.8 0.7 6.4 42.8 20.5 0.1 4.2 47.1 88.7 0.0 0.1 29.8 21.5 1.0 2.8 17.3 27.6 0.0 1.3 0.6 0.0 0.0 88.9 0.0 4.8 2.2 2.1 0.0 0.4 1.1 0.0 1.1 18.6 0.0 7.2 0.0 0.0 0.0 61.8 317.5 0.0 0.1 0.0 6.1 0.8 0.4 0.0 0.9 23.7 14.2 0.0 1.0 45.1 0.0 0.0 0.1 2.0 0.0 0.0 1.4 4.2 0.0 0.2 3.4 2.8 0.0 1.0 2.3 0.0 0.0 1.5 1.1 0.8 0.9 0.0 0.0 2.2 CHRM4 ENSG00000180720 "Cholinergic receptor muscarinic 4" P08173 11 46385098-46386608 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 18.5;intestine: 6.8;lymphoid tissue: 15.9;testis: 5.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in many" 6 "basal ganglia: 18.5;cerebral cortex: 4.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 3.4;SCLC-21H: 10.0;U-2 OS: 2.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 16.8" "CAB022444, HPA072083" Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Nucleoplasm "CAB022444: , HPA072083: " "unprognostic (7.11e-2)" "unprognostic (3.79e-1)" "unprognostic (5.31e-2)" "unprognostic (7.38e-2)" "unprognostic (8.63e-3)" "unprognostic (1.38e-1)" "unprognostic (6.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (2.96e-3)" "unprognostic (4.08e-3)" "unprognostic (5.02e-2)" "unprognostic (3.83e-2)" "unprognostic (3.64e-1)" "unprognostic (1.71e-1)" "unprognostic (3.56e-1)" "unprognostic (5.08e-2)" 0.1 0.5 1.6 0.2 18.5 1.7 0.1 0.0 4.6 0.1 0.0 1.5 3.2 0.1 0.0 0.0 0.1 0.0 0.1 1.8 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.2 0.2 1.2 0.0 0.0 0.0 0.1 2.4 0.1 0.0 0.0 2.0 6.8 0.1 0.0 15.9 0.6 5.0 1.7 2.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.2 0.0 0.1 0.0 2.1 0.0 0.1 0.1 0.1 1.0 0.1 0.2 0.2 0.0 1.8 0.1 1.3 0.1 0.0 1.6 0.2 0.4 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.7 0.2 0.1 0.4 0.1 0.1 0.0 3.4 0.0 0.0 0.1 10.0 0.2 0.2 0.0 0.1 0.2 0.1 1.7 0.0 0.3 2.8 0.0 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 18.5 0.0 4.6 1.8 0.1 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST11 "C4ST, C4St-1, C4ST1, HSA269537" ENSG00000171310 "Carbohydrate sulfotransferase 11" Q9NPF2 12 104455295-104762014 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0;choroid plexus: 59.1" "Group enriched" "Detected in many" 4 "Microglial cells: 281.1;Oligodendrocyte precursor cells: 1012.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 12.7;eosinophil: 11.2;neutrophil: 15.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 15.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052828 Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA 55000 "Cluster 5: Granulocytes - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" "HPA052828: AB_2681966" "unprognostic (6.35e-2)" "unprognostic (2.68e-3)" "unprognostic (2.28e-2)" "unprognostic (7.53e-2)" "unprognostic (3.45e-2)" "unprognostic (2.64e-2)" "unprognostic (1.64e-3)" "unprognostic (9.21e-3)" "unprognostic (3.12e-1)" "unprognostic (9.02e-2)" "unprognostic (1.22e-2)" "unprognostic (5.44e-2)" "prognostic unfavorable (7.59e-11)" "unprognostic (1.64e-2)" "unprognostic (5.60e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (8.42e-4)" 5.0 10.2 14.5 20.1 13.9 39.0 3.5 11.1 14.1 5.6 59.1 4.2 3.0 11.9 13.3 3.4 3.7 9.4 4.5 15.0 16.0 3.6 3.0 12.2 15.2 17.9 16.4 6.2 4.6 1.3 4.5 15.5 17.1 3.9 4.0 2.2 2.2 8.0 1.1 1.7 6.2 10.9 13.1 12.8 6.3 2.3 17.3 19.5 3.3 1.0 11.7 8.3 3.8 17.5 38.8 18.2 8.2 5.3 20.5 10.0 27.8 3.1 1.2 1.8 1.5 0.0 51.2 0.2 5.6 5.4 42.3 9.9 4.9 20.8 2.2 0.4 7.1 53.2 4.8 0.2 3.1 62.4 60.6 3.7 2.9 32.9 5.4 30.7 13.2 74.4 82.8 13.2 3.5 9.7 47.8 73.1 6.6 0.4 7.0 54.0 27.3 12.9 17.0 0.4 13.6 21.9 2.1 26.3 48.3 7.2 7.7 62.7 29.2 5.7 6.2 29.4 32.3 67.2 75.9 10.6 26.3 43.5 57.7 12.7 1.4 11.2 3.0 1.4 1.7 1.0 1.5 2.2 0.8 2.8 0.7 1.9 15.6 1.6 1.3 2.9 3.2 0.8 14.5 13.9 11.1 14.1 15.0 16.0 17.9 16.4 17.1 13.1 17.3 17.5 8.4 16.0 13.1 142.4 33.8 2.8 18.2 2.6 4.0 3.1 0.5 1.1 5.7 1.5 6.4 5.5 0.0 41.6 45.6 0.1 0.0 4.9 0.9 1.3 24.7 12.9 0.0 36.2 43.8 61.4 12.0 9.5 2.6 0.9 41.3 1.4 18.2 0.5 42.6 10.1 114.4 0.0 0.0 26.8 42.9 2.0 7.5 56.5 3.6 281.1 65.6 2.3 30.9 1012.8 3.5 28.6 0.0 17.0 64.0 3.9 0.0 6.0 8.1 0.6 6.6 1.8 12.8 0.6 2.5 0.9 2.8 26.5 49.0 15.5 0.3 3.7 CHST12 "C4S-2, C4ST2" ENSG00000136213 "Carbohydrate sulfotransferase 12" Q9NRB3 7 2403588-2448484 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "dendritic cells: 158.7;Hepatic stellate cells: 152.8;NK-cells: 368.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 60.1;NB-4: 57.4;U-266/70: 88.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041680 Approved Approved "Golgi apparatus" NA NA 960000 "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA041680: AB_10959789" "unprognostic (4.12e-2)" "unprognostic (3.56e-1)" "unprognostic (3.04e-3)" "unprognostic (1.59e-1)" "unprognostic (2.05e-3)" "unprognostic (7.15e-2)" "unprognostic (2.01e-3)" "unprognostic (1.34e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-2)" "prognostic favorable (1.32e-5)" "unprognostic (9.61e-2)" "unprognostic (1.66e-3)" "unprognostic (4.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" 16.1 13.3 4.5 5.1 3.5 6.1 15.0 7.3 5.0 15.4 0.2 13.7 5.4 17.8 0.6 7.9 15.8 1.2 15.5 9.0 2.6 11.3 7.1 14.5 2.9 9.4 4.7 11.6 11.7 1.4 17.6 2.8 4.6 13.6 0.6 1.2 10.3 2.8 8.3 15.6 10.6 1.4 3.8 24.5 11.1 9.1 5.9 1.4 14.1 0.9 1.0 13.1 13.1 4.3 9.5 9.1 2.7 10.0 3.8 2.3 29.5 17.2 4.2 4.2 5.7 9.0 3.2 8.5 31.6 2.7 10.3 7.1 1.6 2.2 0.8 11.2 17.7 5.9 7.0 9.9 2.6 19.4 60.1 4.8 0.9 3.8 0.5 3.3 4.2 11.5 15.1 25.0 1.2 6.8 19.8 57.4 19.1 1.3 14.4 7.1 7.6 42.1 1.2 3.8 6.8 28.7 8.4 4.5 4.0 2.0 6.6 22.3 13.0 9.6 26.5 20.0 15.2 88.9 37.1 3.9 7.8 8.8 17.9 59.1 10.4 53.2 87.6 9.1 54.4 14.7 30.0 71.4 20.4 18.3 12.6 37.8 3.1 121.6 3.9 64.9 33.0 22.9 4.5 3.5 7.3 5.0 9.0 2.6 9.4 4.7 4.6 3.8 5.9 4.3 36.8 16.0 50.5 9.1 32.8 18.1 35.5 24.3 18.8 45.6 18.0 13.0 8.3 15.7 30.5 18.4 66.7 104.5 158.7 6.2 1.9 22.4 6.7 4.7 21.1 59.4 12.7 37.0 11.0 15.3 15.0 37.0 6.1 6.4 38.0 13.4 152.8 7.2 24.8 47.1 12.3 9.1 24.4 26.4 22.9 5.8 95.7 21.2 21.4 10.3 21.3 15.1 368.7 14.1 9.5 13.3 6.7 67.7 107.8 18.4 16.2 9.5 15.2 50.5 19.7 25.6 17.9 37.8 30.6 9.2 15.3 133.5 93.2 18.4 12.2 13.1 CHST13 C4ST3 ENSG00000180767 "Carbohydrate sulfotransferase 13" Q8NET6 3 126524155-126543291 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 59.6;testis: 18.3" "Group enriched" "Detected in some" 5 "Early spermatids: 104.0;Hepatocytes: 40.3;Spermatocytes: 126.2" "Group enriched" "Detected in many" 4 "liver cancer: 25.0;renal cancer: 6.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 5 "eosinophil: 155.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 155.2" "Group enriched" "Detected in some" 8 "CACO-2: 15.6;Hep G2: 28.4;NB-4: 19.0;THP-1: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA067960 Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 62: Liver - Hemostasis" "Cluster 39: CACO-2 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA067960: " "unprognostic (5.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (6.42e-4)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (8.45e-3)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (5.75e-2)" "unprognostic (5.16e-2)" "unprognostic (6.68e-2)" "unprognostic (2.26e-1)" "unprognostic (1.59e-2)" 0.3 0.4 0.2 0.4 0.2 0.6 0.1 0.0 0.3 0.1 0.0 0.9 0.6 0.1 0.0 0.0 0.2 0.0 0.4 0.3 0.2 3.2 59.6 0.6 0.1 0.4 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 3.5 0.4 18.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.7 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.7 0.3 28.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.9 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.1 33.0 155.2 0.0 20.5 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 30.7 0.0 17.5 0.0 0.0 13.1 0.2 0.2 0.0 0.3 0.3 0.2 0.4 0.5 0.2 0.4 0.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 104.0 0.6 0.0 0.1 1.2 5.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.7 40.3 13.1 0.0 0.0 1.0 0.0 7.5 1.3 16.9 1.5 6.2 0.0 1.9 7.2 0.0 0.0 0.0 0.1 0.0 2.8 1.2 0.3 0.0 8.5 9.9 0.1 0.0 0.0 0.0 0.0 126.2 2.8 0.0 0.0 0.3 0.2 0.0 1.8 0.0 CHST14 "D4ST-1, D4ST1, HD4ST" ENSG00000169105 "Carbohydrate sulfotransferase 14" Q8NCH0 15 40470984-40473158 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.5;Extravillous trophoblasts: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057697, HPA071601" Enhanced Approved "Golgi apparatus" NA NA 20000 "Cluster 34: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" "HPA057697: AB_2683505, HPA071601: AB_2686425" "unprognostic (5.46e-2)" "unprognostic (9.23e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-2)" "unprognostic (6.94e-2)" "unprognostic (1.70e-1)" "unprognostic (9.95e-2)" "unprognostic (2.84e-1)" "unprognostic (3.17e-2)" "unprognostic (5.85e-3)" "unprognostic (2.01e-3)" "unprognostic (1.94e-1)" "unprognostic (6.34e-2)" "unprognostic (2.25e-2)" 14.2 9.6 6.8 7.7 7.5 3.4 13.7 7.0 6.5 22.0 7.3 11.8 4.5 21.6 8.0 8.7 16.5 11.3 13.8 6.2 7.0 10.1 8.8 13.0 8.5 8.0 7.1 21.1 8.1 11.3 14.4 27.0 7.2 14.6 4.6 1.6 11.0 15.4 5.0 9.1 9.9 12.6 7.5 13.6 9.4 7.9 7.0 8.6 15.8 7.4 7.5 16.1 16.1 7.3 26.2 17.1 26.4 71.6 40.4 31.0 43.0 25.2 47.3 43.5 40.9 21.2 12.8 4.3 37.6 42.7 76.7 43.7 23.7 14.2 20.3 31.5 15.0 13.4 16.9 19.8 22.5 5.7 33.4 38.3 11.6 15.4 11.6 47.8 39.2 15.1 13.6 15.0 32.6 20.1 9.6 29.8 17.0 7.9 20.1 26.2 33.4 7.6 29.5 13.3 19.7 30.2 22.2 24.4 8.4 31.9 35.7 23.9 31.9 73.0 27.1 23.3 25.5 30.3 22.6 12.2 32.8 19.6 53.7 7.6 1.1 2.2 2.2 1.1 0.6 0.3 1.1 1.9 2.0 1.1 0.9 0.8 0.1 3.3 0.6 0.7 0.8 0.7 6.8 7.5 7.0 6.5 6.2 7.0 8.0 7.1 7.2 7.5 7.0 7.3 10.6 12.8 1.1 2.0 5.8 3.4 5.4 4.1 9.1 0.6 5.8 9.7 3.2 7.2 4.6 3.7 0.0 46.5 3.5 0.5 0.0 7.7 1.8 3.2 14.5 10.2 2.4 10.7 0.1 4.9 32.4 19.3 0.0 5.6 4.5 14.9 15.4 3.7 9.3 1.7 0.1 1.4 2.0 5.6 3.3 1.3 17.7 5.6 5.4 2.8 3.4 9.8 6.2 2.0 0.5 5.2 0.3 11.7 1.9 3.6 0.2 1.1 3.0 0.8 6.6 11.8 9.2 7.5 1.3 5.6 2.6 13.5 4.9 3.9 1.9 1.3 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119771-143124014 "Metabolic proteins, Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.4" "Cell type enhanced" "Detected in many" "Muller glia cells: 114.4;NK-cells: 233.8;Plasma cells: 79.3;Sertoli cells: 92.1;Theca cells: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 4.3;NK-cell: 4.9;non-classical monocyte: 11.4" "Group enriched" "Detected in many" 5 "monocytes: 11.4;NK-cells: 4.9" "Cell line enhanced" "Detected in many" "ASC diff: 57.7;ASC TERT1: 58.8;HEL: 48.2;HHSteC: 118.4;HMC-1: 55.4;HSkMC: 62.3;U-266/70: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 5: Muller glia cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: AB_2668861" "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 7.7 2.7 17.8 8.1 13.7 16.8 6.3 16.7 14.6 5.7 6.0 3.0 2.1 8.4 1.4 1.1 2.1 1.7 5.6 9.7 13.4 8.4 1.3 7.5 7.7 31.0 18.4 4.9 1.3 0.9 6.9 10.3 28.1 7.4 1.1 11.0 2.7 9.9 1.6 4.4 7.5 3.7 21.4 18.2 3.4 1.7 28.7 14.5 6.7 0.8 5.4 7.1 7.6 48.4 0.0 0.3 3.1 2.6 57.7 58.8 0.2 3.3 9.5 2.3 2.1 0.0 0.0 0.6 2.0 2.3 3.1 0.1 2.3 8.2 1.2 0.8 1.5 48.2 0.1 0.0 118.4 1.2 55.4 62.3 9.7 3.1 10.1 3.6 3.6 7.2 5.5 2.9 15.4 0.0 9.1 12.2 16.5 0.0 8.0 0.5 1.0 0.1 1.7 2.2 3.7 0.0 0.7 0.0 5.6 2.9 0.0 1.9 12.3 7.0 4.1 9.5 13.9 52.4 0.8 3.3 13.8 9.3 37.4 0.7 0.5 0.7 0.3 4.3 0.0 1.1 0.1 0.2 1.6 0.8 0.6 0.5 0.3 4.9 11.4 0.1 0.5 0.9 17.8 13.7 16.7 14.6 9.7 13.4 31.0 18.4 28.1 21.4 28.7 48.4 11.3 0.0 0.0 3.6 17.7 2.4 7.3 2.5 0.0 25.0 2.8 2.7 1.4 0.0 1.8 3.7 2.1 0.6 41.9 0.0 0.0 0.4 0.2 5.7 29.8 9.4 0.0 39.1 6.8 0.2 0.6 14.4 2.0 6.5 11.4 12.5 3.6 0.4 2.8 1.7 8.1 0.0 0.0 10.3 32.2 1.3 12.8 20.2 17.8 1.0 13.6 114.4 233.8 2.5 6.1 5.9 0.0 2.2 79.3 13.1 0.0 0.0 0.1 23.8 92.1 0.8 20.2 0.0 2.2 0.1 0.6 1.0 9.8 58.1 1.3 14.8 CHST3 "C6ST, C6ST1" ENSG00000122863 "Carbohydrate sulfotransferase 3" Q7LGC8 10 71964395-72013558 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 26.9;Oligodendrocyte precursor cells: 26.7;Oligodendrocytes: 27.1;Skeletal myocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 65.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047523, HPA055704" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 690000 "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus, Cytosol" "HPA047523: AB_2680075, HPA055704: AB_2682891" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.13e-3)" "unprognostic (1.16e-3)" "unprognostic (2.44e-1)" "unprognostic (4.67e-2)" "unprognostic (4.79e-2)" "unprognostic (7.53e-2)" "unprognostic (7.99e-2)" "unprognostic (3.71e-2)" "unprognostic (2.83e-3)" "unprognostic (5.99e-2)" "unprognostic (1.40e-2)" "unprognostic (2.65e-2)" "unprognostic (7.77e-2)" "unprognostic (2.56e-2)" "unprognostic (2.54e-3)" 18.4 13.4 10.7 5.5 17.9 0.0 11.4 16.8 11.5 10.7 6.2 11.9 0.9 16.0 3.7 6.4 12.9 4.7 14.3 9.9 12.9 7.9 1.2 7.9 1.6 27.9 18.2 20.6 4.6 1.2 4.6 8.0 19.8 11.1 2.1 2.1 6.4 14.8 17.7 8.7 5.4 17.1 14.0 2.5 14.7 18.1 17.3 4.2 5.5 9.0 1.4 9.4 8.4 25.3 15.4 16.4 8.2 20.3 36.6 14.4 0.3 32.0 30.4 19.3 12.8 14.4 30.1 0.0 21.4 37.9 15.5 19.7 7.4 21.9 15.3 0.4 5.5 0.1 27.8 13.8 18.7 0.0 0.1 19.8 24.9 19.0 25.9 37.3 5.7 0.7 4.7 0.0 20.6 0.4 0.0 0.1 3.5 0.5 5.3 0.2 9.9 0.0 26.9 15.7 0.5 8.1 24.2 0.6 24.1 9.9 1.8 3.1 11.9 23.6 27.1 39.6 65.1 0.0 0.1 0.1 17.2 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 17.9 16.8 11.5 9.9 12.9 27.9 18.2 19.8 14.0 17.3 25.3 23.9 0.0 1.9 14.0 0.1 2.8 4.9 6.1 13.6 0.1 4.3 8.0 10.4 5.7 2.5 7.3 0.0 4.6 0.0 0.1 3.9 9.7 0.8 20.1 24.7 5.6 0.0 0.0 0.2 2.7 2.2 9.3 2.6 17.9 1.3 26.9 13.6 0.3 0.8 0.0 0.3 0.0 2.0 0.6 1.9 3.2 20.5 0.7 8.8 4.7 0.7 6.6 0.0 26.7 27.1 12.7 0.0 21.8 0.0 4.2 0.0 3.6 2.0 0.2 6.6 26.8 13.9 1.0 2.1 7.5 2.4 1.1 0.4 5.5 0.1 1.3 CLASP2 KIAA0627 ENSG00000163539 "Cytoplasmic linker associated protein 2" O75122 3 33496245-33718356 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 176.6;retina: 126.4" "Cell type enhanced" "Detected in all" "Astrocytes: 294.5;Excitatory neurons: 514.2;Inhibitory neurons: 526.3;Oligodendrocyte precursor cells: 739.9;Oligodendrocytes: 1315.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067071 Supported "Golgi apparatus,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Cytosol "HPA067071: AB_2685775" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (7.24e-3)" "unprognostic (5.46e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (1.27e-2)" "unprognostic (4.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-2)" "unprognostic (2.60e-3)" "unprognostic (3.25e-2)" "prognostic favorable (1.48e-6)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (1.07e-2)" "unprognostic (5.72e-2)" 14.0 25.1 43.4 12.1 84.1 12.3 15.8 100.7 79.1 21.4 0.0 16.9 9.9 20.5 11.3 17.9 16.0 17.7 40.4 44.8 57.5 18.1 10.8 15.3 15.4 69.0 49.9 27.3 11.5 17.7 33.3 15.6 85.9 16.6 13.1 126.4 8.8 20.7 64.9 13.0 11.0 19.4 67.8 14.5 11.2 11.8 60.0 16.1 14.1 63.4 15.9 14.5 11.5 176.6 13.5 29.4 32.9 27.8 20.9 20.4 23.6 24.8 23.2 28.5 30.6 17.2 13.8 44.4 14.1 19.6 18.3 11.5 43.0 19.7 34.4 36.0 30.5 43.7 24.6 15.4 9.9 43.6 35.8 12.7 19.3 30.9 29.2 16.5 28.0 27.0 43.3 24.8 31.1 7.6 32.5 18.6 24.5 13.5 18.4 34.5 30.9 24.1 17.9 15.2 27.4 46.4 28.7 22.1 24.7 26.5 20.9 38.1 27.0 22.3 19.4 16.9 27.7 17.3 34.6 36.5 20.2 29.6 28.8 3.7 4.6 2.6 3.3 4.5 5.1 6.1 2.9 3.2 6.5 3.7 3.9 3.6 0.9 9.1 7.0 6.1 3.5 4.8 43.4 84.1 100.7 79.1 44.8 57.5 69.0 49.9 85.9 67.8 60.0 176.6 19.7 6.4 11.7 294.5 29.9 21.0 8.6 8.8 18.8 103.3 26.0 13.8 37.4 15.7 12.7 14.7 156.4 12.3 36.2 9.9 1.9 6.4 2.8 20.8 15.6 16.1 14.4 12.2 514.2 7.0 8.1 19.2 26.5 27.9 12.0 17.8 16.1 13.9 15.0 92.5 526.3 8.8 8.2 32.3 26.6 2.9 14.3 26.0 16.0 128.4 19.5 32.0 22.6 739.9 1315.9 8.0 5.6 13.5 28.8 12.3 6.1 12.2 13.8 120.6 6.6 34.2 22.9 11.1 14.4 19.3 30.7 12.9 25.6 15.5 11.2 8.8 CLCN5 "ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN" ENSG00000171365 "Chloride voltage-gated channel 5" P51795 X 49922596-50099235 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "epididymis: 23.7;kidney: 46.2;liver: 16.9" "Cell type enriched" "Detected in many" 4 "Skeletal myocytes: 214.4" "Cancer enhanced" "Detected in all" "renal cancer: 9.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.6;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in all" 4 "CACO-2: 49.0;RH-30: 66.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000401, HPA003213" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Plasma membrane" Cytosol "HPA000401: AB_1078531, HPA003213: AB_2666843" "unprognostic (3.33e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.57e-1)" "unprognostic (7.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.54e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.20e-4)" "unprognostic (3.59e-2)" "prognostic favorable (2.05e-8)" "unprognostic (7.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" 2.1 2.5 1.7 1.7 1.9 1.5 1.6 3.8 1.6 1.8 2.5 2.4 4.9 4.0 23.7 2.4 3.0 3.9 1.3 1.5 2.9 46.2 16.9 2.8 1.3 3.2 3.2 7.0 2.1 1.4 2.3 5.8 3.7 1.7 2.8 3.4 2.5 1.0 4.0 4.8 3.8 2.9 2.5 1.8 2.9 2.1 2.7 1.1 2.2 2.8 1.2 1.4 2.0 2.3 2.9 5.4 4.2 5.5 12.8 7.5 7.9 2.8 1.2 1.6 1.9 49.0 3.0 3.5 1.2 2.5 9.7 2.8 9.9 1.7 2.2 1.1 7.5 3.3 2.7 12.8 7.2 4.1 5.7 4.9 1.6 3.7 5.9 1.2 5.8 4.0 4.3 4.7 5.3 3.2 1.6 1.4 5.7 7.4 2.4 1.9 66.0 5.2 6.0 5.5 7.2 5.2 3.3 3.0 5.1 14.1 3.0 2.1 3.8 1.6 3.7 12.7 1.4 3.6 11.9 7.3 2.8 6.6 8.5 0.0 0.9 0.0 0.1 0.9 0.1 0.1 0.2 0.2 2.6 0.1 0.0 0.0 0.2 0.1 0.1 2.8 0.0 0.3 1.7 1.9 3.8 1.6 1.5 2.9 3.2 3.2 3.7 2.5 2.7 2.3 4.3 9.6 8.4 20.5 2.1 7.1 1.8 1.6 5.2 27.4 1.8 1.4 1.9 2.8 2.3 12.9 2.1 6.2 17.7 11.3 11.7 4.1 2.0 8.0 10.0 5.5 0.0 3.4 11.5 3.5 2.6 7.9 8.6 22.8 2.5 0.8 1.4 35.2 11.1 8.4 15.6 6.6 4.1 17.6 19.8 0.6 5.3 10.9 3.6 46.9 10.1 2.7 2.1 20.6 9.6 7.7 7.3 13.2 2.2 4.0 20.4 38.8 4.2 4.3 0.0 214.4 4.8 0.9 2.3 8.1 9.5 5.1 1.9 9.3 7.0 4.8 CLEC14A C14orf27 ENSG00000176435 "C-type lectin domain containing 14A" Q86T13 14 38254000-38256093 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 13 "Adipocytes: 396.6;Endothelial cells: 272.8;Hepatic stellate cells: 567.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 83.7;HUVEC TERT2: 451.8;TIME: 158.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039468, HPA048119" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 4100000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Endoplasmic reticulum, Golgi apparatus" "HPA039468: AB_2676524, HPA048119: AB_2680270" "unprognostic (4.02e-1)" "unprognostic (4.26e-2)" "unprognostic (4.20e-3)" "unprognostic (9.44e-2)" "unprognostic (1.35e-1)" "prognostic favorable (4.13e-6)" "unprognostic (2.55e-3)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (6.90e-2)" "unprognostic (5.41e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-2)" "unprognostic (1.75e-2)" "unprognostic (1.55e-1)" "unprognostic (4.97e-2)" "unprognostic (5.28e-2)" 67.1 9.5 13.6 7.9 13.4 0.1 50.6 13.8 15.2 24.8 10.9 15.2 10.1 31.2 7.6 11.1 22.6 19.0 65.1 11.5 13.3 15.9 9.4 55.5 6.6 15.0 13.9 9.5 7.8 10.5 6.1 25.0 15.4 14.5 7.2 0.8 13.6 9.8 33.2 15.8 18.8 19.8 13.1 16.7 13.8 3.5 14.9 4.6 31.4 43.3 4.2 19.2 16.8 15.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 451.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 13.4 13.8 15.2 11.5 13.3 15.0 13.9 15.4 13.1 14.9 15.6 396.6 0.0 3.2 0.0 0.9 3.4 0.2 0.0 1.8 0.1 1.5 2.5 6.4 1.5 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.1 0.2 0.5 272.8 0.0 0.0 0.4 0.2 0.1 31.0 0.0 0.3 1.3 0.1 567.2 2.1 0.4 0.0 0.2 0.0 0.0 6.4 3.1 1.0 0.6 1.1 5.4 15.0 0.0 0.2 0.0 4.0 2.9 0.0 0.0 0.4 1.4 0.2 0.0 0.0 0.0 0.5 0.0 14.1 7.5 1.6 0.9 0.9 3.1 0.1 1.3 6.7 0.0 0.3 CLEC2D "CLAX, LLT1, OCIL" ENSG00000069493 "C-type lectin domain family 2 member D" Q9UHP7 12 9664969-9699553 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.5" "Cell type enhanced" "Detected in many" "B-cells: 128.6;dendritic cells: 112.0;Early spermatids: 95.5;monocytes: 81.6;NK-cells: 131.8;T-cells: 215.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 10 "gdT-cell: 188.1;MAIT T-cell: 114.5;memory B-cell: 95.0;memory CD4 T-cell: 183.3;memory CD8 T-cell: 208.7;naive B-cell: 127.5;naive CD4 T-cell: 192.3;naive CD8 T-cell: 223.0;T-reg: 175.2" "Group enriched" "Detected in all" 11 "B-cells: 127.5;T-cells: 223.0" "Group enriched" "Detected in many" 4 "Daudi: 67.9;HDLM-2: 53.3;Karpas-707: 31.0;U-698: 105.8" "HPA017649, HPA047584" Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA017649: AB_1846912, HPA047584: " "unprognostic (1.09e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (1.29e-1)" "unprognostic (2.77e-4)" "unprognostic (4.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.85e-11)" "unprognostic (1.17e-1)" "unprognostic (2.70e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.68e-7)" 6.1 1.8 3.6 16.7 3.5 16.0 5.6 3.3 4.9 6.4 3.1 4.8 3.3 4.5 11.8 3.2 5.3 5.5 5.3 3.2 3.7 3.9 2.9 8.6 53.5 4.0 3.4 6.0 2.4 0.8 2.3 2.6 3.9 7.3 3.9 2.2 6.5 4.5 2.9 3.7 20.3 2.0 3.5 26.6 5.5 9.5 4.1 31.6 4.5 1.3 41.7 5.7 4.6 4.2 1.2 2.5 3.5 0.3 0.5 1.4 4.0 1.7 2.5 0.6 2.1 1.9 2.1 67.9 0.3 1.8 1.0 0.7 1.2 0.2 1.1 53.3 0.9 2.1 1.6 2.9 5.7 1.7 1.7 2.3 1.7 0.5 2.1 8.0 0.1 1.2 0.5 31.0 1.5 4.5 0.7 5.9 3.2 0.2 0.4 14.9 1.6 2.2 3.4 3.6 0.6 1.3 0.9 2.8 3.0 6.6 0.6 1.8 0.6 1.3 1.8 1.0 1.2 4.4 1.1 105.8 2.8 3.1 2.1 6.8 2.1 1.5 188.1 1.4 114.5 95.0 183.3 208.7 2.3 127.5 192.3 223.0 6.0 16.5 1.3 1.6 175.2 109.8 3.6 3.5 3.3 4.9 3.2 3.7 4.0 3.4 3.9 3.5 4.1 4.2 8.9 6.4 20.7 11.8 128.6 4.1 39.7 2.1 1.8 1.3 6.5 6.1 9.6 4.3 7.1 1.8 4.2 10.4 112.0 0.8 7.9 3.0 95.5 3.6 6.9 13.0 0.0 21.5 6.3 1.9 6.0 12.2 4.6 6.2 20.2 18.1 12.5 2.3 9.2 5.0 6.8 2.5 0.0 20.9 17.8 28.3 8.4 19.4 1.8 56.2 81.6 3.2 131.8 27.6 4.4 2.8 2.0 9.8 71.5 17.2 0.5 2.1 7.4 2.3 19.7 26.2 8.7 5.7 6.3 1.9 4.8 4.8 215.1 7.4 3.5 24.3 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769978 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in some" 6 "basal ganglia: 7.8" "Low region specificity" "Detected in many" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" Yes Yes "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA026305: AB_2671833, HPA026312: AB_2671837" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favorable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 0.5 0.2 0.7 3.2 0.6 11.3 0.5 0.6 1.4 0.2 0.4 1.4 1.0 0.4 0.7 0.9 0.2 0.3 0.1 1.3 0.3 0.2 0.5 0.4 4.9 0.4 0.4 0.1 0.1 0.2 0.0 1.5 0.6 0.2 2.0 6.8 0.2 0.1 0.6 1.2 1.0 0.9 0.2 1.3 0.9 5.7 0.6 7.9 0.2 0.0 5.2 0.6 0.4 0.9 22.0 17.5 37.8 19.9 2.6 4.8 14.1 43.6 12.0 31.0 41.3 27.9 19.6 45.7 13.9 11.8 22.7 21.4 37.1 14.9 48.1 31.6 16.8 64.5 38.1 12.6 0.1 54.0 36.8 1.0 0.6 53.8 3.7 3.7 16.9 27.1 44.2 30.8 30.3 14.1 56.9 13.1 36.0 14.9 12.2 36.0 57.0 13.8 6.4 35.3 14.0 16.2 37.7 11.6 7.4 25.6 10.0 21.1 12.5 44.6 33.8 27.6 49.3 11.1 29.1 47.1 14.1 37.4 37.0 1.1 0.3 0.3 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.2 1.0 0.5 0.2 0.2 0.3 0.3 0.7 0.6 0.6 1.4 1.3 0.3 0.4 0.4 0.6 0.2 0.6 0.9 2.6 0.0 0.5 0.3 6.5 5.6 5.7 4.4 1.2 9.4 2.9 3.8 1.4 2.8 2.7 0.0 12.5 19.7 4.6 12.8 0.0 1.6 7.9 1.0 3.6 3.6 1.2 55.6 1.6 0.6 41.1 5.2 4.6 3.3 1.3 12.0 2.2 0.4 16.9 1.7 1.5 9.4 2.0 3.0 8.2 6.1 2.5 5.8 3.6 0.0 9.1 9.4 4.1 0.0 0.6 1.4 9.5 0.4 32.5 1.8 0.4 0.2 0.0 101.0 6.6 5.3 8.7 281.1 263.3 5.8 2.0 10.4 7.2 1.2 12.0 3.9 CMTM4 CKLFSF4 ENSG00000183723 "CKLF like MARVEL transmembrane domain containing 4" Q8IZR5 16 66614750-66696743 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 68.0;Granulosa cells: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014704, HPA023890" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus, Vesicles, Plasma membrane" "HPA014704: AB_1847005, HPA023890: AB_1847007" "unprognostic (2.65e-3)" "unprognostic (1.16e-1)" "unprognostic (6.17e-3)" "unprognostic (3.43e-1)" "unprognostic (5.13e-1)" "unprognostic (8.30e-2)" "unprognostic (2.88e-2)" "unprognostic (2.65e-1)" "unprognostic (3.35e-3)" "unprognostic (6.06e-3)" "unprognostic (2.07e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.72e-9)" "unprognostic (1.41e-1)" "unprognostic (2.31e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" 4.5 5.0 36.4 2.7 34.1 2.5 5.7 32.8 34.5 3.9 28.3 16.1 11.9 4.4 20.1 6.0 10.6 2.9 4.1 43.1 37.1 26.3 4.1 8.4 0.6 42.1 41.7 3.4 19.2 32.7 14.4 2.1 35.4 7.7 12.6 7.8 11.1 3.8 3.3 7.7 12.9 3.4 41.8 2.0 31.4 6.9 45.5 0.5 38.6 2.1 1.1 3.2 4.1 41.6 16.0 12.9 7.8 19.1 2.6 4.2 31.7 6.6 5.9 3.5 5.6 24.2 17.7 0.7 10.8 3.9 4.8 20.0 19.7 7.8 5.2 1.3 17.2 1.7 5.3 15.2 5.6 1.4 3.0 6.7 13.4 4.2 8.1 11.9 2.0 2.3 8.0 4.1 5.1 18.5 0.1 3.2 8.7 28.6 8.6 3.5 10.6 4.9 15.2 14.2 17.9 7.1 27.4 14.6 9.3 5.6 15.3 3.4 4.3 6.5 7.0 1.8 6.6 1.4 3.3 0.7 8.1 3.2 7.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 36.4 34.1 32.8 34.5 43.1 37.1 42.1 41.7 35.4 41.8 45.5 41.6 2.6 22.4 11.1 32.7 0.8 5.2 8.8 21.9 4.6 9.5 23.5 10.8 7.1 15.7 19.3 23.9 8.4 5.0 1.6 51.7 13.7 15.9 1.9 20.7 2.7 4.3 39.0 0.8 68.0 24.0 29.6 3.5 27.5 12.3 4.5 67.6 1.8 6.1 2.4 30.3 37.7 24.1 20.3 2.8 0.9 3.0 2.5 1.9 3.6 7.5 4.4 24.2 0.0 37.7 51.3 30.8 19.5 3.0 0.6 29.0 30.7 19.9 40.0 11.1 6.6 3.1 8.8 6.4 7.7 7.5 5.5 2.9 0.9 2.5 43.4 19.4 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376773-23379772 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 182.4;choroid plexus: 49.5" "Cell type enhanced" "Detected in some" "Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 20.8" "Lineage enriched" "Detected in many" 19 "granulocytes: 20.8" "Cell line enriched" "Detected in some" 7 "HEL: 91.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 540000 "Cluster 34: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.1 1.0 75.6 0.5 119.1 8.2 0.9 123.8 101.7 2.8 49.5 5.8 0.5 0.8 1.1 1.2 1.2 2.1 22.7 73.9 85.2 0.5 0.3 1.5 0.2 150.9 106.2 0.8 0.2 0.1 0.6 0.7 135.2 2.1 0.8 2.3 2.2 3.2 3.1 0.7 1.7 0.8 113.4 2.8 1.4 0.1 110.2 0.1 0.5 0.9 0.0 1.2 2.6 182.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 91.8 0.0 0.0 0.2 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.2 20.8 0.7 0.9 0.1 0.4 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 4.2 0.0 0.0 1.0 0.4 30.0 75.6 119.1 123.8 101.7 73.9 85.2 150.9 106.2 135.2 113.4 110.2 182.4 0.5 0.0 0.0 6.5 0.4 1.0 0.1 0.0 1.2 0.2 1.3 5.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.4 0.0 0.0 93.7 5.4 0.0 1.5 32.0 0.0 20.6 106.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 3.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 CNKSR2 "CNK2, KIAA0902, KSR2" ENSG00000149970 "Connector enhancer of kinase suppressor of Ras 2" Q8WXI2 X 21372801-21654695 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 22.6;retina: 17.9" "Cell type enhanced" "Detected in many" "Astrocytes: 111.7;Excitatory neurons: 497.7;Inhibitory neurons: 143.6;Oligodendrocyte precursor cells: 93.5;Rod photoreceptor cells: 86.1" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.9;AF22: 4.0;NTERA-2: 8.9;PC-3: 4.8;RH-30: 8.2;U-251 MG: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001502 Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 58: Brain - Synaptic function" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Plasma membrane" "HPA001502: AB_1078542" "unprognostic (1.33e-2)" "unprognostic (1.00e-3)" "unprognostic (5.35e-2)" "unprognostic (4.90e-4)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-2)" "unprognostic (3.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-2)" "unprognostic (3.93e-2)" "unprognostic (2.27e-2)" "unprognostic (4.13e-2)" 1.5 2.6 8.4 0.3 12.2 0.2 1.4 22.6 16.4 1.0 0.0 0.7 0.1 0.3 0.5 0.0 1.3 0.1 0.8 20.3 0.0 0.1 0.7 1.2 0.9 0.0 0.0 0.6 2.5 0.0 1.6 0.1 0.0 0.7 0.0 17.9 0.5 0.1 4.7 0.8 0.6 0.1 0.0 0.5 1.2 0.6 0.0 0.9 0.9 1.3 1.0 0.6 0.9 5.3 0.0 5.9 4.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 2.0 0.0 8.9 0.0 4.8 0.0 8.2 0.0 0.0 0.0 3.9 1.6 0.0 0.1 0.3 2.1 0.0 0.6 0.0 0.1 1.9 0.0 5.3 3.1 0.0 3.4 0.8 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.9 0.8 0.2 0.0 0.0 0.0 0.0 0.2 0.1 8.4 12.2 22.6 16.4 20.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.3 16.0 1.3 111.7 9.0 1.3 0.5 0.0 1.2 17.8 0.3 0.6 5.7 1.5 5.6 0.0 20.9 0.1 2.1 0.4 0.0 0.3 0.3 1.0 13.6 0.3 0.0 0.8 497.7 2.3 0.0 6.7 0.0 1.3 1.3 1.0 0.0 2.1 0.1 23.5 143.6 0.5 0.0 0.0 2.6 0.0 0.6 0.2 0.0 15.9 0.2 12.7 0.0 93.5 10.6 0.6 0.1 1.5 3.1 2.0 1.3 0.3 0.0 86.1 0.0 0.6 0.9 6.0 7.7 0.1 1.8 0.0 2.9 1.5 0.4 0.0 COG2 LDLC ENSG00000135775 "Component of oligomeric golgi complex 2" Q14746 1 230642481-230693982 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 71.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076994 Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA076994: AB_2686823" "unprognostic (2.21e-1)" "unprognostic (7.35e-2)" "prognostic favorable (9.76e-4)" "unprognostic (2.91e-1)" "unprognostic (1.32e-3)" "unprognostic (3.59e-1)" "unprognostic (1.08e-1)" "unprognostic (4.06e-1)" "unprognostic (2.18e-1)" "unprognostic (5.87e-2)" "unprognostic (6.83e-3)" "unprognostic (1.08e-1)" "unprognostic (2.73e-2)" "unprognostic (2.61e-1)" "unprognostic (4.44e-2)" "unprognostic (2.18e-2)" "unprognostic (5.62e-2)" 10.1 22.0 10.7 11.0 11.8 9.1 12.9 14.7 13.1 13.1 13.5 19.0 13.5 10.0 13.8 8.9 14.2 10.9 17.2 10.0 10.9 16.6 9.9 10.0 16.3 11.0 11.2 10.0 14.1 71.2 8.5 8.9 10.9 12.1 22.7 10.9 12.8 10.9 20.1 11.8 13.3 11.7 11.1 15.1 14.4 10.9 11.5 16.6 15.0 19.9 16.2 11.1 9.1 12.4 15.6 18.0 21.1 20.4 20.6 16.0 30.7 13.2 20.4 21.4 18.6 24.2 23.2 47.6 20.2 18.1 13.8 22.8 20.1 23.6 20.3 38.8 39.8 16.8 17.0 24.9 25.4 43.6 25.1 21.7 25.6 13.6 19.5 13.7 18.0 29.1 29.5 25.8 17.4 12.5 39.7 21.2 30.5 47.1 33.1 33.8 33.8 56.7 22.1 22.8 21.7 29.7 15.5 27.9 30.5 9.4 33.6 41.9 15.3 10.3 9.5 12.8 25.9 31.7 28.3 37.7 17.2 17.7 22.1 18.7 15.7 20.5 16.0 19.4 18.5 13.9 15.1 15.5 18.1 15.2 21.6 19.0 0.8 22.9 29.4 9.1 13.5 18.2 10.7 11.8 14.7 13.1 10.0 10.9 11.0 11.2 10.9 11.1 11.5 12.4 12.5 22.4 19.5 22.9 21.0 5.2 6.1 7.8 8.6 16.1 12.3 10.8 25.9 20.0 15.1 12.9 29.2 13.1 19.6 19.8 27.4 18.7 19.3 17.6 15.2 10.7 18.6 14.9 22.3 23.3 11.8 10.8 15.8 10.7 23.4 14.2 11.0 14.1 14.0 25.2 20.5 37.1 12.2 20.1 6.0 6.4 11.5 12.3 7.2 17.8 19.0 20.5 21.6 23.1 22.6 18.0 12.8 14.7 13.0 9.0 15.2 20.3 28.9 42.9 13.1 13.9 13.3 23.3 25.2 10.0 4.8 9.2 18.4 21.0 21.6 6.0 COG3 SEC34 ENSG00000136152 "Component of oligomeric golgi complex 3" Q96JB2 13 45464898-45536701 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040353, HPA054470" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA040353: AB_10794027, HPA054470: AB_2732585" "unprognostic (1.75e-1)" "unprognostic (3.03e-3)" "unprognostic (1.75e-1)" "unprognostic (4.04e-3)" "unprognostic (9.69e-2)" "unprognostic (2.86e-2)" "unprognostic (2.18e-2)" "unprognostic (4.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (5.82e-2)" "unprognostic (1.21e-2)" "unprognostic (4.49e-2)" "unprognostic (7.06e-3)" "unprognostic (1.13e-1)" "unprognostic (8.25e-2)" "unprognostic (1.71e-1)" 11.2 15.0 7.5 9.3 7.7 11.8 15.6 10.5 9.3 15.2 10.5 16.2 12.6 13.0 16.8 12.4 12.2 9.5 11.8 7.4 7.2 12.3 29.5 10.4 10.7 7.0 7.0 15.1 20.8 12.3 14.9 13.0 7.0 18.7 18.9 10.0 18.0 12.4 11.4 13.2 13.2 12.1 6.8 12.4 14.7 9.7 7.5 12.2 17.0 9.7 10.9 12.7 13.1 9.4 8.3 7.4 13.9 12.6 17.9 20.4 13.2 13.5 19.1 15.4 12.8 10.8 14.9 11.3 5.9 16.2 11.4 17.7 11.6 13.7 23.3 8.9 9.3 12.7 9.2 19.2 22.1 18.8 11.7 15.4 20.3 10.3 36.1 18.6 15.2 11.0 8.3 6.8 18.7 12.9 10.5 17.6 11.4 41.5 8.7 12.1 8.1 10.6 14.4 13.4 6.9 12.5 8.7 17.1 18.2 13.1 11.7 19.3 14.4 7.4 5.7 13.9 8.7 9.4 5.4 11.7 14.2 9.4 13.5 3.5 1.9 3.6 3.4 2.2 3.6 2.2 2.6 2.9 1.4 2.3 2.9 2.7 1.7 2.5 1.3 3.4 3.0 1.7 7.5 7.7 10.5 9.3 7.4 7.2 7.0 7.0 7.0 6.8 7.5 9.4 15.8 9.6 31.4 23.2 18.9 15.8 15.2 13.1 14.2 9.7 22.0 17.9 19.7 24.3 19.8 12.9 14.6 14.2 35.5 32.5 15.6 11.6 24.1 15.0 20.1 16.7 22.2 11.4 39.3 37.9 18.8 14.3 26.0 30.8 17.1 22.4 18.9 72.8 10.8 10.1 34.7 54.5 6.1 20.9 9.0 9.0 14.0 13.3 10.6 22.5 13.2 7.6 15.5 34.2 36.9 22.7 32.8 13.5 31.3 26.6 29.4 17.3 11.7 11.2 6.6 12.8 11.7 12.7 8.9 17.7 16.1 32.8 21.2 21.7 24.4 37.3 COG4 "COD1, DKFZP586E1519" ENSG00000103051 "Component of oligomeric golgi complex 4" 16 70480568-70523560 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040924, HPA042539" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" Vesicles "HPA040924: AB_2677203, HPA042539: AB_2678044" "unprognostic (1.30e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (6.08e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (1.64e-5)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "unprognostic (3.02e-1)" "unprognostic (3.35e-1)" "unprognostic (1.99e-2)" "unprognostic (1.79e-1)" 17.8 22.0 25.3 12.8 27.2 14.2 15.7 27.8 27.0 20.2 29.0 20.3 10.5 17.4 11.1 30.1 19.7 12.8 25.7 25.3 26.5 16.9 16.9 18.3 15.4 26.9 26.3 18.8 10.6 27.9 19.0 19.8 26.6 14.4 16.6 14.5 17.1 16.5 67.7 23.8 16.3 19.2 25.9 17.9 17.4 19.2 27.7 22.3 15.9 49.4 17.7 18.5 20.7 28.3 37.3 59.9 47.1 31.3 62.6 43.7 53.0 41.0 53.7 51.0 43.9 48.3 66.7 25.0 57.7 64.9 35.5 53.4 60.8 65.3 70.9 21.5 36.7 23.1 59.8 47.5 36.7 15.3 15.0 51.9 41.9 66.1 40.6 59.7 51.7 31.6 55.9 18.1 57.6 75.9 25.1 23.4 45.2 50.4 30.9 46.8 31.2 57.4 42.3 31.0 43.9 45.5 80.7 30.5 24.3 48.0 77.9 26.4 49.7 46.3 29.1 35.3 29.8 19.1 26.2 78.0 50.7 15.8 46.1 20.6 26.4 23.8 19.7 28.8 14.4 11.8 19.3 17.9 32.8 14.6 16.9 15.7 13.8 14.4 34.4 15.2 24.4 25.1 25.3 27.2 27.8 27.0 25.3 26.5 26.9 26.3 26.6 25.9 27.7 28.3 13.6 16.0 16.0 21.9 11.0 9.1 12.1 22.6 11.4 24.5 9.2 8.0 23.3 2.8 21.1 3.7 14.6 47.7 13.1 20.8 9.8 23.4 3.1 11.9 13.0 16.8 12.6 12.6 10.9 16.0 26.8 16.5 18.8 13.4 8.8 28.7 16.8 17.8 24.7 8.4 13.0 18.0 24.4 14.1 8.9 6.7 14.6 11.1 8.8 7.5 14.7 29.3 12.3 19.6 19.1 17.6 21.0 19.2 12.3 6.3 21.7 13.8 18.5 29.9 32.9 14.0 18.6 37.5 25.7 13.1 10.7 39.0 12.9 37.3 19.4 8.9 COG5 "GOLTC1, GTC90" ENSG00000164597 "Component of oligomeric golgi complex 5" Q9UP83 7 107201372-107564261 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020300, HPA041583" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoplasm "HPA020300: AB_2081406, HPA041583: AB_2677564" "unprognostic (3.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (3.40e-3)" "unprognostic (1.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.91e-3)" "unprognostic (8.73e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (1.15e-1)" 11.4 12.1 6.7 9.5 7.7 14.2 10.8 7.7 8.5 20.4 8.1 12.0 9.3 17.1 10.0 12.8 9.0 12.9 19.7 7.1 7.5 9.7 6.8 10.2 9.5 7.0 7.5 12.4 14.7 19.4 10.2 10.5 7.6 17.8 12.4 11.8 22.8 11.0 14.0 12.9 10.1 14.4 6.3 9.0 11.7 8.6 7.5 6.2 20.3 15.4 10.4 10.5 16.7 9.4 39.3 14.9 16.1 15.1 14.7 16.2 12.6 27.0 28.2 11.7 20.5 12.0 17.5 7.9 14.9 27.0 26.5 15.5 10.7 16.0 18.2 23.5 9.6 8.7 9.9 15.1 17.4 18.8 19.0 15.4 15.3 20.4 24.0 32.1 31.7 17.1 16.6 25.1 21.5 18.5 19.2 17.8 5.9 30.0 19.1 6.8 13.6 18.6 13.6 17.9 7.6 21.8 16.6 27.2 31.2 23.8 6.2 12.2 36.6 12.6 16.0 39.7 17.2 16.3 16.9 17.3 24.2 21.0 33.9 9.4 6.6 7.5 6.1 7.6 8.4 6.0 7.7 6.9 5.4 5.8 6.4 6.4 3.4 5.1 9.3 3.7 6.5 5.9 6.7 7.7 7.7 8.5 7.1 7.5 7.0 7.5 7.6 6.3 7.5 9.4 14.8 3.2 15.5 124.4 21.7 12.2 15.0 11.1 24.5 23.2 10.0 7.7 27.6 7.2 16.5 14.7 33.3 10.2 16.5 15.8 1.9 10.5 22.6 11.8 21.8 11.0 10.3 5.9 147.0 10.9 8.5 14.4 14.8 19.8 3.8 12.3 9.7 5.8 11.3 11.8 196.1 36.2 18.3 14.8 12.3 22.1 11.8 15.3 12.4 147.1 15.7 9.0 11.3 136.7 183.2 10.8 10.1 12.4 20.7 20.6 14.5 6.5 16.3 17.4 26.3 15.4 10.2 18.2 14.0 19.0 13.4 10.5 18.9 7.5 14.9 16.1 COG6 "COD2, KIAA1134" ENSG00000133103 "Component of oligomeric golgi complex 6" Q9Y2V7 13 39655627-39791665 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 123.1;Inhibitory neurons: 99.9;Oligodendrocyte precursor cells: 82.9;Oligodendrocytes: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040410, HPA040441" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear speckles, Golgi apparatus" "HPA040410: AB_10793964, HPA040441: AB_10794030" "unprognostic (2.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.85e-2)" "unprognostic (1.05e-2)" "unprognostic (4.81e-2)" "unprognostic (4.99e-2)" "unprognostic (6.81e-2)" "unprognostic (9.59e-2)" "unprognostic (3.66e-2)" "unprognostic (1.14e-1)" "unprognostic (9.07e-2)" "unprognostic (1.62e-1)" "unprognostic (6.60e-3)" "prognostic favorable (2.81e-4)" "unprognostic (4.87e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" 8.7 10.5 2.1 7.9 3.8 2.1 9.7 5.3 5.8 12.0 5.0 9.3 10.5 9.2 4.4 10.6 9.9 10.5 15.8 5.5 2.6 9.8 8.9 6.8 8.3 2.1 2.3 14.2 19.0 18.3 13.3 13.7 3.2 13.0 8.4 7.2 13.0 8.8 6.4 10.1 9.7 7.7 1.7 8.0 12.5 16.4 2.1 8.8 14.0 8.5 7.7 10.2 6.4 6.1 10.8 7.0 10.8 7.7 21.0 26.5 20.6 17.0 24.1 14.2 17.4 8.6 16.8 18.2 9.6 24.7 16.7 13.5 11.5 12.9 15.1 21.5 16.1 17.7 7.0 12.5 12.0 17.9 18.1 11.2 15.9 8.9 10.0 17.8 13.9 16.5 7.5 6.8 23.1 11.0 13.4 16.5 10.6 30.2 8.9 12.8 29.3 8.8 10.0 13.6 6.3 8.2 15.4 12.8 13.0 14.8 14.9 11.2 20.7 7.9 9.3 17.6 8.5 5.3 5.5 13.6 23.4 9.5 23.6 3.0 3.2 4.0 3.8 5.0 6.6 4.7 4.9 5.3 4.5 4.4 4.1 5.4 0.7 7.1 3.1 2.5 6.4 4.2 2.1 3.8 5.3 5.8 5.5 2.6 2.1 2.3 3.2 1.7 2.1 6.1 8.7 19.2 7.8 46.0 12.6 9.7 5.9 9.5 8.0 15.2 11.0 8.4 22.0 2.8 10.2 12.9 10.4 15.6 9.5 9.9 5.9 7.7 23.4 13.9 14.8 8.5 9.1 9.5 123.1 10.0 29.6 12.3 10.7 13.0 10.1 9.7 12.1 9.6 8.6 5.0 99.9 19.8 8.2 6.7 3.9 12.6 13.4 7.6 1.8 37.5 5.9 15.5 7.2 82.9 89.4 8.7 10.8 12.8 17.7 5.0 10.2 12.4 13.2 12.5 6.6 12.2 9.7 39.0 27.4 11.9 13.4 16.0 10.3 12.6 10.3 5.7 COG7 ENSG00000168434 "Component of oligomeric golgi complex 7" P83436 16 23388493-23453189 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040758, HPA041824, HPA064645" Uncertain Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA040758: AB_2677120, HPA041824: , HPA064645: AB_2685311" "unprognostic (1.72e-1)" "unprognostic (1.02e-2)" "unprognostic (8.21e-2)" "prognostic favorable (6.95e-4)" "unprognostic (3.71e-1)" "unprognostic (2.15e-1)" "unprognostic (5.95e-2)" "unprognostic (2.70e-2)" "unprognostic (3.10e-1)" "unprognostic (4.15e-1)" "unprognostic (6.07e-3)" "unprognostic (1.58e-1)" "prognostic favorable (3.14e-4)" "unprognostic (3.77e-1)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 8.7 13.1 9.2 7.2 8.7 9.8 10.3 7.5 10.0 14.9 16.7 13.2 8.3 10.9 11.2 12.1 15.0 8.4 10.0 8.6 8.6 12.7 9.5 10.0 6.8 8.8 9.4 13.4 10.2 16.3 23.8 7.5 9.1 16.2 11.8 13.8 13.4 10.4 9.8 12.2 10.5 8.6 7.4 9.8 12.7 10.0 8.8 8.1 14.6 6.4 7.2 11.4 12.2 10.7 10.2 19.5 11.9 13.5 10.4 16.9 10.8 11.2 14.1 12.9 12.9 8.3 17.6 4.8 11.6 17.8 8.2 15.2 10.8 13.8 9.8 15.7 16.3 5.0 15.3 22.2 11.0 13.9 14.2 11.0 11.0 9.9 10.4 16.0 15.2 15.7 12.2 13.6 10.5 29.9 9.3 10.2 10.7 15.7 9.3 18.7 10.3 17.3 14.0 10.0 7.2 9.2 12.6 14.2 9.7 8.9 21.0 17.8 10.7 14.3 7.5 13.4 8.2 12.4 14.1 6.5 19.1 8.1 14.0 8.4 6.7 7.3 6.0 7.7 7.6 3.9 5.5 5.7 8.0 4.6 5.6 8.5 1.6 5.6 10.0 5.7 7.0 4.9 9.2 8.7 7.5 10.0 8.6 8.6 8.8 9.4 9.1 7.4 8.8 10.7 8.0 25.6 16.9 30.3 6.2 6.6 10.1 13.7 10.2 10.1 12.0 12.2 7.2 8.6 19.9 12.9 31.3 12.5 5.5 19.4 1.9 12.0 5.0 24.4 10.8 7.7 19.2 10.8 39.7 13.8 7.6 9.8 27.5 14.2 8.2 13.1 6.1 6.0 6.4 11.8 39.8 19.3 8.2 4.0 2.3 3.6 9.9 7.7 8.8 19.7 4.4 9.2 5.2 45.8 40.6 12.9 11.3 12.4 7.2 9.3 11.6 8.7 39.1 22.4 13.1 10.1 8.6 16.5 13.3 9.1 5.4 11.8 8.9 7.2 15.9 10.7 COG8 "DOR1, FLJ22315" ENSG00000213380 "Component of oligomeric golgi complex 8" Q96MW5 16 69320140-69339583 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041406, HPA049429" Approved Supported "Golgi apparatus" No No "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA041406: AB_2677459, HPA049429: AB_2680763" "unprognostic (4.02e-2)" "unprognostic (6.46e-2)" "unprognostic (2.90e-1)" "unprognostic (1.19e-2)" "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (4.35e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-1)" "prognostic favorable (3.12e-5)" "unprognostic (3.10e-1)" "prognostic favorable (2.47e-7)" "unprognostic (4.73e-2)" "unprognostic (2.58e-1)" "unprognostic (7.83e-2)" "unprognostic (1.35e-2)" 9.9 14.5 19.7 8.5 23.2 6.5 11.1 23.2 24.4 9.8 24.0 10.5 10.5 10.8 14.1 9.9 13.9 7.7 11.2 19.4 19.7 13.4 15.0 10.2 11.3 21.1 20.6 13.7 14.2 19.9 12.0 7.9 21.2 10.3 9.9 7.7 13.8 10.6 18.1 16.3 10.0 10.5 20.3 10.9 11.2 20.3 20.9 12.2 13.0 15.8 11.3 9.4 7.7 28.1 13.2 28.5 18.2 26.7 30.1 21.0 19.4 16.9 18.6 23.0 18.7 26.2 19.8 23.7 18.1 23.0 12.4 24.9 29.5 24.3 19.8 11.9 26.4 17.0 19.9 35.0 21.3 21.1 14.8 25.2 23.5 25.2 14.7 22.2 22.6 20.4 35.4 5.7 16.7 38.3 19.4 31.3 32.2 17.8 20.5 35.6 12.6 33.3 23.6 11.1 26.0 31.1 37.5 15.0 17.5 18.4 35.4 17.8 20.5 16.8 14.4 15.8 14.1 31.3 27.1 36.8 17.3 18.8 19.2 41.4 19.6 20.6 17.8 19.0 19.6 13.3 19.2 18.2 18.6 19.0 17.4 16.7 15.6 22.2 17.6 10.7 19.6 16.8 19.7 23.2 23.2 24.4 19.4 19.7 21.1 20.6 21.2 20.3 20.9 28.1 3.2 9.6 9.7 1.3 9.4 4.2 10.4 5.8 5.2 18.9 7.3 6.7 0.0 24.3 10.6 11.0 18.8 15.0 5.0 12.6 1.9 7.6 17.4 6.1 6.4 7.2 12.7 5.5 1.9 8.0 9.1 7.4 7.1 4.6 7.0 9.0 15.7 28.5 9.5 11.8 2.0 11.7 20.3 7.9 3.3 4.8 12.8 3.1 5.4 1.0 8.4 12.1 10.3 2.0 2.6 5.4 9.5 15.8 9.0 9.6 19.3 15.3 10.2 19.9 13.1 15.5 6.2 9.9 13.6 7.2 4.1 9.2 8.3 5.4 16.7 7.2 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104085880 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 580.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 227.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7" "Region enriched" "Detected in single" 4 "cerebellum: 1.0" "Low region specificity" "Detected in many" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" NA NA 32000 "Cluster 1: Neutrophils - Mixed function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: AB_2681999" "prognostic favorable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 1.5 0.4 0.8 6.6 1.1 12.2 37.3 1.0 1.4 50.1 0.6 37.4 10.7 0.6 6.6 116.6 1.1 0.3 0.5 0.5 0.6 0.3 0.3 0.9 0.1 0.6 0.7 0.2 0.4 0.0 1.2 35.4 0.6 17.9 27.3 0.0 82.2 9.6 0.5 580.3 37.2 1.0 0.5 2.3 19.8 25.4 0.6 42.7 5.1 0.0 19.8 9.9 102.0 0.8 26.3 0.4 1.5 0.2 0.1 0.0 80.6 0.5 0.3 0.1 0.2 0.3 204.3 0.0 5.1 0.3 3.9 463.8 0.7 745.8 0.7 0.0 0.7 0.0 0.3 0.2 0.1 0.0 0.4 0.7 914.1 0.5 783.7 0.2 3.5 0.1 0.1 0.9 0.0 0.0 0.0 0.3 1.7 5.1 2.6 0.0 0.0 0.3 35.9 26.4 0.2 0.3 0.0 0.2 0.9 4.0 0.2 0.0 1.5 0.5 5.0 0.3 5.5 0.1 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 1.1 1.0 1.4 0.5 0.6 0.6 0.7 0.6 0.5 0.6 0.8 1.0 0.0 1.1 0.7 0.3 585.7 17.7 136.0 299.9 0.6 1.7 85.5 1.1 0.0 16.5 0.0 0.0 10.2 0.3 211.5 0.0 0.8 14.2 23.7 2.3 3.7 2.4 0.0 0.1 0.9 18.9 2.4 23.0 8.1 0.0 0.1 0.0 0.0 1.3 0.0 0.2 5.7 6.1 0.0 28.9 3.6 0.3 0.7 33.8 0.0 0.0 0.4 0.0 0.0 0.4 78.8 35.7 0.7 1.4 16.6 108.5 0.1 5.9 0.4 0.0 0.4 3.0 22.7 1.5 31.9 139.4 5.6 1.3 0.1 21.6 10.7 COL18A1 "KNO, KNO1, KS" ENSG00000182871 "Collagen type XVIII alpha 1 chain" P39060 21 45405165-45513720 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 561.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 479.6;Sertoli cells: 223.5;Smooth muscle cells: 268.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 139.0;EFO-21: 309.4;NTERA-2: 170.6;RPTEC TERT1: 131.6;TIME: 186.0" "Region enriched" "Detected in all" 6 "cerebellum: 22.1" "Low region specificity" "Detected in all" "HPA030933, HPA036104" Supported Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 290000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA030933: , HPA036104: AB_2674943" "unprognostic (4.32e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (3.47e-2)" "unprognostic (3.25e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.16e-4)" "unprognostic (4.23e-3)" "unprognostic (9.93e-2)" "unprognostic (3.48e-1)" "unprognostic (2.77e-1)" "unprognostic (5.50e-2)" "unprognostic (1.70e-1)" "unprognostic (1.83e-2)" "unprognostic (9.44e-2)" "unprognostic (9.10e-3)" "unprognostic (2.25e-3)" 136.4 87.6 14.5 33.9 22.3 15.9 97.1 26.4 21.8 229.4 34.4 91.2 30.4 135.6 35.4 50.1 118.3 28.9 122.2 15.7 18.1 218.2 561.9 83.2 19.8 43.7 28.6 257.3 102.3 7.9 106.5 40.7 39.1 91.0 5.5 5.4 35.8 46.8 26.5 77.8 65.7 28.5 26.6 86.8 44.5 30.0 27.0 9.0 101.1 7.4 7.2 109.8 112.2 45.4 10.5 84.0 20.6 18.0 38.6 31.9 3.3 82.0 139.0 39.1 10.5 48.8 28.9 1.5 309.4 82.8 21.6 37.9 4.6 5.0 7.4 0.7 20.0 47.9 1.4 69.6 37.3 0.7 4.4 37.6 3.3 3.8 4.5 8.5 121.3 0.5 49.6 0.3 14.4 16.7 0.8 3.2 170.6 3.2 30.7 0.7 12.6 4.0 131.6 1.3 22.8 16.3 7.6 7.8 26.6 73.0 7.5 9.9 186.0 0.5 11.4 0.4 17.7 0.4 0.8 1.5 0.1 1.7 32.7 0.8 0.1 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 3.2 0.0 0.0 0.1 0.0 0.1 14.5 22.3 26.4 21.8 15.7 18.1 43.7 28.6 39.1 26.6 27.0 45.4 156.9 0.0 4.1 6.5 3.9 67.7 15.5 19.0 67.7 13.5 9.3 32.1 15.7 61.5 5.0 112.2 4.2 1.9 3.4 0.1 9.8 117.5 1.5 58.3 99.5 91.2 0.0 33.0 4.9 5.8 1.1 101.1 3.6 144.2 57.8 6.6 75.0 479.6 2.4 0.0 15.8 0.1 4.1 12.1 32.5 6.7 79.9 6.5 49.8 82.4 3.2 141.9 7.2 4.0 28.0 9.9 0.0 126.0 4.6 14.0 0.0 72.9 0.7 6.3 223.5 138.2 268.6 4.1 6.0 7.9 28.6 2.5 15.3 47.5 0.4 2.6 COL8A2 "FECD, FECD1, PPCD, PPCD2" ENSG00000171812 "Collagen type VIII alpha 2 chain" P25067 1 36095239-36125222 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 10.2;Cardiomyocytes: 13.5;Fibroblasts: 13.4;Macrophages: 6.8;Melanocytes: 7.2;Microglial cells: 8.4;Sertoli cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 5.8;fHDF/TERT166: 4.3;HHSteC: 14.1;hTERT-RPE1: 18.2;THP-1: 4.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "spinal cord: 3.6" HPA049788 Uncertain Uncertain "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA049788: AB_2680882" "unprognostic (9.98e-2)" "unprognostic (3.26e-2)" "unprognostic (2.51e-2)" "unprognostic (8.41e-3)" "unprognostic (8.76e-2)" "prognostic favorable (9.44e-4)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (3.50e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.35e-5)" "unprognostic (1.08e-2)" "unprognostic (6.77e-2)" "unprognostic (2.24e-2)" "unprognostic (1.16e-3)" 5.2 1.2 2.5 4.4 2.2 0.5 5.6 6.1 2.4 9.0 18.3 5.9 1.4 5.7 1.6 5.8 4.2 4.8 5.4 2.3 2.9 1.1 0.6 4.6 3.1 9.0 4.2 3.3 0.8 0.7 4.0 12.8 7.1 6.1 2.0 0.4 7.4 11.4 0.6 5.5 2.4 3.7 6.1 8.5 9.1 0.9 4.2 4.9 7.5 2.1 3.5 13.3 5.9 5.7 0.0 0.0 0.0 0.0 0.5 1.0 0.1 5.8 1.7 1.6 0.9 0.2 0.1 0.0 0.8 4.3 0.0 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 14.1 0.0 0.0 1.7 0.1 0.7 0.0 18.2 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.1 0.1 0.0 0.5 0.5 0.5 0.0 0.2 0.4 0.0 4.7 0.1 2.3 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.5 2.2 6.1 2.4 2.3 2.9 9.0 4.2 7.1 6.1 4.2 5.7 0.6 0.0 1.8 0.3 0.0 2.2 2.2 1.8 0.0 0.1 1.3 10.2 13.5 0.0 0.7 0.0 0.0 0.4 1.4 0.0 0.0 0.4 0.1 0.2 0.2 0.7 0.0 0.0 0.2 0.2 0.3 13.4 0.5 0.3 2.5 0.5 1.1 0.0 6.2 0.0 0.4 0.0 0.0 2.0 2.7 0.2 3.1 6.8 7.2 8.4 1.2 0.3 0.0 0.5 0.1 0.6 0.0 6.0 0.1 5.3 0.0 0.0 0.2 0.2 6.6 0.7 1.4 0.0 0.3 0.1 1.3 0.8 1.2 0.3 0.0 0.4 COLEC12 "CL-P1, SCARA4, SRCL" ENSG00000158270 "Collectin subfamily member 12" Q5KU26 18 316737-500722 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 31.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 104.4;Cytotrophoblasts: 149.0;Fibroblasts: 79.6;Hofbauer cells: 155.9;Microglial cells: 245.4;Muller glia cells: 74.5;Syncytiotrophoblasts: 111.2" "Cancer enhanced" "Detected in all" "prostate cancer: 14.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 24.3;BJ: 12.1;HSkMC: 20.0;U-2197: 31.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047917, HPA071056" Enhanced Approved "Golgi apparatus,Vesicles,Cell Junctions" NA NA 580000 "Cluster 17: Basophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Vesicles" "Cell Junctions" "HPA047917: AB_2680208, HPA071056: AB_2686338" "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (3.60e-2)" "unprognostic (6.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.14e-4)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "unprognostic (4.86e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (2.61e-1)" "unprognostic (2.24e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.01e-3)" 12.4 1.7 5.1 2.4 4.8 0.2 5.5 4.7 5.7 31.6 9.7 5.5 1.5 9.0 1.0 2.0 6.5 4.4 6.6 4.6 7.2 2.4 0.3 11.4 2.0 7.7 6.5 2.0 1.1 0.9 0.9 20.0 5.2 4.0 2.4 5.3 4.1 1.4 3.1 3.6 3.5 5.1 4.3 0.3 3.4 1.4 6.5 1.3 5.2 2.0 2.5 8.1 4.0 5.5 0.0 0.0 2.1 0.0 2.3 24.3 0.8 12.1 4.2 1.7 3.1 0.0 0.0 0.0 0.1 2.0 0.1 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.1 0.0 0.0 20.0 0.0 1.0 0.0 0.7 4.7 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.7 0.0 6.5 0.0 0.0 0.1 0.3 0.0 0.1 0.0 1.9 0.1 0.0 0.0 2.8 0.4 31.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 5.1 4.8 4.7 5.7 4.6 7.2 7.7 6.5 5.2 4.3 6.5 5.5 6.8 3.2 104.4 34.3 2.1 4.1 3.2 0.0 1.2 6.4 2.6 1.7 4.0 2.8 10.7 3.7 10.4 149.0 1.4 0.3 0.0 0.2 11.1 0.5 3.9 15.8 15.7 2.7 0.5 0.0 5.3 79.6 0.0 0.8 13.9 1.2 5.7 0.4 155.9 6.7 1.4 1.0 0.0 4.9 8.9 31.4 61.5 32.1 1.8 245.4 16.2 74.5 3.1 2.0 10.4 0.3 0.6 7.2 1.2 6.5 1.4 0.2 1.7 12.4 0.0 13.2 21.6 1.3 2.5 1.8 3.8 111.2 4.8 11.6 0.8 1.3 COMMD9 "FLJ31106, HSPC166" ENSG00000110442 "COMM domain containing 9" Q9P000 11 36269284-36289449 "Predicted intracellular proteins" "Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009142 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 18: U-2197 - ECM organization" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "Golgi apparatus, Cytosol" "HPA009142: AB_1847105" "unprognostic (1.56e-2)" "unprognostic (4.75e-3)" "unprognostic (7.57e-2)" "unprognostic (4.40e-3)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-3)" "unprognostic (2.62e-1)" "unprognostic (6.15e-2)" "prognostic favorable (8.54e-4)" "unprognostic (4.94e-2)" "unprognostic (2.40e-1)" "unprognostic (6.08e-3)" "unprognostic (7.24e-2)" "unprognostic (1.71e-1)" "unprognostic (7.31e-3)" "unprognostic (1.88e-1)" 26.8 32.1 33.8 21.8 34.1 50.8 24.3 35.1 36.7 17.2 29.6 19.6 21.1 14.1 25.1 24.9 20.3 20.5 31.1 33.8 33.8 38.7 36.6 26.8 26.0 34.2 34.4 19.4 26.4 27.4 23.2 24.8 33.9 14.0 24.2 20.3 21.9 13.3 64.2 27.1 20.2 21.9 36.9 26.8 19.7 14.9 36.0 30.6 25.1 61.7 32.0 20.6 16.6 39.1 28.8 33.4 36.1 38.2 54.5 37.8 20.0 33.6 42.6 74.7 69.8 27.3 23.9 33.0 32.5 67.1 57.5 41.4 64.0 45.2 69.6 39.9 75.2 18.2 57.6 48.0 51.0 71.6 52.3 48.0 49.5 40.9 25.0 38.5 62.2 43.3 45.7 34.7 59.4 36.9 47.9 49.6 38.5 55.6 70.3 52.1 81.7 38.9 78.6 26.6 44.1 49.2 47.9 47.1 43.6 29.2 102.7 27.0 41.9 45.0 34.4 107.9 49.8 24.3 53.2 37.2 51.8 66.4 44.0 85.6 376.6 173.7 91.4 359.0 86.8 130.7 87.5 88.4 383.6 138.3 99.8 83.4 42.7 94.8 300.9 145.8 114.5 315.2 33.8 34.1 35.1 36.7 33.8 33.8 34.2 34.4 33.9 36.9 36.0 39.1 26.9 22.4 29.4 2.6 27.0 15.3 12.7 37.4 13.1 16.6 25.6 38.7 29.9 12.8 20.2 18.4 10.4 43.2 28.3 16.9 78.2 70.1 9.5 13.2 20.3 22.8 25.7 23.1 9.4 46.4 52.9 21.2 11.7 17.0 19.0 25.6 15.4 17.1 105.1 5.0 8.7 20.4 34.6 59.5 35.6 28.9 17.7 57.5 24.9 1.9 61.3 36.3 33.0 4.5 8.8 46.5 17.7 11.7 10.4 4.9 30.3 62.5 8.5 22.9 13.1 12.3 22.8 32.8 33.3 19.6 21.6 24.9 19.2 28.4 24.6 12.0 COMP "EDM1, EPD1, MED, PSACH, THBS5" ENSG00000105664 "Cartilage oligomeric matrix protein" P49747 19 18782773-18791305 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cell adhesion" Heparin-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 77.6;heart muscle: 65.3;skin 1: 80.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 19.3;Early spermatids: 37.0;Fibroblasts: 32.0;Glandular and luminal cells: 32.0;Late spermatids: 75.3;Spermatocytes: 16.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 859.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077555 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 1500000000 "Cluster 31: Skin - Epidermis development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA077555: " "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "prognostic unfavorable (9.08e-5)" "prognostic unfavorable (2.04e-4)" "unprognostic (8.05e-2)" "unprognostic (8.45e-2)" "unprognostic (3.62e-2)" "unprognostic (5.12e-2)" "unprognostic (1.65e-1)" "unprognostic (1.55e-2)" "unprognostic (2.18e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (5.96e-3)" "unprognostic (1.44e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (6.95e-4)" 77.6 0.2 0.0 1.1 0.2 0.0 11.0 1.3 0.2 7.5 0.0 2.3 0.0 4.6 7.6 9.5 1.2 16.1 65.3 0.0 0.0 5.2 0.3 8.0 3.6 0.3 0.1 0.4 2.8 2.2 0.4 8.2 0.1 10.2 0.0 0.0 14.1 6.7 18.0 80.6 0.9 12.1 0.3 0.3 2.5 14.9 0.0 0.1 10.3 0.6 0.3 6.5 22.7 0.1 0.0 0.0 0.0 0.0 178.4 0.4 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 859.6 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.3 0.0 0.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.2 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.1 3.2 0.5 0.0 0.0 11.5 0.6 19.3 0.0 1.4 0.3 0.3 0.8 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 37.0 2.8 3.7 1.0 0.0 0.0 0.1 0.2 0.2 32.0 0.0 32.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 1.3 0.0 0.0 10.7 75.3 0.9 0.7 10.6 0.0 0.1 1.6 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.3 0.0 0.0 0.7 0.4 6.6 2.4 4.2 16.8 1.6 0.0 7.1 0.5 1.0 0.0 0.2 0.3 COMTD1 FLJ23841 ENSG00000165644 "Catechol-O-methyltransferase domain containing 1" Q86VU5 10 75233641-75236030 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 128.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 334.8;Exocrine glandular cells: 249.5;Paneth cells: 272.5;Proximal enterocytes: 435.9;Squamous epithelial cells: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.2;PC-3: 38.3;RPMI-8226: 24.5;U-266/70: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042165 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "Plasma membrane, Cytosol" "HPA042165: AB_10794042" "unprognostic (2.53e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (9.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.23e-2)" "unprognostic (8.08e-3)" "unprognostic (9.35e-2)" "unprognostic (6.74e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.12e-1)" "unprognostic (2.35e-1)" 11.0 17.9 1.1 1.0 1.5 1.5 9.8 1.2 1.8 18.3 5.8 23.3 7.4 7.5 0.4 70.6 7.2 0.4 33.5 1.3 1.7 29.1 37.5 11.7 0.6 1.7 2.0 8.0 128.6 3.4 17.1 0.9 1.7 11.8 1.0 1.1 23.9 1.0 28.2 25.3 25.2 0.5 1.1 12.4 27.8 3.4 1.6 0.5 18.5 0.7 0.7 8.3 29.0 0.9 6.9 2.2 0.5 1.3 0.1 0.7 19.0 2.1 1.0 0.3 0.6 1.6 6.0 20.0 3.5 0.4 1.1 9.0 0.9 1.9 0.1 3.2 30.2 0.8 4.8 3.3 1.1 3.5 3.3 0.6 3.2 0.1 2.9 1.3 0.3 3.6 7.8 4.7 0.1 6.2 5.3 11.0 1.2 5.1 38.3 10.6 1.3 24.5 1.8 0.6 8.4 2.3 2.4 16.0 4.8 0.5 8.9 0.5 1.4 0.6 5.9 1.2 2.1 21.5 4.5 9.8 0.7 3.4 0.6 0.0 7.1 3.9 10.6 10.0 11.6 7.1 10.6 11.0 8.5 5.6 3.5 6.1 1.4 7.3 9.4 15.3 8.9 6.8 1.1 1.5 1.2 1.8 1.3 1.7 1.7 2.0 1.7 1.1 1.6 0.9 23.6 19.2 11.5 1.6 18.2 29.4 40.5 54.1 133.1 6.0 29.3 37.1 31.1 57.2 33.8 53.3 10.4 33.4 30.8 334.8 144.8 162.8 1.6 10.5 7.7 13.5 40.2 16.0 3.4 249.5 79.1 13.4 148.8 33.4 12.7 10.3 25.4 84.0 35.1 1.7 3.9 206.0 42.7 24.2 21.3 3.5 9.6 21.8 37.4 6.5 31.8 10.7 24.7 1.5 0.5 109.2 272.5 7.2 50.8 38.7 435.9 140.3 11.3 34.5 32.9 6.2 25.6 2.6 3.4 285.3 38.2 30.4 29.2 10.7 143.8 56.7 COPA HEP-COP ENSG00000122218 "COPI coat complex subunit alpha" P53621 1 160288594-160343273 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" Hormone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028024 Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA 150000 "Cluster 18: Basophils - Vesicular transport" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA028024: AB_10603787" "unprognostic (1.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.77e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.42e-2)" "unprognostic (3.14e-1)" "unprognostic (2.21e-1)" "unprognostic (5.03e-2)" "unprognostic (3.10e-1)" "unprognostic (2.05e-2)" "unprognostic (8.70e-2)" "unprognostic (2.03e-1)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" 47.7 43.1 46.6 38.5 48.9 30.0 42.0 57.2 57.1 52.9 67.4 42.3 53.7 46.7 55.1 38.3 41.2 38.6 55.1 48.6 53.7 48.6 55.0 47.0 36.1 57.9 51.0 46.9 49.9 51.8 59.8 48.3 60.0 43.5 47.9 26.2 57.6 39.4 59.1 40.0 49.0 50.0 53.9 42.7 43.5 24.4 51.1 37.6 60.1 38.2 38.9 41.3 37.9 66.4 91.0 68.5 70.1 66.9 164.9 154.7 78.6 116.5 144.3 103.1 138.7 72.0 60.5 64.4 73.3 194.0 57.7 86.0 92.0 81.3 126.5 68.6 64.3 76.8 95.2 79.0 115.1 94.1 74.5 134.8 49.1 140.0 128.9 126.3 126.4 64.4 71.9 69.7 124.4 43.6 49.3 53.3 80.1 97.3 79.0 49.2 89.2 118.9 94.3 94.7 62.1 84.3 157.3 109.2 148.0 115.0 140.4 133.9 162.8 84.3 54.1 108.2 80.2 106.8 76.3 106.6 104.2 51.3 122.8 48.1 39.0 25.4 18.6 36.7 25.5 17.8 16.7 21.3 40.4 14.2 14.3 17.9 10.9 26.7 36.2 17.8 22.9 35.5 46.6 48.9 57.2 57.1 48.6 53.7 57.9 51.0 60.0 53.9 51.1 66.4 53.6 76.9 54.7 44.7 66.4 28.2 35.5 41.6 29.6 52.4 53.0 41.3 51.8 42.9 49.7 40.5 81.3 41.0 83.2 66.8 13.7 49.9 14.7 50.7 68.1 50.4 55.3 37.0 77.6 49.6 63.3 66.2 65.2 64.3 45.6 63.0 52.8 71.1 51.2 45.4 73.8 83.8 30.5 93.7 58.0 6.4 71.1 84.3 26.6 67.5 75.0 41.0 38.1 65.9 178.9 55.5 48.1 56.8 115.9 52.9 98.9 41.4 66.2 53.7 39.5 57.6 52.4 37.6 25.7 35.8 31.8 69.2 58.3 58.1 66.6 61.2 COPB1 COPB ENSG00000129083 "COPI coat complex subunit beta 1" P53618 11 14443440-14500027 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012338, HPA043954, HPA064403" Supported Enhanced "Golgi apparatus,Vesicles,Cytosol" NA NA 330000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles, Cytosol" "CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258" "unprognostic (2.35e-1)" "unprognostic (1.02e-3)" "unprognostic (1.36e-2)" "unprognostic (4.76e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (6.91e-4)" "prognostic unfavorable (5.63e-7)" "unprognostic (4.69e-3)" "unprognostic (3.42e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (8.94e-2)" "unprognostic (1.78e-2)" "unprognostic (3.02e-2)" "unprognostic (8.00e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" 48.1 47.1 19.9 55.0 21.8 79.8 62.6 26.2 25.3 64.9 44.7 59.8 57.7 52.6 69.3 46.7 49.2 54.9 43.7 20.1 23.6 65.3 73.6 49.9 59.1 24.2 21.8 49.1 59.2 67.6 48.4 69.2 23.7 66.9 67.1 39.3 67.5 53.8 33.1 36.6 58.8 61.1 23.5 46.3 59.7 46.8 23.0 68.1 81.0 38.1 64.5 60.4 40.0 27.6 134.9 113.6 118.6 89.4 193.1 221.3 95.9 199.2 206.5 173.1 202.0 89.1 203.5 130.1 87.1 252.9 164.6 144.7 134.6 133.3 212.1 122.7 114.0 138.3 74.3 135.8 171.3 128.9 134.4 156.3 172.4 116.0 217.8 158.9 183.7 71.6 104.5 103.8 221.1 101.6 117.2 78.7 61.7 163.3 123.1 94.9 163.1 89.0 156.1 123.3 75.6 81.2 154.2 123.2 104.8 135.5 112.3 110.1 189.5 166.2 85.4 181.3 110.1 55.2 100.5 143.8 125.1 79.2 158.6 52.8 38.7 43.5 45.7 47.8 55.7 38.4 38.1 47.6 52.3 32.0 37.8 39.8 31.2 44.6 49.8 31.1 44.8 43.2 19.9 21.8 26.2 25.3 20.1 23.6 24.2 21.8 23.7 23.5 23.0 27.6 55.6 109.0 63.2 29.0 64.3 38.9 59.7 82.6 52.3 28.4 43.0 27.9 31.3 35.8 107.8 44.1 27.1 65.4 71.2 55.9 41.1 77.1 17.2 72.6 81.4 55.5 43.8 50.9 36.9 81.7 69.6 70.5 63.2 72.5 65.2 50.7 51.4 58.1 60.9 18.5 39.1 87.5 61.1 50.7 43.5 10.7 51.0 61.5 21.4 35.6 70.1 34.0 44.3 32.6 49.6 93.6 37.5 55.3 107.4 54.3 60.6 57.3 131.9 29.5 52.6 60.8 78.7 87.5 64.3 48.7 35.8 117.0 77.0 49.3 51.5 60.7 COPB2 "beta'-COP, betaprime-COP" ENSG00000184432 "COPI coat complex subunit beta 2" P35606 3 139353946-139389736 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036867, HPA058180" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA 63000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "Golgi apparatus" "HPA036867: AB_10672271, HPA058180: AB_2683630" "unprognostic (3.37e-2)" "unprognostic (2.04e-1)" "unprognostic (9.38e-2)" "unprognostic (6.93e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.41e-7)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (8.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.44e-2)" "unprognostic (1.14e-1)" "unprognostic (6.05e-2)" "unprognostic (4.95e-2)" 46.7 58.2 17.9 50.5 19.7 22.3 60.4 20.4 21.0 76.5 35.9 62.5 57.4 48.5 62.5 55.0 47.5 48.4 47.9 17.4 21.8 52.9 71.1 44.3 44.8 20.5 18.9 38.9 89.7 68.2 60.0 68.9 20.4 72.2 71.7 37.0 71.1 57.0 33.5 37.4 53.4 63.5 20.8 42.8 60.7 35.0 20.2 54.4 64.3 31.2 61.5 56.2 42.2 25.0 192.1 84.0 111.2 99.0 247.2 214.9 96.8 223.9 235.9 158.2 204.7 143.4 83.5 90.2 203.0 287.1 145.1 110.9 136.2 141.0 210.6 139.0 85.2 138.2 114.9 152.3 152.7 121.9 139.7 160.1 114.7 132.2 138.5 178.6 161.6 76.5 86.7 105.7 199.4 138.6 59.4 59.7 102.2 215.0 99.5 75.8 93.6 149.5 141.2 133.4 85.2 61.7 254.6 212.0 147.2 168.6 193.2 123.2 185.1 90.3 66.4 122.8 83.7 148.0 80.8 129.7 115.2 61.0 138.0 74.4 49.8 52.0 36.0 56.3 35.8 35.3 31.0 37.6 57.7 23.8 24.2 31.1 45.0 44.1 57.2 30.2 38.1 44.2 17.9 19.7 20.4 21.0 17.4 21.8 20.5 18.9 20.4 20.8 20.2 25.0 36.6 57.7 46.6 18.3 45.8 19.6 39.5 61.2 29.6 38.0 41.3 29.3 58.5 32.9 74.5 20.2 31.3 83.3 34.9 52.4 41.1 83.4 40.8 64.9 62.9 45.2 63.9 51.1 25.1 82.1 76.1 66.6 75.4 54.8 45.0 50.4 36.4 48.5 52.7 42.1 25.5 86.7 46.8 34.6 21.3 8.6 54.7 42.8 21.4 13.1 60.1 62.0 29.9 20.1 30.8 79.7 34.8 50.0 118.6 46.6 46.9 42.4 108.6 51.1 19.7 47.3 69.6 83.1 45.6 36.5 14.9 133.1 37.5 74.4 44.7 52.9 COPE epsilon-COP ENSG00000105669 "COPI coat complex subunit epsilon" O14579 19 18899514-18919387 "Metabolic proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034345, HPA041605, HPA043576" Supported Enhanced "Golgi apparatus" NA NA 66000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563" "unprognostic (1.48e-1)" "prognostic favorable (2.41e-4)" "unprognostic (1.15e-1)" "unprognostic (5.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.40e-2)" "unprognostic (3.39e-2)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (1.97e-2)" "unprognostic (8.75e-2)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.26e-1)" "unprognostic (3.16e-2)" "unprognostic (6.75e-2)" 102.3 163.7 127.2 85.5 133.4 159.6 100.3 139.4 176.0 101.3 131.3 113.8 90.5 104.1 45.0 160.3 89.8 44.1 135.2 122.4 131.0 141.9 194.3 108.3 91.7 140.6 132.0 80.8 152.0 80.8 160.1 59.3 130.0 127.4 37.7 23.5 144.2 65.4 128.0 120.9 107.8 42.9 137.1 150.0 126.8 171.9 135.9 82.4 123.7 50.0 56.9 99.2 107.1 151.2 186.7 177.4 99.3 177.3 89.0 104.7 287.2 159.2 150.8 174.8 198.7 215.1 148.2 150.8 210.5 134.9 112.9 123.2 82.5 161.0 33.9 94.2 369.9 89.6 150.9 331.1 236.1 180.0 221.1 128.3 149.2 106.2 115.6 92.5 138.9 170.5 140.2 373.6 90.0 443.0 196.9 341.0 188.4 243.0 420.2 222.4 89.6 448.2 115.8 185.4 138.8 222.4 100.0 159.1 181.1 44.9 134.8 291.3 140.9 110.5 81.5 283.3 170.9 357.7 337.5 187.7 189.1 309.9 187.3 656.0 598.5 639.1 337.1 533.1 298.1 391.2 321.9 298.6 528.4 381.9 236.4 270.9 594.9 344.4 468.5 659.3 449.3 930.0 127.2 133.4 139.4 176.0 122.4 131.0 140.6 132.0 130.0 137.1 135.9 151.2 110.5 3.2 16.2 22.2 204.7 159.8 197.9 390.9 54.1 53.2 140.5 111.6 10.4 111.5 205.8 115.8 29.2 386.5 242.8 408.9 463.7 323.7 179.7 134.4 131.8 127.1 168.5 130.5 8.6 368.7 439.1 140.7 166.2 187.8 102.9 176.7 113.6 153.4 447.2 57.2 11.3 445.5 303.2 189.4 286.8 381.0 144.8 217.8 245.5 4.7 373.5 251.9 187.4 8.5 20.8 336.7 421.4 133.2 417.5 255.7 425.6 493.1 152.6 72.1 124.9 92.8 200.5 178.4 202.1 108.6 196.6 542.2 174.9 235.3 297.4 267.2 COPG1 COPG ENSG00000181789 "COPI coat complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No 57000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428" "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 84.7 111.0 66.6 59.0 68.2 59.4 79.8 69.5 80.7 100.4 93.0 107.6 86.7 75.5 157.4 86.8 70.0 53.8 95.5 70.3 73.7 82.7 149.5 84.4 54.8 74.3 71.5 77.9 162.4 96.3 139.0 81.9 77.4 107.7 109.8 33.4 130.7 72.7 75.7 74.4 86.7 72.2 66.4 81.9 114.0 46.5 73.2 53.5 83.3 43.2 67.1 67.2 72.2 73.2 167.8 83.2 119.1 104.0 272.8 219.0 126.9 266.3 251.8 179.5 225.2 153.9 101.2 91.1 150.8 380.7 145.6 98.4 99.5 157.2 193.6 112.0 41.4 151.9 103.2 252.6 247.9 116.4 156.4 230.9 135.6 143.8 235.0 196.1 164.3 68.9 54.2 213.6 219.2 253.4 68.7 117.7 71.3 243.6 100.9 73.3 111.8 178.3 227.3 136.7 74.1 86.1 204.2 150.3 255.9 129.8 167.1 167.6 223.9 96.9 91.7 207.2 104.2 165.7 86.1 158.9 236.4 86.9 190.0 79.1 49.9 37.2 44.1 59.2 53.6 24.9 39.8 43.9 57.0 26.9 30.0 36.2 37.2 57.0 57.3 52.2 43.8 56.2 66.6 68.2 69.5 80.7 70.3 73.7 74.3 71.5 77.4 66.4 73.2 73.2 16.6 16.0 31.5 7.8 19.2 8.8 16.9 35.4 12.0 9.2 18.9 8.6 23.3 17.2 34.6 27.6 4.2 55.6 19.7 77.0 43.0 44.5 10.4 26.2 27.7 22.8 38.6 22.9 14.1 46.5 63.1 32.5 53.0 36.9 15.2 28.6 28.9 56.5 39.0 5.0 14.8 75.1 22.4 31.2 14.8 4.7 41.0 21.6 23.2 7.5 36.5 12.7 18.6 4.5 11.8 40.8 44.6 31.2 68.4 24.4 64.5 39.5 32.6 7.1 19.7 20.2 33.3 24.3 17.0 16.4 10.2 72.2 19.4 27.7 44.6 20.6 COQ10A FLJ32452 ENSG00000135469 "Coenzyme Q10A" Q96MF6 12 56266890-56270966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "heart muscle: 166.3;skeletal muscle: 280.7;tongue: 387.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 120.5;Distal tubular cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068931 Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 24: NB-4 - Immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol "Endoplasmic reticulum, Golgi apparatus" "HPA068931: AB_2686061" "unprognostic (4.55e-2)" "unprognostic (4.88e-3)" "prognostic unfavorable (5.46e-4)" "unprognostic (8.99e-3)" "unprognostic (2.77e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-1)" "unprognostic (2.86e-3)" "unprognostic (6.09e-2)" "unprognostic (8.57e-2)" "prognostic favorable (2.06e-4)" "unprognostic (5.03e-2)" "prognostic favorable (3.44e-4)" "unprognostic (1.67e-1)" "unprognostic (8.07e-2)" "unprognostic (7.20e-2)" "unprognostic (1.15e-1)" 7.0 33.3 16.3 3.5 16.9 4.6 7.2 17.7 19.7 9.1 21.1 9.5 3.2 10.0 16.2 9.0 10.8 6.3 166.3 16.2 17.6 17.1 37.0 6.7 7.8 16.5 18.3 10.2 18.0 15.7 25.4 2.7 17.2 11.9 5.0 26.0 12.6 9.8 280.7 5.0 9.7 7.2 16.4 12.2 8.8 6.8 18.6 7.9 10.3 387.5 8.9 8.5 6.8 15.8 3.7 15.2 14.4 9.4 8.1 8.0 6.0 5.2 12.5 18.3 18.2 11.9 5.6 21.5 11.3 13.3 5.1 3.5 16.8 3.0 10.9 3.2 17.0 10.2 14.1 12.4 11.0 8.1 5.9 8.4 4.9 13.6 5.3 11.4 9.8 14.9 6.8 8.8 17.1 5.1 11.7 29.1 12.0 2.7 8.7 24.2 15.6 14.5 10.1 2.2 20.5 22.0 18.1 3.8 5.8 10.6 5.8 8.9 6.9 3.4 10.0 9.5 5.3 18.1 20.4 10.8 10.2 7.6 2.6 14.1 1.1 1.1 7.4 1.0 7.4 12.7 7.0 7.8 1.7 6.8 8.3 8.1 0.4 5.8 0.9 6.9 5.1 3.9 16.3 16.9 17.7 19.7 16.2 17.6 16.5 18.3 17.2 16.4 18.6 15.8 8.1 3.2 7.2 12.4 20.8 13.4 13.0 2.3 15.4 17.9 8.4 12.7 120.5 7.2 3.2 11.0 16.7 5.8 32.0 2.0 52.8 2.8 0.2 13.7 6.3 9.6 16.2 4.2 3.9 4.6 6.8 10.9 6.6 5.1 4.5 8.2 3.6 15.2 5.2 32.0 6.2 3.4 4.1 2.5 12.1 1.7 8.4 4.5 12.4 3.7 2.5 26.5 13.4 4.5 2.3 2.7 2.5 17.0 18.6 4.4 3.1 18.1 11.0 32.3 39.5 22.1 14.0 4.0 22.2 4.9 10.5 3.0 19.5 10.4 4.4 5.9 CORO6 FLJ14871 ENSG00000167549 "Coronin 6" Q6QEF8 17 29614756-29622907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 600.0;tongue: 252.6" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 38.1;Excitatory neurons: 64.1;Extravillous trophoblasts: 32.7;Horizontal cells: 30.3;Inhibitory neurons: 73.8;Skeletal myocytes: 25.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "REH: 16.5;RH-30: 17.8;SH-SY5Y: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021556 Approved "Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" "Golgi apparatus" "HPA021556: " "unprognostic (7.12e-3)" "unprognostic (2.68e-2)" "unprognostic (2.60e-4)" "unprognostic (9.25e-4)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (1.11e-2)" "unprognostic (1.62e-1)" "unprognostic (3.00e-4)" "unprognostic (6.70e-2)" "unprognostic (6.61e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.61e-7)" "unprognostic (8.48e-2)" "unprognostic (4.09e-1)" "unprognostic (1.92e-1)" "unprognostic (1.13e-2)" 11.2 3.2 7.6 1.2 7.8 0.5 10.3 1.1 23.0 6.8 0.0 23.2 1.3 14.4 1.9 15.3 15.8 4.1 70.6 5.9 5.3 1.9 0.7 9.7 0.7 11.9 2.5 4.7 1.5 16.0 4.3 27.9 10.8 14.6 2.2 2.0 16.0 4.4 600.0 6.2 11.7 11.9 2.2 1.4 8.9 1.9 6.4 1.8 99.4 252.6 0.8 21.7 8.5 12.6 10.2 4.4 3.8 0.0 5.9 3.2 6.0 3.3 1.2 2.1 0.8 0.3 0.0 0.1 0.8 5.3 0.3 10.5 2.9 0.6 1.0 0.2 4.9 0.0 9.8 1.3 9.4 0.0 0.6 11.5 0.9 1.1 0.0 5.4 2.2 0.0 0.7 0.2 7.1 0.0 6.8 0.3 1.2 0.0 0.2 16.5 17.8 0.4 0.5 0.0 0.1 21.9 0.9 3.0 0.0 2.8 0.0 1.4 0.6 1.4 0.0 1.7 1.4 8.3 4.7 1.2 3.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 7.8 1.1 23.0 5.9 5.3 11.9 2.5 10.8 2.2 6.4 12.6 1.1 0.0 0.0 4.6 0.4 1.5 2.5 0.6 1.8 3.5 0.8 1.9 38.1 0.0 0.6 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.2 0.1 2.4 1.8 0.0 0.0 64.1 0.0 32.7 7.7 0.5 0.2 0.0 1.0 2.2 0.1 1.3 30.3 73.8 0.0 2.0 1.2 0.8 0.6 7.2 0.7 0.0 7.5 0.0 0.2 2.1 5.0 6.6 0.0 0.0 4.1 0.7 1.0 0.0 0.3 0.2 1.5 6.6 25.6 6.0 2.4 3.9 0.2 0.4 2.5 1.3 1.1 0.0 0.2 CPA2 ENSG00000158516 "Carboxypeptidase A2" P48052 7 130266863-130289798 "Enzymes, Metabolic proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 416 "pancreas: 45360.2" "Cell type enriched" "Detected in some" 10 "Exocrine glandular cells: 4973.8" "Cancer enriched" "Detected in many" 60 "pancreatic cancer: 411.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.2;CACO-2: 3.8;RH-30: 3.0;SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA020342, HPA021317" Enhanced Approved "Golgi apparatus" "Secreted to digestive system" NA NA 1500000 "Cluster 25: Pancreas - Digestion" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" "HPA020342: AB_1846007, HPA021317: AB_1846008" "unprognostic (1.12e-1)" "unprognostic (3.97e-1)" "unprognostic (4.21e-2)" "unprognostic (1.82e-2)" "unprognostic (1.38e-1)" "unprognostic (6.76e-2)" "unprognostic (4.65e-2)" "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.66e-1)" "unprognostic (3.84e-5)" "unprognostic (7.52e-2)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (8.48e-2)" 5.5 1.0 0.3 0.7 0.8 0.4 2.6 1.0 0.9 1.9 0.2 1.3 17.4 0.8 0.1 1.5 0.7 0.0 8.4 0.3 0.6 0.9 2.6 0.7 1.4 2.8 1.3 19.7 45360.2 0.0 1.4 3.2 2.5 1.5 0.4 0.8 7.8 0.0 0.8 1.1 30.6 0.0 1.2 1.2 108.9 2.2 1.1 0.1 0.6 0.0 0.0 0.5 0.8 3.1 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.8 0.0 0.0 0.5 0.0 0.3 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 3.0 0.0 0.0 0.3 1.6 0.0 0.1 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.6 0.4 0.3 0.0 0.4 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.0 0.9 0.3 0.6 2.8 1.3 2.5 1.2 1.1 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.6 1.9 8.1 4.3 0.0 0.0 0.9 0.0 0.0 0.1 4973.8 0.0 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 10.5 0.3 0.5 0.0 0.0 13.9 4.6 0.0 0.5 1.0 471.3 52.9 0.0 0.0 0.0 9.9 0.0 0.0 0.3 0.0 0.0 1.3 0.4 2.0 0.0 0.1 0.3 0.0 0.2 1.5 0.2 CPA3 ENSG00000163751 "Carboxypeptidase A3" P15088 3 148865296-148897203 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 112.0;lung: 86.3" "Cell type enriched" "Detected in some" 26 "granulocytes: 4422.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 1534 "basophil: 1115.4" "Lineage enriched" "Detected in single" 5518 "granulocytes: 1115.4" "Cell line enriched" "Detected in some" 45 "HEL: 303.3" "Not detected" "Not detected" "HPA006479, HPA008689, CAB020712" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" Nucleoplasm "CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-3)" "unprognostic (9.13e-3)" "unprognostic (3.50e-1)" "unprognostic (1.18e-3)" "unprognostic (2.47e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (1.89e-1)" "unprognostic (5.30e-3)" "unprognostic (3.50e-3)" "unprognostic (5.18e-3)" "unprognostic (3.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.69e-3)" 18.2 2.6 0.0 19.9 0.4 25.7 20.9 0.0 0.0 59.4 0.3 39.2 27.3 26.1 19.3 41.1 6.6 112.0 6.2 0.0 0.0 3.3 2.7 86.3 11.2 0.0 0.0 0.9 21.0 2.8 0.9 1.7 0.0 18.5 56.6 0.0 12.1 15.1 1.6 17.7 45.9 25.7 0.0 1.1 45.3 3.8 0.0 14.9 0.9 10.2 15.1 54.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 303.3 0.0 0.0 0.2 0.2 6.7 0.2 0.0 0.1 0.3 0.5 3.8 0.0 0.1 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1115.4 0.0 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 2.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 163.9 0.0 0.5 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.7 0.0 16.0 0.0 1.6 0.0 3.5 0.5 0.0 4422.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 5.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 6.7 0.3 0.0 0.0 8.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.3 0.0 41.7 0.0 0.0 0.3 CPEB4 KIAA1673 ENSG00000113742 "Cytoplasmic polyadenylation element binding protein 4" Q17RY0 5 173888349-173961980 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 322.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/70: 112.1;U-266/84: 173.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038394 Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 16: U-266 - Nucleosome" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Golgi apparatus" Vesicles "HPA038394: AB_10671226" "unprognostic (2.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.12e-1)" "unprognostic (3.99e-1)" "unprognostic (8.80e-2)" "unprognostic (2.91e-1)" "unprognostic (4.58e-1)" "unprognostic (8.75e-2)" "unprognostic (2.54e-1)" "unprognostic (9.37e-3)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "prognostic favorable (4.99e-8)" "unprognostic (2.66e-1)" "unprognostic (4.73e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" 20.0 66.2 22.4 17.8 29.4 72.0 17.3 44.7 29.3 17.4 44.2 12.8 13.7 12.7 6.9 30.8 10.4 20.0 46.6 23.7 24.8 50.7 79.1 16.6 12.5 20.6 27.8 10.7 36.6 73.1 12.3 18.3 22.7 12.2 13.0 41.7 23.0 15.4 62.1 12.0 15.1 16.3 23.0 14.7 19.2 15.7 26.3 9.4 33.4 62.5 16.3 22.2 8.8 32.4 12.6 18.4 9.2 5.4 14.0 8.5 16.0 21.5 20.2 7.6 9.3 16.1 8.5 15.9 16.0 12.0 24.5 1.0 7.4 12.6 12.0 32.3 8.4 11.0 42.2 10.9 30.5 4.5 19.4 13.2 24.9 19.6 29.3 32.5 8.5 6.7 33.8 35.5 17.6 8.8 3.7 3.5 4.8 5.3 17.9 3.5 8.5 50.7 10.8 21.6 9.8 10.6 2.5 29.6 39.0 13.7 20.9 7.7 22.6 12.8 6.9 6.5 15.1 112.1 173.8 8.6 28.8 8.1 15.9 0.4 1.1 1.2 0.7 1.1 1.0 1.2 0.9 0.6 0.5 0.9 0.9 0.5 5.7 0.5 1.5 0.5 0.9 0.6 22.4 29.4 44.7 29.3 23.7 24.8 20.6 27.8 22.7 23.0 26.3 32.4 66.1 76.9 34.3 270.3 39.6 42.4 14.0 23.0 23.3 163.8 80.2 30.0 221.8 97.2 55.2 53.3 135.5 11.5 36.9 68.2 23.5 31.5 67.6 104.4 38.6 54.3 62.7 244.4 190.4 26.5 5.8 26.1 59.1 133.7 90.0 7.6 59.6 144.1 69.2 146.4 163.2 26.8 52.9 109.9 95.8 47.8 8.7 87.5 74.7 61.8 50.8 108.6 18.6 322.2 237.5 43.8 59.4 21.4 174.8 43.3 39.4 81.5 74.9 131.3 0.0 49.2 47.7 55.9 19.9 45.6 51.3 62.0 26.9 36.6 21.3 64.4 CPQ "LDP, PGCP" ENSG00000104324 "Carboxypeptidase Q" Q9Y646 8 96645242-97149654 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 225.9" "Cell type enhanced" "Detected in all" "Astrocytes: 150.2;Oligodendrocytes: 299.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 250.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 116.1;ASC TERT1: 131.4;hTERT-RPE1: 108.2;Karpas-707: 97.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023235, HPA024490" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 51000000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 1: Thyroid gland - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Vesicles" "HPA023235: AB_1855257, HPA024490: AB_1855258" "unprognostic (4.04e-2)" "unprognostic (5.46e-2)" "unprognostic (4.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "unprognostic (3.98e-3)" "unprognostic (5.24e-2)" "unprognostic (2.92e-2)" "unprognostic (2.67e-2)" "unprognostic (9.19e-2)" "unprognostic (2.38e-3)" "unprognostic (6.16e-3)" "prognostic favorable (5.40e-5)" "unprognostic (6.74e-3)" "unprognostic (8.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" 46.2 35.9 22.6 25.4 33.9 31.8 34.7 28.0 26.7 75.1 20.6 39.6 29.3 46.0 36.2 25.9 39.8 57.8 51.8 21.6 27.0 80.5 70.0 32.3 22.8 32.6 27.5 87.4 46.7 60.7 25.6 39.2 33.2 40.2 33.1 16.8 32.8 54.2 13.3 20.6 35.0 64.7 25.9 31.3 32.1 13.9 30.3 8.2 225.9 33.2 17.0 46.3 38.6 38.6 0.6 2.1 2.1 0.1 116.1 131.4 0.5 35.3 55.6 12.8 26.5 2.0 0.9 0.4 27.2 59.0 15.7 1.0 2.4 2.8 12.0 31.4 4.4 28.4 1.5 17.7 25.6 4.9 37.0 69.6 6.5 15.0 3.7 108.2 6.0 0.1 27.1 97.0 29.4 1.2 0.5 14.1 2.5 0.2 5.2 4.3 0.0 0.6 26.7 13.2 2.4 0.3 10.2 0.4 28.2 25.8 12.3 28.6 21.3 51.9 4.9 0.8 11.5 7.9 0.9 0.3 32.2 21.6 33.5 32.0 71.3 45.1 27.3 49.6 27.6 5.4 20.3 24.0 51.8 7.4 17.6 24.6 250.5 25.9 47.5 14.8 22.2 40.6 22.6 33.9 28.0 26.7 21.6 27.0 32.6 27.5 33.2 25.9 30.3 38.6 46.6 12.8 12.5 150.2 11.7 19.4 25.7 21.3 9.6 12.7 12.1 27.9 27.2 42.9 13.9 47.8 29.2 12.1 40.8 9.3 17.6 22.7 5.0 6.6 43.3 27.1 13.8 7.2 24.0 10.7 1.8 123.8 10.7 8.6 38.0 43.1 51.0 48.3 54.0 10.1 31.3 7.9 24.4 56.0 44.9 9.0 72.4 39.4 78.2 131.2 33.7 43.4 39.1 44.7 299.6 11.7 9.5 73.0 11.9 12.4 42.4 56.0 9.7 16.3 52.6 71.1 67.8 5.6 3.4 2.8 13.1 6.0 23.8 38.6 12.2 13.5 CRACD "CRAD, KIAA1211" ENSG00000109265 "Capping protein inhibiting regulator of actin dynamics" Q6ZU35 4 56049073-56328625 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;intestine: 19.7;testis: 29.6" "Cell type enriched" "Detected in single" 11 "Cardiomyocytes: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.7;SH-SY5Y: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043249, HPA048148" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 59000 "Cluster 45: Intestine - Brush border" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Golgi apparatus" "HPA043249: AB_2678388, HPA048148: AB_2680286" "unprognostic (1.65e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-3)" "unprognostic (1.31e-1)" "unprognostic (6.04e-1)" "unprognostic (6.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" "unprognostic (8.05e-6)" "unprognostic (1.02e-1)" "unprognostic (6.54e-2)" "unprognostic (2.79e-2)" "unprognostic (2.93e-1)" 0.5 2.3 6.6 3.1 9.6 3.9 0.3 8.7 5.6 1.6 0.0 9.5 13.8 3.5 4.2 0.5 2.9 11.3 0.8 5.7 12.8 0.7 0.6 1.0 2.2 18.8 13.3 1.2 1.8 6.3 0.9 0.6 19.1 1.7 8.1 4.1 1.0 3.5 0.0 0.5 19.7 4.4 8.7 2.5 2.7 29.6 11.9 0.6 0.1 0.2 1.9 1.3 1.2 6.2 0.0 2.9 11.2 0.9 0.3 0.0 4.1 0.1 0.4 0.5 1.2 3.4 0.4 10.2 0.3 0.0 9.1 0.0 9.6 0.2 0.3 0.9 5.6 5.7 5.1 0.5 1.6 4.8 0.8 0.4 0.2 0.0 0.1 3.6 5.3 9.1 0.0 9.8 0.1 1.4 7.1 0.4 6.0 8.7 7.2 6.8 6.1 0.2 0.1 2.6 26.7 56.7 1.0 0.3 6.9 9.4 2.4 0.5 2.1 0.3 2.8 0.7 2.6 9.7 6.9 0.1 2.8 0.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 9.6 8.7 5.6 5.7 12.8 18.8 13.3 19.1 8.7 11.9 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CRYL1 "GDH, lambda-CRY, MGC149525, MGC149526" ENSG00000165475 "Crystallin lambda 1" Q9Y2S2 13 20403666-20525873 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 329.8;liver: 254.1" "Cell type enhanced" "Detected in all" "Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040403, HPA058848" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA 690000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Nucleoli" "Golgi apparatus, Plasma membrane" "HPA040403: AB_10795632, HPA058848: " "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (3.25e-2)" "prognostic favorable (1.76e-5)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-3)" "unprognostic (4.75e-3)" "unprognostic (1.19e-1)" "unprognostic (4.09e-2)" "unprognostic (2.12e-2)" "unprognostic (8.80e-2)" "prognostic favorable (2.30e-9)" "unprognostic (9.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (3.11e-1)" 33.7 31.8 69.5 15.4 81.3 11.2 27.1 75.4 78.1 33.0 65.6 62.1 190.2 30.5 51.7 24.7 26.5 30.0 30.4 65.2 79.0 329.8 254.1 19.9 19.4 76.3 71.9 19.8 46.9 31.4 38.1 16.1 76.1 32.2 49.3 20.7 41.6 36.5 17.0 16.3 131.6 22.8 77.2 23.3 45.2 4.9 71.9 18.0 35.0 20.7 16.3 20.9 23.6 89.8 8.1 6.9 6.4 42.7 31.6 36.1 5.8 11.1 20.0 4.8 3.9 2.6 7.8 0.1 20.6 15.5 10.9 1.9 5.7 9.9 4.9 19.4 4.7 14.2 0.8 55.1 18.1 4.6 12.2 21.5 6.4 3.9 22.0 17.1 51.7 20.3 1.0 5.8 12.7 29.2 12.7 7.2 0.4 68.7 10.2 6.4 3.8 1.0 40.8 16.9 4.2 5.0 6.6 3.1 51.0 3.0 21.2 18.0 50.1 5.8 2.6 14.3 7.1 7.6 1.6 0.0 11.1 7.9 24.5 5.8 50.7 3.2 23.2 59.6 18.9 20.5 30.6 22.1 60.5 23.1 23.5 22.2 1.7 15.6 50.6 6.4 37.5 43.8 69.5 81.3 75.4 78.1 65.2 79.0 76.3 71.9 76.1 77.2 71.9 89.8 29.2 6.4 10.3 57.8 17.7 10.3 15.9 29.7 6.2 6.1 22.0 11.6 10.5 35.8 25.6 77.3 12.5 22.0 10.0 138.5 485.2 26.1 3.6 32.5 8.8 29.1 9.1 6.9 54.5 31.6 11.2 29.8 34.1 27.2 25.3 8.8 50.7 306.1 71.4 1.7 35.3 89.0 32.6 91.6 34.3 4.3 26.1 51.3 37.4 13.1 19.3 112.2 9.2 33.7 114.1 43.2 219.1 24.0 14.3 23.0 509.9 1033.9 20.9 12.6 19.7 23.4 14.7 1.0 2.7 13.0 9.2 20.8 20.1 20.7 105.2 15.0 CSF2RB "betaGMR, CD131, IL3RB, IL5RB" ENSG00000100368 "Colony stimulating factor 2 receptor subunit beta" P32927 22 36913628-36940439 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 54.5;lymphoid tissue: 65.5" "Cell type enhanced" "Detected in many" "dendritic cells: 44.8;Extravillous trophoblasts: 37.9;granulocytes: 91.2;Langerhans cells: 68.3;Late spermatids: 41.2;Macrophages: 34.7;monocytes: 42.3;Plasma cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basophil: 238.1;neutrophil: 76.0" "Lineage enriched" "Detected in many" 16 "granulocytes: 238.1" "Group enriched" "Detected in some" 5 "HEL: 107.3;HMC-1: 321.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA078677 Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA078677: AB_2732389" "unprognostic (1.67e-2)" "unprognostic (9.44e-3)" "unprognostic (1.03e-2)" "unprognostic (6.66e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.47e-5)" "unprognostic (1.86e-1)" "unprognostic (1.94e-2)" "unprognostic (4.38e-1)" "unprognostic (9.57e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (1.82e-3)" "unprognostic (5.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.95e-1)" "unprognostic (8.52e-2)" 10.1 2.0 1.0 65.5 1.1 54.5 5.4 1.2 5.2 2.5 1.3 9.9 10.3 2.0 0.7 6.6 2.6 9.8 2.3 0.9 1.6 1.8 2.6 15.1 40.1 2.6 2.1 0.5 2.1 0.9 0.7 31.3 3.1 1.6 8.5 0.0 4.9 1.5 1.0 5.4 11.0 7.0 2.3 22.8 9.3 2.1 3.0 9.8 2.7 4.0 62.5 18.3 2.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 26.8 0.1 0.0 0.0 0.3 0.0 0.0 0.1 16.1 0.0 107.3 0.0 0.0 0.1 1.7 321.1 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.1 12.6 0.0 0.0 0.1 11.2 0.0 0.0 0.0 10.7 0.0 40.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.1 0.1 9.6 0.3 1.0 0.1 0.3 0.0 1.6 1.1 6.8 0.2 15.6 0.1 238.1 9.1 23.5 0.0 7.7 0.0 1.6 0.2 0.0 4.8 1.1 0.0 0.0 76.0 0.0 7.0 14.4 2.3 10.3 1.0 1.1 1.2 5.2 0.9 1.6 2.6 2.1 3.1 2.3 3.0 2.9 4.3 0.0 9.1 1.6 9.1 7.1 0.0 0.0 0.0 0.0 0.2 0.3 1.2 2.8 1.8 0.0 0.0 3.4 44.8 0.0 0.0 0.0 13.4 0.0 0.2 22.0 0.0 32.0 0.1 0.2 37.9 2.8 0.0 0.0 91.2 0.0 4.6 0.0 20.1 0.0 0.1 0.0 0.0 31.9 68.3 41.2 0.0 34.7 12.4 5.6 42.3 0.0 2.1 0.0 0.0 0.0 0.0 0.4 49.5 0.1 0.0 0.1 2.9 0.0 0.0 0.3 0.5 0.0 0.0 0.1 6.3 16.6 2.9 0.1 0.0 0.2 CSGALNACT1 "ChGn, CSGalNAcT-1, FLJ11264" ENSG00000147408 "Chondroitin sulfate N-acetylgalactosaminyltransferase 1" Q8TDX6 8 19404161-19758029 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 86.7" "Cell type enhanced" "Detected in many" "Astrocytes: 494.3;Excitatory neurons: 144.4;Granulosa cells: 214.1;Microglial cells: 224.9;Oligodendrocyte precursor cells: 355.9" "Cancer enhanced" "Detected in all" "prostate cancer: 22.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 62.6" "Group enriched" "Detected in all" 5 "B-cells: 44.5;granulocytes: 24.9;T-cells: 62.6" "Cell line enhanced" "Detected in many" "A549: 57.8;BJ hTERT+: 32.3;GAMG: 22.9;RPTEC TERT1: 39.6;U-2197: 36.8;U-87 MG: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068462 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 89: Fibroblasts - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Golgi apparatus" "HPA068462: " "unprognostic (8.90e-2)" "unprognostic (1.57e-2)" "unprognostic (4.66e-2)" "unprognostic (2.58e-1)" "unprognostic (6.03e-2)" "unprognostic (3.17e-3)" "unprognostic (9.78e-2)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-2)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (1.22e-2)" "unprognostic (1.89e-1)" "unprognostic (2.38e-2)" "unprognostic (1.46e-3)" "unprognostic (1.02e-2)" 19.4 12.5 20.3 8.8 15.7 11.1 7.4 4.8 18.3 18.0 0.7 4.7 3.5 7.0 5.4 31.2 11.8 16.1 35.8 16.3 11.5 6.0 2.8 11.7 7.6 6.3 11.2 57.0 7.9 11.4 3.0 38.8 7.6 31.8 2.5 2.5 6.8 9.8 5.8 4.8 4.7 12.3 6.7 8.7 6.9 2.8 8.9 11.7 86.7 11.0 8.8 23.4 8.1 10.7 2.1 57.8 0.5 0.0 9.3 2.1 7.9 1.4 32.3 0.3 0.3 3.1 1.0 0.0 0.3 0.0 22.9 0.7 0.0 0.0 0.4 7.5 0.4 0.2 16.2 1.9 4.1 0.0 0.1 0.9 1.6 0.7 0.3 0.4 11.6 0.2 0.0 0.1 0.1 2.6 2.9 0.2 0.3 8.3 1.7 0.3 0.1 0.0 39.6 1.6 0.2 0.3 17.2 6.9 2.4 1.5 0.1 0.4 1.0 1.1 1.3 36.8 0.9 0.3 0.0 0.0 26.0 3.4 11.4 0.1 2.9 24.9 5.6 0.1 0.6 44.5 25.7 8.5 2.8 15.9 44.6 11.6 15.6 8.4 0.4 4.2 62.6 11.7 20.3 15.7 4.8 18.3 16.3 11.5 6.3 11.2 7.6 6.7 8.9 10.7 33.3 3.2 1.1 494.3 27.3 4.5 7.4 0.2 0.6 0.3 4.1 0.8 45.8 0.0 0.9 12.9 10.4 1.9 6.2 0.0 1.9 5.7 6.9 7.5 1.2 38.5 3.0 3.2 144.4 1.7 14.6 20.9 2.0 2.0 0.0 214.1 26.7 0.2 15.8 18.5 76.5 0.0 16.2 27.4 6.5 7.4 5.3 14.1 12.4 224.9 3.5 1.0 6.2 355.9 4.6 3.1 0.0 12.0 21.3 21.8 0.0 0.1 1.5 1.0 6.6 2.1 12.0 0.7 0.1 0.5 3.1 8.3 9.6 77.0 0.1 2.8 CST3 ENSG00000101439 "Cystatin C" P01034 20 23626706-23638473 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 4217.6" "Cell type enriched" "Detected in all" 4 "Langerhans cells: 18746.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4" "Group enriched" "Detected in all" 9 "dendritic cells: 7959.0;monocytes: 6424.5" "Cell line enhanced" "Detected in many" "ASC diff: 1733.4;ASC TERT1: 1179.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000118, HPA013143" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1040000000 2800000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 41: Macrophages - Immune response" "Golgi apparatus, Vesicles" "CAB000118: , HPA013143: AB_1847417" "unprognostic (3.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.83e-4)" "unprognostic (8.53e-2)" "unprognostic (4.06e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.46e-2)" "unprognostic (3.72e-1)" "unprognostic (2.29e-3)" "unprognostic (3.51e-2)" "unprognostic (1.85e-1)" "unprognostic (1.16e-1)" "unprognostic (2.97e-1)" "unprognostic (5.01e-2)" "prognostic favorable (8.77e-4)" 1046.2 707.6 3041.2 262.3 3117.9 170.8 900.3 2823.3 4217.6 587.8 3094.8 788.7 389.6 708.3 875.9 557.1 802.7 583.0 1275.3 2976.3 2707.6 517.4 833.6 595.8 463.5 3258.4 3096.2 575.8 944.1 320.0 670.1 165.9 2939.3 773.9 416.9 46.9 2008.0 441.5 749.0 497.1 800.3 367.6 3028.1 723.7 979.9 761.3 3302.7 418.9 658.8 517.4 208.1 703.0 618.4 2883.1 155.2 328.2 75.4 175.8 1733.4 1179.8 145.3 261.4 350.7 170.3 137.7 625.1 219.7 0.8 241.0 345.2 221.3 496.2 69.6 499.9 51.9 0.9 253.5 157.6 61.1 1082.9 621.2 7.5 251.0 919.0 415.9 226.6 241.5 352.5 268.5 18.5 147.6 4.0 239.5 234.4 1.5 162.2 103.5 461.9 752.2 5.7 96.4 215.2 708.0 328.3 84.7 98.2 191.1 54.6 343.3 107.7 156.5 548.2 702.0 163.4 119.0 231.6 97.7 157.1 6.2 1.8 138.0 339.5 184.0 48.1 4967.5 33.2 66.9 6424.5 25.5 23.1 18.3 45.8 7959.0 13.6 16.9 31.1 809.3 191.4 4297.7 4427.4 13.6 4250.8 3041.2 3117.9 2823.3 4217.6 2976.3 2707.6 3258.4 3096.2 2939.3 3028.1 3302.7 2883.1 662.4 115.4 168.8 849.5 93.8 942.9 571.1 568.2 213.9 152.4 660.2 512.1 240.7 1361.2 514.5 641.9 29.2 476.8 603.3 1889.9 414.8 489.9 46.2 441.1 795.0 728.2 882.1 252.1 4.5 783.6 308.7 3026.2 981.7 631.0 359.9 687.0 491.9 2563.0 1816.7 48.8 11.2 1360.6 691.7 4301.1 18746.6 184.3 2132.6 4542.6 1563.5 87.1 2025.6 248.7 99.9 263.9 6.0 1458.5 2342.1 1790.4 67.9 786.0 4301.1 1098.6 364.4 36.3 2195.7 1417.0 846.2 125.5 400.6 461.5 822.0 469.0 117.4 208.1 1039.4 1079.7 CTSL "CTSL1, FLJ31037" ENSG00000135047 "Cathepsin L" P07711 9 87724051-87731469 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 563.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1081.6;Extravillous trophoblasts: 1012.3;Hepatic stellate cells: 580.4;Hofbauer cells: 1105.7;Macrophages: 537.2;Syncytiotrophoblasts: 1543.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 128.1;non-classical monocyte: 195.2" "Lineage enriched" "Detected in many" 12 "monocytes: 195.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 2305.0;HSkMC: 1061.0" "Low region specificity" "Detected in all" "CAB000459, HPA070413" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 17000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" "CAB000459: AB_2292484, HPA070413: " "unprognostic (1.05e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.19e-3)" "unprognostic (8.12e-3)" "prognostic unfavorable (5.15e-5)" "unprognostic (2.09e-1)" "unprognostic (3.15e-1)" "unprognostic (6.80e-2)" "unprognostic (3.21e-1)" "prognostic favorable (4.34e-4)" "unprognostic (5.64e-3)" "unprognostic (2.26e-2)" "unprognostic (1.72e-1)" "unprognostic (7.11e-3)" 232.4 86.6 49.2 136.0 55.4 84.8 110.0 52.9 67.5 69.5 67.9 110.3 39.7 108.1 81.6 33.3 108.4 85.0 112.5 47.0 52.3 207.3 333.5 154.9 101.1 54.4 54.0 96.4 61.9 151.1 69.5 563.6 57.5 68.2 58.8 32.3 77.6 91.7 71.9 39.8 57.1 125.2 52.4 124.4 71.4 80.1 112.2 33.0 76.1 79.8 49.4 209.8 48.0 59.6 88.1 423.0 32.6 55.3 514.0 2305.0 198.4 267.2 781.8 232.2 300.6 43.0 86.3 0.0 128.9 355.4 754.0 67.5 49.8 86.0 198.4 1.9 37.8 18.1 111.2 105.1 352.6 0.1 51.4 1061.0 138.9 373.7 134.9 186.6 194.9 0.0 162.5 0.7 326.6 115.6 0.5 9.9 67.7 128.6 77.5 21.6 21.5 0.6 158.6 39.0 42.8 50.6 62.1 133.5 312.3 177.9 14.5 97.9 296.9 190.8 104.7 750.6 125.9 18.5 84.1 0.9 692.6 0.2 67.9 0.3 13.5 0.6 0.3 128.1 0.0 0.0 6.6 0.1 7.9 0.1 16.7 1.3 0.5 0.2 195.2 0.3 1.7 10.1 49.2 55.4 52.9 67.5 47.0 52.3 54.4 54.0 57.5 52.4 112.2 59.6 86.1 41.7 52.9 15.3 11.2 37.7 82.1 58.0 15.4 43.8 12.2 33.4 96.8 87.2 46.4 75.4 18.8 1081.6 0.3 16.3 27.4 91.8 5.3 48.1 119.9 110.0 11.5 251.2 18.6 93.4 1012.3 261.7 10.2 27.6 29.7 63.6 580.4 122.6 1105.7 13.5 24.0 8.5 20.3 206.9 105.4 17.4 156.9 537.2 64.0 14.0 16.2 79.5 0.0 17.6 31.7 67.2 5.6 187.3 1.9 34.5 8.0 138.3 67.3 45.4 92.1 176.9 136.3 207.4 60.5 6.8 34.0 1543.6 10.8 30.8 11.7 44.8 CTTN EMS1 ENSG00000085733 Cortactin Q14247 11 70398404-70436584 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.2;neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in many" "A-431: 450.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011235, HPA057242" Supported Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" NA NA 11000000 "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane, Cytosol" "Golgi apparatus, Vesicles" "CAB011235: , HPA057242: AB_2683379" "unprognostic (6.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.05e-1)" "unprognostic (3.13e-2)" "unprognostic (5.81e-2)" "prognostic unfavorable (2.19e-6)" "prognostic unfavorable (4.45e-4)" "unprognostic (6.10e-2)" "unprognostic (2.39e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-3)" "unprognostic (1.20e-1)" "unprognostic (1.50e-2)" "unprognostic (6.97e-2)" "unprognostic (2.79e-1)" "unprognostic (3.72e-3)" "unprognostic (1.94e-1)" 91.7 142.5 28.3 15.6 30.0 4.9 82.9 29.7 32.3 112.3 28.5 84.9 28.4 117.8 18.7 131.6 85.0 35.1 106.9 27.7 28.2 109.6 66.9 74.8 9.0 33.2 30.8 112.9 79.5 18.1 94.1 23.9 30.9 101.6 23.8 8.4 92.9 27.0 65.7 104.4 70.9 31.8 29.5 53.3 92.2 62.0 30.3 8.7 89.5 14.5 12.7 88.1 101.2 32.5 450.2 97.2 32.0 37.2 53.2 81.9 52.5 93.8 92.5 80.7 63.4 129.5 110.3 17.5 90.6 121.1 86.3 97.3 38.6 98.7 58.7 35.5 39.1 1.7 73.6 61.1 113.9 0.4 22.6 116.6 68.0 89.4 50.2 84.4 68.8 0.5 51.3 3.3 80.9 122.9 0.9 6.4 35.0 163.4 58.6 0.2 39.3 14.3 90.5 143.7 26.3 44.9 68.3 93.2 158.0 57.2 75.8 1.9 86.8 70.8 45.3 111.2 63.6 7.4 5.2 1.0 141.1 0.4 98.9 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.1 0.4 0.0 6.8 28.3 30.0 29.7 32.3 27.7 28.2 33.2 30.8 30.9 29.5 30.3 32.5 95.3 44.8 51.8 61.7 4.0 151.9 102.8 85.8 46.1 39.4 81.0 57.9 64.1 80.1 95.4 134.3 18.8 83.8 1.6 224.4 64.6 146.5 12.4 86.4 84.8 89.9 74.4 18.9 93.4 221.5 95.6 89.1 76.0 116.1 6.3 117.7 78.9 44.1 10.4 38.7 65.4 123.8 57.0 8.9 34.1 26.1 103.2 38.6 122.7 28.1 5.9 42.5 0.0 40.2 145.8 260.6 177.8 98.9 3.1 153.5 108.4 164.3 89.4 32.5 59.2 61.0 87.5 32.0 47.0 76.7 174.9 106.3 5.4 91.4 111.9 258.1 CUL5 VACM-1 ENSG00000166266 "Cullin 5" Q93034 11 108008898-108107761 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002185, CAB017787" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 59: Non-specific - Translation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Cytosol" "CAB017787: , HPA002185: AB_1078587" "unprognostic (5.66e-2)" "unprognostic (6.58e-2)" "unprognostic (7.16e-3)" "unprognostic (1.30e-1)" "unprognostic (5.54e-2)" "unprognostic (1.62e-1)" "unprognostic (2.32e-2)" "unprognostic (2.80e-1)" "unprognostic (5.97e-3)" "unprognostic (1.78e-1)" "unprognostic (9.17e-2)" "unprognostic (1.77e-2)" "prognostic favorable (1.06e-5)" "unprognostic (3.83e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 9.8 11.5 6.8 9.5 7.0 28.3 13.0 10.9 9.1 11.8 7.3 9.1 9.0 13.1 9.9 10.6 9.6 8.5 15.2 6.8 8.0 16.3 14.2 8.8 11.2 6.4 6.8 12.4 8.9 13.4 5.7 11.4 6.5 12.1 9.1 12.7 8.5 9.5 46.4 11.4 8.6 10.5 7.4 9.8 9.4 6.5 6.8 12.7 14.4 37.5 10.3 10.0 7.0 10.3 14.4 6.6 19.6 15.1 12.5 20.2 9.7 15.0 16.3 13.4 15.0 21.3 16.5 20.1 27.3 18.8 14.0 18.0 18.4 12.3 19.4 13.2 11.1 18.9 6.2 15.7 21.1 21.8 14.9 15.8 16.1 14.1 18.6 17.5 18.7 16.2 25.0 7.2 21.4 7.9 20.9 18.1 10.3 18.4 11.6 15.0 14.6 21.8 16.4 21.2 13.9 19.6 20.4 21.1 12.3 12.0 31.1 17.0 19.7 24.6 11.4 17.6 16.2 7.2 6.2 26.5 9.6 24.0 16.0 1.2 2.3 1.6 2.1 2.1 2.0 1.7 2.1 1.9 2.3 2.2 2.3 2.3 0.4 1.6 2.2 2.5 1.7 1.3 6.8 7.0 10.9 9.1 6.8 8.0 6.4 6.8 6.5 7.4 6.8 10.3 50.2 57.7 42.5 66.3 49.0 29.8 29.3 26.0 44.3 52.7 35.1 25.7 111.9 37.1 39.2 31.3 66.7 37.6 49.2 21.8 50.9 29.6 6.0 45.4 48.7 41.3 17.6 34.3 84.9 23.5 23.6 42.6 33.1 40.9 43.1 42.8 40.0 54.8 27.1 55.5 83.8 28.7 22.4 41.6 20.3 8.0 30.7 41.2 14.2 61.8 51.7 31.5 30.9 74.4 101.7 29.1 29.0 38.0 48.4 36.6 27.9 76.7 36.6 59.4 19.7 56.0 53.1 35.5 44.0 43.9 30.3 35.8 38.8 48.0 30.3 32.9 CUX1 "CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6" ENSG00000257923 "Cut like homeobox 1" "P39880, Q13948" 7 101815904-102283958 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Transport" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 35.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003277, HPA003317" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Golgi apparatus" "HPA003277: AB_10601804, HPA003317: AB_2666891" "unprognostic (5.86e-2)" "unprognostic (5.39e-3)" "unprognostic (9.62e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.51e-4)" "unprognostic (5.85e-2)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (2.89e-3)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "prognostic favorable (5.72e-7)" "unprognostic (1.12e-1)" "unprognostic (8.85e-2)" "unprognostic (1.97e-2)" "unprognostic (2.97e-1)" 30.5 18.0 23.8 24.8 33.6 33.4 17.9 54.0 48.2 35.5 28.0 40.5 33.7 60.9 16.9 32.6 35.3 31.7 82.8 21.5 23.3 40.0 23.2 33.1 19.4 30.8 27.5 46.9 63.3 46.0 24.6 23.1 27.4 30.7 25.3 19.2 36.1 23.2 45.5 24.0 37.3 40.8 26.2 16.9 35.3 9.6 29.3 34.7 49.4 38.8 20.6 32.4 24.8 30.5 41.8 44.0 30.3 37.7 24.1 49.3 18.4 41.1 43.0 17.0 10.9 26.2 26.2 53.6 64.2 40.8 31.3 33.4 19.4 32.9 10.1 25.9 21.8 18.8 32.8 22.2 63.7 24.7 9.9 34.6 65.9 13.1 29.5 48.7 22.3 34.0 44.5 44.2 16.3 85.9 80.8 30.1 12.3 64.0 45.4 52.6 25.1 64.4 27.6 46.5 27.7 82.6 35.8 88.4 35.4 25.1 17.4 29.0 33.5 71.2 47.8 54.4 23.7 28.8 14.5 114.7 65.8 22.3 50.8 3.3 13.9 2.3 3.1 13.4 3.0 2.9 2.3 3.1 10.8 2.4 2.2 3.1 7.0 4.5 35.0 18.2 2.2 8.4 23.8 33.6 54.0 48.2 21.5 23.3 30.8 27.5 27.4 26.2 29.3 30.5 33.7 99.3 60.5 78.4 35.3 26.3 30.9 30.9 33.6 67.2 23.9 17.1 110.5 31.5 40.3 40.5 68.8 54.6 59.6 69.2 9.8 34.4 9.5 50.6 165.2 42.1 42.5 50.0 129.0 24.0 55.5 51.8 62.2 85.0 12.0 97.8 37.5 36.1 32.8 53.8 116.2 48.7 38.7 70.2 42.5 9.4 41.3 75.4 17.8 139.6 65.2 47.7 32.0 96.0 117.5 34.1 50.2 60.9 46.0 55.5 42.9 64.5 37.9 57.3 26.3 105.2 56.6 13.5 14.4 39.9 43.3 88.0 25.7 34.7 46.0 43.8 CWF19L1 "FLJ10998, hDrn1" ENSG00000095485 "CWF19 like cell cycle control factor 1" Q69YN2 10 100232298-100267680 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036889, HPA036890" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Golgi apparatus" "HPA036889: AB_10670928, HPA036890: AB_10696789" "unprognostic (2.76e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.66e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.90e-4)" "unprognostic (3.04e-1)" "unprognostic (9.17e-3)" "unprognostic (3.61e-1)" "unprognostic (2.70e-2)" "unprognostic (6.50e-3)" "unprognostic (5.61e-3)" "unprognostic (6.16e-2)" "unprognostic (2.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" 8.1 6.9 5.9 11.4 6.3 18.8 11.6 7.5 7.6 7.9 5.1 7.2 6.8 8.2 5.7 6.9 8.7 6.7 7.4 5.9 6.5 7.8 8.2 7.5 16.4 6.0 5.8 10.3 8.0 9.0 6.1 9.0 6.3 6.8 8.6 10.3 8.6 6.5 10.1 11.2 8.1 9.3 6.3 11.8 6.6 14.3 6.0 14.8 8.1 10.2 16.9 8.5 6.6 8.4 29.1 18.8 18.7 29.2 9.1 10.8 20.7 17.2 23.8 37.5 30.6 21.5 22.6 30.5 19.4 16.6 16.3 27.9 42.2 24.9 39.6 19.4 20.8 17.5 15.8 20.6 15.8 44.7 19.6 15.2 10.4 28.0 26.2 14.2 26.6 30.8 20.7 26.8 21.9 18.3 36.2 32.4 14.7 15.0 23.2 12.6 29.2 21.2 15.0 16.5 9.4 16.8 20.6 10.3 26.0 12.6 37.3 19.1 18.6 15.8 21.5 18.3 32.8 23.9 29.6 17.9 20.1 39.1 11.4 10.0 17.0 22.7 12.8 15.9 16.3 14.0 13.3 14.4 14.9 13.0 14.9 15.0 9.6 18.1 14.7 6.8 17.7 13.8 5.9 6.3 7.5 7.6 5.9 6.5 6.0 5.8 6.3 6.3 6.0 8.4 8.0 19.2 10.8 14.0 16.2 4.5 7.7 6.8 4.6 9.5 4.8 3.9 8.0 5.7 11.3 5.5 4.2 10.4 13.5 4.3 7.9 6.0 23.6 6.8 6.4 8.3 4.2 11.2 26.8 7.7 11.0 6.7 4.6 6.3 17.7 8.3 7.5 5.9 9.5 10.1 24.3 4.2 10.2 13.1 5.7 5.3 6.8 11.3 8.8 14.0 15.5 5.1 19.6 18.6 24.0 7.2 6.7 4.1 11.3 5.3 4.5 6.2 12.5 12.3 0.0 8.4 6.9 18.4 12.2 5.8 7.7 10.9 12.8 6.7 5.3 4.4 CWH43 "CWH43-C, FLJ21511, PGAP2IP" ENSG00000109182 "Cell wall biogenesis 43 C-terminal homolog" Q9H720 4 48986275-49062081 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.0;prostate: 42.8;skin 1: 25.5" "Cell type enhanced" "Detected in some" "Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0" "Cancer enriched" "Detected in many" 4 "prostate cancer: 20.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA042814, HPA048140" Uncertain Uncertain "Golgi apparatus,Plasma membrane" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Plasma membrane" "HPA042814: AB_2678182, HPA048140: AB_2680280" "unprognostic (9.38e-3)" "unprognostic (6.23e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.32e-4)" "unprognostic (2.14e-1)" "unprognostic (5.00e-2)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-1)" "unprognostic (2.49e-4)" "unprognostic (1.24e-1)" "prognostic favorable (2.29e-11)" "unprognostic (5.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.82e-2)" "unprognostic (2.51e-2)" 0.0 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.0 6.0 0.0 16.9 0.4 0.6 0.4 21.0 14.5 0.0 0.0 0.0 0.0 9.0 0.7 0.7 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 42.8 15.6 0.0 3.0 7.7 0.0 25.5 0.0 0.8 0.1 0.0 9.6 0.0 0.1 0.1 10.2 0.0 1.5 2.1 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 1.9 0.1 0.8 0.0 0.0 0.6 0.1 0.6 0.0 2.3 7.3 0.0 0.0 0.0 10.4 1.9 0.0 0.2 41.3 2.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 10.7 21.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 15.4 0.0 0.0 7.6 0.0 2.9 29.5 0.0 0.0 0.0 0.5 0.0 0.5 3.2 9.1 0.0 0.2 0.0 15.0 0.3 CXCL16 "CXCLG16, SR-PSOX, SRPSOX" ENSG00000161921 "C-X-C motif chemokine ligand 16" Q9H2A7 17 4733533-4739928 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 4051.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 63.3;intermediate monocyte: 107.5;myeloid DC: 38.2;neutrophil: 103.2;non-classical monocyte: 141.6" "Group enriched" "Detected in many" 7 "dendritic cells: 38.2;granulocytes: 103.2;monocytes: 141.6" "Cell line enhanced" "Detected in many" "A-431: 86.5;CACO-2: 63.5;CAPAN-2: 58.4;HaCaT: 97.9;T-47d: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053253, HPA066315" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1100000 6800000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 83: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "HPA053253: AB_2682091, HPA066315: AB_2685657" "unprognostic (4.64e-3)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (3.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (4.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.78e-2)" "unprognostic (4.74e-2)" "unprognostic (2.37e-2)" "unprognostic (2.48e-2)" "unprognostic (2.60e-1)" 27.6 18.1 18.7 56.0 19.4 70.4 29.3 20.0 30.7 19.8 20.8 21.9 45.7 11.7 15.3 24.6 24.0 54.0 7.8 17.4 23.0 19.6 52.6 106.0 23.7 32.5 22.7 10.5 20.8 61.8 14.4 31.1 27.9 16.3 25.8 10.2 47.1 14.4 2.6 21.8 39.3 17.6 25.2 43.8 41.2 112.6 28.7 12.5 10.5 3.3 17.9 60.6 14.3 34.2 86.5 12.4 0.4 44.7 0.7 3.1 11.5 1.1 8.9 11.2 15.6 63.5 58.4 0.1 10.0 1.5 8.6 97.9 20.0 14.1 5.3 8.9 14.8 0.4 1.7 29.5 8.5 0.1 15.8 0.7 26.6 5.9 1.3 7.4 3.1 0.9 0.4 0.7 0.8 20.9 0.3 1.8 0.4 42.1 7.2 1.2 0.0 13.2 30.4 15.8 0.4 1.4 17.6 11.3 5.5 2.3 57.4 1.4 0.4 1.5 6.8 2.2 5.3 3.0 3.9 0.1 0.5 2.9 2.4 0.6 63.3 16.7 0.5 107.5 0.7 9.5 1.1 0.8 38.2 13.0 0.8 1.2 103.2 0.6 141.6 16.0 0.1 29.2 18.7 19.4 20.0 30.7 17.4 23.0 32.5 22.7 27.9 25.2 28.7 34.2 9.7 73.7 46.6 1.6 17.4 70.1 130.4 133.4 40.5 2.6 64.8 50.3 0.8 58.6 132.4 40.5 2.1 3.4 11.1 28.1 3.9 151.0 795.4 22.1 4.1 25.4 30.9 2.7 0.1 145.9 2.5 14.2 36.7 32.7 74.1 2.3 132.1 9.0 196.4 3.3 0.3 32.2 44.7 231.6 406.3 4051.5 24.5 270.6 26.6 15.0 556.1 13.2 1.0 5.0 1.2 188.1 44.5 30.1 2.2 277.2 51.3 17.4 62.4 1.3 19.7 3.4 14.4 22.7 11.5 33.7 76.4 2.9 11.7 1.6 23.7 272.7 CXCL8 "3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1" ENSG00000169429 "C-X-C motif chemokine ligand 8" P10145 4 73740541-73743716 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 3301.3" "Group enriched" "Detected in many" 5 "Basal prostatic cells: 13262.1;Macrophages: 3685.4;Prostatic glandular cells: 8869.1;Urothelial cells: 13149.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 9 "cerebral cortex: 136.1" "Immune cell enriched" "Detected in some" 451 "neutrophil: 483.0" "Lineage enriched" "Detected in single" 788 "granulocytes: 483.0" "Group enriched" "Detected in many" 5 "BJ hTERT+: 4072.6;GAMG: 1080.2" "Not detected" "Not detected" HPA057179 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 7260 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA057179: AB_2683362" "unprognostic (3.42e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (3.91e-3)" "unprognostic (8.49e-2)" "unprognostic (3.29e-2)" "unprognostic (3.03e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.37e-3)" "unprognostic (3.19e-1)" "unprognostic (4.46e-1)" "unprognostic (7.19e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.13e-6)" "unprognostic (4.73e-2)" "unprognostic (8.57e-2)" "unprognostic (1.64e-2)" "unprognostic (6.15e-2)" 67.9 13.5 1.8 209.9 2.8 3301.3 3.6 1.7 136.1 54.5 7.6 10.6 3.6 41.0 0.2 3.7 8.9 177.2 33.8 1.7 1.6 10.8 77.7 91.2 1.2 2.1 1.6 6.0 16.1 1.8 3.2 41.1 15.1 9.6 7.3 0.9 25.4 1.5 1.3 3.2 4.9 12.7 1.9 10.3 8.8 0.7 4.9 15.2 3.4 8.1 8.7 456.7 4.0 1.9 2.7 1.4 0.0 0.1 3.9 19.4 0.2 25.7 4072.6 35.9 117.0 0.2 13.0 0.2 547.6 1.3 1080.2 48.2 0.0 1.0 562.3 1.8 0.2 0.9 0.4 6.5 6.8 41.0 2.5 12.4 1.7 119.0 2.9 12.9 124.9 0.0 1.4 0.8 0.7 0.0 0.0 55.7 0.0 14.7 20.3 0.3 0.5 0.9 317.3 17.2 0.1 0.0 1.9 0.1 61.1 0.8 0.1 5.6 308.3 56.8 5.1 15.1 55.0 0.4 0.7 1.7 252.5 30.9 88.2 1.0 0.6 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 483.0 0.0 0.0 0.0 0.0 0.1 1.8 2.8 1.7 136.1 1.7 1.6 2.1 1.6 15.1 1.9 4.9 1.9 28.6 51.3 254.1 0.0 26.4 0.0 13262.1 0.0 164.4 0.5 40.2 15.4 23.8 127.2 426.5 0.0 0.0 4.3 17.7 14.4 0.0 1695.0 3.2 717.6 257.1 712.2 19.1 8.0 0.0 260.7 5.2 1475.1 54.0 1708.7 51.2 0.5 15.7 3.6 367.1 0.0 0.0 26.4 0.0 543.0 0.0 1.9 0.6 3685.4 0.0 0.0 1178.5 0.5 0.0 0.0 0.0 584.9 0.3 0.4 27.3 8869.1 0.9 1.0 178.6 1.1 39.5 44.3 263.0 0.3 2.5 124.9 0.0 21.3 138.8 0.0 18.5 13149.4 CXXC4 IDAX ENSG00000168772 "CXXC finger protein 4" 4 104468308-104494901 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.1;retina: 7.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 48.0;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 102.1;Horizontal cells: 45.4;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 30.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.0;AN3-CA: 9.7;Karpas-707: 9.0;RPMI-8226: 5.5;SCLC-21H: 12.0;U-266/70: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036600, HPA036925" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 12: NES - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Golgi apparatus" Nucleoplasm "HPA036600: AB_10673659, HPA036925: " "unprognostic (1.37e-2)" "unprognostic (1.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.86e-2)" "unprognostic (9.07e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (9.69e-3)" "unprognostic (2.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.82e-1)" "unprognostic (4.52e-3)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (2.38e-1)" "unprognostic (4.42e-3)" 0.6 1.3 4.9 0.1 3.9 0.0 1.4 3.0 16.1 0.7 0.2 1.3 1.8 0.4 1.7 0.1 2.3 0.3 1.9 4.3 10.1 0.4 0.8 0.6 0.0 5.0 6.1 1.8 3.0 0.7 4.4 0.3 4.5 0.5 0.8 7.3 2.9 0.4 0.3 0.2 1.9 0.4 4.4 0.4 1.3 1.6 11.9 0.5 2.4 0.1 0.0 0.2 0.3 4.8 0.0 0.2 7.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 9.0 0.0 0.0 2.7 0.0 2.5 0.1 0.1 0.0 0.0 5.5 0.0 0.1 12.0 2.2 0.0 0.6 0.0 2.8 0.3 0.0 0.0 0.0 1.5 0.0 0.1 9.7 2.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 3.9 3.0 16.1 4.3 10.1 5.0 6.1 4.5 4.4 11.9 4.8 12.4 0.0 6.4 10.4 0.1 0.3 1.0 0.8 1.2 48.0 8.4 5.6 15.9 2.8 2.2 0.0 31.3 0.2 0.8 0.4 0.0 0.1 0.3 13.0 0.9 2.9 102.1 0.0 23.8 3.3 0.0 1.0 0.0 0.6 0.0 1.2 1.1 2.7 0.1 45.4 27.5 6.2 0.0 0.3 0.3 0.9 0.3 0.1 1.8 0.0 0.0 13.8 1.0 64.3 30.8 1.5 1.2 10.9 0.3 0.6 10.2 1.1 12.6 26.7 0.0 15.6 0.9 0.0 4.8 0.1 0.0 0.3 0.5 0.1 2.6 0.5 CYB5D1 FLJ32499 ENSG00000182224 "Cytochrome b5 domain containing 1" Q6P9G0 17 7857746-7862282 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 71.9;Endometrial ciliated cells: 45.5;Late spermatids: 42.6;Respiratory ciliated cells: 47.3;Skeletal myocytes: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021632 Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 30: Non-specific - Translation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Golgi apparatus" "HPA021632: AB_1847368" "unprognostic (1.99e-1)" "unprognostic (2.91e-1)" "unprognostic (1.23e-1)" "unprognostic (5.10e-3)" "unprognostic (2.34e-1)" "unprognostic (4.44e-3)" "unprognostic (1.12e-1)" "unprognostic (2.16e-2)" "unprognostic (1.34e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-4)" "unprognostic (2.38e-2)" "unprognostic (1.25e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-2)" 17.2 13.0 8.6 5.5 9.4 7.8 12.1 9.6 9.7 10.2 16.0 9.4 6.2 10.1 15.2 8.2 26.4 8.7 15.0 9.0 10.1 17.9 12.6 8.3 4.8 10.0 10.8 13.0 11.4 10.8 16.6 6.6 9.0 11.3 7.1 30.0 10.3 11.6 10.6 9.6 6.3 8.7 9.3 6.0 8.8 8.8 11.5 7.5 21.3 13.6 5.4 7.4 7.8 8.0 24.6 17.9 8.5 22.4 14.8 13.0 5.0 12.5 12.2 13.0 12.4 11.3 4.6 10.5 8.6 10.0 7.6 21.3 18.9 16.1 19.4 7.1 21.9 6.9 24.6 16.3 6.7 12.4 4.7 11.2 19.9 22.8 20.2 8.0 14.0 25.3 5.2 7.0 7.3 10.7 19.5 5.0 10.7 16.0 18.2 13.2 3.9 10.7 20.4 4.7 11.4 7.6 19.9 10.8 11.6 8.5 12.6 5.0 9.9 9.9 8.7 17.8 15.9 3.7 9.7 5.8 20.8 6.7 6.5 0.3 0.9 0.0 1.0 0.7 1.1 1.2 0.8 0.5 1.2 0.5 2.1 1.1 0.9 0.6 0.4 0.5 0.8 0.7 8.6 9.4 9.6 9.7 9.0 10.1 10.0 10.8 9.0 9.3 11.5 8.0 21.8 12.8 19.5 5.9 4.5 5.1 6.7 4.9 1.8 4.8 22.2 18.4 0.3 7.2 11.0 5.5 20.9 4.2 7.7 5.0 13.7 4.2 71.9 45.5 16.3 14.7 6.0 0.8 6.8 3.1 2.7 13.2 13.3 27.2 10.8 4.6 6.8 8.3 3.9 1.7 5.9 8.5 4.1 1.6 4.3 42.6 4.7 29.1 5.4 2.8 0.3 6.7 0.0 0.5 2.2 7.7 4.5 3.8 5.1 7.8 4.5 11.9 47.3 20.3 6.6 41.9 7.5 4.4 2.7 8.5 6.1 2.6 4.4 2.9 8.3 2.5 CYB5R2 ENSG00000166394 "Cytochrome b5 reductase 2" Q6BCY4 11 7665100-7677222 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 139.2;testis: 133.6" "Cell type enhanced" "Detected in many" "Early spermatids: 268.0;Late spermatids: 601.1;Spermatocytes: 115.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 6.1;memory B-cell: 10.6;naive B-cell: 2.8" "Group enriched" "Detected in many" 9 "B-cells: 10.6;granulocytes: 6.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 125.1;BJ hTERT+ SV40 Large T+: 65.9;BJ hTERT+ SV40 Large T+ RasG12V: 59.4;HBF TERT88: 52.0;NTERA-2: 69.8;WM-115: 96.3" "Low region specificity" "Detected in single" "HPA038962, HPA061707" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 77: Retina - Visual perception" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA038962: AB_10675954, HPA061707: AB_2732668" "unprognostic (1.47e-1)" "unprognostic (2.56e-2)" "unprognostic (8.90e-3)" "unprognostic (4.41e-2)" "unprognostic (4.13e-3)" "unprognostic (1.60e-2)" "unprognostic (4.02e-2)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-2)" "unprognostic (2.64e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.40e-1)" "unprognostic (8.16e-2)" "unprognostic (1.70e-1)" "unprognostic (7.01e-2)" 8.8 3.6 17.2 5.7 23.1 4.1 15.6 18.7 25.3 15.6 13.2 4.6 2.4 22.8 25.5 19.6 10.1 6.8 4.7 18.2 19.7 5.9 5.1 11.5 2.7 19.5 22.5 29.3 4.3 29.0 1.3 13.8 19.2 19.5 5.3 139.2 35.7 22.3 1.7 51.1 4.3 13.2 16.9 3.0 5.6 133.6 21.8 0.9 5.1 1.7 10.5 13.3 17.7 28.0 7.1 3.6 1.5 0.0 0.3 1.7 22.8 43.9 125.1 65.9 59.4 0.7 9.4 0.2 10.3 22.7 20.2 0.8 0.1 0.3 52.0 0.1 0.2 0.0 3.8 0.9 35.0 0.4 6.6 17.7 1.4 0.3 3.7 0.1 5.6 0.0 6.9 0.1 0.5 0.0 0.0 0.1 69.8 7.4 3.4 34.1 0.1 0.0 0.0 4.4 0.0 0.7 0.3 28.0 1.9 11.1 4.8 9.4 0.0 6.1 0.1 0.3 3.4 0.2 0.0 10.7 0.5 0.0 96.3 0.0 0.9 6.1 0.0 0.5 0.0 10.6 0.1 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 17.2 23.1 18.7 25.3 18.2 19.7 19.5 22.5 19.2 16.9 21.8 28.0 0.6 22.4 5.1 0.0 2.3 7.0 8.4 12.3 8.6 1.3 8.8 12.8 3.0 1.5 6.3 3.7 20.9 5.3 0.1 0.6 0.0 1.4 268.0 5.5 11.2 1.7 0.0 0.0 0.0 4.7 20.0 8.1 1.5 14.3 2.5 0.5 0.4 1.8 2.5 0.0 0.1 1.8 6.1 0.0 0.5 601.1 4.7 1.5 5.4 1.9 0.5 0.8 0.0 0.5 8.5 6.0 1.4 6.0 2.9 11.2 0.3 0.4 10.2 35.2 13.1 2.3 7.5 115.6 9.8 12.8 10.1 4.5 0.2 1.8 1.8 11.4 CYP2D6 "CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D" ENSG00000100197 "Cytochrome P450 family 2 subfamily D member 6" P10635 22 42126499-42130865 "Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 320.0" "Group enriched" "Detected in many" 35 "Hepatocytes: 512.8;Proximal enterocytes: 465.2" "Cancer enriched" "Detected in many" 35 "liver cancer: 90.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.8" "Low region specificity" "Detected in many" HPA045223 Enhanced Approved "Golgi apparatus" No No "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA045223: AB_10962927" "unprognostic (4.40e-3)" "unprognostic (7.68e-3)" "unprognostic (5.45e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.29e-4)" "unprognostic (3.83e-2)" "unprognostic (7.27e-3)" "unprognostic (1.13e-1)" "unprognostic (1.71e-1)" "unprognostic (4.03e-4)" "unprognostic (2.11e-2)" "unprognostic (5.61e-5)" "unprognostic (3.01e-1)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (4.82e-5)" 0.1 0.2 0.2 0.0 0.3 0.3 0.1 0.8 0.2 0.1 0.3 0.3 3.7 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.3 320.0 0.1 0.1 0.2 0.0 0.2 0.8 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.2 11.7 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.2 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.3 0.6 0.0 1.1 5.5 0.7 0.5 0.7 1.3 2.8 7.3 1.1 1.4 0.4 2.8 0.7 1.8 2.1 0.1 0.6 2.9 1.9 0.7 3.1 0.8 0.6 0.6 1.2 0.0 6.5 0.6 0.1 0.3 4.1 1.4 0.0 0.7 5.7 512.8 0.1 11.8 9.4 7.6 0.0 5.6 0.0 13.6 0.0 0.4 0.0 0.0 0.1 0.7 0.0 5.0 4.9 0.7 11.3 1.5 0.4 0.6 465.2 0.5 1.3 2.3 0.0 0.4 2.1 0.8 0.4 0.6 1.1 0.4 1.0 0.1 3.4 0.3 CYP2U1 "SPG49, SPG56" ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931549-107953461 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 84.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 30.2;Inhibitory neurons: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362" "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favorable (2.75e-5)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 7.7 6.4 6.6 4.0 8.3 0.5 4.5 7.6 7.3 5.1 10.1 5.8 3.4 6.6 3.6 3.5 7.8 5.6 7.7 6.5 8.7 5.3 5.9 5.7 6.3 9.0 7.9 9.5 2.3 10.7 4.7 2.4 8.2 9.9 3.9 5.8 3.4 8.7 3.6 2.7 4.7 10.2 8.1 7.6 3.2 3.0 8.0 84.9 3.6 7.2 4.7 4.7 3.8 9.5 4.0 1.9 5.2 9.5 28.6 13.4 0.8 16.8 25.3 10.2 15.7 0.1 2.5 10.8 1.1 10.1 7.8 0.2 8.1 6.4 15.4 3.0 2.5 2.3 3.5 0.5 11.3 3.2 0.0 15.3 5.3 4.7 3.2 20.8 4.0 12.0 0.1 5.0 8.4 2.9 11.8 0.0 5.4 0.4 4.7 6.5 6.3 0.1 3.3 6.7 10.0 7.6 4.2 7.3 18.6 4.3 3.6 1.5 10.6 6.5 0.8 9.3 6.9 21.1 21.2 3.4 5.5 0.0 7.4 0.0 0.1 0.3 0.4 0.5 0.3 0.8 0.3 0.4 0.9 1.1 0.7 0.5 0.0 0.7 2.8 1.1 0.0 0.2 6.6 8.3 7.6 7.3 6.5 8.7 9.0 7.9 8.2 8.1 8.0 9.5 5.5 3.2 3.9 18.6 12.9 1.1 4.6 2.2 15.4 4.1 2.8 5.8 6.2 1.5 2.4 9.2 4.2 0.4 10.1 1.4 0.0 0.9 13.2 6.9 6.3 5.8 3.0 1.7 30.2 2.0 0.3 12.6 3.1 6.2 4.5 2.5 8.6 7.3 2.3 1.7 34.3 1.2 0.0 6.2 3.3 9.5 17.7 4.7 19.6 5.6 3.7 9.5 1.0 20.1 12.1 0.4 0.1 17.7 4.2 1.5 9.9 3.0 8.6 3.1 0.0 20.0 8.1 1.0 4.2 2.0 1.4 0.3 3.6 5.1 3.1 0.8 CYTH2 "ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like" ENSG00000105443 "Cytohesin 2" Q99418 19 48469208-48482314 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 285.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014872, HPA060662" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 10: Non-specific - Unknown function" Cytosol "Golgi apparatus, Plasma membrane" "CAB014872: , HPA060662: AB_2732652" "unprognostic (2.28e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.72e-1)" "unprognostic (4.97e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (1.66e-1)" "unprognostic (2.83e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (2.33e-2)" "unprognostic (9.19e-2)" "unprognostic (3.14e-1)" "unprognostic (1.22e-1)" "unprognostic (1.24e-1)" "prognostic favorable (3.21e-4)" 8.1 12.1 17.2 11.4 17.8 8.1 14.2 20.3 19.0 15.9 15.4 9.3 21.5 10.7 13.6 15.3 7.6 23.2 7.4 16.2 17.1 21.0 7.2 11.2 8.2 18.1 19.1 7.5 16.6 19.6 14.8 16.3 17.4 15.0 8.3 39.0 22.6 9.1 3.6 15.1 21.3 8.2 15.3 10.6 17.5 35.6 21.2 14.9 52.5 5.7 8.8 10.9 10.6 21.2 24.7 36.8 107.9 24.7 16.2 13.9 19.6 18.9 17.3 19.9 18.7 20.1 32.9 16.1 19.2 16.6 16.5 30.4 21.1 23.1 12.5 24.6 28.1 22.5 52.6 22.0 14.6 14.0 29.7 18.0 38.5 24.6 15.9 90.2 26.0 23.4 22.9 55.0 26.6 20.0 23.9 102.5 11.8 22.1 14.9 29.6 15.9 11.2 34.2 52.1 31.9 30.9 20.7 57.6 16.8 34.0 27.1 18.8 28.3 42.6 21.3 10.3 27.8 54.1 30.8 10.8 15.5 27.1 30.7 2.8 2.7 2.3 2.6 2.1 1.8 2.6 3.2 3.7 2.4 1.8 2.8 2.0 7.2 1.4 2.7 3.9 3.6 2.1 17.2 17.8 20.3 19.0 16.2 17.1 18.1 19.1 17.4 15.3 21.2 21.2 48.5 28.9 33.5 15.0 18.7 45.9 115.0 81.1 26.7 35.6 47.6 28.7 11.5 55.8 63.2 40.5 25.0 51.2 42.6 35.0 35.2 82.7 285.9 85.3 26.5 56.0 26.0 4.6 5.7 93.6 47.0 33.5 55.0 56.3 17.7 32.5 50.3 8.3 43.7 21.9 6.8 29.3 67.1 27.9 39.7 163.0 37.3 34.9 35.6 9.4 52.0 42.6 22.6 4.5 12.0 136.6 36.2 36.9 23.2 77.1 57.9 53.3 80.6 59.5 52.6 42.9 70.9 63.5 53.2 23.2 47.5 142.7 33.2 26.0 25.4 139.2 DAPK2 "DRP-1, MGC119312" ENSG00000035664 "Death associated protein kinase 2" Q9UIK4 15 63907036-64072033 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 50.2;thyroid gland: 41.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 86.6;Late spermatids: 112.5;Oligodendrocytes: 99.9;Proximal enterocytes: 64.0" "Cancer enriched" "Detected in many" 15 "thyroid cancer: 30.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 94.3;eosinophil: 213.0;neutrophil: 65.9" "Lineage enriched" "Detected in many" 25 "granulocytes: 213.0" "Cell line enhanced" "Detected in many" "ASC diff: 10.6;HaCaT: 9.2;HMC-1: 18.3;MCF7: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071581 Supported "Golgi apparatus,Vesicles" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA071581: AB_2686421" "unprognostic (3.20e-2)" "unprognostic (4.07e-2)" "unprognostic (4.23e-2)" "unprognostic (1.95e-3)" "unprognostic (2.88e-2)" "unprognostic (1.30e-2)" "unprognostic (2.32e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.04e-1)" "unprognostic (3.18e-1)" "unprognostic (9.21e-2)" "unprognostic (8.51e-2)" "unprognostic (4.77e-7)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (3.20e-3)" "unprognostic (9.07e-2)" 12.5 2.2 5.9 2.7 7.6 15.9 8.8 5.9 8.1 6.7 4.3 9.8 20.6 1.6 0.2 3.3 1.7 1.5 28.0 5.5 6.7 4.5 2.0 20.0 3.1 6.2 6.8 0.9 2.7 0.9 1.6 0.4 6.6 5.1 6.6 0.4 7.5 3.6 50.2 8.1 21.3 1.7 6.0 7.8 9.9 3.1 6.6 1.5 41.9 19.6 2.6 2.4 9.5 9.5 3.1 2.3 6.1 1.5 10.6 0.5 0.0 2.1 6.7 1.1 1.2 1.0 1.6 0.2 0.7 6.7 3.7 9.2 3.8 0.1 0.6 0.2 0.2 1.3 4.5 0.1 0.1 0.1 18.3 1.1 7.9 0.4 0.2 7.0 0.7 0.1 0.4 0.1 0.7 9.7 0.0 0.4 0.7 3.1 2.2 2.9 0.0 0.3 0.0 3.2 0.4 0.3 0.4 1.2 0.0 1.5 5.2 0.4 0.4 0.9 1.0 1.4 1.8 0.6 0.2 0.0 0.0 3.0 0.3 94.3 0.2 213.0 2.1 0.1 0.9 1.3 0.6 2.2 0.2 0.4 0.0 1.4 65.9 2.7 0.1 8.6 0.1 1.3 5.9 7.6 5.9 8.1 5.5 6.7 6.2 6.8 6.6 6.0 6.6 9.5 24.9 86.6 22.3 5.2 4.8 11.6 7.0 8.7 0.6 0.1 9.4 7.4 46.2 1.5 14.6 0.0 0.0 0.1 22.6 45.2 1.9 9.1 25.3 3.0 1.6 6.4 8.4 0.8 15.9 35.6 0.2 8.7 16.3 7.8 15.2 1.3 5.7 1.3 0.4 5.0 2.1 17.0 6.1 1.3 0.8 112.5 3.1 3.2 0.0 15.0 0.3 2.1 2.1 11.1 99.9 9.4 30.6 5.7 0.4 12.0 64.0 0.3 2.8 0.3 13.1 7.6 4.5 2.6 4.9 0.5 4.1 0.1 14.9 1.9 19.6 14.0 DCBLD2 "CLCP1, ESDN" ENSG00000057019 "Discoidin, CUB and LCCL domain containing 2" Q96PD2 3 98795941-98901695 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 83.8;Oligodendrocyte precursor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 455.0;hTERT-RPE1: 648.9;LHCN-M2: 776.8;RPTEC TERT1: 479.0;U-87 MG: 581.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016909 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 2200000 "Cluster 21: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane, Cytosol" "Golgi apparatus" "HPA016909: AB_1847510" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-1)" "unprognostic (5.97e-3)" "unprognostic (9.29e-3)" "unprognostic (8.31e-3)" "unprognostic (1.06e-3)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.32e-5)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.76e-2)" "unprognostic (3.93e-2)" "unprognostic (1.59e-3)" 12.2 13.3 4.0 4.5 3.8 1.2 8.2 8.1 5.8 8.3 6.6 11.5 2.8 14.6 8.0 6.4 14.5 12.5 27.6 3.4 5.9 11.0 9.8 11.5 3.6 6.5 6.9 17.8 5.8 13.2 6.6 8.0 26.7 11.5 7.0 22.4 10.1 14.9 5.2 8.3 4.1 16.3 4.8 1.6 6.5 23.8 7.3 6.9 15.7 8.4 3.9 7.8 5.1 5.0 55.3 397.0 52.3 41.2 67.8 160.1 22.7 122.0 57.9 81.4 91.9 33.9 171.6 0.1 373.7 211.5 249.0 50.3 24.1 198.8 186.2 0.8 8.4 19.4 12.1 51.5 41.6 9.3 8.7 63.8 30.3 234.3 455.0 648.9 54.6 7.1 4.0 5.0 776.8 14.6 7.7 5.5 36.5 0.4 135.6 8.1 98.2 4.8 479.0 14.4 14.0 24.3 33.5 6.9 145.9 35.2 26.4 7.3 90.4 208.0 166.6 53.8 433.0 6.3 9.7 7.4 581.3 3.4 92.8 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.0 3.8 8.1 5.8 3.4 5.9 6.5 6.9 26.7 4.8 7.3 5.0 5.9 32.1 52.8 18.3 2.7 22.8 15.5 18.2 17.1 12.9 15.5 16.3 83.8 17.2 19.0 18.4 77.2 12.4 1.6 4.3 0.0 30.5 3.1 32.2 39.5 7.7 3.6 5.9 51.6 8.0 9.7 33.8 6.1 38.3 38.0 52.2 6.8 20.5 4.0 13.5 51.3 8.0 20.3 3.2 6.2 5.8 22.1 4.0 8.8 25.3 1.4 40.9 2.1 88.4 38.9 26.3 4.6 50.4 1.6 11.9 0.7 7.9 22.8 48.9 0.0 12.3 31.3 15.8 24.2 14.1 15.6 4.0 1.8 34.4 8.2 7.1 DCC "IGDCC1, NTN1R1" ENSG00000187323 "DCC netrin 1 receptor" P43146 18 52340197-53535903 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.9;testis: 7.6" "Cell type enhanced" "Detected in some" "Early spermatids: 205.7;Excitatory neurons: 439.7;Inhibitory neurons: 455.8;Late spermatids: 174.9;Oligodendrocyte precursor cells: 1305.9" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 36.4;U-266/70: 112.5;U-266/84: 57.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055376, HPA069552" Enhanced Approved "Golgi apparatus" NA NA 64000 "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" "HPA055376: AB_2682798, HPA069552: AB_2686151" "unprognostic (1.96e-3)" "unprognostic (1.69e-2)" "unprognostic (3.13e-1)" "unprognostic (3.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-3)" "unprognostic (2.59e-1)" "unprognostic (5.59e-2)" "unprognostic (2.00e-1)" "unprognostic (2.58e-1)" "unprognostic (8.22e-4)" "unprognostic (4.14e-2)" "unprognostic (1.27e-4)" "unprognostic (7.21e-2)" "unprognostic (1.84e-2)" "unprognostic (1.42e-1)" "unprognostic (2.69e-3)" 0.0 0.6 1.2 0.2 6.3 0.0 0.0 0.0 3.9 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 6.9 3.6 0.2 0.0 1.4 0.0 0.7 4.7 0.1 0.3 0.0 0.6 0.0 1.5 0.3 0.1 0.3 0.1 1.2 0.0 0.1 0.1 0.0 0.0 0.2 0.2 7.6 1.1 1.0 0.0 0.0 0.3 0.1 0.1 0.9 0.1 0.1 36.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.1 112.5 57.1 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 6.3 0.0 3.9 6.9 3.6 0.7 4.7 1.5 0.0 1.1 0.9 1.4 0.0 6.0 10.1 0.3 0.0 0.1 0.0 0.0 2.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 205.7 0.0 0.0 0.1 0.0 0.0 439.7 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 455.8 0.0 0.0 0.0 0.0 174.9 1.2 0.2 0.0 54.4 0.0 0.2 0.0 1305.9 58.6 0.0 0.0 1.2 5.7 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.1 2.6 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 DCLRE1C "A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C" ENSG00000152457 "DNA cross-link repair 1C" Q96SD1 10 14897359-14954432 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069295 Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Golgi apparatus" "HPA069295: AB_2686112" "unprognostic (8.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.66e-2)" "unprognostic (2.40e-2)" "unprognostic (1.36e-2)" "prognostic favorable (1.30e-4)" "unprognostic (8.02e-4)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic favorable (7.98e-4)" "unprognostic (1.91e-1)" "unprognostic (4.20e-2)" "prognostic unfavorable (9.03e-8)" "unprognostic (2.43e-2)" "unprognostic (2.32e-1)" "unprognostic (2.51e-1)" "unprognostic (5.45e-3)" 4.2 3.3 2.2 8.0 3.2 14.0 6.1 5.7 3.4 4.5 3.7 4.3 5.2 4.4 3.8 7.1 3.7 4.0 2.3 2.2 2.2 3.5 2.6 4.9 14.1 2.8 2.7 4.5 3.1 3.8 2.2 4.4 3.1 4.0 5.2 4.9 4.5 3.7 3.0 6.9 5.4 3.9 2.5 10.4 5.9 1.9 2.9 12.3 5.5 2.7 12.8 5.4 5.1 3.7 16.2 7.8 6.9 13.8 6.4 8.2 6.6 9.7 5.3 13.0 13.5 8.9 13.4 21.7 3.8 7.6 9.2 13.7 7.6 5.1 10.9 13.4 8.0 16.7 8.9 6.0 5.1 10.0 18.4 6.6 4.8 12.7 5.3 8.2 7.4 13.9 10.5 17.4 8.6 7.4 14.9 9.9 4.7 14.4 3.5 17.2 9.2 12.1 6.5 6.0 3.6 6.9 10.7 10.2 27.5 5.3 12.8 18.5 6.0 8.3 11.6 17.1 10.8 9.9 19.1 21.5 8.1 10.5 11.8 27.4 13.9 20.0 12.1 18.9 14.5 25.1 14.1 15.0 20.9 28.1 12.2 13.2 13.2 11.0 17.5 22.4 11.9 8.9 2.2 3.2 5.7 3.4 2.2 2.2 2.8 2.7 3.1 2.5 2.9 3.7 6.6 3.2 6.9 17.9 27.6 17.3 20.8 10.9 5.7 24.8 7.8 4.3 4.4 11.5 26.1 14.7 62.6 15.1 21.8 10.9 3.9 9.9 26.8 8.5 8.6 8.2 6.7 22.7 12.4 11.1 21.9 10.2 7.1 13.1 6.3 14.1 10.4 1.9 10.2 32.0 10.6 7.3 10.2 19.8 20.6 2.3 12.5 13.3 19.6 16.9 21.8 10.4 35.0 12.5 11.9 14.9 15.5 11.3 13.4 21.5 12.3 2.7 22.3 47.9 19.7 18.1 11.9 13.9 18.5 7.3 21.2 5.1 14.8 12.4 8.6 41.4 DDX31 "FLJ13633, FLJ14578, FLJ23349, PPP1R25" ENSG00000125485 "DEAD-box helicase 31" Q9H8H2 9 132592997-132670401 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020891 Supported "Nucleoli,Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoli "Golgi apparatus, Vesicles" "HPA020891: " "unprognostic (5.71e-2)" "unprognostic (1.76e-2)" "unprognostic (2.56e-1)" "unprognostic (7.91e-2)" "unprognostic (5.79e-2)" "unprognostic (9.94e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (9.57e-3)" "unprognostic (4.57e-3)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" 3.9 3.8 3.3 5.3 3.9 4.2 6.3 8.8 3.2 4.8 4.0 3.9 3.1 4.5 5.0 5.7 5.2 3.6 3.3 2.8 3.7 6.0 5.5 4.5 6.6 5.1 3.8 9.9 5.8 5.4 4.2 3.5 5.7 5.4 4.7 3.2 8.2 4.3 6.1 8.4 4.2 4.2 2.9 4.8 4.0 6.0 3.6 5.5 13.8 4.2 7.2 5.2 4.9 4.7 12.4 22.2 10.8 14.4 12.4 11.1 20.4 12.9 12.2 19.2 14.5 24.9 24.1 29.9 11.2 11.7 20.8 33.5 32.8 14.6 15.4 18.4 12.3 16.4 19.5 13.1 14.9 29.7 12.8 9.9 19.5 19.7 27.5 7.5 12.7 22.1 30.6 11.4 16.1 26.3 20.6 15.9 26.2 35.4 22.2 21.4 19.3 34.6 17.5 11.4 18.8 13.5 23.4 20.2 18.0 12.2 42.8 8.4 11.1 32.5 15.0 18.7 19.8 5.5 18.8 23.5 12.0 18.2 25.2 0.0 1.1 1.2 3.1 1.6 2.4 2.1 2.9 2.4 2.5 2.7 3.6 2.7 0.2 2.0 1.1 1.6 2.0 1.7 3.3 3.9 8.8 3.2 2.8 3.7 5.1 3.8 5.7 2.9 3.6 4.7 3.3 6.4 6.0 16.6 7.2 5.6 4.5 3.0 9.1 4.3 5.9 8.1 4.4 0.0 10.2 7.3 4.2 5.7 4.7 3.6 1.9 6.2 4.1 3.9 6.6 3.6 24.6 1.7 9.7 5.4 6.8 4.4 4.1 4.6 1.3 6.1 2.9 4.1 5.2 1.7 13.9 5.8 6.1 2.9 1.8 3.0 18.0 2.9 1.8 5.6 4.5 1.7 8.2 26.7 17.1 5.9 1.2 13.2 5.7 5.8 0.7 7.1 5.7 3.7 0.0 4.1 3.4 14.0 13.7 8.8 6.3 3.0 5.0 5.7 6.1 3.5 DDX54 "APR-5, DP97, MGC2835" ENSG00000123064 "DEAD-box helicase 54" Q8TDD1 12 113157173-113185479 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028244, HPA070786" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA028244: AB_10603885, HPA070786: AB_2686311" "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (8.54e-2)" "unprognostic (8.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.83e-2)" "unprognostic (1.15e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" 19.6 21.7 7.4 28.9 8.6 38.8 18.7 8.0 9.7 20.0 12.0 17.9 26.8 21.4 5.6 24.0 21.1 13.3 17.8 7.4 7.3 16.2 20.8 17.0 28.5 8.9 8.1 23.2 30.3 20.7 8.4 16.8 9.3 16.2 11.4 7.3 19.7 15.8 53.9 24.7 21.0 13.5 7.7 21.5 21.8 9.2 9.2 21.3 19.0 20.4 16.5 19.9 18.2 9.0 82.7 84.0 30.8 57.1 20.2 24.1 79.3 43.8 40.3 58.3 31.9 87.1 39.0 105.8 49.7 36.8 43.4 59.8 55.0 56.8 22.0 61.3 67.7 64.0 45.1 60.3 35.3 107.5 72.1 39.8 44.1 56.7 34.7 47.7 48.4 63.2 94.2 37.1 30.4 75.8 93.0 152.4 72.1 57.6 59.2 68.2 45.6 107.8 31.7 84.3 39.8 36.0 61.8 93.4 39.9 25.2 80.4 82.6 36.3 49.2 54.8 59.1 92.7 53.3 66.4 119.5 43.4 59.0 52.9 13.0 11.3 2.9 12.6 16.7 13.1 12.4 11.5 12.6 14.5 11.3 11.6 12.9 0.6 13.1 11.7 10.9 10.1 12.7 7.4 8.6 8.0 9.7 7.4 7.3 8.9 8.1 9.3 7.7 9.2 9.0 19.1 32.1 29.8 6.5 39.4 17.3 35.9 26.4 34.7 20.5 28.2 24.3 14.5 21.5 24.1 12.9 2.1 63.9 30.6 29.2 25.4 44.5 1.2 23.3 21.8 25.7 28.2 33.4 5.9 49.9 57.2 23.2 26.0 28.5 25.3 35.6 17.9 38.2 38.6 26.9 4.3 31.5 24.4 35.9 20.9 2.4 29.5 22.3 12.4 6.5 29.5 26.8 51.5 2.0 4.8 43.0 33.4 24.0 35.0 52.9 49.3 50.5 12.8 18.1 6.6 28.7 24.9 14.8 20.1 39.5 19.6 72.4 33.3 56.8 43.8 38.0 DELE1 "DELE, KIAA0141" ENSG00000081791 "DAP3 binding cell death enhancer 1" Q14154 5 141923855-141942047 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 31.3;Cytotrophoblasts: 26.2;Exocrine glandular cells: 24.3;Granulosa cells: 24.4;Hofbauer cells: 29.1;Syncytiotrophoblasts: 25.7;Theca cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036548, HPA061490" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Golgi apparatus" "HPA036548: AB_10673356, HPA061490: " "unprognostic (1.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (1.80e-1)" "unprognostic (7.77e-2)" "unprognostic (2.72e-2)" "unprognostic (7.99e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (6.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.80e-1)" "unprognostic (2.15e-3)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (2.28e-3)" 42.5 54.2 26.5 22.5 29.1 39.7 42.0 30.4 32.9 43.3 33.6 43.8 30.3 41.2 14.6 35.4 38.8 24.9 78.9 26.8 27.7 44.5 53.5 46.2 30.2 29.9 28.6 37.9 42.9 38.1 34.0 29.4 28.9 41.4 31.2 14.0 33.1 24.5 71.1 32.3 39.6 30.1 27.7 65.7 42.4 15.6 29.5 19.3 40.3 49.7 27.1 43.4 38.7 29.6 23.6 31.5 44.7 65.9 34.7 45.5 29.7 29.8 48.8 51.6 56.8 46.0 54.0 55.1 33.2 32.9 29.9 35.1 27.2 62.8 28.4 31.7 24.0 33.4 37.9 34.5 43.8 48.3 63.3 55.8 31.3 45.4 37.0 46.0 54.5 11.5 21.4 72.9 26.9 30.8 13.0 26.8 17.2 28.6 49.9 43.5 29.7 61.8 37.2 33.7 25.0 31.8 35.2 54.0 72.6 28.8 70.3 42.6 44.1 38.9 23.8 20.7 27.0 20.1 23.3 34.0 32.0 38.1 43.4 21.2 43.0 14.8 21.2 56.7 19.7 20.6 16.5 20.7 56.1 19.1 13.8 18.2 18.2 24.7 66.9 22.2 27.2 25.3 26.5 29.1 30.4 32.9 26.8 27.7 29.9 28.6 28.9 27.7 29.5 29.6 31.3 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 16.0 17.0 0.0 0.0 0.0 11.0 0.0 26.2 13.7 0.0 13.7 12.4 0.0 12.0 13.7 10.9 0.0 0.0 0.0 24.3 13.8 6.3 0.0 12.1 0.0 24.4 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 17.2 0.0 0.0 5.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 25.7 4.8 34.5 0.0 0.0 DENND11 "KIAA1147, LCHN" ENSG00000257093 "DENN domain containing 11" A4D1U4 7 141656728-141702166 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 9.2;B-cells: 3.8;Cardiomyocytes: 4.3;dendritic cells: 8.5;Hofbauer cells: 7.6;Plasma cells: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "basophil: 1.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "HDLM-2: 5.5;HEK 293: 5.3;U-266/70: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029467, HPA061437" Approved Approved "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA029467: AB_10602915, HPA061437: AB_2684517" "unprognostic (1.27e-1)" "unprognostic (5.68e-2)" "unprognostic (7.05e-2)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "prognostic favorable (6.24e-4)" "unprognostic (6.49e-2)" "unprognostic (3.63e-2)" "unprognostic (3.02e-2)" "unprognostic (4.27e-1)" "unprognostic (7.62e-2)" "unprognostic (3.75e-2)" "prognostic favorable (8.01e-4)" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.91e-3)" "unprognostic (1.78e-1)" 8.7 5.9 7.1 1.0 8.0 0.9 9.6 5.4 10.2 8.0 4.3 11.0 3.6 7.0 0.5 12.5 8.1 0.5 6.8 10.7 5.3 8.8 14.7 13.3 1.6 9.0 7.7 7.5 17.4 1.0 11.8 0.3 8.6 9.0 1.5 2.8 20.6 0.7 5.7 8.7 14.4 0.6 7.0 14.2 17.8 1.4 6.9 0.6 12.4 0.5 1.2 8.5 11.3 10.6 1.9 1.5 0.9 1.2 0.5 0.2 0.3 0.4 0.3 0.3 0.3 1.9 1.3 0.1 3.1 0.3 0.8 0.6 1.0 0.8 0.7 5.5 5.3 0.9 0.8 0.3 0.1 1.7 0.3 0.2 0.7 0.2 0.3 0.8 1.3 1.0 0.0 0.3 0.2 0.7 1.5 1.2 1.5 2.1 1.0 3.6 0.2 1.7 0.6 1.0 1.4 2.7 1.2 2.1 0.2 0.5 0.8 0.2 4.3 0.2 1.0 0.4 2.2 7.5 1.8 2.4 0.6 2.3 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.1 8.0 5.4 10.2 10.7 5.3 9.0 7.7 8.6 7.0 6.9 10.6 9.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 8.5 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 DENND4B KIAA0476 ENSG00000198837 "DENN domain containing 4B" O75064 1 153929501-153946718 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040188, HPA071133" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Golgi apparatus" "HPA040188: AB_10671168, HPA071133: AB_2732173" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (1.59e-2)" "unprognostic (9.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.45e-3)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.58e-1)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "prognostic favorable (3.18e-5)" "unprognostic (2.21e-1)" "prognostic unfavorable (9.27e-9)" "unprognostic (4.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.56e-3)" 18.2 13.4 10.9 24.3 11.1 37.1 15.7 2.3 19.1 17.1 0.0 15.6 9.5 16.3 3.4 10.2 16.2 10.0 21.3 10.2 6.5 13.8 11.4 24.2 30.1 12.0 7.8 19.6 15.5 7.7 13.1 10.3 13.0 13.0 6.0 9.5 11.7 7.0 49.2 11.0 22.0 8.9 3.1 41.0 12.9 7.6 9.8 14.6 15.2 29.5 17.3 15.1 12.9 10.0 12.0 22.7 17.1 17.3 10.0 9.7 17.8 11.5 12.4 17.8 16.6 13.8 13.4 29.9 19.1 7.8 13.5 20.9 15.5 10.6 8.0 27.5 14.0 26.5 26.1 13.3 13.9 28.0 51.5 8.8 18.3 16.6 17.8 14.8 12.8 32.3 28.7 16.4 10.3 24.6 34.2 25.7 23.8 14.1 21.8 36.2 11.5 17.3 8.5 17.6 20.3 24.9 12.1 28.4 16.7 17.0 20.6 68.0 13.5 19.2 18.5 16.1 18.7 49.3 37.7 39.5 13.2 21.7 23.5 1.5 1.6 0.4 1.1 2.4 1.4 1.0 0.9 0.7 1.4 0.9 0.4 1.0 1.5 0.7 1.9 1.9 0.7 1.5 10.9 11.1 2.3 19.1 10.2 6.5 12.0 7.8 13.0 3.1 9.8 10.0 14.7 9.6 10.3 18.6 20.3 4.7 3.7 4.6 1.2 22.3 7.1 6.9 22.9 8.6 5.7 7.3 6.2 4.6 31.9 4.8 5.9 5.2 1.2 4.0 8.0 11.8 4.9 9.5 21.8 6.5 4.7 7.2 13.7 7.4 17.2 12.5 10.8 9.2 18.0 35.3 23.6 4.6 2.0 30.2 11.7 1.9 7.5 31.1 5.4 18.7 22.5 5.8 30.9 19.1 27.9 6.1 4.8 7.9 7.1 6.8 7.6 2.7 4.4 17.8 6.6 7.9 6.0 6.4 8.1 5.7 3.4 3.4 17.0 9.2 7.1 5.2 DENND4C "bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF" ENSG00000137145 "DENN domain containing 4C" Q5VZ89 9 19230435-19374281 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 120.9;Oligodendrocyte precursor cells: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014917, HPA015096" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 31: Skin - Epidermis development" "Cluster 36: HEL - Hemostasis" "Cluster 59: Non-specific - Transcription" "Golgi apparatus, Vesicles, Cytosol" "HPA014917: AB_2261659, HPA015096: AB_1845831" "unprognostic (4.57e-2)" "unprognostic (1.73e-2)" "unprognostic (6.81e-2)" "unprognostic (1.71e-1)" "unprognostic (1.87e-2)" "unprognostic (1.48e-1)" "unprognostic (2.43e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "prognostic favorable (3.51e-5)" "unprognostic (3.27e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" 21.7 11.9 5.9 9.2 7.0 10.6 21.7 14.1 6.3 17.2 8.0 17.4 25.1 17.2 14.3 14.5 16.4 13.8 14.5 5.3 5.6 13.9 15.2 18.0 11.8 5.9 5.7 21.4 12.9 19.0 8.7 19.6 5.7 16.1 19.8 11.8 15.1 13.4 10.6 29.6 22.4 14.6 5.8 12.7 19.8 11.2 7.2 17.7 17.3 12.4 11.2 16.6 16.0 6.6 17.7 17.5 11.7 15.3 26.6 28.5 21.4 10.0 14.9 10.2 13.7 8.4 11.6 7.5 8.3 13.6 11.8 9.4 13.7 9.4 12.0 47.2 7.8 34.4 18.5 10.4 13.4 8.3 18.8 11.7 18.7 9.0 15.5 21.6 20.2 9.9 9.4 8.5 13.1 7.4 13.8 18.8 9.0 24.7 8.5 12.6 6.6 10.9 29.2 34.1 10.9 8.5 8.4 20.1 7.4 11.0 12.1 11.3 18.5 8.9 5.2 10.0 10.5 5.8 14.9 4.0 7.7 7.6 5.2 8.3 1.6 1.9 5.4 0.8 7.0 1.7 4.6 5.5 3.1 2.3 4.3 5.0 0.9 6.4 0.9 3.2 3.8 2.4 5.9 7.0 14.1 6.3 5.3 5.6 5.9 5.7 5.7 5.8 7.2 6.6 28.6 9.6 11.5 85.8 21.3 51.2 16.7 18.0 65.4 20.9 16.0 11.0 12.4 14.3 21.6 16.5 60.5 29.4 22.6 26.6 1.9 9.8 7.7 12.7 15.5 22.9 19.8 9.7 78.6 12.5 13.5 24.0 47.4 20.4 27.1 24.8 51.0 11.5 19.0 23.5 87.2 22.6 24.4 23.9 22.0 5.2 18.6 32.2 21.4 120.9 8.5 13.6 27.8 107.1 69.1 12.1 20.9 20.3 14.1 19.4 26.4 4.9 21.6 16.3 0.0 19.5 16.2 3.3 6.8 30.9 49.3 16.1 28.2 12.0 23.3 23.2 DENND5A "FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1" ENSG00000184014 "DENN domain containing 5A" Q6IQ26 11 9138825-9265959 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 287.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052923, HPA055009" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Vesicles" "HPA052923: AB_2681989, HPA055009: AB_2682669" "unprognostic (5.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" "unprognostic (1.28e-2)" "unprognostic (4.03e-1)" "unprognostic (3.48e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (1.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "unprognostic (5.15e-2)" "unprognostic (3.10e-1)" "prognostic unfavorable (1.14e-6)" "unprognostic (9.86e-3)" "unprognostic (1.03e-1)" "unprognostic (4.32e-1)" "unprognostic (1.40e-2)" 45.8 23.5 72.4 23.2 90.5 21.7 36.3 85.0 80.7 36.1 45.5 44.2 5.8 38.5 14.1 17.4 37.5 23.3 58.0 65.1 85.4 25.5 15.7 46.1 16.8 81.5 86.6 30.2 23.2 18.5 20.5 28.8 77.0 24.5 12.9 34.7 19.5 40.0 26.7 17.3 20.2 47.5 74.9 31.4 23.7 15.8 87.3 28.0 22.0 33.7 15.9 40.4 25.1 81.3 18.8 23.3 63.7 56.1 113.0 92.0 61.7 69.2 99.8 85.7 104.5 16.4 13.6 0.0 30.5 129.0 82.4 12.7 64.3 22.5 111.4 73.0 30.9 6.2 32.2 34.5 61.0 34.4 13.9 76.8 11.5 51.1 74.6 59.7 83.8 21.9 33.6 0.3 101.9 11.0 19.4 15.1 19.7 3.2 28.6 34.2 46.1 0.3 41.6 13.4 15.9 32.1 65.8 29.7 27.2 70.4 15.7 24.6 59.2 63.0 41.0 78.7 47.3 1.4 0.4 18.7 63.4 14.1 51.9 4.4 5.0 5.7 0.1 6.3 0.6 1.8 1.3 1.3 4.6 0.2 3.8 1.9 10.8 1.0 9.2 1.1 0.0 1.9 72.4 90.5 85.0 80.7 65.1 85.4 81.5 86.6 77.0 74.9 87.3 81.3 34.1 19.2 14.5 43.8 7.4 21.7 19.3 10.3 10.2 9.7 15.3 13.8 33.2 14.3 8.0 14.7 60.5 15.9 6.4 0.3 0.0 7.3 1.1 26.3 31.8 31.3 6.6 7.8 47.7 6.7 20.1 27.1 3.1 57.8 2.5 11.6 21.4 10.9 21.8 13.5 74.2 2.2 4.1 36.3 63.4 2.0 21.5 48.9 19.6 68.4 41.1 11.6 3.1 136.2 287.1 8.4 1.4 20.7 0.9 32.5 0.1 10.3 4.8 10.5 26.3 34.4 31.6 7.9 12.3 6.3 8.2 11.2 6.3 16.0 0.8 15.0 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.1;gallbladder: 21.0;lymphoid tissue: 20.7;testis: 12.6" "Cell type enhanced" "Detected in many" "Cholangiocytes: 18.6;Erythroid cells: 23.8;Extravillous trophoblasts: 21.6;Spermatocytes: 37.2;Syncytiotrophoblasts: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: AB_2686534" "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favorable (2.42e-4)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (3.08e-4)" "prognostic unfavorable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.3 0.2 0.4 3.9 0.7 11.1 0.9 0.5 0.5 0.6 0.1 4.1 6.0 0.6 0.0 2.5 0.2 21.0 0.1 0.3 0.6 2.9 0.4 0.4 9.1 1.2 0.5 0.2 0.1 0.0 0.0 7.5 1.4 0.2 5.5 0.1 0.5 0.1 0.0 2.1 6.4 0.9 0.6 1.6 1.4 12.6 0.6 20.7 1.2 0.0 9.7 1.0 1.1 1.5 61.0 20.3 60.5 37.2 1.3 1.9 66.2 16.1 10.9 27.7 35.8 34.0 37.5 34.6 38.5 5.0 36.0 19.8 49.2 36.1 36.9 49.5 35.5 43.3 22.7 42.6 1.0 36.7 40.3 1.2 3.7 9.0 12.9 5.4 26.1 36.3 31.4 45.8 24.7 38.0 59.8 31.9 44.7 13.0 32.6 65.4 49.2 29.4 22.8 29.9 33.6 15.4 37.7 13.4 17.7 27.0 24.9 28.8 12.1 11.7 34.2 9.5 41.6 23.0 43.3 68.0 14.7 53.2 33.3 1.5 0.1 0.9 0.2 0.0 0.2 0.4 1.0 0.7 0.3 0.0 0.1 0.1 0.0 0.6 0.0 0.0 3.2 0.4 0.4 0.7 0.5 0.5 0.3 0.6 1.2 0.5 1.4 0.6 0.6 1.5 0.2 0.0 1.8 0.0 1.9 4.7 1.0 1.5 0.0 0.1 0.5 0.8 0.1 18.6 0.3 0.0 0.0 7.4 1.1 3.1 0.0 0.3 1.9 3.3 1.4 0.9 0.0 23.8 5.5 0.2 21.6 1.1 2.6 11.7 3.8 5.2 0.0 0.3 6.4 0.0 1.7 2.3 0.0 1.6 2.9 2.4 0.3 1.9 0.0 4.7 0.1 0.2 0.0 2.0 7.0 0.9 5.8 0.0 15.9 0.7 3.7 1.0 0.1 0.1 6.6 0.3 1.4 37.2 12.7 5.8 2.0 46.9 4.5 0.6 7.9 0.9 DHRS11 "MGC4172, SDR24C1" ENSG00000278535 "Dehydrogenase/reductase 11" Q6UWP2 17 36591879-36600804 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "intestine: 216.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 129.3;Distal enterocytes: 317.3;Paneth cells: 154.2;Proximal enterocytes: 527.9;Undifferentiated cells: 148.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041226, HPA048236, HPA053623" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted to digestive system" NA NA 42000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 56: Intestine - Transmembrane transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 45: Enterocytes - Digestion" Cytosol "Golgi apparatus" "HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209" "unprognostic (2.00e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-2)" "unprognostic (3.74e-1)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (1.80e-2)" "unprognostic (3.67e-1)" "unprognostic (5.94e-2)" "unprognostic (1.33e-2)" "unprognostic (4.11e-2)" "prognostic favorable (3.24e-4)" "unprognostic (1.45e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" 10.0 10.5 6.9 5.4 7.9 4.4 10.9 6.7 9.8 9.5 9.0 74.3 216.0 5.7 1.9 14.6 7.3 2.4 17.2 8.6 9.0 21.9 14.8 4.3 2.4 7.4 7.5 5.1 15.4 9.5 13.3 2.0 7.9 8.0 57.1 22.4 10.3 4.5 16.7 14.4 177.0 6.3 6.6 4.7 11.7 17.0 8.2 2.1 11.9 9.9 3.6 6.8 10.5 7.7 13.9 10.0 3.6 13.8 1.2 2.5 10.6 3.8 2.6 11.9 10.7 22.2 10.1 0.8 1.9 4.0 4.8 13.9 11.5 6.7 10.5 7.1 15.2 3.7 10.1 35.6 5.5 3.0 1.2 2.2 7.3 8.6 6.5 1.9 8.8 11.2 36.1 9.3 5.9 12.5 12.6 5.5 4.5 14.2 0.4 15.2 12.8 22.0 9.9 11.4 10.4 4.9 16.0 12.9 33.3 6.6 19.1 3.6 4.8 1.6 18.2 7.6 10.0 14.1 16.7 4.4 6.5 9.3 5.5 0.1 0.1 0.4 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.7 0.0 6.9 7.9 6.7 9.8 8.6 9.0 7.4 7.5 7.9 6.6 8.2 7.7 9.1 0.0 1.5 4.2 3.3 4.2 8.9 2.8 4.0 20.7 14.6 13.3 9.6 2.8 2.4 7.3 129.3 7.9 1.4 317.3 58.7 10.7 22.9 10.2 5.0 6.7 12.1 31.5 8.2 11.4 4.7 3.4 8.6 6.8 0.0 5.3 5.3 12.7 3.5 16.8 9.6 72.2 2.0 1.9 4.2 30.5 4.1 2.6 19.6 2.8 3.6 15.8 1.0 4.0 2.0 7.5 154.2 5.3 9.1 11.7 527.9 43.1 3.8 71.0 0.0 5.9 5.9 27.7 6.5 12.0 6.0 7.0 3.1 9.3 148.5 15.2 DHRS12 "FLJ13639, SDR40C1" ENSG00000102796 "Dehydrogenase/reductase 12" A0PJE2 13 51767993-51804162 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "pancreas: 66.8" "Cell type enhanced" "Detected in many" "Late spermatids: 69.1;Proximal tubular cells: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB034238, HPA057028, HPA058315" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Golgi apparatus, Vesicles" "CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678" "prognostic favorable (1.41e-4)" "unprognostic (1.98e-2)" "unprognostic (2.98e-1)" "unprognostic (7.57e-2)" "unprognostic (2.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.47e-3)" "unprognostic (1.70e-1)" "unprognostic (3.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.21e-2)" "unprognostic (3.98e-1)" "prognostic favorable (2.22e-16)" "unprognostic (2.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.03e-2)" "unprognostic (3.44e-1)" 22.7 10.6 7.8 2.9 7.3 4.5 20.5 8.9 7.8 13.9 6.5 14.0 5.5 13.1 5.0 10.3 14.5 6.1 14.3 7.3 6.7 24.6 28.9 11.7 5.3 7.2 6.6 18.4 66.8 6.6 18.7 3.6 7.0 15.4 3.7 5.9 15.0 5.9 16.0 14.1 12.5 4.0 7.6 15.7 15.0 8.2 7.0 2.3 18.8 4.1 3.5 13.2 11.2 8.3 1.1 2.5 3.8 5.6 1.2 2.6 4.4 1.6 4.1 1.8 1.3 4.5 8.6 4.2 1.2 2.5 2.5 2.0 0.0 0.3 0.3 4.2 3.4 0.6 1.1 3.2 6.6 0.4 0.7 2.7 3.9 0.6 2.4 4.5 5.2 4.0 2.0 3.0 1.3 5.5 1.0 3.5 6.1 4.2 0.6 0.5 0.8 5.8 5.6 3.2 3.4 6.9 2.9 2.5 7.1 5.0 2.8 2.8 3.7 1.3 1.5 0.1 1.7 1.4 1.8 1.9 2.3 1.4 3.7 6.6 16.6 0.5 14.0 14.2 24.1 13.7 19.7 16.9 9.0 13.4 16.4 12.9 31.4 3.8 16.5 10.6 19.8 13.5 7.8 7.3 8.9 7.8 7.3 6.7 7.2 6.6 7.0 7.6 7.0 8.3 14.1 12.8 14.8 11.1 11.4 11.3 12.1 22.2 10.8 11.9 23.5 22.9 15.7 18.6 13.3 16.5 8.4 24.9 8.0 7.8 52.8 12.5 26.1 5.6 7.7 10.1 10.3 2.1 4.9 16.7 17.5 17.1 7.1 6.4 12.0 6.8 8.6 30.7 17.1 3.3 5.4 12.4 22.4 11.2 11.6 69.1 11.1 10.1 14.2 3.7 10.5 32.4 8.2 24.6 12.9 12.6 21.9 9.8 4.8 12.2 25.5 83.5 19.5 18.5 0.0 14.2 11.4 1.4 8.2 10.5 14.9 23.8 13.7 13.4 11.0 12.2 DHX58 "D11LGP2, LGP2" ENSG00000108771 "DExH-box helicase 58" Q96C10 17 42101404-42112714 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "monocytes: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 52.9;SK-MEL-30: 27.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018670, HPA019570" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 3: Monocytes - Immune response regulation" "Golgi apparatus, Cytosol" Nucleoplasm "HPA018670: AB_1847665, HPA019570: AB_1847666" "prognostic favorable (3.45e-4)" "unprognostic (1.03e-2)" "unprognostic (3.56e-3)" "unprognostic (1.54e-2)" "unprognostic (2.45e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-3)" "unprognostic (5.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.15e-1)" "unprognostic (6.02e-2)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (8.65e-2)" "unprognostic (8.01e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 8.9 11.9 5.5 10.2 6.1 12.3 7.6 4.7 7.4 7.7 4.9 7.0 8.5 7.0 5.9 6.4 11.5 12.1 4.9 4.6 4.8 7.3 14.5 11.8 12.5 6.9 5.4 11.9 6.0 7.2 6.9 7.0 6.2 8.7 5.1 0.6 18.6 8.2 3.7 7.5 8.5 7.3 7.5 18.4 9.3 10.8 5.4 12.5 5.5 4.3 7.4 8.0 5.9 6.7 2.5 0.0 0.1 1.3 11.3 9.9 0.3 3.3 22.4 45.5 52.9 0.3 14.6 0.2 3.4 5.4 10.2 2.0 0.2 3.5 1.7 9.3 0.3 3.9 2.6 0.9 12.6 3.6 8.6 15.9 5.9 4.0 3.9 8.0 5.5 23.5 0.0 12.8 2.5 0.0 21.7 4.5 0.4 0.6 0.0 7.8 0.0 1.2 5.2 8.6 0.4 0.0 1.5 5.9 27.0 0.0 7.9 3.8 2.4 2.3 0.1 0.8 1.1 4.3 3.8 0.2 4.6 3.3 2.6 2.3 7.7 6.9 3.1 9.7 4.8 4.6 4.7 2.9 5.9 3.5 5.1 3.8 3.2 6.8 8.6 2.0 4.4 5.0 5.5 6.1 4.7 7.4 4.6 4.8 6.9 5.4 6.2 7.5 5.4 6.7 9.1 9.6 3.4 6.8 4.8 1.5 3.9 6.2 3.4 1.0 3.5 3.7 1.7 8.6 7.6 7.3 0.0 4.0 4.7 2.3 1.9 7.0 9.0 4.5 2.9 7.0 0.0 0.4 1.9 6.9 4.6 4.1 3.6 4.0 1.3 7.5 3.3 14.0 9.8 0.0 2.4 3.2 4.1 7.0 0.7 12.1 8.7 7.4 3.6 8.4 39.9 2.4 2.1 4.0 1.8 5.7 4.3 9.1 1.3 5.4 3.9 5.7 11.6 0.6 0.0 3.7 3.8 18.1 1.0 2.3 1.6 0.8 6.6 8.2 1.9 2.9 DKK2 ENSG00000155011 "Dickkopf WNT signaling pathway inhibitor 2" Q9UBU2 4 106921802-107283806 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 15.2" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.6;Fibroblasts: 18.7;Hofbauer cells: 16.8;Inhibitory neurons: 32.5;Langerhans cells: 11.8;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 22.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebral cortex: 1.5;midbrain: 5.0;pons: 6.3;thalamus: 5.7" "CAB009727, HPA052611" Uncertain Supported "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "CAB009727: AB_2091492, HPA052611: AB_2732576" "unprognostic (3.14e-3)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (3.21e-2)" "unprognostic (9.75e-2)" "unprognostic (3.68e-1)" "unprognostic (1.04e-3)" "unprognostic (2.47e-2)" "unprognostic (5.11e-1)" "unprognostic (5.21e-2)" "unprognostic (3.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (6.86e-2)" "unprognostic (3.22e-1)" "unprognostic (4.58e-2)" 1.4 0.8 0.4 0.4 1.4 0.0 3.0 0.0 1.5 15.2 1.2 1.7 0.0 1.0 0.4 1.2 0.5 0.7 2.2 0.7 0.6 0.2 0.2 5.3 0.7 0.9 4.5 4.4 0.2 0.6 1.5 2.8 0.3 2.3 0.5 0.4 1.3 1.7 1.9 4.7 0.3 0.6 0.2 1.3 0.1 0.1 2.3 1.0 0.9 1.2 3.0 0.2 0.8 0.8 0.0 0.0 3.6 0.0 0.6 0.3 0.0 0.1 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 1.5 0.7 0.6 0.9 4.5 0.3 0.2 2.3 0.8 2.6 0.0 0.0 0.3 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.1 5.4 0.0 0.0 5.2 0.0 0.2 18.7 0.0 0.1 0.0 0.0 3.3 0.0 16.8 0.0 32.5 0.0 0.0 0.3 11.8 0.0 4.1 0.3 7.2 2.8 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 7.4 0.0 0.8 2.0 0.0 0.0 DLK1 "Delta1, FA1, pG2, Pref-1, ZOG" ENSG00000185559 "Delta like non-canonical Notch ligand 1" P80370 14 100725705-100738224 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 1330.8;pituitary gland: 772.9;placenta: 1631.2" "Cell type enhanced" "Detected in some" "Exocrine glandular cells: 576.5;Fibroblasts: 699.3;Leydig cells: 1357.0;Skeletal myocytes: 2360.1" "Cancer enhanced" "Detected in many" "liver cancer: 28.1;testis cancer: 25.4" "Region enhanced" "Detected in many" "hypothalamus: 163.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 120.0;Hep G2: 419.1;SH-SY5Y: 473.8" "Region enhanced" "Detected in many" "hypothalamus: 111.7" "Group enriched" "Detected in many" 5 "hypothalamus: 41.2;midbrain: 156.8" "CAB005872, HPA062262" Enhanced Approved "Golgi apparatus" NA NA 2600000 "Cluster 28: Placenta - Pregnancy" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "CAB005872: AB_731965, HPA062262: AB_2684729" "unprognostic (2.16e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (4.89e-3)" "unprognostic (5.75e-2)" "unprognostic (1.87e-2)" "unprognostic (1.12e-1)" "unprognostic (5.24e-1)" "unprognostic (3.11e-2)" "unprognostic (6.57e-2)" 3.1 1330.8 3.4 6.1 1.9 0.1 7.1 0.0 0.8 9.4 0.3 0.2 1.8 0.7 0.2 2.6 3.1 2.2 45.7 0.5 163.3 0.6 1.8 0.8 0.5 15.4 38.7 277.2 21.2 0.0 772.9 1631.2 81.7 1.4 0.0 0.0 26.9 0.0 17.5 1.2 1.3 0.2 2.1 1.1 1.0 40.9 14.7 1.7 0.2 83.1 0.0 1.0 1.5 0.9 0.0 0.0 120.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 12.6 0.3 419.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 1.4 0.1 0.0 0.5 33.7 473.8 0.0 0.1 0.0 2.9 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 1.9 0.0 0.8 0.5 163.3 15.4 38.7 81.7 2.1 14.7 0.9 0.4 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 1.3 1.0 2.6 0.0 0.0 0.0 0.0 55.2 0.2 0.0 0.0 4.8 7.1 0.0 0.0 6.7 0.0 0.0 0.0 576.5 45.3 699.3 0.0 0.0 0.0 0.8 0.0 0.0 84.3 0.0 0.0 0.0 0.0 0.0 0.3 35.0 1357.0 4.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.0 0.0 172.6 0.0 1.3 0.0 0.2 0.0 0.0 59.2 2360.1 3.0 13.5 69.9 0.0 0.4 105.8 0.8 63.2 0.0 0.2 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 5.7;choroid plexus: 2.3;pituitary gland: 3.4;testis: 1.4" "Group enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 24.6;Spermatogonia: 39.5" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.6;naive CD8 T-cell: 1.4" "Group enriched" "Detected in many" 13 "B-cells: 2.6;T-cells: 1.4" "Cell line enriched" "Detected in some" 6 "SK-MEL-30: 83.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA024559, HPA056533" Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 65: Brain - Ion transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA024559: , HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.0 0.0 5.1 0.1 5.7 0.0 0.0 3.1 5.6 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 4.7 0.0 0.0 0.0 0.1 4.9 4.7 0.2 0.0 0.5 3.4 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.1 0.0 1.4 4.6 0.0 0.1 0.0 0.1 0.0 0.0 5.4 0.1 3.9 0.9 2.0 0.0 0.0 0.6 1.1 0.0 0.7 0.2 0.5 0.9 0.1 3.7 0.0 1.5 0.1 2.3 1.0 0.2 1.2 6.0 0.2 0.1 0.3 0.3 1.0 4.6 0.0 0.0 0.1 0.1 0.1 0.1 4.3 1.1 0.1 0.3 0.0 0.2 0.0 0.7 0.0 6.2 0.6 0.2 0.2 0.2 0.2 13.6 14.1 2.9 0.1 83.7 0.3 0.0 0.2 0.0 0.0 2.6 0.1 1.0 1.4 0.0 0.9 0.1 0.5 2.3 0.0 0.0 0.0 0.3 0.0 0.1 2.6 0.1 0.5 0.1 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 5.1 5.7 3.1 5.6 4.7 4.7 4.9 4.7 4.2 4.4 4.6 5.4 0.3 0.0 0.0 0.3 1.1 0.3 0.3 0.4 0.0 0.5 1.3 4.7 0.5 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.7 0.6 0.1 0.7 0.2 3.0 0.0 1.7 0.6 0.6 1.0 0.5 0.3 0.0 1.7 0.0 0.0 0.3 0.0 3.4 0.3 0.0 0.0 0.0 2.2 1.2 0.1 1.8 0.0 0.0 0.9 0.0 24.6 0.5 0.1 0.0 1.5 0.2 0.6 0.0 0.0 0.0 0.7 6.6 0.0 0.6 6.5 39.5 0.2 0.1 0.3 0.5 1.7 0.0 0.1 DNAJC5 "CLN4, DNAJC5A, FLJ00118, FLJ13070" ENSG00000101152 "DnaJ heat shock protein family (Hsp40) member C5" Q9H3Z4 20 63895126-63936031 "Disease related genes, Human disease related genes, Predicted membrane proteins" Chaperone "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012139, HPA012737, HPA013154" Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus, Plasma membrane" Vesicles "HPA012139: , HPA012737: AB_1847293, HPA013154: AB_1847292" "unprognostic (9.96e-3)" "unprognostic (2.75e-1)" "unprognostic (3.91e-1)" "unprognostic (3.61e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (8.82e-6)" "unprognostic (3.04e-2)" "unprognostic (2.73e-1)" "unprognostic (2.65e-2)" "unprognostic (1.78e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.70e-6)" "unprognostic (2.24e-2)" "unprognostic (3.54e-2)" "unprognostic (4.28e-3)" "unprognostic (1.08e-2)" 12.6 22.1 30.8 10.7 33.0 16.9 11.1 10.2 39.1 11.4 2.1 17.6 11.5 12.1 5.7 42.0 11.6 7.4 25.8 36.2 31.0 17.7 12.8 18.0 9.9 27.9 23.9 8.8 22.7 21.2 28.5 8.4 30.4 16.7 6.9 28.1 16.2 11.5 14.5 19.2 17.5 8.6 13.8 22.2 20.8 10.7 26.8 8.4 16.8 9.5 8.5 13.4 16.9 25.7 25.2 23.7 19.8 18.8 19.4 15.9 14.6 28.6 27.4 49.4 23.8 52.7 30.2 9.8 31.6 28.2 22.7 36.4 15.9 53.6 16.0 8.2 11.3 19.3 17.4 25.8 18.1 19.2 43.5 18.0 39.9 22.9 11.7 19.1 24.2 16.5 19.2 8.9 22.6 17.3 21.1 30.9 7.1 21.0 26.5 21.0 10.9 10.7 16.4 22.6 21.4 13.9 30.8 48.7 17.8 11.6 23.5 75.9 43.7 42.6 14.4 20.4 21.5 11.1 5.6 13.6 42.9 25.3 25.4 0.7 3.2 2.6 3.2 3.7 1.8 1.6 1.8 2.7 2.5 1.4 2.5 2.5 3.1 1.5 3.1 3.9 3.1 2.6 30.8 33.0 10.2 39.1 36.2 31.0 27.9 23.9 30.4 13.8 26.8 25.7 12.8 6.4 17.8 19.2 10.4 20.8 18.5 25.5 20.5 60.7 17.4 14.1 31.7 14.3 23.2 23.9 62.6 18.5 19.1 71.7 13.7 20.5 48.9 23.9 8.5 18.7 32.4 10.3 37.1 37.6 18.4 12.4 27.0 23.5 1.3 12.1 23.9 27.8 43.5 79.1 38.8 33.3 14.2 51.0 24.8 123.5 7.2 31.4 14.2 25.3 36.9 27.9 22.6 19.1 26.2 59.0 41.1 12.4 17.3 39.5 62.0 22.9 29.4 47.0 13.1 9.0 13.1 13.5 13.2 28.0 22.9 30.2 15.0 13.3 28.4 64.5 DNM2 "CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII" ENSG00000079805 "Dynamin 2" P50570 19 10718079-10833488 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Phagocytosis" "Hydrolase, Motor protein" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 242.8;Paneth cells: 177.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054246 Supported Approved "Golgi apparatus,Cytosol" NA NA 230000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus, Cytosol" "HPA054246: AB_2682427" "unprognostic (2.30e-1)" "unprognostic (5.23e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "prognostic favorable (8.91e-4)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.03e-1)" "unprognostic (3.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.75e-2)" "unprognostic (5.35e-2)" "unprognostic (5.47e-2)" "unprognostic (5.40e-3)" "unprognostic (2.68e-1)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" 55.1 69.9 50.5 63.2 77.8 125.7 46.1 74.1 64.1 49.0 38.8 105.8 65.9 42.2 25.3 67.6 42.5 40.5 87.2 52.3 57.4 72.8 57.2 87.0 62.4 82.7 78.9 36.6 68.2 38.9 41.9 51.3 79.8 47.4 83.9 30.7 55.0 55.7 108.1 92.8 99.6 35.1 60.3 81.0 98.6 55.1 72.9 58.6 47.6 82.8 65.4 64.6 54.5 101.6 116.4 92.8 67.6 54.6 67.6 65.4 86.5 75.1 70.5 108.8 91.7 94.2 74.7 83.2 132.2 81.5 52.5 99.4 92.6 82.1 90.8 103.1 72.4 160.1 81.7 107.1 82.9 87.8 146.5 67.8 62.4 83.5 77.9 66.2 107.3 84.9 131.5 139.1 68.0 140.1 126.3 85.7 76.6 138.3 109.7 125.6 72.6 95.7 71.3 171.1 97.1 63.8 86.6 73.6 54.2 74.9 58.8 106.2 99.6 120.7 40.5 172.0 102.7 112.7 127.3 77.9 89.9 134.0 61.0 3.5 3.5 7.0 4.0 6.2 3.8 2.5 3.0 4.4 4.2 2.1 1.7 3.0 6.5 8.9 8.4 8.4 3.8 4.1 50.5 77.8 74.1 64.1 52.3 57.4 82.7 78.9 79.8 60.3 72.9 101.6 37.8 32.1 22.3 24.8 48.8 23.2 17.1 13.8 22.2 28.8 19.7 16.3 30.3 14.3 25.7 51.5 22.9 25.7 57.2 242.8 50.9 35.2 48.4 32.2 17.9 33.1 21.6 38.1 29.2 32.0 106.9 19.5 168.7 39.7 19.0 36.8 20.3 22.8 49.1 43.7 31.1 106.9 14.2 28.0 39.6 98.0 16.8 55.2 19.6 60.9 43.4 17.2 39.1 23.1 90.9 45.2 177.3 27.8 92.2 20.2 90.7 38.8 18.0 26.3 26.3 18.7 27.6 15.0 12.3 26.6 31.5 31.7 46.4 40.7 82.5 22.8 DNM3 KIAA0820 ENSG00000197959 "Dynamin 3" Q9UQ16 1 171841498-172418466 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 66.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 365.7;Inhibitory neurons: 631.8;Oligodendrocyte precursor cells: 976.1;Oligodendrocytes: 1970.9" "Cancer enhanced" "Detected in many" "glioma: 2.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 22.9;HMC-1: 10.2;RPTEC TERT1: 19.0;U-251 MG: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064121 Approved "Golgi apparatus" NA NA 70000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 70: Brain - Nervous system development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA064121: AB_2685193" "unprognostic (8.21e-2)" "unprognostic (6.80e-3)" "unprognostic (1.68e-1)" "unprognostic (1.41e-2)" "unprognostic (8.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.52e-3)" "unprognostic (6.46e-2)" "unprognostic (5.52e-2)" "unprognostic (2.96e-2)" "unprognostic (2.45e-2)" "unprognostic (3.37e-1)" "unprognostic (6.10e-4)" "unprognostic (1.60e-3)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (2.70e-3)" 4.2 11.9 15.3 1.0 29.9 1.3 4.0 59.4 24.3 5.8 0.0 2.4 0.6 3.2 1.3 1.3 3.2 2.7 2.1 12.2 36.0 4.1 0.4 4.4 1.1 42.8 29.5 2.6 1.1 1.2 6.2 0.4 47.8 2.6 1.1 13.4 2.1 1.6 1.2 2.4 1.4 3.1 10.6 1.8 2.7 3.2 32.3 1.8 3.3 1.3 0.8 2.2 5.1 66.9 0.8 2.5 2.0 0.4 1.5 1.0 0.0 0.5 1.2 1.0 1.3 0.0 3.7 0.0 7.5 1.1 1.2 0.3 1.5 2.9 0.9 1.0 2.9 22.9 3.7 0.0 0.1 0.5 10.2 0.7 0.5 1.2 0.7 1.1 0.5 2.0 0.0 0.3 0.4 0.0 1.5 0.1 5.8 9.5 1.7 1.5 9.9 0.0 19.0 0.1 3.9 0.8 2.7 0.7 0.2 0.7 0.0 0.9 0.3 2.8 3.8 2.3 14.3 3.8 0.7 0.2 2.7 1.2 1.0 0.0 0.1 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.2 0.0 0.3 0.5 0.3 0.3 0.1 0.0 1.4 1.2 15.3 29.9 59.4 24.3 12.2 36.0 42.8 29.5 47.8 10.6 32.3 66.9 21.8 0.0 6.8 207.3 1.5 2.4 1.5 0.7 3.4 25.1 1.4 1.3 2.4 0.0 0.4 0.0 29.2 0.1 0.7 0.2 3.9 0.3 8.2 7.3 1.3 19.5 0.0 0.8 365.7 0.4 0.1 3.2 7.1 1.0 1.3 0.8 8.2 0.2 0.7 8.4 631.8 0.7 0.0 0.6 3.1 3.9 1.8 13.4 0.0 178.0 0.3 5.9 0.0 976.1 1970.9 2.5 0.1 2.6 0.3 0.7 0.0 0.8 2.2 29.0 0.0 4.5 2.2 5.3 0.4 1.1 1.7 0.3 0.9 10.3 0.8 0.7 DNMBP "ARHGEF36, KIAA1010, Tuba" ENSG00000107554 "Dynamin binding protein" Q6XZF7 10 99875577-100009947 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037878, HPA058216" Uncertain Approved "Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 41: Macrophages - Immune response" "Nucleoli, Golgi apparatus, Cytosol" "Nuclear bodies" "HPA037878: AB_10675622, HPA058216: AB_2683640" "unprognostic (3.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.95e-6)" "unprognostic (3.92e-2)" "unprognostic (4.13e-1)" "unprognostic (9.79e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (8.67e-3)" "unprognostic (4.03e-2)" "unprognostic (5.07e-3)" "unprognostic (6.52e-2)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "prognostic favorable (6.15e-4)" 13.6 6.0 3.6 5.5 3.7 10.3 10.2 6.2 5.3 15.8 8.6 17.7 22.5 9.6 12.5 10.2 11.3 11.0 7.5 4.7 4.2 20.6 13.1 8.4 4.6 3.7 3.6 11.5 17.6 31.7 3.9 10.5 3.8 8.9 20.7 15.8 8.4 12.8 13.4 27.4 27.2 8.8 3.0 7.7 23.8 6.9 5.2 20.1 8.1 11.1 5.2 19.8 17.7 3.1 25.7 20.7 18.4 29.2 32.9 27.4 4.4 45.2 43.6 21.5 20.7 14.2 38.0 26.6 18.9 34.9 11.8 19.9 21.6 26.1 29.9 1.4 6.7 3.8 23.7 10.0 17.1 2.6 1.8 13.0 5.7 26.6 23.4 75.5 52.1 8.5 3.6 0.0 44.1 3.2 4.5 5.1 17.7 18.0 12.3 5.5 18.7 1.4 36.6 21.9 3.1 4.2 7.4 1.9 5.7 25.3 1.5 2.4 63.4 16.0 15.3 13.1 29.8 2.1 1.7 36.3 15.2 8.4 12.2 0.0 0.8 0.2 0.7 1.2 0.7 1.2 0.1 0.4 0.3 1.9 0.1 0.3 0.7 2.1 1.2 0.3 0.0 0.6 3.6 3.7 6.2 5.3 4.7 4.2 3.7 3.6 3.8 3.0 5.2 3.1 6.8 9.6 11.0 11.1 14.8 35.1 7.2 5.0 5.2 6.3 9.3 6.3 6.1 12.8 11.2 12.9 35.5 7.7 4.4 36.7 3.9 7.5 1.0 27.0 11.0 12.6 3.6 0.0 15.9 14.3 1.4 17.6 26.0 43.9 2.5 4.1 11.4 12.8 4.7 13.5 24.8 25.0 6.1 10.7 9.6 3.2 13.7 20.5 3.6 23.4 3.3 4.3 0.0 10.6 2.6 19.3 23.6 9.1 6.1 4.0 36.5 3.7 19.9 26.6 0.0 4.3 6.9 4.2 9.3 9.0 45.6 3.7 4.3 15.0 28.4 21.8 DOCK4 "FLJ34238, KIAA0716" ENSG00000128512 "Dedicator of cytokinesis 4" Q8N1I0 7 111726110-112206407 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.6" "Group enriched" "Detected in many" 4 "Astrocytes: 791.0;Excitatory neurons: 422.8;Microglial cells: 1568.3;Oligodendrocyte precursor cells: 434.3;Oligodendrocytes: 815.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 43.3;HUVEC TERT2: 75.5;TIME: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071516 Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 65: Brain - Ion transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Plasma membrane" "Golgi apparatus, Cytosol" "HPA071516: AB_2686407" "unprognostic (1.37e-1)" "unprognostic (4.18e-1)" "unprognostic (1.53e-1)" "unprognostic (2.48e-2)" "unprognostic (7.10e-2)" "unprognostic (2.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" "unprognostic (5.78e-2)" "unprognostic (7.06e-2)" "unprognostic (3.66e-1)" "unprognostic (5.71e-2)" "unprognostic (1.89e-2)" "unprognostic (9.48e-2)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" 7.8 4.4 17.1 6.6 41.6 1.4 4.8 11.4 21.9 5.0 0.0 3.2 1.5 4.6 2.8 2.5 5.2 5.0 4.9 40.6 17.8 4.5 10.0 17.3 2.7 16.5 18.1 8.4 3.2 3.3 3.2 6.9 15.6 4.0 2.8 10.5 3.3 2.5 6.2 2.5 2.4 7.3 14.9 1.8 2.2 2.1 19.2 1.7 3.5 7.3 2.2 3.7 3.5 26.0 0.1 3.5 8.8 7.8 7.2 10.4 5.3 1.0 9.6 1.7 2.8 0.0 0.2 0.8 7.6 2.3 2.0 0.5 1.5 8.8 6.5 2.9 12.9 0.4 5.8 14.3 5.1 1.1 0.4 4.9 1.0 43.3 20.8 3.0 75.5 3.4 0.1 22.6 3.8 1.0 2.0 0.7 5.1 1.5 15.8 0.8 7.0 3.6 6.0 0.5 1.9 7.5 6.2 4.3 5.8 8.2 0.8 0.4 69.0 6.6 3.4 13.7 3.0 1.2 0.5 0.9 0.7 1.8 16.5 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.1 0.1 0.0 0.1 17.1 41.6 11.4 21.9 40.6 17.8 16.5 18.1 15.6 14.9 19.2 26.0 56.4 48.1 6.8 791.0 1.1 5.2 3.3 7.5 8.6 27.4 3.7 6.3 13.1 2.8 16.7 3.7 22.9 0.3 0.1 2.3 0.0 2.1 3.8 1.3 5.5 47.1 10.9 5.3 422.8 0.4 0.2 21.4 0.5 2.2 2.5 5.0 43.9 17.0 14.6 94.2 177.1 0.7 14.2 16.7 21.0 1.5 5.6 27.4 8.8 1568.3 6.1 5.4 0.0 434.3 815.3 1.2 8.0 8.2 0.2 8.2 0.0 1.8 12.2 11.4 13.1 4.2 5.8 0.6 1.9 2.3 2.7 0.0 0.6 26.2 1.5 1.8 DOK2 "Dok-2, p56dok-2" ENSG00000147443 "Docking protein 2" O60496 8 21908873-21913690 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 25.6;lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" "dendritic cells: 130.6;Hofbauer cells: 131.8;Kupffer cells: 171.8;Langerhans cells: 288.4;Macrophages: 181.5;NK-cells: 344.0;T-cells: 147.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 1565.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 25.3;HEL: 54.3;HMC-1: 119.8;JURKAT: 22.3;THP-1: 43.1;U-937: 42.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004379, HPA005507, HPA066571" Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 220000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "Nucleoplasm, Nuclear bodies, Golgi apparatus" "CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749" "unprognostic (5.39e-2)" "unprognostic (8.84e-3)" "unprognostic (8.72e-3)" "unprognostic (1.74e-3)" "unprognostic (2.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.34e-1)" "unprognostic (7.22e-2)" "prognostic favorable (4.31e-4)" "unprognostic (2.22e-1)" "unprognostic (4.19e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.88e-1)" "unprognostic (1.24e-2)" "unprognostic (3.19e-1)" "unprognostic (2.80e-1)" 9.5 5.0 1.1 26.5 1.2 19.5 5.0 1.2 2.3 1.9 2.5 5.5 7.0 2.2 0.5 2.3 3.5 6.5 3.5 1.3 1.3 3.0 6.1 25.6 26.3 1.4 1.5 1.4 1.9 0.5 1.1 7.9 1.5 2.3 3.6 0.0 3.4 1.5 2.0 2.3 9.5 6.9 1.2 40.9 6.8 1.6 4.5 16.4 2.4 1.6 7.8 8.4 2.3 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 54.3 0.0 0.1 0.0 0.4 119.8 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.8 5.0 0.0 0.0 0.9 8.7 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.3 0.0 0.1 0.2 0.1 0.2 0.1 0.3 1.4 42.0 0.2 577.6 484.3 1565.6 398.3 624.0 184.5 14.5 274.3 304.8 421.9 6.6 151.0 185.9 37.2 307.6 580.7 7.6 597.2 810.3 1.1 1.2 1.2 2.3 1.3 1.3 1.4 1.5 1.5 1.2 4.5 1.5 2.0 3.2 18.1 0.0 13.2 11.5 0.6 0.0 0.0 0.0 1.2 1.8 2.1 0.0 1.3 3.7 0.0 0.7 130.6 0.3 0.0 0.1 0.2 0.2 0.5 2.8 0.0 10.5 0.1 0.0 1.0 2.6 3.1 0.4 36.3 0.1 5.7 1.1 131.8 0.0 0.0 0.2 0.0 171.8 288.4 0.6 0.3 181.5 19.6 0.0 74.8 0.0 344.0 0.0 0.0 0.0 0.0 0.0 15.4 0.2 0.0 0.7 1.5 0.0 0.0 0.6 2.5 0.2 4.3 0.7 8.5 1.0 147.4 0.0 0.2 0.8 DPH5 CGI-30 ENSG00000117543 "Diphthamide biosynthesis 5" Q9H2P9 1 100989623-101026088 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046439, HPA076234" Approved Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Golgi apparatus" Nucleoli "HPA046439: AB_2679667, HPA076234: AB_2797274" "unprognostic (1.31e-1)" "unprognostic (3.37e-2)" "unprognostic (1.98e-2)" "unprognostic (7.82e-2)" "unprognostic (1.22e-2)" "unprognostic (2.23e-1)" "unprognostic (2.81e-2)" "unprognostic (3.57e-2)" "unprognostic (8.59e-2)" "unprognostic (8.12e-2)" "unprognostic (1.37e-2)" "unprognostic (2.56e-1)" "unprognostic (1.58e-2)" "unprognostic (2.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.88e-1)" "unprognostic (9.00e-2)" 12.5 23.2 17.2 8.4 17.8 10.7 28.8 17.3 22.5 23.2 18.3 14.6 7.1 17.2 23.8 13.7 26.2 11.6 23.5 17.4 18.7 19.5 25.3 10.1 18.1 17.8 18.0 49.8 31.4 20.0 15.5 12.3 17.8 15.0 17.5 8.8 11.9 17.1 20.8 15.0 11.2 19.7 17.6 15.4 14.1 9.8 19.0 29.0 20.7 25.0 25.4 14.7 13.3 18.0 28.1 30.1 40.1 37.0 48.3 154.7 34.9 24.9 42.9 41.0 34.5 35.3 7.7 46.0 33.2 22.2 23.1 20.0 47.5 41.1 62.6 20.0 35.8 22.1 26.7 71.4 84.1 33.4 13.8 97.1 63.9 38.8 118.6 67.4 64.8 33.4 62.6 16.7 70.3 26.3 40.7 36.7 31.5 15.2 46.4 37.8 51.1 32.6 50.0 25.7 44.2 22.2 13.7 36.2 114.0 29.6 27.3 18.3 25.1 23.0 28.7 28.8 34.4 20.0 24.1 31.9 31.5 29.6 7.9 5.7 7.5 4.6 16.1 8.9 21.7 19.2 17.9 17.7 13.6 15.1 24.0 20.9 2.7 24.7 10.6 9.8 12.8 10.2 17.2 17.8 17.3 22.5 17.4 18.7 17.8 18.0 17.8 17.6 19.0 18.0 8.1 6.4 14.6 17.0 30.3 15.8 17.0 24.2 19.9 5.3 18.7 12.3 23.8 21.5 12.7 7.3 0.0 26.2 10.1 4.7 23.5 14.0 1.8 14.2 19.6 11.2 10.2 17.7 12.0 18.4 27.8 13.5 5.6 8.2 25.4 29.0 12.1 29.3 18.9 1.7 14.6 15.0 22.4 28.4 13.1 3.0 27.1 14.0 12.4 8.4 27.7 16.5 27.8 27.2 28.3 8.9 12.9 13.9 10.3 10.8 8.1 30.9 16.8 6.5 6.6 16.6 12.5 15.7 17.6 17.0 18.0 13.0 19.4 33.4 23.7 11.3 DPP7 "DPP2, DPPII" ENSG00000176978 "Dipeptidyl peptidase 7" Q9UHL4 9 137110546-137115177 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 997.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 232.0;THP-1: 218.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021282, CAB025541, HPA059381" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted - unknown location" NA NA 1600000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999" "unprognostic (1.15e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (6.78e-3)" "unprognostic (1.25e-1)" "unprognostic (8.33e-2)" "unprognostic (7.49e-2)" "unprognostic (6.10e-2)" "unprognostic (2.28e-2)" "unprognostic (5.71e-3)" "prognostic favorable (8.31e-5)" "unprognostic (7.99e-2)" "unprognostic (1.46e-2)" "unprognostic (2.56e-2)" "unprognostic (1.72e-1)" "unprognostic (2.15e-1)" "unprognostic (1.02e-1)" 60.2 98.8 42.1 28.0 43.2 45.8 56.8 43.4 64.9 45.4 83.6 65.3 28.4 46.3 16.7 46.0 53.6 31.3 116.4 43.8 52.0 58.7 70.0 57.3 41.7 53.4 48.0 37.7 82.8 54.3 112.3 26.7 45.7 81.1 7.3 8.0 92.3 46.2 52.8 56.6 51.7 12.8 45.6 79.0 69.4 75.3 48.3 19.8 83.7 21.4 14.4 59.3 48.0 49.2 28.0 43.1 3.5 3.6 51.1 40.5 5.7 42.2 66.2 26.6 17.4 41.0 22.2 56.2 44.4 27.2 1.2 60.3 30.7 8.2 1.3 54.8 2.1 26.4 63.6 1.3 113.5 69.1 135.5 50.0 31.7 11.6 24.1 38.3 35.1 65.8 57.5 41.2 18.0 76.4 35.7 65.7 14.8 99.9 42.8 52.8 0.5 232.0 43.3 30.5 67.7 46.7 47.8 122.6 118.9 0.8 43.5 218.1 44.1 67.4 23.5 43.4 29.5 51.7 31.8 14.9 80.9 41.1 31.1 40.2 194.8 59.2 148.8 176.2 151.8 86.6 131.4 127.9 190.6 83.4 117.1 106.2 12.0 95.0 110.6 276.6 173.6 204.1 42.1 43.2 43.4 64.9 43.8 52.0 53.4 48.0 45.7 45.6 48.3 49.2 80.5 54.5 80.9 54.9 96.8 67.0 103.2 109.2 59.7 74.5 90.3 82.2 66.5 94.4 76.8 53.3 35.5 55.2 129.2 28.2 37.2 121.0 288.7 35.9 40.7 58.2 88.1 35.9 31.4 68.1 115.3 97.2 33.6 47.3 74.3 178.7 64.6 77.1 315.7 121.1 27.9 32.3 107.8 171.7 106.2 997.8 155.4 150.1 167.2 9.4 165.5 123.9 122.6 16.6 26.4 58.2 54.3 169.2 190.2 108.5 97.3 84.9 75.4 83.6 52.6 57.4 58.4 106.2 46.2 47.3 64.9 51.4 115.4 19.0 43.1 90.4 DPY30 "Cps25, HDPY-30, Saf19" ENSG00000162961 "Dpy-30 histone methyltransferase complex regulatory subunit" Q9C005 2 31867809-32039805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 388.8;Respiratory ciliated cells: 396.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043761 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA 29000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA043761: AB_10960501" "unprognostic (2.76e-2)" "unprognostic (1.48e-1)" "unprognostic (2.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (7.87e-2)" "unprognostic (1.01e-3)" "unprognostic (1.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.79e-2)" "unprognostic (1.49e-1)" 40.2 75.2 66.9 34.3 68.6 31.4 61.3 72.1 84.4 53.2 73.6 50.9 43.4 38.3 78.3 60.2 90.5 42.4 46.7 68.4 73.6 79.1 84.8 44.1 51.8 71.6 71.5 42.7 48.1 58.3 50.9 43.9 73.6 57.3 46.4 33.3 64.6 47.0 48.8 49.7 44.4 37.4 73.2 36.1 46.8 22.6 69.1 52.3 81.6 45.4 49.3 51.8 50.0 77.5 201.8 136.8 100.8 78.1 86.7 128.8 134.9 102.1 90.8 81.2 79.5 197.2 158.3 123.2 102.2 90.8 148.3 79.9 93.1 118.6 88.1 146.4 149.5 110.8 89.7 225.5 76.5 114.3 66.8 87.4 135.6 87.4 76.9 109.1 130.4 55.1 132.5 85.3 125.6 219.4 128.8 228.9 139.2 184.3 140.5 104.0 118.9 155.7 144.2 137.1 162.5 115.9 101.2 141.1 143.6 118.2 98.3 82.1 100.5 73.9 119.1 69.2 125.4 99.9 161.3 166.2 77.6 123.2 91.7 177.6 101.0 150.8 95.5 99.9 116.5 165.9 133.5 119.4 100.5 135.6 118.1 112.0 117.3 105.8 112.8 91.5 200.3 130.6 66.9 68.6 72.1 84.4 68.4 73.6 71.6 71.5 73.6 73.2 69.1 77.5 65.7 51.3 61.5 10.1 61.7 98.0 107.7 233.5 53.5 17.9 110.5 135.1 71.3 80.1 140.8 103.0 0.0 190.2 41.0 84.2 283.7 114.3 64.5 388.8 59.7 62.9 92.1 55.5 16.0 117.2 252.4 63.1 44.4 107.3 46.9 65.1 63.1 102.7 123.5 21.9 17.7 107.6 175.0 65.4 67.2 18.5 72.4 58.7 65.8 13.1 106.8 50.8 55.6 13.6 26.7 125.7 117.8 88.0 40.6 130.5 138.4 296.7 396.4 26.8 85.5 52.4 108.4 65.7 57.4 72.0 122.6 138.7 67.3 67.7 109.0 127.5 DRAM2 "MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154" ENSG00000156171 "DNA damage regulated autophagy modulator 2" Q6UX65 1 111117163-111140203 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018036, HPA061701" Supported Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus, Vesicles" "HPA018036: AB_1858134, HPA061701: AB_2684590" "unprognostic (9.38e-3)" "unprognostic (1.58e-2)" "unprognostic (2.16e-3)" "unprognostic (5.22e-2)" "unprognostic (1.12e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (3.45e-5)" "unprognostic (6.57e-3)" "prognostic unfavorable (6.43e-4)" "unprognostic (2.69e-1)" "unprognostic (4.37e-3)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (1.77e-3)" 38.0 23.1 13.9 33.1 14.5 17.9 26.8 17.7 19.9 23.1 22.7 26.7 28.6 17.7 17.6 15.0 30.1 36.4 23.7 13.5 15.2 26.5 24.9 25.0 55.3 15.6 14.9 24.3 25.6 28.3 4.6 41.2 16.2 17.8 30.7 16.9 25.8 16.7 16.6 17.9 26.3 17.0 15.5 45.3 23.4 10.3 15.0 27.8 22.0 23.6 50.3 29.4 4.2 17.8 38.0 12.9 24.0 10.8 57.3 56.2 23.4 28.7 29.9 24.7 24.9 12.5 38.2 28.7 17.2 25.6 12.1 37.4 30.5 24.0 31.9 26.8 25.6 16.8 18.4 16.4 41.4 19.4 15.4 38.5 41.4 18.3 38.4 53.6 29.9 29.1 34.1 19.6 30.1 19.6 16.6 28.8 14.5 43.3 13.2 11.1 40.0 14.0 42.5 25.8 19.1 18.2 16.8 52.4 80.1 33.1 16.7 84.6 24.8 20.6 13.8 16.2 18.9 25.7 9.6 29.8 33.4 34.7 29.6 41.7 47.3 11.5 14.2 61.0 19.4 65.7 17.5 15.3 45.1 54.1 22.3 19.0 7.2 25.0 49.8 28.6 17.7 35.5 13.9 14.5 17.7 19.9 13.5 15.2 15.6 14.9 16.2 15.5 15.0 17.8 34.5 12.8 12.0 17.3 146.2 47.0 54.4 82.5 34.1 11.6 53.6 43.9 29.7 32.9 53.1 44.1 2.1 98.1 38.9 41.2 43.0 59.2 8.5 51.7 19.5 36.4 13.2 28.6 20.6 46.6 102.3 39.2 24.5 17.6 23.6 18.5 42.8 26.0 183.1 20.2 31.7 45.7 77.3 189.4 97.8 7.8 33.5 110.3 81.8 39.4 89.0 27.1 56.7 31.7 42.6 41.9 64.3 24.8 54.7 46.3 88.4 80.4 95.8 10.1 39.5 26.4 32.5 4.7 14.6 40.8 53.0 73.3 38.6 26.3 43.7 70.1 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847158 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.6;pituitary gland: 4.2;retina: 1.9" "Cell type enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 4376.6" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019324, HPA057493" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA019324: AB_2670118, HPA057493: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.0 0.0 5.4 0.0 5.8 0.0 0.1 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.6 4.2 0.0 0.1 0.0 0.0 2.3 2.8 0.0 0.1 0.0 4.2 0.7 3.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.8 0.1 6.6 5.6 4.2 2.3 2.8 3.5 2.9 4.1 4.1 0.0 0.0 0.0 19.9 0.0 0.0 0.1 0.0 0.0 19.6 0.0 0.4 1.1 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.4 0.0 0.0 1083.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 16.8 649.1 0.0 0.0 2.4 0.0 4.2 0.0 0.0 0.0 200.5 0.0 0.7 0.0 4376.6 21.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.0 0.1 1.7 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 70.7" "Cancer enriched" "Detected in all" 4 "glioma: 54.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 5 "NK-cells: 1.0;T-cells: 2.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 84.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Cluster 20: T-cells - T-cell receptor" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: AB_2684097" "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favorable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 36.6 58.2 117.1 15.8 120.2 7.2 36.4 117.5 138.2 97.6 115.0 117.4 11.5 95.5 50.7 24.2 92.0 24.5 67.6 124.5 111.4 63.8 12.3 37.2 21.2 107.8 112.1 124.3 41.9 39.4 145.1 28.1 108.6 82.1 16.8 80.8 31.4 48.2 21.0 21.1 46.2 48.5 105.3 46.0 51.0 29.0 112.6 23.6 75.9 16.6 15.5 65.0 60.7 119.0 8.8 22.7 65.9 0.1 0.0 0.1 0.4 13.8 35.4 29.7 30.0 11.8 36.5 12.3 20.5 30.0 0.3 14.2 0.0 1.7 20.9 31.1 4.1 7.1 39.4 12.5 49.4 0.0 0.1 24.5 16.7 22.8 0.3 84.4 33.6 0.1 0.0 40.9 23.1 19.2 38.4 0.3 52.1 7.2 2.0 0.0 55.1 0.7 2.8 22.7 47.7 75.5 10.9 3.1 7.0 15.8 38.4 18.9 0.1 38.6 15.3 17.9 20.2 66.2 53.6 0.2 24.8 0.1 20.6 0.0 0.0 0.0 2.5 0.0 0.6 0.1 0.9 1.2 0.1 0.1 0.8 1.6 0.0 1.0 0.0 0.3 2.2 1.2 117.1 120.2 117.5 138.2 124.5 111.4 107.8 112.1 108.6 105.3 112.6 119.0 4.9 16.0 15.6 25.8 2.9 6.2 10.0 8.7 21.1 47.8 12.2 19.9 11.0 11.5 10.5 12.9 50.1 0.5 10.6 0.5 13.7 8.2 0.9 17.8 17.4 8.5 15.6 4.4 29.9 1.9 0.3 15.1 6.1 5.5 5.7 17.2 15.0 0.6 0.6 70.7 29.3 0.9 10.2 2.0 2.1 2.8 34.2 1.6 3.6 8.4 0.8 27.4 36.0 25.1 19.0 2.6 0.0 31.6 5.8 7.1 0.0 4.6 30.9 42.0 46.0 11.5 37.5 4.6 5.7 2.8 2.8 1.2 10.4 16.8 0.7 3.5 DUSP10 "MKP-5, MKP5" ENSG00000143507 "Dual specificity phosphatase 10" Q9Y6W6 1 221701424-221742089 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 32.9" "Cell type enhanced" "Detected in many" "granulocytes: 133.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 19.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 102.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016758 Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No "Cluster 15: NK-cells - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Golgi apparatus, Cytosol" "HPA016758: AB_1847880" "unprognostic (1.55e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-1)" "unprognostic (6.65e-2)" "unprognostic (3.83e-2)" "unprognostic (2.85e-3)" "prognostic favorable (5.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.89e-2)" "unprognostic (9.68e-2)" "unprognostic (2.38e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (8.88e-3)" "unprognostic (1.97e-2)" 3.8 2.4 4.3 5.2 7.4 25.0 6.0 7.7 5.3 4.5 4.7 8.0 1.4 3.6 1.2 6.0 6.4 6.6 2.6 4.5 4.5 1.4 32.9 6.2 9.1 7.1 6.0 1.6 17.0 1.2 1.2 3.8 5.8 2.7 4.1 14.9 6.3 0.9 22.9 6.1 3.9 8.9 3.8 6.1 2.5 3.1 9.0 5.6 4.4 3.6 7.6 6.1 2.7 13.5 15.2 6.4 0.5 0.4 45.4 22.6 0.5 10.1 25.9 16.2 12.5 0.3 4.2 11.6 3.3 26.1 11.9 102.3 2.2 9.8 14.0 30.5 1.2 20.4 3.0 1.8 10.6 9.1 13.3 31.9 7.0 17.6 17.8 7.5 0.6 3.0 2.1 4.0 16.0 0.3 1.8 7.2 1.5 3.2 0.7 1.1 28.5 0.9 5.7 9.1 37.4 3.0 1.3 1.2 43.6 5.6 2.1 5.5 3.6 8.1 2.2 12.6 12.4 6.8 5.1 6.2 12.8 4.1 8.9 8.2 5.5 0.3 4.5 4.6 3.9 0.8 2.9 3.1 7.0 0.9 1.0 1.7 0.5 19.7 1.9 0.2 16.9 2.2 4.3 7.4 7.7 5.3 4.5 4.5 7.1 6.0 5.8 3.8 9.0 13.5 4.9 0.0 1.7 2.6 21.7 50.9 13.5 13.6 25.6 6.0 42.4 18.7 4.7 14.3 19.2 3.7 20.9 2.8 39.0 3.1 0.0 35.9 61.1 57.9 6.6 6.7 43.9 2.5 0.3 9.1 3.7 7.9 4.6 53.7 133.5 0.2 1.8 53.6 22.3 1.7 30.9 17.7 69.2 9.7 46.9 7.1 24.8 26.0 23.2 2.8 14.1 14.3 17.5 17.1 50.5 26.2 0.8 12.8 9.9 11.0 0.4 1.1 18.5 34.2 0.0 33.7 5.3 9.7 3.2 16.7 41.3 3.4 47.0 28.7 3.6 16.5 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Group enriched" "Detected in some" 26 "Early spermatids: 4.9;Late spermatids: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;U-2 OS: 2.2;U-266/70: 4.7;U-266/84: 6.9;U-698: 1.5" "Low region specificity" "Detected in some" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: AB_2683722" 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 2.2 0.4 0.0 4.7 6.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYM "DMC, FLJ20071, SMC" ENSG00000141627 Dymeclin Q7RTS9 18 49036387-49461347 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 113.6;Early spermatids: 353.4;Excitatory neurons: 173.2;Inhibitory neurons: 204.1;Late spermatids: 176.1;Microglial cells: 149.9;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 299.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043551, HPA049187" Approved Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Golgi apparatus" "HPA043551: AB_2678547, HPA049187: AB_2680668" "unprognostic (1.88e-2)" "unprognostic (1.23e-1)" "unprognostic (3.12e-3)" "unprognostic (1.33e-2)" "unprognostic (1.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.85e-3)" "unprognostic (1.77e-1)" "unprognostic (1.72e-1)" "unprognostic (8.30e-3)" "unprognostic (2.53e-2)" "unprognostic (2.58e-2)" "prognostic favorable (2.76e-5)" "unprognostic (3.89e-1)" "unprognostic (1.69e-1)" "unprognostic (4.26e-3)" "prognostic unfavorable (5.26e-5)" 17.9 19.2 17.3 14.8 19.6 24.0 23.3 24.9 20.4 24.9 24.4 20.7 15.8 19.8 20.2 25.3 18.6 17.7 21.1 16.7 20.4 21.1 19.7 15.7 17.0 22.8 21.1 29.4 80.7 28.6 9.9 14.6 24.5 20.6 16.8 36.0 36.6 22.0 49.6 18.2 14.1 25.1 19.0 12.7 16.6 44.0 19.1 33.0 32.6 46.0 20.7 23.2 22.3 23.9 32.9 19.8 30.6 47.0 56.9 63.9 24.1 32.2 42.1 37.7 36.8 14.6 20.7 102.1 27.8 60.1 27.9 41.0 48.1 42.1 46.0 38.6 24.7 23.8 16.9 43.4 56.7 83.5 41.5 50.1 49.1 44.1 112.7 63.3 59.0 51.6 25.7 60.5 30.4 35.0 56.5 35.5 9.8 27.1 15.2 29.2 39.2 48.3 34.8 37.2 56.5 36.5 21.9 26.1 30.2 34.5 36.7 29.8 32.6 35.6 16.9 15.5 18.9 67.8 52.7 57.4 19.1 51.6 40.5 20.9 26.9 32.7 20.2 23.4 27.2 17.0 19.3 18.7 29.2 13.9 19.6 15.2 11.9 30.6 20.6 8.4 21.4 21.4 17.3 19.6 24.9 20.4 16.7 20.4 22.8 21.1 24.5 19.0 19.1 23.9 16.0 6.4 6.9 113.6 29.1 11.6 20.4 8.1 29.0 20.1 17.9 15.4 24.5 17.2 8.4 3.7 6.2 19.5 17.4 10.5 13.7 18.1 353.4 11.6 17.2 16.3 16.2 17.9 173.2 20.3 22.2 20.6 17.3 14.8 16.5 23.3 14.3 11.5 16.7 21.9 204.1 15.1 6.1 23.0 15.1 176.1 27.7 20.5 3.6 149.9 19.7 16.1 24.7 167.9 299.4 14.7 11.4 27.1 23.8 25.0 16.1 22.5 13.4 24.9 13.1 22.4 15.4 49.8 16.2 19.4 11.4 35.2 21.6 18.1 16.2 20.2 EAPP "BM036, C14orf11, FLJ20578" ENSG00000129518 "E2F associated phosphoprotein" Q56P03 14 34515938-34539711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002916 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA002916: AB_1078715" "unprognostic (8.76e-3)" "unprognostic (1.27e-3)" "unprognostic (2.08e-3)" "unprognostic (1.94e-1)" "unprognostic (4.59e-2)" "unprognostic (1.64e-1)" "unprognostic (2.80e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.81e-1)" "unprognostic (6.38e-2)" "unprognostic (2.05e-1)" "unprognostic (7.80e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.64e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.96e-4)" "unprognostic (3.24e-2)" 37.3 35.8 26.3 24.6 27.0 89.2 51.0 29.7 35.5 33.3 27.1 50.8 35.7 35.0 44.7 29.0 39.4 28.1 29.0 27.1 28.6 42.4 50.2 29.5 37.2 25.9 26.5 49.7 26.7 54.7 21.6 35.2 26.3 33.7 51.7 37.1 36.4 31.2 37.0 46.9 45.6 29.2 28.1 31.3 29.3 23.5 27.1 49.1 45.5 29.3 37.1 31.1 30.0 30.0 37.7 45.1 41.3 24.4 47.8 48.7 64.1 33.8 51.6 41.5 43.1 21.6 48.6 39.1 46.6 41.5 24.7 34.5 30.8 45.1 48.3 49.1 27.1 28.7 31.6 91.7 65.1 51.5 30.4 56.3 56.7 23.8 60.9 54.6 41.7 54.1 28.9 42.0 39.1 88.0 71.4 41.5 24.3 69.4 50.0 44.8 49.5 39.5 50.2 50.3 33.1 36.5 47.8 45.6 76.4 39.4 79.7 32.3 45.2 21.4 18.1 28.1 22.0 52.8 63.1 41.5 20.1 28.0 27.6 139.9 61.9 134.3 65.3 57.8 79.1 107.7 81.9 75.0 54.9 101.0 82.7 75.8 140.2 100.6 80.9 47.8 124.4 80.0 26.3 27.0 29.7 35.5 27.1 28.6 25.9 26.5 26.3 28.1 27.1 30.0 59.8 22.4 53.3 17.0 78.6 46.4 67.2 145.0 74.6 75.6 60.0 70.1 35.4 60.1 78.8 82.8 31.3 125.3 76.3 91.8 174.1 86.6 20.9 82.0 59.6 57.8 66.0 66.7 20.5 84.5 76.5 67.6 26.5 54.8 73.5 98.7 57.5 109.0 58.8 25.2 21.3 112.8 87.5 50.6 33.9 14.9 89.5 47.5 90.7 16.9 71.3 122.0 87.6 17.6 23.1 59.8 102.5 94.4 46.8 61.4 131.5 164.8 102.0 75.7 72.3 69.9 78.7 103.3 38.3 63.8 66.5 189.4 74.2 101.2 98.0 58.2 EBAG9 "EB9, RCAS1" ENSG00000147654 "Estrogen receptor binding site associated antigen 9" O00559 8 109539711-109565996 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021153, HPA021154, CAB072810, CAB072811, CAB072812" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "CAB072810: , CAB072811: , CAB072812: , HPA021153: AB_1856151, HPA021154: AB_1856152" "unprognostic (3.04e-2)" "unprognostic (9.99e-2)" "unprognostic (2.08e-1)" "unprognostic (1.99e-1)" "unprognostic (5.06e-2)" "unprognostic (8.13e-2)" "unprognostic (2.63e-1)" "unprognostic (3.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.22e-2)" "unprognostic (1.04e-1)" "unprognostic (3.72e-1)" "unprognostic (9.72e-3)" "unprognostic (6.46e-2)" "unprognostic (5.16e-1)" "unprognostic (3.53e-1)" "unprognostic (3.71e-2)" 23.3 28.4 18.6 17.6 19.9 16.9 32.4 23.4 26.3 36.1 19.8 28.6 23.5 22.8 44.7 17.0 27.6 19.4 24.7 19.1 20.5 37.0 45.2 28.1 25.4 18.9 19.0 22.2 36.7 34.9 20.5 18.1 19.0 23.3 31.2 32.5 42.9 27.6 53.2 17.9 21.0 17.0 19.1 20.7 27.2 25.3 19.3 20.6 57.4 42.3 27.0 17.2 15.3 20.2 36.7 25.2 25.3 17.3 15.3 24.9 19.7 19.5 14.6 27.0 25.4 25.7 38.1 51.7 33.0 13.8 21.8 25.2 24.4 31.3 28.5 57.6 26.9 56.9 15.8 39.6 34.3 20.0 16.1 19.9 60.1 23.4 47.2 21.9 25.7 45.8 59.8 37.0 24.0 55.8 58.2 31.5 15.8 70.1 25.2 30.9 20.1 43.7 31.4 23.7 27.6 22.1 21.3 22.6 27.6 18.4 44.7 25.6 17.5 20.9 15.0 19.1 14.4 54.9 38.3 48.7 21.2 52.7 19.6 5.8 13.4 14.7 19.3 19.5 34.1 40.7 27.1 27.0 22.5 40.3 33.5 30.4 2.8 29.4 17.3 23.8 33.4 14.7 18.6 19.9 23.4 26.3 19.1 20.5 18.9 19.0 19.0 19.1 19.3 20.2 32.0 121.8 102.4 12.7 40.2 21.7 28.6 51.8 44.9 34.5 36.8 46.0 37.6 54.3 65.1 29.5 6.2 50.2 24.0 33.6 64.6 47.3 134.7 42.9 26.7 34.5 31.8 36.0 16.1 65.8 34.0 28.8 22.4 33.0 46.9 16.0 23.2 48.8 32.7 50.5 16.1 39.4 50.8 24.7 22.1 115.0 29.2 27.9 19.6 11.2 25.3 53.4 27.8 18.1 16.1 38.5 41.3 23.0 53.8 36.8 50.5 58.5 61.8 34.7 32.9 35.1 32.1 101.6 50.4 40.5 19.9 22.2 28.5 34.7 46.0 31.7 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290361-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 44.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 749.7;Ductal cells: 316.3;Glandular and luminal cells: 289.7;Pancreatic endocrine cells: 268.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "non-classical monocyte: 4.9" "Lineage enriched" "Detected in single" 6 "monocytes: 4.9" "Cell line enhanced" "Detected in many" "EFO-21: 660.4;HUVEC TERT2: 446.8;T-47d: 137.5;TIME: 334.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" NA Yes 9740 "Cluster 14: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 44.6 1.8 14.7 7.3 13.8 4.7 23.6 13.6 18.2 6.2 9.7 10.6 10.4 7.0 6.3 12.1 9.4 13.5 7.8 12.6 12.2 7.7 3.1 36.6 5.6 15.1 13.6 2.6 9.6 1.4 1.1 18.5 15.2 5.5 14.5 1.0 12.1 8.9 7.6 11.8 9.8 11.3 13.1 12.3 10.4 4.7 15.7 1.7 3.4 6.4 2.4 9.9 5.9 14.2 10.3 57.6 1.1 0.1 0.3 0.2 0.2 18.2 16.0 15.0 12.4 74.6 8.6 0.0 660.4 7.2 9.2 5.4 0.0 10.6 11.0 0.8 0.0 0.0 2.1 2.3 0.8 0.0 0.0 0.4 6.2 3.0 2.1 4.7 446.8 0.0 0.0 0.0 56.8 1.6 0.2 0.3 0.6 10.4 0.7 0.2 5.1 0.1 35.3 9.4 0.6 0.0 1.8 53.1 0.1 117.2 137.5 0.8 334.3 37.1 30.1 0.7 23.5 0.3 0.4 1.3 0.3 0.0 1.6 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 4.9 0.1 0.0 0.0 14.7 13.8 13.6 18.2 12.6 12.2 15.1 13.6 15.2 13.1 15.7 14.2 190.7 173.1 23.8 2.9 0.8 189.9 749.7 99.9 151.4 0.2 68.7 26.8 2.2 8.6 110.6 38.6 0.0 1.8 0.8 189.7 3.9 316.3 13.3 187.2 16.3 236.8 15.6 2.7 3.6 218.9 0.4 9.0 22.4 289.7 1.3 0.8 169.2 1.8 1.8 1.7 3.0 43.8 12.2 5.0 6.7 19.8 5.6 5.3 8.8 6.5 10.9 0.3 0.0 3.5 0.6 268.5 145.7 0.4 0.4 185.8 119.6 8.3 27.4 0.4 6.6 1.8 21.8 1.0 0.6 53.7 64.5 0.8 9.7 0.1 196.6 141.8 EEF1G EF1G ENSG00000254772 "Eukaryotic translation elongation factor 1 gamma" P26641 11 62559596-62574086 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1021.0;Plasma cells: 770.5;Squamous epithelial cells: 1166.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040688, HPA055316" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 2500000 "Cluster 30: Non-specific - Translation" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Cytosol "Golgi apparatus" "HPA040688: AB_10961632, HPA055316: AB_2732593" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (2.44e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-1)" "unprognostic (9.22e-4)" "unprognostic (1.14e-1)" "unprognostic (5.14e-2)" "unprognostic (5.07e-3)" "unprognostic (1.86e-1)" "unprognostic (8.59e-2)" "unprognostic (8.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" "unprognostic (6.04e-2)" 1237.6 883.6 646.7 951.1 663.7 1897.3 1890.9 640.9 722.0 1595.1 659.8 1229.0 1094.9 1078.6 1079.3 1634.9 1555.9 749.8 1089.3 616.4 690.9 1162.4 885.3 818.1 1532.7 678.1 661.0 2604.5 2191.5 835.7 708.1 780.5 675.9 1219.1 1272.4 416.0 1588.0 875.6 4810.2 2215.7 1098.5 991.5 690.1 1073.0 1090.2 441.9 677.4 1281.7 1050.2 3030.5 1951.7 1173.7 1440.6 676.7 1773.6 1824.3 1859.1 2656.2 2742.6 3529.1 1866.2 1505.0 2692.9 1830.1 1392.3 2045.9 2161.9 5161.2 2365.4 2392.2 1048.0 2018.3 2229.8 2200.1 1663.3 1693.2 2071.2 1348.7 2061.8 2120.7 2974.2 2810.2 1523.6 4060.8 3913.9 1812.1 4419.8 3014.9 2562.7 1777.2 2755.8 2451.2 2190.6 3611.0 3035.5 4895.3 2304.9 1546.3 1575.0 2545.1 2390.9 4978.7 2454.9 2276.4 1608.2 2002.3 901.7 3010.3 4214.5 1179.1 3496.3 3012.0 1759.8 1057.1 1476.4 2070.0 1338.6 1680.0 1783.1 2609.2 1210.8 2005.2 1517.1 883.9 2365.5 589.6 2182.3 2151.6 4333.1 5399.6 4153.2 2825.0 3623.0 5080.7 6117.7 4188.5 320.6 3285.2 1837.0 2869.7 3307.5 11090.3 646.7 663.7 640.9 722.0 616.4 690.9 678.1 661.0 675.9 690.1 677.4 676.7 2.8 150.6 366.9 14.4 403.6 7.9 2.5 8.8 1021.0 0.5 21.9 10.3 0.0 14.3 300.8 1.8 2.1 17.7 9.6 63.7 3.9 124.8 4.3 2.2 7.2 70.2 148.5 405.0 8.4 188.5 26.8 149.5 252.8 3.5 375.6 1.8 11.0 4.9 12.5 0.0 13.8 152.0 4.1 8.8 4.9 18.8 3.1 134.7 1.8 24.4 126.4 0.8 16.5 6.0 13.0 114.9 121.0 2.2 770.5 3.0 132.1 12.1 152.0 0.5 0.0 1.6 43.9 1.4 0.8 1166.7 6.1 21.1 235.3 1.1 223.8 2.3 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46674659-46719146 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 159.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA 110000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 44: HDLM-2 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 49.8 23.8 26.0 25.4 35.5 8.5 30.5 31.9 21.3 42.4 15.5 37.4 30.2 31.7 24.7 39.6 38.4 33.3 36.1 21.3 28.1 44.2 30.6 43.0 26.2 37.5 33.7 35.8 23.1 159.5 18.0 43.6 33.4 30.7 39.3 12.3 30.5 40.1 34.6 28.7 31.5 38.9 29.9 31.7 65.9 27.3 29.9 34.1 43.9 45.9 35.2 40.1 27.1 38.2 34.9 20.3 13.4 23.8 75.2 48.6 37.3 35.4 56.7 40.3 40.6 22.4 23.1 26.5 38.5 51.6 53.7 41.0 28.1 41.3 51.7 62.4 16.9 33.8 15.1 8.7 26.9 44.3 67.1 43.9 61.5 31.4 28.2 37.4 52.6 26.3 23.5 37.9 37.7 12.4 30.6 10.6 22.2 39.8 21.1 22.1 45.9 25.2 37.6 68.4 7.4 9.9 47.7 64.2 29.9 43.3 29.0 38.6 46.0 33.1 16.8 38.1 37.0 38.0 65.2 22.7 43.6 34.5 25.9 23.4 22.6 36.8 25.3 28.0 34.0 18.0 23.0 22.9 19.5 17.0 21.0 21.7 15.4 21.8 26.3 14.1 21.1 24.3 26.0 35.5 31.9 21.3 21.3 28.1 37.5 33.7 33.4 29.9 29.9 38.2 152.3 73.7 84.6 31.3 45.9 31.7 52.3 32.0 44.9 31.6 56.3 34.0 44.9 47.1 46.1 114.0 31.3 40.6 64.4 80.8 31.3 36.2 70.6 36.1 37.4 74.8 37.8 31.1 20.3 38.4 32.0 48.8 79.0 52.2 101.8 27.4 50.7 57.9 42.2 47.1 27.8 64.6 54.9 75.5 44.0 18.9 47.2 52.0 26.6 29.0 65.0 50.6 84.5 29.7 46.2 48.5 61.3 49.7 34.8 73.8 50.5 34.4 49.9 18.6 26.3 50.2 49.9 51.3 27.7 46.5 43.5 59.0 52.0 30.4 46.2 128.4 EFHD1 FLJ13612 ENSG00000115468 "EF-hand domain family member D1" Q9BUP0 2 232606057-232682780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 414.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 241.8;Breast myoepithelial cells: 129.0;Distal tubular cells: 393.2;Oligodendrocytes: 173.4;Sertoli cells: 197.2;Smooth muscle cells: 130.9;Syncytiotrophoblasts: 263.9" "Cancer enriched" "Detected in all" 5 "breast cancer: 100.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 125.8;RPTEC TERT1: 68.6;SK-BR-3: 301.8;T-47d: 236.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049331, HPA056959" Enhanced Supported "Nucleoli fibrillar center,Golgi apparatus" No NA 14000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "Golgi apparatus" "Nucleoli fibrillar center" "HPA049331: AB_2680716, HPA056959: AB_2683288" "unprognostic (9.51e-3)" "unprognostic (2.21e-2)" "unprognostic (4.78e-3)" "unprognostic (3.25e-1)" "unprognostic (3.40e-1)" "unprognostic (9.70e-2)" "unprognostic (9.02e-2)" "unprognostic (1.13e-1)" "unprognostic (3.29e-3)" "unprognostic (1.21e-1)" "unprognostic (5.57e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.93e-7)" "unprognostic (2.00e-2)" "unprognostic (1.84e-1)" "unprognostic (2.51e-2)" "unprognostic (2.29e-3)" 86.3 7.0 199.7 3.7 303.2 0.8 180.7 244.9 261.3 86.9 129.9 16.9 4.4 72.4 33.7 9.6 73.7 12.0 46.0 196.6 217.4 186.2 54.6 15.3 3.9 253.6 258.7 76.5 86.5 10.5 16.5 77.9 261.8 25.6 5.7 9.5 22.2 27.7 35.5 30.9 16.2 20.6 201.4 52.5 17.6 20.1 237.8 3.0 32.7 42.7 2.4 22.0 44.5 414.6 0.0 3.4 5.7 1.4 2.2 0.1 125.8 26.8 2.1 2.3 1.9 0.9 0.6 0.1 2.0 11.6 2.9 0.2 19.0 0.0 0.3 0.5 9.2 0.0 2.4 1.9 0.0 0.1 0.3 1.0 0.4 0.2 0.0 0.4 0.0 5.5 3.9 0.5 0.5 2.3 0.6 0.2 8.4 0.0 0.2 0.6 7.2 0.4 68.6 0.7 0.3 3.2 9.1 301.8 18.3 42.3 236.9 2.6 0.0 0.0 1.8 0.4 0.8 0.2 0.1 0.1 0.3 0.1 13.4 1.0 0.2 0.1 0.2 0.1 0.4 0.3 0.3 0.4 0.1 0.1 0.6 0.6 2.2 0.1 0.1 0.2 0.1 0.1 199.7 303.2 244.9 261.3 196.6 217.4 253.6 258.7 261.8 201.4 237.8 414.6 15.6 0.0 0.0 37.5 1.5 3.6 2.8 1.3 1.2 0.5 241.8 129.0 7.4 1.5 4.6 35.0 0.0 112.0 3.0 0.3 393.2 0.0 9.0 1.1 37.8 16.8 0.0 2.7 2.6 0.0 19.7 41.1 0.0 1.7 0.0 3.2 6.4 89.4 8.7 0.0 5.3 0.1 59.0 1.3 3.0 7.0 44.4 2.1 8.8 18.7 0.0 48.0 0.0 1.5 173.4 0.0 0.0 57.2 0.1 4.6 0.0 116.5 1.9 1.4 197.2 8.7 130.9 17.3 13.6 0.4 3.1 263.9 2.5 1.5 0.3 2.0 EHF "ESE3, ESEJ" ENSG00000135373 "ETS homologous factor" Q9NZC4 11 34621093-34663288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 287.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "myeloid DC: 1.7" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA050923, HPA060734" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" No NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Golgi apparatus" "HPA050923: AB_2681275, HPA060734: AB_2684351" "unprognostic (1.06e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.82e-1)" "unprognostic (5.62e-2)" "unprognostic (1.22e-3)" "unprognostic (2.44e-1)" "unprognostic (2.04e-1)" "unprognostic (1.38e-1)" "unprognostic (6.79e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.89e-1)" "unprognostic (7.08e-2)" 0.9 1.1 0.9 14.7 1.7 0.2 199.5 0.9 0.6 120.8 1.3 99.3 42.2 13.9 95.0 200.7 129.6 32.2 0.3 1.1 0.8 25.7 1.3 23.4 1.5 2.6 4.0 0.2 41.1 18.5 0.7 0.1 2.8 82.7 126.3 0.8 287.7 153.4 0.2 53.6 34.1 3.5 2.5 1.2 59.5 0.7 1.3 1.3 2.5 0.0 67.3 50.7 79.2 4.7 46.5 26.8 0.0 0.3 0.0 0.0 0.8 0.0 3.9 0.0 0.2 0.4 138.4 0.1 17.1 0.0 0.2 95.7 0.0 107.6 0.5 0.1 0.2 0.0 1.5 0.2 0.0 0.2 0.0 0.0 41.7 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.1 2.6 0.1 0.8 0.2 132.9 1.0 0.0 0.1 1.0 20.2 214.8 0.0 0.2 0.5 14.8 0.2 0.0 213.5 0.5 0.0 0.2 1.2 5.1 0.4 0.5 0.2 0.3 0.3 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.9 0.6 1.1 0.8 2.6 4.0 2.8 2.5 1.3 4.7 0.8 48.1 97.2 1.3 0.6 109.6 400.8 271.6 133.1 0.0 123.0 51.9 0.9 60.1 323.3 55.2 0.0 0.1 1.1 62.7 15.6 77.8 14.2 229.6 17.7 4.0 23.3 0.0 0.7 86.5 0.0 3.2 53.5 281.8 1.3 0.0 0.0 0.4 0.1 0.0 0.0 82.8 116.0 0.0 17.7 1.0 0.0 5.1 12.4 0.0 5.6 3.8 0.0 0.0 2.4 104.8 30.2 0.0 1.2 173.1 14.1 0.3 204.6 0.0 0.0 0.0 9.6 0.4 0.1 251.1 170.1 1.4 4.9 0.0 74.5 397.3 EI24 "EPG4, PIG8, TP53I8" ENSG00000149547 "EI24 autophagy associated transmembrane protein" O14681 11 125569280-125584684 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 461.9" "Cell type enhanced" "Detected in all" "Hepatocytes: 575.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 760.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047165, HPA051029" Approved Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 36: HEL - Hemostasis" "Cluster 2: Hepatocytes - Metabolism" "Endoplasmic reticulum, Cytosol" "Golgi apparatus" "HPA047165: AB_2679965, HPA051029: AB_2681317" "unprognostic (2.04e-3)" "unprognostic (2.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.43e-2)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.02e-2)" "unprognostic (6.38e-2)" "unprognostic (6.74e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (3.50e-2)" "unprognostic (1.35e-1)" "unprognostic (4.58e-2)" "unprognostic (8.35e-2)" "unprognostic (2.07e-1)" "unprognostic (3.01e-1)" 53.4 32.6 61.1 36.2 62.5 23.2 72.6 59.7 72.4 51.3 59.8 77.8 49.6 46.2 57.4 80.8 50.8 46.3 55.7 60.2 61.5 61.0 248.4 45.0 28.4 60.2 62.5 42.4 101.8 461.9 30.6 48.5 60.2 49.6 80.4 39.4 75.3 58.0 119.5 70.2 49.3 62.5 62.4 30.5 59.7 33.1 64.4 35.3 40.5 104.6 42.3 78.9 48.4 61.0 156.6 115.6 129.5 160.5 207.7 155.9 162.4 159.6 116.8 104.3 93.4 178.9 303.4 158.0 264.0 146.5 110.8 176.1 199.0 326.8 135.2 42.0 142.6 760.9 77.2 179.9 154.1 170.9 78.4 147.5 292.7 157.4 230.2 102.8 223.9 85.1 351.1 61.1 149.4 113.8 79.0 96.4 173.6 398.3 139.5 113.9 155.4 132.8 177.0 272.4 120.1 116.9 187.1 215.5 63.4 212.3 436.4 165.7 195.2 133.8 93.3 94.7 128.7 39.7 84.8 200.5 58.5 256.1 182.2 4.3 7.0 5.9 7.2 6.7 7.2 8.4 5.7 9.0 10.9 6.3 8.1 6.7 0.8 6.5 4.9 14.5 9.1 5.3 61.1 62.5 59.7 72.4 60.2 61.5 60.2 62.5 60.2 62.4 64.4 61.0 73.5 32.1 38.3 13.4 34.8 120.6 130.3 132.6 120.1 58.9 148.8 100.6 61.9 124.4 69.5 110.3 37.5 166.9 32.4 66.4 144.8 178.6 31.1 34.4 59.3 87.1 98.4 102.7 25.1 181.8 201.2 80.1 87.7 46.5 27.3 76.2 74.6 575.0 110.5 82.4 24.0 115.3 105.8 49.8 96.1 49.7 71.4 40.9 90.7 11.2 40.9 107.1 50.4 13.0 23.0 182.1 67.6 72.2 79.1 270.0 68.5 122.7 43.9 36.9 46.0 60.8 80.1 95.9 112.3 176.3 181.4 140.1 31.0 71.3 135.7 189.4 EMC8 "C16orf2, C16orf4, COX4NB, FAM158B, NOC4" ENSG00000131148 "ER membrane protein complex subunit 8" O43402 16 85771758-85799608 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 230.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049476 Approved Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Endoplasmic reticulum" "Golgi apparatus" "HPA049476: AB_2680784" "unprognostic (2.69e-1)" "unprognostic (2.62e-2)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.88e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.49e-4)" "unprognostic (1.30e-1)" "unprognostic (2.41e-1)" "unprognostic (2.67e-3)" "unprognostic (1.03e-1)" "unprognostic (6.91e-3)" "prognostic favorable (6.39e-4)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" 13.5 12.9 13.9 8.3 14.7 17.4 12.7 14.7 13.6 9.7 13.2 12.5 10.6 12.7 7.2 13.1 9.2 6.3 19.5 13.9 13.9 13.8 12.8 9.3 10.1 14.8 14.3 8.2 10.9 11.0 10.2 9.3 13.8 9.9 8.7 7.1 9.9 8.7 20.8 10.5 10.5 9.3 15.1 10.9 11.7 12.2 14.8 10.3 9.6 12.5 9.5 11.7 9.4 16.0 29.8 34.1 21.3 19.5 22.6 21.6 41.4 28.7 28.4 46.9 20.8 54.7 33.5 25.6 32.5 29.1 21.0 33.3 32.0 30.1 41.5 10.9 45.7 21.1 17.3 50.3 34.2 21.7 13.7 23.8 20.1 35.7 41.5 20.2 27.1 30.9 48.6 9.6 29.2 50.7 34.5 61.4 42.5 27.4 43.3 50.0 17.4 21.8 29.9 20.7 35.9 21.4 52.8 17.1 33.9 18.9 33.9 38.1 23.8 28.1 28.7 24.9 37.1 26.6 27.3 102.8 24.1 41.3 30.2 17.9 18.1 25.6 10.9 19.2 12.7 11.1 11.8 14.8 24.2 15.6 14.7 14.4 7.5 19.2 19.5 17.8 12.3 12.3 13.9 14.7 14.7 13.6 13.9 13.9 14.8 14.3 13.8 15.1 14.8 16.0 60.1 6.4 8.6 10.4 25.0 61.3 30.1 28.9 25.0 33.7 26.7 26.0 19.9 15.7 18.5 25.8 12.5 48.5 25.0 28.8 60.7 46.9 230.2 37.1 28.3 33.6 46.6 21.5 6.1 42.1 60.7 26.2 18.8 40.9 9.5 25.1 23.6 23.3 47.0 15.2 7.8 27.4 26.4 28.0 38.0 55.0 24.8 27.1 28.4 8.4 41.9 27.8 27.8 8.0 12.2 50.0 27.2 31.6 33.3 51.1 29.1 46.5 12.5 18.6 26.3 22.5 28.9 54.2 56.5 33.5 54.6 51.0 22.4 37.0 35.6 41.9 EMILIN3 "C20orf130, dJ620E11.4, EMILIN5" ENSG00000183798 "Elastin microfibril interfacer 3" Q9NT22 20 41359962-41366818 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 53.6" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 17.7;Granulosa cells: 7.6;Microglial cells: 4.7;Oligodendrocyte precursor cells: 3.5;Peritubular cells: 4.9;Skeletal myocytes: 3.2" "Group enriched" "Detected in many" 5 "glioma: 10.8;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;HAP1: 11.1;NTERA-2: 7.0;SCLC-21H: 13.0" "Region enriched" "Detected in single" 30 "cerebellum: 3.3" "Region enriched" "Detected in single" 4 "spinal cord: 4.1" "HPA044034, HPA059912, HPA078559" Enhanced Approved "Golgi apparatus,Microtubules,Cytokinetic bridge" "Secreted to extracellular matrix" Yes NA 1200000 "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" "Microtubules, Cytokinetic bridge" "HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: " "unprognostic (1.66e-4)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.14e-1)" "unprognostic (2.65e-1)" "unprognostic (2.15e-2)" "unprognostic (1.71e-1)" "unprognostic (7.66e-2)" "unprognostic (2.18e-3)" "unprognostic (2.57e-1)" "unprognostic (6.54e-2)" "unprognostic (7.66e-2)" "unprognostic (3.13e-7)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (9.62e-2)" 0.6 1.4 2.5 0.1 2.4 0.0 3.5 2.3 3.8 8.6 1.8 4.9 0.6 2.3 53.6 0.8 4.2 0.3 7.8 2.1 2.2 1.0 0.6 0.3 0.1 3.7 2.7 8.9 0.2 0.1 1.8 0.0 3.0 6.7 0.3 0.0 1.0 9.9 0.9 3.9 1.7 0.9 2.5 0.1 2.0 1.7 2.6 0.5 0.3 2.6 0.2 2.3 4.7 3.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 11.1 0.0 0.2 0.0 1.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.0 1.3 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.4 2.3 3.8 2.1 2.2 3.7 2.7 3.0 2.5 2.6 3.0 0.6 0.0 0.0 0.7 0.0 0.9 0.2 0.0 0.0 0.3 1.2 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 17.7 0.4 0.0 0.0 1.1 0.0 0.0 0.8 0.0 0.7 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 1.8 0.1 0.0 4.7 0.0 0.1 0.0 3.5 0.1 0.0 1.2 4.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 3.2 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 383.3;choroid plexus: 753.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1041.6" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 53.8" "Lineage enriched" "Detected in many" 8 "granulocytes: 53.8" "Cell line enhanced" "Detected in many" "AF22: 111.4;ASC diff: 147.7;ASC TERT1: 312.5;BJ: 103.2;BJ hTERT+: 188.9;fHDF/TERT166: 124.2;HSkMC: 144.7;U-2197: 108.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Secreted to blood" NA NA 1200000000 "Cluster 46: Basophils - DNA binding" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: AB_2682218" "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favorable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 104.7 46.7 98.9 62.0 208.4 2.7 89.7 188.1 150.1 73.6 753.4 32.6 67.5 139.2 20.2 9.0 55.7 39.9 9.9 111.0 133.0 76.6 28.5 42.7 109.8 246.2 164.4 15.2 15.9 20.2 11.8 252.3 244.4 26.4 32.3 6.9 9.9 27.3 8.9 17.5 45.8 85.1 147.8 51.4 26.9 31.3 153.7 20.8 10.8 23.9 85.8 45.1 18.1 383.3 0.0 0.0 111.4 0.0 147.7 312.5 0.4 103.2 188.9 43.9 42.1 0.0 0.0 0.1 1.3 124.2 0.1 0.3 2.3 0.0 31.3 8.7 3.4 0.0 0.2 3.1 67.0 0.0 0.5 144.7 1.3 89.3 4.3 0.6 0.5 0.1 0.1 18.1 2.5 0.0 0.1 0.7 4.4 0.0 0.5 0.1 0.1 0.6 0.3 0.0 1.1 2.2 0.1 0.4 0.2 4.2 0.1 0.0 0.0 89.6 1.9 108.6 0.9 0.9 0.0 0.0 75.0 0.8 2.4 53.8 0.2 9.5 0.0 0.1 0.1 0.4 0.5 0.0 1.0 0.1 3.0 1.1 0.5 0.4 0.2 6.8 0.0 0.6 98.9 208.4 188.1 150.1 111.0 133.0 246.2 164.4 244.4 147.8 153.7 383.3 231.4 12.8 3.6 2.0 1.8 10.6 0.5 0.0 19.9 1.9 2.1 2.8 1.8 35.8 0.6 1.8 0.0 5.2 4.9 0.3 1.9 0.1 83.9 12.7 8.8 79.9 54.0 0.8 2.5 0.0 2.2 76.9 3.6 1.4 6.3 0.4 31.1 0.8 65.8 0.0 4.2 3.3 0.0 18.6 14.9 9.5 3.1 16.2 46.2 6.5 0.1 6.4 0.0 16.6 1041.6 0.7 2.6 3.4 1.9 0.1 4.2 47.6 3.7 1.2 0.0 3.1 9.6 1.7 0.4 7.8 5.3 6.4 1.7 1.1 2.8 1.4 ENPP6 MGC33971 ENSG00000164303 "Ectonucleotide pyrophosphatase/phosphodiesterase 6" Q6UWR7 4 184088706-184221230 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4;kidney: 30.6;ovary: 12.5" "Cell type enhanced" "Detected in some" "Oligodendrocytes: 119.9;Peritubular cells: 35.3;Proximal tubular cells: 31.3;Theca cells: 23.9" "Cancer enriched" "Detected in some" 5 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.2;SH-SY5Y: 3.6;U-266/70: 2.9;U-266/84: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042740, HPA069197" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA 290000 "Cluster 21: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA042740: AB_10793984, HPA069197: " "unprognostic (4.81e-4)" "unprognostic (1.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.69e-3)" "unprognostic (3.07e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.60e-3)" "unprognostic (3.04e-2)" "unprognostic (1.72e-1)" "unprognostic (2.98e-2)" "unprognostic (2.82e-1)" "unprognostic (3.93e-3)" "unprognostic (2.01e-1)" 0.2 0.3 2.7 0.8 11.8 0.9 0.8 14.2 5.5 0.2 2.3 1.0 1.7 0.2 6.1 1.0 0.3 0.5 0.2 2.7 6.1 30.6 0.1 0.3 0.9 20.4 9.6 12.5 0.0 0.0 4.2 0.1 18.1 2.2 1.0 0.1 0.7 6.1 0.2 0.1 2.2 0.1 12.5 1.0 1.2 2.4 11.1 1.9 0.1 1.3 2.8 0.6 0.3 29.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 3.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.9 1.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 2.7 11.8 14.2 5.5 2.7 6.1 20.4 9.6 18.1 12.5 11.1 29.4 0.5 0.0 0.0 5.9 0.1 0.0 0.2 0.9 0.6 0.0 0.1 0.5 0.9 0.0 0.4 1.8 0.0 0.0 0.0 0.0 3.9 1.1 1.0 0.0 0.0 0.5 0.0 0.0 4.3 0.2 0.0 8.7 0.0 0.0 5.7 0.0 0.0 0.4 0.2 0.0 1.5 0.0 0.0 0.6 0.0 0.4 4.1 0.6 1.8 4.7 1.1 0.0 0.0 6.6 119.9 0.0 0.0 35.3 0.5 0.1 0.0 31.3 0.2 0.0 0.0 5.1 0.6 0.1 1.6 0.0 0.0 0.0 0.3 23.9 0.0 0.3 ENTPD6 "CD39L2, dJ738P15.3, IL6ST2, NTPDase-6" ENSG00000197586 "Ectonucleoside triphosphate diphosphohydrolase 6" O75354 20 25195693-25228075 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 289.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015491, HPA069555" Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 41000 "Cluster 39: Non-specific - mRNA processing" "Cluster 22: Non-specific - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA015491: AB_2669200, HPA069555: AB_2686152" "unprognostic (3.24e-1)" "unprognostic (1.27e-2)" "unprognostic (5.91e-2)" "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (4.44e-1)" "unprognostic (2.10e-3)" "unprognostic (7.41e-3)" "unprognostic (2.74e-3)" "unprognostic (1.17e-1)" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (8.14e-3)" "unprognostic (1.78e-2)" "unprognostic (2.74e-1)" "unprognostic (4.86e-2)" "unprognostic (4.48e-2)" 24.8 55.4 54.3 22.8 64.0 15.2 27.7 39.7 65.9 22.9 26.5 61.0 60.0 21.8 18.4 25.3 23.2 26.5 75.9 56.0 49.8 40.4 38.9 25.4 16.1 29.6 32.2 36.2 49.6 23.5 60.0 25.2 45.2 55.7 44.9 15.7 71.2 17.2 38.7 19.4 63.0 18.6 25.7 19.8 47.2 36.3 48.5 29.8 28.8 21.9 13.0 24.5 21.8 38.9 78.8 122.8 32.9 64.0 41.0 50.8 70.8 63.0 45.0 54.0 48.3 65.5 60.0 47.6 91.4 60.9 104.7 100.3 40.1 96.2 35.5 29.2 36.2 38.3 18.2 150.4 60.7 52.7 57.3 47.4 53.1 67.7 51.4 39.4 43.7 46.1 51.5 78.8 40.0 75.6 49.2 32.6 20.8 63.9 96.0 27.1 102.9 108.4 67.8 46.3 52.0 26.7 17.7 105.1 289.4 29.6 75.3 43.4 48.6 61.9 63.7 51.6 75.7 50.5 43.8 21.0 44.5 34.1 116.3 0.1 25.2 4.9 18.8 17.0 25.6 8.7 16.5 15.0 26.4 11.0 16.9 15.5 1.1 14.1 7.6 18.5 17.2 22.1 54.3 64.0 39.7 65.9 56.0 49.8 29.6 32.2 45.2 25.7 48.5 38.9 6.4 19.2 28.5 12.4 9.9 9.8 16.2 23.6 6.2 19.2 25.8 21.8 5.8 25.8 14.8 18.4 10.4 63.2 11.0 81.4 9.8 42.5 22.1 10.5 7.6 7.6 34.0 4.2 18.6 40.1 21.7 12.8 52.5 15.4 3.8 65.2 14.3 15.0 26.7 25.2 19.4 57.5 26.4 17.7 17.4 65.2 20.5 17.6 10.6 11.2 16.0 4.2 10.3 13.0 9.2 33.8 59.8 42.2 16.5 27.9 68.4 13.5 10.7 9.1 6.6 6.3 9.6 3.0 8.8 8.6 6.0 59.8 12.0 25.8 72.6 12.1 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 8.4;lymphoid tissue: 15.0" "Cell type enhanced" "Detected in some" "dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in single" 13 "cerebellum: 8.4" "Group enriched" "Detected in many" 7 "gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0" "Group enriched" "Detected in many" 107 "NK-cells: 33.0;T-cells: 26.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9" "Region enriched" "Detected in many" 8 "olfactory bulb: 77.5" "Group enriched" "Detected in some" 27 "cerebellum: 30.2;olfactory bulb: 12.7" HPA028896 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Golgi apparatus, Cytosol" "HPA028896: AB_10601370" "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 1.0 0.6 0.2 3.2 0.1 1.8 0.6 8.4 0.4 0.4 0.4 0.7 0.4 0.8 0.8 0.3 0.4 1.6 0.3 0.2 0.3 0.4 2.4 2.2 15.0 0.2 0.3 0.5 0.3 0.1 0.2 0.4 0.6 0.5 0.8 1.6 0.9 0.1 0.1 0.2 1.4 0.4 0.3 12.8 1.3 0.4 0.2 1.5 0.5 0.1 5.4 1.3 0.4 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.6 1.3 0.0 7.4 1.1 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.8 0.0 0.9 0.3 0.0 8.3 0.2 0.0 0.0 2.0 2.0 0.0 0.2 0.2 0.9 1.3 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.9 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 16.5 0.0 26.2 0.0 3.0 19.5 0.0 0.0 0.2 11.9 0.2 33.0 0.1 0.1 0.0 2.9 0.2 0.1 8.4 0.4 0.2 0.3 0.2 0.3 0.6 0.3 0.2 0.4 0.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.4 0.2 0.3 0.8 1.5 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 16.8 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 2.2 1.6 0.2 0.0 0.0 0.0 0.0 3.1 0.7 0.0 0.3 1.3 1.8 1.0 1.1 0.1 93.7 0.0 0.0 0.0 0.0 0.4 9.8 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.7 0.0 2.0 0.0 0.1 0.0 31.5 0.0 0.0 0.0 EPHA2 ECK ENSG00000142627 "EPH receptor A2" P29317 1 16124337-16156069 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cataract, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 147.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 202.3;Glandular and luminal cells: 182.9;Squamous epithelial cells: 156.3;Suprabasal keratinocytes: 248.3;Urothelial cells: 200.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 94 "plasmacytoid DC: 9.4" "Lineage enriched" "Detected in single" 94 "dendritic cells: 9.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 201.1;PC-3: 229.0;U-251 MG: 242.1;WM-115: 258.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB010464 Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions" NA Yes 12000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "Plasma membrane, Cell Junctions" "Nuclear speckles, Golgi apparatus" "CAB010464: AB_631436" "unprognostic (9.41e-2)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.67e-2)" "unprognostic (6.22e-2)" "unprognostic (9.12e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-3)" "unprognostic (2.52e-2)" "unprognostic (7.05e-3)" "unprognostic (1.52e-3)" "unprognostic (2.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (4.77e-3)" "unprognostic (4.40e-2)" 21.4 9.5 3.5 4.8 3.1 0.3 14.6 2.9 3.7 38.2 11.7 12.4 10.0 12.1 1.3 147.9 13.5 28.2 15.8 3.1 3.1 18.7 18.9 17.9 7.6 3.8 3.7 5.8 23.2 3.7 7.4 14.0 3.8 11.2 5.8 6.4 67.7 4.2 4.6 40.3 12.8 3.7 3.6 7.6 15.6 1.8 4.3 3.2 15.2 5.1 11.1 56.1 58.8 3.1 76.9 151.7 41.4 20.1 2.9 3.5 24.3 45.2 63.4 79.9 50.6 63.9 201.1 0.1 189.8 25.9 98.8 30.6 9.9 104.4 27.6 0.4 7.0 0.0 46.7 41.1 51.3 0.1 0.2 4.8 38.1 43.7 95.6 125.0 86.4 0.0 0.3 0.1 51.6 24.3 0.0 0.0 20.0 57.2 229.0 0.1 37.6 0.2 85.1 39.0 0.1 6.4 87.8 21.2 6.1 21.3 3.0 0.9 108.1 28.5 76.7 2.0 242.1 0.0 0.5 0.6 22.0 0.1 258.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 3.5 3.1 2.9 3.7 3.1 3.1 3.8 3.7 3.8 3.6 4.3 3.1 17.1 54.5 38.4 2.0 1.2 202.3 114.3 110.9 66.0 2.7 39.5 43.9 6.5 44.3 113.4 9.2 4.2 9.7 8.9 96.8 0.0 33.8 5.8 104.5 19.2 26.3 3.0 0.0 0.1 14.2 1.2 5.8 68.3 182.9 5.7 0.4 29.3 23.3 1.9 0.0 0.2 42.0 34.6 1.6 17.0 0.2 3.4 3.7 26.6 4.7 1.1 7.1 0.0 0.0 0.0 104.6 111.7 0.0 0.0 60.8 22.4 1.8 89.8 2.5 32.9 11.6 21.2 0.2 0.8 156.3 248.3 7.5 2.6 0.4 42.9 200.4 EPS8 ENSG00000151491 "Epidermal growth factor receptor pathway substrate 8" Q12929 12 15620134-15882329 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 317.0;Sertoli cells: 401.0;Smooth muscle cells: 313.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 22.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 253.0;HHSteC: 218.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003897 Approved Approved "Golgi apparatus" NA NA 17000 "Cluster 51: Monocytes - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA003897: AB_1848224" "unprognostic (6.16e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-2)" "unprognostic (5.43e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (5.81e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (3.33e-7)" "unprognostic (2.68e-1)" "prognostic favorable (1.45e-7)" "unprognostic (7.47e-3)" "unprognostic (7.20e-2)" "prognostic favorable (5.11e-4)" "unprognostic (1.79e-2)" 62.3 13.0 12.9 16.1 17.4 0.6 33.7 15.3 14.0 53.9 14.1 49.7 37.6 46.2 47.1 20.5 20.1 56.0 26.4 11.1 17.2 55.8 37.8 29.0 9.4 18.5 20.1 49.2 15.1 21.6 3.5 53.1 19.7 16.4 53.7 39.8 13.4 39.8 13.8 11.9 42.7 53.7 15.5 11.9 32.0 15.6 16.1 4.8 22.8 24.3 5.2 51.7 21.4 20.8 65.0 38.8 37.7 1.4 253.0 177.6 53.1 73.6 59.8 34.5 46.1 33.3 97.3 0.0 2.4 140.4 114.4 16.4 11.3 9.5 52.4 0.2 12.6 5.7 11.2 34.7 218.1 4.4 0.2 159.8 42.8 91.7 115.7 44.6 17.7 0.2 0.1 0.2 169.0 17.5 0.2 2.8 5.2 50.3 30.8 0.0 109.5 0.8 97.7 92.5 3.1 4.9 21.4 12.4 91.5 6.2 34.2 4.3 28.7 54.7 14.3 32.4 30.7 3.6 0.4 0.1 32.1 10.7 160.0 0.0 2.7 0.2 0.2 10.8 0.1 1.3 0.9 0.4 5.5 0.3 1.1 0.5 4.4 1.0 22.2 0.4 0.1 1.7 12.9 17.4 15.3 14.0 11.1 17.2 18.5 20.1 19.7 15.5 16.1 20.8 121.4 12.8 175.9 91.1 11.6 17.0 39.6 32.0 13.6 9.7 28.7 42.8 27.6 87.2 58.3 23.9 66.7 33.0 15.2 317.0 60.7 69.4 67.6 87.4 72.0 61.4 38.3 0.4 2.2 68.9 7.3 73.4 81.1 152.2 6.3 139.4 36.0 36.0 65.8 6.7 31.1 54.5 67.1 54.1 35.6 49.4 134.8 46.2 35.6 148.0 8.6 15.4 0.0 121.2 96.9 97.0 217.8 43.6 5.2 26.9 69.0 114.6 104.8 153.7 401.0 18.1 313.1 10.9 4.2 22.8 13.1 21.1 11.8 40.0 80.0 97.6 ERAP2 "L-RAP, LRAP" ENSG00000164308 "Endoplasmic reticulum aminopeptidase 2" Q6P179 5 96875986-96919703 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 176.1;GAMG: 105.0;hTEC/SVTERT24-B: 83.2;MOLT-4: 98.8;TIME: 188.7" "Low region specificity" "Detected in all" "CAB025618, HPA034498, HPA064360" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 11000000 "Cluster 15: NK-cells - Transcription" "Cluster 3: T-cells - Adaptive immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "CAB025618: , HPA034498: AB_2674191, HPA064360: " "unprognostic (4.62e-2)" "unprognostic (1.60e-1)" "unprognostic (4.98e-2)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (8.71e-2)" "unprognostic (2.60e-2)" "unprognostic (1.17e-2)" "unprognostic (5.03e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.01e-1)" "unprognostic (9.54e-3)" "unprognostic (6.59e-2)" "unprognostic (8.48e-2)" "unprognostic (4.65e-2)" "unprognostic (3.05e-1)" 7.8 7.1 3.0 31.5 3.0 7.5 11.9 2.3 4.3 12.2 3.0 16.2 32.6 8.4 17.5 10.5 7.0 11.0 7.5 2.9 2.5 11.3 14.5 18.1 46.4 4.3 3.3 8.5 2.9 3.7 3.6 11.0 3.5 10.3 6.2 2.3 6.6 7.0 8.9 10.1 21.5 3.4 2.7 36.7 19.0 1.7 3.8 49.9 5.6 9.9 29.7 14.7 6.8 3.5 2.1 2.4 1.7 0.9 1.9 3.8 0.6 8.1 13.8 7.3 12.3 7.9 176.1 12.2 35.1 11.5 105.0 2.9 0.9 65.4 5.8 4.3 7.9 0.6 3.0 8.5 2.7 43.2 19.2 25.3 12.8 83.2 0.6 1.2 4.9 27.4 0.2 25.8 20.8 1.4 98.8 22.5 0.2 0.0 3.7 45.7 16.2 29.3 55.2 15.4 3.5 0.2 1.1 0.9 16.5 0.4 6.5 1.7 188.7 3.9 1.1 10.0 24.6 26.2 23.2 4.2 50.8 5.8 0.9 23.0 12.1 15.4 24.8 27.5 31.3 28.5 34.6 30.6 19.8 17.7 37.4 28.9 4.2 45.4 28.5 6.9 34.6 27.6 3.0 3.0 2.3 4.3 2.9 2.5 4.3 3.3 3.5 2.7 3.8 3.5 46.7 32.1 20.0 11.8 62.6 5.7 11.2 24.4 12.0 1.5 3.1 5.8 4.4 8.6 15.9 44.1 0.0 11.5 35.6 48.1 0.0 5.3 0.3 7.0 10.6 34.1 1.8 15.8 2.5 25.5 17.0 23.4 17.3 7.4 7.0 33.4 31.4 16.3 12.3 0.0 2.1 23.3 8.2 29.4 14.2 0.7 10.5 33.0 7.2 21.5 19.4 6.5 20.6 7.1 4.9 22.1 27.6 7.9 56.0 4.3 52.4 6.2 15.7 2.8 0.0 12.2 12.2 0.9 0.8 10.0 3.0 6.7 54.2 9.3 34.2 10.5 ERGIC2 "Erv41, PTX1" ENSG00000087502 "ERGIC and golgi 2" Q96RQ1 12 29337352-29381189 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 383.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049695 Approved Supported "Nucleoli rim,Golgi apparatus,Vesicles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "Nucleoli rim" "HPA049695: AB_2680855" "unprognostic (1.62e-2)" "unprognostic (3.50e-2)" "unprognostic (5.53e-2)" "unprognostic (3.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.19e-3)" "prognostic unfavorable (8.06e-6)" "unprognostic (3.70e-2)" "unprognostic (2.32e-2)" "prognostic favorable (8.18e-4)" "prognostic unfavorable (7.02e-6)" "unprognostic (2.67e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (6.02e-2)" "unprognostic (2.08e-1)" "unprognostic (3.19e-2)" "unprognostic (2.64e-1)" 38.5 32.5 22.7 37.8 24.6 10.5 46.0 25.1 29.0 34.4 20.8 37.1 34.4 34.4 50.1 46.0 24.2 33.1 52.4 22.6 25.9 30.6 47.6 26.3 33.8 24.9 23.9 26.9 40.2 47.2 20.7 53.1 24.3 39.5 33.7 29.4 49.2 34.5 33.8 19.2 34.9 39.3 25.4 26.7 32.6 57.8 24.4 35.0 45.1 47.0 43.6 50.1 22.1 34.4 96.7 87.0 69.1 46.8 94.8 111.5 170.1 153.1 123.4 92.7 98.3 115.7 157.6 51.3 149.1 120.7 168.7 98.7 66.0 98.3 146.4 112.6 69.4 84.0 114.6 68.3 55.7 121.2 70.0 79.1 75.9 115.8 116.7 169.3 71.8 69.8 70.5 144.6 122.6 52.3 60.3 126.2 98.9 101.3 235.0 54.9 189.9 107.6 75.5 140.1 26.5 43.2 77.2 86.5 91.5 145.9 168.0 96.7 81.8 124.1 108.1 169.1 167.6 106.4 145.5 106.0 103.7 87.3 105.3 92.3 50.2 70.6 84.7 79.9 102.9 83.2 107.6 101.2 55.1 71.0 106.6 90.3 181.1 72.1 101.1 120.9 130.8 90.1 22.7 24.6 25.1 29.0 22.6 25.9 24.9 23.9 24.3 25.4 24.4 34.4 54.6 28.9 28.6 20.9 74.3 57.9 68.9 144.1 39.9 54.8 57.2 55.1 61.7 38.6 99.0 53.3 54.2 119.2 60.8 19.4 49.0 72.7 383.0 48.7 66.5 43.7 41.8 44.8 39.2 62.8 120.6 73.0 25.5 54.6 55.8 44.2 34.6 50.2 56.4 48.8 37.8 33.5 87.5 25.5 40.2 51.9 52.5 37.1 62.2 14.0 41.6 69.5 52.5 32.2 48.3 58.1 20.5 59.8 154.0 85.7 32.4 49.5 64.6 60.0 32.9 58.5 105.7 75.0 36.3 49.4 66.3 156.2 68.0 54.0 34.7 78.8 ERI2 "EXOD1, KIAA1504, MGC16943, ZGRF5" ENSG00000196678 "ERI1 exoribonuclease family member 2" A8K979 16 20780193-20900349 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 13.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 13.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035384, HPA035385" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Golgi apparatus" "HPA035384: AB_10602316, HPA035385: AB_2674600" "unprognostic (1.25e-1)" "unprognostic (1.47e-1)" "unprognostic (2.01e-3)" "unprognostic (4.36e-2)" "unprognostic (8.64e-2)" "unprognostic (2.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.99e-2)" "unprognostic (3.04e-2)" "unprognostic (2.07e-2)" "unprognostic (1.08e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.05e-2)" "unprognostic (9.28e-3)" 4.7 6.8 4.3 3.7 4.9 6.4 9.2 4.4 5.5 3.9 4.8 7.4 8.1 4.1 7.6 6.7 5.7 4.5 4.4 4.1 4.4 6.5 12.1 4.7 3.8 4.9 4.4 4.5 7.4 14.0 5.0 5.4 4.9 7.5 10.2 4.2 5.1 4.8 5.1 7.1 7.8 4.6 4.6 3.6 8.4 13.1 4.7 7.5 6.2 3.7 4.4 4.5 4.7 5.7 17.1 7.9 21.6 9.5 6.5 8.3 13.0 13.3 7.9 11.8 14.9 10.2 17.0 4.8 14.6 7.3 8.2 12.7 21.8 13.7 21.8 15.3 11.4 11.5 9.7 17.6 6.0 22.3 9.0 7.5 16.7 15.9 13.2 6.3 7.2 0.0 37.1 13.5 20.0 15.3 3.2 19.8 13.4 17.5 4.5 25.5 17.7 10.5 11.0 13.4 11.0 13.5 8.5 16.0 10.3 11.4 33.7 24.7 5.5 12.5 7.0 12.2 17.9 8.3 13.4 2.9 11.9 17.9 17.6 13.8 1.8 1.7 0.4 1.3 0.3 0.5 0.4 0.4 1.9 0.0 0.3 0.2 0.1 0.5 2.6 0.6 0.8 0.4 4.3 4.9 4.4 5.5 4.1 4.4 4.9 4.4 4.9 4.6 4.7 5.7 4.0 16.0 6.7 18.3 1.0 5.0 5.3 5.6 8.0 5.3 11.3 5.8 7.3 5.7 8.5 9.2 0.0 8.3 0.9 8.0 9.8 4.1 22.5 6.9 5.5 3.0 0.0 22.7 10.4 5.2 9.1 4.3 9.7 6.0 0.0 7.1 2.9 10.9 8.4 3.3 10.6 9.6 6.1 8.2 4.1 14.7 6.2 5.8 1.8 5.6 6.7 5.0 3.1 10.6 20.3 4.7 6.6 5.3 2.8 4.5 7.5 6.8 12.6 3.5 0.0 5.6 3.5 39.3 20.0 9.7 3.7 3.7 2.5 4.5 8.5 5.7 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064522-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 9 "myeloid DC: 2.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2" "Not detected" "Not detected" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 15: RT4 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favorable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favorable (9.38e-4)" 0.5 0.1 1.5 0.3 2.4 0.0 1.0 0.9 1.4 2.5 1.2 1.9 5.3 1.3 0.6 0.7 11.1 12.3 5.3 1.0 2.4 5.6 10.2 0.9 1.0 1.8 2.1 0.9 34.2 2.2 1.3 0.2 1.9 2.7 3.3 2.3 1.3 2.3 0.0 0.7 1.5 0.5 1.1 0.2 12.6 2.4 4.7 0.7 0.6 0.0 0.7 1.9 0.5 1.3 0.0 7.3 0.0 0.0 0.1 0.0 4.7 4.6 1.8 2.3 1.8 0.1 2.4 0.0 6.0 1.2 3.6 0.4 8.0 0.2 2.8 0.0 11.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.0 14.7 0.0 0.0 0.1 0.2 0.0 0.8 1.6 0.2 2.8 0.0 0.0 0.2 7.5 18.2 4.1 0.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 2.4 0.9 1.4 1.0 2.4 1.8 2.1 1.9 1.1 4.7 1.3 0.0 3.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.2 2.1 1.3 8.0 100.1 3.1 7.3 0.0 0.3 0.0 1.6 0.0 57.6 0.3 27.8 0.6 0.8 18.0 0.0 1.1 18.4 1.8 0.2 7.7 7.7 0.0 4.3 0.4 2.6 0.1 0.0 1.6 2.4 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.1 8.0 0.0 0.5 0.1 14.8 1.6 0.0 0.0 2.5 0.7 24.5 39.4 0.1 0.0 0.2 1.0 0.2 4.7 1.1 0.0 0.1 0.2 0.7 3.6 2.6 ERMAP "BTN5, RD, SC" ENSG00000164010 "Erythroblast membrane associated protein (Scianna blood group)" Q96PL5 1 42817122-42844991 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 38.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA042573, HPA054672" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus" Cytosol "HPA042573: AB_10794282, HPA054672: " "unprognostic (9.46e-2)" "unprognostic (4.47e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-1)" "unprognostic (6.09e-2)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (7.48e-2)" "unprognostic (2.71e-3)" "unprognostic (6.46e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (8.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.48e-1)" "unprognostic (9.48e-2)" 8.0 9.2 3.9 4.7 4.2 30.5 8.3 3.8 4.6 8.6 4.8 7.3 6.5 6.0 15.8 7.2 10.1 7.5 4.3 3.8 5.0 7.1 13.2 7.2 4.9 5.0 4.5 5.5 9.5 8.4 5.8 5.9 4.4 7.8 8.1 4.3 8.6 6.2 2.3 9.3 6.1 6.3 4.4 5.2 7.8 4.1 4.8 5.3 13.0 3.6 5.4 5.5 3.9 5.0 5.2 7.1 2.1 7.0 7.7 22.4 2.0 10.5 17.8 9.3 9.3 2.9 9.6 4.6 3.5 11.2 4.4 6.5 2.4 3.2 8.3 7.8 8.2 38.3 5.2 2.3 9.5 5.2 18.8 13.7 11.8 4.3 9.9 16.8 6.1 5.6 26.4 4.7 8.6 3.6 2.3 1.6 5.1 3.3 3.8 2.6 2.8 4.3 8.0 8.1 4.7 3.2 9.0 3.3 4.0 3.7 6.6 19.6 9.6 6.9 3.9 5.9 4.8 1.8 4.4 2.0 5.6 5.8 4.4 0.0 4.3 2.1 1.2 4.5 0.6 1.3 1.2 0.9 5.1 0.7 1.0 1.0 1.3 2.2 3.0 1.0 3.2 1.9 3.9 4.2 3.8 4.6 3.8 5.0 5.0 4.5 4.4 4.4 4.8 5.0 2.4 12.8 10.9 9.8 2.9 3.8 2.9 3.2 6.2 1.8 6.6 6.3 2.2 4.3 6.2 3.7 22.9 3.1 4.4 4.8 1.9 3.6 4.3 4.7 6.2 3.3 5.4 81.7 5.5 7.2 1.6 3.6 6.1 5.6 2.5 10.4 3.6 12.9 7.8 11.8 2.2 4.4 0.0 11.7 2.9 25.7 2.8 7.4 5.4 14.0 7.1 4.8 1.0 9.5 10.6 4.8 3.9 4.1 2.1 2.9 3.5 4.0 6.5 4.5 0.0 4.7 2.6 0.1 0.7 5.7 3.8 2.9 2.3 7.4 5.5 2.3 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;intestine: 11.0;lymphoid tissue: 8.5;testis: 5.7" "Group enriched" "Detected in many" 4 "Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 0.5 0.4 0.0 2.7 0.2 6.0 1.2 0.4 0.2 0.5 0.0 3.7 11.0 0.6 0.0 2.4 0.2 0.6 0.2 0.0 0.0 0.1 0.7 0.4 4.6 0.0 0.0 0.1 1.0 0.3 0.0 1.1 0.1 0.3 4.3 0.5 0.3 0.1 0.0 1.1 7.9 0.7 0.0 0.8 2.5 5.7 0.0 8.5 0.3 0.2 5.7 0.8 0.5 0.2 54.6 39.9 17.9 22.0 2.3 3.9 10.2 31.6 12.9 27.8 32.5 14.2 10.7 21.0 16.6 8.3 24.7 29.2 22.0 8.5 43.6 15.8 9.2 24.4 16.2 15.3 0.3 12.5 21.4 0.7 0.9 17.0 4.2 3.0 11.6 15.2 20.0 30.0 17.7 10.5 49.8 5.9 12.2 29.9 13.4 21.7 53.0 14.8 9.6 31.9 8.0 11.7 15.5 19.6 7.9 6.5 13.2 14.1 5.2 17.9 37.0 36.2 25.7 4.0 11.1 25.2 10.2 20.5 25.2 0.0 0.2 0.1 0.0 0.4 0.0 0.4 0.2 0.2 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.0 1.3 0.3 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 4.7 0.0 2.4 2.3 0.6 2.1 1.8 1.2 1.5 1.7 1.2 0.0 3.3 0.0 4.2 4.6 1.3 8.2 0.0 0.4 5.4 1.3 2.6 1.0 1.2 44.6 0.3 0.0 6.6 3.2 5.6 3.1 1.3 11.4 1.4 1.5 5.4 0.0 0.4 4.4 2.0 2.5 3.5 0.8 1.8 3.2 0.0 1.0 0.5 0.1 4.1 1.0 0.9 0.1 1.5 0.0 11.5 0.6 15.1 0.1 1.6 2.0 6.6 0.8 2.3 62.0 80.0 6.8 0.6 1.0 3.1 1.8 8.0 1.4 ESD ENSG00000139684 "Esterase D" P10768 13 46771256-46797420 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 569.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039700 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 12000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039700: AB_10697553" "unprognostic (3.05e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (7.66e-2)" "unprognostic (1.75e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.73e-2)" "unprognostic (3.31e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (2.91e-2)" "unprognostic (2.71e-2)" "unprognostic (2.18e-1)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" 123.8 87.5 83.0 73.0 85.5 95.1 146.7 86.3 110.8 141.0 87.7 125.7 106.7 129.7 160.1 93.6 121.8 96.4 151.5 84.3 98.6 194.4 277.2 92.3 93.5 87.3 85.6 179.0 67.3 109.9 81.5 81.9 89.7 112.5 135.0 122.0 92.8 140.3 149.8 83.3 93.4 166.2 94.3 63.9 83.0 54.2 82.4 155.7 155.0 179.0 110.3 104.9 96.2 100.0 138.4 77.9 229.8 160.4 264.5 441.9 62.5 190.8 280.9 264.7 204.6 131.6 162.8 156.5 56.9 233.3 194.0 137.1 256.8 227.2 333.0 180.4 270.4 200.3 70.7 208.6 220.5 400.1 82.2 304.6 207.0 167.9 229.4 316.2 253.2 260.3 200.3 40.7 433.5 135.1 352.7 260.0 59.8 175.2 148.8 277.1 133.6 106.2 378.4 55.4 115.0 130.1 85.0 72.6 160.3 157.6 137.1 223.0 169.2 94.4 113.0 187.5 181.8 27.6 63.5 135.7 205.3 223.2 131.2 35.0 129.4 55.7 48.5 113.6 80.9 104.1 97.6 76.3 142.8 83.4 114.1 90.5 15.0 109.3 106.1 170.7 90.6 100.3 83.0 85.5 86.3 110.8 84.3 98.6 87.3 85.6 89.7 94.3 82.4 100.0 139.0 54.5 56.8 37.5 77.2 134.1 227.4 300.5 148.0 51.5 114.1 123.2 99.2 167.3 111.7 154.5 41.7 160.4 51.2 59.1 360.0 168.0 135.5 102.2 120.6 112.5 108.8 99.5 22.7 103.2 141.0 162.9 51.0 80.7 96.4 71.1 132.1 154.7 227.5 21.9 19.3 114.6 175.0 140.2 148.0 34.8 267.8 108.2 165.4 25.3 144.3 199.5 36.0 23.6 36.2 85.4 92.3 211.4 35.9 99.1 137.1 569.1 94.2 77.3 151.2 196.0 484.2 61.6 46.3 120.6 129.3 74.4 78.2 151.2 199.8 143.6 EVI5 NB4S ENSG00000067208 "Ecotropic viral integration site 5" O60447 1 92508696-92792404 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027339 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 15: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" Vesicles "HPA027339: AB_1848308" "unprognostic (1.23e-1)" "unprognostic (2.84e-1)" "unprognostic (4.29e-3)" "unprognostic (1.65e-1)" "unprognostic (4.94e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-3)" "unprognostic (7.43e-2)" "unprognostic (1.12e-1)" "unprognostic (9.11e-2)" "unprognostic (9.04e-3)" "unprognostic (2.25e-1)" "unprognostic (6.15e-2)" "unprognostic (8.30e-2)" "unprognostic (5.40e-1)" "unprognostic (6.38e-2)" "unprognostic (2.35e-2)" 5.7 8.1 5.9 4.5 8.3 2.7 4.4 8.5 5.8 5.9 8.2 4.8 4.3 6.4 4.6 4.0 5.1 5.8 7.1 4.2 7.7 5.0 16.4 7.1 3.2 8.1 6.2 3.8 3.8 7.9 3.9 12.1 6.8 5.3 5.5 4.9 4.5 5.6 2.9 5.0 4.0 7.1 8.6 4.5 6.4 9.6 6.3 1.3 6.6 3.6 3.3 5.5 3.8 10.9 5.4 5.9 9.1 8.9 14.5 18.2 8.6 12.2 18.5 8.2 9.4 10.4 1.4 2.4 16.8 14.0 15.2 6.1 8.6 9.0 14.6 0.2 3.3 4.3 5.6 6.2 14.2 3.1 4.8 11.5 7.2 14.2 8.5 23.9 17.9 0.2 7.7 3.8 13.9 2.7 0.3 3.6 2.6 3.5 4.8 2.2 21.7 3.2 6.3 15.5 3.4 7.0 14.4 7.4 16.6 9.8 3.6 7.1 11.8 9.1 6.6 12.2 8.1 5.5 3.4 3.8 6.0 5.0 7.6 0.9 2.7 2.8 0.1 1.9 0.0 1.2 0.1 0.0 1.3 1.2 0.0 0.0 3.4 0.1 2.9 0.8 0.0 0.4 5.9 8.3 8.5 5.8 4.2 7.7 8.1 6.2 6.8 8.6 6.3 10.9 27.2 60.9 29.9 91.4 18.7 43.5 29.3 23.0 18.2 24.5 20.5 17.7 51.8 22.8 32.3 16.5 25.0 48.4 7.5 22.9 17.6 27.9 3.0 67.8 39.4 31.2 22.1 11.4 158.4 29.9 26.0 42.5 42.3 26.2 13.3 21.9 43.2 52.4 32.2 30.3 149.3 27.0 14.2 54.0 27.0 5.8 28.3 45.1 26.6 114.3 48.9 28.5 5.2 112.6 199.6 68.4 19.3 54.2 28.8 28.1 21.8 20.1 46.9 25.4 13.1 51.4 56.4 37.4 42.4 21.2 50.0 65.5 5.5 60.9 20.0 32.1 EXOC3L2 "FLJ36147, XTP7" ENSG00000283632 "Exocyst complex component 3 like 2" 19 45212370-45245407 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 19.0;thyroid gland: 17.9" "Group enriched" "Detected in some" 4 "Adipocytes: 15.3;Endothelial cells: 17.7;Hepatic stellate cells: 51.4;Theca cells: 21.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEL: 19.1;K-562: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041595, HPA061110" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Nucleoplasm, Golgi apparatus, Cytosol" "HPA041595: AB_10794521, HPA061110: AB_2684431" 4.3 8.3 0.3 2.1 0.6 1.6 2.9 0.5 0.4 4.0 1.6 2.7 2.4 4.9 0.4 1.9 2.8 2.3 2.3 0.4 0.3 19.0 2.7 2.7 1.1 0.7 0.5 0.9 2.7 3.3 5.0 0.4 0.5 5.2 0.7 0.1 1.8 2.2 0.9 2.1 3.2 1.9 0.3 8.3 2.9 3.3 0.4 0.4 17.9 0.3 0.5 3.2 2.4 0.7 0.1 0.3 2.5 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.1 2.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.1 19.1 0.6 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 16.6 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.5 1.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.1 1.0 0.1 0.3 0.6 0.8 1.5 0.2 0.1 0.2 0.1 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.4 0.4 0.3 0.7 0.5 0.5 0.3 0.4 0.7 15.3 0.0 1.3 0.7 0.7 0.4 0.3 0.0 0.0 0.7 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 17.7 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.2 0.0 0.4 51.4 0.3 0.0 0.0 1.1 0.6 0.0 1.6 0.0 0.0 1.8 2.8 0.0 0.0 0.1 0.2 2.1 0.5 0.7 0.0 0.0 1.9 0.1 0.2 0.1 0.1 0.0 0.2 0.0 0.3 0.6 0.4 6.2 0.2 0.9 0.0 0.1 21.2 0.0 0.3 EXT2 SOTV ENSG00000151348 "Exostosin glycosyltransferase 2" Q93063 11 44095673-44251962 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease variant, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078409 Supported "Golgi apparatus" NA NA 39000000 "Cluster 27: Non-specific - Gene expression" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA078409: AB_2686884" "unprognostic (5.87e-2)" "unprognostic (3.05e-3)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.77e-3)" "unprognostic (2.22e-2)" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.70e-2)" "prognostic unfavorable (5.36e-6)" "unprognostic (7.07e-3)" "unprognostic (2.97e-1)" "unprognostic (3.85e-1)" "unprognostic (1.36e-2)" 33.5 22.8 14.4 22.1 15.4 11.2 29.3 15.4 16.3 36.1 17.5 29.1 26.5 43.1 33.3 20.1 33.7 28.1 27.3 15.6 18.1 26.5 26.9 27.9 16.0 15.5 16.0 33.5 26.5 28.9 20.1 61.9 15.5 29.8 28.7 20.9 26.7 30.2 16.2 25.8 31.0 49.3 14.7 21.6 23.8 21.6 19.4 15.2 27.6 18.4 17.3 29.7 28.5 16.1 57.9 71.6 38.3 121.5 170.4 124.2 60.8 181.1 198.0 93.1 125.1 51.2 36.5 40.4 82.1 188.8 98.5 90.0 41.0 114.0 110.0 83.2 71.5 38.4 33.7 39.7 67.5 37.5 76.6 97.7 73.4 56.3 86.6 108.8 132.7 34.8 50.0 63.9 68.4 40.3 25.9 22.3 43.8 67.1 70.9 32.3 116.1 21.1 53.9 49.1 30.9 35.5 118.1 41.4 28.1 67.0 69.8 37.2 137.8 127.4 90.6 133.1 111.4 33.4 46.0 30.4 84.7 27.9 140.0 15.2 17.5 19.4 20.9 17.7 23.5 9.0 16.5 19.3 21.3 8.8 15.4 15.2 3.4 26.3 12.8 7.4 14.2 15.5 14.4 15.4 15.4 16.3 15.6 18.1 15.5 16.0 15.5 14.7 19.4 16.1 24.5 16.0 10.6 41.4 8.7 15.2 17.3 22.0 10.8 11.5 11.0 11.4 10.2 8.6 13.5 12.9 14.6 34.3 10.6 21.1 5.9 33.5 43.2 7.9 17.1 19.2 1.8 6.7 64.3 23.7 37.0 32.3 7.7 11.5 6.3 22.7 22.9 18.3 18.3 13.5 63.3 12.9 12.2 10.8 7.2 23.0 27.4 10.4 5.4 28.1 10.2 17.4 7.2 50.3 51.8 24.0 14.9 28.6 7.0 23.6 31.6 8.2 8.1 15.0 19.7 15.8 20.7 51.2 24.4 10.2 12.6 35.3 9.2 12.2 15.0 15.3 F5 ENSG00000198734 "Coagulation factor V" P12259 1 169511951-169586588 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "choroid plexus: 142.8;liver: 176.2;placenta: 46.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5" "Cancer enriched" "Detected in many" 7 "liver cancer: 69.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2" "Group enriched" "Detected in many" 13 "granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2" "Group enriched" "Detected in some" 23 "Hep G2: 32.8;OE19: 125.5" "Group enriched" "Detected in many" 5 "basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4" "Group enriched" "Detected in all" 7 "amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6" HPA002036 Approved "Golgi apparatus" "Secreted to blood" NA NA 7670000000 13000000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA002036: AB_1078787" "unprognostic (3.67e-2)" "unprognostic (2.77e-4)" "unprognostic (5.42e-2)" "unprognostic (2.56e-4)" "unprognostic (2.03e-1)" "unprognostic (2.39e-4)" "unprognostic (3.46e-3)" "unprognostic (9.25e-3)" "unprognostic (2.02e-1)" "unprognostic (8.99e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.15e-2)" "unprognostic (3.41e-1)" "unprognostic (4.31e-1)" 1.1 0.0 0.3 3.2 1.4 3.7 0.6 4.4 1.3 0.1 142.8 0.3 0.9 0.1 0.2 0.2 3.5 17.6 2.7 4.4 1.6 1.5 176.2 0.9 2.2 1.9 2.2 0.0 0.8 0.0 1.6 46.9 2.4 1.3 0.6 1.0 6.2 0.0 0.2 1.3 0.3 1.1 0.8 1.8 4.9 0.5 2.2 0.5 0.4 0.2 2.3 3.8 0.1 4.2 0.0 0.6 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.2 1.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 32.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 125.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 4.1 8.1 0.0 0.2 0.0 0.0 1.4 0.2 0.4 0.0 0.3 0.0 7.0 0.0 0.0 0.0 6.2 1.1 0.3 1.4 4.4 1.3 4.4 1.6 1.9 2.2 2.4 0.8 2.2 4.2 0.0 3.2 0.6 1.6 0.7 0.1 6.1 0.0 0.0 0.3 0.7 0.3 9.4 74.4 1.9 0.0 2.1 82.7 0.1 0.3 0.0 2.4 2.4 0.9 0.0 2.4 25.2 0.0 5.4 0.2 2.3 5.3 4.1 0.2 0.0 2.8 3.6 253.4 5.3 0.0 2.6 0.1 0.0 12.3 0.4 0.3 0.0 7.1 3.6 0.0 18.2 1.0 2.1 0.5 1.0 1.9 0.0 0.0 0.1 1.8 0.0 0.2 3.1 0.1 0.0 2.4 0.2 0.5 0.5 0.0 0.0 59.5 2.5 0.0 0.0 11.8 FABP3 "FABP11, H-FABP, MDGI, O-FABP" ENSG00000121769 "Fatty acid binding protein 3" P05413 1 31365253-31376850 "Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "heart muscle: 5666.1;skeletal muscle: 2202.5;tongue: 1442.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 629.8;Cardiomyocytes: 2495.2;Distal tubular cells: 452.0;Proximal tubular cells: 703.6" "Cancer enhanced" "Detected in all" "renal cancer: 92.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "ASC TERT1: 215.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017830, HPA055754" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Focal adhesion sites" NA NA 1640000 3000000 "Cluster 22: NK-cells - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 30: Mammary glandular cells - Lactation" "Focal adhesion sites" "Golgi apparatus, Plasma membrane" "CAB017830: , HPA055754: AB_2682909" "unprognostic (2.07e-2)" "unprognostic (2.50e-2)" "unprognostic (1.32e-3)" "unprognostic (1.73e-2)" "unprognostic (2.05e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-3)" "unprognostic (1.04e-1)" "unprognostic (6.86e-2)" "unprognostic (1.18e-1)" "unprognostic (2.85e-1)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-7)" "unprognostic (5.80e-3)" "unprognostic (3.45e-1)" "unprognostic (7.38e-3)" "unprognostic (9.76e-3)" 31.4 63.5 33.7 2.1 39.2 1.6 95.4 42.3 51.5 40.4 14.8 16.3 0.8 93.9 6.4 9.5 37.2 3.7 5666.1 52.0 37.3 229.8 6.6 26.4 3.4 50.5 38.3 20.3 2.2 0.3 9.0 2.8 55.2 48.9 4.8 17.8 46.5 52.2 2202.5 16.3 7.5 44.2 31.4 28.8 60.3 15.3 36.1 2.3 6.8 1442.4 1.4 12.5 32.5 36.8 1.0 0.4 8.8 1.1 50.6 215.0 2.0 2.6 17.3 0.3 6.6 1.3 1.9 1.6 17.8 5.2 0.3 2.1 2.5 0.0 0.5 0.8 3.7 1.8 2.7 5.3 2.2 1.7 0.5 16.9 0.0 3.9 0.0 2.5 0.0 1.4 2.2 0.5 2.2 0.5 0.7 1.5 11.4 0.9 3.1 0.4 5.7 0.6 4.1 0.7 2.1 0.5 1.5 0.7 28.4 13.2 0.9 3.1 1.7 1.0 1.0 6.0 1.3 1.0 2.3 1.3 2.9 1.5 1.7 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.3 0.1 0.2 0.1 0.4 0.0 0.2 0.1 0.1 0.1 0.1 33.7 39.2 42.3 51.5 52.0 37.3 50.5 38.3 55.2 31.4 36.1 36.8 4.9 0.0 1.7 2.9 7.7 3.6 1.5 0.4 0.0 6.1 629.8 13.2 2495.2 2.8 1.3 27.6 2.1 3.8 2.1 0.4 452.0 0.4 2.5 0.4 0.5 25.6 0.0 0.0 16.1 0.4 1.4 67.2 1.1 3.1 1.3 43.8 2.2 0.1 114.7 8.4 14.6 0.1 0.0 27.8 10.3 5.4 6.8 19.1 8.8 3.7 0.0 2.6 0.0 3.5 8.9 0.3 12.3 7.9 0.1 6.8 0.1 703.6 1.5 10.2 0.0 14.9 40.7 2.9 0.2 0.2 3.0 1.6 5.1 97.9 0.3 36.5 FABP7 "B-FABP, BLBP" ENSG00000164434 "Fatty acid binding protein 7" O15540 6 122779716-122784074 "Metabolic proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 366.1;choroid plexus: 164.8;retina: 175.3;tongue: 199.3" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 1407.3" "Group enriched" "Detected in many" 6 "glioma: 139.3;renal cancer: 51.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AF22: 105.5;U-251 MG: 28.8;WM-115: 63.7" "Region enriched" "Detected in all" 5 "olfactory bulb: 1195.2" "Low region specificity" "Detected in all" "CAB025488, HPA028825, CAB058697" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 58: Brain - Synaptic function" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "Golgi apparatus, Cytosol" "CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130" "prognostic favorable (2.49e-4)" "unprognostic (1.56e-2)" "unprognostic (2.53e-3)" "unprognostic (5.80e-2)" "unprognostic (2.29e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (1.65e-6)" "unprognostic (9.83e-2)" "unprognostic (1.30e-2)" "unprognostic (2.50e-1)" "unprognostic (8.66e-2)" 1.9 0.4 184.8 0.1 210.5 0.3 38.0 228.1 366.1 1.2 164.8 0.7 0.1 0.1 0.2 0.8 0.1 0.1 0.3 198.7 176.2 0.8 0.3 0.0 0.1 188.0 175.5 0.1 0.1 0.0 8.0 0.4 171.2 0.3 0.1 175.3 8.8 3.9 8.8 41.8 0.1 0.0 170.8 0.0 0.4 0.2 174.0 1.8 0.0 199.3 0.1 0.2 0.4 182.9 0.0 0.1 105.5 0.0 0.0 0.0 3.8 0.0 0.9 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.0 0.1 0.2 0.1 0.2 0.0 0.1 28.8 0.0 0.0 0.0 1.2 0.1 63.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 184.8 210.5 228.1 366.1 198.7 176.2 188.0 175.5 171.2 170.8 174.0 182.9 0.1 0.0 0.0 14.0 0.0 12.2 0.3 0.0 0.0 11.6 44.5 38.9 1.3 0.0 0.0 0.0 12.5 4.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 2.9 0.0 228.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 5.0 1.1 0.0 0.0 0.0 1.4 0.0 0.0 0.1 30.2 0.0 0.0 1407.3 0.0 41.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 48.0 0.0 0.5 0.3 0.0 0.3 0.0 18.9 7.1 0.3 0.0 0.0 0.0 FAM107B "C10orf45, FLJ45505, HITS, MGC11034" ENSG00000065809 "Family with sequence similarity 107 member B" Q9H098 10 14518557-14774897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 526.5;Proximal tubular cells: 359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 63.8;NK-cells: 53.8;T-cells: 106.2" "Cell line enhanced" "Detected in all" "Daudi: 373.0;HDLM-2: 449.6;Karpas-707: 309.6;THP-1: 294.4" "Low region specificity" "Detected in all" "HPA039661, HPA058814, HPA073195" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 15000 "Cluster 20: T-cells - T-cell receptor" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Golgi apparatus" "HPA039661: AB_10794751, HPA058814: AB_2683825, HPA073195: AB_2732221" "unprognostic (1.24e-1)" "unprognostic (1.91e-2)" "unprognostic (1.15e-1)" "unprognostic (1.80e-2)" "unprognostic (8.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.67e-1)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (6.82e-2)" "unprognostic (5.60e-2)" "unprognostic (4.63e-1)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (6.93e-2)" "unprognostic (7.01e-2)" "unprognostic (3.53e-2)" 48.4 44.7 82.3 90.2 150.8 171.5 44.3 112.4 112.5 42.2 90.8 64.2 32.7 48.2 11.4 22.8 20.6 66.1 11.1 84.2 102.1 119.6 147.3 64.8 152.3 136.8 125.9 7.3 70.6 70.0 21.3 22.2 130.7 27.6 42.5 15.2 68.6 113.7 3.5 22.2 55.9 31.4 95.5 50.6 122.8 37.3 118.7 48.0 12.6 9.3 134.0 66.7 17.1 223.6 60.8 129.1 50.3 3.4 7.6 1.7 21.3 59.7 85.8 35.9 25.6 79.9 49.9 373.0 52.8 27.5 13.4 18.6 16.1 36.4 63.5 449.6 13.9 10.3 55.6 95.0 26.7 136.6 23.3 4.2 28.0 14.9 7.2 42.4 154.6 72.5 1.1 309.6 28.2 15.6 33.6 39.5 12.5 72.7 28.2 240.8 39.1 140.2 81.9 39.0 18.7 53.5 23.6 12.4 39.0 44.7 46.0 294.4 50.8 37.0 31.2 118.3 20.3 136.2 131.7 241.3 6.5 117.5 10.1 52.3 6.0 63.8 100.2 7.1 97.7 12.4 79.4 85.0 5.2 12.6 105.7 106.2 25.2 53.8 14.9 3.5 78.0 74.8 82.3 150.8 112.4 112.5 84.2 102.1 136.8 125.9 130.7 95.5 118.7 223.6 12.8 105.8 44.4 7.2 203.6 89.7 147.1 25.4 16.5 4.8 94.6 30.4 4.1 134.4 52.5 286.9 2.1 18.1 194.7 65.9 223.0 44.3 27.0 234.9 98.7 37.8 14.3 22.7 1.6 106.8 38.2 49.7 175.3 268.2 119.2 32.7 72.8 177.4 37.1 201.9 7.3 110.5 36.7 53.9 120.9 53.2 2.5 110.7 51.6 15.0 68.8 13.6 198.8 11.1 526.5 90.3 44.3 4.9 176.6 139.6 25.9 359.9 85.3 15.0 0.0 5.4 64.6 56.2 35.7 8.3 82.3 62.5 237.7 3.8 39.9 240.2 FAM114A1 Noxp20 ENSG00000197712 "Family with sequence similarity 114 member A1" Q8IWE2 4 38867677-38945739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.6;granulocytes: 2.4;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 204.7;BJ hTERT+: 244.1;fHDF/TERT166: 273.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067948, HPA069104, HPA069701" Uncertain Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 96000 "Cluster 7: Monocytes - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus, Cytosol" Nucleoplasm "HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175" "unprognostic (2.13e-3)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (4.66e-2)" "unprognostic (9.40e-3)" "unprognostic (6.77e-2)" "unprognostic (2.54e-1)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.63e-6)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (3.44e-3)" 28.4 48.1 7.9 23.6 11.8 2.0 20.2 7.8 9.2 48.4 23.7 34.6 22.9 29.2 17.8 35.1 19.5 36.4 23.7 9.9 11.4 11.8 54.2 21.2 8.9 13.7 12.5 41.5 25.6 22.4 18.5 35.6 11.2 35.5 33.7 3.1 61.2 27.8 16.6 15.6 24.4 61.7 9.0 8.8 34.4 12.5 12.1 4.3 17.6 22.7 19.5 35.6 26.4 13.4 43.5 30.7 18.5 21.9 197.4 204.7 6.1 167.9 244.1 69.7 105.8 8.1 33.0 0.0 23.0 273.8 118.8 11.9 0.1 53.7 80.1 0.2 4.6 3.1 30.3 40.6 70.6 0.1 5.8 122.1 17.0 101.2 23.3 157.2 101.4 0.1 3.4 0.2 102.9 11.0 0.1 2.3 3.8 18.3 15.6 0.8 90.9 3.2 23.4 8.7 0.7 9.4 33.8 0.7 33.8 42.8 20.8 3.8 156.3 75.4 34.8 95.3 39.5 0.7 0.2 0.3 123.3 3.3 63.0 0.6 3.2 0.0 0.1 3.6 0.0 0.4 0.1 0.1 2.6 0.1 0.1 0.1 2.4 0.0 1.4 0.3 0.0 0.9 7.9 11.8 7.8 9.2 9.9 11.4 13.7 12.5 11.2 9.0 12.1 13.4 28.1 16.0 13.2 5.9 2.2 12.2 47.4 43.7 15.4 0.3 29.9 21.2 17.2 14.3 56.0 7.3 0.0 2.2 0.2 46.8 9.8 45.6 1.0 17.5 88.6 35.2 15.7 3.6 1.0 61.0 47.0 94.9 35.7 39.1 1.3 30.4 31.1 68.3 16.1 0.0 1.8 78.7 83.4 7.2 15.0 6.3 110.9 8.7 21.4 17.8 6.4 12.2 0.0 14.6 31.0 47.6 41.6 116.2 8.5 92.6 39.0 11.7 47.8 1.2 19.7 49.4 44.3 1.2 5.5 23.6 10.2 3.4 3.1 94.1 32.0 82.7 FAM149A "DKFZP564J102, MST119, MSTP119" ENSG00000109794 "Family with sequence similarity 149 member A" A5PLN7 4 186104419-186172667 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 50.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Microglial cells: 41.2;Muller glia cells: 29.1;Rod photoreceptor cells: 35.5" "Cancer enhanced" "Detected in many" "renal cancer: 9.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 11.1;JURKAT: 8.3;MOLT-4: 8.5;RT4: 9.6;SCLC-21H: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044019, HPA055004" Uncertain Approved "Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA044019: AB_2732513, HPA055004: AB_2682667" "unprognostic (1.80e-2)" "unprognostic (8.44e-2)" "unprognostic (4.64e-2)" "prognostic favorable (2.67e-6)" "unprognostic (7.08e-2)" "unprognostic (9.12e-2)" "unprognostic (1.41e-3)" "unprognostic (1.06e-1)" "unprognostic (2.52e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.81e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-1)" "unprognostic (2.36e-1)" 11.8 5.1 22.7 1.6 25.5 0.1 6.0 20.1 26.5 7.4 25.9 13.0 5.7 7.4 11.9 11.2 13.7 14.8 7.2 28.7 22.0 35.7 50.4 5.4 1.4 23.4 22.7 7.5 25.7 9.4 5.7 2.2 23.2 9.5 7.6 26.6 9.9 16.0 10.0 2.7 5.2 7.2 23.0 2.3 14.8 5.2 24.7 2.1 3.4 11.4 1.7 11.1 5.4 23.2 0.0 3.3 2.9 0.1 11.1 4.5 0.1 0.0 0.0 0.3 0.3 0.0 1.9 0.0 1.6 1.5 2.9 0.0 5.3 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.7 0.1 0.2 2.0 0.3 0.2 0.0 1.1 0.0 8.3 0.0 2.5 1.3 1.7 8.5 0.4 5.1 0.0 0.0 0.3 0.0 2.1 1.7 9.6 14.2 3.9 0.1 0.0 4.7 0.9 1.0 0.0 0.9 0.2 1.6 0.0 1.7 0.0 0.1 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.2 0.0 22.7 25.5 20.1 26.5 28.7 22.0 23.4 22.7 23.2 23.0 24.7 23.2 1.8 0.0 1.5 8.1 0.5 0.5 2.4 0.4 1.2 11.8 0.6 1.0 8.5 22.8 4.4 5.5 45.9 0.7 0.0 1.6 5.9 9.5 15.3 17.4 3.7 1.8 9.5 2.7 8.8 5.4 0.9 5.0 4.1 16.7 0.0 0.4 1.4 13.8 0.2 1.7 12.4 3.7 2.0 1.3 1.8 5.6 3.4 2.6 3.6 41.2 0.0 29.1 0.0 7.5 0.5 5.0 4.0 4.1 2.9 2.3 0.8 8.5 11.1 35.5 6.6 2.5 3.3 1.0 4.7 1.6 0.3 0.8 1.1 0.1 3.3 2.8 FAM174A "NS5ATP6, TMEM157, UNQ1912" ENSG00000174132 "Family with sequence similarity 174 member A" Q8TBP5 5 100535374-100586741 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 154.5;Respiratory ciliated cells: 222.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 7 "neutrophil: 55.8" "Lineage enriched" "Detected in all" 10 "granulocytes: 55.8" "Cell line enhanced" "Detected in all" "U-266/84: 61.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019539 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" Cytosol "HPA019539: AB_2293743" "unprognostic (2.34e-1)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (9.02e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (5.55e-3)" "unprognostic (3.06e-1)" "unprognostic (2.60e-1)" "unprognostic (3.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.73e-2)" "unprognostic (7.69e-2)" "prognostic favorable (5.48e-4)" "unprognostic (1.74e-1)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" 16.1 23.1 13.0 8.1 14.4 2.8 15.3 13.4 16.5 11.4 23.3 12.6 11.2 12.1 12.1 24.3 34.8 7.5 19.5 13.8 18.6 17.3 15.7 17.2 5.6 13.9 14.0 10.1 22.6 29.3 27.4 15.1 14.9 18.2 8.5 16.8 17.4 11.8 42.8 30.3 10.3 8.0 13.9 10.2 15.5 22.0 14.6 5.3 13.6 24.7 5.4 13.0 16.9 14.6 10.3 10.7 4.3 13.6 10.3 8.4 15.1 23.1 12.9 9.3 12.7 2.2 13.1 1.8 46.2 10.1 16.2 8.6 3.6 15.1 7.0 12.8 10.9 1.3 18.6 6.4 13.9 5.3 12.4 10.7 35.4 7.2 5.5 21.3 14.3 5.3 3.8 13.7 15.9 20.7 1.6 11.1 2.4 1.2 29.1 3.6 16.2 18.2 17.0 12.3 8.6 23.4 16.2 14.5 13.7 5.0 13.9 11.5 16.1 11.7 7.4 19.0 18.5 44.3 61.5 2.4 14.5 7.1 10.4 7.9 4.9 7.1 3.3 5.5 5.1 2.8 3.3 4.0 4.4 3.3 2.9 3.8 55.8 5.5 5.7 4.4 4.4 3.3 13.0 14.4 13.4 16.5 13.8 18.6 13.9 14.0 14.9 13.9 14.6 14.6 40.8 32.1 31.8 13.1 13.8 88.1 31.4 80.3 43.3 29.7 57.3 31.2 17.4 34.3 54.7 29.5 4.2 44.5 10.0 17.8 43.0 30.6 33.2 154.5 13.8 27.1 34.8 20.6 26.0 30.0 40.3 26.9 18.8 25.3 13.3 8.1 35.0 30.6 23.5 30.3 38.3 32.3 85.5 16.8 22.1 10.1 18.0 14.1 49.8 15.9 17.1 75.4 6.2 19.1 25.1 30.2 23.3 24.5 60.7 28.1 23.2 40.0 222.5 42.3 13.1 48.7 24.3 91.5 20.7 59.6 115.1 50.3 13.8 18.4 18.9 43.1 FAM174C "C19orf24, FLJ20640" ENSG00000228300 "Family with sequence similarity 174 member C" Q9BVV8 19 1275530-1279244 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 89.9;Extravillous trophoblasts: 148.9;Hofbauer cells: 121.6;Syncytiotrophoblasts: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043279, HPA047026" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles" "Golgi apparatus" "HPA043279: AB_10794656, HPA047026: AB_2679906" "unprognostic (1.10e-1)" "unprognostic (3.39e-1)" "unprognostic (1.12e-1)" "unprognostic (1.65e-3)" "unprognostic (7.05e-2)" "unprognostic (4.90e-1)" "unprognostic (4.23e-3)" "unprognostic (3.12e-2)" "unprognostic (1.18e-1)" "unprognostic (3.59e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (2.54e-3)" "unprognostic (2.16e-1)" "unprognostic (1.10e-1)" "unprognostic (2.25e-2)" 43.0 73.4 32.9 27.6 34.5 24.8 38.9 34.2 45.8 34.0 36.2 36.6 27.6 36.6 11.5 52.3 29.5 20.0 33.4 32.6 31.5 52.3 121.9 31.7 31.8 34.9 33.4 27.7 56.1 12.1 42.3 16.5 35.5 49.2 7.2 2.1 40.8 16.4 21.8 48.5 36.4 9.5 32.7 54.1 42.9 44.7 34.6 17.7 44.7 4.8 10.4 40.1 33.4 34.9 97.3 90.3 8.6 72.6 13.8 32.7 34.0 48.0 24.8 48.2 42.4 102.8 52.2 29.5 64.3 16.5 32.0 51.5 15.3 48.8 5.6 103.2 87.0 31.2 79.1 61.1 57.6 67.1 65.3 39.2 61.1 36.3 16.0 14.0 35.2 85.3 61.1 153.8 19.6 96.0 78.9 94.4 43.7 45.4 96.4 58.2 17.4 172.4 26.9 50.5 60.4 39.6 31.0 69.2 109.0 5.9 50.5 105.1 24.2 86.6 27.9 106.6 111.2 102.4 146.1 36.6 93.5 80.2 79.2 46.6 94.6 35.3 107.8 104.2 106.6 153.2 114.9 114.2 97.9 136.8 106.2 109.0 16.4 78.5 93.5 165.3 121.5 81.4 32.9 34.5 34.2 45.8 32.6 31.5 34.9 33.4 35.5 32.7 34.6 34.9 16.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 89.9 17.6 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 148.9 7.3 0.0 0.0 0.0 0.0 0.0 0.0 121.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 96.2 3.0 0.0 0.0 0.0 FAM178B LOC51252 ENSG00000168754 "Family with sequence similarity 178 member B" Q8IXR5 2 96875882-96986580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 18.9;brain: 10.5;epididymis: 5.5;lymphoid tissue: 12.1;testis: 8.2" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 88.3" "Cancer enriched" "Detected in many" 5 "melanoma: 8.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 25.7;OE19: 7.0;RPMI-8226: 28.0;WM-115: 27.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "spinal cord: 2.4" "HPA042516, HPA062110" Uncertain Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 25: RPMI-8226 - Immune response" "Cluster 33: Fibroblasts - ECM organization" "Nuclear speckles" "Golgi apparatus" "HPA042516: AB_10806241, HPA062110: " "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" "unprognostic (8.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.28e-2)" "unprognostic (9.02e-4)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (6.49e-3)" "unprognostic (1.49e-1)" "unprognostic (5.13e-2)" "unprognostic (9.82e-11)" "unprognostic (6.93e-2)" "unprognostic (1.57e-1)" "unprognostic (9.63e-3)" "unprognostic (1.08e-1)" 1.7 0.0 4.9 0.0 8.7 18.9 0.9 6.3 7.3 0.5 2.3 2.2 0.0 1.6 5.5 0.7 1.3 0.1 0.4 4.7 6.8 0.1 0.0 0.4 0.1 7.7 8.0 0.5 0.0 0.0 0.1 0.9 7.4 1.1 0.1 0.1 0.3 0.8 0.2 1.2 0.5 0.4 6.5 12.1 0.3 8.2 7.3 0.1 0.1 0.0 0.0 2.1 0.8 10.5 6.2 0.0 0.0 2.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.5 2.5 0.0 0.0 0.2 7.0 0.0 0.0 6.7 28.0 0.0 0.0 0.8 0.0 0.0 4.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 4.9 8.7 6.3 7.3 4.7 6.8 7.7 8.0 7.4 6.5 7.3 10.5 0.2 0.0 0.0 1.0 1.2 0.8 0.6 0.4 0.0 0.2 0.5 1.4 0.4 0.0 0.0 0.0 2.1 3.2 0.5 0.1 0.0 0.0 3.6 0.1 0.3 0.2 0.0 88.3 7.2 0.0 7.1 3.0 0.0 0.1 0.0 0.2 0.4 0.0 1.2 1.7 1.1 0.0 10.2 0.0 0.9 7.8 0.9 1.0 3.6 1.0 0.2 2.9 1.0 1.0 20.7 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.4 0.2 0.0 2.8 1.6 3.2 20.1 0.6 1.7 2.5 0.2 0.3 0.1 0.4 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.3;choroid plexus: 30.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 103.0;Astrocytes: 261.2;Oligodendrocyte precursor cells: 88.4;Syncytiotrophoblasts: 266.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 11.8;HEK 293: 11.1;Hep G2: 7.9;JURKAT: 11.6;K-562: 10.4;SCLC-21H: 8.5;SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 57: Non-specific - Angiogenesis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 3.1 1.6 33.3 1.3 36.3 0.2 4.7 37.3 43.3 3.6 30.5 3.5 3.0 2.5 3.0 1.4 3.2 1.8 2.5 34.3 33.0 6.7 6.3 9.9 3.5 31.9 32.4 4.5 3.2 4.8 11.0 23.0 32.4 3.9 0.9 16.3 3.3 2.8 0.9 1.7 1.6 1.6 29.1 0.6 1.7 16.9 32.6 0.6 7.0 2.2 3.5 2.4 2.1 34.5 0.1 0.3 11.8 0.9 0.3 0.3 0.0 0.6 0.4 0.5 0.9 2.0 1.1 0.9 0.0 0.2 5.3 0.0 3.4 0.0 0.2 1.3 11.1 0.1 0.9 7.9 0.2 0.0 0.6 0.4 0.1 0.1 0.0 0.3 0.0 11.6 10.4 0.7 0.3 0.3 0.4 0.1 6.0 0.6 1.3 0.0 0.1 0.0 0.1 0.1 8.5 8.0 0.7 0.6 1.8 2.2 2.1 1.4 0.3 0.8 0.5 0.2 2.9 4.9 3.3 0.3 1.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 33.3 36.3 37.3 43.3 34.3 33.0 31.9 32.4 32.4 29.1 32.6 34.5 21.0 48.1 103.0 261.2 0.7 2.4 5.9 0.4 11.4 35.2 3.8 8.8 6.4 2.8 17.7 3.7 29.2 61.4 0.6 0.4 17.6 1.0 22.9 2.0 2.0 5.3 6.0 0.4 66.9 1.1 18.9 11.8 1.5 0.8 6.3 8.9 1.8 4.0 5.6 13.5 55.5 0.6 0.0 0.3 1.8 9.2 3.7 1.0 0.0 34.7 0.0 11.1 0.0 88.4 20.6 0.3 1.2 7.2 2.7 1.6 0.4 3.1 37.3 28.4 6.6 45.2 4.1 61.8 16.0 4.2 3.4 266.4 5.8 1.4 0.7 2.0 FAM199X CXorf39 ENSG00000123575 "Family with sequence similarity 199, X-linked" Q6PEV8 X 104166453-104195902 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003093 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 68: Epididymis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA003093: AB_1078597" "unprognostic (2.03e-3)" "unprognostic (4.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.18e-2)" "unprognostic (1.89e-2)" "unprognostic (6.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (1.18e-1)" "unprognostic (9.13e-2)" "unprognostic (6.07e-3)" "unprognostic (1.08e-2)" "unprognostic (4.73e-2)" "unprognostic (4.00e-2)" "unprognostic (2.39e-2)" 19.9 11.7 17.0 7.1 16.9 13.8 11.6 18.2 18.7 9.2 10.2 8.4 7.9 10.6 34.8 7.8 9.1 6.8 7.3 15.2 18.8 15.1 7.7 8.1 8.6 15.5 19.1 11.9 11.1 19.9 8.5 9.0 17.5 10.2 8.4 16.1 10.2 13.9 9.4 9.5 7.2 8.7 16.8 8.8 8.3 10.1 20.5 9.0 17.5 9.7 7.8 8.0 7.6 18.8 23.9 14.9 13.2 14.5 9.6 11.5 13.3 12.4 11.6 15.8 14.7 11.6 19.4 13.1 15.0 11.4 12.5 17.6 23.9 18.3 25.7 6.4 13.4 10.4 19.0 13.2 13.7 20.0 14.1 9.0 22.9 15.5 15.6 24.7 16.2 8.3 11.5 28.6 17.8 17.1 10.8 14.2 13.2 20.9 17.3 11.4 8.6 16.5 26.9 15.8 7.1 8.8 30.0 19.7 21.4 12.9 9.8 9.8 20.1 17.6 6.4 13.8 13.5 13.6 12.1 14.4 19.8 21.1 13.1 0.6 0.5 0.3 0.7 0.4 0.7 0.4 0.6 0.8 0.6 1.3 0.9 0.5 0.6 0.3 0.5 0.3 0.8 0.3 17.0 16.9 18.2 18.7 15.2 18.8 15.5 19.1 17.5 16.8 20.5 18.8 18.6 16.0 14.5 33.0 17.8 24.0 11.5 12.6 13.6 23.3 21.3 14.7 13.7 17.2 12.2 62.5 14.6 11.8 23.1 23.9 23.5 11.9 0.6 20.6 27.3 15.7 16.8 9.4 25.9 18.7 13.0 11.7 18.3 31.5 9.5 16.8 14.6 18.8 17.6 33.7 24.5 17.0 16.2 21.4 27.0 3.9 11.8 15.7 10.6 15.9 14.6 20.0 22.6 26.2 21.6 15.4 18.9 14.7 20.2 14.6 14.2 34.8 10.3 16.9 26.3 17.1 13.7 4.1 9.7 21.0 26.3 14.6 15.9 21.6 15.9 15.5 FAM20B "GXK1, KIAA0475" ENSG00000116199 "FAM20B glycosaminoglycan xylosylkinase" O75063 1 179025804-179076567 "Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007409 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 14000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 38: Heart - Muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus" Nucleoplasm "HPA007409: AB_10601649" "unprognostic (7.58e-2)" "unprognostic (1.12e-1)" "unprognostic (4.97e-2)" "unprognostic (6.23e-3)" "unprognostic (3.29e-1)" "unprognostic (3.07e-1)" "unprognostic (4.76e-2)" "unprognostic (7.70e-3)" "unprognostic (7.85e-2)" "unprognostic (3.93e-2)" "unprognostic (5.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.76e-1)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" 20.9 22.4 15.0 11.2 17.2 11.7 15.9 12.7 17.1 16.1 7.7 22.2 9.9 18.0 15.4 17.6 15.4 13.6 23.4 18.0 17.2 17.3 16.5 16.3 11.3 14.0 14.6 19.9 11.4 21.4 14.4 17.0 14.5 16.5 14.4 28.7 11.8 19.4 19.6 12.8 11.5 19.4 13.5 12.4 13.6 8.0 15.3 11.5 17.9 25.6 10.8 16.2 12.3 14.7 41.4 37.1 28.2 30.0 49.1 51.4 31.2 33.7 38.3 23.2 20.7 18.7 40.1 21.3 43.2 59.7 19.1 29.3 29.0 24.8 33.8 27.3 19.5 67.9 34.8 23.9 24.5 45.5 41.1 30.1 26.5 31.7 24.5 35.4 29.0 29.2 77.0 30.2 37.5 23.1 19.9 16.4 37.1 46.2 7.9 24.1 29.7 28.4 19.5 46.1 37.5 91.8 35.5 39.7 34.5 39.8 34.4 32.8 30.8 36.7 32.2 51.1 46.0 24.5 48.5 18.2 36.5 21.7 37.3 0.9 0.6 0.2 1.3 0.6 1.3 1.4 0.7 1.1 0.8 1.5 1.1 1.0 0.6 1.6 0.8 1.2 1.0 0.5 15.0 17.2 12.7 17.1 18.0 17.2 14.0 14.6 14.5 13.5 15.3 14.7 16.8 6.4 11.4 16.0 7.5 15.6 12.6 8.9 4.6 15.7 12.2 9.3 40.1 12.8 9.0 18.4 25.0 9.0 9.0 10.6 3.9 8.8 5.2 8.8 17.8 13.8 14.4 43.3 28.3 13.0 7.7 14.6 9.2 14.5 17.1 20.2 9.3 14.2 7.6 38.7 32.0 7.9 10.2 11.6 8.1 5.1 17.7 9.6 16.0 19.7 14.1 9.0 2.1 17.6 32.5 13.7 3.8 21.4 6.2 19.7 5.0 5.9 8.8 21.0 13.1 20.0 17.7 17.6 13.8 9.6 12.9 7.5 8.0 24.1 8.5 24.7 FAM20C "DKFZp547D065, DMP4, G-CK, IMAGE:4942737" ENSG00000177706 "FAM20C golgi associated secretory pathway kinase" Q8IXL6 7 192571-260772 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" Biomineralization "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 55.2;Hepatocytes: 94.0;Hofbauer cells: 54.9;Peritubular cells: 56.4;Proximal tubular cells: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 55.3;hTERT-RPE1: 39.9;U-87 MG: 36.0;WM-115: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019823 Approved "Nucleoplasm,Golgi apparatus" "Secreted in other tissues" NA NA 240000000 "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" Nucleoplasm "HPA019823: AB_1848389" "unprognostic (1.94e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (3.15e-2)" "unprognostic (1.03e-2)" "unprognostic (3.33e-3)" "unprognostic (2.47e-2)" "unprognostic (7.86e-2)" "unprognostic (2.45e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (9.40e-6)" "unprognostic (1.97e-3)" "unprognostic (2.49e-1)" "unprognostic (3.08e-3)" "unprognostic (1.94e-2)" "unprognostic (3.92e-2)" "unprognostic (2.16e-2)" "unprognostic (3.83e-3)" 32.5 14.8 7.0 7.3 5.7 1.5 32.8 5.0 7.0 19.4 0.8 44.3 4.5 19.4 2.1 14.3 20.2 5.9 30.2 4.3 5.0 34.9 56.5 27.9 1.1 12.5 9.7 20.3 13.4 1.6 18.3 2.6 6.7 29.9 1.4 1.1 20.3 3.6 30.7 14.7 23.3 6.8 6.4 8.9 38.9 7.8 12.6 0.6 19.6 6.3 0.6 36.8 15.1 6.2 19.6 6.4 0.3 10.3 11.8 20.3 0.0 17.4 23.2 7.9 5.9 0.9 10.1 0.0 9.3 21.8 10.4 14.9 1.1 0.6 1.6 4.5 0.6 0.0 3.1 3.4 8.8 0.0 1.0 55.3 1.6 0.3 0.7 39.9 5.0 0.0 0.0 0.0 1.8 1.9 0.0 0.7 8.9 0.1 0.3 2.3 0.5 0.0 4.9 0.0 4.4 0.2 17.2 0.0 2.3 1.1 9.7 6.5 14.6 10.3 5.3 7.7 5.3 0.0 0.0 0.0 36.0 1.0 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 5.7 5.0 7.0 4.3 5.0 12.5 9.7 6.7 6.4 12.6 6.2 5.0 6.4 5.1 11.8 1.2 10.1 2.3 4.5 1.8 26.9 27.6 18.7 9.9 21.5 1.0 55.2 0.0 0.5 4.6 3.4 5.9 1.8 0.0 4.1 19.0 4.5 11.9 0.4 7.4 4.8 0.5 22.6 13.7 9.5 3.8 3.1 9.3 94.0 54.9 1.7 17.0 5.3 2.0 24.4 9.8 2.6 16.1 34.5 1.8 5.6 10.8 17.1 0.0 8.5 15.3 6.3 3.7 56.4 0.1 6.6 33.7 48.7 3.4 9.0 13.1 8.7 17.3 0.3 1.0 3.5 8.1 0.5 0.9 0.6 9.0 1.9 FAM210A "C18orf19, HsT2329, MGC24180" ENSG00000177150 "Family with sequence similarity 210 member A" Q96ND0 18 13663347-13726663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 33.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014324, HPA051564" Uncertain Approved "Nucleoplasm,Golgi apparatus,Mitochondria" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Golgi apparatus, Mitochondria" "HPA014324: AB_2668972, HPA051564: AB_2681536" "unprognostic (1.32e-1)" "unprognostic (6.98e-2)" "unprognostic (5.78e-2)" "unprognostic (9.18e-3)" "unprognostic (4.13e-2)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.23e-3)" "unprognostic (1.11e-2)" "unprognostic (2.26e-1)" "unprognostic (5.53e-3)" "unprognostic (6.79e-3)" "unprognostic (2.98e-2)" "unprognostic (3.27e-3)" "unprognostic (7.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" "unprognostic (4.82e-2)" 6.1 4.7 4.7 5.5 4.5 3.5 4.8 5.8 7.1 4.2 8.0 6.9 9.3 3.9 2.9 8.8 4.2 4.0 21.8 4.6 5.3 9.4 13.2 4.0 6.4 5.2 7.0 5.6 3.3 6.4 2.6 7.5 5.6 4.4 6.4 11.5 5.1 4.6 25.5 3.3 6.2 6.2 5.1 3.7 4.7 8.4 6.3 5.3 6.3 33.1 7.3 6.3 5.0 5.7 24.6 13.6 9.4 8.8 10.9 11.2 13.6 16.5 15.3 18.2 21.1 18.4 11.6 24.9 20.2 11.8 33.6 11.5 18.2 20.6 29.5 17.4 8.4 17.7 9.7 13.0 12.9 30.3 15.9 9.7 15.9 17.5 61.6 12.7 11.9 14.8 24.2 13.4 21.2 16.8 18.7 19.5 10.6 47.7 13.5 15.2 22.3 29.1 15.1 15.3 6.0 10.1 14.5 21.1 40.0 13.4 10.8 14.2 13.2 46.4 45.7 29.1 20.6 15.1 20.1 28.8 24.6 15.6 18.9 3.5 5.3 3.3 6.2 8.0 6.8 5.7 5.2 5.4 6.4 6.3 6.4 6.2 0.8 6.0 4.2 4.0 5.4 3.8 4.7 4.5 5.8 7.1 4.6 5.3 5.2 7.0 5.6 5.1 6.3 5.7 14.9 9.6 8.3 13.7 29.8 55.3 14.8 28.3 12.5 63.2 11.0 11.2 66.4 12.8 14.6 7.3 20.9 20.6 11.6 9.1 21.5 18.6 20.5 16.7 21.6 18.3 11.4 5.9 18.0 8.8 39.0 17.4 10.2 32.7 7.0 36.7 6.8 20.7 20.0 30.3 23.5 10.0 10.2 9.5 43.4 6.1 9.3 26.5 8.8 15.0 11.4 19.0 15.5 18.6 24.8 12.6 4.1 10.1 14.2 19.9 12.1 29.8 5.0 29.9 6.6 16.3 15.4 31.4 32.3 20.6 57.3 25.7 16.8 45.6 20.5 14.8 FAM219A "bA573M23.5, C9orf25, FLJ39031" ENSG00000164970 "Family with sequence similarity 219 member A" Q8IW50 9 34398184-34458570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 94.6" "Cell type enhanced" "Detected in many" "Horizontal cells: 53.8;Late spermatids: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HDLM-2: 96.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019338, HPA052909" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA019338: AB_1845819, HPA052909: AB_2681986" "unprognostic (9.96e-3)" "unprognostic (2.16e-1)" "unprognostic (1.50e-2)" "unprognostic (1.23e-2)" "unprognostic (6.81e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.98e-5)" "unprognostic (2.71e-2)" "unprognostic (2.50e-1)" "unprognostic (2.95e-1)" "prognostic favorable (2.46e-4)" "unprognostic (3.46e-3)" "prognostic unfavorable (5.54e-5)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.34e-1)" "unprognostic (2.76e-1)" 19.8 14.0 82.5 9.0 79.4 3.8 17.5 72.4 88.0 18.5 25.9 17.0 5.4 22.5 6.2 9.8 15.7 5.6 29.9 75.9 77.5 15.7 12.7 18.8 6.5 90.0 84.8 15.3 13.2 6.4 26.3 13.4 94.6 16.3 4.6 19.3 12.1 7.0 42.7 16.2 11.9 11.9 83.8 15.1 12.7 9.7 82.9 8.3 14.9 12.6 5.0 17.7 15.7 85.4 27.9 10.6 24.5 14.0 22.3 8.5 23.8 16.5 12.4 14.0 17.7 7.4 6.3 6.1 16.6 16.1 27.7 11.4 19.6 10.6 14.0 96.0 11.2 2.5 14.6 8.0 12.5 6.1 13.6 9.0 10.5 21.0 11.7 17.4 23.4 10.6 6.1 29.6 11.0 5.6 9.5 8.5 15.8 3.8 15.6 12.1 4.1 5.3 10.1 5.9 7.8 24.8 14.3 10.3 8.5 22.2 5.2 6.1 28.0 15.4 11.9 32.3 23.2 7.8 12.0 5.1 44.2 13.9 27.8 0.6 0.1 1.1 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.5 0.2 0.2 0.1 0.4 0.1 82.5 79.4 72.4 88.0 75.9 77.5 90.0 84.8 94.6 83.8 82.9 85.4 14.3 6.4 3.3 17.3 3.3 6.2 3.7 5.6 4.0 21.1 5.1 2.9 11.7 1.5 2.5 3.7 4.2 9.4 4.3 2.1 0.0 6.1 13.8 2.0 6.0 17.4 10.8 0.4 28.6 5.1 16.8 7.8 6.1 2.8 2.5 3.4 9.3 2.8 5.9 53.8 31.8 2.3 8.2 5.5 2.6 35.1 3.7 4.1 8.8 15.0 4.5 9.3 3.1 22.1 15.9 6.6 1.7 5.7 3.0 5.1 1.3 3.0 2.3 11.0 6.6 5.2 9.1 9.9 3.8 3.0 6.5 20.7 3.5 2.9 0.9 2.7 FAM219B "C15orf17, FLJ00005" ENSG00000178761 "Family with sequence similarity 219 member B" Q5XKK7 15 74899992-74906883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048929, HPA058064" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Golgi apparatus" "HPA048929: AB_2680561, HPA058064: AB_2683592" "unprognostic (1.12e-1)" "unprognostic (6.10e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.08e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "unprognostic (2.41e-2)" "unprognostic (5.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.92e-1)" "unprognostic (3.17e-2)" "unprognostic (3.11e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (4.91e-3)" 21.9 19.8 31.5 9.9 30.8 6.4 13.7 31.9 35.5 15.4 32.5 17.1 12.0 16.8 22.5 23.6 22.3 10.6 30.3 31.6 36.3 16.1 6.6 16.9 15.2 32.7 33.6 19.5 13.0 32.4 28.1 13.3 35.0 24.0 14.6 44.7 18.2 17.0 18.7 22.0 13.9 17.8 31.6 24.3 15.3 6.3 34.4 8.5 18.2 25.1 17.4 20.1 16.0 31.3 6.6 9.6 25.9 11.4 42.9 31.6 11.6 18.7 9.8 16.7 10.5 9.1 18.0 12.9 10.4 13.0 16.8 16.8 35.9 10.3 9.1 32.5 20.4 12.3 22.9 7.7 20.3 11.9 16.2 19.2 47.3 7.3 13.7 36.0 18.7 9.6 9.6 15.4 17.1 5.5 7.1 10.4 14.3 19.4 14.4 19.0 9.0 9.7 25.7 21.1 21.7 14.1 20.9 11.6 33.7 27.1 23.3 14.0 21.7 13.5 7.3 11.4 15.2 11.6 12.1 5.5 17.1 24.2 13.8 3.8 1.0 6.9 1.4 0.9 2.4 2.2 2.1 1.2 1.0 2.0 0.9 1.5 1.2 1.8 1.3 0.1 0.2 1.3 31.5 30.8 31.9 35.5 31.6 36.3 32.7 33.6 35.0 31.6 34.4 31.3 13.3 19.2 20.6 22.5 18.4 6.4 21.2 17.9 13.6 41.6 16.2 13.5 5.1 10.0 18.9 27.6 58.4 17.1 22.3 23.3 13.7 14.4 1.0 22.9 14.8 16.0 20.9 7.6 23.9 10.5 11.4 17.4 9.7 13.9 24.7 15.0 17.2 5.8 17.9 23.5 20.8 16.0 28.5 13.3 8.5 4.7 23.3 13.0 14.2 13.1 19.8 26.7 30.9 11.1 9.4 17.5 16.2 28.6 15.7 19.9 23.3 11.9 30.6 69.2 26.3 15.8 15.2 9.1 17.5 18.2 7.7 8.3 16.0 15.0 14.0 22.6 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109713825-109770495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3;Early spermatids: 29.1;Horizontal cells: 77.4;Oligodendrocytes: 78.5;Rod photoreceptor cells: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 116.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA075616" Uncertain Approved "Golgi apparatus,Cell Junctions,Midbody ring" Yes NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "Cell Junctions, Midbody ring" "HPA040181: AB_10796448, HPA075616: " "unprognostic (8.59e-3)" "prognostic favorable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favorable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 0.7 19.0 23.7 0.7 45.2 0.6 1.2 36.7 34.2 0.6 5.6 1.9 4.8 0.3 0.8 2.3 0.4 0.8 8.9 20.0 27.6 10.6 4.0 2.1 0.4 41.2 43.1 13.4 3.9 0.7 22.4 0.1 37.7 1.8 1.0 22.1 3.4 0.5 4.3 3.2 2.2 0.4 29.0 6.2 7.2 23.4 48.4 0.4 0.7 0.6 0.6 0.9 1.8 65.6 2.0 3.1 1.6 3.7 1.0 0.0 1.1 0.6 0.3 1.6 0.2 28.1 0.5 0.3 2.2 0.8 1.7 1.2 1.9 0.1 0.6 16.8 4.0 3.5 0.9 6.5 0.2 2.8 3.6 0.2 0.2 0.3 0.0 0.4 0.1 2.0 1.2 0.6 0.3 11.5 0.7 3.6 3.0 3.3 5.3 2.3 8.0 1.2 3.5 1.5 19.2 116.4 2.5 3.7 8.2 0.5 4.5 3.0 0.2 0.5 3.2 1.3 2.4 2.9 4.0 2.4 0.3 2.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 45.2 36.7 34.2 20.0 27.6 41.2 43.1 37.7 29.0 48.4 65.6 2.1 0.0 0.0 2.3 3.6 2.2 0.9 0.1 3.4 23.4 7.4 6.1 8.1 1.5 0.8 1.8 33.3 0.3 10.4 1.2 7.9 1.7 29.1 1.2 0.5 1.3 7.7 0.0 1.3 0.8 0.2 1.5 1.5 1.8 0.0 0.7 0.7 1.3 0.3 77.4 6.7 5.8 0.0 0.0 2.1 13.4 1.2 1.9 7.2 0.0 0.1 11.2 0.0 9.5 78.5 1.1 0.2 0.4 1.3 1.7 0.9 0.7 0.6 50.3 0.0 2.6 1.5 1.1 5.7 3.3 1.8 0.8 3.7 6.0 1.6 0.4 FAM228B ENSG00000219626 "Family with sequence similarity 228 member B" P0C875 2 24076526-24169640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 116.9;Late spermatids: 100.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052598, HPA063357" Uncertain Approved "Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Golgi apparatus" "HPA052598: AB_2681880, HPA063357: AB_2684994" "unprognostic (2.48e-1)" "unprognostic (1.98e-1)" "unprognostic (1.15e-2)" "unprognostic (2.66e-1)" "unprognostic (3.81e-1)" "unprognostic (5.05e-2)" "unprognostic (1.85e-2)" "unprognostic (9.14e-2)" "unprognostic (3.32e-1)" "unprognostic (1.32e-1)" "unprognostic (3.39e-5)" "unprognostic (5.62e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (5.15e-1)" "unprognostic (6.93e-2)" 21.8 15.0 44.4 2.9 48.1 7.9 17.1 53.2 63.6 21.1 33.8 20.7 1.7 12.2 19.2 6.8 18.4 9.2 26.0 40.4 47.3 17.0 4.9 11.0 5.5 45.3 43.8 21.4 8.3 14.9 30.6 6.5 45.5 21.6 4.3 8.9 7.5 12.4 13.2 8.2 10.4 7.8 45.6 12.7 11.4 33.4 45.1 6.2 14.0 9.7 5.0 16.9 14.5 54.9 2.6 1.9 3.7 13.9 9.6 12.5 0.4 6.3 5.9 2.3 1.5 0.2 1.6 3.3 3.1 4.8 4.6 0.2 0.9 0.7 2.2 5.0 6.1 4.0 0.6 0.7 18.6 2.0 1.0 11.7 6.5 1.0 9.3 15.5 5.0 3.0 0.4 4.0 3.1 4.1 0.6 9.4 1.2 0.3 5.4 3.2 1.7 1.5 6.8 2.7 1.3 10.0 2.0 0.0 11.3 5.9 3.8 9.3 5.2 4.2 0.4 0.8 2.1 6.7 2.2 3.9 9.2 7.1 2.9 9.4 5.0 10.1 5.2 3.5 2.6 7.4 3.7 4.2 6.0 4.8 5.5 5.7 4.1 4.5 3.3 9.9 3.8 3.1 44.4 48.1 53.2 63.6 40.4 47.3 45.3 43.8 45.5 45.6 45.1 54.9 19.1 51.3 35.3 49.9 10.7 6.4 9.5 8.8 5.2 24.7 11.5 18.7 24.7 10.0 34.9 14.7 8.4 9.7 17.2 1.6 31.3 5.4 116.9 13.2 11.8 17.4 9.6 6.9 52.1 5.5 4.2 20.1 2.6 5.5 25.9 22.3 20.7 3.5 10.4 37.0 52.1 3.2 10.2 12.8 21.7 100.5 42.3 13.2 10.6 39.4 14.7 39.0 21.6 41.7 78.3 3.8 1.1 38.4 4.6 4.3 2.4 12.3 41.9 27.7 52.6 24.3 21.6 39.4 11.4 2.6 7.4 3.3 13.2 17.4 3.1 5.4 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087591-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 448.1" "Group enriched" "Detected in many" 8 "Early spermatids: 3403.2;Late spermatids: 7607.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 18: U-2197 - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favorable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 18.2 21.7 62.1 3.6 69.4 3.7 16.9 68.5 85.4 20.7 67.9 21.1 3.5 25.8 36.4 7.2 53.4 19.1 69.9 60.5 68.7 29.2 25.0 15.3 3.5 70.0 69.7 25.9 8.6 43.6 66.1 10.6 71.3 19.2 5.4 35.4 9.0 22.6 13.6 7.7 7.4 18.4 72.8 5.2 18.7 448.1 65.2 10.9 21.1 15.3 3.3 19.0 11.3 77.1 4.0 9.9 39.9 19.5 34.3 34.0 1.9 14.9 56.6 21.0 44.0 1.7 9.4 3.1 43.0 27.7 21.9 2.5 8.4 21.7 33.4 1.0 27.7 3.7 4.1 15.7 21.3 8.1 1.8 20.7 14.3 34.8 5.9 48.6 20.9 35.2 4.9 7.8 26.0 1.0 15.1 12.9 10.4 2.9 23.2 23.3 10.0 3.2 31.3 0.6 37.0 15.5 11.9 1.3 23.9 21.4 19.1 7.4 12.0 17.5 7.4 67.1 20.2 5.8 0.3 28.6 27.7 6.8 23.5 0.1 0.0 2.1 3.0 0.0 3.9 1.8 2.6 2.4 0.4 2.6 5.6 5.1 0.2 4.6 0.2 2.5 0.3 1.9 62.1 69.4 68.5 85.4 60.5 68.7 70.0 69.7 71.3 72.8 65.2 77.1 53.7 3.2 11.4 10.4 4.7 8.4 18.8 48.6 12.0 31.3 23.6 34.7 93.9 21.5 42.1 51.5 12.5 1.5 1.9 0.3 133.1 31.7 3403.2 207.7 18.5 24.6 3.0 9.0 17.2 10.4 6.9 32.9 7.1 11.6 1.3 36.1 33.2 54.4 3.1 16.8 14.8 0.6 52.9 3.2 7.3 7607.9 72.7 6.2 24.9 6.5 2.1 83.5 4.1 12.1 35.8 6.7 0.1 90.7 5.0 11.6 0.1 93.0 409.9 36.9 59.2 26.5 32.6 663.2 51.1 5.5 8.7 0.5 4.4 64.0 0.7 12.2 FAM241A "C4orf32, FLJ39370" ENSG00000174749 "Family with sequence similarity 241 member A" Q8N8J7 4 112145454-112195256 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 272.0;Alveolar cells type 1: 60.9;Alveolar cells type 2: 69.9;Breast glandular cells: 87.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 41.3;HUVEC TERT2: 28.0" "Low region specificity" "Detected in all" "HPA062443, HPA069294" Approved Enhanced "Golgi apparatus" No No "Cluster 17: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA062443: AB_2684765, HPA069294: AB_2686111" "unprognostic (3.07e-1)" "unprognostic (1.11e-2)" "unprognostic (2.42e-2)" "unprognostic (5.58e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (1.61e-2)" "unprognostic (3.16e-1)" "unprognostic (1.21e-1)" "unprognostic (5.05e-2)" "unprognostic (4.81e-2)" "unprognostic (5.25e-2)" "unprognostic (9.20e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (4.08e-1)" "unprognostic (7.16e-2)" "unprognostic (1.39e-2)" 16.7 4.1 7.7 5.3 8.6 7.2 11.2 16.6 15.5 2.8 0.5 2.8 2.9 3.8 3.8 4.3 2.3 5.1 7.2 6.7 1.7 4.5 4.6 5.1 5.2 1.6 2.3 2.8 2.2 3.9 1.5 10.8 2.9 3.8 2.8 10.5 8.8 2.9 6.0 6.3 3.4 5.1 0.4 5.0 7.3 6.0 3.9 3.2 4.2 5.0 4.1 5.1 2.5 13.7 6.3 2.4 2.5 2.1 12.5 7.1 3.7 5.3 1.2 1.0 1.6 1.9 7.9 41.3 4.9 2.9 3.5 3.1 3.9 5.5 1.8 19.7 6.6 4.4 6.4 3.4 7.4 10.3 2.7 7.8 8.7 1.5 9.1 2.0 28.0 5.8 8.4 19.6 3.1 6.5 3.8 7.4 3.2 10.3 5.9 8.6 4.2 8.5 4.2 6.1 4.6 3.8 5.0 9.0 2.7 3.6 6.5 4.4 17.9 3.2 9.7 2.1 1.9 8.2 11.3 19.1 7.3 5.1 4.1 2.8 0.6 0.6 0.5 0.5 0.4 0.6 0.5 0.4 0.3 0.9 0.5 0.6 1.5 0.6 0.6 1.0 0.6 0.3 7.7 8.6 16.6 15.5 6.7 1.7 1.6 2.3 2.9 0.4 3.9 13.7 272.0 60.9 69.9 0.0 4.9 0.0 0.0 0.0 0.0 0.0 87.0 42.2 0.0 0.0 36.5 33.1 0.0 1.6 9.2 0.0 7.9 12.0 0.0 4.6 3.9 44.0 0.0 0.0 0.0 17.3 2.8 13.8 0.0 12.0 32.8 0.4 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 28.2 0.0 0.0 4.0 0.0 0.0 3.5 42.3 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 2.5 9.8 1.3 0.0 0.0 FAM3C "GS3876, ILEI" ENSG00000196937 "FAM3 metabolism regulating signaling molecule C" Q92520 7 121348878-121396364 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 415.8;Urothelial cells: 425.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "memory B-cell: 22.5;naive B-cell: 19.9" "Lineage enriched" "Detected in many" 7 "B-cells: 22.5" "Cell line enhanced" "Detected in all" "CAPAN-2: 1257.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043376, HPA050548" Enhanced Enhanced "Golgi apparatus" "Secreted in other tissues" NA NA 48000000 "Cluster 37: B-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus" "HPA043376: AB_2678452, HPA050548: AB_2681169" "unprognostic (9.44e-2)" "unprognostic (3.91e-1)" "unprognostic (1.75e-1)" "unprognostic (8.11e-3)" "unprognostic (1.26e-2)" "unprognostic (3.09e-3)" "unprognostic (3.38e-3)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (1.22e-2)" "unprognostic (2.15e-3)" "unprognostic (1.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.48e-1)" "unprognostic (9.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.06e-2)" 40.4 45.9 23.8 38.5 26.8 9.6 42.1 20.4 46.5 96.5 15.9 46.5 177.0 51.4 57.5 32.0 34.5 35.3 64.0 33.8 22.6 62.9 49.5 34.5 44.6 29.3 20.7 36.7 74.0 57.3 29.6 44.5 30.4 31.7 54.0 47.8 38.1 32.3 19.0 32.2 158.2 44.3 19.1 47.4 61.8 24.5 21.8 17.1 111.1 24.5 44.8 56.6 31.3 25.4 133.1 33.2 60.7 64.9 100.3 164.2 55.6 139.7 61.5 41.2 52.1 26.4 1257.1 125.4 65.4 72.5 116.7 85.2 35.1 77.7 87.3 15.3 72.5 35.6 19.3 27.4 73.5 59.0 65.3 165.7 52.1 58.9 57.1 110.4 74.8 24.6 23.3 152.3 326.6 22.3 24.6 45.2 108.1 45.4 45.3 34.2 63.8 51.1 256.7 75.1 38.6 38.1 41.4 167.4 80.6 126.2 24.0 32.5 178.8 105.1 37.7 236.1 96.9 148.0 71.3 48.7 114.0 60.6 192.5 0.0 1.1 0.8 2.1 1.2 2.0 22.5 0.9 1.7 1.0 19.9 1.3 0.9 0.2 3.0 0.9 1.5 0.7 0.8 23.8 26.8 20.4 46.5 33.8 22.6 29.3 20.7 30.4 19.1 21.8 25.4 49.8 9.6 33.3 17.3 103.0 71.8 257.1 183.0 61.5 137.3 47.5 28.8 65.7 71.4 134.4 55.2 22.9 88.1 44.8 66.8 60.7 182.2 3.5 76.0 81.8 58.9 52.3 10.3 64.6 191.0 188.6 104.3 46.4 170.1 19.7 33.3 50.0 37.0 43.6 45.4 64.3 49.1 101.7 29.6 88.4 6.7 96.0 30.9 99.6 24.4 31.7 49.4 58.7 42.3 24.7 415.8 71.9 95.9 129.8 325.0 327.0 66.8 63.9 67.1 72.3 93.6 68.7 23.8 22.4 61.7 66.3 120.4 44.3 35.6 86.7 425.8 FAM78B ENSG00000188859 "Family with sequence similarity 78 member B" Q5VT40 1 166057426-166167001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 87.6;Excitatory neurons: 55.4;Horizontal cells: 82.4;Inhibitory neurons: 85.0;Oligodendrocyte precursor cells: 45.8" "Cancer enhanced" "Detected in many" "melanoma: 3.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HDLM-2: 8.6;RT4: 4.9;SK-MEL-30: 10.1;U-2 OS: 2.6;WM-115: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052789, HPA073246" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA052789: AB_2681949, HPA073246: AB_2686588" "unprognostic (7.38e-3)" "unprognostic (1.14e-3)" "unprognostic (7.96e-2)" "unprognostic (3.16e-2)" "unprognostic (3.77e-2)" "unprognostic (3.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-3)" "unprognostic (3.25e-2)" "unprognostic (1.69e-3)" "unprognostic (3.87e-2)" "unprognostic (1.87e-11)" "unprognostic (7.41e-2)" "unprognostic (2.09e-1)" "unprognostic (5.41e-2)" "unprognostic (2.69e-2)" 0.7 0.2 0.9 0.0 0.7 0.0 0.5 0.5 2.6 1.1 0.0 0.5 0.2 0.7 0.0 0.4 0.2 0.1 0.6 1.0 0.1 0.2 0.7 0.2 0.1 0.6 0.1 0.3 0.4 0.1 0.5 0.0 0.1 0.4 0.1 0.8 0.3 0.1 0.7 0.5 0.1 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.4 0.1 0.1 0.8 0.5 0.5 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 8.6 0.0 0.0 0.1 0.3 0.2 0.0 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 4.9 0.8 0.5 0.0 0.1 10.1 0.0 0.3 0.2 0.1 0.6 2.6 0.0 0.1 0.0 0.0 0.0 0.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.5 2.6 1.0 0.1 0.6 0.1 0.1 0.2 0.1 0.5 1.2 0.0 1.7 5.5 0.4 0.5 0.5 0.0 1.8 15.5 1.0 0.8 9.9 2.8 0.0 0.0 87.6 0.0 0.0 0.4 1.9 0.7 2.5 0.1 1.7 1.6 0.0 0.0 55.4 0.2 0.0 1.6 0.0 0.1 0.0 1.1 0.4 1.6 0.0 82.4 85.0 0.6 0.0 0.3 0.6 2.6 1.2 0.1 1.8 5.6 0.6 2.2 0.0 45.8 5.7 0.3 0.3 0.7 0.0 0.2 0.1 1.3 0.0 12.9 0.0 4.5 1.0 0.6 4.4 0.6 0.1 0.0 0.7 0.4 1.1 0.2 FAM89A "C1orf153, MGC15887" ENSG00000182118 "Family with sequence similarity 89 member A" Q96GI7 1 231018958-231040254 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 60.0;placenta: 68.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 186.3;Extravillous trophoblasts: 267.5;Rod photoreceptor cells: 102.5;Syncytiotrophoblasts: 278.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 145.4;SK-MEL-30: 81.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA059052, HPA059578" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Golgi apparatus, Vesicles" Nucleoplasm "HPA059052: AB_2683890, HPA059578: AB_2684070" "unprognostic (7.80e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-3)" "unprognostic (1.32e-2)" "unprognostic (2.77e-1)" "unprognostic (1.41e-2)" "unprognostic (1.98e-2)" "unprognostic (1.10e-1)" "unprognostic (8.05e-3)" "unprognostic (4.85e-1)" "unprognostic (1.54e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.01e-1)" "unprognostic (9.26e-2)" 60.0 18.0 16.0 4.8 15.3 5.9 36.5 20.7 16.4 11.0 21.3 4.4 1.7 7.5 1.6 6.5 7.1 5.9 10.6 14.2 23.4 22.2 9.2 19.2 5.9 22.6 21.4 6.0 10.6 6.0 5.8 68.2 20.9 7.1 2.7 17.3 5.3 4.6 5.9 30.6 4.6 4.1 21.2 17.5 7.6 3.0 25.1 2.9 5.5 6.7 4.7 8.9 9.2 19.5 0.9 13.7 6.3 13.4 15.0 3.0 145.4 7.8 5.8 2.8 5.1 21.1 12.1 0.0 1.8 5.1 16.7 8.4 12.0 1.9 2.3 42.4 28.9 6.7 0.3 0.9 57.6 5.0 35.2 50.1 26.6 0.0 13.2 0.1 7.4 15.0 53.4 8.6 2.7 5.0 3.2 8.8 9.4 12.6 4.3 16.6 20.3 16.0 10.1 14.8 5.8 16.1 2.6 1.2 81.6 13.9 0.8 29.2 1.1 22.5 0.1 0.4 14.7 18.3 23.7 11.6 6.7 9.8 45.7 1.4 0.2 0.0 0.2 0.0 0.3 0.3 0.2 0.5 0.0 0.1 0.4 0.9 0.0 0.1 0.0 0.0 0.0 0.2 16.0 15.3 20.7 16.4 14.2 23.4 22.6 21.4 20.9 21.2 25.1 19.5 82.3 0.0 2.6 3.6 4.2 30.1 22.0 0.3 8.0 48.1 3.8 5.2 3.3 7.2 0.7 0.0 77.2 186.3 4.9 0.3 3.9 2.8 1.3 1.3 39.3 44.5 0.0 14.9 1.1 3.3 267.5 11.6 0.5 2.6 4.5 0.5 10.8 11.1 51.0 8.4 10.8 0.6 0.0 19.6 2.1 3.6 2.8 8.5 21.4 22.5 0.5 26.2 1.0 10.1 2.0 4.4 0.5 1.5 1.4 30.2 0.0 5.1 0.1 102.5 0.0 9.9 8.5 4.2 11.6 1.7 32.8 278.3 5.5 0.4 1.3 15.4 FAM8A1 AHCP ENSG00000137414 "Family with sequence similarity 8 member A1" Q9UBU6 6 17600302-17611715 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 759.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044698, HPA073675" Approved Approved "Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA044698: AB_2679051, HPA073675: AB_2732236" "unprognostic (4.06e-1)" "unprognostic (2.32e-1)" "unprognostic (9.11e-2)" "unprognostic (6.90e-2)" "unprognostic (1.99e-2)" "unprognostic (5.17e-3)" "unprognostic (6.13e-2)" "unprognostic (1.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.09e-3)" "unprognostic (4.44e-2)" "unprognostic (3.50e-1)" "unprognostic (1.56e-2)" "unprognostic (3.85e-2)" "unprognostic (3.71e-1)" "unprognostic (7.59e-2)" "unprognostic (2.98e-1)" 18.6 16.1 16.3 10.7 17.3 31.6 19.1 19.0 19.5 20.4 16.6 19.9 16.9 27.3 18.9 13.9 20.6 21.1 14.8 17.4 20.3 24.0 77.9 18.9 10.4 18.2 17.2 27.8 15.0 22.3 13.0 14.9 18.2 20.9 22.8 27.1 23.0 22.3 18.9 14.0 16.7 24.8 20.2 14.3 12.7 17.2 21.1 17.1 23.2 21.7 8.2 14.5 12.6 20.6 9.5 3.7 13.5 32.3 45.6 42.6 11.1 15.0 20.4 7.6 13.1 21.4 3.1 8.1 35.2 25.6 8.3 7.6 20.5 13.0 9.9 6.9 29.1 9.8 12.5 46.2 20.1 6.2 9.6 22.6 20.7 8.7 6.0 24.2 17.0 8.9 20.2 16.2 12.0 11.7 4.6 19.2 5.6 11.6 5.6 12.1 13.0 25.0 25.6 7.5 4.1 21.4 11.7 25.0 23.7 23.1 29.0 9.5 13.3 9.7 3.4 14.9 5.5 13.4 12.0 8.0 8.8 7.1 13.4 2.6 0.3 1.0 1.1 0.4 1.2 0.0 0.5 1.0 0.2 0.1 0.7 1.1 5.5 1.5 0.2 0.2 0.4 0.3 16.3 17.3 19.0 19.5 17.4 20.3 18.2 17.2 18.2 20.2 21.1 20.6 16.8 19.2 27.1 8.8 7.0 13.4 9.7 6.6 14.2 27.6 15.1 13.5 15.3 21.5 12.1 29.5 14.6 10.0 15.7 63.4 5.9 9.2 759.2 26.4 24.0 14.1 12.0 4.2 17.1 7.9 12.0 23.0 10.7 20.6 1.3 8.6 25.4 77.5 6.2 15.2 17.9 10.8 8.2 24.4 6.4 187.8 36.7 8.6 5.4 3.7 8.7 19.3 14.4 8.0 13.8 7.5 25.7 30.9 12.8 7.5 30.4 12.4 20.5 16.7 32.9 20.3 18.7 46.6 18.0 14.3 15.9 12.2 14.0 9.7 16.7 7.8 FAR2 "FLJ10462, MLSTD1, SDR10E2" ENSG00000064763 "Fatty acyl-CoA reductase 2" Q96K12 12 29149103-29340980 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 36.2;intestine: 34.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 114.3;Inhibitory neurons: 172.1;Microglial cells: 63.7;Syncytiotrophoblasts: 193.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 50.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 76.2;HUVEC TERT2: 84.0;NB-4: 74.2;SK-BR-3: 89.6;TIME: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015884 Approved Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoli "HPA015884: AB_1853998" "unprognostic (6.32e-2)" "unprognostic (2.40e-2)" "unprognostic (1.50e-3)" "unprognostic (3.33e-3)" "unprognostic (2.41e-1)" "unprognostic (4.13e-3)" "unprognostic (4.30e-2)" "unprognostic (1.18e-1)" "unprognostic (3.11e-2)" "unprognostic (6.37e-2)" "unprognostic (5.70e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.33e-1)" "unprognostic (5.22e-3)" 8.3 9.0 4.1 9.3 8.3 17.1 9.3 1.2 8.5 4.3 0.0 34.5 17.6 5.6 36.2 7.4 3.6 5.2 6.6 6.2 9.2 5.0 3.8 11.3 7.9 1.2 2.9 2.3 3.2 1.3 2.4 18.1 1.3 2.6 28.2 9.4 4.4 1.9 6.3 9.0 19.2 7.6 1.4 12.2 4.9 9.2 5.2 7.0 4.4 2.6 3.0 6.5 3.7 4.9 2.5 4.9 4.9 1.2 6.8 26.9 2.1 21.3 24.7 5.8 5.4 8.2 28.0 3.7 5.4 3.4 4.3 1.5 13.4 0.2 1.4 1.8 32.2 76.2 10.7 2.7 14.7 30.0 24.0 7.5 0.2 8.7 11.0 14.3 84.0 2.9 6.6 2.7 0.9 0.8 19.9 74.2 19.3 1.6 54.5 16.1 7.9 3.1 25.7 7.2 8.6 7.9 4.8 89.6 37.8 9.7 4.1 28.2 68.2 15.6 4.6 5.6 9.3 4.4 4.9 1.8 24.5 38.5 13.7 3.8 22.8 50.0 5.0 13.9 3.4 2.0 8.3 6.2 8.1 1.8 2.9 3.2 41.0 4.0 8.0 3.1 16.1 9.6 4.1 8.3 1.2 8.5 6.2 9.2 1.2 2.9 1.3 1.4 5.2 4.9 9.1 0.0 3.3 7.8 0.6 1.3 0.1 0.2 0.6 2.0 1.4 0.8 12.1 0.0 1.4 0.0 0.0 16.0 1.1 35.7 0.0 0.1 31.5 0.4 2.9 11.9 7.2 4.6 114.3 0.2 19.6 4.8 5.6 0.4 10.8 0.0 9.7 0.0 19.3 5.0 172.1 21.8 0.0 22.2 3.7 6.4 1.2 12.2 16.0 63.7 6.9 0.5 1.0 24.6 6.9 3.3 36.8 0.4 8.0 0.4 15.1 0.4 3.2 1.2 0.0 4.2 3.6 16.6 1.0 0.3 0.3 193.9 4.2 0.9 23.7 0.3 FBXL14 "Fbl14, MGC40195" ENSG00000171823 "F-box and leucine rich repeat protein 14" Q8N1E6 12 1565993-1594581 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 47.4;Late spermatids: 103.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053889 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 78: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" Cytosol "HPA053889: AB_2682293" "unprognostic (8.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.82e-1)" "unprognostic (4.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.27e-1)" "unprognostic (5.90e-2)" "unprognostic (8.98e-2)" "prognostic favorable (9.04e-6)" "unprognostic (5.60e-3)" "unprognostic (1.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.12e-3)" 5.2 4.3 7.9 5.9 10.6 5.8 4.6 8.7 21.4 3.6 2.4 8.4 4.9 4.5 1.6 6.0 5.7 4.8 5.2 10.6 7.8 4.6 3.9 5.7 7.5 7.8 8.1 4.7 11.3 7.1 8.7 4.2 8.3 3.7 3.5 4.2 6.2 4.0 3.3 3.4 6.2 2.1 7.4 6.4 9.7 21.1 9.0 8.3 6.4 2.5 3.3 4.7 4.3 8.6 11.8 16.3 4.8 8.4 4.0 4.1 14.3 2.6 4.7 2.4 2.7 17.1 14.8 15.8 3.1 2.9 4.0 8.1 3.9 6.0 0.4 27.2 19.0 19.6 4.7 5.5 5.3 15.0 14.4 6.5 2.7 4.4 3.7 4.3 4.3 13.4 8.3 43.2 2.9 12.4 15.9 7.4 21.2 6.4 6.7 13.5 7.8 9.9 3.8 10.3 9.2 9.1 6.3 9.5 9.8 4.9 7.5 12.1 6.4 5.3 17.5 6.8 9.5 5.3 6.1 19.7 11.3 8.7 8.2 0.7 0.1 0.0 0.1 0.1 0.1 0.2 0.4 0.4 0.2 1.7 0.4 0.2 0.3 0.6 0.2 0.2 1.6 0.1 7.9 10.6 8.7 21.4 10.6 7.8 7.8 8.1 8.3 7.4 9.0 8.6 1.9 0.0 0.0 11.4 1.1 0.0 0.3 0.5 1.8 4.2 1.1 0.9 0.9 0.0 0.3 0.0 0.0 0.2 0.5 1.6 0.0 0.2 47.4 1.7 0.8 2.3 0.0 0.4 12.3 0.5 0.1 1.3 1.5 0.9 0.0 0.5 2.9 1.1 0.6 10.1 13.4 0.7 2.0 0.8 0.8 103.7 0.3 1.2 0.0 12.2 0.8 2.7 0.0 10.6 17.1 0.1 0.7 1.5 1.8 0.8 1.4 0.8 1.0 3.0 0.0 1.7 1.1 10.4 0.5 2.9 0.0 0.1 1.8 0.9 1.2 0.3 FBXL8 Fbl8 ENSG00000135722 "F-box and leucine rich repeat protein 8" Q96CD0 16 67159932-67164570 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 43.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035587, HPA035588" Uncertain Approved "Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 6: T47d - Mammary gland" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA035587: AB_2674690, HPA035588: AB_10670023" "unprognostic (1.31e-1)" "unprognostic (1.95e-1)" "unprognostic (3.57e-2)" "prognostic favorable (5.39e-4)" "unprognostic (3.79e-1)" "unprognostic (3.27e-2)" "unprognostic (2.94e-2)" "unprognostic (9.14e-2)" "unprognostic (1.21e-1)" "unprognostic (4.67e-1)" "unprognostic (1.06e-2)" "unprognostic (2.22e-2)" "unprognostic (1.13e-3)" "unprognostic (2.68e-1)" "unprognostic (3.88e-2)" "unprognostic (1.47e-1)" "unprognostic (7.17e-3)" 12.2 24.0 3.1 5.4 4.2 3.4 18.4 5.3 5.7 17.7 1.7 16.6 9.8 17.0 2.5 15.6 20.3 2.3 10.9 3.7 1.7 14.6 16.7 14.6 4.3 5.2 3.2 16.2 53.5 4.9 24.9 5.7 4.3 35.5 6.4 2.2 35.8 2.6 11.2 30.1 12.2 2.5 2.2 13.5 22.6 4.3 3.9 2.0 20.9 1.2 2.7 12.7 14.9 8.6 5.9 7.2 1.1 9.7 5.2 9.2 25.0 4.9 4.0 4.0 4.0 6.8 16.0 4.6 7.4 4.6 4.0 19.9 2.9 4.8 1.1 11.9 11.7 4.7 17.2 7.5 3.7 2.7 18.1 6.9 5.2 4.2 3.4 11.6 2.6 12.6 9.3 10.1 2.8 16.8 3.9 10.4 0.6 5.4 17.6 12.7 3.3 22.4 6.1 8.1 10.2 9.5 12.4 6.4 3.3 2.9 31.7 6.2 6.3 10.0 11.5 23.4 4.4 43.4 10.4 6.0 11.0 8.7 6.1 5.1 4.7 4.9 3.8 2.2 3.4 1.6 10.7 5.0 2.4 1.7 2.3 2.4 6.4 5.8 2.0 4.3 4.0 3.1 3.1 4.2 5.3 5.7 3.7 1.7 5.2 3.2 4.3 2.2 3.9 8.6 3.4 0.0 3.1 0.0 2.8 3.2 4.4 3.4 17.1 1.7 5.0 4.3 0.9 7.2 5.1 5.5 8.4 2.8 6.0 7.6 1.9 6.9 0.1 3.3 3.4 3.2 6.7 0.4 0.2 8.0 3.1 4.6 18.8 3.7 0.0 4.7 1.8 4.4 2.8 5.0 0.1 10.4 2.0 1.9 2.9 0.5 9.3 2.9 10.6 0.0 7.7 1.9 8.2 0.0 1.1 9.3 5.2 5.7 4.6 5.4 10.6 6.2 4.1 4.7 6.6 2.4 4.2 0.1 1.0 7.2 4.4 1.5 4.2 8.4 9.0 5.6 FBXO31 "FBX14, Fbx31, FBXO14, MGC15419" ENSG00000103264 "F-box protein 31" Q5XUX0 16 87326987-87392142 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 65.3" "Cell type enhanced" "Detected in many" "Adipocytes: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030150 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Golgi apparatus, Cytosol" "HPA030150: AB_10670559" "unprognostic (4.85e-1)" "unprognostic (5.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.53e-2)" "unprognostic (4.04e-1)" "unprognostic (2.25e-1)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.16e-5)" "unprognostic (3.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.57e-3)" "unprognostic (2.26e-3)" 33.7 12.8 6.8 6.0 8.5 5.7 24.3 39.0 14.5 14.9 0.0 20.9 8.6 21.7 4.4 10.2 16.8 6.2 18.2 11.9 13.4 5.3 15.9 8.7 6.4 8.3 5.5 15.0 13.1 8.2 19.4 4.9 11.1 10.2 5.8 8.1 11.1 10.7 65.3 17.0 15.9 11.1 2.7 5.2 11.5 18.7 9.5 5.7 8.7 36.8 4.6 21.8 13.0 7.6 7.0 13.1 4.3 11.7 21.6 12.9 12.5 12.0 11.9 11.6 6.1 11.9 5.8 16.3 12.9 12.7 5.9 10.6 8.3 10.0 7.7 7.5 15.5 5.5 8.7 34.1 12.1 5.3 4.4 15.4 8.3 15.2 14.3 7.6 7.2 8.3 15.9 6.3 6.3 10.1 13.0 7.3 8.4 7.3 11.5 16.1 5.1 7.0 5.2 4.9 20.0 9.7 26.7 5.4 8.3 3.1 8.5 4.6 10.1 11.2 8.5 10.8 9.6 14.4 12.0 20.1 9.0 9.8 7.0 0.5 0.1 0.0 0.2 0.1 0.4 0.6 0.4 0.6 0.1 0.3 0.4 0.5 0.2 0.0 0.2 0.2 1.1 0.4 6.8 8.5 39.0 14.5 11.9 13.4 8.3 5.5 11.1 2.7 9.5 7.6 61.3 0.0 4.6 13.1 7.3 14.7 5.1 3.3 17.1 13.8 6.4 6.7 20.6 2.8 2.1 5.5 33.3 10.8 4.6 19.3 0.0 3.6 9.2 18.0 10.6 16.0 9.0 9.5 21.6 5.1 3.1 10.1 6.6 11.1 0.0 5.3 5.3 29.5 4.0 0.0 21.9 11.7 4.1 4.4 7.7 26.3 8.1 2.9 3.6 10.3 4.1 5.3 3.1 8.5 13.6 3.5 17.2 11.3 7.2 5.4 33.6 5.5 11.7 11.9 19.7 8.6 9.8 17.9 6.1 14.6 12.9 7.3 9.0 5.9 16.5 4.5 FBXW4 "dactylin, Fbw4, SHFM3" ENSG00000107829 "F-box and WD repeat domain containing 4" P57775 10 101610664-101695295 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043496 Approved Approved "Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA043496: AB_2678514" "unprognostic (4.31e-2)" "unprognostic (5.43e-3)" "unprognostic (8.40e-3)" "prognostic favorable (4.91e-4)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-1)" "unprognostic (9.96e-3)" "unprognostic (1.87e-1)" "unprognostic (3.96e-1)" "prognostic favorable (4.67e-4)" "unprognostic (1.13e-2)" "prognostic favorable (3.41e-5)" "unprognostic (2.94e-3)" "unprognostic (1.81e-1)" "unprognostic (4.99e-2)" "unprognostic (1.85e-2)" 38.4 30.4 89.9 10.4 96.6 16.0 34.8 83.5 96.3 33.2 71.3 59.9 16.5 26.7 29.6 38.7 28.9 12.9 62.4 80.9 81.1 36.4 34.9 35.8 18.0 92.3 92.1 30.2 44.2 47.0 46.7 16.4 87.8 49.1 16.5 14.2 41.4 26.8 80.0 49.7 31.5 14.7 94.8 30.1 40.8 22.8 94.2 18.1 40.2 44.4 17.9 49.0 32.9 98.0 22.1 25.7 4.0 28.9 20.1 16.5 18.9 11.3 31.1 12.8 10.0 12.0 22.9 25.1 17.5 23.4 13.1 13.4 11.0 16.7 4.3 26.8 15.2 6.0 9.1 26.1 35.7 10.0 7.6 15.2 52.0 6.9 42.8 29.8 11.0 17.6 6.2 15.3 14.2 45.9 11.4 14.2 11.3 11.4 12.3 9.4 29.6 10.7 25.1 14.7 12.3 21.6 21.8 8.1 20.7 6.0 33.6 17.8 11.8 13.8 1.8 5.8 11.5 31.9 15.4 11.1 11.3 12.7 8.1 1.3 1.4 2.2 4.3 0.8 2.6 3.8 4.3 4.2 1.1 4.8 4.5 3.7 0.2 4.2 1.4 4.1 1.4 1.2 89.9 96.6 83.5 96.3 80.9 81.1 92.3 92.1 87.8 94.8 94.2 98.0 13.6 3.2 36.9 45.4 14.0 11.2 16.4 11.9 6.8 28.5 25.7 21.8 35.8 12.8 11.1 11.0 18.8 17.0 24.4 29.1 3.9 15.2 50.2 15.3 16.3 10.0 20.4 7.0 57.5 26.1 9.2 11.3 17.3 27.2 5.1 32.3 8.9 24.7 8.8 37.0 55.7 27.8 14.2 8.6 7.4 28.9 14.3 8.7 14.2 55.3 10.7 29.9 15.5 54.8 70.3 19.4 24.4 17.0 14.1 22.2 21.1 13.3 7.5 22.7 13.1 15.4 14.7 4.9 6.0 11.3 12.5 15.6 16.9 10.9 21.7 18.7 FCGBP FC(GAMMA)BP ENSG00000275395 "Fc fragment of IgG binding protein" 19 39863323-39934626 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 206.9;salivary gland: 85.4;stomach 1: 85.5;thyroid gland: 99.9" "Cell type enriched" "Detected in many" 9 "Intestinal goblet cells: 6081.9" "Cancer enhanced" "Detected in all" "colorectal cancer: 63.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.6;Daudi: 1.8;JURKAT: 1.7;MOLT-4: 1.8;RH-30: 7.1" "HPA003517, HPA003564" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytokinetic bridge" "Secreted in other tissues" Yes NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane" "Golgi apparatus, Cytokinetic bridge" "HPA003517: AB_1078838, HPA003564: AB_2231648" "unprognostic (1.65e-2)" "unprognostic (1.92e-2)" "unprognostic (1.62e-3)" "unprognostic (1.77e-2)" "unprognostic (2.04e-2)" "prognostic favorable (1.28e-5)" "prognostic unfavorable (4.74e-5)" "unprognostic (1.36e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (9.70e-6)" "unprognostic (9.44e-2)" "unprognostic (3.03e-2)" "unprognostic (5.92e-3)" "unprognostic (8.60e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.08e-1)" 5.9 10.0 5.1 14.0 7.2 0.4 3.2 4.0 8.4 56.4 15.0 206.9 68.7 1.2 0.6 4.6 9.8 49.2 2.9 5.6 6.8 11.3 1.0 1.9 0.9 20.1 10.6 3.7 4.9 0.5 3.4 2.9 11.1 3.8 67.7 0.6 85.4 1.4 0.4 14.8 148.7 2.6 5.9 1.5 85.5 2.9 14.0 1.5 99.9 0.0 0.7 3.4 1.6 12.0 0.0 4.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 1.8 0.6 0.1 1.5 0.3 0.1 7.1 1.6 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.1 5.1 7.2 4.0 8.4 5.6 6.8 20.1 10.6 11.1 5.9 14.0 12.0 0.6 3.2 5.1 2.6 4.6 3.7 1.9 15.8 1.2 1.1 1.3 3.4 2.8 70.1 60.0 25.8 0.0 0.7 1.8 622.2 0.0 5.2 7.2 4.2 0.3 26.7 81.1 0.0 0.6 0.9 0.4 1.9 552.0 4.0 15.9 0.4 0.7 1.3 44.0 0.0 0.4 6081.9 2.0 30.2 12.6 9.2 0.9 21.6 8.8 15.9 0.9 0.4 1.0 0.5 0.2 3.9 253.6 0.0 2.1 13.8 413.5 1.2 11.0 2.0 59.2 0.5 1.1 0.5 2.4 0.4 6.8 0.4 5.6 0.9 191.4 164.1 FCGR1A "CD64, CD64A" ENSG00000150337 "Fc fragment of IgG receptor Ia" P12314 1 149782671-149791675 "CD markers, FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 93.3;lymphoid tissue: 41.3" "Cell type enhanced" "Detected in some" "Hofbauer cells: 283.3;Kupffer cells: 140.9;Late spermatids: 64.9;Macrophages: 94.9" "Cancer enriched" "Detected in many" 4 "glioma: 10.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 131.5;intermediate monocyte: 54.7;myeloid DC: 35.6;neutrophil: 93.4" "Group enriched" "Detected in many" 53 "dendritic cells: 35.6;granulocytes: 93.4;monocytes: 131.5" "Cell line enriched" "Detected in some" 5 "THP-1: 191.6" "Low region specificity" "Detected in all" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (5.27e-2)" "unprognostic (2.89e-2)" "unprognostic (2.34e-2)" "unprognostic (7.97e-2)" "unprognostic (8.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (4.83e-8)" "unprognostic (1.28e-1)" "unprognostic (4.51e-2)" "unprognostic (9.99e-2)" "unprognostic (9.03e-2)" 12.2 7.2 8.4 41.3 8.9 17.9 3.6 8.8 12.8 4.2 8.4 2.3 1.1 1.6 93.3 1.7 1.8 8.2 2.2 8.6 9.4 2.8 4.2 28.6 14.4 14.6 10.6 2.3 4.3 2.7 2.5 32.6 13.0 1.6 2.1 2.3 1.9 2.4 0.3 0.4 1.3 19.1 13.2 12.5 2.1 3.7 12.2 1.4 1.4 0.8 0.8 14.7 0.8 18.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 13.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.3 191.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 24.4 0.0 2.0 131.5 1.6 0.0 54.7 0.7 1.6 0.0 0.3 35.6 0.0 0.0 0.1 93.4 0.0 11.8 0.9 0.3 48.5 8.4 8.9 8.8 12.8 8.6 9.4 14.6 10.6 13.0 13.2 12.2 18.9 0.3 0.0 3.1 0.0 0.8 0.1 0.0 0.0 0.6 1.5 0.2 0.8 1.7 1.5 1.3 0.0 2.1 2.7 0.0 0.0 0.0 0.0 30.8 0.1 0.1 9.3 0.0 2.7 0.1 0.0 1.3 1.0 0.0 0.1 0.0 0.2 1.8 0.5 283.3 0.0 0.1 0.0 0.0 140.9 6.0 64.9 0.3 94.9 0.0 7.5 34.7 0.3 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.7 1.3 6.6 0.2 0.3 0.6 0.4 0.1 0.0 4.1 0.6 0.1 0.1 0.0 FCGR1B CD64b ENSG00000198019 "Fc fragment of IgG receptor Ib" Q92637 1 121087345-121097161 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 51.5;lymphoid tissue: 18.9" "Cell type enhanced" "Detected in some" "Hofbauer cells: 86.5;Kupffer cells: 51.5;Late spermatids: 14.6;Macrophages: 36.6;monocytes: 16.4;Sertoli cells: 19.7" "Cancer enriched" "Detected in single" 4 "glioma: 1.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 31.2;neutrophil: 36.3" "Group enriched" "Detected in many" 4 "granulocytes: 36.3;monocytes: 31.2" "Group enriched" "Detected in some" 6 "NB-4: 19.8;THP-1: 73.9" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (3.21e-2)" "unprognostic (4.35e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (9.60e-2)" "unprognostic (1.56e-2)" "unprognostic (6.42e-2)" "unprognostic (3.10e-2)" "unprognostic (8.17e-2)" "unprognostic (1.91e-1)" "unprognostic (3.65e-1)" "unprognostic (3.24e-10)" "unprognostic (8.99e-2)" "unprognostic (2.85e-2)" "unprognostic (7.86e-3)" "unprognostic (8.93e-2)" 5.0 3.0 4.4 18.9 4.5 6.6 1.8 4.5 7.8 1.0 3.7 0.7 0.5 0.7 51.5 0.7 0.8 1.9 1.1 4.6 4.7 1.4 1.7 6.8 2.2 6.1 5.7 0.6 2.6 0.7 1.0 11.0 6.2 0.8 0.8 0.8 0.9 0.6 0.4 0.2 0.7 5.8 6.0 7.2 0.9 0.7 6.2 0.4 2.1 0.1 0.3 4.0 0.4 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.9 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 19.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.3 1.0 73.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 31.2 0.6 0.0 19.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 36.3 0.0 12.4 0.3 0.0 8.8 4.4 4.5 4.5 7.8 4.6 4.7 6.1 5.7 6.2 6.0 6.2 6.4 0.4 0.0 2.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.6 2.2 0.0 0.6 0.0 2.1 0.8 0.1 0.1 0.0 0.0 7.7 0.2 0.2 2.0 0.0 0.8 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.4 0.4 0.3 86.5 3.3 0.1 0.0 0.0 51.5 4.1 14.6 1.2 36.6 0.0 11.2 16.4 0.1 1.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 19.7 0.6 0.1 0.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.1 FCGR2A "CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2" ENSG00000143226 "Fc fragment of IgG receptor IIa" P12318 1 161505430-161524013 "CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 101.7;placenta: 107.3" "Cell type enhanced" "Detected in many" "Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 2322.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 2322.4" "Cell line enhanced" "Detected in some" "HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7" "HPA010718, HPA010776, HPA014730" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA 46000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 19: Lung - Lung function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane" "Golgi apparatus" "HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074" "unprognostic (2.57e-2)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (4.12e-2)" "unprognostic (5.89e-2)" "unprognostic (6.17e-2)" "unprognostic (1.24e-2)" "unprognostic (1.17e-1)" "unprognostic (7.63e-2)" "unprognostic (1.17e-3)" "unprognostic (2.43e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (6.49e-7)" "unprognostic (8.85e-3)" "unprognostic (6.47e-3)" "unprognostic (1.54e-1)" "unprognostic (3.42e-2)" 68.0 24.8 7.3 101.7 6.6 48.6 13.3 8.0 12.1 18.1 13.9 16.0 8.1 7.3 4.3 11.7 14.6 36.8 11.5 6.5 11.5 12.7 12.3 77.5 16.1 15.1 11.4 7.2 12.7 8.5 7.6 107.3 13.3 6.1 21.0 2.3 9.9 9.6 2.6 3.5 10.8 40.9 11.9 61.8 10.1 4.4 13.8 9.8 6.4 10.2 7.7 68.3 5.2 21.8 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.0 0.0 2.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 29.4 0.3 0.0 0.7 8.6 56.2 0.5 0.0 0.0 0.0 0.7 0.1 0.0 17.9 0.5 0.0 0.0 0.4 15.8 0.0 0.0 1.1 0.2 1.2 8.1 0.0 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 61.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.4 26.7 6.6 2.4 358.3 421.8 0.7 268.4 1.0 3.2 0.5 0.4 89.9 1.7 0.4 0.7 2322.4 0.4 232.7 3.8 0.9 170.3 7.3 6.6 8.0 12.1 6.5 11.5 15.1 11.4 13.3 11.9 13.8 21.8 2.3 22.4 49.1 0.0 8.6 8.7 0.9 0.3 1.2 0.4 1.1 3.8 1.8 2.8 12.1 0.0 0.0 1.0 3.4 0.1 9.8 0.2 38.2 0.1 0.8 15.6 0.0 3.0 0.1 0.6 1.6 8.9 1.1 0.1 30.4 0.1 3.9 2.1 178.2 0.0 0.1 0.0 0.0 159.1 336.6 66.5 1.5 305.0 17.8 12.2 97.3 0.5 7.2 1.0 0.6 0.5 0.0 0.0 4.6 0.3 0.0 9.6 3.7 0.2 6.6 1.5 6.0 0.4 0.6 0.8 7.7 1.6 4.8 0.2 0.1 0.4 FEM1A ENSG00000141965 "Fem-1 homolog A" Q9BSK4 19 4791734-4801273 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "skeletal muscle: 273.6;tongue: 121.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016565, HPA063622" Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Golgi apparatus" Cytosol "HPA016565: AB_1848489, HPA063622: AB_2685063" "unprognostic (4.62e-2)" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" "unprognostic (3.60e-1)" "unprognostic (2.42e-3)" "unprognostic (2.04e-1)" "unprognostic (6.74e-2)" "unprognostic (1.25e-2)" "unprognostic (9.21e-2)" "unprognostic (2.28e-3)" "unprognostic (6.25e-2)" "unprognostic (6.18e-5)" "unprognostic (3.72e-3)" "unprognostic (1.25e-1)" "unprognostic (1.91e-1)" "unprognostic (4.70e-2)" 4.3 3.7 8.0 4.0 7.8 7.5 4.4 8.1 8.0 3.2 6.8 3.8 3.7 3.0 3.6 8.4 3.4 2.7 17.8 8.2 6.1 3.8 4.4 4.2 4.7 7.9 7.5 3.5 8.5 9.6 0.9 4.2 7.3 4.9 3.3 3.0 5.9 3.3 273.6 8.5 3.3 3.9 7.1 4.3 3.9 2.4 7.8 4.8 3.5 121.2 4.6 4.1 1.0 8.5 9.2 6.2 5.7 12.4 6.2 3.6 8.3 5.4 4.4 8.5 6.0 9.7 4.1 10.4 5.4 6.7 4.6 9.3 10.1 8.9 5.5 12.4 11.6 10.1 4.9 7.4 9.4 17.0 12.4 5.3 13.6 6.6 9.4 4.0 6.2 13.9 15.1 19.3 5.9 9.3 14.3 6.2 17.7 5.7 15.0 13.1 7.4 11.0 7.7 11.6 18.5 13.1 7.1 13.2 10.4 4.3 10.2 14.5 8.7 7.7 5.6 12.1 14.4 22.3 20.0 8.8 7.9 12.1 11.1 4.7 2.8 2.8 2.5 3.2 2.1 1.9 2.0 2.3 2.6 2.5 1.7 2.0 2.4 2.6 3.0 2.6 1.5 1.8 8.0 7.8 8.1 8.0 8.2 6.1 7.9 7.5 7.3 7.1 7.8 8.5 7.9 25.6 32.8 1.6 16.6 20.1 14.9 7.7 12.5 16.8 20.8 16.4 6.5 18.6 15.5 1.8 16.7 21.2 16.1 16.7 13.7 10.3 5.3 8.7 11.6 12.3 13.1 28.6 2.7 11.8 13.8 9.2 6.1 19.1 22.8 7.5 15.4 18.7 12.3 11.8 3.2 15.5 4.1 15.4 8.7 3.5 9.0 13.1 3.6 2.8 17.2 12.1 32.0 2.5 2.3 12.4 9.4 8.2 9.9 15.5 10.9 10.1 11.3 19.8 6.6 27.1 9.3 12.7 6.2 18.3 29.5 27.1 14.3 16.8 18.0 17.7 FEZ2 ENSG00000171055 "Fasciculation and elongation protein zeta 2" Q9UHY8 2 36531805-36646087 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 15.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035978 Uncertain Approved "Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoli, Nucleoli rim" "Golgi apparatus, Cytosol" "HPA035978: AB_10672235" "unprognostic (1.42e-1)" "unprognostic (5.02e-3)" "unprognostic (2.89e-1)" "unprognostic (1.15e-2)" "unprognostic (2.91e-2)" "unprognostic (1.94e-3)" "prognostic unfavorable (7.79e-6)" "unprognostic (1.09e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.65e-2)" "unprognostic (7.82e-3)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" 53.0 39.1 48.2 21.0 51.6 16.5 35.9 48.2 68.6 26.9 42.8 34.5 22.1 33.1 18.9 31.7 23.8 23.6 46.7 49.2 48.4 33.6 29.4 27.1 24.3 49.5 46.3 27.6 10.8 20.3 14.2 46.8 48.2 23.5 27.9 26.5 17.1 32.5 108.1 17.0 28.5 41.1 50.1 30.3 21.9 20.8 49.6 18.2 23.9 78.5 19.5 29.1 24.3 56.3 64.9 37.1 49.4 22.3 91.3 122.1 39.5 157.1 76.5 90.7 56.0 24.6 21.5 39.1 94.7 199.2 41.0 25.1 42.4 54.3 98.5 9.3 24.7 31.7 12.2 43.5 44.4 32.9 8.5 119.9 44.2 57.8 69.6 61.2 131.0 9.5 35.4 12.0 170.2 22.7 19.6 27.5 27.1 33.9 57.8 16.9 44.3 14.0 72.9 57.6 1.9 45.7 38.7 31.9 37.8 51.7 11.3 39.1 161.2 59.7 32.9 33.4 92.9 9.8 11.5 26.6 58.9 22.4 84.8 2.5 3.5 5.1 1.7 3.4 1.0 1.6 1.3 1.0 3.5 1.0 1.5 0.7 4.2 3.2 2.3 15.6 1.4 0.8 48.2 51.6 48.2 68.6 49.2 48.4 49.5 46.3 48.2 50.1 49.6 56.3 109.4 54.5 37.5 25.8 23.7 31.4 94.7 45.5 41.5 52.5 31.7 33.1 43.1 17.2 70.2 58.8 45.9 96.4 61.1 57.6 56.7 80.3 5.6 38.4 44.7 100.9 24.0 15.3 45.4 30.6 87.6 50.7 27.0 64.3 24.1 66.0 97.5 37.2 93.7 21.9 22.9 28.8 38.7 88.1 65.4 10.7 54.3 64.6 56.9 45.0 56.0 97.1 35.0 23.1 50.5 74.4 41.4 66.2 17.9 99.1 65.6 45.1 35.9 36.3 59.2 64.0 51.2 12.1 34.9 24.0 32.1 180.1 24.2 47.2 37.7 140.6 FKBP14 "FKBP22, FLJ20731" ENSG00000106080 "FKBP prolyl isomerase 14" Q9NWM8 7 30010587-30026702 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Deafness, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013329, HPA026829" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 44: Endometrium - Transcription" Cytosol "Nucleoplasm, Golgi apparatus" "HPA013329: AB_1848613, HPA026829: AB_10601651" "prognostic unfavorable (1.60e-4)" "unprognostic (1.12e-3)" "unprognostic (6.84e-2)" "unprognostic (1.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.41e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (6.06e-2)" "unprognostic (7.00e-2)" "unprognostic (6.99e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.57e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-3)" "prognostic unfavorable (4.25e-4)" 6.5 5.1 3.4 7.0 3.5 4.3 6.4 5.4 3.6 9.9 3.1 4.7 3.0 8.5 10.0 4.7 4.3 6.0 6.8 3.2 3.2 3.1 3.2 4.1 3.1 3.3 3.1 5.4 5.8 6.2 7.7 7.9 3.0 6.8 4.8 7.2 4.3 7.5 2.1 4.7 2.9 13.9 3.0 2.7 4.0 2.2 3.5 1.8 3.3 3.2 3.2 8.9 3.8 3.5 7.0 5.2 14.4 33.6 36.8 46.8 6.5 34.9 32.7 12.0 23.3 4.4 4.3 2.4 16.0 31.0 14.7 14.8 8.1 12.8 23.9 1.3 11.6 5.6 9.2 13.1 18.6 4.0 9.3 29.4 13.1 20.9 24.6 28.2 27.0 3.6 9.2 5.0 21.8 2.9 2.1 4.9 7.5 7.7 9.2 0.1 9.6 8.2 11.8 6.1 3.8 12.5 12.2 27.5 8.8 17.0 6.2 5.3 21.7 12.6 14.6 21.8 14.0 7.6 8.3 4.2 18.0 3.8 40.2 0.5 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.4 0.2 0.0 0.6 0.2 0.1 3.4 3.5 5.4 3.6 3.2 3.2 3.3 3.1 3.0 3.0 3.5 3.5 13.5 19.2 16.0 7.2 7.9 27.4 22.0 15.8 35.9 16.3 13.3 13.0 15.7 5.7 11.7 18.4 27.1 11.6 9.4 5.3 1.9 7.4 0.4 30.4 44.3 12.9 1.2 6.5 19.4 3.7 27.3 40.0 15.3 40.0 2.5 9.1 8.6 6.5 6.0 15.2 12.7 9.7 8.2 2.5 11.2 0.4 13.1 5.7 10.6 10.3 3.6 26.5 2.1 11.6 16.6 5.7 19.0 20.7 43.8 17.8 3.3 2.7 6.0 21.4 6.6 13.8 20.4 1.4 3.4 27.5 18.3 15.7 6.0 20.8 6.1 28.0 FKBP9 "FKBP60, FKBP63" ENSG00000122642 "FKBP prolyl isomerase 9" O95302 7 32957404-33006930 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 108.6;Fibroblasts: 89.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 379.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012595, HPA055256" Approved Approved "Golgi apparatus,Vesicles,Mitochondria" "Intracellular and membrane" No No 63000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Mitochondria" Vesicles "HPA012595: AB_1848629, HPA055256: AB_2682761" "unprognostic (1.23e-2)" "prognostic unfavorable (4.22e-4)" "unprognostic (6.94e-2)" "unprognostic (6.25e-3)" "prognostic unfavorable (5.80e-4)" "prognostic unfavorable (2.02e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (3.40e-2)" "unprognostic (9.59e-2)" "unprognostic (2.58e-1)" "unprognostic (3.63e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-2)" "unprognostic (6.31e-2)" "unprognostic (1.97e-1)" "unprognostic (8.90e-3)" "prognostic unfavorable (7.02e-6)" 80.7 44.8 23.9 16.8 24.0 2.3 59.1 26.5 25.3 65.9 28.1 44.8 19.7 55.7 22.4 35.6 50.6 44.4 77.1 21.4 32.1 38.2 21.1 49.6 13.6 28.9 30.2 46.3 40.8 25.1 34.8 77.4 29.3 42.3 45.3 11.7 36.0 52.1 35.0 64.4 31.0 74.4 28.0 23.7 41.0 11.4 34.2 8.2 40.8 49.7 15.8 43.3 52.2 27.9 38.9 71.4 27.6 113.4 254.1 290.2 36.4 202.6 209.9 65.5 103.9 31.6 89.2 0.2 80.7 379.5 105.1 73.3 40.8 100.0 75.2 0.1 11.9 6.6 72.3 31.6 105.6 0.4 10.8 191.8 59.6 59.0 56.9 156.3 83.9 0.1 15.0 7.7 137.3 37.1 0.2 19.4 5.8 76.6 37.3 0.3 73.7 0.3 73.0 13.0 25.7 62.4 115.6 58.4 73.4 69.6 41.1 18.7 112.8 107.0 99.8 67.4 46.8 23.9 48.9 0.2 104.4 0.3 218.5 0.9 2.2 0.5 0.0 1.6 0.0 0.2 0.0 0.0 0.8 0.1 0.1 0.0 4.0 0.1 0.4 0.1 0.0 0.6 23.9 24.0 26.5 25.3 21.4 32.1 28.9 30.2 29.3 28.0 34.2 27.9 108.6 12.8 21.7 22.9 0.6 34.3 12.7 31.4 10.2 8.2 15.7 16.5 46.1 17.2 10.3 18.4 10.4 18.8 0.6 23.2 5.9 19.5 0.5 22.6 25.8 80.1 12.2 1.7 9.8 41.5 27.7 89.1 17.9 23.0 5.7 81.0 60.0 18.0 7.6 11.8 10.2 25.4 10.2 8.6 23.5 3.2 36.7 5.4 60.5 15.0 2.9 30.5 0.0 8.5 8.8 36.5 22.1 55.3 4.4 8.1 18.8 8.1 11.0 5.2 46.0 21.2 45.8 1.0 1.3 12.1 28.6 13.1 3.1 12.3 27.7 10.5 FKRP "FKTR, LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: AB_2678324, HPA060454: AB_2684281" "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favorable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 10.5 9.1 8.5 8.1 8.2 8.8 9.9 3.7 11.5 11.4 4.5 13.3 4.8 15.2 5.0 8.8 12.6 6.0 15.8 8.5 10.4 12.0 11.9 10.4 7.4 10.1 7.3 12.7 11.1 7.5 16.8 10.1 8.8 13.5 4.3 5.7 11.1 7.4 19.6 7.2 10.5 5.8 6.1 14.7 10.9 9.3 9.4 5.6 13.6 9.8 4.9 13.0 10.5 8.7 12.7 26.5 17.8 12.5 15.4 16.9 15.8 31.7 21.0 12.6 19.9 17.0 21.4 11.7 17.0 18.2 20.9 13.0 6.6 14.8 11.5 21.9 22.2 11.7 14.4 10.7 13.3 9.3 19.8 19.4 12.5 15.6 15.2 14.6 16.7 6.0 12.2 11.0 12.7 5.8 6.8 22.8 17.2 7.8 6.5 18.3 11.1 4.0 8.0 26.4 12.0 23.1 15.8 7.6 10.6 11.7 8.9 7.3 16.8 18.4 19.8 6.7 25.7 11.6 15.4 11.0 15.0 7.5 25.6 1.3 1.8 0.8 1.5 1.0 0.9 1.7 1.1 1.7 1.1 2.4 1.2 1.6 2.2 2.0 1.1 1.9 0.6 1.2 8.5 8.2 3.7 11.5 8.5 10.4 10.1 7.3 8.8 6.1 9.4 8.7 4.7 9.6 7.4 6.8 3.9 0.8 4.8 3.0 1.2 9.8 5.3 5.2 15.5 4.3 5.6 5.5 6.2 9.6 9.1 4.5 5.9 4.2 12.0 7.9 7.3 6.0 7.8 7.8 6.8 2.4 5.9 6.6 3.6 5.1 1.3 6.7 11.4 16.6 7.6 3.3 8.2 4.2 2.0 10.0 1.2 13.2 5.6 4.3 5.4 3.7 6.1 7.8 2.1 8.0 6.2 4.1 4.7 4.1 3.6 4.3 4.2 8.2 9.7 11.0 6.6 7.2 7.0 12.2 4.0 2.4 1.6 18.7 4.3 4.5 4.0 4.3 FLNB "ABP-278, FH1, FLN1L, LRS1, TABP, TAP" ENSG00000136068 "Filamin B" O75369 3 58008400-58172251 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Differentiation, Myogenesis" "Actin-binding, Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 344.9;Pancreatic endocrine cells: 385.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 17.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 523.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004747, HPA004886, CAB019322" Enhanced Supported "Golgi apparatus,Plasma membrane,Actin filaments,Cytosol" NA NA 20000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 1: Thyroid gland - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Golgi apparatus, Actin filaments, Cytosol" "CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600" "unprognostic (1.29e-2)" "unprognostic (1.08e-2)" "unprognostic (5.97e-2)" "unprognostic (6.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.05e-1)" "unprognostic (6.52e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (8.45e-5)" "unprognostic (9.23e-2)" "prognostic favorable (3.45e-6)" "unprognostic (4.38e-2)" "unprognostic (1.36e-1)" "unprognostic (6.65e-3)" "unprognostic (2.33e-1)" 74.6 63.1 42.8 22.3 51.3 7.4 90.4 50.9 52.4 45.5 57.1 122.2 52.8 75.5 120.3 57.7 75.9 19.6 47.2 40.1 41.6 96.7 71.5 49.9 24.4 54.4 52.3 68.9 83.2 59.9 38.1 48.0 52.6 124.4 74.4 10.2 64.0 51.4 16.3 91.3 92.7 36.2 48.1 55.3 70.2 30.4 50.0 74.8 91.1 17.8 23.8 114.7 58.6 58.3 134.4 225.0 22.3 32.9 14.8 25.0 385.7 49.0 39.3 106.6 108.4 227.1 223.1 21.9 18.1 172.9 172.8 215.9 42.1 311.5 103.0 121.6 20.8 18.4 192.7 110.5 107.8 16.2 63.1 40.2 132.1 148.5 448.3 125.2 365.4 94.7 30.9 6.6 67.0 29.2 49.3 38.5 34.5 146.6 192.1 21.6 5.8 18.7 143.8 224.6 24.7 23.1 247.3 132.6 27.4 160.9 110.3 44.6 523.3 27.8 84.5 334.1 175.6 4.8 1.7 17.0 102.2 29.2 29.9 10.1 0.3 5.0 0.5 0.8 2.7 4.1 1.7 0.8 1.4 1.6 5.1 3.8 0.2 7.3 1.5 17.9 2.0 1.5 42.8 51.3 50.9 52.4 40.1 41.6 54.4 52.3 52.6 48.1 50.0 58.3 133.7 51.3 30.2 3.9 11.0 50.6 42.9 73.2 29.0 3.3 86.6 43.4 10.0 57.2 62.0 47.8 39.6 28.7 36.8 344.9 0.0 93.8 15.6 103.6 24.4 92.9 49.2 10.3 34.1 67.1 207.1 28.8 88.7 133.8 24.7 34.4 151.3 52.0 14.6 1.7 34.3 82.8 38.7 11.3 12.2 22.4 16.1 11.1 5.4 22.5 11.6 9.1 2.1 25.1 40.9 385.7 161.0 27.8 3.4 115.2 157.3 6.5 76.1 10.6 0.0 4.4 25.9 4.4 6.9 46.4 51.7 49.8 9.9 84.6 93.0 88.4 FLOT1 ENSG00000137312 "Flotillin 1" O75955 6 30727709-30742732 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 314.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 423.3;hTERT-RPE1: 242.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001393, CAB007766" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA 160000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "Vesicles, Plasma membrane" "CAB007766: AB_562116, HPA001393: AB_1078892" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (5.78e-4)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (3.41e-3)" "unprognostic (2.68e-3)" "unprognostic (1.86e-1)" "unprognostic (2.65e-1)" "prognostic favorable (3.06e-4)" "unprognostic (1.81e-2)" "unprognostic (9.36e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (6.43e-3)" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (2.46e-2)" 141.7 239.5 49.3 27.9 54.6 41.7 129.8 49.4 60.9 111.1 56.8 150.3 28.7 108.9 8.4 81.8 95.8 23.1 234.5 55.1 57.9 146.1 127.3 136.8 22.1 50.9 51.5 84.1 88.5 41.4 102.5 35.0 57.4 109.6 17.7 6.3 99.1 45.8 190.0 51.7 87.1 33.0 45.8 129.6 96.9 65.0 53.6 24.9 111.7 83.1 17.0 134.5 96.9 48.8 54.3 18.3 46.4 62.0 49.1 71.0 1.3 59.7 67.5 82.8 79.3 19.4 30.0 13.0 29.0 101.3 423.3 41.8 35.0 20.1 28.6 36.1 1.3 41.1 17.5 19.1 119.2 12.2 67.0 75.4 30.6 40.9 71.3 242.7 65.9 37.9 21.7 52.7 77.9 22.9 38.0 14.5 15.1 29.4 15.7 20.2 48.4 38.0 30.3 13.0 16.4 17.2 33.7 28.7 164.6 30.4 43.8 10.1 44.0 199.5 37.6 20.6 120.6 18.6 19.7 28.8 26.2 42.6 122.7 179.3 76.9 132.0 35.0 38.9 24.1 28.0 21.3 30.4 58.9 23.0 23.7 27.4 314.3 79.9 26.3 59.2 3.9 58.3 49.3 54.6 49.4 60.9 55.1 57.9 50.9 51.5 57.4 45.8 53.6 48.8 175.4 89.8 77.0 26.1 38.1 28.7 111.5 44.9 80.2 14.7 72.1 73.4 90.6 62.9 59.2 84.6 6.2 82.2 57.7 103.2 123.3 77.6 60.2 73.9 50.1 141.6 68.8 41.7 41.3 85.9 70.7 67.6 55.5 75.2 143.3 41.4 154.9 59.7 130.6 20.2 40.2 66.6 57.0 61.3 84.9 144.1 61.8 89.4 71.2 28.1 99.2 64.7 68.0 27.2 22.7 65.7 112.0 38.0 60.4 69.5 89.0 172.1 80.7 18.1 52.6 58.1 65.9 80.2 26.7 63.7 26.9 61.6 51.2 29.1 83.2 99.4 FMNL2 "FHOD2, KIAA1902" ENSG00000157827 "Formin like 2" Q96PY5 2 152335174-152649826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 223.5" "Cell type enhanced" "Detected in many" "Astrocytes: 668.0;Excitatory neurons: 574.9;Inhibitory neurons: 321.9;Oligodendrocyte precursor cells: 371.0;Oligodendrocytes: 2442.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 5 "monocytes: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 191.4;hTERT-HME1: 123.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005464 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 28: BEWO - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "Golgi apparatus, Plasma membrane" "HPA005464: AB_1848965" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (8.75e-3)" "unprognostic (3.06e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (9.04e-4)" "unprognostic (1.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (2.54e-1)" "unprognostic (4.66e-2)" "unprognostic (5.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.58e-1)" "unprognostic (3.73e-2)" "unprognostic (1.58e-1)" 26.4 25.2 88.9 11.1 152.3 0.7 20.8 135.2 119.3 18.1 73.6 15.2 8.9 20.7 14.9 8.5 15.3 16.8 12.0 92.9 102.6 22.2 8.1 32.2 14.2 172.3 136.3 54.0 18.1 23.1 28.4 58.2 165.5 15.2 12.3 10.6 32.1 11.7 24.1 11.3 11.6 16.3 121.6 19.8 17.3 9.0 128.5 14.8 33.1 19.3 8.4 19.3 18.3 223.5 14.5 15.1 45.9 25.5 54.5 58.3 191.4 14.4 29.4 24.9 34.8 16.3 0.9 0.3 29.8 12.6 53.7 16.2 22.4 45.8 39.6 0.1 23.4 0.2 10.0 70.2 15.7 4.0 0.8 38.4 27.8 48.2 123.5 48.3 44.7 6.6 0.6 0.3 13.9 4.0 0.8 4.5 29.5 12.4 30.0 25.9 9.9 20.9 72.9 9.9 46.6 38.0 12.2 4.5 51.4 38.7 1.1 1.5 49.9 37.4 1.0 12.7 25.0 1.3 0.5 0.1 34.7 3.3 77.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 88.9 152.3 135.2 119.3 92.9 102.6 172.3 136.3 165.5 121.6 128.5 223.5 21.5 25.6 25.9 668.0 2.7 26.4 23.0 14.0 19.4 23.8 11.4 10.0 3.8 1.5 16.4 11.0 0.0 36.1 4.5 2.6 13.7 20.4 24.5 14.1 10.8 29.1 8.3 0.4 574.9 6.9 17.8 36.2 8.2 27.0 1.3 36.0 20.0 1.3 40.6 0.0 321.9 3.3 10.2 64.8 53.0 10.5 35.1 31.5 7.2 245.4 4.4 3.9 1.0 371.0 2442.0 10.0 2.1 41.3 5.6 33.5 0.7 8.9 8.5 2.0 6.6 18.7 13.2 6.7 8.0 6.3 16.9 27.0 2.1 13.0 6.1 13.2 FMNL3 "DKFZp762B245, MGC45819, WBP3" ENSG00000161791 "Formin like 3" Q8IVF7 12 49636499-49708165 "Predicted intracellular proteins" Angiogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 35.8;Cone photoreceptor cells: 39.6;dendritic cells: 48.6;Microglial cells: 119.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002552, HPA023201" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Vesicles, Plasma membrane" Cytosol "HPA002552: AB_1078862, HPA023201: AB_1848575" "unprognostic (2.97e-1)" "unprognostic (2.77e-3)" "unprognostic (4.97e-3)" "unprognostic (7.19e-2)" "unprognostic (5.42e-2)" "unprognostic (2.33e-3)" "unprognostic (5.37e-3)" "unprognostic (1.52e-2)" "unprognostic (2.83e-1)" "unprognostic (1.54e-1)" "unprognostic (6.67e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (3.58e-5)" "unprognostic (1.04e-1)" "unprognostic (2.31e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" 12.2 5.7 13.7 20.5 13.2 5.2 10.6 13.0 11.2 9.6 3.0 8.0 5.7 11.2 19.2 4.5 6.9 11.1 12.6 11.0 12.6 9.3 2.7 17.4 23.5 21.7 14.6 16.1 3.2 3.6 4.1 14.0 18.2 6.0 5.6 2.7 4.6 4.4 5.6 4.4 10.2 11.5 17.7 13.4 6.6 10.1 20.4 20.1 13.4 6.7 28.3 8.6 6.3 20.4 8.6 2.5 18.4 6.1 5.0 20.1 0.2 10.4 21.0 13.8 12.1 9.7 2.3 18.2 19.5 12.4 15.2 0.4 9.5 4.3 12.6 16.2 3.6 20.1 2.9 0.5 8.8 4.0 25.1 12.7 0.7 21.7 9.1 41.2 37.1 9.0 4.6 13.0 20.5 6.3 16.6 6.0 6.0 0.9 5.5 7.9 23.0 2.8 13.1 1.3 3.0 8.6 6.0 0.8 11.8 9.3 1.5 5.9 47.2 34.2 11.8 0.6 18.2 6.7 0.4 9.8 21.3 12.4 14.7 3.0 0.1 0.8 0.8 0.4 0.4 0.2 0.3 0.5 0.2 1.1 0.4 0.5 0.0 0.6 0.3 5.1 0.1 0.5 13.7 13.2 13.0 11.2 11.0 12.6 21.7 14.6 18.2 17.7 20.4 20.4 35.8 3.2 3.4 6.8 17.5 1.7 0.7 0.4 2.2 11.3 1.3 2.3 3.3 0.0 1.4 1.8 39.6 2.1 48.6 0.1 0.0 0.3 2.0 0.7 2.6 29.7 0.0 1.7 16.0 0.6 0.8 7.1 1.5 2.0 27.8 5.4 15.7 0.8 11.1 3.3 6.5 0.8 0.0 6.9 9.0 4.6 3.7 17.7 5.4 119.0 22.9 0.5 16.5 27.6 5.5 0.8 0.1 6.4 1.8 0.8 0.0 0.2 0.2 2.0 13.1 15.5 10.3 5.9 7.5 0.4 1.4 2.5 13.6 2.6 0.1 0.4 FNDC3A "bA203I16.5, FNDC3, KIAA0970" ENSG00000102531 "Fibronectin type III domain containing 3A" Q9Y2H6 13 48975912-49209779 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008927, HPA012555, HPA012825" Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Golgi apparatus, Centrosome" Cytosol "HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985" "unprognostic (1.54e-1)" "unprognostic (1.34e-3)" "unprognostic (8.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (2.91e-2)" "unprognostic (5.71e-2)" "unprognostic (6.17e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-2)" "unprognostic (4.03e-2)" "prognostic favorable (4.25e-4)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (9.60e-2)" "unprognostic (6.14e-2)" 17.8 39.9 15.2 18.7 18.6 17.0 26.3 12.7 16.4 35.2 13.6 23.3 27.5 32.1 38.8 13.1 26.5 26.8 14.0 15.3 39.4 29.7 66.9 21.6 16.7 16.7 19.6 35.4 43.1 27.7 30.8 44.1 17.4 22.1 24.0 21.9 36.8 33.9 10.1 11.4 23.8 26.0 15.5 22.6 28.8 30.4 31.9 21.3 51.2 13.1 18.9 25.6 14.1 17.9 11.6 13.1 47.1 12.4 58.3 73.0 9.2 53.3 70.8 50.2 36.3 17.9 27.7 8.8 9.7 40.5 21.8 12.4 28.4 18.1 72.6 22.1 21.9 14.3 36.9 33.2 35.3 13.4 2.3 37.7 24.8 44.7 51.4 47.1 52.6 11.9 18.0 21.0 55.4 4.7 13.3 26.7 23.2 25.0 11.0 12.6 18.8 16.4 42.4 21.2 17.8 29.4 20.1 17.8 38.8 29.8 9.6 26.0 41.7 26.1 17.9 24.3 38.3 25.4 14.4 8.1 19.6 16.9 27.4 1.9 3.0 1.9 2.5 2.0 3.6 3.3 2.9 2.2 1.9 2.2 3.7 3.3 4.5 2.1 4.0 4.0 2.6 1.7 15.2 18.6 12.7 16.4 15.3 39.4 16.7 19.6 17.4 15.5 31.9 17.9 46.7 54.5 49.0 88.2 36.2 18.4 37.4 17.5 44.3 52.0 33.4 25.5 27.1 27.1 28.9 36.8 37.5 13.2 36.4 21.6 13.7 30.6 45.9 42.1 74.3 42.4 43.5 17.9 159.5 36.2 38.2 58.0 57.6 56.4 31.6 38.8 32.9 74.2 25.4 35.3 170.8 37.4 18.3 31.8 24.4 13.1 33.8 45.5 37.4 112.4 27.0 52.7 24.7 177.9 178.2 25.5 29.0 39.5 165.9 44.2 37.8 48.0 35.6 42.5 6.6 48.0 50.8 89.8 33.7 20.3 11.9 32.3 30.9 46.4 24.7 26.4 FO681492.1 ENSG00000277758 Synaptotagmin-15 10 47749758-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.3;lung: 12.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 11.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-BR-3: 68.9" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 2.7 0.7 2.1 1.2 2.4 0.1 2.2 0.0 11.3 2.3 0.0 0.8 0.3 1.3 0.5 2.5 2.1 1.1 1.3 5.0 0.0 0.5 0.4 12.2 3.7 0.0 0.0 0.7 4.1 0.8 0.3 2.5 0.0 1.1 0.6 0.5 1.8 1.3 0.6 3.2 0.8 0.9 0.2 0.9 0.6 0.3 0.2 0.8 1.1 0.6 1.9 1.1 2.0 1.0 0.4 4.1 0.4 0.5 0.2 0.3 0.2 2.8 0.4 0.3 0.3 4.5 4.0 0.1 0.3 2.2 1.3 0.5 0.0 0.1 0.4 0.1 1.6 0.0 0.8 0.4 3.9 0.3 0.8 0.4 0.2 0.3 0.7 0.4 0.3 1.9 0.1 0.4 0.2 7.6 0.2 0.6 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.2 0.6 0.2 5.2 68.9 0.2 0.2 5.4 0.3 0.5 0.3 0.7 0.3 0.2 0.3 0.3 0.2 0.4 0.1 0.9 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 11.3 5.0 0.0 0.0 0.0 0.0 0.2 0.2 1.0 0.1 3.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 195.3;lymphoid tissue: 166.0" "Group enriched" "Detected in many" 5 "Hofbauer cells: 119.6;Kupffer cells: 215.3;Macrophages: 178.5;monocytes: 89.7" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 4199.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 4199.5" "Group enriched" "Detected in some" 5 "LHCN-M2: 17.2;U-87 MG: 67.1" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: AB_2679694, HPA061744: AB_2684600" "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 69.6 10.0 3.8 166.0 4.4 195.3 5.3 4.1 8.7 8.2 5.7 4.6 3.1 3.7 0.5 8.9 15.4 28.6 7.5 3.6 8.1 4.5 21.4 50.8 12.7 15.2 8.2 2.4 11.2 5.1 3.5 45.1 11.9 3.1 3.3 2.6 4.1 2.3 1.8 1.3 5.2 42.9 8.6 129.2 5.4 2.2 9.9 8.4 3.1 22.8 10.3 66.9 2.7 18.2 0.5 0.8 0.3 0.4 1.0 2.1 0.5 0.2 0.0 0.5 2.0 0.3 0.7 1.2 0.6 0.0 3.9 0.4 0.0 0.0 0.1 0.1 0.0 0.7 0.9 1.0 6.0 0.3 0.5 4.8 0.2 1.8 1.8 9.2 0.0 0.3 0.1 0.6 17.2 0.9 0.1 0.3 0.4 0.3 0.7 0.3 0.7 0.0 1.5 0.5 0.2 0.3 0.6 0.1 0.5 0.2 1.0 1.1 1.0 2.0 0.4 0.1 3.5 0.2 0.0 0.5 67.1 1.7 0.1 317.1 759.9 204.9 1.6 319.7 1.5 0.7 1.0 0.7 174.1 1.0 1.0 1.2 4199.5 0.4 201.8 8.1 1.3 420.3 3.8 4.4 4.1 8.7 3.6 8.1 15.2 8.2 11.9 8.6 9.9 18.2 0.1 16.0 25.7 0.0 1.8 0.6 0.3 0.0 0.0 1.0 0.1 0.3 0.2 0.0 15.5 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.8 0.0 0.1 6.3 0.0 2.5 0.2 0.0 1.6 4.7 0.5 0.1 26.5 0.0 2.5 2.1 119.6 0.0 0.1 0.0 0.0 215.3 4.7 2.0 0.3 178.5 0.0 3.7 89.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.4 8.8 0.3 6.6 0.6 0.8 0.6 0.8 0.2 0.0 3.0 2.5 0.0 0.0 0.1 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 85.0;skeletal muscle: 81.2;tongue: 74.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 108.6;Cardiomyocytes: 73.7;Cone photoreceptor cells: 79.2;Early spermatids: 121.9;Horizontal cells: 101.0;Late spermatids: 122.8;Sertoli cells: 72.3" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 27.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.0;intermediate monocyte: 3.4;neutrophil: 2.5;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 7 "granulocytes: 2.5;monocytes: 3.4" "Cell line enhanced" "Detected in many" "HEL: 24.0;OE19: 49.2;RPMI-8226: 79.6;SCLC-21H: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 38: Heart - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "Plasma membrane" "HPA017285: AB_2669569" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.68e-3)" 9.4 7.3 6.6 2.0 5.5 5.4 6.7 4.3 6.8 3.0 12.0 5.5 2.9 2.7 15.7 2.5 2.2 2.5 85.0 6.3 7.7 14.9 0.7 4.0 1.3 10.1 8.5 1.4 1.6 20.6 4.2 14.8 7.3 2.8 6.6 21.6 2.9 7.8 81.2 2.1 6.7 3.5 7.6 7.2 2.8 9.9 9.9 1.1 7.1 74.7 0.5 4.6 2.6 5.4 0.0 4.3 3.8 0.3 0.7 0.2 0.3 4.1 0.3 0.1 0.0 0.5 5.2 0.9 4.7 1.9 0.9 0.2 0.2 0.0 0.0 0.2 0.2 24.0 4.8 2.8 0.2 0.0 0.3 1.0 0.1 0.0 0.2 0.2 2.7 0.1 0.1 0.1 4.9 0.7 0.0 0.1 0.4 49.2 7.2 0.1 3.0 79.6 6.2 10.1 28.4 13.8 1.4 0.3 0.9 0.6 1.7 0.8 4.4 0.2 0.6 0.1 2.9 0.4 0.3 0.0 0.9 7.6 2.8 0.0 2.0 0.0 0.2 3.4 0.4 0.3 0.1 0.0 0.2 0.4 0.0 0.0 2.5 0.3 1.5 0.4 0.0 6.0 6.6 5.5 4.3 6.8 6.3 7.7 10.1 8.5 7.3 7.6 9.9 5.4 38.4 22.4 1.1 6.2 0.4 1.0 1.0 0.6 0.6 108.6 2.6 1.9 73.7 15.7 1.8 1.8 79.2 0.4 0.2 28.9 17.6 2.8 121.9 2.8 1.4 25.8 1.2 0.8 37.9 2.0 1.2 8.8 2.0 3.9 0.0 0.4 4.2 0.3 0.8 101.0 70.0 38.3 0.0 4.4 0.6 122.8 2.1 8.3 0.0 27.2 4.2 3.9 1.0 10.1 16.0 2.3 10.0 4.9 0.0 1.6 43.6 12.4 3.2 7.0 72.3 66.6 50.7 4.1 1.4 0.2 1.3 0.1 0.9 29.8 2.4 2.3 FRMD4A "bA295P9.4, FLJ10210, FRMD4, KIAA1294" ENSG00000151474 "FERM domain containing 4A" Q9P2Q2 10 13643706-14462142 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.8" "Group enriched" "Detected in many" 7 "Excitatory neurons: 1527.6;Inhibitory neurons: 1622.8;Microglial cells: 1329.4;Oligodendrocyte precursor cells: 442.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.3" "Lineage enriched" "Detected in single" 5 "B-cells: 2.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 134.0;HUVEC TERT2: 105.8;TIME: 191.6;WM-115: 163.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038449 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoplasm "HPA038449: AB_10669539" "unprognostic (6.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.51e-3)" "unprognostic (5.68e-2)" "unprognostic (1.55e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.21e-3)" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (9.20e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" "unprognostic (8.16e-2)" "unprognostic (1.84e-1)" 60.8 5.2 38.9 11.7 28.1 5.4 18.7 0.0 29.2 8.6 0.0 13.1 5.7 5.7 4.0 9.4 8.8 9.6 16.7 24.1 8.5 19.5 12.2 14.2 9.1 15.6 10.9 6.8 15.5 2.4 8.7 22.5 6.2 10.3 6.4 14.1 13.6 10.2 8.1 32.0 7.4 6.5 10.0 32.8 7.9 8.8 14.4 15.6 8.1 7.3 8.4 10.4 8.9 18.9 7.0 7.1 90.1 0.5 12.3 22.0 16.9 40.8 36.5 35.2 48.7 12.1 4.2 0.1 28.3 21.5 48.6 13.5 0.3 3.3 30.7 0.3 9.9 1.4 0.9 0.2 11.0 0.5 1.1 12.8 3.2 134.0 16.4 98.9 105.8 3.1 13.6 0.4 64.7 8.5 4.6 0.8 24.6 0.3 9.6 0.4 30.8 0.2 16.6 5.8 4.3 15.9 0.2 32.7 64.4 16.1 18.5 3.3 191.6 48.8 17.4 47.6 49.3 0.3 0.4 0.3 41.7 1.0 163.4 0.1 0.1 0.0 0.0 0.1 0.1 0.8 0.3 0.1 0.0 2.3 0.3 0.0 0.3 0.2 0.0 0.4 0.4 0.0 38.9 28.1 0.0 29.2 24.1 8.5 15.6 10.9 6.2 10.0 14.4 18.9 48.6 32.1 2.6 168.1 1.7 35.1 13.1 3.0 9.1 54.2 17.1 14.4 11.4 45.8 4.1 33.1 18.8 69.6 0.4 1.1 11.7 15.8 42.5 13.1 5.5 44.0 4.8 81.7 1527.6 4.0 42.1 14.9 4.6 26.9 15.2 58.1 44.3 6.2 35.9 80.8 1622.8 3.4 6.1 95.6 19.9 98.8 2.1 25.5 16.0 1329.4 2.7 46.0 0.0 442.3 61.0 1.8 1.4 1.9 0.9 8.0 0.3 2.7 2.5 12.9 13.1 41.2 45.5 1.3 2.1 20.6 32.7 28.7 3.0 5.3 5.4 4.3 FRMD4B "GRSP1, KIAA1013" ENSG00000114541 "FERM domain containing 4B" Q9Y2L6 3 69168782-69542583 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.0" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1209.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 39.8;hTERT-HME1: 52.7;HUVEC TERT2: 55.1;TIME: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009705 Uncertain Supported Approved "Nucleoplasm,Golgi apparatus,Centriolar satellite" NA NA 17000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Centriolar satellite" "Nucleoplasm, Golgi apparatus" "HPA009705: AB_1849147" "unprognostic (1.36e-1)" "unprognostic (2.92e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (4.59e-2)" "unprognostic (9.73e-2)" "unprognostic (1.49e-1)" "unprognostic (2.02e-1)" "unprognostic (2.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.09e-2)" "unprognostic (8.23e-2)" "prognostic favorable (5.01e-4)" "unprognostic (1.49e-1)" "unprognostic (7.54e-2)" "unprognostic (2.79e-1)" "unprognostic (4.39e-3)" 11.0 4.8 17.5 12.3 46.7 15.5 16.1 26.9 30.9 24.9 7.0 12.8 9.1 11.3 9.3 26.8 13.2 19.2 17.4 20.8 29.3 16.3 34.5 24.8 10.9 39.4 37.1 10.9 8.2 3.7 4.0 25.5 36.3 16.9 12.9 21.9 37.1 10.5 2.3 23.0 12.5 10.5 22.7 32.3 15.0 4.7 42.0 14.1 27.1 4.6 11.2 13.7 15.8 84.0 6.7 1.8 10.4 0.3 0.2 1.5 11.3 0.5 1.7 0.8 0.5 39.8 11.3 0.8 3.5 0.5 1.0 25.9 4.9 35.3 1.2 2.2 3.3 20.4 2.6 2.3 0.7 5.2 10.2 1.7 35.2 1.0 52.7 1.6 55.1 4.7 1.6 5.8 3.0 7.7 0.5 0.8 5.6 8.9 8.5 32.2 2.8 1.0 14.8 4.6 12.1 15.6 1.7 12.2 35.5 9.3 4.6 6.8 47.1 0.6 4.3 0.4 1.8 0.6 0.3 1.2 0.4 13.5 13.5 18.3 27.6 2.3 1.9 13.8 7.0 1.6 6.3 2.8 16.9 2.0 1.9 1.8 7.1 3.8 2.3 16.8 15.4 7.7 17.5 46.7 26.9 30.9 20.8 29.3 39.4 37.1 36.3 22.7 42.0 84.0 20.6 41.7 83.6 2.9 3.6 60.7 33.4 57.8 69.4 13.8 34.4 21.7 33.4 41.5 58.5 14.7 218.9 49.9 20.3 74.4 33.2 32.6 18.9 207.9 49.3 64.3 24.5 8.6 4.2 17.3 19.7 32.1 75.4 282.6 34.7 97.5 89.3 53.6 92.6 0.0 92.7 42.1 36.7 138.7 112.7 4.0 6.5 105.2 28.4 93.7 26.3 13.5 1.0 129.2 1209.1 24.5 67.0 18.4 6.9 61.1 10.7 55.6 38.2 109.2 6.6 11.8 21.0 0.0 3.5 79.9 51.4 58.3 44.6 32.1 32.2 172.8 FSD1L "CCDC10, CSDUFD1, FSD1CL, FSD1NL" ENSG00000106701 "Fibronectin type III and SPRY domain containing 1 like" Q9BXM9 9 105447796-105552433 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 43.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 423.3;Early spermatids: 97.2;Excitatory neurons: 79.0;Rod photoreceptor cells: 121.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035138 Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" "Golgi apparatus, Vesicles" "HPA035138: AB_10601324" "unprognostic (9.28e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.88e-3)" "unprognostic (3.93e-2)" "unprognostic (1.82e-2)" "unprognostic (3.17e-5)" "unprognostic (4.20e-2)" "unprognostic (5.65e-2)" "unprognostic (9.64e-3)" "unprognostic (2.66e-3)" "unprognostic (3.32e-2)" "unprognostic (8.28e-2)" "unprognostic (2.92e-1)" "unprognostic (1.87e-1)" "unprognostic (8.07e-2)" "unprognostic (1.22e-3)" 1.2 3.5 8.4 2.1 9.4 2.4 1.6 7.8 10.0 1.7 6.3 2.6 4.5 2.1 3.3 0.9 7.1 1.4 4.1 8.9 12.3 2.1 0.7 2.2 1.4 13.2 11.4 1.4 1.4 2.0 3.3 0.9 11.5 1.6 2.4 43.2 1.1 1.6 7.3 1.1 3.7 1.5 11.7 1.4 2.2 5.8 12.5 1.6 2.0 13.3 1.5 1.1 0.9 12.0 3.3 3.8 5.6 3.9 1.6 3.2 2.0 3.1 1.8 2.5 2.5 1.7 1.4 8.3 1.2 2.7 3.0 1.3 3.6 1.6 3.5 11.1 1.3 1.4 5.3 2.3 2.5 4.9 3.4 1.5 1.6 3.6 5.5 3.2 2.4 3.9 1.8 5.1 2.5 1.1 8.4 3.1 3.5 0.4 2.2 10.6 3.8 0.7 2.6 0.7 12.3 5.9 3.5 0.9 3.0 2.3 3.7 1.7 3.2 4.4 2.7 3.7 4.2 2.6 9.9 2.2 3.1 3.0 1.6 0.4 0.9 0.0 0.5 0.6 0.2 1.8 0.7 0.5 0.6 0.6 0.0 0.3 0.2 0.5 0.4 0.6 0.2 0.2 8.4 9.4 7.8 10.0 8.9 12.3 13.2 11.4 11.5 11.7 12.5 12.0 2.9 3.2 1.1 23.8 4.2 1.0 2.0 2.5 0.0 23.1 2.3 2.0 6.0 1.5 3.5 7.3 423.3 0.3 3.4 3.0 1.9 22.7 97.2 47.5 5.7 3.3 10.7 1.7 79.0 3.8 1.3 5.2 2.6 15.1 14.0 10.4 1.1 1.3 3.8 52.2 59.2 6.3 2.0 1.2 3.5 68.2 5.0 5.3 10.6 16.9 21.0 12.7 1.0 21.6 66.9 5.2 7.1 6.8 3.0 1.1 7.8 2.4 44.9 121.1 13.1 6.3 4.1 26.0 26.1 0.3 0.9 0.0 2.8 2.2 6.8 0.2 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868588-90883564 "Enzymes, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 305.6;salivary gland: 220.5" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009499, HPA067869" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 130000 "Cluster 10: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095, HPA067869: " "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 54.5 24.4 12.8 36.4 10.5 73.8 42.4 10.6 14.5 26.4 11.7 32.8 27.6 32.3 9.8 33.7 30.4 19.4 58.5 14.9 9.0 56.8 305.6 63.2 13.0 12.5 10.8 22.4 108.6 27.3 45.9 40.6 11.3 60.1 12.1 12.9 220.5 17.7 61.3 62.7 35.5 14.3 10.4 51.4 34.0 8.6 15.6 11.8 56.1 25.3 11.2 30.2 33.3 9.3 50.8 31.2 6.8 29.8 49.4 32.1 77.5 64.4 48.1 26.3 18.1 45.4 54.3 1.9 148.8 47.5 46.1 91.5 14.0 32.5 5.4 148.0 35.2 90.9 52.8 57.7 26.2 13.0 141.2 35.6 35.3 29.5 13.2 62.4 84.7 14.6 70.5 8.5 17.8 32.3 5.0 29.2 21.5 44.2 9.3 7.9 26.6 10.9 35.2 39.1 13.1 9.2 54.5 28.5 42.5 31.9 10.7 31.4 125.9 29.4 60.1 43.7 95.5 15.2 93.4 3.4 55.8 40.1 60.7 2.0 0.9 1.5 0.7 0.1 0.2 0.4 0.2 0.3 0.6 0.1 0.0 0.1 0.7 0.4 0.0 0.3 0.0 1.1 12.8 10.5 10.6 14.5 14.9 9.0 12.5 10.8 11.3 10.4 15.6 9.3 44.1 3.2 27.4 4.2 7.3 19.4 10.0 10.4 2.8 12.8 12.0 9.0 16.3 21.5 8.5 22.0 25.0 20.9 26.9 49.5 0.0 47.1 0.5 15.2 9.7 29.4 37.8 26.5 7.9 117.5 16.5 11.4 21.9 32.3 15.8 7.0 23.9 131.8 24.8 8.4 7.5 31.7 10.2 35.3 42.1 1.4 11.1 33.6 16.0 5.6 14.0 13.6 24.7 2.0 4.4 108.3 26.4 10.9 7.2 24.3 28.7 7.8 2.0 28.0 26.3 10.5 18.6 2.8 3.6 8.5 23.0 84.3 19.6 4.7 17.9 16.4 FUT10 ENSG00000172728 "Fucosyltransferase 10" Q6P4F1 8 33370824-33473146 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Astrocytes: 140.0;Early spermatids: 248.8;Late spermatids: 334.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053970, HPA058655" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Endoplasmic reticulum, Golgi apparatus" "HPA053970: AB_2682327, HPA058655: AB_2683789" "unprognostic (6.02e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-3)" "unprognostic (6.24e-2)" "unprognostic (1.01e-1)" "unprognostic (4.80e-2)" "unprognostic (5.40e-3)" "unprognostic (6.07e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (9.10e-3)" "unprognostic (2.76e-4)" "unprognostic (3.06e-3)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-3)" "unprognostic (6.01e-3)" 1.9 2.2 4.3 1.0 4.7 0.8 3.4 4.2 4.2 4.0 2.0 2.5 2.5 3.1 1.2 1.9 3.3 1.8 1.7 3.0 3.3 3.1 2.0 2.4 1.8 4.3 5.5 5.2 2.6 5.1 1.3 3.5 3.3 2.2 2.7 5.2 2.7 2.1 0.6 3.2 2.6 2.9 2.7 1.5 2.3 1.5 4.8 2.9 2.8 1.2 2.2 2.2 2.2 2.5 2.4 4.5 6.8 8.3 10.8 10.8 3.4 4.3 7.1 4.2 5.4 6.3 3.6 2.7 5.1 5.8 3.5 5.9 10.4 4.1 4.1 5.8 3.8 8.6 3.6 7.0 4.9 1.9 2.9 8.0 7.0 1.1 5.4 8.8 8.6 4.4 8.0 3.2 3.9 1.4 6.6 2.8 9.1 6.4 3.0 4.8 5.1 1.4 6.1 5.4 2.4 2.3 2.5 3.7 5.1 7.0 3.8 1.9 6.6 3.2 1.4 8.1 3.6 1.3 2.2 1.8 2.0 5.4 3.4 0.4 0.6 0.7 1.3 0.2 1.4 1.0 0.7 1.2 1.3 0.3 0.8 0.8 0.4 1.6 0.2 0.7 1.7 0.6 4.3 4.7 4.2 4.2 3.0 3.3 4.3 5.5 3.3 2.7 4.8 2.5 4.5 3.2 2.0 140.0 2.5 2.7 2.7 3.4 4.0 2.9 3.7 3.8 2.5 2.8 3.2 3.7 10.4 12.0 3.0 1.5 1.9 4.5 248.8 2.8 5.7 3.8 3.6 3.8 16.3 4.0 7.0 5.8 6.1 3.0 5.7 10.1 5.3 3.6 3.4 3.3 20.2 3.2 4.1 2.2 1.8 334.2 6.8 2.2 1.8 29.0 3.0 29.9 5.2 44.2 16.4 4.0 1.0 4.9 5.0 1.4 5.3 3.0 2.0 11.0 0.0 5.7 4.6 7.0 2.7 5.5 1.7 6.0 2.6 6.5 3.6 1.3 FUT11 MGC33202 ENSG00000196968 "Fucosyltransferase 11" Q495W5 10 73772276-73780251 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 171.6;Late spermatids: 234.7;NK-cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014033 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" NA NA 1200000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 34: Spermatids - Unknown function" "Nuclear membrane" "Golgi apparatus" "HPA014033: AB_1849192" "prognostic unfavorable (6.78e-4)" "prognostic unfavorable (2.39e-6)" "unprognostic (1.47e-2)" "unprognostic (2.42e-3)" "unprognostic (3.27e-1)" "unprognostic (7.64e-2)" "unprognostic (2.29e-2)" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (9.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.59e-2)" "unprognostic (1.71e-1)" "unprognostic (3.61e-1)" "unprognostic (2.66e-2)" 9.4 5.1 2.5 6.8 3.2 6.4 5.2 4.4 2.8 8.9 1.8 4.5 3.1 6.0 3.2 7.0 4.7 9.0 9.4 2.1 3.8 4.7 5.1 8.7 6.4 4.9 4.8 6.3 4.1 3.7 3.1 17.4 4.1 4.3 3.8 10.0 4.1 6.4 4.1 4.5 3.7 8.3 4.1 10.2 4.9 10.2 5.0 4.3 7.0 4.8 6.2 7.0 4.8 4.9 26.4 14.2 9.9 20.8 19.2 22.2 2.9 13.1 31.3 16.3 31.7 4.7 13.8 6.1 9.3 21.7 5.5 10.9 5.2 13.3 18.1 14.4 10.9 8.1 11.4 7.6 7.5 11.6 24.5 14.8 3.0 15.5 15.9 50.3 30.1 2.7 8.1 10.5 16.4 3.2 2.0 6.0 4.7 2.5 35.1 2.8 6.1 7.2 5.9 4.7 3.0 9.6 11.5 12.0 7.5 8.4 8.2 5.0 31.3 21.1 9.0 10.6 16.4 13.8 5.1 1.4 29.6 10.2 7.0 5.4 1.4 1.4 20.0 1.6 14.2 2.1 5.9 14.3 1.7 1.8 4.3 8.9 0.3 10.9 1.8 3.5 2.6 6.9 2.5 3.2 4.4 2.8 2.1 3.8 4.9 4.8 4.1 4.1 5.0 4.9 22.4 16.0 13.1 6.2 12.1 13.6 5.6 22.7 5.2 14.6 6.1 6.1 12.2 7.2 9.8 11.0 14.6 10.7 23.1 4.9 0.0 13.3 171.6 6.7 12.0 28.0 4.8 15.8 6.0 6.8 25.2 15.8 2.6 10.5 14.0 7.1 38.2 5.2 12.5 20.2 5.7 4.6 2.0 18.1 16.7 234.7 16.1 11.0 17.8 11.2 11.4 8.3 69.0 5.0 6.5 10.3 5.2 14.7 10.2 8.9 2.6 3.4 9.8 13.0 6.6 14.3 11.7 20.7 19.0 5.5 11.5 9.7 19.9 6.8 3.1 6.4 FUT6 "FCT3A, FLJ40754, FT1A, FucT-VI" ENSG00000156413 "Fucosyltransferase 6" P51993 19 5830408-5839722 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 79.4;kidney: 36.1;salivary gland: 45.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 9.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "Hep G2: 10.5;RPMI-8226: 4.0" "HPA043707, HPA046966" Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 51000 "Cluster 10: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA043707: AB_2678628, HPA046966: AB_2679879" "unprognostic (3.65e-2)" "unprognostic (3.00e-3)" "unprognostic (2.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.02e-2)" "unprognostic (6.68e-3)" "unprognostic (4.01e-2)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (4.94e-2)" "prognostic favorable (3.17e-8)" "unprognostic (1.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" 0.1 0.0 0.1 2.6 0.1 0.4 1.7 0.2 0.1 17.3 0.4 17.3 28.6 0.3 0.0 79.4 0.6 9.3 0.0 0.1 0.1 36.1 12.4 0.2 0.1 0.1 0.1 0.0 3.7 0.0 0.0 0.0 0.1 0.2 11.6 2.0 45.7 2.5 0.0 0.1 27.0 0.4 0.1 0.1 4.8 0.2 0.1 0.0 0.0 0.0 6.7 0.0 26.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.2 10.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.7 4.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.5 0.0 0.7 0.0 0.4 3.5 0.0 0.4 3.7 1.9 0.3 18.6 15.7 1.8 0.0 0.2 0.3 35.6 3.9 6.8 0.3 0.6 0.7 0.3 4.9 0.0 0.1 0.4 0.1 0.3 0.0 0.7 0.0 0.2 0.7 5.1 0.1 0.0 0.1 39.4 8.2 0.0 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.9 0.0 0.5 0.1 2.7 21.5 0.0 0.0 0.2 101.4 45.3 6.4 11.5 0.0 0.3 0.7 1.0 0.6 3.6 0.1 0.0 0.5 0.1 29.0 1.7 FUT7 ENSG00000180549 "Fucosyltransferase 7" Q11130 9 137030174-137032088 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 3.9;brain: 2.5;lymphoid tissue: 6.1" "Group enriched" "Detected in some" 8 "dendritic cells: 66.9;Langerhans cells: 38.7;monocytes: 20.7;NK-cells: 28.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 210.0" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "NB-4: 23.7;THP-1: 24.0;U-937: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA042780 Approved "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 2: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA042780: AB_2678162" "unprognostic (1.33e-2)" "unprognostic (4.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (5.42e-2)" "unprognostic (5.01e-6)" "unprognostic (2.50e-1)" "unprognostic (2.35e-2)" "unprognostic (6.75e-4)" "unprognostic (4.68e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (6.69e-6)" "unprognostic (3.99e-2)" "unprognostic (4.14e-2)" "unprognostic (1.03e-1)" "unprognostic (8.75e-2)" 0.3 0.1 0.6 1.7 1.7 3.9 0.1 1.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.7 1.2 0.1 0.1 0.9 4.6 1.9 1.2 0.0 0.0 0.0 0.2 0.1 1.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.1 0.7 6.1 0.3 0.2 1.2 1.0 0.2 0.4 3.2 0.3 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 23.7 0.0 0.2 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 2.0 7.5 1.5 10.4 1.6 52.5 20.1 52.1 28.9 21.7 5.5 0.9 4.3 91.6 127.1 0.2 210.0 90.2 15.4 0.6 1.7 1.0 1.3 0.7 1.2 1.9 1.2 1.1 0.7 1.2 2.5 0.1 0.0 0.0 0.0 3.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.2 0.0 3.7 38.7 0.0 0.0 2.7 0.0 0.0 20.7 0.0 28.8 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.7 0.0 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 64.3" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1019.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 15.6;NK-cells: 14.8;T-cells: 10.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA043410" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA043410: AB_2678467" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 7.9 8.2 21.0 11.9 38.2 3.6 10.5 44.1 28.2 6.9 0.0 11.4 17.5 9.0 5.3 6.8 15.6 11.1 4.7 20.4 27.7 6.9 3.4 8.1 11.7 32.8 29.9 7.3 9.9 9.6 4.6 17.3 29.3 5.8 11.6 8.3 42.6 10.5 2.5 5.3 17.4 11.0 29.4 10.2 31.8 16.4 29.7 11.3 8.4 6.3 18.6 13.3 4.5 64.3 115.9 22.5 12.6 110.6 49.5 38.4 61.6 35.9 64.8 30.3 32.6 16.9 44.8 30.7 29.2 40.1 79.4 9.0 29.9 11.4 45.6 124.2 11.0 33.5 7.2 23.0 26.8 7.6 23.9 96.0 6.8 39.3 19.4 124.4 69.6 17.1 14.1 28.8 20.8 60.8 36.6 16.7 14.7 59.6 66.6 26.9 10.3 17.2 46.5 33.1 23.4 16.6 20.8 9.8 8.0 70.6 10.2 12.9 141.8 34.5 36.0 15.3 30.5 47.3 18.5 74.3 68.6 13.6 11.1 0.7 2.0 0.7 3.6 0.9 3.8 15.6 6.2 5.6 2.6 8.3 6.6 6.6 0.3 14.8 1.4 2.6 10.0 2.9 21.0 38.2 44.1 28.2 20.4 27.7 32.8 29.9 29.3 29.4 29.7 64.3 19.0 12.8 32.5 227.5 43.1 12.1 7.4 11.5 17.1 10.1 18.3 11.7 5.9 8.6 18.9 12.9 4.2 45.5 8.3 5.9 0.0 9.1 37.9 9.9 14.6 16.0 5.4 15.8 169.0 31.7 28.1 22.7 78.0 10.2 7.6 3.3 14.6 3.5 13.0 8.4 166.4 26.5 2.0 12.2 8.6 15.3 12.8 10.2 1.8 70.3 3.6 27.8 9.2 138.7 1019.1 54.7 10.3 13.5 124.3 8.8 24.5 8.4 15.3 9.1 0.0 14.3 13.2 34.6 26.8 7.4 9.8 14.1 18.9 10.6 21.7 7.2 G2E3 "FLJ20333, KIAA1333, PHF7B" ENSG00000092140 "G2/M-phase specific E3 ubiquitin protein ligase" Q7L622 14 30559158-30620064 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 42.3" "Group enriched" "Detected in all" 6 "Early spermatids: 722.5;Late spermatids: 233.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001601 Uncertain Approved "Golgi apparatus,Vesicles,Cytosol" NA Yes "Cluster 18: Basophils - Vesicular transport" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "Golgi apparatus, Vesicles" "HPA001601: AB_1079198" "unprognostic (4.75e-2)" "unprognostic (6.31e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (9.10e-2)" "unprognostic (3.99e-2)" "unprognostic (5.44e-6)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (1.86e-1)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" 4.8 3.2 2.1 6.4 7.0 10.0 6.4 11.6 5.5 6.4 0.7 5.6 5.0 6.3 3.7 6.2 4.8 3.8 4.8 2.4 5.6 4.5 5.2 4.5 9.1 3.1 2.5 6.1 5.2 5.6 2.7 6.3 2.7 5.1 5.3 13.8 4.9 4.6 3.0 5.9 4.9 6.2 1.0 6.3 5.3 42.3 7.0 14.3 6.6 3.9 8.9 4.9 3.9 9.6 37.9 15.6 33.7 16.1 11.2 15.0 30.5 31.9 12.9 20.2 22.9 17.1 20.5 32.9 10.9 18.4 15.9 29.7 36.4 18.8 42.2 25.7 15.7 19.6 17.1 31.0 10.3 34.0 22.5 8.1 7.4 15.1 34.9 18.3 22.9 22.5 21.2 24.2 29.0 21.9 22.6 9.6 31.2 27.5 32.7 21.4 0.0 8.2 10.5 22.3 28.4 19.9 27.7 16.0 7.9 20.5 19.1 12.5 17.3 19.7 21.9 16.9 21.9 14.1 47.7 38.8 5.4 16.6 29.2 20.2 6.5 12.9 7.6 8.5 10.1 9.2 7.4 6.3 5.6 9.9 9.2 7.8 5.9 6.5 11.3 6.8 6.6 4.1 2.1 7.0 11.6 5.5 2.4 5.6 3.1 2.5 2.7 1.0 7.0 9.6 22.6 19.2 9.0 17.9 32.9 21.9 22.5 11.8 26.7 34.9 13.0 10.8 10.0 12.8 13.6 5.5 25.0 17.8 23.0 9.0 9.8 8.9 722.5 13.9 26.6 17.0 13.8 42.7 45.3 7.1 22.7 20.6 14.3 14.1 17.1 23.3 13.2 7.5 14.2 35.3 38.4 14.7 14.2 13.9 12.4 233.9 16.4 16.5 8.8 24.4 16.2 15.5 32.0 41.7 43.1 10.7 9.4 14.3 14.4 22.5 5.6 12.0 10.9 33.4 52.6 18.0 18.6 69.8 42.7 20.7 25.4 10.0 24.9 11.9 12.4 20.6 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor subunit delta" O14764 1 2019329-2030758 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 49.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 14.7;Excitatory neurons: 30.0;Horizontal cells: 13.5;Inhibitory neurons: 37.4;Spermatogonia: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HMC-1: 1.2;MCF7: 4.4;NB-4: 2.7;SH-SY5Y: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 6: Brain - Smell perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA044371: AB_2678916" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 0.3 1.5 12.8 0.0 16.9 0.0 0.5 49.6 40.5 0.1 0.1 0.2 0.0 0.3 0.1 0.3 0.2 0.4 0.7 14.7 5.4 0.7 0.2 0.9 0.2 14.3 18.1 0.2 0.1 0.7 2.7 0.1 20.2 0.2 0.0 1.4 0.3 0.0 0.3 0.4 0.2 0.3 1.0 0.3 0.1 3.6 29.7 0.1 0.9 0.4 0.0 0.2 0.2 14.7 0.0 0.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 2.7 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.8 16.9 49.6 40.5 14.7 5.4 14.3 18.1 20.2 1.0 29.7 14.7 1.0 3.2 3.6 4.9 0.1 0.5 0.0 0.0 0.0 14.7 0.3 0.0 0.9 0.0 6.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 3.4 0.0 0.0 30.0 0.0 0.3 0.5 0.0 0.2 2.5 0.3 0.0 0.0 0.1 13.5 37.4 0.0 0.0 0.0 0.3 0.2 0.0 0.9 0.0 8.4 0.0 1.4 0.0 3.0 4.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.4 1.6 0.0 0.0 4.8 0.1 11.3 0.1 0.0 0.3 0.4 0.2 0.1 0.1 GAGE1 CT4.1 ENSG00000205777 "G antigen 1" P0DTW1 X 49599025-49608536 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 9.1" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 113.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AN3-CA: 739.9" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 739.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 24.4 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE10 ENSG00000215274 "G antigen 10" A6NGK3 X 49303669-49319844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.0;testis: 1.6" "Cell type enhanced" "Detected in some" "Granulosa cells: 2.1;Leydig cells: 1.2;Microglial cells: 1.0;Peritubular cells: 1.2;Spermatocytes: 3.2;Spermatogonia: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.5;WM-115: 1.0" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (2.81e-2)" "unprognostic (2.26e-1)" "unprognostic (3.97e-1)" 0.0 0.0 1.0 0.0 1.4 0.0 0.2 0.9 2.0 0.1 0.8 0.1 0.0 0.1 0.5 0.0 0.4 0.0 0.1 1.0 0.8 0.0 0.0 0.0 0.2 0.9 1.1 0.9 0.0 0.0 0.8 0.0 1.0 0.1 0.1 0.6 0.0 0.3 0.1 0.0 0.0 0.3 0.9 0.1 0.0 1.6 0.8 0.0 0.2 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.2 2.5 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.9 2.0 1.0 0.8 0.9 1.1 1.0 0.9 0.8 1.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.2 5.2 0.0 0.1 0.0 0.0 0.6 0.0 0.1 GAGE12C ENSG00000237671 "G antigen 12C" A1L429 X 49532211-49539538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 271 "testis: 27.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/84: 37.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 9.1 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12D ENSG00000227488 "G antigen 12D" A1L429 X 49541767-49549094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 271 "testis: 27.0" "Cell type enriched" "Detected in single" 10 "Spermatogonia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/84: 37.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 9.1 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12E ENSG00000216649 "G antigen 12E" A1L429 X 49551333-49558649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 1.8" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.4;U-266/84: 2.1" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12F ENSG00000236362 "G antigen 12F" "P0CL80, O76087, P0CL82" X 49551278-49568218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 178.7" "Cell type enhanced" "Detected in single" "Spermatogonia: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "AN3-CA: 1630.3;K-562: 1415.3" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.7 178.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.9 0.0 0.0 1630.3 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1415.3 30.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 360.9 0.0 5.1 56.9 7.5 0.3 1.0 0.6 72.0 0.0 0.2 0.0 171.2 1.3 11.5 4.6 4.8 12.1 3.4 8.4 12.6 8.7 0.0 7.8 9.7 8.6 1.4 14.7 10.5 12.4 20.2 11.5 0.4 0.6 0.2 0.3 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12G ENSG00000215269 "G antigen 12G" "P0CL81, O76087, P0CL82" X 49570434-49577754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "retina: 1.6;stomach 1: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 4.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "AN3-CA: 439.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 23: AN3-CA - Transcription regulation" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 439.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 54.7 0.0 0.0 8.4 0.5 0.1 0.2 0.0 0.0 0.0 0.2 0.0 20.8 0.2 1.5 0.9 0.5 1.6 0.8 0.8 2.0 0.2 0.0 1.5 0.3 1.7 0.0 0.3 1.4 0.9 4.7 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12H ENSG00000224902 "G antigen 12H" A6NDE8 X 49579983-49587301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 230 "testis: 22.9" "Group enriched" "Detected in some" 15 "Spermatocytes: 1.4;Spermatogonia: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 55 "A-431: 53.9;U-266/84: 164.9" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.3 1.4 0.0 0.0 0.0 164.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12J GAGE11 ENSG00000224659 "G antigen 12J" A6NER3 X 49322057-49329384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 35.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "AN3-CA: 1145.9;K-562: 290.3" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 35.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1145.9 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 2.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 290.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 32.4 0.0 0.0 0.0 0.2 0.5 0.0 2.5 32.2 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE13 GAGE12A ENSG00000274274 "G antigen 13" Q4V321 X 49331616-49338952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 36.1" "Group enriched" "Detected in some" 22 "Spermatocytes: 4.2;Spermatogonia: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "AN3-CA: 303.6;T-47d: 165.3;WM-115: 83.9" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 303.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 3.6 0.0 2.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 165.3 0.0 0.7 3.4 1.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE2A "CT4.2, GAGE2" ENSG00000189064 "G antigen 2A" Q6NT46 X 49589529-49596827 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 108 "testis: 92.5" "Group enriched" "Detected in some" 17 "Spermatocytes: 108.0;Spermatogonia: 358.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 86.8;T-47d: 289.7;WM-115: 325.3" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 86.8 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 289.7 0.0 0.0 47.3 10.6 0.1 0.0 1.2 13.8 0.0 2.9 0.0 325.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 108.0 358.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE2E GAGE8 ENSG00000275113 "G antigen 2E" Q4V326 X 49341192-49345922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 13 "stomach 1: 12.8;testis: 26.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "T-reg: 2.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AN3-CA: 2587.1;K-562: 674.0" HPA043232 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.2 12.8 26.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2587.1 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 4.3 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.7 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 674.0 12.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.0 5.0 0.3 0.3 364.7 0.1 3.3 61.8 2.4 0.2 0.2 0.8 20.9 0.0 0.7 0.2 138.5 0.4 0.6 0.1 0.5 0.0 0.0 0.6 0.1 1.0 0.0 1.2 2.1 0.0 0.4 0.4 0.0 1.5 2.9 0.1 0.1 0.3 0.0 0.3 0.2 0.0 0.1 0.5 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAK DNAJC26 ENSG00000178950 "Cyclin G associated kinase" O14976 4 849276-932373 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 134.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027405, HPA027459, HPA027463" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.24e-3)" "unprognostic (1.07e-1)" "unprognostic (3.50e-3)" "unprognostic (1.68e-1)" "unprognostic (7.07e-2)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (3.33e-3)" "prognostic favorable (1.70e-6)" "unprognostic (1.09e-3)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "prognostic favorable (7.41e-4)" 31.9 40.7 21.1 25.9 22.5 35.5 34.0 20.1 29.7 42.7 20.1 56.3 51.2 41.9 8.0 49.7 43.0 17.7 25.4 21.5 17.8 55.0 47.7 46.0 25.6 28.7 19.8 40.5 53.1 22.7 37.1 15.6 22.1 41.8 14.8 9.4 71.0 13.3 31.4 40.4 57.4 9.8 17.7 61.5 54.2 45.8 20.6 21.6 38.5 6.6 12.9 38.7 39.3 20.5 36.0 28.3 16.9 29.0 16.6 14.2 43.6 33.0 19.7 22.3 18.5 35.9 49.8 30.4 20.9 20.1 40.3 29.7 17.7 27.4 10.5 30.7 27.9 35.3 29.5 27.5 31.1 36.2 53.0 20.5 23.2 22.7 11.0 14.2 24.7 35.3 38.4 37.4 15.2 34.7 61.6 92.1 30.4 38.2 46.3 50.2 19.4 27.4 18.2 28.8 29.0 31.3 19.3 24.2 23.3 14.1 39.2 30.7 40.8 30.9 18.0 31.8 45.1 59.5 41.3 33.8 34.9 43.7 29.0 3.0 10.3 12.8 8.8 9.8 7.6 4.9 5.8 6.1 6.5 3.9 3.3 4.8 7.4 4.8 24.6 7.6 5.6 9.4 21.1 22.5 20.1 29.7 21.5 17.8 28.7 19.8 22.1 17.7 20.6 20.5 24.7 25.6 33.2 34.0 33.9 17.0 15.3 17.9 14.8 27.2 25.3 17.7 12.2 18.6 28.2 25.8 64.6 19.0 46.2 131.3 9.8 18.8 99.1 32.2 21.6 26.7 29.4 26.1 25.7 28.0 17.5 19.5 93.8 52.5 18.3 31.2 18.5 31.6 36.6 11.8 23.5 66.5 26.4 35.9 18.4 134.7 25.1 35.5 16.0 59.0 28.8 16.3 35.0 9.0 24.4 37.6 71.1 18.8 26.1 28.4 65.8 31.0 33.8 26.9 19.7 17.9 18.0 32.9 27.4 19.9 22.3 31.1 34.6 41.6 65.0 44.6 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "brain: 645.9;pituitary gland: 885.8" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3" "Cancer enhanced" "Detected in many" "testis cancer: 22.2" "Region enriched" "Detected in many" 13 "hypothalamus: 645.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6" "Region enhanced" "Detected in many" "hypothalamus: 82.6" "Low region specificity" "Detected in all" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 60000 200000 "Cluster 7: Monocytes - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 24: NB-4 - Immune response" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" Vesicles "CAB079779: , HPA049864: AB_2680922" "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 3.2 0.9 2.8 14.9 2.1 0.7 4.4 1.1 5.2 1.0 0.8 17.6 1.8 0.2 0.0 0.8 1.0 0.2 1.0 2.2 645.9 1.5 0.3 0.5 0.1 48.5 5.1 0.2 2.1 0.1 885.8 0.3 13.8 4.4 4.0 0.0 0.9 0.2 0.4 33.3 4.1 9.9 0.6 0.3 9.7 1.0 19.5 0.7 0.4 0.0 0.0 0.7 2.9 2.6 0.0 11.0 1.1 0.3 0.0 0.0 24.0 36.7 0.0 0.7 0.0 267.2 9.9 0.0 12.7 1.3 0.4 0.1 0.0 0.2 0.0 0.0 119.3 6.4 74.6 0.0 1.3 3.7 0.0 1.7 4.0 0.0 0.1 0.0 6.3 0.0 139.5 0.0 0.2 77.2 0.0 493.5 60.3 2.9 23.7 0.0 0.1 51.1 0.6 0.0 49.8 189.6 25.8 1.5 0.0 26.8 1.5 57.6 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.1 1.1 5.2 2.2 645.9 48.5 5.1 13.8 0.6 19.5 2.6 0.6 0.0 0.0 0.0 0.2 2.0 22.2 0.1 0.0 0.0 3.2 5.8 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.7 0.0 38.9 0.1 64.2 50.8 3.4 1.8 4.2 2.1 52.1 48.7 6.6 2.0 26.4 4.5 0.4 0.0 0.0 2.0 0.0 0.2 1.1 4.1 0.0 1.2 0.2 0.0 0.7 1.8 0.0 0.6 0.0 0.0 0.0 0.3 39.5 0.1 0.0 1.0 82.5 0.0 0.4 0.0 0.0 0.0 1.6 6.7 2.2 10.9 1.1 3.4 1.9 0.8 0.0 1.3 24.3 GALE SDR1E1 ENSG00000117308 UDP-galactose-4-epimerase Q14376 1 23795599-23800781 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" Isomerase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 122.4" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070023 Approved "Golgi apparatus,Cytosol" NA NA 16000 "Cluster 27: Non-specific - Gene expression" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Cytosol" "HPA070023: " "unprognostic (1.65e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (1.41e-2)" "unprognostic (3.03e-3)" "unprognostic (1.17e-2)" "unprognostic (3.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.59e-1)" "unprognostic (2.65e-1)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (7.51e-2)" "unprognostic (2.12e-1)" "prognostic favorable (2.68e-4)" "unprognostic (1.41e-2)" 8.9 12.8 12.3 16.0 12.5 6.0 12.8 12.2 17.7 22.3 11.5 58.6 54.6 6.7 12.7 63.1 16.6 31.5 7.1 12.5 12.5 34.0 61.2 20.6 7.5 12.5 12.3 4.6 15.2 15.5 6.7 17.8 12.4 11.0 60.0 6.3 59.7 16.4 4.3 9.7 38.3 10.8 12.6 17.6 122.4 8.7 13.2 8.0 4.7 5.4 15.8 20.9 22.2 12.6 60.3 71.5 27.8 44.5 9.8 13.9 26.9 40.7 53.4 68.6 50.9 65.3 195.4 14.3 54.7 23.5 91.9 65.8 24.5 101.8 51.5 29.4 16.2 40.6 34.4 71.6 102.0 18.4 11.6 30.1 53.4 63.4 156.8 69.2 59.5 30.1 45.9 3.8 49.5 64.5 29.0 19.5 7.8 83.1 67.7 33.6 27.1 18.5 112.7 41.4 10.7 24.1 73.9 66.7 70.6 31.1 47.9 14.5 33.7 52.0 74.9 52.0 50.3 18.5 46.4 18.9 53.0 74.5 27.8 1.7 13.5 3.0 8.5 29.3 8.5 5.4 5.0 6.9 19.0 1.7 5.8 4.1 3.4 37.3 37.1 5.2 9.5 8.8 12.3 12.5 12.2 17.7 12.5 12.5 12.5 12.3 12.4 12.6 13.2 12.6 9.6 12.8 49.3 6.8 7.5 7.6 18.8 110.4 6.2 17.2 26.7 10.9 3.5 37.1 90.6 40.5 16.7 54.1 7.4 131.8 35.2 67.6 21.5 19.9 9.1 14.3 12.1 8.2 9.4 114.8 106.3 14.0 276.8 36.2 10.8 17.4 10.8 38.3 99.3 8.4 10.8 149.5 73.2 5.7 6.8 5.0 4.7 12.5 24.9 5.6 19.4 21.2 7.2 4.5 2.1 92.0 109.0 3.4 9.4 24.9 78.6 89.5 37.0 14.8 0.0 3.7 13.1 14.5 9.7 19.6 4.8 96.3 7.6 99.6 73.8 46.0 GALK1 GALK ENSG00000108479 "Galactokinase 1" P51570 17 75751594-75765236 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Kinase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 126.4" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 100.1;Hepatocytes: 116.7;Proximal enterocytes: 139.4;Proximal tubular cells: 122.0" "Cancer enhanced" "Detected in all" "liver cancer: 42.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007094, HPA016960" Approved Approved "Golgi apparatus,Cytosol" NA NA 57000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Golgi apparatus" "HPA007094: AB_1078939, HPA016960: AB_1849430" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (1.81e-2)" "unprognostic (2.94e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.04e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (3.04e-1)" "unprognostic (1.71e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.62e-5)" 18.6 12.5 5.9 7.8 6.7 5.6 17.1 6.4 8.4 17.5 5.9 12.5 20.6 16.5 1.0 24.4 14.9 4.3 19.7 6.0 6.6 32.0 126.4 18.7 7.4 7.9 6.3 13.7 31.2 10.6 5.7 5.8 7.5 13.3 2.0 0.7 20.0 5.7 8.6 20.6 18.3 3.9 7.0 24.5 17.6 16.0 6.8 6.1 11.6 3.6 3.4 13.0 17.8 8.2 20.4 65.2 4.9 20.7 6.8 16.6 16.7 16.9 14.3 16.8 15.8 35.4 4.2 31.2 19.5 9.3 12.6 11.9 5.0 4.4 1.9 14.2 39.3 20.1 25.1 62.4 22.1 13.0 41.9 15.3 6.9 8.5 3.5 8.5 39.1 16.9 15.9 21.2 11.7 77.3 38.6 44.7 4.7 9.8 32.3 43.6 50.1 50.9 9.8 7.3 9.9 26.1 14.6 35.8 35.0 3.8 29.8 20.9 33.4 24.3 22.3 21.7 14.6 44.4 12.4 8.2 26.7 30.3 18.3 7.2 77.2 23.0 23.0 67.8 20.8 27.7 18.5 21.2 70.1 18.9 10.0 14.5 53.1 16.2 55.6 93.3 23.6 40.8 5.9 6.7 6.4 8.4 6.0 6.6 7.9 6.3 7.5 7.0 6.8 8.2 42.1 16.0 12.9 3.3 17.7 8.7 10.0 4.4 7.4 7.3 22.4 20.6 22.6 22.8 10.6 12.9 0.0 48.4 16.3 8.4 68.4 28.5 1.3 4.9 24.5 23.5 8.4 9.0 1.5 55.2 100.1 25.3 10.2 8.6 27.9 16.6 29.3 116.7 56.1 3.3 1.7 20.9 22.4 49.0 25.2 5.6 31.1 33.3 39.2 0.0 42.3 19.2 20.6 2.5 1.6 19.3 49.6 24.0 29.1 5.7 139.4 122.0 4.0 6.1 6.6 19.2 20.8 1.7 22.1 16.6 12.5 42.3 14.9 6.1 28.2 9.2 GALNT10 GalNAc-T10 ENSG00000164574 "Polypeptide N-acetylgalactosaminyltransferase 10" Q86SR1 5 154190730-154420984 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 65.8" "Cell type enhanced" "Detected in many" "Microglial cells: 74.0;Oligodendrocyte precursor cells: 156.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 284.9;TIME: 161.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007525 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 1100000 "Cluster 41: Basophils - Cellular respiration" "Cluster 89: Fibroblasts - ECM organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 68: Oligodendrocytes - Mixed function" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA007525: AB_1849443" "unprognostic (6.99e-2)" "unprognostic (4.33e-2)" "unprognostic (9.85e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.63e-1)" "unprognostic (6.98e-2)" "unprognostic (6.95e-3)" "unprognostic (2.38e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.69e-4)" "unprognostic (2.88e-3)" "unprognostic (2.63e-1)" "unprognostic (1.54e-1)" "unprognostic (7.76e-3)" "unprognostic (1.22e-1)" "unprognostic (1.61e-2)" "unprognostic (3.08e-1)" 12.1 15.6 10.7 14.4 14.5 19.3 13.5 12.1 10.0 24.1 33.0 16.1 14.4 6.3 6.0 4.9 14.6 16.7 9.0 9.5 12.5 9.7 4.4 15.5 9.9 16.1 13.9 65.8 9.8 13.6 11.5 4.7 12.3 9.1 14.7 7.8 13.5 3.7 5.4 6.0 12.6 11.6 9.9 15.8 22.0 4.5 13.9 7.8 16.6 8.2 9.4 11.1 5.2 12.6 25.6 85.3 20.3 17.8 42.2 37.3 15.6 71.7 39.9 27.9 26.7 12.1 56.7 16.6 49.3 121.4 49.9 4.4 9.4 56.0 25.4 43.2 6.7 45.4 16.0 16.5 32.4 9.9 42.3 46.7 12.9 22.7 33.2 284.9 54.4 12.5 10.5 50.9 48.4 26.4 1.1 6.8 8.0 71.1 17.3 5.1 10.7 16.6 38.6 17.1 2.7 6.6 31.8 117.0 9.4 29.6 45.6 7.4 161.2 67.5 15.9 16.8 77.7 14.5 15.0 8.7 44.2 19.3 21.1 2.0 1.2 2.4 3.1 1.6 2.8 1.9 1.8 2.0 1.4 2.1 0.8 2.1 2.5 1.9 1.8 1.1 1.6 1.0 10.7 14.5 12.1 10.0 9.5 12.5 16.1 13.9 12.3 9.9 13.9 12.6 17.4 9.6 46.4 32.7 17.4 4.8 3.9 5.6 1.8 4.6 12.4 8.6 5.0 5.7 8.7 14.7 4.2 0.7 27.7 23.0 9.8 9.1 10.3 12.4 7.4 14.1 3.0 21.4 14.3 30.1 1.5 13.7 30.5 22.3 10.2 10.5 23.9 5.3 8.5 0.0 15.9 20.4 6.1 19.5 7.8 22.5 38.2 12.4 0.0 74.0 11.9 17.4 44.3 156.9 66.9 36.8 13.6 50.0 15.4 8.2 15.3 2.7 0.7 10.5 6.6 5.6 7.8 2.0 4.0 1.2 3.7 0.8 21.7 27.3 12.2 4.2 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.3" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 21.6;Excitatory neurons: 29.1;Inhibitory neurons: 79.2;Proximal enterocytes: 21.9;Proximal tubular cells: 45.5" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 8 "neutrophil: 8.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.5" "Cell line enhanced" "Detected in many" "A549: 28.6;RPMI-8226: 32.3;RPTEC TERT1: 41.3;RT4: 35.3;SCLC-21H: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030138 Approved "Nucleoplasm,Golgi apparatus" NA NA 27000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoplasm "HPA030138: AB_2673332" "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 3.9 1.0 10.6 5.9 0.8 2.0 4.5 1.3 3.6 0.3 0.5 0.3 0.3 11.8 1.2 2.2 0.3 2.9 3.2 41.3 1.3 0.6 2.2 1.7 6.7 0.1 3.1 4.0 5.9 0.0 0.8 1.6 0.1 0.6 1.2 0.0 0.1 2.1 3.3 0.7 1.8 2.4 0.5 2.5 10.9 0.4 0.9 0.4 4.8 2.3 1.3 3.3 23.6 28.6 0.0 0.0 0.0 0.0 0.0 7.9 4.1 4.9 0.6 0.0 0.0 22.1 7.8 0.4 0.0 0.0 1.0 1.0 0.8 0.6 2.8 12.1 0.0 0.0 0.0 18.2 0.0 0.1 4.5 0.0 17.0 0.2 0.0 0.6 0.0 19.0 0.0 10.7 0.1 0.0 12.6 0.0 0.0 15.5 0.0 32.3 41.3 35.3 24.4 18.3 0.0 0.0 0.1 4.4 0.1 0.0 0.0 0.0 19.6 0.0 0.5 1.9 6.2 0.1 0.0 11.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 3.9 10.6 2.0 4.5 2.9 3.2 1.7 6.7 0.8 1.8 10.9 3.3 2.2 0.0 0.0 1.0 1.4 2.8 4.1 5.3 21.6 0.3 0.6 2.4 1.1 0.0 6.2 9.2 0.0 0.0 0.0 0.3 13.7 2.9 5.7 0.0 0.1 1.2 0.0 0.0 29.1 0.4 0.0 1.1 0.5 0.4 0.0 0.0 8.2 0.2 0.1 0.0 79.2 0.9 2.0 0.6 0.3 12.0 0.0 0.4 0.0 2.8 0.0 0.2 0.0 4.0 8.7 2.6 0.0 0.0 3.1 14.2 21.9 45.5 1.1 0.4 6.6 0.4 2.2 3.4 6.9 9.2 0.9 0.0 0.4 0.2 1.8 5.1 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174680-16231992 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 157.4;brain: 141.7" "Cell type enhanced" "Detected in many" "Adipocytes: 103.9;Astrocytes: 34.6;Early spermatids: 26.6;Endothelial cells: 26.9;Hepatic stellate cells: 41.7;Muller glia cells: 47.4;Oligodendrocytes: 69.3" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "ASC diff: 133.0;ASC TERT1: 128.8;HSkMC: 102.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 40000 "Cluster 15: NK-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 157.4 4.9 45.1 1.7 55.8 2.7 87.2 62.5 49.3 12.3 14.4 21.7 3.0 11.4 11.9 12.4 24.9 5.6 18.1 47.9 90.8 11.8 4.0 9.4 4.1 137.6 60.4 22.3 3.6 2.4 3.5 32.3 130.8 6.0 3.9 13.4 25.5 4.7 36.3 41.7 21.2 7.0 102.4 12.3 15.3 9.1 62.8 4.0 18.3 35.3 1.3 33.0 22.8 141.7 0.4 1.3 0.9 1.0 133.0 128.8 0.3 3.4 2.5 0.4 1.3 0.0 0.5 0.5 1.9 7.8 2.3 0.8 0.5 1.4 2.0 0.6 1.4 1.1 1.9 0.0 7.4 1.5 0.4 102.8 0.0 1.2 1.8 2.4 2.8 0.7 0.2 3.0 1.1 1.9 0.0 2.1 0.5 0.8 1.1 0.3 1.1 24.1 0.5 0.5 0.4 0.3 0.4 1.0 0.6 0.6 0.7 1.8 3.9 0.6 4.3 26.8 0.6 1.4 5.1 1.4 2.5 0.4 0.4 0.5 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 45.1 55.8 62.5 49.3 47.9 90.8 137.6 60.4 130.8 102.4 62.8 141.7 103.9 0.0 1.7 34.6 0.1 0.5 0.4 0.0 0.0 3.8 1.1 0.9 2.8 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 26.6 0.5 3.3 26.9 0.0 0.0 4.9 0.0 0.1 24.7 0.0 1.0 1.3 0.1 41.7 1.8 0.1 0.0 3.9 0.0 0.0 0.8 2.1 16.7 1.8 0.5 0.0 22.5 0.1 47.4 0.0 5.0 69.3 0.2 0.0 0.7 1.8 2.1 0.0 0.1 0.0 3.2 0.0 7.3 2.1 25.5 0.5 0.1 0.9 0.0 0.2 0.3 0.0 0.3 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132144-71713600 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.0;choroid plexus: 46.0;heart muscle: 43.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Endometrial stromal cells: 7.4;Fibroblasts: 1.5;Granulosa cells: 1.7;Theca cells: 2.3" "Cancer enhanced" "Detected in many" "prostate cancer: 8.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.3;NTERA-2: 10.8;RPMI-8226: 12.6;SK-BR-3: 45.7;SuSa: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 3.2 8.7 30.5 1.9 37.9 0.0 2.0 35.9 51.2 4.0 46.0 16.6 0.3 16.6 3.1 9.3 8.7 2.5 43.5 55.0 3.2 5.7 0.4 9.3 0.0 2.1 3.8 31.6 10.1 1.2 13.3 0.2 3.0 14.7 1.0 3.3 3.3 8.2 4.7 2.2 3.9 8.3 0.0 3.4 2.4 5.0 11.2 2.6 10.1 2.9 1.5 21.2 3.3 24.8 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.7 0.0 0.0 45.7 0.0 14.1 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 37.9 35.9 51.2 55.0 3.2 2.1 3.8 3.0 0.0 11.2 24.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 GALNT18 "GalNAc-T18, GALNT15, GALNTL4, MGC71806" ENSG00000110328 "Polypeptide N-acetylgalactosaminyltransferase 18" Q6P9A2 11 11270877-11622005 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 149.5;Excitatory neurons: 104.4;Inhibitory neurons: 156.3;Microglial cells: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 42.1;HaCaT: 52.4;HBEC3-KT: 36.5;PC-3: 36.4;RPMI-8226: 39.3;SK-BR-3: 47.2;U-87 MG: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012955, HPA070681" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA 300000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Vesicles, Cytosol" "HPA012955: AB_1849460, HPA070681: " "unprognostic (1.26e-1)" "unprognostic (2.80e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (7.37e-2)" "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (6.68e-2)" "unprognostic (6.04e-2)" "unprognostic (2.05e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-1)" "unprognostic (2.66e-3)" "unprognostic (3.54e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-1)" "unprognostic (1.81e-2)" 18.0 4.7 19.1 4.1 17.7 0.0 15.6 17.1 20.8 13.0 10.7 24.8 3.0 24.0 2.4 7.7 12.0 11.2 26.9 29.5 12.9 26.5 10.5 51.2 5.4 12.2 17.2 4.9 8.2 9.8 6.4 24.4 13.9 13.0 3.2 3.6 17.0 9.3 10.7 13.0 8.8 13.3 12.3 3.6 6.8 14.7 19.7 6.3 42.8 6.2 3.3 11.7 11.5 12.9 42.1 15.0 2.0 9.1 0.0 0.0 0.3 4.5 11.2 0.6 0.0 1.7 5.4 0.1 3.1 0.1 5.6 52.4 9.9 36.5 0.1 0.0 14.6 0.0 0.1 0.1 0.5 0.0 0.0 0.2 14.9 0.0 13.5 0.0 0.0 18.5 0.0 0.1 1.9 10.2 0.5 0.1 1.5 0.1 36.4 0.0 0.0 39.3 27.5 5.1 0.6 4.1 7.6 47.2 0.3 1.4 9.9 0.1 0.0 0.7 8.1 0.4 0.2 0.0 0.0 0.0 33.6 0.0 10.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 17.7 17.1 20.8 29.5 12.9 12.2 17.2 13.9 12.3 19.7 12.9 40.5 44.8 6.9 149.5 0.1 5.6 6.6 18.3 12.0 1.6 1.6 2.5 8.5 30.0 13.7 20.2 2.1 49.2 0.4 0.8 15.6 19.9 2.2 1.9 0.4 40.6 0.0 0.0 104.4 4.0 3.5 5.4 0.0 1.3 1.3 16.7 18.5 2.6 2.6 0.0 156.3 0.4 8.2 0.8 1.1 1.4 1.5 0.4 1.8 79.6 0.0 43.1 0.0 8.5 10.5 7.3 0.2 3.0 0.2 13.4 0.0 40.8 14.3 2.1 13.1 15.1 7.4 0.6 1.1 1.8 5.4 15.5 0.3 46.7 1.1 1.9 GALNT2 GalNAc-T2 ENSG00000143641 "Polypeptide N-acetylgalactosaminyltransferase 2" Q10471 1 230057990-230282122 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 133.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 429.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011222 Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 13000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA011222: AB_1849446" "unprognostic (1.26e-1)" "prognostic unfavorable (1.22e-6)" "unprognostic (1.15e-2)" "unprognostic (1.35e-2)" "unprognostic (8.70e-3)" "unprognostic (7.77e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.48e-8)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (1.70e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.79e-13)" "unprognostic (3.79e-3)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" 32.9 49.6 17.0 34.8 19.9 13.9 21.9 15.2 16.7 24.7 22.0 28.9 19.5 27.1 6.9 21.0 22.4 21.2 27.4 15.8 18.6 18.5 100.1 27.1 14.0 23.0 19.5 39.2 68.1 9.9 13.6 27.6 18.3 21.4 12.4 19.8 22.1 14.3 67.4 14.7 23.6 25.0 15.3 17.4 33.1 19.7 25.1 42.8 19.0 27.4 11.2 33.4 19.5 15.5 79.5 103.7 59.9 71.4 112.4 95.3 122.8 146.3 90.0 58.4 55.6 45.2 146.5 20.0 106.2 77.7 135.9 150.7 39.9 123.0 48.6 200.1 52.0 60.7 217.2 50.9 60.9 23.4 114.8 136.9 59.8 78.0 30.9 127.3 69.2 110.1 77.0 29.6 65.6 21.8 122.3 23.9 82.1 52.8 97.7 134.3 85.5 61.7 57.4 92.9 18.9 70.1 148.4 7.9 91.0 31.7 46.5 43.5 165.3 56.7 107.9 129.5 118.0 97.9 60.3 44.4 146.1 46.3 429.7 1.5 10.7 3.6 4.4 9.3 3.2 3.4 2.6 4.5 7.8 5.8 2.5 5.0 3.2 2.8 10.2 13.2 3.3 7.7 17.0 19.9 15.2 16.7 15.8 18.6 23.0 19.5 18.3 15.3 25.1 15.5 18.6 16.0 21.3 71.5 32.1 15.3 20.0 52.8 20.5 30.8 13.8 10.7 13.6 18.6 30.1 23.9 33.3 7.3 21.7 24.1 5.9 49.7 47.2 18.7 15.4 17.9 16.8 27.6 67.3 133.0 123.4 36.1 21.4 24.5 13.3 20.5 19.6 98.8 24.9 28.6 82.0 18.9 4.1 42.4 9.7 24.6 35.8 28.9 24.9 106.8 44.0 10.9 18.6 72.9 44.6 88.5 21.6 29.3 109.0 23.5 17.9 19.2 23.5 73.5 13.1 33.1 25.4 3.4 14.0 16.6 8.0 16.6 21.2 32.8 17.6 29.9 GALNT3 "GalNAc-T3, HFTC, HHS" ENSG00000115339 "Polypeptide N-acetylgalactosaminyltransferase 3" Q14435 2 165747588-165794659 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 77.3" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 152.8;Pancreatic endocrine cells: 188.1;Prostatic glandular cells: 155.7;Urothelial cells: 274.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 50.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 85.4;HaCaT: 108.3;HBEC3-KT: 69.2;hTCEpi: 88.2;OE19: 201.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA007613 Enhanced Supported "Golgi apparatus" NA NA 440000 "Cluster 46: Basophils - DNA binding" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA007613: AB_1078941" "unprognostic (1.95e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.16e-3)" "unprognostic (2.78e-1)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (4.13e-2)" "unprognostic (4.47e-2)" "unprognostic (2.74e-1)" "unprognostic (6.44e-2)" "unprognostic (3.62e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.57e-1)" 1.5 1.7 1.7 8.4 2.1 54.0 26.0 2.7 1.8 29.3 4.3 48.9 43.5 5.2 9.3 27.4 38.8 32.2 0.6 1.8 3.4 10.9 2.4 14.0 3.7 4.5 5.2 6.8 26.2 6.9 9.8 6.4 3.3 25.2 53.2 3.7 55.3 8.2 0.3 15.3 39.5 2.5 7.0 20.1 77.3 25.8 1.9 3.3 25.4 0.4 12.3 17.3 12.6 5.4 61.5 0.0 0.6 0.2 0.1 2.6 43.0 18.3 7.7 6.6 16.0 32.0 85.4 0.4 0.1 0.0 0.1 108.3 0.0 69.2 13.5 1.3 13.0 0.0 14.9 0.3 0.3 14.5 0.4 0.5 88.2 0.0 30.3 2.1 0.1 2.9 0.0 55.0 5.0 42.7 0.5 5.6 0.1 201.1 7.8 0.2 0.0 1.7 17.8 42.0 6.5 0.1 0.3 49.6 16.8 1.9 21.7 0.9 0.5 0.1 1.0 0.1 0.3 34.4 16.3 1.3 0.2 14.0 0.6 50.5 6.8 32.2 10.2 9.0 7.5 6.6 3.1 5.8 11.4 6.0 1.0 3.4 25.2 10.6 13.8 17.3 5.6 6.2 1.7 2.1 2.7 1.8 1.8 3.4 4.5 5.2 3.3 7.0 1.9 5.4 1.0 12.8 34.4 7.8 13.6 38.0 107.9 36.5 29.6 0.6 45.0 26.8 0.4 35.8 45.9 66.2 0.0 8.5 37.7 68.6 3.9 70.2 127.5 91.8 5.2 2.9 23.4 1.3 10.5 113.2 22.5 2.3 102.4 70.5 45.7 0.7 1.1 0.6 8.2 0.0 5.1 152.8 28.5 1.9 12.4 14.1 2.5 8.3 16.0 1.0 7.5 16.1 15.5 27.6 1.4 188.1 46.5 0.4 29.7 155.7 32.6 3.1 89.3 1.0 6.6 0.6 4.3 71.5 1.1 42.4 41.3 11.2 14.4 1.2 61.8 274.4 GALNT4 GalNAc-T4 ENSG00000257594 "Polypeptide N-acetylgalactosaminyltransferase 4" Q8N4A0 12 89519412-89524796 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 31.6" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 11.2;Glandular and luminal cells: 3.4;Paneth cells: 3.4;Respiratory ciliated cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 22.2" HPA076116 Approved "Golgi apparatus" NA NA 520000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus" "HPA076116: AB_2686778" "unprognostic (2.96e-2)" "unprognostic (7.65e-3)" "unprognostic (8.76e-2)" "unprognostic (3.94e-5)" "unprognostic (3.50e-1)" "unprognostic (4.87e-2)" "unprognostic (2.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.24e-1)" "unprognostic (5.81e-6)" "unprognostic (2.34e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-2)" "unprognostic (2.52e-1)" 3.1 2.2 1.2 6.1 1.7 7.7 4.0 1.3 1.7 16.1 1.1 18.6 17.3 13.5 2.6 3.3 11.9 11.8 1.9 1.3 1.7 5.6 4.8 3.7 3.4 1.9 1.4 2.8 5.0 1.9 1.2 3.0 1.8 3.8 17.3 3.9 16.1 2.2 0.3 1.9 18.4 3.1 1.7 5.9 31.6 0.8 1.5 1.2 3.2 1.7 3.5 4.9 1.5 1.7 3.2 9.4 3.3 18.2 6.3 9.1 2.3 7.6 3.6 3.1 3.3 3.5 5.8 0.0 1.9 5.7 1.3 4.8 0.9 4.9 5.2 8.4 2.1 3.9 1.6 3.2 3.3 3.8 8.3 4.1 2.2 6.3 2.7 7.1 9.9 0.7 2.5 1.7 4.8 2.6 0.3 7.2 2.2 7.1 22.2 1.0 0.6 1.6 9.2 9.6 0.2 1.7 1.0 5.0 7.0 3.1 10.0 3.7 9.1 6.2 2.2 3.9 2.7 1.7 2.9 1.6 3.2 2.0 3.8 3.9 3.3 1.6 2.0 4.9 3.5 1.3 1.1 1.5 2.2 1.9 1.5 1.3 3.2 4.9 5.3 0.8 1.3 2.0 1.2 1.7 1.3 1.7 1.3 1.7 1.9 1.4 1.8 1.7 1.5 1.7 0.1 0.0 0.6 0.0 0.6 0.0 0.0 0.0 1.2 0.3 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 1.0 0.6 0.1 0.0 1.3 0.0 0.2 0.0 0.7 11.2 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.4 0.0 2.9 0.9 0.0 0.1 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.1 0.1 0.1 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257705-157318491 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.5;lung: 10.2;stomach 1: 12.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 157.0;Distal enterocytes: 48.3;Intestinal goblet cells: 75.5;Pancreatic endocrine cells: 53.5;Prostatic glandular cells: 40.1;Urothelial cells: 115.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 9 "cerebellum: 4.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 45.3;BJ: 29.8;BJ hTERT+: 53.5;fHDF/TERT166: 64.5;HaCaT: 51.8;K-562: 30.7;LHCN-M2: 52.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA 1300000 "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Cytosol" "Nucleoli, Vesicles" "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.1 0.0 0.0 0.7 0.0 0.6 1.1 4.0 0.3 1.1 5.2 10.6 2.2 0.1 0.1 4.5 0.0 2.7 0.4 0.4 0.0 0.0 0.0 10.2 0.0 0.1 0.1 0.1 0.0 0.1 0.6 0.0 0.2 0.7 13.5 0.1 8.2 0.1 0.0 0.3 4.1 0.4 0.0 0.1 12.8 0.1 0.1 0.1 0.1 0.1 1.7 4.5 4.6 0.2 45.3 4.8 0.0 0.0 2.0 17.0 0.0 29.8 53.5 0.5 1.1 1.9 24.4 0.0 0.1 64.5 0.0 51.8 0.9 10.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.9 0.0 0.0 0.0 30.7 0.0 52.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 25.4 0.3 0.6 0.1 0.0 0.1 0.0 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.3 0.4 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.1 157.0 36.1 0.0 0.1 0.8 13.3 20.2 6.2 0.0 0.5 2.8 0.5 2.8 32.9 0.0 0.0 0.0 0.2 48.3 0.0 1.2 6.9 1.2 0.0 0.6 2.4 5.2 0.8 3.2 0.0 2.1 35.7 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.1 75.5 6.1 0.0 0.7 0.5 0.0 0.3 3.6 0.0 1.6 0.0 0.0 0.0 0.1 53.5 26.4 0.0 1.4 40.1 3.1 0.2 10.0 0.0 0.0 0.5 1.2 2.6 0.5 4.5 0.1 0.0 0.3 0.0 22.7 115.1 GALNT6 GalNAc-T6 ENSG00000139629 "Polypeptide N-acetylgalactosaminyltransferase 6" Q8NCL4 12 51351247-51392867 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 62.6" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 49.2;Gastric mucus-secreting cells: 130.5;granulocytes: 164.5;Oligodendrocytes: 57.6" "Cancer enhanced" "Detected in many" "breast cancer: 31.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 29.1" "Group enriched" "Detected in all" 4 "granulocytes: 29.1;monocytes: 9.7;NK-cells: 15.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 107.0;CACO-2: 104.1;OE19: 97.6;SK-BR-3: 110.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA011762, HPA017086" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 4800000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Golgi apparatus" "HPA011762: AB_1849450, HPA017086: AB_1849452" "unprognostic (2.03e-1)" "unprognostic (6.65e-2)" "unprognostic (2.26e-2)" "prognostic favorable (9.85e-4)" "unprognostic (1.35e-2)" "unprognostic (1.18e-1)" "unprognostic (7.15e-3)" "unprognostic (2.05e-1)" "unprognostic (2.27e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.88e-2)" "unprognostic (5.25e-2)" "unprognostic (7.13e-4)" "unprognostic (5.65e-3)" "unprognostic (3.18e-1)" "unprognostic (2.16e-2)" "unprognostic (1.18e-2)" 1.7 3.1 3.3 8.0 11.8 9.6 18.1 7.2 9.1 32.2 0.2 6.7 21.2 1.3 24.7 2.4 6.5 2.4 0.4 4.2 7.3 2.9 1.2 5.7 7.2 8.8 11.1 0.9 8.3 1.4 1.1 9.6 10.8 0.9 6.9 0.1 31.0 3.2 0.4 5.6 21.6 1.6 5.2 8.2 62.6 0.6 9.7 6.8 2.5 0.1 5.9 3.7 1.8 18.1 39.0 4.1 0.7 0.1 0.0 0.6 59.8 63.0 107.0 25.4 17.0 104.1 19.0 0.5 5.8 34.4 0.0 35.9 1.5 27.3 17.1 8.3 4.1 24.6 0.7 0.8 1.0 13.6 82.2 2.3 25.2 23.1 23.0 0.2 65.7 14.2 5.4 1.0 0.1 73.7 43.2 10.1 5.3 97.6 66.6 0.2 0.1 10.3 21.3 2.2 0.5 23.5 0.4 110.5 0.1 12.2 59.3 5.9 75.7 0.2 12.9 0.2 0.3 2.1 0.5 3.6 7.2 29.5 0.2 7.1 5.8 29.1 3.8 5.2 1.6 1.2 2.2 3.1 4.5 3.3 3.4 2.9 1.1 15.5 9.7 4.1 1.7 3.2 3.3 11.8 7.2 9.1 4.2 7.3 8.8 11.1 10.8 5.2 9.7 18.1 0.8 3.2 2.4 0.3 11.8 2.9 3.8 5.8 5.7 0.4 38.9 18.4 1.3 1.5 15.6 1.8 0.0 14.1 11.3 12.4 3.9 2.6 2.0 3.5 0.3 4.1 0.0 15.3 1.0 10.9 49.2 1.6 130.5 5.8 164.5 3.8 1.4 0.3 14.4 0.0 0.5 17.4 2.0 16.3 10.3 1.5 0.0 15.1 1.8 1.0 7.2 0.2 9.2 0.0 57.6 24.3 33.9 0.4 5.5 7.6 39.6 2.0 12.4 0.0 0.0 1.5 1.5 0.4 1.6 2.6 9.2 4.8 14.9 1.8 11.8 5.8 GALNT7 GALNAC-T7 ENSG00000109586 "Polypeptide N-acetylgalactosaminyltransferase 7" Q86SF2 4 173168811-173323967 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 143.4;Inhibitory neurons: 172.0;Intestinal goblet cells: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064243, HPA065317" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 6200000 "Cluster 5: Granulocytes - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" Nucleoplasm "HPA064243: AB_2685223, HPA065317: AB_2685465" "unprognostic (1.81e-1)" "unprognostic (2.11e-1)" "prognostic favorable (4.53e-4)" "unprognostic (1.37e-3)" "unprognostic (1.48e-1)" "unprognostic (6.86e-3)" "unprognostic (2.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.33e-1)" "unprognostic (4.66e-3)" "unprognostic (3.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.34e-3)" "unprognostic (5.97e-2)" 6.4 6.4 6.4 16.3 8.8 11.5 23.3 34.2 8.3 25.1 3.5 47.8 29.1 16.9 7.0 14.9 9.8 15.6 5.9 6.6 7.8 7.8 2.9 9.6 12.2 12.6 8.3 11.2 22.2 8.7 5.2 13.0 11.7 39.7 52.8 22.4 27.4 8.1 1.4 3.9 33.7 16.7 10.1 11.0 65.7 11.9 8.4 60.0 13.5 3.9 9.8 17.0 5.9 16.0 71.1 37.2 35.0 11.2 18.6 27.1 50.3 18.1 20.5 16.7 23.0 11.5 109.9 39.4 13.3 16.6 45.2 59.2 15.0 32.0 22.7 154.3 29.1 47.8 72.2 0.4 12.2 71.6 32.8 17.5 28.3 37.6 18.9 63.4 112.3 28.2 32.6 59.3 86.0 23.5 52.7 39.4 34.8 70.2 24.0 52.1 32.4 10.2 123.2 32.8 28.2 21.5 8.5 50.4 25.4 45.3 20.2 21.0 135.6 11.9 52.3 0.6 40.0 17.2 0.2 20.8 48.6 42.3 43.6 13.2 14.3 18.9 5.1 7.5 7.2 6.2 5.7 5.3 12.4 3.3 4.4 3.3 21.3 7.5 8.0 5.0 9.2 6.4 6.4 8.8 34.2 8.3 6.6 7.8 12.6 8.3 11.7 10.1 8.4 16.0 10.0 6.4 38.0 72.8 12.1 1.8 9.0 12.3 4.0 47.9 41.1 19.8 9.6 8.6 36.0 20.2 2.1 1.4 16.4 143.4 0.0 14.4 2.5 28.3 13.3 11.3 22.8 12.0 74.4 48.9 3.7 12.1 102.4 52.9 24.1 14.8 12.1 0.2 10.3 10.1 172.0 126.8 24.4 17.9 6.2 4.2 9.3 17.2 8.8 62.8 16.3 8.1 5.2 71.4 54.1 39.9 50.0 5.3 6.6 52.8 63.7 10.0 17.4 25.5 13.1 16.1 11.7 3.8 5.5 14.9 1.1 0.8 9.9 13.1 48.6 19.4 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" Q9NY28 12 4720400-4851927 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 31.3;testis: 13.5" "Group enriched" "Detected in some" 6 "Early spermatids: 95.2;Intestinal goblet cells: 47.0;Late spermatids: 150.2" "Group enriched" "Detected in some" 4 "colorectal cancer: 1.2;glioma: 1.8;pancreatic cancer: 0.8;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 23.4;U-266/84: 7.6" "Not detected" "Not detected" "HPA012638, HPA073461" Supported Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA No "Cluster 22: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 2: Karpas-707 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: AB_2686604" "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 0.4 0.6 3.2 1.8 3.3 0.0 0.6 2.7 5.1 0.5 2.0 14.0 5.7 0.3 0.1 0.1 0.6 0.0 2.5 3.2 2.8 0.4 0.2 0.3 0.2 3.4 3.2 0.7 0.2 0.0 2.8 0.1 3.3 0.4 31.3 0.2 0.4 0.3 0.1 0.2 12.6 0.8 2.9 0.5 0.5 13.5 3.3 0.0 0.2 0.0 0.0 0.4 0.3 4.1 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 23.4 0.0 0.0 0.0 0.1 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 3.2 3.3 2.7 5.1 3.2 2.8 3.4 3.2 3.3 2.9 3.3 4.1 0.1 6.4 0.5 1.3 0.5 0.0 0.0 0.1 0.6 2.1 0.1 2.3 4.5 0.0 0.0 0.0 0.0 0.0 1.5 1.8 0.0 0.0 95.2 0.5 0.1 0.5 6.6 0.0 1.1 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 47.0 0.0 0.0 0.0 150.2 1.5 0.1 0.0 3.7 0.2 0.5 0.0 15.1 7.4 0.2 0.6 2.6 0.0 0.1 1.0 1.0 0.0 0.6 6.6 0.7 0.1 12.3 8.3 0.0 0.0 0.0 0.8 0.3 2.2 0.0 GAPT "C5orf29, FLJ33641" ENSG00000175857 "GRB2 binding adaptor protein, transmembrane" Q8N292 5 58491435-58497090 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 16.9;lymphoid tissue: 42.7" "Cell type enhanced" "Detected in some" "B-cells: 84.8;dendritic cells: 160.1;granulocytes: 55.0;Macrophages: 43.0;monocytes: 41.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "eosinophil: 1000.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 1000.3" "Cell line enhanced" "Detected in some" "HEL: 71.5;HL-60: 41.8;NB-4: 43.3;THP-1: 33.7;U-937: 118.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA011048, HPA011070" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane" "Golgi apparatus, Vesicles" "HPA011048: , HPA011070: AB_1848887" "unprognostic (9.79e-2)" "unprognostic (5.67e-3)" "unprognostic (2.39e-2)" "unprognostic (3.26e-2)" "unprognostic (3.36e-2)" "unprognostic (8.09e-4)" "unprognostic (4.32e-1)" "unprognostic (1.23e-3)" "unprognostic (4.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.28e-2)" "unprognostic (2.93e-1)" "unprognostic (3.52e-3)" "unprognostic (3.74e-2)" "unprognostic (2.42e-2)" "unprognostic (2.33e-2)" "unprognostic (1.40e-2)" 1.7 0.8 0.7 28.5 0.7 16.9 2.3 0.7 1.1 2.7 1.3 2.7 3.7 1.3 1.1 2.1 1.6 5.7 0.7 0.7 1.0 0.8 2.0 4.2 25.3 1.3 1.1 0.4 1.1 1.1 0.6 1.0 1.3 1.8 3.8 0.5 1.9 1.2 0.2 0.8 6.6 4.7 1.0 18.2 3.7 0.7 1.1 6.9 0.6 0.7 42.7 6.0 0.5 1.8 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 71.5 0.2 0.0 0.0 41.8 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 43.3 0.0 0.0 0.0 17.7 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 33.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 118.4 0.0 125.5 66.7 1000.3 0.4 46.5 0.5 97.0 0.4 0.4 76.8 97.4 0.3 0.3 82.0 1.4 59.3 205.4 0.3 32.0 0.7 0.7 0.7 1.1 0.7 1.0 1.3 1.1 1.3 1.0 1.1 1.8 0.4 3.2 1.9 0.0 84.8 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.2 0.0 0.6 0.0 0.0 0.0 160.1 0.0 0.0 0.0 1.6 0.0 0.1 0.9 0.0 8.8 0.0 0.0 0.1 0.4 0.5 0.0 55.0 0.0 0.4 0.0 14.3 0.0 0.0 0.0 0.0 19.4 6.0 0.5 0.0 43.0 0.0 1.9 41.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 GASK1B "C4orf18, DKFZp434L142, ENED, FAM198B, FLJ38155" ENSG00000164125 "Golgi associated kinase 1B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 206.2" "Cell type enhanced" "Detected in some" "Adipocytes: 22.9;Cardiomyocytes: 33.8;Endothelial cells: 12.1;Fibroblasts: 14.5;Hofbauer cells: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "classical monocyte: 50.6;intermediate monocyte: 28.8;myeloid DC: 15.1;non-classical monocyte: 14.0" "Group enriched" "Detected in many" 41 "dendritic cells: 15.1;monocytes: 50.6" "Cell line enhanced" "Detected in many" "ASC diff: 77.0;ASC TERT1: 143.3;HSkMC: 166.4;HUVEC TERT2: 193.3;WM-115: 74.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA 13000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 73.9 206.2 29.0 39.8 29.2 2.8 47.3 21.8 23.3 47.0 11.9 23.4 13.3 77.7 21.8 17.2 19.4 37.1 77.9 28.7 29.6 9.5 8.6 14.1 11.2 51.7 33.0 140.3 14.2 11.5 2.8 29.0 26.9 23.6 23.3 0.8 23.6 30.0 12.4 7.3 18.5 70.2 34.1 20.8 11.8 10.4 35.5 5.7 17.7 16.7 6.8 43.2 9.2 33.0 12.5 9.9 6.1 1.1 77.0 143.3 11.4 3.1 2.4 0.6 3.7 13.3 4.9 0.1 0.3 5.0 5.1 0.2 70.7 18.9 1.8 0.1 0.2 1.0 0.0 37.0 51.4 0.6 0.3 166.4 4.6 24.2 2.6 8.0 193.3 0.0 13.0 0.0 35.7 0.8 0.0 0.2 0.4 43.4 0.2 0.1 0.5 0.2 0.0 27.5 0.4 0.1 0.0 27.8 8.2 33.4 5.4 0.3 9.3 16.0 17.1 9.6 6.1 0.0 0.1 44.8 2.5 0.3 74.3 0.1 50.6 0.0 0.1 28.8 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.7 0.1 14.0 0.6 0.0 17.8 29.0 29.2 21.8 23.3 28.7 29.6 51.7 33.0 26.9 34.1 35.5 33.0 22.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 1.2 14.5 0.0 0.0 0.0 0.0 0.0 0.0 67.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 GBA2 "AD035, DKFZp762K054, KIAA1605, SPG46" ENSG00000070610 "Glucosylceramidase beta 2" Q9HCG7 9 35736866-35749228 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 102.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024026 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Golgi apparatus" Cytosol "HPA024026: AB_1849530" "unprognostic (3.34e-2)" "unprognostic (2.90e-1)" "unprognostic (2.99e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (2.09e-2)" "unprognostic (3.99e-2)" "unprognostic (8.69e-2)" "prognostic favorable (6.00e-4)" "unprognostic (9.01e-3)" "prognostic favorable (1.24e-11)" "unprognostic (7.62e-3)" "unprognostic (2.94e-1)" "unprognostic (7.69e-2)" "prognostic favorable (6.60e-4)" 39.3 45.7 48.5 23.2 47.5 16.3 39.9 52.8 53.7 46.4 63.3 83.5 54.2 44.6 26.9 36.3 44.2 26.3 83.3 47.2 54.2 84.4 65.9 54.1 24.6 54.1 56.2 39.8 54.1 37.2 65.5 24.7 56.1 60.2 41.0 71.1 50.0 27.7 75.8 39.3 89.7 22.9 45.1 58.5 63.9 30.8 58.9 18.3 61.7 43.7 21.6 53.0 40.9 48.7 18.1 29.3 39.6 38.4 18.8 11.4 40.0 24.1 18.8 23.9 25.0 32.8 14.1 19.3 17.1 14.7 51.5 18.4 38.2 16.2 12.0 27.5 26.2 20.8 87.8 35.6 20.8 31.2 49.4 19.8 29.8 20.3 21.1 57.9 63.4 18.9 20.7 36.0 22.6 18.0 8.5 32.0 41.2 36.6 45.7 15.5 16.0 16.3 33.3 41.9 32.2 43.0 13.5 33.3 24.5 48.1 22.8 27.8 44.6 25.8 30.9 22.4 29.9 24.2 16.5 16.0 32.3 11.3 20.5 11.1 2.9 2.0 3.8 3.9 2.5 3.7 3.7 4.7 2.8 4.7 2.2 1.9 3.2 2.4 2.5 4.4 2.8 2.2 48.5 47.5 52.8 53.7 47.2 54.2 54.1 56.2 56.1 45.1 58.9 48.7 12.7 12.8 8.0 45.1 11.2 7.4 18.2 9.4 6.2 77.5 15.0 10.8 13.7 17.2 14.5 27.6 114.7 11.1 16.6 71.7 21.5 10.5 14.1 10.0 8.1 16.0 35.8 17.2 23.5 12.0 10.2 8.0 46.4 13.8 14.0 18.7 30.7 20.1 9.2 52.2 26.4 35.8 16.2 12.8 10.7 24.3 12.5 10.7 12.4 8.4 13.3 16.2 12.3 18.1 20.2 15.1 57.6 9.8 11.7 15.8 87.4 17.8 17.9 102.9 13.1 12.2 12.2 9.2 5.7 8.8 9.9 22.2 9.4 11.3 41.4 26.3 GBF1 "ARF1GEF, KIAA0248" ENSG00000107862 "Golgi brefeldin A resistant guanine nucleotide exchange factor 1" Q92538 10 102245371-102382899 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 28.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037759, HPA037760" Uncertain Supported "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA037759: AB_10671884, HPA037760: AB_2675651" "unprognostic (5.97e-2)" "unprognostic (3.33e-1)" "unprognostic (2.74e-3)" "unprognostic (7.02e-2)" "unprognostic (2.03e-1)" "unprognostic (6.72e-2)" "unprognostic (3.78e-2)" "unprognostic (8.28e-2)" "unprognostic (1.12e-2)" "unprognostic (5.34e-3)" "unprognostic (2.04e-2)" "unprognostic (6.06e-2)" "unprognostic (1.87e-1)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (3.02e-1)" "unprognostic (3.09e-2)" 19.4 21.1 31.5 16.0 31.7 25.0 19.3 28.7 47.2 21.7 34.9 24.6 20.6 23.5 12.7 21.9 19.7 9.8 30.0 32.2 27.7 21.7 23.2 20.5 14.6 28.5 37.3 21.6 25.6 24.4 31.5 11.5 30.6 24.2 13.9 19.2 24.5 15.2 48.1 24.9 25.8 16.4 27.1 21.7 21.2 20.5 29.8 11.8 25.4 30.1 13.8 21.7 20.5 29.1 19.4 49.7 23.3 25.1 62.9 40.7 28.1 37.7 56.0 45.3 48.1 52.7 35.1 21.7 29.7 59.6 33.8 38.6 45.9 52.8 33.8 35.4 36.9 33.3 38.1 44.6 26.4 35.2 46.8 37.3 28.0 60.7 57.5 77.2 45.2 22.5 20.7 53.7 41.8 36.9 24.2 38.9 15.4 29.5 35.6 33.6 72.1 18.8 39.3 30.9 15.0 16.3 30.2 22.3 26.5 33.1 50.4 30.8 60.5 29.1 29.6 37.7 55.6 32.4 36.3 26.5 30.0 36.3 22.1 28.6 4.5 4.3 4.9 5.0 5.9 6.5 3.6 6.5 5.0 3.9 5.7 5.3 4.6 4.6 4.1 4.2 7.4 3.9 31.5 31.7 28.7 47.2 32.2 27.7 28.5 37.3 30.6 27.1 29.8 29.1 12.5 12.8 10.1 56.5 15.5 9.8 5.5 10.6 17.6 24.7 15.7 12.8 17.0 15.7 10.9 12.9 56.3 12.2 15.1 31.4 3.9 12.5 4.9 14.3 18.1 12.3 12.0 13.9 72.1 16.7 16.3 14.6 31.1 15.6 7.6 10.3 8.2 17.6 12.2 52.2 73.0 21.9 12.2 11.0 5.0 4.7 10.2 13.4 12.4 66.5 9.5 11.1 9.2 80.9 71.1 18.6 20.7 11.3 46.0 7.7 27.1 9.0 12.3 41.0 6.6 21.7 12.3 36.0 25.4 20.7 13.1 17.6 16.0 19.1 19.4 6.7 GBP4 Mpa2 ENSG00000162654 "Guanylate binding protein 4" Q96PP9 1 89181144-89198942 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0" "HPA030101, HPA062039" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 15: RT4 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "Plasma membrane" "HPA030101: AB_10601654, HPA062039: " "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (1.02e-2)" "unprognostic (1.07e-3)" "unprognostic (3.22e-1)" "unprognostic (9.93e-3)" "unprognostic (5.65e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (1.22e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.02e-3)" 11.3 5.2 4.0 29.5 3.9 6.6 6.7 4.4 4.8 4.2 2.6 6.6 12.4 8.8 4.5 7.2 9.1 8.8 11.0 3.8 4.3 9.8 14.1 31.2 34.3 7.1 3.7 16.4 1.6 6.5 2.7 11.9 7.7 5.8 7.2 3.4 7.1 6.7 7.1 2.1 11.8 7.7 3.9 29.0 11.9 2.9 4.4 10.0 7.8 9.4 11.0 13.1 4.5 3.9 0.8 0.0 0.1 0.3 0.1 0.1 0.6 1.8 7.6 8.0 7.2 0.1 12.1 0.6 1.0 2.3 0.6 0.9 0.0 0.3 0.4 9.9 0.1 13.0 0.4 0.3 1.0 0.2 0.3 0.4 0.0 0.1 0.0 1.2 1.9 0.3 0.4 2.3 0.0 0.2 6.6 0.3 0.4 0.1 0.1 11.1 0.2 0.4 0.1 18.3 0.2 0.5 0.3 0.7 0.3 0.6 0.5 1.4 0.4 0.3 1.6 0.2 0.2 16.0 0.3 0.3 0.3 0.1 2.3 0.6 4.1 0.4 7.1 14.1 6.1 2.5 7.6 7.9 2.2 3.3 5.6 5.2 5.6 13.8 14.5 0.9 9.0 5.5 4.0 3.9 4.4 4.8 3.8 4.3 7.1 3.7 7.7 3.9 4.4 3.9 84.4 32.1 39.3 0.0 28.3 4.6 9.1 20.7 1.8 2.8 3.5 2.4 3.6 8.6 25.3 5.5 8.4 0.9 29.0 5.1 0.0 2.2 1.9 4.8 8.4 81.2 0.0 11.2 0.5 3.3 1.6 22.2 9.2 7.4 21.5 17.9 92.4 6.5 8.3 0.0 2.5 4.3 4.1 29.2 10.9 1.2 3.7 33.7 5.4 15.9 33.8 15.5 36.0 1.0 0.6 36.3 1.9 1.9 7.2 24.4 4.4 1.5 43.3 12.2 0.0 5.3 11.3 2.4 3.4 2.9 3.0 1.5 34.2 122.6 2.4 13.6 GCC1 "FLJ22035, GCC1P, GCC88, MGC20706" ENSG00000179562 "GRIP and coiled-coil domain containing 1" Q96CN9 7 127580628-127593611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 102.7;Late spermatids: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019369, HPA021323" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "Plasma membrane, Cytosol" "HPA019369: AB_1849552, HPA021323: AB_1849554" "unprognostic (1.09e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.08e-2)" "unprognostic (4.81e-2)" "unprognostic (4.50e-3)" "unprognostic (1.17e-3)" "unprognostic (4.17e-3)" "unprognostic (1.22e-1)" "unprognostic (8.65e-2)" "unprognostic (9.96e-2)" 6.6 6.6 5.4 7.8 6.3 13.5 9.2 6.4 5.7 7.0 6.2 6.9 6.5 6.1 6.5 7.0 5.9 6.3 4.8 5.2 5.9 6.2 10.6 6.9 8.6 6.3 6.3 8.0 6.9 9.4 4.5 7.5 6.1 7.3 6.2 3.6 8.2 6.7 6.6 7.8 6.5 5.1 6.2 8.3 7.7 11.0 6.1 8.3 7.7 6.7 9.9 7.1 4.7 7.2 15.7 20.8 9.0 19.5 19.7 13.5 12.4 13.4 15.5 13.2 16.5 17.5 10.5 14.4 8.0 12.6 29.7 17.0 13.1 14.7 14.1 20.3 11.9 10.6 11.4 9.2 29.2 18.5 16.9 12.7 39.7 14.1 27.8 12.4 12.6 14.2 17.6 16.1 15.0 15.6 18.0 16.0 18.8 17.2 16.1 12.7 9.8 16.5 11.4 12.0 14.2 20.6 14.4 67.9 27.5 16.1 11.6 13.2 16.4 19.5 6.3 17.0 15.6 43.6 20.6 9.1 19.3 18.6 20.2 5.3 7.1 13.2 7.1 6.9 9.1 6.6 6.4 7.0 6.6 6.3 5.1 5.2 13.1 8.7 8.2 3.8 6.5 8.1 5.4 6.3 6.4 5.7 5.2 5.9 6.3 6.3 6.1 6.2 6.1 7.2 4.8 12.8 7.7 0.0 9.6 10.6 5.0 2.7 12.0 4.1 11.5 6.1 3.6 4.3 3.7 3.7 4.2 7.2 7.3 10.0 5.9 5.1 102.7 4.3 5.5 6.7 7.2 8.2 0.0 6.4 4.6 5.0 8.6 6.8 1.3 5.9 5.0 7.4 5.2 11.8 0.0 8.2 2.0 10.1 8.3 131.7 5.3 7.6 12.4 0.0 6.9 4.9 5.2 0.0 0.0 5.9 6.6 3.8 6.3 5.4 6.0 4.5 2.4 5.9 6.6 5.9 6.5 7.8 4.6 6.3 10.4 10.4 8.8 5.8 5.8 5.4 GCC2 "GCC185, KIAA0336" ENSG00000135968 "GRIP and coiled-coil domain containing 2" Q8IWJ2 2 108449191-108509415 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035849, HPA035850" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA035849: AB_10671941, HPA035850: AB_2674821" "unprognostic (1.35e-1)" "unprognostic (1.29e-2)" "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.59e-1)" "unprognostic (3.11e-2)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.53e-2)" "unprognostic (6.53e-3)" "unprognostic (3.99e-1)" "unprognostic (4.71e-1)" "unprognostic (9.61e-2)" "unprognostic (1.64e-2)" 9.0 12.7 3.4 17.6 5.1 25.2 17.4 0.0 5.5 12.5 26.2 19.2 21.7 15.3 41.7 7.5 15.0 21.4 8.4 3.2 3.8 16.6 10.7 14.8 21.5 2.5 4.2 15.5 12.5 15.0 4.1 13.7 2.8 19.6 20.8 17.3 15.2 17.1 2.3 7.9 22.9 9.4 0.9 18.8 26.4 16.6 1.4 18.9 20.5 9.4 16.3 14.1 3.6 6.0 12.5 10.4 12.6 5.5 14.2 22.6 27.4 17.6 26.8 9.2 12.9 18.4 17.2 14.9 22.3 16.0 16.7 10.4 10.0 14.1 15.8 16.9 13.6 18.7 16.3 15.8 12.7 26.4 14.3 29.1 13.3 23.1 16.3 20.0 13.6 13.9 25.3 12.4 17.4 7.1 13.6 18.1 21.9 11.5 12.0 11.7 17.9 16.1 12.2 20.1 13.6 12.5 21.1 16.7 18.7 18.2 8.3 12.8 21.3 13.3 20.2 12.4 6.7 18.0 26.9 18.2 17.2 7.0 9.8 47.3 8.9 25.9 25.5 8.0 25.1 27.0 28.2 27.8 7.3 24.3 38.2 33.5 35.6 14.9 17.6 31.8 23.0 8.2 3.4 5.1 0.0 5.5 3.2 3.8 2.5 4.2 2.8 0.9 1.4 6.0 92.6 150.6 103.3 44.1 125.2 23.8 68.6 54.8 29.6 155.9 60.3 57.5 85.6 75.8 95.7 104.8 139.7 44.2 157.6 152.1 50.9 114.5 73.9 253.3 85.1 68.1 85.6 39.5 104.9 81.6 56.3 74.2 65.7 118.6 82.2 113.9 65.0 36.7 37.0 70.7 73.6 152.6 52.9 49.8 39.3 39.9 71.4 66.0 33.8 62.8 88.5 59.0 134.9 50.8 66.1 116.1 125.2 82.8 108.7 91.7 134.0 63.1 259.7 127.2 52.6 61.4 66.2 163.0 120.7 21.0 17.5 65.0 139.1 138.0 88.3 114.5 GCGR GGR ENSG00000215644 "Glucagon receptor" P47871 17 81804132-81814008 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "kidney: 50.0;liver: 169.6" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 74.6" "Cancer enriched" "Detected in many" 4 "liver cancer: 10.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.0;MCF7: 1.4;SK-BR-3: 1.2;U-87 MG: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071228 Uncertain "Golgi apparatus" NA NA "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA071228: AB_2686368" "unprognostic (3.28e-4)" "unprognostic (9.30e-2)" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.11e-1)" "unprognostic (2.30e-3)" "unprognostic (4.38e-2)" "unprognostic (1.79e-3)" "unprognostic (2.18e-1)" "unprognostic (2.77e-1)" "unprognostic (3.09e-1)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (5.99e-3)" "unprognostic (1.71e-1)" "unprognostic (1.17e-3)" "unprognostic (8.36e-3)" 0.2 2.5 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.2 0.0 0.8 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 50.0 169.6 0.0 0.1 0.3 0.1 0.0 1.4 6.3 0.2 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.0 1.5 0.6 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.9 0.0 0.6 0.0 0.5 0.0 0.3 0.6 0.0 0.3 3.7 2.1 0.0 0.0 0.1 3.9 0.2 0.1 0.4 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.4 74.6 0.1 0.0 0.5 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.6 0.4 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.0 0.2 0.0 0.1 0.0 GCK "HK4, MODY2" ENSG00000106633 Glucokinase P35557 7 44143213-44198170 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 12.6;choroid plexus: 7.4;heart muscle: 8.8;liver: 21.5;pituitary gland: 23.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7" "Cancer enhanced" "Detected in some" "liver cancer: 4.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.3;naive CD4 T-cell: 2.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007034, HPA007093" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 15: Liver - Metabolism" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus, Cytosol" "HPA007034: AB_1079050, HPA007093: AB_1079051" "unprognostic (3.09e-1)" "unprognostic (2.99e-2)" "unprognostic (3.32e-2)" "unprognostic (6.64e-7)" "unprognostic (8.00e-2)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (2.68e-1)" "unprognostic (1.24e-1)" "unprognostic (5.48e-2)" "unprognostic (8.11e-3)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (2.01e-2)" "unprognostic (3.24e-1)" "unprognostic (4.36e-2)" "unprognostic (1.53e-1)" 0.8 0.3 8.9 0.3 8.3 0.2 0.7 8.1 9.5 2.8 7.4 0.5 0.1 1.2 0.8 0.4 1.2 0.5 8.8 8.2 11.0 1.2 21.5 0.4 0.2 9.0 9.9 1.4 1.8 0.1 23.9 1.6 9.1 1.2 0.2 1.0 0.3 0.7 0.2 0.7 0.5 0.3 8.3 0.6 0.6 0.4 12.6 0.1 0.5 0.1 0.2 1.1 2.0 7.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 1.2 1.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.6 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.3 2.3 0.7 0.1 0.1 0.3 2.0 0.4 0.8 0.1 0.0 0.1 0.0 0.3 8.9 8.3 8.1 9.5 8.2 11.0 9.0 9.9 9.1 8.3 12.6 7.9 0.3 0.0 0.0 0.7 0.3 1.1 0.7 0.0 1.2 5.0 0.1 0.8 4.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 1.3 0.5 2.4 0.0 1.8 0.0 0.2 5.2 0.0 0.0 0.0 2.4 0.0 0.4 0.7 5.0 2.4 0.0 0.0 0.0 0.7 0.3 0.9 0.1 0.0 1.0 0.0 2.8 0.0 0.5 1.0 0.1 0.1 2.2 0.2 1.7 0.0 0.1 0.0 0.8 0.0 0.6 3.7 0.5 1.1 0.0 0.1 0.8 0.3 0.5 0.0 0.7 GCNT2 "bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3" ENSG00000111846 "Glucosaminyl (N-acetyl) transferase 2 (I blood group)" Q8N0V5 6 10492223-10629368 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 13.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4" "Region enriched" "Detected in all" 4 "basal ganglia: 61.1" "Low region specificity" "Detected in all" HPA026776 Approved Approved "Golgi apparatus" No No 750000 "Cluster 41: Basophils - Cellular respiration" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA026776: AB_1849573" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (3.12e-1)" "unprognostic (1.42e-2)" "unprognostic (9.31e-2)" "unprognostic (2.51e-1)" "unprognostic (4.11e-2)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (6.28e-4)" "unprognostic (3.96e-2)" "unprognostic (1.58e-3)" "unprognostic (6.54e-2)" "unprognostic (6.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" 0.6 0.3 0.7 1.0 0.6 0.3 10.1 2.5 1.1 4.2 4.5 3.6 5.2 1.4 0.2 1.4 0.8 1.5 6.6 0.8 1.1 5.7 5.1 3.9 1.8 1.2 1.0 0.3 1.3 0.4 1.4 2.6 1.4 13.5 2.0 0.3 4.2 0.3 0.7 1.4 5.8 1.6 0.9 1.5 5.9 2.5 0.9 0.5 1.2 1.8 2.4 1.0 0.7 1.0 6.3 4.9 1.5 4.8 0.0 0.0 9.6 0.0 4.1 1.1 0.5 11.0 5.2 3.5 44.2 0.0 3.2 0.3 0.4 5.1 2.9 3.1 1.8 0.5 2.6 19.7 0.0 1.7 4.7 0.0 0.0 0.5 0.0 2.4 9.1 0.0 0.4 0.0 0.4 0.0 0.0 4.0 4.4 0.0 3.6 0.2 3.8 6.0 16.0 2.9 4.0 1.2 0.0 14.4 17.1 21.4 0.3 0.8 6.4 0.8 0.5 0.0 5.0 0.1 0.0 2.4 0.8 0.3 2.3 1.9 1.1 0.5 0.1 0.8 0.0 0.7 0.1 0.1 0.8 0.4 0.1 0.2 0.1 0.2 0.2 0.2 0.0 0.3 0.7 0.6 2.5 1.1 0.8 1.1 1.2 1.0 1.4 0.9 0.9 1.0 1.4 76.9 32.4 1.0 9.5 4.6 6.6 15.5 9.6 5.1 30.5 16.1 18.4 2.8 28.6 7.3 0.0 27.9 6.4 15.5 11.7 2.9 4.3 79.1 5.5 11.0 2.4 25.9 0.7 24.7 2.1 2.0 16.8 105.5 2.5 0.0 12.8 32.0 15.8 3.3 11.8 5.6 6.1 7.7 9.4 8.2 0.3 7.8 49.8 52.5 11.1 2.4 0.0 18.6 1.1 12.0 11.9 0.0 1.0 16.6 44.3 13.4 27.9 0.6 0.0 0.7 2.2 6.2 27.6 11.2 1.7 10.9 3.1 0.0 16.3 8.1 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 75.5;intestine: 142.9;salivary gland: 55.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5" "Group enriched" "Detected in many" 4 "colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favorable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.2 0.7 0.2 11.9 0.2 0.5 0.4 0.6 0.4 19.2 0.2 142.9 97.5 2.0 0.0 15.8 4.2 75.5 0.1 0.2 0.1 17.9 0.4 0.7 0.9 0.1 0.4 0.1 2.1 0.9 0.1 0.1 0.2 1.2 123.2 0.1 55.8 0.3 0.2 0.3 123.3 4.6 0.0 0.1 25.8 4.3 0.2 1.3 2.1 0.0 10.6 9.1 29.9 0.4 0.1 147.4 0.0 0.2 0.0 1.0 0.2 0.1 7.7 0.0 0.0 6.3 6.0 0.6 24.6 0.0 9.5 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.5 30.3 0.0 0.2 0.2 0.3 3.5 0.7 0.0 0.1 0.0 0.2 0.0 0.4 1.4 0.6 0.1 0.2 0.2 75.9 0.3 0.4 0.0 0.6 10.2 1.2 0.2 0.2 0.0 0.2 0.4 0.1 0.1 0.0 0.1 0.2 0.4 7.3 0.1 0.2 0.5 0.8 8.9 0.3 0.1 0.9 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.2 0.1 0.3 0.1 0.0 0.2 0.2 0.6 0.4 0.2 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.0 0.0 2.2 0.0 1.0 0.0 18.3 8.9 0.0 0.0 0.5 0.0 0.7 11.5 40.5 104.8 0.0 0.0 0.1 360.1 0.0 92.6 9.8 23.3 8.6 0.3 7.8 0.0 0.0 14.9 0.0 0.2 27.5 75.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 26.9 8.2 0.6 0.0 19.2 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 58.4 163.2 0.0 0.1 8.0 85.5 4.4 9.8 0.0 6.6 0.6 1.5 3.0 0.3 1.4 0.0 0.0 0.8 0.0 48.5 52.4 GCNT4 "C2GNT3, LINC01336" ENSG00000176928 "Glucosaminyl (N-acetyl) transferase 4" Q9P109 5 75025346-75052558 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.0;lymphoid tissue: 15.4;stomach 1: 18.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 20 "amygdala: 1.1;basal ganglia: 1.8;cerebral cortex: 3.3;hippocampal formation: 2.1;white matter: 1.4" "Immune cell enhanced" "Detected in many" "basophil: 22.4" "Group enriched" "Detected in many" 53 "granulocytes: 22.4;T-cells: 18.2" "Cell line enriched" "Detected in some" 5 "RT4: 37.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037431 Approved Supported "Nucleoplasm,Golgi apparatus" No NA "Cluster 20: T-cells - T-cell receptor" "Cluster 56: Intestine - Transmembrane transport" "Cluster 15: RT4 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" Nucleoplasm "HPA037431: AB_10670382" "unprognostic (1.88e-2)" "unprognostic (5.63e-2)" "unprognostic (6.05e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" "unprognostic (4.98e-2)" "unprognostic (4.11e-3)" "unprognostic (1.63e-2)" "unprognostic (3.47e-1)" "unprognostic (2.20e-2)" "unprognostic (4.49e-3)" "unprognostic (6.04e-2)" "prognostic favorable (1.93e-7)" "unprognostic (8.39e-2)" "unprognostic (1.93e-1)" "unprognostic (6.06e-2)" "unprognostic (5.82e-2)" 0.9 0.8 1.1 2.9 1.8 0.7 1.3 0.0 3.3 1.4 0.0 1.4 24.0 1.2 1.9 2.2 2.1 5.3 0.4 2.1 0.0 4.1 1.1 1.7 4.4 0.0 0.0 1.0 4.6 9.6 0.2 6.3 0.0 1.7 1.3 0.1 0.5 4.8 1.0 2.1 20.2 2.3 0.0 1.7 18.5 1.6 0.0 15.4 0.5 1.4 3.0 4.1 1.8 1.4 0.3 0.2 1.4 2.3 2.5 0.8 0.1 2.8 7.2 1.5 1.2 3.7 0.2 0.0 0.4 2.2 0.8 1.0 1.4 2.5 0.3 0.0 0.1 1.2 0.3 0.3 1.1 0.0 0.0 0.4 3.9 0.1 0.5 0.0 0.0 2.2 0.0 0.5 0.2 0.0 2.1 0.1 0.6 8.0 0.0 0.0 0.0 3.6 0.3 37.1 0.0 0.1 0.3 0.0 0.1 7.0 0.0 0.0 0.0 0.8 0.2 1.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 22.4 0.0 0.0 1.2 0.0 5.0 0.0 11.4 3.7 0.0 0.0 11.1 8.1 0.2 0.3 0.2 0.1 18.2 2.3 1.1 1.8 0.0 3.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 3.2 5.0 0.7 0.3 0.6 8.7 0.5 0.0 0.0 0.9 2.3 0.5 32.9 2.7 12.9 0.0 39.6 0.8 4.9 9.8 7.1 0.1 11.9 2.4 1.8 0.0 0.0 1.3 4.4 0.9 2.5 14.8 16.7 7.6 2.0 3.3 0.7 2.3 0.0 0.0 2.7 0.0 0.3 0.0 0.3 4.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.2 6.9 2.6 0.5 3.0 28.0 0.7 0.6 0.0 6.6 1.6 2.5 0.2 1.7 0.6 0.1 24.4 3.7 0.0 4.4 4.2 GDF15 "MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB" ENSG00000130513 "Growth differentiation factor 15" Q99988 19 18374731-18389176 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 371.8;urinary bladder: 175.4" "Cell type enhanced" "Detected in many" "Club cells: 1160.8;Syncytiotrophoblasts: 4304.7;Urothelial cells: 3294.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.7" "Group enriched" "Detected in many" 5 "granulocytes: 2.7;monocytes: 1.2" "Cell line enhanced" "Detected in many" "BEWO: 416.5;Hep G2: 225.5;HHSteC: 564.9;TIME: 213.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011191, CAB062554, HPA070957" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1260000 960000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168" "unprognostic (1.04e-1)" "unprognostic (1.89e-2)" "unprognostic (3.45e-2)" "unprognostic (3.36e-2)" "unprognostic (2.04e-2)" "unprognostic (2.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.30e-2)" "unprognostic (2.80e-1)" "unprognostic (2.89e-1)" "unprognostic (5.09e-2)" "unprognostic (1.46e-1)" "unprognostic (6.55e-3)" "unprognostic (3.81e-2)" "unprognostic (8.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.04e-3)" 34.8 11.7 1.3 1.5 1.4 0.4 24.9 1.0 2.3 18.9 40.9 29.2 4.5 13.6 2.2 4.8 5.5 19.9 4.5 4.3 1.3 371.8 88.6 46.9 0.6 2.0 1.7 4.7 112.3 25.9 12.3 86.9 1.5 105.3 24.4 1.2 12.5 4.6 5.5 6.4 12.3 1.9 1.2 11.4 75.5 1.6 2.5 0.3 11.2 0.5 1.7 175.4 19.2 1.6 1.8 95.6 9.4 3.5 22.3 18.5 416.5 33.1 17.9 1.2 18.8 4.2 29.6 0.4 58.8 3.0 97.0 0.7 0.0 12.2 4.7 0.2 2.2 0.9 9.2 225.5 564.9 0.1 35.7 48.8 140.1 90.7 58.6 0.7 99.5 0.0 152.4 0.7 22.9 23.5 0.1 0.8 5.4 34.4 52.5 0.2 3.7 0.2 69.9 94.6 0.9 1.0 0.4 5.5 127.9 35.1 2.6 0.4 213.1 0.0 7.4 1.8 1.5 1.5 4.0 0.4 51.9 0.1 27.8 0.0 0.7 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 1.2 0.0 0.0 0.1 1.3 1.4 1.0 2.3 4.3 1.3 2.0 1.7 1.5 1.2 2.5 1.6 6.6 35.3 62.4 0.0 1.8 1.3 350.6 366.1 0.0 0.1 54.2 15.5 0.7 47.1 1160.8 259.3 0.0 60.6 0.4 176.0 33.2 316.9 0.0 166.8 35.4 31.9 84.8 0.0 0.1 381.9 263.4 52.9 224.8 261.8 29.2 0.2 2.5 7.0 33.8 0.0 0.1 357.6 453.7 1.6 3.7 0.0 0.9 14.1 3.6 0.0 9.9 0.5 1.0 0.0 0.0 440.4 146.6 1.5 1.3 780.2 22.9 85.7 681.4 0.6 0.0 9.5 46.7 0.7 0.5 1.3 1.7 4304.7 5.5 3.4 291.0 3294.2 GDF9 ENSG00000164404 "Growth differentiation factor 9" O60383 5 132861181-132866884 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.9" "Cell type enhanced" "Detected in some" "Early spermatids: 19.9;Late spermatids: 5.2;Spermatocytes: 15.2" "Cancer enriched" "Detected in some" 5 "breast cancer: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069146 Supported Approved "Golgi apparatus,Cytosol" "Secreted in female reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Cytosol "HPA069146: AB_2686094" "unprognostic (4.64e-1)" "unprognostic (1.22e-1)" "unprognostic (1.25e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.61e-2)" "unprognostic (4.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.70e-3)" "unprognostic (1.04e-1)" "unprognostic (1.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (4.75e-3)" "unprognostic (3.10e-2)" 0.3 0.6 1.3 0.2 1.5 0.3 0.8 1.3 2.0 0.4 0.9 0.3 0.4 0.3 4.1 0.3 0.8 0.2 0.3 1.3 1.4 1.4 0.6 0.3 0.5 1.2 1.4 0.5 1.0 0.7 1.7 0.2 1.4 0.6 0.3 1.3 0.8 0.5 0.7 1.0 0.4 0.2 1.4 0.4 1.0 8.9 1.3 0.7 1.0 0.7 0.4 0.6 0.3 1.4 0.2 0.1 0.5 1.1 0.7 0.3 0.1 0.0 0.1 0.1 0.1 0.3 0.8 0.2 0.6 0.1 0.9 0.2 0.4 0.4 0.1 0.4 0.7 0.5 0.5 0.1 0.1 0.1 0.0 0.3 0.6 0.0 0.3 0.1 0.0 3.9 0.0 1.2 0.2 0.2 0.7 0.8 0.2 0.1 0.0 0.6 0.0 0.2 0.3 0.2 1.0 0.9 0.2 0.1 0.5 0.7 0.5 0.1 0.1 0.9 0.4 0.2 0.1 1.3 1.7 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.5 1.3 2.0 1.3 1.4 1.2 1.4 1.4 1.4 1.3 1.4 0.9 0.0 0.0 1.6 0.1 0.1 0.4 0.1 0.0 0.4 1.9 2.2 0.6 0.0 0.1 0.0 4.2 0.4 0.3 0.7 3.9 0.1 19.9 1.4 0.9 0.5 0.0 0.0 0.5 0.2 0.3 0.4 0.0 1.9 0.0 0.5 0.4 0.2 0.1 0.0 0.8 0.9 0.0 0.3 0.0 5.2 0.6 0.5 0.0 0.0 0.0 1.0 0.0 2.0 0.9 0.1 0.1 0.4 0.1 0.6 0.3 0.4 0.6 1.0 0.0 1.6 0.8 15.2 2.5 1.1 0.1 0.7 0.2 0.2 0.5 0.2 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525941 "Enzymes, Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 116.6;retina: 83.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 60.9;Cone photoreceptor cells: 148.0;Early spermatids: 52.1;Late spermatids: 178.0;Rod photoreceptor cells: 88.4;Syncytiotrophoblasts: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.7" "Group enriched" "Detected in many" 6 "granulocytes: 7.7;T-cells: 2.0" "Cell line enhanced" "Detected in many" "EFO-21: 32.8;fHDF/TERT166: 32.4;HDLM-2: 66.9;U-2 OS: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" No No "Cluster 38: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 31.0 8.7 19.5 4.8 22.1 12.8 24.6 17.4 12.9 12.4 6.0 7.3 2.7 17.9 1.8 3.3 10.3 4.3 9.5 10.5 14.5 7.8 8.1 15.2 6.7 14.2 27.0 7.3 38.1 0.8 19.1 14.0 10.2 11.5 1.6 83.5 21.3 5.3 13.1 7.4 10.0 6.5 7.4 116.6 4.8 38.9 42.1 3.1 7.7 8.7 4.7 12.6 9.9 12.4 2.1 7.5 3.2 3.7 2.2 1.1 11.1 2.3 3.1 1.1 0.7 10.0 4.4 14.2 32.8 32.4 8.1 4.7 4.0 3.8 0.6 66.9 3.1 2.6 11.7 21.2 3.2 1.6 10.7 2.4 2.0 0.8 1.6 3.2 26.7 12.7 4.7 6.3 1.5 4.5 3.9 7.1 5.7 3.7 10.6 4.5 0.9 3.9 0.9 3.6 1.7 1.2 4.8 18.3 9.3 4.1 2.7 6.3 7.9 7.5 30.4 5.8 2.6 1.6 0.3 2.8 1.7 8.5 0.8 7.7 0.8 0.5 1.2 0.3 1.7 0.6 1.3 0.9 0.2 0.2 0.7 0.9 0.1 0.0 0.0 0.7 2.0 0.5 19.5 22.1 17.4 12.9 10.5 14.5 14.2 27.0 10.2 7.4 42.1 12.4 4.2 6.4 0.0 1.6 5.4 1.0 0.3 0.7 0.6 60.9 3.6 3.4 3.0 1.5 1.3 0.0 148.0 3.2 9.1 0.5 0.0 4.2 52.1 1.0 10.4 7.0 0.0 8.2 5.0 9.3 1.5 6.6 1.1 1.5 4.5 1.6 20.7 2.4 1.9 5.0 15.8 0.7 0.0 2.8 3.7 178.0 5.9 3.1 5.4 8.4 4.9 8.9 1.0 1.0 0.8 4.7 0.3 2.6 5.0 0.8 0.3 0.1 0.8 88.4 0.0 4.6 1.9 12.9 8.2 0.1 1.1 46.0 7.0 0.9 2.0 0.6 GFRA1 "GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1" ENSG00000151892 "GDNF family receptor alpha 1" P56159 10 116056925-116273284 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1" "Cancer enriched" "Detected in many" 11 "breast cancer: 40.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043829 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 140000 "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Nucleoplasm "HPA043829: AB_2678689" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (7.60e-2)" "unprognostic (1.06e-3)" "unprognostic (4.10e-2)" "unprognostic (6.95e-3)" "unprognostic (2.35e-3)" "unprognostic (1.48e-3)" "unprognostic (3.16e-1)" "unprognostic (2.06e-3)" "unprognostic (1.31e-2)" "unprognostic (2.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.20e-3)" "unprognostic (1.69e-1)" "unprognostic (2.27e-2)" "unprognostic (3.64e-2)" 10.9 3.4 7.2 4.2 14.9 0.0 23.2 2.6 9.5 9.9 0.3 18.3 1.7 4.9 20.5 6.9 17.2 5.6 4.8 9.7 18.0 6.0 16.0 2.8 4.0 7.8 28.5 4.5 6.6 2.7 3.2 0.0 7.2 4.5 3.9 3.2 6.0 5.4 4.3 7.2 8.2 4.8 6.2 3.9 8.2 3.1 7.6 4.1 2.8 13.9 6.4 7.0 9.2 6.1 0.1 3.7 12.2 0.0 0.0 0.1 0.0 7.9 0.4 44.7 77.2 0.0 0.0 0.0 46.5 89.3 0.0 0.0 0.1 0.0 63.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 11.5 0.0 3.9 0.0 9.1 0.0 0.0 5.6 59.5 7.6 0.0 5.0 0.0 0.0 0.0 1.9 0.0 5.0 0.0 1.6 0.1 0.0 0.0 0.1 2.1 0.4 0.0 0.4 0.0 0.4 0.1 53.5 0.0 0.0 0.1 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 14.9 2.6 9.5 9.7 18.0 7.8 28.5 7.2 6.2 7.6 6.1 6.1 0.0 0.0 40.5 0.5 5.7 0.0 0.0 1.8 4.1 33.1 11.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 13.2 0.0 0.2 3.2 6.0 0.0 5.1 13.5 0.0 51.2 3.1 0.0 6.3 0.1 0.4 42.2 0.0 0.0 6.6 0.0 0.0 1.0 9.6 12.8 8.1 1.0 5.4 1.9 0.0 12.6 0.0 91.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.5 0.0 100.1 16.7 0.1 10.4 0.7 4.5 0.0 0.7 0.1 0.0 0.2 GGA1 ENSG00000100083 "Golgi associated, gamma adaptin ear containing, ARF binding protein 1" Q9UJY5 22 37608725-37633564 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 179.3" "Cell type enhanced" "Detected in all" "Late spermatids: 221.2;Spermatocytes: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048280, HPA051016" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 43: Testis - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus, Vesicles" Nucleoplasm "HPA048280: AB_2680338, HPA051016: AB_2681312" "unprognostic (1.64e-1)" "unprognostic (1.42e-2)" "unprognostic (4.08e-1)" "unprognostic (9.23e-3)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.42e-2)" "unprognostic (1.53e-2)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.16e-3)" 25.0 49.3 35.9 23.3 39.7 37.2 27.3 39.0 42.3 38.0 41.0 35.0 24.3 32.1 21.5 41.1 37.4 20.4 29.5 35.3 35.0 42.4 42.1 33.7 29.1 41.1 37.6 46.3 34.5 33.2 52.7 19.1 38.4 40.0 17.8 22.8 34.9 19.6 43.1 35.7 40.7 16.9 36.1 55.6 34.9 179.3 41.2 26.9 44.7 24.6 21.1 31.6 33.5 45.0 37.4 28.3 32.9 31.1 28.0 23.0 35.4 30.8 25.0 27.0 29.6 23.3 21.8 59.9 20.6 22.9 17.0 35.0 29.4 35.6 24.8 51.0 53.6 24.0 52.3 27.3 28.1 56.1 42.6 28.4 31.3 38.9 24.2 45.1 26.5 30.3 48.0 36.8 27.8 37.7 24.8 64.2 26.2 39.2 28.7 28.5 25.8 25.2 28.8 31.0 30.4 54.0 18.7 39.0 48.9 31.3 42.4 42.0 31.0 36.8 35.2 32.1 24.4 81.1 35.3 62.5 39.9 33.6 30.8 8.1 10.7 6.1 18.0 10.2 22.1 8.3 7.2 23.3 6.7 5.0 5.1 16.5 4.5 11.6 7.9 5.8 8.0 11.5 35.9 39.7 39.0 42.3 35.3 35.0 41.1 37.6 38.4 36.1 41.2 45.0 17.9 25.6 38.5 26.8 50.9 24.2 31.1 36.5 21.1 57.6 26.5 20.8 19.2 20.0 34.5 44.1 83.4 38.8 34.7 67.3 5.9 34.9 148.2 27.6 19.8 32.6 32.4 38.3 18.4 20.1 37.4 18.8 44.4 26.5 49.4 33.3 40.7 20.4 77.1 25.2 19.3 40.4 32.6 66.9 40.3 221.2 26.4 50.5 16.0 20.6 47.9 37.0 73.2 16.6 28.7 36.6 51.6 22.6 24.4 24.7 55.4 13.2 46.7 74.1 26.3 26.9 22.1 193.4 50.4 19.7 28.6 56.8 59.6 44.4 42.8 33.6 GGA2 "KIAA1080, VEAR" ENSG00000103365 "Golgi associated, gamma adaptin ear containing, ARF binding protein 2" Q9UJY4 16 23463542-23521995 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 153.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 159.9;U-698: 170.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034422, HPA043313, HPA063634" Approved Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "CAB034422: AB_2110748, HPA043313: AB_2678421, HPA063634: AB_2685067" "unprognostic (1.27e-1)" "prognostic favorable (1.71e-5)" "unprognostic (8.53e-2)" "unprognostic (2.22e-2)" "unprognostic (4.91e-2)" "prognostic favorable (9.70e-5)" "unprognostic (1.68e-1)" "prognostic favorable (1.68e-4)" "unprognostic (7.82e-3)" "unprognostic (3.88e-2)" "unprognostic (2.15e-3)" "unprognostic (8.55e-2)" "prognostic favorable (3.91e-5)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (3.89e-2)" "unprognostic (2.08e-1)" 15.1 36.3 13.0 32.0 13.1 37.6 19.9 18.6 14.8 20.7 25.2 16.5 10.0 16.1 19.6 17.9 18.4 13.4 18.5 13.8 15.3 26.9 16.4 34.1 72.9 11.7 12.9 34.0 54.3 29.2 26.0 17.6 11.9 27.4 15.8 79.3 37.6 21.3 25.5 21.1 33.6 14.9 10.8 44.2 25.7 12.4 17.8 37.2 36.2 19.0 87.3 16.3 18.7 12.3 18.8 22.9 29.6 26.1 16.5 17.9 25.3 19.7 20.0 15.2 19.3 32.1 18.9 159.9 31.4 21.1 4.3 28.7 49.1 25.8 19.4 25.1 45.6 28.8 29.5 51.2 16.2 48.0 18.2 18.7 22.7 20.8 9.7 22.1 22.0 12.8 50.3 23.0 19.8 29.8 17.0 31.9 39.6 18.3 20.2 108.3 38.4 41.2 24.8 25.6 21.1 25.3 18.3 27.0 27.1 31.5 23.7 59.7 24.5 18.1 19.6 20.3 18.5 42.0 41.8 170.8 16.5 32.2 20.6 0.2 4.2 7.0 3.1 4.3 3.2 16.2 3.9 3.7 4.9 21.6 4.0 4.0 0.5 3.1 4.0 15.9 4.5 3.1 13.0 13.1 18.6 14.8 13.8 15.3 11.7 12.9 11.9 10.8 17.8 12.3 11.7 48.1 41.4 28.7 102.3 34.2 33.6 16.5 39.3 73.2 25.0 26.0 27.3 21.5 17.6 22.0 114.7 23.0 80.6 7.3 25.4 19.3 22.0 25.4 17.6 19.0 17.6 9.9 44.2 18.9 40.7 17.3 15.3 37.3 9.5 88.5 12.5 16.1 69.1 6.7 61.5 12.6 12.2 26.1 19.7 30.8 24.5 37.7 26.6 36.5 87.9 23.8 23.7 26.2 8.3 16.2 6.1 26.4 36.1 20.7 8.7 21.5 16.2 153.3 19.7 16.0 16.3 30.5 60.5 25.4 14.6 22.7 34.8 56.8 11.9 18.6 GGA3 KIAA0154 ENSG00000125447 "Golgi associated, gamma adaptin ear containing, ARF binding protein 3" Q9NZ52 17 75236599-75262363 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022945, HPA024645" Approved Supported "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA022945: AB_1849639, HPA024645: AB_2671629" "unprognostic (9.16e-2)" "unprognostic (8.89e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.26e-4)" "unprognostic (1.20e-1)" "unprognostic (4.60e-3)" "prognostic unfavorable (2.77e-6)" "unprognostic (6.33e-2)" "unprognostic (1.42e-1)" "unprognostic (9.30e-2)" "unprognostic (4.63e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (3.41e-4)" "unprognostic (1.27e-1)" "unprognostic (2.99e-3)" "unprognostic (1.28e-2)" "unprognostic (9.68e-3)" 11.7 9.8 9.0 13.0 8.4 15.7 10.8 7.7 11.4 12.3 4.3 12.4 11.5 10.8 9.8 17.0 10.2 11.4 12.8 8.4 6.7 11.1 11.6 13.0 17.5 8.9 7.6 15.3 12.3 9.1 9.0 14.6 7.6 10.1 11.7 6.7 12.3 7.8 22.7 15.7 15.0 11.8 6.8 19.6 13.0 11.5 7.8 12.8 9.9 10.5 19.0 11.6 12.2 9.4 16.9 21.1 19.5 11.9 21.5 17.9 22.8 18.5 13.3 24.9 21.2 24.8 18.4 21.4 8.2 16.4 19.9 10.6 13.8 8.0 25.7 15.1 21.4 34.3 19.2 19.6 10.3 32.5 24.3 14.1 19.7 13.6 23.5 13.2 26.5 16.1 37.8 19.1 17.7 17.4 42.5 9.6 13.8 19.6 14.9 16.9 28.0 14.3 17.1 18.4 14.0 23.9 18.5 33.2 14.9 27.3 25.3 17.4 29.6 25.7 18.7 17.4 19.9 19.8 15.1 27.5 20.8 23.0 17.2 5.1 6.8 2.9 5.5 5.9 5.1 3.9 4.9 4.2 6.4 4.7 4.3 4.6 7.3 8.4 5.8 6.6 5.4 6.0 9.0 8.4 7.7 11.4 8.4 6.7 8.9 7.6 7.6 6.8 7.8 9.4 9.5 35.3 21.0 13.4 15.5 2.5 4.9 5.2 8.0 8.1 8.8 7.6 12.6 4.3 9.6 0.0 10.4 10.3 21.2 14.3 5.9 5.2 27.6 10.5 13.6 10.2 0.0 4.6 20.6 7.0 11.0 7.7 21.9 14.7 10.1 12.4 9.7 10.4 12.5 6.7 20.2 10.0 6.1 19.2 7.1 30.1 9.3 19.4 12.4 16.9 20.3 5.9 10.3 18.1 21.2 11.6 9.1 10.1 11.0 8.2 9.5 3.5 10.2 8.9 0.0 7.7 6.1 8.1 6.9 7.8 5.3 13.0 12.2 7.0 12.8 8.5 GIMAP7 "IAN7, MGC27027" ENSG00000179144 "GTPase, IMAP family member 7" Q8NHV1 7 150514872-150521073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 170.1" "Cell type enhanced" "Detected in many" "Adipocytes: 265.8;Endothelial cells: 263.3;Hepatic stellate cells: 267.4;Kupffer cells: 156.8;monocytes: 140.8;NK-cells: 632.4;T-cells: 255.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "monocytes: 666.6;NK-cells: 1121.0;T-cells: 2269.3" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 92.9;MOLT-4: 78.6" "Not detected" "Not detected" "HPA020266, HPA020268" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus, Vesicles" "HPA020266: AB_1849680, HPA020268: AB_1849682" "unprognostic (4.85e-3)" "unprognostic (1.65e-3)" "unprognostic (6.11e-2)" "unprognostic (1.32e-2)" "unprognostic (3.71e-1)" "prognostic favorable (7.43e-4)" "prognostic favorable (8.98e-5)" "unprognostic (6.49e-3)" "unprognostic (5.24e-2)" "unprognostic (6.12e-3)" "unprognostic (2.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.07e-3)" "unprognostic (2.07e-1)" "unprognostic (3.14e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" 49.8 15.0 16.3 73.6 17.4 6.6 37.4 17.1 21.3 19.2 16.0 20.3 21.1 27.8 19.8 12.6 21.5 22.1 40.1 15.5 17.2 20.9 20.4 61.0 170.1 19.0 17.8 7.4 7.6 10.5 5.6 31.5 19.1 10.9 23.3 1.2 13.7 12.0 27.8 9.3 40.1 33.6 17.6 124.3 22.0 4.5 18.0 52.5 28.2 56.1 99.2 29.6 13.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 92.9 9.4 0.0 0.0 0.0 0.0 78.6 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.7 656.5 9.6 1184.0 595.9 1164.2 6.5 1762.9 1440.6 286.3 6.5 2269.3 1597.2 52.5 1121.0 666.6 16.3 1076.9 2581.7 16.3 17.4 17.1 21.3 15.5 17.2 19.0 17.8 19.1 17.6 18.0 17.6 265.8 0.0 13.2 0.3 13.1 2.4 0.4 0.0 2.8 0.0 2.8 5.6 14.6 5.7 0.6 1.8 0.0 0.2 125.1 0.2 0.0 0.5 1.3 0.9 0.6 263.3 0.0 17.0 0.0 0.7 0.0 8.0 3.1 0.7 13.9 0.0 267.4 5.3 15.5 0.0 0.0 0.1 0.0 156.8 10.6 2.0 2.5 54.9 1.8 22.5 140.8 0.4 632.4 0.5 0.1 0.4 1.2 0.4 19.3 0.2 0.0 1.7 0.7 0.4 0.0 6.0 9.4 0.2 0.9 1.1 3.3 0.4 255.9 0.9 0.2 0.0 GIPC3 "C19orf64, DFNB15, DFNB72, DFNB95" ENSG00000179855 "GIPC PDZ domain containing family member 3" Q8TF64 19 3585478-3593541 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.7" "Group enriched" "Detected in some" 4 "Adipocytes: 10.4;Endothelial cells: 6.2;Hepatic stellate cells: 12.8;Rod photoreceptor cells: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 19.0;HMC-1: 11.8;THP-1: 23.1;WM-115: 44.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA067765 Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 77: Retina - Visual perception" "Cluster 17: WM-115 - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA067765: " "unprognostic (1.77e-1)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (6.99e-2)" "unprognostic (1.22e-1)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (3.67e-3)" "unprognostic (4.76e-2)" "unprognostic (2.97e-1)" "unprognostic (5.06e-3)" "unprognostic (2.26e-2)" "unprognostic (1.51e-3)" "unprognostic (1.96e-2)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" 4.6 2.2 1.4 1.0 1.0 0.3 2.8 1.0 1.1 3.0 0.8 1.9 1.2 2.8 2.9 5.2 2.1 2.1 3.9 1.2 1.2 3.6 1.4 3.8 2.4 1.6 1.2 0.7 0.7 2.7 1.0 1.1 1.6 3.5 1.4 16.7 0.7 2.3 1.7 1.1 4.4 8.3 1.4 3.9 2.0 0.3 1.6 3.1 3.0 1.9 1.6 1.1 1.8 1.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.9 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.4 0.0 1.5 0.0 0.2 6.9 19.0 0.0 0.7 0.0 11.8 0.2 0.0 1.1 0.0 0.0 2.1 0.2 3.2 0.0 0.3 0.0 0.0 1.1 0.7 0.0 1.2 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.5 0.0 4.7 1.1 0.0 23.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 44.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 1.0 1.1 1.2 1.2 1.6 1.2 1.6 1.4 1.6 1.1 10.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.4 0.1 0.3 2.4 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 12.8 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.8 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.2 1.1 0.0 0.4 0.1 0.3 0.1 0.3 0.1 0.0 0.1 GLB1 "EBP, ELNR1" ENSG00000170266 "Galactosidase beta 1" P16278 3 32996609-33097202 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 857.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008382, HPA040610, HPA069503" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2700000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" Vesicles "Golgi apparatus" "CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142" "unprognostic (1.51e-2)" "unprognostic (3.66e-2)" "unprognostic (5.02e-3)" "unprognostic (9.66e-3)" "unprognostic (9.61e-3)" "unprognostic (1.04e-1)" "unprognostic (2.31e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.08e-1)" "prognostic favorable (1.14e-5)" "unprognostic (3.05e-1)" "unprognostic (2.33e-1)" "unprognostic (2.20e-1)" "unprognostic (5.85e-2)" 22.0 36.1 12.1 27.8 13.0 21.9 20.5 12.5 14.8 33.4 16.0 43.5 43.0 21.9 103.6 15.4 28.2 32.0 15.5 12.5 14.8 46.0 48.2 42.7 25.8 14.3 12.9 21.4 30.8 59.4 18.5 53.8 15.4 23.2 45.6 14.9 25.3 29.3 7.7 15.8 31.0 30.6 12.4 24.4 35.5 13.5 13.5 17.5 52.8 10.8 23.0 31.8 16.2 15.1 37.4 63.6 39.8 48.3 241.9 123.7 857.2 59.1 157.6 73.7 95.1 91.3 86.5 17.9 50.9 120.9 53.9 35.1 38.1 75.5 53.7 104.9 33.0 69.9 35.3 47.4 124.3 50.5 69.9 144.9 70.2 67.0 39.2 144.1 116.5 24.7 64.3 67.0 81.8 44.6 29.6 31.6 26.4 78.0 27.0 24.7 26.4 86.6 78.4 54.4 12.0 40.3 75.0 120.2 74.4 69.3 80.3 130.2 67.7 46.8 32.2 65.2 50.1 53.2 87.9 5.9 99.6 71.2 36.7 43.9 146.2 86.4 29.2 125.8 40.4 37.9 34.3 31.8 166.5 35.6 17.9 21.8 56.6 26.0 92.1 35.1 77.1 91.9 12.1 13.0 12.5 14.8 12.5 14.8 14.3 12.9 15.4 12.4 13.5 15.1 8.7 19.2 25.3 39.2 18.6 6.0 13.6 60.1 10.8 11.3 11.5 7.5 9.1 34.3 43.3 27.6 6.2 100.1 14.1 41.9 27.4 53.5 24.8 18.7 16.0 17.4 16.9 20.6 46.7 35.4 55.3 29.2 26.0 27.1 26.6 20.6 19.6 39.7 79.5 5.0 46.0 23.5 40.7 43.9 13.9 5.0 15.2 41.7 14.2 23.4 64.6 16.5 10.3 27.2 24.2 28.1 43.4 21.1 19.8 9.9 36.2 33.1 31.0 16.2 13.1 12.9 16.3 1.0 6.6 10.1 3.4 49.1 18.7 51.0 32.0 12.1 GLG1 "CFR-1, ESL-1, MG-160" ENSG00000090863 "Golgi glycoprotein 1" Q92896 16 74447427-74607144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010815 Supported Supported "Golgi apparatus" NA NA 2100000 "Cluster 32: T-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA010815: AB_2232486" "unprognostic (3.70e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (7.42e-2)" "unprognostic (3.30e-2)" "unprognostic (1.90e-1)" "unprognostic (5.02e-3)" "unprognostic (5.13e-3)" "unprognostic (9.45e-3)" "unprognostic (8.46e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (8.85e-2)" "prognostic favorable (1.56e-7)" "unprognostic (3.54e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.97e-4)" 42.7 36.8 25.0 17.4 26.3 9.0 40.3 24.0 25.7 53.3 17.3 44.5 17.3 57.8 22.4 30.9 46.7 20.4 50.5 24.7 27.5 42.6 25.6 38.2 16.3 27.0 29.0 69.0 58.1 34.3 38.9 24.9 25.2 37.5 18.7 20.3 36.1 24.9 53.8 35.2 36.4 29.9 25.0 35.1 36.3 40.6 29.5 20.0 43.1 16.4 18.9 42.3 40.8 30.0 38.4 52.2 44.7 43.3 113.7 113.2 42.8 45.0 64.2 48.6 68.3 34.4 116.0 22.8 59.8 102.9 35.8 71.1 30.1 62.1 80.1 10.3 26.1 17.9 37.8 54.3 70.5 29.3 12.6 68.0 32.8 63.6 66.3 91.3 100.8 54.8 19.0 24.9 44.2 70.0 14.1 26.0 34.7 81.2 20.6 33.9 32.6 59.5 31.6 17.1 15.8 23.3 87.3 24.9 25.0 47.7 28.2 36.5 79.1 46.1 40.9 48.2 30.3 47.4 51.2 41.1 86.3 22.5 46.6 3.2 16.7 13.3 19.1 15.7 19.2 11.6 23.8 20.9 18.5 10.1 28.2 22.6 7.3 15.4 19.9 18.4 21.0 19.0 25.0 26.3 24.0 25.7 24.7 27.5 27.0 29.0 25.2 25.0 29.5 30.0 52.8 64.1 50.7 114.3 46.4 27.1 27.2 33.0 55.8 68.5 35.6 35.6 79.5 77.2 39.7 51.5 146.0 78.0 75.6 33.5 7.9 39.9 39.7 49.2 79.3 62.0 38.6 25.0 133.4 42.5 43.6 101.4 38.7 58.0 3.8 91.0 75.3 40.7 50.1 70.7 155.3 31.9 24.4 68.8 42.1 28.1 96.9 44.4 42.7 62.8 64.8 59.6 111.2 97.5 137.3 40.8 28.8 114.3 100.2 33.6 47.8 44.2 44.3 57.9 92.1 84.6 59.9 89.2 87.9 30.5 21.6 75.2 72.4 72.4 32.9 26.4 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391089-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 46.8" "Group enriched" "Detected in many" 7 "Early spermatids: 254.0;Spermatocytes: 306.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 4.2;SK-BR-3: 5.6;U-2 OS: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Vesicles "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.0 2.7 5.1 0.8 5.2 0.3 2.4 6.5 5.9 2.1 2.5 0.9 0.6 2.3 3.7 1.0 3.1 1.0 2.3 5.5 5.0 2.0 1.5 1.2 0.7 4.0 4.3 7.1 2.6 4.1 2.6 0.9 4.4 1.5 0.4 3.0 1.0 3.0 2.3 1.9 0.8 1.1 4.0 1.6 0.7 46.8 4.7 1.3 2.4 1.6 0.4 0.9 0.9 6.3 0.2 0.4 0.2 0.4 2.9 1.6 0.5 0.4 0.3 0.1 0.2 0.1 0.3 0.2 1.0 0.3 0.7 0.1 0.0 0.1 0.3 0.6 0.2 0.1 0.6 4.2 2.1 0.4 0.0 0.5 0.9 0.4 1.5 2.5 0.1 0.1 0.2 0.5 0.8 0.1 0.4 0.3 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 0.7 0.3 0.5 5.6 1.7 0.2 1.7 0.1 0.8 0.6 7.6 0.9 0.3 0.7 0.7 0.2 0.2 0.2 0.5 0.7 0.0 0.1 0.3 0.0 0.1 0.3 0.3 0.5 0.1 0.3 0.5 0.9 0.6 0.3 0.1 0.7 1.0 0.2 5.1 5.2 6.5 5.9 5.5 5.0 4.0 4.3 4.4 4.0 4.7 6.3 1.5 0.0 3.1 15.0 0.3 0.9 4.6 1.7 3.4 5.6 2.9 3.0 4.0 1.5 1.8 0.0 0.0 1.7 1.5 0.1 9.8 0.6 254.0 4.9 1.4 1.5 0.0 0.4 7.4 0.0 0.2 3.0 1.1 0.5 1.3 1.4 0.0 0.2 0.6 1.7 13.3 0.1 0.0 0.3 0.3 39.0 7.5 0.7 0.0 10.3 0.0 6.7 0.0 27.2 28.1 0.1 0.0 5.7 0.1 1.2 0.1 1.4 14.1 2.0 6.6 5.6 1.9 306.8 19.4 0.3 0.4 0.4 0.6 2.1 0.3 2.1 GLT8D2 FLJ31494 ENSG00000120820 "Glycosyltransferase 8 domain containing 2" Q9H1C3 12 103988987-104064183 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012740, HPA026904, HPA070791" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Vesicles" "HPA012740: , HPA026904: AB_1849731, HPA070791: " "unprognostic (4.02e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (9.53e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-3)" "unprognostic (2.57e-1)" "unprognostic (1.25e-1)" "unprognostic (7.55e-2)" "unprognostic (5.03e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (1.58e-6)" "prognostic unfavorable (7.92e-4)" "unprognostic (7.15e-2)" "unprognostic (7.70e-3)" "unprognostic (7.03e-3)" 16.9 10.9 4.2 5.2 4.9 1.5 19.5 2.6 5.1 29.6 11.2 17.6 5.8 27.4 21.6 7.5 22.3 35.8 15.4 4.8 3.7 4.3 2.7 10.2 6.0 2.9 3.1 41.6 4.5 6.6 9.6 9.4 3.1 13.3 11.4 1.0 7.7 16.0 3.2 4.1 7.7 21.8 2.8 1.6 8.4 6.8 3.7 2.2 26.3 11.5 5.8 20.8 18.9 4.4 0.3 0.6 0.7 22.2 28.3 69.3 0.5 32.0 89.4 8.3 10.5 0.4 0.2 0.9 1.8 37.5 0.4 0.1 0.4 11.9 7.0 1.6 10.0 0.6 11.2 0.2 12.7 0.9 0.5 63.2 0.7 10.0 13.8 51.9 4.4 0.6 0.4 1.3 36.5 0.3 0.8 0.5 2.7 0.1 6.7 1.0 33.6 0.2 45.5 0.4 1.3 1.7 33.5 0.8 0.4 2.4 6.0 0.5 0.7 13.2 6.2 1.3 1.9 3.9 0.8 0.3 1.0 0.7 1.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 4.9 2.6 5.1 4.8 3.7 2.9 3.1 3.1 2.8 3.7 4.4 8.0 0.0 4.6 2.9 0.3 2.8 4.2 2.4 0.0 0.8 1.0 26.3 3.9 1.5 0.1 0.0 2.1 4.1 0.4 0.0 0.0 0.1 41.2 0.6 8.3 7.5 1.8 0.0 10.2 0.0 0.8 55.9 1.1 0.4 0.0 0.1 20.7 0.3 0.6 0.0 10.5 1.3 0.0 0.6 2.8 11.5 55.9 0.4 3.6 4.7 0.6 0.5 0.0 1.0 2.6 0.3 0.0 51.9 1.2 1.4 0.0 0.0 0.1 0.5 6.6 25.2 18.0 1.1 1.1 0.2 2.4 1.4 0.6 10.7 0.0 0.1 GLYATL1 "FLJ34646, MGC15397" ENSG00000166840 "Glycine-N-acyltransferase like 1" Q969I3 11 58905398-59043527 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 576.3" "Group enriched" "Detected in some" 4 "Hepatocytes: 234.3;Proximal tubular cells: 797.1" "Group enriched" "Detected in some" 8 "liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;Daudi: 4.9;RPTEC TERT1: 1.5;U-2197: 1.2" HPA039501 Supported Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 85: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (9.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.90e-5)" "unprognostic (3.93e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.62e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.03e-5)" "unprognostic (1.50e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.3 0.4 0.1 0.4 0.3 1.6 0.1 0.7 0.1 1.3 0.9 0.0 0.1 0.3 141.4 576.3 0.0 0.1 0.9 0.2 0.0 1.7 2.6 0.0 0.0 1.1 11.1 0.3 0.2 1.9 0.0 0.0 0.6 0.2 0.0 0.3 0.1 2.7 0.1 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.1 0.5 0.4 2.0 0.0 4.9 0.0 0.3 0.4 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.5 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.3 0.9 0.2 1.1 0.3 0.3 0.3 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.3 12.8 0.0 14.7 0.0 0.0 0.0 0.1 107.6 0.1 0.0 2.5 0.1 0.5 0.0 8.0 0.7 0.6 0.0 0.1 0.0 0.1 0.0 0.1 5.0 234.3 0.0 0.0 0.8 0.1 0.0 8.1 0.0 0.0 0.0 3.1 1.8 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 1.3 0.0 797.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.9 0.1 0.9 0.2 GLYATL1B GLYATL1P3 ENSG00000255151 "Glycine-N-acyltransferase like 1B" A0A0U1RQE8 11 59086307-59094786 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 7 "breast: 7.3;lymphoid tissue: 2.8" "Cell type enriched" "Detected in single" 57 "Proximal tubular cells: 5.8" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.5" "Lineage enriched" "Detected in single" 15 "B-cells: 1.5" "Cell line enhanced" "Detected in some" "Daudi: 1.8;T-47d: 1.2;U-266/70: 1.8" HPA039501 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (5.20e-2)" "unprognostic (2.62e-1)" "unprognostic (2.11e-1)" "unprognostic (3.21e-4)" "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.8 0.0 0.0 7.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.9 0.0 1.8 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLYCTK "HBEBP2, HBEBP4" ENSG00000168237 "Glycerate kinase" Q8IVS8 3 52287089-52295257 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 275.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0" "Cancer enriched" "Detected in all" 6 "liver cancer: 52.7" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006913 Approved Approved "Golgi apparatus,Cytosol,Rods & Rings" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 21: OE19 - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" Cytosol "Golgi apparatus, Rods & Rings" "HPA006913: AB_1078993" "unprognostic (1.51e-2)" "unprognostic (2.55e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.64e-4)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (7.73e-3)" "unprognostic (1.82e-1)" "unprognostic (3.36e-3)" "unprognostic (2.15e-1)" "unprognostic (3.30e-2)" "unprognostic (3.42e-1)" "unprognostic (3.77e-1)" "unprognostic (3.82e-2)" "unprognostic (9.00e-3)" 14.8 8.3 1.0 4.5 0.9 6.7 9.3 0.5 1.5 2.9 0.9 11.4 22.4 3.2 0.6 3.8 2.7 2.2 4.4 0.9 1.2 24.9 275.1 4.2 4.6 1.4 0.9 2.4 5.9 2.5 2.9 2.2 1.2 3.7 3.6 0.6 3.1 1.0 3.6 1.9 21.7 1.6 0.4 8.9 8.5 2.3 1.2 2.3 4.1 1.0 3.2 3.3 2.5 1.2 2.9 5.8 3.4 1.2 15.7 2.4 1.8 2.4 2.6 4.6 3.9 12.1 2.4 6.7 1.6 2.7 3.7 1.6 1.7 7.8 0.8 2.0 1.8 9.3 7.5 16.2 1.7 2.8 5.0 2.4 3.5 7.6 3.2 2.1 10.2 5.2 2.4 4.5 3.6 1.9 5.9 2.7 1.5 14.2 4.2 1.9 2.5 11.1 5.8 3.9 1.9 1.9 2.6 1.4 3.0 1.0 3.2 1.7 3.8 3.5 4.1 2.4 6.1 5.1 3.9 5.4 2.7 4.9 2.2 2.2 5.2 6.6 5.6 2.8 2.6 4.4 4.2 4.9 5.6 2.6 3.3 4.3 4.4 3.6 3.5 3.4 6.6 3.7 1.0 0.9 0.5 1.5 0.9 1.2 1.4 0.9 1.2 0.4 1.2 1.2 5.4 6.4 3.2 0.7 8.2 0.4 3.2 4.1 1.8 1.6 2.1 1.4 1.6 18.6 3.0 9.2 0.0 7.9 9.2 18.4 19.6 5.4 0.3 4.4 2.7 8.3 23.4 26.5 0.6 6.2 5.3 2.9 27.0 8.6 1.3 3.4 14.6 183.0 13.2 0.0 0.4 15.8 2.0 16.6 2.4 0.0 1.2 9.1 3.6 1.0 7.7 1.2 9.2 0.5 0.7 4.0 40.6 0.0 13.5 2.8 105.2 83.0 2.4 1.5 0.0 2.7 2.7 1.8 8.3 2.1 1.3 11.1 9.3 7.7 24.9 4.3 GNB1 ENSG00000078369 "G protein subunit beta 1" P62873 1 1785285-1891117 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "retina: 2629.0" "Cell type enriched" "Detected in all" 5 "Rod photoreceptor cells: 1373.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040736 Supported Approved "Golgi apparatus,Plasma membrane" NA NA 1900000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 79: Retina - Phototransduction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (9.49e-2)" "unprognostic (4.91e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (9.07e-3)" "prognostic unfavorable (3.61e-6)" "unprognostic (1.99e-2)" "unprognostic (3.60e-1)" "unprognostic (7.27e-2)" "unprognostic (8.47e-3)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (1.08e-1)" "unprognostic (4.62e-2)" "unprognostic (1.14e-1)" "unprognostic (7.90e-2)" 178.1 123.8 167.9 179.9 212.3 147.6 119.7 147.8 234.4 124.3 87.1 165.7 173.7 127.1 90.8 126.7 114.4 110.9 119.6 228.3 172.0 125.1 103.3 146.7 160.0 159.5 153.2 130.2 105.9 148.2 106.8 141.1 169.5 118.3 123.1 2629.0 120.6 118.9 66.8 111.8 208.2 156.1 131.6 142.6 129.7 99.0 168.9 167.3 113.6 97.1 145.6 152.6 102.7 203.9 373.2 344.2 400.2 280.4 222.4 242.4 154.4 515.4 339.9 456.2 355.2 282.8 361.8 385.5 369.3 522.5 258.6 192.0 405.5 373.5 411.4 595.9 199.2 375.0 308.2 325.6 279.1 227.7 394.4 216.4 256.6 437.2 402.9 306.1 376.8 298.8 236.8 337.8 440.0 230.3 501.9 177.4 230.8 190.0 275.0 482.9 308.7 306.4 310.8 227.5 489.9 556.5 477.1 306.6 420.5 272.8 214.8 305.9 579.4 399.3 267.5 314.8 379.1 227.1 432.8 888.7 341.4 470.1 230.5 11.4 13.3 21.9 9.9 16.4 9.1 9.0 9.9 11.2 13.3 9.6 6.7 7.2 22.1 12.8 17.5 22.7 12.5 8.2 167.9 212.3 147.8 234.4 228.3 172.0 159.5 153.2 169.5 131.6 168.9 203.9 172.0 70.5 42.6 57.5 67.9 86.3 51.6 47.4 33.0 149.8 65.3 57.8 60.6 52.9 42.4 75.4 175.2 44.2 124.4 140.9 46.9 88.0 29.1 93.3 112.9 131.6 122.9 40.3 102.4 100.5 99.4 77.8 52.0 121.6 53.8 101.9 95.3 60.3 100.8 180.0 101.9 95.5 40.7 152.7 114.6 33.8 76.1 128.0 53.4 115.2 119.5 250.3 73.2 70.9 110.1 175.4 91.0 88.0 75.3 100.5 167.6 67.4 41.1 1373.7 78.9 71.0 105.9 68.8 67.1 51.6 101.7 36.4 74.5 83.7 83.0 94.1 GNB3 ENSG00000111664 "G protein subunit beta 3" P16520 12 6839954-6847393 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "retina: 426.5" "Group enriched" "Detected in many" 7 "Bipolar cells: 471.3;Cone photoreceptor cells: 932.0;Rod photoreceptor cells: 462.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 14.1;NTERA-2: 17.0;U-698: 40.9" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 5.1" HPA040736 Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 79: Retina - Phototransduction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (3.86e-2)" "unprognostic (1.58e-1)" "unprognostic (4.96e-2)" "unprognostic (8.75e-2)" "unprognostic (2.53e-2)" "unprognostic (5.74e-3)" "unprognostic (5.98e-2)" "unprognostic (4.43e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.25e-5)" "unprognostic (3.21e-2)" "unprognostic (4.77e-11)" "unprognostic (2.43e-1)" "unprognostic (6.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.07e-2)" 0.9 1.4 6.3 1.6 6.0 1.0 0.6 6.7 9.5 2.3 6.7 1.4 1.7 2.2 0.7 0.4 1.6 1.1 4.4 5.9 6.6 2.0 0.2 0.7 1.6 5.7 5.3 2.8 0.7 1.5 36.2 0.4 5.6 2.1 0.6 426.5 2.1 1.4 1.3 0.7 1.5 3.2 5.2 0.9 1.0 0.6 5.7 0.3 1.6 0.3 1.6 1.6 1.1 6.4 0.4 1.2 9.4 3.1 1.3 2.0 0.9 4.8 0.8 2.5 2.1 1.9 0.5 14.1 0.1 5.1 0.1 0.5 9.2 0.3 2.3 1.2 2.1 3.4 6.8 1.5 0.9 1.1 2.3 2.4 0.5 2.4 2.7 9.6 2.5 1.8 1.5 1.3 1.2 0.7 0.7 0.8 17.0 0.1 0.5 0.7 2.8 0.9 0.5 0.4 1.1 2.2 0.4 0.1 1.0 2.5 0.1 0.6 4.0 3.2 3.8 4.8 6.7 1.4 1.0 40.9 1.3 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 6.0 6.7 9.5 5.9 6.6 5.7 5.3 5.6 5.2 5.7 6.4 0.3 0.0 0.0 5.2 1.3 0.4 0.4 0.2 1.2 471.3 0.8 1.3 6.1 0.0 0.1 0.0 932.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.0 3.3 0.0 1.3 12.3 0.0 0.0 2.3 2.0 0.1 0.0 0.1 1.1 0.0 0.1 74.0 12.4 0.0 4.1 0.3 0.4 0.0 3.7 0.1 1.8 3.7 0.1 86.7 0.0 6.0 1.2 0.1 0.0 3.4 3.2 0.8 0.0 0.1 0.6 462.8 0.0 0.3 1.4 0.1 0.5 0.0 0.0 0.0 0.4 0.2 0.1 0.2 GNPDA1 "GNPDA, GNPI, GPI, HLN, KIAA0060" ENSG00000113552 "Glucosamine-6-phosphate deaminase 1" P46926 5 141991749-142013041 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 127.2;Proximal tubular cells: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 382.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 930000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: AB_2679857" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (6.79e-2)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (8.89e-3)" "prognostic unfavorable (2.60e-6)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.09e-1)" "unprognostic (1.58e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "unprognostic (5.82e-2)" "unprognostic (9.66e-2)" "unprognostic (2.05e-3)" 18.8 38.4 26.9 17.3 28.8 8.1 20.9 26.2 35.2 26.7 27.7 19.7 29.5 28.7 51.9 13.6 18.4 22.3 17.3 28.1 30.8 76.4 16.6 17.6 22.7 27.0 27.7 31.8 11.3 27.9 20.5 22.2 29.3 22.2 21.9 17.7 14.6 28.3 26.4 14.8 22.5 29.2 27.0 30.9 14.5 18.8 29.7 24.9 27.8 25.7 19.8 33.3 17.1 30.7 42.6 61.0 23.2 115.8 77.1 51.9 54.6 32.6 78.7 84.7 95.8 91.3 49.2 0.2 72.9 23.6 382.3 44.0 109.9 98.0 74.8 32.9 46.5 31.3 33.1 65.5 137.2 86.4 39.2 63.5 56.9 54.5 144.8 63.2 91.6 80.6 37.3 110.1 93.0 27.2 66.8 9.8 88.0 62.8 121.4 25.5 76.3 94.3 81.8 114.8 20.6 54.0 65.0 67.8 127.9 67.5 54.6 26.5 43.3 50.9 33.3 76.9 47.5 61.2 126.9 47.1 74.2 29.3 45.0 0.3 48.6 7.1 37.2 59.1 77.9 19.4 30.0 34.2 51.7 11.1 35.3 38.8 12.7 15.8 56.3 29.6 27.6 40.2 26.9 28.8 26.2 35.2 28.1 30.8 27.0 27.7 29.3 27.0 29.7 30.7 10.5 9.6 14.9 10.7 8.2 6.0 40.8 20.9 21.1 11.6 12.6 17.8 12.6 12.8 20.1 18.4 8.4 26.7 11.1 6.9 35.2 29.3 1.1 5.8 19.8 14.6 15.0 9.9 11.5 14.2 48.6 22.8 7.7 9.6 12.0 30.8 15.4 7.4 127.2 6.7 12.7 6.2 12.2 60.2 10.7 3.6 19.9 48.5 14.2 12.2 23.5 40.5 15.5 7.1 11.5 21.6 7.1 26.7 7.8 32.9 19.4 102.3 8.0 7.9 0.0 10.4 11.7 10.4 17.0 17.6 7.4 29.7 16.6 64.8 9.1 34.7 GNPDA2 SB52 ENSG00000163281 "Glucosamine-6-phosphate deaminase 2" Q8TDQ7 4 44682200-44726588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" NA NA 820000 "Cluster 44: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: AB_2679857" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (3.29e-1)" "unprognostic (1.55e-3)" "unprognostic (1.02e-1)" "unprognostic (1.33e-1)" "unprognostic (9.57e-2)" "unprognostic (9.75e-3)" "unprognostic (1.03e-1)" "unprognostic (1.28e-3)" "unprognostic (4.18e-2)" "unprognostic (6.86e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" 13.1 12.6 9.6 9.8 10.8 8.4 14.5 21.9 13.3 13.9 7.5 12.3 7.9 16.6 14.0 10.1 12.6 10.5 17.5 10.8 9.9 13.8 4.0 10.0 12.6 9.5 9.8 22.6 8.2 13.0 12.8 6.7 9.9 14.7 8.2 18.5 9.2 15.2 11.3 9.7 8.5 16.5 10.4 11.8 9.1 11.6 9.8 13.2 18.1 10.1 10.5 12.0 10.0 12.5 15.7 10.9 11.4 9.7 17.8 24.7 3.9 27.1 30.3 17.9 16.7 5.6 19.1 13.6 15.5 23.4 29.8 5.3 10.6 26.3 19.7 18.4 11.9 19.3 16.6 9.2 18.8 20.8 17.7 28.5 18.1 17.9 13.1 22.6 26.5 18.1 12.2 17.9 33.6 0.7 25.2 11.6 5.5 10.4 19.5 16.3 24.3 8.0 17.3 9.5 19.5 15.8 12.1 7.0 27.2 5.4 14.9 12.1 25.9 23.7 22.6 38.5 31.6 23.0 38.7 19.7 38.6 14.3 21.3 9.3 2.4 5.0 9.7 3.6 11.2 12.2 9.0 9.3 3.7 10.5 11.2 10.8 1.1 9.8 4.9 2.8 10.7 4.7 9.6 10.8 21.9 13.3 10.8 9.9 9.5 9.8 9.9 10.4 9.8 12.5 18.4 9.6 4.6 17.0 19.8 12.5 8.9 18.6 8.0 15.6 9.2 8.1 14.1 2.8 9.4 14.7 8.4 1.2 15.7 3.0 15.6 13.3 30.3 7.9 21.9 14.4 6.7 6.5 29.1 15.1 1.1 22.0 7.1 8.5 15.8 8.5 11.4 1.6 4.8 13.5 29.2 4.4 18.3 3.7 8.7 5.0 16.1 4.2 8.8 8.4 4.3 19.8 13.4 31.2 20.4 14.2 2.9 23.7 6.3 5.2 2.9 13.2 8.0 18.2 13.1 14.3 20.0 34.4 29.9 5.7 10.7 0.5 13.7 20.0 4.4 5.2 GNPTAB "GNPTA, KIAA1208, MGC4170" ENSG00000111670 "N-acetylglucosamine-1-phosphate transferase subunits alpha and beta" Q3T906 12 101745499-101830959 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cancer-related genes, Disease variant, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 192.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014558, HPA042343" Approved Supported "Golgi apparatus" NA NA 160000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA014558: AB_2732409, HPA042343: " "unprognostic (6.72e-2)" "unprognostic (1.66e-1)" "unprognostic (8.71e-3)" "prognostic favorable (8.48e-4)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (2.73e-1)" "unprognostic (8.57e-2)" "unprognostic (3.73e-2)" "unprognostic (1.09e-2)" "unprognostic (2.28e-2)" "unprognostic (2.00e-1)" "unprognostic (6.86e-2)" "unprognostic (3.44e-1)" "unprognostic (1.02e-1)" "unprognostic (5.44e-2)" "unprognostic (4.98e-2)" 11.9 7.9 18.8 16.2 22.2 23.9 16.4 14.4 20.0 17.4 2.7 29.6 14.2 11.8 6.2 15.6 8.8 14.8 21.5 22.7 10.8 14.5 9.4 27.0 20.6 8.5 11.1 7.2 11.3 23.0 8.4 14.8 9.7 20.1 30.3 13.0 54.3 13.0 16.4 25.1 16.2 15.9 8.9 19.0 21.3 10.4 12.4 34.1 13.9 25.9 17.8 19.3 12.0 13.3 18.2 17.5 6.4 10.9 52.3 24.8 19.6 25.4 52.3 24.7 32.2 13.5 12.4 38.1 17.9 35.1 20.1 23.2 29.8 32.8 38.4 18.1 15.6 16.3 15.4 19.3 9.7 15.0 31.7 19.3 17.7 23.5 13.8 61.4 44.0 30.0 25.9 11.0 23.4 27.8 45.6 21.0 22.0 22.6 12.5 10.6 32.6 51.2 39.5 46.8 13.6 11.2 42.3 29.7 60.7 23.5 30.6 9.8 43.6 23.1 12.5 19.6 14.4 30.0 32.9 21.5 26.4 21.8 14.6 8.6 3.8 4.4 18.8 3.6 6.2 3.0 4.0 10.3 7.1 4.9 5.1 7.9 1.4 17.0 4.6 6.9 3.3 3.7 18.8 22.2 14.4 20.0 22.7 10.8 8.5 11.1 9.7 8.9 12.4 13.3 25.3 60.9 65.0 35.9 42.1 16.8 32.9 16.2 17.1 23.6 25.2 18.9 43.5 18.6 27.8 22.0 25.0 25.7 107.3 68.3 7.9 10.3 0.6 25.3 23.7 21.1 18.0 19.5 84.5 15.1 15.0 18.9 33.1 61.6 122.8 24.6 10.4 9.7 46.7 8.4 83.8 29.6 24.4 46.7 17.6 3.8 17.1 41.2 42.7 30.0 43.5 26.9 192.6 135.2 19.8 15.7 129.3 12.8 63.9 28.1 17.7 13.8 10.0 37.0 0.0 18.6 14.9 12.4 33.0 26.7 14.3 8.8 63.4 30.6 49.7 46.5 GOLGA1 "golgin-97, MGC33154" ENSG00000136935 "Golgin A1" Q92805 9 124878275-124948492 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013065, HPA044329, HPA050555" Supported Enhanced "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174" "unprognostic (5.44e-2)" "unprognostic (9.35e-2)" "unprognostic (6.92e-2)" "prognostic favorable (2.21e-4)" "unprognostic (9.34e-2)" "unprognostic (4.43e-1)" "unprognostic (4.40e-2)" "unprognostic (6.03e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-3)" "unprognostic (3.06e-1)" "unprognostic (6.28e-3)" "unprognostic (4.05e-3)" "unprognostic (2.38e-1)" "unprognostic (2.24e-3)" "unprognostic (2.52e-2)" 8.7 9.4 5.4 8.7 7.0 5.9 7.8 5.8 6.3 8.0 7.1 10.8 10.1 8.8 5.9 9.9 7.7 7.6 10.2 5.1 5.9 6.8 9.5 7.5 7.6 6.1 6.4 8.0 10.8 9.1 8.0 5.6 6.9 8.3 9.3 37.7 8.4 8.3 13.2 10.8 9.6 8.6 6.1 8.5 8.7 15.2 6.8 5.3 8.2 9.6 7.4 10.4 8.1 9.0 8.4 14.7 8.6 9.1 14.7 13.0 11.0 13.5 14.3 14.0 10.2 9.7 9.6 5.6 6.5 15.0 10.8 21.2 7.1 11.4 10.2 8.0 7.0 5.9 20.5 12.9 16.9 7.1 13.7 8.8 8.1 13.5 16.3 9.9 12.7 7.0 9.8 9.4 10.0 17.5 5.1 8.0 3.2 19.7 13.5 3.2 12.7 12.3 7.0 11.3 5.0 9.5 16.2 13.0 8.5 7.6 25.1 5.0 14.8 13.0 7.2 16.8 12.6 11.4 19.6 6.5 16.3 7.4 13.8 8.1 3.4 4.3 4.2 3.5 3.4 3.0 2.6 4.5 3.3 3.5 2.7 2.5 7.6 3.2 2.8 4.6 2.7 1.3 5.4 7.0 5.8 6.3 5.1 5.9 6.1 6.4 6.9 6.1 6.8 9.0 11.8 6.4 14.4 32.3 8.1 2.0 4.2 5.8 6.2 16.3 10.2 10.2 21.0 7.2 10.8 5.5 64.6 6.8 11.5 11.7 3.9 9.5 16.2 10.4 13.6 10.0 5.4 5.0 31.7 8.9 4.9 7.8 10.7 8.8 15.8 14.6 10.8 14.8 6.6 18.5 31.4 9.7 12.2 7.3 4.2 9.8 5.9 9.3 8.8 20.6 10.1 15.2 9.2 27.2 34.3 9.0 2.7 9.1 11.1 4.5 7.8 6.1 17.8 38.0 6.6 15.4 12.3 50.1 21.4 11.0 4.3 8.6 9.1 10.9 8.8 4.0 GOLGA2 "GM130, golgin-95" ENSG00000167110 "Golgin A2" Q08379 9 128255829-128275995 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015421, HPA021178, HPA021230, HPA021799" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "CAB015421: AB_831377, HPA021178: AB_1849837, HPA021230: AB_1849839, HPA021799: AB_1849841" "unprognostic (2.88e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (3.70e-2)" "unprognostic (4.34e-2)" "unprognostic (1.84e-1)" "unprognostic (3.20e-1)" "unprognostic (2.83e-1)" "unprognostic (1.58e-1)" "unprognostic (3.50e-1)" "unprognostic (4.07e-1)" "unprognostic (2.21e-2)" "prognostic favorable (9.77e-5)" "unprognostic (3.92e-2)" "unprognostic (6.44e-2)" "unprognostic (4.84e-2)" "unprognostic (4.27e-2)" 51.8 44.2 31.5 31.3 31.8 33.4 49.6 30.4 31.5 73.5 44.1 48.2 28.9 57.0 59.7 75.0 49.9 42.2 63.9 30.9 36.2 42.3 50.3 47.3 24.5 34.0 36.3 57.4 65.3 77.4 122.4 56.9 36.7 54.4 44.5 31.4 65.1 54.9 57.2 73.4 38.0 58.1 28.7 33.4 51.7 35.8 33.0 23.3 53.3 51.1 32.1 48.6 66.3 31.8 49.1 48.1 52.8 54.9 130.4 148.3 46.3 93.6 129.2 79.4 71.1 60.7 44.7 23.1 34.4 154.3 84.4 94.4 30.3 47.4 74.2 34.1 28.9 25.5 114.0 48.3 85.2 38.2 71.4 95.4 74.0 79.1 81.9 124.9 64.3 55.1 83.8 58.6 77.6 99.8 33.0 33.9 16.2 92.0 86.2 32.9 58.1 40.0 63.4 42.5 29.3 34.9 62.5 52.1 43.2 53.3 117.0 32.2 86.3 102.9 51.8 66.9 50.8 40.7 51.1 29.7 89.8 20.0 65.6 32.4 6.6 12.2 6.2 5.3 3.8 6.0 4.1 3.4 2.7 7.3 4.4 6.1 30.2 7.4 8.2 13.2 3.6 2.9 31.5 31.8 30.4 31.5 30.9 36.2 34.0 36.3 36.7 28.7 33.0 31.8 33.9 44.8 66.8 20.9 27.0 31.7 27.7 45.1 41.5 68.0 53.8 34.8 88.1 45.8 57.8 42.3 41.7 37.9 32.6 69.6 43.0 47.6 41.5 62.9 82.2 35.5 46.1 18.7 15.1 60.8 35.6 67.1 59.7 94.3 65.9 33.6 44.6 72.3 28.3 25.2 20.4 90.9 40.7 24.9 23.1 7.7 68.3 34.2 24.9 10.3 19.5 33.4 28.8 15.6 15.5 57.7 45.1 64.7 55.6 43.7 42.6 35.4 73.2 51.7 13.1 59.6 43.3 99.5 51.1 71.4 45.5 102.3 28.1 29.5 42.6 44.2 GOLGA3 "GCP170, golgin-160, MEA-2" ENSG00000090615 "Golgin A3" Q08378 12 132768914-132829078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 110.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039809, HPA040044" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" Nucleoplasm "HPA039809: AB_10962348, HPA040044: AB_10981600" "unprognostic (1.93e-1)" "unprognostic (7.91e-2)" "unprognostic (6.80e-2)" "unprognostic (1.41e-1)" "unprognostic (2.56e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (1.10e-1)" "unprognostic (7.69e-2)" "unprognostic (1.55e-2)" "prognostic favorable (3.87e-4)" "unprognostic (2.99e-1)" "prognostic unfavorable (6.47e-5)" "unprognostic (1.40e-2)" "unprognostic (1.45e-1)" "unprognostic (2.01e-2)" "unprognostic (1.20e-1)" 12.4 12.3 19.2 12.5 18.8 13.7 11.6 14.8 20.2 15.9 20.6 15.8 7.9 14.7 9.2 16.2 12.8 8.7 13.7 19.1 18.6 9.7 14.0 13.5 12.8 18.6 19.1 17.0 19.6 7.8 26.9 10.5 20.1 14.7 11.7 26.3 17.3 10.8 14.7 15.4 13.6 12.3 13.3 15.1 15.1 11.6 20.5 17.7 12.5 8.6 11.1 14.5 14.3 17.4 19.7 39.1 13.4 23.2 42.2 28.7 25.9 34.1 23.3 23.8 20.9 40.7 8.7 25.6 16.8 45.4 17.1 19.7 16.3 19.6 14.1 6.4 17.3 27.6 44.6 26.0 25.9 29.5 36.2 23.4 22.8 26.8 26.6 23.4 22.7 19.1 27.1 9.8 21.0 30.2 27.0 26.7 14.0 15.1 24.8 21.8 14.1 10.9 13.4 47.1 16.1 10.5 27.0 22.9 14.6 15.2 31.1 22.2 38.7 23.5 17.6 26.8 21.9 31.0 32.0 40.4 28.8 16.3 28.7 3.2 2.0 2.6 3.4 2.9 3.1 2.5 2.6 3.3 2.3 3.4 2.7 2.9 1.5 3.9 2.3 3.9 3.6 2.0 19.2 18.8 14.8 20.2 19.1 18.6 18.6 19.1 20.1 13.3 20.5 17.4 22.9 44.8 40.6 25.8 22.0 21.7 12.7 17.0 13.1 26.0 21.2 16.1 35.4 8.6 26.8 14.7 100.1 13.4 20.6 63.0 7.9 15.2 23.8 21.8 46.9 24.8 22.2 16.4 40.2 27.8 24.2 29.0 48.9 47.5 12.0 33.3 14.6 24.1 16.0 18.5 41.1 50.2 10.2 15.1 16.4 34.6 25.7 18.2 17.8 21.5 18.4 20.1 23.7 22.6 33.3 31.5 27.1 22.6 54.2 32.3 17.9 8.6 26.4 110.6 6.6 32.1 27.7 25.1 24.8 19.0 33.1 23.1 21.7 24.6 32.5 29.4 GOLGA4 "GCP2, GOLG, golgin-240, p230" ENSG00000144674 "Golgin A4" Q13439 3 37243177-37366751 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 683.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035102, HPA040675" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" Nucleoplasm "HPA035102: AB_10601472, HPA040675: " "unprognostic (9.46e-2)" "unprognostic (1.55e-1)" "unprognostic (1.18e-2)" "unprognostic (5.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.54e-1)" "unprognostic (5.61e-2)" "unprognostic (1.38e-1)" "unprognostic (5.79e-3)" "unprognostic (3.90e-2)" "unprognostic (5.62e-2)" "unprognostic (8.55e-2)" "prognostic favorable (3.62e-6)" "unprognostic (7.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.92e-2)" "unprognostic (1.33e-1)" 38.6 36.3 18.3 19.5 26.7 21.2 28.8 26.6 22.3 27.6 58.3 28.1 38.8 20.0 23.5 37.3 21.1 19.3 63.7 17.6 20.8 34.5 60.8 25.7 17.0 27.2 24.6 23.4 48.0 33.5 40.6 36.1 27.5 29.6 28.1 56.8 38.4 20.7 118.8 48.2 36.9 19.5 21.8 24.1 38.2 44.3 22.3 17.6 47.2 102.3 19.6 25.0 28.9 29.9 62.6 42.3 21.4 27.1 55.2 47.2 54.4 78.3 65.2 30.2 36.3 36.5 33.9 21.4 19.9 67.1 34.7 35.9 34.4 55.5 62.3 27.4 25.2 28.9 37.9 58.5 55.2 30.9 20.3 25.4 51.8 47.7 92.1 48.8 44.4 15.8 35.9 32.6 49.1 26.8 23.7 13.4 23.4 31.7 39.9 5.4 64.8 22.8 37.4 64.4 13.7 18.1 48.6 51.8 61.4 40.8 76.3 22.4 54.0 30.7 35.6 60.0 56.7 39.8 30.1 18.3 54.4 26.6 36.8 30.7 6.6 15.5 16.2 7.6 14.0 9.9 10.3 11.9 5.5 11.6 10.7 8.1 8.9 15.7 15.2 11.8 7.6 4.3 18.3 26.7 26.6 22.3 17.6 20.8 27.2 24.6 27.5 21.8 22.3 29.9 85.4 237.2 312.9 142.0 98.2 158.3 134.0 70.2 128.1 171.9 97.0 84.1 683.5 84.4 147.4 46.0 358.6 112.7 126.4 154.3 29.4 117.5 240.7 131.6 141.8 102.2 89.6 127.1 154.5 120.2 117.8 128.0 140.2 242.7 62.0 112.9 63.1 147.5 92.0 188.4 168.6 166.2 65.1 73.1 73.9 46.7 119.9 80.3 69.4 107.7 91.9 145.8 132.8 133.7 223.2 136.4 109.1 113.6 150.2 169.7 181.2 64.5 82.4 361.0 85.5 161.8 95.7 435.6 227.2 98.5 175.7 249.6 97.2 125.7 139.3 189.2 GOLGA5 "golgin-84, GOLIM5, ret-II, rfg5" ENSG00000066455 "Golgin A5" Q8TBA6 14 92794305-92839947 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000992, HPA063876" Enhanced Supported Supported "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA000992: AB_1079009, HPA063876: AB_2685140" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (2.77e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-1)" "unprognostic (1.78e-1)" "unprognostic (5.02e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-2)" "unprognostic (7.67e-2)" "unprognostic (6.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.06e-2)" "unprognostic (2.49e-2)" 26.0 23.3 21.4 18.2 23.7 10.4 33.1 22.4 26.4 32.2 23.9 26.4 23.3 21.9 54.2 25.0 19.2 24.0 21.5 20.8 22.3 25.5 54.3 22.4 18.8 22.6 22.4 20.6 32.2 33.6 23.5 28.2 23.1 31.2 32.5 15.8 32.4 25.8 26.9 23.3 22.9 26.0 22.6 19.1 32.9 34.3 22.1 16.9 33.2 20.0 23.3 24.1 19.6 25.9 32.4 29.4 25.9 23.7 53.1 71.4 44.3 43.9 80.4 41.9 49.2 21.8 43.4 21.0 35.1 70.2 29.2 33.4 23.1 35.9 56.6 25.8 11.2 19.9 14.0 29.3 61.5 23.3 31.8 55.1 63.7 29.5 60.6 46.2 42.0 21.8 17.7 27.3 46.5 60.1 18.1 19.6 16.1 70.2 31.0 13.9 37.9 21.1 42.8 38.9 18.4 26.0 40.0 29.6 45.7 35.7 51.0 25.6 35.0 23.9 15.6 31.3 22.2 33.3 27.6 18.2 54.9 18.2 40.8 10.4 10.0 23.6 10.3 13.0 11.8 9.5 10.4 10.6 9.9 9.5 9.2 8.1 8.8 8.7 11.9 9.1 12.9 6.7 21.4 23.7 22.4 26.4 20.8 22.3 22.6 22.4 23.1 22.6 22.1 25.9 18.7 28.9 26.3 8.8 15.7 7.8 11.2 17.9 16.5 7.5 16.2 11.9 26.8 8.6 19.6 14.7 12.5 23.7 17.2 23.8 29.4 25.3 31.6 17.6 24.6 16.7 22.3 15.8 17.6 32.7 32.0 21.7 33.1 25.7 9.5 29.7 13.9 33.5 15.4 25.2 15.6 31.6 4.1 14.7 10.3 18.5 23.0 14.6 12.4 15.0 18.2 15.6 16.5 14.6 21.9 28.9 12.0 25.2 29.2 19.4 19.9 24.2 18.7 10.7 26.3 18.0 19.3 34.1 37.0 16.5 11.4 50.3 15.9 15.6 16.5 16.5 GOLGA8A "CFAP286, FAP286, GM88, GOLGIN-67" ENSG00000175265 "Golgin A8 family member A" A7E2F4 15 34379068-34437466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 211.5;Oligodendrocyte precursor cells: 146.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 48.0;HeLa: 80.1" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (4.80e-2)" "unprognostic (1.26e-2)" "unprognostic (4.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.42e-2)" "unprognostic (2.10e-2)" "unprognostic (8.11e-3)" "prognostic favorable (7.58e-4)" "unprognostic (2.74e-2)" "unprognostic (4.37e-1)" "unprognostic (2.63e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "prognostic favorable (5.68e-6)" 24.5 18.6 16.1 10.4 11.7 7.9 32.4 18.5 21.4 56.3 11.0 32.7 10.5 31.6 31.8 31.2 37.6 7.3 23.6 13.1 10.0 33.2 6.8 22.4 14.0 17.8 8.8 62.5 22.9 6.3 22.8 2.2 11.9 37.8 2.2 26.4 26.8 10.2 7.6 36.8 38.2 3.2 7.0 48.1 30.3 40.0 12.8 1.2 56.8 1.0 2.1 33.0 40.2 12.2 2.4 13.4 3.7 12.5 0.1 0.0 2.8 20.3 0.1 3.4 1.5 23.3 0.0 0.1 3.6 2.4 6.9 21.7 9.5 6.8 5.3 20.1 7.6 48.0 80.1 15.0 1.3 18.4 12.6 0.0 19.5 2.3 0.5 2.3 0.3 7.0 46.0 40.0 9.2 4.3 4.7 34.6 6.9 6.4 7.2 19.6 11.2 16.2 7.7 13.8 17.1 8.2 13.6 9.2 2.2 0.1 3.6 11.4 10.5 15.7 3.5 0.0 3.6 37.5 13.4 5.5 4.7 38.9 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.1 11.7 18.5 21.4 13.1 10.0 17.8 8.8 11.9 7.0 12.8 12.2 37.3 211.5 71.6 82.9 16.1 26.1 10.9 13.4 7.4 95.3 36.1 41.9 35.0 5.7 127.6 1.8 100.1 2.9 21.1 6.5 0.0 4.2 37.5 17.6 83.9 18.4 16.1 2.5 114.4 2.6 5.0 17.4 13.7 52.3 13.9 39.3 14.6 1.5 2.4 84.1 91.8 11.9 14.2 6.8 20.1 8.4 31.4 8.5 23.2 38.4 1.7 14.8 6.2 146.8 62.5 4.7 6.9 21.1 19.3 8.5 6.6 0.9 52.0 117.6 0.0 26.7 22.4 33.0 23.5 7.8 21.6 3.3 32.9 39.9 11.7 9.4 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 228.4" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 14.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 25: Pancreas - Digestion" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favorable (5.79e-4)" 16.5 28.8 10.9 7.2 11.0 18.4 20.8 13.8 15.0 28.7 10.8 18.6 0.9 16.8 11.9 10.0 27.9 6.9 15.5 11.0 11.1 41.1 41.8 23.8 19.6 11.2 10.9 55.6 228.4 0.7 60.6 3.0 10.9 37.8 1.4 8.0 18.1 10.6 10.1 13.4 25.2 2.0 10.9 38.5 28.7 43.2 11.1 2.8 113.8 1.3 7.4 19.7 13.4 11.2 2.6 2.8 0.3 5.3 2.8 5.4 7.3 2.3 0.7 2.5 4.0 2.8 3.5 0.0 4.7 2.5 0.3 2.1 0.9 2.4 1.9 3.6 8.4 0.4 20.4 16.2 3.9 2.3 2.5 7.8 3.3 1.5 4.5 2.7 2.6 4.0 0.9 0.2 2.3 1.2 1.2 24.5 3.2 5.0 4.6 0.1 0.0 0.4 2.2 4.9 3.8 5.8 1.3 0.4 3.2 3.9 2.2 4.8 0.0 3.7 8.8 1.1 4.0 1.8 1.7 3.9 1.2 1.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 11.0 13.8 15.0 11.0 11.1 11.2 10.9 10.9 10.9 11.1 11.2 19.0 192.3 66.5 95.0 34.8 21.9 8.8 10.9 33.0 53.6 30.9 34.3 37.4 20.0 74.7 31.3 73.0 7.6 30.6 2.8 1.9 9.2 53.8 17.3 27.1 11.0 7.2 13.0 133.4 13.0 5.4 12.7 20.4 24.5 9.5 36.4 11.0 28.7 1.5 45.4 126.1 10.1 12.2 6.6 9.9 10.8 39.4 5.0 21.4 12.2 6.4 9.3 32.0 112.1 24.2 16.8 4.9 37.6 45.1 7.6 7.1 5.8 39.9 67.8 13.1 13.5 13.8 48.9 28.4 10.0 14.8 2.9 49.8 22.0 9.4 6.6 GOLGB1 "GCP, GCP372, giantin, GOLIM1" ENSG00000173230 "Golgin B1" Q14789 3 121663199-121749767 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011008, HPA011555" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA011008: AB_1079011, HPA011555: AB_1079010" "unprognostic (2.56e-2)" "unprognostic (7.69e-2)" "unprognostic (1.46e-1)" "unprognostic (6.57e-2)" "unprognostic (5.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (6.58e-2)" "unprognostic (7.49e-2)" "unprognostic (3.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-1)" "unprognostic (9.90e-3)" "unprognostic (9.05e-2)" 19.9 25.2 11.0 7.1 12.7 14.1 24.1 15.0 12.9 21.9 26.5 18.8 12.2 17.4 32.1 15.1 15.8 13.3 18.5 13.2 10.5 18.6 17.9 15.3 8.4 8.5 9.9 21.9 27.1 20.7 25.0 13.4 9.0 25.8 17.1 31.0 25.2 19.9 14.2 20.2 19.0 10.0 9.6 16.6 19.7 14.6 9.3 11.3 21.0 11.1 9.8 16.3 15.7 11.5 19.9 15.7 15.3 9.9 28.8 31.0 9.6 12.6 27.5 11.9 13.4 13.8 7.1 4.3 10.4 23.6 11.9 9.0 9.2 13.7 14.1 6.3 17.5 12.2 20.1 19.2 17.2 13.7 16.0 25.4 31.9 7.5 18.7 25.8 15.3 7.3 5.8 9.6 12.7 14.3 4.1 9.9 9.9 19.1 16.4 5.4 12.0 10.3 17.7 20.2 10.8 12.0 15.5 11.0 16.7 17.3 13.6 15.2 21.5 11.4 6.9 4.9 9.2 17.8 11.4 7.2 15.3 6.6 4.3 1.6 4.1 4.3 4.3 2.2 3.5 3.4 3.5 3.3 2.6 2.8 3.3 3.6 15.4 3.9 1.7 5.5 3.9 1.6 11.0 12.7 15.0 12.9 13.2 10.5 8.5 9.9 9.0 9.6 9.3 11.5 118.9 291.7 233.9 101.2 97.3 51.6 89.1 62.1 96.8 101.4 110.2 130.3 274.8 74.4 179.2 53.3 123.0 78.7 134.7 148.6 11.7 104.3 56.0 247.9 186.4 102.7 91.9 36.8 72.9 111.0 53.0 135.5 144.8 284.0 115.6 220.7 74.3 68.9 34.5 69.0 80.2 176.8 65.1 47.2 48.3 23.8 198.5 82.1 33.8 68.4 76.8 82.1 54.6 50.3 72.8 100.2 95.7 199.0 176.0 74.9 79.9 29.3 165.7 193.6 85.5 165.9 120.5 155.0 66.8 70.2 45.7 150.8 102.6 197.7 101.7 88.3 GOLIM4 "GIMPC, GOLPH4, GPP130, P138" ENSG00000173905 "Golgi integral membrane protein 4" O00461 3 168008689-168095924 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 370.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 10.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001677, HPA002315" Enhanced Enhanced "Golgi apparatus" NA NA 1000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA001677: AB_1079017, HPA002315: AB_1079018" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (6.27e-2)" "unprognostic (2.11e-1)" "unprognostic (4.76e-2)" "unprognostic (2.44e-1)" "unprognostic (5.17e-2)" "unprognostic (1.39e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (6.31e-2)" "unprognostic (1.84e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (9.62e-3)" 24.8 12.6 25.4 21.4 23.0 9.0 12.9 24.7 32.1 16.8 13.9 53.4 65.8 21.9 8.9 15.7 15.7 28.5 54.6 27.7 34.8 31.3 59.2 29.1 11.3 39.5 29.5 19.9 11.9 12.8 9.6 22.4 40.1 15.2 51.1 53.0 17.3 13.6 32.4 9.3 85.2 26.6 35.1 23.0 24.3 9.0 27.5 6.5 19.0 30.7 9.5 16.8 10.7 33.6 23.7 34.5 47.8 30.4 79.7 58.6 14.5 135.8 72.4 36.3 33.2 38.7 28.4 51.6 159.1 82.4 58.4 42.5 44.4 39.9 54.9 81.3 57.0 83.8 100.2 48.1 32.1 80.5 45.8 61.5 20.9 33.4 32.8 32.2 42.1 0.0 43.7 146.2 41.9 39.2 0.1 21.8 46.9 44.2 36.6 0.1 48.1 72.2 20.6 8.5 42.9 55.5 83.5 25.1 28.4 31.7 30.9 36.1 79.0 114.9 44.2 81.3 110.1 56.4 43.4 109.4 57.1 47.4 52.4 3.2 2.5 10.8 0.6 2.8 0.2 1.2 0.1 0.5 3.3 2.0 0.0 0.2 0.0 5.5 2.3 4.0 0.0 0.7 25.4 23.0 24.7 32.1 27.7 34.8 39.5 29.5 40.1 35.1 27.5 33.6 74.9 48.1 124.8 141.0 11.1 41.4 24.4 18.3 41.5 16.2 21.3 20.6 157.3 67.2 23.3 36.8 37.5 11.4 33.5 184.5 17.6 21.8 1.7 20.6 51.5 70.9 63.3 33.9 18.1 29.6 17.2 119.2 34.1 30.9 58.3 23.3 45.3 178.8 39.1 16.8 84.2 136.5 12.2 50.7 57.5 3.3 39.7 42.2 37.4 38.4 22.0 370.3 14.4 145.8 44.7 23.6 181.2 51.1 28.9 26.0 195.2 31.6 9.2 62.8 46.0 108.2 82.5 5.5 37.6 20.1 35.9 5.5 16.5 20.4 167.6 8.4 GOLM1 "bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73" ENSG00000135052 "Golgi membrane protein 1" Q8NBJ4 9 86026146-86100173 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 396.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 362.8;Early spermatids: 339.0;Gastric mucus-secreting cells: 245.6;Ionocytes: 325.5;Late spermatids: 391.6;Pancreatic endocrine cells: 282.9;Paneth cells: 265.2;Undifferentiated cells: 245.6" "Cancer enhanced" "Detected in all" "prostate cancer: 343.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 1.9;classical monocyte: 3.6;gdT-cell: 3.5;intermediate monocyte: 2.6;neutrophil: 4.2;non-classical monocyte: 4.2;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 372.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010638, HPA011929, CAB015341" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 81000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" "unprognostic (1.10e-1)" "prognostic favorable (8.14e-5)" "unprognostic (1.97e-1)" "unprognostic (4.40e-3)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.89e-3)" "unprognostic (2.81e-1)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "unprognostic (1.34e-2)" "unprognostic (5.59e-3)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (2.87e-3)" "unprognostic (1.23e-1)" 22.2 159.8 72.5 33.8 78.8 6.6 39.5 69.2 84.5 70.0 99.0 195.7 235.1 40.1 15.7 13.6 38.1 131.0 12.7 72.1 93.8 74.7 19.0 14.7 9.7 73.4 76.1 36.9 41.6 37.6 36.4 17.2 69.9 143.2 163.9 25.5 173.4 10.5 9.4 14.9 61.3 28.4 80.1 41.7 396.2 17.4 108.0 45.4 68.1 4.8 5.6 38.3 14.9 79.2 146.0 139.5 102.4 116.7 129.3 74.3 108.0 64.8 46.6 99.9 80.5 69.4 282.9 2.7 62.6 126.2 96.6 109.4 63.7 64.1 71.9 5.0 101.2 45.3 89.1 3.4 76.8 67.3 34.9 113.4 34.2 94.1 34.0 124.9 172.9 21.2 28.7 4.2 57.3 68.4 8.3 49.6 161.9 188.9 99.6 42.9 116.9 21.8 166.0 61.2 115.1 72.0 88.2 189.0 73.8 66.1 106.7 68.1 110.5 25.9 72.6 79.3 78.3 372.3 37.4 0.9 112.2 29.8 57.8 1.9 3.6 0.4 3.5 2.6 0.4 0.6 0.2 0.5 0.4 0.6 0.4 0.7 4.2 0.7 4.2 1.5 0.1 1.8 72.5 78.8 69.2 84.5 72.1 93.8 73.4 76.1 69.9 80.1 108.0 79.2 13.8 9.6 15.3 30.3 1.7 2.3 10.8 11.3 4.6 20.1 41.4 21.1 4.9 80.1 80.9 35.0 8.4 8.4 10.7 362.8 25.4 168.4 339.0 78.0 49.8 20.5 73.1 11.2 47.0 222.2 35.0 30.4 245.6 56.8 1.3 65.9 8.6 11.1 11.8 67.3 43.2 95.5 325.5 5.0 2.6 391.6 18.3 6.6 23.2 6.5 6.9 16.9 12.3 82.0 19.3 282.9 265.2 13.2 3.2 72.6 71.8 16.0 78.6 6.7 0.0 13.5 19.5 10.3 38.7 2.9 1.0 6.4 5.2 60.7 245.6 29.1 GOLM2 "CASC4, DKFZp459F1927, H63" ENSG00000166734 "Golgi membrane protein 2" Q6P4E1 15 44288719-44415758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 19.9;Cardiomyocytes: 24.0;Cytotrophoblasts: 16.3;dendritic cells: 16.1;Extravillous trophoblasts: 19.4;Fibroblasts: 18.2;Hofbauer cells: 27.3;Syncytiotrophoblasts: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043015, HPA049488" Enhanced Enhanced "Golgi apparatus" NA NA 1200000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA043015: AB_2678271, HPA049488: AB_2680790" "unprognostic (2.64e-2)" "unprognostic (2.63e-1)" "unprognostic (3.38e-1)" "unprognostic (1.81e-2)" "unprognostic (8.08e-2)" "unprognostic (1.35e-1)" "unprognostic (1.20e-2)" "unprognostic (2.20e-1)" "unprognostic (2.40e-1)" "unprognostic (1.68e-2)" "unprognostic (4.99e-2)" "unprognostic (2.60e-2)" "prognostic favorable (1.45e-5)" "unprognostic (2.15e-1)" "unprognostic (3.56e-2)" "unprognostic (9.65e-2)" "unprognostic (1.12e-1)" 39.5 84.5 48.5 32.4 47.0 16.5 43.2 43.1 59.2 57.9 62.4 45.7 28.8 50.4 53.5 23.7 53.8 50.5 33.1 42.8 52.6 54.0 60.9 40.9 30.8 49.6 51.5 55.3 37.4 82.0 38.7 34.4 46.9 67.5 43.8 33.7 47.8 56.1 22.3 13.2 29.8 44.4 46.7 35.4 49.4 34.6 52.9 28.9 84.6 26.3 29.5 39.2 24.3 52.7 45.0 38.7 51.9 92.6 141.4 121.8 32.0 78.6 125.2 44.9 57.1 19.3 80.0 13.5 106.4 119.3 47.8 53.8 34.4 25.5 48.2 64.6 19.5 21.4 41.8 35.9 65.1 42.5 68.1 72.1 28.3 49.8 38.4 126.8 53.4 34.2 33.0 103.4 56.2 23.2 36.7 33.2 14.8 60.8 27.5 30.5 29.3 43.3 58.8 54.4 23.3 53.2 60.7 57.0 26.6 28.1 64.1 49.2 76.4 78.1 39.8 112.5 69.5 79.0 145.1 27.9 92.6 58.5 51.7 20.9 14.7 20.8 15.2 9.8 16.3 11.9 12.4 15.2 12.0 10.7 9.5 9.9 37.8 10.5 18.2 10.6 13.2 13.6 48.5 47.0 43.1 59.2 42.8 52.6 49.6 51.5 46.9 46.7 52.9 52.7 19.9 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 16.3 16.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 19.4 18.2 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 12.7 2.9 0.0 0.0 0.0 GOLPH3 "GOPP1, GPP34, MIDAS, Vps74" ENSG00000113384 "Golgi phosphoprotein 3" Q9H4A6 5 32124716-32174319 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044564, HPA055841" Approved Supported "Golgi apparatus,Vesicles" NA NA 23000 "Cluster 26: Non-specific - Mitochondria" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 28: BEWO - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus, Vesicles" "HPA044564: AB_10795169, HPA055841: AB_2682940" "unprognostic (1.64e-2)" "unprognostic (1.66e-1)" "unprognostic (9.27e-2)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-2)" "unprognostic (1.89e-2)" "unprognostic (8.19e-2)" "unprognostic (2.95e-2)" "unprognostic (7.48e-2)" "unprognostic (2.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (1.11e-1)" "unprognostic (1.52e-2)" 50.1 38.3 28.5 41.9 29.2 20.8 50.0 29.8 34.5 56.2 32.9 76.6 46.3 41.6 58.7 43.1 41.0 77.7 38.4 26.5 29.6 61.5 110.1 50.7 49.2 30.2 29.5 51.5 62.6 54.9 29.8 68.4 29.9 75.3 60.2 19.8 64.8 50.4 37.3 32.8 49.3 52.3 29.1 39.5 52.9 27.0 29.7 43.9 48.0 57.0 52.4 60.5 41.3 32.3 57.7 37.9 59.9 65.5 111.3 106.1 171.6 77.8 103.3 71.5 67.7 51.9 101.3 51.7 75.0 105.7 69.3 52.8 75.1 54.9 89.7 67.7 44.9 56.9 119.9 99.4 89.4 88.8 64.0 81.3 77.1 70.3 80.1 65.8 57.9 33.6 60.5 121.8 80.4 58.0 57.1 115.3 51.8 78.0 38.5 52.8 86.4 53.8 89.9 72.1 45.6 51.0 180.8 186.9 79.4 75.6 76.4 97.1 56.5 62.7 58.5 49.7 55.6 136.1 179.3 62.5 56.3 125.8 76.4 6.8 8.0 19.2 7.8 10.6 6.8 11.5 8.4 10.1 8.9 16.0 9.9 7.2 7.9 8.5 10.5 6.9 13.2 4.2 28.5 29.2 29.8 34.5 26.5 29.6 30.2 29.5 29.9 29.1 29.7 32.3 33.9 60.9 49.2 26.8 53.3 70.0 44.5 30.0 51.2 13.5 59.6 30.7 31.7 88.6 42.8 44.1 10.4 67.3 52.0 72.6 52.8 58.0 5.2 46.3 35.8 46.2 52.0 50.5 47.9 44.1 111.6 51.7 57.6 71.3 14.5 16.8 59.3 153.6 54.4 13.5 45.8 86.3 40.7 63.7 56.2 16.1 50.7 49.1 44.4 43.1 48.7 20.2 36.0 53.8 60.1 49.7 35.1 57.2 120.0 83.9 59.8 59.8 49.1 10.0 39.5 30.8 52.1 15.4 25.1 68.2 73.6 110.0 45.6 50.4 50.2 80.7 GOLPH3L GPP34R ENSG00000143457 "Golgi phosphoprotein 3 like" Q9H4A5 1 150646230-150697154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 313.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072016 Supported "Golgi apparatus,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Cytosol "HPA072016: " "unprognostic (1.21e-1)" "unprognostic (2.61e-1)" "unprognostic (3.76e-3)" "unprognostic (3.24e-1)" "unprognostic (3.24e-2)" "unprognostic (1.82e-1)" "unprognostic (3.18e-2)" "unprognostic (4.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (9.88e-3)" "unprognostic (2.71e-1)" "unprognostic (3.36e-2)" "unprognostic (1.67e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.93e-2)" 10.9 14.3 8.8 11.8 9.3 6.0 20.8 9.3 11.4 21.8 13.5 31.1 17.9 14.7 33.3 30.3 25.3 14.1 10.3 8.7 11.4 18.6 9.6 13.6 12.6 9.3 13.3 21.4 22.8 19.0 11.0 13.0 11.7 15.8 36.4 12.8 23.3 17.6 14.7 18.9 20.1 15.2 9.0 11.0 22.7 14.4 10.9 15.8 25.7 13.5 18.5 21.5 13.5 8.5 25.2 23.0 12.2 7.6 31.8 22.5 21.8 22.6 33.0 23.7 32.9 10.3 45.1 29.3 31.5 14.7 16.1 21.6 20.8 18.5 28.6 21.1 21.5 33.8 13.2 15.2 26.7 27.8 28.2 16.1 31.8 24.2 54.4 26.1 37.5 21.1 27.6 19.6 14.1 25.4 24.2 13.1 25.7 46.1 21.6 16.8 14.5 36.5 30.6 17.5 19.3 18.8 11.6 33.2 18.0 31.4 25.6 32.5 29.3 7.3 13.3 10.2 18.5 23.8 22.9 313.5 22.3 28.3 10.9 7.5 1.6 2.8 9.5 1.6 13.0 10.5 9.9 9.7 8.7 9.8 12.7 9.4 1.4 18.0 3.6 12.6 11.6 5.4 8.8 9.3 9.3 11.4 8.7 11.4 9.3 13.3 11.7 9.0 10.9 8.5 11.7 9.6 10.3 12.1 9.8 12.9 11.3 16.7 9.6 9.0 26.3 14.4 10.4 24.3 22.6 12.9 6.2 22.1 9.7 50.0 25.4 21.6 22.2 27.5 10.3 14.1 21.0 10.9 12.7 36.6 17.9 12.9 17.9 15.6 11.4 48.6 16.1 10.9 12.4 0.0 13.6 46.6 14.2 9.1 7.4 12.7 16.4 7.5 16.0 24.4 13.1 14.9 6.2 11.6 13.5 21.2 34.6 19.9 15.0 27.7 31.6 26.9 51.2 13.3 0.0 10.0 9.5 14.6 4.3 15.7 17.8 30.8 10.4 22.0 36.0 39.6 GOPC "CAL, dJ94G16.2, FIG, GOPC1, PIST" ENSG00000047932 "Golgi associated PDZ and coiled-coil motif containing" Q9HD26 6 117560269-117602542 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019477, HPA024018" Approved Enhanced "Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA019477: AB_1849890, HPA024018: AB_1849891" "unprognostic (2.48e-2)" "unprognostic (1.63e-3)" "unprognostic (1.71e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (3.17e-2)" "unprognostic (3.12e-2)" "unprognostic (9.21e-2)" "unprognostic (6.22e-2)" "unprognostic (6.77e-2)" "unprognostic (8.23e-2)" "unprognostic (9.46e-2)" "unprognostic (1.40e-2)" "unprognostic (2.67e-2)" "unprognostic (1.38e-1)" "unprognostic (9.55e-2)" "unprognostic (3.01e-2)" 15.5 14.2 14.6 15.8 14.9 7.1 20.2 15.6 18.0 23.4 11.0 18.7 12.2 23.5 18.0 12.1 17.4 16.3 22.1 15.9 13.3 14.5 16.4 13.6 19.9 12.5 12.5 25.6 12.7 22.1 16.1 19.9 13.1 16.2 20.3 13.5 14.3 17.3 15.8 18.7 15.0 18.4 13.6 16.9 14.9 17.7 12.6 21.0 23.9 17.4 17.2 15.1 14.7 16.8 14.1 15.0 19.1 25.6 40.1 47.9 30.3 57.1 41.7 30.6 31.5 23.1 15.5 42.2 24.3 32.4 60.4 31.2 37.2 27.6 42.8 21.2 20.8 38.7 39.9 37.5 42.4 52.2 24.8 57.4 74.9 22.8 65.7 60.6 26.5 29.0 36.7 16.8 62.2 12.9 21.8 40.3 16.5 24.0 16.0 33.0 37.0 30.8 23.3 12.9 26.7 21.0 57.6 19.7 15.8 36.3 14.3 49.7 31.8 2.2 27.9 28.5 62.6 29.9 28.8 35.4 37.9 43.4 23.9 10.5 4.2 3.2 6.7 3.9 9.3 7.9 7.1 7.1 5.5 7.7 8.2 8.5 2.9 9.2 4.7 9.2 7.7 4.1 14.6 14.9 15.6 18.0 15.9 13.3 12.5 12.5 13.1 13.6 12.6 16.8 43.2 22.4 22.7 46.4 33.4 46.7 25.1 63.9 46.7 59.2 47.0 67.3 46.2 34.3 32.2 20.2 22.9 77.0 28.6 40.4 27.4 27.9 35.1 30.4 77.4 38.1 33.6 26.5 52.9 25.6 62.4 48.3 30.1 30.6 31.1 50.4 35.0 38.7 38.5 74.0 46.2 65.2 24.4 24.2 22.9 13.7 42.3 27.0 28.4 32.8 24.1 39.3 35.0 73.9 64.5 21.1 40.9 42.2 38.7 40.3 20.9 27.1 35.3 35.9 32.9 50.0 44.3 115.6 51.4 36.7 59.8 52.3 38.7 43.3 37.7 27.3 GORAB "FLJ11752, GO, NTKL-BP1, SCYL1BP1" ENSG00000120370 "Golgin, RAB6 interacting" Q5T7V8 1 170532131-170553834 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027250, HPA027746" Approved Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA027250: AB_10611253, HPA027746: " "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-3)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (5.26e-4)" "unprognostic (8.48e-3)" "unprognostic (2.94e-2)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (7.83e-12)" "unprognostic (2.52e-2)" "unprognostic (2.83e-1)" "unprognostic (7.71e-2)" "unprognostic (1.70e-1)" 3.1 5.2 1.6 1.9 1.6 0.6 2.8 1.6 3.1 3.8 1.9 3.6 1.4 3.2 3.5 2.3 2.1 2.1 3.1 1.5 2.3 2.5 4.3 2.5 3.6 1.6 1.8 4.3 3.7 1.9 3.0 3.1 1.7 2.8 3.3 1.3 3.3 2.6 1.1 1.9 2.7 2.0 1.7 3.1 2.1 2.0 2.0 2.8 3.0 2.1 3.0 3.1 3.3 1.8 3.4 3.8 4.5 2.0 9.0 5.8 2.9 4.8 7.5 3.6 4.6 1.9 4.9 5.1 6.1 4.3 2.4 4.0 6.4 2.8 6.0 4.8 1.6 2.5 4.0 2.8 4.9 4.4 3.1 4.4 2.5 4.2 3.9 5.5 3.5 2.3 4.4 2.3 5.3 0.6 5.8 4.0 4.7 6.2 4.0 3.9 3.8 6.0 4.2 1.9 1.4 3.0 3.6 4.8 11.5 3.1 2.7 8.4 4.4 6.8 3.1 2.9 7.2 3.5 4.4 3.8 5.2 4.0 5.4 0.7 3.9 0.0 2.3 4.2 3.9 2.8 4.1 3.5 4.3 2.8 3.6 3.0 0.5 3.8 3.1 2.7 5.3 2.6 1.6 1.6 1.6 3.1 1.5 2.3 1.6 1.8 1.7 1.7 2.0 1.8 8.1 0.0 11.4 8.8 8.9 2.8 4.0 6.5 8.6 4.7 5.2 7.1 9.4 10.0 7.1 5.5 2.1 6.0 6.2 12.8 3.9 12.3 2.3 5.5 10.4 8.3 0.0 3.4 9.3 6.0 7.3 10.5 9.2 6.7 13.9 5.2 5.3 6.6 7.1 5.0 7.7 9.4 8.2 6.9 4.6 3.2 14.0 5.6 3.6 3.7 10.1 4.3 3.1 9.0 7.3 5.7 9.8 6.4 10.3 4.9 4.3 6.0 2.4 7.1 6.6 8.2 9.3 13.1 8.1 5.4 1.6 5.6 6.3 5.1 6.4 3.0 GORASP1 "FLJ23443, GOLPH5, GRASP65, P65" ENSG00000114745 "Golgi reassembly stacking protein 1" Q9BQQ3 3 39096599-39107863 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 98.9;Late spermatids: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056283 Supported Supported "Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA056283: AB_2683085" "unprognostic (1.06e-1)" "unprognostic (8.31e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.92e-6)" "unprognostic (2.77e-1)" "unprognostic (1.98e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (2.13e-2)" "unprognostic (8.79e-3)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.73e-3)" "prognostic favorable (1.91e-6)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.44e-1)" "unprognostic (3.24e-3)" 16.9 13.5 35.4 12.8 36.4 11.5 18.6 38.7 35.7 25.2 30.3 23.6 13.6 18.8 16.6 20.0 22.2 15.6 21.3 34.1 35.9 26.9 26.3 19.6 13.4 41.7 36.9 13.3 24.5 22.5 15.4 21.0 38.0 22.1 26.0 20.6 26.2 30.7 16.3 16.4 18.5 24.0 42.0 21.5 19.1 10.5 38.8 11.8 18.4 19.0 17.4 17.9 14.8 46.6 15.6 19.0 18.0 17.8 42.8 28.1 16.6 27.1 31.1 27.5 24.6 11.3 18.4 16.8 15.7 41.4 17.2 24.7 20.7 32.2 19.3 22.4 14.3 23.8 18.7 16.0 19.3 20.0 25.8 22.0 43.8 28.5 28.0 30.6 38.2 6.0 19.8 20.3 26.3 22.6 5.6 18.9 13.1 35.7 23.1 6.0 10.7 23.8 27.4 28.1 7.1 14.0 25.7 51.4 16.1 24.4 33.2 20.7 29.0 15.4 14.3 37.0 15.0 14.1 14.8 4.1 18.3 16.7 23.0 6.5 12.0 7.0 3.3 12.7 4.5 11.7 4.1 3.1 12.8 9.3 4.7 3.4 6.9 2.8 17.2 7.2 6.7 8.0 35.4 36.4 38.7 35.7 34.1 35.9 41.7 36.9 38.0 42.0 38.8 46.6 21.1 3.2 9.8 23.2 8.7 4.1 10.6 6.5 8.0 8.5 12.9 9.7 8.7 12.8 7.2 12.9 0.0 14.0 3.4 21.4 11.7 10.7 98.9 15.5 11.4 13.4 11.4 5.5 7.7 8.7 11.1 8.9 24.5 16.3 1.3 8.8 8.9 11.4 9.5 8.4 9.2 15.3 8.2 7.2 9.8 56.1 7.2 9.5 12.4 9.4 7.0 7.3 0.0 9.0 9.6 11.0 8.0 6.4 5.7 11.4 14.2 6.0 10.7 11.1 0.0 8.8 10.0 10.1 6.8 8.0 5.8 19.8 4.4 6.5 15.1 12.6 GORASP2 "GOLPH6, GRASP55, GRS2" ENSG00000115806 "Golgi reassembly stacking protein 2" Q9H8Y8 2 170928464-170967130 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 380.7;Syncytiotrophoblasts: 229.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035274, HPA035275, CAB075758" Enhanced Enhanced "Golgi apparatus" NA NA 830000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "CAB075758: AB_2665764, HPA035274: AB_2674546, HPA035275: AB_10602600" "unprognostic (2.04e-2)" "unprognostic (4.37e-3)" "unprognostic (4.61e-1)" "unprognostic (1.64e-1)" "unprognostic (9.94e-2)" "prognostic unfavorable (7.32e-4)" "unprognostic (3.13e-2)" "unprognostic (3.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.58e-1)" "unprognostic (4.56e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.38e-8)" "unprognostic (1.26e-1)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (3.13e-1)" 32.1 43.1 32.6 32.0 34.6 33.7 40.5 35.8 36.7 62.6 34.1 43.5 38.3 43.2 60.4 46.8 34.3 37.2 57.6 32.5 35.9 33.6 45.6 34.3 39.9 34.2 34.5 37.3 67.1 47.3 40.0 55.5 34.8 40.7 43.6 37.0 68.4 52.6 39.7 38.6 36.7 46.1 34.6 31.1 42.0 32.0 34.4 41.8 50.8 38.1 44.2 53.3 24.0 37.0 66.1 51.7 72.2 54.9 137.5 103.2 83.0 101.5 113.9 89.6 113.8 132.8 84.2 97.0 59.7 143.2 61.0 75.9 82.3 96.0 102.2 57.8 81.2 107.5 41.2 198.8 138.4 90.2 62.9 79.2 102.9 90.0 148.3 95.7 98.9 64.5 92.4 72.4 80.3 103.2 85.5 87.0 74.3 109.9 49.3 68.4 64.5 115.0 112.9 91.8 59.3 54.3 58.4 91.6 95.9 59.0 60.8 73.6 93.5 82.8 56.2 79.5 55.7 81.1 56.2 112.4 86.6 58.3 95.6 48.3 38.3 27.0 53.0 40.6 81.7 44.8 59.1 63.4 48.3 40.7 58.0 48.5 9.6 64.5 46.8 63.9 57.0 62.8 32.6 34.6 35.8 36.7 32.5 35.9 34.2 34.5 34.8 34.6 34.4 37.0 28.7 41.7 36.6 15.0 46.7 37.2 39.6 83.4 38.1 30.6 33.0 22.5 40.9 27.1 64.2 20.2 31.3 114.4 49.3 39.2 56.7 69.1 196.6 16.2 34.4 32.1 31.3 35.1 20.1 78.1 112.1 48.4 48.4 32.7 20.3 25.7 38.9 45.0 46.4 42.1 23.0 63.9 48.8 22.7 29.7 380.7 58.7 23.9 48.0 22.5 46.3 39.3 35.0 27.2 31.7 69.7 41.9 49.7 171.9 62.1 31.7 43.7 23.1 34.8 59.2 27.5 40.3 39.6 39.6 47.1 36.1 229.7 43.4 44.9 48.2 67.7 GOSR2 "Bos1, GS27" ENSG00000108433 "Golgi SNAP receptor complex member 2" O14653 17 46923075-46975524 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 303.0;Late spermatids: 796.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB017456, HPA048956, HPA054472" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Golgi apparatus" "CAB017456: AB_10532285, HPA048956: AB_2680569, HPA054472: AB_2682499" "unprognostic (3.28e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.30e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (2.41e-2)" "unprognostic (7.23e-3)" "unprognostic (2.41e-1)" "unprognostic (2.46e-3)" "unprognostic (4.50e-1)" "unprognostic (3.07e-1)" "unprognostic (2.84e-3)" "unprognostic (4.29e-2)" 23.2 25.6 28.5 21.7 28.7 16.4 24.8 31.6 37.6 24.8 32.9 22.8 49.8 23.8 31.6 21.5 21.3 18.3 32.5 29.3 29.3 42.2 33.9 23.6 26.4 28.7 29.7 26.1 31.3 35.5 37.1 28.7 29.2 23.1 27.4 25.0 32.5 30.5 43.1 21.9 43.2 29.8 28.1 30.1 23.1 48.3 29.5 27.1 26.6 34.3 31.8 25.2 18.6 30.9 44.6 47.2 33.5 40.3 54.9 39.3 37.8 59.7 58.5 63.5 56.7 60.1 25.7 37.7 33.1 75.4 66.5 30.1 43.4 48.5 77.8 83.0 33.3 56.8 37.4 60.1 60.3 44.9 44.1 40.8 47.1 52.2 73.2 49.0 52.6 43.7 56.5 50.9 46.2 46.8 50.0 24.2 31.1 60.1 65.8 43.5 64.0 44.5 40.7 37.7 28.8 61.5 33.3 19.2 47.9 57.1 55.1 31.3 62.1 60.0 38.8 47.4 58.9 64.6 39.4 60.1 56.1 28.6 67.1 39.5 33.1 29.2 33.9 63.2 31.3 29.8 29.7 27.8 32.7 38.6 29.1 25.4 3.6 31.2 86.0 29.7 38.8 35.2 28.5 28.7 31.6 37.6 29.3 29.3 28.7 29.7 29.2 28.1 29.5 30.9 23.7 25.6 18.7 17.9 22.0 16.6 17.3 16.7 4.6 18.5 21.1 18.0 16.2 15.7 14.5 33.1 6.2 30.2 23.8 15.9 23.5 34.5 303.0 9.1 18.0 25.2 7.2 20.6 24.2 42.7 33.1 18.4 15.3 11.0 14.5 22.7 21.8 22.4 45.1 23.5 26.3 16.8 16.2 22.0 14.7 796.1 16.8 15.0 10.6 21.5 22.0 16.4 14.4 17.1 28.4 58.1 24.2 14.3 23.5 22.1 96.5 90.0 13.7 20.4 0.0 9.3 26.8 33.1 26.7 7.4 16.9 52.7 14.9 18.4 12.6 20.5 GPATCH1 "ECGP, FLJ10206, FLJ38686, GPATC1" ENSG00000076650 "G-patch domain containing 1" Q9BRR8 19 33080899-33130542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043430, HPA043604, HPA074327" Approved Approved "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Golgi apparatus, Cell Junctions" "HPA043430: AB_10960493, HPA043604: AB_10960499, HPA074327: " "unprognostic (2.38e-2)" "unprognostic (1.71e-2)" "unprognostic (9.95e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.41e-1)" "unprognostic (1.28e-2)" "unprognostic (4.60e-3)" "unprognostic (3.54e-2)" "unprognostic (5.17e-2)" "unprognostic (3.56e-2)" "unprognostic (6.53e-2)" "unprognostic (5.37e-3)" "unprognostic (8.10e-2)" "unprognostic (4.57e-2)" "unprognostic (1.25e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-3)" 3.5 3.1 3.0 3.5 3.2 3.7 4.4 5.1 4.0 4.0 2.0 4.8 5.4 4.5 4.4 4.3 3.9 2.8 3.8 3.1 2.9 4.4 3.4 3.4 4.9 2.8 3.0 7.2 3.8 6.3 2.6 4.2 3.0 4.2 4.5 3.9 4.6 3.4 4.2 5.6 4.6 4.4 2.7 4.3 4.9 4.4 3.3 5.9 4.7 3.2 5.0 3.6 3.6 3.4 8.8 18.2 8.4 9.1 5.5 6.2 7.1 7.8 5.4 11.6 9.7 12.9 7.9 12.3 9.7 6.2 5.5 7.7 10.6 6.4 10.1 21.4 6.6 11.7 6.8 9.8 7.2 20.3 7.6 5.3 7.4 7.9 7.2 5.6 6.6 9.6 12.5 7.7 5.8 11.2 11.8 7.1 5.9 11.5 7.5 11.9 10.6 5.5 5.4 5.4 9.3 6.2 12.3 7.6 4.6 7.2 6.4 14.5 7.5 10.2 7.6 5.6 11.3 6.4 11.1 10.6 6.3 10.3 9.5 23.1 6.4 7.4 6.0 6.6 4.1 6.2 5.6 7.7 6.0 7.0 9.6 6.0 4.7 3.5 3.7 5.3 9.2 5.0 3.0 3.2 5.1 4.0 3.1 2.9 2.8 3.0 3.0 2.7 3.3 3.4 6.5 9.6 7.9 5.9 9.1 6.1 5.0 6.0 10.8 9.7 5.2 4.6 11.8 1.5 9.8 7.3 14.6 10.5 10.7 12.0 15.6 6.8 3.2 5.2 9.4 6.4 4.2 4.2 7.2 4.5 5.2 7.5 10.2 6.8 16.5 10.1 7.9 4.6 4.1 3.3 7.0 7.7 8.2 6.0 5.2 2.1 10.2 5.8 8.8 2.8 5.8 7.1 16.5 5.5 7.0 9.0 8.7 8.2 5.5 3.3 6.8 6.6 10.3 11.9 0.0 8.0 7.3 19.5 14.8 6.5 3.7 5.5 9.1 7.0 6.5 3.4 GPC6 ENSG00000183098 "Glypican 6" Q9Y625 13 93226807-94408020 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 163.2;Excitatory neurons: 333.6;Inhibitory neurons: 496.1;Oligodendrocyte precursor cells: 691.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 62.5;HSkMC: 70.8;hTERT-RPE1: 64.3;SuSa: 39.5;U-87 MG: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA017671 Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 420000 "Cluster 48: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA017671: AB_1849833" "unprognostic (5.24e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" "unprognostic (9.76e-2)" "unprognostic (1.72e-1)" "unprognostic (5.50e-2)" "unprognostic (1.28e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.33e-2)" "unprognostic (3.71e-2)" "unprognostic (2.53e-3)" "unprognostic (6.21e-3)" "unprognostic (7.42e-2)" "unprognostic (3.36e-1)" "unprognostic (3.35e-3)" 9.1 2.2 0.8 8.9 1.9 0.1 2.2 1.7 1.5 3.6 1.1 6.3 2.3 2.4 2.4 5.2 4.1 17.0 6.2 1.3 3.1 7.7 17.7 3.5 0.4 1.7 2.4 7.3 1.6 1.8 2.9 1.3 2.3 6.2 6.5 5.6 3.1 15.1 0.6 1.1 4.3 7.8 2.0 2.2 5.4 2.0 1.9 1.7 1.7 1.9 0.9 11.6 2.4 2.1 0.0 4.7 10.2 4.5 62.5 19.5 0.0 7.2 0.0 4.9 6.4 0.0 0.0 0.2 0.0 16.0 0.0 0.0 5.7 1.2 9.1 0.0 4.1 0.0 0.1 20.2 37.8 0.1 0.1 70.8 0.5 11.7 8.1 64.3 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.1 6.4 0.0 3.4 0.0 1.6 0.1 5.5 0.0 4.1 16.8 0.0 1.9 0.0 39.5 14.0 0.0 0.0 26.9 22.6 25.4 12.3 15.9 0.1 0.0 52.8 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 1.9 1.7 1.5 1.3 3.1 1.7 2.4 2.3 2.0 1.9 2.1 0.6 0.0 0.5 163.2 0.0 0.6 0.5 0.5 0.6 50.3 0.6 1.9 1.7 4.3 0.7 7.3 10.4 0.2 0.0 0.1 0.0 0.3 6.7 1.6 25.9 1.1 0.0 0.0 333.6 0.0 0.1 31.2 0.0 3.1 0.0 36.0 5.7 41.2 0.5 0.0 496.1 0.1 2.0 1.3 1.0 5.0 4.7 0.5 1.8 31.9 0.0 2.7 0.0 691.6 13.2 0.1 0.0 1.9 0.1 1.6 0.0 14.5 0.0 115.0 0.0 34.4 20.9 4.2 2.7 0.5 0.4 0.1 0.7 11.9 0.1 0.2 GPR107 "FLJ20998, KIAA1624, LUSTR1, RP11-88G17" ENSG00000148358 "G protein-coupled receptor 107" Q5VW38 9 130053426-130140169 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031704 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" Nucleoplasm "HPA031704: AB_10601018" "prognostic unfavorable (3.56e-5)" "unprognostic (7.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (8.72e-2)" "unprognostic (1.10e-3)" "unprognostic (1.35e-2)" "unprognostic (2.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.59e-1)" "unprognostic (1.85e-1)" "prognostic favorable (1.87e-5)" "unprognostic (4.10e-2)" "unprognostic (5.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.34e-3)" 18.9 17.3 21.0 15.1 22.1 12.2 20.3 21.9 21.3 20.1 24.4 21.3 11.6 18.8 15.3 18.7 22.0 16.1 18.3 19.5 23.9 20.5 13.0 20.3 11.0 23.4 25.3 17.9 18.8 28.7 16.6 23.3 25.6 23.6 22.6 26.3 18.3 19.9 17.8 22.7 12.9 23.2 21.8 13.4 16.7 17.3 23.5 14.3 34.9 17.0 14.2 15.8 14.2 23.8 29.7 42.0 39.6 31.7 42.4 44.6 39.9 45.9 52.5 37.9 37.5 40.6 39.5 16.4 33.4 52.1 44.5 73.0 30.7 28.6 32.3 24.7 20.3 17.0 49.1 23.8 40.9 36.2 24.4 37.5 44.3 38.1 38.7 44.1 35.9 19.0 25.0 15.8 33.6 36.6 19.4 14.7 26.8 60.0 31.7 18.3 58.7 25.9 32.1 40.2 13.6 30.7 59.8 42.8 33.1 34.9 75.0 19.3 42.9 48.1 25.1 40.3 35.3 9.8 35.6 15.2 43.5 17.0 46.9 1.5 2.8 1.9 0.7 3.4 1.0 1.0 0.7 0.8 1.8 1.0 0.5 1.2 3.3 0.9 3.6 1.1 0.7 1.3 21.0 22.1 21.9 21.3 19.5 23.9 23.4 25.3 25.6 21.8 23.5 23.8 14.8 25.6 19.3 47.7 8.0 6.4 5.1 14.8 5.2 16.9 17.8 12.2 23.0 14.3 16.4 16.5 39.6 15.4 11.4 20.7 0.0 13.4 6.5 23.7 19.3 14.3 9.6 4.6 32.7 17.6 19.2 16.2 16.8 26.4 6.3 17.9 24.3 11.6 15.1 18.5 39.7 19.4 6.1 17.0 17.6 5.7 19.0 13.8 14.2 22.5 15.6 11.0 9.2 38.2 48.6 21.9 15.9 19.2 11.2 13.2 9.3 6.5 24.5 15.5 0.0 16.3 15.3 16.2 11.5 12.2 10.9 26.7 10.4 13.5 18.4 10.9 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favorable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 29.9 45.2 26.9 18.8 29.3 26.2 32.7 29.7 27.2 36.8 29.9 39.9 32.9 31.6 31.6 39.6 40.1 32.2 22.5 24.2 29.4 42.1 34.4 32.4 23.2 28.9 28.1 34.5 46.7 49.0 23.2 22.2 27.5 34.4 28.1 27.8 57.5 40.2 18.4 31.2 36.6 26.3 27.7 33.3 35.8 25.5 29.1 23.5 41.3 20.5 27.8 31.0 32.9 27.8 33.5 35.9 21.7 42.6 83.0 44.8 24.4 25.6 77.0 34.7 36.7 22.2 37.5 15.8 46.4 52.4 41.6 28.1 24.7 53.3 17.8 64.1 28.4 25.7 37.7 29.6 81.3 16.7 33.7 48.7 100.2 33.5 67.2 45.9 41.3 37.9 26.4 102.7 35.6 23.3 29.5 24.0 15.6 60.2 31.5 23.7 24.7 61.0 72.7 32.6 0.2 23.4 25.9 41.8 38.7 18.4 39.9 40.0 34.4 19.7 12.5 63.2 27.6 66.2 39.3 11.4 68.0 52.9 21.7 79.3 116.1 123.0 82.6 109.7 75.2 48.2 65.2 70.4 84.6 49.9 45.9 52.8 178.4 80.9 130.5 30.0 81.2 132.7 26.9 29.3 29.7 27.2 24.2 29.4 28.9 28.1 27.5 27.7 29.1 27.8 40.8 9.6 14.5 12.7 26.3 26.5 43.7 107.4 21.1 28.3 42.7 33.0 8.0 45.8 59.7 36.8 22.9 58.7 31.1 76.4 37.2 87.7 38.0 30.8 23.6 32.7 21.7 6.9 5.4 110.1 37.2 27.4 39.3 44.1 26.0 15.0 40.7 26.7 57.1 21.9 6.0 57.6 81.4 30.3 46.7 94.9 23.6 42.4 30.2 5.6 50.3 46.0 42.2 7.5 9.6 83.3 83.7 18.4 27.8 29.1 121.2 55.0 39.8 43.0 39.5 22.2 26.4 34.3 19.9 27.2 31.8 58.6 38.9 28.3 47.1 36.1 GPSM1 "AGS3, DKFZP727I051" ENSG00000160360 "G protein signaling modulator 1" Q86YR5 9 136327476-136359605 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 26.1;Bipolar cells: 37.2;Cone photoreceptor cells: 22.9;Muller glia cells: 36.0;Rod photoreceptor cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 82.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042199, HPA060736" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 5: Muller glia cells - Visual perception" "Golgi apparatus" Nucleoplasm "HPA042199: AB_10959329, HPA060736: " "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (4.07e-3)" "unprognostic (3.44e-1)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.37e-2)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (5.96e-3)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (4.66e-2)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.48e-2)" 13.0 21.7 32.6 4.2 30.6 4.5 12.4 50.9 44.4 38.7 12.7 18.5 3.3 23.3 7.2 6.0 20.3 4.7 74.9 30.5 26.7 19.6 4.7 35.4 2.1 34.9 29.8 38.1 42.3 3.8 19.7 6.6 28.7 30.6 1.2 18.7 8.6 5.9 2.7 17.0 9.3 4.0 25.1 19.9 17.2 29.4 28.6 2.0 12.4 0.7 1.1 15.1 24.4 28.6 3.9 6.2 14.5 25.4 8.1 14.1 12.1 43.0 17.6 11.8 6.4 12.5 4.1 0.0 17.8 26.0 9.9 2.9 2.3 8.8 2.6 35.1 25.5 5.0 23.4 2.3 34.7 0.3 6.1 23.0 5.8 10.8 6.2 14.5 12.0 5.9 13.5 0.2 7.9 14.2 2.4 4.9 15.5 1.4 22.5 82.3 26.2 12.7 3.2 2.8 35.6 44.4 8.0 1.0 13.7 5.6 17.7 8.6 20.0 21.7 17.5 25.7 8.9 7.6 0.3 0.1 13.0 0.0 21.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 32.6 30.6 50.9 44.4 30.5 26.7 34.9 29.8 28.7 25.1 28.6 28.6 4.7 3.2 3.3 26.1 0.6 4.2 2.3 0.8 0.0 37.2 2.5 5.8 12.4 0.0 0.8 0.0 22.9 0.6 1.6 0.0 11.7 3.3 0.6 2.7 18.1 3.9 1.8 2.5 9.0 1.9 0.8 9.1 0.5 5.5 5.7 14.2 3.6 0.0 1.1 10.1 11.6 0.0 0.0 0.3 2.8 1.3 10.5 1.5 8.8 6.5 0.5 36.0 0.0 9.5 10.4 7.3 0.0 9.4 0.3 10.6 0.0 0.1 0.6 43.0 0.0 5.8 6.0 0.4 3.7 0.1 3.3 0.3 1.1 3.3 0.0 4.0 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 73.2;Club cells: 45.8;Endometrial ciliated cells: 51.8;Endometrial stromal cells: 49.0;Extravillous trophoblasts: 46.5;Glandular and luminal cells: 153.2;Respiratory ciliated cells: 48.8;Syncytiotrophoblasts: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.9;MAIT T-cell: 2.8;memory CD4 T-cell: 1.6;memory CD8 T-cell: 2.3;myeloid DC: 1.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 1.8;NK-cell: 1.1;plasmacytoid DC: 4.3;T-reg: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 4.3;NK-cells: 1.1;T-cells: 3.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 114.1;CAPAN-2: 73.6;fHDF/TERT166: 75.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 12.8 16.0 56.5 6.9 57.1 1.6 38.7 54.1 55.1 32.2 47.7 28.6 29.6 29.4 15.5 8.9 34.3 10.9 11.7 49.4 54.6 32.9 24.4 11.3 7.4 61.3 64.7 30.3 8.9 8.7 10.0 24.7 55.2 16.9 29.8 6.6 23.1 23.7 3.8 27.3 36.0 22.1 64.9 6.1 16.4 4.1 54.0 13.2 40.4 5.6 11.2 13.8 16.3 60.5 66.1 3.7 3.0 14.6 62.4 21.5 19.4 71.2 114.1 28.7 37.2 2.6 73.6 0.0 26.4 75.4 0.7 17.5 0.9 27.6 30.9 6.1 4.8 3.1 8.2 3.9 14.2 0.0 2.3 34.6 10.4 29.2 9.4 36.4 0.2 0.0 0.0 0.0 50.7 6.7 0.0 0.9 3.1 13.7 4.6 1.3 17.6 14.3 38.8 69.1 1.1 0.1 11.9 6.0 21.2 12.8 22.9 4.2 6.6 6.6 2.1 11.6 12.7 3.9 3.5 0.1 1.4 0.0 19.2 0.2 0.4 0.0 2.9 0.4 2.8 0.5 1.6 2.3 1.7 0.2 3.0 1.8 0.3 1.1 0.3 4.3 2.4 1.2 56.5 57.1 54.1 55.1 49.4 54.6 61.3 64.7 55.2 64.9 54.0 60.5 10.2 16.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 25.5 73.2 0.0 0.0 45.8 40.5 0.0 32.3 10.0 0.0 23.5 14.1 0.0 51.8 49.0 3.2 0.0 0.0 0.0 8.7 46.5 8.7 0.0 153.2 3.8 4.9 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 2.8 0.0 0.0 18.3 48.8 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 58.6 4.7 2.8 0.0 0.0 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 166.1;Early spermatids: 384.9;Late spermatids: 321.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus, Vesicles" Nucleoli "HPA043054: AB_2678293, HPA046782: AB_2679803" "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 11.4 13.1 13.6 17.5 16.7 16.2 13.2 14.7 16.7 10.4 10.9 60.4 48.3 10.6 11.3 41.0 10.9 14.2 11.0 15.7 14.8 16.4 23.3 9.7 19.6 12.9 12.0 6.7 9.9 9.5 8.1 13.8 13.3 13.9 54.6 67.8 12.1 9.9 12.7 14.5 56.6 15.9 13.9 11.8 23.3 48.7 13.7 11.1 10.3 10.6 22.4 21.1 16.2 14.9 21.9 30.5 33.6 23.1 25.2 29.1 56.6 39.7 30.7 26.2 28.8 22.7 36.6 20.9 23.6 30.4 15.9 23.8 22.1 24.2 37.9 49.9 21.1 8.8 16.1 17.5 23.4 23.1 14.5 23.2 37.7 33.1 32.7 20.1 34.6 23.5 19.2 18.7 33.6 53.5 17.0 18.6 37.3 33.9 38.3 16.7 31.4 19.3 61.5 79.9 11.8 38.4 44.8 41.6 34.9 33.7 31.9 14.3 37.8 12.0 15.1 25.6 12.8 21.7 67.0 17.8 30.6 16.4 19.6 64.4 20.9 47.0 27.7 24.3 42.8 38.3 37.6 32.4 21.2 33.1 37.0 34.5 40.9 37.5 33.6 17.9 66.6 28.6 13.6 16.7 14.7 16.7 15.7 14.8 12.9 12.0 13.3 13.9 13.7 14.9 12.6 12.8 7.4 5.9 24.8 45.2 24.2 27.6 19.9 26.8 18.4 14.5 18.9 14.3 21.7 20.2 41.7 42.7 17.9 166.1 72.4 34.1 384.9 32.3 11.1 17.4 28.1 24.0 14.3 39.4 43.3 12.1 41.8 32.2 19.7 6.6 17.9 17.3 23.6 23.5 10.8 73.0 52.9 19.8 19.6 321.7 8.1 16.8 19.6 5.6 25.2 22.3 16.5 10.6 17.9 39.9 102.9 7.9 22.6 37.4 81.8 47.4 28.6 104.0 19.7 6.5 16.5 40.0 34.1 35.7 65.9 119.6 24.4 7.9 69.1 43.7 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792483-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "brain: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enriched" "Detected in some" 4 "hypothalamus: 7.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA047096 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 43: Cardiomyocytes - Nuclear processes" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA047096: AB_2679929" "unprognostic (1.62e-1)" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.3 0.3 7.5 0.4 0.2 0.2 0.2 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GTPBP1 "GP-1, HSPC018" ENSG00000100226 "GTP binding protein 1" O00178 22 38705742-38738299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003166, HPA064702" Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 64000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Cytosol" "Nuclear bodies" "HPA003166: AB_10601476, HPA064702: AB_2685329" "unprognostic (1.42e-3)" "unprognostic (5.82e-3)" "unprognostic (1.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.94e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (3.17e-1)" "unprognostic (3.67e-2)" "unprognostic (1.56e-2)" "unprognostic (2.95e-2)" "unprognostic (2.88e-1)" "unprognostic (5.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.76e-2)" "unprognostic (3.40e-1)" "unprognostic (1.98e-3)" 18.4 19.0 16.5 23.4 19.1 105.4 18.4 20.0 44.3 20.3 20.8 20.5 20.5 20.0 12.1 22.4 22.1 17.7 20.0 18.4 19.3 18.4 17.1 28.9 23.0 19.3 17.0 27.4 22.0 19.2 25.5 16.0 17.0 23.8 17.6 34.7 21.2 15.5 31.7 27.5 22.9 16.6 15.5 28.0 20.4 20.3 16.7 20.0 24.9 19.9 23.0 18.7 19.4 23.9 29.2 10.5 37.4 30.2 12.6 19.7 18.3 27.4 28.7 39.0 33.9 22.0 16.3 27.9 9.8 26.9 17.5 26.6 45.5 28.8 21.6 49.2 32.8 48.7 36.9 16.3 23.9 57.7 24.3 20.3 22.0 31.2 48.7 21.3 24.3 20.2 29.4 56.5 21.8 12.1 32.1 26.1 27.0 16.7 20.8 61.8 38.2 36.7 13.8 23.3 51.0 17.7 33.3 21.0 19.6 16.2 19.0 24.2 26.1 22.3 22.0 16.4 21.2 51.8 18.7 38.5 20.1 29.0 16.9 3.5 3.1 3.9 4.7 4.6 4.2 4.6 3.5 4.9 3.4 3.8 2.5 3.7 7.8 2.3 5.1 1.7 3.3 3.4 16.5 19.1 20.0 44.3 18.4 19.3 19.3 17.0 17.0 15.5 16.7 23.9 17.8 9.6 8.4 7.8 31.8 27.8 36.0 12.7 15.4 32.6 17.5 15.5 11.2 5.7 12.4 12.9 22.9 7.2 35.9 40.3 5.9 13.2 4.5 22.2 14.3 13.1 16.2 35.3 5.5 19.3 7.9 14.5 23.4 26.4 14.0 17.5 13.6 12.4 8.6 20.2 7.9 24.3 16.2 18.4 43.9 5.4 16.1 19.3 10.6 4.7 26.6 13.2 20.6 5.5 15.2 19.9 21.1 19.2 52.8 47.4 29.8 6.1 16.6 41.0 26.3 19.9 14.5 17.2 7.7 19.2 34.2 19.0 31.9 15.5 13.0 51.0 H1-0 "H1.0, H1F0, H1FV" ENSG00000189060 "H1.0 linker histone" P07305 22 37805093-37807436 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 660.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 51.4;Cytotrophoblasts: 42.9;Extravillous trophoblasts: 125.7;Hofbauer cells: 73.2;Syncytiotrophoblasts: 219.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.1;granulocytes: 17.1;monocytes: 11.7" "Cell line enhanced" "Detected in many" "OE19: 662.8;U-2 OS: 823.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000843 Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments" Yes No 120000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" "Golgi apparatus, Actin filaments" "HPA000843: AB_1079062" "unprognostic (1.29e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.31e-3)" "unprognostic (1.19e-1)" "unprognostic (2.18e-1)" "unprognostic (3.85e-1)" "unprognostic (7.68e-2)" "unprognostic (1.86e-1)" "unprognostic (5.95e-3)" "unprognostic (4.86e-3)" "prognostic favorable (7.68e-7)" "unprognostic (3.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 89.8 53.5 56.6 36.7 55.4 660.5 121.4 72.5 64.1 218.3 42.5 146.2 129.9 168.2 43.5 230.6 119.7 56.3 86.5 55.4 67.1 292.8 179.3 72.4 24.4 58.4 54.2 120.7 125.9 93.2 58.2 80.0 57.7 151.7 120.0 39.9 155.3 40.2 216.2 228.6 137.1 97.7 52.6 36.7 131.2 42.4 58.3 136.2 93.9 93.5 46.6 85.6 194.9 55.8 159.6 67.9 206.0 91.8 53.4 48.4 291.6 126.9 262.3 362.6 512.6 278.1 247.3 0.2 31.1 106.3 84.1 303.8 0.0 87.2 256.0 0.9 15.3 268.2 25.3 187.4 185.8 0.1 0.7 45.4 152.4 182.3 203.2 4.0 97.8 60.4 0.1 0.5 28.5 263.3 45.4 26.5 80.2 662.8 329.9 74.6 122.6 56.1 58.0 42.7 47.3 263.9 349.9 235.4 473.9 91.8 184.2 167.1 65.4 27.4 823.3 122.7 25.9 0.7 18.5 1.2 33.5 95.9 80.3 17.1 9.9 15.7 0.1 11.7 0.1 0.0 1.0 0.2 8.1 0.1 2.8 0.4 5.4 0.1 10.3 7.4 0.2 6.9 56.6 55.4 72.5 64.1 55.4 67.1 58.4 54.2 57.7 52.6 58.3 55.8 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.4 0.0 0.0 0.0 0.0 42.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 125.7 25.2 0.0 0.0 0.0 0.0 0.0 0.0 73.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 219.7 0.0 0.0 0.0 0.0 HCST "DAP10, DKFZP586C1522, KAP10, PIK3AP" ENSG00000126264 "Hematopoietic cell signal transducer" Q9UBK5 19 35902529-35904377 "Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 253.7;lymphoid tissue: 115.6" "Cell type enhanced" "Detected in many" "dendritic cells: 993.2;Hofbauer cells: 571.1;Kupffer cells: 396.6;Langerhans cells: 584.5;Macrophages: 392.7;NK-cells: 1687.0;T-cells: 769.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 239.9;HL-60: 139.6;HMC-1: 154.3;THP-1: 177.8;U-937: 272.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034435, HPA063026" Enhanced Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus, Plasma membrane" Vesicles "CAB034435: AB_2117803, HPA063026: " "unprognostic (1.40e-3)" "unprognostic (3.07e-2)" "unprognostic (3.04e-2)" "unprognostic (7.27e-3)" "unprognostic (1.23e-1)" "unprognostic (8.23e-3)" "unprognostic (1.85e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.97e-2)" "unprognostic (1.94e-3)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.59e-10)" "unprognostic (3.78e-1)" "unprognostic (3.25e-2)" "unprognostic (1.65e-1)" "unprognostic (1.56e-1)" 27.2 9.5 14.0 53.6 13.8 253.7 14.1 13.7 18.5 9.6 16.6 12.7 11.3 8.3 4.7 5.5 9.9 11.5 8.3 13.5 17.0 10.6 14.5 40.3 68.0 18.3 14.7 5.7 6.7 2.5 9.6 24.7 17.6 9.4 8.6 2.2 10.7 8.2 4.2 6.6 28.2 11.2 17.1 115.6 15.4 3.4 18.2 59.6 7.9 3.0 37.8 16.4 8.0 22.2 0.9 0.0 0.3 0.5 1.1 0.0 0.3 1.9 1.1 0.0 0.6 0.8 1.2 26.9 1.7 2.0 0.4 0.9 0.0 0.2 0.0 0.6 0.0 239.9 0.5 0.7 0.9 139.6 154.3 1.6 0.3 0.0 0.0 0.7 0.0 14.8 2.1 33.4 0.4 0.4 16.9 54.7 0.3 0.3 0.7 0.8 0.5 2.0 0.4 0.1 0.9 0.4 1.3 0.7 0.9 0.2 0.5 177.8 0.5 1.4 1.8 0.2 0.2 1.6 1.1 39.5 1.4 272.2 0.3 124.7 725.8 105.8 1583.4 546.1 1172.3 78.6 664.6 1293.3 409.8 51.0 550.6 1108.0 196.1 1290.7 314.4 823.7 629.9 1421.2 14.0 13.8 13.7 18.5 13.5 17.0 18.3 14.7 17.6 17.1 18.2 22.2 12.3 6.4 43.3 0.0 85.3 28.6 1.3 1.7 2.8 0.4 11.4 12.8 1.2 15.7 7.1 9.2 0.0 3.8 993.2 1.8 0.0 2.8 1.3 4.0 2.5 18.3 0.0 84.2 0.1 1.2 4.7 9.5 14.8 5.5 240.4 0.3 21.0 14.3 571.1 1.7 0.1 0.9 2.0 396.6 584.5 3.0 2.1 392.7 44.4 5.6 309.9 0.7 1687.0 0.0 0.1 1.0 1.4 0.0 97.7 0.6 2.0 6.1 5.1 2.2 19.7 4.2 6.2 2.2 4.9 2.7 21.0 6.0 769.9 1.0 2.7 1.2 HDAC3 "HD3, KDAC3, RPD3, RPD3-2" ENSG00000171720 "Histone deacetylase 3" O15379 5 141620876-141636849 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005583, HPA052052, CAB072336" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 3: Monocytes - Immune response regulation" Nucleoplasm "Golgi apparatus" "CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708" "unprognostic (6.65e-2)" "unprognostic (1.96e-1)" "prognostic favorable (3.39e-4)" "unprognostic (1.17e-1)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.19e-2)" "unprognostic (3.16e-1)" "unprognostic (5.56e-2)" "unprognostic (2.45e-2)" "prognostic favorable (3.95e-4)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.65e-6)" "unprognostic (1.85e-1)" "unprognostic (1.63e-2)" "unprognostic (2.28e-3)" "unprognostic (2.17e-1)" 24.3 39.8 7.8 22.7 8.4 37.3 25.3 7.8 9.5 25.7 9.9 23.3 18.7 23.5 26.4 34.1 26.5 20.3 24.4 8.7 8.4 24.2 39.6 21.4 32.7 8.2 8.0 26.0 28.4 44.9 18.4 22.4 7.9 20.6 24.5 16.4 25.5 21.9 40.2 40.8 23.5 26.1 8.5 27.8 23.3 15.8 8.5 38.3 24.1 34.1 42.7 26.2 25.8 8.2 59.8 40.2 74.0 109.5 68.5 54.3 47.0 42.6 93.5 94.8 134.8 86.5 49.7 86.4 54.0 56.2 67.3 51.2 72.9 98.8 117.0 74.6 79.0 68.8 33.3 50.4 48.1 83.5 60.1 47.0 63.2 55.3 71.3 49.6 61.9 76.8 67.6 44.7 61.5 55.8 92.1 72.9 63.9 36.8 31.0 65.8 76.2 62.3 49.9 59.7 60.2 49.4 57.0 57.1 71.7 46.2 61.8 52.3 32.1 58.3 36.1 45.8 71.8 36.6 47.8 82.1 48.8 78.6 50.8 41.3 51.7 39.6 34.1 53.8 45.5 47.8 42.5 41.9 107.5 47.5 45.9 38.5 21.5 35.1 46.8 55.1 55.6 43.8 7.8 8.4 7.8 9.5 8.7 8.4 8.2 8.0 7.9 8.5 8.5 8.2 19.1 9.6 13.2 16.6 36.0 44.2 26.8 38.1 37.0 33.2 29.0 25.5 15.9 18.6 19.6 12.9 60.5 55.3 43.8 18.5 21.5 33.4 10.4 10.0 21.0 21.3 18.0 50.7 40.6 35.4 51.6 28.8 19.9 10.2 18.4 33.9 21.4 18.7 38.8 50.5 38.2 19.7 28.5 19.5 44.9 4.2 22.4 31.7 32.0 10.3 51.1 33.3 38.1 22.1 21.9 33.4 16.3 22.2 36.3 28.7 19.5 20.5 10.8 36.5 26.3 18.1 24.7 25.4 27.5 38.1 51.4 61.2 30.3 42.6 25.9 30.3 HDAC5 "FLJ90614, KIAA0600, NY-CO-9" ENSG00000108840 "Histone deacetylase 5" Q9UQL6 17 44076746-44123702 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 118.9;Syncytiotrophoblasts: 218.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019400, HPA030991" Approved Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nuclear speckles" "Golgi apparatus, Cytosol" "CAB019400: AB_2116626, HPA030991: AB_10795286" "unprognostic (1.30e-2)" "prognostic favorable (6.14e-4)" "unprognostic (6.65e-2)" "unprognostic (8.06e-2)" "unprognostic (3.49e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (8.80e-3)" "unprognostic (3.80e-2)" "unprognostic (2.37e-2)" "unprognostic (4.91e-3)" "unprognostic (4.30e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.51e-2)" "unprognostic (3.11e-1)" "unprognostic (6.00e-2)" "unprognostic (1.76e-2)" 30.8 24.7 39.3 10.9 33.5 20.7 28.8 48.8 48.5 40.6 3.3 36.3 11.6 33.2 15.5 45.1 34.1 15.9 53.5 40.4 31.6 24.8 17.4 33.6 14.0 37.6 41.1 45.0 22.5 31.5 48.1 22.6 35.1 29.2 7.3 24.3 22.9 15.1 77.5 71.3 22.9 14.8 22.4 26.4 24.0 19.7 40.0 10.4 30.8 28.6 11.6 29.2 37.0 50.3 8.7 5.5 14.9 3.5 28.2 21.7 53.6 22.8 56.1 11.3 18.1 12.3 9.1 13.5 9.0 54.4 16.5 6.9 17.6 9.8 4.7 21.2 28.7 26.3 18.6 28.6 12.2 8.7 35.7 31.2 16.5 12.8 15.8 19.0 9.3 10.6 20.0 26.5 65.5 6.7 14.3 26.2 16.4 6.7 13.0 54.7 41.6 35.4 1.2 3.8 38.6 20.3 6.7 27.6 31.2 21.8 39.3 49.6 5.1 27.8 17.5 6.6 11.7 43.6 39.7 16.2 16.0 10.7 13.4 11.6 9.2 9.7 5.4 13.5 3.8 7.2 4.3 5.4 11.1 7.5 4.5 4.0 20.9 4.5 16.8 9.7 4.1 7.3 39.3 33.5 48.8 48.5 40.4 31.6 37.6 41.1 35.1 22.4 40.0 50.3 24.0 12.8 13.7 11.1 20.4 29.2 32.3 9.0 26.2 87.8 23.8 21.3 27.1 30.0 11.9 20.2 118.9 21.9 19.6 22.4 21.5 17.2 20.2 17.1 10.7 22.1 46.0 9.3 18.9 8.7 53.1 24.1 10.2 25.1 12.6 47.0 24.3 9.3 22.7 82.4 31.0 14.9 6.1 18.5 17.8 10.0 48.4 29.8 14.2 12.2 16.5 18.9 11.3 14.1 26.2 11.5 16.5 43.6 14.2 41.2 21.5 7.3 12.4 60.4 65.7 31.8 40.1 4.2 32.7 28.1 32.8 218.1 17.0 29.9 11.3 25.3 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.3;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in many" "Spermatocytes: 182.0;Spermatogonia: 173.9" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 5.5" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 36.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" No Yes "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: AB_2684968" "unprognostic (1.94e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.1 1.2 0.8 6.4 0.3 16.3 3.0 5.5 1.2 3.2 1.3 4.3 2.9 2.9 1.4 5.9 1.7 2.0 0.7 0.4 1.3 2.5 1.8 1.7 12.4 0.8 0.8 2.6 1.2 1.4 3.0 4.1 1.0 2.1 5.1 1.1 1.9 1.0 0.3 5.3 3.9 2.2 0.9 4.3 3.7 12.8 0.9 15.9 1.1 0.2 12.6 3.6 3.2 1.5 57.7 55.4 70.6 90.1 2.9 6.4 37.4 42.9 27.8 34.4 54.6 70.3 45.5 70.0 16.7 15.5 29.1 56.3 40.9 34.9 50.7 68.5 45.5 37.3 56.3 58.0 1.7 71.2 31.6 3.6 2.0 42.1 20.0 9.4 24.0 46.0 20.7 43.5 43.1 54.9 75.2 35.6 73.4 42.3 24.1 70.3 62.1 16.3 24.2 72.2 28.4 22.8 50.3 14.5 7.8 59.0 60.9 23.1 17.2 38.4 19.4 35.4 52.4 22.3 47.6 74.5 19.0 42.8 17.9 0.3 0.7 0.0 7.0 1.5 2.4 18.8 11.4 9.4 2.3 23.2 5.2 7.7 1.0 10.2 1.0 36.8 19.7 2.3 0.8 0.3 5.5 1.2 0.4 1.3 0.8 0.8 1.0 0.9 0.9 1.5 4.7 9.6 3.9 0.0 19.7 21.5 11.5 12.6 13.1 16.4 10.0 15.0 1.0 12.8 12.6 22.0 0.0 46.3 13.2 26.2 3.9 9.0 2.0 9.3 16.4 8.1 10.8 50.5 3.3 6.2 43.4 13.0 17.9 16.3 5.7 60.6 5.7 3.6 15.1 6.7 5.4 17.8 8.2 2.2 10.3 5.3 9.0 7.3 1.8 9.4 5.7 4.3 1.0 4.5 6.6 4.7 1.8 5.7 37.5 3.7 1.7 1.6 6.3 11.4 19.7 10.5 16.4 182.0 173.9 22.9 9.9 11.1 15.7 16.5 30.9 11.7 HEPN1 ENSG00000221932 "Hepatocellular carcinoma, down-regulated 1" Q6WQI6 11 124919244-124920677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 11.4;brain: 37.3;liver: 20.9" "Group enriched" "Detected in some" 23 "Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 287 "Hep G2: 55.5" "HPA043768, HPA063054" Uncertain Approved "Golgi apparatus" Yes NA "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Golgi apparatus" "HPA043768: AB_2678662, HPA063054: AB_2684932" 11.4 0.2 6.1 0.1 23.1 0.0 8.3 0.3 9.4 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.6 5.0 6.1 0.2 20.9 0.1 0.1 37.3 10.3 0.1 0.2 0.0 2.4 0.0 13.5 0.8 0.0 2.2 0.4 0.0 0.2 0.3 0.7 0.0 5.1 0.1 0.5 0.5 19.0 0.0 0.2 0.0 0.0 0.2 0.5 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 23.1 0.3 9.4 5.0 6.1 37.3 10.3 13.5 5.1 19.0 17.9 0.2 0.0 0.0 94.3 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 3.1 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.5 0.6 0.0 0.0 1.9 0.0 29.1 0.0 49.3 114.6 0.0 0.0 1.2 0.0 0.1 0.0 2.2 0.0 1.9 0.0 0.1 0.1 1.8 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 HFM1 "FLJ36760, FLJ39011, MER3, SEC63D1" ENSG00000162669 "Helicase for meiosis 1" A2PYH4 1 91260766-91404856 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Meiosis "Helicase, Hydrolase" "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 9.3;testis: 13.8" "Cell type enhanced" "Detected in some" "Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035036, HPA035557" Supported "Golgi apparatus,Vesicles" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA035036: AB_2797224, HPA035557: AB_10696507" "unprognostic (1.35e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-1)" "unprognostic (2.83e-4)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (7.43e-3)" "unprognostic (1.79e-1)" "unprognostic (7.75e-2)" "unprognostic (7.97e-2)" "unprognostic (1.76e-4)" "unprognostic (2.81e-2)" "unprognostic (1.06e-2)" "unprognostic (2.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.77e-4)" "unprognostic (9.59e-2)" 0.4 0.3 1.0 0.1 1.0 0.2 0.4 5.1 1.0 0.9 0.0 0.5 0.3 2.3 1.1 0.1 0.8 0.2 0.6 0.7 1.6 0.7 0.1 0.2 0.1 1.7 1.6 3.9 0.7 0.1 9.3 0.5 1.1 0.6 0.3 4.5 0.5 1.1 1.5 0.1 0.2 0.9 1.1 0.4 0.2 13.8 1.6 0.1 1.6 1.1 0.2 0.4 0.3 1.3 0.0 0.1 5.2 2.8 0.0 0.1 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.3 0.1 1.6 0.0 0.0 0.2 1.0 0.0 0.0 0.0 1.7 2.1 0.0 0.0 0.7 1.4 0.0 0.5 0.0 0.0 0.5 0.5 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 5.1 1.0 0.7 1.6 1.7 1.6 1.1 1.1 1.6 1.3 0.2 0.0 1.1 50.9 0.0 0.0 0.0 0.0 0.6 3.9 0.1 0.3 3.1 0.0 0.0 0.0 6.2 0.5 0.0 0.0 0.0 0.4 17.8 0.2 1.9 0.4 0.0 2.5 17.6 0.2 0.2 0.6 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 38.4 0.0 0.0 0.0 0.0 5.0 4.1 0.0 0.0 10.3 0.0 2.4 0.0 90.5 9.5 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 6.2 0.0 2.0 1.4 58.9 15.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 HGD "AKU, HGO" ENSG00000113924 "Homogentisate 1,2-dioxygenase" Q93099 3 120628172-120682269 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "kidney: 200.3;liver: 752.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5" "Cancer enriched" "Detected in many" 4 "liver cancer: 119.8" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.2" "HPA047374, HPA052359" Enhanced Approved "Golgi apparatus" NA NA 700000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA047374: AB_2680019, HPA052359: AB_2681798" "unprognostic (1.36e-1)" "unprognostic (9.89e-2)" "unprognostic (3.93e-2)" "prognostic favorable (1.78e-4)" "unprognostic (1.56e-1)" "unprognostic (2.05e-1)" "unprognostic (5.65e-3)" "unprognostic (7.20e-2)" "unprognostic (6.05e-2)" "unprognostic (2.41e-3)" "unprognostic (2.68e-2)" "unprognostic (1.16e-1)" "unprognostic (4.29e-3)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.43e-1)" 0.4 0.3 0.4 2.5 1.9 0.5 12.5 0.6 0.8 27.4 1.5 16.7 31.6 3.1 13.0 0.4 4.2 61.7 0.3 0.5 0.4 200.3 752.6 0.8 0.4 0.4 0.4 0.2 31.2 7.0 0.2 0.2 0.4 44.5 20.3 0.7 4.2 4.2 0.1 0.9 25.6 0.5 0.4 0.6 25.5 0.1 0.5 0.7 55.1 0.2 0.1 0.2 0.1 0.6 0.0 12.3 4.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 55.8 10.7 0.1 82.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.2 186.6 0.0 0.4 1.0 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.5 0.0 0.0 0.2 0.3 328.0 0.0 0.1 0.3 0.1 212.2 0.0 0.2 0.2 0.2 0.9 0.0 0.0 0.2 1.0 0.6 0.1 0.9 0.2 0.1 0.0 0.3 0.5 0.2 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.3 0.4 1.9 0.6 0.8 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.6 0.1 0.0 2.0 0.3 5.9 0.0 0.4 0.6 0.0 0.3 7.5 1.7 0.3 81.5 4.9 27.6 2.1 0.0 0.3 18.5 103.7 7.2 0.2 113.9 17.1 1.2 43.8 24.0 3.2 17.8 0.0 0.4 19.4 127.8 1.3 0.0 16.4 534.7 0.2 0.0 0.6 16.0 2.0 16.1 0.0 0.0 0.0 21.3 0.0 1.9 2.0 4.2 0.0 0.0 0.5 12.1 35.6 0.0 0.0 12.9 54.6 477.5 4.1 0.2 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 3.8 0.4 9.1 0.4 HHAT "FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn" ENSG00000054392 "Hedgehog acyltransferase" Q5VTY9 1 210328252-210676296 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 25.8;Excitatory neurons: 47.7;Microglial cells: 20.6;Oligodendrocytes: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.8;dendritic cells: 3.7;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HMC-1: 13.6;LHCN-M2: 11.6;RH-30: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA016462 Approved Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA016462: AB_2669360" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (5.02e-3)" "unprognostic (8.89e-3)" "unprognostic (4.81e-2)" "unprognostic (3.32e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (1.67e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-3)" "prognostic favorable (8.47e-7)" "unprognostic (2.55e-1)" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (5.67e-2)" 2.1 6.5 1.1 0.6 1.1 0.4 3.3 0.3 1.6 3.4 3.6 2.3 1.1 2.5 3.1 2.8 2.8 2.2 2.4 1.0 0.4 4.0 2.7 2.1 0.8 0.7 0.8 2.1 2.3 1.7 3.2 1.3 0.6 4.0 1.3 1.7 4.4 2.0 0.3 3.4 2.5 1.1 0.9 2.2 1.8 2.5 0.6 2.0 4.6 0.2 0.8 3.1 2.9 0.9 0.8 0.9 2.3 1.3 1.0 1.3 4.8 1.2 1.1 1.9 3.1 0.2 0.9 0.0 1.2 0.9 3.1 0.6 0.5 0.5 2.2 1.7 1.2 0.0 0.1 1.1 0.2 0.3 13.6 1.2 2.7 1.6 1.2 3.2 0.3 1.2 0.0 0.0 11.6 1.2 0.6 0.0 0.6 0.7 0.1 1.3 12.4 0.0 7.5 2.6 1.9 7.8 2.1 0.0 6.0 5.9 4.0 0.7 1.7 2.8 8.5 1.6 4.7 3.8 0.2 0.0 1.1 0.8 2.3 0.0 0.3 0.0 0.7 0.4 1.3 1.5 0.9 0.8 0.4 1.8 0.0 0.2 0.0 0.1 0.1 3.7 0.2 0.4 1.1 1.1 0.3 1.6 1.0 0.4 0.7 0.8 0.6 0.9 0.6 0.9 2.0 0.0 2.4 25.8 5.3 2.2 5.7 2.8 6.8 0.5 5.8 2.4 2.4 4.3 1.2 9.2 0.0 4.6 13.9 1.9 3.9 2.6 1.2 8.8 2.6 2.0 0.0 0.4 47.7 0.7 3.6 3.0 2.6 5.8 0.0 4.6 3.6 2.5 1.9 0.0 11.8 2.7 4.1 2.9 0.5 0.5 1.2 1.5 0.0 20.6 1.0 15.6 0.0 17.1 26.0 1.2 2.1 0.4 2.2 3.7 2.3 0.6 12.9 0.5 0.0 1.7 1.7 0.3 1.3 3.1 2.6 2.2 2.8 0.4 2.0 5.2 HID1 "C17orf28, DMC1, HID-1" ENSG00000167861 "HID1 domain containing" Q8IV36 17 74950742-74973166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 111.2" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 71.4;Intestinal goblet cells: 89.5;Paneth cells: 87.8;Proximal enterocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 115.9;OE19: 99.2;SH-SY5Y: 56.7;SK-BR-3: 172.6;T-47d: 101.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031406 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Cytosol" "HPA031406: AB_2673866" "unprognostic (7.41e-2)" "unprognostic (1.96e-1)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (4.47e-3)" "unprognostic (6.79e-3)" "unprognostic (4.00e-2)" "unprognostic (1.11e-1)" "unprognostic (2.78e-1)" "unprognostic (3.90e-1)" "unprognostic (1.54e-3)" "unprognostic (1.37e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.17e-1)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic favorable (1.34e-4)" 13.2 5.8 21.7 6.6 26.9 2.0 23.2 41.5 33.3 19.9 2.8 17.9 39.1 11.9 29.1 5.5 19.0 21.6 12.4 22.0 24.3 12.3 4.4 20.4 5.3 27.4 22.7 3.0 111.2 14.4 44.0 20.1 30.3 36.2 17.9 8.7 86.2 20.2 4.6 7.6 27.3 6.3 10.4 16.7 68.7 6.8 25.4 2.8 16.8 5.7 6.3 12.3 7.6 39.1 5.2 11.4 1.3 15.8 0.0 0.0 2.7 0.0 0.6 1.1 1.0 10.6 5.8 0.0 1.0 0.0 1.4 4.9 14.5 1.0 0.8 0.0 11.4 0.1 0.3 10.1 2.7 0.0 1.1 0.2 6.0 0.1 2.4 0.3 26.0 3.8 0.7 4.0 0.0 115.9 0.7 0.2 0.4 99.2 7.1 0.2 0.0 21.8 14.5 44.8 21.1 56.7 0.0 172.6 0.0 3.6 101.2 0.0 0.5 0.1 1.4 0.4 0.0 2.0 0.3 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.9 0.7 0.0 0.1 1.0 1.1 0.0 0.0 0.0 2.6 0.0 0.4 21.7 26.9 41.5 33.3 22.0 24.3 27.4 22.7 30.3 10.4 25.4 39.1 21.4 0.0 5.5 4.9 4.6 1.5 2.6 3.1 0.6 14.3 20.4 12.3 3.8 4.3 8.6 0.0 0.0 26.3 1.1 16.0 3.9 19.0 0.4 10.2 3.0 19.1 35.3 0.0 16.1 26.9 1.7 1.0 71.4 20.3 0.0 1.1 20.7 0.4 2.5 20.2 15.5 89.5 16.2 0.8 0.4 1.0 0.9 0.7 7.2 6.5 0.6 2.8 0.0 8.0 50.9 22.9 87.8 0.0 22.7 17.8 107.4 0.5 6.5 4.4 0.0 1.5 1.8 0.4 2.1 0.5 0.4 35.0 1.8 0.1 15.6 13.9 HLA-A ENSG00000206503 "Major histocompatibility complex, class I, A" P04439 6 29941260-29945884 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 3747.8;Proximal enterocytes: 5267.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 1363.9;fHDF/TERT166: 360.3;HBEC3-KT: 366.7;RPMI-8226: 372.1;U-266/70: 344.6" CAB078470 Supported "Golgi apparatus,Plasma membrane" NA NA 170000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Golgi apparatus" "CAB078470: AB_10985125" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (1.34e-2)" "prognostic favorable (9.59e-4)" "unprognostic (3.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "unprognostic (7.28e-2)" "unprognostic (3.42e-2)" "prognostic favorable (6.47e-4)" "unprognostic (2.96e-1)" "unprognostic (3.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.54e-2)" 635.4 714.2 15.0 34.8 15.5 137.7 566.7 14.7 36.5 504.9 18.0 737.5 278.3 476.1 181.1 366.8 390.3 239.9 473.4 14.6 17.0 687.0 392.0 1007.3 132.0 19.1 15.8 338.8 200.0 18.5 406.5 52.1 16.5 370.9 94.6 9.9 364.1 1.2 246.5 673.3 959.1 14.5 16.8 1413.1 442.2 132.6 18.0 138.9 531.9 14.5 178.3 412.3 466.8 18.3 1363.9 35.0 0.0 0.0 205.9 193.7 1.4 1.4 2.5 2.1 2.3 0.2 0.1 4.0 0.6 360.3 179.1 31.2 0.2 366.7 0.5 3.1 13.5 237.5 9.5 7.4 11.2 0.5 14.4 2.0 0.0 2.5 1.1 0.6 0.2 177.8 0.4 1.4 0.5 0.0 1.1 24.3 2.9 0.2 4.1 27.5 2.5 372.1 246.7 276.5 0.6 12.4 29.3 0.2 11.8 82.8 1.6 30.4 5.8 18.7 0.8 5.8 4.0 344.6 92.6 77.7 0.4 199.9 0.2 321.6 119.0 182.7 164.7 95.5 134.8 96.9 125.4 146.3 18.6 64.3 86.5 119.2 248.7 133.1 109.6 54.6 222.2 191.9 15.0 15.5 14.7 36.5 14.6 17.0 19.1 15.8 16.5 16.8 18.0 18.3 1622.4 371.8 478.6 22.9 1316.2 856.4 886.2 1417.5 228.8 30.8 289.6 188.5 147.4 936.5 952.5 503.9 6.2 18.3 1879.4 2631.8 88.0 3747.8 52.2 239.4 374.0 1717.8 955.2 499.4 3.6 1310.0 18.5 743.5 853.7 556.2 603.0 253.3 1266.2 276.4 1840.9 37.0 19.3 1755.3 1265.4 1575.0 1124.0 95.6 704.6 1419.1 635.0 67.5 3258.0 170.4 3201.9 49.3 16.1 1802.9 2452.4 484.1 1110.7 1026.6 5267.3 294.9 609.6 24.4 558.8 397.3 579.2 197.4 23.8 216.5 947.7 31.7 2234.9 1021.3 1225.4 1262.8 HLA-DQB1 "CELIAC1, HLA-DQB, IDDM1" ENSG00000179344 "Major histocompatibility complex, class II, DQ beta 1" 6 32659467-32668383 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 179.1;lymphoid tissue: 301.8" "Cell type enhanced" "Detected in many" "B-cells: 995.1;Langerhans cells: 4144.8;Macrophages: 1090.5;monocytes: 1038.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 153.5;intermediate monocyte: 142.9;memory B-cell: 159.2;myeloid DC: 386.3;naive B-cell: 169.1;plasmacytoid DC: 116.5" "Group enriched" "Detected in all" 6 "B-cells: 169.1;dendritic cells: 386.3;monocytes: 153.5" "Cell line enriched" "Detected in some" 6 "HDLM-2: 599.9" HPA013667 Enhanced Supported "Golgi apparatus,Rods & Rings" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 16: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" "Rods & Rings" "Golgi apparatus" "HPA013667: AB_1853932" "unprognostic (8.60e-3)" "unprognostic (1.91e-2)" "unprognostic (5.91e-2)" "unprognostic (9.85e-3)" "unprognostic (4.48e-1)" "unprognostic (5.30e-2)" "unprognostic (4.75e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-2)" "unprognostic (1.48e-1)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.34e-2)" "unprognostic (3.13e-1)" "unprognostic (4.16e-1)" "unprognostic (2.43e-1)" "unprognostic (1.40e-1)" 56.6 23.9 2.2 77.8 2.2 40.0 45.3 2.7 3.1 19.9 3.0 45.8 0.2 18.9 126.9 21.3 22.2 43.6 21.6 2.0 3.6 34.3 37.1 179.1 301.8 4.7 3.8 7.4 14.3 10.6 21.3 10.1 2.9 17.1 39.0 1.7 24.2 11.9 9.6 31.8 78.0 11.2 4.6 139.3 128.0 7.0 3.1 108.2 26.3 0.0 122.3 89.9 16.9 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 93.9 2.2 0.0 0.0 19.2 0.0 19.2 0.0 599.9 13.4 0.0 0.0 0.0 0.0 0.2 7.8 0.0 3.0 0.0 0.0 0.0 0.0 2.9 0.0 1.8 0.0 7.2 0.1 0.9 0.1 0.0 0.0 0.0 0.1 0.2 0.0 1.3 0.0 0.1 1.6 1.1 1.4 0.0 3.3 10.9 0.2 0.0 0.6 0.8 0.4 68.7 2.1 66.0 47.1 0.1 0.0 0.3 153.5 27.9 12.8 142.9 6.6 159.2 6.9 20.0 386.3 169.1 0.4 6.3 11.8 10.4 41.1 116.5 41.1 217.0 2.2 2.2 2.7 3.1 2.0 3.6 4.7 3.8 2.9 4.6 3.1 5.5 162.9 41.7 181.1 0.0 995.1 89.9 8.7 23.1 31.3 5.1 16.8 32.1 3.2 27.1 40.7 18.4 10.4 1.4 188.2 10.3 7.9 38.8 16.5 4.1 1.0 135.3 22.8 37.2 0.2 20.0 3.0 18.8 41.8 5.2 38.5 7.9 25.0 2.3 422.1 0.0 0.8 24.7 12.2 487.3 4144.8 7.5 6.5 1090.5 97.8 8.4 1038.0 1.1 25.7 0.0 0.1 28.3 27.4 9.8 86.9 8.7 417.9 18.5 53.0 2.7 6.6 4.8 9.6 2.7 2.5 18.5 66.3 3.0 84.5 0.9 36.1 49.1 HMCN1 "ARMD1, FBLN6, FIBL-6, FIBL6" ENSG00000143341 "Hemicentin 1" Q96RW7 1 185734391-186190949 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell cycle, Cell division, Sensory transduction, Vision" "Age-related macular degeneration, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 20.3" "Cell type enhanced" "Detected in many" "Adipocytes: 33.8;Endothelial cells: 21.4;Fibroblasts: 22.2;Horizontal cells: 26.9;Microglial cells: 45.0" "Cancer enriched" "Detected in many" 6 "melanoma: 14.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 22.3;hTERT-RPE1: 20.1;MCF7: 76.5;SK-MEL-30: 50.2;WM-115: 43.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "olfactory bulb: 9.9" "HPA008220, HPA051677" Uncertain Approved "Golgi apparatus,Cytosol" "Secreted to extracellular matrix" NA NA 9200000 "Cluster 35: T-regs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Cytosol" "HPA008220: , HPA051677: AB_2681572" "unprognostic (1.90e-1)" "unprognostic (2.66e-1)" "unprognostic (8.00e-2)" "unprognostic (1.10e-1)" "unprognostic (7.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (4.36e-2)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.59e-7)" "unprognostic (1.22e-2)" "unprognostic (5.17e-3)" "unprognostic (3.52e-1)" "unprognostic (2.00e-3)" 9.7 1.4 1.3 0.6 1.2 0.0 8.4 0.9 1.1 3.7 1.3 9.0 0.9 1.9 2.5 5.4 1.8 6.5 8.4 0.8 1.1 2.5 7.8 20.3 0.4 1.5 1.9 3.9 0.9 0.9 3.2 4.8 1.5 7.5 2.8 0.6 7.7 1.4 4.8 4.1 3.1 4.3 1.4 8.4 1.7 2.6 1.7 0.8 3.2 7.0 2.4 1.8 3.8 0.9 0.2 0.1 1.6 0.0 4.7 4.7 0.0 0.5 0.9 0.3 0.5 0.0 0.1 1.9 0.2 22.3 1.6 5.0 0.1 0.2 0.1 0.2 0.0 0.5 0.0 0.0 0.3 0.0 0.0 4.7 0.0 5.6 0.4 20.1 2.8 0.0 0.2 0.0 0.0 76.5 0.0 0.0 3.3 0.1 0.1 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.0 50.2 4.5 0.1 0.0 0.0 13.7 1.3 0.0 5.1 0.2 0.0 0.3 2.7 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.3 1.2 0.9 1.1 0.8 1.1 1.5 1.9 1.5 1.4 1.7 0.9 33.8 3.2 7.0 0.3 0.0 3.2 0.2 4.9 2.2 1.7 1.2 1.8 2.8 0.0 0.8 0.0 0.0 0.1 0.2 0.3 0.0 0.0 8.3 0.6 1.5 21.4 0.0 0.0 1.1 0.0 0.8 22.2 0.0 0.9 0.0 5.2 7.9 1.9 0.1 26.9 3.8 0.0 0.0 0.3 2.8 2.7 3.7 0.4 5.4 45.0 0.0 0.1 0.0 3.0 1.5 0.0 0.0 2.2 1.2 0.1 0.0 0.2 1.0 0.0 0.0 2.5 7.7 0.5 0.1 0.4 1.7 0.0 0.4 0.1 0.0 0.2 HMOX1 "bK286B10, HO-1" ENSG00000100292 "Heme oxygenase 1" P09601 22 35380361-35394214 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 612.2" "Cell type enhanced" "Detected in many" "Endothelial cells: 327.1;Extravillous trophoblasts: 285.2;Hofbauer cells: 494.9;Kupffer cells: 954.1;Macrophages: 271.5;Syncytiotrophoblasts: 502.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 98.8;intermediate monocyte: 238.8;non-classical monocyte: 329.2" "Lineage enriched" "Detected in all" 7 "monocytes: 329.2" "Cell line enhanced" "Detected in many" "BEWO: 869.1;GAMG: 631.2;U-138 MG: 506.2;U-87 MG: 489.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000635, CAB017444" Enhanced Uncertain "Golgi apparatus,Plasma membrane" NA NA 170000 "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Plasma membrane" "CAB017444: AB_10617276, HPA000635: AB_1079089" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.57e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.56e-2)" "unprognostic (1.71e-1)" "unprognostic (4.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.95e-3)" "unprognostic (1.91e-1)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" 150.2 48.9 40.9 64.6 48.8 99.3 20.6 42.4 66.3 28.2 46.4 35.2 106.0 10.4 7.6 48.4 40.7 52.6 18.2 40.6 46.6 96.2 136.5 113.6 57.2 52.3 46.5 139.0 41.7 7.4 9.6 72.2 56.3 6.7 31.1 1.7 15.1 4.0 107.1 74.1 64.5 38.7 45.9 612.2 19.9 17.8 60.7 25.1 11.3 21.4 49.4 46.2 29.2 56.2 12.2 179.1 1.8 37.7 170.9 49.6 869.1 83.2 57.6 42.9 48.6 82.1 11.3 0.1 18.3 83.3 631.2 10.1 11.4 1.9 16.1 308.6 9.2 4.3 51.5 179.3 218.9 11.5 54.8 146.3 4.2 282.3 19.7 74.6 130.9 0.5 0.0 87.4 152.5 6.9 0.2 4.3 18.1 130.4 20.7 1.2 15.6 28.4 35.2 104.5 2.7 2.4 215.8 19.1 15.5 92.5 8.9 3.0 44.3 506.2 22.1 82.5 82.5 53.5 77.0 9.3 489.4 5.7 8.6 11.3 98.8 7.7 1.1 238.8 0.4 24.8 0.7 1.7 44.6 2.9 0.1 0.5 47.1 5.3 329.2 1.1 1.8 70.9 40.9 48.8 42.4 66.3 40.6 46.6 52.3 46.5 56.3 45.9 60.7 56.2 19.3 3.2 19.0 0.0 11.5 16.4 27.5 11.0 10.8 0.0 25.0 9.1 2.9 24.3 10.5 5.5 0.0 50.5 3.5 59.1 21.5 13.6 2.1 39.6 12.9 327.1 16.0 5.7 0.2 1.5 285.2 64.1 9.2 74.6 11.4 98.4 23.6 23.6 494.9 0.0 0.4 8.3 18.3 954.1 175.8 4.1 31.1 271.5 35.6 1.9 184.7 0.4 9.2 0.5 1.4 8.3 26.1 5.3 2.5 110.6 61.5 157.9 7.1 0.6 0.0 40.8 52.7 0.9 4.4 5.5 15.6 502.0 6.8 6.9 6.1 118.3 HOOK3 HK3 ENSG00000168172 "Hook microtubule tethering protein 3" Q86VS8 8 42896946-43030535 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024756 Approved Supported "Golgi apparatus,Centriolar satellite,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" "Centriolar satellite" "Golgi apparatus, Cytosol" "HPA024756: AB_1850913" "unprognostic (1.84e-2)" "unprognostic (1.61e-1)" "unprognostic (2.73e-1)" "unprognostic (8.61e-3)" "unprognostic (6.05e-2)" "unprognostic (1.77e-3)" "unprognostic (2.36e-1)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.13e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.63e-1)" "unprognostic (3.78e-1)" "unprognostic (2.55e-1)" "unprognostic (7.12e-2)" 9.8 6.2 3.1 7.4 8.7 11.1 8.9 11.9 8.9 8.2 1.5 7.5 7.5 8.3 8.2 10.6 7.0 14.4 4.6 4.0 11.1 6.6 7.3 8.0 6.6 7.6 4.9 6.1 7.6 7.2 4.1 8.6 7.3 12.4 7.7 8.8 9.6 7.1 10.6 8.1 8.9 6.7 4.4 6.6 9.5 11.4 4.9 6.4 21.7 8.2 7.4 9.3 6.0 15.5 11.2 10.9 26.2 14.2 19.0 16.7 10.1 14.0 11.6 11.5 10.7 14.5 12.8 13.9 13.9 18.8 10.9 6.4 22.1 9.5 18.5 9.5 6.4 26.3 9.2 10.2 10.6 2.8 14.9 13.7 6.6 15.4 13.2 15.9 16.7 9.7 14.7 15.9 14.0 2.7 21.7 5.2 9.5 8.8 3.3 12.6 27.3 3.5 8.6 16.5 6.7 10.6 15.9 6.7 7.4 11.4 12.2 9.4 30.2 17.1 13.2 20.9 9.0 15.6 18.6 18.1 14.5 9.9 25.8 9.4 2.0 2.0 1.2 2.0 0.4 0.9 1.1 0.9 2.4 0.9 0.6 0.8 2.2 1.2 1.9 1.4 0.8 1.1 3.1 8.7 11.9 8.9 4.0 11.1 7.6 4.9 7.3 4.4 4.9 15.5 75.3 93.0 60.6 90.1 43.2 68.3 36.2 28.7 43.3 40.1 29.4 22.4 48.2 44.3 43.6 25.8 33.3 43.6 40.6 26.1 27.4 47.1 120.3 60.0 84.0 65.2 65.4 34.5 102.1 32.8 25.9 65.8 33.1 93.8 53.8 37.9 60.3 36.4 38.0 75.7 107.6 26.9 20.3 79.4 96.4 36.3 44.7 82.8 55.2 78.7 118.6 36.3 37.0 119.1 157.8 59.7 27.6 53.8 43.6 43.5 37.3 21.4 35.2 32.2 65.7 63.4 74.6 28.0 21.5 39.8 74.7 113.7 40.9 42.6 16.2 71.1 HOXB6 "HOX2, HOX2B" ENSG00000108511 "Homeobox B6" P17509 17 48595751-48604992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 40.3;kidney: 60.2" "Group enriched" "Detected in many" 4 "Collecting duct cells: 136.1;Distal tubular cells: 113.5;Endometrial ciliated cells: 80.7;Glandular and luminal cells: 56.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 32.7" "Group enriched" "Detected in some" 17 "medulla oblongata: 12.9;spinal cord: 22.6;white matter: 6.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 28.2;HEK 293: 80.3;RPTEC TERT1: 53.2;TIME: 30.1" "Region enriched" "Detected in single" 102 "pons and medulla: 10.1" "Group enriched" "Detected in some" 168 "medulla oblongata: 8.1;spinal cord: 25.4" HPA042063 Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Golgi apparatus" "HPA042063: AB_10796470" "unprognostic (5.01e-2)" "unprognostic (4.48e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.80e-3)" "unprognostic (5.64e-2)" "unprognostic (2.06e-3)" "unprognostic (3.97e-2)" "unprognostic (1.84e-2)" "unprognostic (6.97e-2)" "unprognostic (6.64e-2)" "unprognostic (2.50e-3)" "unprognostic (2.53e-3)" "unprognostic (5.76e-2)" "unprognostic (7.11e-2)" "unprognostic (4.19e-3)" 10.2 7.4 0.2 4.4 0.1 0.2 4.6 0.3 0.2 18.3 0.0 16.1 1.0 4.3 40.3 0.3 13.4 0.3 0.7 0.1 0.0 60.2 0.8 6.2 0.4 12.9 0.0 0.3 1.2 1.3 0.1 2.6 0.8 2.0 6.1 0.0 0.2 21.1 1.7 1.2 14.0 2.3 22.6 3.0 9.3 1.1 0.1 0.0 0.7 0.5 0.0 3.8 2.2 6.3 5.2 11.9 0.0 6.2 5.3 5.5 0.1 0.0 0.0 0.0 0.0 6.5 7.7 0.0 28.2 14.2 2.0 0.1 1.4 0.4 0.0 0.2 80.3 7.1 23.8 0.0 7.9 0.6 18.0 6.9 0.2 11.4 0.2 4.3 5.4 0.5 4.7 0.1 15.7 0.3 0.0 0.3 0.0 20.0 4.7 0.0 13.1 0.7 53.2 2.6 0.0 0.0 4.4 0.0 8.2 0.1 2.1 2.5 30.1 1.0 6.0 5.0 22.2 0.0 0.0 0.1 0.9 0.0 9.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.0 12.9 0.0 0.8 22.6 0.1 6.3 10.6 0.0 0.0 0.0 0.4 0.8 0.5 0.0 0.0 0.0 0.4 0.5 0.4 0.0 0.0 136.1 0.0 0.2 0.0 18.1 113.5 0.1 1.0 80.7 5.5 10.6 7.7 0.4 0.0 2.0 2.9 3.0 0.0 56.4 0.0 0.0 4.2 0.0 1.7 0.0 0.0 9.0 0.0 18.6 3.1 0.3 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 20.8 0.0 0.0 0.6 9.5 2.8 0.0 0.0 0.0 0.9 6.4 4.8 6.2 0.0 1.1 0.3 1.2 0.0 11.0 1.2 HPS3 "BLOC2S1, SUTAL" ENSG00000163755 "HPS3 biogenesis of lysosomal organelles complex 2 subunit 1" Q969F9 3 149129638-149173732 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 115.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046281, HPA052778" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus, Plasma membrane" "HPA046281: AB_10961641, HPA052778: AB_2681943" "unprognostic (1.47e-2)" "unprognostic (7.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.82e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (3.06e-2)" 7.6 9.2 4.2 11.4 4.7 5.6 7.9 4.8 4.2 7.5 8.3 7.5 11.0 9.9 4.9 5.6 8.6 9.0 5.0 3.7 6.0 12.0 8.0 9.7 17.6 6.7 5.6 14.0 6.7 5.7 3.7 10.6 6.8 9.3 9.1 9.6 6.6 8.5 2.8 4.7 10.8 10.3 5.6 16.0 9.2 6.9 5.2 16.8 8.8 3.9 16.4 8.4 5.2 8.5 49.1 26.5 15.7 16.3 21.4 27.4 11.7 19.7 38.4 25.3 32.4 9.1 31.8 12.4 23.8 23.7 115.3 16.5 17.4 13.4 32.4 30.6 13.9 5.8 11.8 9.9 19.1 15.7 9.1 18.0 13.5 24.4 10.0 51.6 26.2 20.2 6.5 29.4 32.5 30.3 11.3 22.1 37.7 26.3 21.1 13.4 10.3 33.7 13.9 24.1 4.7 12.4 16.8 17.7 35.9 33.4 19.2 20.5 13.2 25.2 4.5 26.0 29.0 24.0 10.0 30.6 37.7 30.1 6.3 20.7 12.5 12.1 12.0 15.2 14.5 15.4 10.9 12.9 19.5 12.2 8.4 10.9 5.7 9.8 10.3 11.0 10.7 10.9 4.2 4.7 4.8 4.2 3.7 6.0 6.7 5.6 6.8 5.6 5.2 8.5 9.9 12.8 19.5 17.6 28.6 3.7 3.9 11.5 6.8 6.7 9.1 7.4 2.5 5.7 22.9 7.3 2.1 21.0 24.3 8.0 5.9 10.7 3.0 10.6 11.6 9.9 9.0 7.4 13.3 18.1 14.6 10.8 16.8 10.4 15.2 18.0 17.5 6.9 19.8 3.3 16.5 8.8 14.2 29.3 23.8 4.8 11.5 33.1 14.2 38.4 14.4 25.1 19.6 19.1 27.3 12.9 4.9 30.1 15.4 6.8 13.6 22.8 20.7 5.2 0.0 7.4 8.4 4.4 8.4 8.7 5.3 14.1 18.9 5.4 7.5 5.1 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.5;kidney: 13.9;ovary: 14.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 35.7;Excitatory neurons: 37.5;Inhibitory neurons: 44.2;Leydig cells: 62.7;Oligodendrocyte precursor cells: 54.3;Peritubular cells: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 46.2;HeLa: 28.1;RH-30: 66.1;RT4: 33.7;SH-SY5Y: 82.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034625 Uncertain Approved "Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA034625: AB_10612119" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.2 2.4 12.4 0.6 10.0 0.0 2.0 1.2 7.4 1.0 0.0 0.6 0.1 3.5 2.4 3.9 1.8 0.3 0.2 9.6 10.7 13.9 0.0 0.7 0.1 6.3 22.5 14.1 5.3 0.3 1.1 8.4 7.3 2.8 0.8 1.5 0.9 0.8 6.2 0.2 0.1 1.5 4.9 0.0 0.9 2.9 20.3 0.6 0.4 0.9 0.5 2.5 0.7 2.6 10.7 0.1 14.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 17.0 0.0 0.0 15.2 0.0 0.0 0.5 21.7 0.1 0.0 0.0 46.2 0.1 28.1 0.0 0.0 0.0 0.0 0.7 20.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 7.8 0.3 0.1 11.8 7.2 0.6 0.0 66.1 0.0 13.3 33.7 1.8 82.0 14.8 0.0 0.1 23.7 0.0 0.1 0.0 0.0 2.6 9.6 23.8 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.4 10.0 1.2 7.4 9.6 10.7 6.3 22.5 7.3 4.9 20.3 2.6 0.0 0.0 0.0 1.6 0.0 0.3 0.2 1.8 6.8 0.2 4.3 2.4 0.8 0.0 5.5 3.7 0.0 35.7 0.2 0.3 5.9 0.0 0.5 0.3 0.6 0.5 0.0 0.0 37.5 2.0 2.6 2.6 0.0 0.1 0.0 0.1 0.0 0.0 3.4 0.0 44.2 0.2 2.0 0.0 0.0 1.1 62.7 0.2 0.0 10.3 0.0 5.3 0.0 54.3 1.4 0.8 0.2 35.3 0.0 1.3 0.0 0.1 9.8 0.4 0.0 17.9 0.3 0.3 1.1 11.1 0.3 17.4 0.1 0.3 0.2 1.8 HSD17B13 "SCDR9, SDR16C3" ENSG00000170509 "Hydroxysteroid 17-beta dehydrogenase 13" Q7Z5P4 4 87303789-87322886 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "liver: 573.7" "Cell type enhanced" "Detected in many" "Adipocytes: 100.0;Club cells: 42.9;Hepatocytes: 131.3;Respiratory ciliated cells: 34.0;Urothelial cells: 57.0" "Cancer enriched" "Detected in some" 26 "liver cancer: 52.9" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "NB-4: 1.4" "Not detected" "Not detected" HPA029125 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Golgi apparatus" "HPA029125: AB_10601580" "unprognostic (2.49e-1)" "unprognostic (7.46e-2)" "unprognostic (7.02e-2)" "unprognostic (1.86e-4)" "unprognostic (4.74e-2)" "unprognostic (8.44e-2)" "prognostic favorable (2.94e-4)" "prognostic favorable (7.80e-4)" "unprognostic (4.97e-1)" "unprognostic (2.22e-2)" "unprognostic (1.00e-1)" "unprognostic (2.46e-1)" "unprognostic (7.18e-4)" "unprognostic (3.62e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-3)" 9.4 0.3 0.6 0.2 0.6 1.4 6.4 2.4 1.0 2.7 0.1 0.7 0.4 2.7 0.2 0.2 1.0 0.2 0.4 0.6 0.5 0.4 573.7 3.6 0.2 0.8 0.5 0.5 1.8 0.1 0.2 0.8 0.9 4.5 0.4 0.8 0.2 0.2 0.3 6.5 0.7 4.2 0.4 0.7 0.3 0.4 0.5 0.3 0.2 0.1 0.1 1.2 7.8 0.9 0.0 0.1 0.2 0.2 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.4 0.2 0.7 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.1 0.0 0.1 1.4 0.1 0.4 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.2 1.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.2 0.1 0.6 0.1 0.0 0.1 0.1 0.0 0.6 0.6 2.4 1.0 0.6 0.5 0.8 0.5 0.9 0.4 0.5 0.9 100.0 3.2 6.4 1.6 0.0 2.5 22.6 0.3 0.0 0.2 0.2 0.3 0.3 4.3 42.9 1.8 0.0 0.1 0.4 1.0 0.0 0.1 2.7 0.4 0.5 2.4 1.8 5.3 3.7 0.4 0.3 0.8 0.0 0.1 0.0 0.2 1.8 131.3 0.2 0.0 3.0 0.5 0.0 2.4 0.4 2.7 0.0 0.7 0.0 0.0 0.3 0.3 0.0 1.5 2.8 0.1 1.4 0.4 0.1 4.7 0.2 0.5 34.0 0.1 0.0 0.7 0.4 0.0 0.9 0.2 0.4 0.0 0.7 0.2 0.7 57.0 HSPA12A "FLJ13874, KIAA0417" ENSG00000165868 "Heat shock protein family A (Hsp70) member 12A" O43301 10 116671192-116850251 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 205.0;Inhibitory neurons: 186.4;Leydig cells: 63.3;Peritubular cells: 68.4;Theca cells: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 1.3;naive B-cell: 1.7;T-reg: 1.0" "Group enriched" "Detected in many" 14 "B-cells: 1.7;T-cells: 1.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011273, HPA073244" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Cytosol" "HPA011273: AB_1851190, HPA073244: AB_2686586" "unprognostic (7.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-2)" "unprognostic (1.44e-1)" "unprognostic (7.31e-3)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (3.75e-1)" "unprognostic (5.55e-4)" 15.8 21.9 10.9 1.5 13.5 0.0 8.8 11.2 28.2 13.7 7.9 12.4 0.7 9.2 12.5 3.9 10.3 2.3 9.6 16.6 11.1 17.4 1.6 3.0 2.7 17.3 12.2 20.5 2.7 20.0 7.9 0.8 16.4 5.6 1.9 11.0 2.6 5.5 4.9 5.7 4.1 4.6 2.7 3.8 4.7 6.2 27.3 2.1 9.4 3.4 2.8 7.9 10.0 14.7 8.0 10.0 0.1 7.1 6.6 4.4 0.1 5.5 10.1 1.9 1.0 10.0 2.8 0.0 4.1 7.6 5.2 6.1 8.4 0.7 4.9 0.0 3.2 0.0 0.8 5.5 1.9 0.0 1.0 1.7 6.6 7.3 0.9 13.9 0.0 3.3 0.0 0.0 2.1 4.0 0.0 0.0 1.2 0.0 0.1 0.0 1.0 1.2 22.1 1.8 5.3 12.7 4.0 2.9 3.0 2.4 3.2 0.0 0.0 1.4 5.5 12.3 10.2 0.1 3.2 0.0 3.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 10.9 13.5 11.2 28.2 16.6 11.1 17.3 12.2 16.4 2.7 27.3 14.7 2.1 6.4 3.6 27.7 1.0 11.1 1.6 0.5 2.8 35.8 5.2 6.9 7.8 2.8 2.0 12.9 22.9 0.1 0.1 1.6 15.6 4.2 4.4 12.5 16.1 3.1 0.0 0.0 205.0 3.5 0.1 17.8 0.0 4.4 0.0 2.4 2.9 0.4 0.1 30.3 186.4 0.3 0.0 0.0 5.2 9.7 63.3 0.5 26.6 9.4 0.0 35.8 0.0 27.6 54.8 2.4 0.0 68.4 0.1 2.1 0.0 25.4 11.3 10.2 13.1 14.7 14.9 1.0 5.2 0.5 5.1 0.3 0.8 82.0 0.3 0.7 HSPB6 "FLJ32389, Hsp20, PPP1R91" ENSG00000004776 "Heat shock protein family B (small) member 6" O14558 19 35754566-35758079 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 2969.8;tongue: 1759.1" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0" "Cancer enhanced" "Detected in all" "stomach cancer: 93.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001974, HPA044153, HPA054811" Enhanced Supported "Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 310000 "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "Nucleoli, Golgi apparatus" "CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610" "unprognostic (3.19e-2)" "unprognostic (8.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.21e-3)" "unprognostic (7.02e-2)" "unprognostic (9.67e-2)" "unprognostic (7.57e-2)" "unprognostic (1.18e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.32e-2)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.43e-6)" 650.0 414.0 37.3 45.4 40.6 0.4 394.9 32.5 49.2 581.9 26.1 699.9 28.1 565.1 101.6 112.3 495.1 97.9 1463.9 30.0 43.6 69.0 42.3 126.6 5.7 76.7 48.5 455.2 50.5 4.2 17.5 40.2 73.7 271.2 44.0 21.1 115.9 194.7 2969.8 39.1 180.0 278.2 50.8 15.7 362.1 60.6 53.8 6.2 99.5 1759.1 2.7 537.3 290.6 49.3 0.6 0.7 2.1 2.5 1774.3 742.0 1.2 83.0 1.3 4.9 9.3 1.1 0.4 0.7 0.6 252.4 0.0 0.2 0.4 0.7 3.9 0.9 0.5 0.4 1.3 0.5 599.9 0.2 0.9 700.3 0.0 19.1 0.9 2.2 5.4 0.3 0.5 1.0 0.2 0.3 0.4 1.9 1.2 2.3 0.6 1.5 0.5 0.7 0.0 0.1 0.8 0.7 0.1 0.2 0.7 0.3 0.3 0.5 0.1 153.2 0.9 17.3 0.6 1.0 2.8 0.3 20.5 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 40.6 32.5 49.2 30.0 43.6 76.7 48.5 73.7 50.8 53.8 49.3 11.1 3.2 0.6 1.6 0.1 1.8 0.4 0.0 3.4 7.8 0.5 0.5 29.7 0.0 0.0 0.0 0.0 2.5 0.1 0.1 0.0 0.1 27.0 4.9 165.7 3.6 0.0 5.2 0.2 0.0 2.5 125.2 4.1 3.5 0.0 3.6 17.5 0.3 5.0 0.0 0.5 0.0 0.0 0.3 3.6 18.9 271.8 2.7 1.8 0.0 0.6 44.5 0.0 0.0 0.1 0.2 0.0 220.4 0.1 0.4 0.0 0.4 0.0 2.8 26.3 38.0 102.6 2.3 1.4 1.9 2.0 4.8 1.8 311.0 0.0 0.5 HYI HT036 ENSG00000178922 "Hydroxypyruvate isomerase (putative)" Q5T013 1 43450989-43453989 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 232.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 29.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 97.7;HUVEC TERT2: 106.7;U-251 MG: 99.2;WM-115: 105.5" "Low region specificity" "Detected in all" HPA040092 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 22: Non-specific - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane, Cytosol" "Golgi apparatus" "HPA040092: AB_10795374" "prognostic favorable (9.18e-4)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.68e-2)" "unprognostic (3.86e-1)" "unprognostic (4.40e-2)" "prognostic unfavorable (5.55e-4)" "unprognostic (2.75e-2)" "unprognostic (1.42e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (2.75e-5)" "unprognostic (5.10e-2)" "unprognostic (7.93e-2)" "unprognostic (3.58e-2)" "prognostic favorable (2.72e-5)" 31.7 22.8 28.1 9.3 29.2 12.1 19.3 29.6 36.3 23.4 27.9 21.3 44.1 23.3 15.4 15.0 24.2 18.7 20.8 27.0 31.2 29.5 44.6 23.0 11.3 30.9 28.9 42.1 53.7 25.2 14.6 10.5 30.9 19.8 12.3 4.1 35.3 47.0 20.8 16.2 34.4 13.2 30.0 12.2 23.9 3.9 28.4 8.8 19.1 10.2 9.2 17.4 15.3 32.4 58.7 7.3 2.2 3.5 9.8 15.1 0.2 48.4 35.7 52.6 34.3 24.2 97.7 0.0 4.1 29.7 25.1 10.9 0.0 45.8 21.6 15.2 20.5 10.2 25.0 0.0 58.8 0.0 0.0 9.4 12.4 64.0 0.0 56.3 106.7 0.5 1.2 0.0 34.5 1.2 9.6 8.8 11.1 5.6 15.5 46.0 0.0 0.3 37.5 2.2 27.2 20.3 56.0 30.4 13.2 8.7 9.2 72.0 59.5 3.7 0.0 12.4 99.2 0.0 0.0 0.0 4.1 13.4 105.5 10.6 1.7 3.7 4.2 1.3 5.5 4.3 7.1 3.3 5.8 5.3 6.6 2.0 0.1 7.5 1.8 29.9 0.7 4.0 28.1 29.2 29.6 36.3 27.0 31.2 30.9 28.9 30.9 30.0 28.4 32.4 29.8 19.2 64.4 5.9 16.1 28.0 45.2 22.8 51.8 16.9 41.0 65.3 0.4 65.8 23.0 57.0 10.4 18.6 19.2 56.6 45.0 106.7 1.2 9.9 23.6 23.2 69.5 21.5 1.4 86.1 115.9 45.7 25.5 18.7 43.2 33.5 25.0 59.0 29.8 8.4 1.9 89.1 16.2 8.5 31.0 4.5 31.7 23.5 40.9 1.9 15.8 45.0 8.2 4.5 4.8 109.6 97.0 30.5 41.7 33.7 232.5 146.9 12.4 16.7 26.3 31.3 58.2 1.4 3.0 27.3 22.0 12.0 12.3 49.8 47.6 38.4 IFITM1 "9-27, CD225, DSPA2a, IFI17" ENSG00000185885 "Interferon induced transmembrane protein 1" P13164 11 310041-315272 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, Osteogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8" "Group enriched" "Detected in all" 7 "granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9" "HPA004810, CAB017615" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 58: T-cells - T-cell receptor" "Golgi apparatus" "Plasma membrane, Cytosol" "CAB017615: AB_2264496, HPA004810: AB_1851419" "unprognostic (1.03e-3)" "unprognostic (6.79e-2)" "unprognostic (1.03e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-1)" "unprognostic (9.06e-2)" "unprognostic (7.58e-2)" "unprognostic (3.03e-1)" "unprognostic (6.21e-2)" "unprognostic (5.53e-2)" "unprognostic (6.64e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (5.77e-9)" "unprognostic (7.29e-2)" "unprognostic (6.29e-2)" "unprognostic (3.15e-2)" "unprognostic (3.82e-2)" 477.7 102.3 291.8 282.0 303.4 367.1 401.7 293.8 402.1 563.3 321.5 249.0 128.4 314.6 1152.4 147.4 537.4 247.9 368.4 292.6 305.4 317.5 191.4 246.5 417.2 324.8 295.6 607.5 78.8 154.0 145.1 278.5 322.5 190.6 172.0 14.9 199.8 324.3 134.2 164.6 252.4 367.4 308.6 679.7 141.6 56.3 317.5 296.5 263.4 259.3 295.9 307.4 364.7 304.3 125.7 5.5 1011.4 74.5 79.1 279.8 7.4 250.1 1038.8 2266.3 4016.8 3.7 782.2 3.0 157.9 257.1 23.5 269.0 36.5 26.2 52.0 255.3 51.8 125.9 77.5 11.8 668.2 182.8 1138.9 496.3 0.2 26.6 2.6 27.0 4.2 41.1 450.0 880.7 1.7 23.9 85.1 318.2 264.5 0.5 33.5 27.1 3.1 24.5 654.9 0.0 1.0 2.2 122.7 11.9 196.9 138.5 42.1 17.0 8.8 3.8 4.7 1.5 1.1 61.6 44.8 6.8 3.4 253.8 3.1 544.4 62.1 1494.7 2906.3 312.7 2003.4 364.9 3120.6 3000.3 114.2 323.6 2939.3 2996.4 2741.6 4679.9 539.0 33.7 1944.8 4673.8 291.8 303.4 293.8 402.1 292.6 305.4 324.8 295.6 322.5 308.6 317.5 304.3 240.7 35.3 119.4 2.6 88.2 27.9 17.1 70.2 673.8 0.0 13.0 12.6 8.4 2.8 115.3 33.1 0.0 3.3 258.6 13.7 5.9 1.7 1.4 14.6 96.5 364.4 1.2 27.8 0.0 1.4 30.7 236.0 33.6 20.8 18.9 5.6 164.6 24.6 11.8 0.0 0.0 17.3 10.2 10.1 26.8 3.8 300.8 45.4 78.2 42.2 2.1 0.0 126.7 0.0 0.2 0.7 15.0 124.5 141.2 2.3 15.0 1.0 26.0 0.0 276.1 16.4 213.4 0.6 1.5 50.4 14.3 4.0 595.8 2.1 29.2 5.7 IFNGR2 "AF-1, IFNGT1" ENSG00000159128 "Interferon gamma receptor 2" P38484 21 33403413-33479348 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Prostatic glandular cells: 433.1;Urothelial cells: 602.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 661.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001535 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Golgi apparatus" "HPA001535: AB_1078432" "unprognostic (9.58e-2)" "unprognostic (5.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (3.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.53e-2)" "unprognostic (3.25e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.13e-10)" "unprognostic (6.74e-3)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (2.15e-3)" 72.9 41.1 5.9 8.6 7.0 46.6 65.6 2.4 8.2 48.3 7.9 46.8 14.2 31.2 3.4 67.4 37.8 11.6 46.4 7.0 11.2 53.1 43.1 61.8 10.6 8.8 6.4 38.8 32.0 5.6 37.8 18.6 7.6 48.2 7.9 1.0 64.5 6.3 30.0 53.3 51.6 8.6 10.0 80.8 35.8 29.5 12.2 8.1 52.3 10.3 11.9 46.4 56.8 14.0 10.1 10.2 5.9 9.7 16.6 28.2 13.1 30.4 30.0 8.9 13.8 11.3 7.7 15.6 19.8 23.8 24.2 8.6 10.9 25.6 3.1 76.3 44.9 6.0 5.0 12.2 11.0 19.5 17.7 21.4 17.0 14.7 16.6 15.9 20.1 9.9 33.4 11.9 10.2 4.4 5.0 23.2 18.1 15.8 48.0 20.2 14.1 19.6 8.5 10.8 7.9 15.5 19.3 1.9 38.4 1.5 7.1 17.7 30.8 10.1 22.0 8.9 8.8 24.6 28.2 25.4 8.5 23.3 44.7 221.7 283.8 181.7 0.9 281.2 1.2 145.6 16.4 1.7 104.0 158.2 37.7 16.3 661.8 3.5 314.8 31.9 19.2 198.5 5.9 7.0 2.4 8.2 7.0 11.2 8.8 6.4 7.6 10.0 12.2 14.0 72.2 41.7 20.5 9.1 101.4 72.0 225.1 164.8 147.4 9.0 69.3 39.2 18.4 38.6 58.2 27.6 8.4 33.6 11.2 185.3 27.4 117.8 44.6 32.1 51.0 55.1 51.6 17.7 18.7 55.7 86.1 66.8 62.7 50.4 60.3 52.1 40.0 29.6 167.6 15.2 18.9 56.2 57.0 154.5 146.7 60.8 42.0 190.8 56.9 45.0 246.6 8.7 6.2 15.6 5.0 138.6 150.3 32.7 67.9 433.1 151.9 50.1 25.4 8.4 13.1 61.3 33.7 13.4 2.8 90.5 70.0 17.4 16.9 3.4 41.3 602.7 IGF2R "CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI" ENSG00000197081 "Insulin like growth factor 2 receptor" P11717 6 159969082-160113507 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 69.5" "Cell type enhanced" "Detected in many" "NK-cells: 264.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009661, HPA011332" Supported Enhanced "Golgi apparatus,Vesicles" NA NA 190000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus, Vesicles" "CAB009661: AB_2122795, HPA011332: AB_1846276" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (2.92e-5)" "unprognostic (5.83e-2)" "unprognostic (1.72e-1)" "unprognostic (4.15e-1)" "unprognostic (3.25e-1)" "unprognostic (7.32e-3)" "unprognostic (2.32e-1)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.37e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.08e-4)" 20.3 21.9 1.8 11.4 3.7 13.3 16.0 3.9 4.3 15.2 11.7 17.4 7.4 19.3 4.8 16.7 13.9 10.7 21.8 3.2 4.2 14.8 23.9 22.2 8.2 4.3 3.6 17.0 16.6 14.3 9.5 15.3 3.8 11.0 11.6 3.2 18.4 6.7 69.5 16.5 14.7 16.0 3.2 23.2 15.5 7.7 4.8 15.9 14.5 27.2 7.8 15.3 16.5 5.9 20.8 18.1 32.6 44.6 108.4 76.4 36.9 30.1 80.4 30.3 52.8 28.3 37.2 7.3 30.9 38.4 101.7 25.4 27.0 140.0 52.0 47.7 19.4 3.6 30.0 32.1 49.2 20.7 31.2 52.7 45.4 57.6 144.8 65.4 19.2 36.0 42.2 48.2 46.4 10.1 8.8 13.4 13.1 19.3 23.2 23.2 20.6 46.1 29.9 20.8 11.3 25.4 45.0 34.5 44.8 41.4 15.7 49.4 25.3 27.0 27.9 57.3 60.4 16.7 40.2 9.1 49.0 23.7 38.9 0.5 1.0 0.8 1.1 0.3 0.4 0.2 0.5 0.4 0.2 0.2 0.5 0.7 4.4 0.7 0.4 1.3 0.2 0.3 1.8 3.7 3.9 4.3 3.2 4.2 4.3 3.6 3.8 3.2 4.8 5.9 44.7 48.1 47.3 34.6 16.7 22.2 10.0 16.0 17.1 13.0 20.2 14.7 33.6 24.3 22.1 16.5 20.9 7.5 107.0 46.2 0.0 29.3 7.5 25.8 38.7 29.6 22.3 9.5 33.0 19.4 12.3 29.9 16.8 39.7 3.8 41.7 28.9 63.4 22.2 15.2 34.2 18.4 12.2 59.4 12.8 5.2 47.5 37.6 12.4 31.9 65.9 11.7 264.7 30.7 40.0 40.8 17.2 38.4 35.9 17.1 23.2 23.6 12.2 15.1 65.7 63.7 32.6 10.9 10.4 28.9 19.7 9.3 38.8 38.8 20.9 16.7 IGFBP1 "AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12" ENSG00000146678 "Insulin like growth factor binding protein 1" P08833 7 45888360-45893660 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 1198.4" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 994.8" "Cancer enriched" "Detected in many" 29 "liver cancer: 385.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004445, HPA046972, HPA050640" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 28100000 25000000 "Cluster 85: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197" "unprognostic (8.66e-3)" "unprognostic (1.45e-1)" "unprognostic (9.41e-2)" "unprognostic (7.80e-2)" "unprognostic (7.04e-2)" "unprognostic (2.93e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.89e-2)" "unprognostic (2.09e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.90e-11)" "prognostic unfavorable (6.64e-4)" "unprognostic (7.20e-2)" "unprognostic (7.98e-2)" "unprognostic (3.43e-1)" 2.6 0.1 0.2 0.0 0.2 0.0 2.4 0.2 0.3 0.3 0.1 0.0 0.3 79.6 0.1 0.0 4.1 0.3 0.5 0.2 0.3 1.6 1198.4 0.1 0.1 0.8 0.3 46.3 0.5 0.0 0.5 204.5 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.5 0.1 0.1 0.3 1.1 0.3 0.0 0.0 0.0 0.2 0.2 0.2 6.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.6 0.3 1.4 0.1 1.6 0.3 0.0 0.0 0.7 0.0 0.0 0.3 0.5 54.7 0.3 1.1 0.1 0.1 0.7 11.3 0.1 0.6 0.3 0.0 0.2 0.1 1.3 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.3 0.0 2.2 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 84.9 0.0 0.0 0.0 0.2 145.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.8 0.3 0.9 0.2 0.3 0.2 0.4 0.0 0.5 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 5.7 1.0 35.8 0.7 0.0 0.0 0.9 0.0 0.0 0.0 11.0 0.1 4.7 94.3 0.9 3.5 10.7 0.1 0.0 1.6 1.8 0.0 15.9 0.0 2.1 6.8 994.8 1.7 0.0 0.1 0.0 0.0 14.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.7 0.1 0.5 0.0 0.0 3.4 0.8 0.0 0.0 0.0 IGFBP5 ENSG00000115461 "Insulin like growth factor binding protein 5" P24593 2 216672105-216695549 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 1492.5;ovary: 1323.4" "Cell type enhanced" "Detected in many" "Fibroblasts: 1104.1;Ionocytes: 980.6;Leydig cells: 1828.2;Peritubular cells: 981.7;Sertoli cells: 1275.3;Skeletal myocytes: 2750.9;Smooth muscle cells: 1376.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 831.3;BJ hTERT+: 2192.6;T-47d: 531.7;U-138 MG: 710.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059827, HPA070407" Supported Approved "Nuclear bodies,Golgi apparatus,Vesicles" "Secreted to blood" NA NA 110000000 380000000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus, Vesicles" "Nuclear bodies" "HPA059827: AB_2732640, HPA070407: " "unprognostic (7.69e-2)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.58e-2)" "unprognostic (3.47e-1)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (1.32e-1)" "unprognostic (9.58e-2)" "unprognostic (1.12e-1)" "unprognostic (2.41e-2)" "unprognostic (4.04e-2)" "unprognostic (9.62e-3)" "unprognostic (1.55e-1)" "unprognostic (3.28e-2)" "unprognostic (1.91e-3)" 375.1 221.8 35.6 178.2 35.1 0.7 354.6 21.9 30.9 1492.5 46.9 232.3 35.0 837.7 121.3 166.4 953.0 129.3 155.0 50.4 41.8 479.1 34.2 78.2 71.3 36.3 37.9 1323.4 30.7 30.7 272.8 290.7 31.5 241.4 66.2 105.4 111.0 121.8 470.9 129.0 139.3 621.2 28.1 38.7 323.5 28.8 43.8 95.0 326.2 292.9 45.9 259.2 382.9 62.4 0.0 0.0 210.6 0.9 237.1 7.5 0.8 831.3 2192.6 108.8 10.4 0.0 1.0 0.1 3.3 2.3 0.0 0.1 26.2 0.0 5.6 0.1 8.2 218.1 4.4 0.2 103.1 0.1 1.8 33.1 0.0 14.7 0.1 24.8 0.1 0.2 0.7 0.1 0.5 70.9 0.9 1.2 2.3 0.0 3.4 0.3 0.8 1.2 70.3 249.1 14.5 8.5 14.6 100.4 0.0 12.8 531.7 0.1 80.3 710.2 42.2 109.3 41.0 0.7 0.1 0.1 1.4 0.1 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 35.1 21.9 30.9 50.4 41.8 36.3 37.9 31.5 28.1 43.8 62.4 237.3 3.2 4.4 40.1 20.6 102.5 13.5 211.0 25.0 8.7 73.9 199.9 92.0 5.7 251.6 112.2 6.2 3.9 1.7 0.0 5.9 10.3 8.4 140.2 250.7 120.8 0.0 0.0 6.0 0.0 4.5 1104.1 30.5 128.5 2.5 11.4 49.6 1.4 8.7 3.3 13.7 0.0 980.6 0.6 189.7 39.9 1828.2 18.4 101.4 29.0 0.6 674.4 0.0 5.5 0.4 2.2 0.0 981.7 5.5 17.0 0.0 1.1 120.9 18.7 1275.3 2750.9 1376.0 2.2 3.0 17.7 67.9 5.6 18.4 124.7 0.1 16.8 IGFBP7 "FSTL2, IGFBP-7, MAC25, PSF" ENSG00000163453 "Insulin like growth factor binding protein 7" Q16270 4 57030773-57110385 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 11440.4;Peritubular cells: 11731.6;Sertoli cells: 8184.6;Smooth muscle cells: 4434.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 21.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 693.6;BJ hTERT+: 643.1;hTERT-RPE1: 1471.3;RPTEC TERT1: 682.7;TIME: 1009.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002196, CAB020668" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 30300000 190000000 "Cluster 52: Eosinophils - Transcription" "Cluster 7: Kidney - Transmembrane transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "CAB020668: , HPA002196: AB_1079107" "unprognostic (2.76e-1)" "unprognostic (1.39e-2)" "unprognostic (6.82e-2)" "unprognostic (5.97e-3)" "unprognostic (3.86e-1)" "unprognostic (3.18e-1)" "unprognostic (2.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.62e-1)" "unprognostic (1.01e-2)" "unprognostic (2.57e-1)" "unprognostic (6.65e-2)" "unprognostic (2.28e-1)" "unprognostic (2.62e-3)" "unprognostic (1.78e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" 833.0 374.9 99.4 151.1 124.0 44.2 583.2 112.7 149.7 640.3 1299.1 473.1 105.6 653.2 260.4 115.3 618.1 405.7 1117.2 132.7 143.8 1298.6 283.2 532.4 133.1 185.2 138.7 359.1 270.1 77.2 246.0 66.6 146.4 506.0 83.2 4.7 193.7 659.0 185.6 193.6 259.6 334.9 136.8 436.9 267.4 259.2 187.9 48.9 995.3 91.8 81.9 546.4 494.0 132.6 1.3 4.8 1.1 0.0 134.8 50.4 4.7 693.6 643.1 59.2 19.0 2.8 0.1 0.3 433.7 33.5 35.3 70.2 0.7 111.1 15.7 1.3 5.4 2.5 78.7 0.5 207.7 17.1 17.9 234.7 55.8 96.8 26.2 1471.3 138.2 0.6 0.5 0.9 142.8 0.0 0.5 74.5 5.9 0.0 1.3 13.4 0.4 2.8 682.7 0.0 1.0 1.8 130.2 9.5 0.0 276.3 1.8 64.6 1009.4 60.5 46.4 7.8 114.8 41.1 0.4 1.4 159.2 58.3 1.8 2.0 3.9 21.7 0.1 4.1 0.1 0.0 0.0 0.0 10.7 0.0 0.0 0.1 0.3 10.8 4.5 0.4 0.1 1.7 99.4 124.0 112.7 149.7 132.7 143.8 185.2 138.7 146.4 136.8 187.9 132.6 2254.8 112.2 20.2 164.9 16.2 238.5 127.2 300.5 24.5 5.9 27.7 53.5 148.2 20.0 90.6 2087.4 22.9 6.6 76.9 1.4 516.5 2455.3 75.9 1235.5 702.2 2740.1 1.2 82.7 0.7 15.1 8.3 1435.9 29.0 381.3 15.8 1205.0 3079.4 16.4 26.5 0.0 3.7 1.0 61.1 101.9 375.7 335.4 11440.4 70.4 944.5 151.8 41.8 17.1 345.0 11.6 0.8 84.6 1.5 11731.6 11.0 113.3 0.0 692.2 731.0 12.5 8184.6 155.0 4434.0 36.6 38.6 9.9 179.1 5.7 51.3 759.1 2.5 64.0 IGSF9B "KIAA1030, LINC00947, LOC283174, MIR4697HG" ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133896438-133956968 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.8;choroid plexus: 20.2" "Group enriched" "Detected in some" 4 "Excitatory neurons: 25.2;Inhibitory neurons: 11.6;Oligodendrocyte precursor cells: 30.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 38.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 10.0;SCLC-21H: 17.7;SH-SY5Y: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010802 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 6: Brain - Smell perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Cell Junctions" "HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 1.0 1.4 9.4 1.4 3.8 0.2 0.8 38.8 30.7 2.2 20.2 4.7 0.5 4.8 3.0 2.8 4.6 1.2 6.7 8.3 0.0 0.4 0.0 0.8 0.7 0.0 0.9 1.0 0.9 0.7 2.6 0.6 1.1 2.6 1.3 9.3 0.8 4.1 4.7 2.3 1.3 4.5 0.0 0.9 1.9 3.3 0.0 0.5 2.5 3.5 0.7 2.6 1.6 0.0 0.0 0.6 1.2 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.1 2.6 1.6 0.7 0.6 0.3 3.7 3.9 0.0 0.1 2.8 3.1 0.0 0.0 0.0 0.1 1.0 5.1 0.1 0.0 0.0 0.5 0.5 0.0 4.7 0.0 0.0 0.0 1.9 0.5 0.4 2.5 10.0 0.0 0.0 0.0 0.0 0.9 0.0 17.7 11.1 0.1 0.2 0.0 3.7 1.8 0.0 0.0 1.2 1.3 1.0 0.9 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.4 3.8 38.8 30.7 8.3 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 3.4 0.1 0.2 0.0 2.9 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.4 0.0 0.0 0.9 0.0 0.0 25.2 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 30.7 0.2 0.1 0.1 0.4 0.0 0.2 0.0 0.1 0.0 0.9 0.0 0.2 0.6 0.0 0.3 0.1 4.8 0.0 0.6 0.1 0.2 0.1 IL17RD "FLJ35755, IL-17RD, IL17RLM, SEF" ENSG00000144730 "Interleukin 17 receptor D" Q8NFM7 3 57089982-57170306 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 28.0" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039577, HPA043550" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Nucleoplasm "HPA039577: AB_2676580, HPA043550: AB_2678546" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (2.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-2)" "unprognostic (9.62e-2)" "unprognostic (1.17e-2)" "unprognostic (1.60e-1)" "unprognostic (3.72e-1)" "unprognostic (2.11e-3)" "unprognostic (4.79e-2)" "unprognostic (1.25e-1)" "prognostic favorable (2.92e-9)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.63e-3)" "unprognostic (9.58e-3)" 1.9 0.8 4.7 0.9 5.7 0.0 7.4 5.2 4.0 6.0 28.0 5.9 0.4 13.5 10.6 2.4 6.4 3.3 1.9 5.5 6.5 5.7 0.2 0.6 0.3 8.9 8.8 7.4 0.9 9.4 2.3 0.3 5.5 5.1 1.8 0.3 6.0 8.5 0.6 2.0 1.0 12.0 6.2 2.5 1.2 9.7 4.8 0.3 0.5 2.6 0.5 2.8 3.3 6.5 4.0 0.8 25.0 67.9 0.1 0.6 4.0 0.4 0.2 0.3 0.8 0.5 1.9 0.0 0.2 1.4 5.3 0.2 4.8 1.0 0.8 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.1 1.0 2.6 0.0 0.5 16.6 1.1 0.6 0.0 0.1 1.4 0.5 0.0 0.1 39.2 2.2 1.9 0.0 9.1 0.0 5.2 1.0 0.6 102.0 1.0 1.5 2.9 8.1 0.9 0.0 0.7 1.3 1.6 1.2 4.2 0.0 0.0 0.1 0.7 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 5.7 5.2 4.0 5.5 6.5 8.9 8.8 5.5 6.2 4.8 6.5 1.4 0.0 2.3 11.4 0.0 0.9 2.0 3.1 0.0 0.1 1.5 14.0 1.6 1.5 2.4 0.0 0.0 0.3 0.1 0.1 0.0 3.1 17.9 0.5 5.5 4.0 0.0 0.0 0.6 0.2 0.1 10.1 0.0 1.0 0.0 2.0 1.1 0.1 0.1 0.0 0.9 0.3 2.0 0.0 1.2 23.7 11.5 0.6 0.0 15.0 0.0 0.6 0.0 7.5 2.1 0.7 0.7 25.9 0.0 2.9 0.0 5.0 1.8 0.0 0.0 4.8 1.3 10.6 7.5 1.1 0.9 0.1 0.3 6.5 0.3 0.7 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143253-112164096 "Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 124.5;skin 1: 149.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 173.1;Basal respiratory cells: 186.4;Basal squamous epithelial cells: 215.1;Kupffer cells: 241.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 25.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 117.9;CAPAN-2: 182.3;HaCaT: 167.0;HBEC3-KT: 125.8;hTCEpi: 188.5;PC-3: 110.2;U-2 OS: 208.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 16000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 19.9 6.1 5.3 18.2 5.4 31.6 12.6 5.9 8.6 38.0 7.0 34.1 22.0 2.4 3.3 124.5 8.0 23.0 3.0 5.3 6.0 23.8 9.1 23.0 67.8 7.5 6.2 1.9 17.9 1.3 2.9 6.7 7.4 6.1 29.1 6.9 15.0 3.0 6.0 149.6 22.0 3.6 6.7 29.3 13.4 1.9 5.7 8.0 3.7 2.1 25.7 25.3 77.0 11.3 117.9 40.0 0.0 0.4 0.0 0.0 0.7 2.0 0.0 0.0 0.1 22.4 182.3 0.1 25.7 0.3 3.2 167.0 0.0 125.8 0.0 0.3 1.2 17.5 35.6 9.9 3.9 9.3 32.6 0.2 188.5 0.3 43.5 0.2 0.1 0.1 0.5 0.3 1.6 0.2 0.2 0.9 0.2 31.9 110.2 0.1 0.1 0.4 79.9 24.8 0.1 0.0 78.4 52.1 0.5 1.0 31.0 25.4 0.3 0.4 208.9 1.2 35.9 0.4 0.3 0.6 0.2 67.1 0.2 6.8 8.7 16.0 0.1 10.9 0.0 0.7 0.1 0.0 25.8 0.7 0.0 0.5 9.5 19.6 6.3 5.6 0.0 2.5 5.3 5.4 5.9 8.6 5.3 6.0 7.5 6.2 7.4 6.7 5.7 11.3 1.0 173.1 38.4 0.7 6.0 122.9 33.5 186.4 215.1 2.6 4.6 7.7 1.0 41.5 66.1 9.2 0.0 2.3 10.8 109.9 80.3 24.7 2.4 94.9 1.4 4.6 14.5 26.3 3.8 143.0 3.7 18.8 20.9 32.5 101.2 2.8 8.2 1.9 68.4 0.0 4.6 30.1 57.0 241.0 37.3 1.9 0.0 123.8 3.6 61.8 38.8 2.7 6.2 2.0 1.1 161.4 104.6 4.5 4.6 23.6 67.5 22.3 69.6 39.1 6.6 0.6 3.9 1.5 1.3 152.6 111.2 1.8 9.6 0.3 47.8 90.5 IL6ST "CD130, GP130, sGP130" ENSG00000134352 "Interleukin 6 signal transducer" P40189 5 55935095-55995022 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 580.3;Hepatic stellate cells: 808.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 16.7" "Lineage enriched" "Detected in many" 4 "T-cells: 16.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 151.3;BJ hTERT+: 175.2;HHSteC: 155.1;HSkMC: 135.1;TIME: 147.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010558, CAB025784" Approved Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 160000000 "Cluster 32: T-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" "Plasma membrane" "Golgi apparatus" "CAB025784: , HPA010558: AB_1078439" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (3.95e-2)" "unprognostic (8.93e-2)" "unprognostic (3.99e-2)" "unprognostic (5.18e-2)" "unprognostic (9.53e-3)" "unprognostic (1.89e-2)" "unprognostic (2.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (3.69e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" 67.1 46.0 26.8 14.1 31.0 9.6 51.3 30.9 36.7 43.0 21.3 33.9 4.2 35.2 18.5 18.4 34.2 23.6 35.1 23.5 31.4 30.0 77.6 53.3 15.9 32.1 27.0 36.9 21.9 39.6 22.5 101.7 35.9 32.6 14.3 28.6 31.9 29.9 41.0 17.8 31.1 28.7 35.1 34.7 27.8 8.9 25.3 23.6 40.4 34.7 16.2 37.7 35.1 42.9 14.4 35.6 9.4 18.8 75.5 151.3 22.3 54.5 175.2 44.1 62.4 40.5 16.3 1.1 33.7 52.5 71.6 7.8 9.8 19.2 84.1 1.6 8.5 4.6 20.1 14.2 155.1 0.4 6.2 135.1 11.1 103.1 42.7 43.6 101.8 1.9 3.7 51.0 47.0 2.9 0.7 0.8 1.5 1.8 10.1 1.1 22.5 14.4 22.5 12.1 3.8 5.9 26.6 5.7 19.7 13.7 29.5 3.1 147.8 12.4 10.1 44.5 24.6 14.6 8.2 0.5 28.9 1.1 31.1 0.0 3.9 0.1 0.7 3.4 0.3 0.8 3.7 0.8 2.1 0.4 16.7 4.8 0.6 0.8 0.5 1.9 4.1 4.0 26.8 31.0 30.9 36.7 23.5 31.4 32.1 27.0 35.9 35.1 25.3 42.9 221.6 134.6 149.8 59.4 30.0 103.9 98.0 60.6 71.2 56.5 202.4 81.3 81.5 124.4 105.4 68.0 35.5 77.9 33.1 34.5 7.9 85.3 12.3 76.4 227.6 256.2 19.8 41.1 25.7 62.0 75.5 285.5 59.1 580.3 32.9 58.6 808.5 219.8 56.0 16.8 70.0 34.1 46.8 93.7 99.1 16.7 105.9 60.3 80.0 188.3 45.8 190.8 7.2 75.4 64.2 80.8 35.6 130.5 100.6 163.9 33.6 52.2 80.3 39.3 98.6 158.7 150.3 54.4 38.6 44.9 83.5 101.8 75.5 228.7 17.1 106.1 ILVBL "209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535" ENSG00000105135 "IlvB acetolactate synthase like" A1L0T0 19 15114984-15125786 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 148.2;Syncytiotrophoblasts: 253.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067682 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Golgi apparatus, Vesicles" "HPA067682: AB_2685885" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.04e-2)" "unprognostic (2.53e-1)" "unprognostic (3.83e-1)" "unprognostic (5.60e-2)" "unprognostic (1.77e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.91e-8)" "unprognostic (4.65e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (2.40e-1)" 29.7 45.5 22.7 13.9 27.5 15.5 27.5 30.9 25.1 29.7 32.8 46.2 50.1 24.3 14.4 40.9 22.6 25.5 73.7 21.4 25.5 41.6 56.8 19.2 15.5 29.2 25.3 28.3 42.5 65.8 34.4 19.2 26.3 24.2 18.6 13.8 27.7 23.2 18.7 43.4 43.7 13.7 24.8 17.6 41.1 25.5 25.2 10.5 48.0 25.0 10.6 28.5 30.6 32.3 68.8 41.0 34.4 40.7 43.8 29.7 39.6 31.6 42.2 37.2 47.5 65.5 162.1 29.7 61.1 34.2 22.3 50.6 20.9 38.5 10.8 27.5 41.1 43.7 41.3 72.4 70.1 37.2 37.0 44.6 43.9 21.7 28.3 30.4 35.0 29.6 17.9 37.6 29.3 159.0 24.9 29.6 31.9 54.9 58.8 36.0 31.1 46.5 32.3 33.6 28.4 38.3 18.8 81.2 62.1 13.2 37.2 31.2 37.7 55.9 30.7 71.0 45.1 26.1 29.2 15.1 35.9 35.8 43.1 22.7 22.2 5.5 21.1 31.8 24.0 11.9 17.7 22.0 26.3 12.9 22.9 23.6 2.5 23.7 30.3 19.1 20.2 23.3 22.7 27.5 30.9 25.1 21.4 25.5 29.2 25.3 26.3 24.8 25.2 32.3 28.0 25.6 11.7 18.3 12.7 12.7 26.8 53.8 22.2 95.3 18.0 14.9 36.1 62.9 43.0 25.8 27.1 84.2 15.8 67.8 19.6 48.4 6.2 9.9 13.4 23.2 44.4 12.6 4.9 50.6 148.2 21.4 40.2 13.0 11.4 29.0 26.7 59.3 43.2 18.5 8.3 60.6 28.5 12.1 9.5 6.5 25.7 15.8 83.6 5.6 6.8 48.0 7.2 9.0 15.7 32.3 68.4 19.9 17.2 18.6 123.0 50.4 26.1 36.8 19.7 14.7 21.2 20.3 20.8 25.0 16.2 253.4 11.8 48.2 73.2 23.4 INHA ENSG00000123999 "Inhibin subunit alpha" P05111 2 219569162-219575711 "Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 75.6;ovary: 104.4;testis: 95.3" "Cell type enhanced" "Detected in some" "Granulosa cells: 254.3;Syncytiotrophoblasts: 331.0;Theca cells: 75.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.5;HEL: 4.5;SK-BR-3: 9.9;SuSa: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB000047, HPA019141, HPA048834" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Golgi apparatus" "CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: " "unprognostic (8.90e-3)" "unprognostic (2.91e-2)" "unprognostic (2.82e-1)" "unprognostic (7.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.45e-1)" "unprognostic (3.57e-1)" "unprognostic (9.61e-3)" "unprognostic (4.15e-3)" "unprognostic (6.71e-2)" "unprognostic (3.73e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (4.85e-2)" "unprognostic (7.20e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" 1.2 75.6 3.4 0.2 3.7 0.1 1.4 2.7 4.8 2.0 2.2 0.9 0.2 2.0 2.2 0.8 3.0 0.4 16.3 3.5 3.2 3.1 0.7 0.8 0.1 3.4 2.9 104.4 12.3 0.7 6.6 11.3 3.5 3.1 0.0 1.9 1.5 1.1 0.8 2.1 0.4 0.4 2.5 0.4 0.7 95.3 3.4 0.0 3.3 0.0 0.0 1.0 1.8 3.0 0.4 0.2 0.0 1.9 0.6 0.1 3.5 0.3 0.2 0.5 0.2 0.3 3.2 0.0 0.2 0.7 0.5 2.0 0.2 0.5 0.0 0.0 0.6 4.5 1.8 2.4 0.3 0.0 0.0 0.6 0.8 0.0 0.5 1.4 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.1 1.2 0.1 0.9 0.1 0.2 0.0 0.5 0.2 0.3 0.8 1.1 9.9 0.3 4.9 0.5 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.7 2.7 4.8 3.5 3.2 3.4 2.9 3.5 2.5 3.4 3.0 0.1 0.0 0.0 5.9 0.0 0.0 0.1 0.8 0.0 2.7 0.3 0.3 2.2 0.0 0.1 7.3 2.1 11.8 0.0 0.0 0.0 2.8 0.8 0.5 0.5 0.2 0.0 0.0 5.9 8.9 35.5 1.2 0.0 0.5 0.0 254.3 0.7 0.1 2.6 6.7 6.9 0.0 0.0 0.3 0.0 5.0 4.1 0.2 0.0 0.0 0.0 3.7 0.0 1.0 0.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 3.4 0.6 0.0 0.0 331.0 0.0 75.6 0.0 0.0 INMT ENSG00000241644 "Indolethylamine N-methyltransferase" O95050 7 30697985-30757602 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Detoxification "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 205.8" "Group enriched" "Detected in many" 7 "Endothelial cells: 150.4;Hepatic stellate cells: 268.4;Leydig cells: 285.2;Peritubular cells: 455.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CACO-2: 16.7;HHSteC: 6.7" HPA061343 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Vesicles" "HPA061343: AB_2684483" "unprognostic (1.70e-1)" "unprognostic (4.36e-2)" "unprognostic (5.26e-2)" "unprognostic (6.78e-3)" "unprognostic (1.59e-1)" "unprognostic (3.39e-4)" "prognostic favorable (5.72e-4)" "unprognostic (3.08e-2)" "unprognostic (3.94e-2)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (9.07e-2)" "unprognostic (4.97e-2)" "unprognostic (1.62e-2)" "unprognostic (1.43e-2)" "unprognostic (9.71e-2)" "unprognostic (1.58e-2)" 64.5 51.2 3.1 2.7 6.0 0.7 10.2 7.9 13.1 6.4 9.3 9.5 2.8 16.0 25.4 15.0 43.8 8.3 75.6 7.6 8.7 20.0 23.3 205.8 7.6 9.6 6.0 17.7 11.3 5.7 7.8 33.7 5.6 29.6 4.6 0.5 9.1 48.0 14.4 4.2 8.5 25.7 2.5 13.0 12.7 15.8 4.8 1.7 21.3 13.2 4.0 11.1 7.2 16.6 0.0 0.1 0.0 0.1 1.5 2.1 0.3 0.2 2.1 0.0 0.0 16.7 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 6.7 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.2 0.2 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.5 0.1 0.6 0.0 0.6 0.1 0.0 1.0 0.0 0.6 0.2 0.0 0.7 0.3 0.0 0.2 0.1 0.3 1.6 0.2 0.2 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.5 0.1 0.3 0.1 0.2 3.1 6.0 7.9 13.1 7.6 8.7 9.6 6.0 5.6 2.5 4.8 16.6 39.4 0.0 3.6 0.0 1.0 2.2 0.1 0.0 1.2 0.0 0.4 0.6 10.0 7.2 2.5 0.0 0.0 0.7 0.3 0.0 0.0 0.0 2.3 0.1 0.8 150.4 1.2 8.0 0.0 0.0 0.4 38.2 0.0 0.0 0.0 0.9 268.4 5.1 0.8 0.0 0.0 0.2 0.0 16.6 4.4 16.0 285.2 0.7 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 455.5 1.5 0.2 0.0 0.1 0.7 0.0 32.9 5.0 19.6 1.3 1.3 0.4 2.3 1.8 1.3 0.2 0.0 0.4 INPP5E "CORS1, JBTS1, pharbin, PPI5PIV" ENSG00000148384 "Inositol polyphosphate-5-phosphatase E" Q9NRR6 9 136428619-136439845 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065758 Approved Approved "Golgi apparatus,Focal adhesion sites" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Focal adhesion sites" "HPA065758: AB_2685554" "unprognostic (1.99e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-2)" "unprognostic (4.00e-1)" "unprognostic (6.92e-2)" "unprognostic (9.60e-3)" "unprognostic (3.21e-1)" "unprognostic (5.81e-2)" "unprognostic (2.65e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.03e-1)" "unprognostic (3.04e-2)" "unprognostic (3.76e-1)" "unprognostic (5.48e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" 12.1 10.8 15.0 6.9 15.0 6.4 11.7 15.3 19.9 15.1 11.3 13.1 5.7 15.2 2.3 10.6 17.6 5.3 13.7 14.0 14.3 13.3 12.2 11.9 8.2 15.1 13.3 16.2 10.8 6.6 14.3 5.7 15.5 12.3 3.3 7.4 9.5 5.3 8.5 11.2 11.7 5.6 11.4 20.8 8.9 20.1 14.8 6.4 15.1 3.8 4.7 12.2 12.0 13.9 8.9 10.3 12.6 13.2 6.5 7.1 14.9 10.7 5.7 7.4 5.1 12.5 6.0 10.8 10.5 11.1 11.9 25.2 6.2 8.6 2.8 36.8 25.4 8.5 27.1 8.4 10.3 9.5 11.9 10.9 8.8 9.8 7.2 10.3 8.9 14.8 14.5 14.0 7.0 22.3 11.4 19.9 8.1 5.3 16.0 21.1 8.7 8.3 7.4 9.8 14.1 12.2 10.4 8.5 7.6 7.6 15.1 15.6 11.8 24.1 9.4 10.1 18.2 11.6 10.6 4.5 12.0 7.8 9.7 0.0 0.1 0.5 0.5 0.0 0.3 0.7 0.6 0.4 0.1 0.4 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.1 15.0 15.0 15.3 19.9 14.0 14.3 15.1 13.3 15.5 11.4 14.8 13.9 14.7 3.2 6.9 17.0 5.0 5.5 1.8 2.6 5.7 7.4 6.5 6.9 5.0 7.2 3.4 3.7 2.1 2.3 7.6 4.0 1.9 4.8 0.9 11.8 8.1 7.4 6.1 0.8 12.2 5.6 2.8 5.7 3.6 6.8 8.9 8.3 6.1 3.8 3.2 15.2 12.9 2.6 6.1 3.5 3.5 1.3 7.5 3.7 5.4 6.5 3.5 8.9 1.0 8.5 8.5 6.7 1.6 5.7 2.5 3.3 3.4 2.4 10.0 10.8 0.0 5.5 7.5 15.3 9.1 5.4 4.8 0.8 5.3 5.6 3.9 1.6 INPPL1 SHIP2 ENSG00000165458 "Inositol polyphosphate phosphatase like 1" O15357 11 72223701-72239147 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Immunity" "Actin-binding, Hydrolase" "Cancer-related genes, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 344.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037601 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Golgi apparatus" "HPA037601: AB_10672281" "unprognostic (2.68e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.68e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.51e-2)" "unprognostic (1.64e-1)" "unprognostic (4.34e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (1.99e-3)" "unprognostic (2.07e-1)" 45.2 56.4 39.0 34.4 43.4 51.3 44.7 41.3 40.5 63.8 47.3 87.5 35.9 56.1 18.2 34.6 61.3 33.7 73.6 33.2 42.5 60.0 36.6 61.8 36.8 53.9 43.2 68.6 55.7 36.4 60.5 39.7 45.8 68.7 23.3 14.9 53.8 39.5 116.6 31.4 57.1 33.4 45.0 66.1 60.8 24.2 48.8 19.3 67.7 43.0 23.2 59.9 43.4 41.2 28.7 62.1 71.5 49.8 35.4 41.1 122.5 118.9 61.2 80.6 49.6 84.3 72.2 79.5 125.6 101.7 57.8 106.7 60.4 37.6 28.0 101.9 59.1 84.8 344.5 31.9 68.1 56.1 176.7 58.2 39.1 78.0 31.4 100.5 44.2 29.3 59.7 34.7 45.1 78.8 42.1 224.9 67.7 20.7 93.7 185.0 161.0 18.2 94.8 48.6 33.8 48.6 133.9 85.1 182.8 36.6 88.8 106.0 74.5 86.4 96.7 129.9 43.1 94.5 17.5 80.1 24.7 51.7 47.2 2.5 3.5 3.3 1.9 2.0 1.7 0.9 1.6 1.3 2.4 1.0 1.1 1.6 2.3 2.2 3.6 1.8 1.5 1.8 39.0 43.4 41.3 40.5 33.2 42.5 53.9 43.2 45.8 45.0 48.8 41.2 13.9 3.2 12.8 47.0 8.1 7.1 4.9 10.8 14.2 1.7 20.3 17.3 13.6 11.5 11.7 12.9 27.1 27.9 9.1 28.3 1.9 11.6 1.5 14.6 16.3 11.2 22.7 5.7 2.6 12.5 15.4 10.8 24.5 25.5 7.6 21.0 8.9 12.5 21.7 10.1 2.2 16.4 18.3 27.6 16.2 2.1 9.9 29.8 10.6 18.7 17.6 16.8 14.4 15.1 6.1 14.9 17.5 13.9 7.8 7.8 15.2 16.2 10.2 17.2 6.6 12.9 14.5 1.4 4.9 6.7 4.8 32.4 11.6 10.1 21.8 5.4 IRX1 IRX-5 ENSG00000170549 "Iroquois homeobox 1" P78414 5 3595832-3601403 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.5;breast: 16.2;kidney: 28.9;salivary gland: 17.8" "Group enriched" "Detected in some" 4 "Breast glandular cells: 51.4;Breast myoepithelial cells: 87.6" "Group enriched" "Detected in many" 6 "breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.8;REH: 37.8;U-251 MG: 15.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043160 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" Nucleoplasm "HPA043160: AB_10794771" "unprognostic (1.52e-2)" "unprognostic (1.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-2)" "unprognostic (4.30e-3)" "unprognostic (2.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.03e-2)" "unprognostic (9.78e-4)" "unprognostic (5.11e-2)" "unprognostic (2.78e-2)" "unprognostic (3.58e-2)" 7.3 0.0 3.6 0.0 4.2 0.6 16.2 6.8 1.6 0.2 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 1.8 5.4 28.9 0.0 3.1 0.1 16.9 10.2 0.0 0.2 0.2 1.0 0.0 17.5 0.1 0.0 0.1 17.8 0.5 0.1 8.9 0.0 0.0 7.5 0.0 0.0 0.1 6.8 0.3 0.3 0.0 0.0 0.0 0.5 6.4 0.0 0.0 8.8 0.0 0.5 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.8 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 37.8 0.0 0.0 2.8 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 4.2 6.8 1.6 1.8 5.4 16.9 10.2 17.5 7.5 6.8 6.4 2.5 6.4 3.7 0.0 0.4 3.6 0.0 1.6 1.2 0.8 51.4 87.6 3.5 0.0 1.5 5.5 0.0 0.3 1.0 0.0 15.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.3 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 1.0 0.0 0.5 3.7 0.0 0.2 1.1 3.0 0.3 0.6 0.0 0.0 0.0 ISLR HsT17563 ENSG00000129009 "Immunoglobulin superfamily containing leucine rich repeat" O14498 15 74173710-74176872 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 216.2" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0" "Region enriched" "Detected in all" 5 "olfactory bulb: 118.0" "Region enriched" "Detected in all" 5 "spinal cord: 124.7" "HPA040326, HPA050811" Approved Approved "Golgi apparatus,Plasma membrane" "Secreted - unknown location" NA NA 130000000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "Golgi apparatus" "HPA040326: AB_2676928, HPA050811: AB_2681243" "unprognostic (2.58e-1)" "unprognostic (1.36e-2)" "unprognostic (3.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (6.76e-3)" "unprognostic (1.16e-2)" "unprognostic (6.81e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.89e-8)" "unprognostic (1.64e-2)" "unprognostic (3.42e-2)" "unprognostic (2.28e-1)" "unprognostic (9.86e-3)" 89.3 17.5 4.4 5.5 11.8 0.0 66.9 1.7 10.4 216.2 5.4 75.1 5.7 181.4 18.9 17.1 78.7 38.6 63.3 4.6 5.2 20.9 8.2 37.7 9.9 2.8 3.2 170.9 10.1 2.1 44.6 10.2 2.8 51.4 5.2 0.3 33.6 22.9 18.5 46.7 31.3 26.3 2.3 33.0 32.5 14.9 4.5 3.3 63.4 19.7 5.3 63.5 111.9 5.0 0.0 1.5 0.1 0.0 62.7 33.5 0.2 10.2 0.1 0.0 0.0 0.0 4.0 0.0 0.6 148.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 25.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.5 5.8 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 0.4 7.6 0.1 0.1 1.1 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 11.8 1.7 10.4 4.6 5.2 2.8 3.2 2.8 2.3 4.5 5.0 10.3 0.0 1.3 0.7 0.1 11.7 0.1 0.2 0.0 0.1 4.8 3.9 3.9 1.5 0.7 0.0 0.0 1.3 0.8 0.0 0.0 0.2 2.4 7.2 193.5 14.0 0.0 0.0 1.9 0.2 1.4 154.5 2.0 4.2 0.0 0.0 7.5 0.0 3.8 0.0 0.2 0.0 0.0 0.0 16.2 6.1 214.9 2.6 12.4 34.7 0.0 0.2 0.0 0.5 0.7 0.8 0.0 159.9 0.0 0.1 0.0 0.1 1.5 0.5 26.3 7.0 49.8 0.7 0.7 1.3 8.8 1.0 2.6 7.0 0.0 0.2 ITIH2 H2P ENSG00000151655 "Inter-alpha-trypsin inhibitor heavy chain 2" P19823 10 7703316-7749520 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 668 "liver: 2156.1" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 489.6" "Cancer enriched" "Detected in many" 279 "liver cancer: 626.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 453 "Hep G2: 1103.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059150 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 32000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA059150: AB_2683930" "unprognostic (4.82e-2)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.21e-2)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (2.28e-1)" "unprognostic (2.02e-1)" "unprognostic (2.10e-8)" "unprognostic (9.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.35e-1)" "unprognostic (4.46e-4)" 0.1 0.2 0.3 0.1 1.1 0.1 3.0 1.6 3.2 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.6 1.0 0.8 2156.1 0.6 0.1 0.6 0.5 0.0 0.2 0.0 1.7 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.8 0.4 0.0 0.0 0.9 0.3 0.5 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 1103.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 2.4 0.0 0.1 0.7 0.0 0.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.1 1.6 3.2 0.6 1.0 0.6 0.5 0.6 0.9 0.9 0.7 0.1 0.0 2.2 0.7 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.4 117.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.1 0.0 0.0 0.6 0.0 2.7 3.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 8.2 489.6 0.1 0.0 1.4 0.0 0.0 9.4 0.0 2.1 0.0 0.0 0.0 18.7 0.0 0.0 0.0 1.5 1.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 ITIH5 MGC10848 ENSG00000123243 "Inter-alpha-trypsin inhibitor heavy chain 5" 10 7559270-7666998 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 112.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 282.7;Fibroblasts: 111.3;Microglial cells: 160.2;Smooth muscle cells: 110.1;Syncytiotrophoblasts: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038305 Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Vesicles "HPA038305: AB_10670662" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "unprognostic (3.11e-3)" "unprognostic (6.80e-2)" "unprognostic (1.80e-1)" "unprognostic (5.84e-3)" "unprognostic (1.63e-1)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (2.90e-1)" "unprognostic (5.80e-3)" "unprognostic (6.11e-2)" "unprognostic (1.36e-1)" "unprognostic (6.79e-3)" "unprognostic (2.00e-2)" "unprognostic (4.50e-2)" "unprognostic (3.48e-2)" 112.7 3.7 17.9 19.4 18.6 0.2 53.3 19.7 23.2 17.4 28.6 62.7 13.9 24.3 6.3 21.4 10.5 27.7 16.8 14.7 18.0 16.4 1.6 22.4 12.5 18.9 18.1 21.2 15.0 6.3 5.4 86.9 19.7 24.0 16.8 3.5 9.5 46.6 17.8 12.0 21.6 28.8 15.7 3.4 24.0 6.2 22.5 3.8 24.5 22.5 13.4 51.4 15.3 15.2 0.0 0.0 0.0 0.1 0.0 0.0 7.0 18.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.5 14.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 0.1 0.0 0.0 0.0 102.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 18.6 19.7 23.2 14.7 18.0 18.9 18.1 19.7 15.7 22.5 15.2 74.9 3.2 2.7 1.3 0.2 11.3 3.0 0.1 6.8 2.7 1.6 17.3 8.7 8.6 3.7 0.0 2.1 282.7 0.8 0.1 0.0 25.7 2.0 18.7 1.5 58.8 0.0 0.0 0.5 0.4 70.2 111.3 0.0 34.1 2.5 0.5 1.8 0.1 20.7 0.0 0.7 0.0 8.2 1.2 19.6 2.2 5.3 3.6 14.2 160.2 1.1 21.9 0.0 1.5 1.0 0.3 0.0 15.4 0.9 1.8 0.2 2.1 0.7 3.2 78.9 32.3 110.1 1.7 7.7 0.7 8.8 221.9 3.0 0.3 0.0 1.6 ITM2A "BRICD2A, E25A" ENSG00000078596 "Integral membrane protein 2A" O43736 X 79360384-79367667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 322.9" "Cell type enhanced" "Detected in many" "Adipocytes: 390.0;Endothelial cells: 368.4;Fibroblasts: 302.1;granulocytes: 194.6;Leydig cells: 335.5;Muller glia cells: 188.9;T-cells: 239.2" "Cancer enhanced" "Detected in all" "glioma: 51.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 172.6;eosinophil: 88.5;gdT-cell: 107.1;MAIT T-cell: 79.3;memory CD4 T-cell: 204.7;memory CD8 T-cell: 170.5;naive CD4 T-cell: 216.7;naive CD8 T-cell: 101.6;NK-cell: 130.3;T-reg: 168.1" "Group enriched" "Detected in all" 7 "granulocytes: 172.6;NK-cells: 130.3;T-cells: 216.7" "Cell line enriched" "Detected in some" 5 "MOLT-4: 1749.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000296 Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Golgi apparatus, Plasma membrane" "HPA000296: " "unprognostic (1.05e-2)" "unprognostic (5.22e-3)" "unprognostic (2.77e-3)" "unprognostic (5.65e-2)" "unprognostic (1.73e-2)" "unprognostic (1.06e-3)" "prognostic favorable (3.66e-6)" "unprognostic (1.57e-1)" "unprognostic (4.94e-2)" "unprognostic (9.85e-2)" "unprognostic (1.33e-2)" "unprognostic (2.57e-1)" "unprognostic (1.04e-2)" "unprognostic (1.56e-1)" "unprognostic (3.31e-1)" "unprognostic (2.18e-1)" "unprognostic (4.30e-1)" 80.2 10.8 103.4 26.8 95.2 45.8 74.5 99.4 172.0 55.3 75.5 30.5 15.1 44.4 18.8 40.1 42.8 28.8 115.3 92.1 105.4 20.6 6.3 52.2 87.2 101.5 102.2 181.4 10.0 14.9 21.0 29.7 102.0 22.8 32.2 11.9 74.9 22.4 41.2 25.0 22.1 56.6 95.2 24.5 24.2 15.9 109.8 322.9 83.1 75.2 46.9 42.3 26.0 95.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 216.6 2.5 0.0 4.4 0.0 69.9 0.0 0.0 0.0 113.1 124.2 19.5 0.0 0.0 0.0 0.1 0.0 333.3 80.2 0.0 0.0 0.0 1749.0 77.6 25.0 0.0 0.0 0.7 0.1 0.3 64.6 0.0 0.2 19.0 0.0 0.9 0.0 17.6 2.2 2.5 3.0 0.0 1.8 0.4 1.1 208.1 0.0 0.0 0.2 0.0 8.7 172.6 0.8 88.5 107.1 1.3 79.3 23.4 204.7 170.5 0.8 23.5 216.7 101.6 3.9 130.3 1.1 6.1 168.1 115.3 103.4 95.2 99.4 172.0 92.1 105.4 101.5 102.2 102.0 95.2 109.8 95.8 390.0 3.2 14.8 1.0 28.0 67.4 13.2 2.1 50.1 3.1 21.1 81.9 29.3 2.8 4.4 1.8 0.0 0.4 64.8 2.1 5.9 0.4 3.1 0.4 2.6 368.4 2.4 42.7 3.5 50.9 0.2 302.1 29.6 0.6 194.6 1.4 135.0 1.0 1.3 1.7 2.3 85.6 0.0 9.5 39.5 7.1 335.5 8.6 62.2 114.3 3.2 188.9 65.9 18.1 60.2 1.0 1.4 117.8 81.8 12.3 0.2 1.4 0.7 12.1 0.0 31.8 22.5 0.5 2.6 24.3 47.0 0.3 239.2 2.0 2.9 2.5 ITM2B "BRI, BRI2, BRICD2B, E25B, E3-16" ENSG00000136156 "Integral membrane protein 2B" Q9Y287 13 48232612-48270357 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Amyloidosis, Deafness, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 4375.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 4375.2" "Cell line enhanced" "Detected in all" "HMC-1: 731.2;RPTEC TERT1: 1718.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029292, HPA071992" Enhanced Enhanced "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 5800000 "Cluster 5: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus, Vesicles" "HPA029292: AB_10601917, HPA071992: AB_2686480" "unprognostic (4.66e-2)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.00e-1)" "unprognostic (4.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "unprognostic (9.88e-2)" "unprognostic (2.42e-1)" "unprognostic (5.89e-2)" "unprognostic (2.87e-2)" "prognostic favorable (3.73e-5)" "unprognostic (4.38e-2)" "unprognostic (4.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.22e-1)" 510.2 367.4 286.9 172.5 301.0 125.6 323.8 328.6 489.0 416.1 406.6 260.1 289.2 388.8 1171.8 399.9 305.4 257.5 381.0 320.1 339.2 1306.3 391.2 376.1 236.7 334.9 308.0 507.2 179.6 233.7 290.5 573.8 304.4 312.5 191.4 174.4 408.7 386.2 164.7 399.6 287.4 232.5 373.6 435.2 312.8 121.4 308.8 188.3 386.1 206.2 187.4 305.1 402.2 394.8 67.6 51.8 73.1 116.3 348.5 254.5 119.2 215.0 202.2 87.5 100.6 29.1 248.3 16.6 168.8 121.6 48.5 214.1 61.3 107.0 107.4 69.9 147.3 137.9 29.0 99.0 138.5 140.6 731.2 113.4 149.1 45.1 62.0 375.7 131.2 78.3 24.5 90.9 174.8 29.6 200.4 310.1 266.0 116.5 103.6 100.1 100.5 73.6 1718.9 268.6 26.2 119.5 154.5 110.2 111.0 306.0 74.0 119.4 180.5 62.9 73.8 95.7 85.4 72.9 59.6 2.5 78.0 75.3 155.3 3091.4 864.5 2737.9 387.4 661.3 512.5 235.3 523.1 476.4 428.9 245.3 551.3 466.8 4375.2 356.5 692.7 196.2 563.4 1723.5 286.9 301.0 328.6 489.0 320.1 339.2 334.9 308.0 304.4 373.6 308.8 394.8 1380.0 695.5 300.4 174.6 408.6 862.4 1661.1 2606.2 1006.2 653.1 460.1 573.5 384.8 722.0 1121.9 1991.8 187.7 1164.3 448.2 754.2 545.9 910.2 23.6 751.8 802.2 1166.2 283.3 307.0 114.2 682.9 2362.8 1334.0 302.8 1177.2 578.0 421.2 1319.7 557.3 2117.8 353.3 142.6 503.2 1129.1 1569.8 900.6 76.7 1867.0 1381.5 681.3 252.0 1415.7 1634.9 425.3 174.4 237.9 515.7 788.3 2011.6 445.4 922.5 1259.3 2748.9 795.6 219.4 1222.7 602.4 1022.9 143.6 256.4 1384.6 1149.6 1471.5 723.2 665.5 440.9 1613.4 JAG1 "AGS, AHD, AWS, CD339, HJ1, JAGL1" ENSG00000101384 "Jagged canonical Notch ligand 1" P78504 20 10637684-10673999 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 211.1;Endometrial ciliated cells: 197.4;Smooth muscle cells: 190.1;Squamous epithelial cells: 343.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 219.2;hTERT-HME1: 131.1;U-251 MG: 187.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010343, HPA021555" Supported Approved "Golgi apparatus,Plasma membrane" NA NA 25000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Golgi apparatus, Plasma membrane" "CAB010343: AB_649685, HPA021555: AB_1851969" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (4.15e-2)" "unprognostic (1.21e-1)" "unprognostic (6.42e-2)" "unprognostic (4.21e-2)" "unprognostic (8.94e-3)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (4.10e-6)" "unprognostic (5.48e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-1)" "unprognostic (1.66e-1)" "unprognostic (3.10e-1)" "unprognostic (1.41e-3)" 44.2 10.1 10.3 13.0 9.5 21.8 30.3 8.4 12.0 44.0 8.9 23.7 13.8 27.3 19.5 52.4 27.0 21.6 20.7 12.8 9.8 21.7 6.2 23.9 8.4 12.4 14.2 20.3 22.0 20.9 8.2 67.9 10.0 25.9 23.0 22.1 15.8 26.7 9.8 57.2 13.6 23.6 9.7 23.3 25.1 4.5 12.1 9.3 19.9 22.8 15.6 28.5 50.0 8.5 4.1 20.6 63.1 78.1 11.8 11.3 2.3 2.4 11.9 3.3 1.8 18.5 11.2 0.7 59.0 2.4 17.7 85.8 9.4 219.2 2.7 0.2 4.5 7.0 2.2 87.9 5.8 28.4 0.5 4.6 63.7 10.6 131.1 12.5 21.1 0.3 0.1 8.8 6.0 0.2 0.0 20.2 18.2 68.7 20.3 5.3 3.9 13.1 29.9 25.6 2.8 2.1 6.3 4.4 26.2 49.8 0.3 3.3 80.5 14.2 9.9 11.8 187.9 3.6 0.6 0.9 9.1 10.3 11.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 10.3 9.5 8.4 12.0 12.8 9.8 12.4 14.2 10.0 9.7 12.1 8.5 73.0 41.7 15.4 5.9 1.1 104.6 54.9 76.3 211.1 9.7 13.2 29.1 20.6 30.0 34.4 16.5 43.8 16.9 6.8 64.3 1.9 31.6 5.0 197.4 22.2 102.5 5.3 0.0 6.9 30.4 1.0 41.9 76.0 96.4 7.0 2.7 60.0 1.8 4.2 21.9 9.2 12.8 20.3 5.9 33.9 9.6 21.5 9.1 14.2 22.5 2.8 11.9 2.1 24.6 1.3 97.3 18.3 33.8 4.3 24.5 7.8 2.3 30.2 69.1 85.5 46.7 190.1 0.9 3.2 343.9 106.8 2.2 4.3 107.2 39.1 33.7 JAKMIP2 "JAMIP2, KIAA0555" ENSG00000176049 "Janus kinase and microtubule interacting protein 2" Q96AA8 5 147585438-147782775 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8" "Group enriched" "Detected in many" 6 "Astrocytes: 195.5;Excitatory neurons: 250.7;Horizontal cells: 85.8;Inhibitory neurons: 229.4;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 198.5" "Cancer enriched" "Detected in some" 6 "glioma: 4.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 7.3;MAIT T-cell: 5.3;memory CD4 T-cell: 2.8;memory CD8 T-cell: 5.5;naive CD8 T-cell: 4.6;NK-cell: 7.0" "Group enriched" "Detected in many" 6 "NK-cells: 7.0;T-cells: 7.3" "Cell line enhanced" "Detected in many" "AF22: 19.9;Karpas-707: 47.5;RH-30: 47.8;RPMI-8226: 16.0;SCLC-21H: 22.4;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046929, HPA065023" Approved Supported "Golgi apparatus" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA046929: AB_2679867, HPA065023: AB_2685407" "unprognostic (3.69e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (3.58e-2)" "unprognostic (1.63e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.21e-4)" "unprognostic (1.28e-1)" "unprognostic (5.20e-8)" "unprognostic (1.54e-3)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.2 3.3 11.4 1.0 12.5 0.5 0.1 24.8 14.3 0.5 0.1 2.2 0.4 1.0 0.2 1.3 0.1 1.4 0.4 11.4 12.1 0.3 2.6 2.0 0.9 11.7 11.8 0.1 0.8 1.0 8.3 0.1 12.4 0.6 0.5 5.3 0.2 0.4 0.0 0.3 0.6 1.5 10.4 0.8 1.8 2.9 13.0 7.0 0.1 1.6 0.9 0.7 0.2 16.6 0.0 0.0 19.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.1 0.0 0.0 4.8 0.1 0.0 0.0 0.0 3.1 6.9 2.0 0.0 0.0 0.3 0.0 5.7 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 47.5 0.0 0.1 5.1 0.0 11.4 0.1 0.1 2.0 47.8 16.0 0.0 0.1 22.4 15.4 0.0 0.3 0.1 2.5 0.0 0.0 0.0 3.5 4.0 0.0 1.1 3.3 2.0 4.6 8.9 0.0 0.0 0.0 0.0 0.4 7.3 0.0 5.3 0.7 2.8 5.5 0.1 0.3 0.7 4.6 0.5 7.0 0.2 1.1 1.3 1.5 11.4 12.5 24.8 14.3 11.4 12.1 11.7 11.8 12.4 10.4 13.0 16.6 0.2 0.0 1.5 195.5 1.5 0.0 0.0 0.0 0.0 23.2 0.0 0.1 0.7 0.0 1.3 0.0 2.1 0.0 13.3 0.0 0.0 0.8 11.3 0.2 0.5 0.3 1.2 3.0 250.7 0.0 0.0 1.2 0.5 0.1 29.1 10.3 0.7 3.1 1.3 85.8 229.4 0.8 0.0 0.9 0.0 8.4 0.0 4.2 0.0 11.2 0.4 24.4 23.7 159.3 198.5 0.2 0.0 0.0 3.1 0.0 0.1 0.1 1.5 7.9 0.0 0.4 0.7 7.8 2.0 0.1 0.1 0.3 13.8 18.9 0.0 0.3 JAM3 "JAM-C, JAMC" ENSG00000166086 "Junctional adhesion molecule 3" Q9BX67 11 134069071-134152001 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 342.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 5.3" "Group enriched" "Detected in many" 7 "B-cells: 5.3;T-cells: 2.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 99.5;RH-30: 122.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003417, HPA050434" Approved Enhanced "Golgi apparatus" "Secreted to blood" NA NA 44000 "Cluster 43: B-cells - Humoral immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA003417: AB_1851981, HPA050434: AB_2681126" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (3.24e-1)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.23e-3)" "unprognostic (2.17e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.68e-4)" 23.6 18.7 53.4 10.1 86.3 1.3 19.2 68.7 73.4 33.4 52.9 54.6 6.6 40.8 17.5 21.5 28.7 24.5 31.0 56.5 61.3 11.4 3.2 29.6 7.8 73.5 76.8 48.7 5.1 17.7 33.3 102.7 71.0 32.5 12.9 47.3 13.3 44.5 7.0 13.0 22.5 42.8 59.7 13.5 22.4 35.7 73.3 17.6 15.8 14.6 7.5 41.7 23.4 115.2 0.0 1.0 87.9 42.5 85.3 62.7 75.4 37.0 49.1 15.1 14.8 0.3 0.6 0.0 38.7 53.3 56.2 0.5 70.0 0.7 28.2 0.2 29.6 0.3 0.0 6.9 24.9 0.4 36.2 43.2 0.0 10.7 9.6 35.8 99.5 40.8 0.3 0.2 64.5 1.0 27.5 0.2 18.9 0.6 2.9 0.5 122.8 0.0 0.9 0.2 57.5 32.2 0.0 0.2 1.0 35.3 0.2 0.2 0.6 25.1 18.4 40.3 24.7 0.1 0.1 0.4 27.6 1.2 48.0 0.0 0.0 0.1 1.3 0.0 1.6 5.3 1.6 0.9 0.0 3.1 2.3 1.7 0.5 0.0 0.0 0.0 0.0 1.8 53.4 86.3 68.7 73.4 56.5 61.3 73.5 76.8 71.0 59.7 73.3 115.2 22.2 0.0 6.0 12.7 10.9 5.1 5.6 0.9 0.0 21.7 0.3 9.3 15.7 0.0 0.7 5.5 8.4 6.0 1.2 0.1 1.9 0.4 2.1 0.8 23.3 35.5 0.0 0.4 84.3 0.2 71.2 29.6 1.5 0.5 1.3 11.7 12.5 0.0 8.6 8.4 44.2 0.0 12.2 0.6 4.2 4.9 42.9 10.9 17.8 24.4 0.2 20.2 1.0 76.4 342.8 0.3 0.0 64.3 0.9 2.2 0.0 0.2 1.5 75.6 26.3 19.0 24.3 15.5 19.2 0.2 3.8 6.2 3.5 9.7 0.0 1.0 JHY "C11orf63, FLJ23554" ENSG00000109944 "Junctional cadherin complex regulator" Q6NUN7 11 122882683-122963862 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Endometrial ciliated cells: 41.5;Glandular and luminal cells: 8.7;Proximal tubular cells: 12.0;Respiratory ciliated cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039612, HPA040344, HPA077658, HPA077748" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "prognostic favorable (7.94e-5)" "unprognostic (9.97e-5)" "unprognostic (1.64e-1)" "unprognostic (2.02e-3)" "unprognostic (1.94e-3)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (4.13e-2)" "unprognostic (2.97e-1)" "prognostic favorable (8.77e-4)" "unprognostic (6.46e-3)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (7.79e-2)" 6.0 1.8 1.7 2.2 2.7 1.1 3.6 3.4 2.4 3.1 17.3 3.5 1.5 2.1 2.7 1.8 7.4 2.6 2.2 1.8 3.8 7.8 0.4 4.5 2.2 4.1 5.4 3.2 2.8 5.6 4.8 1.3 3.8 3.5 1.7 1.6 1.4 2.5 0.2 1.9 1.9 2.0 3.8 2.5 2.0 35.7 3.2 3.2 5.1 0.8 2.0 2.6 1.8 3.6 2.8 3.9 2.2 0.1 0.6 0.4 0.7 5.9 6.8 2.5 1.1 0.3 10.3 0.1 1.5 9.1 13.6 2.4 2.7 1.4 1.1 9.5 2.8 0.1 1.8 0.1 0.9 1.7 4.7 2.8 7.4 0.4 0.6 6.3 3.8 4.1 0.0 0.1 2.0 1.8 0.1 0.6 0.3 8.2 3.5 1.0 0.0 1.3 7.0 3.2 5.8 4.2 7.1 3.9 2.6 2.8 4.7 0.6 1.2 7.9 1.0 0.2 4.8 0.1 0.0 0.1 2.1 2.1 5.3 0.5 0.3 0.1 1.3 0.1 1.8 1.1 1.3 1.7 2.4 0.6 0.9 1.0 0.4 2.4 0.1 0.6 0.3 0.5 1.7 2.7 3.4 2.4 1.8 3.8 4.1 5.4 3.8 3.8 3.2 3.6 4.4 12.8 4.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.3 3.2 0.0 0.0 7.4 5.5 0.0 0.2 2.2 0.0 3.9 5.5 0.0 41.5 3.1 1.1 0.0 0.0 0.0 1.4 0.9 2.2 0.0 8.7 0.0 2.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.7 0.0 0.0 12.0 19.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 1.8 1.3 0.0 0.0 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911934-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 28.9;choroid plexus: 32.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 9.3;Extravillous trophoblasts: 14.4;Inhibitory neurons: 8.8;Oligodendrocyte precursor cells: 18.1;Syncytiotrophoblasts: 7.7" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 14.3;MCF7: 5.1;T-47d: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014738, HPA062278" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA014738: AB_1852114, HPA062278: AB_2732679" "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.1 0.0 20.6 0.1 28.9 0.0 0.2 0.0 21.5 0.0 32.1 1.2 0.2 0.6 0.0 0.2 0.1 0.1 0.7 28.8 14.7 0.4 0.0 0.3 0.1 0.0 5.3 0.0 0.9 0.3 0.8 0.0 0.0 0.7 0.2 0.2 0.1 0.3 0.0 0.0 0.6 0.0 0.6 0.5 0.3 0.5 12.5 0.3 0.0 0.0 0.0 0.6 0.0 15.8 0.1 14.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 2.1 0.1 1.5 0.0 0.1 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.1 6.1 0.7 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 28.9 0.0 21.5 28.8 14.7 0.0 5.3 0.0 0.6 12.5 15.8 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 2.0 0.8 1.4 1.4 0.0 0.0 0.0 2.1 0.0 0.1 1.6 0.0 0.0 2.2 0.8 0.3 0.9 1.2 0.0 9.3 0.0 14.4 0.7 0.0 2.0 0.0 0.2 0.0 0.0 0.2 0.0 8.8 0.2 0.0 0.0 0.0 3.4 0.3 0.1 0.0 1.9 0.0 0.3 0.0 18.1 1.4 0.1 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 7.7 0.0 0.4 0.3 0.1 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium inwardly rectifying channel subfamily J member 12" Q14500 17 21376357-21419870 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 25.5;skeletal muscle: 69.1;tongue: 25.7" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 89.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 25.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.3;HeLa: 3.9;PC-3: 4.3;SCLC-21H: 4.8;SiHa: 2.5;SuSa: 5.2;U-2197: 4.2" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.3 1.1 2.9 0.6 2.2 0.4 0.8 25.5 3.3 1.2 0.0 0.9 0.1 0.5 0.6 1.4 2.1 0.4 6.4 1.5 2.9 1.3 0.1 1.9 0.1 4.0 6.0 0.4 0.2 5.5 0.8 0.4 3.1 0.6 0.3 1.3 0.7 0.6 69.1 3.6 0.4 0.6 1.1 1.2 1.1 0.8 10.8 0.1 1.1 25.7 1.0 0.7 0.5 1.4 0.0 0.7 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.0 0.0 4.3 0.0 0.6 1.1 0.0 0.0 4.8 0.2 2.5 0.0 1.1 5.2 0.0 0.0 2.0 0.0 0.3 4.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.2 25.5 3.3 1.5 2.9 4.0 6.0 3.1 1.1 10.8 1.4 1.4 0.0 0.0 0.7 0.0 1.5 0.0 2.3 0.0 2.9 0.0 0.3 14.3 0.0 1.2 1.8 0.0 0.0 0.1 1.1 1.9 0.0 0.5 0.4 0.5 3.4 1.2 0.0 2.8 0.0 0.0 3.4 0.5 1.8 0.0 0.0 6.8 0.1 0.2 89.2 5.7 1.4 4.1 0.0 1.2 0.5 7.5 0.1 0.0 2.8 0.0 10.2 0.0 0.0 0.2 0.0 0.5 4.1 0.0 0.2 0.0 0.8 0.1 1.5 0.0 3.0 0.7 0.6 2.5 0.0 2.3 0.1 0.5 0.0 1.8 0.2 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium inwardly rectifying channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 7.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8;head and neck cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 61: Skin - Cornification" "Cluster 43: Cardiomyocytes - Nuclear processes" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNS3 Kv9.3 ENSG00000170745 "Potassium voltage-gated channel modifier subfamily S member 3" Q9BQ31 2 17877847-18361616 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lung: 23.5;skeletal muscle: 86.0;tongue: 45.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Enteroendocrine cells: 32.5;Theca cells: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 69.2;RPMI-8226: 28.9;RT4: 48.2;U-266/84: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014864 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Golgi apparatus, Plasma membrane" "HPA014864: AB_1852155" "unprognostic (5.62e-2)" "unprognostic (4.27e-3)" "unprognostic (6.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.19e-1)" "unprognostic (1.64e-2)" "unprognostic (3.30e-1)" "unprognostic (9.47e-3)" "unprognostic (9.06e-2)" "unprognostic (8.45e-2)" "unprognostic (5.82e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" 2.9 1.1 2.6 3.8 2.9 0.0 6.2 3.9 4.0 7.8 9.5 12.5 3.7 3.2 2.6 6.0 3.9 5.4 6.6 2.9 4.2 5.0 3.8 23.5 0.6 10.5 7.9 1.0 9.8 2.9 1.2 11.0 12.5 6.5 5.0 0.4 11.2 3.1 86.0 5.6 5.4 3.3 5.3 1.0 9.5 3.9 4.3 1.4 2.3 45.5 2.0 6.8 6.3 4.4 8.5 1.4 0.7 0.0 1.6 0.8 3.8 2.8 8.5 1.7 2.0 0.1 17.1 0.0 0.9 3.0 1.9 2.7 20.7 0.1 1.8 0.0 5.7 0.0 0.2 0.1 8.1 0.2 0.7 0.7 12.9 0.1 1.2 15.5 0.4 3.9 0.4 0.0 1.0 2.2 0.0 0.0 10.2 11.5 0.2 2.4 69.2 28.9 1.8 48.2 20.3 0.7 0.0 5.3 6.1 4.8 2.8 0.0 0.2 2.7 0.0 0.2 21.6 0.1 34.9 0.1 15.2 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.9 3.9 4.0 2.9 4.2 10.5 7.9 12.5 5.3 4.3 4.4 3.8 28.9 8.2 0.0 0.0 13.9 16.8 6.9 21.1 0.2 11.5 7.0 0.5 18.6 6.8 11.0 0.0 0.6 0.0 10.9 0.0 21.5 0.3 0.9 0.6 5.9 32.5 0.0 0.3 0.4 3.5 12.1 8.2 0.9 1.3 4.3 2.5 5.4 0.5 0.0 16.9 5.6 14.2 0.0 4.5 1.2 1.5 0.4 21.4 1.9 0.7 0.1 0.0 7.1 2.5 2.4 4.9 3.8 1.2 13.6 4.1 5.5 1.7 0.2 6.6 13.5 10.6 0.3 3.4 8.0 5.8 0.8 0.6 30.6 10.3 7.1 KCTD15 MGC25497 ENSG00000153885 "Potassium channel tetramerization domain containing 15" Q96SI1 19 33795933-33815763 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 44.4;Granulosa cells: 94.8;Hepatic stellate cells: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 1.8;eosinophil: 5.9;intermediate monocyte: 3.3;myeloid DC: 2.5;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.5;granulocytes: 5.9;monocytes: 4.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050822 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA050822: AB_2681250" "unprognostic (1.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (6.62e-3)" "unprognostic (1.67e-2)" "unprognostic (2.66e-2)" "unprognostic (3.09e-2)" "unprognostic (5.60e-2)" "unprognostic (6.33e-2)" "unprognostic (5.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.65e-8)" "unprognostic (1.40e-1)" "unprognostic (1.89e-3)" "unprognostic (6.13e-2)" "unprognostic (7.30e-2)" 19.2 6.3 29.4 11.3 28.0 6.1 14.2 24.9 34.9 38.8 15.0 41.3 7.0 43.1 3.2 34.8 36.1 10.8 19.1 28.7 29.6 24.7 12.9 24.7 3.0 26.0 30.2 22.7 32.5 4.5 10.3 11.0 24.2 25.0 6.0 15.2 11.6 19.0 6.0 73.2 15.7 20.7 25.8 17.4 23.3 10.5 30.2 1.3 23.0 6.4 4.1 32.0 31.3 23.3 16.7 37.5 33.2 50.8 10.8 5.7 26.2 21.6 4.0 11.7 6.1 21.2 11.1 0.1 47.6 30.3 5.5 19.3 24.3 16.9 4.4 18.1 42.7 68.5 25.3 20.7 29.8 13.3 12.0 11.2 69.4 4.5 26.5 0.0 23.2 9.8 17.3 0.4 2.0 42.0 0.5 37.8 30.4 27.9 62.8 32.0 17.9 6.3 13.3 7.5 25.7 88.0 42.0 59.0 80.0 14.1 43.7 34.7 38.3 54.7 48.9 1.1 3.8 40.9 2.3 27.2 0.1 23.0 68.4 0.6 1.8 5.9 0.0 3.3 0.1 0.0 0.8 0.1 2.5 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.5 0.7 29.4 28.0 24.9 34.9 28.7 29.6 26.0 30.2 24.2 25.8 30.2 23.3 17.8 0.0 1.7 44.4 0.3 15.8 3.3 4.1 10.8 3.5 5.4 5.0 3.2 1.5 2.9 0.0 10.4 0.2 0.4 0.9 3.9 0.7 0.7 3.4 15.1 15.3 1.2 4.2 1.9 8.4 0.4 5.5 1.5 2.5 8.8 94.8 27.8 2.0 1.2 1.7 5.3 3.6 0.0 3.7 5.4 1.9 4.4 3.7 5.4 4.7 3.1 5.0 0.0 11.1 0.3 2.1 1.0 9.1 0.1 3.9 0.3 0.2 0.7 11.7 0.0 3.1 8.7 0.0 1.9 14.3 19.5 0.3 0.7 2.4 1.9 3.1 KDELR1 "ERD2, ERD2.1, HDEL" ENSG00000105438 "KDEL endoplasmic reticulum protein retention receptor 1" P24390 19 48382575-48391551 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 605.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 856.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017455 Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Vesicles, Cytosol" "CAB017455: AB_10615208" "unprognostic (3.10e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.49e-4)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.35e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (7.55e-2)" "unprognostic (4.97e-2)" "unprognostic (3.81e-1)" "unprognostic (2.74e-1)" "unprognostic (3.06e-1)" "unprognostic (1.68e-2)" 109.3 124.4 58.0 61.7 56.5 45.8 106.6 54.5 59.7 132.5 78.1 120.3 132.5 110.0 117.3 107.3 112.2 100.9 96.6 56.1 62.5 119.5 127.2 101.4 53.3 61.1 59.1 165.8 138.9 191.7 116.2 128.7 59.0 102.5 128.5 39.0 137.7 105.0 76.8 103.8 114.5 100.6 56.2 79.5 120.1 93.7 62.9 51.6 121.8 58.4 73.2 102.5 102.4 58.0 216.2 305.3 173.1 184.7 379.7 440.6 126.5 207.4 363.9 247.0 281.0 202.3 238.7 89.1 132.6 456.4 154.4 187.6 211.1 222.2 234.0 72.7 224.5 74.4 99.4 382.2 329.6 84.1 133.4 419.6 268.0 168.5 178.5 387.4 233.0 75.3 131.7 160.9 333.1 173.6 79.4 856.7 126.3 426.8 122.5 112.1 103.4 141.0 316.2 176.3 172.9 134.5 182.1 160.6 113.1 196.7 126.6 102.1 182.6 173.4 142.6 145.3 179.3 451.1 382.0 60.2 110.1 112.4 181.1 10.8 41.0 12.6 18.1 34.7 20.8 17.0 17.6 19.7 30.6 14.3 14.3 16.1 9.9 20.2 30.2 45.4 20.4 18.2 58.0 56.5 54.5 59.7 56.1 62.5 61.1 59.1 59.0 56.2 62.9 58.0 150.8 35.3 54.2 8.5 82.2 75.3 130.6 147.1 124.7 39.4 141.0 154.4 28.8 98.7 110.9 93.8 6.2 231.7 59.5 153.0 56.7 224.1 6.2 72.0 188.8 111.4 145.0 56.8 8.7 169.0 605.5 161.0 120.3 166.3 62.7 149.2 102.8 79.6 180.0 40.4 12.7 379.6 93.6 107.6 73.5 14.2 163.5 103.1 92.5 8.4 102.3 89.8 35.0 10.6 10.6 190.3 199.8 132.0 365.9 161.2 213.8 149.6 49.2 28.1 85.5 87.9 131.6 41.8 69.1 127.7 70.2 387.7 55.4 191.3 202.9 157.6 KEL "CD238, ECE3" ENSG00000197993 "Kell metallo-endopeptidase (Kell blood group)" P23276 7 142941114-142962363 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 56.3;testis: 32.3" "Cell type enhanced" "Detected in some" "Erythroid cells: 79.7;Oligodendrocytes: 30.1;Squamous epithelial cells: 16.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "HEL: 31.7;K-562: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA064442 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 1.8 0.8 2.7 56.3 0.3 1.7 2.2 0.9 1.4 0.1 0.0 0.2 0.0 0.8 0.5 0.0 0.3 2.0 1.5 0.6 0.3 0.5 10.6 2.5 2.2 0.2 0.2 0.0 0.2 0.4 2.4 0.3 0.0 0.1 0.6 0.1 0.2 0.1 0.9 0.0 1.9 4.9 0.2 32.3 2.4 1.3 0.3 0.0 6.7 0.1 0.4 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 31.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.5 0.1 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.2 0.0 0.0 0.3 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 1.7 2.2 2.0 1.5 2.5 2.2 2.4 1.9 2.4 2.8 0.2 0.0 0.0 0.3 0.0 0.0 1.3 0.2 4.0 0.0 0.3 0.1 0.4 0.0 1.4 3.7 0.0 0.1 0.1 0.0 1.9 0.3 2.4 0.2 0.1 0.1 0.0 79.7 3.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 3.1 0.0 1.4 0.2 16.8 0.0 0.1 0.0 0.0 0.0 0.9 KIAA0319L "AAVR, KIAA1837" ENSG00000142687 "KIAA0319 like" Q8IZA0 1 35433492-35557950 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 47.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072692 Supported Supported "Nucleoli,Golgi apparatus" NA NA 1100000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoli "HPA072692: AB_2686549" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (4.23e-3)" "unprognostic (1.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.92e-5)" "unprognostic (3.41e-3)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.79e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.47e-1)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (1.84e-1)" 14.3 26.6 28.3 13.0 28.0 15.9 27.8 23.4 28.0 25.6 28.9 25.6 26.3 14.4 26.2 18.3 35.1 21.3 44.5 28.0 27.6 38.2 34.2 30.9 17.7 26.9 29.2 14.9 42.1 45.6 26.9 30.6 25.5 34.9 30.0 34.1 33.5 18.5 37.7 20.1 24.8 14.4 24.8 20.1 34.4 17.1 32.4 17.8 41.4 40.1 16.8 15.8 15.1 24.9 13.5 19.6 39.8 31.5 52.7 36.9 37.8 17.9 37.8 25.5 37.5 21.2 52.9 15.0 48.0 19.6 38.1 26.1 29.7 28.8 28.9 23.8 21.7 20.3 23.4 23.6 41.3 16.9 26.8 52.3 36.2 29.5 38.0 84.3 42.2 18.1 27.2 21.0 35.2 13.6 10.1 14.3 45.3 37.4 11.7 11.3 33.8 18.7 41.8 32.4 8.7 24.6 25.8 30.6 53.3 86.9 32.3 23.1 43.6 17.4 18.7 14.9 28.0 31.1 26.7 9.8 44.3 21.8 17.7 8.8 19.4 9.4 5.0 6.1 4.8 3.4 4.1 4.7 5.6 4.1 5.5 4.0 47.2 9.8 4.0 3.7 4.0 8.7 28.3 28.0 23.4 28.0 28.0 27.6 26.9 29.2 25.5 24.8 32.4 24.9 24.2 73.7 74.1 85.2 18.3 7.9 14.4 16.5 15.4 74.8 33.9 26.0 55.0 47.1 42.4 35.0 108.4 33.3 16.6 35.4 3.9 19.2 9.6 21.0 17.7 24.6 21.6 14.7 93.2 32.5 22.5 19.4 28.5 30.8 21.5 42.7 28.9 47.4 19.1 63.9 95.2 59.5 16.2 31.4 7.6 7.5 17.4 19.2 14.2 62.8 31.4 30.5 29.9 115.1 99.3 30.3 27.6 17.3 17.2 26.0 36.8 17.5 45.4 61.9 6.6 24.5 15.7 22.5 21.2 17.8 9.2 31.2 21.9 30.1 31.2 14.8 KIAA1210 ENSG00000250423 KIAA1210 Q9ULL0 X 119078635-119150579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 39.4;seminal vesicle: 19.8;testis: 30.9" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Endometrial stromal cells: 25.2;Granulosa cells: 11.1;Late spermatids: 11.5;Peritubular cells: 6.0" "Cancer enhanced" "Detected in single" "prostate cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.0" "Not detected" "Not detected" "HPA000551, HPA048322" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus, Vesicles" "HPA000551: AB_1079165, HPA048322: AB_2680358" "unprognostic (2.48e-1)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-1)" "unprognostic (2.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (5.69e-2)" "unprognostic (1.05e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.24e-1)" "unprognostic (6.26e-4)" 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 1.6 39.4 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 19.8 0.3 0.0 0.0 0.2 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.0 1.9 25.2 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.6 0.0 11.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 11.5 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.4 1.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210503-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 105.0" "Group enriched" "Detected in some" 4 "Astrocytes: 63.3;Microglial cells: 67.5;Oligodendrocytes: 135.6" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 75.6;ASC diff: 11.3;ASC TERT1: 16.9;WM-115: 19.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoli "Golgi apparatus, Vesicles" "HPA051064: AB_2681331" "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 5.6 2.1 18.4 6.0 87.7 0.5 3.4 39.2 42.2 13.1 0.0 9.0 2.4 14.6 6.4 5.1 8.7 16.2 11.4 29.0 64.1 4.1 1.2 2.5 5.0 59.2 62.3 13.6 0.9 0.1 2.2 0.1 54.7 6.6 4.2 0.5 5.8 7.3 0.6 1.4 4.2 14.7 18.3 2.7 3.6 2.6 75.3 8.3 2.0 1.7 4.7 5.2 4.8 105.0 3.0 0.3 75.6 0.1 11.3 16.9 0.0 7.6 4.3 0.0 0.0 0.3 2.2 0.0 0.3 2.4 2.5 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.3 0.0 2.2 1.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 2.0 0.1 0.0 0.0 0.4 0.0 1.1 0.4 1.4 0.0 0.0 0.0 0.2 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 87.7 39.2 42.2 29.0 64.1 59.2 62.3 54.7 18.3 75.3 105.0 0.1 0.0 0.0 63.3 0.0 0.3 0.0 0.0 0.0 0.0 0.8 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.5 0.1 2.5 0.2 0.0 0.0 0.8 0.0 0.0 4.4 0.0 0.6 0.0 0.0 0.4 1.1 0.1 0.0 0.5 0.0 0.0 0.0 0.5 1.9 3.7 0.2 1.8 67.5 0.0 0.0 0.0 19.6 135.6 0.6 0.0 7.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 1.1 1.2 0.3 0.3 0.2 0.3 0.0 0.0 0.4 0.0 0.0 KIAA2013 "MGC33867, RP5-1077B9.1" ENSG00000116685 KIAA2013 Q8IYS2 1 11919591-11926428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 116.7;Proximal enterocytes: 139.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052677, HPA060536" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" Cytosol "HPA052677: AB_2681911, HPA060536: AB_2684313" "unprognostic (3.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.63e-2)" "unprognostic (1.48e-1)" "unprognostic (2.02e-2)" "unprognostic (1.87e-2)" "unprognostic (5.51e-3)" "unprognostic (8.60e-2)" "unprognostic (5.26e-2)" "unprognostic (2.92e-1)" "unprognostic (1.10e-2)" "unprognostic (5.04e-2)" "unprognostic (6.05e-2)" "unprognostic (2.04e-2)" "unprognostic (2.94e-2)" "unprognostic (8.24e-3)" "unprognostic (3.74e-3)" 27.9 25.6 23.6 17.3 28.7 19.3 25.5 28.0 24.1 25.4 24.9 43.7 65.5 35.5 35.7 30.1 27.1 20.6 39.1 23.9 24.3 30.2 59.4 23.8 21.8 32.3 28.8 19.7 42.4 20.0 31.8 20.9 27.7 27.8 20.1 6.1 40.4 25.7 51.9 37.8 61.8 17.2 27.6 35.1 31.4 37.2 27.3 16.8 26.8 23.2 13.1 32.2 25.5 31.6 61.2 44.5 20.5 40.6 34.0 23.2 33.8 38.1 39.8 45.0 46.4 55.1 61.7 39.8 56.9 36.2 35.2 69.3 27.8 37.6 23.8 46.3 71.4 27.4 39.7 95.7 38.4 57.2 54.3 29.7 41.0 44.1 19.4 48.7 43.6 31.2 42.6 51.5 27.2 46.2 36.6 80.1 27.0 27.0 60.6 46.3 37.4 97.6 29.0 16.5 76.1 43.0 30.9 34.1 74.8 20.4 28.6 52.6 42.1 37.9 49.2 56.3 52.6 61.8 47.1 46.0 45.1 91.8 41.1 3.3 4.9 5.1 4.7 4.2 3.7 5.2 2.5 3.6 3.5 6.8 2.5 3.3 11.1 4.1 3.5 8.5 5.5 2.6 23.6 28.7 28.0 24.1 23.9 24.3 32.3 28.8 27.7 27.6 27.3 31.6 26.1 22.4 13.4 12.4 18.7 22.2 9.2 13.6 6.8 20.7 30.5 27.1 18.7 18.6 13.0 25.8 12.5 18.1 32.6 116.7 3.9 15.5 24.4 23.7 18.4 22.9 40.9 11.8 9.9 19.3 30.8 18.7 17.3 27.7 13.3 23.1 27.1 75.2 26.5 32.0 8.8 50.1 22.4 40.3 23.0 41.5 22.7 27.1 19.6 6.5 26.5 18.7 28.8 8.5 22.1 24.7 72.2 23.0 18.4 17.3 139.9 22.3 17.8 22.1 19.7 27.5 15.7 17.6 8.6 15.0 28.1 13.3 16.0 31.1 59.4 17.3 KIF12 ENSG00000136883 "Kinesin family member 12" Q96FN5 9 114086126-114099291 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 162.3;pancreas: 85.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 105.8;Collecting duct cells: 90.1;Distal tubular cells: 80.3;Ductal cells: 43.3;Enteroendocrine cells: 64.1;Proximal enterocytes: 60.3;Proximal tubular cells: 79.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 9.6;OE19: 17.2;RPTEC TERT1: 44.8;SCLC-21H: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020192, HPA024127" Uncertain Uncertain "Golgi apparatus,Plasma membrane" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus, Plasma membrane" "HPA020192: AB_1852467, HPA024127: AB_1852469" "unprognostic (5.29e-2)" "unprognostic (5.03e-2)" "unprognostic (3.34e-1)" "unprognostic (1.84e-2)" "unprognostic (5.80e-2)" "unprognostic (8.38e-2)" "unprognostic (9.81e-2)" "unprognostic (4.41e-2)" "unprognostic (1.90e-1)" "unprognostic (3.98e-2)" "unprognostic (1.69e-2)" "unprognostic (3.33e-2)" "unprognostic (1.10e-2)" "unprognostic (4.51e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" 0.1 0.0 2.2 1.1 2.1 0.0 25.3 0.4 3.6 11.4 2.8 7.8 25.5 4.2 1.0 0.2 8.0 24.7 0.2 2.0 0.9 162.3 27.7 1.6 0.5 0.6 1.1 0.7 85.4 0.8 0.6 1.1 1.0 7.0 4.2 0.1 3.6 4.8 0.0 1.4 16.1 0.4 0.4 0.2 11.0 2.4 1.3 1.3 31.8 0.0 0.1 0.2 0.3 0.8 0.0 4.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.6 0.2 0.0 5.2 0.0 0.6 0.0 0.2 0.1 0.2 0.0 0.9 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.0 0.0 0.4 0.1 17.2 0.6 0.0 0.0 0.1 44.8 0.2 6.6 0.1 0.0 0.9 0.0 0.2 4.5 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.1 0.4 3.6 2.0 0.9 0.6 1.1 1.0 0.4 1.3 0.8 0.1 0.0 4.4 0.0 1.3 0.0 0.9 0.6 0.0 0.0 20.3 10.8 0.4 105.8 0.0 90.1 0.0 0.1 0.0 7.9 80.3 43.3 7.0 8.3 1.5 0.3 64.1 0.0 0.7 11.8 9.3 0.4 14.8 15.6 0.0 0.0 0.0 10.2 0.3 0.0 0.3 22.0 0.0 0.3 0.0 14.7 0.6 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.1 5.7 21.3 0.0 0.0 2.2 60.3 79.1 0.0 0.0 0.0 0.0 0.3 3.2 7.9 0.0 0.0 0.5 0.9 0.3 28.9 0.5 KLF5 "BTEB2, CKLF, IKLF" ENSG00000102554 "Kruppel like factor 5" Q13887 13 73054976-73077541 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 242.0;skin 1: 234.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 1105.5;Basal squamous epithelial cells: 757.5;Glandular and luminal cells: 678.2;Squamous epithelial cells: 1028.4;Suprabasal keratinocytes: 685.9;Urothelial cells: 1495.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 21 "basophil: 24.0" "Lineage enriched" "Detected in single" 140 "granulocytes: 24.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 111.8;HaCaT: 128.8;HBEC3-KT: 112.2;hTCEpi: 156.1;OE19: 246.3;RT4: 136.3;SiHa: 114.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 23.2" HPA040398 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Golgi apparatus, Vesicles" "HPA040398: AB_10673267" "unprognostic (7.90e-3)" "unprognostic (5.11e-2)" "unprognostic (2.03e-2)" "unprognostic (1.56e-1)" "unprognostic (4.69e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (3.97e-2)" "unprognostic (5.82e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (4.43e-2)" "unprognostic (1.42e-3)" "unprognostic (3.56e-3)" "unprognostic (3.98e-1)" "unprognostic (5.09e-2)" "unprognostic (1.54e-2)" 6.5 5.9 4.2 18.0 9.1 63.5 36.2 0.6 3.3 49.9 2.7 161.2 130.4 6.7 6.6 242.0 37.5 55.9 3.3 2.6 3.4 8.5 4.7 29.6 2.0 0.8 3.4 4.5 11.9 0.5 10.9 18.8 0.7 23.1 145.4 0.4 79.8 14.4 19.2 234.9 146.2 6.6 0.5 1.5 82.2 12.0 4.1 12.0 25.7 7.8 53.6 111.5 122.2 1.0 22.3 31.1 0.2 0.4 1.1 1.5 34.1 12.9 29.8 5.6 6.9 28.5 111.8 0.4 68.9 11.4 2.3 128.8 39.0 112.2 8.9 0.9 11.0 0.4 61.9 2.8 7.8 10.5 1.9 8.1 156.1 1.7 61.1 5.7 0.1 3.8 1.6 2.2 25.5 7.9 2.1 0.8 1.4 246.3 43.3 2.0 28.3 2.5 87.3 136.3 2.9 1.3 114.5 18.3 8.5 13.9 2.5 2.5 0.3 7.8 23.1 0.2 5.4 3.7 1.9 3.8 10.8 2.1 9.5 24.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.1 4.2 9.1 0.6 3.3 2.6 3.4 0.8 3.4 0.7 0.5 4.1 1.0 7.8 163.5 123.3 0.7 5.2 518.9 1105.5 185.6 757.5 0.4 79.9 57.0 6.0 91.5 218.5 36.8 2.1 77.8 4.6 420.7 21.5 31.8 448.3 302.1 44.1 12.5 203.2 0.4 1.6 46.1 98.5 33.4 425.1 678.2 3.8 0.9 2.2 4.7 6.1 10.1 11.6 387.4 46.8 0.9 34.6 241.4 6.5 12.4 58.7 1.9 4.3 0.0 1.0 1.0 0.6 88.6 374.9 1.5 15.7 632.1 260.0 3.5 159.3 0.2 0.0 38.4 32.4 8.8 26.3 1028.4 685.9 58.0 17.4 0.5 505.4 1495.5 KLHL20 "KHLHX, KLEIP" ENSG00000076321 "Kelch like family member 20" Q9Y2M5 1 173714941-173786692 "Predicted intracellular proteins" "Protein transport, Transport, Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025034, HPA053704" Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus, Cytosol" "HPA025034: AB_1852578, HPA053704: AB_2682234" "unprognostic (2.97e-3)" "unprognostic (3.11e-2)" "unprognostic (8.27e-2)" "unprognostic (6.48e-3)" "unprognostic (1.56e-2)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (1.84e-2)" "unprognostic (2.14e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (8.66e-2)" "unprognostic (3.02e-1)" "unprognostic (1.90e-1)" "unprognostic (2.62e-2)" 13.8 10.2 5.8 7.6 7.1 5.9 8.7 7.3 6.7 11.8 4.7 9.7 6.7 13.6 6.9 9.8 8.1 9.3 10.8 6.5 6.3 10.8 16.2 10.0 9.7 7.4 6.7 12.0 6.0 7.9 5.3 11.4 7.1 13.1 8.9 9.0 6.1 9.3 12.5 9.5 7.8 13.4 6.9 10.3 7.5 15.9 6.5 12.3 8.4 13.9 9.1 10.0 8.2 6.9 12.8 8.0 12.5 13.1 28.7 26.4 10.2 19.7 19.2 14.9 15.6 5.8 8.7 9.0 16.4 21.3 7.9 12.5 11.2 14.2 17.4 11.0 6.0 8.2 10.8 6.9 18.4 15.5 9.3 22.6 16.1 13.8 18.4 17.3 22.2 9.0 18.5 10.0 27.6 4.7 9.1 8.0 13.3 11.3 36.1 9.7 15.4 9.8 11.4 8.1 5.3 14.7 18.0 12.1 12.3 16.9 10.8 18.0 22.2 14.3 8.6 17.6 15.7 13.3 7.4 13.5 9.4 11.0 16.2 7.0 2.9 4.3 4.5 3.2 4.0 3.6 4.4 5.5 2.8 3.5 5.6 5.7 1.6 3.2 2.4 4.6 5.6 2.3 5.8 7.1 7.3 6.7 6.5 6.3 7.4 6.7 7.1 6.9 6.5 6.9 21.8 16.0 25.9 36.2 17.3 11.1 8.1 13.5 8.0 13.3 8.0 8.0 12.8 17.2 12.8 12.9 37.5 13.1 18.1 13.5 1.9 9.9 132.4 4.4 14.0 23.4 9.6 11.1 28.1 12.1 10.1 18.2 16.3 5.6 7.6 14.9 42.1 21.0 11.2 11.8 37.3 9.1 10.2 18.5 9.1 30.2 22.4 10.0 3.6 18.7 9.4 16.4 20.6 33.7 35.2 11.4 8.9 28.6 12.3 8.8 16.3 14.1 8.2 20.7 0.0 20.9 16.4 55.8 35.6 11.3 10.5 9.9 16.9 24.1 9.7 7.8 KRBOX1 ENSG00000240747 "KRAB box domain containing 1" C9JBD0 3 42809483-42942792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 24 "testis: 197.8" "Cell type enhanced" "Detected in many" "Early spermatids: 250.9;Late spermatids: 111.3;Spermatocytes: 883.9;Spermatogonia: 176.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.2;CAPAN-2: 50.0;EFO-21: 22.6;GAMG: 35.2;hTEC/SVTERT24-B: 33.7;hTERT-HME1: 23.0;U-2197: 67.7" HPA046901 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 83: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus" "HPA046901: AB_2797232" "unprognostic (2.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-3)" "unprognostic (7.63e-3)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (2.27e-1)" "unprognostic (5.64e-2)" "unprognostic (2.95e-2)" "unprognostic (9.66e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" 3.4 4.7 2.9 0.2 2.9 0.5 3.9 3.1 3.8 5.8 2.8 4.9 1.7 5.3 8.1 4.3 3.9 1.2 3.8 3.0 3.0 6.0 0.6 1.5 0.9 3.1 2.9 6.9 3.9 0.8 4.0 1.3 2.9 3.6 2.0 1.9 2.3 5.3 1.6 5.1 1.8 4.7 2.9 1.2 2.7 197.8 2.9 1.5 5.2 1.1 1.6 3.8 3.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 8.7 22.2 0.2 0.0 0.1 50.0 0.0 22.6 1.8 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 9.7 0.0 33.7 23.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 17.0 0.0 67.7 0.0 7.4 2.6 0.0 3.8 0.0 1.4 0.0 0.3 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 4.0 0.7 1.0 0.3 0.0 2.9 2.9 3.1 3.8 3.0 3.0 3.1 2.9 2.9 2.9 2.9 3.1 2.2 0.0 2.6 1.6 0.1 0.0 2.6 0.0 0.6 8.8 4.2 11.3 5.6 2.8 1.8 5.5 2.1 12.0 0.2 0.4 19.6 4.2 250.9 4.4 7.7 1.6 0.0 0.0 0.8 12.0 10.1 6.1 0.0 2.5 0.0 3.8 1.4 1.0 2.2 1.7 1.4 1.4 0.0 0.0 0.0 111.3 20.2 1.0 0.0 1.0 0.0 18.3 1.0 1.5 1.0 6.8 3.2 13.5 0.0 1.8 1.2 3.1 0.7 8.8 13.1 5.2 6.9 883.9 176.0 0.6 0.0 9.0 0.2 14.3 2.8 1.0 KRT2 "KRT2A, KRTE" ENSG00000172867 "Keratin 2" P35908 12 52644558-52652211 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 57 "skin 1: 4660.3" "Cell type enriched" "Detected in some" 14 "Suprabasal keratinocytes: 265.4" "Cancer enriched" "Detected in some" 5 "melanoma: 23.4" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in single" "HEL: 2.0" "Group enriched" "Detected in some" 6 "amygdala: 1.7;hippocampal formation: 2.7" "Not detected" "Not detected" "HPA006299, CAB037321" Enhanced Approved "Golgi apparatus,Intermediate filaments,Cytosol" NA NA 9700000000 "Cluster 32: T-cells - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 3: HMC-1 - Innate immune response" "Cluster 28: Keratinocytes - Keratinization" "Intermediate filaments, Cytosol" "Golgi apparatus" "CAB037321: , HPA006299: AB_1079180" "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (8.47e-3)" "unprognostic (1.69e-2)" "unprognostic (1.84e-1)" "unprognostic (3.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.76e-2)" "unprognostic (3.56e-7)" "unprognostic (6.43e-2)" "unprognostic (5.98e-3)" "unprognostic (6.69e-2)" "unprognostic (3.46e-1)" 3.0 0.5 0.0 0.1 0.0 1.0 81.9 0.0 0.0 0.8 0.0 0.9 1.6 0.4 0.3 1.1 0.1 0.0 1.7 0.0 0.0 0.5 1.2 1.0 0.5 0.0 0.0 0.5 1.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 1.6 0.0 47.8 4660.3 0.8 0.0 0.0 0.5 0.7 1.0 0.0 6.8 0.8 0.0 6.1 0.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.5 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 9.5 0.0 0.0 0.1 8.8 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 265.4 0.1 1.0 0.0 0.6 0.1 LACTB2 CGI-83 ENSG00000147592 "Lactamase beta 2" Q53H82 8 70635318-70669185 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.0" "Cell type enhanced" "Detected in all" "Early spermatids: 286.3;Proximal tubular cells: 325.7;Spermatocytes: 263.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 437.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044391, HPA053040" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 37000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Nucleoplasm, Golgi apparatus" "HPA044391: AB_10965168, HPA053040: AB_2682022" "unprognostic (6.33e-3)" "unprognostic (3.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.23e-2)" "unprognostic (1.82e-1)" "unprognostic (4.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.34e-1)" "unprognostic (8.10e-2)" "unprognostic (3.95e-1)" "unprognostic (7.73e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.60e-4)" "unprognostic (3.70e-1)" "unprognostic (7.49e-2)" "unprognostic (2.93e-1)" "unprognostic (5.93e-2)" 20.4 39.3 6.4 12.9 8.0 3.2 18.4 8.4 9.0 10.8 8.7 21.9 38.8 9.6 11.5 10.2 9.3 28.7 29.8 5.8 8.3 77.0 96.0 20.1 15.6 8.1 7.9 10.0 14.8 21.0 8.3 10.6 8.9 15.4 21.3 12.7 15.0 9.2 28.2 12.4 33.8 15.7 8.1 11.5 16.0 63.2 7.6 14.5 20.2 32.1 13.5 13.2 7.9 10.6 65.7 66.4 20.8 8.6 35.6 53.7 12.5 36.0 20.7 37.7 28.2 32.3 72.3 0.1 14.4 17.4 75.7 45.9 25.0 38.0 30.2 38.8 26.6 30.5 8.1 18.0 74.0 30.1 25.5 64.6 44.8 18.6 28.2 18.0 10.0 23.2 53.4 60.1 50.6 19.6 17.1 5.5 22.3 88.2 60.3 15.2 12.1 14.0 146.3 33.8 29.6 10.3 79.7 437.8 41.0 27.0 72.7 40.1 16.0 3.0 20.8 67.4 29.4 47.7 38.1 0.2 21.1 50.6 28.7 15.8 13.8 13.0 8.5 16.8 10.6 12.6 8.8 8.4 17.3 11.7 8.3 9.2 5.8 11.0 16.7 11.9 13.4 5.9 6.4 8.0 8.4 9.0 5.8 8.3 8.1 7.9 8.9 8.1 7.6 10.6 15.1 57.7 45.1 3.6 16.0 16.4 22.1 58.9 12.5 15.4 12.1 15.1 38.4 18.6 43.9 18.4 8.4 25.1 12.0 27.2 76.3 51.2 286.3 29.4 11.7 15.3 12.1 19.6 3.9 117.2 15.3 15.1 20.4 31.5 9.5 8.7 19.2 76.1 48.0 8.4 4.6 25.8 34.6 34.5 11.2 40.9 20.5 24.2 16.0 3.7 19.4 35.3 8.2 2.5 10.3 70.2 25.1 15.1 18.3 16.0 59.8 325.7 44.9 14.7 6.6 9.6 14.4 263.1 25.0 12.4 16.8 19.4 13.9 34.2 34.7 11.0 LAMC2 "BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa" ENSG00000058085 "Laminin subunit gamma 2" Q13753 1 183186238-183245127 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 39.3" "Cell type enriched" "Detected in many" 5 "Pancreatic endocrine cells: 1531.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 231.3" "Region enhanced" "Detected in some" "cerebellum: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 574.7;CAPAN-2: 501.6;HBEC3-KT: 2492.2;hTERT-HME1: 1487.5;RPTEC TERT1: 579.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004257, HPA024638, HPA046539, CAB078165" Enhanced Uncertain "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" No No 130000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Endoplasmic reticulum, Golgi apparatus" "CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689, HPA046539: " "unprognostic (7.27e-3)" "unprognostic (7.21e-3)" "unprognostic (3.24e-1)" "unprognostic (6.20e-3)" "unprognostic (9.43e-2)" "unprognostic (4.94e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.25e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (7.11e-5)" "unprognostic (2.77e-1)" "unprognostic (7.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" 3.5 0.1 0.2 16.2 1.9 0.1 20.9 2.6 0.6 15.1 0.2 12.1 2.6 12.3 2.1 7.7 34.9 13.0 3.0 0.2 0.2 13.8 0.7 24.9 8.0 0.0 0.1 1.0 3.3 0.0 4.2 10.9 0.1 5.4 12.9 0.1 12.9 6.1 1.7 17.5 15.0 3.3 0.0 0.9 14.9 2.8 0.1 11.3 18.5 2.3 12.3 39.3 6.3 0.2 574.7 25.4 0.0 0.7 4.9 11.9 40.2 4.3 4.7 2.1 0.7 41.4 501.6 0.0 207.9 1.4 16.4 252.4 0.1 2492.2 2.7 0.7 0.2 0.0 0.5 0.1 1.2 0.0 0.2 6.1 189.7 6.0 1487.5 2.3 32.6 0.0 0.0 0.2 2.5 1.1 0.0 0.1 4.5 206.7 35.2 0.1 1.2 0.0 579.4 147.1 30.5 0.1 14.7 0.4 0.9 14.9 2.0 2.7 3.8 2.2 30.2 15.0 7.8 0.9 0.7 0.7 4.1 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.9 2.6 0.6 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.5 218.0 17.8 0.0 0.2 86.3 227.1 232.7 105.3 0.0 8.2 26.2 2.3 10.0 56.8 23.9 0.0 30.7 0.4 74.4 0.0 183.4 19.6 68.9 3.6 7.8 9.0 0.0 0.4 94.0 11.7 17.2 59.7 97.4 0.0 0.0 0.0 0.0 2.5 0.0 0.3 34.1 14.2 0.0 4.9 11.8 3.4 3.1 8.8 1.0 2.6 0.0 0.0 0.0 0.3 1531.1 91.2 0.4 0.3 302.0 16.7 0.2 69.3 0.0 0.0 3.4 9.6 3.6 1.0 60.3 29.7 83.3 5.3 0.1 15.3 169.9 LAMTOR1 "C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1" ENSG00000149357 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1" Q6IAA8 11 72085895-72103297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002997 Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA 160000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus" "Vesicles, Plasma membrane" "HPA002997: AB_1845531" "unprognostic (7.32e-2)" "unprognostic (1.79e-1)" "unprognostic (3.94e-2)" "unprognostic (3.77e-2)" "unprognostic (2.30e-1)" "unprognostic (2.71e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-3)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.04e-1)" 100.7 143.8 171.2 69.1 177.8 118.6 96.2 173.2 180.4 87.0 162.1 88.6 67.5 86.5 90.0 114.1 74.9 65.8 131.9 163.5 169.5 129.5 114.2 91.3 80.6 177.4 177.2 81.5 85.6 87.0 92.0 67.4 174.9 102.4 76.5 46.6 85.8 71.7 126.4 89.9 82.5 73.7 175.4 130.9 96.6 41.2 176.1 75.4 112.3 109.3 79.4 88.5 77.9 172.5 94.2 181.0 97.3 132.0 224.7 152.3 97.6 129.0 201.6 206.2 151.7 230.9 139.7 93.1 162.3 216.9 214.2 138.1 171.1 260.1 155.8 117.8 99.3 245.6 108.5 156.5 291.4 97.2 147.7 252.3 199.2 224.4 224.0 116.4 173.1 102.5 104.1 96.0 211.4 295.6 86.2 146.1 93.9 291.8 194.9 73.7 178.9 78.8 246.8 195.1 65.7 103.3 127.6 127.5 343.7 106.4 192.6 93.2 125.3 137.5 98.0 323.8 93.0 111.6 139.0 80.4 81.8 81.8 113.0 113.4 414.3 274.1 80.6 228.8 77.7 132.1 75.6 81.1 332.6 146.2 63.4 77.9 229.5 122.8 180.6 197.1 98.8 397.5 171.2 177.8 173.2 180.4 163.5 169.5 177.4 177.2 174.9 175.4 176.1 172.5 132.6 44.8 71.6 9.1 109.7 55.7 161.7 271.1 117.8 58.5 159.9 195.7 66.4 121.5 120.2 128.8 12.5 266.5 110.7 235.4 295.4 276.4 12.4 61.2 98.9 134.9 116.4 133.5 9.8 340.2 300.1 111.6 71.4 85.2 97.7 71.5 142.1 86.9 468.0 77.4 12.9 140.2 170.9 248.5 111.6 19.2 107.8 311.5 113.8 8.4 413.6 223.7 177.1 10.1 24.2 307.3 202.6 102.7 87.9 193.4 230.3 370.9 61.0 56.1 111.7 102.5 116.3 58.7 103.3 126.1 55.4 282.0 89.4 178.5 170.8 157.2 LAPTM4A "HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp" ENSG00000068697 "Lysosomal protein transmembrane 4 alpha" Q15012 2 20032650-20051628 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 1393.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031402, HPA031404, HPA068554" Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Vesicles" "Plasma membrane" "HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: AB_2686003" "unprognostic (2.01e-1)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (5.73e-1)" "unprognostic (6.04e-2)" "unprognostic (3.00e-2)" "unprognostic (1.53e-3)" "unprognostic (5.37e-2)" "unprognostic (1.27e-1)" "unprognostic (3.65e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (8.70e-2)" "unprognostic (1.05e-2)" "unprognostic (7.78e-3)" "unprognostic (2.18e-2)" "unprognostic (7.98e-3)" "unprognostic (2.36e-1)" 360.5 451.0 116.8 177.1 114.9 199.5 338.5 120.7 146.8 469.8 150.8 256.2 219.6 507.6 339.7 315.4 370.1 383.7 322.5 112.7 130.2 460.9 409.2 308.0 160.1 123.3 122.2 460.3 290.8 289.2 155.6 397.6 128.1 306.3 233.9 59.1 306.0 611.8 204.4 247.2 227.7 412.2 130.1 190.9 240.5 389.3 125.5 122.8 365.8 234.8 178.5 342.1 248.7 128.0 417.7 228.8 136.4 283.2 1393.4 1031.8 509.1 514.3 651.8 349.3 393.6 180.5 398.4 73.2 116.2 637.9 356.9 400.7 115.0 250.6 317.8 181.2 183.2 112.4 244.3 520.1 534.8 86.7 294.9 691.7 501.2 338.7 386.4 481.9 367.6 62.2 86.6 135.8 527.5 243.3 53.8 114.0 299.2 353.1 207.1 89.3 397.5 139.7 858.6 347.7 214.8 207.3 480.4 390.5 335.9 492.9 169.6 70.1 467.5 575.7 203.8 500.3 336.5 221.7 349.2 118.3 455.3 172.8 234.4 737.8 382.3 289.3 94.6 324.9 116.4 197.4 112.9 106.9 269.2 192.3 126.7 113.7 200.1 124.3 393.4 226.9 119.3 427.0 116.8 114.9 120.7 146.8 112.7 130.2 123.3 122.2 128.1 130.1 125.5 128.0 351.7 195.5 203.1 39.2 156.5 659.0 601.1 1210.5 339.2 24.4 330.3 306.1 211.7 380.3 727.7 553.6 12.5 224.4 109.8 174.8 162.4 539.4 1235.7 195.7 407.1 384.0 138.1 65.0 15.0 347.6 1035.3 896.8 111.6 286.0 521.9 445.7 331.3 519.4 311.3 20.2 14.3 203.6 767.0 299.3 716.0 1080.9 835.3 254.4 588.7 39.4 278.0 315.3 48.4 34.7 18.7 289.4 246.2 600.7 156.8 331.2 171.5 940.9 506.7 24.7 532.5 389.4 583.0 356.3 173.5 268.2 709.8 302.9 146.4 579.1 224.8 500.9 LAPTM4B LC27 ENSG00000104341 "Lysosomal protein transmembrane 4 beta" Q86VI4 8 97775057-97853013 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 380.1" "Cell type enhanced" "Detected in all" "Granulosa cells: 348.5;Rod photoreceptor cells: 575.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.3" "Group enriched" "Detected in many" 7 "granulocytes: 3.3;T-cells: 1.4" "Cell line enhanced" "Detected in many" "HEL: 611.7;RPTEC TERT1: 549.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020782, HPA068830" Uncertain Approved "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "CAB020782: , HPA068830: AB_2686044" "prognostic unfavorable (5.63e-4)" "unprognostic (1.91e-2)" "unprognostic (7.04e-2)" "unprognostic (6.83e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (2.70e-6)" "unprognostic (9.25e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-1)" "unprognostic (7.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.65e-1)" "unprognostic (3.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" 24.2 43.2 30.2 18.0 29.7 5.3 42.9 37.3 29.6 50.1 78.2 34.0 79.7 71.0 29.3 33.7 67.5 46.3 220.9 23.6 35.3 67.3 25.3 39.6 13.7 42.1 36.1 45.1 28.8 185.5 20.3 28.2 39.5 29.2 32.9 380.1 32.8 44.9 153.7 43.9 43.0 47.8 45.2 38.3 32.2 62.5 44.2 8.6 43.0 117.0 20.2 41.0 28.5 50.1 219.2 170.8 171.9 350.3 80.2 61.0 108.1 98.0 50.1 222.9 188.6 103.1 168.0 1.0 378.0 73.5 75.2 241.2 208.8 94.8 242.9 1.5 282.4 611.7 130.6 169.0 66.1 0.3 101.5 83.8 71.0 130.8 66.0 75.1 29.1 69.5 375.7 0.8 92.4 164.1 54.5 34.1 318.8 116.5 106.5 0.6 90.5 0.7 549.4 100.9 172.8 287.1 133.6 63.8 159.4 188.0 154.3 83.7 8.1 47.7 92.0 99.0 70.7 22.4 68.8 2.2 60.8 0.5 144.9 3.3 0.1 0.0 0.5 0.0 1.4 0.3 0.4 0.3 0.1 0.1 0.8 0.9 0.1 0.3 0.0 0.1 0.2 0.2 30.2 29.7 37.3 29.6 23.6 35.3 42.1 36.1 39.5 45.2 44.2 50.1 60.5 102.5 56.1 8.5 4.9 55.2 68.1 63.9 89.4 195.9 59.8 55.6 208.1 82.9 30.9 106.7 223.1 26.6 3.9 17.9 39.2 244.5 7.1 70.6 59.6 77.4 35.4 36.6 15.0 123.6 33.2 72.2 19.4 105.6 12.7 348.5 132.8 32.6 8.6 134.6 36.6 29.6 59.0 3.7 10.1 8.6 23.9 6.6 42.7 4.7 2.8 135.0 1.0 19.1 20.1 72.1 34.4 30.9 1.7 77.0 95.9 62.1 10.5 575.3 59.2 62.6 75.4 7.4 35.8 45.1 44.3 14.1 10.2 119.9 52.1 86.4 LAT LAT1 ENSG00000213658 "Linker for activation of T cells" O43561 16 28984826-28990784 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.9" "Group enriched" "Detected in many" 6 "dendritic cells: 80.7;granulocytes: 78.9;Macrophages: 55.9;NK-cells: 152.4;T-cells: 151.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 19 "basophil: 307.7;gdT-cell: 303.4;MAIT T-cell: 212.5;memory CD4 T-cell: 295.1;memory CD8 T-cell: 307.2;naive CD4 T-cell: 276.0;naive CD8 T-cell: 266.9;NK-cell: 114.6;T-reg: 410.8" "Group enriched" "Detected in all" 142 "granulocytes: 307.7;NK-cells: 114.6;T-cells: 410.8" "Cell line enhanced" "Detected in many" "HEL: 189.8;HMC-1: 765.9;MOLT-4: 279.5" "Not detected" "Not detected" "CAB002223, HPA011157, CAB012978, CAB079960" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 140000 "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Golgi apparatus" "CAB002223: AB_563852, CAB012978: , CAB079960: , HPA011157: AB_1079237" "unprognostic (4.35e-3)" "unprognostic (5.17e-3)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-1)" "unprognostic (7.15e-5)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (1.52e-3)" "unprognostic (5.33e-2)" "unprognostic (1.02e-8)" "unprognostic (1.04e-2)" "unprognostic (5.58e-2)" "unprognostic (3.25e-1)" "unprognostic (1.51e-4)" 8.1 4.4 9.1 23.9 9.6 17.5 6.6 9.0 11.9 15.6 8.1 31.3 9.2 19.3 5.2 8.1 11.6 9.6 3.9 9.2 8.5 15.3 10.5 14.1 65.9 9.2 8.5 7.7 5.7 2.0 14.2 3.9 9.0 21.6 5.2 3.5 7.8 9.5 4.2 10.7 22.7 5.7 8.0 32.0 13.4 4.1 9.7 117.9 17.6 1.6 29.0 24.7 13.3 8.9 1.0 2.3 1.5 2.5 3.7 2.4 4.9 5.5 1.4 1.7 2.2 2.3 3.0 0.7 7.2 2.2 0.6 2.9 2.6 1.3 0.8 1.6 3.3 189.8 5.4 3.3 1.0 5.9 765.9 2.1 3.8 1.7 0.7 2.8 0.9 62.7 2.6 21.7 0.8 5.6 279.5 38.3 3.4 0.4 2.7 3.2 0.8 24.9 1.9 1.6 5.3 1.0 0.9 1.8 2.7 1.4 2.7 31.7 3.6 3.6 18.0 3.9 1.3 7.6 7.0 3.1 45.5 2.7 2.9 307.7 1.4 0.7 303.4 1.5 212.5 1.7 295.1 307.2 1.1 1.7 276.0 266.9 14.6 114.6 1.3 1.9 410.8 196.5 9.1 9.6 9.0 11.9 9.2 8.5 9.2 8.5 9.0 8.0 9.7 8.9 5.2 0.0 13.1 4.6 6.2 7.1 2.1 1.1 2.8 11.0 3.7 4.3 1.7 7.2 3.1 9.2 6.2 2.6 80.7 1.2 1.9 1.7 0.3 1.5 2.3 4.7 0.0 16.6 4.7 0.5 0.9 3.0 7.7 2.7 78.9 4.9 8.6 2.9 14.3 6.7 5.5 1.5 0.0 7.3 9.4 0.1 1.5 55.9 10.6 5.6 9.2 3.0 152.4 3.0 3.5 1.0 0.7 0.7 17.0 2.2 1.3 1.3 1.3 9.6 0.0 3.0 3.8 1.7 2.1 1.9 5.3 2.7 151.7 1.7 1.4 1.3 LAX1 "FLJ20340, LAX" ENSG00000122188 "Lymphocyte transmembrane adaptor 1" Q8IWV1 1 203765177-203776372 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 21.2" "Cell type enhanced" "Detected in some" "dendritic cells: 23.2;granulocytes: 82.2;NK-cells: 30.9;Plasma cells: 65.1;T-cells: 29.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 14 "B-cells: 7.5;NK-cells: 5.2;T-cells: 12.0" "Group enriched" "Detected in some" 4 "Karpas-707: 22.8;U-266/70: 28.2;U-266/84: 71.9;U-698: 24.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002461, HPA003887, CAB025358" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 16: Immune cells - Immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 55: Plasma cells - Humoral immune response" "Plasma membrane, Cytosol" "Golgi apparatus" "CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240" "unprognostic (2.85e-3)" "unprognostic (3.83e-3)" "unprognostic (3.90e-4)" "unprognostic (3.65e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-5)" "unprognostic (2.99e-2)" "unprognostic (4.91e-2)" "unprognostic (4.36e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (4.36e-1)" "unprognostic (4.23e-4)" "unprognostic (3.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" 0.5 0.6 0.2 8.8 0.3 1.6 1.7 0.4 0.4 1.4 0.3 3.7 3.1 0.3 0.3 0.9 0.4 2.6 0.3 0.3 0.2 0.2 0.9 2.7 11.8 0.5 0.2 0.2 0.4 0.1 0.0 0.1 0.5 0.7 3.4 0.1 1.2 0.4 0.1 0.2 2.0 0.7 0.2 7.2 4.5 0.3 0.3 11.1 0.2 0.3 21.2 5.1 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 8.0 0.2 22.8 0.0 0.0 8.7 0.0 0.1 0.0 0.0 2.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.2 71.9 24.9 0.0 1.9 0.0 0.3 0.0 0.5 12.0 0.0 9.1 7.5 7.1 9.4 0.0 2.5 5.5 7.1 0.3 5.2 0.0 0.0 8.1 3.5 0.2 0.3 0.4 0.4 0.3 0.2 0.5 0.2 0.5 0.2 0.3 0.7 0.9 0.0 1.9 0.0 14.6 1.1 0.4 0.0 0.0 0.0 0.3 0.1 2.6 0.0 0.6 0.0 0.0 0.1 23.2 0.1 0.0 0.2 0.0 0.4 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.6 1.5 0.4 82.2 0.0 2.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 1.2 0.0 0.0 1.9 10.6 0.0 0.4 0.0 30.9 0.5 0.0 0.1 0.0 0.0 65.1 0.4 0.6 0.1 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.2 0.4 0.0 29.2 0.1 0.3 0.5 LCK ENSG00000182866 "LCK proto-oncogene, Src family tyrosine kinase" P06239 1 32251239-32286165 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "lymphoid tissue: 343.0" "Group enriched" "Detected in many" 9 "dendritic cells: 143.9;NK-cells: 272.9;T-cells: 255.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in all" 12 "gdT-cell: 1109.8;MAIT T-cell: 1034.8;memory CD4 T-cell: 1123.8;memory CD8 T-cell: 1201.7;naive CD4 T-cell: 1260.7;naive CD8 T-cell: 1168.7;NK-cell: 641.5;T-reg: 1682.7" "Group enriched" "Detected in all" 12 "NK-cells: 641.5;T-cells: 1682.7" "Group enriched" "Detected in some" 6 "JURKAT: 365.7;MOLT-4: 536.9;U-698: 302.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA003494, CAB003816" Enhanced Approved "Golgi apparatus" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "CAB003816: AB_562158, HPA003494: AB_1852751" "unprognostic (6.38e-3)" "unprognostic (5.45e-3)" "unprognostic (8.39e-2)" "prognostic favorable (2.96e-6)" "unprognostic (2.20e-2)" "prognostic favorable (2.91e-4)" "unprognostic (4.78e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.65e-5)" "unprognostic (3.07e-2)" "unprognostic (3.80e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (8.15e-2)" "unprognostic (4.05e-2)" "unprognostic (7.39e-2)" "unprognostic (1.17e-2)" 3.4 2.2 0.4 50.6 0.5 13.7 2.3 0.4 0.5 2.2 0.7 6.9 7.6 1.7 13.0 3.9 2.1 9.4 1.9 0.5 0.4 3.8 3.8 11.4 111.0 0.8 0.5 1.6 0.9 0.5 0.8 1.1 0.6 2.8 6.5 0.0 4.8 1.4 1.3 1.9 23.1 2.3 0.6 39.9 12.1 1.1 0.5 343.0 3.7 1.4 79.6 13.2 2.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.7 64.1 3.5 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.6 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 365.7 0.2 0.0 0.0 0.0 536.9 0.2 5.9 4.6 0.3 20.6 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.3 0.3 0.4 0.6 0.4 0.0 0.0 1.7 0.1 0.1 0.7 0.3 302.7 0.0 0.1 0.0 12.8 5.2 6.0 1109.8 4.9 1034.8 62.0 1123.8 1201.7 5.2 98.9 1260.7 1168.7 33.6 641.5 6.0 7.7 1682.7 1836.9 0.4 0.5 0.4 0.5 0.5 0.4 0.8 0.5 0.6 0.6 0.5 0.6 4.9 0.0 9.3 0.0 23.4 4.6 1.2 0.4 0.0 0.0 3.5 5.2 1.8 4.3 1.6 3.7 0.0 0.3 143.9 0.9 0.0 0.6 0.1 1.0 0.5 3.4 2.4 10.1 0.2 0.5 0.2 3.1 7.7 0.7 5.1 0.0 4.6 1.5 0.3 0.0 0.2 0.3 0.0 7.8 7.3 0.0 0.0 8.1 3.6 0.0 8.7 0.0 272.9 0.5 0.1 4.7 0.0 0.4 15.7 1.0 0.0 1.4 1.8 0.0 0.0 1.5 2.4 4.5 2.0 0.5 3.1 0.4 255.5 2.9 1.3 1.1 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007298-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "fallopian tube: 116.2" "Group enriched" "Detected in some" 9 "Endometrial ciliated cells: 98.1;Respiratory ciliated cells: 329.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 2.2;Hep G2: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA052489: AB_2681850" "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.5 0.2 0.1 0.1 0.1 0.6 0.6 0.2 4.4 0.2 0.1 0.0 0.7 0.1 0.6 116.2 0.8 0.0 0.1 0.1 0.1 0.1 6.9 0.1 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.2 1.1 0.2 0.1 3.4 0.1 0.2 0.3 0.1 0.0 0.0 0.2 1.4 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 2.2 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.6 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.2 0.1 0.1 0.3 0.1 0.2 0.0 0.2 0.5 0.0 6.4 7.2 0.0 0.0 0.0 0.2 5.0 0.0 0.0 0.5 0.1 0.1 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 98.1 0.8 0.7 20.9 0.0 0.1 0.2 0.0 1.1 0.0 2.1 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 12.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.0 0.0 329.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 LFNG SCDO3 ENSG00000106003 "LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q8NES3 7 2512529-2529177 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 74.4" "Cell type enhanced" "Detected in many" "dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069130 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" NA NA 880000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "Nuclear membrane" "HPA069130: AB_2686091" "unprognostic (4.58e-2)" "unprognostic (1.17e-2)" "unprognostic (2.52e-2)" "prognostic favorable (6.36e-4)" "unprognostic (1.85e-2)" "unprognostic (8.34e-2)" "unprognostic (4.15e-1)" "unprognostic (7.86e-2)" "unprognostic (1.91e-1)" "unprognostic (2.25e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (5.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.09e-1)" "unprognostic (1.97e-2)" "unprognostic (2.28e-2)" 16.7 6.5 23.3 17.3 25.9 9.8 13.7 29.3 22.4 9.9 11.1 23.1 15.5 9.4 2.2 11.4 6.1 11.8 13.1 17.4 30.1 9.0 2.5 14.4 18.6 34.1 35.6 1.8 74.4 3.0 3.7 6.5 24.8 17.1 12.0 3.0 33.4 4.6 4.6 58.2 17.2 5.8 25.0 20.9 37.8 4.2 38.1 5.8 6.7 3.6 10.8 12.2 13.8 23.6 1.5 14.3 18.4 2.5 2.0 1.7 1.2 5.4 2.8 4.7 5.9 6.0 37.7 1.1 16.7 14.8 8.1 27.1 2.9 5.1 2.3 8.6 0.6 4.3 7.7 3.2 0.1 6.2 7.7 3.3 12.6 7.8 0.8 3.2 1.9 0.3 0.7 0.2 3.6 34.5 0.1 8.7 22.4 46.4 10.3 1.8 46.0 2.9 1.8 4.5 16.9 4.2 6.2 1.4 0.3 4.7 10.2 7.3 4.5 10.5 49.7 0.4 15.4 0.2 0.0 1.4 11.8 16.4 2.0 6.3 5.3 12.7 1.8 6.9 2.0 1.1 1.7 0.9 2.3 2.0 1.8 1.8 2.8 1.3 6.6 0.6 4.2 1.7 23.3 25.9 29.3 22.4 17.4 30.1 34.1 35.6 24.8 25.0 38.1 23.6 23.3 6.4 6.0 18.9 15.6 6.8 2.5 10.6 3.4 8.5 5.3 12.4 3.6 5.7 2.8 0.0 0.0 0.1 40.3 23.1 0.0 1.2 0.1 2.4 8.5 16.0 87.4 2.7 0.0 6.4 0.3 5.7 30.5 1.2 17.7 0.1 13.9 0.6 7.0 0.0 0.1 34.5 6.1 30.4 13.8 0.5 1.8 30.6 3.6 11.2 38.2 31.3 19.6 1.5 0.1 21.7 3.1 0.0 12.6 2.2 8.8 0.4 1.2 0.8 0.0 0.6 5.0 0.3 3.1 0.6 4.0 0.0 15.9 0.5 15.3 0.7 LGI4 ENSG00000153902 "Leucine rich repeat LGI family member 4" Q8N135 19 35124513-35142451 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 74.7;Distal enterocytes: 33.1;Muller glia cells: 95.5;Sertoli cells: 78.9;Smooth muscle cells: 104.4" "Group enriched" "Detected in many" 6 "glioma: 4.5;melanoma: 11.5;renal cancer: 13.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 27 "WM-115: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042116, HPA043556" Approved Approved "Golgi apparatus" "Secreted in brain" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA042116: AB_2677855, HPA043556: AB_2678550" "unprognostic (3.79e-1)" "unprognostic (6.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-2)" "unprognostic (3.71e-2)" "unprognostic (2.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.84e-7)" "unprognostic (1.71e-2)" "unprognostic (4.47e-1)" "unprognostic (7.73e-2)" "unprognostic (7.13e-2)" 77.6 5.4 71.2 4.1 72.3 0.2 36.1 70.3 98.4 99.9 52.1 100.5 3.6 35.5 2.3 15.0 43.7 5.0 39.4 67.8 61.3 4.7 8.0 14.3 2.1 86.5 68.4 13.3 6.4 1.4 4.4 3.6 70.1 37.2 3.7 7.2 12.2 13.3 39.1 21.2 35.1 4.8 72.8 1.9 27.0 2.7 72.0 0.5 19.1 5.4 0.5 33.5 79.3 81.4 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 71.2 72.3 70.3 98.4 67.8 61.3 86.5 68.4 70.1 72.8 72.0 81.4 13.3 0.0 0.0 74.7 0.2 2.5 0.6 0.3 3.4 0.8 1.5 1.5 17.1 0.0 0.8 1.8 2.1 0.0 0.2 33.1 0.0 0.0 0.1 0.2 2.8 5.4 1.8 0.0 21.9 0.0 0.3 12.7 0.0 0.2 0.0 0.0 7.9 2.0 0.1 0.0 2.2 0.9 0.0 0.0 4.6 0.3 14.6 0.7 10.6 5.6 0.1 95.5 0.0 2.0 9.2 0.1 21.8 7.2 0.3 1.2 1.1 0.1 0.9 3.1 78.9 7.9 104.4 2.8 2.8 0.8 2.4 0.0 0.7 0.0 0.7 1.1 LGR5 "FEX, GPR49, GPR67, HG38" ENSG00000139292 "Leucine rich repeat containing G protein-coupled receptor 5" O75473 12 71439798-71586310 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;fallopian tube: 16.8;placenta: 19.0;skeletal muscle: 22.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 55.2;Endometrial ciliated cells: 35.7;Glandular and luminal cells: 84.4;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 105.0;Syncytiotrophoblasts: 26.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 26.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Hep G2: 37.1;SH-SY5Y: 104.5" "Region enriched" "Detected in many" 8 "olfactory bulb: 34.1" "Low region specificity" "Detected in many" HPA012530 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" Nucleoplasm "HPA012530: AB_1849329" "unprognostic (5.19e-2)" "unprognostic (3.79e-1)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-3)" "unprognostic (1.52e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (3.71e-1)" "unprognostic (8.10e-2)" "unprognostic (2.01e-5)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (6.25e-3)" 1.4 1.6 2.7 0.4 7.6 0.0 1.5 4.6 4.7 1.5 0.1 3.3 5.1 4.0 1.1 0.1 16.8 0.4 0.2 2.9 5.7 0.8 0.9 0.9 0.1 9.5 5.2 0.7 0.0 0.2 1.0 19.0 9.0 1.2 3.6 0.2 1.9 7.3 22.3 2.9 5.5 0.2 6.0 0.0 2.3 0.1 5.6 0.1 0.3 0.8 1.7 0.1 0.4 19.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 13.3 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.5 0.0 11.9 0.0 1.0 37.1 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 12.2 1.6 2.4 0.0 0.0 0.0 14.6 0.2 104.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 7.6 4.6 4.7 2.9 5.7 9.5 5.2 9.0 6.0 5.6 19.2 0.0 0.0 0.0 1.3 0.2 0.9 0.0 1.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 55.2 0.0 1.2 0.0 0.0 0.6 35.7 5.3 0.5 4.9 0.0 6.8 0.0 2.3 1.4 0.0 84.4 0.0 0.0 0.0 1.0 6.4 0.0 12.3 3.0 0.0 0.0 1.6 0.2 0.0 0.4 1.8 0.0 0.0 0.0 0.0 45.2 105.0 0.1 0.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 3.4 0.0 0.0 0.0 1.3 26.4 0.5 0.0 20.3 0.0 LHFPL4 GARLH4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553822 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 15.5;pituitary gland: 12.2;retina: 9.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4" "Group enriched" "Detected in some" 4 "glioma: 6.8;testis cancer: 5.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.0 2.0 11.1 0.0 11.4 0.0 0.0 7.1 15.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.7 0.0 0.0 0.0 0.0 10.4 7.4 0.0 0.5 0.1 12.2 0.0 10.2 0.0 0.2 9.3 0.0 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.2 0.7 12.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.0 11.3 0.0 0.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.1 11.4 7.1 15.5 11.3 12.7 10.4 7.4 10.2 3.3 12.1 9.8 0.4 0.0 0.0 4.6 0.5 0.0 2.9 0.0 0.0 42.4 0.4 0.3 0.8 0.0 0.0 0.0 18.8 0.6 0.6 0.6 0.0 0.3 0.6 0.7 1.1 0.8 1.2 0.0 60.0 0.2 1.4 0.6 0.0 1.3 1.3 0.5 4.2 0.2 0.3 15.2 67.2 0.7 0.0 0.3 0.0 0.7 0.0 0.8 0.0 1.0 0.1 2.0 3.1 34.2 5.6 0.4 1.7 0.0 0.0 6.3 0.8 0.2 0.0 17.4 0.0 2.7 0.4 1.7 1.1 0.0 0.0 1.4 0.4 0.3 0.8 2.5 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "kidney: 10.7" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 361.7" "Group enriched" "Detected in some" 4 "ovarian cancer: 8.1;testis cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0" "Region enhanced" "Detected in many" "cerebellum: 19.1" "Region enriched" "Detected in many" 4 "cerebellum: 15.7" "HPA044307, HPA073521, HPA074382" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: AB_2732226, HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 10.7 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.5 0.2 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.4 2.1 0.0 0.0 42.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 361.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 13.0 0.0 1.6 0.0 0.0 0.2 1.1 2.3 0.0 0.0 0.4 0.3 0.0 0.2 0.0 LIG1 ENSG00000105486 "DNA ligase 1" P18858 19 48115445-48170603 "Enzymes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 34.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037015, HPA041431, HPA048071" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus, Vesicles" "CAB037015: , HPA041431: AB_2677476, HPA048071: AB_2680248" "unprognostic (1.83e-1)" "unprognostic (1.48e-3)" "unprognostic (6.45e-2)" "unprognostic (9.76e-2)" "unprognostic (9.47e-2)" "unprognostic (9.24e-3)" "unprognostic (1.17e-3)" "unprognostic (2.28e-1)" "unprognostic (6.03e-3)" "unprognostic (4.26e-1)" "unprognostic (1.78e-2)" "unprognostic (1.10e-3)" "prognostic unfavorable (5.75e-5)" "unprognostic (3.59e-2)" "unprognostic (4.09e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" 2.8 3.2 3.3 9.0 3.2 34.5 3.6 3.6 3.5 5.5 2.3 6.8 8.6 4.0 2.5 7.4 5.9 2.3 1.6 2.9 3.2 2.9 4.0 3.4 15.6 4.4 2.9 6.0 7.0 4.2 4.8 5.1 4.5 4.0 4.2 2.7 4.8 3.0 3.8 10.4 9.6 2.2 2.6 6.0 5.2 8.2 3.1 20.7 5.1 1.0 9.7 3.5 5.0 3.9 43.4 64.1 57.1 37.6 2.6 4.2 41.7 27.0 19.1 44.1 47.2 35.0 42.9 83.7 15.3 11.2 11.9 30.1 24.7 26.7 16.9 45.2 48.8 56.4 38.7 47.5 1.0 63.0 43.7 5.7 2.5 23.0 3.4 5.0 24.0 51.0 46.3 29.8 23.3 44.0 107.3 123.7 33.6 46.7 15.9 84.1 48.4 43.6 12.3 64.8 36.3 36.5 32.3 33.6 10.1 12.5 22.7 44.5 22.6 31.7 54.3 23.9 40.3 29.3 49.0 83.1 12.7 38.0 33.3 0.0 1.6 2.6 7.8 6.8 7.7 10.9 8.8 8.3 1.6 10.0 11.5 8.2 1.3 12.1 3.3 1.5 10.9 5.7 3.3 3.2 3.6 3.5 2.9 3.2 4.4 2.9 4.5 2.6 3.1 3.9 3.9 3.2 13.6 5.9 16.1 8.3 9.5 8.7 24.5 21.5 7.8 12.3 3.9 7.2 10.3 3.7 10.4 31.1 9.6 10.2 7.9 5.8 19.3 12.0 5.1 8.3 0.0 36.2 4.2 5.2 35.8 6.8 5.1 8.3 6.3 23.1 5.0 5.3 16.4 8.4 5.6 10.0 6.1 3.5 6.8 8.5 2.1 6.6 3.6 3.7 7.2 10.9 11.3 3.5 8.4 3.0 4.4 1.9 23.0 2.8 7.6 4.7 19.5 11.3 13.1 4.5 6.5 13.5 26.1 15.9 9.1 10.0 13.9 6.0 15.3 8.7 LINGO4 LRRN6D ENSG00000213171 "Leucine rich repeat and Ig domain containing 4" Q6UY18 1 151800264-151805419 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 21.3;tongue: 5.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Melanocytes: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 1.8;hypothalamus: 1.0;midbrain: 2.7;pons and medulla: 4.0;thalamus: 1.4" "Region enriched" "Detected in many" 7 "spinal cord: 19.7" HPA060781 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus, Vesicles" "HPA060781: AB_2684361" "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.33e-3)" "unprognostic (1.96e-1)" "unprognostic (8.65e-2)" "unprognostic (3.16e-2)" "unprognostic (1.49e-5)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (2.39e-1)" "unprognostic (1.94e-4)" "unprognostic (6.92e-2)" "unprognostic (3.94e-4)" "unprognostic (3.84e-1)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.60e-2)" 0.0 2.0 0.1 0.1 0.1 0.0 0.1 4.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.1 0.7 0.1 0.7 0.3 0.5 0.3 1.1 0.2 0.2 2.8 1.6 0.0 0.4 0.5 1.4 0.0 3.9 0.7 0.1 0.1 0.6 0.2 21.3 0.6 0.2 0.0 1.3 0.1 0.4 0.6 1.6 1.2 0.6 5.6 0.2 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 0.2 0.3 0.5 2.8 1.6 3.9 1.3 1.6 2.1 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 LITAF "FLJ38636, PIG7, SIMPLE, TP53I7" ENSG00000189067 "Lipopolysaccharide induced TNF factor" Q99732 16 11547722-11636381 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 701.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 2578.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 2578.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006960 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Golgi apparatus, Vesicles" "HPA006960: AB_1079254" "unprognostic (2.26e-1)" "unprognostic (4.96e-2)" "unprognostic (2.32e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.07e-2)" "unprognostic (8.75e-3)" "unprognostic (3.60e-1)" "unprognostic (6.15e-3)" "unprognostic (1.04e-1)" "unprognostic (4.61e-2)" "unprognostic (5.01e-1)" "unprognostic (1.85e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (3.57e-2)" "unprognostic (1.60e-1)" 139.3 43.7 53.5 165.8 81.9 207.0 95.5 79.6 70.0 121.2 70.5 121.1 46.3 100.5 77.8 62.7 108.2 114.1 63.9 52.2 63.0 182.3 107.7 192.1 112.3 94.0 79.4 67.6 64.6 56.5 39.0 71.3 92.7 105.9 116.1 63.9 116.4 83.4 36.3 71.6 57.9 93.5 77.3 119.6 70.7 10.6 77.6 68.6 116.8 37.6 123.7 214.1 83.1 109.4 79.2 157.8 89.4 43.8 13.9 11.0 90.7 100.2 309.0 93.6 139.1 62.6 206.3 39.9 126.8 86.1 108.7 95.5 40.1 186.4 88.4 304.2 45.8 2.8 117.1 310.3 212.9 12.5 12.9 35.0 320.8 79.6 210.7 84.4 0.3 2.7 25.3 149.5 1.5 75.8 1.8 183.3 146.4 104.0 0.6 12.1 19.6 228.2 79.0 110.4 22.2 68.0 172.9 219.4 183.9 136.3 122.5 66.7 0.8 38.7 65.3 23.0 24.2 59.2 140.6 100.5 45.1 95.8 225.5 508.8 149.5 284.0 459.6 130.2 277.2 174.0 284.0 412.7 178.0 173.9 318.9 381.4 2578.1 274.5 81.9 220.1 350.3 584.9 53.5 81.9 79.6 70.0 52.2 63.0 94.0 79.4 92.7 77.3 77.6 109.4 297.5 44.8 70.0 7.5 176.7 157.4 336.2 365.4 68.3 2.2 180.5 157.6 48.8 148.7 222.2 163.7 0.0 56.4 505.5 305.4 485.2 245.8 2.3 112.2 151.9 76.3 17.5 18.3 1.1 72.9 471.9 156.7 39.8 108.1 214.9 1.1 94.2 52.9 227.8 0.0 1.6 153.1 175.0 156.9 701.0 11.3 56.2 422.0 156.5 7.5 391.8 232.7 433.5 11.6 59.5 123.3 236.1 68.4 186.3 239.8 23.3 104.3 150.3 5.4 52.6 89.6 176.1 0.2 5.4 37.1 132.1 37.1 278.7 16.6 88.9 368.6 LMX1A "LMX1, LMX1.1" ENSG00000162761 "LIM homeobox transcription factor 1 alpha" Q8TE12 1 165201867-165356715 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "choroid plexus: 20.4" "Group enriched" "Detected in some" 16 "Early spermatids: 30.6;Enteroendocrine cells: 41.9;Late spermatids: 23.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA028051, HPA030088" Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA028051: AB_10599731, HPA030088: AB_10601106" "unprognostic (1.73e-1)" "unprognostic (9.57e-2)" "unprognostic (7.58e-2)" "unprognostic (1.59e-1)" "unprognostic (2.17e-1)" "unprognostic (2.82e-1)" "unprognostic (2.63e-1)" "unprognostic (3.22e-2)" "unprognostic (2.10e-3)" "unprognostic (1.51e-1)" "unprognostic (9.82e-3)" 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.3 20.4 0.3 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.7 1.3 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 3.1 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 1.3 2.5 0.0 0.1 1.0 0.0 0.2 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.7 1.3 0.2 2.1 0.5 0.0 2.5 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.6 0.2 0.0 0.1 41.9 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 23.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753120 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6" "Cell type enriched" "Detected in many" 6 "Granulosa cells: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "NTERA-2: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.2 0.2 0.6 0.2 0.7 0.5 0.4 0.7 2.6 0.2 1.6 0.5 1.2 0.1 0.3 0.0 0.2 0.5 0.1 0.7 1.2 0.1 2.1 0.3 0.1 1.0 1.1 0.3 0.8 0.2 0.2 0.1 1.3 0.4 0.1 1.0 0.1 0.5 0.8 0.4 1.6 0.1 0.7 0.1 0.3 0.8 0.7 0.0 1.5 0.0 0.1 0.1 0.1 0.9 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.1 1.4 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.6 1.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 1.5 0.2 0.1 0.1 0.8 0.2 0.2 0.2 0.1 2.2 0.6 0.7 0.7 2.6 0.7 1.2 1.0 1.1 1.3 0.7 0.7 0.9 0.2 0.0 4.4 4.6 0.1 1.1 4.4 4.0 0.6 0.5 8.6 9.1 0.3 11.5 1.7 0.0 0.0 0.1 0.3 0.8 3.9 1.2 15.2 0.9 0.5 0.3 0.0 0.0 2.2 0.8 0.1 1.5 2.0 2.2 0.0 104.4 1.4 2.2 0.1 0.0 0.6 0.9 2.0 0.8 2.8 3.2 0.0 0.3 5.4 0.0 0.0 3.9 0.0 1.0 2.2 1.2 0.0 0.0 0.0 2.4 12.3 1.0 0.9 0.8 0.0 1.4 8.1 10.5 4.7 1.4 1.1 0.3 0.6 0.0 1.2 0.6 LRBA "BGL, CDC4L, LAB300, LBA" ENSG00000198589 "LPS responsive beige-like anchor protein" P50851 4 150264435-151015727 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 213.7;Inhibitory neurons: 192.6;Microglial cells: 161.1;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 217.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019366, HPA023597" Approved Approved "Golgi apparatus,Cytosol" NA NA 340000 "Cluster 44: Non-specific - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" Cytosol "HPA019366: AB_2138441, HPA023597: AB_1853256" "unprognostic (2.60e-1)" "unprognostic (4.70e-2)" "unprognostic (1.64e-3)" "unprognostic (4.49e-3)" "unprognostic (4.38e-1)" "unprognostic (8.65e-2)" "unprognostic (5.88e-2)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (6.92e-2)" "unprognostic (2.29e-2)" "unprognostic (5.88e-2)" "prognostic favorable (2.22e-16)" "unprognostic (7.15e-2)" "unprognostic (2.36e-1)" "unprognostic (4.79e-1)" "unprognostic (3.00e-1)" 7.3 10.7 3.4 9.3 6.9 11.1 22.7 11.1 3.8 13.1 18.6 16.7 13.3 6.9 14.2 13.9 15.2 9.9 8.3 2.9 2.2 23.5 13.4 11.0 15.8 5.1 4.5 8.9 13.5 34.2 6.5 7.0 6.1 20.0 17.4 14.9 13.8 8.9 7.2 19.3 11.5 6.6 3.4 9.6 17.0 9.4 3.7 18.7 19.1 8.9 17.7 12.3 7.0 6.3 27.6 14.3 11.9 11.1 12.2 18.5 17.0 6.0 15.8 10.9 10.2 30.9 35.6 33.7 7.2 8.6 7.5 13.7 22.1 36.6 15.3 25.9 15.8 20.8 19.8 19.0 7.5 29.0 16.2 14.6 21.1 16.0 24.6 23.9 32.9 14.8 22.4 24.3 12.9 21.9 21.9 7.7 10.7 23.7 10.3 18.4 12.0 12.6 42.0 33.7 39.3 13.0 15.1 32.1 7.4 18.1 32.4 6.1 17.2 16.8 12.2 8.7 11.4 20.9 20.5 20.5 26.2 16.0 6.6 5.7 0.6 1.2 5.0 0.2 3.3 4.9 3.3 4.7 1.0 2.1 2.3 4.0 0.1 3.2 2.1 2.1 4.6 1.8 3.4 6.9 11.1 3.8 2.9 2.2 5.1 4.5 6.1 3.4 3.7 6.3 10.4 16.0 14.9 148.5 42.5 17.5 16.4 21.0 28.5 33.5 30.8 18.2 55.9 21.5 21.5 51.5 148.0 23.7 37.7 19.7 9.8 15.2 25.5 51.2 11.0 13.3 42.0 40.2 213.7 13.5 10.6 12.8 56.6 61.8 6.3 22.4 10.0 20.5 6.1 30.3 192.6 23.8 24.4 11.1 12.8 5.5 9.6 17.7 16.0 161.1 8.2 17.7 46.4 239.8 217.4 17.2 20.2 10.1 38.3 22.4 22.0 15.8 36.7 72.6 6.6 13.7 9.8 16.6 22.3 37.3 23.7 24.2 45.6 25.9 27.2 24.0 LRIG2 KIAA0806 ENSG00000198799 "Leucine rich repeats and immunoglobulin like domains 2" O94898 1 113073198-113132260 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015538 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 2100000 "Cluster 17: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 18: U-2197 - ECM organization" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA015538: AB_2250170" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (9.08e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (4.72e-2)" "unprognostic (1.27e-3)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (3.27e-2)" "unprognostic (5.95e-2)" "unprognostic (1.03e-2)" "unprognostic (1.03e-2)" "unprognostic (1.27e-2)" "unprognostic (2.34e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 2.6 2.2 3.1 2.1 4.6 1.0 2.7 4.7 3.4 3.2 3.2 2.9 2.8 3.1 3.8 2.3 2.5 1.4 2.4 2.8 3.6 2.2 2.0 2.0 2.6 4.2 3.8 3.8 2.6 2.9 2.9 2.4 3.9 2.5 2.1 6.4 2.4 2.2 3.9 4.5 3.0 1.7 3.8 3.0 2.3 1.7 3.9 2.9 3.4 2.1 2.4 2.5 2.7 6.8 2.6 1.3 3.8 2.9 3.6 3.6 2.1 1.6 2.4 1.9 3.2 2.0 1.6 2.6 2.8 2.0 1.1 2.8 2.6 1.7 3.2 1.8 1.5 2.8 2.9 1.0 3.6 3.4 1.3 3.6 3.1 3.0 4.0 2.9 2.5 3.6 3.4 2.4 2.4 1.9 3.5 3.5 3.5 1.0 2.3 3.1 4.8 1.3 1.9 1.7 2.6 2.1 2.8 1.8 3.6 3.1 1.4 3.8 3.9 3.5 1.9 4.9 2.6 2.6 1.3 2.6 3.8 2.1 3.3 1.9 0.7 0.5 0.8 0.6 1.0 0.9 1.0 0.9 0.6 1.4 1.1 1.0 0.4 1.4 0.7 0.7 0.8 0.5 3.1 4.6 4.7 3.4 2.8 3.6 4.2 3.8 3.9 3.8 3.9 6.8 9.4 0.0 15.5 14.4 12.7 8.4 3.1 5.7 8.0 21.0 7.0 7.2 11.6 7.2 7.1 14.7 37.5 7.8 14.6 13.5 0.0 3.2 1.3 6.9 14.6 9.4 5.4 5.5 22.9 2.6 5.1 10.2 13.7 8.0 5.7 22.0 6.1 5.4 4.8 18.5 23.8 8.7 0.0 8.2 5.6 0.9 18.3 6.4 7.2 19.7 11.9 20.6 17.5 25.1 40.9 3.3 7.5 16.1 7.8 5.5 8.9 4.4 10.8 23.4 0.0 12.6 8.2 11.1 16.1 5.5 6.7 5.3 10.3 20.4 9.8 3.3 LRRC27 KIAA1674 ENSG00000148814 "Leucine rich repeat containing 27" Q9C0I9 10 132332154-132381508 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 75.6" "Group enriched" "Detected in many" 6 "Early spermatids: 491.0;Late spermatids: 953.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 17.2;hTERT-RPE1: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037595, HPA067395" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA037595: , HPA067395: AB_2732766" "unprognostic (1.97e-1)" "unprognostic (5.76e-4)" "unprognostic (1.48e-3)" "unprognostic (1.94e-3)" "unprognostic (6.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.41e-1)" "unprognostic (1.04e-2)" "unprognostic (8.26e-2)" "unprognostic (1.75e-2)" "unprognostic (5.94e-3)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (9.27e-4)" 3.2 4.1 11.6 1.9 12.1 1.6 5.0 9.4 13.3 4.5 12.0 4.7 2.5 4.5 6.7 2.0 13.1 4.3 3.5 13.0 11.2 7.1 3.0 3.9 2.6 12.1 11.8 6.3 3.9 8.0 8.0 2.6 10.9 5.2 2.5 10.9 3.3 4.7 2.0 2.7 3.3 4.2 11.5 5.5 3.9 75.6 11.8 2.8 6.4 1.6 1.4 4.0 2.8 10.9 3.1 5.6 12.2 17.2 10.4 10.6 1.2 3.0 9.7 4.9 4.4 1.0 6.3 1.7 1.7 7.0 3.7 2.1 2.7 1.5 3.1 3.6 2.4 0.5 4.5 3.0 7.4 1.4 2.0 4.6 9.4 5.0 6.6 21.9 3.5 4.2 1.1 1.3 3.8 5.2 2.7 3.9 3.4 2.2 1.9 2.4 1.9 1.0 8.9 0.8 2.2 6.1 1.5 1.0 3.9 2.4 2.8 3.1 4.7 1.9 2.4 4.4 1.9 0.9 0.4 1.0 8.9 2.7 1.2 4.1 4.7 0.8 1.1 4.1 0.9 2.3 0.7 0.7 5.2 2.9 1.8 1.0 0.6 2.4 2.8 5.6 0.5 2.0 11.6 12.1 9.4 13.3 13.0 11.2 12.1 11.8 10.9 11.5 11.8 10.9 2.9 9.6 12.8 23.8 5.0 2.8 2.5 5.1 3.4 8.2 6.3 3.8 5.2 5.7 6.9 3.7 10.4 3.6 6.0 1.7 19.6 8.2 491.0 18.8 5.4 4.9 5.4 2.5 14.2 5.1 1.3 5.5 7.1 4.8 8.8 10.3 11.4 2.2 7.7 8.4 10.9 2.3 2.0 10.4 6.0 953.9 4.7 6.7 7.2 6.5 9.0 10.5 8.2 8.0 9.3 3.3 1.3 11.7 0.9 2.9 3.8 13.9 37.7 18.3 6.6 3.8 3.5 119.9 19.2 2.3 3.1 1.4 2.9 6.2 3.5 1.8 LRRC28 "FLJ34269, FLJ45242, MGC24976" ENSG00000168904 "Leucine rich repeat containing 28" Q86X40 15 99251362-99390729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell type enhanced" "Detected in many" "Early spermatids: 159.2;Excitatory neurons: 127.4;Late spermatids: 406.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039378, HPA040784, HPA066130" Approved Approved "Nucleoplasm,Golgi apparatus,Mitochondria" No No "Cluster 2: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Golgi apparatus, Mitochondria" "HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623" "unprognostic (4.84e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.82e-3)" "unprognostic (9.86e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.97e-5)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (5.89e-2)" "unprognostic (8.37e-2)" "unprognostic (3.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.41e-1)" 8.1 7.8 4.4 4.4 5.1 8.6 6.4 4.5 5.8 6.1 4.3 8.0 16.9 5.8 7.4 9.7 4.8 9.1 9.7 5.3 3.9 19.4 47.1 5.3 6.9 3.7 3.5 4.9 19.5 9.4 4.1 6.1 3.5 5.3 9.7 6.8 6.1 6.6 18.3 10.4 16.5 7.9 3.3 4.9 8.2 28.5 3.9 22.6 6.6 18.4 9.4 6.5 6.3 4.4 4.0 9.8 9.5 12.3 13.2 18.7 4.0 4.2 11.9 7.1 8.3 7.4 8.6 8.2 7.6 10.1 8.7 8.8 7.0 13.5 10.3 5.0 10.2 5.5 4.0 7.7 11.7 5.5 8.6 11.1 18.2 6.7 13.4 16.0 22.7 13.0 4.9 8.1 14.9 8.0 15.2 8.9 4.0 31.2 3.7 9.3 8.0 7.6 15.1 12.8 4.3 5.5 10.1 5.4 16.4 14.4 8.4 10.2 8.3 7.0 4.8 5.4 8.4 15.9 24.1 5.1 8.8 5.4 13.3 23.4 9.3 32.0 7.2 7.8 5.8 6.2 6.7 7.7 8.4 5.8 6.2 5.4 5.0 5.1 8.0 6.9 10.4 6.1 4.4 5.1 4.5 5.8 5.3 3.9 3.7 3.5 3.5 3.3 3.9 4.4 13.2 16.0 4.1 29.0 13.5 13.8 14.5 14.5 12.5 19.9 8.9 12.4 13.4 12.8 11.0 11.0 22.9 17.5 11.4 18.6 27.4 12.7 159.2 7.4 8.4 11.9 9.1 12.4 127.4 29.5 22.6 8.5 15.8 6.5 2.5 15.0 12.8 37.0 19.3 21.9 86.8 16.0 20.3 19.8 20.1 406.4 12.8 15.3 14.2 37.5 19.1 14.4 14.4 63.3 63.0 14.8 24.2 8.6 14.7 8.4 72.3 74.1 10.1 19.8 0.0 10.7 11.7 77.1 39.0 15.1 15.8 13.0 11.3 18.0 19.5 15.4 LRRC4 NAG14 ENSG00000128594 "Leucine rich repeat containing 4" Q9HBW1 7 128027071-128032107 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.5" "Cell type enhanced" "Detected in many" "Club cells: 33.2;Cone photoreceptor cells: 27.1;Horizontal cells: 55.5;Respiratory ciliated cells: 53.0;Rod photoreceptor cells: 35.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 38.5" "Immune cell enriched" "Detected in some" 5 "neutrophil: 13.1" "Lineage enriched" "Detected in single" 20 "granulocytes: 13.1" "Group enriched" "Detected in some" 6 "AF22: 15.9;NTERA-2: 35.4;REH: 33.5;SCLC-21H: 18.2;SH-SY5Y: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051100 Approved "Golgi apparatus" NA NA 2100000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA051100: AB_2797241" "unprognostic (7.98e-2)" "unprognostic (6.15e-3)" "unprognostic (2.85e-2)" "prognostic favorable (8.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.34e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (3.23e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.98e-4)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-1)" "unprognostic (5.84e-3)" 2.3 6.7 8.4 2.7 11.4 10.9 0.6 7.8 38.5 1.6 0.0 0.9 0.6 3.2 0.3 4.1 6.6 3.2 2.6 14.4 0.0 3.2 1.9 6.0 1.8 0.0 0.0 4.8 0.4 6.8 1.8 4.4 0.0 0.7 0.5 4.3 1.5 2.8 0.8 0.4 0.8 1.6 0.0 4.7 1.9 6.2 0.0 5.1 0.5 1.8 2.1 1.5 2.8 11.9 0.0 0.2 15.9 0.0 0.6 0.0 0.0 0.9 0.0 1.4 0.4 0.0 0.0 0.0 1.1 1.5 0.0 1.4 0.0 0.0 0.8 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 2.0 0.0 0.1 0.1 35.4 0.0 0.0 33.5 0.0 0.3 0.2 0.0 18.2 10.9 0.0 0.0 1.3 2.5 0.0 3.7 0.4 1.1 0.2 0.1 0.9 0.0 0.0 0.0 0.2 0.0 2.3 0.5 0.2 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.1 0.0 0.6 0.0 0.0 0.1 8.4 11.4 7.8 38.5 14.4 0.0 0.0 0.0 0.0 0.0 0.0 11.9 1.8 16.0 14.3 5.5 0.6 0.1 1.6 5.7 0.6 11.3 0.5 0.4 1.4 0.0 33.2 1.8 27.1 0.2 0.7 0.2 0.0 0.1 6.6 11.6 5.2 5.1 0.0 0.0 18.3 0.0 0.3 1.2 0.0 18.7 1.3 1.8 11.0 0.1 19.8 55.5 22.6 0.0 2.0 11.2 0.7 0.9 0.0 1.6 1.8 9.4 0.6 0.8 0.0 11.6 2.1 0.0 0.5 0.7 0.9 4.5 0.1 0.6 53.0 35.1 0.0 2.4 2.0 6.2 4.6 5.6 0.0 0.4 0.5 0.7 0.3 19.0 LRRC43 MGC35140 ENSG00000158113 "Leucine rich repeat containing 43" Q8N309 12 122167738-122203471 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 4.9;choroid plexus: 16.1;fallopian tube: 19.0;testis: 6.4" "Cell type enhanced" "Detected in some" "Early spermatids: 23.2;Endometrial ciliated cells: 21.8;Late spermatids: 43.5;Proximal tubular cells: 15.9;Respiratory ciliated cells: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.1;HSkMC: 1.3;HUVEC TERT2: 2.7;SCLC-21H: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA039425 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" Vesicles "HPA039425: AB_2676501" "unprognostic (6.42e-3)" "unprognostic (1.33e-1)" "unprognostic (2.71e-1)" "unprognostic (2.83e-3)" "unprognostic (2.48e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.56e-2)" "unprognostic (6.03e-5)" "unprognostic (1.19e-1)" "unprognostic (4.52e-3)" "unprognostic (2.61e-1)" "unprognostic (6.21e-4)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.39e-1)" "unprognostic (2.49e-1)" 0.5 0.3 2.1 0.0 2.7 0.5 0.3 1.5 2.2 1.1 16.1 0.3 0.5 0.7 1.8 0.1 19.0 0.9 0.7 2.3 2.7 2.1 0.1 1.6 0.0 3.5 4.9 0.3 0.6 1.9 2.2 0.1 2.8 0.7 0.1 0.6 1.1 1.2 0.1 0.3 0.1 0.2 3.7 0.3 0.2 6.4 2.9 0.0 1.6 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.7 0.2 0.2 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.1 0.0 0.2 1.3 0.0 0.4 0.0 0.0 2.7 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.1 0.0 0.3 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.9 0.2 0.2 0.0 0.2 2.1 2.7 1.5 2.2 2.3 2.7 3.5 4.9 2.8 3.7 2.9 1.4 0.0 6.4 0.0 4.6 0.1 0.0 0.1 1.0 0.0 0.4 0.3 0.3 0.5 0.0 2.7 1.8 4.2 0.1 1.7 0.2 1.9 0.1 23.2 21.8 0.4 0.1 0.0 0.8 3.5 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.0 2.8 0.0 2.0 0.0 0.3 43.5 0.6 0.3 0.0 1.0 0.0 0.9 2.1 2.0 0.7 0.0 0.0 0.4 0.1 0.1 0.0 15.9 35.2 0.1 0.0 0.1 0.5 8.2 1.2 0.0 0.0 0.1 0.5 0.0 0.1 0.1 LRRC63 RP11-139H14.4 ENSG00000173988 "Leucine rich repeat containing 63" 13 46211940-46277366 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;testis: 3.4" "Cell type enriched" "Detected in some" 7 "Oligodendrocytes: 255.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HDLM-2: 1.7;JURKAT: 3.0;Karpas-707: 1.6;U-87 MG: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039318, HPA039763" Uncertain Approved "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA039318: AB_10796224, HPA039763: AB_10795408" "unprognostic (3.40e-2)" "unprognostic (2.81e-1)" "unprognostic (5.33e-1)" "unprognostic (2.12e-3)" "unprognostic (1.96e-1)" "unprognostic (3.99e-1)" "unprognostic (1.06e-2)" "unprognostic (7.28e-2)" "unprognostic (3.05e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-2)" "unprognostic (7.61e-2)" "unprognostic (1.18e-6)" "unprognostic (1.27e-1)" "unprognostic (2.98e-1)" "unprognostic (4.57e-2)" "unprognostic (7.31e-2)" 0.1 0.3 1.8 0.1 5.0 0.3 0.1 4.9 2.9 0.2 0.7 0.1 0.0 0.0 2.4 0.0 1.1 0.1 0.1 1.7 2.9 0.1 0.1 0.4 0.2 6.6 4.0 0.0 0.0 0.1 0.0 0.1 6.2 0.5 0.0 2.4 0.3 0.1 0.0 0.0 0.0 0.1 4.8 0.1 0.1 3.4 4.1 1.3 0.0 0.1 0.1 0.0 0.0 10.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.4 0.7 0.6 0.0 2.1 0.0 0.2 0.0 0.1 1.7 0.5 0.7 0.0 0.0 0.1 0.4 1.1 0.4 0.0 0.2 0.0 0.0 0.0 3.0 0.0 1.6 0.0 0.0 1.0 0.3 0.1 0.0 0.2 0.2 0.0 0.2 0.3 0.0 0.5 0.6 0.0 0.0 0.7 0.8 0.0 0.5 0.3 0.2 0.1 0.0 0.3 0.6 1.3 0.1 2.0 1.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.5 0.1 0.1 1.8 5.0 4.9 2.9 1.7 2.9 6.6 4.0 6.2 4.8 4.1 10.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 34.1 3.1 0.1 0.1 0.0 1.3 0.9 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.0 0.0 0.5 0.0 5.2 0.0 0.0 0.8 0.3 8.4 0.0 0.2 0.0 1.9 0.0 0.1 0.0 4.0 255.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 2.8 0.0 0.0 0.2 3.8 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 LRRC8C AD158 ENSG00000171488 "Leucine rich repeat containing 8 VRAC subunit C" Q8TDW0 1 89633072-89769903 "Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 73.5;Excitatory neurons: 73.6;Inhibitory neurons: 99.2;Microglial cells: 185.5;Oligodendrocytes: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.9;monocytes: 6.6;T-cells: 11.3" "Cell line enhanced" "Detected in many" "THP-1: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029347 Uncertain Approved "Golgi apparatus" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 28: Placenta - Pregnancy" "Cluster 43: THP-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA029347: AB_10601544" "unprognostic (2.61e-2)" "unprognostic (3.09e-2)" "unprognostic (3.83e-2)" "unprognostic (1.76e-2)" "unprognostic (3.32e-2)" "unprognostic (1.65e-2)" "unprognostic (5.02e-2)" "unprognostic (3.76e-3)" "unprognostic (4.28e-2)" "unprognostic (4.90e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (2.78e-2)" "unprognostic (4.42e-2)" "unprognostic (1.94e-2)" "unprognostic (3.38e-2)" 14.3 7.6 3.8 9.0 4.5 8.0 7.7 4.5 5.8 3.2 11.4 3.2 3.2 7.3 1.9 2.9 2.8 6.6 6.2 4.1 4.1 2.5 3.3 7.7 12.2 4.6 5.0 5.3 1.8 2.8 2.3 6.6 5.1 2.3 3.7 1.6 2.0 2.0 2.7 6.0 3.8 15.8 4.8 9.2 2.9 4.0 4.7 5.6 3.5 8.0 7.7 6.2 2.0 6.0 0.3 3.8 3.0 2.7 9.1 10.2 1.4 19.3 21.6 8.7 8.0 0.0 1.3 6.0 5.3 8.5 14.9 13.1 10.1 29.0 20.9 14.8 6.1 5.7 2.9 0.3 7.4 26.6 1.9 4.4 5.8 18.8 10.0 5.8 35.6 9.2 3.9 7.9 7.5 0.7 3.9 26.2 3.3 0.1 7.8 26.5 1.4 2.0 1.8 3.2 2.3 10.7 7.1 0.7 16.2 4.7 0.2 41.3 29.9 15.3 7.3 5.3 14.9 2.9 2.6 3.1 4.7 19.6 2.6 0.4 6.0 0.0 3.8 5.2 3.3 0.7 6.1 5.1 8.9 0.5 4.8 4.5 0.8 2.0 6.6 0.7 11.3 3.2 3.8 4.5 4.5 5.8 4.1 4.1 4.6 5.0 5.1 4.8 4.7 6.0 73.5 3.2 3.6 31.3 7.6 45.4 3.8 5.6 3.4 2.3 1.7 2.9 6.3 2.8 2.7 0.0 0.0 0.1 24.6 0.3 0.0 1.7 36.3 0.2 1.9 47.3 1.2 4.8 73.6 2.4 1.1 8.7 2.6 0.6 0.0 58.5 28.9 0.1 13.6 1.7 99.2 0.3 2.0 29.5 36.9 21.3 0.0 27.8 26.6 185.5 21.3 0.5 13.4 22.1 85.2 12.8 1.9 0.7 20.8 2.1 0.3 0.6 2.9 1.2 0.0 2.2 24.2 3.9 2.0 1.3 44.9 0.3 27.1 3.4 0.3 2.5 LRRTM1 FLJ32082 ENSG00000162951 "Leucine rich repeat transmembrane neuronal 1" Q86UE6 2 80288351-80304752 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 22.4;salivary gland: 12.8" "Group enriched" "Detected in some" 4 "Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6" "Group enriched" "Detected in many" 11 "endometrial cancer: 8.8;ovarian cancer: 16.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046607, HPA062660" Approved Approved "Golgi apparatus" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA046607: , HPA062660: AB_2684824" "unprognostic (2.47e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (5.63e-2)" "unprognostic (6.67e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-1)" "unprognostic (8.16e-2)" "unprognostic (6.03e-3)" "unprognostic (7.10e-4)" "unprognostic (3.16e-2)" "unprognostic (1.90e-1)" "unprognostic (4.96e-4)" 0.5 0.9 6.4 0.3 13.4 0.0 0.1 0.0 10.0 2.2 0.0 3.7 0.6 0.6 0.3 0.3 1.2 0.2 1.3 16.3 5.2 0.3 0.4 0.1 0.0 0.9 9.4 0.3 0.1 0.0 1.9 0.0 2.0 1.0 0.3 0.4 12.8 1.2 0.0 0.1 1.3 0.3 0.2 0.0 0.7 0.2 22.4 0.0 1.6 0.1 0.0 0.6 0.8 4.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.4 0.0 10.0 16.3 5.2 0.9 9.4 2.0 0.2 22.4 4.6 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.3 1.0 4.8 0.3 0.0 0.0 7.2 0.7 0.0 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 10.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 6.6 0.0 0.9 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 LTBR "D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3" ENSG00000111321 "Lymphotoxin beta receptor" P36941 12 6375045-6391571 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 71.3;intermediate monocyte: 66.3;myeloid DC: 49.8;neutrophil: 45.0;non-classical monocyte: 50.1" "Group enriched" "Detected in many" 36 "dendritic cells: 49.8;granulocytes: 45.0;monocytes: 71.3" "Cell line enhanced" "Detected in many" "HHSteC: 393.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026202, HPA061617" Uncertain Supported "Golgi apparatus" NA Yes "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Golgi apparatus" "CAB026202: , HPA061617: AB_2732666" "unprognostic (2.60e-2)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.23e-2)" "unprognostic (3.01e-2)" "unprognostic (3.24e-3)" "prognostic unfavorable (5.13e-4)" "unprognostic (2.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (3.66e-2)" "unprognostic (9.84e-3)" "unprognostic (6.91e-2)" "unprognostic (2.86e-1)" 67.6 64.4 13.9 36.4 14.6 11.7 60.3 14.7 15.9 65.8 18.0 72.7 48.6 68.1 20.7 81.3 49.6 48.3 37.2 13.3 15.8 55.1 135.8 66.0 14.6 19.6 17.3 46.3 78.7 54.9 26.3 48.6 18.8 61.9 34.3 1.9 61.5 44.0 26.3 75.1 51.1 62.6 17.4 44.8 67.7 13.3 18.1 11.7 57.2 23.5 18.0 65.8 65.1 17.0 98.2 130.3 0.0 41.1 245.9 183.7 89.9 67.9 153.1 98.8 101.1 62.0 148.7 0.1 39.5 145.7 0.5 112.2 0.5 140.5 38.9 0.0 0.2 58.1 53.2 36.6 393.1 4.1 94.6 270.8 255.2 70.7 197.1 102.6 91.2 0.0 55.5 0.5 115.0 93.5 0.4 29.3 1.2 155.7 74.4 0.0 6.6 0.2 149.2 112.2 0.7 0.5 63.6 122.9 143.6 5.0 20.5 105.3 58.0 34.6 39.6 129.0 72.1 0.0 0.4 0.1 14.6 35.9 129.5 5.4 71.3 0.5 0.2 66.3 0.0 0.1 0.1 0.1 49.8 0.1 0.3 0.2 45.0 1.5 50.1 11.8 0.1 27.2 13.9 14.6 14.7 15.9 13.3 15.8 19.6 17.3 18.8 17.4 18.1 17.0 47.0 60.9 68.9 2.9 3.6 39.0 87.2 46.4 72.3 4.1 33.9 35.9 15.5 45.8 60.7 31.3 0.0 31.3 12.4 78.3 9.8 52.2 0.7 23.8 48.6 49.3 52.0 15.8 0.5 99.8 43.6 50.5 89.7 45.2 29.7 30.1 50.7 66.5 48.7 0.0 0.5 57.1 34.6 77.3 34.6 5.1 52.8 50.8 23.2 14.0 43.1 9.6 11.3 5.5 1.1 69.5 82.3 39.9 3.3 110.7 136.9 30.1 42.8 1.6 26.3 33.1 42.0 1.6 0.9 78.9 61.7 37.5 4.9 28.0 63.4 97.6 LY75 "CD205, CLEC13B, DEC-205" ENSG00000054219 "Lymphocyte antigen 75" O60449 2 159803355-159904756 "CD markers, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 78.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 27.8;monocytes: 96.5;Proximal enterocytes: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 21.8;HDLM-2: 21.7;Karpas-707: 85.3;RT4: 30.1;THP-1: 22.3" "CAB001450, HPA049108, HPA054073" Enhanced Approved "Golgi apparatus" NA NA 1300000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 3: T-cells - Adaptive immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Golgi apparatus" "CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: AB_2682370" "unprognostic (7.29e-3)" "unprognostic (1.92e-3)" "unprognostic (3.15e-1)" "unprognostic (1.52e-2)" "unprognostic (4.60e-3)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (6.24e-2)" "unprognostic (2.80e-1)" "unprognostic (2.36e-1)" "unprognostic (8.74e-3)" "unprognostic (3.92e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (2.66e-1)" "unprognostic (4.89e-2)" "unprognostic (1.94e-2)" "prognostic favorable (3.86e-4)" 2.0 1.9 1.1 18.7 1.0 9.6 9.4 1.1 1.2 7.3 0.7 12.4 18.0 2.6 0.7 5.0 8.5 7.7 1.0 0.9 1.3 3.7 2.0 7.7 30.3 1.7 1.1 1.0 1.4 1.1 0.6 1.3 1.6 1.8 11.9 0.7 7.8 2.6 0.3 7.4 17.6 2.3 1.8 18.4 7.1 0.4 1.2 78.4 17.3 0.9 22.1 10.3 2.2 1.8 3.5 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 9.1 21.8 15.7 0.7 0.0 0.0 0.4 0.0 0.1 0.0 21.7 0.0 4.4 0.2 0.1 0.4 3.3 0.1 0.3 0.1 0.6 0.2 0.0 11.1 0.0 0.0 85.3 0.0 0.0 0.0 5.8 0.5 0.5 0.0 6.0 0.0 3.8 6.4 30.1 0.0 0.0 7.0 5.0 0.0 0.2 0.0 22.3 16.7 0.0 0.0 0.0 0.0 13.2 2.4 3.0 0.0 7.7 0.0 2.6 1.2 2.4 4.2 1.7 4.6 3.7 3.8 4.8 2.9 2.7 4.3 5.1 3.7 5.2 0.7 1.0 3.0 1.4 1.1 1.0 1.1 1.2 0.9 1.3 1.7 1.1 1.6 1.8 1.2 1.8 1.7 0.0 3.4 0.0 15.4 7.5 2.2 5.6 7.4 0.2 9.9 12.1 0.5 4.3 6.3 23.9 2.1 0.1 10.6 27.8 0.0 0.8 0.6 15.4 1.3 3.3 1.8 6.9 0.0 5.5 0.1 1.8 8.6 9.4 11.4 1.7 2.2 0.2 3.9 0.0 0.0 9.8 4.1 10.1 11.3 0.3 2.5 11.5 5.4 0.0 96.5 0.2 13.4 0.0 0.0 4.9 10.9 0.4 8.1 1.3 33.5 2.0 20.7 0.2 0.0 3.7 1.3 0.0 0.7 4.5 6.7 0.3 14.2 0.9 12.3 5.6 LYN JTK8 ENSG00000254087 "LYN proto-oncogene, Src family tyrosine kinase" P07948 8 55879835-56014169 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 73.8;lymphoid tissue: 85.4" "Cell type enhanced" "Detected in many" "B-cells: 237.5;Kupffer cells: 183.7;Macrophages: 226.0;monocytes: 182.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 64.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 198.4;HMC-1: 193.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001231, CAB004492" Enhanced Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA 770000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus, Plasma membrane" Vesicles "CAB004492: AB_627897, HPA001231: AB_1079286" "unprognostic (7.87e-2)" "unprognostic (4.89e-2)" "unprognostic (9.04e-2)" "unprognostic (3.74e-1)" "unprognostic (8.12e-2)" "unprognostic (2.17e-1)" "unprognostic (5.70e-2)" "unprognostic (1.11e-1)" "unprognostic (2.79e-1)" "unprognostic (8.80e-2)" "unprognostic (3.68e-2)" "unprognostic (7.15e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.13e-1)" "unprognostic (2.72e-3)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" 17.2 7.3 3.9 79.2 4.0 73.8 9.2 7.4 8.7 11.0 7.8 14.2 36.3 6.2 4.8 8.6 10.0 23.5 5.4 4.4 5.5 5.9 14.9 28.2 49.2 9.4 7.2 3.6 9.5 6.3 4.8 23.5 8.3 5.6 13.3 8.9 17.0 9.7 1.6 3.7 31.6 14.2 7.2 85.4 13.3 3.1 9.0 10.4 10.6 4.4 53.1 29.7 5.7 11.2 47.2 24.6 6.9 0.7 0.5 0.0 43.6 34.6 54.7 21.0 15.7 18.0 15.5 41.2 15.0 12.1 15.3 19.3 22.2 23.8 14.6 70.0 19.8 198.4 6.9 5.5 4.0 20.6 193.4 0.8 7.8 0.6 13.6 13.1 27.2 0.0 98.3 90.2 3.0 3.3 0.1 21.5 38.6 72.9 2.1 3.3 9.6 5.0 9.8 24.9 4.5 74.8 17.3 0.1 7.5 44.9 3.4 41.4 33.1 0.0 10.0 0.1 15.0 26.4 13.2 102.4 1.5 38.8 1.7 4.5 12.2 22.7 1.6 28.3 1.3 15.9 0.3 0.6 10.3 16.1 0.2 0.7 64.4 4.3 49.1 16.2 0.0 5.0 3.9 4.0 7.4 8.7 4.4 5.5 9.4 7.2 8.3 7.2 9.0 11.2 21.0 35.3 37.5 27.7 237.5 5.4 23.8 32.4 4.6 6.3 10.3 7.0 2.2 18.6 44.5 9.2 2.1 2.9 130.0 14.5 0.0 21.8 0.9 14.6 26.2 28.1 6.0 40.4 1.1 53.0 65.2 13.6 18.8 15.9 72.8 0.5 22.9 13.2 126.6 0.0 2.5 14.1 14.2 183.7 96.1 2.4 3.4 226.0 5.4 92.8 182.6 54.3 94.7 13.0 1.7 40.7 13.3 1.2 58.9 62.9 26.0 2.1 40.9 2.6 19.7 3.7 6.4 1.2 2.1 4.9 5.8 38.7 25.0 62.5 17.1 82.4 LYZ ENSG00000090382 Lysozyme P61626 12 69348381-69354234 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Amyloidosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5" "Cancer enhanced" "Detected in all" "stomach cancer: 976.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 25266.2;myeloid DC: 14438.7" "Group enriched" "Detected in all" 20 "dendritic cells: 14438.7;monocytes: 25266.2" "Cell line enriched" "Detected in many" 13 "OE19: 12130.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000055, HPA048284, HPA066182" Enhanced Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Secreted to blood" NA NA 1500000000 1500000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Actin filaments" Nucleoplasm "CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741" "unprognostic (8.52e-2)" "unprognostic (6.12e-3)" "unprognostic (2.83e-1)" "unprognostic (7.29e-2)" "unprognostic (7.91e-2)" "prognostic favorable (7.45e-4)" "unprognostic (1.21e-1)" "unprognostic (7.40e-2)" "unprognostic (1.41e-1)" "unprognostic (2.08e-2)" "unprognostic (1.44e-1)" "unprognostic (3.13e-1)" "unprognostic (2.50e-1)" "unprognostic (2.37e-1)" "unprognostic (3.65e-2)" "unprognostic (5.78e-2)" "unprognostic (3.62e-2)" 95.8 27.8 3.5 802.1 4.0 10588.1 128.2 3.7 18.5 156.2 11.4 309.0 3605.0 65.7 4.2 106.3 33.9 1054.6 34.8 2.6 4.3 32.4 138.0 1355.2 739.7 8.0 7.3 20.4 63.1 13.8 7.2 91.3 12.2 40.2 273.8 4.4 21115.5 21.8 34.0 58.7 1322.2 123.9 5.4 621.0 8941.1 21.8 10.9 321.8 27.8 36.4 652.8 428.5 16.2 11.7 0.6 0.1 0.0 0.2 0.0 0.0 4.8 0.0 0.0 0.0 0.3 9.5 6.5 4.2 1.5 0.0 3.6 1.2 0.0 0.0 0.2 1.2 0.1 62.4 1.0 960.4 0.0 110.6 50.5 0.0 0.1 0.0 0.0 0.2 0.0 0.3 7.7 0.3 0.0 0.2 2.6 109.5 2.3 12130.8 0.2 1.6 1.4 16.7 0.3 0.5 0.8 3.6 0.5 0.1 0.5 0.7 0.0 489.0 0.6 0.0 2.6 2.3 0.9 2.6 1.1 1.2 0.1 518.5 0.0 443.4 25266.2 298.2 32.6 4798.4 52.3 100.5 20.1 22.7 14438.7 20.8 20.0 17.8 1007.7 108.1 880.1 301.2 31.1 25392.1 3.5 4.0 3.7 18.5 2.6 4.3 8.0 7.3 12.2 5.4 10.9 11.7 24.0 86.6 285.8 0.0 80.8 57.2 1.7 1.2 1.2 0.3 1205.7 32.3 0.2 734.9 51.1 27.6 0.0 5.6 39.6 32.1 0.0 55.1 1.9 2.6 1.9 25.1 12.5 264.6 0.2 547.3 9.4 26.8 3106.1 2.9 123.6 0.5 29.6 25.4 887.1 0.0 0.2 112.4 0.0 2841.2 4859.1 17.4 4.1 4870.7 53.4 0.0 7063.0 0.1 176.1 0.0 0.3 3152.5 600.5 2.2 9.0 2.7 41.8 6.6 33.8 1.0 39.5 7.4 9.9 0.7 3.9 1.5 38.2 8.5 50.6 0.3 111.4 38.3 MAB21L4 "C2orf54, FLJ22671" ENSG00000172478 "Mab-21 like 4" Q08AI8 2 240886048-240896889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 262.6;vagina: 80.4" "Cell type enriched" "Detected in single" 7 "Cytotrophoblasts: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 45.9;HaCaT: 34.3;SK-BR-3: 117.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052722 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA052722: " "unprognostic (5.86e-3)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.43e-2)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (1.70e-1)" "unprognostic (1.89e-2)" "unprognostic (2.83e-2)" "unprognostic (2.96e-1)" "unprognostic (2.08e-1)" "unprognostic (6.46e-2)" "unprognostic (1.55e-1)" "unprognostic (8.26e-2)" "unprognostic (2.05e-1)" 0.2 0.1 0.3 1.0 0.5 0.0 1.8 0.5 1.3 36.0 0.0 2.9 11.5 0.2 0.1 262.6 0.9 0.5 0.1 0.8 0.0 13.3 13.0 10.0 0.3 0.3 0.0 0.1 1.2 0.0 0.2 0.8 0.5 1.5 2.5 0.3 29.2 0.2 0.3 60.8 4.9 0.1 0.0 0.2 5.8 0.2 0.2 1.1 0.1 0.0 23.5 2.0 80.4 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 45.9 2.7 0.3 0.3 0.0 0.0 34.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 5.7 0.1 0.1 0.2 7.3 0.0 0.1 0.0 11.4 0.3 5.9 2.3 0.0 0.0 117.0 0.0 0.2 0.9 0.7 0.0 0.0 1.2 0.1 0.0 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.5 0.5 1.3 0.8 0.0 0.3 0.0 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MAFB KRML ENSG00000204103 "MAF bZIP transcription factor B" Q9Y5Q3 20 40685848-40689236 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 273.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 264.0;Hofbauer cells: 377.6;Kupffer cells: 672.8;Macrophages: 456.7;Squamous epithelial cells: 361.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 88.3;non-classical monocyte: 121.4" "Lineage enriched" "Detected in many" 15 "monocytes: 121.4" "Cell line enhanced" "Detected in some" "HSkMC: 28.6;hTCEpi: 61.2;SCLC-21H: 16.7;SiHa: 15.6;U-138 MG: 16.4;U-2197: 24.4;U-87 MG: 16.0" "Low region specificity" "Detected in many" HPA005653 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" Yes NA "Cluster 51: Monocytes - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "Nucleoli, Golgi apparatus, Cytosol" "HPA005653: AB_1079293" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.16e-3)" "prognostic unfavorable (5.64e-4)" "unprognostic (9.16e-2)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-1)" "unprognostic (2.57e-2)" "unprognostic (6.09e-2)" "unprognostic (5.45e-3)" "unprognostic (9.92e-2)" "unprognostic (3.95e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-3)" "unprognostic (3.49e-2)" "unprognostic (2.30e-2)" 35.3 13.8 4.8 37.3 4.9 59.2 27.3 4.4 10.5 16.5 6.9 9.5 7.8 9.3 5.4 33.0 11.3 24.4 10.7 3.7 5.7 17.5 29.3 20.9 27.8 14.3 6.3 6.8 15.8 273.1 3.1 13.2 7.2 8.3 7.2 0.6 18.3 4.7 15.8 85.3 13.2 14.2 9.0 96.3 11.0 3.9 13.1 6.7 50.1 16.7 12.7 13.9 21.9 15.8 0.0 0.0 0.0 2.6 1.5 0.2 0.4 0.3 0.1 0.3 0.1 0.4 0.2 0.0 1.9 0.4 0.0 3.8 0.0 0.0 0.0 0.0 1.4 0.0 1.2 0.2 0.9 0.0 0.1 28.6 61.2 0.2 2.1 0.0 0.4 0.0 0.0 0.0 0.1 0.9 0.3 7.4 2.6 6.2 0.0 0.0 0.0 0.0 0.5 0.4 16.7 1.4 15.6 1.5 3.9 5.4 1.5 0.3 0.5 16.4 0.3 24.4 0.0 0.0 0.0 0.0 16.0 0.6 0.0 0.4 24.3 0.0 0.0 88.3 0.0 0.0 0.0 0.1 7.9 0.1 0.0 0.0 2.1 0.0 121.4 0.1 0.0 10.6 4.8 4.9 4.4 10.5 3.7 5.7 14.3 6.3 7.2 9.0 13.1 15.8 70.0 22.4 37.9 1.6 7.8 68.6 50.5 17.1 264.0 12.0 112.2 217.8 208.9 7.2 16.8 51.5 25.0 9.8 7.6 117.1 1.9 2.3 0.8 15.7 64.4 39.1 57.7 4.0 0.8 3.4 2.8 172.7 49.5 27.6 10.8 0.9 34.6 36.1 377.6 3.3 25.4 50.7 6.1 672.8 91.7 2.8 29.5 456.7 21.4 6.5 65.3 21.9 3.1 2.0 1.3 4.9 30.9 24.5 5.6 29.7 89.5 1.3 2.4 8.3 13.1 160.6 102.4 0.8 1.7 361.5 88.2 12.4 9.5 114.6 39.0 19.2 MAGEA9 "CT1.9, MAGE9, MGC8421" ENSG00000123584 "MAGE family member A9" P43362 X 149781930-149787737 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 38 "testis: 3.7" "Group enriched" "Detected in some" 16 "Spermatocytes: 2.3;Spermatogonia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "U-266/70: 45.2;U-266/84: 32.9" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.2 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA9B ENSG00000267978 "MAGE family member A9B" P43362 X 149581653-149587453 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "testis: 10.0" "Group enriched" "Detected in some" 4 "Spermatocytes: 39.6;Spermatogonia: 16.0" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "OE19: 82.4;RT4: 131.1;U-266/70: 55.1;U-266/84: 73.7" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 21: OE19 - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " "unprognostic (6.12e-3)" "unprognostic (3.26e-1)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.0 0.1 82.4 0.0 0.2 0.0 6.3 0.0 131.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 55.1 73.7 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 39.6 16.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MAL "MVP17, VIP17" ENSG00000172005 "Mal, T cell differentiation protein" P21145 2 95025677-95053992 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 2817.9;vagina: 863.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 373.3;Distal tubular cells: 236.7;Muller glia cells: 91.5;Oligodendrocytes: 168.1;Skeletal myocytes: 82.3;Squamous epithelial cells: 90.9" "Cancer enhanced" "Detected in many" "renal cancer: 101.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 217.6;naive CD4 T-cell: 293.3;naive CD8 T-cell: 138.1;T-reg: 233.6" "Lineage enriched" "Detected in many" 38 "T-cells: 293.3" "Cell line enhanced" "Detected in some" "HDLM-2: 516.4;MOLT-4: 722.0;RPMI-8226: 256.7;RPTEC TERT1: 2531.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065691 Approved "Golgi apparatus,Centrosome" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" Centrosome "HPA065691: AB_2685533" "unprognostic (1.57e-3)" "unprognostic (2.64e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (5.18e-6)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.35e-2)" "unprognostic (1.06e-1)" "unprognostic (3.59e-1)" "unprognostic (4.61e-2)" "unprognostic (3.89e-2)" "prognostic favorable (3.96e-9)" "unprognostic (1.91e-1)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.57e-1)" 5.3 1.8 251.3 10.8 333.9 12.7 4.4 264.8 400.2 450.7 177.4 50.8 2.2 2.6 8.3 2817.9 8.9 2.9 17.9 260.8 256.7 400.4 1.7 25.3 25.1 281.3 282.1 3.2 3.0 0.4 3.9 3.4 272.9 21.8 6.3 10.1 544.0 11.1 2.8 12.6 17.0 2.4 264.0 9.4 52.7 1.1 303.2 261.2 21.3 4.3 352.8 15.0 863.2 449.3 51.3 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 12.0 0.0 0.3 2.4 0.2 0.0 0.5 516.4 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.4 2.4 0.4 0.1 0.1 0.0 722.0 0.2 0.2 0.0 0.0 0.7 0.0 256.7 2531.4 65.3 0.6 0.0 0.1 9.4 1.6 2.1 0.3 0.9 0.8 0.0 0.2 0.1 0.5 0.4 0.3 0.3 0.3 0.4 0.1 0.7 0.6 0.1 4.7 0.3 2.1 3.1 217.6 38.4 0.5 3.5 293.3 138.1 2.6 7.7 0.6 1.2 233.6 71.0 251.3 333.9 264.8 400.2 260.8 256.7 281.3 282.1 272.9 264.0 303.2 449.3 0.9 0.0 0.0 12.1 3.1 1.1 0.2 0.0 1.8 1.5 1.2 0.9 11.3 0.0 1.3 373.3 4.2 0.2 0.9 0.0 236.7 0.1 5.3 4.3 0.6 0.5 0.0 46.1 0.5 0.0 0.0 4.7 24.5 8.2 1.3 3.2 2.5 0.0 0.1 5.0 0.5 0.0 14.2 0.0 1.3 19.5 0.9 1.0 17.8 1.9 2.5 91.5 4.1 6.6 168.1 0.1 0.0 0.0 8.9 0.2 0.0 3.2 0.0 2.7 6.6 82.3 5.3 0.0 0.6 90.9 1.0 0.3 35.8 0.0 0.1 0.8 MALRD1 "bA265G8.2, C10orf112, Diet1" ENSG00000204740 "MAM and LDL receptor class A domain containing 1" Q5VYJ5 10 19048801-19790401 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "intestine: 31.1" "Group enriched" "Detected in some" 4 "Astrocytes: 37.9;Oligodendrocyte precursor cells: 76.4;Proximal enterocytes: 69.3" "Cancer enhanced" "Detected in some" "breast cancer: 0.9;stomach cancer: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Karpas-707: 44.2" "Not detected" "Not detected" "HPA035732, HPA038106, HPA046848" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837" "unprognostic (9.03e-3)" "unprognostic (1.38e-1)" "unprognostic (2.40e-2)" "unprognostic (4.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (2.74e-2)" "unprognostic (5.57e-2)" "unprognostic (5.01e-1)" "unprognostic (1.00e-1)" "unprognostic (3.55e-1)" "unprognostic (7.69e-2)" "unprognostic (3.16e-2)" "unprognostic (9.80e-2)" "unprognostic (8.90e-2)" "unprognostic (3.13e-2)" "unprognostic (3.78e-4)" 0.5 0.7 1.9 0.2 1.9 0.4 0.6 1.0 1.6 0.7 1.3 0.5 30.6 0.6 2.2 0.2 0.2 0.4 1.4 1.8 2.1 1.5 0.1 0.9 0.1 1.5 1.7 1.2 0.1 0.0 1.5 0.4 1.5 0.6 0.1 0.3 0.1 0.3 0.6 0.2 31.1 0.4 1.7 0.2 0.3 2.1 1.9 1.9 0.5 0.1 0.0 0.6 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.8 0.0 2.6 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 44.2 0.0 4.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.9 1.9 1.0 1.6 1.8 2.1 1.5 1.7 1.5 1.7 1.9 1.5 0.0 0.0 1.8 37.9 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.6 1.6 0.0 0.0 0.0 0.0 0.8 1.3 0.0 1.9 0.1 7.9 0.1 0.3 0.1 0.0 4.2 11.6 0.0 0.8 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 11.0 9.5 0.0 0.0 0.3 1.8 0.0 0.0 0.0 5.6 0.0 1.4 0.0 76.4 4.9 0.0 13.8 0.7 0.0 0.2 69.3 0.2 0.0 0.0 0.0 0.1 0.2 9.0 4.1 0.1 0.1 0.3 0.0 1.9 9.7 0.0 MAN1A1 ENSG00000111885 "Mannosidase alpha class 1A member 1" P33908 6 119177205-119349761 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 154.6" "Cell type enhanced" "Detected in many" "Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037058, HPA053198, HPA063561" Uncertain Supported "Golgi apparatus" NA NA 460000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" "CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042" "unprognostic (1.50e-1)" "unprognostic (7.36e-3)" "unprognostic (4.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.33e-3)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" "unprognostic (5.11e-2)" "unprognostic (1.68e-3)" "unprognostic (4.62e-1)" "unprognostic (2.37e-2)" "unprognostic (3.49e-2)" "unprognostic (2.25e-1)" "unprognostic (6.89e-2)" "unprognostic (3.40e-1)" 102.2 48.5 4.2 32.8 12.3 28.9 34.3 1.2 8.9 25.9 5.1 36.1 52.7 23.8 8.8 22.7 16.0 47.1 15.3 8.0 4.6 66.6 154.6 35.8 34.8 2.9 5.0 20.1 32.7 25.8 4.6 79.4 2.5 18.1 29.3 6.2 42.7 15.0 7.6 14.3 69.8 27.2 3.3 36.5 25.9 7.0 8.4 18.9 22.6 31.0 25.9 56.0 17.1 5.9 0.2 0.0 3.4 0.0 273.1 119.9 6.6 6.9 41.4 5.1 12.5 19.8 2.6 43.2 0.3 26.5 65.7 0.4 7.6 0.1 6.4 64.5 19.4 36.3 3.9 204.0 27.2 0.1 17.7 82.4 5.3 41.6 25.3 22.1 3.4 12.6 128.1 219.6 39.7 6.1 1.7 0.3 2.3 20.0 10.0 12.1 4.2 66.6 13.4 35.4 14.1 21.0 0.1 0.6 0.0 8.3 10.4 4.8 24.8 16.9 15.4 32.0 15.8 294.5 44.6 84.8 50.2 0.7 10.4 4.3 0.3 1.1 1.1 0.5 2.3 0.7 0.6 0.6 0.3 0.4 0.3 0.9 1.9 0.9 0.5 2.8 0.7 0.3 4.2 12.3 1.2 8.9 8.0 4.6 2.9 5.0 2.5 3.3 8.4 5.9 37.1 9.6 46.1 19.9 31.0 31.7 5.7 1.2 5.2 28.1 18.8 5.8 4.4 44.3 6.9 106.7 0.0 6.8 40.6 23.3 5.9 9.4 232.5 5.9 63.9 42.1 48.0 40.4 165.0 37.8 12.4 98.4 18.8 10.7 3.8 24.0 97.5 270.5 101.1 0.0 79.4 61.1 0.0 84.6 91.2 39.3 26.4 98.0 28.4 128.4 13.5 1.7 42.2 4.5 3.7 14.8 18.9 4.1 147.5 5.3 92.2 33.5 4.6 5.0 6.6 12.9 27.8 2.8 3.9 3.4 27.8 6.2 24.3 14.6 18.9 9.7 MAN1A2 MAN1B ENSG00000198162 "Mannosidase alpha class 1A member 2" O60476 1 117367449-117528872 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 236.1;Inhibitory neurons: 238.0;Syncytiotrophoblasts: 380.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034559, HPA057364" Enhanced Enhanced "Golgi apparatus" NA NA 2000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA034559: AB_10671229, HPA057364: AB_2683419" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-3)" "unprognostic (2.15e-1)" "unprognostic (3.11e-2)" "unprognostic (9.70e-2)" "unprognostic (1.95e-2)" "unprognostic (8.01e-2)" "unprognostic (8.19e-3)" "prognostic favorable (4.08e-4)" "unprognostic (1.41e-1)" "unprognostic (4.38e-2)" "unprognostic (6.84e-2)" "unprognostic (1.45e-1)" "unprognostic (7.39e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-2)" 15.6 11.7 6.7 13.0 12.0 6.3 12.9 8.8 11.6 17.5 7.7 12.5 11.1 16.4 13.7 15.2 14.2 12.3 11.0 7.2 8.5 15.3 21.1 10.8 14.1 1.6 5.0 14.3 36.2 32.9 6.7 21.7 1.6 14.4 12.5 18.2 14.0 13.1 8.4 10.3 11.6 18.0 1.0 12.2 14.2 10.8 6.2 14.7 25.4 10.1 13.8 17.8 7.7 9.8 32.4 13.8 23.2 20.1 29.8 35.7 74.2 26.3 40.9 11.6 10.9 10.7 18.2 24.2 47.4 33.9 10.8 18.7 11.0 22.3 26.0 30.3 16.4 14.4 18.5 11.8 18.1 22.7 31.6 24.2 23.5 17.8 15.5 21.3 35.0 16.7 23.5 36.1 24.5 62.6 14.0 7.2 11.9 16.4 14.4 12.5 50.5 16.7 15.9 43.3 12.6 18.4 26.2 27.6 21.1 30.1 13.8 14.2 33.6 26.0 21.4 18.6 27.2 24.4 18.0 15.9 34.4 17.8 63.1 0.9 1.5 2.6 3.0 1.2 3.6 1.9 2.4 2.5 1.4 1.9 2.0 2.9 1.2 3.8 1.1 2.7 6.3 1.5 6.7 12.0 8.8 11.6 7.2 8.5 1.6 5.0 1.6 1.0 6.2 9.8 40.3 38.5 33.4 71.5 45.1 31.0 34.8 26.7 39.3 63.5 43.3 46.0 101.8 35.8 39.1 44.1 22.9 55.1 52.6 24.7 17.6 32.3 33.1 43.2 52.0 40.6 21.7 43.8 188.5 60.4 236.1 50.7 28.5 54.7 16.4 32.3 42.1 88.7 29.4 43.7 238.0 37.1 20.3 36.2 22.0 22.5 53.7 37.2 40.9 101.2 39.2 51.3 55.6 136.7 149.1 37.5 25.1 65.5 120.2 43.0 28.6 22.1 40.9 42.2 39.5 69.1 53.5 72.9 56.2 53.0 34.5 380.5 45.8 68.3 30.8 47.3 MAN2A1 "GOLIM7, MANA2" ENSG00000112893 "Mannosidase alpha class 2A member 1" Q16706 5 109689927-109869625 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 107.8" "Cell type enriched" "Detected in many" 9 "Oligodendrocytes: 2117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022377, HPA026896" Enhanced Supported "Golgi apparatus" NA NA 110000000 "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 2: Karpas-707 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "CAB022377: , HPA026896: AB_1853512" "unprognostic (1.62e-2)" "unprognostic (4.06e-2)" "unprognostic (1.25e-2)" "unprognostic (6.96e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (4.20e-2)" "unprognostic (3.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.73e-2)" "unprognostic (1.23e-1)" "unprognostic (6.77e-3)" "unprognostic (2.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.11e-3)" "unprognostic (5.31e-3)" 11.2 17.0 28.0 13.9 66.1 12.7 11.3 41.4 29.6 13.8 3.8 20.7 30.1 12.0 4.2 8.5 9.0 18.1 3.7 21.7 31.5 17.4 42.4 10.1 15.8 64.5 49.9 9.8 22.2 20.7 0.9 15.3 62.1 9.1 20.8 1.7 6.5 10.2 6.0 7.4 25.7 18.3 39.4 14.1 15.7 9.5 42.8 22.7 14.7 11.5 14.7 16.1 2.7 107.8 23.1 18.6 26.5 11.0 56.2 42.2 97.5 49.3 78.0 26.1 46.7 23.2 37.0 17.4 30.7 63.3 18.5 26.5 14.5 56.0 59.7 16.3 9.7 32.6 13.5 30.7 34.6 15.9 15.5 39.7 25.0 43.4 61.4 37.3 54.5 16.9 8.8 87.0 70.5 13.8 27.6 9.1 20.4 17.9 7.3 10.8 40.0 78.5 34.1 32.8 3.7 3.3 22.6 24.9 16.1 29.1 20.5 17.1 56.4 53.7 21.3 30.1 32.9 48.7 58.7 13.6 41.8 22.4 30.3 4.1 2.0 0.6 1.6 2.8 1.3 1.9 2.8 2.8 1.8 1.6 3.3 2.7 1.6 0.5 4.4 2.0 2.8 1.1 28.0 66.1 41.4 29.6 21.7 31.5 64.5 49.9 62.1 39.4 42.8 107.8 20.9 6.4 8.4 100.9 41.1 17.8 15.8 12.7 29.6 0.6 20.0 9.5 7.6 34.3 14.7 31.3 0.0 19.4 28.9 65.8 1.9 27.1 13.7 10.2 35.8 21.6 24.7 29.2 220.8 35.3 98.0 32.3 45.3 33.3 15.2 19.2 36.8 130.3 18.0 0.0 115.2 35.2 22.4 74.8 24.6 8.3 9.9 47.4 26.6 102.1 39.6 5.9 13.4 46.8 2117.7 28.8 28.4 6.8 84.0 39.8 60.6 24.7 12.1 0.2 19.7 52.6 16.5 16.5 19.9 33.6 23.7 23.7 34.7 14.2 49.6 24.2 MANEA "FLJ12838, mandaselin" ENSG00000172469 "Mannosidase endo-alpha" Q5SRI9 6 95577535-95609452 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 59.8;Plasma cells: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011046, HPA011069" Enhanced Supported "Golgi apparatus" NA NA 140000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 1: Thyroid gland - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA011046: AB_1079303, HPA011069: AB_1079304" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "prognostic favorable (3.04e-4)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (5.03e-2)" "unprognostic (2.98e-3)" "unprognostic (2.74e-1)" "unprognostic (5.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (9.07e-2)" "unprognostic (2.86e-3)" "unprognostic (5.18e-2)" "unprognostic (3.08e-1)" "unprognostic (9.68e-2)" "unprognostic (7.47e-2)" 11.9 6.9 3.1 7.9 3.6 3.3 8.9 3.7 3.7 8.4 4.2 8.1 8.8 6.8 6.3 8.0 6.4 7.9 5.6 2.5 3.7 12.0 24.0 7.3 9.2 4.3 3.3 9.7 8.4 11.1 2.1 6.3 4.4 7.0 8.7 6.1 5.6 7.9 1.4 6.8 8.8 6.7 3.6 9.6 12.1 6.1 3.7 9.1 11.6 3.4 11.2 9.0 3.5 5.6 6.5 5.3 20.4 16.6 33.1 38.5 7.7 17.7 16.2 10.1 14.8 6.1 16.0 12.3 21.7 11.7 14.9 10.4 14.1 12.0 23.2 20.9 12.6 16.6 4.7 10.2 11.5 22.3 14.4 38.4 13.7 12.0 8.5 14.6 24.3 12.1 26.2 28.1 22.0 4.5 13.1 9.5 3.0 17.1 5.5 15.4 19.9 18.8 15.5 11.2 16.3 8.8 10.0 7.2 6.5 14.3 11.4 20.7 22.0 10.1 7.1 18.4 17.8 20.9 12.9 15.2 18.2 19.1 23.6 8.5 2.3 1.3 3.2 4.1 4.6 4.5 3.9 3.8 2.5 2.3 4.5 3.1 0.5 2.9 3.7 1.0 7.7 2.4 3.1 3.6 3.7 3.7 2.5 3.7 4.3 3.3 4.4 3.6 3.7 5.6 11.6 12.8 8.4 7.8 15.5 7.4 4.4 6.4 8.6 8.1 8.4 7.4 4.5 10.0 7.4 12.9 4.2 5.4 5.4 1.8 5.9 4.1 16.7 7.3 14.4 10.7 1.8 8.2 6.0 7.3 5.6 12.0 8.2 8.1 2.5 17.8 28.2 59.8 11.0 11.8 7.3 4.6 0.0 12.0 5.8 11.7 5.9 7.9 8.8 8.4 6.8 10.5 3.1 16.1 18.7 3.4 2.8 15.8 113.4 3.4 4.8 8.5 8.5 5.3 13.1 9.8 17.1 7.1 12.1 11.8 7.0 1.4 9.2 13.5 5.0 3.5 MANEAL FLJ31434 ENSG00000185090 "Mannosidase endo-alpha like" Q5VSG8 1 37793847-37801137 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 16.5;Enteroendocrine cells: 30.5;Horizontal cells: 26.9;Inhibitory neurons: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063423 Approved "Golgi apparatus" "Intracellular and membrane" NA NA 47000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Golgi apparatus" "HPA063423: AB_2685011" "unprognostic (8.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (7.92e-2)" "prognostic favorable (5.28e-4)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.02e-1)" "unprognostic (1.03e-2)" "unprognostic (7.67e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.17e-3)" "unprognostic (8.29e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (2.26e-1)" 1.1 7.1 16.3 2.1 16.7 0.2 5.0 12.3 18.2 2.9 4.6 6.1 3.5 1.9 6.5 4.7 2.8 1.3 1.3 16.6 21.4 3.6 9.1 3.0 1.2 16.1 17.0 1.2 10.1 5.9 19.3 0.9 20.0 4.2 6.3 13.3 3.6 2.7 4.0 4.1 3.5 2.3 11.9 1.9 4.6 2.7 20.1 1.3 5.6 2.6 1.9 2.3 2.4 13.6 24.0 30.1 5.4 57.1 7.3 2.7 51.7 4.4 26.0 22.1 9.6 50.3 55.0 40.0 18.8 3.1 26.1 5.4 11.1 5.9 7.9 47.5 23.7 29.4 25.5 41.0 0.5 42.3 23.4 0.9 30.6 1.2 1.1 30.7 0.6 7.1 17.5 30.4 3.5 47.8 11.9 0.1 18.1 57.0 31.8 18.2 39.0 46.2 13.1 62.8 139.8 42.4 63.0 2.0 23.6 1.0 27.3 4.4 3.5 31.0 19.0 30.2 41.0 43.6 45.0 13.1 5.1 13.7 23.2 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 16.3 16.7 12.3 18.2 16.6 21.4 16.1 17.0 20.0 11.9 20.1 13.6 1.1 3.2 2.7 0.3 1.0 0.5 1.1 0.3 2.2 16.5 4.3 4.3 1.1 1.5 0.6 3.7 4.2 0.2 1.1 2.3 0.0 1.6 0.2 1.1 0.7 0.8 30.5 0.0 9.0 6.0 2.0 1.0 1.1 2.5 0.0 1.8 0.0 5.0 0.9 26.9 12.1 3.7 0.0 0.8 0.4 0.0 0.3 0.5 3.6 3.7 0.0 5.0 0.0 9.5 2.7 2.4 2.3 0.0 2.4 1.7 1.1 0.4 0.2 9.5 0.0 0.7 0.4 0.0 1.5 1.5 0.0 0.1 0.7 0.5 4.1 1.3 MANSC1 "FLJ10298, LOH12CR3" ENSG00000111261 "MANSC domain containing 1" Q9H8J5 12 12326056-12350242 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 70.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "neutrophil: 98.3" "Lineage enriched" "Detected in many" 39 "granulocytes: 98.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 50.7;OE19: 54.3;RPTEC TERT1: 25.9" "Low region specificity" "Detected in all" "HPA007955, HPA007956" Approved Approved "Golgi apparatus,Vesicles" NA NA 44000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Vesicles" "HPA007955: AB_1079306, HPA007956: AB_1079305" "unprognostic (5.41e-3)" "unprognostic (3.10e-2)" "unprognostic (1.24e-1)" "unprognostic (5.46e-3)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-2)" "unprognostic (8.47e-2)" "unprognostic (9.18e-2)" "unprognostic (5.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.03e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.15e-2)" "unprognostic (4.46e-2)" "unprognostic (3.65e-1)" "unprognostic (1.03e-2)" 18.9 12.1 3.4 4.3 4.1 3.5 19.5 3.9 6.5 16.9 5.0 22.9 11.7 22.1 11.5 42.3 16.6 10.2 11.2 4.1 3.0 13.2 9.7 12.3 2.3 3.2 3.3 11.3 25.2 11.3 17.9 9.5 3.2 15.1 15.8 5.4 70.0 10.8 4.0 21.7 15.2 12.1 2.6 11.3 21.5 8.4 3.8 1.4 13.8 4.4 6.4 16.3 20.6 4.0 0.3 5.7 1.8 0.1 5.6 5.5 6.2 3.9 4.6 2.0 2.5 4.8 18.2 0.0 4.2 3.9 2.1 0.8 7.1 3.3 1.5 0.0 6.9 8.3 6.4 4.2 0.9 1.4 2.3 3.5 5.3 1.3 0.9 13.8 50.7 0.1 5.6 0.1 0.6 11.0 0.0 0.6 6.5 54.3 3.0 0.2 0.0 0.1 25.9 18.8 2.6 10.3 2.1 16.9 6.0 2.8 15.4 5.0 20.5 2.8 2.3 0.7 5.5 0.4 0.2 2.8 2.0 0.0 2.1 6.6 1.2 1.0 0.1 0.9 0.0 0.2 0.3 0.0 0.6 0.4 2.5 0.4 98.3 0.6 0.4 0.1 0.0 0.6 3.4 4.1 3.9 6.5 4.1 3.0 3.2 3.3 3.2 2.6 3.8 4.0 29.0 9.6 21.2 8.8 3.3 4.0 7.1 7.2 6.2 6.1 21.2 13.5 2.6 28.6 11.9 23.9 8.4 35.4 4.5 33.6 1.9 19.0 0.9 15.1 5.2 28.8 21.7 3.6 16.6 37.9 7.4 10.4 23.0 20.5 2.5 8.6 37.1 9.8 8.0 10.1 13.5 33.4 8.2 5.5 0.7 2.2 13.7 2.0 0.0 15.0 2.7 11.4 9.2 7.5 11.4 16.3 25.2 16.6 1.0 7.4 16.7 3.0 18.1 13.1 0.0 4.8 6.5 2.1 1.5 22.1 4.7 17.0 3.0 9.7 26.5 8.8 MAP2K7 "Jnkk2, MKK7, PRKMK7" ENSG00000076984 "Mitogen-activated protein kinase kinase 7" O14733 19 7903843-7914478 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001633, CAB004262, HPA064711" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "Golgi apparatus" "CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331" "unprognostic (1.77e-1)" "unprognostic (5.04e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-1)" "unprognostic (4.24e-2)" "prognostic favorable (8.54e-5)" "unprognostic (1.80e-3)" "unprognostic (2.55e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-2)" "unprognostic (1.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.54e-2)" "unprognostic (3.71e-2)" "unprognostic (6.05e-2)" "unprognostic (1.73e-2)" "prognostic favorable (1.56e-4)" 19.1 17.0 17.9 11.7 17.8 19.4 19.5 16.8 19.0 25.1 10.4 24.4 13.1 26.1 3.7 20.2 20.5 5.9 20.8 14.8 15.2 18.7 24.7 17.1 11.7 17.3 17.3 23.2 21.6 9.6 23.4 9.2 17.1 21.0 4.6 5.6 19.2 7.9 52.4 27.9 20.1 6.2 15.1 24.5 18.8 17.5 17.3 10.9 19.0 16.4 6.1 22.0 22.4 19.9 25.8 14.4 12.2 20.2 9.7 9.3 22.8 16.5 8.0 11.0 11.3 20.9 15.2 30.5 25.9 8.8 10.7 22.9 10.7 12.8 4.3 24.7 53.3 21.4 20.9 15.6 12.4 20.1 26.0 10.8 16.1 8.7 9.8 14.5 10.0 21.9 31.9 38.5 6.5 13.4 28.8 48.6 21.7 13.6 32.0 28.5 13.4 31.0 9.8 21.0 22.4 22.5 11.3 19.4 23.9 7.3 21.0 22.7 15.3 33.2 19.0 23.7 22.7 55.5 27.7 28.8 16.6 29.2 13.6 0.0 0.8 0.6 0.6 0.8 0.4 0.7 0.5 0.6 0.4 1.0 0.5 0.7 1.5 1.0 0.5 0.8 0.2 0.4 17.9 17.8 16.8 19.0 14.8 15.2 17.3 17.3 17.1 15.1 17.3 19.9 15.4 25.6 18.1 11.1 27.0 38.6 37.2 22.7 22.2 52.9 23.5 16.5 14.4 24.3 14.5 20.2 77.2 28.3 27.8 31.1 13.7 22.8 4.8 16.2 20.3 19.5 36.5 23.6 9.9 19.0 31.1 18.5 16.3 24.8 10.8 33.3 21.4 22.2 18.6 57.2 11.0 24.0 32.6 22.2 17.1 11.7 28.9 20.5 32.0 6.5 25.3 23.9 46.4 9.0 15.0 25.7 20.8 12.4 30.4 39.8 38.7 18.4 15.3 65.7 32.9 30.2 22.1 17.7 36.4 22.7 42.6 49.3 30.3 30.3 27.6 33.2 MAPK4 "Erk3-related, Erk4, PRKM4" ENSG00000141639 "Mitogen-activated protein kinase 4" P31152 18 50560087-50731826 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;parathyroid gland: 51.0" "Cell type enhanced" "Detected in some" "Astrocytes: 202.7;Excitatory neurons: 105.2;Inhibitory neurons: 58.5;Late spermatids: 66.4;Muller glia cells: 62.6" "Cancer enriched" "Detected in many" 4 "glioma: 15.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.3;HeLa: 3.3;NTERA-2: 2.2;SCLC-21H: 11.6;SH-SY5Y: 2.8;SK-MEL-30: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007461 Approved "Nucleoplasm,Golgi apparatus,Midbody" Yes NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Golgi apparatus" Midbody "HPA007461: AB_1079308" "unprognostic (4.12e-2)" "unprognostic (3.24e-2)" "unprognostic (3.60e-1)" "unprognostic (1.42e-3)" "unprognostic (5.17e-2)" "unprognostic (1.84e-2)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.24e-2)" "unprognostic (1.61e-1)" "unprognostic (4.38e-3)" "unprognostic (2.16e-1)" "unprognostic (3.44e-7)" "unprognostic (1.96e-4)" "unprognostic (5.99e-4)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" 0.9 26.8 56.5 0.2 79.9 0.0 0.8 56.4 46.0 1.5 28.0 6.8 0.6 0.8 3.1 2.3 1.5 1.8 22.1 41.6 57.5 3.3 4.5 2.3 0.0 65.4 70.0 2.9 1.4 51.0 17.8 2.6 56.7 5.0 0.8 22.6 0.9 9.8 1.5 1.3 1.6 1.8 48.8 0.1 2.1 2.4 81.9 7.3 6.2 1.5 0.0 4.6 1.3 38.7 0.0 0.0 1.0 0.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.1 1.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.6 2.8 0.0 0.8 1.9 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.5 79.9 56.4 46.0 41.6 57.5 65.4 70.0 56.7 48.8 81.9 38.7 0.4 9.6 0.0 202.7 0.0 0.0 0.4 0.0 0.0 11.4 0.9 1.1 22.9 1.5 0.0 0.0 0.0 4.6 0.0 0.0 5.9 0.9 30.1 0.0 0.0 0.3 0.0 0.0 105.2 0.0 0.3 1.0 0.0 0.0 0.0 0.7 0.0 1.0 0.4 5.0 58.5 0.0 0.0 0.0 0.0 66.4 0.9 0.1 0.0 7.5 0.0 62.6 0.0 18.6 1.9 0.4 0.0 1.5 0.0 0.7 0.0 0.2 0.0 1.0 0.0 1.0 0.7 0.8 0.6 0.0 0.0 1.8 0.0 0.4 0.0 0.1 MARCHF1 "FLJ20668, MARCH-I, MARCH1, RNF171" ENSG00000145416 "Membrane associated ring-CH-type finger 1" Q8TCQ1 4 163524298-164384050 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.6;retina: 27.5" "Group enriched" "Detected in some" 4 "B-cells: 21.4;Hofbauer cells: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 94 "classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 7.1;U-266/70: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014600, HPA048024" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Vesicles "Endoplasmic reticulum, Golgi apparatus" "HPA014600: AB_1853573, HPA048024: " "unprognostic (7.29e-2)" "unprognostic (5.82e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" "unprognostic (8.25e-2)" "unprognostic (2.98e-2)" "unprognostic (4.79e-3)" "unprognostic (9.00e-2)" "unprognostic (3.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-1)" "unprognostic (2.20e-1)" "unprognostic (1.24e-1)" "unprognostic (7.00e-2)" "unprognostic (2.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.91e-2)" 6.4 3.5 7.8 21.5 8.1 3.9 2.7 3.6 7.7 3.1 1.8 3.5 3.9 2.5 0.7 3.0 2.8 5.3 1.7 6.6 10.1 1.8 4.1 8.0 31.6 8.0 8.2 2.7 2.8 0.8 2.5 9.9 6.9 2.3 4.5 27.5 3.2 1.2 1.0 4.5 7.0 6.2 7.0 25.8 3.9 1.7 12.1 5.6 2.1 1.0 25.5 7.7 2.9 14.4 0.6 0.5 2.1 1.2 0.0 0.0 1.3 0.9 0.0 0.0 0.0 1.2 2.4 7.1 2.5 0.0 0.2 1.0 0.0 0.0 0.0 0.8 0.7 5.0 3.0 0.5 0.0 3.1 1.6 0.0 0.0 0.0 0.1 2.8 0.0 1.3 1.9 3.6 2.4 0.7 1.8 1.9 2.6 0.2 0.9 2.0 0.3 0.5 0.1 1.1 1.0 0.9 0.6 1.0 0.4 1.4 2.9 0.5 2.3 0.8 1.4 0.5 1.7 7.0 2.5 1.9 0.9 1.5 1.1 0.0 41.8 25.5 0.1 41.0 0.0 42.3 0.1 0.0 44.2 35.8 0.0 0.0 0.3 0.3 45.4 16.5 0.0 18.4 7.8 8.1 3.6 7.7 6.6 10.1 8.0 8.2 6.9 7.0 12.1 14.4 0.1 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 MARCO "SCARA2, SR-A6" ENSG00000019169 "Macrophage receptor with collagenous structure" Q9UEW3 2 118942194-118994660 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 94.9;lung: 199.6;lymphoid tissue: 87.9" "Cell type enriched" "Detected in many" 6 "Kupffer cells: 1269.8" "Cancer enhanced" "Detected in many" "lung cancer: 21.6" "Group enriched" "Detected in many" 4 "cerebral cortex: 4.1;thalamus: 12.6" "Group enriched" "Detected in some" 4 "classical monocyte: 33.7;intermediate monocyte: 56.5" "Lineage enriched" "Detected in many" 5 "monocytes: 56.5" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;THP-1: 2.5;U-2 OS: 2.6;U-266/70: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA063793 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 30000000 "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" Vesicles "HPA063793: AB_2685123" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (5.96e-3)" "unprognostic (3.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.58e-2)" "unprognostic (3.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (6.27e-3)" "unprognostic (5.13e-2)" "unprognostic (2.24e-3)" "unprognostic (1.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (6.55e-2)" 64.7 31.1 0.4 87.9 1.4 3.4 7.4 0.7 4.1 0.7 4.4 5.7 2.0 0.7 1.3 2.4 25.5 2.4 19.0 0.9 1.0 1.6 94.9 199.6 17.7 1.2 1.7 7.5 0.8 0.3 1.5 2.8 1.9 1.8 2.1 0.0 4.4 2.3 1.5 2.5 3.1 29.8 1.2 37.1 3.5 2.0 12.6 1.3 1.5 5.0 1.1 25.2 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 2.6 0.4 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.0 33.7 0.0 0.0 56.5 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.7 0.0 7.2 1.0 0.0 9.2 0.4 1.4 0.7 4.1 0.9 1.0 1.2 1.7 1.9 1.2 12.6 0.7 0.7 25.6 45.1 0.0 1.0 1.1 0.1 0.0 0.0 0.0 3.4 1.8 0.4 1.5 16.7 3.7 0.0 0.7 1.4 0.1 0.0 3.9 0.0 0.0 0.0 5.2 0.0 8.0 0.0 0.2 1.1 2.6 0.0 0.0 12.6 0.0 11.4 3.4 169.6 0.0 0.0 0.0 0.0 1269.8 46.4 0.1 0.0 199.3 0.0 2.8 23.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.5 0.1 0.0 0.2 13.1 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.9 1.9 4.1 0.0 0.0 0.1 MARF1 "KIAA0430, LKAP, LMKB, PPP1R34" ENSG00000166783 "Meiosis regulator and mRNA stability factor 1" Q9Y4F3 16 15594387-15643154 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 28.7;Breast glandular cells: 26.3;Endometrial stromal cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017992 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Vesicles" "HPA017992: AB_1852921" "unprognostic (2.33e-1)" "unprognostic (6.44e-3)" "unprognostic (8.84e-2)" "unprognostic (3.78e-2)" "unprognostic (1.28e-1)" "unprognostic (6.13e-3)" "unprognostic (2.35e-1)" "unprognostic (2.10e-2)" "unprognostic (2.47e-2)" "unprognostic (6.93e-2)" "unprognostic (8.44e-3)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (8.74e-2)" "unprognostic (7.94e-2)" 10.5 7.1 2.1 10.8 5.2 9.7 9.4 1.5 6.6 10.0 3.7 16.0 10.4 12.8 1.0 12.3 13.7 12.5 9.2 4.5 3.4 13.5 8.3 9.3 14.6 3.6 4.5 18.2 12.9 12.3 5.9 9.4 2.6 10.4 12.1 8.4 14.4 13.7 18.3 10.5 11.2 12.0 0.0 12.1 10.1 4.9 4.4 12.7 14.8 15.2 22.0 12.1 8.8 4.5 8.3 9.4 15.0 8.2 12.1 22.4 7.2 9.6 12.4 8.2 13.5 2.7 6.2 29.8 17.0 12.3 6.7 5.6 7.7 12.4 13.6 11.6 5.0 13.1 12.3 10.4 13.4 15.7 10.5 13.4 13.4 15.3 15.5 16.9 19.5 12.8 12.6 13.3 15.6 7.7 13.9 2.6 5.6 7.1 7.2 19.5 22.0 5.9 7.1 6.4 9.1 10.8 7.7 8.9 14.3 6.7 9.2 13.2 19.7 11.2 5.5 11.6 6.3 12.3 12.9 15.9 12.4 9.6 16.4 2.5 0.7 4.6 1.1 1.2 0.7 4.1 1.7 1.3 0.8 5.2 1.9 1.4 7.1 0.9 1.8 0.3 1.7 0.9 2.1 5.2 1.5 6.6 4.5 3.4 3.6 4.5 2.6 0.0 4.4 4.5 21.4 22.4 28.7 0.0 10.7 0.0 0.0 0.0 0.0 0.0 26.3 19.8 0.0 0.0 18.6 23.9 0.0 5.7 14.7 0.0 15.6 10.4 0.0 17.8 27.5 8.4 0.0 0.0 0.0 14.2 5.9 7.7 0.0 20.0 11.4 23.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 7.2 0.0 0.0 0.0 0.0 13.7 0.0 0.0 6.8 0.0 0.0 19.0 17.5 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 7.7 7.8 17.9 0.0 0.0 MASP2 MASP1P1 ENSG00000009724 "Mannan binding lectin serine peptidase 2" O00187 1 11026523-11047239 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 64 "liver: 476.5" "Cell type enriched" "Detected in some" 52 "Hepatocytes: 658.6" "Cancer enriched" "Detected in some" 71 "liver cancer: 41.9" "Region enriched" "Detected in single" 9 "cerebellum: 6.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Hep G2: 16.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029313, HPA029314" Uncertain Supported "Golgi apparatus" "Secreted to blood" NA NA 340000000 820000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA029313: AB_10669654, HPA029314: AB_10670029" "unprognostic (7.00e-2)" "unprognostic (8.37e-2)" "unprognostic (2.75e-2)" "unprognostic (2.89e-1)" "unprognostic (1.86e-1)" "unprognostic (3.26e-3)" "prognostic favorable (1.60e-4)" "unprognostic (2.92e-3)" "unprognostic (3.13e-2)" "unprognostic (4.04e-2)" "unprognostic (6.90e-3)" "unprognostic (8.30e-4)" "unprognostic (7.14e-2)" "unprognostic (3.91e-1)" "unprognostic (2.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-4)" 2.1 1.2 0.0 1.7 0.0 7.4 2.2 6.4 0.7 2.4 0.0 2.7 1.6 2.8 0.0 1.2 2.7 1.2 1.3 0.1 0.0 1.0 476.5 1.8 2.7 0.0 0.0 2.9 2.9 0.0 2.3 0.6 0.2 1.6 0.0 6.9 2.5 0.0 5.1 5.3 3.4 0.0 0.0 2.5 2.4 1.5 0.0 0.0 1.9 0.0 0.0 2.1 1.6 0.4 0.5 0.3 2.6 1.6 0.0 0.1 0.4 0.7 0.0 0.0 0.0 1.2 1.0 2.3 0.6 0.0 0.5 0.7 0.0 0.0 0.0 0.6 2.3 1.3 2.7 16.4 0.0 2.0 1.5 0.0 0.0 0.1 0.0 1.8 0.0 1.7 0.7 0.5 0.0 0.5 0.6 1.1 0.3 0.2 0.7 1.6 0.9 0.6 0.0 1.3 1.7 0.7 0.9 0.4 0.4 1.6 0.6 1.2 1.2 0.9 0.5 0.8 0.5 0.5 0.9 1.5 0.5 1.7 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 4.6 1.1 0.9 0.2 0.0 0.6 0.2 0.2 0.0 0.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.0 5.3 9.5 0.0 0.0 0.1 0.0 0.1 1.3 0.0 8.2 658.6 0.1 0.0 8.3 0.0 0.0 12.6 0.3 0.0 0.0 0.0 1.8 1.9 0.0 0.1 0.0 8.0 10.4 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.7 0.4 0.0 0.7 0.2 0.0 0.0 0.4 0.6 0.0 0.8 0.1 0.0 0.1 MATN3 "EDM5, HOA" ENSG00000132031 "Matrilin 3" O15232 2 19992052-20012668 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 13.2;placenta: 11.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 38.5;Sertoli cells: 26.3" "Cancer enhanced" "Detected in all" "pancreatic cancer: 13.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "Hep G2: 143.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 1.7" HPA051250 Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" NA NA 440000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 48: Smooth muscle cells - ECM organization" "Endoplasmic reticulum, Golgi apparatus" "HPA051250: AB_2681406" "unprognostic (3.47e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (7.57e-2)" "unprognostic (2.75e-2)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.62e-5)" "unprognostic (1.27e-1)" "unprognostic (4.84e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.54e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.51e-1)" "unprognostic (7.04e-2)" "unprognostic (3.15e-2)" 2.2 0.6 5.1 0.5 3.2 0.0 2.7 3.4 5.7 2.5 2.5 0.6 0.4 2.1 0.9 0.5 1.9 2.1 0.4 3.4 3.9 1.9 0.0 13.2 0.3 5.2 6.0 0.7 0.4 0.4 0.3 11.3 5.2 1.6 0.5 0.3 0.6 4.6 0.3 0.8 0.4 1.7 4.7 0.3 1.8 0.9 7.6 0.1 1.3 0.6 0.3 0.8 1.2 3.6 6.4 4.9 16.1 0.1 4.5 9.7 1.0 2.0 1.1 6.5 8.2 4.7 2.7 0.0 0.8 1.7 6.2 1.1 0.4 12.7 9.2 0.0 0.4 0.0 1.1 143.4 1.1 0.0 0.0 21.3 0.7 7.1 1.7 4.5 8.7 0.0 0.0 0.0 13.8 2.5 0.0 0.0 5.0 0.2 2.4 0.0 0.0 0.0 19.5 4.5 0.1 2.1 10.6 1.8 6.5 27.1 19.2 0.1 4.9 9.5 11.4 0.4 1.2 0.1 0.0 0.0 1.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 3.2 3.4 5.7 3.4 3.9 5.2 6.0 5.2 4.7 7.6 3.6 1.6 38.5 2.2 0.0 0.0 0.3 0.3 2.6 0.0 0.0 5.4 1.3 0.3 0.0 2.3 1.8 0.0 0.1 0.1 0.0 0.0 0.4 0.4 0.3 0.8 2.8 0.0 0.0 0.1 0.2 1.9 1.9 0.0 0.5 0.0 4.4 0.0 0.0 0.1 0.0 0.2 0.0 4.1 0.0 0.3 0.4 1.5 0.1 3.6 4.7 0.0 0.0 0.0 0.5 0.2 1.1 0.0 4.5 0.0 0.3 0.0 0.8 1.6 0.0 26.3 0.8 6.8 0.0 1.3 0.0 0.1 0.1 0.1 6.3 0.0 0.2 MAX "bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8" ENSG00000125952 "MYC associated factor X" P61244 14 65006174-65102695 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 390.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000328, HPA003474" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "Golgi apparatus, Vesicles" "CAB000328: AB_2281783, HPA003474: AB_1079317" "unprognostic (4.50e-3)" "unprognostic (1.51e-3)" "unprognostic (4.08e-2)" "unprognostic (2.87e-1)" "unprognostic (8.37e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (1.30e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-3)" "unprognostic (7.19e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (2.99e-1)" "unprognostic (4.68e-2)" "prognostic favorable (2.12e-4)" "unprognostic (6.03e-2)" 48.1 36.3 57.4 43.5 63.2 105.1 41.2 74.6 62.9 61.0 44.8 51.1 41.3 51.1 29.2 75.8 67.2 36.2 52.8 55.0 59.4 39.5 36.8 51.6 63.7 65.5 61.8 56.2 29.3 31.3 32.5 39.8 65.0 52.2 31.8 23.6 43.5 38.7 43.8 55.3 51.7 39.5 59.4 66.3 39.4 21.5 62.1 63.7 42.7 54.0 55.1 51.3 68.7 65.3 117.1 40.4 27.8 44.6 73.4 58.0 35.4 39.9 62.3 47.5 58.4 29.1 86.7 88.1 33.1 48.8 45.0 60.4 63.4 52.7 37.3 84.5 40.5 143.4 29.9 32.0 90.9 56.2 390.3 67.6 43.5 42.7 54.9 71.9 54.9 71.8 66.8 42.4 53.1 63.9 140.1 217.6 36.3 71.3 70.6 75.2 42.7 47.3 49.2 38.8 61.8 38.2 49.6 60.6 60.4 25.1 58.0 71.6 69.7 47.8 55.8 42.0 33.6 50.7 43.6 61.7 56.9 56.1 46.0 667.6 141.9 540.8 125.7 126.4 140.1 115.7 147.5 130.5 119.9 114.9 151.1 127.9 305.1 126.9 120.3 114.6 194.0 314.2 57.4 63.2 74.6 62.9 55.0 59.4 65.5 61.8 65.0 59.4 62.1 65.3 45.8 28.9 27.4 31.0 74.5 170.2 66.0 63.3 126.3 28.2 59.8 43.1 27.4 32.9 42.0 18.4 20.9 38.4 79.1 116.3 52.8 38.8 45.5 38.1 43.6 59.9 44.3 40.4 50.7 31.4 43.4 46.7 32.6 36.0 62.8 38.2 71.0 23.8 59.9 47.1 43.3 49.7 38.7 81.8 66.7 115.6 77.9 147.2 56.9 32.8 67.1 47.3 69.0 28.1 60.4 61.6 96.7 60.2 58.0 80.3 100.6 66.4 32.9 16.9 138.1 47.4 76.3 43.2 28.4 84.8 180.6 54.0 83.9 25.4 29.7 76.2 MBNL3 "CHCR, FLJ11316, MBLX39, MBXL" ENSG00000076770 "Muscleblind like splicing regulator 3" Q9NUK0 X 132369317-132489968 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.3;placenta: 170.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 328.3;Hepatocytes: 119.6;Syncytiotrophoblasts: 344.1" "Cancer enhanced" "Detected in all" "liver cancer: 13.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 123.8;Hep G2: 171.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001584 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 28: Placenta - Pregnancy" "Cluster 39: CACO-2 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Golgi apparatus" "HPA001584: AB_1079326" "unprognostic (3.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (1.87e-1)" "unprognostic (2.67e-3)" "unprognostic (8.74e-2)" "unprognostic (3.46e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-3)" "unprognostic (4.36e-3)" "unprognostic (1.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.43e-1)" "unprognostic (8.28e-2)" "unprognostic (2.37e-1)" 6.8 11.6 1.3 8.7 1.9 14.8 4.7 1.7 1.0 3.7 2.4 11.7 9.9 4.9 24.3 10.9 9.4 5.7 9.7 1.1 4.4 8.0 59.3 5.9 13.8 3.6 3.1 4.8 10.0 4.2 1.6 170.8 3.2 4.0 11.5 0.1 6.6 11.1 0.6 12.6 9.8 4.0 2.0 11.3 13.0 42.8 1.6 14.3 8.2 3.4 15.1 8.5 2.8 3.7 7.2 0.0 8.6 1.4 1.6 3.6 15.7 0.5 3.2 1.1 0.0 123.8 22.7 32.6 0.7 1.3 1.1 7.7 19.8 8.2 0.8 3.3 7.6 29.1 25.9 171.5 1.5 32.9 10.2 1.5 7.1 0.0 3.6 0.1 1.1 20.4 2.6 9.2 1.6 19.2 56.3 12.5 1.3 27.5 1.6 53.2 10.7 18.6 5.7 18.6 3.1 10.5 14.8 8.6 4.3 15.1 3.1 8.4 3.9 6.3 1.2 8.2 6.7 18.2 13.0 47.0 1.2 21.8 20.2 11.9 7.9 5.5 16.6 9.9 14.4 20.6 9.8 11.6 8.8 25.5 10.0 11.2 1.2 18.7 21.7 17.0 2.2 9.1 1.3 1.9 1.7 1.0 1.1 4.4 3.6 3.1 3.2 2.0 1.6 3.7 4.1 3.2 6.8 16.0 16.9 8.8 2.2 2.1 5.2 0.7 3.5 3.6 14.7 41.5 5.0 11.0 0.0 328.3 9.5 12.8 3.9 1.5 5.8 12.6 1.3 3.6 6.7 55.8 0.9 5.4 56.6 7.5 15.3 6.6 8.8 6.8 6.4 119.6 29.3 0.0 0.9 9.8 0.0 27.2 6.5 9.4 23.0 9.6 7.2 30.0 10.6 0.2 9.2 0.0 20.6 1.3 3.6 50.8 12.2 1.4 6.4 9.7 4.5 1.9 0.0 3.1 2.7 2.1 1.7 13.6 8.5 344.1 10.3 5.7 10.3 3.3 MBOAT4 "FKSG89, GOAT, OACT4" ENSG00000177669 "Membrane bound O-acyltransferase domain containing 4" Q96T53 8 30131671-30144665 "Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 3.6;stomach 1: 3.7" "Cell type enhanced" "Detected in some" "Astrocytes: 3.6;Cholangiocytes: 12.8;Ductal cells: 3.1;Enteroendocrine cells: 3.5;Excitatory neurons: 2.4;Inhibitory neurons: 3.1;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 5.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 3.1;OE19: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044509 Supported "Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 25: Pancreas - Digestion" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA044509: AB_2678966" "unprognostic (4.35e-3)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (3.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.76e-2)" "unprognostic (1.85e-3)" "unprognostic (4.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (6.30e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-6)" "unprognostic (9.87e-3)" "unprognostic (1.58e-1)" "unprognostic (2.18e-1)" "unprognostic (3.66e-2)" 0.1 0.5 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 1.7 0.9 0.2 0.1 0.1 0.1 0.4 0.3 0.4 0.1 0.1 0.1 3.6 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.4 3.7 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.1 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.1 0.1 0.1 0.6 0.1 0.4 0.7 0.0 0.4 0.6 0.2 1.0 0.7 1.2 0.8 0.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.1 1.1 0.0 0.0 0.0 3.5 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.0 3.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522624-7534009 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease variant, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 109.4;Kupffer cells: 117.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 117.5;classical monocyte: 45.2;eosinophil: 105.7;intermediate monocyte: 95.5;neutrophil: 41.1;non-classical monocyte: 105.1" "Group enriched" "Detected in all" 5 "granulocytes: 117.5;monocytes: 105.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 18: U-2197 - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favorable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 21.2 37.4 6.4 9.2 6.5 10.4 15.3 7.0 8.4 11.7 8.3 13.6 8.3 11.6 2.7 11.0 12.2 10.1 15.7 7.0 7.4 11.7 14.7 20.3 13.2 8.2 7.4 10.0 9.9 10.2 21.7 15.9 9.0 8.7 5.6 5.0 12.3 6.1 22.2 20.8 12.1 8.1 7.1 48.2 12.8 5.6 8.2 6.2 8.5 11.7 4.1 15.8 10.9 9.9 11.6 11.7 5.6 19.1 32.0 10.3 16.1 21.2 16.9 25.2 21.6 9.0 10.0 6.5 25.5 14.5 22.2 5.3 9.5 7.3 7.4 12.7 21.1 5.8 11.0 7.3 28.0 6.6 24.5 14.5 16.8 24.1 4.2 7.9 10.7 14.2 10.9 27.9 14.7 3.9 9.1 6.6 12.6 6.1 24.8 12.6 9.4 13.8 9.6 9.9 14.4 17.8 9.1 15.8 26.8 6.1 9.6 11.4 13.5 12.0 6.9 48.8 16.0 21.5 35.5 4.7 19.2 9.2 18.4 117.5 45.2 105.7 7.7 95.5 6.3 4.2 6.5 6.3 19.2 4.1 6.0 6.5 41.1 10.3 105.1 21.1 10.0 17.1 6.4 6.5 7.0 8.4 7.0 7.4 8.2 7.4 9.0 7.1 8.2 9.9 15.1 3.2 2.6 5.9 8.0 13.4 6.5 16.9 10.2 27.3 15.9 15.0 2.3 15.7 8.1 31.3 22.9 11.6 12.1 32.0 1.9 23.7 4.8 5.0 19.8 14.1 16.8 21.7 10.6 23.1 20.0 16.0 9.7 6.5 1.3 22.2 13.6 13.6 109.4 58.9 8.0 10.0 22.4 117.1 32.2 17.0 16.4 70.6 21.4 7.5 18.0 23.0 16.5 7.5 11.4 23.4 19.3 15.8 8.0 5.6 21.8 12.3 6.5 44.1 6.6 11.2 14.8 10.3 14.7 8.9 17.3 29.6 8.7 17.3 9.4 4.8 MDFIC "HIC, MDFIC1" ENSG00000135272 "MyoD family inhibitor domain containing" Q9P1T7 7 114922359-115019202 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Muller glia cells: 139.7;Skeletal myocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 109.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030716 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 16: Immune cells - Immune response" "Cluster 18: U-2197 - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Golgi apparatus" "HPA030716: AB_10671364" "unprognostic (1.24e-3)" "unprognostic (4.15e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-3)" "unprognostic (1.73e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (6.38e-3)" "unprognostic (3.68e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (6.13e-3)" "unprognostic (7.10e-2)" "unprognostic (1.42e-1)" "unprognostic (3.55e-1)" 44.9 17.3 4.9 22.5 4.3 11.1 14.5 4.7 5.2 21.1 25.5 10.6 7.2 20.6 5.1 17.2 12.2 13.2 24.6 4.1 7.2 12.6 13.3 23.3 32.1 12.1 9.0 16.1 5.0 16.7 4.6 20.2 8.8 10.2 10.3 21.1 15.7 11.1 27.6 10.3 9.4 17.7 12.8 33.7 10.5 1.8 6.0 17.2 19.3 14.2 30.0 16.4 8.2 9.2 0.1 13.2 18.3 0.1 37.8 52.0 7.1 69.9 83.9 15.9 19.8 0.4 41.7 9.8 0.8 46.4 25.4 7.7 5.7 12.2 27.1 34.0 12.3 0.0 16.8 0.0 19.5 22.2 14.2 43.7 11.5 35.7 11.1 40.2 10.7 9.7 0.0 66.8 54.2 0.2 0.1 1.8 14.8 0.6 15.6 0.2 53.5 21.5 16.2 16.9 0.7 0.0 30.5 28.3 32.5 24.7 9.0 19.7 30.2 58.2 16.4 109.1 34.1 27.5 0.1 0.2 40.8 0.1 50.9 0.2 0.9 0.6 1.8 1.2 2.8 2.3 4.1 3.6 1.5 2.4 2.3 2.1 0.0 1.6 1.8 5.5 3.5 0.7 4.9 4.3 4.7 5.2 4.1 7.2 12.1 9.0 8.8 12.8 6.0 9.2 61.3 16.0 26.1 32.7 41.5 9.4 7.0 2.2 17.6 0.5 13.1 10.2 24.8 24.3 12.2 14.7 0.0 7.5 58.1 1.5 9.8 2.3 2.5 9.4 12.7 42.8 0.0 1.7 27.2 2.9 5.3 25.8 5.6 1.3 2.5 29.9 59.6 18.6 21.9 0.0 5.4 2.7 0.0 55.6 34.0 1.3 4.4 41.1 37.4 55.3 22.0 139.7 21.6 6.6 0.8 9.2 2.0 2.6 63.2 6.6 0.1 5.1 15.1 5.0 6.6 131.8 13.8 0.2 1.0 20.0 13.8 3.7 70.6 38.2 4.6 10.2 MDGA1 "GPIM, MAMDC3" ENSG00000112139 "MAM domain containing glycosylphosphatidylinositol anchor 1" Q8NFP4 6 37630679-37699306 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 79.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 34.0;Cone photoreceptor cells: 50.1;Horizontal cells: 57.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 9 "cerebellum: 79.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA031235, HPA050382" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 1200000 "Cluster 32: T-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" "Golgi apparatus" "HPA031235: AB_10603017, HPA050382: AB_2681108" "unprognostic (4.67e-2)" "unprognostic (6.97e-3)" "unprognostic (3.24e-1)" "unprognostic (5.69e-4)" "unprognostic (2.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.45e-2)" "unprognostic (2.00e-1)" "unprognostic (2.02e-2)" "unprognostic (1.45e-1)" "unprognostic (2.16e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-5)" "unprognostic (9.19e-3)" "unprognostic (5.28e-3)" "unprognostic (3.80e-3)" "unprognostic (4.60e-2)" 2.6 2.9 4.2 2.6 3.9 0.3 1.6 79.9 5.3 5.4 0.0 2.6 0.5 3.4 1.8 3.7 2.7 3.2 2.3 8.8 4.9 1.2 0.6 3.1 2.6 4.3 4.7 6.5 2.4 4.1 4.8 0.3 7.4 2.1 1.1 4.0 1.1 1.3 1.1 4.9 2.8 2.5 1.0 3.1 2.0 1.5 2.1 0.8 1.4 1.7 2.1 1.9 4.4 3.2 0.2 3.5 4.8 2.4 12.3 4.3 2.2 2.8 2.2 3.5 3.2 0.0 0.0 0.7 0.5 1.7 3.0 5.4 0.5 0.0 1.0 4.9 3.4 0.0 0.3 0.0 0.5 0.0 1.1 1.0 0.0 1.4 0.0 6.8 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.1 0.4 5.9 1.7 0.0 0.8 3.7 4.3 0.0 1.5 0.3 2.6 0.2 3.1 0.6 0.3 3.4 1.4 1.2 4.3 0.0 0.1 0.0 4.2 1.0 2.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.1 4.2 3.9 79.9 5.3 8.8 4.9 4.3 4.7 7.4 1.0 2.1 3.2 3.0 9.6 0.5 12.7 2.0 2.3 2.4 0.7 1.2 34.0 0.4 0.6 5.7 1.5 0.8 3.7 50.1 0.2 3.1 0.0 0.0 0.5 2.6 0.6 1.8 1.6 1.8 0.0 4.9 0.0 1.4 4.4 0.5 0.5 0.0 1.1 1.4 0.0 0.1 57.2 4.9 0.0 0.0 0.3 1.1 0.2 10.2 0.3 1.8 1.9 0.0 2.6 4.1 4.0 2.1 0.6 0.0 4.9 1.7 2.0 0.0 0.5 1.9 2.0 0.0 2.6 3.0 2.1 1.3 2.8 3.0 0.7 2.9 0.2 0.0 5.1 MDM2 "HDM2, MGC5370" ENSG00000135679 "MDM2 proto-oncogene" Q00987 12 68808177-68850686 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 257.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 504.6;U-698: 517.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000086, CAB016303, CAB079977" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB000086: AB_563872, CAB016303: AB_627920, CAB079977: " "unprognostic (1.16e-1)" "prognostic favorable (3.23e-4)" "unprognostic (6.16e-2)" "prognostic favorable (4.51e-7)" "unprognostic (7.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.77e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-2)" "unprognostic (3.23e-1)" "unprognostic (1.80e-3)" "unprognostic (2.36e-1)" "unprognostic (4.22e-2)" "unprognostic (4.59e-2)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (8.95e-2)" 14.0 11.6 5.4 10.4 10.0 28.6 11.9 7.4 7.6 13.9 28.0 20.7 6.4 9.5 7.1 13.0 14.1 12.0 6.8 3.8 7.4 9.5 26.9 14.3 13.8 9.9 8.5 10.8 14.3 10.9 5.0 16.4 9.2 11.3 21.9 14.2 9.6 11.5 18.6 10.9 7.5 12.4 6.0 11.4 10.0 6.6 9.2 15.6 15.4 12.9 17.0 15.1 10.8 12.8 18.7 42.1 43.5 22.6 55.9 51.5 223.4 49.7 50.3 26.2 41.5 26.8 8.4 188.6 13.5 34.7 7.3 11.0 31.4 504.6 42.1 51.0 22.0 35.3 36.0 115.0 55.7 32.6 31.0 77.8 46.5 101.5 69.4 26.9 73.7 32.1 37.1 45.4 50.8 28.0 43.1 10.7 36.9 10.1 8.2 149.4 31.7 16.2 16.0 146.0 34.3 20.2 32.0 25.0 11.3 88.8 58.3 21.4 82.3 20.2 38.0 16.8 18.5 68.2 47.7 517.6 31.3 12.8 81.2 6.1 5.4 5.2 4.1 4.1 3.7 4.7 3.5 4.1 3.0 5.4 3.6 3.5 19.2 3.7 7.2 3.9 4.1 3.6 5.4 10.0 7.4 7.6 3.8 7.4 9.9 8.5 9.2 6.0 9.2 12.8 23.1 32.1 56.3 26.1 36.4 15.6 30.5 42.6 22.8 26.8 21.4 17.1 20.9 24.3 75.8 25.8 33.3 47.5 32.1 19.3 13.7 19.5 2.5 257.4 34.5 22.0 25.1 29.9 28.8 24.2 28.0 31.9 28.5 74.8 32.9 33.2 15.7 45.0 18.3 30.3 32.9 23.4 32.6 49.0 25.0 2.9 19.3 44.9 12.4 37.5 35.4 27.8 10.3 25.6 71.8 22.4 20.1 15.1 117.7 39.8 15.8 21.3 141.7 35.3 19.7 30.0 32.4 17.3 20.0 59.5 22.0 94.3 31.8 49.4 20.9 82.0 MED13L "KIAA1025, THRAP2, TRAP240L" ENSG00000123066 "Mediator complex subunit 13L" Q71F56 12 115957905-116277693 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 303.9;Excitatory neurons: 311.5;Inhibitory neurons: 321.0;Microglial cells: 427.2;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 305.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "T-47d: 124.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039445 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Golgi apparatus" "HPA039445: AB_10673532" "unprognostic (1.81e-2)" "unprognostic (1.87e-2)" "unprognostic (3.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (8.62e-3)" "unprognostic (1.54e-1)" "unprognostic (5.08e-2)" "unprognostic (1.83e-2)" "unprognostic (6.82e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (4.64e-1)" 18.4 7.9 5.5 15.8 7.3 52.7 20.8 27.0 6.3 15.8 5.3 12.9 10.3 20.5 6.5 13.8 12.5 13.2 11.5 6.4 5.9 12.4 7.9 14.4 14.6 9.2 7.3 24.3 17.5 15.3 5.5 16.3 6.9 12.7 13.5 12.6 14.8 12.8 18.6 19.0 13.4 15.9 6.3 16.6 12.2 13.8 7.7 39.1 18.0 25.8 16.2 13.1 12.7 10.7 16.9 33.2 19.6 16.9 23.6 42.0 16.5 15.8 21.3 23.7 16.3 25.2 5.9 13.3 13.6 29.0 14.5 9.9 20.4 14.2 29.6 24.3 14.0 26.9 10.0 7.2 26.2 24.8 28.6 30.6 21.8 26.8 40.7 17.4 15.9 28.2 28.9 11.4 18.7 21.8 42.1 22.2 10.5 7.1 8.2 28.7 25.0 24.8 11.1 18.4 17.7 12.4 14.2 7.8 15.0 34.9 124.8 39.9 20.7 26.0 16.8 17.2 19.5 17.9 9.7 21.6 12.0 22.3 12.8 1.5 0.6 1.5 0.2 0.3 0.2 0.3 0.5 0.2 0.7 0.7 0.3 0.4 3.5 0.3 0.4 1.1 0.0 0.1 5.5 7.3 27.0 6.3 6.4 5.9 9.2 7.3 6.9 6.3 7.7 10.7 84.4 64.1 54.9 303.9 47.5 99.2 38.4 21.7 70.6 52.4 51.4 42.4 35.6 21.5 35.5 25.8 54.2 9.4 38.5 30.5 3.9 13.5 84.0 42.5 115.2 56.9 31.3 49.6 311.5 26.0 19.6 56.0 29.0 96.7 14.0 93.4 53.6 30.6 21.1 57.2 321.0 31.8 14.2 48.7 60.6 47.2 92.2 60.5 32.0 427.2 56.4 22.8 17.5 352.8 305.4 26.8 21.0 67.0 65.6 49.4 22.7 12.3 27.2 44.6 46.0 61.9 57.0 20.3 23.3 48.0 101.6 14.2 30.5 23.7 25.9 51.0 MED8 "ARC32, MGC17544, MGC19641" ENSG00000159479 "Mediator complex subunit 8" Q96G25 1 43383917-43389808 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028377, HPA028438" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Golgi apparatus" "HPA028377: AB_10600112, HPA028438: AB_10600057" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (1.49e-2)" "unprognostic (2.37e-2)" "unprognostic (8.58e-3)" "prognostic unfavorable (2.04e-7)" "unprognostic (2.60e-2)" "unprognostic (1.82e-2)" "unprognostic (1.87e-2)" "unprognostic (5.17e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.11e-7)" "unprognostic (7.08e-2)" "unprognostic (3.28e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-1)" 30.4 27.8 24.0 20.9 25.1 27.0 26.5 24.6 29.1 24.0 27.3 25.1 23.1 21.8 24.0 43.5 20.6 16.8 20.7 24.6 25.1 27.3 43.6 24.4 21.7 26.8 25.0 21.9 29.5 20.9 36.3 25.5 26.1 23.7 24.7 40.3 26.9 20.5 22.4 36.4 22.9 24.3 24.8 25.9 28.2 22.3 25.3 17.5 25.6 14.5 28.1 24.1 27.3 27.2 56.8 35.3 31.8 38.0 48.7 48.2 42.7 56.5 51.4 65.8 69.3 65.7 40.7 33.2 39.7 71.8 43.2 34.7 50.2 47.7 62.9 47.9 48.5 56.5 60.5 82.8 82.3 50.7 57.5 47.5 60.6 71.2 84.6 39.4 53.3 31.1 50.8 57.1 42.9 36.4 26.1 40.8 30.5 52.3 39.9 30.9 37.3 53.6 43.5 35.8 33.2 25.1 33.2 53.7 111.9 43.6 36.3 97.8 39.9 29.2 52.0 55.9 80.5 67.5 83.4 40.2 60.8 61.2 39.0 44.7 57.0 54.9 33.6 53.1 32.1 44.5 30.5 38.0 57.0 36.8 30.7 32.0 45.3 32.6 48.4 26.2 43.3 38.8 24.0 25.1 24.6 29.1 24.6 25.1 26.8 25.0 26.1 24.8 25.3 27.2 25.6 16.0 12.9 5.9 25.8 18.7 23.2 35.6 11.4 27.7 23.9 23.4 12.6 27.1 28.2 14.7 14.6 52.9 26.2 26.4 33.2 51.1 13.6 16.3 23.9 25.1 19.3 42.5 11.5 75.6 72.3 30.3 23.0 19.7 31.7 21.8 16.4 27.8 60.4 16.8 8.0 29.2 28.5 18.2 32.0 22.8 24.5 26.2 19.6 4.7 35.9 32.3 28.8 6.6 13.8 57.9 30.0 21.8 41.2 24.6 40.8 48.5 16.0 58.7 26.3 12.3 42.9 64.6 45.0 24.3 25.4 88.4 23.3 31.9 22.6 39.9 MEST PEG1 ENSG00000106484 "Mesoderm specific transcript" Q5EB52 7 130486171-130506465 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "placenta: 771.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 833.5;Syncytiotrophoblasts: 999.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive CD8 T-cell: 24.2" "Group enriched" "Detected in all" 4 "dendritic cells: 9.1;granulocytes: 19.4;T-cells: 24.2" "Cell line enriched" "Detected in many" 6 "AN3-CA: 12338.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005623 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus, Cytosol" "HPA005623: AB_1079364" "unprognostic (6.14e-2)" "unprognostic (5.06e-3)" "unprognostic (9.82e-2)" "unprognostic (1.64e-3)" "unprognostic (3.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.36e-3)" "unprognostic (1.12e-1)" "unprognostic (7.81e-2)" "unprognostic (6.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (6.20e-5)" "unprognostic (7.09e-2)" "unprognostic (1.05e-1)" "unprognostic (2.30e-1)" "unprognostic (1.67e-2)" 117.5 56.2 30.7 16.1 31.3 12.6 63.1 0.0 27.5 6.1 24.1 27.4 28.7 24.4 6.6 6.8 12.0 23.4 7.5 30.2 73.5 17.8 51.8 43.4 5.5 10.2 19.3 18.8 30.0 8.0 33.2 771.8 14.0 12.7 20.9 39.2 21.4 5.5 6.9 4.6 21.6 17.8 2.5 90.2 8.8 26.3 68.4 10.3 11.8 5.2 4.8 11.0 3.9 9.8 77.9 41.7 197.1 12338.6 3.9 1.2 1.1 84.7 38.5 85.1 40.3 237.2 114.4 37.7 27.1 2.6 74.7 11.0 2.9 1.1 33.3 0.4 0.5 66.8 57.0 39.9 322.2 3.2 0.5 5.9 3.1 64.3 0.1 427.5 32.3 0.1 76.5 0.3 164.9 107.6 7.8 85.0 124.1 113.3 20.0 0.8 2168.8 24.5 92.0 72.0 693.2 2.0 71.9 234.0 1.0 195.6 9.2 57.3 33.6 29.2 0.7 276.1 5.6 3.4 8.6 0.7 103.3 1.2 9.7 19.4 2.6 9.1 0.9 2.9 2.2 3.9 2.5 1.8 9.1 3.4 9.4 24.2 1.5 4.3 1.7 0.4 0.1 6.7 30.7 31.3 0.0 27.5 30.2 73.5 10.2 19.3 14.0 2.5 68.4 9.8 7.4 6.4 6.2 12.7 3.3 4.5 47.3 8.6 9.1 13.5 33.3 36.1 0.9 20.0 5.7 16.5 4.2 833.5 2.1 9.3 11.7 20.3 62.7 8.2 12.7 6.0 29.5 35.9 40.8 40.0 187.8 200.3 3.1 9.5 0.0 6.3 44.6 20.4 92.7 1.7 28.1 19.4 6.1 8.8 3.2 37.5 84.8 6.6 1.8 11.2 1.3 45.3 0.0 18.1 1.8 22.8 27.5 13.5 2.3 27.1 24.6 12.3 2.9 22.0 19.7 205.6 12.0 35.7 36.7 10.0 0.6 999.6 2.1 124.8 31.5 23.4 METTL15 "FLJ33979, METT5D1" ENSG00000169519 "Methyltransferase like 15" A6NJ78 11 28108248-28527041 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 130.2;Oligodendrocyte precursor cells: 132.7;Oligodendrocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039885 Approved "Golgi apparatus,Plasma membrane,Actin filaments" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Plasma membrane" "Actin filaments" "HPA039885: AB_2676725" "unprognostic (2.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-2)" "unprognostic (2.66e-2)" "unprognostic (1.83e-1)" "unprognostic (4.17e-2)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (7.93e-2)" "unprognostic (6.31e-3)" "unprognostic (2.28e-1)" "prognostic favorable (7.95e-5)" "unprognostic (7.77e-2)" "unprognostic (1.38e-1)" "unprognostic (6.58e-2)" "unprognostic (6.84e-3)" 4.3 8.1 4.8 4.1 4.5 2.3 6.2 5.5 5.4 6.1 6.1 7.0 5.1 5.0 5.7 4.6 5.7 4.5 7.7 4.9 5.4 7.7 9.3 4.3 5.3 4.9 4.8 5.9 4.4 7.0 4.2 5.1 5.2 6.3 6.9 7.0 4.5 5.6 8.7 5.1 5.1 4.5 4.5 4.3 5.4 3.3 5.2 5.2 7.6 11.2 5.3 4.4 3.3 6.2 8.8 9.2 9.3 7.1 11.3 18.0 6.5 10.6 8.1 10.6 10.9 6.3 5.9 20.2 6.2 8.8 6.7 7.3 12.3 10.9 20.2 12.5 10.8 6.4 6.5 7.3 12.6 12.1 5.6 10.2 16.0 5.9 15.1 11.5 10.3 6.7 13.7 8.9 12.6 6.0 8.4 7.4 7.2 9.2 6.8 4.5 20.2 7.4 15.8 5.0 8.2 6.7 8.8 7.8 12.7 8.9 15.4 7.4 7.8 9.6 7.4 12.3 9.4 6.0 7.6 11.7 13.5 12.0 10.6 2.1 1.4 3.7 2.2 1.0 2.7 3.6 2.6 2.9 1.7 1.8 2.8 3.6 0.6 4.4 1.2 1.8 3.1 1.5 4.8 4.5 5.5 5.4 4.9 5.4 4.9 4.8 5.2 4.5 5.2 6.2 16.5 12.8 24.3 130.2 21.3 44.0 38.1 37.1 23.9 13.6 21.6 15.0 14.3 14.3 20.3 11.0 18.8 11.3 28.7 18.2 11.7 10.6 34.5 19.6 24.7 15.7 9.6 17.0 96.8 11.8 14.1 23.5 16.3 28.2 5.1 18.1 12.8 15.0 10.4 13.5 93.9 17.6 10.2 14.2 50.7 12.6 10.8 17.9 14.2 105.9 6.1 8.7 19.6 132.7 146.1 9.9 13.3 8.2 21.0 57.2 13.0 14.9 18.9 16.1 6.6 60.7 23.2 17.9 10.0 17.4 35.7 8.5 35.5 21.3 16.2 53.1 METTL26 "C16orf13, MGC13114" ENSG00000130731 "Methyltransferase like 26" Q96S19 16 634427-636366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 172.6;Distal tubular cells: 168.3;Extravillous trophoblasts: 187.2;Proximal tubular cells: 289.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044004, HPA067414" Uncertain Approved "Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA044004: AB_10964777, HPA067414: " "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (3.35e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (6.27e-2)" "unprognostic (6.93e-2)" "unprognostic (6.21e-2)" "unprognostic (1.20e-1)" "unprognostic (4.71e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.73e-6)" "unprognostic (2.59e-1)" "unprognostic (1.37e-1)" "unprognostic (2.53e-1)" "unprognostic (2.72e-2)" 55.7 71.7 97.8 14.5 100.4 23.6 49.9 90.3 158.9 55.2 90.2 65.7 18.6 57.0 23.8 47.4 50.3 10.6 82.3 102.3 95.8 68.8 75.5 44.9 12.0 92.5 92.7 65.5 50.3 30.2 54.3 13.7 93.0 59.0 10.5 5.2 49.1 22.3 91.3 54.0 39.7 13.6 91.4 47.3 56.0 55.1 97.2 25.8 46.3 35.1 11.8 55.2 47.9 97.7 59.6 60.7 20.0 48.6 28.7 47.2 72.5 46.5 39.2 40.1 30.3 55.6 50.2 71.8 77.7 38.2 47.9 74.5 28.7 73.8 12.5 54.1 140.1 45.9 86.6 83.0 68.5 68.6 41.5 43.1 41.3 53.5 39.9 47.0 48.8 87.7 55.5 29.2 23.3 94.0 75.8 120.4 61.7 83.5 174.9 105.2 23.1 147.6 64.2 25.4 86.9 60.1 43.0 77.9 57.5 14.3 57.4 67.7 35.1 40.4 52.9 67.1 46.5 69.8 47.2 52.7 41.2 43.6 35.7 102.9 119.8 68.3 110.1 145.3 121.6 145.4 114.9 109.2 150.7 124.1 108.6 105.2 26.2 123.0 167.7 162.7 160.0 120.9 97.8 100.4 90.3 158.9 102.3 95.8 92.5 92.7 93.0 91.4 97.2 97.7 70.2 32.1 61.3 0.0 20.9 0.0 0.0 0.0 0.0 0.0 119.6 172.6 0.0 0.0 19.2 49.7 0.0 113.3 52.9 0.0 168.3 118.6 0.0 72.7 73.3 29.2 0.0 0.0 0.0 94.1 187.2 42.7 0.0 59.0 25.2 119.7 0.0 0.0 106.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 41.3 0.0 0.0 0.0 0.0 91.8 0.0 0.0 8.4 0.0 0.0 289.7 28.4 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 57.9 30.9 125.9 0.0 0.0 MFAP3 ENSG00000037749 "Microfibril associated protein 3" P55082 5 154038959-154220478 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 24.3;Inhibitory neurons: 24.5;Microglial cells: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015883, HPA049198" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoplasm "HPA015883: AB_1853840, HPA049198: AB_2680672" "unprognostic (6.02e-2)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.58e-3)" "unprognostic (2.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.07e-2)" "unprognostic (1.53e-2)" "unprognostic (7.00e-2)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (9.35e-3)" 16.0 8.5 5.4 13.2 5.4 12.1 12.5 8.1 7.0 13.2 10.1 10.8 9.5 12.0 9.8 14.7 9.7 11.8 14.1 5.3 6.3 13.5 13.7 11.3 10.6 5.8 6.2 9.4 7.1 24.4 3.1 19.6 6.3 9.4 10.8 12.2 7.2 9.0 10.4 7.6 9.6 16.6 6.5 11.4 9.6 5.7 5.7 11.8 13.4 17.1 13.0 16.1 6.5 6.0 14.9 19.7 36.5 37.7 29.8 24.7 31.5 26.4 28.0 27.0 37.1 27.4 34.1 25.0 30.6 26.3 25.8 33.5 32.5 35.6 41.9 9.5 21.0 15.7 26.5 12.9 29.5 27.7 16.0 29.2 32.4 35.0 29.1 22.6 38.4 19.9 17.5 20.5 21.4 11.0 15.2 9.9 20.0 16.0 9.9 14.6 40.7 20.8 20.8 21.0 32.1 40.3 27.4 35.0 31.1 30.1 34.6 14.8 32.9 34.3 26.4 19.4 26.9 25.7 33.5 21.4 18.7 19.2 27.4 6.7 7.5 11.9 5.0 7.9 6.9 2.4 4.0 3.5 8.1 2.5 5.2 4.1 6.8 6.5 5.6 3.7 3.9 4.3 5.4 5.4 8.1 7.0 5.3 6.3 5.8 6.2 6.3 6.5 5.7 6.0 9.7 0.0 0.5 14.0 3.5 6.0 1.0 6.1 6.2 3.2 1.6 1.5 2.7 0.0 3.9 5.5 6.2 4.3 2.7 1.9 1.9 1.4 7.1 1.4 4.3 7.6 0.0 9.1 24.3 1.1 3.0 3.9 4.1 2.2 4.5 2.1 1.4 1.9 1.9 3.3 24.5 1.2 8.2 0.6 4.4 4.9 1.8 2.7 8.8 17.8 0.7 6.9 1.0 12.1 15.1 1.1 0.3 0.0 9.5 1.3 2.1 1.1 4.6 4.6 0.0 1.5 3.3 3.9 2.0 4.3 5.5 6.0 4.0 1.2 1.0 1.5 MFSD13A "bA18I14.8, C10orf77, FLJ22529, TMEM180" ENSG00000138111 "Major facilitator superfamily domain containing 13A" Q14CX5 10 102461395-102477045 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.4;Hofbauer cells: 15.7;Horizontal cells: 21.9;Syncytiotrophoblasts: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018031 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Cytosol" "HPA018031: AB_2204891" "unprognostic (2.24e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.79e-1)" "unprognostic (2.11e-1)" "unprognostic (9.16e-3)" "unprognostic (4.70e-2)" "unprognostic (4.03e-2)" "unprognostic (8.10e-2)" "unprognostic (2.04e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.66e-3)" "unprognostic (2.44e-1)" "unprognostic (2.74e-1)" "unprognostic (4.02e-2)" 2.3 2.5 10.0 3.2 13.0 5.2 2.1 14.1 12.8 2.4 2.3 5.0 5.5 3.1 0.7 3.0 2.3 2.3 3.2 10.8 7.2 2.5 6.3 9.0 3.2 7.7 7.7 1.4 3.8 1.7 4.1 2.3 7.8 3.1 3.2 4.9 1.8 0.9 2.3 11.7 4.4 2.5 6.5 6.9 4.0 3.7 9.2 1.8 5.4 1.4 3.6 2.2 2.6 9.4 12.0 5.4 4.0 9.6 0.4 0.4 6.2 2.3 6.0 4.6 10.5 10.7 16.0 10.6 11.8 0.9 4.4 14.6 7.4 6.3 1.7 13.5 6.8 13.1 8.2 5.6 10.1 6.7 12.3 5.2 2.6 2.6 4.6 3.7 5.3 14.2 3.0 5.7 0.4 2.4 11.3 4.3 6.8 10.5 5.2 13.6 0.6 1.8 2.0 3.1 10.0 9.5 2.2 1.2 5.2 1.4 6.0 4.0 1.6 2.1 2.5 2.6 3.3 1.9 5.5 14.0 11.6 10.9 2.9 0.4 4.3 3.5 2.9 3.2 2.8 3.4 2.7 2.3 4.5 1.4 2.8 3.2 2.5 1.2 1.8 0.4 0.8 2.6 10.0 13.0 14.1 12.8 10.8 7.2 7.7 7.7 7.8 6.5 9.2 9.4 4.1 19.2 15.4 0.0 1.1 0.0 1.5 0.0 0.6 8.2 1.5 1.9 0.0 1.5 0.6 1.8 4.2 1.8 5.7 2.6 0.0 2.8 1.8 1.0 1.0 3.8 2.4 3.6 0.0 3.6 2.6 1.6 5.6 1.6 1.3 2.8 6.4 4.0 15.7 21.9 0.0 3.8 0.0 4.8 0.0 1.0 0.9 8.7 0.0 0.0 5.6 3.2 2.1 0.0 0.0 3.2 4.6 2.2 0.8 1.4 5.6 1.5 0.7 13.8 0.0 2.8 1.1 4.5 3.0 2.4 0.0 28.5 3.2 4.0 4.5 1.4 MGAT2 GNT-II ENSG00000168282 "Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase" Q10469 14 49620799-49623481 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043721, HPA056824" Approved Supported "Golgi apparatus" NA Yes 5100000 "Cluster 44: Non-specific - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA043721: AB_2678636, HPA056824: AB_2683248" "unprognostic (1.20e-2)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.84e-1)" "unprognostic (5.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (3.77e-1)" "unprognostic (1.92e-2)" "unprognostic (1.14e-1)" "unprognostic (7.44e-2)" "unprognostic (7.12e-2)" "unprognostic (5.63e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-2)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" 16.8 17.6 5.9 24.3 5.8 10.3 13.3 6.9 6.8 17.4 9.0 23.6 23.1 12.7 21.7 11.8 11.9 15.2 11.7 5.6 6.7 14.2 40.7 13.8 25.3 6.4 6.3 13.1 23.8 8.2 7.9 22.0 6.6 14.1 21.9 8.2 15.8 13.7 5.0 9.3 22.5 16.0 6.9 20.2 21.0 24.3 7.2 16.4 13.3 5.6 25.1 20.9 8.8 7.3 63.5 30.7 23.2 39.2 53.6 51.7 15.1 68.6 67.7 62.2 55.8 37.5 47.1 63.7 56.9 62.9 36.0 49.5 32.9 39.7 66.7 65.5 29.1 40.7 21.7 37.2 42.3 94.5 91.2 39.8 31.2 36.8 51.8 45.5 75.5 31.4 31.7 170.4 66.3 24.2 32.9 60.1 23.8 22.2 49.1 36.7 67.1 55.6 49.3 36.2 24.0 25.6 49.3 12.9 39.8 22.2 39.1 63.6 78.9 56.1 60.8 41.1 49.6 182.8 94.6 56.7 27.3 46.5 38.6 49.4 38.6 39.3 36.6 34.1 39.3 25.1 33.3 33.1 39.9 15.9 19.3 26.8 11.6 22.3 39.8 47.2 31.6 44.8 5.9 5.8 6.9 6.8 5.6 6.7 6.4 6.3 6.6 6.9 7.2 7.3 17.4 12.8 8.6 2.0 31.7 15.7 25.7 28.8 14.2 13.7 15.5 8.9 0.1 24.3 18.0 11.0 4.2 26.4 46.9 34.6 9.8 31.0 7.9 12.5 20.7 20.8 12.1 19.0 3.0 34.4 40.3 24.3 13.7 11.7 17.1 27.7 27.1 63.0 37.2 18.5 4.3 20.5 40.7 34.5 28.8 6.0 17.4 26.3 21.4 2.8 40.6 16.7 63.8 6.0 4.5 36.5 25.1 22.2 77.1 27.0 26.7 15.2 23.5 15.8 6.6 15.8 34.6 56.4 13.0 15.2 14.1 5.3 31.5 23.2 20.0 25.5 MGAT4A "GnT-4a, GnT-Iva" ENSG00000071073 "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A" Q9UM21 2 98619106-98731132 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 96.0" "Cell type enhanced" "Detected in many" "Microglial cells: 175.2;Proximal enterocytes: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 127.2;HUVEC TERT2: 48.3;JURKAT: 86.5;TIME: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007608 Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 28: BEWO - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA007608: AB_10602008" "prognostic unfavorable (4.30e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.48e-8)" "unprognostic (1.35e-1)" "unprognostic (2.28e-2)" "unprognostic (3.82e-3)" "unprognostic (1.89e-1)" "unprognostic (3.76e-1)" "unprognostic (3.58e-1)" "unprognostic (2.80e-2)" "unprognostic (2.32e-2)" "unprognostic (4.17e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.04e-2)" "unprognostic (2.04e-1)" 11.2 7.8 13.2 20.8 17.8 96.0 12.5 26.1 15.6 8.9 15.1 24.4 29.5 5.8 3.7 6.3 7.0 12.7 7.6 13.1 15.2 27.5 9.7 16.9 21.1 16.4 15.8 3.2 38.8 28.0 9.8 19.6 15.5 7.5 25.5 5.4 25.9 6.4 3.8 4.1 43.8 11.5 18.1 8.1 11.3 6.3 15.5 20.5 8.7 4.7 18.2 13.1 4.7 22.9 8.8 1.7 3.4 7.3 0.0 0.0 127.2 0.0 0.1 0.9 0.0 21.0 10.6 0.0 18.9 0.0 2.4 0.4 7.2 1.0 0.2 10.6 7.9 0.5 0.0 36.7 0.2 17.8 6.4 0.0 4.7 0.0 0.7 0.3 48.3 86.5 1.6 9.2 0.0 17.3 39.3 30.9 1.1 7.6 1.4 9.8 0.0 10.5 24.8 17.6 10.4 3.3 2.5 32.2 4.8 9.2 7.6 23.8 78.8 0.0 4.0 0.1 2.6 3.2 7.6 2.2 0.0 26.7 0.6 7.0 5.1 12.7 20.8 1.0 27.5 3.6 25.2 23.7 3.8 2.5 32.6 27.2 14.0 15.3 2.5 17.1 16.0 12.5 13.2 17.8 26.1 15.6 13.1 15.2 16.4 15.8 15.5 18.1 15.5 22.9 80.8 54.5 25.7 19.2 22.7 9.9 21.1 6.1 11.4 19.8 28.2 15.6 13.4 11.5 17.6 22.0 4.2 6.2 116.9 92.4 21.5 20.8 12.7 14.2 3.8 39.8 53.0 6.3 58.0 29.8 77.9 7.2 19.4 35.1 13.3 5.1 18.9 10.4 57.2 48.8 48.6 41.3 34.6 33.9 18.3 17.5 2.5 54.5 10.6 175.2 21.0 13.4 89.6 36.7 42.0 21.6 58.2 2.2 31.4 17.8 132.4 27.3 7.1 4.8 6.6 6.8 4.9 2.5 7.7 8.6 10.5 14.9 112.2 0.7 40.9 30.2 MGAT4B GnT-Ivb ENSG00000161013 "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B" Q9UQ53 5 179797597-179806952 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 277.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 224.7;Proximal enterocytes: 224.5;Undifferentiated cells: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "eosinophil: 5.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012804, HPA052134" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA 19000 "Cluster 52: Eosinophils - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Golgi apparatus, Vesicles, Cytosol" "HPA012804: , HPA052134: AB_2681741" "unprognostic (2.01e-2)" "unprognostic (8.68e-3)" "unprognostic (1.40e-1)" "unprognostic (3.83e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (3.61e-3)" "unprognostic (7.57e-3)" "unprognostic (1.22e-2)" "unprognostic (2.02e-1)" "unprognostic (5.13e-2)" "unprognostic (2.26e-2)" "unprognostic (2.27e-2)" "prognostic favorable (5.78e-4)" "unprognostic (1.52e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-2)" "unprognostic (1.42e-1)" 48.4 105.0 17.2 19.0 16.9 24.6 39.9 16.8 19.3 37.0 18.1 147.0 134.1 36.9 13.4 75.1 37.2 23.5 103.3 18.9 14.2 124.8 277.1 61.2 15.5 16.3 15.0 41.1 63.3 22.9 37.7 17.9 15.1 42.3 65.0 4.4 57.9 11.9 43.8 53.4 168.3 14.9 14.6 52.8 96.3 30.6 18.0 10.5 60.1 14.9 16.0 38.7 42.1 16.2 84.2 85.3 40.8 93.7 117.4 65.1 71.1 48.3 98.3 44.4 34.8 91.7 226.4 14.4 122.3 108.2 193.1 61.6 57.9 110.1 32.2 121.0 33.0 43.5 75.1 78.4 85.9 53.7 13.4 70.5 76.6 44.1 53.0 165.2 89.1 16.9 28.7 38.5 73.6 92.6 8.4 47.4 24.7 123.7 35.1 21.6 31.4 40.4 132.3 158.5 67.5 39.7 73.7 75.2 139.1 33.8 51.3 56.3 109.2 106.6 48.6 61.2 80.2 32.5 39.5 35.4 125.0 68.2 78.7 0.0 0.4 5.5 0.1 0.1 0.0 0.0 0.3 0.1 0.3 0.9 0.2 0.3 0.1 0.0 0.3 0.3 0.0 0.2 17.2 16.9 16.8 19.3 18.9 14.2 16.3 15.0 15.1 14.6 18.0 16.2 35.7 12.8 9.2 9.4 7.7 12.5 17.8 12.5 5.2 15.5 29.6 30.7 24.1 37.1 11.1 27.6 4.2 8.1 22.1 224.7 3.9 66.7 0.7 27.2 17.8 24.3 22.9 5.5 11.4 54.0 11.1 15.3 78.5 50.5 5.1 39.5 26.7 89.9 17.7 30.3 10.0 72.2 14.2 20.7 11.7 2.6 15.2 24.5 10.6 9.4 16.8 25.7 6.2 4.5 6.3 89.9 114.6 17.0 7.0 49.0 224.5 22.4 7.7 11.1 13.1 16.2 24.7 1.5 6.5 21.1 11.9 14.0 12.5 24.9 131.8 64.8 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" O94851 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 193.5;Inhibitory neurons: 108.8;Late spermatids: 192.7;Peritubular cells: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 109.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 58: Brain - Synaptic function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.7 3.8 13.9 12.2 13.6 11.6 2.5 61.6 38.1 6.9 42.6 18.8 9.8 12.3 7.2 18.6 7.4 10.0 42.2 37.8 0.0 2.3 2.9 17.5 3.3 0.0 0.0 3.9 4.1 1.0 0.2 7.3 0.0 2.9 16.3 4.0 0.8 9.6 16.8 14.0 10.8 30.8 0.0 3.3 6.7 32.5 0.0 1.9 6.1 4.1 2.5 12.4 0.3 19.9 29.1 9.7 0.4 2.7 2.3 6.8 14.2 32.1 53.7 16.2 28.3 24.3 23.3 0.2 8.4 25.3 47.7 25.0 4.0 65.1 41.6 35.9 4.8 27.5 4.1 0.9 12.8 5.3 2.7 12.7 11.1 76.0 54.6 25.3 46.9 1.6 43.5 0.8 22.9 1.2 0.3 1.6 1.2 13.6 9.8 0.3 15.2 14.2 2.1 35.5 14.3 0.8 8.6 38.6 2.9 9.9 4.5 2.3 42.6 109.6 35.0 17.4 39.6 0.9 2.6 1.5 64.3 5.2 1.4 0.1 4.2 0.5 1.3 0.7 1.5 0.1 0.8 0.4 3.4 0.2 0.0 0.4 8.9 2.2 0.4 0.9 0.7 1.5 13.9 13.6 61.6 38.1 37.8 0.0 0.0 0.0 0.0 0.0 0.0 19.9 3.2 41.7 37.1 7.2 1.2 10.1 11.8 4.5 4.0 5.7 4.2 5.3 32.2 7.2 8.5 3.7 0.0 2.6 11.2 66.5 0.0 10.2 74.4 7.8 8.9 9.2 22.6 35.6 193.5 14.3 12.6 9.0 12.2 11.4 1.3 1.4 12.8 19.6 3.4 0.0 108.8 10.6 6.1 10.1 5.6 192.7 21.1 11.1 5.4 4.7 21.6 0.5 8.2 6.6 17.5 42.5 24.0 112.8 2.1 8.9 18.3 0.9 5.5 1.6 13.1 1.9 29.4 1.2 1.3 1.7 9.5 2.3 10.8 0.7 14.5 11.9 MICB PERB11.2 ENSG00000204516 "MHC class I polypeptide-related sequence B" Q29980 6 31494881-31511124 "Disease related genes, Predicted membrane proteins" "Adaptive immunity, Cytolysis, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 9.9" "Cell type enhanced" "Detected in many" "dendritic cells: 10.3;Erythroid cells: 10.5;Hofbauer cells: 11.1;Kupffer cells: 17.8;monocytes: 13.2;T-cells: 11.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 15.2;U-266/84: 36.5" HPA064618 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 64: Macrophages - Immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA064618: AB_2685301" "unprognostic (3.63e-3)" "unprognostic (8.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (8.44e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (7.04e-5)" "unprognostic (2.05e-1)" "unprognostic (2.61e-1)" "unprognostic (1.67e-3)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.94e-9)" "unprognostic (1.91e-3)" "unprognostic (2.80e-2)" "unprognostic (9.72e-2)" "unprognostic (1.21e-2)" 2.6 1.2 0.1 1.4 0.2 2.2 2.2 0.2 0.4 1.4 0.2 1.9 0.2 1.7 0.3 1.4 1.2 0.4 2.5 0.2 0.1 1.8 1.2 6.2 2.8 0.2 0.1 0.7 0.8 0.1 0.6 0.2 0.2 1.1 0.5 0.0 1.3 0.0 0.5 1.0 4.5 0.4 0.1 9.9 1.4 1.3 0.3 0.7 1.6 0.7 1.6 1.4 1.5 0.2 3.4 1.3 0.0 0.0 1.9 3.2 0.1 2.3 2.2 2.9 3.7 0.0 0.4 3.9 5.9 4.3 8.1 0.8 1.0 4.1 1.0 3.4 2.3 4.6 0.6 1.3 0.7 1.4 3.5 4.1 0.8 5.0 3.5 3.1 1.9 6.0 4.2 7.8 3.5 0.0 1.3 5.9 0.4 0.0 0.5 4.7 0.0 8.2 3.8 0.2 0.0 0.0 1.5 0.0 0.7 1.2 2.0 1.6 1.9 2.2 0.0 1.9 0.1 15.2 36.5 8.3 0.5 12.0 4.9 1.8 0.9 1.2 0.8 1.1 1.0 0.6 0.8 1.1 0.6 0.5 0.4 0.9 0.9 0.6 1.6 0.4 1.4 0.7 0.1 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.2 3.0 3.2 1.5 0.0 8.2 2.9 0.5 0.3 0.0 0.0 3.1 1.9 0.5 1.5 0.8 0.0 0.0 0.1 10.3 0.8 1.9 1.6 0.0 3.1 1.6 3.0 0.0 10.5 0.6 0.7 0.3 1.5 2.0 5.2 0.0 0.1 3.9 0.1 11.1 0.0 0.1 0.6 0.0 17.8 8.2 0.4 0.3 8.0 1.8 3.7 13.2 0.0 7.2 0.0 0.1 1.9 1.9 0.4 8.7 2.1 0.5 0.3 0.9 0.0 0.0 0.6 2.2 4.6 5.2 0.1 1.1 0.1 11.3 0.5 2.1 1.1 MID1 "FXY, OS, RNF59, TRIM18" ENSG00000101871 "Midline 1" O15344 X 10445310-10833654 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 129.3;Basal squamous epithelial cells: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 156.1;AF22: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002878, HPA003715" Approved Uncertain "Golgi apparatus,Centriolar satellite,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Centriolar satellite" "Golgi apparatus, Cytosol" "HPA002878: , HPA003715: AB_1079384" "unprognostic (1.99e-1)" "unprognostic (2.81e-1)" "unprognostic (4.66e-2)" "unprognostic (2.79e-1)" "unprognostic (2.78e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.09e-1)" "unprognostic (2.87e-1)" "unprognostic (9.43e-2)" "unprognostic (1.25e-3)" "unprognostic (9.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.12e-3)" "unprognostic (5.88e-2)" 5.9 2.5 6.9 5.0 7.7 1.7 5.3 17.2 5.0 7.0 6.5 17.3 5.7 8.9 4.9 7.0 6.4 6.8 9.3 7.0 4.9 7.3 4.2 6.5 2.2 3.6 10.4 4.4 3.5 2.8 4.2 6.2 4.9 10.4 10.6 12.3 4.9 12.9 0.7 2.9 5.8 12.3 2.1 1.0 3.8 3.6 8.2 2.3 4.2 2.2 3.1 11.7 6.2 4.4 33.2 156.1 132.5 16.7 8.1 9.2 14.6 16.2 17.8 19.7 20.7 31.0 9.7 10.6 6.5 21.9 58.4 22.5 11.0 15.1 23.0 1.3 11.0 2.7 24.3 1.1 2.8 0.3 1.2 12.1 7.0 16.1 15.8 20.4 23.1 5.1 2.1 3.2 9.6 8.0 5.3 0.5 32.7 5.1 10.0 3.9 28.9 0.4 18.7 36.2 7.1 3.5 7.4 23.5 10.1 42.7 19.2 0.2 13.7 7.2 1.0 34.1 17.0 2.8 1.2 0.4 13.5 0.3 31.3 0.5 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.7 0.0 0.1 0.4 0.0 0.1 6.9 7.7 17.2 5.0 7.0 4.9 3.6 10.4 4.9 2.1 8.2 4.4 16.5 35.3 20.7 129.3 0.7 21.4 31.5 24.7 82.6 10.7 8.5 13.2 4.8 8.6 19.6 23.9 18.8 9.1 1.3 22.6 1.9 13.4 2.2 39.8 8.9 25.4 12.1 2.7 15.5 8.7 26.9 16.2 10.7 38.5 1.3 13.4 69.9 4.0 1.5 69.0 44.3 9.0 2.0 2.5 5.8 7.9 30.1 1.2 3.6 23.4 0.0 37.0 0.0 66.4 59.2 7.3 17.2 41.3 0.2 8.2 11.3 1.5 19.3 2.9 6.6 3.7 3.3 0.3 2.4 36.1 10.1 20.0 0.8 9.7 20.0 49.2 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271231 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 6: T47d - Mammary gland" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoli "Golgi apparatus, Cytosol" "HPA051222: AB_2681393" "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 29.7 22.5 15.6 18.7 17.7 43.6 23.4 16.9 16.4 22.2 12.9 24.1 12.6 23.1 8.2 28.4 18.2 17.3 23.0 15.1 16.5 24.5 17.6 25.4 33.2 17.3 17.2 14.2 27.6 21.5 11.8 12.3 18.4 16.4 15.1 6.0 19.9 14.4 63.2 32.8 25.1 16.9 17.4 35.7 19.5 17.9 16.6 24.5 16.6 26.8 27.0 23.7 21.6 18.6 25.6 43.5 8.9 20.3 17.9 5.4 12.7 6.2 19.1 13.0 9.5 14.4 29.8 38.7 11.7 11.9 14.6 19.8 13.6 24.4 10.5 19.2 27.3 20.2 16.5 14.1 19.9 18.9 20.4 4.8 37.7 8.7 39.7 17.7 27.3 44.7 25.7 50.0 3.6 47.6 58.6 39.0 3.5 29.0 21.3 36.6 11.3 58.6 29.4 14.1 11.7 17.1 13.9 34.5 33.0 23.4 65.9 41.2 9.7 5.6 13.8 7.2 12.1 67.8 17.5 33.3 11.7 31.3 8.7 27.5 77.6 44.4 54.6 41.1 56.6 49.3 43.0 47.9 91.4 44.2 37.1 39.9 13.1 56.4 55.4 226.4 68.3 60.3 15.6 17.7 16.9 16.4 15.1 16.5 17.3 17.2 18.4 17.4 16.6 18.6 33.2 0.0 11.0 3.3 30.5 11.5 14.8 11.1 5.2 3.8 23.8 23.4 4.2 31.5 15.3 12.9 0.0 15.0 73.4 12.1 21.5 45.2 32.6 11.6 4.7 20.1 15.6 11.1 3.0 43.4 9.4 12.3 9.2 12.0 31.8 13.0 17.5 9.0 44.9 1.7 3.1 18.0 28.5 47.4 45.1 19.8 9.3 45.4 16.0 7.5 47.7 30.5 53.5 5.0 8.2 24.8 22.7 15.8 22.5 14.3 22.3 29.3 17.6 6.0 19.7 13.0 22.0 19.6 22.1 23.2 18.9 9.3 33.5 7.4 16.9 14.1 MINAR1 "KIAA1024, UBTOR" ENSG00000169330 "Membrane integral NOTCH2 associated receptor 1" Q9UPX6 15 79432336-79472304 "Predicted membrane proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 10.3;brain: 4.7;retina: 6.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "melanoma: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011545 Uncertain Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 10: BJ & FHDF - ECM organization" "Golgi apparatus" "HPA011545: AB_1852361" "unprognostic (5.45e-5)" "unprognostic (3.26e-1)" "unprognostic (4.56e-3)" "unprognostic (2.12e-2)" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (4.49e-2)" "unprognostic (5.66e-2)" "unprognostic (2.90e-1)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "unprognostic (4.45e-2)" "unprognostic (6.66e-13)" "unprognostic (7.08e-2)" "unprognostic (2.73e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" 0.1 10.3 1.0 0.1 0.8 0.4 0.3 4.7 0.7 0.3 0.2 0.2 0.0 0.2 0.3 0.2 0.1 0.3 0.1 0.6 1.6 0.1 0.0 0.1 0.4 3.2 3.5 0.1 2.1 0.0 0.7 0.2 3.4 0.7 0.2 6.8 2.8 0.1 0.1 0.2 0.2 0.1 1.5 0.3 0.3 0.2 1.8 0.2 0.2 0.0 0.2 0.1 0.2 1.1 0.3 0.2 0.4 0.5 1.1 0.9 0.4 0.5 0.8 0.4 0.4 0.0 0.3 0.7 0.1 0.8 0.5 0.2 0.9 0.1 0.3 0.8 1.0 1.9 0.5 0.0 0.6 2.7 0.9 0.4 0.2 0.7 0.1 0.8 0.4 0.8 0.1 0.0 0.1 0.0 0.3 1.0 0.4 0.4 0.4 0.4 0.1 0.4 0.1 0.0 1.8 1.0 0.2 1.6 1.0 0.7 0.2 1.3 0.3 8.7 0.3 0.0 1.9 1.1 1.4 0.3 0.9 1.5 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.8 4.7 0.7 0.6 1.6 3.2 3.5 3.4 1.5 1.8 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MKRN2OS "C3orf83, MKRN2-AS1" ENSG00000225526 "MKRN2 opposite strand" H3BPM6 3 12514934-12561059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 9.2;intestine: 8.0" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 6.6;Proximal enterocytes: 7.5;Respiratory ciliated cells: 4.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 4.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.9;CAPAN-2: 13.8;HBEC3-KT: 3.4;MCF7: 3.2;RT4: 5.7;T-47d: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065586, HPA065753" Uncertain Approved "Golgi apparatus" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA065586: AB_2685514, HPA065753: AB_2685553" "unprognostic (2.53e-2)" "unprognostic (1.01e-2)" "unprognostic (3.89e-3)" "unprognostic (2.03e-3)" "unprognostic (3.81e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.29e-1)" "unprognostic (5.26e-2)" "unprognostic (3.86e-2)" "unprognostic (1.58e-2)" "unprognostic (4.29e-3)" "unprognostic (2.53e-5)" "unprognostic (1.02e-1)" "unprognostic (2.48e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-3)" 0.1 0.0 0.1 0.4 0.4 0.0 1.3 4.4 0.8 1.8 0.0 4.3 8.0 0.2 9.2 4.6 1.9 2.2 2.0 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.2 4.1 1.0 1.6 0.4 0.2 0.9 5.0 1.3 7.0 1.9 0.4 2.5 7.6 0.0 0.0 0.0 5.1 0.1 0.1 0.2 0.6 0.0 0.9 0.9 1.1 0.1 2.9 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 13.8 0.0 0.3 0.0 0.0 0.6 0.0 3.4 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 2.0 5.7 0.2 0.0 0.0 0.8 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 4.4 0.8 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 1.1 0.3 0.5 0.0 0.7 0.0 1.8 0.7 2.9 1.3 0.7 2.8 0.6 3.7 0.0 2.7 0.0 1.9 0.0 1.7 1.5 3.0 0.5 0.2 0.0 0.0 2.3 2.2 0.6 0.0 6.6 2.8 0.0 0.2 0.0 0.0 0.2 0.0 2.6 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.8 2.1 2.2 0.0 0.2 0.4 7.5 1.1 4.4 1.0 0.0 0.1 0.1 0.2 0.1 3.4 0.0 0.3 0.0 0.1 2.1 0.9 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209453 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 105.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: AB_2677701" "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 16.7 29.4 31.5 9.8 31.8 13.3 17.1 31.4 51.1 16.0 25.5 17.3 12.5 15.5 5.6 24.8 14.6 9.1 25.0 32.4 29.9 26.0 31.3 13.3 10.5 32.0 31.0 19.4 35.8 13.3 19.8 11.1 32.4 20.5 4.6 5.7 19.7 8.0 39.4 22.2 15.6 4.5 29.4 16.5 22.3 33.6 32.5 9.7 22.4 21.8 5.2 16.7 15.5 34.1 20.5 61.9 23.1 60.5 29.6 20.8 38.2 17.9 20.4 26.7 22.9 83.4 29.5 51.3 40.6 20.1 12.7 25.8 23.1 51.4 3.1 39.4 113.4 36.0 61.0 51.7 44.7 57.3 49.7 29.7 34.8 31.7 41.8 22.6 28.6 74.1 54.9 35.9 14.8 89.4 55.5 74.9 47.3 18.1 57.4 55.6 23.4 93.8 20.7 13.4 73.5 40.1 26.6 62.1 46.3 8.7 38.6 54.2 22.4 33.5 38.9 27.3 23.7 43.0 26.4 57.8 17.6 47.5 29.9 0.0 25.0 4.2 14.1 29.9 11.8 14.4 13.1 15.2 24.6 12.5 15.0 15.1 2.8 14.6 30.1 13.3 13.1 20.7 31.5 31.8 31.4 51.1 32.4 29.9 32.0 31.0 32.4 29.4 32.5 34.1 11.5 6.4 16.0 10.4 24.6 14.7 16.2 29.6 21.6 31.5 24.7 29.8 3.3 15.7 16.2 16.5 20.9 63.2 13.0 44.6 35.2 34.4 48.7 9.6 13.1 16.8 28.8 26.9 8.9 42.6 50.4 19.2 42.8 11.2 8.2 26.8 20.3 16.7 46.9 30.3 8.4 37.9 22.4 19.1 14.6 105.4 14.9 18.4 17.8 1.0 28.0 29.4 19.6 5.5 5.9 28.6 37.9 15.1 34.1 17.9 43.2 36.3 11.1 30.6 19.7 11.6 16.5 34.7 28.2 29.4 15.5 52.7 15.4 26.8 49.3 17.4 MMP11 STMY3 ENSG00000099953 "Matrix metallopeptidase 11" P24347 22 23768226-23784316 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 64.8;endometrium 1: 142.8;placenta: 39.6" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 84.9;Extravillous trophoblasts: 37.6;Granulosa cells: 61.9;Smooth muscle cells: 35.8" "Cancer enhanced" "Detected in all" "pancreatic cancer: 119.1" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 4.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.4" "Cell line enhanced" "Detected in many" "AN3-CA: 38.4;hTERT-RPE1: 19.7;REH: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002593, HPA055204, HPA068864" Approved Approved "Golgi apparatus,Cytosol" "Secreted to extracellular matrix" NA NA 640000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" Cytosol "CAB002593: , HPA055204: , HPA068864: AB_2686051" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (1.83e-1)" "unprognostic (1.84e-3)" "unprognostic (2.77e-2)" "unprognostic (6.73e-2)" "unprognostic (2.14e-2)" "unprognostic (5.15e-1)" "unprognostic (2.73e-2)" "unprognostic (2.20e-1)" "unprognostic (1.89e-3)" "unprognostic (7.04e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (8.05e-2)" "unprognostic (6.78e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-2)" 3.3 1.6 0.4 1.4 0.3 0.5 2.2 0.3 1.2 64.8 0.3 3.9 6.8 142.8 0.1 1.0 5.7 6.8 7.2 0.3 0.4 2.5 0.6 1.4 3.9 0.4 0.4 12.5 1.3 3.3 0.5 39.6 0.4 1.9 3.5 0.0 5.3 1.5 0.9 3.8 6.0 9.4 0.4 1.4 2.6 6.7 0.4 3.1 1.3 0.9 1.7 2.9 3.6 0.4 0.3 0.0 4.8 38.4 5.7 8.3 0.1 0.6 10.4 1.3 0.8 0.4 1.3 1.3 5.1 2.8 1.8 0.2 2.2 0.0 0.4 0.0 0.8 0.0 0.0 2.2 4.2 0.0 0.0 5.4 0.9 1.1 0.1 19.7 6.0 0.4 0.6 0.0 1.4 0.3 0.1 0.1 1.4 1.2 0.2 16.6 0.0 0.4 0.7 0.0 6.0 10.3 3.9 0.6 0.0 5.9 3.6 0.0 2.7 0.6 0.0 1.6 0.1 0.1 0.2 5.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.4 0.3 0.3 1.2 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.2 0.0 2.5 0.3 3.4 1.0 0.8 0.8 0.6 0.4 1.9 0.5 6.1 1.5 0.1 0.0 0.0 0.7 1.8 0.4 1.9 8.6 10.3 4.4 84.9 0.9 1.8 0.0 0.2 0.7 37.6 8.4 1.5 4.1 1.3 61.9 1.1 0.0 0.8 0.0 0.4 1.3 2.0 0.0 1.1 10.5 0.6 1.0 1.8 1.0 0.0 0.3 0.0 0.0 0.2 1.4 0.2 0.4 0.2 0.5 0.1 2.2 0.8 0.5 0.0 2.7 35.8 3.1 5.5 0.5 0.6 18.6 2.0 5.7 1.0 0.3 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Excitatory neurons: 87.7;Inhibitory neurons: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus, Centrosome" "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 4.6 5.4 13.7 8.0 15.2 26.2 5.0 21.6 19.8 4.7 18.9 6.1 6.8 5.3 11.1 3.1 5.3 3.6 5.6 14.3 13.2 6.2 9.6 3.9 12.1 13.8 13.7 4.5 4.0 8.9 4.4 5.2 13.9 4.6 6.8 21.3 5.5 4.4 6.8 5.0 5.2 5.2 13.4 8.1 5.1 12.4 14.4 32.8 5.2 7.8 10.3 4.2 1.9 16.0 15.0 15.9 23.9 28.0 10.7 10.1 9.1 15.7 7.8 18.7 15.2 15.1 7.2 29.6 10.6 10.1 15.7 10.2 30.3 11.1 26.0 17.6 20.7 30.5 17.9 15.0 6.6 27.0 24.6 10.5 4.7 18.2 16.1 15.6 19.5 40.1 21.4 12.7 17.3 12.9 32.6 44.6 17.1 9.4 17.2 27.6 24.9 19.1 14.7 14.8 31.4 15.0 23.7 9.3 15.4 22.4 17.5 21.2 11.1 15.3 21.5 17.5 22.1 19.0 33.8 24.4 12.2 26.4 32.4 11.5 3.7 5.4 10.1 3.7 7.2 6.5 8.4 9.5 3.7 6.0 11.6 12.0 0.8 10.1 3.3 5.3 7.8 2.8 13.7 15.2 21.6 19.8 14.3 13.2 13.8 13.7 13.9 13.4 14.4 16.0 7.3 9.6 9.5 50.3 15.6 4.5 4.5 5.7 8.6 43.5 5.8 5.2 16.3 10.0 7.2 7.3 114.7 12.2 25.3 2.8 5.9 4.8 57.9 21.2 12.4 8.5 14.3 33.6 87.7 1.8 7.1 10.6 5.1 6.5 2.5 23.6 7.9 31.1 8.6 53.8 84.7 5.6 6.1 15.3 7.4 73.3 7.2 10.4 3.6 24.4 17.0 14.7 32.0 46.3 48.1 1.8 1.6 11.3 21.4 3.0 4.3 11.0 14.9 65.9 0.0 11.6 7.2 31.7 20.4 8.4 2.3 1.6 26.8 17.2 9.8 2.7 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.8;skin 1: 8.3" "Cell type enriched" "Detected in single" 14 "granulocytes: 10.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 14 "HEL: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 330000 "Cluster 15: NK-cells - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" "Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA054404: , HPA073017: AB_2686566" "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.5 0.0 0.0 0.1 0.0 1.1 0.4 0.1 0.2 1.0 0.1 0.3 0.1 0.4 0.0 1.6 0.5 0.2 0.8 0.1 0.1 0.1 0.3 3.5 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.6 0.0 0.2 8.3 0.4 0.0 0.0 4.8 0.3 2.3 0.1 0.0 0.5 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.8 0.0 2.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 MPLKIP "C7orf11, ORF20, TTDN1" ENSG00000168303 "M-phase specific PLK1 interacting protein" Q8TAP9 7 40126027-40134622 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058457, HPA065463" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Golgi apparatus, Vesicles" "HPA058457: AB_2683724, HPA065463: AB_2685493" "unprognostic (5.59e-2)" "unprognostic (1.74e-1)" "unprognostic (9.40e-2)" "unprognostic (2.39e-2)" "unprognostic (5.55e-2)" "unprognostic (1.34e-3)" "unprognostic (2.73e-1)" "unprognostic (3.40e-2)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (3.16e-3)" "unprognostic (8.89e-2)" "unprognostic (1.61e-2)" "unprognostic (8.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-2)" "unprognostic (6.08e-2)" 2.9 3.8 2.6 2.0 2.6 2.4 2.8 4.7 3.0 2.8 3.0 2.8 2.2 2.6 2.0 3.1 2.5 1.2 2.1 2.6 2.3 4.2 8.0 2.1 2.6 2.4 2.3 2.8 2.9 2.5 3.0 1.8 2.6 2.5 1.8 3.1 2.7 1.5 2.4 3.0 2.6 1.1 2.0 3.1 2.4 2.3 2.5 3.3 3.0 1.4 2.0 2.5 2.7 4.0 8.2 2.5 4.8 6.6 4.3 4.9 4.9 3.1 3.3 4.4 4.3 3.1 4.0 6.8 4.2 3.0 8.7 10.3 3.0 5.3 5.6 5.2 9.2 5.4 3.7 6.9 4.9 6.7 5.2 4.8 6.7 3.4 4.1 4.5 5.1 7.5 13.1 5.5 4.4 4.1 6.8 20.4 6.7 6.7 7.4 9.6 3.3 8.9 5.0 2.1 7.1 8.4 5.0 4.8 7.7 6.2 6.1 9.3 5.5 2.8 7.5 3.6 4.7 8.6 9.6 10.9 4.4 10.5 7.6 20.6 11.2 16.8 8.0 10.8 9.0 16.9 10.1 9.4 11.8 15.3 11.3 9.9 9.2 10.6 10.4 13.1 14.2 13.1 2.6 2.6 4.7 3.0 2.6 2.3 2.4 2.3 2.6 2.0 2.5 4.0 49.8 51.3 34.5 6.5 53.3 110.1 96.2 151.8 58.6 43.5 53.8 66.2 18.0 67.2 79.6 58.8 25.0 110.8 41.3 60.3 117.4 66.6 118.4 73.6 62.3 58.0 48.6 52.2 7.4 54.6 79.7 51.1 35.7 56.6 51.3 63.6 47.2 133.4 69.0 53.8 8.1 63.4 85.5 59.3 62.6 38.6 75.8 50.4 58.7 7.5 74.6 52.9 66.9 12.1 12.5 59.9 97.2 55.3 36.3 76.2 61.6 190.5 91.1 50.1 52.6 57.1 58.4 66.6 53.9 67.1 134.1 95.6 46.8 125.7 82.3 105.7 MPPE1 "Cdc1, PGAP5" ENSG00000154889 "Metallophosphoesterase 1" Q53F39 18 11882622-11908366 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, GPI-anchor biosynthesis, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 100.8;neutrophil: 293.9" "Lineage enriched" "Detected in all" 7 "granulocytes: 293.9" "Cell line enhanced" "Detected in all" "OE19: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012639 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Golgi apparatus" "HPA012639: AB_1854088" "unprognostic (9.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.61e-1)" "prognostic favorable (6.45e-7)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (7.79e-2)" "unprognostic (6.15e-2)" 14.9 13.1 11.3 20.0 11.7 28.3 15.4 11.0 11.9 16.1 11.7 21.5 17.7 17.0 20.6 17.2 16.4 21.8 18.6 10.9 11.9 28.8 23.8 25.6 16.0 12.6 11.8 12.7 31.8 20.1 15.0 14.1 12.5 16.3 21.4 15.9 15.0 19.0 23.5 29.0 20.3 15.8 10.6 15.9 22.8 8.5 12.1 16.0 47.1 11.7 14.7 14.9 13.7 13.1 7.8 11.1 8.4 19.9 22.9 26.7 7.9 18.6 26.0 10.6 16.5 20.8 21.6 15.8 39.2 17.6 10.7 8.6 5.8 10.1 9.9 17.7 10.4 4.6 22.9 4.9 31.9 20.3 30.9 40.1 13.3 9.4 6.6 15.7 6.5 13.9 5.8 14.5 17.8 18.1 15.1 13.6 5.6 65.9 3.1 6.0 5.4 18.8 17.2 11.9 11.8 6.7 17.1 13.5 16.0 9.3 9.8 25.9 13.5 21.4 8.3 20.5 10.3 22.6 21.5 19.7 15.8 10.4 21.5 20.6 42.9 100.8 24.8 34.5 18.1 17.9 15.2 23.9 37.3 21.7 18.5 23.8 293.9 29.2 24.6 29.6 27.0 31.8 11.3 11.7 11.0 11.9 10.9 11.9 12.6 11.8 12.5 10.6 12.1 13.1 19.3 57.7 33.0 13.4 24.5 18.0 16.2 20.7 12.5 17.4 14.6 11.6 2.4 24.3 23.1 22.0 12.5 27.9 35.7 43.9 21.5 30.5 20.5 17.9 14.8 15.5 9.6 13.3 20.9 41.9 32.5 16.6 29.6 22.6 27.8 23.5 15.7 27.6 25.4 8.4 21.4 23.4 14.2 33.2 25.7 36.0 12.8 24.8 19.6 20.6 24.2 23.3 52.5 12.5 24.4 36.3 18.4 15.1 16.0 10.1 36.3 27.0 26.7 20.5 13.1 17.2 13.9 7.0 8.7 21.8 20.0 16.7 33.7 16.4 16.1 22.0 MPZL3 ENSG00000160588 "Myelin protein zero like 3" Q6UWV2 11 118226690-118252365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.3;skin 1: 30.4" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 43.8;Suprabasal keratinocytes: 63.9;T-cells: 44.3;Urothelial cells: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 6 "basophil: 44.3;eosinophil: 99.4;MAIT T-cell: 28.9;neutrophil: 87.8" "Group enriched" "Detected in all" 8 "granulocytes: 99.4;T-cells: 28.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.3;HMC-1: 29.0;MCF7: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029116 Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA029116: AB_10610142" "unprognostic (2.54e-2)" "unprognostic (1.24e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (8.74e-3)" "unprognostic (2.86e-2)" "unprognostic (9.82e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.86e-2)" "unprognostic (1.58e-2)" "unprognostic (1.89e-1)" "unprognostic (3.90e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.20e-1)" 3.3 0.5 0.7 4.7 1.0 7.3 8.2 2.8 0.7 11.5 1.7 5.6 5.4 1.5 4.9 33.3 5.4 7.6 1.6 0.7 0.8 3.1 7.5 7.9 4.8 1.0 0.7 0.5 7.2 6.7 3.8 0.8 0.9 5.6 6.1 1.3 11.7 2.7 1.7 30.4 5.3 1.5 0.7 6.0 6.8 1.1 0.8 2.8 6.1 0.9 12.6 4.4 16.8 0.7 5.0 0.6 0.0 0.7 0.0 0.0 0.7 0.6 0.1 0.1 0.1 16.7 26.3 4.9 12.5 0.0 1.9 6.8 1.2 5.6 0.1 0.3 2.0 3.0 1.4 8.1 0.2 4.1 29.0 0.3 13.6 0.0 5.4 0.0 8.8 3.3 3.8 2.7 0.1 17.1 1.9 2.2 2.4 16.5 1.2 0.0 0.0 7.4 10.0 6.2 3.4 0.3 6.6 8.6 0.5 1.3 15.4 2.2 4.3 0.1 1.3 0.1 0.1 0.4 5.1 3.1 0.1 0.1 0.3 44.3 6.0 99.4 7.0 3.7 28.9 1.7 11.3 9.6 8.1 1.9 8.4 6.9 87.8 8.2 2.6 1.1 8.4 5.3 0.7 1.0 2.8 0.7 0.7 0.8 1.0 0.7 0.9 0.7 0.8 0.7 2.4 16.0 26.9 0.0 4.9 35.6 21.7 11.8 9.6 0.3 28.2 14.7 1.7 5.7 15.9 9.2 2.1 0.6 9.6 19.6 0.0 10.5 7.4 32.7 4.1 4.9 12.0 0.4 2.2 8.8 0.7 1.6 18.3 34.0 1.3 0.1 2.2 8.2 1.3 0.0 2.3 5.1 14.2 5.1 18.7 7.7 0.0 5.5 10.6 1.9 3.8 0.3 4.1 0.5 0.3 16.7 9.1 0.4 6.6 30.6 9.3 1.1 43.8 1.7 0.0 0.4 2.3 1.7 0.8 14.3 63.9 1.6 44.3 0.2 8.1 46.4 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "intestine: 254.3" "Cell type enriched" "Detected in some" 4 "Distal enterocytes: 1139.3" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: AB_2683491" "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.2 0.0 0.0 10.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 234.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 254.3 0.0 0.0 0.5 0.0 0.0 0.3 4.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1139.3 0.0 0.0 0.4 0.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 255.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.6 0.1 27.8 0.0 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071115 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 93 "bone marrow: 420.2" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 1478 "basophil: 2686.3" "Lineage enriched" "Detected in single" 4507 "granulocytes: 2686.3" "Cell line enhanced" "Detected in some" "HEL: 48.9;K-562: 94.2;NB-4: 109.8;THP-1: 319.0;U-937: 126.2" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.1 0.0 0.0 0.3 0.0 420.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 4.5 0.0 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.9 0.0 0.0 0.0 17.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.2 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 319.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 126.2 0.0 2686.3 0.1 1.8 0.1 0.1 0.3 0.2 0.4 0.0 0.3 0.2 0.2 0.4 0.9 0.1 0.5 0.2 0.1 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 19.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.3 0.0 0.0 0.8 0.0 3.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810063 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 119.6;Theca cells: 114.9" "Cancer enhanced" "Detected in all" "testis cancer: 31.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA Yes 15000 "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavorable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 11.7 22.7 9.3 17.7 13.7 24.0 16.2 15.0 12.7 15.5 12.7 13.0 9.0 27.7 10.2 11.7 17.8 10.9 9.3 8.9 11.5 12.1 19.8 11.6 28.4 12.7 11.7 53.0 31.3 17.0 9.8 20.3 13.0 15.0 12.4 21.6 10.8 15.6 10.5 13.1 9.8 27.2 10.7 12.7 10.9 35.3 11.3 36.3 17.2 11.2 31.0 12.8 12.2 19.9 116.5 77.6 128.4 37.5 42.3 46.3 67.9 63.6 51.1 60.2 59.8 67.2 41.4 158.1 84.5 59.5 82.0 46.0 130.3 74.3 82.1 80.7 69.0 117.0 60.8 71.1 28.8 131.5 37.8 38.6 28.3 60.7 41.6 53.8 40.8 5.3 115.9 69.8 61.8 85.5 144.2 80.1 130.7 81.3 37.7 219.6 204.3 84.7 44.5 76.2 92.8 100.3 79.1 40.4 42.7 124.3 54.6 42.6 33.4 72.2 92.3 54.6 80.6 63.8 79.3 276.2 61.9 77.9 42.4 7.7 3.7 3.8 4.8 6.2 5.5 4.3 5.5 5.0 5.5 4.2 8.4 4.5 2.5 5.9 6.4 2.7 5.3 3.6 9.3 13.7 15.0 12.7 8.9 11.5 12.7 11.7 13.0 10.7 11.3 19.9 19.8 28.9 21.4 5.9 19.2 25.2 22.0 12.3 31.9 25.4 14.4 15.1 8.6 2.8 21.8 7.3 35.5 35.6 20.7 7.4 3.9 15.7 46.4 27.1 31.1 18.4 4.8 47.1 8.5 9.6 21.8 24.0 8.6 31.7 17.7 119.6 13.6 10.2 13.0 15.2 12.1 9.7 20.3 5.6 13.2 17.5 25.4 16.8 3.6 7.5 10.0 22.7 8.2 9.5 27.4 9.1 3.7 22.6 31.1 16.1 2.6 6.7 22.1 31.4 6.6 27.4 33.0 54.3 48.8 22.0 17.5 9.6 19.8 114.9 12.1 11.7 MVB12B "C9orf28, FAM125B, FLJ00001" ENSG00000196814 "Multivesicular body subunit 12B" Q9H7P6 9 126326829-126507041 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 99.3" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 505.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043683, HPA049383" Approved "Golgi apparatus,Vesicles" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Vesicles" "HPA043683: AB_2678616, HPA049383: AB_2680737" "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (6.82e-2)" "unprognostic (9.59e-3)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (4.45e-3)" "unprognostic (4.33e-1)" "unprognostic (1.05e-1)" "prognostic favorable (7.89e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-3)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (5.79e-2)" "unprognostic (1.12e-3)" 5.8 5.2 32.5 4.5 63.6 12.3 4.8 58.6 44.5 6.4 27.6 8.2 3.7 6.8 3.0 4.1 9.9 3.8 5.4 32.0 40.1 4.4 4.2 18.0 6.9 81.1 59.4 6.4 3.2 7.7 8.3 15.0 68.4 6.6 6.2 6.2 3.1 8.4 24.6 5.0 5.5 6.4 57.2 11.1 6.4 5.7 56.7 8.4 5.8 13.0 2.6 7.9 5.0 99.3 4.8 6.5 34.6 19.1 1.2 0.4 20.4 4.0 3.1 7.0 1.3 5.6 0.3 0.0 2.4 3.8 10.3 2.1 10.7 1.9 4.3 8.0 6.7 1.7 1.1 24.6 2.7 3.2 1.5 2.6 3.5 1.4 0.1 5.8 5.4 25.5 0.0 0.0 5.2 3.9 5.3 10.0 7.6 0.8 8.6 7.6 18.9 0.0 0.3 19.5 8.7 15.9 6.4 4.6 4.1 14.4 4.6 19.2 7.9 7.8 5.8 4.4 8.2 0.1 0.0 1.9 2.2 14.2 4.2 0.0 0.8 0.1 1.4 0.2 2.5 0.1 0.6 2.3 1.0 0.2 0.1 1.0 0.0 0.0 0.2 0.0 0.0 0.9 32.5 63.6 58.6 44.5 32.0 40.1 81.1 59.4 68.4 57.2 56.7 99.3 6.3 6.4 7.3 75.4 1.8 3.6 3.2 1.0 6.8 9.4 3.3 3.6 3.6 4.3 1.3 1.8 4.2 12.4 4.7 8.8 0.0 1.6 0.8 6.2 3.0 5.8 2.4 1.7 64.5 1.4 2.6 3.1 2.6 2.4 7.0 5.5 2.2 6.2 1.6 10.1 58.2 2.5 6.1 23.3 6.2 2.7 2.8 10.2 0.0 74.9 3.9 9.1 2.1 56.8 505.6 1.0 5.5 6.4 2.2 1.2 0.9 0.3 6.9 5.3 0.0 2.6 2.7 3.4 6.4 2.9 2.6 3.4 10.9 0.8 3.0 1.6 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750922 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 30.1;tongue: 72.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 7.8;Inhibitory neurons: 7.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 8.0;Proximal tubular cells: 4.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HEL: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 1.2 0.5 0.6 0.3 0.6 0.8 1.0 0.6 0.9 0.6 0.7 0.4 0.3 0.6 0.7 1.3 0.5 0.4 1.4 0.7 0.7 3.0 0.5 1.2 0.4 0.4 0.5 0.4 0.9 0.9 1.3 0.6 0.4 0.7 0.3 0.8 2.4 0.6 30.1 1.4 0.6 0.3 0.4 0.6 0.6 0.4 0.6 0.3 0.8 72.1 0.7 0.6 0.8 0.6 0.1 0.1 0.3 0.6 0.5 0.6 0.3 0.4 0.8 0.2 0.2 0.3 0.6 0.6 0.9 0.4 0.1 1.0 0.1 0.2 0.3 0.1 0.3 7.2 0.4 0.0 0.2 0.2 0.3 0.8 0.3 0.0 0.6 0.3 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.8 0.1 0.2 0.0 0.5 0.0 0.0 0.4 0.1 0.5 0.3 0.1 0.1 0.3 0.5 0.2 0.5 0.4 0.2 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 0.9 0.7 0.7 0.4 0.5 0.4 0.4 0.6 0.6 0.5 3.2 1.1 1.6 0.5 0.1 0.1 0.5 0.6 1.0 0.6 0.3 1.9 1.5 1.0 0.0 0.0 0.3 0.1 0.2 0.0 0.3 0.4 0.1 0.7 0.6 1.2 0.0 7.8 0.2 0.0 0.5 0.0 0.2 0.0 0.6 1.1 0.2 0.3 1.7 7.2 0.0 0.0 0.8 1.2 0.2 0.3 0.4 0.0 4.7 1.1 0.3 0.0 8.0 2.9 0.0 0.0 1.5 0.0 0.2 0.1 4.5 0.3 0.3 0.0 0.8 0.3 0.0 0.3 0.3 0.9 0.3 0.2 0.4 0.3 0.2 MYOM3 FLJ35961 ENSG00000142661 "Myomesin 3" Q5VTT5 1 24056035-24112135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 222.5;skeletal muscle: 321.5;tongue: 255.9" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 198.3" "Cancer enhanced" "Detected in some" "renal cancer: 6.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 4.6;Hep G2: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028132, HPA028340" Approved "Golgi apparatus,Vesicles,Cytokinetic bridge" Yes No 830000 "Cluster 38: Heart - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 54: Cardiomyocytes - Muscle contraction" Vesicles "Golgi apparatus, Cytokinetic bridge" "HPA028132: AB_10599293, HPA028340: " "unprognostic (8.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.39e-1)" "unprognostic (8.60e-3)" "unprognostic (1.52e-2)" "unprognostic (7.31e-2)" "unprognostic (3.00e-2)" "unprognostic (1.40e-2)" "unprognostic (4.66e-1)" "unprognostic (2.21e-1)" "unprognostic (2.73e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.28e-6)" "unprognostic (2.77e-2)" "unprognostic (1.60e-3)" "unprognostic (7.75e-2)" "unprognostic (1.68e-1)" 0.4 0.2 0.0 0.2 0.0 0.0 0.7 0.3 0.1 0.2 0.0 0.6 1.1 0.3 0.0 6.0 0.9 0.4 222.5 0.1 0.1 31.4 0.2 0.3 0.1 0.1 0.1 0.1 1.2 0.0 0.0 0.0 0.1 4.5 0.7 1.2 7.1 0.0 321.5 2.2 5.2 0.2 0.0 0.0 0.2 9.0 0.0 1.7 0.3 255.9 0.1 0.1 0.4 0.2 0.1 4.6 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.3 0.0 1.9 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.8 18.1 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.2 0.1 1.0 0.2 0.5 0.6 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.6 0.2 0.1 0.6 0.0 0.1 0.6 198.3 0.0 0.0 3.7 0.0 0.0 0.1 3.6 1.9 0.1 16.2 0.4 0.0 1.6 1.2 0.0 0.4 0.4 0.0 6.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.7 10.3 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.5 2.4 0.0 0.0 0.2 13.0 33.2 0.0 2.5 6.6 10.0 1.3 0.0 0.2 0.0 0.6 0.0 0.3 2.3 2.2 0.3 MYRIP "DKFZp586F1018, exophilin-8, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 295.6;Inhibitory neurons: 507.3;Microglial cells: 210.8;Oligodendrocyte precursor cells: 98.0" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.1;HUVEC TERT2: 15.6;REH: 3.7;SCLC-21H: 3.2;SH-SY5Y: 9.4;T-47d: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 4.1 1.0 16.8 1.3 13.3 0.0 3.7 11.1 18.4 5.7 15.4 2.7 1.7 3.2 2.2 1.3 2.8 2.7 2.4 17.3 7.7 1.5 11.5 0.8 1.6 9.2 17.8 3.1 8.9 2.1 2.9 0.1 13.0 2.0 2.6 4.3 12.5 0.8 1.7 1.2 2.4 2.3 4.2 7.2 5.6 0.9 12.0 0.5 1.5 0.5 1.7 1.4 2.6 15.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.1 3.7 0.0 0.0 0.4 2.0 3.2 9.4 0.0 0.0 0.0 0.0 3.8 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 13.3 11.1 18.4 17.3 7.7 9.2 17.8 13.0 4.2 12.0 15.0 15.8 0.0 3.2 36.2 0.4 0.8 0.1 0.0 1.2 2.7 0.5 0.3 2.4 5.7 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.1 19.9 1.1 0.7 21.3 0.0 1.7 295.6 2.8 0.0 1.6 3.1 6.2 2.5 14.0 42.8 17.4 0.0 5.0 507.3 11.9 0.0 2.8 0.7 6.1 0.9 0.1 0.0 210.8 0.0 6.6 0.0 98.0 24.5 0.6 0.1 0.0 0.0 1.4 0.1 1.8 0.1 4.2 0.0 0.3 0.7 3.1 0.6 0.1 0.6 0.0 0.3 0.1 0.7 0.1 MZB1 "HSPC190, MEDA-7, MGC29506, PACAP, pERp1" ENSG00000170476 "Marginal zone B and B1 cell specific protein" Q8WU39 5 139387467-139390081 "Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 89.8;lymphoid tissue: 272.2" "Cell type enriched" "Detected in many" 6 "Plasma cells: 4000.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 160.4;plasmacytoid DC: 569.3" "Group enriched" "Detected in many" 116 "B-cells: 160.4;dendritic cells: 569.3" "Group enriched" "Detected in some" 5 "Karpas-707: 581.5;RPMI-8226: 2193.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043745, HPA052694" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 350000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA043745: AB_10960359, HPA052694: AB_2681919" "unprognostic (4.97e-3)" "unprognostic (1.75e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.27e-4)" "unprognostic (2.21e-2)" "prognostic favorable (4.60e-5)" "unprognostic (6.57e-2)" "unprognostic (1.35e-1)" "unprognostic (6.45e-3)" "unprognostic (7.10e-3)" "unprognostic (2.57e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.15e-8)" "unprognostic (7.22e-2)" "unprognostic (3.14e-1)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" 4.4 9.1 0.0 87.4 0.1 33.0 21.0 0.0 0.7 18.3 0.2 70.1 89.8 1.8 0.4 10.1 5.7 14.3 2.3 0.0 0.0 5.9 5.8 15.9 123.2 0.1 0.0 4.9 1.3 0.0 0.7 0.0 0.1 5.1 39.9 0.0 56.7 4.9 0.1 0.4 47.8 2.1 0.4 272.2 66.6 2.4 0.1 147.3 9.1 0.0 117.8 58.7 3.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 256.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 144.6 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 128.5 0.5 581.5 0.0 0.0 227.8 2.2 0.0 0.0 0.0 90.1 0.3 2193.9 0.0 0.0 0.3 0.8 0.0 11.4 0.0 0.0 3.1 0.1 0.6 0.0 1.8 0.1 0.0 262.0 16.7 223.0 0.1 0.4 0.0 0.0 0.1 0.1 1.5 0.1 3.0 160.4 0.6 1.1 0.5 75.6 0.1 0.2 3.1 2.7 0.0 569.3 0.2 26.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.3 0.4 6.4 10.1 0.0 665.7 2.5 1.3 0.1 0.0 0.0 3.7 3.2 1.1 4.3 2.0 0.0 0.0 0.1 235.0 0.9 0.0 0.1 0.1 1.8 0.4 2.0 1.2 49.3 0.0 0.0 0.1 2.0 6.1 0.4 2.5 0.1 11.4 14.0 0.1 0.0 0.0 1.1 0.0 7.1 3.4 1.1 0.0 4.7 540.7 0.0 1.0 0.0 4.1 0.0 0.0 0.1 0.4 0.0 4000.1 3.0 1.2 1.9 1.2 0.0 0.0 1.7 2.1 0.1 0.1 0.4 2.4 2.2 100.7 0.5 9.7 0.4 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N-alpha-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326061 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 2.6;placenta: 4.2;testis: 6.2" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 19.4;Early spermatids: 30.6;Extravillous trophoblasts: 16.4;Late spermatids: 23.9;Spermatocytes: 25.1;Spermatogonia: 15.9;Syncytiotrophoblasts: 13.3" "Cancer enriched" "Detected in some" 4 "testis cancer: 2.1" "Region enriched" "Detected in single" 5 "cerebellum: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "GAMG: 19.3;K-562: 12.3;U-266/70: 32.9;U-266/84: 11.3" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 2.6 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.0 0.0 4.2 0.3 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 6.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.3 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.0 32.9 11.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.6 0.1 0.1 0.2 0.5 0.4 0.3 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 15.9 0.0 0.0 13.3 0.0 0.0 0.0 0.0 NAA25 "C12orf30, FLJ13089" ENSG00000111300 "N-alpha-acetyltransferase 25, NatB auxiliary subunit" Q14CX7 12 112026689-112108796 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039322 Approved Supported "Golgi apparatus,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus, Cytosol" "HPA039322: AB_10697548" "unprognostic (1.26e-1)" "unprognostic (1.31e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (9.09e-3)" "unprognostic (3.24e-2)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (8.34e-2)" "prognostic unfavorable (1.32e-8)" "unprognostic (2.44e-2)" "unprognostic (2.01e-1)" "unprognostic (9.34e-2)" "unprognostic (9.18e-2)" 5.5 6.1 4.6 6.0 5.0 9.8 6.8 6.4 8.1 6.8 8.5 6.8 3.9 5.5 4.3 7.6 5.8 3.7 5.6 5.3 5.1 4.6 5.6 4.9 6.6 5.6 4.7 7.0 6.9 5.9 4.3 5.3 7.7 5.4 4.2 14.8 4.9 4.4 14.9 7.5 4.8 5.4 3.6 5.3 4.9 5.1 4.9 6.0 5.7 9.9 6.9 6.4 6.7 8.0 16.7 16.1 14.8 11.9 8.1 14.0 17.9 15.3 12.4 18.3 12.4 16.2 8.6 28.9 14.4 12.3 10.5 19.2 32.8 13.0 25.1 16.6 22.9 23.6 15.9 15.0 13.2 34.0 13.7 12.1 15.9 21.3 21.8 15.5 16.1 12.6 35.3 3.7 16.7 13.5 19.6 24.9 22.1 34.2 18.6 21.5 15.2 19.7 14.0 27.0 19.1 10.5 16.9 19.8 15.0 14.0 19.3 13.4 13.7 15.2 13.6 17.0 21.3 15.0 30.4 33.0 19.4 14.7 15.5 0.0 1.7 0.5 2.4 1.9 3.7 2.5 3.0 2.3 3.5 2.8 4.2 4.1 0.0 1.6 2.5 3.7 2.5 1.6 4.6 5.0 6.4 8.1 5.3 5.1 5.6 4.7 7.7 3.6 4.9 8.0 16.1 9.6 16.2 44.1 23.3 66.7 34.5 17.1 22.8 38.9 18.9 12.4 23.5 12.8 26.5 7.3 146.0 25.6 20.4 10.1 3.9 15.3 26.5 15.1 23.9 17.4 16.2 17.0 71.6 19.4 21.6 17.8 15.8 14.8 20.3 20.7 15.4 19.4 14.0 23.5 68.0 11.9 28.5 15.4 25.2 8.6 17.4 16.5 16.0 30.0 83.8 13.0 12.3 48.2 109.6 17.4 7.5 12.8 15.7 61.5 7.4 4.7 25.0 67.7 6.6 28.7 22.7 31.5 29.5 28.5 70.2 22.6 15.3 20.0 14.7 48.1 NAB1 ENSG00000138386 "NGFI-A binding protein 1" Q13506 2 190646746-190692766 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 102.0;Suprabasal keratinocytes: 138.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002738 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 28: Keratinocytes - Keratinization" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "HPA002738: AB_1079447" "unprognostic (1.44e-1)" "unprognostic (2.65e-2)" "unprognostic (6.02e-3)" "unprognostic (4.04e-3)" "unprognostic (9.05e-2)" "unprognostic (9.45e-2)" "unprognostic (7.12e-3)" "unprognostic (6.41e-2)" "unprognostic (2.13e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.52e-1)" "unprognostic (7.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (3.85e-2)" 29.3 20.3 19.4 23.5 16.7 18.6 34.8 50.4 23.5 28.1 7.4 22.8 15.8 32.3 50.1 36.3 27.5 28.0 28.5 18.7 9.7 19.9 37.8 22.8 26.8 13.4 13.2 26.0 17.9 23.5 21.1 26.4 14.9 18.5 25.6 41.4 20.7 20.9 8.0 66.7 17.1 25.2 14.9 19.8 37.9 26.0 13.8 21.2 37.9 17.2 26.3 31.2 24.2 25.9 35.5 25.8 65.0 22.6 24.5 42.7 111.0 35.5 55.7 26.4 29.8 62.8 38.4 39.6 40.6 28.3 48.9 88.4 37.4 45.9 51.8 126.1 31.0 46.7 96.3 30.2 15.8 19.8 22.4 24.6 70.4 55.9 17.1 37.4 41.5 23.9 46.3 33.2 40.6 17.4 28.7 20.0 22.8 38.4 35.2 35.0 46.7 15.9 19.3 34.5 57.9 46.9 41.8 13.9 37.3 82.8 11.4 30.6 29.0 54.5 43.0 31.0 21.6 25.7 30.3 29.5 57.3 17.6 43.7 0.0 1.3 0.6 1.3 1.1 1.9 0.7 1.3 1.7 0.9 0.4 1.4 1.5 2.9 2.6 3.7 0.8 3.3 0.8 19.4 16.7 50.4 23.5 18.7 9.7 13.4 13.2 14.9 14.9 13.8 25.9 24.1 6.4 21.2 14.0 5.9 102.0 23.1 24.6 31.3 26.1 19.7 19.7 18.2 11.5 29.8 12.9 12.5 4.3 9.2 11.4 3.9 10.3 1.4 17.5 10.8 30.1 14.4 12.0 37.2 8.0 11.1 25.2 21.4 23.4 20.3 14.2 44.6 25.7 6.7 6.7 21.2 17.5 14.2 17.3 77.4 3.2 13.4 20.7 39.2 24.4 10.6 12.4 11.3 29.1 28.3 10.2 26.3 14.7 14.9 30.5 4.8 5.1 22.3 15.5 46.0 24.6 39.2 1.7 27.3 55.7 138.9 1.2 16.7 7.3 16.0 29.9 NADSYN1 FLJ10631 ENSG00000172890 "NAD synthetase 1" Q6IA69 11 71453109-71524107 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017798, HPA038523, HPA038524" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 45: Enterocytes - Digestion" Vesicles "Golgi apparatus, Cytosol" "CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" "unprognostic (7.30e-2)" "unprognostic (2.63e-3)" "unprognostic (1.75e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.17e-6)" "unprognostic (1.19e-2)" "unprognostic (4.38e-2)" "unprognostic (1.41e-1)" "unprognostic (9.41e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (4.12e-3)" "unprognostic (1.38e-1)" "unprognostic (1.54e-2)" "prognostic favorable (5.10e-4)" 29.5 34.1 18.8 24.1 20.4 67.6 26.2 18.5 21.2 30.4 20.3 48.6 39.5 26.0 24.2 56.3 31.2 25.8 20.3 17.8 18.3 33.2 49.8 35.3 33.3 22.4 19.6 27.6 29.5 13.4 36.0 16.5 21.0 45.3 36.0 6.9 32.9 22.8 11.0 31.1 51.1 19.3 18.8 58.4 34.3 25.6 21.7 27.9 31.8 5.1 28.2 43.4 33.4 24.4 15.9 37.8 12.0 21.6 35.0 50.6 32.4 29.7 27.2 15.4 17.0 32.4 25.7 13.4 33.1 35.3 20.7 55.2 15.9 42.6 8.2 27.9 12.8 22.2 27.6 36.3 43.3 45.1 40.9 72.0 65.8 19.9 17.8 34.9 54.6 24.2 11.9 18.5 21.9 49.7 22.4 29.9 7.0 69.6 21.3 27.5 37.2 13.5 37.8 72.1 8.9 12.7 21.2 27.9 56.0 17.9 24.9 24.4 66.2 16.7 14.2 30.9 11.8 24.3 11.0 11.7 29.9 25.6 12.0 6.1 28.0 17.3 15.3 25.0 12.7 12.2 13.5 13.8 31.1 9.2 8.8 11.4 17.7 16.3 22.6 23.0 17.7 21.4 18.8 20.4 18.5 21.2 17.8 18.3 22.4 19.6 21.0 18.8 21.7 24.4 12.6 22.4 32.3 4.2 24.0 6.2 17.8 18.4 26.2 7.8 13.5 10.9 8.3 12.8 19.8 11.0 4.2 17.4 27.3 65.3 3.9 16.5 22.6 21.1 11.1 15.6 23.4 20.2 5.1 17.3 14.5 12.8 51.0 19.7 22.1 23.1 13.9 16.7 20.1 13.5 5.8 30.3 16.2 23.2 18.5 60.9 9.3 25.4 8.8 8.4 25.8 5.9 29.9 7.5 18.5 20.0 55.8 10.1 18.0 17.9 73.3 16.2 16.5 7.3 13.1 9.6 9.8 15.9 5.0 38.3 12.8 17.2 22.3 17.1 43.7 24.2 NAPRT "NAPRT1, PP3856" ENSG00000147813 "Nicotinate phosphoribosyltransferase" Q6XQN6 8 143574785-143578649 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Ligase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 63.1" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 597.2;Proximal tubular cells: 203.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 49.8;RPMI-8226: 73.4;SK-BR-3: 84.1" "Low region specificity" "Detected in all" "HPA023739, HPA024017, CAB068206, CAB068207" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 2300000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309" "unprognostic (7.08e-2)" "unprognostic (1.55e-1)" "unprognostic (5.76e-3)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.30e-1)" "unprognostic (7.65e-2)" "unprognostic (2.19e-1)" "unprognostic (2.84e-1)" "unprognostic (1.08e-2)" "unprognostic (1.75e-1)" "unprognostic (4.13e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.02e-2)" "unprognostic (3.97e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-2)" 15.7 13.6 4.1 6.3 4.7 21.9 14.6 3.9 8.7 15.8 4.6 22.2 61.4 9.7 1.7 37.1 10.6 5.8 10.8 4.3 4.8 15.7 63.1 13.8 6.6 5.4 4.1 9.6 12.4 5.0 6.0 5.4 4.0 11.3 3.9 0.2 29.2 10.5 10.1 27.9 47.3 2.9 4.4 19.4 22.5 10.5 4.7 4.1 9.8 4.6 5.2 13.2 18.1 5.6 14.8 7.2 0.6 1.4 3.2 2.0 4.0 0.7 7.5 4.5 1.7 5.6 34.3 1.8 7.8 0.5 0.0 25.6 1.8 34.6 0.4 4.3 12.1 16.7 25.5 1.9 42.5 2.1 14.8 3.2 16.6 0.3 0.0 0.1 18.1 32.9 21.5 8.8 0.1 11.1 6.7 8.0 5.6 49.8 4.2 13.8 0.3 73.4 16.0 2.0 7.4 0.9 9.1 84.1 30.7 0.6 2.1 20.3 3.8 0.9 10.1 8.0 2.9 0.8 0.8 3.1 1.8 41.8 16.1 6.9 11.4 14.1 2.9 12.7 1.9 2.0 4.4 1.9 6.7 1.3 1.3 2.4 10.6 0.8 23.0 6.9 1.9 5.8 4.1 4.7 3.9 8.7 4.3 4.8 5.4 4.1 4.0 4.4 4.7 5.6 50.6 35.3 23.1 7.5 16.2 0.0 64.9 0.0 24.5 12.1 18.3 14.7 10.0 54.3 9.3 75.4 18.8 48.8 21.8 88.0 68.4 62.7 44.2 18.5 26.0 32.7 10.9 63.8 3.8 54.3 74.8 20.6 100.9 26.8 7.6 21.7 49.6 117.4 80.6 16.8 3.2 70.4 0.0 89.7 0.0 59.8 32.0 55.0 0.0 7.5 108.9 23.7 28.8 1.5 2.8 111.7 124.6 21.8 12.7 44.2 597.2 203.7 1.5 13.4 13.1 15.8 16.5 41.7 16.0 35.9 0.0 56.2 17.2 29.7 100.9 73.9 NBAS NAG ENSG00000151779 "NBAS subunit of NRZ tethering complex" A2RRP1 2 15166914-15561334 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 217.8;Inhibitory neurons: 187.9;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (5.84e-5)" 16.8 21.0 37.4 7.2 38.8 16.1 15.9 37.7 42.7 18.8 35.7 22.7 8.2 18.4 13.7 17.2 18.8 8.1 38.3 37.2 36.3 19.9 21.6 15.8 9.4 37.0 35.2 22.5 34.4 16.3 29.6 10.1 38.7 19.0 10.5 13.4 15.4 10.4 30.5 21.8 20.1 11.8 34.4 21.1 24.5 41.2 37.2 14.5 17.4 17.7 9.1 19.7 16.5 38.1 10.5 13.7 14.8 10.7 37.8 41.5 15.2 19.1 20.8 14.5 14.6 13.8 15.0 13.4 4.3 29.3 15.1 12.5 16.5 23.9 17.2 13.5 10.4 51.3 11.5 38.8 38.8 13.4 25.1 27.3 18.9 19.2 32.8 30.2 30.4 18.7 40.6 15.0 22.4 13.0 11.2 30.1 12.8 17.1 12.8 11.7 26.0 16.2 30.5 14.0 8.7 14.2 16.2 13.4 25.2 18.3 9.4 12.0 26.6 18.5 11.2 13.5 13.9 22.1 20.3 18.7 33.1 15.5 16.8 1.5 4.4 2.5 5.7 3.1 6.7 4.1 4.2 7.3 4.0 3.4 4.2 4.3 0.8 7.2 7.5 4.5 5.3 2.9 37.4 38.8 37.7 42.7 37.2 36.3 37.0 35.2 38.7 34.4 37.2 38.1 16.1 19.2 13.8 96.6 15.1 7.4 9.3 11.9 12.0 17.3 11.7 9.4 32.3 17.2 13.8 18.4 29.2 11.5 15.1 9.4 0.0 11.1 39.3 22.2 21.3 14.6 7.3 38.7 217.8 14.0 13.1 13.4 20.9 14.8 38.6 30.2 8.9 9.1 9.0 13.5 187.9 14.8 10.2 6.9 8.0 61.9 11.5 11.6 5.4 106.8 18.4 12.5 9.2 159.3 159.2 8.6 9.5 16.6 27.2 9.2 39.3 8.5 26.0 25.5 0.0 24.7 16.3 33.7 22.4 12.9 11.2 10.4 19.9 70.0 12.5 7.6 NBEA "BCL8B, FLJ10197, KIAA1544, LYST2" ENSG00000172915 Neurobeachin Q8NFP9 13 34942270-35673022 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 23.5;retina: 65.7" "Group enriched" "Detected in many" 4 "Excitatory neurons: 1016.1;Inhibitory neurons: 953.0;Oligodendrocyte precursor cells: 466.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 33.1;SH-SY5Y: 80.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039730, HPA040385" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA039730: AB_10794202, HPA040385: AB_10795523" "unprognostic (1.80e-2)" "unprognostic (2.90e-1)" "unprognostic (4.99e-2)" "unprognostic (3.89e-4)" "unprognostic (3.59e-1)" "unprognostic (2.04e-1)" "unprognostic (8.75e-2)" "unprognostic (6.95e-3)" "unprognostic (5.01e-1)" "unprognostic (7.43e-2)" "unprognostic (1.03e-3)" "unprognostic (2.45e-1)" "prognostic favorable (7.86e-8)" "unprognostic (2.28e-2)" "unprognostic (9.35e-2)" "unprognostic (1.17e-1)" "unprognostic (6.46e-2)" 2.4 7.2 7.7 1.5 10.7 0.3 4.9 19.0 23.5 3.5 2.8 5.8 1.4 6.1 2.2 3.3 5.5 3.4 6.9 17.4 2.8 4.1 0.6 2.0 1.6 4.1 0.1 6.2 3.1 7.1 8.3 0.6 4.8 6.6 2.5 65.7 4.7 8.4 5.6 1.5 2.5 6.5 0.4 3.2 2.7 3.5 0.0 5.6 6.3 5.7 1.2 3.6 2.8 4.5 0.0 4.5 10.9 6.1 0.7 0.1 0.3 7.0 10.8 7.9 6.6 0.1 1.0 3.0 0.0 12.9 4.7 0.3 3.7 1.5 16.3 1.4 3.6 0.0 3.4 1.2 0.5 1.9 4.7 2.1 1.2 0.1 0.7 33.1 1.8 1.2 0.1 17.6 1.1 1.9 1.1 0.0 4.6 6.2 2.0 1.1 4.7 0.9 9.3 2.1 6.2 80.1 5.4 0.1 3.6 8.1 2.0 0.4 0.1 2.0 1.2 0.0 1.6 1.9 0.5 1.3 5.4 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 7.7 10.7 19.0 23.5 17.4 2.8 4.1 0.1 4.8 0.4 0.0 4.5 19.7 28.9 9.2 132.9 5.2 1.0 5.3 2.7 1.2 124.8 5.0 6.5 51.8 11.5 14.1 9.2 146.0 0.1 4.4 0.3 1.9 9.2 19.3 5.6 18.4 10.1 22.9 0.8 1016.1 1.8 0.1 12.3 2.0 0.6 25.2 20.7 11.0 0.3 0.9 47.1 953.0 2.1 6.1 3.5 3.9 13.6 17.7 3.5 7.2 150.9 1.2 69.1 0.0 466.9 163.7 2.3 0.1 19.2 5.8 8.5 0.2 7.6 56.5 87.0 6.6 22.2 13.1 8.5 8.0 0.3 0.9 0.0 1.2 11.9 1.1 13.5 NBN "AT-V1, AT-V2, ATV, NBS, NBS1" ENSG00000104320 Nibrin O60934 8 89933331-90003228 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 265.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001429, CAB003836" Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" Nucleoplasm "CAB003836: AB_562172, HPA001429: AB_1854460" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-3)" "unprognostic (7.46e-2)" "unprognostic (2.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (5.05e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.15e-1)" "unprognostic (6.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.28e-1)" "unprognostic (2.84e-2)" "unprognostic (1.03e-1)" 22.5 12.4 9.2 27.8 12.8 54.0 25.4 9.3 10.0 16.9 7.4 18.3 15.1 22.3 11.4 20.0 14.5 22.5 12.1 10.2 12.5 20.7 22.3 18.1 24.3 10.7 8.6 16.9 15.5 15.4 9.0 14.1 9.9 17.5 22.5 9.8 16.6 14.9 10.0 10.3 16.0 24.2 11.0 23.4 12.7 16.4 11.0 19.0 22.7 16.2 26.4 21.8 9.6 15.0 54.8 30.1 29.3 15.6 16.5 38.7 18.9 37.9 49.5 46.6 50.8 17.2 41.8 83.8 42.2 35.5 19.1 17.7 35.7 35.7 59.8 38.0 19.7 67.7 16.8 23.6 30.8 40.0 35.2 30.5 18.3 27.2 57.9 22.8 39.5 33.9 50.6 46.6 55.3 46.9 65.6 26.0 8.5 39.5 31.4 42.3 25.3 47.0 62.8 73.8 8.1 26.6 23.5 265.1 23.1 16.3 49.8 31.4 29.2 40.9 28.0 25.5 38.0 21.2 25.0 45.5 41.3 39.4 39.1 32.4 17.7 32.9 11.9 19.7 12.7 15.2 8.5 8.8 18.9 8.9 8.1 9.0 34.4 16.1 31.5 10.4 5.9 13.1 9.2 12.8 9.3 10.0 10.2 12.5 10.7 8.6 9.9 11.0 11.0 15.0 36.9 48.1 14.2 24.5 39.8 11.9 13.5 20.4 23.9 25.4 29.7 22.9 30.3 14.3 33.7 27.6 2.1 23.0 29.3 11.2 43.0 35.1 17.6 45.4 46.9 22.9 12.1 31.7 45.0 32.0 19.7 36.3 19.9 31.2 79.7 38.3 18.9 30.6 25.9 13.5 39.9 16.9 16.2 29.2 27.1 7.2 19.0 51.1 12.4 32.8 54.7 29.4 36.0 40.7 40.3 24.7 9.9 26.4 38.8 11.6 9.9 40.5 36.4 11.2 6.6 50.3 31.7 20.2 46.0 31.5 13.5 10.8 35.3 68.7 19.4 11.0 NCKAP5 "ERIH1, ERIH2, NAP5" ENSG00000176771 "NCK associated protein 5" O14513 2 132671788-133568463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 34.8;lung: 11.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 262.8;Astrocytes: 478.6;Oligodendrocyte precursor cells: 774.6;Oligodendrocytes: 2156.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034639, HPA044859" Uncertain Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoli "Golgi apparatus, Plasma membrane, Cytosol" "HPA034639: AB_10669678, HPA044859: AB_2679114" "unprognostic (2.54e-1)" "unprognostic (1.95e-2)" "unprognostic (2.30e-2)" "unprognostic (2.58e-2)" "unprognostic (2.49e-2)" "unprognostic (3.13e-1)" "unprognostic (7.07e-2)" "unprognostic (1.90e-1)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.46e-1)" "unprognostic (2.93e-1)" "unprognostic (1.06e-11)" "unprognostic (4.56e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.03e-1)" 1.9 1.0 9.6 0.5 31.3 0.0 3.0 18.6 12.3 1.2 2.5 1.2 2.2 0.4 0.6 4.0 0.4 0.7 2.6 9.5 14.5 4.1 3.9 11.4 1.3 23.4 28.6 2.4 0.9 0.6 0.6 2.6 22.9 0.8 1.0 4.7 2.1 0.3 0.5 2.1 3.2 0.4 10.1 1.7 1.7 1.1 28.6 0.8 1.1 0.6 1.0 0.5 2.0 34.8 0.0 2.2 46.2 0.0 0.1 0.4 0.2 0.7 8.3 0.7 0.8 0.0 0.1 3.6 0.0 0.5 0.5 0.2 0.3 0.7 2.5 0.0 0.3 0.0 7.1 0.0 0.0 0.0 0.0 0.5 3.8 4.4 0.6 7.2 0.8 0.0 0.0 0.0 1.3 0.5 0.0 0.0 1.1 0.3 1.4 0.4 0.0 1.9 1.1 1.1 0.2 1.4 0.0 1.7 2.4 0.4 0.7 0.0 2.4 0.3 0.4 6.7 0.1 0.2 0.0 1.3 0.4 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 31.3 18.6 12.3 9.5 14.5 23.4 28.6 22.9 10.1 28.6 34.8 6.0 262.8 13.3 478.6 0.6 8.9 0.7 1.4 15.4 179.6 14.5 10.8 16.8 0.0 28.6 1.8 41.7 0.1 0.1 5.3 3.9 0.3 6.8 1.1 1.1 2.9 3.6 0.0 16.4 0.2 0.2 6.8 7.7 1.4 1.3 0.0 0.7 6.3 0.6 33.7 41.3 5.4 10.2 7.9 32.2 3.3 26.4 6.2 1.8 147.1 4.1 56.9 0.0 774.6 2156.8 1.0 5.2 7.5 0.0 0.5 20.7 14.0 1.2 7.8 6.6 8.7 24.7 0.1 1.3 15.5 2.8 0.0 0.7 0.0 1.6 1.5 NCOA4 "ARA70, DKFZp762E1112, ELE1, PTC3, RFG" ENSG00000266412 "Nuclear receptor coactivator 4" Q13772 10 46005088-46030623 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 476.2;Macrophages: 316.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 251.9;granulocytes: 839.6;monocytes: 363.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051260, HPA065208" Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 51: Myeloid cells - Hemostasis" Nucleoli "Golgi apparatus, Cytosol" "HPA051260: AB_2681412, HPA065208: AB_2685432" "unprognostic (4.23e-2)" "unprognostic (1.50e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.34e-1)" "unprognostic (1.80e-1)" "unprognostic (9.34e-2)" "unprognostic (4.67e-2)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.04e-2)" "prognostic favorable (8.04e-6)" "unprognostic (1.35e-1)" "unprognostic (4.71e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" 117.1 67.8 45.6 91.5 52.5 189.5 96.9 56.1 50.9 85.1 50.7 110.3 249.7 70.2 74.6 110.3 62.6 87.8 156.8 40.6 55.8 159.7 372.9 108.3 102.6 52.4 53.5 65.5 64.6 97.9 25.2 131.3 53.6 132.2 115.7 33.7 79.2 78.7 163.5 71.1 155.9 98.3 52.6 148.1 90.3 43.6 51.6 124.4 87.0 193.6 150.3 104.6 46.8 60.0 142.7 58.5 68.0 70.4 176.9 159.4 170.3 128.3 204.8 122.1 119.6 91.0 102.3 161.2 149.2 211.2 69.1 141.8 72.6 142.3 137.1 114.4 74.1 108.4 74.3 263.5 124.0 279.9 229.7 156.1 139.2 104.2 175.7 131.6 185.5 79.5 119.7 93.5 171.9 64.0 136.1 104.3 41.4 110.2 34.8 79.5 99.3 96.7 148.9 119.4 68.2 46.1 128.9 146.2 131.5 133.5 105.7 135.3 171.6 75.8 89.9 81.3 87.5 69.3 79.1 156.9 94.6 231.2 41.2 692.1 363.6 611.8 78.9 223.6 86.2 57.6 73.3 74.9 251.9 53.8 78.2 66.4 839.6 119.0 275.3 77.4 92.8 559.4 45.6 52.5 56.1 50.9 40.6 55.8 52.4 53.5 53.6 52.6 51.6 60.0 44.5 51.3 95.2 13.4 44.6 49.5 39.3 126.2 50.7 14.3 49.6 38.5 161.3 45.8 96.2 44.1 29.2 104.7 58.2 108.8 80.3 45.3 105.4 45.1 37.7 52.9 26.9 476.2 17.4 51.8 107.2 45.3 42.3 56.9 195.2 28.2 55.3 166.7 181.4 20.2 20.5 45.4 59.0 254.5 74.2 72.4 37.3 316.1 51.6 16.9 158.4 38.2 44.3 18.6 22.9 47.8 63.9 47.4 37.6 62.0 162.5 128.8 59.7 13.0 13.1 36.7 46.7 24.5 16.5 71.9 56.7 158.2 41.3 60.7 71.3 52.0 NCOA7 "dJ187J11.3, ERAP140, TLDC4" ENSG00000111912 "Nuclear receptor coactivator 7" Q8NI08 6 125781161-125932034 "Predicted intracellular proteins, Transporters" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030289, HPA030290, HPA030291, HPA030292" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 15: RT4 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834" "unprognostic (1.01e-2)" "unprognostic (3.21e-2)" "unprognostic (7.32e-3)" "unprognostic (7.27e-3)" "unprognostic (1.54e-1)" "unprognostic (4.67e-2)" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (2.73e-1)" "unprognostic (2.14e-1)" "unprognostic (6.08e-2)" "unprognostic (4.37e-2)" "prognostic favorable (1.78e-6)" "unprognostic (2.10e-1)" "unprognostic (2.58e-1)" "unprognostic (1.14e-1)" "unprognostic (8.10e-2)" 53.9 60.4 19.5 45.8 30.6 42.7 27.4 21.4 50.2 29.0 0.0 30.1 33.0 22.3 5.2 30.4 15.9 46.6 16.0 28.2 23.9 56.6 32.9 52.1 30.1 47.5 12.3 14.8 19.9 8.8 29.7 12.9 45.0 18.6 29.2 18.2 38.2 12.9 6.9 11.1 39.2 28.3 10.6 24.4 30.8 7.8 19.0 21.7 25.1 9.2 28.5 101.8 19.7 48.3 13.7 36.6 2.2 16.0 78.2 46.3 23.7 18.2 71.9 22.1 30.1 34.3 12.7 55.2 96.5 10.0 108.0 78.7 12.6 12.4 13.3 120.2 16.5 28.0 43.7 12.3 44.5 16.4 25.4 33.3 29.4 21.1 16.3 39.1 46.7 18.0 38.7 30.6 13.9 13.7 16.1 16.2 2.7 33.8 7.6 12.3 5.7 10.3 39.1 90.4 36.9 33.5 93.7 22.6 42.1 6.5 3.8 19.3 27.7 5.1 10.9 26.3 14.1 39.9 34.1 28.8 11.5 21.2 18.7 17.0 11.4 4.0 19.2 9.1 24.1 17.7 18.1 15.6 10.0 11.1 9.6 9.4 6.4 13.6 14.2 34.1 8.1 5.1 19.5 30.6 21.4 50.2 28.2 23.9 47.5 12.3 45.0 10.6 19.0 48.3 144.6 314.1 371.9 27.7 33.7 98.1 270.8 311.2 709.7 50.2 94.2 47.9 11.4 98.7 324.1 62.5 43.8 9.3 84.6 113.2 80.3 241.7 0.9 160.1 90.2 130.2 35.8 29.8 144.9 139.2 8.9 94.8 142.8 298.2 37.3 18.5 106.7 23.2 13.6 37.0 89.5 119.3 288.9 33.8 57.4 6.8 42.3 41.9 51.6 75.9 33.4 76.8 59.8 34.2 303.9 108.7 160.1 29.3 44.1 129.5 24.3 103.2 335.8 53.3 13.1 33.8 49.3 11.2 33.9 515.9 59.2 3.8 63.5 36.5 130.6 294.4 NECAB3 "APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51" ENSG00000125967 "N-terminal EF-hand calcium binding protein 3" Q96P71 20 33657087-33674463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044785, HPA070595, HPA071786" Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186" "unprognostic (8.95e-2)" "unprognostic (1.45e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.44e-1)" "unprognostic (4.05e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.19e-5)" "unprognostic (3.13e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (6.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-1)" 10.2 55.9 20.1 2.2 21.2 1.5 10.4 18.9 33.9 11.8 20.4 14.4 13.6 9.1 6.9 8.9 10.9 4.5 45.7 21.7 21.2 13.3 13.3 11.1 2.3 23.3 19.1 41.2 19.1 17.5 10.3 3.9 24.4 27.2 4.4 6.5 13.6 7.8 60.3 6.9 10.6 3.7 16.6 6.5 30.5 10.6 23.2 1.9 19.2 31.7 1.7 14.6 10.0 22.3 8.2 7.1 5.1 10.5 4.0 7.8 24.6 11.2 4.2 7.1 6.2 33.2 5.3 9.1 26.2 6.6 16.7 9.7 5.3 3.3 2.6 3.2 7.7 8.7 30.7 39.3 10.5 2.1 8.0 9.7 4.8 6.6 2.1 7.6 4.8 4.8 12.6 4.8 9.3 12.5 3.3 8.6 2.2 8.7 17.5 9.7 13.3 15.9 6.6 6.1 32.4 9.0 26.1 28.7 12.0 5.6 36.6 10.4 4.0 8.6 12.4 11.3 12.7 17.7 7.8 17.1 16.9 4.0 3.8 0.0 1.3 1.8 0.3 1.3 0.9 0.2 0.6 0.3 1.2 0.9 0.4 0.1 0.0 1.2 3.5 0.0 1.6 0.6 20.1 21.2 18.9 33.9 21.7 21.2 23.3 19.1 24.4 16.6 23.2 22.3 5.4 16.0 45.5 14.7 4.1 3.1 6.5 2.7 8.6 19.4 20.5 11.6 29.9 10.0 5.9 5.5 8.4 20.6 3.8 22.5 33.2 3.7 93.1 5.7 7.2 2.4 19.9 4.0 13.0 7.5 26.1 12.5 26.5 5.4 3.8 14.0 2.2 9.1 8.9 8.4 14.5 16.2 4.1 6.0 6.2 54.0 26.4 5.5 12.4 1.0 3.6 18.2 2.1 6.0 4.5 4.4 15.1 23.7 11.7 14.2 45.9 12.2 3.8 20.8 6.6 9.2 12.1 20.5 20.6 9.3 3.1 20.7 5.4 23.9 20.0 10.0 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305205 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 231.8;Excitatory neurons: 124.5;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 439.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 390000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 12: NES - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 9.6 7.4 28.9 8.9 43.8 1.5 16.7 38.1 31.4 18.2 10.7 46.0 27.3 19.6 9.9 11.5 21.9 19.6 7.8 29.4 29.2 23.4 8.7 15.9 3.9 34.6 38.0 24.8 17.2 41.8 6.7 1.7 35.6 33.0 55.1 19.5 18.3 36.0 30.9 37.5 26.5 23.3 28.7 5.3 22.9 13.5 36.6 7.2 18.2 24.8 6.2 10.5 9.6 60.0 8.9 42.9 50.1 33.2 29.6 8.6 12.5 3.3 4.1 8.2 1.7 6.4 42.8 2.5 4.9 9.4 30.8 1.9 35.3 19.5 3.5 15.8 26.0 29.0 0.5 6.0 8.6 0.8 0.9 21.3 35.4 1.6 16.2 9.5 0.0 22.3 0.2 53.9 2.0 26.8 10.5 0.7 47.9 6.7 3.6 23.9 26.8 5.8 15.8 23.7 22.7 32.1 40.2 17.6 20.7 39.9 18.6 5.3 0.1 38.0 19.9 12.5 9.3 22.8 45.2 6.2 8.2 8.3 10.9 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 28.9 43.8 38.1 31.4 29.4 29.2 34.6 38.0 35.6 28.7 36.6 60.0 3.1 9.6 10.4 231.8 2.3 14.1 8.2 20.7 13.6 15.7 14.2 18.2 6.9 21.5 11.4 22.0 14.6 0.5 4.8 55.6 1.9 11.6 3.3 14.4 13.4 3.4 60.1 3.0 124.5 6.4 0.8 14.6 20.9 24.6 0.0 11.8 5.7 8.9 0.9 10.1 72.8 51.2 10.2 1.2 2.7 7.1 31.7 1.2 10.6 62.8 0.1 12.5 2.1 120.1 439.4 9.9 40.0 62.8 2.6 11.5 39.6 15.5 12.7 21.9 6.6 22.2 10.2 11.8 20.3 14.7 25.4 0.3 6.0 3.1 60.5 7.2 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 21.9;retina: 34.6" "Group enriched" "Detected in some" 14 "Bipolar cells: 206.4;Excitatory neurons: 307.1;Inhibitory neurons: 345.9;Oligodendrocyte precursor cells: 172.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Group enriched" "Detected in many" 41 "amygdala: 6.6;basal ganglia: 12.4;cerebral cortex: 21.9;hippocampal formation: 17.5;white matter: 16.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 21.9;REH: 20.6;RPMI-8226: 32.7;RT4: 24.7;SCLC-21H: 26.9;U-2 OS: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064630 Approved "Golgi apparatus" "Secreted in brain" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 58: Brain - Synaptic function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA064630: AB_2685305" "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 1.2 0.0 6.6 0.3 12.4 0.1 1.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 17.5 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.3 0.0 0.1 34.6 0.2 0.0 0.0 0.3 0.5 0.0 0.0 3.1 0.2 0.8 0.2 0.4 0.6 0.0 1.2 0.1 0.0 16.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 8.7 0.0 0.0 20.6 0.0 32.7 4.0 24.7 26.9 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 12.4 0.0 21.9 17.5 0.0 0.3 0.0 0.3 0.0 0.2 16.3 2.0 0.0 0.0 16.6 6.1 0.0 0.0 0.0 0.0 206.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 307.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 17.8 0.0 2.2 0.0 172.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NETO2 "FLJ10430, NEOT2" ENSG00000171208 "Neuropilin and tolloid like 2" Q8NC67 16 47077703-47143945 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8;lymphoid tissue: 22.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 96.5;Inhibitory neurons: 176.6;Oligodendrocyte precursor cells: 79.4;Theca cells: 98.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013180 Uncertain Approved "Golgi apparatus" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA013180: AB_1854383" "unprognostic (2.67e-2)" "unprognostic (3.46e-2)" "unprognostic (3.90e-1)" "unprognostic (1.51e-3)" "unprognostic (2.25e-1)" "unprognostic (5.26e-3)" "unprognostic (1.10e-2)" "unprognostic (5.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (3.98e-1)" "prognostic unfavorable (5.53e-6)" "unprognostic (3.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.79e-2)" "unprognostic (1.32e-1)" 2.7 7.2 6.1 6.4 19.8 2.4 2.8 3.6 9.3 1.6 1.0 8.5 1.6 2.2 0.6 6.1 0.8 4.8 2.6 4.1 8.3 2.7 0.7 5.9 6.3 6.9 0.8 1.6 2.5 10.7 1.2 3.4 6.4 1.1 2.4 7.5 2.7 1.2 4.4 1.8 2.8 1.6 1.7 22.7 2.2 8.0 3.5 5.4 8.8 2.2 6.2 4.9 2.9 4.2 86.8 94.4 133.9 0.3 19.3 111.6 22.2 84.0 13.2 72.9 39.3 19.9 54.0 21.3 50.4 18.0 70.2 37.9 86.4 83.6 89.0 0.3 55.7 17.2 32.8 21.3 23.9 55.8 43.7 67.9 54.7 29.5 41.2 70.5 49.2 50.5 25.9 25.7 47.4 23.5 31.9 30.4 64.7 25.8 68.8 0.1 26.2 43.0 51.4 18.3 87.8 63.5 110.9 8.6 12.5 21.8 1.7 40.3 24.1 0.1 0.3 0.1 0.5 27.5 24.7 47.6 58.9 38.9 59.6 0.3 0.9 0.0 0.0 0.5 0.3 0.2 0.3 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.1 6.1 19.8 3.6 9.3 4.1 8.3 6.9 0.8 6.4 1.7 3.5 4.2 4.9 0.0 4.5 4.6 6.5 7.8 0.6 10.4 13.1 2.2 5.2 8.9 1.3 0.0 3.6 0.0 0.0 1.4 2.1 15.9 0.0 0.4 3.1 2.1 4.0 10.6 10.8 0.4 96.5 3.1 0.5 4.9 1.5 0.9 2.5 18.0 2.9 0.4 6.6 0.0 176.6 2.6 6.1 11.4 14.6 5.7 0.6 16.6 3.6 8.4 7.3 39.9 1.0 79.4 3.1 1.3 1.5 0.0 13.7 4.9 2.9 0.1 2.4 1.6 6.6 5.3 3.6 17.9 22.2 18.8 3.3 0.8 5.2 98.7 2.8 1.4 NHLH1 "bHLHa35, HEN1, NSCL, NSCL1" ENSG00000171786 "Nescient helix-loop-helix 1" Q02575 1 160367071-160372846 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.9" "Cell type enhanced" "Detected in some" "Astrocytes: 8.5;Excitatory neurons: 22.5;Inhibitory neurons: 18.6;Microglial cells: 9.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 48.6" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 26.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.0" "Region enriched" "Detected in some" 12 "cerebellum: 19.1" HPA017943 Approved "Golgi apparatus" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA017943: AB_2732421" "unprognostic (6.95e-2)" "unprognostic (3.02e-1)" "unprognostic (3.81e-1)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-2)" "unprognostic (7.06e-2)" "unprognostic (1.96e-2)" "unprognostic (4.21e-8)" "unprognostic (4.09e-2)" "unprognostic (2.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.36e-1)" 0.2 0.1 1.2 0.1 1.9 0.0 0.1 1.5 1.9 0.0 0.9 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 1.5 1.3 0.1 0.2 0.2 0.0 2.2 1.6 0.1 0.1 0.0 0.3 0.0 1.5 0.1 0.0 0.7 0.2 0.0 0.3 0.6 0.2 0.0 2.9 0.6 0.1 0.3 1.4 0.6 0.1 0.0 0.0 0.1 0.1 1.5 0.0 0.1 2.6 0.0 0.6 0.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.2 1.2 0.5 0.2 0.6 0.0 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.4 0.5 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.2 0.1 0.0 0.0 26.3 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.1 0.1 0.2 0.3 0.0 1.9 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.9 1.5 1.9 1.5 1.3 2.2 1.6 1.5 2.9 1.4 1.5 0.5 0.0 0.0 8.5 0.5 0.3 0.0 0.1 0.6 0.9 0.5 0.8 0.7 0.0 0.1 0.0 2.1 0.1 0.3 0.2 0.0 0.2 0.0 0.2 0.3 0.3 1.8 0.0 22.5 0.2 0.1 0.2 0.0 0.5 0.0 0.2 0.4 0.0 0.2 3.3 18.6 0.6 0.0 1.9 0.6 0.0 0.3 1.1 0.0 9.4 0.4 0.2 0.0 16.6 48.6 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.1 1.4 0.0 0.5 0.1 1.1 0.6 0.3 0.0 0.3 0.2 0.2 0.0 0.1 NIPA2 SLC57A2 ENSG00000140157 "NIPA magnesium transporter 2" Q8N8Q9 15 22838644-22869362 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067160, HPA071342" Approved Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "HPA067160: AB_2685794, HPA071342: AB_2686391" "unprognostic (2.88e-3)" "unprognostic (1.82e-1)" "unprognostic (9.34e-3)" "unprognostic (1.17e-1)" "unprognostic (4.49e-1)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.22e-2)" "unprognostic (2.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (2.94e-1)" "unprognostic (7.75e-3)" "unprognostic (3.53e-2)" "unprognostic (1.59e-1)" "unprognostic (3.22e-2)" "unprognostic (2.93e-2)" 24.0 26.9 15.5 35.0 15.4 30.6 20.7 14.8 16.3 21.2 19.1 40.5 39.7 21.1 18.5 25.5 17.1 24.7 18.9 15.5 17.3 31.0 27.3 23.0 36.3 15.3 17.4 15.0 24.2 25.5 18.5 28.7 17.1 26.4 38.9 15.9 26.6 17.1 27.5 15.3 35.7 24.4 16.3 27.1 28.5 16.9 16.5 28.7 26.8 27.2 42.9 34.8 15.3 16.6 103.6 103.7 51.7 61.7 55.9 58.1 57.3 117.3 99.1 78.4 90.4 76.5 64.3 101.0 70.6 71.7 88.6 82.6 99.9 58.3 77.3 109.7 61.0 89.9 66.4 61.2 72.3 127.0 81.8 54.9 61.2 64.2 65.5 51.6 87.7 79.2 137.4 117.1 99.8 39.2 40.1 56.0 60.2 109.9 99.9 88.3 87.0 74.9 71.6 120.9 69.4 71.7 95.6 84.8 98.9 48.4 74.4 114.3 91.4 104.0 65.6 73.2 237.5 90.0 153.3 107.4 76.3 129.9 88.2 72.1 44.5 38.9 41.1 55.4 46.9 76.3 36.9 45.4 54.9 67.1 34.2 34.6 32.7 48.6 55.7 82.0 52.8 49.2 15.5 15.4 14.8 16.3 15.5 17.3 15.3 17.4 17.1 16.3 16.5 16.6 26.0 16.0 23.1 10.7 62.9 45.0 41.3 26.1 20.5 9.4 25.2 16.5 3.8 22.8 25.0 12.9 12.5 39.9 45.0 53.7 21.5 39.6 10.7 21.7 24.5 28.5 24.4 29.2 14.7 43.8 65.4 23.4 26.0 27.6 10.1 26.2 22.9 22.1 48.3 21.9 15.4 30.2 38.7 30.3 41.3 3.3 13.4 35.5 23.2 14.0 31.4 27.3 35.0 9.5 13.3 57.8 31.1 21.1 60.8 56.5 31.8 23.3 20.6 13.0 13.1 17.6 28.6 32.8 35.2 28.8 57.8 84.4 37.3 38.7 38.1 89.7 NIPAL1 "DKFZp686A06115, NPAL1" ENSG00000163293 "NIPA like domain containing 1" Q6NVV3 4 47914142-48040173 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.8;skin 1: 25.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 42.0;Collecting duct cells: 42.3;Distal enterocytes: 56.2;Squamous epithelial cells: 44.4;Undifferentiated cells: 38.6;Urothelial cells: 55.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 13.3;CAPAN-2: 11.6;HaCaT: 15.3;HBEC3-KT: 11.1;RT4: 17.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA036765 Uncertain Approved "Golgi apparatus" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA036765: AB_10672366" "unprognostic (3.03e-1)" "unprognostic (4.55e-2)" "unprognostic (2.34e-3)" "unprognostic (2.18e-2)" "unprognostic (1.12e-2)" "unprognostic (3.57e-1)" "unprognostic (9.55e-2)" "unprognostic (4.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (3.71e-3)" "unprognostic (1.34e-1)" "unprognostic (9.03e-7)" "unprognostic (2.55e-1)" "unprognostic (3.73e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" 0.3 0.1 0.1 1.7 0.3 0.2 3.6 0.3 0.3 2.0 0.3 14.1 5.4 0.3 7.3 21.8 2.1 1.4 0.1 0.1 0.4 3.3 16.2 0.4 0.1 0.2 0.2 0.0 1.9 3.7 0.6 1.8 0.2 2.1 13.3 1.8 5.1 1.2 1.6 25.7 7.1 0.5 0.1 0.2 7.1 0.6 1.0 0.3 1.6 0.1 3.0 7.7 4.8 0.1 13.3 0.2 0.0 0.0 0.0 0.0 2.1 2.4 2.3 1.8 3.2 7.8 11.6 0.0 1.7 0.0 3.3 15.3 2.2 11.1 4.7 0.1 2.8 0.0 0.1 0.5 0.0 0.1 0.1 0.1 4.0 0.2 2.6 3.1 0.6 0.8 0.1 0.0 2.6 5.1 0.1 0.1 1.9 9.1 3.4 0.0 0.0 0.0 6.4 17.9 1.1 0.3 1.2 4.3 1.9 1.0 2.7 0.0 5.0 0.1 4.5 0.0 0.3 0.1 0.2 0.0 0.2 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.3 0.3 0.1 0.4 0.2 0.2 0.2 0.1 1.0 0.1 0.3 9.6 6.1 0.0 0.4 14.4 42.0 6.4 4.6 0.2 9.9 5.0 2.8 4.3 12.6 42.3 0.0 2.1 0.2 56.2 0.0 15.7 0.7 7.3 1.1 1.1 11.5 0.0 0.9 6.7 1.4 1.5 11.2 14.2 0.0 0.3 0.4 18.5 0.4 0.0 1.0 27.5 4.1 1.2 2.1 0.3 0.0 0.6 1.8 1.0 0.6 0.7 0.0 0.5 0.1 16.1 31.2 0.0 1.4 27.4 31.8 1.0 3.2 5.1 0.0 1.9 2.8 1.3 2.8 44.4 33.0 3.6 1.0 0.1 38.6 55.2 NKX2-1 "BCH, NKX2A, TITF1, TTF-1, TTF1" ENSG00000136352 "NK2 homeobox 1" P43699 14 36516392-36521149 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "lung: 53.1;thyroid gland: 172.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 137.8;Alveolar cells type 2: 124.8" "Group enriched" "Detected in some" 39 "lung cancer: 30.9;thyroid cancer: 103.2" "Region enhanced" "Detected in many" "thalamus: 17.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SCLC-21H: 78.7" "Group enriched" "Detected in some" 5 "basal ganglia: 3.2;hypothalamus: 10.2" "Group enriched" "Detected in some" 13 "basal ganglia: 4.3;hypothalamus: 10.4" "CAB000078, CAB053633, HPA074316" Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus, Vesicles" "CAB000078: , CAB053633: AB_442138, HPA074316: " "unprognostic (3.79e-1)" "unprognostic (4.25e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" "unprognostic (1.26e-2)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.83e-2)" "unprognostic (4.18e-1)" 0.0 0.1 1.1 0.0 2.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 10.1 0.0 0.0 53.1 0.0 0.0 0.3 0.1 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 17.8 0.0 172.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 78.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.0 0.0 4.0 0.1 10.1 0.0 0.3 0.0 0.0 17.8 0.1 0.0 137.8 124.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 NLGN3 "ASPGX1, AUTSX1, HNL3, KIAA1480" ENSG00000196338 "Neuroligin 3" Q9NZ94 X 71144831-71171201 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.1;seminal vesicle: 12.5" "Cell type enhanced" "Detected in some" "Astrocytes: 19.6;Inhibitory neurons: 12.7;Oligodendrocyte precursor cells: 92.0;Oligodendrocytes: 43.7;Peritubular cells: 17.3" "Cancer enriched" "Detected in many" 19 "glioma: 37.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.7;NTERA-2: 5.3;SH-SY5Y: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003183, HPA004066" Enhanced Supported "Golgi apparatus,Cell Junctions" "Intracellular and membrane" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus, Cell Junctions" "HPA003183: AB_1079469, HPA004066: AB_2732397" "unprognostic (4.06e-2)" "unprognostic (1.77e-1)" "unprognostic (1.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-1)" "unprognostic (6.52e-2)" "unprognostic (1.63e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (6.18e-2)" "unprognostic (4.27e-9)" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (2.22e-5)" "unprognostic (9.01e-2)" 0.5 6.6 10.1 0.8 8.5 1.4 0.4 6.4 11.1 1.9 0.0 1.8 0.2 2.7 6.4 0.6 4.3 1.4 1.1 10.3 10.2 0.3 0.1 0.6 0.4 7.3 7.0 4.4 0.3 0.5 1.0 0.6 4.8 6.0 0.5 1.9 0.6 12.5 0.1 0.7 0.7 1.9 5.5 0.6 0.6 2.6 7.3 0.4 0.4 0.4 0.2 0.7 1.2 9.7 0.0 0.5 6.7 0.2 1.6 0.6 1.2 0.0 0.0 0.0 0.1 0.1 0.3 0.5 0.5 0.1 0.0 0.1 0.2 0.0 0.1 0.4 0.9 0.4 0.4 0.0 0.0 0.1 0.4 0.4 0.1 0.2 0.0 0.3 0.1 2.0 0.5 1.5 0.0 0.3 0.5 1.2 5.3 0.0 0.0 0.6 0.2 0.3 0.0 0.8 1.7 2.5 0.2 0.0 0.6 0.8 0.0 0.3 0.1 0.1 0.8 0.2 0.0 1.1 1.1 0.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 10.1 8.5 6.4 11.1 10.3 10.2 7.3 7.0 4.8 5.5 7.3 9.7 0.3 0.0 0.0 19.6 0.0 0.6 0.3 0.2 1.2 2.6 0.3 0.9 0.4 0.0 0.1 0.0 0.0 1.0 0.2 0.2 0.0 0.1 1.3 0.2 1.1 0.5 0.0 0.0 11.3 0.0 0.2 1.3 0.0 0.4 0.0 1.0 0.7 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.8 3.9 2.1 0.2 0.0 2.8 0.1 2.5 0.0 92.0 43.7 0.2 0.1 17.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.2 0.6 0.2 0.0 0.1 0.4 0.3 0.2 4.5 0.1 0.3 NLRP2 "CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2" ENSG00000022556 "NLR family pyrin domain containing 2" Q9NX02 19 54953130-55001142 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 45.2;Extravillous trophoblasts: 216.1;Syncytiotrophoblasts: 97.3" "Cancer enriched" "Detected in many" 7 "testis cancer: 78.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 42.2;BEWO: 177.9;OE19: 79.7;SuSa: 80.3;T-47d: 46.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA021183 Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Golgi apparatus, Vesicles, Cytosol" "HPA021183: AB_2670615" "unprognostic (1.66e-2)" "unprognostic (9.28e-2)" "unprognostic (6.60e-2)" "unprognostic (6.50e-3)" "unprognostic (1.09e-2)" "unprognostic (4.57e-3)" "unprognostic (4.27e-1)" "unprognostic (1.79e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (3.63e-1)" "unprognostic (2.34e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.86e-2)" "unprognostic (7.57e-2)" 0.4 0.3 0.9 2.7 0.6 1.0 1.0 0.0 0.8 2.6 0.1 1.7 1.8 1.1 1.8 7.9 1.9 0.9 0.4 0.7 0.1 1.9 0.4 1.6 2.1 0.1 0.2 0.3 1.6 0.4 1.2 7.1 0.1 1.5 1.9 3.1 2.4 1.1 0.6 3.0 1.7 0.8 0.0 2.1 2.5 7.2 0.3 3.4 4.4 0.0 1.9 7.1 4.3 0.2 20.4 42.2 15.8 0.4 0.2 0.1 177.9 0.1 0.0 0.6 0.2 35.9 0.7 14.7 0.1 0.1 0.1 8.1 0.0 24.4 0.3 1.7 0.2 9.8 0.5 0.1 0.4 0.1 0.4 0.2 0.3 0.0 0.1 0.1 0.9 0.0 32.7 0.2 0.0 0.3 0.1 1.3 5.0 79.7 0.0 8.8 0.0 24.0 26.4 0.7 5.3 0.7 0.0 8.1 0.0 80.3 46.7 0.2 0.0 0.3 0.7 0.4 0.3 5.2 16.6 0.7 0.4 1.0 0.0 0.1 0.2 0.0 1.8 0.3 1.3 0.6 0.4 0.7 0.2 0.6 0.3 0.8 0.2 3.0 0.1 1.0 1.3 0.4 0.9 0.6 0.0 0.8 0.7 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.0 9.6 7.3 0.3 1.5 0.5 1.9 8.1 0.0 2.7 1.9 1.5 0.8 4.3 10.1 1.8 4.2 45.2 3.5 2.9 0.0 5.3 23.1 8.6 1.3 0.7 2.4 0.8 3.0 1.9 216.1 1.1 2.0 13.1 4.5 0.7 0.0 0.0 11.6 0.0 1.9 3.0 6.1 0.3 0.5 7.2 0.9 1.1 0.0 0.0 3.0 0.7 8.2 0.5 0.5 6.7 1.0 0.0 1.5 2.5 0.8 0.4 8.4 2.7 0.0 0.3 0.8 16.8 11.7 0.0 1.3 97.3 2.4 0.3 3.0 4.7 NLRP5 "CLR19.8, MATER, NALP5, PAN11, PYPAF8" ENSG00000171487 "NLR family pyrin domain containing 5" P59047 19 55999726-56061810 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "parathyroid gland: 22.4" "Cell type enhanced" "Detected in some" "Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "Karpas-707: 1.3;U-2 OS: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047260, HPA056271" Uncertain Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 9: U-2 OS - Unknown function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" Vesicles "HPA047260: , HPA056271: AB_2683083" "unprognostic (9.67e-2)" "unprognostic (2.22e-2)" "unprognostic (5.03e-1)" "unprognostic (7.78e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 22.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP7 "CLR19.4, NALP7, NOD12, PAN7, PYPAF3" ENSG00000167634 "NLR family pyrin domain containing 7" Q8WX94 19 54923509-54966312 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.9" "Cell type enhanced" "Detected in some" "dendritic cells: 8.2;Early spermatids: 8.3;Extravillous trophoblasts: 5.7;Late spermatids: 14.8;Plasma cells: 5.2;Spermatocytes: 6.4;Spermatogonia: 5.6" "Cancer enriched" "Detected in many" 30 "testis cancer: 146.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 6 "dendritic cells: 3.9" "Cell line enhanced" "Detected in some" "BEWO: 1.9;RT4: 1.0;SuSa: 1.5;U-266/84: 5.0" HPA051382 Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 83: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA051382: AB_2681461" "unprognostic (2.15e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-3)" "unprognostic (1.24e-2)" "unprognostic (5.29e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-1)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.34e-1)" "unprognostic (3.25e-8)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (7.31e-3)" "unprognostic (4.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 8.2 0.0 0.0 0.0 8.3 0.3 0.0 0.0 0.0 0.0 0.9 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.4 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 5.6 0.0 0.0 1.9 0.3 0.0 0.0 0.6 NMT2 ENSG00000152465 "N-myristoyltransferase 2" O60551 10 15102584-15168693 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 93.6;Hepatocytes: 141.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 14.5;eosinophil: 13.6;gdT-cell: 11.0;MAIT T-cell: 19.8;memory CD4 T-cell: 17.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 21.8;naive CD8 T-cell: 14.5;NK-cell: 20.8;T-reg: 29.5" "Group enriched" "Detected in many" 8 "granulocytes: 14.5;NK-cells: 20.8;T-cells: 29.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 102.6;TIME: 147.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001303 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus, Plasma membrane, Cytosol" "HPA001303: AB_1079494" "unprognostic (1.08e-1)" "unprognostic (7.65e-2)" "unprognostic (8.78e-2)" "unprognostic (1.15e-3)" "unprognostic (6.97e-2)" "unprognostic (2.24e-1)" "unprognostic (7.11e-2)" "unprognostic (5.13e-2)" "unprognostic (3.20e-1)" "unprognostic (4.01e-3)" "unprognostic (3.31e-1)" "unprognostic (2.00e-1)" "unprognostic (7.06e-2)" "unprognostic (3.79e-3)" "unprognostic (2.00e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" 25.9 4.4 7.3 6.1 8.7 3.7 17.5 12.2 10.0 9.8 4.0 8.8 6.6 12.7 3.5 7.0 8.3 7.0 8.7 7.0 4.9 9.4 16.8 6.3 8.9 5.0 7.6 15.4 5.6 16.5 5.5 4.4 5.1 9.0 9.2 7.0 5.2 7.7 8.3 10.1 10.9 10.5 4.3 9.4 7.9 13.4 9.1 27.0 5.9 8.5 8.0 8.6 7.9 7.3 8.8 11.3 12.7 9.3 33.7 35.9 2.3 18.8 15.3 17.0 23.0 10.9 38.7 0.4 12.7 102.6 46.6 10.6 11.4 10.7 28.3 11.7 13.9 23.4 5.4 15.2 22.4 1.7 84.0 31.9 10.8 23.8 7.2 62.2 65.8 16.3 11.2 1.5 63.7 10.9 18.3 4.4 9.3 10.0 10.5 13.6 18.5 1.8 12.6 1.8 3.9 14.4 22.8 3.7 6.3 10.5 11.7 7.3 147.1 16.7 24.4 75.0 13.7 13.0 14.3 1.0 20.7 6.3 12.4 14.5 0.5 13.6 11.0 0.7 19.8 2.2 17.5 12.9 0.5 2.5 21.8 14.5 1.9 20.8 0.8 0.5 29.5 6.5 7.3 8.7 12.2 10.0 7.0 4.9 5.0 7.6 5.1 4.3 9.1 7.3 52.5 9.6 8.8 25.1 16.0 16.6 23.4 8.3 7.4 20.6 14.7 13.1 13.5 57.2 10.9 27.6 4.2 1.3 16.9 32.8 9.8 33.9 6.6 4.7 20.5 21.7 18.0 15.1 39.6 19.5 3.0 16.3 9.2 10.3 93.6 13.2 25.4 141.9 2.8 20.2 30.1 11.4 4.1 7.9 7.1 14.5 21.8 5.8 12.4 17.8 10.1 12.9 40.2 12.5 15.3 27.1 15.9 20.7 10.0 17.9 38.4 63.2 5.3 17.2 0.0 13.4 21.0 8.1 46.8 6.8 14.8 2.6 33.9 11.0 18.1 16.7 NNMT ENSG00000166741 "Nicotinamide N-methyltransferase" P40261 11 114257787-114313536 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 388.9" "Group enriched" "Detected in many" 6 "Hepatocytes: 3913.2;Skeletal myocytes: 1639.1" "Cancer enhanced" "Detected in all" "renal cancer: 204.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059180 Approved Approved "Golgi apparatus,Cytosol" NA NA 410000 "Cluster 85: Liver - Metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" Cytosol "HPA059180: AB_2683940" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" "unprognostic (1.61e-2)" "unprognostic (6.14e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (1.76e-1)" "unprognostic (5.84e-2)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-6)" "prognostic unfavorable (1.75e-4)" "unprognostic (1.11e-1)" "unprognostic (3.37e-3)" "unprognostic (2.77e-2)" 130.9 11.4 1.0 25.2 1.1 0.9 91.9 1.4 1.5 36.0 1.9 37.1 1.5 31.0 2.8 15.4 55.0 43.1 35.5 1.3 1.4 24.1 388.9 64.6 9.6 3.9 1.6 21.3 11.4 1.6 10.6 23.8 2.2 31.9 8.7 0.3 21.1 3.1 73.1 49.3 32.2 30.1 1.7 36.7 30.1 2.2 1.2 2.7 33.0 5.3 8.8 48.6 33.9 3.1 0.2 17.6 0.3 18.6 92.0 118.3 0.1 21.2 58.7 35.2 69.2 0.0 17.5 0.2 58.1 45.1 4.2 0.2 0.0 8.0 34.1 0.2 0.0 0.2 16.7 0.0 123.3 0.2 0.0 255.3 89.4 24.1 37.3 29.8 50.1 0.1 0.3 0.2 144.1 0.1 0.1 0.2 0.1 0.0 0.5 0.2 79.0 0.0 479.6 0.1 0.2 0.2 97.7 0.1 0.3 5.3 0.0 0.2 37.4 18.3 34.3 23.8 3.1 0.3 0.3 0.4 6.4 0.3 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.0 1.1 1.4 1.5 1.3 1.4 3.9 1.6 2.2 1.7 1.2 3.1 411.8 44.8 411.3 1.0 11.2 103.6 13.2 16.5 2.2 1.9 38.5 73.9 4.7 75.8 13.3 80.9 0.0 1.0 1.6 0.0 9.8 238.3 0.3 19.0 89.9 190.0 5.3 147.2 1.3 157.0 2.5 452.2 5.1 80.5 13.9 0.5 195.2 3913.2 28.4 0.0 1.6 0.0 0.0 126.8 142.1 1.6 74.3 9.2 96.0 1.9 5.7 0.0 0.0 0.0 0.2 323.1 0.0 13.2 1.5 10.8 0.0 99.2 11.9 0.2 0.0 1639.1 154.3 0.3 0.8 1.9 92.1 2.2 20.1 0.0 0.0 3.1 NOD2 "BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1" ENSG00000167207 "Nucleotide binding oligomerization domain containing 2" Q9HC29 16 50693588-50734041 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0" "Group enriched" "Detected in many" 5 "dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0" "Cell line enhanced" "Detected in some" "HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041985, HPA054494" Enhanced Approved "Golgi apparatus,Cytosol" No NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Cytosol" "HPA041985: AB_2677780, HPA054494: AB_2682505" "unprognostic (1.01e-1)" "unprognostic (4.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.02e-3)" "unprognostic (9.91e-3)" "unprognostic (5.84e-2)" "unprognostic (5.90e-3)" "unprognostic (1.23e-1)" "unprognostic (4.17e-1)" "unprognostic (3.88e-2)" "unprognostic (6.94e-3)" "unprognostic (1.48e-2)" "unprognostic (2.31e-9)" "unprognostic (4.38e-2)" "unprognostic (1.08e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" 1.5 0.5 0.5 5.9 0.2 13.6 1.5 0.2 1.0 5.6 0.7 0.9 1.5 0.6 0.3 11.7 0.9 1.3 0.7 0.2 0.4 0.6 1.7 4.3 2.7 1.0 0.9 0.4 0.3 0.2 0.4 1.2 0.7 0.9 0.9 0.0 4.3 0.4 0.6 14.4 1.3 1.8 0.7 4.4 1.4 0.5 1.4 0.8 0.4 0.3 2.3 1.6 12.3 0.8 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 11.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.1 0.0 1.5 0.0 0.0 5.8 7.3 0.0 0.0 0.0 0.0 0.0 15.9 7.2 0.0 0.3 0.1 0.0 3.0 23.0 6.0 0.4 13.1 0.7 0.1 1.3 1.4 21.3 0.0 0.1 0.5 10.5 3.4 9.0 1.0 0.9 11.1 0.5 0.2 0.2 1.0 0.2 0.4 1.0 0.9 0.7 0.7 1.4 0.8 0.2 0.0 3.7 0.0 1.9 5.9 0.3 1.2 0.0 0.0 1.4 1.1 0.4 1.5 2.3 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 5.6 0.8 0.6 1.2 0.8 0.1 0.0 0.0 0.4 0.0 8.3 1.3 0.5 0.0 0.5 2.5 0.0 0.1 0.0 2.0 9.0 22.5 0.0 0.0 15.2 1.8 1.9 15.6 0.0 1.0 0.0 0.2 0.0 0.0 0.4 4.3 0.4 0.0 0.1 1.0 0.0 0.0 0.1 0.4 0.1 0.4 6.1 15.5 0.3 2.3 0.1 0.1 0.3 NOVA2 "ANOVA, NOVA-2, NOVA3" ENSG00000104967 "NOVA alternative splicing regulator 2" Q9UNW9 19 45933734-45974044 "Human disease related genes, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell type enhanced" "Detected in some" "Adipocytes: 39.4;Bipolar cells: 56.7;Endothelial cells: 32.0;Excitatory neurons: 21.8;Hepatic stellate cells: 42.5;Horizontal cells: 21.9;Inhibitory neurons: 20.9" "Cancer enriched" "Detected in many" 4 "glioma: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;HDLM-2: 11.0;HUVEC TERT2: 16.9;SH-SY5Y: 5.6;TIME: 25.8;U-2 OS: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045607 Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Cluster 10: Brain - Neuronal signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "HPA045607: AB_10962628" "unprognostic (9.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (3.04e-3)" "unprognostic (1.46e-1)" "unprognostic (6.21e-2)" "unprognostic (2.36e-1)" "unprognostic (3.02e-3)" "unprognostic (6.42e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (5.05e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-1)" "unprognostic (8.31e-2)" 6.7 1.9 12.4 0.7 15.1 0.0 5.7 0.5 16.7 3.2 0.0 1.8 0.6 3.4 0.6 1.4 2.9 1.4 6.7 16.0 5.8 4.7 1.0 9.3 0.5 4.6 3.0 1.2 1.1 1.0 6.2 3.9 3.6 2.3 0.5 5.6 1.1 0.8 2.3 1.1 1.7 2.0 0.6 1.5 1.5 2.0 4.6 0.4 4.5 2.5 0.2 2.5 2.0 9.8 0.0 0.1 9.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 1.3 0.0 0.0 11.0 0.4 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 5.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 15.1 0.5 16.7 16.0 5.8 4.6 3.0 3.6 0.6 4.6 9.8 39.4 0.0 0.0 5.9 0.1 0.6 0.2 0.0 0.6 56.7 0.1 0.5 3.4 1.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.1 32.0 0.0 0.0 21.8 0.2 0.0 1.2 0.0 0.1 0.0 0.1 42.5 0.5 0.1 21.9 20.9 0.0 0.0 1.6 1.5 3.5 0.0 0.1 0.0 9.4 0.0 1.3 0.0 11.6 9.5 0.2 0.0 0.4 1.2 0.3 0.0 0.0 0.0 3.3 0.0 0.6 0.6 2.4 2.3 0.3 0.1 0.0 0.5 0.4 0.0 0.3 NPTX2 ENSG00000106236 "Neuronal pentraxin 2" P47972 7 98617285-98629869 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 135.8;pituitary gland: 210.8" "Cell type enhanced" "Detected in many" "Granulosa cells: 93.5;Peritubular cells: 326.1;Sertoli cells: 151.2;Spermatocytes: 85.2;Spermatogonia: 94.8" "Cancer enhanced" "Detected in all" "renal cancer: 41.7" "Region enhanced" "Detected in all" "cerebral cortex: 135.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "LHCN-M2: 717.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020801, HPA049799, HPA058320" Enhanced Approved "Golgi apparatus,Actin filaments,Centrosome" "Secreted to blood" NA NA 2490000 360000 "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus, Actin filaments" Centrosome "CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621" "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (1.91e-3)" "unprognostic (9.20e-2)" "unprognostic (2.42e-2)" "unprognostic (6.04e-3)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (7.64e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (5.46e-9)" "unprognostic (1.06e-2)" "unprognostic (1.21e-1)" "unprognostic (5.33e-2)" "unprognostic (3.69e-2)" 7.0 39.2 11.2 1.9 13.6 0.5 3.8 10.1 135.8 9.9 2.5 15.3 0.5 5.7 3.5 3.0 2.8 1.1 9.8 39.2 47.3 1.1 2.6 0.9 0.1 13.8 14.5 3.7 21.4 0.6 210.8 0.1 16.2 7.2 0.8 4.7 3.7 1.6 8.9 8.2 5.4 2.5 6.4 13.0 6.7 34.3 45.6 0.5 3.1 6.7 0.3 5.5 6.9 16.8 0.0 0.0 6.5 0.2 0.0 0.5 0.0 8.8 0.0 0.1 0.0 0.0 0.0 0.0 21.1 2.8 1.5 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 717.9 0.0 5.7 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.1 33.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.5 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 13.6 10.1 135.8 39.2 47.3 13.8 14.5 16.2 6.4 45.6 16.8 8.6 0.0 0.6 2.9 0.3 3.8 0.5 0.0 0.0 19.9 0.2 1.4 3.4 5.7 1.3 0.0 4.2 0.0 1.0 4.5 0.0 5.4 12.0 8.5 1.8 16.9 16.0 0.0 22.1 12.8 0.2 11.1 1.5 10.5 0.0 93.5 3.9 0.7 0.5 0.0 5.3 1.2 0.0 0.0 5.4 24.2 14.0 1.3 12.4 5.6 0.0 1.6 0.0 1.0 1.8 2.9 1.1 326.1 1.0 5.2 0.5 0.1 0.0 2.8 151.2 57.2 27.1 85.2 94.8 0.1 3.0 0.1 0.8 12.7 2.3 1.2 NPY PYY4 ENSG00000122585 "Neuropeptide Y" P01303 7 24284188-24291862 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Neuropeptide "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adrenal gland: 122.6;brain: 423.9;prostate: 332.8" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 56.7;Prostatic glandular cells: 100.6" "Cancer enriched" "Detected in many" 187 "prostate cancer: 1214.9" "Region enriched" "Detected in all" 7 "hypothalamus: 423.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 34 "SH-SY5Y: 700.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016733, CAB034368, HPA036636, HPA044572, HPA056798" Supported Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 30700000 21000 "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 35: Glandular cells - Unknown function" "Golgi apparatus" "CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371" "unprognostic (2.00e-1)" "prognostic unfavorable (5.78e-4)" "unprognostic (4.15e-1)" "unprognostic (3.76e-2)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "unprognostic (6.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.78e-1)" "unprognostic (2.52e-1)" 1.8 122.6 32.8 12.8 59.0 5.6 2.2 11.0 39.1 1.3 11.3 2.9 9.7 0.3 0.3 2.3 0.5 1.1 0.8 31.7 423.9 0.5 0.2 0.3 0.0 24.2 25.1 0.5 8.8 0.1 4.7 0.0 15.2 332.8 1.9 4.4 0.3 3.9 0.2 0.2 13.1 1.2 18.8 0.0 8.8 1.1 29.2 0.2 0.9 0.2 0.0 1.4 23.8 33.1 0.0 0.0 2.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 2.0 0.0 0.2 20.5 0.0 0.6 0.0 0.0 0.8 700.2 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 59.0 11.0 39.1 31.7 423.9 24.2 25.1 15.2 18.8 29.2 33.1 0.0 0.0 0.0 2.0 0.5 0.1 1.3 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 56.7 0.0 0.0 0.0 0.0 16.1 0.3 0.7 1.8 1.0 0.0 0.8 0.0 2.0 1.9 0.3 0.0 0.4 0.0 100.6 0.0 0.0 0.0 0.7 0.0 15.6 0.3 2.4 2.8 0.0 0.0 5.1 0.3 0.0 0.0 2.0 NRTN NTN ENSG00000171119 Neurturin Q99748 19 5823802-5828324 "Disease related genes, Predicted secreted proteins" "Growth factor" "Disease variant, Hirschsprung disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 25.6;pancreas: 16.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 17.2;Cone photoreceptor cells: 12.5;Endometrial ciliated cells: 14.9;Hepatocytes: 12.3;Rod photoreceptor cells: 50.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 8.2;K-562: 8.1;REH: 21.0;SH-SY5Y: 10.8;U-266/70: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA065260 Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 14: REH - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA065260: AB_2685448" "unprognostic (4.85e-2)" "unprognostic (1.66e-2)" "unprognostic (2.96e-2)" "prognostic favorable (3.86e-4)" "unprognostic (1.60e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.21e-3)" "unprognostic (5.60e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.38e-1)" "unprognostic (2.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.78e-3)" "unprognostic (3.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.32e-2)" 0.3 8.2 0.1 0.4 0.2 0.0 0.8 0.4 0.5 1.5 0.4 9.6 1.2 0.4 0.6 4.4 1.1 0.5 25.6 0.2 0.2 2.8 14.4 0.8 0.0 0.5 0.5 0.1 16.9 1.5 1.1 0.2 0.6 2.8 0.2 9.7 5.3 0.9 0.0 6.1 3.1 0.9 0.1 0.2 9.4 1.3 0.4 0.4 0.4 0.0 0.2 4.6 3.0 0.4 0.6 0.8 0.9 3.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.9 0.0 0.5 0.1 3.2 0.0 0.0 8.2 5.7 0.0 0.0 2.6 0.9 0.1 2.1 0.1 0.8 0.0 0.0 0.0 0.0 2.7 8.1 0.0 0.0 1.7 0.7 0.9 2.6 1.2 2.0 21.0 2.6 4.9 0.3 0.0 0.5 10.8 0.2 1.0 1.2 0.3 0.4 0.7 0.0 0.0 1.6 0.0 0.0 11.5 2.6 0.7 0.0 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.2 0.4 0.5 0.2 0.2 0.5 0.5 0.6 0.1 0.4 0.4 0.3 0.0 1.8 0.3 0.4 1.9 1.4 0.4 1.8 4.6 3.0 6.9 17.2 1.5 0.1 3.7 12.5 0.1 0.4 1.0 3.9 0.3 0.1 14.9 4.3 0.6 1.2 0.0 0.5 0.7 0.0 1.3 2.0 2.6 0.0 1.1 3.6 12.3 0.3 0.0 0.7 1.8 0.0 0.3 0.2 0.6 0.9 0.3 5.4 0.0 0.1 6.0 1.0 0.5 1.0 0.7 0.1 0.0 2.5 1.0 0.2 0.7 0.2 50.0 0.0 0.0 0.9 0.4 3.4 1.4 4.5 0.1 0.6 0.5 1.4 1.1 NSF "SEC18, SKD2" ENSG00000073969 "N-ethylmaleimide sensitive factor, vesicle fusing ATPase" P46459 17 46590669-46757464 "Enzymes, Predicted intracellular proteins, Transporters" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 276.3;Inhibitory neurons: 284.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003154, CAB009324, HPA071089" Enhanced Supported "Golgi apparatus,Cytosol" NA NA 59000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 58: Brain - Synaptic function" "Cluster 21: OE19 - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Golgi apparatus" "CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343" "unprognostic (5.70e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-3)" "unprognostic (1.98e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.95e-2)" "unprognostic (5.48e-2)" "unprognostic (2.37e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (3.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.74e-1)" 13.5 20.2 29.9 8.0 28.8 5.7 12.5 7.7 58.7 14.1 0.0 18.3 4.9 11.8 7.3 21.6 9.7 8.0 11.3 39.2 28.6 12.9 13.7 11.6 9.6 36.8 14.3 7.0 22.9 15.3 43.1 7.7 36.6 12.4 13.9 63.0 18.4 5.8 38.9 16.5 16.1 6.4 4.1 14.9 15.6 16.7 15.6 7.9 11.9 13.5 10.0 13.2 14.3 21.1 11.7 25.4 16.6 1.2 9.6 13.4 13.5 15.6 18.2 14.7 14.3 17.5 0.1 28.5 27.3 34.8 15.3 2.0 18.9 5.8 23.9 10.1 24.6 1.0 17.4 24.2 14.3 0.8 6.1 12.3 7.8 29.8 12.3 7.8 23.4 7.0 19.4 15.0 32.9 22.8 19.4 7.5 9.4 36.0 29.9 13.7 16.1 26.7 16.7 24.0 15.2 17.2 23.1 0.1 11.1 17.5 28.5 35.1 19.3 41.2 14.4 22.0 23.7 32.0 19.9 16.4 11.5 15.2 29.7 9.3 11.5 6.6 6.1 9.8 6.7 5.4 6.2 8.1 12.6 6.1 5.1 6.1 4.8 5.9 10.8 5.0 9.4 7.5 29.9 28.8 7.7 58.7 39.2 28.6 36.8 14.3 36.6 4.1 15.6 21.1 16.3 9.6 11.3 54.9 28.2 4.0 3.6 6.7 6.2 106.6 14.0 10.0 8.1 7.2 10.9 22.0 87.6 13.0 18.8 32.3 11.7 12.4 45.2 8.3 19.7 11.5 30.5 8.6 276.3 16.2 14.4 10.9 13.7 11.2 9.5 8.2 11.0 19.3 18.8 43.7 284.7 26.3 24.4 29.9 10.9 45.8 5.9 20.5 10.6 69.3 35.4 24.5 8.2 98.5 71.8 13.7 17.4 8.6 21.7 9.0 18.5 14.7 8.7 89.9 0.0 10.6 12.9 40.6 31.4 9.5 5.7 18.5 14.8 18.3 20.6 8.6 NSG2 "CALY3, HMP19" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045706-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 198.5" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 59 "SCLC-21H: 39.5;SH-SY5Y: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA046531: AB_2732528, HPA056191: AB_2683062" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 0.5 33.3 115.8 2.6 198.5 0.0 0.1 43.8 152.8 0.0 1.7 6.9 2.3 0.0 0.4 0.1 0.0 0.3 1.0 125.2 171.9 0.7 0.4 0.3 0.0 54.5 82.1 0.1 0.9 0.0 7.0 0.0 101.1 0.2 3.9 39.2 0.1 0.1 0.3 0.1 3.8 1.8 52.4 0.2 3.0 14.7 100.3 0.0 0.6 0.0 0.0 0.1 1.2 47.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 64.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.8 198.5 43.8 152.8 125.2 171.9 54.5 82.1 101.1 52.4 100.3 47.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NSUN6 "ARL5B-AS1, FLJ23743, NOPD1" ENSG00000241058 "NOP2/Sun RNA methyltransferase 6" Q8TEA1 10 18545561-18659285 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 61.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045902 Approved Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA045902: AB_10962354" "unprognostic (7.34e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-3)" "unprognostic (9.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.33e-3)" "unprognostic (1.63e-2)" "prognostic favorable (8.42e-4)" "unprognostic (1.60e-1)" "unprognostic (2.45e-1)" "unprognostic (9.96e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (2.23e-1)" "unprognostic (7.53e-3)" "unprognostic (3.18e-2)" "unprognostic (2.00e-3)" 6.4 12.2 13.6 7.5 14.3 12.4 9.3 16.0 15.9 9.0 13.5 6.1 8.6 9.6 12.2 5.7 8.7 6.0 8.6 14.0 14.1 10.6 61.1 6.5 11.3 13.8 14.8 12.7 12.0 7.8 17.2 6.5 14.7 10.5 8.4 12.9 8.4 5.6 4.5 9.1 8.7 6.1 13.9 9.8 8.5 17.5 13.8 11.8 12.0 4.8 10.9 9.1 7.6 17.6 7.5 6.3 16.6 12.3 8.1 11.1 7.2 10.3 2.5 8.4 11.3 12.0 11.2 17.0 4.3 4.0 5.9 11.0 17.1 10.8 10.8 16.6 13.9 17.8 8.8 14.5 8.3 8.1 11.6 8.6 10.3 8.0 5.5 8.3 3.9 20.0 25.1 16.1 8.2 4.2 18.6 9.3 8.5 14.8 4.8 13.1 8.6 17.4 6.3 9.1 8.9 11.0 8.7 9.0 7.3 11.3 5.8 6.4 6.7 7.0 8.1 12.8 7.6 9.9 11.0 18.8 5.0 14.5 4.3 1.5 3.5 2.8 4.4 4.7 7.0 8.0 6.3 5.6 2.9 6.1 7.8 6.7 1.6 5.3 8.2 4.0 10.5 2.5 13.6 14.3 16.0 15.9 14.0 14.1 13.8 14.8 14.7 13.9 13.8 17.6 75.4 9.6 15.1 57.8 34.9 28.7 17.1 11.0 30.1 33.2 32.4 34.7 8.1 18.6 13.6 9.2 22.9 10.1 39.6 19.5 5.9 10.0 19.7 23.6 38.9 37.5 14.5 20.8 43.5 12.7 8.0 19.2 40.2 49.0 17.7 32.0 26.7 86.6 7.4 25.2 45.0 24.5 18.3 24.2 52.4 12.7 25.7 28.5 12.4 23.4 15.3 15.3 17.5 43.7 57.6 11.1 20.0 17.0 31.0 10.1 40.2 10.9 14.5 28.9 13.1 20.1 19.1 49.5 21.8 21.3 26.7 6.7 31.0 26.7 18.7 14.2 NTAN1 ENSG00000157045 "N-terminal asparagine amidase" Q96AB6 16 15037854-15056079 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 17.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 18.5;REH: 9.2;U-266/84: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051418 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Golgi apparatus" "HPA051418: " "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.69e-4)" "unprognostic (1.87e-2)" "unprognostic (9.16e-2)" "unprognostic (8.11e-3)" "unprognostic (2.79e-1)" "unprognostic (1.75e-1)" "unprognostic (5.05e-2)" "unprognostic (1.65e-1)" "unprognostic (9.30e-3)" "prognostic unfavorable (9.07e-4)" "unprognostic (4.35e-1)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" 38.6 10.2 3.6 0.5 3.9 2.2 28.1 3.8 8.9 25.3 2.1 30.3 0.1 20.7 1.4 19.4 18.8 1.2 19.3 3.4 3.7 15.9 15.2 21.6 0.7 3.8 4.1 19.7 11.0 0.5 6.5 0.4 4.1 20.2 0.3 1.3 15.8 0.4 24.5 21.6 15.6 0.8 2.9 20.5 17.9 20.3 3.7 0.8 13.5 0.6 0.4 27.8 21.8 3.5 3.6 0.0 1.8 0.7 1.2 0.6 0.6 6.2 2.6 1.0 2.8 0.0 0.0 3.2 2.5 4.7 1.7 0.1 0.9 0.7 0.9 5.0 5.9 0.3 0.0 0.0 1.1 1.7 4.3 0.8 0.4 3.4 1.5 1.5 1.3 2.6 0.5 3.2 0.9 0.3 5.3 18.5 1.1 0.0 0.2 9.2 0.1 1.3 1.2 0.0 0.7 2.1 0.0 0.1 1.5 0.4 0.0 0.6 4.1 1.1 3.8 1.1 1.1 4.2 10.1 2.5 1.5 1.3 2.2 4.9 1.3 17.5 2.8 1.7 3.0 4.2 3.4 2.6 1.9 3.8 3.9 1.3 1.6 3.8 2.0 5.7 5.9 3.1 3.6 3.9 3.8 8.9 3.4 3.7 3.8 4.1 4.1 2.9 3.7 3.5 79.7 3.2 3.9 7.8 24.7 33.6 16.4 24.1 7.4 6.1 20.2 33.4 3.2 12.8 13.8 18.4 10.4 77.4 30.4 25.1 45.0 49.3 48.9 8.8 29.3 55.0 6.7 25.3 12.6 23.6 23.8 51.3 8.2 12.7 8.8 22.0 62.8 23.0 116.6 25.2 15.6 7.2 30.5 75.0 48.3 32.4 83.0 53.9 58.7 12.2 46.0 15.2 37.0 3.0 6.6 56.9 14.6 75.2 37.6 21.2 9.6 38.6 6.0 9.4 39.5 20.8 52.3 33.3 30.7 16.0 21.7 56.9 25.6 23.5 13.5 23.9 NTF4 "GLC1O, NT-4/5, NTF5" ENSG00000225950 "Neurotrophin 4" P34130 19 49061066-49065054 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 20.1;skeletal muscle: 17.1;skin 1: 31.1" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 35.6;Basal respiratory cells: 24.0;Basal squamous epithelial cells: 15.4;Breast myoepithelial cells: 24.3;Club cells: 9.5;Cytotrophoblasts: 13.6;Urothelial cells: 11.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.8;HaCaT: 31.1;HBEC3-KT: 11.7;hTCEpi: 50.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049376 Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA049376: AB_2680735" "unprognostic (4.15e-2)" "unprognostic (1.07e-1)" "unprognostic (9.27e-4)" "unprognostic (1.76e-4)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (2.73e-2)" "unprognostic (4.87e-3)" "unprognostic (3.90e-4)" "unprognostic (2.97e-1)" "unprognostic (1.40e-3)" "unprognostic (3.71e-2)" "unprognostic (2.49e-1)" "unprognostic (1.89e-2)" "unprognostic (2.46e-3)" 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 4.3 0.7 0.0 0.0 0.1 3.7 10.8 2.5 0.0 1.0 0.1 0.0 0.1 0.0 3.5 0.0 0.1 0.2 0.2 0.0 0.0 1.6 3.2 0.1 20.1 0.0 0.0 8.2 7.1 17.1 31.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.9 1.5 2.5 1.1 6.5 9.6 0.1 3.9 0.2 0.3 2.1 0.0 0.0 9.3 0.0 0.0 0.1 0.0 3.4 13.8 0.0 3.5 0.0 0.5 31.1 0.1 11.7 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 50.4 0.0 1.6 3.1 0.0 0.1 0.0 0.2 0.4 1.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 8.8 0.0 0.1 0.7 0.1 0.0 4.3 8.0 0.1 0.2 1.8 3.5 0.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 3.2 0.0 0.0 0.0 7.0 35.6 24.0 15.4 0.0 3.4 24.3 0.4 0.0 9.5 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 5.7 0.0 0.0 0.0 0.9 0.0 1.3 1.7 3.1 2.7 0.3 0.1 0.0 11.9 NUCB1 "Calnuc, NUC" ENSG00000104805 "Nucleobindin 1" Q02818 19 48900312-48923372 "Plasma proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 453.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008176 Supported Supported "Golgi apparatus,Microtubules" "Secreted to blood" NA NA 27000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 16: U-266 - Nucleosome" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" Microtubules "HPA008176: AB_1845923" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (4.36e-3)" "unprognostic (6.28e-2)" "unprognostic (1.06e-2)" "unprognostic (2.95e-1)" "unprognostic (6.86e-2)" "unprognostic (1.98e-1)" "unprognostic (9.51e-2)" "unprognostic (8.14e-3)" "unprognostic (2.34e-3)" "unprognostic (9.89e-2)" "unprognostic (5.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (8.90e-3)" "unprognostic (3.41e-1)" 181.3 103.5 55.8 106.8 60.4 82.3 141.6 65.5 68.1 115.0 79.4 122.1 179.9 127.6 61.3 111.2 116.9 108.3 204.0 58.2 63.0 154.6 264.5 157.1 82.1 65.9 62.9 125.6 130.1 173.5 69.5 114.8 67.5 109.2 54.8 30.2 117.8 103.0 180.1 96.6 163.6 106.0 57.7 111.1 118.8 34.7 73.1 49.5 122.2 110.7 53.1 130.1 108.9 61.6 54.8 182.1 84.2 188.5 304.6 249.2 97.6 208.1 189.9 103.3 144.2 92.9 203.1 54.7 151.8 250.6 98.9 132.0 48.6 107.0 43.3 194.6 90.3 141.6 119.0 131.6 156.6 85.1 183.6 288.0 52.1 96.8 62.9 275.2 167.2 60.7 173.1 278.8 107.0 71.6 42.3 68.6 42.2 132.1 93.5 78.7 125.3 114.9 90.2 134.6 61.2 123.2 247.1 152.2 88.1 79.7 78.8 112.1 234.6 172.3 114.3 107.0 99.3 210.8 501.1 37.1 132.5 54.3 207.3 102.9 108.5 105.7 100.6 128.5 75.3 46.8 67.5 77.2 79.0 37.3 55.3 56.7 104.7 69.2 114.2 113.9 74.6 129.5 55.8 60.4 65.5 68.1 58.2 63.0 65.9 62.9 67.5 57.7 73.1 61.6 154.5 41.7 72.1 17.6 51.0 48.3 67.2 81.3 66.0 21.7 57.6 57.5 58.0 78.6 51.5 69.9 14.6 101.5 69.6 153.0 41.1 148.0 10.8 27.4 65.5 116.0 74.4 54.5 14.5 118.3 150.9 126.7 76.0 50.2 95.2 64.1 122.0 149.2 213.7 20.2 18.9 109.9 69.2 138.3 74.6 9.3 110.3 101.9 101.4 17.8 120.3 52.6 74.2 8.5 11.8 100.0 149.2 124.1 126.3 63.8 453.3 135.4 24.4 20.5 92.1 51.0 79.0 21.9 37.6 65.6 49.9 102.1 73.0 103.9 123.3 68.1 NUCB2 NEFA ENSG00000070081 "Nucleobindin 2" P80303 11 17208153-17349980 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 758.3;salivary gland: 771.4" "Cell type enhanced" "Detected in all" "Early spermatids: 690.6;Late spermatids: 508.5;Respiratory ciliated cells: 618.8;Syncytiotrophoblasts: 1158.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 1867.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008395, CAB015931, CAB079781" Enhanced Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1250000 690000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 32: U-937 - Innate immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Golgi apparatus" "CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683" "unprognostic (2.49e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.27e-6)" "unprognostic (5.24e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-3)" "unprognostic (3.66e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.46e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" 56.2 75.7 23.9 62.1 27.8 619.9 141.1 28.8 32.1 137.2 58.0 68.3 57.3 60.8 458.2 146.3 107.2 60.8 95.7 22.8 34.7 43.2 102.2 49.8 60.2 25.7 28.2 56.0 758.3 479.1 113.0 90.9 26.8 70.9 68.4 64.5 771.4 190.9 38.5 21.1 40.7 78.5 26.2 42.2 92.9 119.2 28.4 334.2 153.9 30.4 78.5 61.8 44.9 26.6 119.9 49.0 53.7 163.4 118.9 162.3 65.0 260.5 381.0 115.1 203.0 48.7 26.8 182.9 63.5 250.7 107.1 50.1 34.4 66.8 178.7 126.7 76.3 135.8 57.8 85.2 340.5 1867.0 238.6 71.1 86.8 82.9 200.9 284.9 143.3 672.1 120.1 361.1 114.9 105.9 656.2 670.3 12.9 194.0 50.5 239.8 130.4 15.1 51.9 37.5 63.5 35.4 114.6 114.2 61.4 78.0 93.5 498.1 128.1 120.9 110.9 369.1 112.1 70.3 41.3 101.1 140.5 646.1 106.4 210.5 43.5 168.2 94.1 30.5 122.9 22.7 88.5 173.7 40.6 14.5 246.7 271.2 39.3 277.9 25.6 426.0 42.7 119.8 23.9 27.8 28.8 32.1 22.8 34.7 25.7 28.2 26.8 26.2 28.4 26.6 118.7 44.8 70.4 16.3 54.8 27.5 60.2 156.3 14.8 71.0 152.8 87.0 193.8 55.8 176.5 42.3 54.2 127.1 136.5 17.6 27.4 91.1 690.6 112.4 92.9 94.7 42.4 137.8 21.9 132.6 319.1 148.8 40.2 97.0 67.6 80.0 108.5 141.8 70.7 35.3 23.5 189.0 189.2 29.4 40.0 508.5 149.8 37.6 69.4 18.7 24.1 111.2 95.8 13.6 10.8 75.2 13.2 114.3 256.5 108.7 3.9 28.5 618.8 99.3 46.0 50.8 75.4 174.9 61.3 87.7 30.1 1158.2 92.3 88.3 45.3 61.2 NUDT18 "FLJ22494, MTH3" ENSG00000275074 "Nudix hydrolase 18" Q6ZVK8 8 22106874-22109419 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028581, HPA030125" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 25: Pancreas - Digestion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Golgi apparatus" "HPA028581: AB_10601381, HPA030125: AB_2673324" "unprognostic (9.90e-3)" "prognostic favorable (1.43e-4)" "unprognostic (4.88e-3)" "prognostic favorable (2.49e-6)" "unprognostic (1.29e-2)" "unprognostic (6.82e-3)" "unprognostic (1.20e-1)" "unprognostic (1.54e-2)" "unprognostic (5.30e-2)" "unprognostic (1.67e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.43e-1)" "prognostic favorable (8.30e-4)" "unprognostic (3.59e-3)" "unprognostic (1.05e-1)" "unprognostic (6.84e-2)" "unprognostic (2.32e-1)" 7.4 6.4 5.1 4.8 5.2 4.4 6.7 5.4 5.5 4.9 4.3 5.7 6.5 5.4 12.9 8.0 5.3 4.2 4.8 5.4 4.8 6.8 5.6 6.1 8.8 5.3 4.8 2.3 17.0 2.7 9.1 2.7 5.7 7.8 4.7 1.2 8.5 4.6 2.3 7.1 7.6 3.6 4.4 10.4 8.9 7.7 5.4 6.8 8.2 1.2 6.3 5.7 5.5 4.6 8.1 16.8 0.5 3.6 12.4 4.6 9.0 4.8 12.6 6.1 7.0 4.0 6.3 6.0 7.5 5.7 15.5 13.8 2.3 7.7 2.0 7.5 2.3 5.1 4.9 3.9 8.3 1.7 15.2 8.5 7.2 2.4 6.4 7.9 7.7 13.0 3.8 9.9 6.0 8.6 6.9 4.6 0.9 4.8 4.1 3.0 1.5 6.5 9.0 7.1 1.8 2.8 3.3 4.0 4.2 3.7 9.4 8.3 6.4 4.0 2.2 5.4 2.5 4.4 0.5 1.9 7.0 4.5 9.8 0.0 1.5 3.0 2.2 1.6 2.1 1.4 1.8 1.3 1.0 2.0 2.0 1.1 0.3 4.0 1.3 1.9 0.7 0.9 5.1 5.2 5.4 5.5 5.4 4.8 5.3 4.8 5.7 4.4 5.4 4.6 5.6 3.2 2.2 1.0 7.3 2.0 3.4 5.2 1.2 3.3 5.9 4.6 1.9 8.6 3.0 5.5 0.0 6.7 6.8 12.5 5.9 9.5 14.6 5.9 2.4 4.7 3.0 5.2 1.6 13.6 9.6 5.9 6.1 4.1 0.0 6.3 5.7 4.0 14.5 3.3 1.7 10.9 2.0 16.8 1.3 15.1 3.1 9.0 5.4 2.8 15.3 4.1 19.6 0.5 1.6 10.1 14.6 3.4 6.2 4.6 41.2 13.6 7.0 1.2 0.0 3.1 3.7 3.5 2.7 6.3 1.8 3.1 7.9 5.3 7.0 2.3 NUDT7 ENSG00000140876 "Nudix hydrolase 7" P0C024 16 77722492-77742260 "Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 70.1" "Cell type enhanced" "Detected in many" "Distal tubular cells: 58.7;Proximal tubular cells: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 49.7;U-698: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042042 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 85: Liver - Metabolism" "Cluster 43: THP-1 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" Nucleoplasm "HPA042042: AB_10806232" "unprognostic (1.92e-1)" "unprognostic (1.17e-2)" "unprognostic (6.64e-2)" "unprognostic (5.95e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.84e-4)" "unprognostic (2.48e-1)" "unprognostic (4.05e-2)" "unprognostic (2.11e-1)" "unprognostic (2.46e-2)" "unprognostic (4.74e-2)" "unprognostic (4.52e-1)" "prognostic favorable (5.36e-11)" "unprognostic (1.19e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (3.42e-2)" 14.4 23.6 5.9 5.2 6.0 2.2 9.2 6.4 7.4 5.8 15.6 12.0 10.8 7.8 17.5 6.6 10.2 6.8 37.6 5.6 7.8 22.1 70.1 6.1 8.9 5.5 5.4 7.3 9.5 16.3 6.0 4.5 6.0 6.6 12.3 9.7 9.0 7.2 8.1 9.0 8.7 7.4 5.3 7.0 7.5 8.7 6.8 6.4 11.8 12.1 9.1 8.2 5.8 6.1 2.1 7.0 6.2 3.5 28.4 7.2 5.8 1.8 9.1 2.7 3.5 2.0 8.8 10.3 6.6 6.9 6.5 6.9 4.7 7.6 1.6 3.3 6.4 0.1 0.4 9.6 3.1 7.1 1.4 12.2 9.4 1.5 5.3 1.2 4.8 14.7 7.6 4.4 1.1 19.1 3.7 16.8 6.6 12.4 1.7 7.8 0.8 3.1 14.1 0.0 5.1 5.0 6.5 2.6 5.7 10.6 18.6 49.7 3.7 3.1 0.4 1.4 0.3 0.0 0.0 40.6 12.1 8.8 0.0 3.8 12.4 1.7 12.6 17.5 14.4 14.2 14.8 15.1 10.2 19.8 19.5 13.5 2.0 3.5 17.5 11.7 31.5 8.8 5.9 6.0 6.4 7.4 5.6 7.8 5.5 5.4 6.0 5.3 6.8 6.1 8.3 16.0 8.7 12.7 4.1 9.7 6.5 14.6 14.2 2.5 10.9 14.5 17.9 18.6 7.9 14.7 0.0 20.3 7.9 12.1 58.7 8.0 11.6 19.5 4.7 8.2 6.7 3.6 4.3 9.5 9.1 8.5 3.6 6.6 1.3 7.0 5.3 41.2 5.9 6.7 5.6 6.6 10.2 9.2 4.4 4.6 5.6 4.1 8.8 1.9 2.1 25.0 10.3 3.5 2.7 4.0 10.4 4.9 1.1 2.0 22.6 42.2 21.0 7.3 6.6 7.1 8.9 14.2 20.0 12.2 13.9 6.7 6.9 10.7 14.8 4.5 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.5;pituitary gland: 22.0" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Bipolar cells: 6.2;Excitatory neurons: 11.1;Granulosa cells: 5.6;Horizontal cells: 13.5;Inhibitory neurons: 10.3" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.8;HUVEC TERT2: 3.9;SH-SY5Y: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Golgi apparatus" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 2.1 2.5 6.4 0.3 8.4 0.1 1.6 0.0 22.5 2.9 0.0 1.3 0.2 4.6 0.0 1.1 2.2 0.2 0.7 11.4 2.9 1.9 0.4 0.3 0.1 6.6 0.6 5.3 0.9 0.0 22.0 0.3 6.8 2.0 0.1 1.9 0.9 0.9 0.1 1.4 0.8 0.5 0.0 0.8 0.8 9.1 2.0 0.1 0.7 0.1 0.0 0.6 2.0 8.2 0.0 1.1 3.0 1.4 2.0 1.2 0.2 0.1 1.0 0.1 0.4 0.4 0.2 0.0 1.0 0.3 7.8 0.1 0.6 0.1 0.0 1.4 0.2 0.1 0.3 0.2 1.4 0.0 0.8 1.3 0.0 0.4 0.5 0.3 3.9 0.2 0.5 0.1 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 9.4 0.3 0.2 1.0 1.1 0.1 0.0 1.4 0.0 1.9 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.4 0.0 22.5 11.4 2.9 6.6 0.6 6.8 0.0 2.0 8.2 3.2 0.0 0.0 9.4 0.0 0.1 0.2 0.1 0.6 6.2 0.3 1.9 1.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.2 0.4 1.4 0.0 0.8 11.1 0.0 0.0 0.9 0.0 0.4 0.0 5.6 0.7 0.0 0.1 13.5 10.3 0.1 0.0 0.0 0.7 0.7 2.5 0.1 0.0 2.8 0.0 3.3 0.0 2.5 0.6 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.5 0.7 1.3 2.6 0.2 0.1 0.0 0.1 0.8 0.0 0.0 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24399003-24419283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 18.2;Squamous epithelial cells: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HEL: 14.7;HUVEC TERT2: 35.6;RT4: 29.8;TIME: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.7 3.7 4.3 3.1 3.9 0.4 6.3 16.3 4.6 16.8 5.4 7.6 4.0 11.5 28.0 11.6 16.9 8.6 7.5 3.2 6.6 6.3 4.5 8.1 1.9 5.8 5.4 35.1 3.8 5.8 5.8 12.8 6.3 7.5 5.5 1.8 7.4 14.9 3.8 13.3 5.3 10.5 3.2 4.4 6.0 5.1 7.8 4.5 7.8 4.2 2.9 9.5 14.0 2.8 0.2 0.1 4.6 0.0 6.3 13.0 0.3 2.2 2.3 1.5 1.6 3.3 14.4 0.4 0.6 8.6 0.2 0.0 7.5 0.2 1.5 0.0 0.8 14.7 2.0 0.3 4.7 0.0 0.0 13.3 0.6 1.0 0.0 2.6 35.6 0.1 2.4 0.0 0.2 0.6 0.0 0.8 2.7 1.0 0.0 1.9 0.0 0.0 0.0 29.8 0.6 10.0 0.0 1.3 0.2 11.2 2.5 2.1 17.4 0.1 8.2 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.3 3.9 16.3 4.6 3.2 6.6 5.8 5.4 6.3 3.2 7.8 2.8 15.2 3.2 1.7 4.9 0.1 4.6 3.9 9.5 15.4 0.5 1.8 3.6 3.1 8.6 15.6 9.2 0.0 1.1 1.6 2.7 0.0 4.1 0.8 1.4 10.8 15.0 5.4 3.6 1.0 3.0 1.0 10.1 10.7 1.7 0.0 12.0 18.2 2.7 10.7 0.0 3.9 9.0 4.1 9.0 1.4 0.2 2.5 1.4 3.6 3.7 0.7 5.4 0.0 0.5 0.1 4.8 5.1 0.4 1.2 1.2 1.0 0.3 10.8 0.2 0.0 1.2 7.3 0.3 1.2 18.0 3.8 1.1 0.3 1.5 8.8 4.5 OAZ2 ENSG00000180304 "Ornithine decarboxylase antizyme 2" O95190 15 64687573-64703281 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 324.9;Sertoli cells: 374.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 418.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047694 Uncertain Approved "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA047694: AB_2680121" "unprognostic (2.67e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (9.05e-4)" "unprognostic (2.09e-2)" "unprognostic (4.44e-2)" "unprognostic (2.32e-3)" "unprognostic (3.46e-2)" "unprognostic (7.94e-2)" "unprognostic (3.11e-2)" "unprognostic (5.24e-2)" "unprognostic (1.76e-3)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.54e-1)" "unprognostic (1.45e-1)" 65.1 68.5 110.1 49.5 111.8 32.9 55.1 112.2 112.5 61.1 108.0 72.4 28.4 64.7 57.2 44.4 59.8 46.9 79.3 110.1 114.5 68.4 89.3 55.8 50.7 112.6 114.6 56.5 35.9 96.8 75.0 75.1 112.4 53.3 35.8 123.4 45.3 49.1 207.9 45.9 40.9 72.3 114.3 89.8 47.7 80.8 114.4 41.7 65.8 152.5 45.4 56.3 48.3 116.4 71.2 63.5 130.6 43.5 91.8 79.4 24.6 80.5 120.6 113.4 98.5 43.5 62.2 61.6 72.7 113.4 84.5 37.5 126.7 71.6 99.2 82.4 48.3 40.3 48.3 32.5 52.2 35.7 125.7 104.4 49.6 57.0 40.1 147.4 109.2 42.9 30.1 29.6 123.4 45.3 24.5 43.8 223.1 39.1 50.7 57.5 74.5 54.0 102.0 55.7 68.4 125.1 30.4 45.0 80.3 161.6 75.6 52.7 66.0 76.4 102.2 38.0 87.0 65.1 104.6 58.2 87.4 75.2 69.8 22.1 145.3 268.4 29.3 247.8 24.2 30.2 24.6 24.0 91.1 29.1 27.9 25.3 418.0 39.5 209.6 49.4 30.7 115.5 110.1 111.8 112.2 112.5 110.1 114.5 112.6 114.6 112.4 114.3 114.4 116.4 67.5 25.6 43.5 15.3 36.1 121.7 99.5 67.7 47.8 93.8 57.9 40.4 61.9 44.3 41.0 42.3 104.3 114.1 33.4 19.2 168.3 109.5 324.9 35.2 30.0 109.3 81.9 33.3 14.6 66.0 70.9 61.3 14.3 20.5 103.3 36.9 134.6 83.6 133.9 74.0 13.6 26.0 91.6 115.4 238.1 80.9 114.3 86.6 103.2 20.6 114.2 268.2 49.4 12.1 26.9 81.8 25.7 68.1 19.1 88.9 29.2 94.2 51.1 180.8 374.7 68.1 160.9 166.2 83.9 28.0 121.2 68.5 31.7 44.3 27.4 72.4 OCEL1 FLJ22709 ENSG00000099330 "Occludin/ELL domain containing 1" Q9H607 19 17226213-17229219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 75.5" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 137.0;Proximal tubular cells: 150.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042070, HPA043223" Uncertain Approved "Golgi apparatus" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA042070: AB_2677830, HPA043223: " "unprognostic (6.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.13e-1)" "unprognostic (3.00e-3)" "unprognostic (6.40e-2)" "unprognostic (2.06e-2)" "unprognostic (4.33e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (4.64e-1)" "unprognostic (1.34e-1)" "unprognostic (2.52e-1)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "unprognostic (1.18e-3)" 18.3 21.6 14.9 4.7 15.8 5.6 16.4 15.9 24.9 14.8 15.5 20.9 19.0 13.5 18.9 9.4 18.1 5.8 17.4 14.6 15.6 37.4 75.5 14.6 7.3 17.4 16.0 11.2 22.7 7.2 9.2 6.7 17.0 21.1 12.3 8.9 14.9 9.0 14.0 8.8 20.0 7.2 16.4 17.3 22.1 6.7 16.5 6.7 20.5 13.5 9.5 13.9 12.3 15.8 8.2 6.4 3.3 2.9 34.9 13.8 8.5 5.3 14.5 4.1 7.2 4.6 9.8 7.2 19.5 7.8 3.6 3.9 4.5 5.4 3.8 6.0 5.3 6.7 6.8 22.6 11.7 1.4 10.5 11.1 5.6 4.8 8.1 14.2 5.9 8.9 5.8 6.8 7.5 6.7 3.7 4.0 5.6 12.3 11.3 2.7 2.8 18.2 17.7 11.2 1.1 5.6 3.3 10.8 9.4 6.9 16.4 6.8 3.9 2.6 3.0 5.1 2.6 18.5 15.3 5.8 7.7 6.3 1.2 27.7 30.8 15.2 9.9 20.9 9.5 15.7 15.1 11.4 23.3 17.0 16.5 10.8 9.7 16.0 17.1 10.0 19.1 13.4 14.9 15.8 15.9 24.9 14.6 15.6 17.4 16.0 17.0 16.4 16.5 15.8 14.6 12.8 8.2 3.9 16.4 6.4 26.7 18.8 17.1 11.4 21.4 23.7 7.3 27.1 21.9 20.2 2.1 38.6 23.9 66.8 60.7 21.4 6.3 59.3 12.5 15.6 17.4 9.7 4.7 27.1 46.0 17.2 25.5 20.4 15.9 8.0 25.0 93.5 25.8 25.2 5.2 40.5 10.2 26.1 7.5 14.6 28.3 22.3 16.0 3.7 19.2 29.6 24.7 1.0 4.6 21.0 67.4 23.3 23.2 20.7 137.0 150.5 71.8 9.7 32.9 12.5 25.8 7.8 13.8 8.8 6.7 103.2 16.4 19.9 28.1 21.9 ODF3L2 "C19orf19, FLJ40059" ENSG00000181781 "Outer dense fiber of sperm tails 3 like 2" Q3SX64 19 463346-474983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 8.2;testis: 23.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 1184.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA067065, HPA067973" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" Nucleoli "Nucleoplasm, Golgi apparatus" "HPA067065: , HPA067973: AB_2685937" "unprognostic (3.75e-4)" "unprognostic (1.79e-2)" "unprognostic (1.83e-3)" "unprognostic (9.69e-3)" "unprognostic (5.88e-2)" "unprognostic (5.65e-2)" "unprognostic (9.32e-2)" "unprognostic (1.35e-1)" "unprognostic (2.34e-2)" "unprognostic (1.77e-2)" "unprognostic (2.13e-2)" "unprognostic (4.06e-2)" "unprognostic (2.02e-5)" "unprognostic (3.13e-3)" "unprognostic (8.99e-2)" "unprognostic (3.05e-1)" "unprognostic (1.99e-1)" 0.3 0.3 0.7 0.0 0.7 0.0 0.3 0.4 0.9 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.5 0.5 0.2 0.3 0.2 0.0 0.7 0.6 0.1 0.1 0.0 0.1 0.2 0.7 0.2 0.0 0.1 0.0 0.0 8.2 0.1 0.2 0.0 0.5 0.7 0.1 23.4 0.8 0.0 0.3 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.4 0.9 0.5 0.5 0.7 0.6 0.7 0.5 0.8 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.8 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1184.9 8.4 0.6 0.0 1.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 7.6 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OGFRL1 dJ331H24.1 ENSG00000119900 "Opioid growth factor receptor like 1" Q5TC84 6 71288811-71309059 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.6" "Cell type enhanced" "Detected in many" "Astrocytes: 175.3;Langerhans cells: 144.0;Macrophages: 155.7;monocytes: 133.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 11.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027122 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 70: Brain - Nervous system development" "Cluster 32: U-937 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" Nucleoplasm "HPA027122: AB_2156775" "unprognostic (8.44e-3)" "unprognostic (1.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (4.24e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (9.62e-3)" "unprognostic (2.30e-2)" "unprognostic (2.49e-1)" "unprognostic (4.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (3.25e-2)" "unprognostic (5.58e-3)" 25.2 11.2 32.9 16.1 28.1 26.7 51.0 40.5 26.3 7.9 7.8 9.3 3.6 10.4 13.7 33.2 6.5 10.8 6.8 40.9 47.7 7.1 6.4 11.5 14.5 50.8 60.5 6.6 8.0 6.2 7.6 13.5 51.5 8.4 5.3 13.2 46.3 12.8 5.1 20.1 6.8 33.4 55.3 16.8 6.3 2.8 47.9 11.4 5.3 12.1 25.5 7.4 12.5 69.6 9.7 2.9 10.0 0.0 26.5 24.1 3.6 42.2 26.5 16.9 17.0 3.7 1.8 59.1 56.3 18.5 15.6 4.7 7.8 29.4 59.5 12.5 6.1 13.0 10.0 1.5 21.4 6.2 4.4 24.4 24.7 12.5 38.8 14.2 13.7 0.0 0.8 4.5 58.8 8.1 0.0 9.7 4.0 3.8 2.3 4.2 30.4 13.8 38.8 0.7 33.8 15.3 12.6 7.8 2.8 14.3 13.4 48.0 21.1 41.3 20.5 4.3 14.1 6.0 0.4 7.6 13.8 41.0 7.2 3.4 2.6 0.1 0.4 1.7 0.4 0.3 0.3 0.4 2.1 0.5 0.0 0.3 11.1 0.5 1.3 0.8 0.1 0.6 32.9 28.1 40.5 26.3 40.9 47.7 50.8 60.5 51.5 55.3 47.9 69.6 40.3 6.4 18.6 175.3 17.4 38.9 22.3 18.4 22.8 42.8 79.4 86.4 8.7 11.5 14.1 11.0 25.0 23.2 31.7 1.4 1.9 17.0 0.5 8.0 14.2 30.2 14.4 11.1 29.1 32.9 11.0 50.8 5.6 19.1 6.3 6.6 8.9 5.1 61.7 38.7 28.0 2.2 8.2 95.5 144.0 1.2 16.4 155.7 32.0 71.2 133.5 87.0 18.6 13.0 4.0 19.3 2.4 33.1 11.6 16.2 0.1 4.9 3.2 6.0 26.3 26.8 31.3 0.6 1.2 57.9 46.5 19.0 19.3 3.4 4.4 19.3 ORM1 ENSG00000229314 "Orosomucoid 1" P02763 9 114323056-114326475 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 193 "liver: 42973.6" "Cell type enriched" "Detected in some" 46 "Hepatocytes: 58657.7" "Cancer enriched" "Detected in many" 16 "liver cancer: 2506.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 47 "neutrophil: 193.9" "Lineage enriched" "Detected in many" 47 "granulocytes: 193.9" "Cell line enriched" "Detected in some" 12 "Hep G2: 1182.7" "CAB006265, HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 945000000000 61000000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" Vesicles "Golgi apparatus" "CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512" "unprognostic (3.85e-1)" "unprognostic (2.12e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (1.16e-1)" "unprognostic (4.85e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.35e-4)" "unprognostic (2.10e-1)" "unprognostic (4.38e-2)" "unprognostic (9.32e-3)" "unprognostic (4.51e-2)" 13.4 10.3 0.1 12.7 0.3 223.1 6.6 0.0 0.4 2.7 0.2 1.5 0.1 2.7 0.3 1.9 1.9 1.0 3.4 0.2 0.2 4.9 42973.6 24.4 0.7 0.4 0.2 1.6 8.1 0.0 1.4 1.3 0.1 57.6 0.0 1.1 1.4 0.0 2.0 1.7 2.3 0.3 0.2 51.3 19.2 2.7 0.1 1.2 2.8 0.3 0.1 1.6 2.2 0.2 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 3.4 0.6 1182.7 0.1 5.3 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.2 0.0 0.2 1.0 0.1 0.0 0.7 7.1 0.0 0.0 0.4 0.0 0.0 5.7 5.5 0.0 0.0 0.4 102.0 1.2 0.0 0.5 0.0 0.0 1.2 0.6 3.5 0.0 4.3 0.1 0.0 4.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 193.9 0.0 1.0 0.0 0.0 1.8 0.1 0.3 0.0 0.4 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.2 0.0 3.2 18.1 0.0 81.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1166.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 1.3 0.2 34.4 0.0 890.4 0.0 4.9 0.3 0.2 0.0 2.5 0.0 0.0 930.9 58657.7 0.1 0.0 0.0 0.0 0.0 1260.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 78.6 0.0 0.0 0.3 ORM2 "AGP-B, AGP-B', AGP2" ENSG00000228278 "Orosomucoid 2" P19652 9 114329869-114333251 "Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 327 "liver: 8873.2" "Cell type enriched" "Detected in some" 41 "Hepatocytes: 10792.5" "Cancer enriched" "Detected in many" 34 "liver cancer: 873.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 40 "neutrophil: 12.0" "Lineage enriched" "Detected in single" 40 "granulocytes: 12.0" "Cell line enriched" "Detected in some" 232 "Hep G2: 831.1" "HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 422000000 41000000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Golgi apparatus" "HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512" "unprognostic (6.77e-2)" "unprognostic (8.00e-2)" "unprognostic (1.19e-1)" "unprognostic (4.44e-3)" "unprognostic (1.18e-1)" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (9.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (1.23e-9)" "unprognostic (3.23e-1)" "unprognostic (6.80e-2)" "unprognostic (7.62e-2)" "unprognostic (9.15e-4)" 4.0 4.0 0.2 3.2 0.4 27.1 3.0 0.0 0.2 1.3 0.2 0.3 0.2 2.1 0.1 0.4 0.4 0.6 0.8 0.1 0.1 1.7 8873.2 5.8 1.1 0.2 0.3 0.3 2.1 0.0 0.2 0.2 0.1 23.6 0.1 3.6 0.3 0.0 0.4 0.4 0.4 0.1 0.2 7.3 21.9 1.4 0.1 0.5 0.3 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.0 831.1 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.1 1.1 0.4 2.5 0.0 0.3 1.9 0.1 0.0 0.3 0.1 0.0 2.6 2.0 0.2 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.6 2.2 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.2 0.1 0.1 0.2 0.3 0.1 0.2 0.1 0.2 0.0 0.0 10.5 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 263.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.6 1.1 0.1 7.0 0.0 141.7 0.0 6.0 0.0 0.0 15.8 1.3 0.0 0.0 162.8 10792.5 0.0 0.0 0.0 0.0 0.0 236.1 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.2 OSBP OSBP1 ENSG00000110048 "Oxysterol binding protein" P22059 11 59574398-59615774 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039227, HPA043625" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 70000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039227: AB_2676401, HPA043625: AB_2678587" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "prognostic favorable (2.08e-5)" "unprognostic (7.80e-3)" "unprognostic (7.32e-2)" "unprognostic (2.79e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (7.42e-2)" "unprognostic (1.42e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.08e-7)" "unprognostic (1.25e-1)" "unprognostic (9.00e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" 19.6 41.7 14.1 15.5 15.2 27.2 27.4 15.3 18.9 24.7 18.4 26.8 29.4 20.0 31.6 19.6 22.4 19.5 25.5 15.0 15.6 42.8 57.6 18.5 17.8 15.4 16.7 22.4 37.3 44.9 16.1 22.9 16.7 25.9 28.3 15.9 30.1 27.0 57.7 26.6 25.5 21.2 14.0 15.6 27.8 18.0 15.7 24.0 32.3 43.8 23.7 19.6 17.1 15.1 40.9 33.6 24.7 33.2 56.5 52.4 26.8 32.9 42.3 38.4 34.4 38.1 40.2 41.1 42.7 37.9 47.2 41.4 45.4 43.5 43.0 40.0 20.9 28.1 25.1 25.8 60.2 36.2 52.9 40.4 52.8 36.2 94.4 40.0 41.7 38.3 48.6 37.3 34.5 19.0 34.0 26.2 28.0 59.5 32.7 32.5 39.8 28.6 45.6 47.0 28.5 20.3 38.6 47.7 46.0 33.6 66.9 22.7 45.8 32.7 22.8 49.5 22.3 51.9 45.2 41.4 37.0 25.6 26.8 1.7 1.6 1.5 2.8 1.4 2.6 2.2 2.9 2.3 1.6 1.6 2.6 2.1 1.5 2.2 1.3 4.0 1.3 1.1 14.1 15.2 15.3 18.9 15.0 15.6 15.4 16.7 16.7 14.0 15.7 15.1 29.2 25.6 9.0 14.7 18.9 39.6 16.4 13.7 29.6 23.8 38.0 27.1 34.1 32.9 19.0 27.6 22.9 14.2 31.1 34.0 7.9 14.0 8.8 37.9 52.7 21.8 30.0 10.5 25.6 18.6 14.7 21.1 22.4 43.8 27.9 21.8 15.4 67.1 16.0 26.9 22.9 40.0 8.2 12.9 16.9 14.5 15.8 17.9 14.2 12.2 9.6 15.7 18.6 18.1 23.3 20.2 20.5 19.9 32.2 31.2 34.6 21.0 27.8 21.7 6.6 28.4 19.3 25.1 14.5 27.0 47.3 30.8 20.0 43.5 28.4 26.4 OSBPL10 ENSG00000144645 "Oxysterol binding protein like 10" Q9BXB5 3 31657912-32077580 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 440.2;Late spermatids: 1206.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 17 "memory B-cell: 11.5;naive B-cell: 6.7" "Lineage enriched" "Detected in single" 22 "B-cells: 11.5" "Cell line enhanced" "Detected in many" "hTERT-HME1: 93.3;RPTEC TERT1: 118.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003636 Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Plasma membrane, Cytosol" "HPA003636: AB_1079529" "unprognostic (5.28e-3)" "unprognostic (2.06e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.98e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (8.55e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.15e-1)" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.85e-4)" 8.3 2.6 3.1 7.8 3.0 1.2 6.0 0.1 3.6 10.2 6.5 6.5 3.7 8.4 6.6 13.0 5.9 11.4 2.9 4.8 2.7 13.3 2.2 5.8 12.9 1.2 4.9 3.1 1.6 1.6 6.7 22.3 3.0 11.8 7.8 5.5 6.8 20.9 1.6 4.9 6.7 11.1 0.3 9.5 6.1 25.0 1.3 2.8 3.5 2.2 17.8 20.3 5.9 2.6 19.3 10.6 2.0 39.3 4.2 7.4 63.1 5.2 6.1 4.9 6.8 27.0 14.3 45.6 48.8 1.1 17.0 11.5 8.9 45.1 6.0 0.3 8.2 0.1 26.4 18.3 2.7 0.1 0.2 7.7 39.7 7.8 93.3 18.2 23.4 0.2 0.1 0.2 22.7 16.0 0.2 0.1 24.9 64.9 26.5 0.5 0.8 0.9 118.3 7.8 3.0 0.5 8.9 17.0 5.4 36.9 11.1 0.2 15.2 6.1 61.7 0.5 26.2 4.1 3.0 42.6 8.6 0.1 39.3 0.2 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 6.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 3.1 3.0 0.1 3.6 4.8 2.7 1.2 4.9 3.0 0.3 1.3 2.6 20.5 9.6 3.9 2.9 50.6 10.8 7.5 10.1 4.6 7.3 13.8 6.6 2.3 4.3 7.3 7.3 0.0 15.3 2.4 7.9 9.8 1.8 440.2 11.0 26.5 21.1 15.0 5.7 70.5 4.9 25.9 10.4 6.1 26.4 0.0 1.3 18.2 0.6 2.5 0.0 129.9 4.6 6.1 0.9 6.3 1206.2 11.1 2.2 8.8 17.8 1.7 45.7 1.0 12.1 2.3 16.2 9.0 4.1 21.0 18.3 6.1 24.8 6.9 2.3 19.7 4.8 15.6 7.0 4.1 14.4 12.4 30.2 3.5 1.0 8.8 16.3 OSBPL11 "FLJ13012, FLJ13164, ORP-11, ORP11" ENSG00000144909 "Oxysterol binding protein like 11" Q9BXB4 3 125528858-125595497 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 57.3;tongue: 80.1" "Cell type enhanced" "Detected in many" "Kupffer cells: 74.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039144 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Golgi apparatus" "HPA039144: AB_10794086" "unprognostic (1.14e-1)" "unprognostic (1.31e-3)" "unprognostic (2.57e-3)" "unprognostic (9.73e-3)" "unprognostic (6.38e-2)" "unprognostic (6.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.43e-1)" "unprognostic (6.68e-2)" "unprognostic (1.42e-1)" "unprognostic (9.25e-2)" "unprognostic (9.84e-2)" "unprognostic (6.43e-2)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (3.58e-2)" "unprognostic (1.13e-1)" 10.0 5.4 11.6 10.9 13.3 7.0 6.0 8.6 10.5 6.3 4.4 8.2 6.8 7.6 5.6 8.4 5.7 6.5 6.6 9.1 15.2 8.5 28.9 14.0 13.1 11.0 14.1 5.5 3.7 13.3 3.9 10.9 12.6 5.6 8.1 6.0 4.2 7.7 57.3 7.5 6.2 8.8 9.9 15.4 5.2 10.3 12.3 12.4 7.4 80.1 12.2 8.4 4.9 12.3 21.2 10.9 20.4 11.7 22.4 12.0 27.5 15.6 11.9 18.7 21.3 21.3 7.2 34.2 19.2 12.5 15.5 15.5 22.7 13.3 24.7 9.6 10.2 15.6 12.5 14.0 12.6 11.9 20.8 9.7 15.8 15.6 13.6 7.5 13.8 16.2 16.5 15.0 17.1 12.2 24.4 5.8 28.8 15.1 10.0 21.1 11.8 40.4 15.5 12.6 4.6 12.4 18.9 10.6 16.3 13.9 11.2 6.1 14.8 15.2 13.9 22.4 12.2 9.8 11.1 41.5 10.7 4.1 14.9 16.5 12.3 3.1 2.1 12.1 1.8 4.3 1.3 2.2 14.9 3.3 1.4 1.6 18.2 2.5 10.1 6.2 2.9 4.5 11.6 13.3 8.6 10.5 9.1 15.2 11.0 14.1 12.6 9.9 12.3 12.3 14.4 9.6 14.4 33.3 16.0 9.9 7.3 3.9 10.8 18.7 12.1 11.6 9.4 7.2 9.9 9.2 12.5 12.4 22.8 29.1 5.9 8.5 1.3 34.5 13.7 9.7 4.2 9.4 14.8 6.9 10.3 9.4 6.6 24.3 3.8 10.6 10.8 37.6 26.6 8.4 18.6 6.0 0.0 74.0 27.5 4.0 6.5 40.3 12.4 38.4 48.6 12.2 13.4 15.1 18.1 11.4 21.3 7.2 10.5 7.8 10.7 9.7 8.9 33.8 6.6 18.0 10.5 13.0 18.6 9.2 15.8 23.1 11.1 5.3 9.5 10.4 OSBPL9 ENSG00000117859 "Oxysterol binding protein like 9" Q96SU4 1 51577179-51798427 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 216.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027378, HPA027397" Supported Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" Vesicles "HPA027378: AB_1854816, HPA027397: AB_1854817" "unprognostic (5.99e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-2)" "unprognostic (2.43e-3)" "unprognostic (3.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.85e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-3)" "unprognostic (1.58e-1)" "unprognostic (8.36e-3)" "unprognostic (8.61e-2)" "unprognostic (3.64e-2)" "unprognostic (7.53e-3)" "unprognostic (2.55e-1)" "unprognostic (4.95e-2)" "unprognostic (3.37e-1)" 27.5 38.1 17.9 18.1 23.8 30.1 32.6 26.3 23.5 25.5 28.3 20.8 17.4 31.1 31.0 17.7 23.3 17.6 37.0 17.6 23.9 42.8 60.8 27.5 25.9 25.0 21.8 30.5 33.3 60.0 21.1 21.8 26.6 27.8 19.1 53.5 22.0 22.4 70.0 19.6 21.7 24.2 23.0 27.2 34.3 28.4 22.2 21.8 24.7 35.2 33.0 23.7 24.7 32.2 66.3 31.7 69.0 11.2 38.1 17.9 90.7 30.1 50.8 54.9 60.0 53.0 46.6 105.8 54.4 34.1 120.9 26.9 59.2 57.4 76.9 71.9 41.9 77.4 62.7 104.7 36.9 81.7 35.5 44.7 55.0 56.8 31.4 66.8 68.9 52.1 154.4 31.1 26.7 45.4 20.3 92.5 97.0 26.8 15.1 58.2 102.8 110.5 74.0 47.4 31.8 45.2 22.4 79.6 93.7 154.7 38.0 82.8 22.9 11.6 51.2 17.2 58.1 80.2 52.5 120.4 39.3 32.8 23.0 52.7 12.2 30.5 20.1 9.9 28.9 32.6 19.7 20.8 25.0 23.9 21.0 22.2 16.9 16.3 9.4 23.2 20.5 16.4 17.9 23.8 26.3 23.5 17.6 23.9 25.0 21.8 26.6 23.0 22.2 32.2 32.5 80.1 56.8 75.4 39.2 17.7 33.8 25.7 34.1 102.0 34.2 33.0 47.9 38.6 50.5 46.0 41.7 89.2 30.4 20.5 125.2 47.6 40.7 36.3 46.3 30.1 29.8 35.7 64.8 47.8 50.2 48.6 54.0 52.9 33.6 75.7 18.2 61.7 40.1 26.9 113.0 18.3 38.7 22.7 16.0 38.3 62.4 25.3 65.8 63.7 50.1 43.8 29.9 62.8 216.4 41.9 14.3 50.0 81.4 38.5 26.4 59.7 32.1 35.3 46.0 36.9 62.9 32.3 18.9 26.9 18.9 75.5 32.0 52.2 21.2 27.4 OTUD1 "DUBA7, OTDC1" ENSG00000165312 "OTU deubiquitinase 1" Q5VV17 10 23439075-23442377 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 149.0;Langerhans cells: 219.1;Macrophages: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.1;HaCaT: 36.5;SiHa: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038503, HPA038504" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA038503: AB_2676049, HPA038504: AB_10672712" "unprognostic (1.84e-1)" "unprognostic (2.80e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.56e-1)" "unprognostic (1.29e-2)" "unprognostic (3.18e-3)" "unprognostic (2.41e-1)" "unprognostic (7.77e-2)" "unprognostic (4.10e-2)" "unprognostic (1.80e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.61e-7)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-2)" 13.0 11.7 8.0 10.2 8.4 60.4 10.3 9.5 10.2 8.4 8.4 8.7 6.8 10.2 6.8 7.8 11.2 9.7 43.4 8.7 9.0 19.7 7.6 19.7 14.4 8.3 8.0 13.6 6.9 19.4 8.0 12.1 7.6 8.8 7.6 5.9 6.7 7.6 29.4 20.9 8.2 9.4 8.4 13.7 22.9 7.5 9.2 6.8 13.3 22.6 12.5 11.9 7.6 9.2 4.8 2.3 2.4 1.1 9.3 4.6 3.2 1.9 4.2 4.4 4.0 0.9 38.1 2.2 4.1 2.4 1.5 36.5 2.5 4.5 2.9 17.4 7.1 0.1 5.7 1.5 8.0 0.4 3.2 4.8 19.4 1.3 6.1 3.9 1.5 2.2 0.5 15.1 2.5 2.3 1.5 1.4 1.9 2.7 1.3 2.4 10.8 2.2 5.8 4.0 1.1 2.6 23.4 4.1 11.3 6.3 1.7 3.3 2.7 2.5 3.7 7.0 0.8 7.6 15.0 1.1 3.8 1.5 1.0 2.5 0.5 1.0 0.3 0.6 0.3 0.7 0.5 0.3 0.3 1.2 0.4 0.6 1.3 0.0 1.9 0.2 1.3 0.2 8.0 8.4 9.5 10.2 8.7 9.0 8.3 8.0 7.6 8.4 9.2 9.2 17.3 67.3 11.5 3.3 55.9 32.0 7.1 5.0 13.6 20.1 12.3 9.1 149.0 7.2 4.9 5.5 2.1 3.3 9.6 47.2 11.7 6.0 8.0 35.0 44.5 25.6 6.0 13.5 4.3 7.1 3.2 20.8 47.4 33.8 5.7 10.4 16.4 10.1 51.0 53.8 4.8 77.9 10.2 68.2 219.1 7.6 6.5 105.7 33.8 8.4 9.3 33.8 10.3 4.0 6.5 10.1 16.3 13.2 50.0 7.7 8.0 25.1 9.8 26.2 6.6 82.2 19.4 7.2 4.7 15.1 30.5 7.9 16.5 7.5 24.3 10.9 OTUD6B "CGI-77, DUBA5" ENSG00000155100 "OTU deubiquitinase 6B" Q8N6M0 8 91070196-91087095 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024046, HPA024503, HPA024772" Approved Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846" "prognostic unfavorable (7.50e-4)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (4.78e-3)" "unprognostic (4.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.52e-2)" "unprognostic (1.16e-3)" "unprognostic (2.17e-1)" "unprognostic (5.51e-2)" "unprognostic (1.27e-2)" "unprognostic (8.61e-3)" "unprognostic (1.87e-2)" "unprognostic (1.96e-1)" "unprognostic (4.53e-1)" "unprognostic (8.78e-2)" "unprognostic (5.71e-2)" 6.6 6.2 5.7 6.3 6.1 5.9 7.2 5.9 8.6 5.2 5.0 5.3 4.2 6.0 4.6 6.4 4.2 3.9 6.5 5.4 6.1 5.4 5.4 4.7 7.4 6.2 6.2 5.3 4.6 4.0 3.5 8.0 6.3 5.8 5.4 3.1 4.3 4.7 10.2 6.4 4.4 5.5 6.3 5.0 4.3 6.4 5.9 5.7 6.0 9.2 6.1 6.3 5.4 7.5 27.6 11.1 12.8 10.4 6.4 5.6 14.5 19.1 7.4 19.1 12.6 8.6 16.6 25.6 9.0 10.2 7.6 9.1 26.4 16.1 31.6 21.6 16.9 34.5 11.7 8.3 13.3 18.7 21.0 7.2 9.8 14.0 35.5 11.6 17.5 19.4 36.5 19.1 18.9 9.6 31.7 17.5 8.1 20.3 27.3 19.4 11.2 28.9 18.9 15.1 3.5 14.6 2.6 55.9 22.7 16.3 25.5 11.8 15.8 12.3 17.2 20.6 20.5 17.1 29.5 37.2 16.8 26.2 23.1 1.7 1.9 1.1 1.5 2.7 2.0 2.0 1.4 1.7 2.6 1.8 2.1 1.9 0.2 3.4 2.1 4.0 0.8 1.0 5.7 6.1 5.9 8.6 5.4 6.1 6.2 6.2 6.3 6.3 5.9 7.5 11.9 9.6 11.3 9.8 13.7 23.2 6.5 4.0 10.8 13.0 6.5 5.2 14.3 8.6 9.2 1.8 33.3 10.8 16.5 5.1 9.8 4.8 0.9 10.6 9.9 10.9 10.8 8.2 18.0 4.9 10.0 9.0 7.7 8.6 18.4 10.7 8.9 11.7 8.1 11.8 15.5 4.9 4.1 8.7 12.5 2.2 9.6 8.3 3.6 12.2 10.2 12.2 11.3 18.6 21.6 6.6 3.7 4.1 12.0 8.9 2.8 8.2 8.8 15.3 0.0 8.2 9.6 3.2 7.0 12.5 18.2 6.7 10.7 9.9 6.4 5.9 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 22 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "Nucleoplasm, Vesicles, Cytosol" "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 4.9 41.6 2.8 4.9 3.1 1.0 6.5 3.0 3.1 17.0 1.8 24.0 2.7 17.6 18.5 11.0 8.0 4.8 8.8 3.3 4.8 51.3 7.0 28.7 2.4 7.6 4.7 16.1 3.6 2.3 8.2 9.2 6.7 37.6 10.4 19.3 4.9 26.5 1.2 17.8 6.7 32.4 5.2 54.8 23.9 4.2 4.9 5.2 3.0 1.7 2.0 11.9 19.9 8.3 46.9 18.2 35.1 0.2 0.6 1.4 42.1 48.7 19.3 7.8 12.6 15.0 18.0 0.1 27.1 8.6 120.2 109.9 0.1 65.3 16.3 0.4 6.2 0.1 12.1 0.3 35.4 0.2 0.3 16.9 21.4 15.2 5.4 73.5 1.4 0.1 0.1 0.4 12.3 1.1 0.1 0.4 11.0 31.3 3.7 0.1 7.1 2.8 109.8 77.5 2.5 0.3 66.1 3.7 29.3 51.1 0.1 0.7 24.4 45.9 16.8 0.4 8.9 3.4 0.2 0.5 10.6 0.2 60.2 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 28.9 0.0 0.2 2.8 3.1 3.0 3.1 3.3 4.8 7.6 4.7 6.7 5.2 4.9 8.3 5.7 48.1 80.3 19.2 1.0 0.0 7.7 0.0 13.6 2.3 1.6 9.9 1.0 2.8 3.1 44.1 4.2 42.0 9.5 19.8 5.9 4.7 19.6 2.0 27.3 10.5 0.0 2.7 55.6 0.8 14.7 10.3 8.6 1.5 1.3 124.1 32.5 0.8 11.4 10.1 60.4 0.5 0.0 3.2 0.0 14.9 4.7 5.6 0.0 91.8 0.8 44.5 0.0 43.7 4.4 30.6 1.9 0.0 0.2 15.1 0.0 26.2 0.0 1.2 0.0 10.9 45.2 0.5 0.9 13.5 0.0 38.6 0.7 74.3 2.1 3.9 PAGE4 "CT16.7, GAGEC1, PAGE-4" ENSG00000101951 "PAGE family member 4" O60829 X 49829260-49834264 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "epididymis: 871.9;placenta: 1023.1" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 13314.7;Syncytiotrophoblasts: 8524.1" "Group enriched" "Detected in some" 17 "liver cancer: 14.8;prostate cancer: 7.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 10.2;U-266/70: 11.7;U-266/84: 45.1" "Not detected" "Not detected" HPA023880 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Golgi apparatus" "HPA023880: AB_1854930" "unprognostic (8.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-3)" "unprognostic (5.37e-2)" 0.3 5.7 0.1 0.3 0.2 0.0 0.0 0.1 0.5 7.0 0.1 0.2 0.4 51.2 871.9 0.0 21.4 0.0 0.4 0.1 0.2 3.1 0.3 0.2 0.0 0.1 0.1 3.7 2.5 0.0 1.3 1023.1 0.1 171.8 0.0 0.0 0.6 77.2 2.3 0.0 0.3 24.2 0.0 0.3 0.2 5.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.0 0.1 11.7 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13314.7 0.0 0.0 0.0 0.0 4.4 1.9 72.5 25.9 0.0 0.0 0.0 0.0 905.4 72.5 0.0 1.9 0.0 0.0 0.0 0.0 1052.1 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 48.8 20.7 0.0 0.0 8524.1 0.3 0.0 0.0 0.1 PAM "PAL, PHM" ENSG00000145730 "Peptidylglycine alpha-amidating monooxygenase" P19021 5 102753981-103031105 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1560.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 1406.5;Enteroendocrine cells: 321.4;Inhibitory neurons: 487.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 529.9;fHDF/TERT166: 714.5;hTERT-RPE1: 562.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026119, HPA042260" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA 98000000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus, Cytosol" "CAB026119: , HPA042260: AB_2677919" "unprognostic (4.30e-3)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.63e-4)" "unprognostic (4.23e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (7.58e-2)" "unprognostic (6.62e-2)" "unprognostic (2.71e-1)" "unprognostic (9.91e-2)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.08e-1)" "unprognostic (9.79e-2)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" 119.3 202.5 71.6 34.6 81.4 10.1 99.0 50.7 82.5 595.0 96.2 125.1 52.6 140.9 678.2 69.4 87.6 97.3 1560.4 75.2 179.9 116.0 20.1 88.3 27.7 86.5 99.8 136.4 104.4 257.8 137.0 60.0 170.9 91.6 80.4 37.6 205.4 236.5 155.3 66.9 52.1 157.9 55.7 52.5 131.6 22.4 106.0 17.9 95.1 159.4 30.5 103.3 116.1 50.0 111.3 16.3 195.9 87.2 529.9 314.8 78.0 307.6 457.0 89.1 268.9 53.5 143.2 0.1 65.0 714.5 125.7 36.8 11.0 135.3 244.0 13.5 44.7 22.9 60.0 17.7 80.3 7.4 23.9 173.4 57.3 65.6 49.2 562.6 186.8 8.9 0.9 15.0 255.6 22.9 0.1 3.2 35.3 19.7 59.3 8.5 108.9 62.4 346.1 13.0 92.3 63.9 131.2 8.3 83.3 114.0 34.0 7.3 144.9 280.8 72.4 133.3 93.4 33.1 8.6 0.4 322.3 30.8 247.6 4.2 8.0 0.2 20.7 1.5 14.9 0.8 12.3 15.6 3.1 0.4 4.1 6.8 16.6 26.3 3.4 1.6 19.9 10.8 71.6 81.4 50.7 82.5 75.2 179.9 86.5 99.8 170.9 55.7 106.0 50.0 45.7 54.5 39.3 47.0 3.9 28.2 12.0 26.1 12.0 19.1 27.5 12.1 1406.5 0.0 30.4 60.7 2.1 1.6 12.6 13.7 7.9 12.6 8.8 47.6 48.6 63.5 321.4 3.4 229.2 21.5 40.6 220.4 26.0 83.0 9.5 68.3 74.6 3.5 5.9 8.4 487.7 13.8 18.3 10.3 48.3 8.1 60.3 9.3 37.4 192.0 9.5 11.6 22.6 154.8 9.3 30.6 6.3 58.6 12.1 26.4 4.8 43.8 19.2 3.8 19.7 36.4 44.9 2.6 5.6 8.0 23.7 6.7 16.6 19.3 6.3 18.2 PANK3 FLJ12899 ENSG00000120137 "Pantothenate kinase 3" Q9H999 5 168548495-168579368 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078669 Approved Approved "Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA078669: " "unprognostic (1.24e-2)" "unprognostic (5.71e-2)" "prognostic favorable (3.94e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-2)" "unprognostic (2.42e-2)" "unprognostic (1.20e-2)" "unprognostic (8.43e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-1)" "unprognostic (9.48e-2)" "unprognostic (2.30e-1)" "unprognostic (3.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (1.97e-3)" "unprognostic (2.01e-1)" 12.5 20.1 6.8 13.5 8.3 17.9 25.5 20.4 10.0 10.5 2.6 27.0 41.5 13.2 9.3 13.1 7.9 10.0 10.3 8.5 7.9 15.0 43.2 10.3 13.1 8.8 8.7 11.3 10.5 21.8 6.3 14.1 8.5 12.8 25.7 18.0 10.5 7.8 7.7 14.9 30.5 11.7 7.6 12.7 16.1 12.5 9.4 14.2 15.2 12.1 12.5 11.5 11.2 10.4 29.0 16.1 65.2 34.9 23.8 27.5 27.5 17.1 18.0 22.3 32.5 26.9 26.1 44.9 27.3 24.3 35.6 20.3 44.2 34.2 40.1 42.1 21.6 23.4 15.2 20.1 27.7 31.1 29.4 22.1 45.4 28.1 31.4 15.8 26.5 33.1 21.5 43.4 31.0 16.0 31.3 14.1 27.7 22.2 12.1 22.3 44.8 18.2 28.1 42.2 30.2 64.4 19.6 31.5 48.9 32.6 41.2 38.8 27.8 29.9 41.3 17.9 36.8 30.0 45.1 32.5 17.8 31.3 23.8 1.1 1.0 0.5 0.5 1.2 0.7 1.4 0.6 0.6 0.6 0.5 0.4 0.7 0.4 0.3 1.7 0.9 0.7 0.3 6.8 8.3 20.4 10.0 8.5 7.9 8.8 8.7 8.5 7.6 9.4 10.4 26.3 25.6 19.3 6.2 18.3 34.3 23.6 27.4 4.6 28.7 59.1 29.0 16.4 17.2 26.4 25.8 27.1 17.6 29.9 114.8 9.8 17.9 12.8 20.4 28.7 24.8 34.2 36.4 23.3 20.1 14.2 22.0 36.7 32.4 15.2 31.4 14.3 94.2 23.0 28.6 22.6 37.5 26.4 33.6 30.5 17.0 16.8 25.0 23.2 10.3 23.1 12.6 14.4 12.5 17.5 23.0 40.4 17.7 17.0 40.1 98.3 27.2 22.7 26.4 26.3 30.7 28.0 42.1 25.1 26.7 56.1 41.9 18.0 42.4 50.6 52.3 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins, Transporters" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 144.9" "Cell type enhanced" "Detected in many" "Astrocytes: 168.5;Distal enterocytes: 154.3;Microglial cells: 74.0;Oligodendrocytes: 298.2;Paneth cells: 80.7;Proximal enterocytes: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 41.8;OE19: 87.9;SuSa: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Golgi apparatus" "HPA064625: AB_2685304" "prognostic favorable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favorable (6.40e-4)" 2.7 4.0 83.7 9.2 113.9 1.2 2.3 122.9 86.7 4.7 42.0 38.9 19.3 5.1 8.0 17.6 6.3 6.0 3.5 74.4 89.7 8.0 1.5 7.3 10.3 133.8 110.7 24.3 2.8 5.2 2.2 7.0 123.1 4.3 36.7 2.9 2.2 23.3 0.9 3.1 33.7 6.3 102.8 6.2 32.3 3.7 106.4 9.2 2.8 1.5 7.6 9.7 5.5 144.9 0.9 1.0 10.7 4.6 6.3 10.2 7.3 3.2 12.1 2.0 4.4 4.1 3.8 1.1 1.2 2.2 4.7 0.4 1.4 5.3 3.2 14.8 1.7 6.6 1.0 41.8 1.7 1.8 0.9 2.9 0.7 1.4 7.5 7.4 11.5 12.9 1.5 6.4 8.3 1.5 4.4 6.1 5.4 87.9 0.5 11.5 1.7 2.8 12.4 3.1 4.0 8.7 0.8 0.3 12.4 34.4 0.3 14.7 4.8 4.0 1.6 1.2 1.9 1.9 2.6 1.6 3.7 16.9 21.5 3.0 3.2 1.4 2.8 0.6 4.2 1.1 8.3 5.7 7.0 1.0 17.8 8.3 0.6 8.5 0.6 3.5 6.2 4.2 83.7 113.9 122.9 86.7 74.4 89.7 133.8 110.7 123.1 102.8 106.4 144.9 4.9 3.2 10.6 168.5 3.6 2.0 3.7 3.1 0.6 2.1 0.7 1.3 4.4 14.3 3.5 3.7 8.4 1.7 7.6 154.3 0.0 4.4 0.5 12.2 3.9 7.4 22.9 4.2 21.1 1.1 3.1 6.8 18.8 7.5 4.5 23.7 4.2 0.2 8.8 0.0 19.4 45.5 6.1 19.8 3.5 1.6 5.6 7.3 14.2 74.0 11.4 4.2 3.1 19.1 298.2 4.9 80.7 10.1 0.6 6.6 100.5 0.1 8.9 3.3 0.0 1.0 3.6 12.1 3.3 5.3 1.0 0.8 9.2 10.0 42.5 7.3 PARP10 "ARTD10, FLJ14464" ENSG00000178685 "Poly(ADP-ribose) polymerase family member 10" Q53GL7 8 143977153-144012772 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 16.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028122, HPA052427" Approved Supported "Nucleoli rim,Golgi apparatus,Cytosol" No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoli rim" "Golgi apparatus, Cytosol" "HPA028122: AB_10601979, HPA052427: AB_2681828" "unprognostic (9.80e-3)" "unprognostic (5.89e-2)" "unprognostic (2.63e-3)" "unprognostic (9.10e-2)" "unprognostic (1.74e-2)" "unprognostic (1.46e-2)" "unprognostic (7.37e-2)" "unprognostic (3.61e-1)" "unprognostic (9.05e-2)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (1.05e-1)" "unprognostic (4.69e-3)" "unprognostic (1.09e-3)" "unprognostic (4.17e-2)" "unprognostic (8.69e-2)" "unprognostic (5.30e-3)" 25.2 34.9 10.0 36.3 10.6 23.7 24.6 9.8 13.2 31.8 10.4 33.2 28.4 29.1 3.7 21.5 35.7 9.9 13.8 9.0 10.4 38.4 39.7 34.7 35.8 16.0 11.0 40.6 21.7 6.2 26.0 10.2 12.5 35.7 4.9 6.4 38.3 16.6 18.3 23.1 35.4 7.3 13.3 61.2 25.6 35.4 12.3 34.2 29.4 4.5 10.6 17.8 25.1 11.9 17.8 1.8 1.2 3.3 8.4 7.3 9.3 3.0 3.7 18.7 21.0 0.9 29.6 21.9 39.8 9.2 21.4 6.7 0.4 10.1 0.8 49.5 0.1 24.1 10.8 11.0 7.8 9.5 27.7 4.7 9.9 9.3 3.8 2.1 2.9 30.6 0.4 16.9 3.7 21.4 33.4 16.5 1.0 0.2 13.9 30.8 3.5 29.4 7.7 21.6 1.0 1.1 19.8 2.0 38.8 0.4 22.0 13.9 13.1 9.6 14.2 16.4 10.9 28.4 18.3 5.1 13.9 31.6 5.3 0.0 2.4 3.6 4.4 2.8 2.7 1.1 2.1 3.6 2.3 2.0 1.5 2.4 1.0 1.8 2.8 16.5 1.5 3.5 10.0 10.6 9.8 13.2 9.0 10.4 16.0 11.0 12.5 13.3 12.3 11.9 22.3 3.2 5.2 10.4 19.1 7.6 8.2 10.7 17.6 5.7 12.3 16.0 3.2 7.2 6.3 9.2 14.6 2.2 42.2 20.5 1.9 9.2 6.2 12.0 12.7 10.7 19.2 5.7 0.4 5.6 4.0 12.7 23.9 13.3 19.1 25.9 9.3 21.1 12.0 0.0 0.6 17.3 6.1 16.6 6.8 7.9 15.8 21.4 7.2 12.2 25.8 13.4 34.0 4.5 1.0 6.5 13.8 11.3 15.2 4.5 22.0 25.1 6.7 20.4 6.6 11.7 13.4 19.6 9.1 10.4 4.7 1.4 27.0 17.7 16.4 4.0 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149294-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 35.4;placenta: 25.9;prostate: 10.6;seminal vesicle: 17.3" "Cell type enhanced" "Detected in many" "Astrocytes: 58.1;Endometrial ciliated cells: 26.5;Excitatory neurons: 64.9;Glandular and luminal cells: 29.1;Inhibitory neurons: 57.7;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 59.6" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.5;HUVEC TERT2: 27.4;MOLT-4: 24.1;TIME: 55.4;U-138 MG: 14.5;U-251 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA 88000 "Cluster 65: Brain - Ion transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: AB_2686605" "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 0.5 5.1 20.5 0.2 35.4 0.0 0.1 0.9 23.9 1.5 0.0 0.5 0.1 1.6 0.5 0.3 1.2 0.5 1.2 19.6 15.2 2.1 0.1 0.7 0.0 7.7 24.9 2.3 0.2 0.0 1.4 25.9 11.3 10.6 0.2 3.0 0.5 17.3 0.0 0.0 0.4 0.7 3.7 0.0 0.4 1.4 16.8 0.1 0.5 0.0 0.0 1.8 2.8 19.1 0.0 0.7 8.7 0.0 0.3 0.0 0.0 8.6 4.6 0.7 0.4 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.9 0.0 4.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 11.5 27.4 0.0 0.3 0.0 4.2 0.0 24.1 0.0 0.0 0.0 0.3 0.5 0.3 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.3 55.4 14.5 0.0 0.1 12.9 0.0 0.0 0.0 1.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 35.4 0.9 23.9 19.6 15.2 7.7 24.9 11.3 3.7 16.8 19.1 1.4 0.0 0.6 58.1 0.0 0.1 0.5 0.1 1.2 15.0 1.2 2.7 2.3 0.0 0.7 0.0 0.0 0.8 0.0 0.9 1.9 0.0 5.6 26.5 4.6 4.0 0.0 0.0 64.9 0.0 0.9 15.5 0.0 29.1 0.0 5.0 0.0 0.0 1.8 0.0 57.7 0.2 0.0 0.0 0.0 1.7 0.0 0.5 0.0 6.5 0.0 8.6 0.0 46.8 59.6 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.1 2.7 0.0 4.3 11.5 17.4 0.9 0.0 0.3 2.9 0.2 3.9 0.1 0.4 PCDH18 "KIAA1562, PCDH68L" ENSG00000189184 "Protocadherin 18" Q9HCL0 4 137518918-137532494 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.2" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017976 Approved Approved "Golgi apparatus,Cytosol" No NA 5900000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" Cytosol "Golgi apparatus" "HPA017976: AB_1855045" "unprognostic (2.77e-1)" "unprognostic (1.86e-2)" "unprognostic (3.73e-3)" "unprognostic (9.19e-2)" "unprognostic (1.59e-1)" "unprognostic (3.39e-2)" "unprognostic (2.36e-1)" "unprognostic (4.30e-2)" "unprognostic (1.97e-3)" "unprognostic (2.20e-2)" "unprognostic (8.76e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-2)" "unprognostic (6.27e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.71e-4)" 22.2 5.2 2.6 7.9 3.0 0.1 13.5 2.8 3.2 25.3 2.6 12.2 9.3 30.4 11.2 6.4 11.7 22.5 6.5 2.5 4.8 7.1 2.1 7.2 1.7 4.1 5.8 21.0 1.5 2.0 2.4 44.2 3.8 17.5 13.8 2.1 6.5 13.5 2.6 4.1 8.7 18.4 3.2 6.4 6.7 4.5 3.9 3.6 5.1 23.2 1.4 10.8 8.4 3.0 0.0 0.3 148.2 0.0 175.0 190.8 0.1 27.4 86.8 5.0 7.7 0.3 0.0 0.0 0.1 143.3 0.4 0.4 34.2 0.7 2.6 0.2 1.0 0.0 0.0 0.0 129.4 0.0 0.1 195.9 0.3 9.4 3.8 4.7 1.0 0.7 0.0 0.6 2.8 0.0 3.9 0.1 0.3 0.0 2.7 11.7 4.1 0.0 0.0 0.1 0.0 9.6 0.0 0.0 0.2 38.3 0.9 0.0 0.0 69.3 4.2 13.9 0.5 0.2 0.0 0.0 3.9 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.0 2.8 3.2 2.5 4.8 4.1 5.8 3.8 3.2 3.9 3.0 3.4 0.0 0.5 1.3 0.0 4.1 0.4 0.1 2.2 2.5 1.1 1.7 1.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.6 1.9 72.3 3.0 0.0 0.0 0.2 0.0 0.3 56.3 0.0 1.7 0.0 6.4 2.5 0.0 3.1 0.0 9.0 0.0 0.0 0.0 7.8 1.3 37.9 0.9 1.8 10.3 0.0 6.8 0.0 0.0 0.6 0.0 0.0 58.6 0.1 0.0 0.0 0.1 0.0 0.2 19.7 6.6 25.5 0.6 0.1 1.2 2.6 0.8 0.7 18.5 0.0 0.1 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "brain: 28.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 18.2;Excitatory neurons: 24.8;Inhibitory neurons: 18.6;Muller glia cells: 25.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Region enhanced" "Detected in many" "hippocampal formation: 28.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.0 0.0 5.8 0.0 12.1 0.0 0.0 0.0 19.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 4.5 0.0 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 1.4 0.0 1.3 1.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 5.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 12.1 0.0 19.7 28.4 4.5 1.1 1.2 1.3 5.0 0.0 0.0 0.1 0.0 0.0 5.9 0.0 0.1 2.1 0.0 0.0 18.2 0.4 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.6 0.0 0.1 0.0 0.0 24.8 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 18.6 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 3.7 0.0 25.8 0.0 2.5 2.2 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.0 1.6 0.0 0.4 0.1 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.1 1.1 PCED1B "FAM113B, MGC16044" ENSG00000179715 "PC-esterase domain containing 1B" Q96HM7 12 47079603-47236662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.1;lymphoid tissue: 36.0" "Cell type enhanced" "Detected in many" "Astrocytes: 30.3;Excitatory neurons: 32.4;Granulosa cells: 47.8;Hofbauer cells: 37.6;Microglial cells: 60.0;T-cells: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 63.3;K-562: 48.9;SK-BR-3: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043901 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 58: T-cells - T-cell receptor" "Golgi apparatus" Vesicles "HPA043901: AB_10959888" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (3.29e-3)" "unprognostic (1.47e-3)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.32e-2)" "unprognostic (5.13e-2)" "unprognostic (2.36e-3)" "unprognostic (7.74e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "prognostic unfavorable (4.55e-6)" "unprognostic (4.79e-2)" "unprognostic (3.74e-1)" "unprognostic (3.74e-2)" "prognostic favorable (5.36e-5)" 6.5 40.1 3.4 17.9 3.2 10.6 6.1 2.7 3.3 6.7 2.3 10.1 2.2 8.7 2.0 3.1 9.3 5.9 3.3 2.4 3.7 6.0 3.9 9.1 36.0 4.8 5.3 23.4 2.7 1.2 2.3 3.6 4.4 5.8 2.7 0.8 3.3 2.3 1.3 2.7 12.2 4.5 3.6 29.5 3.8 13.7 4.8 7.1 3.4 1.2 24.1 9.6 5.4 5.0 3.4 63.3 1.5 0.0 0.5 0.0 3.0 2.0 3.5 0.7 0.3 3.2 12.3 11.5 3.4 6.5 1.2 9.2 0.0 9.4 0.0 13.5 0.0 0.4 0.6 1.3 1.3 2.7 0.5 0.2 4.1 1.1 7.1 8.8 2.7 0.8 48.9 10.6 4.4 1.5 0.7 2.3 10.6 7.9 0.9 0.2 1.6 8.2 9.7 5.2 0.4 0.0 5.7 31.0 0.0 3.2 5.7 4.0 0.8 0.2 0.9 0.1 2.2 11.4 8.6 20.3 3.0 8.7 0.3 1.7 1.1 2.8 42.5 2.3 48.3 50.1 50.7 54.1 6.4 35.6 88.8 83.5 4.5 30.1 2.6 38.1 59.1 35.4 3.4 3.2 2.7 3.3 2.4 3.7 4.8 5.3 4.4 3.6 4.8 5.0 3.4 3.2 5.6 30.3 23.6 1.1 0.9 4.2 9.1 2.5 4.4 6.2 0.5 0.0 1.5 1.8 0.0 0.5 21.1 0.2 0.0 3.2 0.9 5.1 1.4 3.4 10.2 0.4 32.4 12.8 9.1 3.1 1.5 10.3 1.3 47.8 9.7 0.3 37.6 0.0 2.2 1.4 0.0 4.3 1.8 2.5 3.7 10.7 1.8 60.0 5.3 0.9 23.7 17.6 0.6 11.7 0.8 0.7 28.1 1.4 0.1 0.4 0.8 0.1 0.0 1.3 4.4 0.7 0.2 2.8 0.6 2.1 36.2 22.4 0.3 4.2 PCOLCE "PCPE, PCPE1" ENSG00000106333 "Procollagen C-endopeptidase enhancer" Q15113 7 100602363-100608175 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 81.1" "CAB017623, HPA042927" Approved Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 1300000000 "Cluster 22: NK-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "CAB017623: AB_2251882, HPA042927: AB_2678224" "unprognostic (4.14e-1)" "unprognostic (1.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.92e-1)" "unprognostic (1.70e-2)" "unprognostic (4.48e-2)" "unprognostic (1.33e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.16e-2)" "unprognostic (1.73e-1)" "unprognostic (6.13e-2)" "prognostic unfavorable (1.68e-5)" "unprognostic (1.04e-2)" "unprognostic (3.21e-2)" "unprognostic (1.63e-2)" "unprognostic (1.43e-2)" 101.5 45.5 2.4 51.5 3.8 0.6 72.6 3.5 10.2 162.8 4.6 30.5 7.8 81.7 11.0 26.9 80.6 112.5 110.8 2.3 2.5 21.9 59.7 72.4 41.3 3.0 2.4 47.7 20.6 10.3 31.2 59.5 2.9 45.5 16.7 0.2 24.9 33.5 16.9 45.0 21.6 59.9 3.1 13.8 22.9 13.7 3.6 10.5 49.1 32.7 17.4 86.4 86.7 2.5 0.2 0.5 2.2 3.0 321.5 879.0 2.4 355.5 663.0 161.1 142.7 14.5 0.8 1.1 1.2 404.5 0.5 0.2 0.0 1.2 15.9 2.5 2.5 0.3 6.1 19.8 82.1 0.1 3.5 973.2 0.3 86.3 0.6 0.4 0.1 1.7 8.3 2.0 0.7 2.1 0.6 3.3 72.2 0.0 4.2 1.0 1.5 0.8 0.4 0.6 1.1 689.9 0.2 2.4 1.6 8.2 2.0 0.0 3.5 391.8 107.6 1213.4 0.2 0.4 0.5 0.1 136.6 1.2 68.2 0.0 0.0 0.4 0.1 0.3 0.3 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.1 0.0 2.4 3.8 3.5 10.2 2.3 2.5 3.0 2.4 2.9 3.1 3.6 2.5 33.6 9.6 2.8 2.3 2.5 40.0 3.3 4.2 6.8 4.3 6.6 11.3 16.3 4.3 5.5 5.5 0.0 13.3 4.5 0.8 27.4 6.4 14.8 15.1 491.6 17.2 1.8 5.7 0.5 5.1 11.2 439.9 7.1 11.0 1.3 0.7 33.9 44.8 20.8 16.8 2.5 0.9 6.1 1.9 53.6 27.6 140.5 5.5 32.0 9.4 0.8 12.1 6.2 1.5 0.2 4.1 1.3 50.4 2.1 2.2 0.1 2.5 6.8 2.0 32.9 14.2 442.2 32.8 21.0 3.6 33.1 25.2 9.4 22.6 0.7 3.0 PCSK5 "PC5, PC6, SPC6" ENSG00000099139 "Proprotein convertase subtilisin/kexin type 5" Q92824 9 75890644-76362975 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Pregnancy "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 189.7;Inhibitory neurons: 81.9;NK-cells: 82.4;Oligodendrocyte precursor cells: 149.3;Proximal enterocytes: 99.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 2447.1;neutrophil: 626.3" "Lineage enriched" "Detected in all" 18 "granulocytes: 2447.1" "Cell line enhanced" "Detected in many" "BEWO: 32.6;HaCaT: 46.9;RH-30: 30.4;RPTEC TERT1: 42.5;U-2 OS: 66.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031072 Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 290000 "Cluster 41: Basophils - Cellular respiration" "Cluster 45: Intestine - Brush border" "Cluster 9: U-2 OS - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA031072: AB_10602190" "unprognostic (3.28e-2)" "unprognostic (1.44e-1)" "unprognostic (4.13e-4)" "unprognostic (4.08e-2)" "unprognostic (7.43e-3)" "unprognostic (3.17e-1)" "unprognostic (2.07e-3)" "unprognostic (9.39e-2)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (2.81e-2)" "unprognostic (6.80e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (2.99e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-2)" "unprognostic (1.77e-5)" 17.6 4.2 6.6 5.9 6.6 2.3 6.9 22.2 23.8 9.0 0.0 10.2 25.0 7.1 9.6 8.5 6.9 8.6 5.3 7.4 7.8 3.8 1.7 6.1 2.7 21.7 17.3 13.5 3.0 5.9 2.3 9.4 20.0 3.3 8.4 6.0 3.5 3.0 3.0 3.6 26.4 6.6 23.0 3.3 3.3 6.3 5.3 9.1 4.8 5.4 2.5 5.3 8.8 2.4 2.5 1.8 5.1 3.4 3.2 1.0 32.6 4.7 0.4 0.3 0.0 18.7 2.0 0.8 1.3 0.6 0.1 46.9 2.4 1.4 0.3 0.6 4.1 6.3 4.5 1.6 0.8 1.9 2.8 6.0 0.4 1.0 0.5 0.3 9.6 3.1 7.5 2.4 3.3 11.5 7.4 11.1 22.8 4.3 1.9 1.3 30.4 1.9 42.5 2.9 0.7 0.5 7.1 1.5 0.5 9.5 2.6 8.0 7.6 1.5 66.5 3.8 2.0 0.7 0.3 1.0 5.1 2.7 25.7 2447.1 43.1 192.4 100.0 25.9 85.2 92.3 100.8 93.7 21.8 116.5 98.2 125.2 626.3 135.5 51.6 135.0 96.9 10.1 6.6 6.6 22.2 23.8 7.4 7.8 21.7 17.3 20.0 23.0 5.3 2.4 41.1 6.4 7.2 189.7 0.1 6.5 3.5 8.6 13.6 4.8 0.7 2.0 5.8 11.5 14.3 5.5 0.0 2.1 9.6 47.3 0.0 8.2 19.0 6.0 35.1 19.5 1.2 0.0 33.5 6.1 34.3 26.6 9.7 10.6 0.0 32.1 15.0 0.9 2.9 55.5 81.9 10.2 6.1 4.1 3.9 39.4 20.5 7.5 1.8 70.3 11.4 30.3 82.4 149.3 5.8 10.1 18.5 25.2 0.4 2.9 99.2 4.2 23.4 1.4 19.7 9.1 11.4 1.0 1.9 6.2 3.0 2.5 6.2 5.6 23.9 0.9 PDE4B DPDE4 ENSG00000184588 "Phosphodiesterase 4B" Q07343 1 65792514-66374579 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.5;brain: 109.1" "Group enriched" "Detected in many" 5 "Oligodendrocyte precursor cells: 1722.6;Oligodendrocytes: 4039.6" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 88.9" "Group enriched" "Detected in all" 5 "B-cells: 37.4;granulocytes: 88.9;T-cells: 34.7" "Cell line enhanced" "Detected in many" "AN3-CA: 61.8;HUVEC TERT2: 93.2;NTERA-2: 56.1;SK-MEL-30: 58.6;TIME: 52.6;U-266/84: 51.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003005 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Cytosol "HPA003005: AB_1079587" "unprognostic (7.86e-2)" "unprognostic (3.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.90e-1)" "unprognostic (3.21e-1)" "unprognostic (3.33e-3)" "unprognostic (1.35e-1)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (6.10e-2)" "unprognostic (8.78e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (2.89e-2)" "unprognostic (3.54e-1)" "unprognostic (9.04e-3)" "unprognostic (8.33e-3)" 18.3 3.1 40.1 39.5 82.5 75.5 20.0 63.3 53.5 7.2 1.6 8.3 4.6 8.3 1.1 4.5 4.2 10.1 21.4 45.7 68.4 5.4 10.9 14.7 23.2 85.9 74.4 2.1 1.6 1.4 3.8 17.2 78.5 23.0 10.5 14.1 21.1 12.1 44.3 8.9 12.2 12.4 66.4 22.6 5.1 3.8 62.9 14.0 7.2 15.0 19.9 32.1 4.6 109.1 0.2 18.5 34.7 61.8 1.6 1.7 0.1 11.5 13.3 10.1 13.4 0.0 0.0 5.3 0.2 20.7 0.4 0.1 0.3 0.0 9.7 15.5 0.1 0.3 5.2 0.0 1.2 13.1 0.0 3.4 0.5 4.5 0.2 1.6 93.2 0.0 0.0 3.3 4.7 0.3 0.0 7.5 56.1 0.0 0.7 2.6 6.2 3.6 8.7 0.0 0.2 26.6 0.0 3.0 58.6 2.9 0.2 4.5 52.6 7.2 1.9 4.6 1.9 1.5 51.6 19.3 8.6 13.4 3.7 10.8 6.8 22.0 10.1 5.8 19.5 36.8 19.4 14.8 6.2 37.4 21.3 15.0 88.9 11.3 5.7 6.4 34.7 9.6 40.1 82.5 63.3 53.5 45.7 68.4 85.9 74.4 78.5 66.4 62.9 109.1 24.7 9.6 12.2 531.8 233.3 20.3 28.4 0.5 27.9 40.9 51.6 34.3 25.4 0.0 6.9 5.5 0.0 7.3 79.8 0.4 0.0 0.8 14.4 1.7 14.9 36.8 4.2 0.0 315.6 0.9 2.0 20.2 9.7 4.2 15.2 0.2 11.7 2.4 13.0 114.4 559.7 1.9 8.2 40.6 187.4 9.4 0.3 176.9 51.6 173.3 67.0 19.3 1.0 1722.6 4039.6 0.1 0.4 2.6 351.9 93.6 0.0 2.1 1.5 4.0 0.0 54.0 10.3 0.7 0.8 4.8 8.1 5.6 143.1 0.4 1.3 9.4 PDE4DIP "CMYA2, KIAA0454, KIAA0477, MMGL" ENSG00000178104 "Phosphodiesterase 4D interacting protein" Q5VU43 1 148808181-149048286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "heart muscle: 729.5;skeletal muscle: 2164.0;tongue: 1379.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 702.6;Rod photoreceptor cells: 272.3;Syncytiotrophoblasts: 309.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 289.6;ASC TERT1: 233.8;K-562: 222.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012678 Supported "Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" "HPA012678: AB_1855123" "unprognostic (2.14e-1)" "unprognostic (3.27e-1)" "unprognostic (5.31e-2)" "unprognostic (6.73e-2)" "unprognostic (7.82e-2)" "unprognostic (1.16e-2)" "unprognostic (2.17e-1)" "unprognostic (9.72e-2)" "unprognostic (7.65e-2)" "unprognostic (1.67e-1)" "unprognostic (2.23e-2)" "unprognostic (5.08e-2)" "unprognostic (1.70e-3)" "unprognostic (1.82e-1)" "unprognostic (4.14e-2)" "unprognostic (9.13e-2)" "unprognostic (2.28e-1)" 32.9 16.9 103.0 20.9 82.9 15.8 22.3 142.7 106.1 28.0 32.4 22.5 24.2 17.4 73.5 37.9 19.8 19.5 729.5 115.5 118.5 42.0 63.5 36.1 21.7 102.2 95.6 8.6 21.4 84.6 53.1 68.5 109.7 29.2 25.4 173.3 34.9 22.9 2164.0 26.1 29.4 18.8 96.8 17.2 29.7 9.2 139.9 12.1 16.9 1379.7 23.2 24.0 17.1 114.9 39.2 7.5 10.6 11.6 289.6 233.8 60.7 45.2 42.3 42.7 55.7 35.5 24.1 19.8 13.7 64.5 121.3 19.8 25.7 31.5 72.1 14.7 36.8 10.0 16.2 14.2 76.2 8.8 10.2 167.5 61.9 181.7 97.8 96.9 17.1 16.3 222.1 45.0 76.8 66.2 6.9 5.4 37.1 32.3 15.9 14.6 26.5 7.7 25.4 39.9 50.1 4.7 44.1 123.4 36.1 44.7 37.5 11.7 22.9 49.3 11.2 124.7 100.9 19.9 29.6 29.1 200.6 8.0 30.2 10.6 5.7 4.5 5.3 6.1 5.5 12.0 10.6 7.1 7.0 11.0 8.1 4.5 1.3 4.9 2.1 3.0 14.4 4.8 103.0 82.9 142.7 106.1 115.5 118.5 102.2 95.6 109.7 96.8 139.9 114.9 5.7 51.3 45.1 81.3 24.0 28.8 9.9 19.8 23.3 71.0 16.1 11.3 702.6 24.3 45.4 69.9 114.7 184.6 9.5 24.0 62.6 13.1 38.9 41.1 14.2 15.7 43.2 7.4 85.8 7.1 148.3 54.2 20.4 27.0 13.9 6.1 5.3 80.8 45.0 33.7 81.1 32.0 20.3 46.1 90.4 50.0 10.5 68.7 55.2 6.5 21.5 45.7 14.4 65.9 41.5 4.5 25.1 9.8 37.5 4.1 48.8 20.7 88.0 272.3 32.9 131.2 40.1 8.7 15.9 14.6 16.3 309.2 24.0 4.2 24.2 4.3 PDE8A HsT19550 ENSG00000073417 "Phosphodiesterase 8A" O60658 15 84980440-85139145 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Oligodendrocytes: 968.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RT4: 89.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007722 Approved Approved "Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 45: Intestine - Brush border" "Cluster 15: RT4 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA007722: AB_1855130" "unprognostic (1.68e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (4.97e-2)" "unprognostic (6.25e-2)" "unprognostic (3.47e-2)" "unprognostic (2.97e-2)" "unprognostic (3.94e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (8.99e-3)" "unprognostic (2.75e-2)" "unprognostic (3.42e-1)" "unprognostic (3.72e-1)" "unprognostic (4.26e-1)" "unprognostic (1.31e-1)" "unprognostic (1.94e-2)" 16.7 16.6 20.9 8.5 32.3 3.3 10.5 21.9 22.4 11.6 15.2 24.0 15.3 9.1 7.3 6.4 9.0 15.8 8.0 17.3 20.1 24.3 30.0 10.8 5.6 23.8 28.5 12.7 14.5 16.9 6.7 11.4 23.6 6.9 21.9 14.5 6.4 9.6 5.8 6.3 13.6 10.6 19.5 6.3 11.0 11.0 26.9 4.6 12.3 6.5 5.1 17.7 7.0 45.2 29.0 48.4 7.9 5.4 32.7 17.2 9.6 19.4 21.1 16.6 18.9 10.9 16.9 5.8 14.6 25.9 19.7 20.2 33.8 14.9 22.0 10.8 20.2 7.7 30.3 15.6 23.5 4.5 11.3 17.4 9.1 19.6 18.6 14.3 21.6 6.4 15.6 18.3 15.2 24.5 2.6 4.5 3.8 9.5 8.6 3.6 6.5 8.1 13.2 89.0 18.3 14.1 18.9 20.3 55.5 8.7 6.7 8.7 17.1 38.4 13.6 13.9 31.6 8.9 16.7 6.2 26.1 18.1 11.0 0.0 0.9 0.6 0.3 0.7 0.6 0.2 0.5 0.6 0.5 0.3 0.7 0.3 0.0 0.2 1.6 0.0 1.1 0.2 20.9 32.3 21.9 22.4 17.3 20.1 23.8 28.5 23.6 19.5 26.9 45.2 30.7 6.4 26.5 83.9 14.8 11.3 11.1 13.9 18.2 13.0 6.6 5.2 6.8 41.5 15.4 7.3 12.5 8.0 5.5 58.7 7.9 11.3 6.4 12.5 21.6 24.3 14.5 0.8 60.8 9.6 7.1 16.2 26.5 20.6 22.1 17.9 14.3 23.3 10.8 10.1 126.2 19.0 4.1 12.3 18.9 5.6 10.8 19.2 10.6 85.3 9.0 2.6 10.3 119.1 968.6 11.5 31.8 11.3 7.2 25.4 22.1 21.1 10.5 31.2 39.5 17.8 24.5 25.6 17.3 7.5 10.4 4.5 10.8 25.3 28.5 26.4 PDGFA "PDGF-A, PDGF1" ENSG00000197461 "Platelet derived growth factor subunit A" P04085 7 497258-520296 "Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 89.8;Breast myoepithelial cells: 154.9;Paneth cells: 97.0;Smooth muscle cells: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 11.3" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "WM-115: 311.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005579, HPA065024" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 580000 "Cluster 42: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "CAB005579: AB_2161916, HPA065024: " "unprognostic (2.22e-1)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.75e-4)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.63e-3)" "unprognostic (4.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.85e-1)" "unprognostic (8.26e-2)" "unprognostic (1.07e-2)" "unprognostic (5.87e-2)" "unprognostic (8.35e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (8.67e-4)" 15.4 8.5 29.3 7.9 36.8 1.7 17.0 36.6 32.4 18.1 20.5 29.2 20.2 26.1 11.2 9.6 21.2 11.4 21.1 27.0 27.5 22.2 8.5 24.9 3.5 46.4 37.5 7.7 71.6 6.6 10.2 26.8 40.7 23.3 14.8 5.2 20.3 11.2 95.2 12.5 25.9 10.2 35.8 16.3 32.1 4.5 36.5 6.6 10.0 15.1 2.4 17.8 15.9 58.8 22.9 15.3 1.5 21.6 4.1 0.7 50.7 5.0 2.9 6.4 4.4 23.8 25.3 0.6 8.7 4.3 2.9 56.6 1.5 69.0 3.4 12.9 2.3 0.3 13.3 8.7 26.9 2.4 2.2 3.0 26.8 3.3 21.3 8.5 12.5 1.3 2.3 3.1 15.8 28.7 3.5 5.0 40.1 8.9 3.3 11.6 1.5 2.5 9.0 5.3 2.1 1.8 76.5 4.2 13.3 47.5 10.7 2.6 37.3 13.6 37.8 8.0 31.0 0.9 1.4 0.8 12.3 7.1 311.4 11.3 1.6 2.4 1.6 1.9 2.2 1.9 1.6 1.5 1.5 1.8 1.9 2.0 4.9 3.4 3.3 2.1 1.8 2.1 29.3 36.8 36.6 32.4 27.0 27.5 46.4 37.5 40.7 35.8 36.5 58.8 15.2 89.8 11.9 11.1 1.5 28.0 20.2 12.1 59.7 15.7 12.7 154.9 29.9 15.7 11.0 14.7 8.4 8.8 1.7 76.9 5.9 15.8 0.3 49.0 4.2 19.4 13.1 0.0 7.7 53.3 5.4 12.3 41.8 35.7 10.8 18.1 21.0 1.0 2.0 32.0 5.9 40.5 2.0 1.3 10.4 0.1 2.1 14.8 14.2 6.5 1.5 0.7 1.0 5.0 27.5 72.6 97.0 6.4 4.4 29.4 47.2 8.5 4.5 2.1 39.5 48.9 110.3 0.5 1.8 9.4 9.8 2.9 3.9 0.2 32.1 18.2 PDGFD "IEGF, MSTP036, SCDGF-B" ENSG00000170962 "Platelet derived growth factor D" Q9GZP0 11 103907189-104164379 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 106.5;ovary: 78.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;dendritic cells: 30.0;Ductal cells: 30.6;Fibroblasts: 44.3;Inhibitory neurons: 95.0;Microglial cells: 28.1;NK-cells: 46.4" "Cancer enhanced" "Detected in all" "renal cancer: 17.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 9.5;gdT-cell: 16.4;memory CD8 T-cell: 7.2;naive CD8 T-cell: 6.0;NK-cell: 17.1" "Group enriched" "Detected in many" 29 "granulocytes: 9.5;NK-cells: 17.1;T-cells: 16.4" "Group enriched" "Detected in many" 6 "ASC diff: 139.8;HHSteC: 42.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 39.4" "HPA046183, HPA066271" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 95000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA046183: AB_2679573, HPA066271: AB_2685645" "unprognostic (2.21e-1)" "unprognostic (9.35e-2)" "unprognostic (5.60e-2)" "unprognostic (1.72e-1)" "unprognostic (5.81e-2)" "unprognostic (8.83e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (2.26e-1)" "unprognostic (7.01e-3)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.19e-1)" "unprognostic (6.72e-2)" "unprognostic (3.57e-3)" 20.4 106.5 0.5 3.4 0.8 0.9 21.7 0.7 1.3 25.1 9.0 8.8 4.1 11.8 7.1 1.9 9.3 34.0 23.2 0.8 2.2 7.7 2.3 3.1 7.4 5.1 6.6 78.0 25.7 17.1 13.4 7.0 9.4 10.0 9.8 1.5 8.6 37.4 2.2 7.9 4.8 9.7 1.8 2.8 23.4 3.3 2.0 3.7 18.3 8.8 5.4 15.8 15.4 2.3 0.0 7.8 4.0 0.0 139.8 4.2 0.1 0.9 0.8 0.7 0.8 0.0 1.3 7.4 1.4 7.3 5.2 0.4 0.0 0.2 0.3 0.0 3.2 0.2 1.6 0.3 42.6 0.0 0.1 14.7 0.0 0.1 0.0 0.2 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 1.4 0.0 2.1 0.0 6.7 0.0 0.1 9.6 0.0 13.8 3.2 1.8 0.0 2.0 1.0 0.1 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.8 0.6 0.0 9.5 16.4 0.0 1.4 0.4 1.7 7.2 0.0 0.0 0.2 6.0 0.2 17.1 0.1 0.0 0.1 4.2 0.5 0.8 0.7 1.3 0.8 2.2 5.1 6.6 9.4 1.8 2.0 2.3 15.6 0.0 0.0 1.0 1.6 3.1 7.7 0.2 1.8 2.3 1.7 9.4 4.5 32.9 0.6 5.5 0.0 0.2 30.0 0.2 0.0 30.6 8.2 0.8 1.8 10.3 1.8 1.3 13.9 4.4 0.2 44.3 0.0 1.4 0.0 8.1 2.9 0.0 0.3 26.9 95.0 1.0 0.0 1.3 3.7 13.3 0.3 0.8 0.0 28.1 0.9 1.5 46.4 2.0 2.8 3.0 0.5 2.2 8.4 1.6 0.0 0.3 0.0 0.5 6.6 1.9 3.7 0.4 4.3 0.3 2.0 0.0 10.2 5.2 0.6 3.2 PDGFRB "CD140b, JTK12, PDGFR, PDGFR1" ENSG00000113721 "Platelet derived growth factor receptor beta" P09619 5 150113839-150155872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Chemotaxis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Sertoli cells: 1288.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "ASC diff: 1350.1;ASC TERT1: 462.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003842, CAB018144, HPA028499" Enhanced Supported "Golgi apparatus,Vesicles" NA NA 39000000 "Cluster 14: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "Golgi apparatus" "CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018" "unprognostic (4.75e-2)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.27e-1)" "unprognostic (5.61e-2)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (2.12e-2)" "unprognostic (2.57e-3)" "unprognostic (6.72e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.87e-8)" "unprognostic (3.13e-3)" "unprognostic (1.25e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (8.11e-4)" 171.2 25.1 25.4 27.5 27.2 0.7 106.3 20.5 33.3 155.9 43.5 41.6 11.9 101.1 24.2 24.1 89.6 124.5 75.7 22.1 23.2 49.7 13.4 98.3 27.5 22.1 24.6 105.5 20.8 21.9 23.0 113.3 22.8 56.2 14.1 6.3 34.5 43.3 38.1 65.0 37.9 68.9 19.4 41.4 27.9 18.4 27.7 8.7 66.5 44.1 13.8 58.3 98.6 21.6 0.1 0.3 8.3 0.4 1350.1 462.7 3.0 48.9 202.3 33.5 56.4 5.4 0.0 0.0 6.4 142.0 19.0 0.1 0.1 0.4 15.8 0.0 0.0 0.1 3.3 3.5 190.7 0.0 0.4 210.0 0.0 46.3 0.6 106.6 0.1 0.1 0.1 5.5 5.5 0.0 0.1 0.6 9.0 0.2 0.2 3.7 2.5 0.2 0.0 0.0 0.1 24.8 0.5 0.1 0.0 38.2 0.1 0.6 0.4 53.7 17.2 23.1 2.8 0.4 0.0 0.3 33.4 0.1 1.5 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.2 25.4 27.2 20.5 33.3 22.1 23.2 22.1 24.6 22.8 19.4 27.7 21.6 50.8 0.0 1.1 81.9 0.5 24.0 0.5 0.0 2.2 6.6 1.4 3.3 17.3 1.5 0.0 1.8 4.2 0.6 6.0 0.3 0.0 0.8 1.6 2.8 99.5 32.2 0.0 0.0 7.9 0.0 1.1 123.5 2.0 2.3 0.0 2.5 6.4 1.9 1.5 0.0 1.3 0.7 0.0 0.0 35.6 10.9 165.3 3.1 24.9 45.0 0.7 50.7 23.7 10.1 3.3 0.1 0.1 203.8 2.3 0.7 0.3 0.1 0.7 2.9 1288.5 6.6 288.3 1.9 1.6 0.8 15.3 0.8 4.8 4.0 0.4 1.1 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 36.0;Fibroblasts: 186.2;Leydig cells: 74.6;Peritubular cells: 70.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 22.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "AN3-CA: 189.4;BJ hTERT+: 159.1;HSkMC: 86.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA052801: AB_2681956" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 34.1 4.2 2.5 3.9 3.5 0.2 51.9 2.8 3.0 27.8 1.9 9.0 0.9 15.8 10.3 3.0 23.3 13.4 11.1 2.3 2.3 1.3 0.7 4.7 1.2 2.7 2.6 42.9 6.9 9.0 7.4 9.0 2.5 5.4 3.1 0.6 13.1 6.7 18.4 11.0 2.6 26.0 2.4 0.8 6.2 6.5 2.9 3.8 33.0 38.0 2.0 6.5 12.0 3.3 0.0 17.7 1.0 189.4 5.6 2.5 13.8 4.6 159.1 7.5 31.3 1.0 0.2 0.0 0.9 2.5 24.7 0.0 11.6 0.9 3.7 0.2 14.5 0.0 5.3 4.1 14.6 0.0 0.0 86.9 0.1 9.2 0.1 0.0 13.0 1.6 0.0 2.4 1.1 12.5 0.2 0.4 9.9 0.7 3.6 0.0 0.2 0.4 1.0 11.4 0.6 1.2 1.4 1.7 3.3 11.4 0.6 0.0 2.6 0.2 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 3.5 2.8 3.0 2.3 2.3 2.7 2.6 2.5 2.4 2.9 3.3 15.5 0.0 3.6 2.3 0.3 13.3 0.5 4.3 0.6 0.6 2.9 3.3 4.5 1.5 2.8 0.0 0.0 14.9 0.7 0.4 0.0 4.1 36.0 2.4 5.4 4.1 1.2 0.0 1.1 7.1 19.9 186.2 0.5 4.7 0.0 0.3 1.4 0.2 3.5 0.0 3.5 1.3 2.0 0.0 14.6 6.7 74.6 1.6 10.6 1.9 1.6 1.4 0.0 3.0 1.3 3.1 0.1 70.7 0.2 1.9 0.4 0.1 0.2 0.4 0.0 8.0 10.7 0.8 1.9 0.6 9.9 9.7 1.7 1.5 0.4 0.5 PDIA5 "FLJ30401, PDIR" ENSG00000065485 "Protein disulfide isomerase family A member 5" Q14554 3 123067025-123225227 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.2" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 133.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 12.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030353, HPA030355" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA 4700000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA030353: AB_10599734, HPA030355: AB_10602200" "unprognostic (8.81e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-2)" "prognostic favorable (4.55e-4)" "unprognostic (4.34e-2)" "unprognostic (2.10e-2)" "unprognostic (7.38e-2)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (4.02e-2)" "unprognostic (1.55e-1)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.09e-11)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-2)" "unprognostic (4.06e-3)" 17.9 23.6 0.3 15.2 0.3 17.9 13.8 0.2 1.4 14.5 2.7 20.1 13.9 12.4 30.2 6.1 14.0 19.6 9.9 0.6 0.8 14.5 80.2 17.7 11.1 0.5 0.6 11.5 26.6 10.7 12.7 47.4 0.4 32.3 25.0 4.2 13.7 7.9 4.2 8.8 12.8 17.0 0.3 10.1 33.4 15.3 0.9 4.5 30.8 4.3 12.0 17.9 9.5 0.7 24.0 14.6 17.7 21.5 80.3 71.9 95.0 44.9 74.5 24.5 66.9 47.8 21.6 0.0 57.6 69.9 15.7 12.5 7.8 27.4 25.7 1.1 8.8 10.4 3.9 56.7 33.2 26.5 1.4 62.3 40.2 16.6 34.5 26.1 84.0 10.1 13.6 60.4 16.9 29.6 7.2 31.3 13.1 54.5 15.6 6.7 13.0 67.5 20.7 13.9 19.3 11.4 22.0 24.0 40.4 28.7 21.4 32.3 47.2 6.2 19.5 29.4 12.3 18.1 5.0 10.8 20.2 21.0 21.5 0.0 9.3 0.3 1.4 2.4 2.3 3.5 1.0 0.8 5.5 1.1 0.6 0.6 0.2 0.5 0.5 12.8 0.0 2.3 0.3 0.3 0.2 1.4 0.6 0.8 0.5 0.6 0.4 0.3 0.9 0.7 17.2 19.2 30.7 2.6 5.6 5.0 6.0 6.4 3.4 13.1 6.9 4.7 2.7 35.8 11.3 5.5 39.6 41.8 3.1 5.4 0.0 32.2 1.6 5.4 13.1 24.3 8.4 5.5 9.6 28.6 133.6 20.7 30.5 21.1 3.8 7.3 37.5 50.1 12.1 0.0 7.1 36.9 0.0 7.8 5.5 2.0 24.2 4.4 8.8 5.6 5.0 2.3 0.0 1.0 2.5 11.9 7.6 22.2 40.1 18.1 3.5 5.3 6.4 28.4 13.1 3.6 17.6 1.3 1.5 3.4 4.1 50.2 3.1 23.3 15.1 4.5 PDXDC1 KIAA0251 ENSG00000179889 "Pyridoxal dependent decarboxylase domain containing 1" Q6P996 16 14974591-15139339 "Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 483.6;Late spermatids: 733.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047369, HPA049121, HPA051484" Approved Enhanced "Golgi apparatus,Vesicles" NA NA 9600 "Cluster 39: Non-specific - mRNA processing" "Cluster 71: Testis - DNA repair" "Cluster 6: T47d - Mammary gland" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus, Vesicles" "HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502" "unprognostic (3.67e-2)" "unprognostic (4.99e-1)" "unprognostic (1.97e-3)" "unprognostic (1.84e-1)" "unprognostic (9.08e-2)" "unprognostic (2.18e-1)" "unprognostic (6.47e-3)" "unprognostic (4.97e-2)" "unprognostic (2.43e-1)" "unprognostic (2.74e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "prognostic favorable (3.13e-4)" "unprognostic (4.58e-2)" "unprognostic (8.11e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-1)" 33.3 37.9 4.9 20.9 5.0 12.9 33.1 14.7 6.5 35.7 7.9 61.3 52.5 31.9 17.0 43.4 29.2 20.8 39.1 6.0 4.1 47.6 104.5 34.6 13.4 6.2 4.7 31.1 70.4 27.1 63.2 23.5 7.5 55.8 47.8 13.4 80.5 25.2 52.0 27.8 61.1 18.5 1.2 31.8 56.7 113.2 7.2 11.7 42.9 16.5 15.0 39.1 34.7 5.7 21.4 30.9 31.1 26.1 16.9 20.4 51.4 19.6 17.4 14.3 19.7 38.0 45.3 40.7 42.0 26.5 20.5 34.0 22.1 20.1 20.5 25.0 30.2 24.7 51.8 100.2 44.3 19.7 56.4 21.5 20.4 25.0 20.9 28.0 15.3 21.6 18.5 26.0 34.1 52.2 12.9 10.4 15.3 20.8 11.7 19.9 12.9 48.6 22.7 33.9 31.9 22.8 52.6 30.0 50.9 19.7 121.0 30.3 23.8 11.0 10.0 12.3 25.7 24.2 25.1 39.3 22.7 16.4 35.8 2.9 7.8 11.6 9.4 7.7 10.8 8.3 6.8 7.7 11.7 9.0 8.2 8.1 1.0 7.5 6.2 5.4 6.6 8.2 4.9 5.0 14.7 6.5 6.0 4.1 6.2 4.7 7.5 1.2 7.2 5.7 29.6 38.5 64.6 32.7 33.0 38.2 42.2 21.6 18.8 32.1 57.9 27.8 45.7 58.6 52.9 29.5 31.3 51.7 30.6 149.8 27.4 38.2 483.6 48.1 41.7 35.1 161.2 33.2 80.7 58.3 56.5 36.0 71.9 75.3 39.3 42.1 27.5 123.6 30.5 40.4 68.3 216.7 24.4 33.1 16.8 733.8 49.0 30.9 26.6 31.9 27.5 19.7 39.1 55.8 45.0 46.5 114.4 45.5 45.4 58.1 115.6 53.4 48.3 47.4 46.0 24.0 28.0 142.3 72.7 24.6 42.6 80.7 33.9 21.2 127.2 76.5 PEX5 "PTS1R, PXR1" ENSG00000139197 "Peroxisomal biogenesis factor 5" P50542 12 7188685-7218574 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "Early spermatids: 277.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 156.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039259, HPA039260" Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus, Cytosol" "HPA039259: AB_10673419, HPA039260: AB_2676417" "unprognostic (7.44e-2)" "unprognostic (2.54e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-1)" "unprognostic (1.27e-1)" "unprognostic (4.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (5.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.63e-2)" "unprognostic (2.92e-1)" "unprognostic (5.70e-2)" "unprognostic (7.31e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (1.13e-1)" 33.1 27.8 43.7 13.2 42.8 8.8 34.2 38.0 43.3 25.0 33.5 25.3 12.1 26.0 10.9 18.8 23.2 13.6 22.0 39.1 38.5 24.5 37.8 22.1 18.6 40.9 41.2 29.2 30.4 18.9 44.1 10.0 41.2 19.7 11.8 13.6 22.2 13.6 74.1 26.2 20.3 15.2 43.1 16.0 22.2 50.9 45.4 39.3 20.0 28.4 20.8 21.7 21.2 40.9 14.7 24.7 13.0 34.2 29.1 19.9 24.3 14.0 16.6 16.2 17.2 36.9 21.8 156.1 8.3 16.2 23.6 18.2 22.1 19.5 16.8 20.8 18.2 13.8 19.0 25.7 15.4 21.3 13.6 22.2 35.2 11.1 34.5 22.0 14.2 75.0 28.2 5.3 14.7 20.0 49.7 18.5 38.6 28.0 13.1 23.7 28.1 21.4 13.0 21.4 10.9 22.6 20.9 45.4 20.1 26.2 10.2 12.5 12.7 18.2 29.9 15.8 17.2 9.5 11.6 53.4 18.0 22.8 12.2 0.0 1.6 2.1 2.9 1.4 3.6 1.9 2.0 2.9 2.6 1.4 2.6 2.6 1.2 2.8 4.1 4.6 0.9 2.2 43.7 42.8 38.0 43.3 39.1 38.5 40.9 41.2 41.2 43.1 45.4 40.9 8.6 12.8 20.1 11.4 5.6 14.5 7.2 5.2 8.0 7.8 9.2 8.5 13.7 14.3 5.6 7.3 8.4 11.3 5.1 9.9 9.8 10.1 277.8 7.0 13.6 10.3 7.2 4.6 31.5 14.9 6.4 7.8 4.1 5.2 3.8 7.2 5.7 17.6 4.7 13.5 22.1 7.2 4.1 5.4 5.0 43.7 14.3 5.2 5.4 1.0 4.6 12.7 5.2 16.1 13.3 10.2 14.2 13.9 2.9 14.1 9.9 19.3 9.8 7.0 19.7 12.0 10.2 32.2 16.6 7.4 15.3 7.7 5.8 9.6 10.4 5.7 PFDN6 "H2-KE2, HKE2, KE-2, PFD6" ENSG00000204220 "Prefoldin subunit 6" O15212 6 33289302-33298401 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 220.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043032, HPA048123" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 89000 "Cluster 49: Eosinophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Golgi apparatus" Cytosol "HPA043032: AB_2678278, HPA048123: AB_2680273" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (7.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.35e-2)" "unprognostic (8.29e-2)" "unprognostic (3.36e-1)" "unprognostic (1.55e-1)" "prognostic favorable (1.01e-4)" "unprognostic (6.93e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.97e-4)" "unprognostic (1.79e-1)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.68e-3)" 45.3 78.2 23.7 13.7 24.4 12.9 45.4 24.2 27.3 49.2 22.6 55.9 9.3 54.8 14.2 70.2 46.2 6.7 85.1 24.4 24.4 78.8 98.1 41.7 15.9 24.6 24.6 45.3 51.7 14.4 62.7 13.6 24.7 51.0 11.6 8.6 47.6 8.0 129.3 49.6 45.3 9.9 23.7 49.9 58.4 91.4 24.0 17.1 45.6 14.7 17.0 55.6 46.7 25.2 49.4 36.0 34.9 56.7 22.7 17.3 43.4 37.2 20.6 48.0 48.7 42.6 24.0 102.8 43.1 20.5 83.5 42.2 69.5 47.6 58.3 49.3 52.9 89.8 39.4 78.3 33.2 56.3 49.3 20.7 50.9 64.8 41.6 28.5 40.2 61.2 107.2 29.6 36.7 36.0 73.9 58.7 47.7 33.0 37.6 71.9 38.0 65.2 58.9 23.4 61.3 83.9 32.1 83.3 61.3 35.0 44.4 65.0 22.5 24.7 36.0 26.0 68.7 71.2 220.3 89.4 20.5 71.9 38.1 1.8 2.6 1.8 1.9 3.2 2.1 3.3 2.3 3.1 2.4 3.2 1.8 2.5 1.1 2.1 3.5 3.5 3.5 1.9 23.7 24.4 24.2 27.3 24.4 24.4 24.6 24.6 24.7 23.7 24.0 25.2 17.4 25.6 8.7 5.2 49.1 55.7 45.2 92.6 43.9 24.5 30.2 17.1 20.7 60.1 51.6 55.2 10.4 127.5 37.6 90.0 121.3 87.6 94.2 106.5 64.7 30.6 50.4 48.4 4.3 103.8 126.1 32.6 44.4 66.9 61.6 32.9 19.2 74.0 79.2 18.5 4.1 75.7 87.5 35.4 45.2 42.7 61.8 37.2 71.2 2.8 66.3 51.0 50.4 1.5 7.1 88.0 71.3 49.2 55.3 53.9 76.4 210.0 53.0 29.0 39.5 43.6 96.3 208.2 60.4 64.3 63.9 110.8 36.9 47.4 82.7 46.7 PGPEP1 "Pcp, PGP, PGP-I, PGPI" ENSG00000130517 "Pyroglutamyl-peptidase I" Q9NXJ5 19 18340598-18369950 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 73.9;Proximal enterocytes: 88.2;Proximal tubular cells: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 28.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.4" "Cell line enhanced" "Detected in many" "HMC-1: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035368, HPA055277" Approved Approved "Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA035368: AB_10601388, HPA055277: AB_2682770" "unprognostic (9.52e-3)" "unprognostic (1.37e-2)" "unprognostic (6.95e-2)" "unprognostic (5.74e-3)" "unprognostic (5.29e-2)" "unprognostic (6.60e-2)" "unprognostic (1.96e-2)" "unprognostic (2.11e-3)" "prognostic favorable (6.80e-4)" "unprognostic (2.79e-2)" "prognostic favorable (1.71e-4)" "unprognostic (4.81e-3)" "prognostic favorable (3.71e-8)" "unprognostic (1.12e-2)" "unprognostic (1.66e-1)" "unprognostic (1.51e-1)" "unprognostic (1.20e-3)" 10.1 27.8 30.1 6.9 30.2 13.1 10.3 27.0 36.7 14.9 38.3 23.5 22.4 11.1 12.8 5.5 12.7 7.9 25.1 31.0 30.6 40.8 48.4 14.3 6.5 35.6 28.9 16.5 34.2 13.9 24.4 5.2 36.2 20.3 15.6 4.2 20.4 12.9 27.1 4.9 30.3 6.4 36.2 23.5 23.6 3.8 30.2 8.2 14.6 14.4 6.3 15.9 8.3 35.5 8.7 13.6 11.1 11.2 13.7 10.8 13.5 10.2 15.9 6.9 10.2 9.7 18.4 13.4 16.7 16.8 12.3 2.3 4.4 2.3 3.8 15.9 4.8 14.7 15.0 27.9 19.4 8.7 58.5 10.9 4.9 5.3 1.0 24.6 10.4 22.8 27.5 19.7 5.8 13.9 8.9 7.0 11.3 6.0 4.2 0.1 4.1 12.1 7.5 13.5 3.9 6.1 1.9 1.1 18.4 7.2 5.1 17.3 16.1 7.9 5.3 10.4 4.4 24.3 12.6 8.2 21.0 24.0 7.4 28.4 5.5 8.1 4.8 5.8 2.9 1.9 3.4 4.5 3.5 5.5 4.2 3.8 3.1 4.8 6.8 2.3 4.2 3.9 30.1 30.2 27.0 36.7 31.0 30.6 35.6 28.9 36.2 36.2 30.2 35.5 7.5 9.6 15.0 10.4 12.2 2.3 10.2 9.5 8.6 4.7 14.3 9.8 20.9 37.1 13.2 31.3 10.4 18.6 21.2 73.9 7.9 20.7 0.8 15.2 8.6 10.0 38.9 10.7 11.3 45.4 26.6 9.6 27.5 14.7 35.4 7.9 13.6 72.5 24.1 5.0 7.9 21.0 8.2 29.0 5.4 1.7 7.8 19.3 16.0 8.4 13.1 8.9 24.7 3.5 4.3 44.4 36.5 20.3 25.8 9.2 88.2 85.7 12.3 7.0 6.6 10.3 9.0 2.9 4.7 1.8 1.1 18.7 15.2 9.4 33.4 16.9 PHACTR2 "C6orf56, KIAA0680" ENSG00000112419 "Phosphatase and actin regulator 2" O75167 6 143536845-143831185 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "choroid plexus: 164.2;placenta: 83.8" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 214.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 82.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031719, HPA031720, HPA031725" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "Plasma membrane" "HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279" "unprognostic (3.25e-3)" "unprognostic (1.07e-1)" "unprognostic (4.39e-2)" "unprognostic (5.25e-2)" "unprognostic (1.90e-2)" "unprognostic (8.38e-2)" "unprognostic (3.19e-2)" "unprognostic (9.92e-2)" "unprognostic (7.46e-2)" "unprognostic (3.61e-2)" "unprognostic (2.49e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.99e-4)" "unprognostic (3.60e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" 11.6 25.4 7.0 7.8 9.0 7.6 5.5 4.3 5.7 8.1 164.2 8.5 7.5 9.9 3.6 22.0 5.7 8.4 12.4 10.0 4.9 5.9 7.9 15.7 7.8 12.3 10.3 6.5 4.9 13.1 4.0 83.8 15.1 10.3 8.5 2.7 6.0 6.9 4.5 2.7 6.1 9.8 3.5 13.5 12.0 6.5 16.5 2.7 15.5 7.3 6.7 7.6 6.4 4.5 21.9 13.5 3.6 26.6 3.7 8.0 15.3 18.0 27.2 7.7 9.6 23.9 9.5 1.2 47.5 51.7 5.4 6.5 2.0 17.9 9.1 18.1 8.5 35.5 14.7 14.0 6.1 9.1 10.5 11.2 9.8 7.7 24.9 11.8 47.0 6.7 10.2 0.1 12.4 24.0 1.3 2.1 26.8 7.7 3.8 3.3 26.3 0.2 9.3 19.2 5.2 5.2 20.0 26.1 0.3 13.4 9.8 13.1 82.2 34.9 18.2 15.2 11.8 0.2 0.1 0.3 8.6 9.5 3.2 6.0 3.5 6.7 3.3 2.5 12.3 0.4 4.0 4.4 3.3 0.2 2.4 1.6 1.8 3.5 2.7 3.2 5.5 1.9 7.0 9.0 4.3 5.7 10.0 4.9 12.3 10.3 15.1 3.5 16.5 4.5 160.9 214.7 94.5 41.4 11.7 24.2 16.0 19.5 47.3 37.0 14.2 13.8 71.8 32.9 73.2 22.0 2.1 84.7 27.5 58.9 13.7 30.5 10.1 49.6 43.7 158.6 21.6 32.8 55.2 22.5 49.8 144.8 54.6 64.7 38.7 34.9 157.1 27.6 35.4 101.0 133.8 19.2 24.4 121.1 40.2 23.2 103.2 52.5 24.9 77.8 71.7 10.3 15.5 5.5 20.9 49.4 22.3 120.0 10.6 63.3 20.2 24.8 51.1 3.0 98.6 95.9 83.5 3.1 2.3 33.0 17.2 52.5 51.3 127.9 26.3 30.9 PHF7 "HSPC226, NYD-SP6" ENSG00000010318 "PHD finger protein 7" Q9BWX1 3 52410660-52423641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 212 "testis: 1216.7" "Cell type enhanced" "Detected in many" "Early spermatids: 2630.6;Late spermatids: 8698.5;Spermatocytes: 1456.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 14.8;U-266/70: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA036283, HPA070305" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Golgi apparatus" "HPA036283: AB_10795026, HPA070305: AB_2686248" "prognostic favorable (7.38e-5)" "unprognostic (4.57e-2)" "unprognostic (6.97e-3)" "prognostic favorable (9.44e-5)" "unprognostic (3.63e-1)" "unprognostic (2.61e-3)" "unprognostic (7.44e-2)" "unprognostic (5.78e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-3)" "unprognostic (1.55e-3)" "unprognostic (1.12e-1)" "prognostic favorable (1.05e-6)" "unprognostic (2.07e-2)" "unprognostic (1.82e-1)" "unprognostic (2.34e-2)" "unprognostic (6.79e-2)" 4.8 2.8 0.6 1.3 0.6 4.1 5.0 0.9 1.3 2.1 0.6 4.3 2.7 1.6 3.3 2.6 2.0 1.1 1.9 0.6 0.7 2.9 4.7 2.4 2.1 0.8 0.8 1.4 4.4 5.7 1.7 2.0 0.8 4.3 4.6 0.6 3.5 1.7 2.3 5.0 4.2 1.4 0.7 3.2 2.5 1216.7 0.7 2.8 2.2 0.9 2.2 2.4 2.3 0.8 2.2 0.6 1.6 6.8 1.1 1.6 2.8 2.1 2.2 1.7 2.1 1.1 0.9 3.6 0.2 1.6 1.0 1.2 1.2 3.4 2.9 4.5 1.6 4.1 0.6 2.5 1.1 4.6 7.5 1.0 3.7 1.6 3.5 0.5 2.5 8.3 2.5 14.8 1.3 1.0 5.4 1.7 0.7 0.7 4.6 2.4 1.5 4.5 1.8 0.9 1.1 1.3 2.0 0.1 1.6 2.0 1.0 2.3 1.8 2.8 1.9 3.0 4.5 17.4 9.0 2.1 1.2 10.4 1.7 0.3 1.1 1.8 0.9 1.2 1.1 3.4 1.0 1.6 0.5 1.8 0.7 1.5 0.2 1.1 0.6 1.1 2.5 0.9 0.6 0.6 0.9 1.3 0.6 0.7 0.8 0.8 0.8 0.7 0.7 0.8 4.3 3.2 4.6 15.7 7.8 4.6 4.8 3.5 13.6 11.2 6.2 5.0 9.7 4.3 1.3 7.3 8.4 3.5 5.8 7.7 13.7 3.6 2630.6 5.3 3.1 6.7 11.5 14.7 10.9 2.8 2.0 5.7 6.1 2.1 7.0 3.7 3.3 4.5 4.2 13.5 12.4 4.2 2.0 4.1 2.3 8698.5 77.0 7.9 8.8 1.9 4.4 8.1 7.2 5.5 16.3 3.7 2.4 63.2 7.6 1.7 12.7 7.3 6.0 15.3 52.6 6.0 4.5 1456.7 71.6 7.6 3.0 0.5 5.5 7.2 10.2 2.2 PHKB ENSG00000102893 "Phosphorylase kinase regulatory subunit beta" Q93100 16 47461123-47701523 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" Calmodulin-binding "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 159.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073380 Approved "Golgi apparatus" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA073380: AB_2686598" "unprognostic (2.87e-3)" "unprognostic (2.41e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.98e-2)" "unprognostic (3.98e-2)" "unprognostic (1.28e-2)" "unprognostic (6.73e-2)" "unprognostic (2.99e-2)" "unprognostic (2.35e-3)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "unprognostic (3.01e-2)" "prognostic favorable (3.89e-9)" "unprognostic (3.56e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (2.53e-2)" 29.7 42.4 15.8 21.9 16.2 28.2 36.1 18.3 19.5 33.8 34.1 39.0 37.8 26.8 32.8 34.5 25.6 30.6 32.7 14.3 21.3 47.2 30.1 30.0 26.2 15.8 16.0 24.2 26.6 56.7 21.6 37.1 18.6 36.2 41.5 18.9 46.1 32.2 159.0 18.9 38.0 32.1 13.8 29.0 40.4 30.6 18.9 31.0 54.1 80.7 29.0 26.5 21.2 16.6 36.7 53.3 60.3 39.1 41.2 38.8 74.9 42.8 41.2 30.1 15.0 29.4 62.2 44.5 63.5 62.7 23.7 50.6 57.0 66.9 42.3 13.8 29.8 42.1 45.4 98.3 37.0 46.2 47.7 35.1 33.4 20.3 38.2 65.4 59.8 53.5 58.8 27.4 43.7 26.3 45.2 44.1 25.5 61.1 39.8 75.7 73.3 74.3 59.2 31.1 31.5 35.8 70.9 92.4 12.0 66.1 36.0 37.7 66.5 54.4 25.4 28.0 22.9 31.1 24.6 57.2 34.5 30.2 22.7 11.1 21.0 18.4 11.8 18.9 15.3 30.6 12.2 9.7 20.6 34.7 11.8 11.7 10.4 18.5 23.7 13.9 15.8 12.6 15.8 16.2 18.3 19.5 14.3 21.3 15.8 16.0 18.6 13.8 18.9 16.6 49.3 19.2 38.0 66.9 46.8 8.9 17.5 28.8 18.8 34.9 28.7 23.4 61.2 32.9 39.9 42.3 100.1 48.5 29.3 43.1 23.5 19.6 64.7 33.5 31.1 42.9 30.5 40.1 109.8 15.6 26.3 28.8 47.9 38.3 18.3 52.6 39.3 30.9 28.4 23.5 149.0 37.8 20.3 58.7 17.0 89.8 25.4 45.1 8.8 104.0 72.2 25.8 32.0 133.2 118.4 27.2 26.4 35.7 28.1 30.2 48.9 35.9 26.7 71.8 26.3 33.3 30.6 53.9 19.5 47.2 7.2 33.8 24.7 74.9 38.6 26.7 PI4KB "PI4K-BETA, pi4K92, PIK4CB" ENSG00000143393 "Phosphatidylinositol 4-kinase beta" Q9UBF8 1 151291797-151327715 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006280, HPA006281, CAB022071" Approved Supported "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614" "unprognostic (1.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.42e-3)" "unprognostic (5.23e-3)" "unprognostic (7.32e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.25e-5)" "unprognostic (8.51e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.53e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (7.08e-2)" 45.6 45.0 57.3 33.1 61.4 78.0 47.6 64.4 63.2 62.6 53.2 50.9 35.8 58.8 54.8 48.0 58.6 40.2 45.8 59.2 62.3 50.4 40.5 47.2 46.8 57.9 60.7 60.2 46.1 56.0 56.5 39.6 60.4 57.6 44.0 46.4 45.8 42.6 68.5 60.5 47.0 62.2 54.4 59.8 48.0 46.0 61.0 45.7 67.8 58.6 47.5 48.9 51.3 68.2 49.2 40.1 34.2 53.9 92.8 68.1 28.9 50.9 88.3 65.3 53.8 51.7 43.4 46.1 57.1 78.5 41.1 44.9 57.3 52.5 50.1 63.0 50.9 33.0 48.8 26.6 64.8 38.5 60.9 71.7 62.4 72.3 51.3 56.3 63.7 46.3 57.5 67.9 56.0 91.2 41.0 30.9 27.6 69.5 60.3 36.2 28.8 54.4 45.2 61.2 41.3 35.4 35.5 71.1 46.7 53.9 60.1 71.9 50.3 46.5 36.3 37.3 55.1 71.6 50.4 89.8 52.9 39.7 82.3 41.3 22.7 36.0 17.8 24.7 19.9 20.4 18.5 23.6 24.3 16.7 15.1 14.3 21.0 19.3 26.3 13.9 20.0 23.9 57.3 61.4 64.4 63.2 59.2 62.3 57.9 60.7 60.4 54.4 61.0 68.2 16.8 16.0 24.3 19.2 26.4 22.3 18.2 17.7 28.5 33.5 24.3 24.6 7.0 21.5 17.7 12.9 20.9 30.1 16.0 28.7 19.6 20.9 12.2 21.5 19.9 19.3 18.5 26.9 17.8 24.9 20.5 25.9 23.0 24.6 19.0 30.0 15.4 12.4 29.2 35.3 19.0 16.4 10.2 20.1 20.5 15.5 23.3 21.3 14.2 15.9 29.3 23.1 21.6 18.1 25.8 23.5 17.3 24.8 24.4 17.7 25.7 15.2 17.1 28.4 13.1 24.2 23.2 28.9 25.1 24.8 31.1 48.7 23.8 44.7 20.2 28.1 PIDD1 "DKFZp434D229, LRDD, MGC16925, PIDD" ENSG00000177595 "P53-induced death domain protein 1" Q9HB75 11 799179-809753 "Predicted intracellular proteins" Apoptosis Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 26.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012647, HPA055473, HPA066948" Supported Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Cytosol" "CAB012647: , HPA055473: AB_2682827, HPA066948: " "unprognostic (1.38e-1)" "prognostic favorable (8.19e-5)" "unprognostic (5.07e-3)" "prognostic favorable (3.32e-5)" "unprognostic (7.25e-2)" "prognostic favorable (3.91e-4)" "unprognostic (8.17e-3)" "unprognostic (5.97e-2)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (2.17e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.84e-3)" "unprognostic (8.46e-2)" "unprognostic (2.24e-1)" "unprognostic (2.22e-2)" 3.3 3.1 2.3 2.3 2.8 7.4 3.3 2.5 4.1 3.6 2.8 3.9 3.0 3.0 0.1 4.0 3.3 1.1 2.9 2.1 2.2 3.1 5.5 2.7 3.2 3.6 2.6 2.8 3.7 0.9 2.8 1.9 3.5 4.3 0.6 0.2 3.2 1.0 6.5 5.5 4.5 0.7 2.5 5.0 4.0 2.4 3.0 3.2 3.8 0.8 1.0 3.2 3.1 4.6 5.4 6.2 2.9 6.2 0.6 2.2 26.6 7.5 2.0 2.7 3.6 5.7 10.2 4.4 2.3 1.1 2.5 7.9 2.1 3.0 0.5 9.0 12.3 3.8 5.0 12.0 6.8 4.3 9.4 8.4 5.3 1.4 0.3 0.5 5.0 10.3 4.5 3.3 1.1 2.6 12.0 7.2 4.0 5.8 4.3 19.4 4.2 8.6 1.1 1.9 5.1 6.8 3.1 8.2 2.0 1.6 6.0 7.3 2.7 3.4 7.6 2.5 4.9 10.5 6.4 8.5 4.4 3.5 5.6 0.0 0.5 0.0 0.4 0.4 0.4 0.3 0.3 0.4 0.8 0.4 0.4 0.4 0.0 0.1 0.4 0.2 0.9 0.4 2.3 2.8 2.5 4.1 2.1 2.2 3.6 2.6 3.5 2.5 3.0 4.6 4.9 3.2 8.8 25.8 7.2 0.0 3.6 0.0 6.2 14.9 7.3 8.1 4.2 5.7 5.6 3.7 10.4 29.2 8.9 12.0 1.9 2.5 1.4 6.7 4.2 3.7 9.0 5.7 12.8 4.6 7.5 4.4 10.7 4.2 1.3 14.0 2.2 10.3 5.5 1.7 14.2 8.1 0.0 3.5 0.0 1.9 7.2 3.8 0.0 7.5 4.1 7.0 2.1 6.6 26.9 3.5 9.9 4.1 6.0 4.4 10.0 3.8 0.0 15.4 0.0 5.7 3.5 25.2 20.8 6.7 0.0 9.7 6.3 7.5 10.5 3.6 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584109 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 78.9;Late spermatids: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: AB_2684508" "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favorable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 13.3 23.9 7.1 3.8 8.0 30.4 15.0 2.0 12.0 15.4 8.6 16.2 7.5 18.3 1.4 13.2 16.5 2.8 13.3 9.6 5.2 30.7 19.0 17.9 2.5 6.6 9.7 15.6 21.9 9.4 25.4 3.3 6.5 19.4 1.1 1.2 19.3 5.8 18.4 15.7 12.6 1.6 3.5 15.0 17.0 28.1 6.0 2.7 31.1 1.7 1.2 15.8 12.1 4.3 14.2 21.9 7.3 10.3 4.6 2.7 13.9 14.7 5.6 6.3 6.6 14.6 12.9 7.6 18.6 3.3 5.5 22.2 3.3 6.4 1.3 21.9 30.4 11.4 23.8 10.8 8.9 10.1 10.2 5.2 9.8 10.2 2.0 4.0 6.1 13.7 26.1 4.1 2.1 20.7 18.3 11.4 10.0 3.0 21.9 36.6 6.4 17.7 5.6 5.6 13.2 21.4 16.8 7.6 10.8 2.3 17.3 6.9 14.5 10.4 13.7 11.7 10.4 15.8 5.0 6.0 4.8 5.4 10.4 0.9 2.8 1.6 2.8 3.1 2.4 2.3 2.3 2.6 2.7 2.5 2.5 1.6 3.0 3.3 3.7 5.6 2.4 2.6 7.1 8.0 2.0 12.0 9.6 5.2 6.6 9.7 6.5 3.5 6.0 4.3 9.7 16.0 20.3 14.0 6.9 4.8 6.6 8.4 5.2 12.1 15.8 11.0 8.4 4.3 10.6 40.5 4.2 10.5 8.8 31.5 3.9 19.3 33.6 21.0 7.8 9.0 20.3 78.9 19.3 17.4 8.4 9.4 16.3 11.4 8.2 19.7 6.4 16.4 9.5 10.1 13.8 13.0 8.2 9.1 4.4 61.4 7.5 8.2 16.0 3.7 7.7 14.6 10.3 7.5 6.6 14.1 11.6 7.2 9.1 6.9 7.6 12.4 23.3 13.7 0.0 7.7 9.9 30.1 13.6 6.2 4.8 5.9 7.8 11.1 16.9 5.0 PIK3R6 "C17orf38, FLJ34500, HsT41028, p87PIKAP" ENSG00000276231 "Phosphoinositide-3-kinase regulatory subunit 6" Q5UE93 17 8802722-8867677 "Metabolic proteins, Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.9" "Cell type enhanced" "Detected in some" "Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 21.9;eosinophil: 75.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 75.8" "Cell line enriched" "Detected in some" 8 "HMC-1: 148.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023077 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA023077: AB_1854909" "unprognostic (4.29e-2)" "unprognostic (8.56e-3)" "unprognostic (9.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.46e-1)" "unprognostic (5.25e-3)" "unprognostic (4.50e-3)" "unprognostic (2.29e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (2.20e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-1)" "unprognostic (8.98e-2)" 0.4 0.0 1.1 1.8 1.6 2.2 0.4 0.9 1.1 0.6 0.8 0.8 1.5 0.9 0.1 0.5 0.2 1.2 1.3 1.0 1.1 0.0 0.3 1.2 2.1 1.4 1.5 0.0 0.4 0.1 0.0 0.6 1.6 0.3 0.6 0.0 0.2 0.3 0.5 0.8 2.2 0.7 1.1 2.9 1.0 0.4 1.9 2.1 0.0 0.3 1.5 1.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 14.1 0.0 19.4 0.0 0.0 0.0 0.0 148.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 2.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 21.9 7.2 75.8 0.5 9.6 0.4 2.7 0.1 0.3 10.8 0.3 0.1 0.2 1.1 1.5 7.8 0.0 0.0 3.3 1.1 1.6 0.9 1.1 1.0 1.1 1.4 1.5 1.6 1.1 1.9 1.6 0.2 0.0 1.3 0.3 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 11.5 0.0 0.1 2.6 0.0 0.4 0.6 0.0 0.1 0.2 0.5 0.0 47.4 0.0 0.4 0.0 7.6 0.0 0.5 0.0 0.0 4.4 1.6 20.6 0.0 3.9 1.8 7.5 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.1 0.0 1.6 0.1 0.0 0.0 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1" ENSG00000258724 "PIN2 (TERF1) interacting telomerase inhibitor 1" 8 10725399-10839847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 2.9;vagina: 5.5" "Cell type enhanced" "Detected in many" "Early spermatids: 37.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.9" HPA009065 Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (2.57e-1)" "unprognostic (6.34e-2)" 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 2.9 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 5.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 3.2 6.7 12.4 10.4 26.6 20.7 12.0 14.2 5.6 0.0 0.0 0.0 8.6 8.2 3.7 12.5 0.0 4.0 6.9 11.7 0.0 37.0 0.0 0.0 7.3 8.4 6.9 25.0 0.0 0.0 5.3 7.7 0.0 14.0 0.0 12.5 7.0 0.0 3.3 22.4 5.0 8.2 5.4 10.3 32.7 9.3 3.9 7.2 13.1 3.3 9.0 7.2 17.6 15.3 0.0 5.3 6.4 14.0 20.2 6.5 13.3 7.0 22.1 0.0 12.5 5.5 21.5 22.7 12.0 28.6 0.0 8.3 0.0 9.6 8.9 PIP4K2A "PIP5K2A, PIP5KIIA, PIP5KIIalpha" ENSG00000150867 "Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha" P48426 10 22534854-22714578 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 498.1" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 1585.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065440, HPA068771" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 4900000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 2: Karpas-707 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Plasma membrane, Cytosol" "HPA065440: AB_2685490, HPA068771: AB_2686030" "unprognostic (1.11e-1)" "unprognostic (2.71e-3)" "unprognostic (1.57e-3)" "unprognostic (4.20e-3)" "unprognostic (1.55e-1)" "unprognostic (8.80e-3)" "unprognostic (1.56e-3)" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (7.08e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.52e-3)" "unprognostic (2.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.92e-3)" 28.4 15.5 162.5 47.8 329.4 44.8 15.0 239.0 239.9 26.5 49.8 17.8 13.2 21.1 11.8 19.8 15.2 32.9 13.5 169.7 193.6 16.5 18.6 25.9 81.2 260.6 273.4 8.8 10.9 24.8 8.5 23.7 271.7 9.3 19.1 15.3 7.8 13.0 5.1 8.3 20.6 31.5 171.8 62.6 19.3 12.5 233.3 60.4 12.8 10.9 88.5 24.1 10.5 498.1 30.2 29.2 33.4 10.8 52.3 70.6 25.3 55.0 58.1 29.1 35.7 27.6 47.2 63.2 19.4 111.0 63.7 10.4 29.2 15.4 29.2 140.5 30.4 118.7 21.6 60.9 92.5 23.1 89.1 35.6 13.7 39.7 38.2 44.6 43.7 83.5 67.4 119.1 54.5 12.5 92.3 20.5 13.7 14.5 20.7 36.9 47.8 86.3 43.0 5.8 6.1 13.9 17.7 9.0 86.4 37.6 7.6 39.1 53.0 22.3 32.8 41.7 33.9 75.1 46.3 45.0 60.5 68.3 17.6 72.6 32.6 104.0 119.5 57.9 164.0 52.1 94.2 139.9 43.7 33.1 62.8 118.2 40.5 144.2 67.3 44.8 75.9 183.4 162.5 329.4 239.0 239.9 169.7 193.6 260.6 273.4 271.7 171.8 233.3 498.1 22.5 3.2 6.7 84.9 43.2 17.6 4.0 2.0 3.4 5.7 12.9 5.5 8.1 14.3 5.6 18.4 2.1 8.6 196.9 3.4 11.7 9.7 22.9 7.4 15.7 29.2 4.9 236.9 65.6 10.7 5.4 19.6 6.6 24.8 22.8 13.4 62.4 8.7 31.8 13.5 62.0 2.9 0.0 98.6 80.0 34.5 16.8 82.8 104.9 142.4 81.3 5.0 159.6 167.9 1585.0 22.1 3.7 10.1 36.4 7.1 1.0 15.6 2.2 9.1 19.7 14.1 30.6 6.1 7.9 3.3 16.9 12.4 130.7 8.5 2.8 6.6 PISD "dJ858B16.2, PSDC" ENSG00000241878 "Phosphatidylserine decarboxylase" Q9UG56 22 31618491-31662432 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Decarboxylase, Lyase" "Cataract, Deafness, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 223.5;Syncytiotrophoblasts: 245.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 80.7" "Low region specificity" "Detected in all" "HPA031090, HPA031091" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Cytosol" "HPA031090: AB_10600114, HPA031091: AB_10600893" "unprognostic (7.96e-2)" "unprognostic (5.41e-3)" "unprognostic (2.60e-1)" "unprognostic (8.31e-2)" "unprognostic (5.61e-2)" "unprognostic (4.55e-3)" "unprognostic (2.44e-3)" "unprognostic (8.13e-3)" "unprognostic (6.37e-3)" "unprognostic (1.23e-1)" "unprognostic (1.11e-3)" "unprognostic (1.70e-2)" "unprognostic (4.18e-3)" "unprognostic (1.91e-2)" "unprognostic (4.85e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.27e-5)" 34.1 13.7 6.7 12.2 6.3 18.7 16.0 14.3 9.8 7.4 7.5 8.9 8.8 10.1 4.8 7.3 10.8 7.1 7.3 6.1 7.5 18.9 6.3 14.7 8.4 7.0 6.0 7.6 9.2 5.0 12.6 19.9 6.8 9.0 2.0 3.5 7.5 5.3 5.3 7.8 7.8 3.2 3.8 18.0 8.2 20.3 7.2 3.8 11.5 3.2 4.3 7.3 7.1 5.1 21.7 19.7 5.8 5.8 17.3 6.6 13.2 17.4 13.6 11.9 12.9 28.6 6.6 12.9 18.0 8.8 15.8 24.0 7.9 15.5 1.9 14.4 16.9 13.5 12.8 23.7 35.9 28.7 34.2 12.4 8.5 21.2 9.1 4.9 10.6 9.0 40.3 7.6 6.9 80.7 12.5 12.4 5.7 14.2 8.1 17.4 6.5 13.0 7.6 18.9 14.2 8.4 10.1 31.8 11.0 4.7 26.5 15.5 21.0 14.9 17.7 9.6 16.3 8.9 13.3 16.2 14.2 19.0 12.1 24.1 21.7 16.1 10.6 15.8 10.3 11.9 7.7 9.0 18.3 11.9 10.3 8.6 47.0 10.4 8.7 8.9 8.2 13.8 6.7 6.3 14.3 9.8 6.1 7.5 7.0 6.0 6.8 3.8 7.2 5.1 11.1 16.0 15.6 17.3 12.4 25.6 34.7 31.5 38.7 26.0 18.6 12.6 55.5 12.8 31.1 42.3 20.9 223.5 12.9 12.0 11.7 33.2 60.0 36.2 17.9 19.6 20.9 32.4 40.3 16.8 25.9 13.6 17.3 87.3 18.3 13.2 8.9 7.5 36.4 18.5 35.5 12.9 22.4 36.4 12.7 81.9 9.6 19.8 3.6 9.4 27.1 11.8 24.7 16.1 19.9 15.9 8.4 7.2 11.4 52.1 12.3 13.9 10.9 25.8 19.7 4.9 11.1 25.0 17.9 27.7 21.3 245.0 11.8 8.3 14.2 43.5 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980479 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.6;testis: 56.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 29.0;Extravillous trophoblasts: 52.0;Plasma cells: 22.9;Spermatocytes: 114.7;Spermatogonia: 46.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 6 "T-reg: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 1.1 1.0 0.4 6.8 0.5 27.6 0.6 1.6 1.4 2.2 0.2 3.9 2.8 0.6 0.3 11.5 0.4 0.6 0.9 0.5 0.2 0.9 1.6 2.0 8.0 0.7 0.6 0.3 1.8 0.1 1.0 3.1 0.8 1.0 1.3 17.4 1.9 0.1 2.4 4.4 4.0 1.0 0.5 5.6 3.3 56.9 0.7 9.6 0.5 0.0 4.5 0.7 3.3 0.8 84.2 57.0 22.0 31.2 0.3 0.9 64.0 65.5 15.1 40.0 38.4 45.0 49.3 54.2 29.2 7.9 24.2 106.7 15.7 20.7 7.2 71.7 56.7 27.9 52.7 40.0 0.0 31.2 73.6 0.7 1.8 24.0 6.5 5.0 8.4 57.6 80.6 87.0 13.5 127.5 83.6 88.0 37.9 39.3 34.4 93.7 51.2 100.7 7.8 17.7 42.6 46.7 31.9 77.7 23.9 12.1 44.7 56.9 7.7 53.2 69.7 77.3 68.0 67.6 54.2 94.0 19.4 40.0 61.2 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.3 0.4 0.5 1.6 1.4 0.5 0.2 0.7 0.6 0.8 0.5 0.7 0.8 0.0 0.0 1.1 0.0 1.9 2.5 1.3 2.1 0.6 0.4 1.5 1.3 0.6 1.5 1.6 1.8 6.2 16.0 1.3 5.0 0.0 0.8 20.0 0.6 0.8 0.8 1.8 29.0 0.4 0.6 52.0 2.5 3.1 1.9 0.0 4.5 0.0 0.4 11.8 0.0 0.2 3.6 6.1 2.1 1.8 8.6 0.3 1.9 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.6 0.3 0.4 22.9 0.7 0.3 0.1 0.2 7.1 0.0 0.1 2.6 114.7 46.1 11.2 0.6 7.4 4.2 0.5 8.6 2.0 PLA2G3 GIII-SPLA2 ENSG00000100078 "Phospholipase A2 group III" Q9NZ20 22 31134807-31140508 "Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins" "Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix: 5.9;esophagus: 13.8;skin 1: 15.4;vagina: 7.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.6;Breast glandular cells: 7.5;Suprabasal keratinocytes: 17.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 15.1;AN3-CA: 15.3;NTERA-2: 7.8;SCLC-21H: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021016 Uncertain Uncertain "Endoplasmic reticulum,Golgi apparatus" "Secreted to blood" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 12: NES - Nervous system development" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" "Endoplasmic reticulum" "HPA021016: AB_1855443" "unprognostic (1.80e-1)" "unprognostic (4.63e-3)" "unprognostic (1.07e-1)" "unprognostic (1.49e-2)" "unprognostic (9.72e-2)" "prognostic favorable (4.47e-4)" "unprognostic (1.74e-2)" "unprognostic (2.30e-1)" "unprognostic (4.25e-2)" "unprognostic (9.55e-3)" "unprognostic (4.41e-1)" "unprognostic (3.67e-1)" "unprognostic (3.29e-1)" "unprognostic (9.49e-3)" "unprognostic (3.72e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.8 0.2 5.9 0.7 0.1 0.3 0.0 0.0 13.8 0.0 0.0 0.0 0.4 0.1 0.5 0.0 2.5 0.0 1.6 0.1 0.0 0.0 1.0 0.1 0.0 1.7 0.3 0.0 0.0 1.8 0.3 0.2 15.4 0.2 0.0 0.1 0.0 0.6 0.5 0.1 0.1 0.6 0.0 1.7 0.0 7.1 0.2 0.0 0.0 15.1 15.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.4 0.1 1.6 0.1 1.7 0.1 0.1 0.2 0.0 0.0 3.6 1.6 0.0 1.3 0.2 0.2 0.0 0.0 7.5 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.5 17.8 0.0 0.0 0.0 0.0 0.4 PLAGL1 "LOT1, ZAC" ENSG00000118495 "PLAG1 like zinc finger 1" Q9UM63 6 143940300-144064599 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 252.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 99.0;RH-30: 94.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055706 Supported "Nuclear bodies,Golgi apparatus,Vesicles" No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 33: Fibroblasts - ECM organization" "Nuclear bodies" "Golgi apparatus, Vesicles" "HPA055706: AB_2682893" "unprognostic (4.74e-3)" "unprognostic (8.35e-3)" "unprognostic (5.43e-2)" "unprognostic (1.74e-3)" "unprognostic (5.09e-2)" "unprognostic (1.95e-1)" "unprognostic (9.32e-2)" "unprognostic (6.17e-2)" "unprognostic (3.49e-2)" "unprognostic (5.02e-2)" "unprognostic (1.78e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.94e-6)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.69e-2)" "unprognostic (5.17e-3)" "unprognostic (4.93e-3)" 37.7 74.8 4.1 18.5 5.2 21.7 29.6 1.9 7.0 31.4 5.8 28.8 9.6 29.5 9.0 32.9 20.8 26.9 26.4 3.8 2.9 17.0 3.6 26.7 12.1 3.6 4.1 36.5 27.7 9.5 81.6 252.3 3.9 26.0 21.3 1.6 30.1 12.1 12.2 61.9 20.6 19.7 3.2 15.6 26.9 8.7 6.0 6.6 13.8 22.3 12.1 39.6 34.4 4.0 0.2 5.0 99.0 0.1 39.4 78.0 0.3 32.9 21.6 16.1 33.5 0.3 6.0 2.7 16.0 30.4 4.0 0.0 0.8 12.0 32.2 3.1 4.4 45.2 58.7 0.9 13.9 40.9 8.9 60.5 4.6 15.8 13.8 23.4 33.5 16.1 4.4 0.8 18.0 6.2 16.9 19.8 17.2 0.0 3.7 20.7 94.1 0.1 33.1 1.1 8.7 10.3 51.0 0.1 0.1 29.6 0.1 50.1 19.8 0.2 35.2 77.7 36.4 9.1 9.0 0.6 25.3 16.6 2.0 4.9 12.0 25.1 1.4 9.1 1.4 3.7 1.3 1.9 14.9 5.8 0.9 1.5 21.7 2.2 2.9 6.7 2.0 3.8 4.1 5.2 1.9 7.0 3.8 2.9 3.6 4.1 3.9 3.2 6.0 4.0 19.5 51.3 51.0 28.4 15.2 21.7 14.6 5.3 34.1 2.1 16.8 14.0 8.4 5.7 12.6 5.5 0.0 4.6 19.0 16.1 7.9 11.8 1.8 8.6 91.9 23.8 16.7 19.3 60.3 11.3 15.0 143.6 11.7 13.0 18.4 38.7 8.6 0.2 20.3 8.4 76.6 33.6 18.3 26.8 27.8 5.5 138.5 26.8 8.8 49.6 37.6 0.9 2.1 10.6 5.5 13.0 22.5 97.0 5.7 52.0 4.3 15.3 4.4 0.4 13.1 61.7 31.1 0.9 1.0 24.1 43.3 9.9 10.0 205.8 28.5 19.7 PLAU "UPA, URK" ENSG00000122861 "Plasminogen activator, urokinase" P00749 10 73909177-73917496 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.8;urinary bladder: 128.5" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.0;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070796 Supported Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 647000 88000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Vesicles" "HPA070796: " "unprognostic (1.96e-2)" "unprognostic (2.99e-2)" "unprognostic (7.40e-2)" "prognostic favorable (3.38e-4)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.39e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (2.26e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.83e-1)" "unprognostic (3.37e-2)" "unprognostic (1.51e-2)" "unprognostic (1.77e-2)" 57.6 4.8 2.5 41.7 2.7 36.2 17.6 2.7 8.9 9.3 4.4 13.1 11.9 22.0 16.7 14.4 10.3 28.5 23.1 2.4 2.9 103.8 5.0 22.0 14.3 3.8 2.9 2.3 10.1 8.3 2.9 36.5 5.4 9.1 18.2 0.3 17.3 13.7 10.8 25.5 13.7 23.4 3.3 40.6 15.7 3.7 4.7 5.9 17.9 18.9 7.2 128.5 16.2 4.7 171.1 88.9 36.8 1.7 3.1 59.5 2.0 101.9 461.6 40.0 62.2 2.3 856.0 0.1 184.0 14.5 416.9 114.1 0.9 165.8 44.8 9.9 0.0 0.1 4.4 1.7 72.6 15.6 32.3 158.7 20.2 271.4 103.7 447.0 114.7 1.0 1.1 0.9 822.4 0.2 0.2 22.7 10.8 0.3 244.5 0.4 112.6 0.9 3100.7 130.6 0.1 0.2 0.3 4.0 2.4 25.4 1.2 22.9 300.6 3.5 20.3 21.6 869.8 0.2 1.3 1.6 216.0 25.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.1 0.0 0.0 2.0 0.0 0.1 2.5 2.7 2.7 8.9 2.4 2.9 3.8 2.9 5.4 3.3 4.7 4.7 29.0 3.2 4.6 0.3 1.4 37.3 635.9 237.3 19.9 0.0 3.0 24.4 2.5 0.0 103.6 29.5 0.0 28.0 1.6 0.6 68.4 62.7 0.5 50.7 22.2 46.4 3.5 0.0 0.2 21.3 21.7 69.7 0.0 68.9 31.1 0.1 3.9 0.0 39.8 0.0 0.3 0.1 140.4 4.0 33.1 1.3 2.5 53.4 7.2 4.7 23.8 0.0 0.0 0.5 0.2 613.9 0.3 0.0 0.5 695.0 0.0 1.4 35.4 0.0 6.6 27.6 65.2 0.0 0.2 60.6 29.5 17.5 4.7 0.6 1.7 869.6 PLCB3 ENSG00000149782 "Phospholipase C beta 3" Q01970 11 64251530-64269150 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 113.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 52.3;Proximal enterocytes: 161.7;Undifferentiated cells: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009257, HPA039279, HPA043907" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 210000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 56: Intestine - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Golgi apparatus" "CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "unprognostic (2.86e-1)" "unprognostic (2.35e-1)" "unprognostic (9.35e-2)" "unprognostic (6.23e-3)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.44e-2)" "unprognostic (6.61e-2)" "unprognostic (1.26e-1)" "unprognostic (8.07e-3)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.31e-5)" "unprognostic (5.04e-3)" "unprognostic (1.52e-1)" "unprognostic (1.20e-1)" "unprognostic (3.88e-2)" 12.8 19.1 6.8 9.7 7.3 7.4 11.2 8.2 8.0 19.7 7.0 22.8 113.8 17.8 3.6 35.3 16.5 7.1 11.5 6.5 7.3 11.7 6.4 15.6 4.4 9.2 7.6 15.8 8.6 10.0 5.8 10.3 8.1 13.1 12.5 1.4 13.5 10.4 6.7 20.3 101.6 11.4 7.7 14.5 14.7 9.5 9.2 3.9 10.3 4.2 5.3 13.8 18.8 7.7 45.2 24.9 24.0 36.0 24.6 18.9 23.8 35.3 26.4 29.5 17.9 22.1 33.5 3.2 20.8 44.4 25.4 75.9 27.2 33.0 10.1 21.8 15.1 35.1 54.9 16.7 17.0 8.6 22.3 16.0 21.5 32.1 23.6 32.2 43.5 13.4 17.6 3.8 37.9 54.5 10.9 17.9 38.8 56.9 26.9 23.5 54.0 13.3 18.2 46.8 6.4 26.4 52.0 64.4 25.2 14.8 33.9 16.4 76.4 27.1 32.0 62.7 23.2 4.6 2.4 3.6 44.8 19.9 25.5 0.0 0.4 0.0 0.2 0.4 0.2 0.0 0.2 0.1 0.4 0.0 0.1 0.1 0.2 0.1 0.4 1.2 0.0 0.1 6.8 7.3 8.2 8.0 6.5 7.3 9.2 7.6 8.1 7.7 9.2 7.7 11.2 3.2 7.9 7.5 1.8 13.0 6.0 6.4 6.2 1.2 6.1 4.6 3.3 8.6 6.3 16.5 0.0 9.2 8.3 52.3 1.9 7.8 1.3 3.5 8.7 13.2 2.4 7.8 0.6 7.7 19.1 7.6 28.5 7.1 5.7 20.2 18.2 3.4 9.8 3.3 0.9 46.2 12.2 10.1 13.5 1.4 9.9 8.8 8.8 8.4 22.1 4.7 2.1 1.5 0.6 17.3 23.8 12.4 2.6 7.4 161.7 4.0 2.8 1.1 26.3 6.0 9.8 3.1 8.3 19.4 11.8 14.6 2.7 6.8 65.5 8.3 PLCXD3 ENSG00000182836 "Phosphatidylinositol specific phospholipase C X domain containing 3" Q63HM9 5 41306952-41510628 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;heart muscle: 33.2;ovary: 22.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 138.2;Endometrial stromal cells: 58.7;Enteroendocrine cells: 42.4;Inhibitory neurons: 163.5;Microglial cells: 52.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.5;PC-3: 7.5;SH-SY5Y: 34.3;TIME: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046849 Uncertain Approved "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA046849: AB_2679838" "unprognostic (1.71e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (7.04e-3)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (4.90e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-2)" "unprognostic (3.12e-1)" "unprognostic (6.38e-3)" "unprognostic (2.57e-1)" "unprognostic (2.73e-2)" "unprognostic (2.15e-3)" "unprognostic (5.91e-5)" "unprognostic (5.11e-2)" "unprognostic (6.75e-2)" 3.9 12.7 4.5 0.5 4.1 0.0 2.4 17.8 4.2 2.9 1.1 0.9 0.5 1.1 0.9 0.6 3.4 2.4 33.2 3.4 9.5 5.9 1.6 1.8 1.6 8.2 10.4 22.5 3.6 0.3 5.3 0.1 16.0 1.0 0.6 0.7 0.4 1.0 0.5 0.7 1.2 1.2 7.7 0.2 5.0 0.4 12.1 0.5 1.5 0.7 0.2 1.4 4.0 6.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.8 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.4 34.3 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 4.1 17.8 4.2 3.4 9.5 8.2 10.4 16.0 7.7 12.1 6.3 8.7 0.0 0.0 7.5 0.1 0.1 0.1 0.0 0.0 0.7 0.1 0.0 138.2 5.7 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.3 0.9 1.7 58.7 13.6 42.4 5.3 27.8 0.0 2.0 10.3 0.0 1.1 0.0 33.4 33.2 0.4 0.1 1.7 163.5 2.2 0.0 0.6 0.3 4.4 7.8 0.2 0.0 52.5 0.0 0.4 0.0 7.5 1.3 0.9 0.0 0.4 0.0 0.3 0.1 10.4 0.0 0.2 6.6 0.2 2.9 0.2 0.0 0.2 0.0 0.1 0.3 9.7 0.1 0.1 PLEKHA3 FAPP1 ENSG00000116095 "Pleckstrin homology domain containing A3" Q9HB20 2 178480457-178516463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 196.2;Late spermatids: 413.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034496, HPA034497" Approved Enhanced "Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA034496: AB_2674189, HPA034497: AB_10603126" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" "unprognostic (5.93e-2)" "unprognostic (3.74e-2)" "unprognostic (1.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.22e-3)" "unprognostic (8.83e-2)" "unprognostic (4.02e-2)" "unprognostic (8.23e-3)" "unprognostic (2.96e-2)" "unprognostic (3.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.79e-2)" "unprognostic (2.29e-1)" "unprognostic (3.51e-2)" "unprognostic (8.52e-2)" 3.6 6.6 4.1 3.9 4.7 5.4 3.0 7.1 5.9 3.4 5.9 4.0 4.6 3.5 6.2 3.2 3.5 3.0 6.3 4.2 4.2 4.7 4.1 3.2 3.6 3.8 4.2 3.8 2.7 4.6 4.2 2.7 4.1 3.6 2.6 8.0 2.7 4.3 2.7 1.7 3.4 3.4 4.0 3.4 3.9 10.0 4.3 1.3 3.7 3.2 2.8 3.7 2.5 5.1 4.1 2.7 3.1 4.0 6.0 3.2 5.9 6.6 5.0 3.2 3.5 1.1 2.7 3.5 8.3 4.7 9.0 2.8 2.9 1.7 6.0 10.8 2.8 5.5 2.7 3.2 4.2 3.5 6.0 2.9 5.6 5.9 3.7 5.7 2.9 3.1 2.6 5.4 4.3 1.3 4.7 5.1 5.2 2.9 3.9 2.5 4.6 6.1 4.1 2.4 3.2 4.5 3.3 2.4 10.4 4.3 2.8 6.1 3.3 6.3 6.1 8.0 7.4 6.7 14.2 3.5 8.2 2.9 3.7 0.5 0.2 0.3 0.4 0.2 0.4 0.5 0.7 0.5 0.2 1.5 0.4 0.5 0.6 0.8 0.4 0.6 0.3 0.1 4.1 4.7 7.1 5.9 4.2 4.2 3.8 4.2 4.1 4.0 4.3 5.1 56.7 16.0 14.6 9.8 32.7 43.2 48.4 12.6 50.7 90.3 39.6 35.2 56.1 32.9 13.4 27.6 41.7 29.2 53.6 15.3 78.2 36.9 196.2 44.9 39.5 44.9 25.8 35.3 15.8 47.3 18.6 43.0 21.4 38.0 10.8 23.7 39.3 42.8 15.8 132.9 20.4 23.3 12.2 28.3 44.9 413.6 34.8 33.1 30.2 18.7 28.6 56.7 40.2 11.6 18.5 45.0 11.3 52.3 39.9 91.7 20.0 67.9 17.9 64.0 78.9 54.2 54.4 66.0 41.5 28.6 30.4 30.5 44.0 44.8 19.0 79.7 PLEKHA8 "FAPP2, MGC3358" ENSG00000106086 "Pleckstrin homology domain containing A8" Q96JA3 7 30027404-30130483 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072314 Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" Nucleoplasm "HPA072314: AB_2686511" "unprognostic (5.49e-3)" "unprognostic (8.62e-3)" "unprognostic (2.39e-1)" "unprognostic (5.14e-2)" "unprognostic (1.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.70e-4)" "unprognostic (5.96e-2)" "unprognostic (2.86e-1)" "unprognostic (3.21e-2)" "unprognostic (1.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.96e-2)" "unprognostic (1.48e-1)" "unprognostic (1.82e-1)" "unprognostic (2.19e-2)" "unprognostic (3.07e-2)" 3.6 2.4 3.7 3.2 3.7 1.5 3.6 5.2 4.4 5.0 3.6 4.0 3.7 3.7 4.2 4.1 3.1 3.0 2.8 4.0 3.1 6.1 3.0 3.5 4.3 4.2 3.5 4.1 3.6 4.2 3.2 8.0 3.3 3.6 3.6 11.8 4.0 3.7 2.4 3.9 4.2 3.8 3.2 2.4 3.4 3.5 4.0 2.8 2.8 2.4 4.7 3.8 4.3 4.3 11.4 7.8 34.5 35.3 9.4 7.3 23.2 8.2 6.6 6.3 8.3 14.1 4.9 25.8 10.5 7.4 16.4 8.2 18.2 9.1 8.9 5.0 12.5 15.1 12.8 13.4 7.9 6.9 5.2 3.8 7.3 8.6 12.4 7.8 13.6 12.3 14.3 9.3 9.1 7.2 13.2 4.6 22.7 5.5 8.6 0.0 9.4 18.2 7.1 9.0 4.4 25.2 8.8 28.9 11.5 30.5 10.2 7.0 11.5 5.7 22.8 5.6 9.4 18.9 35.6 15.4 10.8 4.4 12.8 0.3 0.1 0.5 0.3 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.3 0.0 0.2 0.1 0.0 0.1 0.0 3.7 3.7 5.2 4.4 4.0 3.1 4.2 3.5 3.3 3.2 4.0 4.3 8.9 3.2 2.6 32.7 6.6 11.2 6.3 2.3 10.8 14.8 7.0 4.7 3.7 1.5 2.8 12.9 25.0 21.6 4.4 7.2 3.9 11.7 2.0 11.4 10.3 5.8 2.4 3.8 36.0 7.1 19.6 6.0 2.6 14.8 4.5 10.0 3.9 4.6 6.7 10.1 30.2 5.0 8.2 3.4 4.6 1.1 3.4 4.7 10.6 14.0 6.5 6.3 10.3 33.7 24.2 10.2 23.9 4.9 15.8 8.7 9.6 12.2 4.4 18.7 6.6 4.9 10.3 14.0 12.4 7.6 12.6 20.2 4.7 4.9 4.8 10.2 PLEKHH3 FLJ21019 ENSG00000068137 "Pleckstrin homology, MyTH4 and FERM domain containing H3" Q7Z736 17 42667914-42676994 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 41.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 45.5;T-47d: 48.7;U-266/84: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046234 Uncertain Approved "Golgi apparatus" NA NA "Cluster 50: Non-specific - Ribosome" "Cluster 16: U-266 - Nucleosome" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA046234: AB_2679597" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.75e-2)" "unprognostic (5.72e-3)" "unprognostic (1.25e-1)" "unprognostic (3.42e-3)" "unprognostic (5.05e-3)" "unprognostic (5.95e-2)" "unprognostic (6.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.51e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (9.62e-5)" "unprognostic (1.87e-1)" "unprognostic (1.72e-1)" "unprognostic (9.30e-3)" "unprognostic (1.44e-3)" 10.3 11.1 1.3 1.9 1.6 5.2 10.6 3.7 2.4 16.9 0.3 10.6 3.8 15.3 1.6 17.7 16.8 2.8 9.5 0.6 1.3 5.5 7.8 10.1 1.2 2.2 2.4 15.1 41.3 5.2 9.3 3.5 2.0 11.2 1.1 1.3 9.8 6.5 25.8 11.9 4.8 3.6 1.1 4.4 15.6 7.3 2.5 2.5 8.5 4.9 1.2 12.0 14.4 1.2 13.7 12.2 5.7 9.3 7.0 2.9 10.3 5.2 4.7 3.9 3.7 5.7 7.4 2.0 6.1 5.9 6.6 25.1 4.1 6.7 1.2 12.8 9.0 0.9 26.6 4.9 7.6 0.2 8.7 4.8 11.0 5.1 0.8 3.9 2.7 0.8 15.5 30.1 1.7 24.6 0.7 11.0 2.1 6.9 10.8 2.1 5.6 45.5 1.4 15.1 20.4 22.1 8.1 11.1 12.0 1.3 48.7 11.2 4.0 12.2 11.3 14.2 9.3 36.0 42.9 10.5 8.9 3.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.6 3.7 2.4 0.6 1.3 2.2 2.4 2.0 1.1 2.5 1.2 13.4 12.8 13.1 16.3 1.7 15.6 22.9 10.3 41.5 63.2 32.4 29.7 11.3 12.8 9.4 9.2 22.9 11.3 2.1 7.6 0.0 2.7 9.8 15.5 18.4 11.2 7.7 24.4 7.0 7.6 4.4 17.0 30.5 18.3 2.5 2.9 12.8 11.8 2.2 33.7 11.3 5.8 12.2 3.5 11.3 2.7 17.7 2.4 16.0 4.7 1.0 18.0 0.0 6.6 3.9 5.6 1.7 22.6 10.5 12.4 0.7 3.2 7.0 23.1 26.3 16.0 38.0 5.1 16.6 49.4 18.6 6.2 1.8 7.7 6.4 20.0 PLPP3 "LPP3, PAP-2b, PPAP2B" ENSG00000162407 "Phospholipid phosphatase 3" O14495 1 56494761-56645301 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 168.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.4;naive B-cell: 2.3" "Lineage enriched" "Detected in single" 6 "B-cells: 2.4" "Cell line enhanced" "Detected in many" "ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4" "Low region specificity" "Detected in all" HPA072751 Approved Supported "Golgi apparatus" NA Yes "Cluster 19: B-cells - Humoral immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA072751: AB_2686555" "unprognostic (2.50e-2)" "unprognostic (3.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.65e-1)" "unprognostic (2.71e-1)" "unprognostic (2.22e-3)" "unprognostic (5.86e-3)" "unprognostic (7.25e-2)" "unprognostic (1.59e-1)" "unprognostic (3.75e-2)" "unprognostic (3.91e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.59e-4)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (3.54e-2)" "unprognostic (2.09e-1)" 168.4 53.0 93.9 33.6 94.2 13.1 139.8 87.3 105.9 294.6 50.7 56.7 24.0 107.2 56.2 51.3 122.5 66.3 84.6 88.3 90.6 91.4 182.0 87.0 22.4 107.5 108.1 81.9 36.8 130.2 23.1 225.5 87.7 102.8 41.8 19.0 76.2 169.7 50.9 82.1 45.8 65.6 86.8 23.3 66.0 37.3 113.2 29.8 327.6 63.0 19.9 139.2 142.8 88.6 3.3 10.8 14.1 1.5 710.0 351.8 34.5 39.3 39.7 35.5 17.4 31.8 6.2 5.2 4.6 59.3 39.4 5.9 2.1 0.8 7.4 0.0 9.4 1.3 4.4 44.5 17.3 0.1 0.0 438.1 3.0 34.2 28.6 25.1 34.1 0.4 2.9 0.1 39.0 3.2 0.1 0.5 43.3 9.2 42.6 0.1 0.1 1.7 6.1 32.6 0.4 28.1 12.4 16.1 4.2 42.6 5.2 0.0 21.6 176.2 14.4 660.4 1.8 0.0 0.0 0.0 31.0 1.7 12.7 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 93.9 94.2 87.3 105.9 88.3 90.6 107.5 108.1 87.7 86.8 113.2 88.6 148.5 25.6 18.9 0.0 7.2 0.0 19.8 0.0 35.3 3.9 12.2 31.2 0.0 44.3 13.0 22.0 0.0 127.0 1.1 8.1 21.5 21.5 7.9 13.9 139.4 148.3 2.4 8.0 0.0 9.2 9.8 392.7 5.6 16.3 3.8 8.1 779.6 132.6 38.8 0.0 0.0 8.5 0.0 35.2 0.0 28.3 1092.6 14.9 0.0 0.0 0.9 136.0 0.0 0.0 0.0 7.9 5.9 398.7 7.1 20.8 15.5 21.3 4.4 4.1 138.1 179.7 107.2 4.5 3.4 16.4 0.0 214.9 5.0 22.4 7.2 20.1 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821955 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 9.8;brain: 21.1;fallopian tube: 11.1" "Cell type enriched" "Detected in some" 7 "Endometrial ciliated cells: 37.2" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 61.8;THP-1: 128.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 65: Brain - Ion transport" "Cluster 43: THP-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: AB_2681787, HPA057034: AB_2683316" "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.0 0.0 16.8 0.2 14.1 9.8 2.2 0.0 21.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 11.1 0.1 0.1 14.2 11.5 0.0 0.0 2.3 0.1 4.1 8.2 0.3 0.0 0.2 0.4 0.0 1.5 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 2.3 0.2 0.1 3.2 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.5 12.2 0.0 0.0 0.0 6.9 0.2 0.1 0.0 0.0 0.7 0.1 0.1 8.4 0.1 0.1 0.3 2.3 0.0 0.0 0.0 5.2 0.0 1.6 0.0 0.5 4.4 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 12.0 0.3 0.0 1.1 0.0 61.8 9.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 15.5 0.3 0.0 0.0 6.3 5.4 128.9 0.1 0.2 0.2 0.3 0.1 0.2 0.5 0.2 0.0 10.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 14.1 0.0 21.1 14.2 11.5 4.1 8.2 1.5 2.3 13.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 3.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 37.2 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.4 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.1 5.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 PLSCR1 MMTRA1B ENSG00000188313 "Phospholipid scramblase 1" O15162 3 146515180-146544856 "Predicted intracellular proteins, Transporters" "Antiviral defense, Host-virus interaction" "DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 291.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068923, CAB070421" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA Yes "Cluster 25: Monocytes - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB070421: AB_11153452, HPA068923: AB_2686059" "unprognostic (7.88e-2)" "unprognostic (1.10e-1)" "unprognostic (5.34e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (3.35e-1)" "unprognostic (5.22e-2)" "unprognostic (7.73e-3)" "unprognostic (9.19e-3)" "unprognostic (6.93e-3)" "unprognostic (3.07e-3)" "unprognostic (1.10e-1)" "unprognostic (1.09e-3)" "unprognostic (5.26e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-1)" "unprognostic (1.63e-1)" 60.6 23.0 11.4 86.7 12.5 64.4 45.9 12.7 17.6 25.9 11.9 65.0 39.8 28.2 31.0 47.9 40.0 66.1 24.3 12.1 13.5 71.9 49.2 49.3 40.6 17.4 14.2 34.9 38.3 16.8 15.4 56.3 15.3 23.7 59.5 9.8 49.1 49.6 10.8 13.6 45.4 41.9 16.2 64.5 44.0 17.1 14.7 30.0 27.8 17.6 39.4 68.1 29.5 14.0 106.2 41.5 26.4 12.1 40.9 65.0 40.5 32.6 88.4 319.8 418.6 34.0 88.1 8.4 75.6 20.6 245.9 86.2 21.2 32.7 56.6 32.9 21.6 66.1 12.5 25.2 292.9 40.3 35.4 106.3 53.3 36.6 182.3 52.6 49.4 19.1 44.7 104.0 66.9 41.0 30.6 16.1 25.8 71.6 37.6 27.4 28.1 2.9 95.9 29.6 16.3 0.0 42.6 20.9 569.9 35.8 20.7 46.8 30.6 26.9 22.7 59.1 55.8 79.2 15.6 0.4 27.0 29.0 23.3 41.1 157.6 44.3 20.8 159.6 30.0 25.2 13.5 18.5 105.8 19.7 9.3 13.9 100.0 57.8 94.8 28.5 8.3 79.3 11.4 12.5 12.7 17.6 12.1 13.5 17.4 14.2 15.3 16.2 14.7 14.0 191.4 35.3 43.0 12.7 28.2 37.0 106.5 92.1 26.2 0.7 36.0 22.6 7.3 124.4 110.4 95.6 0.0 53.7 25.4 134.2 74.3 291.6 2.0 56.1 24.5 135.2 33.1 18.3 7.1 217.4 114.1 74.8 47.9 58.2 28.4 60.5 100.6 29.7 139.9 0.0 9.0 71.5 79.3 86.2 162.9 6.8 114.9 185.5 48.0 35.6 72.3 64.3 32.0 7.1 0.3 157.6 110.3 45.9 18.2 79.6 40.7 75.0 133.5 1.6 39.5 63.4 59.2 1.5 2.4 21.8 28.6 44.5 25.9 42.6 69.4 211.9 PMEL "D12S53E, gp100, Pmel17, SI, SIL, SILV" ENSG00000185664 "Premelanosome protein" P40967 12 55954105-55973317 "Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "cervix: 80.5;endometrium 1: 32.2;skin 1: 115.2" "Cell type enriched" "Detected in many" 32 "Melanocytes: 1472.7" "Cancer enriched" "Detected in many" 500 "melanoma: 2481.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 68 "SK-MEL-30: 8590.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031649 Enhanced Supported "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA 11000000 "Cluster 6: Non-specific - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 48: Smooth muscle cells - ECM organization" "Endoplasmic reticulum" "Golgi apparatus" "HPA031649: AB_2673976" "unprognostic (4.63e-1)" "unprognostic (8.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.60e-1)" "unprognostic (5.90e-2)" "unprognostic (6.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-3)" "unprognostic (6.44e-2)" "unprognostic (1.21e-1)" "unprognostic (5.12e-2)" "unprognostic (3.98e-1)" "prognostic favorable (3.70e-4)" "unprognostic (2.86e-2)" "unprognostic (1.54e-1)" "unprognostic (7.60e-2)" "unprognostic (1.04e-1)" 3.3 0.8 0.2 0.8 0.2 1.8 8.3 0.7 0.5 80.5 0.3 1.3 1.6 32.2 1.5 0.7 1.2 1.6 0.6 0.3 0.0 2.1 5.0 0.9 5.6 0.0 0.4 4.3 2.3 1.7 0.7 2.8 0.1 0.9 1.2 0.4 3.5 0.8 0.3 115.2 2.1 3.5 0.0 0.5 1.1 4.8 0.0 0.7 1.1 0.2 2.2 1.3 4.0 0.3 14.8 1.1 5.6 0.2 83.6 0.6 126.2 0.9 0.8 1.9 2.0 12.8 6.0 2.6 6.1 0.8 0.3 2.5 0.6 1.0 1.6 3.0 2.1 2.4 2.5 0.7 0.3 1.0 1.4 0.5 1.0 1.2 0.6 1.3 1.0 1.1 0.5 1.8 0.5 2.7 0.4 1.0 17.1 2.8 0.3 1.6 3.5 1.5 1.4 2.7 0.5 2.6 0.3 2.5 8590.9 4.6 4.4 8.8 1.4 0.9 6.5 0.7 7.9 2.1 10.4 3.2 1.0 2.7 0.3 0.0 0.3 0.1 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.2 0.2 0.7 0.5 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.8 0.0 0.5 0.0 0.1 45.9 0.8 1.1 2.8 0.0 1.0 0.9 0.4 1.5 2.2 0.0 0.0 12.1 0.0 1.5 0.0 2.1 8.0 0.7 0.2 1.2 0.0 0.8 0.1 2.3 12.4 1.6 1.1 0.5 0.0 11.1 0.0 2.9 1.7 0.0 0.1 1.6 0.0 0.3 14.6 5.3 12.2 0.6 1472.7 1.0 0.6 0.2 0.0 0.0 0.1 1.0 0.6 0.7 1.2 0.5 2.4 2.8 1.0 0.0 0.0 0.2 1.7 3.9 2.6 1.0 10.2 24.9 0.4 1.3 1.6 0.4 PNCK "CaMK1b, MGC45419" ENSG00000130822 "Pregnancy up-regulated nonubiquitous CaM kinase" Q6P2M8 X 153669733-153689010 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.1;intestine: 81.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 40.9;Excitatory neurons: 29.0;Extravillous trophoblasts: 63.9;Granulosa cells: 46.9;Syncytiotrophoblasts: 49.5" "Cancer enhanced" "Detected in many" "renal cancer: 15.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "AN3-CA: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007458 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA007458: AB_1079644" "unprognostic (1.56e-1)" "unprognostic (2.56e-1)" "unprognostic (1.16e-2)" "unprognostic (5.95e-3)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-2)" "unprognostic (3.60e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.04e-6)" "unprognostic (2.86e-3)" "unprognostic (1.43e-1)" "unprognostic (2.66e-1)" "unprognostic (6.26e-3)" 1.6 1.2 43.7 1.9 48.8 0.0 0.6 6.5 53.3 1.3 4.8 81.7 3.4 6.5 1.7 14.0 4.1 2.6 6.5 49.8 40.8 1.9 0.2 0.6 0.0 19.6 22.8 0.9 0.3 0.5 1.8 2.0 21.1 17.2 3.8 7.9 0.4 37.6 2.0 1.8 13.4 15.7 15.0 0.2 15.9 8.8 65.1 1.4 0.3 0.3 0.1 27.4 2.2 28.5 0.3 0.1 0.4 33.9 0.0 0.0 3.4 0.3 0.3 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.2 0.4 0.5 0.0 0.0 0.0 3.9 0.0 0.0 0.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.0 0.3 0.4 0.3 0.2 0.7 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 3.7 0.0 0.1 2.7 0.9 0.3 0.4 0.0 0.2 1.2 0.0 0.2 0.2 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 48.8 6.5 53.3 49.8 40.8 19.6 22.8 21.1 15.0 65.1 28.5 0.0 0.0 0.0 18.9 0.0 0.6 0.4 40.9 0.0 21.6 0.3 0.9 3.0 0.0 18.0 0.0 22.9 13.5 0.1 1.7 0.0 0.4 0.3 0.3 4.4 0.3 0.0 0.0 29.0 0.4 63.9 0.5 0.0 0.3 0.0 46.9 0.0 0.0 2.4 0.0 24.2 1.1 12.2 0.0 0.0 0.8 0.0 0.3 1.8 1.0 0.0 3.2 0.0 11.1 13.2 2.9 0.1 0.4 0.0 0.3 20.3 0.4 2.6 19.4 0.0 0.0 4.0 0.6 0.9 0.0 0.6 49.5 0.1 0.6 0.4 1.0 PNPLA8 "IPLA2-2, IPLA2G, iPLA2gamma" ENSG00000135241 "Patatin like phospholipase domain containing 8" Q9NP80 7 108470417-108569666 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 236.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020083 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 18: U-2197 - ECM organization" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA020083: AB_1851849" "unprognostic (4.48e-2)" "unprognostic (3.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (4.61e-1)" "unprognostic (2.73e-2)" "unprognostic (3.48e-2)" "unprognostic (3.32e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.86e-6)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (4.28e-3)" "unprognostic (1.24e-1)" 27.8 47.3 23.6 17.9 25.1 82.9 20.2 21.6 29.6 19.4 22.1 14.1 11.8 17.9 17.7 21.1 11.6 21.4 25.3 24.0 26.5 30.0 34.6 17.5 18.0 23.5 23.3 14.7 13.9 28.4 16.5 26.6 23.4 18.0 15.1 24.4 11.9 17.7 35.9 15.0 10.7 20.9 24.9 17.7 15.6 15.5 22.9 18.6 24.3 34.7 22.1 29.1 12.7 26.5 28.6 12.8 22.1 19.7 47.7 32.7 32.4 26.6 47.2 21.6 35.8 12.4 16.0 15.9 33.1 26.4 43.4 10.6 37.9 17.1 32.6 24.2 10.1 11.0 19.3 9.1 34.8 7.6 21.7 29.8 31.7 29.2 26.9 23.4 29.5 17.7 13.0 44.5 27.2 18.9 18.0 18.3 9.8 17.9 17.8 6.5 23.3 34.3 25.9 35.9 18.3 25.3 25.8 27.4 32.7 27.7 11.6 12.6 24.2 35.1 15.7 52.8 15.0 37.4 41.5 23.9 33.4 11.4 23.2 21.9 29.8 26.2 14.6 32.8 17.8 28.6 14.2 14.6 29.2 27.3 15.4 14.7 24.5 22.9 43.4 11.6 19.1 22.9 23.6 25.1 21.6 29.6 24.0 26.5 23.5 23.3 23.4 24.9 22.9 26.5 64.5 41.7 49.3 66.3 91.3 92.9 124.0 42.2 55.2 64.0 45.7 35.9 49.7 8.6 51.2 23.9 18.8 58.0 72.7 44.3 93.9 32.0 52.3 124.9 67.3 57.1 57.1 50.7 42.4 37.8 37.5 76.6 45.3 236.1 71.7 19.0 23.2 44.3 32.2 32.0 42.9 27.8 67.1 45.5 90.0 47.4 32.0 113.8 55.2 23.4 43.5 42.9 18.6 38.2 41.3 29.6 38.6 39.5 76.8 80.1 16.7 41.0 62.0 32.5 19.7 88.9 63.9 18.6 23.1 60.5 135.7 130.2 69.1 43.7 22.9 122.7 PNRC2 ENSG00000189266 "Proline rich nuclear receptor coactivator 2" Q9NPJ4 1 23956839-23963462 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027820, HPA045837" Uncertain Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Golgi apparatus" "HPA027820: AB_10602147, HPA045837: AB_2679467" "prognostic favorable (6.02e-4)" "unprognostic (5.99e-2)" "unprognostic (3.15e-3)" "unprognostic (2.10e-2)" "unprognostic (3.58e-1)" "unprognostic (4.45e-3)" "prognostic unfavorable (7.97e-5)" "unprognostic (4.05e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.92e-3)" "unprognostic (1.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-1)" "unprognostic (4.44e-2)" "prognostic favorable (4.05e-4)" 82.7 82.5 49.5 80.6 52.1 141.0 78.5 53.4 62.0 69.6 56.1 98.1 99.5 87.4 68.6 62.8 58.3 80.5 75.2 49.6 51.9 99.6 66.8 76.0 137.0 52.6 50.7 79.3 52.2 94.3 34.8 103.3 54.4 70.5 92.2 56.2 55.0 56.9 49.8 46.1 84.2 71.8 50.9 87.5 81.9 33.7 51.9 133.5 122.2 63.6 109.5 100.1 51.4 57.8 107.8 42.0 179.5 124.9 121.5 110.7 68.6 116.7 103.7 132.7 106.1 122.7 132.5 291.7 111.5 74.8 49.9 93.5 121.6 101.8 146.7 208.6 78.7 277.5 131.8 130.2 103.3 272.1 122.3 83.9 125.8 109.2 101.0 86.8 130.3 148.4 239.6 159.5 79.0 87.5 169.4 103.3 243.8 101.7 76.5 189.7 116.7 125.0 134.8 113.8 107.4 93.5 101.0 85.7 123.7 130.9 93.6 168.6 105.3 85.6 82.2 84.6 75.4 133.7 164.8 197.6 58.0 259.0 89.8 230.8 112.7 126.8 103.5 115.0 108.8 129.1 112.5 112.2 109.1 131.1 124.9 106.8 74.2 108.6 112.2 77.4 129.4 178.3 49.5 52.1 53.4 62.0 49.6 51.9 52.6 50.7 54.4 50.9 51.9 57.8 119.0 185.9 109.2 11.4 122.5 13.3 231.7 2.0 99.0 33.6 110.5 109.6 84.8 58.6 62.2 62.5 18.8 129.8 104.7 160.5 238.7 90.5 6.9 86.0 96.1 97.3 100.4 157.0 7.9 127.8 101.4 128.7 66.3 130.9 76.5 84.1 86.7 30.0 68.6 20.2 6.4 109.3 0.0 82.3 10.9 14.2 78.9 109.0 1.8 13.1 81.8 66.9 127.7 6.0 11.8 119.2 157.7 81.3 48.8 187.6 90.3 112.0 56.1 28.7 46.0 104.3 104.5 21.2 24.4 97.8 12.6 141.7 104.0 203.9 110.2 314.0 POC1B-GALNT4 ENSG00000259075 "POC1B-GALNT4 readthrough" 12 89519408-89526262 "Metabolic proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "B-cells: 2.5;Basal squamous epithelial cells: 3.4;Club cells: 3.1;Erythroid cells: 3.0;Gastric mucus-secreting cells: 2.6;Glandular and luminal cells: 2.5;Respiratory ciliated cells: 2.9;Squamous epithelial cells: 1.8;T-cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 10.2" HPA076116 Approved "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA076116: AB_2686778" "unprognostic (4.91e-2)" "unprognostic (5.00e-2)" "unprognostic (1.26e-1)" "unprognostic (2.77e-6)" "unprognostic (7.99e-2)" "unprognostic (1.55e-2)" "unprognostic (2.26e-1)" "unprognostic (2.64e-1)" "unprognostic (7.67e-2)" "unprognostic (2.44e-1)" "unprognostic (7.72e-3)" "unprognostic (1.95e-1)" "unprognostic (1.61e-4)" "unprognostic (7.65e-3)" "unprognostic (1.05e-1)" "unprognostic (2.15e-2)" "unprognostic (5.16e-2)" 0.9 0.3 0.2 1.6 0.5 2.8 0.4 0.7 0.5 0.5 0.0 0.8 1.7 1.1 0.0 0.5 1.1 1.3 0.4 0.4 0.6 0.5 0.4 0.5 0.8 0.5 0.4 0.8 0.4 0.5 0.4 0.5 0.5 0.5 1.0 1.3 1.4 0.1 0.8 0.5 0.9 0.4 0.2 0.7 2.0 0.9 0.6 0.4 0.7 0.2 0.5 0.6 0.5 0.6 1.1 1.0 2.2 10.2 0.3 0.2 0.6 0.4 0.9 1.4 1.0 0.9 0.8 0.9 0.2 1.1 0.9 0.8 2.1 0.7 1.5 2.2 1.3 1.6 1.3 1.8 0.0 1.3 1.8 0.0 0.6 1.5 0.8 1.4 1.2 1.6 1.1 0.6 0.4 0.6 1.3 1.5 0.7 2.1 3.9 1.5 1.4 2.6 0.8 1.5 0.9 1.1 1.2 1.0 0.5 0.7 2.0 1.5 1.4 1.5 0.8 0.7 1.2 0.9 1.7 1.2 1.1 1.1 1.4 1.1 0.8 0.8 0.9 0.9 1.5 0.3 0.6 0.7 0.6 0.7 0.7 0.8 1.7 0.8 1.1 0.4 0.7 0.6 0.2 0.5 0.7 0.5 0.4 0.6 0.5 0.4 0.5 0.2 0.6 0.6 0.3 0.0 0.6 0.0 2.5 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.6 0.1 0.0 3.0 0.0 0.0 0.0 0.3 2.6 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 1.8 0.1 0.2 0.1 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629185-127672802 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6;pituitary gland: 59.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 96.3;Early spermatids: 73.5;Horizontal cells: 82.4;Late spermatids: 153.1;Spermatogonia: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 118.1;SCLC-21H: 167.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "CAB024934: , HPA042265: AB_2677920" "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.8 17.3 45.0 2.7 39.9 1.8 8.8 34.1 50.9 2.9 1.9 9.4 7.2 4.4 2.3 4.2 4.3 4.5 4.1 42.3 65.6 7.2 1.6 2.0 2.2 49.2 50.9 11.2 13.5 5.3 59.0 1.0 54.6 13.1 8.2 21.6 24.9 2.0 3.2 7.6 6.7 1.8 32.9 2.0 14.1 30.8 53.6 1.9 5.5 1.8 2.7 3.1 2.8 40.5 0.3 13.8 37.5 89.2 0.0 0.0 55.2 4.3 0.2 7.9 1.6 28.7 1.5 34.0 33.3 0.6 12.1 0.2 30.9 0.0 0.7 0.2 63.3 0.7 30.9 29.3 1.2 78.1 75.7 1.5 6.6 0.2 0.0 20.9 2.2 0.2 45.6 0.2 2.9 17.6 0.3 0.3 56.2 7.9 66.6 0.2 1.0 118.1 10.9 3.9 167.0 94.0 40.9 86.3 77.2 3.7 22.0 39.2 0.4 0.2 17.2 1.5 27.3 0.2 0.0 26.9 0.9 50.1 25.1 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.6 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.6 0.5 0.1 45.0 39.9 34.1 50.9 42.3 65.6 49.2 50.9 54.6 32.9 53.6 40.5 1.6 0.0 1.1 10.4 3.4 5.5 3.7 1.3 9.1 96.3 17.5 18.4 0.5 4.3 1.7 9.2 31.3 2.2 4.4 14.3 1.9 6.8 73.5 8.7 2.5 2.2 63.5 5.5 21.3 20.1 5.9 8.2 25.0 12.3 1.3 9.5 0.7 0.7 1.3 82.4 57.7 23.2 4.1 1.3 2.8 153.1 8.7 1.6 21.4 5.6 8.1 19.0 6.2 29.1 12.5 12.9 16.7 5.7 10.4 9.9 10.8 2.9 1.7 49.9 6.6 3.8 9.8 20.4 80.4 10.0 5.5 1.5 3.3 7.5 21.8 3.1 POF1B "FLJ22792, POF" ENSG00000124429 "POF1B actin binding protein" Q8WVV4 X 85277396-85379717 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.2;skin 1: 123.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 44.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory B-cell: 2.9;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 7 "B-cells: 2.9" "Group enriched" "Detected in some" 5 "OE19: 179.0;RT4: 78.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002033, HPA050027" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 200000 "Cluster 19: B-cells - Humoral immune response" "Cluster 31: Skin - Epidermis development" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Nucleoplasm "HPA002033: AB_1079650, HPA050027: " "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.54e-3)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.97e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (1.86e-1)" "unprognostic (1.72e-1)" "unprognostic (1.30e-1)" "unprognostic (1.17e-2)" "unprognostic (2.50e-1)" "unprognostic (4.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.81e-1)" "unprognostic (5.57e-4)" "unprognostic (1.01e-2)" 0.7 0.3 0.1 6.1 0.1 0.2 11.0 0.8 0.3 6.4 0.0 54.2 34.4 0.2 0.5 33.1 6.2 9.0 10.6 0.1 0.0 1.4 0.4 1.8 0.5 0.0 0.0 0.1 6.9 0.0 0.3 1.0 0.0 2.9 50.9 0.4 8.5 1.3 0.8 123.9 43.4 2.0 0.0 3.5 23.7 0.2 0.0 0.5 0.5 0.0 12.0 14.3 14.7 0.0 3.7 22.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.5 23.9 12.0 3.3 0.0 0.1 23.7 5.1 0.4 0.0 2.4 0.1 4.4 0.1 0.1 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.3 0.7 3.9 0.0 9.6 0.1 0.2 0.0 179.0 0.0 0.2 1.0 0.1 0.0 78.2 0.1 0.1 0.0 6.0 0.0 1.8 2.4 1.0 0.2 0.1 0.1 0.2 0.3 2.0 4.8 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.7 1.2 9.1 4.9 7.9 12.0 0.0 2.5 0.8 24.2 8.6 10.2 5.5 0.0 3.2 0.0 129.8 0.0 13.8 0.0 0.3 0.0 1.7 22.8 0.0 0.4 15.6 0.6 3.4 48.9 0.2 0.0 0.0 0.4 0.2 0.3 0.0 0.4 61.1 6.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.4 24.8 62.5 0.0 0.2 3.9 73.6 0.1 9.5 0.0 0.0 0.1 0.9 0.0 0.1 39.2 28.6 5.3 0.3 0.0 51.1 17.1 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;lymphoid tissue: 4.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.5" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.1 0.2 0.0 1.6 0.1 6.0 0.4 1.0 0.2 0.2 0.0 1.2 1.2 0.2 0.0 2.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 2.0 0.0 0.3 0.0 0.0 1.4 0.9 0.4 0.0 0.8 0.5 2.2 0.0 4.5 0.0 0.0 2.3 0.3 0.5 0.0 18.2 12.1 10.2 7.2 0.9 1.2 9.2 8.5 3.2 9.7 12.9 9.8 6.6 21.5 3.7 4.6 11.7 14.0 12.2 5.4 16.4 6.3 6.7 13.8 8.0 6.1 0.1 15.1 12.1 0.2 0.4 8.9 5.4 1.7 4.9 7.9 9.3 15.9 10.3 7.1 13.7 8.8 9.7 5.5 5.9 11.4 12.2 7.6 3.1 10.3 5.5 5.0 9.8 5.2 3.4 8.8 4.8 14.8 3.8 8.6 11.2 3.4 11.1 8.0 6.9 21.8 4.1 11.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.6 0.7 0.9 0.5 0.6 0.0 0.9 0.6 0.6 1.6 0.0 2.0 0.0 0.0 3.1 0.6 1.6 0.0 0.1 0.4 0.9 1.0 0.5 0.0 16.4 9.5 0.0 3.3 1.2 4.6 1.0 0.0 12.6 0.0 0.2 2.3 0.0 7.8 1.6 2.0 1.3 1.2 0.7 0.3 1.7 0.0 1.0 0.6 0.4 0.0 1.5 1.3 0.2 1.2 0.0 12.2 0.5 0.2 0.1 2.4 0.2 0.0 0.1 1.0 6.8 3.4 4.9 0.1 0.3 1.8 0.9 3.2 0.8 POLR1D "AC19, MGC9850, RPA16, RPA9, RPAC2, RPO1-3" ENSG00000186184 "RNA polymerase I and III subunit D" "P0DPB5, P0DPB6" 13 27620742-27744237 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 819.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039337 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Golgi apparatus" "HPA039337: AB_10672961" "unprognostic (1.33e-3)" "unprognostic (5.96e-2)" "unprognostic (4.35e-2)" "unprognostic (8.50e-3)" "unprognostic (1.98e-2)" "unprognostic (3.71e-3)" "unprognostic (5.33e-3)" "unprognostic (2.04e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-2)" "unprognostic (2.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (2.56e-2)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" 72.1 124.8 56.0 57.4 58.5 150.8 90.6 77.5 75.5 102.5 67.2 98.7 86.2 67.5 78.1 142.3 75.7 55.8 90.7 58.4 57.3 84.4 81.2 76.5 90.8 53.4 54.7 118.7 267.3 54.2 69.3 62.3 54.9 88.6 87.4 58.5 112.5 65.7 119.9 143.4 86.6 66.4 52.7 75.6 132.9 76.0 55.3 117.5 62.2 85.0 87.3 91.7 111.7 56.3 103.2 94.8 106.8 110.5 121.6 213.4 143.4 99.2 171.2 129.2 127.7 155.0 203.9 331.3 73.2 113.9 215.7 155.4 200.4 319.8 152.3 102.5 119.0 236.0 97.4 262.9 181.4 215.7 178.0 195.5 330.2 106.0 194.6 143.9 180.9 187.9 132.3 56.6 126.8 106.7 213.2 257.7 259.1 320.2 100.4 144.0 182.6 151.1 204.7 157.2 182.2 142.3 67.3 132.0 381.4 133.9 81.3 198.6 124.9 56.5 90.1 97.9 110.3 92.2 113.1 188.4 49.5 152.3 112.9 80.0 115.9 56.3 71.0 124.4 94.5 83.9 114.9 91.8 130.9 83.8 121.8 98.4 42.0 88.8 113.5 95.9 179.0 83.8 56.0 58.5 77.5 75.5 58.4 57.3 53.4 54.7 54.9 52.7 55.3 56.3 122.5 89.8 108.8 13.7 147.4 336.6 303.0 247.7 385.3 56.6 171.4 241.4 73.5 118.7 123.8 29.5 16.7 155.0 133.9 104.5 74.3 137.2 464.1 100.9 98.4 111.8 124.4 182.4 30.0 309.2 273.2 100.5 126.4 106.3 95.7 125.8 112.5 81.2 165.7 45.4 22.2 203.5 65.1 205.2 148.2 819.5 116.5 142.5 80.0 19.7 260.9 56.5 151.4 13.6 22.3 232.1 124.6 79.0 105.9 256.2 210.1 152.1 58.5 44.0 78.9 105.2 164.4 268.0 81.9 307.8 317.0 145.8 148.5 179.8 197.2 345.7 POMT1 LGMD2K ENSG00000130714 "Protein O-mannosyltransferase 1" Q9Y6A1 9 131502789-131523806 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 64.5;Spermatocytes: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065252 Uncertain "Golgi apparatus" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA065252: AB_2685445" "unprognostic (2.00e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (5.09e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (5.35e-3)" "unprognostic (1.14e-1)" "unprognostic (9.76e-3)" "unprognostic (2.84e-1)" "prognostic favorable (3.90e-5)" "unprognostic (8.36e-2)" "prognostic favorable (4.68e-5)" "unprognostic (2.41e-2)" "unprognostic (1.61e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-1)" 15.7 20.9 16.6 7.6 16.7 6.6 16.2 18.4 21.0 21.1 15.0 24.8 9.0 17.1 7.2 15.2 18.4 9.3 24.5 25.5 16.0 25.5 24.4 15.6 8.3 16.0 16.2 25.6 25.9 15.5 31.3 9.7 16.5 28.4 6.5 8.1 20.1 8.7 32.9 17.5 19.9 7.1 14.2 22.2 20.4 63.7 16.9 7.1 19.0 13.4 5.4 16.5 17.1 15.5 9.8 17.4 10.5 26.4 19.3 13.5 24.5 12.1 17.0 21.3 14.1 15.8 14.7 2.5 16.9 26.4 8.6 24.1 17.3 16.6 5.9 16.2 21.6 4.2 28.5 7.8 23.1 13.1 10.5 10.8 10.0 12.3 5.0 17.6 15.1 16.4 13.4 15.6 23.2 27.6 15.8 25.2 6.7 9.6 21.1 15.7 13.8 24.6 18.1 1.5 15.0 14.1 25.1 26.8 13.0 5.8 31.4 17.7 20.9 13.8 2.2 28.6 10.3 7.3 7.0 5.2 8.7 29.1 13.0 0.0 2.8 3.4 5.2 3.0 7.7 1.9 5.0 5.3 4.0 2.6 4.8 3.6 0.6 3.2 2.9 2.4 5.2 4.0 16.6 16.7 18.4 21.0 25.5 16.0 16.0 16.2 16.5 14.2 16.9 15.5 5.9 9.6 16.0 18.6 7.1 4.5 4.9 7.2 5.7 13.2 7.8 8.6 9.7 10.0 8.7 12.9 8.4 20.8 6.5 12.9 1.9 10.7 64.5 9.6 7.3 8.0 7.8 1.3 21.5 6.7 12.9 9.0 9.2 9.9 2.5 15.1 11.0 10.1 10.8 21.9 25.9 8.4 10.2 5.4 5.9 33.0 8.7 5.6 5.4 15.9 7.5 12.3 5.2 18.6 11.1 8.1 6.0 10.1 6.8 4.9 14.2 7.5 6.8 16.6 6.6 7.5 7.2 71.6 9.6 5.7 3.0 17.5 9.0 6.2 9.1 2.6 POSTN "OSF-2, periostin, PN" ENSG00000133110 Periostin Q15063 13 37562583-37598844 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 207.2;stomach 1: 174.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5" "Cancer enhanced" "Detected in all" "breast cancer: 231.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "spinal cord: 87.9" HPA012306 Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to extracellular matrix" NA NA 660000000 "Cluster 31: Skin - Epidermis development" "Cluster 18: U-2197 - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" Nucleoplasm "HPA012306: AB_1854827" "unprognostic (7.73e-2)" "unprognostic (1.44e-3)" "unprognostic (2.19e-2)" "unprognostic (2.57e-2)" "unprognostic (4.73e-2)" "unprognostic (2.22e-2)" "unprognostic (4.19e-3)" "prognostic unfavorable (2.93e-4)" "unprognostic (3.05e-3)" "unprognostic (7.10e-2)" "unprognostic (1.32e-2)" "unprognostic (5.93e-2)" "prognostic unfavorable (1.83e-7)" "prognostic unfavorable (4.86e-4)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (8.32e-3)" 71.4 5.2 4.5 23.8 0.1 0.3 84.0 0.0 4.4 20.3 2.9 61.3 5.1 53.2 13.0 20.5 83.5 64.3 83.2 3.0 0.0 28.1 13.0 45.1 12.8 0.9 0.0 3.6 2.2 21.6 2.4 60.9 2.0 16.1 84.9 0.0 17.7 44.8 10.6 207.2 15.0 66.6 0.0 1.1 174.6 3.4 0.1 5.8 19.1 29.9 3.9 91.4 10.7 0.4 0.0 0.0 71.0 1.6 85.0 51.0 0.2 23.1 0.0 5.5 0.7 0.0 1.4 0.1 0.0 18.7 0.1 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.0 0.0 14.2 0.2 0.1 90.8 0.0 490.2 1.9 15.9 0.7 0.0 0.0 0.0 11.8 0.0 0.3 0.4 4.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.6 0.0 440.5 0.9 0.0 0.0 619.3 0.3 427.2 3.4 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 4.4 3.0 0.0 0.9 0.0 2.0 0.0 0.1 0.4 46.7 6.4 10.6 0.7 0.3 295.7 1.3 51.5 0.0 0.0 2.9 158.1 22.8 0.0 18.7 0.0 0.0 2.5 1.0 0.0 0.0 0.0 0.5 0.5 9.8 134.6 0.0 0.0 1.5 0.0 0.2 191.5 0.0 0.3 3.8 0.0 22.5 0.6 3.7 0.0 36.8 0.0 24.4 0.0 27.0 1.1 6.5 0.8 30.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.7 0.4 0.4 0.0 0.0 5.6 0.0 0.0 0.7 151.5 1.3 0.9 0.2 48.4 3.4 2.3 49.3 0.0 0.3 PPHLN1 ENSG00000134283 "Periphilin 1" Q8NEY8 12 42238447-42459715 "Predicted intracellular proteins" "Keratinization, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 337.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038902, HPA038903" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Golgi apparatus" "HPA038902: AB_10674844, HPA038903: AB_2676263" "unprognostic (4.06e-2)" "unprognostic (1.66e-1)" "unprognostic (6.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.80e-1)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.28e-7)" "unprognostic (2.85e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-2)" "unprognostic (1.58e-1)" "unprognostic (4.42e-3)" "prognostic unfavorable (5.06e-5)" "unprognostic (3.16e-1)" "unprognostic (3.08e-1)" "unprognostic (3.22e-3)" "unprognostic (2.04e-2)" 26.0 30.5 21.9 34.9 23.2 51.9 33.2 23.4 26.6 27.7 22.1 29.0 23.2 31.0 31.9 28.2 28.3 28.6 35.7 23.3 22.9 30.1 30.5 28.0 58.4 17.7 19.7 34.1 19.2 25.9 22.9 29.8 20.4 26.0 31.7 25.8 25.9 28.3 34.1 25.9 28.8 33.9 18.9 36.2 25.7 56.1 23.5 52.8 27.4 31.2 59.1 37.0 22.4 23.3 60.7 54.7 63.5 53.4 56.0 61.3 55.8 68.3 79.1 71.8 59.1 89.1 74.3 99.0 86.4 74.6 33.9 53.6 66.2 72.4 87.6 87.3 68.9 159.5 53.8 81.9 58.8 190.4 88.0 74.4 71.9 57.5 54.6 80.3 89.5 87.3 79.2 76.0 78.9 46.3 107.8 111.7 55.0 166.0 54.2 90.4 73.7 93.3 111.7 50.7 44.7 66.0 61.1 48.7 60.1 60.7 75.1 90.7 63.1 41.5 74.5 39.9 60.7 87.4 129.9 163.3 69.8 337.5 27.7 51.7 23.9 44.1 32.7 26.7 39.4 44.3 41.9 44.5 43.8 35.8 37.9 38.1 14.9 44.6 25.9 41.5 61.5 22.6 21.9 23.2 23.4 26.6 23.3 22.9 17.7 19.7 20.4 18.9 23.5 23.3 28.9 41.7 51.8 46.0 78.4 75.8 68.1 116.9 44.9 60.2 30.8 31.0 32.5 40.0 70.7 42.3 29.2 88.1 77.4 31.8 37.2 62.3 243.3 47.5 56.1 48.1 33.6 58.5 128.7 68.3 75.4 47.0 24.5 60.7 57.0 238.1 36.0 35.5 52.9 37.0 93.2 35.8 71.2 40.6 65.4 76.7 58.4 49.1 64.0 49.6 92.9 46.3 72.1 64.3 85.0 71.4 42.1 52.3 63.4 46.4 45.8 55.6 58.6 60.5 52.6 44.6 47.9 120.3 58.8 50.3 59.1 44.2 81.8 84.0 42.4 50.7 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 35.6;testis: 18.9" "Cell type enhanced" "Detected in many" "Early spermatids: 374.4;Endometrial ciliated cells: 226.5;Late spermatids: 75.1;Respiratory ciliated cells: 228.6;Spermatocytes: 101.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;ASC diff: 9.2;ASC TERT1: 11.5;hTERT-RPE1: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.1 0.9 4.7 0.6 5.2 0.2 3.0 5.7 5.3 3.8 12.2 1.3 1.4 3.0 9.0 1.4 35.6 1.1 2.1 4.8 5.2 4.3 0.6 4.7 0.6 7.5 8.2 5.3 2.3 5.2 2.7 1.1 5.5 1.2 1.0 7.4 2.3 2.7 4.3 1.3 0.7 2.0 7.2 0.8 1.7 18.9 5.1 0.8 11.1 1.7 0.6 1.5 1.2 7.6 1.4 1.2 1.1 6.0 9.2 11.5 0.6 0.0 2.2 0.5 0.1 0.1 1.6 0.0 0.4 0.6 0.8 0.9 1.0 0.0 0.3 0.4 0.4 0.5 0.1 0.0 4.6 0.5 0.2 2.4 5.6 0.2 3.5 8.6 0.7 1.3 0.6 0.4 0.4 0.6 0.1 0.7 0.2 4.0 0.8 0.6 0.0 0.5 4.7 0.1 1.3 2.1 0.1 0.3 3.9 0.3 0.4 0.9 0.3 0.1 0.2 1.0 0.2 0.2 0.1 0.1 1.9 0.1 0.4 0.8 0.1 0.2 0.1 0.1 0.1 1.5 0.2 0.1 0.3 0.5 0.1 0.1 0.4 0.4 0.1 0.4 0.1 0.2 4.7 5.2 5.7 5.3 4.8 5.2 7.5 8.2 5.5 7.2 5.1 7.6 2.6 6.4 6.9 11.8 1.8 2.2 3.7 18.2 2.8 2.4 5.7 7.0 3.7 2.8 22.1 3.7 2.1 0.8 0.4 0.9 25.4 1.9 374.4 226.5 7.3 1.8 3.0 0.4 15.0 1.2 0.8 3.9 2.6 5.8 0.0 4.1 1.1 0.2 0.4 1.7 6.1 2.0 22.4 0.0 0.3 75.1 5.3 1.1 3.6 3.7 0.6 7.8 0.0 8.5 6.2 0.7 0.8 5.3 0.8 3.8 1.5 13.0 228.6 13.4 0.0 5.2 5.6 101.4 21.5 1.9 3.0 0.7 1.2 3.0 2.0 1.5 PPP1R15B FLJ14744 ENSG00000158615 "Protein phosphatase 1 regulatory subunit 15B" Q5SWA1 1 204403381-204411817 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Translation regulation" "Diabetes mellitus, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 125.7" "Cell type enhanced" "Detected in all" "Langerhans cells: 171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061088 Approved "Golgi apparatus" No No "Cluster 18: Basophils - Vesicular transport" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 28: BEWO - Transcription regulation" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA061088: AB_2684426" "unprognostic (2.91e-3)" "unprognostic (8.61e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-3)" "unprognostic (1.25e-1)" "unprognostic (1.33e-1)" "unprognostic (5.31e-2)" "unprognostic (2.66e-2)" "unprognostic (7.37e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.74e-5)" "unprognostic (9.52e-3)" "unprognostic (2.47e-1)" "unprognostic (2.99e-2)" "unprognostic (7.50e-2)" 40.7 23.1 12.9 31.0 15.3 125.7 23.0 17.8 13.9 19.6 16.4 23.4 22.4 21.4 13.1 25.9 21.5 30.8 13.0 11.7 13.2 21.0 48.1 24.2 29.1 14.4 15.2 24.5 36.8 18.7 10.5 32.6 14.6 22.5 24.1 16.0 22.1 15.9 13.2 18.1 24.3 29.9 14.6 23.8 27.0 11.7 15.2 33.3 28.2 18.2 24.7 53.2 14.7 19.7 29.3 23.0 26.9 22.8 34.1 23.2 108.7 23.6 28.3 31.9 28.7 27.6 40.3 48.2 16.0 28.9 22.2 36.3 40.2 23.9 29.5 37.3 28.7 28.5 55.7 17.8 41.5 49.1 49.0 29.3 30.4 31.4 34.5 22.9 35.1 40.4 44.4 92.8 21.8 29.1 47.1 30.6 46.2 26.8 32.9 33.2 48.9 49.8 32.0 35.4 25.7 39.3 42.6 59.8 49.3 36.0 39.4 50.2 19.8 22.2 31.3 28.6 40.3 62.5 30.0 47.3 20.0 33.1 23.4 13.1 5.5 5.7 3.2 5.1 3.4 2.0 3.2 3.0 5.0 2.1 4.9 3.5 11.8 3.2 6.2 2.0 4.4 2.9 12.9 15.3 17.8 13.9 11.7 13.2 14.4 15.2 14.6 14.6 15.2 19.7 72.2 48.1 37.9 15.3 40.8 73.7 43.0 23.1 48.3 18.5 43.7 24.6 15.6 32.9 25.9 18.4 20.9 22.9 40.3 70.4 3.9 15.9 9.0 72.0 90.8 50.9 44.7 27.3 12.3 24.0 42.7 54.7 76.5 146.7 49.4 31.0 28.9 48.6 31.8 8.4 13.0 43.3 22.4 42.0 171.9 4.6 13.1 97.9 49.8 10.3 36.8 14.4 11.3 18.1 23.2 30.3 40.5 12.8 50.9 55.0 39.5 11.0 43.0 18.5 6.6 72.7 48.6 17.2 13.2 39.8 64.2 49.3 46.8 31.2 35.6 104.5 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "heart muscle: 21.1" "Group enriched" "Detected in many" 4 "Early spermatids: 168.5;Late spermatids: 219.8;Spermatocytes: 145.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: AB_2797251" "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 21.1 0.3 1.0 0.0 0.8 0.1 0.0 0.7 0.8 0.0 0.3 0.0 0.4 0.0 1.4 1.0 0.0 1.8 0.0 0.0 3.7 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.1 0.7 0.0 3.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.4 0.4 0.3 1.0 0.7 0.8 1.4 0.1 0.1 0.3 0.1 12.8 8.7 6.2 0.0 0.3 0.6 1.2 2.8 1.1 0.3 0.3 40.6 17.2 8.1 3.7 0.0 3.1 0.0 0.5 1.9 2.5 168.5 1.7 0.1 0.6 6.1 0.0 1.1 11.0 6.6 2.4 4.6 0.8 0.0 0.0 0.0 18.5 0.6 0.0 19.4 0.4 10.2 0.8 0.0 219.8 5.9 0.3 3.6 1.9 3.6 12.0 0.0 3.5 0.7 23.1 0.1 0.7 0.0 0.3 0.0 0.7 1.6 1.7 0.0 0.4 0.8 145.1 2.6 1.3 0.3 2.5 0.0 0.8 0.6 1.0 PPP2R3A "PPP2R3, PR130, PR72" ENSG00000073711 "Protein phosphatase 2 regulatory subunit B''alpha" Q06190 3 135965728-136147894 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 51.2;skeletal muscle: 180.5;tongue: 117.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 115.3;Oligodendrocytes: 201.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 37.4;BJ hTERT+: 35.3;RPTEC TERT1: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035829, HPA035830, HPA065338" Uncertain Approved "Golgi apparatus" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" "HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475" "unprognostic (3.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.71e-1)" "unprognostic (4.04e-1)" "unprognostic (1.44e-4)" "unprognostic (9.43e-2)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (8.92e-2)" "prognostic favorable (1.15e-5)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.91e-4)" 3.1 3.4 3.3 2.3 7.2 0.2 7.1 4.3 5.0 5.2 3.9 8.0 2.0 7.7 5.1 8.3 4.1 5.0 51.2 4.2 4.9 22.0 1.1 3.9 0.6 5.7 5.5 5.6 3.4 11.7 1.8 2.8 5.3 5.9 5.4 2.6 8.9 6.5 180.5 18.9 2.3 9.6 4.3 1.1 7.4 7.2 6.0 0.6 3.1 117.6 1.2 4.5 4.0 13.7 37.4 2.0 10.3 5.0 8.1 10.2 11.9 28.5 35.3 13.2 16.3 2.4 2.4 0.1 10.7 29.3 9.5 4.7 4.3 10.0 28.3 0.1 1.4 1.6 1.0 0.1 5.8 0.0 1.4 9.3 8.5 16.8 7.8 13.3 12.8 1.0 1.0 0.1 19.2 6.2 0.3 0.2 7.2 0.4 6.9 0.1 15.1 0.1 46.2 1.4 0.7 5.7 4.7 5.7 10.9 9.2 9.1 0.5 8.4 13.7 7.5 18.8 12.7 0.4 1.0 0.1 10.1 0.8 4.9 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 3.3 7.2 4.3 5.0 4.2 4.9 5.7 5.5 5.3 4.3 6.0 13.7 7.9 28.9 27.6 51.6 2.8 26.4 19.5 7.1 19.4 5.7 19.9 15.5 115.3 8.6 10.0 55.2 0.0 10.9 6.7 25.3 21.5 20.6 8.4 9.9 19.0 11.4 13.1 0.4 35.2 9.9 15.4 14.8 21.9 16.1 3.8 15.7 8.6 2.9 2.5 3.3 47.2 6.9 6.1 2.4 9.8 10.7 24.5 3.2 28.4 13.1 9.6 8.9 2.1 72.4 201.1 17.2 10.6 18.4 1.5 17.8 21.7 40.1 8.1 2.6 6.6 29.0 14.0 10.1 18.6 15.3 33.2 10.4 3.4 6.7 8.9 15.6 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: AB_2683831" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 19.9 15.5 23.5 23.9 25.0 42.8 17.1 24.4 41.6 18.1 23.3 18.6 21.0 16.2 16.4 12.5 14.0 18.6 22.9 23.8 25.6 14.4 16.1 17.7 31.0 25.3 24.4 15.9 10.2 17.0 17.6 18.8 25.6 17.1 20.3 15.4 13.5 14.1 24.9 7.1 22.5 21.0 24.9 24.4 16.2 71.6 24.4 26.4 12.4 25.7 25.9 22.3 10.4 27.5 41.2 21.8 41.7 33.9 32.4 54.5 29.6 33.0 32.0 41.0 48.0 18.1 32.2 47.2 13.4 33.9 15.5 17.6 20.0 13.8 60.5 47.8 19.3 26.2 11.9 65.2 43.3 51.2 51.7 41.9 14.4 29.0 19.7 24.0 55.7 26.2 25.7 46.3 57.4 28.4 46.4 43.1 37.1 27.4 24.3 50.2 27.1 32.8 15.8 24.1 39.9 37.5 41.7 27.6 57.8 19.9 17.9 57.0 47.9 41.3 17.3 36.0 34.9 44.8 52.4 92.8 22.8 47.9 48.1 66.5 41.6 86.9 23.4 52.5 27.0 31.0 24.8 29.5 36.1 33.1 22.0 26.9 76.9 33.1 42.7 16.3 40.8 34.0 23.5 25.0 24.4 41.6 23.8 25.6 25.3 24.4 25.6 24.9 24.4 27.5 35.5 16.0 24.7 32.7 40.2 11.5 23.3 31.7 9.6 15.9 18.8 14.7 26.3 17.2 25.8 20.2 4.2 19.4 48.1 29.1 33.2 31.2 489.7 23.1 28.1 33.8 31.2 69.7 28.3 36.1 26.2 26.5 19.9 21.7 33.7 31.3 34.6 22.8 61.3 8.4 30.4 26.8 32.6 49.7 36.3 233.5 28.3 42.6 28.4 24.4 71.5 28.7 46.4 36.2 58.8 49.2 22.3 30.5 37.4 24.8 37.8 43.2 25.1 21.5 32.9 24.0 43.1 239.2 58.6 19.6 13.5 34.8 45.2 36.2 24.6 30.5 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 525.3;T-cells: 323.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 54.7 58.4 72.7 77.6 75.1 129.2 62.0 67.3 81.2 59.2 55.1 70.7 52.4 53.8 63.5 73.8 49.2 57.7 112.6 89.3 72.5 58.6 89.3 66.8 136.9 73.1 71.1 61.2 59.6 64.1 43.2 45.6 72.4 50.5 74.4 56.2 69.2 55.8 79.2 67.3 57.3 60.8 74.2 72.0 53.8 66.5 71.9 114.4 66.5 73.0 124.6 67.3 44.1 72.8 100.6 67.4 111.8 108.6 99.5 138.8 107.9 92.7 121.5 113.5 107.9 68.2 169.8 272.1 86.9 120.8 79.7 102.7 103.6 98.2 146.6 123.2 48.3 79.0 74.8 66.7 73.3 122.7 162.4 91.9 124.4 78.2 72.1 100.7 103.3 145.3 167.5 111.7 109.7 153.2 124.1 135.1 65.0 200.7 111.2 103.7 125.8 67.8 109.3 112.1 87.2 163.3 125.6 82.2 161.1 78.0 150.2 92.9 103.0 71.1 67.3 276.4 93.0 154.8 249.3 449.4 106.6 89.5 81.0 97.5 72.7 72.6 217.2 94.3 140.0 74.8 139.8 172.3 65.4 68.8 98.4 153.5 133.7 68.2 104.6 95.8 156.2 91.3 72.7 75.1 67.3 81.2 89.3 72.5 73.1 71.1 72.4 74.2 71.9 72.8 51.0 83.3 93.9 61.4 94.4 58.6 45.7 35.0 26.2 30.8 51.7 35.8 133.9 47.1 52.4 36.8 58.4 49.8 525.3 69.3 46.9 38.3 79.6 104.2 39.2 45.9 47.4 45.3 124.6 46.9 46.6 43.4 33.6 54.9 69.6 38.7 59.3 78.5 73.2 26.9 92.2 78.9 38.7 122.9 84.5 69.5 52.5 78.4 85.4 84.3 128.2 49.9 280.2 71.4 89.8 50.6 69.7 45.5 193.9 48.9 51.0 62.8 76.5 43.3 39.5 34.3 54.1 47.1 27.5 36.2 70.3 52.4 323.4 42.7 62.6 71.6 PPT1 "CLN1, INCL, PPT" ENSG00000131238 "Palmitoyl-protein thioesterase 1" P50897 1 40072710-40097260 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 251.9;Kupffer cells: 315.8;Langerhans cells: 328.8;Macrophages: 271.3;monocytes: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 1254.3;eosinophil: 624.2;intermediate monocyte: 1006.3;myeloid DC: 1091.1;neutrophil: 683.9;non-classical monocyte: 815.7" "Group enriched" "Detected in all" 4 "dendritic cells: 1091.1;granulocytes: 683.9;monocytes: 1254.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 1082.7;THP-1: 1449.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021546 Supported Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 240000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" "HPA021546: AB_1855667" "unprognostic (5.02e-2)" "unprognostic (2.73e-1)" "unprognostic (1.64e-1)" "unprognostic (2.06e-3)" "unprognostic (6.68e-2)" "unprognostic (2.83e-2)" "prognostic unfavorable (6.98e-8)" "unprognostic (1.39e-1)" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (8.16e-2)" "unprognostic (2.39e-1)" "unprognostic (5.20e-3)" "unprognostic (1.75e-1)" "unprognostic (2.30e-1)" "unprognostic (2.93e-2)" "unprognostic (2.08e-2)" 69.8 59.4 92.9 92.7 95.6 117.5 95.7 100.4 135.9 70.1 106.1 50.5 32.1 72.7 60.1 45.1 55.4 57.1 45.3 93.6 101.2 75.8 54.1 128.5 93.9 97.0 96.7 68.6 42.6 79.2 39.0 74.8 99.6 73.4 58.8 89.4 56.8 63.2 21.3 40.3 39.2 95.3 101.6 177.0 45.1 37.6 99.1 78.0 60.0 37.1 75.1 79.1 34.7 113.5 115.6 62.5 93.7 81.0 106.5 92.1 209.8 68.4 127.9 153.0 183.3 350.1 270.5 140.1 118.1 65.2 112.2 209.5 154.9 112.7 163.6 186.4 151.4 100.3 127.2 155.5 137.5 233.7 158.9 103.1 107.5 108.7 126.4 79.7 190.9 108.8 167.7 247.0 80.6 168.1 109.8 88.3 258.3 163.9 93.8 116.0 263.7 226.1 89.2 152.0 114.1 96.9 247.9 1082.7 298.6 111.7 199.3 1449.6 85.2 100.7 147.1 70.7 174.9 161.2 383.8 133.9 109.4 408.7 155.5 85.7 1254.3 624.2 122.2 1006.3 137.9 118.8 171.5 131.3 1091.1 118.6 227.0 168.3 683.9 100.3 815.7 101.8 204.1 1586.9 92.9 95.6 100.4 135.9 93.6 101.2 97.0 96.7 99.6 101.6 99.1 113.5 45.2 28.9 47.7 19.9 33.3 39.6 77.1 30.8 34.7 46.6 55.3 37.5 15.7 41.5 40.0 38.6 16.7 51.7 28.9 4.7 5.9 59.0 64.8 13.8 46.4 49.6 19.9 40.1 28.4 42.1 66.5 56.6 14.8 18.2 84.9 34.6 47.5 9.3 251.9 25.2 39.2 8.1 20.3 315.8 328.8 87.6 31.4 271.3 67.6 31.9 227.2 120.3 28.8 27.6 22.7 22.2 6.0 39.5 34.2 42.4 3.2 18.5 32.3 37.0 19.7 30.5 49.3 17.5 33.0 19.1 27.3 41.2 43.5 39.4 11.4 35.6 PRAM1 PML-RAR ENSG00000133246 "PML-RARA regulated adaptor molecule 1" Q96QH2 19 8490056-8502640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 97.0" "Group enriched" "Detected in many" 4 "Hofbauer cells: 30.0;Kupffer cells: 71.5;Macrophages: 49.0;monocytes: 70.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 95.4;intermediate monocyte: 101.3;myeloid DC: 58.6;neutrophil: 54.0;non-classical monocyte: 121.4" "Group enriched" "Detected in many" 7 "dendritic cells: 58.6;granulocytes: 54.0;monocytes: 121.4" "Cell line enhanced" "Detected in some" "HL-60: 23.3;NB-4: 19.4;THP-1: 39.4;U-937: 127.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045236, HPA050161" Approved Approved "Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus" "HPA045236: AB_2679267, HPA050161: AB_2681036" "unprognostic (1.68e-2)" "unprognostic (3.79e-3)" "unprognostic (1.15e-2)" "unprognostic (3.91e-3)" "unprognostic (1.25e-1)" "unprognostic (6.54e-3)" "unprognostic (3.36e-1)" "unprognostic (1.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.26e-1)" "unprognostic (1.28e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.73e-1)" "unprognostic (2.15e-3)" "unprognostic (2.72e-1)" "unprognostic (6.12e-3)" 1.8 1.4 2.8 10.9 3.5 97.0 1.2 3.5 3.9 2.2 1.3 0.9 2.7 1.4 0.2 0.8 2.0 2.0 0.8 2.7 7.2 1.0 2.6 9.8 1.3 11.1 5.8 1.4 1.2 0.3 1.6 1.0 7.4 3.3 0.5 0.8 1.4 0.4 0.6 1.5 2.9 2.2 4.8 12.8 1.1 1.0 7.0 1.0 1.7 0.3 0.4 1.2 1.2 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.1 23.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.1 19.4 0.2 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.4 0.3 0.0 0.1 0.1 0.1 0.7 0.8 0.3 0.0 127.6 0.0 2.8 95.4 3.3 0.2 101.3 0.3 0.1 0.1 0.2 58.6 0.0 0.0 0.4 54.0 11.5 121.4 3.0 0.1 41.9 2.8 3.5 3.5 3.9 2.7 7.2 11.1 5.8 7.4 4.8 7.0 6.3 0.3 6.4 5.0 1.3 0.9 0.4 1.1 0.3 0.0 3.2 0.4 1.0 0.8 4.3 3.2 0.0 0.0 0.3 3.1 0.1 0.0 0.0 0.0 0.3 0.4 1.3 0.0 3.8 0.9 0.0 0.4 0.5 0.0 0.3 2.5 0.6 2.9 0.2 30.0 1.7 1.1 0.2 2.0 71.5 2.0 0.4 0.6 49.0 0.0 12.2 70.1 0.4 3.1 0.0 1.6 0.0 0.0 1.5 0.3 0.3 0.0 0.2 0.2 1.3 0.0 0.5 0.2 0.2 1.8 0.4 0.1 0.3 1.9 1.1 0.0 0.8 PRDM2 "HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2" ENSG00000116731 "PR/SET domain 2" Q13029 1 13700198-13825079 "Enzymes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 182.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005809 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Golgi apparatus" "HPA005809: AB_1079673" "unprognostic (2.22e-1)" "unprognostic (3.28e-1)" "unprognostic (5.34e-2)" "unprognostic (1.28e-2)" "unprognostic (6.70e-2)" "unprognostic (2.72e-3)" "unprognostic (1.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.20e-2)" "unprognostic (2.53e-2)" "unprognostic (2.30e-1)" "unprognostic (1.35e-1)" "unprognostic (9.63e-3)" "unprognostic (3.81e-1)" "unprognostic (2.45e-1)" "unprognostic (1.85e-1)" "unprognostic (5.85e-3)" 21.7 15.2 19.4 19.3 21.2 79.4 21.9 27.5 38.7 27.8 7.6 27.1 13.0 24.2 16.4 21.9 20.9 17.0 19.9 21.5 18.2 14.2 13.1 21.4 27.3 18.5 16.6 34.3 14.9 14.7 16.3 16.7 18.7 24.3 13.8 18.1 21.2 17.6 43.8 27.2 23.6 15.0 12.9 20.2 19.2 18.7 16.9 22.6 24.3 30.0 25.0 27.0 26.8 34.7 15.3 8.5 30.3 11.8 23.5 18.0 14.6 19.5 11.8 13.0 14.5 13.5 16.9 46.4 16.7 18.9 11.0 18.5 22.8 11.4 14.4 28.9 16.3 31.2 10.6 6.4 12.9 10.5 25.8 19.1 19.7 13.8 11.4 12.4 13.0 18.0 28.2 52.0 16.5 7.7 16.9 16.6 9.0 12.1 11.4 23.3 16.4 13.9 7.4 17.0 26.3 17.0 15.7 9.8 21.4 18.0 13.9 16.8 23.2 16.7 18.1 15.3 10.9 75.8 55.4 65.5 14.8 24.1 21.9 4.7 4.9 7.5 5.5 3.2 3.5 18.5 4.4 5.2 3.0 13.4 4.9 4.4 9.9 6.2 6.0 5.6 4.4 2.8 19.4 21.2 27.5 38.7 21.5 18.2 18.5 16.6 18.7 12.9 16.9 34.7 41.3 38.5 39.7 34.3 182.9 62.1 54.8 17.1 61.5 49.5 43.8 33.8 41.3 27.1 33.0 23.9 45.9 25.6 77.7 26.9 17.6 17.3 21.7 84.5 62.5 35.1 37.8 21.7 114.5 13.8 16.2 47.6 25.5 121.2 40.5 50.0 26.0 18.8 16.6 70.7 97.0 24.1 14.2 45.6 39.9 15.6 44.1 42.1 30.2 75.9 41.5 21.2 59.8 70.4 122.5 15.5 25.7 45.1 71.7 54.5 34.2 9.0 43.8 39.7 26.3 86.3 34.4 52.7 49.4 65.4 52.1 18.3 74.4 25.8 19.6 64.5 PRICKLE2 DKFZp686D143 ENSG00000163637 "Prickle planar cell polarity protein 2" Q7Z3G6 3 64092236-64445476 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 114.3;Excitatory neurons: 185.5;Inhibitory neurons: 232.4;Microglial cells: 112.4;Oligodendrocyte precursor cells: 103.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.1;ASC TERT1: 14.9;HSkMC: 22.1;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035493 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Vesicles "HPA035493: AB_10696504" "unprognostic (2.87e-1)" "unprognostic (4.31e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.92e-1)" "unprognostic (3.83e-2)" "unprognostic (3.03e-2)" "unprognostic (6.35e-2)" "unprognostic (1.32e-3)" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (9.04e-3)" "unprognostic (1.77e-1)" 20.8 3.0 14.1 3.9 14.9 0.3 8.0 3.4 15.8 16.4 9.1 18.4 2.3 17.3 6.8 7.7 11.7 8.8 5.6 28.5 10.0 3.8 3.1 10.6 0.8 4.4 8.9 8.4 3.8 5.4 5.6 5.6 6.2 7.3 4.6 10.1 4.9 13.8 1.9 4.3 5.9 16.6 6.3 1.4 8.1 1.7 11.7 1.0 6.9 3.9 1.0 12.4 8.8 9.3 0.0 4.7 1.3 0.1 24.1 14.9 0.0 3.5 4.5 2.8 4.2 8.3 0.1 0.0 0.5 3.4 7.6 0.1 0.0 3.2 2.8 3.3 0.1 0.0 0.5 0.1 6.7 0.0 0.0 22.1 4.0 8.2 3.5 8.4 1.7 0.0 0.0 1.8 3.9 4.6 0.0 0.1 3.0 0.0 0.1 0.0 0.2 0.1 4.5 11.7 1.2 0.2 0.0 0.9 0.1 7.7 1.6 0.1 0.1 11.9 5.4 2.9 6.9 3.7 0.0 0.7 15.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.1 14.9 3.4 15.8 28.5 10.0 4.4 8.9 6.2 6.3 11.7 9.3 12.4 0.0 10.9 114.3 1.5 6.2 4.1 7.3 7.4 25.6 4.3 8.4 6.2 1.5 7.3 3.7 64.6 1.4 0.3 1.6 0.0 2.7 15.1 24.7 47.5 9.5 0.0 0.0 185.5 0.4 0.4 20.3 0.0 8.7 0.0 5.2 33.5 1.7 4.1 16.8 232.4 0.6 4.1 1.2 1.8 3.5 9.9 0.6 5.4 112.4 0.0 7.5 1.0 103.5 26.4 0.7 0.3 23.0 0.2 0.9 0.0 6.2 7.6 4.4 13.1 14.6 14.3 2.0 1.0 6.2 3.0 4.9 0.6 6.6 1.1 2.7 PRKAA2 "AMPK, AMPKa2, PRKAA" ENSG00000162409 "Protein kinase AMP-activated catalytic subunit alpha 2" P54646 1 56645314-56715335 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 40.8;skeletal muscle: 38.7;tongue: 36.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 328.5;Excitatory neurons: 109.4;Inhibitory neurons: 119.0;Oligodendrocyte precursor cells: 84.9;Rod photoreceptor cells: 115.5" "Cancer enhanced" "Detected in many" "renal cancer: 5.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044540 Approved Supported "Nuclear speckles,Golgi apparatus" NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nuclear speckles" "Golgi apparatus" "HPA044540: AB_2678977" "unprognostic (4.17e-3)" "unprognostic (1.62e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (9.35e-2)" "unprognostic (1.92e-3)" "prognostic unfavorable (5.30e-4)" "unprognostic (7.30e-2)" "unprognostic (3.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-1)" "unprognostic (8.64e-2)" "prognostic favorable (4.95e-5)" "unprognostic (1.30e-2)" "unprognostic (4.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.85e-1)" 1.4 1.4 2.0 0.5 3.5 0.0 3.3 3.0 3.5 1.4 4.1 5.0 0.5 1.8 1.1 4.7 2.7 1.9 40.8 3.9 2.1 13.6 0.7 1.4 0.1 0.9 1.3 1.5 1.8 8.3 1.3 0.5 0.9 3.8 1.4 13.5 4.3 2.6 38.7 0.7 1.3 3.1 0.3 1.3 2.2 1.1 1.3 0.4 3.3 36.4 0.1 1.8 1.3 1.5 0.0 3.8 2.1 0.0 0.7 0.5 2.3 1.9 1.5 2.5 4.3 3.9 4.9 0.0 0.6 0.6 7.5 0.1 8.0 0.0 7.1 0.0 8.8 0.0 7.0 5.5 0.0 0.0 0.1 0.6 0.0 3.5 0.3 5.8 0.8 2.0 0.0 0.0 1.1 0.1 0.0 0.0 5.6 0.0 5.5 0.0 0.0 0.0 14.1 1.3 2.0 5.5 6.0 0.1 0.0 6.0 3.3 0.0 0.0 1.5 2.3 2.8 6.6 0.0 0.0 0.0 4.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.5 3.0 3.5 3.9 2.1 0.9 1.3 0.9 0.3 1.3 1.5 1.1 9.6 4.8 30.7 2.0 0.9 8.0 6.7 2.2 42.0 19.4 9.5 328.5 24.3 14.3 49.7 50.1 1.0 0.2 6.1 54.8 9.5 3.9 14.4 2.9 10.3 14.4 0.0 109.4 4.8 0.4 15.3 5.1 17.4 2.5 11.7 9.7 8.1 0.1 26.9 119.0 6.3 8.2 0.0 1.6 4.8 6.8 1.4 5.4 18.7 0.0 18.6 0.0 84.9 20.4 6.2 3.0 29.3 0.0 21.2 0.2 82.4 10.7 115.5 6.6 24.5 17.2 7.2 3.7 17.7 0.4 0.4 1.2 5.3 6.1 13.4 PRKCD ENSG00000163932 "Protein kinase C delta" Q05655 3 53156009-53192717 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 7 "dendritic cells: 57.0;granulocytes: 52.9;monocytes: 73.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 267.7;THP-1: 194.0" "Group enriched" "Detected in all" 5 "basal ganglia: 121.4;thalamus: 334.6" "Low region specificity" "Detected in all" "HPA001863, HPA001890, CAB010469, CAB013225" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA 30000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Endoplasmic reticulum, Golgi apparatus" "CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628" "unprognostic (3.59e-1)" "unprognostic (4.85e-2)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (1.17e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.24e-4)" "prognostic favorable (9.01e-4)" "unprognostic (1.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.89e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (2.48e-2)" "unprognostic (2.06e-3)" "unprognostic (2.95e-3)" 46.1 59.7 10.4 45.4 11.1 90.3 28.9 4.4 11.7 25.9 7.3 43.5 54.8 9.1 39.1 32.7 42.3 32.8 19.6 12.8 11.0 25.6 8.8 44.3 46.8 9.9 8.5 13.6 33.2 20.7 8.2 20.5 7.5 39.3 41.5 2.2 25.9 31.9 6.8 34.0 55.7 16.2 9.5 54.2 65.1 20.8 9.0 16.3 41.8 9.2 62.1 44.2 23.2 12.3 33.5 14.4 5.2 8.7 35.9 21.6 46.2 20.4 25.7 24.5 23.7 34.4 31.9 86.5 8.3 45.6 42.9 14.5 34.1 49.8 20.6 75.2 23.6 50.1 18.3 32.0 23.6 64.8 103.4 17.1 35.8 25.6 23.2 21.8 22.4 9.3 9.7 11.8 36.1 85.0 7.0 81.0 13.0 51.5 23.0 7.6 13.6 20.6 25.5 72.8 8.3 6.5 15.4 267.7 39.6 24.0 22.6 194.0 31.5 11.7 14.4 15.4 19.2 18.1 33.6 45.9 27.6 116.4 22.6 51.8 73.7 50.1 3.6 71.3 2.2 6.2 2.1 2.5 57.0 8.2 2.2 2.0 52.9 6.9 47.7 16.3 2.6 24.1 10.4 11.1 4.4 11.7 12.8 11.0 9.9 8.5 7.5 9.5 9.0 12.3 4.3 3.2 23.5 2.0 25.7 29.2 26.3 8.0 23.9 0.3 11.8 4.3 6.4 14.3 16.1 14.7 0.0 3.1 24.7 61.8 3.9 8.9 34.5 18.5 4.4 2.7 26.5 5.2 3.4 10.7 16.0 6.7 54.0 17.8 5.7 8.9 3.3 2.3 44.8 1.7 4.2 37.1 4.1 47.4 43.0 75.6 9.0 41.5 10.6 20.6 44.9 2.0 8.2 1.0 0.5 13.2 55.4 6.8 25.8 19.7 64.5 13.1 16.5 0.2 6.6 6.5 12.1 23.1 3.7 23.9 27.8 8.8 10.0 10.4 23.0 34.6 PROCA1 MGC39650 ENSG00000167525 "Protein interacting with cyclin A1" Q8NCQ7 17 28703197-28711854 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "testis: 177.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 6882.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 5.6;NB-4: 6.0;REH: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023648, HPA030218" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 83: Testis - Spermatogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear membrane" "Golgi apparatus" "HPA023648: AB_1855726, HPA030218: AB_10601152" "unprognostic (5.78e-2)" "unprognostic (1.17e-2)" "unprognostic (3.11e-3)" "unprognostic (3.07e-2)" "unprognostic (2.97e-2)" "unprognostic (7.26e-3)" "unprognostic (6.90e-2)" "unprognostic (7.11e-3)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "unprognostic (3.01e-3)" "unprognostic (6.88e-2)" "unprognostic (1.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-1)" "unprognostic (1.88e-1)" "unprognostic (5.00e-2)" 2.4 1.7 3.3 1.4 3.2 1.5 1.9 3.8 4.9 3.9 2.9 2.0 1.1 2.9 0.4 1.5 4.3 0.7 2.3 3.1 3.4 8.2 1.2 2.6 2.2 3.7 3.5 6.1 0.9 0.3 2.9 0.6 3.4 3.5 0.4 1.2 1.7 0.5 0.9 1.5 4.0 0.7 3.3 9.8 2.0 177.5 3.2 1.4 1.8 0.5 0.8 2.2 2.7 3.4 0.6 0.9 1.6 5.6 1.0 1.6 1.6 0.9 0.6 0.7 0.6 0.9 2.0 0.0 0.3 0.8 0.1 0.8 1.7 0.2 0.3 1.1 0.4 2.7 1.7 0.4 0.4 4.5 0.1 0.7 0.3 1.2 0.0 0.7 0.1 0.7 2.6 1.6 0.6 0.2 3.3 6.0 4.4 0.3 0.5 7.1 2.4 0.1 0.6 0.2 0.4 0.7 0.4 0.1 0.5 1.0 2.5 3.9 0.5 0.2 1.0 0.6 0.3 0.7 1.0 1.2 0.4 4.1 0.8 4.9 1.1 3.5 0.5 1.6 0.2 1.9 1.1 0.3 0.6 0.5 0.4 0.8 0.7 0.6 1.2 2.5 0.6 0.5 3.3 3.2 3.8 4.9 3.1 3.4 3.7 3.5 3.4 3.3 3.2 3.4 2.3 0.0 1.1 4.6 2.8 1.0 1.2 1.0 0.6 3.7 1.5 1.9 6.6 1.5 1.9 0.0 4.2 0.8 3.9 0.8 0.0 0.6 1682.9 5.3 2.4 2.7 2.4 3.0 0.8 0.2 1.9 2.7 1.1 2.4 15.2 4.2 4.2 0.2 2.8 3.3 1.1 1.5 2.0 5.3 2.9 6882.6 25.4 6.8 0.0 3.7 2.5 7.9 1.0 2.0 0.9 0.6 0.3 19.5 1.2 0.8 2.0 1.2 3.9 4.4 19.7 1.5 2.4 79.2 21.7 1.1 0.3 0.7 2.6 7.5 1.7 0.7 PROSER3 "C19orf55, FLJ30657" ENSG00000167595 "Proline and serine rich 3" Q2NL68 19 35758143-35771028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 89.6;Rod photoreceptor cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 10.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058492 Approved Approved "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA058492: AB_2683733" "unprognostic (1.35e-2)" "unprognostic (1.29e-2)" "unprognostic (6.74e-3)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (9.29e-3)" "unprognostic (1.25e-3)" "unprognostic (5.13e-2)" "unprognostic (2.52e-1)" "unprognostic (1.28e-1)" "unprognostic (2.52e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (3.74e-7)" "unprognostic (8.60e-2)" "unprognostic (2.41e-1)" "unprognostic (2.87e-2)" "unprognostic (9.54e-2)" 2.3 2.4 3.4 4.3 3.7 5.2 2.3 2.3 5.2 3.4 6.7 2.9 1.8 3.8 2.8 2.5 4.3 3.3 2.5 2.8 0.6 1.9 1.3 2.7 3.0 3.6 2.7 4.1 5.1 3.1 3.8 2.8 1.6 2.4 1.9 3.6 2.6 3.1 1.7 5.8 2.6 3.3 0.0 2.9 4.0 8.8 2.6 4.6 3.8 1.4 2.6 3.1 2.9 2.5 9.3 26.7 9.4 9.3 3.7 3.8 3.1 6.7 7.6 7.3 7.7 8.2 6.3 5.2 7.3 6.4 3.5 5.5 4.0 11.8 4.9 12.5 6.8 7.5 12.2 3.4 3.2 6.0 15.6 4.6 6.5 10.2 9.0 5.7 3.2 6.7 6.6 9.3 6.4 4.6 10.7 2.5 2.6 5.4 3.9 8.2 2.3 3.9 4.7 9.8 9.2 8.1 7.4 5.4 1.0 3.5 8.7 5.1 8.2 7.7 8.1 8.0 7.2 11.9 8.6 4.2 8.0 3.8 6.1 5.7 1.7 4.0 1.1 1.0 1.9 2.4 1.7 1.0 0.4 2.6 1.4 0.5 10.3 0.8 1.0 1.5 1.6 0.2 3.4 3.7 2.3 5.2 2.8 0.6 3.6 2.7 1.6 0.0 2.6 2.5 2.6 9.6 1.5 1.6 7.4 0.0 12.8 0.0 6.2 10.8 3.1 2.9 1.4 8.6 1.8 11.0 89.6 8.2 9.4 5.3 0.0 5.9 30.0 8.9 6.3 3.4 9.5 9.5 3.7 1.9 5.4 5.6 10.2 3.6 2.5 4.4 7.5 2.6 2.8 6.7 2.1 3.9 0.0 2.8 0.0 21.2 14.3 3.3 0.0 1.0 7.0 6.0 13.4 1.0 2.1 5.3 3.4 4.1 3.4 9.2 5.3 1.8 14.6 39.5 6.6 7.9 5.0 27.2 6.5 4.0 0.0 7.3 6.6 15.4 4.7 5.7 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874390 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.0;pituitary gland: 29.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 13.4;Breast glandular cells: 9.2;Cone photoreceptor cells: 12.5;Horizontal cells: 10.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 21.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 28.7;SCLC-21H: 8.0;SH-SY5Y: 17.9;T-47d: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Nuclear speckles,Golgi apparatus" Yes No "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 14: REH - Unknown function" "Cluster 35: Glandular cells - Unknown function" "Golgi apparatus" "Nucleoplasm, Nuclear speckles" "HPA062741: AB_2684860" "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favorable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.1 0.9 3.5 0.1 4.0 0.0 2.5 3.0 21.0 0.8 0.0 0.3 0.2 0.6 0.3 0.3 1.2 0.1 0.2 7.5 0.0 3.3 0.2 0.9 0.0 0.0 0.0 0.7 2.8 2.0 29.6 0.0 0.0 2.5 0.0 5.0 4.1 0.3 0.0 0.7 0.2 0.0 0.0 0.1 0.8 0.8 0.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 0.1 0.9 6.6 5.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 2.9 0.0 1.9 0.0 0.6 0.1 5.1 0.0 0.0 0.0 6.4 0.0 0.3 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.2 0.1 0.1 0.0 3.0 0.3 0.3 2.5 0.4 0.6 28.7 0.0 0.3 3.7 5.4 8.0 17.9 0.0 0.3 0.0 0.5 9.1 0.0 0.0 0.0 3.2 0.1 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.0 3.0 21.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.5 0.0 0.8 0.0 2.2 13.4 9.2 7.7 1.3 2.8 0.0 5.5 12.5 0.2 0.2 0.2 5.9 3.0 5.4 4.5 0.7 0.2 3.6 0.0 6.9 0.9 0.4 0.3 2.6 6.7 0.0 1.1 0.0 0.5 0.1 10.1 5.8 0.7 0.0 0.0 0.0 0.7 0.6 0.4 0.0 3.7 0.0 5.4 0.0 4.5 0.8 0.9 0.1 0.0 0.6 1.3 0.1 1.5 0.0 4.5 0.0 0.3 1.1 0.3 3.7 3.1 0.0 0.3 0.3 0.5 0.3 1.0 PRRG4 TMG4 ENSG00000135378 "Proline rich and Gla domain 4" Q9BZD6 11 32829927-32858120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 124.3;Basal squamous epithelial cells: 145.1;Prostatic glandular cells: 153.9;Squamous epithelial cells: 141.8;Suprabasal keratinocytes: 141.5;Urothelial cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "neutrophil: 11.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.9" "Cell line enhanced" "Detected in many" "HaCaT: 52.7;hTCEpi: 28.0;SK-BR-3: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009040, HPA024566" Uncertain Approved "Golgi apparatus" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA009040: AB_1079694, HPA024566: AB_2237712" "unprognostic (3.30e-1)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (6.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.06e-1)" "unprognostic (4.13e-1)" "unprognostic (3.24e-2)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (2.26e-3)" "unprognostic (3.16e-2)" "unprognostic (1.99e-1)" "unprognostic (2.41e-1)" "unprognostic (1.26e-2)" 1.1 1.6 0.7 2.0 0.9 4.6 7.2 0.7 0.8 7.5 2.1 6.9 7.5 1.4 6.1 23.4 5.4 3.4 1.3 0.7 1.5 13.3 22.6 6.4 1.1 1.1 0.9 0.3 3.9 2.9 2.8 5.8 1.1 6.3 6.3 0.2 10.0 6.0 1.1 20.8 7.4 0.9 0.7 3.0 5.4 0.5 1.0 3.6 5.5 1.4 6.6 6.8 13.7 1.3 13.2 0.4 0.1 0.1 0.3 0.0 5.4 0.1 6.5 1.5 2.6 6.2 12.7 0.1 0.4 0.0 3.3 52.7 1.3 3.2 0.4 0.4 8.7 2.7 1.8 0.4 0.0 0.9 2.4 0.4 28.0 0.5 0.1 2.2 0.0 0.0 0.0 0.7 0.5 5.9 1.1 6.0 0.6 10.7 1.5 0.1 0.0 1.6 9.6 16.5 1.8 0.1 8.8 22.0 2.8 1.6 16.0 12.8 0.1 0.6 0.8 2.9 1.3 5.8 4.3 0.1 1.6 7.5 2.5 0.8 2.3 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 11.9 0.2 0.8 0.2 0.1 0.5 0.7 0.9 0.7 0.8 0.7 1.5 1.1 0.9 1.1 0.7 1.0 1.3 4.2 28.9 23.0 1.0 2.8 124.3 92.5 53.6 145.1 0.1 43.0 21.1 1.0 95.8 33.9 47.8 0.0 24.4 1.7 46.8 7.9 31.5 0.7 75.5 7.4 10.2 13.8 2.5 0.3 36.3 16.8 3.6 25.0 81.9 0.0 6.0 8.9 57.1 8.1 1.7 0.3 34.7 24.4 50.0 15.4 0.3 0.3 12.6 12.4 4.7 40.2 0.1 0.0 1.0 0.1 26.4 19.5 1.5 6.9 153.9 48.3 21.4 51.1 0.2 6.6 2.5 8.8 2.4 4.1 141.8 141.5 82.0 2.6 0.2 47.0 167.4 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848614-24952606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 136.1;Oligodendrocyte precursor cells: 111.6;Oligodendrocytes: 148.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "NK-cell: 4.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 4.4" "Cell line enhanced" "Detected in many" "CACO-2: 75.9;CAPAN-2: 94.3;HEL: 56.2" "Low region specificity" "Detected in all" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 5.4 22.2 21.7 4.5 28.7 0.9 7.6 24.9 27.2 12.9 16.1 9.9 17.7 15.8 7.4 5.5 9.8 14.8 10.9 22.4 24.6 4.8 2.8 4.3 4.2 26.7 24.0 20.2 4.6 13.4 11.4 2.9 28.0 7.8 11.3 16.5 9.7 8.2 1.3 1.8 17.1 9.8 25.8 3.2 17.5 2.2 23.7 6.8 5.3 2.8 3.2 7.4 6.3 37.1 19.5 41.3 30.2 12.4 4.9 24.4 0.0 20.2 15.1 14.2 19.3 75.9 94.3 0.0 3.1 23.7 1.2 10.7 34.7 0.0 22.0 0.0 1.4 56.2 7.6 0.1 14.6 0.0 0.0 7.1 0.2 7.7 0.0 13.3 22.6 2.2 18.6 10.5 6.8 0.5 8.8 0.1 20.9 3.3 0.7 9.7 0.1 0.2 12.7 0.5 21.5 0.9 19.3 0.1 0.0 0.6 1.1 4.3 12.2 6.3 15.5 23.1 12.2 0.9 0.0 0.0 16.8 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 4.4 0.0 0.1 0.0 0.9 21.7 28.7 24.9 27.2 22.4 24.6 26.7 24.0 28.0 25.8 23.7 37.1 3.5 0.0 0.5 136.1 0.7 2.7 4.6 5.4 2.8 10.2 1.1 5.8 8.6 7.2 3.9 3.7 2.1 1.0 0.8 3.8 5.9 5.8 1.4 1.5 27.3 2.8 5.4 3.0 38.2 0.5 4.9 20.6 12.2 2.2 0.0 25.1 7.5 0.1 7.2 6.7 43.0 7.3 0.0 0.9 3.1 1.0 12.2 7.8 3.6 24.4 1.5 45.8 0.0 111.6 148.2 2.3 2.1 9.8 1.3 1.1 12.2 0.1 1.1 15.9 0.0 16.4 10.4 3.4 6.3 0.4 2.8 0.8 1.0 22.7 11.6 1.5 PRUNE2 "A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367" ENSG00000106772 "Prune homolog 2 with BCH domain" Q8WUY3 9 76611376-76906114 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 120.6;intestine: 110.9" "Cell type enriched" "Detected in many" 6 "Oligodendrocytes: 918.7" "Cancer enhanced" "Detected in many" "renal cancer: 15.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 51.1;LHCN-M2: 83.2;RH-30: 71.5;RPTEC TERT1: 40.1" "Low region specificity" "Detected in all" "HPA022470, HPA031079" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA022470: AB_1845832, HPA031079: AB_10603230" "unprognostic (1.21e-1)" "unprognostic (3.65e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (2.43e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-2)" "unprognostic (3.60e-1)" "unprognostic (8.69e-2)" "unprognostic (2.11e-2)" "unprognostic (9.79e-2)" "prognostic favorable (1.37e-6)" "unprognostic (7.75e-2)" "unprognostic (1.06e-1)" "unprognostic (3.25e-3)" "unprognostic (3.80e-4)" 11.3 23.2 26.9 11.9 82.9 2.9 5.2 49.5 54.7 16.6 0.0 110.9 7.1 50.6 18.5 34.0 29.4 16.4 8.9 26.9 48.4 15.4 1.9 5.1 2.8 90.0 52.8 4.7 4.3 4.0 30.9 4.0 76.4 47.6 18.5 39.0 14.6 64.8 16.7 5.4 27.7 55.3 31.7 4.4 37.1 4.9 53.1 0.9 2.6 56.8 2.5 69.2 14.4 120.6 0.0 0.0 1.5 0.0 51.1 25.8 0.2 1.8 3.6 6.6 14.7 0.4 0.0 0.3 3.9 4.5 13.6 0.0 0.1 0.0 18.0 0.4 2.9 6.3 3.7 0.0 8.5 0.1 0.3 28.7 0.1 26.7 0.7 15.1 14.4 0.4 0.0 20.8 83.2 0.1 4.6 1.8 4.0 0.0 0.0 0.5 71.5 0.3 40.1 0.0 17.4 0.0 0.0 0.3 4.9 2.8 0.1 0.7 11.9 14.2 0.7 34.9 1.2 22.2 3.2 0.0 11.5 0.3 0.0 0.3 0.5 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.3 0.2 0.1 0.0 0.2 26.9 82.9 49.5 54.7 26.9 48.4 90.0 52.8 76.4 31.7 53.1 120.6 0.4 0.0 1.1 27.7 0.0 2.3 0.4 0.5 0.0 47.5 1.2 3.4 11.1 0.0 1.0 11.0 0.0 0.0 1.6 3.5 1.9 0.0 12.6 37.7 4.7 3.7 54.3 0.0 152.4 0.5 0.2 2.9 3.1 34.7 0.0 0.1 21.8 0.2 3.2 15.2 65.4 36.4 4.1 3.1 3.1 30.0 0.9 2.3 5.4 13.1 1.7 9.9 2.1 134.7 918.7 0.4 8.8 1.5 0.1 5.1 9.9 20.3 17.0 6.5 0.0 27.2 9.6 4.3 4.2 0.0 1.4 0.0 0.7 0.5 5.2 0.6 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393766-40414793 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 34.6" "Cell type enhanced" "Detected in many" "Adipocytes: 17.8;Breast myoepithelial cells: 23.2;Cardiomyocytes: 15.4;Skeletal myocytes: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in some" 8 "spinal cord: 114.2" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 4.5 4.7 6.2 1.3 6.8 1.6 3.9 5.2 6.5 4.8 2.9 3.6 1.1 4.4 1.0 2.0 4.2 1.8 3.1 4.7 4.4 6.7 1.0 34.6 1.3 5.4 4.9 6.2 3.8 5.9 1.5 5.1 6.7 4.6 0.7 0.8 3.8 3.5 4.9 3.2 2.2 2.0 4.9 2.0 3.7 1.6 5.7 0.7 9.6 5.5 0.8 4.3 3.1 4.1 1.6 2.6 2.1 2.7 1.3 4.4 2.6 1.4 1.5 1.9 1.4 1.0 1.7 0.5 1.6 1.3 1.2 0.9 1.0 0.6 0.7 0.8 0.9 0.3 0.3 0.5 2.1 0.1 2.3 3.3 3.2 1.2 1.1 1.7 1.6 2.9 2.0 0.5 1.0 2.2 1.0 0.6 0.6 3.8 1.7 3.2 1.8 1.5 0.4 1.8 0.2 1.0 2.7 2.3 2.0 0.9 3.2 1.2 1.4 3.8 2.9 1.6 0.8 5.3 5.0 0.7 1.1 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 6.2 6.8 5.2 6.5 4.7 4.4 5.4 4.9 6.7 4.9 5.7 4.1 17.8 3.2 5.9 0.7 1.4 6.2 2.3 0.3 5.7 0.1 8.1 23.2 15.4 2.8 0.9 1.8 0.0 1.1 1.7 1.0 0.0 0.3 0.1 1.3 1.7 9.2 0.0 0.4 0.6 0.6 0.7 7.0 0.0 3.0 0.0 2.0 6.8 1.3 1.1 0.0 0.5 0.7 2.0 1.6 2.5 0.1 3.4 2.5 3.6 7.5 0.3 3.3 0.0 0.0 0.5 0.5 1.4 4.5 0.9 1.7 1.2 1.9 0.2 0.1 0.0 30.3 6.1 0.3 0.7 5.0 4.1 2.7 1.1 1.3 1.5 1.0 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Oligodendrocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 25.1 22.6 44.3 26.5 80.7 39.6 28.2 62.4 56.0 28.1 48.9 49.5 50.2 25.3 26.9 35.2 22.9 31.7 18.0 47.4 51.6 35.5 31.9 32.1 22.4 73.0 63.8 22.0 22.9 35.1 11.6 43.1 71.5 24.3 46.3 23.4 22.9 23.4 18.4 38.2 49.0 27.1 55.7 22.6 31.0 32.5 60.8 26.2 36.9 23.3 30.7 35.0 19.2 119.1 37.1 55.9 50.6 20.0 68.9 49.9 46.7 52.5 60.1 52.6 66.7 69.9 88.9 23.7 34.1 50.5 43.0 94.9 43.2 40.1 57.3 54.6 26.7 27.1 35.1 34.4 63.8 27.7 50.7 50.4 71.9 44.3 54.4 48.5 43.2 26.2 31.0 46.6 50.0 72.8 21.0 35.7 22.0 64.5 40.4 26.4 42.7 30.2 73.7 76.5 28.1 38.3 57.4 53.0 47.1 45.4 66.3 60.7 45.7 53.1 43.5 44.1 25.3 30.3 47.9 23.7 44.9 32.8 33.3 126.8 94.5 96.3 23.1 106.0 22.6 23.1 22.3 19.0 83.4 31.8 20.7 20.1 129.3 42.8 125.0 43.6 37.0 70.3 44.3 80.7 62.4 56.0 47.4 51.6 73.0 63.8 71.5 55.7 60.8 119.1 22.2 28.9 30.5 35.9 25.8 28.6 24.6 24.7 12.0 17.1 25.0 17.7 12.5 15.7 30.2 23.9 39.6 27.1 30.7 79.1 5.9 27.1 22.9 26.3 26.4 22.3 16.2 12.0 38.9 26.7 29.2 23.7 32.1 47.4 18.3 29.6 15.7 24.6 30.5 13.5 40.2 39.5 24.4 50.5 40.8 12.9 16.4 52.3 16.0 39.4 51.8 13.8 14.4 48.7 395.8 38.2 58.8 15.4 23.6 38.8 76.2 13.0 29.0 28.0 26.3 20.0 19.0 40.2 14.4 20.4 33.0 49.9 21.6 18.6 41.3 51.5 PSMD11 "MGC3844, p44.5, Rpn6, S9" ENSG00000108671 "Proteasome 26S subunit, non-ATPase 11" O00231 17 32444379-32483319 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 308.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042275, HPA067433" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 95000 "Cluster 44: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA042275: AB_10794793, HPA067433: AB_2685838" "unprognostic (1.16e-1)" "unprognostic (2.71e-1)" "unprognostic (6.94e-2)" "unprognostic (2.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.33e-6)" "unprognostic (2.64e-2)" "unprognostic (3.97e-1)" "unprognostic (8.10e-2)" "unprognostic (5.88e-2)" "unprognostic (9.17e-3)" "prognostic unfavorable (5.73e-6)" "unprognostic (9.39e-3)" "unprognostic (6.65e-2)" "unprognostic (2.90e-1)" "unprognostic (2.17e-2)" 26.9 26.5 25.6 29.4 26.4 34.5 22.6 24.6 29.5 22.8 20.3 27.3 27.2 28.8 23.1 36.3 21.8 22.7 37.0 26.0 25.6 30.1 37.7 24.3 30.2 27.0 25.3 20.6 25.9 35.0 18.5 34.1 28.1 25.0 32.0 23.8 23.3 21.8 96.0 33.8 23.2 35.0 24.4 24.0 22.9 34.2 25.9 38.4 21.6 58.6 39.1 34.0 24.8 31.2 127.0 136.8 98.4 106.2 65.4 48.4 103.8 71.5 90.0 151.9 122.0 139.9 111.5 99.1 110.7 77.0 145.9 143.0 114.5 98.5 147.8 50.9 81.2 81.0 68.7 108.3 63.3 95.5 81.6 43.7 51.0 134.3 91.8 49.0 108.7 87.0 155.5 110.9 90.8 78.0 143.1 57.4 134.5 67.4 68.8 89.2 127.2 132.4 75.2 92.2 86.3 58.8 89.8 63.4 71.0 100.3 154.2 45.1 77.8 84.3 99.5 105.6 166.5 62.2 105.0 129.1 122.5 74.8 145.2 48.3 41.2 26.7 40.2 41.8 44.2 36.3 39.1 40.6 46.6 34.2 34.5 36.4 19.1 47.7 45.6 38.2 51.5 45.6 25.6 26.4 24.6 29.5 26.0 25.6 27.0 25.3 28.1 24.4 25.9 31.2 62.7 48.1 31.5 36.6 56.3 126.9 108.7 116.3 44.9 44.5 47.8 40.8 71.9 41.5 78.0 25.8 31.3 178.2 57.8 87.5 80.3 117.8 205.4 45.8 46.2 69.7 48.8 100.8 36.0 107.3 146.1 63.8 43.8 59.9 45.7 79.8 55.3 107.0 92.3 37.0 36.4 58.7 77.3 48.4 72.6 48.0 49.0 61.1 26.6 15.9 77.5 63.1 40.2 33.2 55.6 117.2 48.0 48.5 79.3 131.9 66.4 120.6 52.6 43.3 52.6 68.0 189.7 152.7 98.4 85.3 117.5 308.9 54.8 52.0 67.6 109.5 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183488 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.3" "Group enriched" "Detected in all" 4 "Early spermatids: 673.8;Spermatocytes: 544.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 36: HEL - Hemostasis" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA057193: AB_2683363, HPA070225: AB_2686236" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.5 9.8 4.0 9.1 4.0 17.3 6.8 2.7 5.5 7.3 2.5 10.5 8.9 7.8 4.8 11.8 6.4 5.4 8.3 4.6 3.8 9.7 15.9 5.7 8.9 2.2 2.4 7.2 10.8 5.1 8.0 7.7 3.2 5.5 9.9 4.9 7.3 3.2 13.8 7.1 8.2 5.1 2.1 6.3 7.1 40.3 3.7 6.3 10.8 5.6 6.2 7.8 7.4 4.0 104.0 34.7 23.5 32.9 12.3 15.1 65.0 55.3 25.9 44.8 28.2 66.6 26.9 113.7 28.9 17.1 38.1 28.5 40.3 30.3 30.2 48.9 61.6 209.6 52.4 83.6 21.9 101.0 40.4 18.9 24.6 46.2 46.5 9.8 24.9 47.0 160.4 61.9 27.2 58.2 63.0 54.7 82.2 38.9 53.5 99.6 29.8 115.8 19.1 30.4 77.6 22.7 70.4 39.1 57.4 4.0 36.6 51.4 26.7 50.1 16.8 66.7 79.9 46.4 79.3 96.8 42.0 170.4 38.6 10.6 6.8 3.9 10.5 9.0 12.3 12.0 14.7 12.4 12.2 10.6 11.5 10.3 0.6 7.5 9.1 11.3 13.7 7.9 4.0 4.0 2.7 5.5 4.6 3.8 2.2 2.4 3.2 2.1 3.7 4.0 23.7 6.4 17.6 5.2 17.8 136.0 44.1 68.6 43.9 14.2 31.3 39.0 24.8 22.8 39.9 20.2 4.2 108.9 12.6 14.7 66.5 50.8 673.8 20.8 36.5 26.3 29.9 63.3 7.5 49.7 118.6 31.8 18.8 21.6 36.1 26.2 18.9 32.7 59.5 8.4 8.0 45.7 69.2 17.7 35.5 88.4 31.7 25.0 46.2 3.7 24.4 18.0 12.3 3.5 5.9 32.4 20.0 33.1 31.7 41.5 30.6 89.4 20.8 19.7 26.3 29.5 31.3 544.1 98.7 51.7 97.7 54.5 20.1 54.7 56.9 27.9 PTCH1 "BCNS, NBCCS, PTCH" ENSG00000185920 "Patched 1" Q13635 9 95442980-95517057 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, Disease variant, Holoprosencephaly, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 26.7" "Cell type enhanced" "Detected in many" "Late spermatids: 237.5;Leydig cells: 191.0;Peritubular cells: 444.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 6.1" "Lineage enriched" "Detected in single" 9 "T-cells: 6.1" "Cell line enhanced" "Detected in many" "NTERA-2: 29.6;WM-115: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013717, HPA075072" Uncertain Approved "Golgi apparatus" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "CAB013717: , HPA075072: AB_2686733" "unprognostic (1.46e-1)" "unprognostic (1.06e-1)" "unprognostic (3.16e-1)" "unprognostic (1.79e-2)" "unprognostic (3.22e-2)" "unprognostic (9.01e-2)" "unprognostic (2.13e-1)" "unprognostic (3.54e-3)" "unprognostic (2.63e-1)" "unprognostic (8.66e-3)" "unprognostic (1.52e-2)" "unprognostic (2.82e-1)" "unprognostic (1.13e-6)" "unprognostic (8.63e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-1)" "unprognostic (2.82e-1)" 3.0 3.5 9.5 4.0 11.6 0.7 2.8 24.6 5.6 26.7 2.7 11.3 8.1 15.6 2.7 2.9 7.1 8.1 2.9 4.7 17.8 4.6 2.2 5.5 2.2 16.0 12.7 5.0 6.4 2.5 2.1 3.8 8.0 6.8 12.3 8.3 7.5 4.0 3.0 3.2 11.6 2.4 7.0 3.3 12.5 14.5 24.0 2.1 4.7 4.8 3.0 7.2 2.9 4.5 10.1 4.7 20.3 12.9 3.0 5.0 11.4 1.9 1.7 2.2 1.4 4.9 4.8 8.0 3.3 3.8 4.4 22.3 11.7 1.6 1.4 7.9 7.8 0.0 4.8 2.3 2.7 0.2 4.2 4.7 2.4 2.2 1.4 4.3 4.2 3.5 7.3 9.1 1.0 1.9 0.1 3.2 29.6 7.2 1.8 0.0 15.5 4.2 1.6 1.5 13.8 7.0 7.1 6.8 2.9 18.8 1.8 2.1 1.1 2.6 12.9 13.6 1.5 18.0 16.8 5.3 3.8 3.9 71.0 0.0 0.0 0.0 6.1 0.0 3.3 0.7 1.1 2.5 0.0 0.2 1.9 2.2 0.0 0.3 0.0 0.0 1.2 1.7 9.5 11.6 24.6 5.6 4.7 17.8 16.0 12.7 8.0 7.0 24.0 4.5 6.0 0.0 6.4 49.0 3.0 4.0 2.7 3.0 4.6 20.3 3.5 4.6 5.9 25.8 2.7 0.0 41.7 3.0 11.8 2.0 5.9 3.5 88.4 12.2 89.8 5.4 21.7 0.4 15.2 4.2 1.9 27.2 1.1 11.0 1.3 2.6 6.4 2.9 0.8 20.2 10.7 11.0 4.1 0.9 1.2 237.5 191.0 1.4 12.4 4.7 0.8 55.6 54.6 39.7 20.5 2.4 3.1 444.5 3.1 4.9 3.1 1.6 5.5 13.4 39.5 4.8 9.4 4.4 35.5 3.0 4.4 1.4 6.5 71.7 4.7 1.4 PTGS1 "COX1, PGHS-1, PTGHS" ENSG00000095303 "Prostaglandin-endoperoxide synthase 1" P23219 9 122370530-122395703 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 108.3;skin 1: 152.5;urinary bladder: 175.0" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 109.9;Glandular and luminal cells: 191.9;granulocytes: 208.0;Hepatic stellate cells: 61.8;Macrophages: 55.3;Suprabasal keratinocytes: 58.7" "Cancer enhanced" "Detected in all" "ovarian cancer: 53.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 28.9" "Group enriched" "Detected in many" 6 "dendritic cells: 20.0;granulocytes: 28.9;monocytes: 13.1" "Cell line enhanced" "Detected in many" "ASC diff: 113.7;ASC TERT1: 89.5;BJ: 115.2;BJ hTERT+: 156.0;HEL: 73.6;HMC-1: 298.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002834, CAB020315" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2100000 "Cluster 2: Granulocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" Vesicles "CAB020315: , HPA002834: AB_1079711" "unprognostic (4.20e-1)" "unprognostic (6.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (5.88e-2)" "unprognostic (2.00e-2)" "unprognostic (1.22e-3)" "unprognostic (3.32e-1)" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (4.03e-2)" "unprognostic (1.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (9.35e-4)" 12.8 2.9 3.1 10.5 3.2 9.0 6.7 4.2 4.8 5.8 5.5 108.3 10.8 6.1 2.2 67.3 43.2 9.6 12.6 7.4 5.5 9.3 3.0 11.3 4.6 6.5 5.2 2.0 1.8 2.0 4.8 2.2 6.3 21.1 24.2 0.7 4.3 6.1 2.1 152.5 17.7 16.1 6.7 8.0 20.5 0.9 7.0 2.2 3.2 4.0 11.6 175.0 15.9 11.9 0.3 0.5 0.4 0.0 113.7 89.5 0.0 115.2 156.0 1.0 1.1 0.0 0.2 4.2 5.4 19.7 0.3 7.1 0.4 10.5 0.9 0.0 0.2 73.6 0.6 0.0 32.9 5.2 298.4 46.1 1.2 5.7 0.3 0.0 42.3 0.1 0.1 0.3 2.3 0.0 0.2 6.6 1.6 0.0 0.5 0.3 1.4 8.6 14.7 0.0 0.5 0.6 0.6 9.5 0.2 0.5 0.3 8.4 1.0 0.7 0.6 1.7 0.1 0.3 0.2 0.0 0.4 31.6 0.3 28.9 12.1 23.3 0.0 13.1 0.0 2.4 0.0 0.0 20.0 3.5 0.1 0.0 5.2 2.8 10.2 1.4 0.2 21.9 3.1 3.2 4.2 4.8 7.4 5.5 6.5 5.2 6.3 6.7 7.0 11.9 0.9 0.0 6.6 0.0 5.9 9.9 2.6 7.7 0.0 0.1 1.1 1.4 1.6 4.3 2.2 42.3 0.0 0.1 0.2 0.1 0.0 0.6 0.1 109.9 10.4 24.7 1.8 18.7 0.8 0.5 0.3 10.7 2.0 191.9 208.0 0.1 61.8 0.8 26.1 0.0 0.5 0.6 4.1 15.5 20.7 0.3 1.5 55.3 3.6 16.9 11.7 0.0 7.2 1.0 0.1 0.6 0.6 0.0 0.3 2.8 0.0 0.0 0.8 0.1 0.0 1.4 3.6 0.0 0.2 18.2 58.7 0.4 3.4 0.1 1.0 0.8 PTHLH "HHM, PLP, PTHR, PTHRP" ENSG00000087494 "Parathyroid hormone like hormone" P12272 12 27958084-27972733 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 22.8" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 254.0;Basal squamous epithelial cells: 93.9;Breast glandular cells: 105.4;Breast myoepithelial cells: 56.3;Club cells: 77.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 64.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HaCaT: 291.3;HBEC3-KT: 359.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035982 Approved Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA035982: AB_10794631" "unprognostic (1.67e-1)" "unprognostic (5.26e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.60e-2)" "unprognostic (1.18e-1)" "unprognostic (5.16e-2)" "unprognostic (4.09e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (1.82e-9)" "unprognostic (2.01e-2)" "unprognostic (1.34e-1)" "unprognostic (5.23e-3)" "unprognostic (7.87e-3)" 3.1 0.8 1.8 1.2 2.3 0.0 20.1 0.6 3.2 13.6 10.2 3.3 2.3 10.7 1.1 16.2 1.5 7.5 4.2 4.1 3.2 0.4 0.2 1.2 1.1 4.0 8.1 1.8 1.7 22.8 2.9 3.0 0.4 5.2 1.6 0.2 8.5 2.4 0.7 2.0 1.6 3.0 0.2 3.6 1.8 1.3 8.6 0.4 1.8 1.7 1.0 9.2 15.2 0.8 1.7 9.9 0.0 0.0 2.9 2.8 0.1 0.3 1.0 0.5 1.3 0.3 7.9 0.0 0.5 2.6 9.1 291.3 1.3 359.8 0.1 7.4 1.7 0.5 1.8 0.1 0.8 0.1 0.4 0.2 19.7 9.1 34.4 0.9 11.2 0.1 0.0 0.4 0.2 0.1 0.1 0.0 1.4 0.4 16.7 0.1 1.5 0.6 34.3 0.3 0.2 0.1 16.4 0.1 2.1 11.5 0.5 0.1 5.6 1.6 8.9 5.1 77.8 4.7 0.1 12.1 7.5 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 2.3 0.6 3.2 4.1 3.2 4.0 8.1 0.4 0.2 8.6 0.8 1.4 0.0 0.0 0.7 0.4 4.6 1.9 254.0 93.9 0.3 105.4 56.3 0.4 0.0 77.5 0.0 0.0 0.0 0.5 0.0 0.0 3.5 5.9 0.9 4.7 4.5 0.0 0.0 0.6 8.9 0.0 13.6 0.0 0.8 0.0 2.6 0.4 0.2 0.0 0.0 11.2 0.0 4.1 0.3 1.3 2.7 0.9 0.6 23.2 1.0 0.6 1.8 0.0 0.0 0.2 8.6 0.0 0.0 6.2 0.5 0.0 0.3 14.8 0.5 6.6 8.0 6.7 3.6 0.2 7.9 1.4 0.0 0.5 0.2 0.0 0.2 PTPN21 "PTPD1, PTPRL10" ENSG00000070778 "Protein tyrosine phosphatase non-receptor type 21" Q16825 14 88465778-88555007 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Syncytiotrophoblasts: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011468, HPA073999" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 61: Skin - Cornification" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "Golgi apparatus" "CAB011468: AB_442979, HPA073999: AB_2732247" "unprognostic (2.18e-1)" "unprognostic (4.21e-2)" "unprognostic (7.60e-2)" "unprognostic (3.09e-2)" "unprognostic (4.60e-2)" "unprognostic (5.71e-2)" "unprognostic (6.55e-2)" "unprognostic (5.19e-3)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-3)" "unprognostic (3.04e-3)" "prognostic favorable (3.16e-9)" "unprognostic (6.52e-2)" "unprognostic (2.69e-1)" "unprognostic (2.56e-1)" "unprognostic (7.67e-2)" 10.0 5.4 6.7 4.1 7.2 0.0 9.2 6.4 6.6 11.5 10.1 11.9 6.0 12.0 5.9 10.3 10.1 8.7 21.3 6.2 8.0 7.8 7.7 17.9 2.1 9.7 7.8 17.5 9.4 8.3 4.5 10.3 7.2 9.3 7.6 9.1 7.4 9.5 11.8 29.0 8.2 10.4 7.9 4.0 9.0 20.2 7.4 1.1 18.7 9.8 1.9 10.1 9.8 7.4 5.8 4.6 11.8 4.6 12.3 10.6 12.1 15.2 11.6 8.8 12.2 8.1 10.2 0.0 3.6 19.6 7.9 5.4 1.7 5.4 12.9 0.3 2.7 0.0 5.6 3.4 13.6 0.1 0.2 7.1 10.4 7.4 8.8 11.4 7.2 0.0 1.8 0.2 22.9 4.7 0.0 0.3 3.5 6.2 8.7 0.1 35.3 0.1 7.7 4.1 0.8 13.6 8.7 21.6 5.2 10.0 10.7 2.3 14.5 16.3 12.8 6.7 10.6 0.5 1.9 0.0 6.0 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 7.2 6.4 6.6 6.2 8.0 9.7 7.8 7.2 7.9 7.4 7.4 7.2 57.7 6.0 14.4 0.0 10.5 6.3 4.0 4.0 7.2 7.1 5.8 34.9 5.7 7.1 7.3 35.5 10.3 0.1 18.1 0.0 5.0 19.1 10.2 11.4 6.0 4.8 8.0 12.8 8.4 5.4 12.0 7.1 7.1 2.5 9.2 6.1 9.7 1.9 1.7 14.4 15.0 8.2 1.3 3.9 5.3 17.1 0.4 0.0 13.1 0.0 4.7 1.0 28.1 20.3 10.7 6.1 27.1 0.0 8.8 6.7 3.5 10.3 9.4 0.0 12.7 10.5 20.2 6.6 3.5 11.9 101.9 0.6 7.4 6.2 4.7 PTPRF LAR ENSG00000142949 "Protein tyrosine phosphatase receptor type F" P10586 1 43525187-43623666 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 259.9;Extravillous trophoblasts: 290.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 314.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012710 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA 160000000 "Cluster 37: Intestine - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA012710: AB_1855933" "unprognostic (8.20e-2)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (9.17e-2)" "unprognostic (8.34e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.59e-1)" "unprognostic (1.51e-1)" "unprognostic (4.97e-2)" "unprognostic (4.68e-2)" "unprognostic (7.07e-2)" "unprognostic (1.99e-2)" "prognostic favorable (7.03e-4)" "unprognostic (2.33e-1)" "unprognostic (3.19e-2)" "unprognostic (2.58e-1)" 91.7 11.9 47.1 14.0 48.4 1.8 57.4 22.3 45.6 36.3 4.7 79.5 70.5 28.0 71.9 101.7 70.5 30.4 7.6 45.3 39.9 27.7 107.2 35.4 4.7 33.1 43.6 22.1 56.8 31.1 23.5 55.7 33.1 67.3 51.4 24.7 101.7 43.1 2.7 107.9 78.5 35.0 30.4 4.0 49.7 9.4 45.6 29.6 23.8 3.4 26.2 40.0 51.2 37.4 165.6 76.5 49.0 58.0 11.2 0.6 274.3 92.1 36.1 73.9 62.6 82.0 214.9 0.4 25.6 40.2 59.2 124.7 57.5 200.7 89.1 2.0 72.1 1.0 48.7 75.3 33.8 1.2 1.3 11.3 113.2 106.4 174.9 92.6 111.5 7.7 25.4 7.1 27.5 94.0 1.2 1.3 75.9 89.8 21.0 57.2 86.9 3.7 28.3 241.5 73.3 28.0 90.8 314.0 11.8 128.8 91.5 17.3 88.2 1.6 116.5 7.5 126.1 3.1 2.7 0.4 7.4 3.9 233.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 48.4 22.3 45.6 45.3 39.9 33.1 43.6 33.1 30.4 45.6 37.4 2.3 157.0 101.1 39.2 2.3 62.8 51.3 67.4 52.9 33.5 146.3 102.9 7.6 130.1 74.9 86.5 43.8 64.3 1.4 259.9 0.0 147.4 4.9 80.6 17.2 7.7 100.9 8.0 40.6 120.8 290.1 19.8 93.8 70.6 5.1 72.8 10.4 159.6 14.1 185.1 16.1 171.7 50.8 4.9 5.8 8.5 6.8 3.4 12.4 7.5 2.9 27.2 2.1 16.6 68.1 165.0 124.7 7.2 1.8 68.0 208.1 13.9 128.3 31.0 0.0 15.8 18.5 9.0 37.5 107.5 91.4 66.2 3.9 9.6 142.5 78.7 PWP1 IEF-SSP-9502 ENSG00000136045 "PWP1 homolog, endonuclein" Q13610 12 107685799-107713162 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038708 Approved "Nucleoli rim,Golgi apparatus" Yes No "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli rim" "Golgi apparatus" "HPA038708: AB_2676163" "unprognostic (7.06e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (9.65e-4)" "prognostic unfavorable (1.40e-5)" "unprognostic (1.97e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.89e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.00e-1)" "unprognostic (6.95e-2)" "unprognostic (6.13e-2)" "unprognostic (1.10e-2)" 29.7 20.9 18.6 26.4 19.0 31.9 33.7 18.8 23.6 24.9 29.5 27.7 17.7 30.3 24.8 28.7 24.7 20.4 17.3 18.9 19.1 30.4 32.2 21.4 32.0 17.4 18.0 32.8 25.8 33.0 17.8 29.5 20.0 25.2 26.0 26.9 24.4 27.5 22.9 28.8 21.7 32.3 18.1 23.7 23.1 30.1 18.8 33.2 25.9 17.6 37.4 31.4 24.5 19.0 71.0 86.9 51.8 49.4 70.9 77.2 68.5 72.9 81.9 100.8 84.8 88.5 32.9 108.8 38.4 112.9 68.4 60.7 70.8 77.0 99.2 54.7 80.6 82.9 50.5 103.2 72.7 101.8 56.9 70.2 69.1 93.5 83.0 79.0 119.8 66.0 110.8 29.8 109.1 78.3 71.6 99.3 62.0 64.8 141.2 58.3 61.2 101.4 62.7 98.3 58.4 46.9 59.6 42.4 104.1 64.8 75.3 49.7 94.9 76.7 38.9 63.0 84.1 42.5 62.8 84.9 34.3 55.3 68.7 29.4 20.8 16.2 41.7 27.8 37.8 68.5 40.6 43.9 35.0 64.1 34.5 47.9 6.6 44.2 34.4 47.3 48.6 29.7 18.6 19.0 18.8 23.6 18.9 19.1 17.4 18.0 20.0 18.1 18.8 19.0 44.1 41.7 38.1 13.7 80.1 48.4 52.3 70.6 36.5 50.4 41.0 41.3 22.1 25.8 48.9 27.6 37.5 69.1 48.4 14.6 58.7 69.7 24.4 34.5 47.3 52.0 21.0 52.2 15.6 63.0 74.5 51.6 30.5 35.8 57.6 41.5 43.5 52.0 46.2 33.7 19.0 31.9 26.4 34.3 28.0 11.1 50.4 33.2 30.2 4.7 75.2 41.4 38.1 15.1 16.7 68.0 19.8 44.0 46.0 50.2 24.5 70.8 42.8 46.2 26.3 41.8 50.9 124.3 79.2 41.9 49.7 45.7 44.0 45.8 34.1 40.5 QPCTL FLJ20084 ENSG00000011478 "Glutaminyl-peptide cyclotransferase like" Q9NXS2 19 45692403-45703989 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 5.5;granulocytes: 5.7;Inhibitory neurons: 6.5;Plasma cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040797 Approved Supported "Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA040797: AB_10794148" "unprognostic (6.50e-2)" "unprognostic (4.14e-2)" "unprognostic (2.09e-1)" "unprognostic (7.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.26e-1)" "unprognostic (8.41e-3)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (3.14e-2)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.15e-8)" "unprognostic (1.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.02e-2)" "unprognostic (5.71e-2)" 4.1 7.8 3.9 3.1 3.9 4.1 4.9 3.6 4.8 4.9 4.1 5.9 4.7 4.8 3.7 4.7 4.8 2.5 3.4 4.2 4.0 5.3 9.2 6.2 4.7 4.5 3.8 6.6 7.5 4.4 7.0 3.7 4.5 6.5 3.9 2.1 6.7 3.4 1.5 5.2 5.5 2.5 3.2 8.5 6.1 4.4 4.2 2.4 6.7 0.8 3.5 4.6 4.4 3.9 16.7 10.8 8.5 36.9 8.6 4.1 6.4 10.3 15.7 15.0 24.7 11.2 12.3 19.7 11.1 11.5 15.4 9.5 10.0 11.9 8.9 5.0 12.7 6.7 10.9 24.6 14.6 7.5 12.0 7.6 14.9 12.6 17.3 10.7 13.6 10.8 9.7 32.1 9.5 13.0 7.0 7.7 5.5 14.2 5.4 7.8 6.4 16.5 16.2 8.0 7.6 4.7 10.6 8.8 18.2 3.7 6.4 10.6 8.4 7.4 12.4 7.3 10.4 28.6 20.2 18.2 26.0 17.2 5.8 1.4 0.3 0.2 1.4 0.5 0.9 0.9 0.6 0.3 0.8 0.6 0.5 0.7 1.3 1.4 0.3 1.0 0.3 0.2 3.9 3.9 3.6 4.8 4.2 4.0 4.5 3.8 4.5 3.2 4.2 3.9 0.5 0.0 1.5 2.3 3.3 1.3 1.2 1.1 0.6 1.1 0.7 0.6 0.8 1.5 1.2 0.0 0.0 0.8 2.1 1.2 0.0 0.6 5.4 0.9 1.4 0.7 0.0 1.3 5.5 0.4 1.4 0.7 1.5 1.4 5.7 0.7 0.0 1.3 0.9 1.7 6.5 0.4 0.0 0.6 1.8 1.3 0.0 1.6 1.8 0.0 0.7 0.3 1.0 3.5 1.6 0.6 0.1 0.0 9.8 1.2 0.7 0.1 2.2 2.4 0.0 0.6 1.1 1.0 0.3 1.4 1.1 0.8 2.4 1.5 1.0 0.5 QSOX1 QSCN6 ENSG00000116260 "Quiescin sulfhydryl oxidase 1" O00391 1 180154869-180204030 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Extravillous trophoblasts: 1616.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 1918.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056243 Supported "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 2600000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" "Golgi apparatus" Vesicles "HPA056243: AB_2683077" "unprognostic (1.13e-1)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.49e-2)" "unprognostic (2.00e-2)" "unprognostic (2.73e-1)" "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.07e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (1.86e-5)" "unprognostic (3.25e-1)" "unprognostic (2.14e-1)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" 84.8 84.9 35.8 52.1 39.4 115.5 53.2 42.7 47.3 81.7 41.1 100.1 67.5 75.2 70.2 178.4 82.3 150.3 244.9 41.5 43.4 73.8 81.7 200.0 16.3 50.0 40.7 196.1 136.3 21.0 60.2 158.9 43.2 92.3 80.9 15.2 105.6 57.5 91.2 58.6 85.7 60.0 44.0 61.9 178.3 172.9 42.6 12.1 31.9 46.0 19.6 174.1 108.7 57.7 441.4 62.0 14.8 181.0 179.1 367.8 712.5 456.5 456.6 381.6 267.1 7.3 137.7 6.8 276.7 367.8 52.6 93.7 17.6 123.5 185.0 26.4 28.0 14.1 33.6 19.4 1918.6 48.6 129.2 197.9 55.5 408.0 484.3 499.9 569.4 32.1 20.2 66.3 255.3 76.4 10.4 89.7 49.4 302.6 174.6 19.7 33.0 11.8 63.1 123.6 51.9 52.6 133.8 179.8 91.9 32.2 33.0 226.3 678.3 473.8 187.5 322.0 392.9 48.3 84.4 12.2 180.9 153.9 146.0 16.2 53.1 20.6 14.0 29.9 10.2 5.4 9.1 9.6 39.2 3.2 8.1 8.0 40.2 16.9 28.6 8.0 11.5 28.6 35.8 39.4 42.7 47.3 41.5 43.4 50.0 40.7 43.2 44.0 42.6 57.7 36.6 57.7 101.6 8.5 7.7 13.8 27.4 81.2 7.4 11.5 86.2 47.9 48.3 51.5 112.5 71.7 25.0 19.5 10.7 138.1 0.0 230.4 49.2 49.2 19.4 41.7 46.2 6.9 17.2 130.1 1616.7 78.0 136.6 80.4 25.4 27.1 89.3 4.3 68.6 6.7 17.0 185.7 132.2 45.2 35.3 20.1 177.7 48.9 44.4 8.4 49.7 53.5 10.3 24.6 23.9 249.8 165.6 71.1 12.8 35.7 9.0 9.1 47.8 6.7 32.9 13.6 31.3 30.2 32.7 10.2 9.9 154.3 13.9 13.9 89.9 68.0 QSOX2 "DKFZp762A2013, QSCN6L1, SOXN" ENSG00000165661 "Quiescin sulfhydryl oxidase 2" Q6ZRP7 9 136206333-136245812 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012716, HPA017280" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 9600000 "Cluster 19: B-cells - Humoral immune response" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA012716: AB_2173315, HPA017280: AB_2669565" "unprognostic (7.29e-2)" "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (5.28e-2)" "unprognostic (1.49e-1)" "unprognostic (4.46e-3)" "unprognostic (1.10e-3)" "unprognostic (4.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.06e-3)" "unprognostic (5.96e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (9.64e-6)" "unprognostic (1.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.10e-2)" 7.5 7.6 7.3 11.2 7.6 15.9 5.9 12.9 8.1 7.3 5.9 6.7 5.1 8.3 10.6 5.3 8.6 4.6 7.6 7.3 7.6 7.5 8.6 7.0 17.5 7.3 7.6 9.5 18.8 8.1 32.3 4.9 6.9 6.4 5.4 12.3 5.9 3.7 5.6 11.1 11.8 6.7 6.0 15.7 7.1 10.8 8.0 8.1 11.7 3.4 14.6 6.3 5.8 7.3 14.7 35.0 28.6 38.2 15.8 19.0 35.9 18.3 20.4 34.9 31.9 26.4 31.1 22.6 29.5 24.7 64.1 46.7 34.2 26.5 28.0 33.5 17.2 12.1 59.8 29.3 22.5 36.4 17.8 15.3 26.3 34.8 41.8 15.4 25.9 23.3 29.8 59.1 18.8 25.0 13.6 24.2 34.0 44.2 22.3 24.8 37.1 37.2 12.0 13.1 30.5 23.1 28.9 22.6 15.9 18.5 16.3 21.1 15.0 42.2 30.4 35.1 42.6 20.9 29.9 49.7 28.3 18.9 40.5 0.4 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 7.3 7.6 12.9 8.1 7.3 7.6 7.3 7.6 6.9 6.0 8.0 7.3 8.8 9.6 7.9 13.7 17.7 5.7 2.8 2.2 1.8 24.4 2.3 2.9 4.3 0.0 4.4 5.5 18.8 1.3 5.8 1.6 1.9 3.4 6.7 5.7 7.4 6.6 16.3 14.5 10.1 4.0 2.8 5.2 4.1 5.6 1.3 7.1 2.9 4.4 2.3 5.0 11.1 3.8 0.0 3.7 8.2 7.3 5.9 3.3 0.0 8.4 4.3 2.6 4.1 6.0 10.7 3.4 0.7 7.2 5.4 7.9 0.9 2.3 9.0 8.8 6.6 9.2 4.7 19.4 24.2 1.8 11.5 1.0 5.1 7.3 3.9 3.6 RAB1B ENSG00000174903 "RAB1B, member RAS oncogene family" Q9H0U4 11 66268590-66277492 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010225, HPA056141" Approved Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "Endoplasmic reticulum" "CAB010225: AB_2284660, HPA056141: AB_2683051" "unprognostic (6.07e-2)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-1)" "unprognostic (2.90e-1)" "unprognostic (9.91e-2)" "unprognostic (2.61e-2)" "unprognostic (2.04e-3)" "unprognostic (2.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (2.00e-1)" "prognostic favorable (1.09e-5)" "unprognostic (2.41e-2)" "unprognostic (9.45e-2)" "unprognostic (9.42e-2)" "unprognostic (5.85e-2)" 127.1 129.7 121.7 84.0 117.4 91.1 120.9 117.7 137.7 113.7 106.2 129.3 112.5 111.2 82.3 180.9 105.7 83.0 146.7 117.5 116.8 127.2 126.4 116.5 90.3 122.7 121.0 103.5 96.1 132.9 112.6 88.4 119.3 140.6 90.3 46.5 128.0 105.1 233.2 147.6 112.9 86.9 119.3 125.3 125.5 79.9 124.2 105.5 111.5 152.8 86.1 113.6 119.2 118.9 226.5 248.0 126.2 166.1 205.6 150.9 113.8 182.7 212.8 232.2 163.4 141.4 223.7 91.7 235.7 263.1 172.1 209.0 140.7 253.9 125.9 190.3 128.0 144.7 156.0 124.2 135.0 124.3 258.2 158.7 212.4 199.6 102.4 163.2 221.1 144.9 153.1 158.8 223.6 434.5 219.1 197.1 131.5 196.1 230.8 133.0 101.8 237.2 234.7 204.5 122.9 137.1 132.7 319.2 133.7 91.4 487.5 141.6 228.1 221.4 152.9 267.9 164.9 89.9 77.9 121.5 251.2 104.3 207.8 173.1 199.8 329.3 227.5 211.9 171.7 109.8 135.5 188.1 163.0 130.2 115.3 140.6 420.5 203.5 243.9 188.3 165.5 375.6 121.7 117.4 117.7 137.7 117.5 116.8 122.7 121.0 119.3 119.3 124.2 118.9 56.3 38.5 59.6 7.8 41.7 33.6 31.4 42.4 53.5 22.0 55.0 53.1 1.1 40.0 47.9 36.8 29.2 56.2 50.8 137.1 50.9 49.3 13.4 41.3 38.6 50.6 54.0 27.1 7.2 71.3 84.2 36.5 58.1 44.9 53.8 24.6 48.9 47.8 54.2 16.8 8.0 85.0 36.7 55.2 26.4 27.2 35.8 51.4 24.9 5.6 47.7 37.8 43.3 5.5 13.1 71.6 80.6 42.2 61.0 41.4 79.6 49.5 36.0 18.2 39.5 36.2 39.7 23.8 17.4 64.5 42.1 80.2 57.4 28.1 64.9 43.5 RAB20 FLJ20429 ENSG00000139832 "RAB20, member RAS oncogene family" Q9NX57 13 110523066-110561722 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 91.3;Hofbauer cells: 105.0;Kupffer cells: 92.1;Macrophages: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 60.9;SK-BR-3: 85.7;T-47d: 54.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002882, HPA052111, HPA068647" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" "HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013" "unprognostic (5.59e-3)" "unprognostic (1.30e-1)" "unprognostic (3.48e-1)" "unprognostic (1.42e-3)" "unprognostic (1.30e-1)" "unprognostic (3.82e-2)" "unprognostic (1.14e-2)" "unprognostic (5.99e-2)" "unprognostic (9.43e-2)" "unprognostic (2.06e-2)" "unprognostic (9.41e-2)" "unprognostic (2.65e-1)" "prognostic favorable (8.57e-4)" "unprognostic (6.96e-2)" "unprognostic (4.32e-2)" "unprognostic (2.28e-2)" "prognostic favorable (4.48e-4)" 31.1 55.4 5.7 21.7 5.5 25.3 23.4 5.6 7.9 11.7 9.6 20.7 27.6 6.9 4.8 4.6 11.5 18.0 21.4 5.2 7.0 26.1 51.4 30.7 16.4 7.0 6.0 20.5 24.2 6.2 9.7 22.8 6.8 12.1 14.3 2.6 10.7 5.0 5.8 4.6 25.3 7.6 6.6 44.5 28.6 10.6 7.4 3.9 22.0 2.3 5.1 20.6 6.7 8.4 20.1 2.9 1.9 3.8 12.4 3.3 31.3 1.7 6.2 8.1 12.5 47.9 39.9 0.0 13.9 1.7 10.8 7.5 3.8 12.3 4.2 22.5 3.0 19.8 3.6 22.6 7.8 2.8 5.7 6.9 2.0 4.2 1.2 6.3 3.1 3.3 3.8 0.0 1.8 24.0 0.1 29.0 4.0 60.9 8.5 1.9 0.1 9.0 14.2 26.3 0.5 2.1 3.8 85.7 27.4 6.2 54.4 30.5 2.3 2.0 4.2 0.2 2.7 0.1 0.0 0.2 27.7 38.9 4.2 7.8 35.5 7.1 1.0 33.3 1.3 3.5 2.8 0.9 15.8 2.8 6.5 2.3 26.3 0.0 26.6 0.8 0.9 11.2 5.7 5.5 5.6 7.9 5.2 7.0 7.0 6.0 6.8 6.6 7.4 8.4 18.6 19.2 20.4 4.2 10.6 4.5 10.9 14.1 10.8 0.2 12.8 13.0 5.0 48.6 16.2 25.8 0.0 34.6 1.8 31.1 31.3 60.3 1.6 20.7 2.6 10.3 18.0 0.0 0.4 67.9 91.3 11.5 15.3 23.2 21.0 41.1 53.6 34.5 105.0 0.0 0.4 23.9 28.5 92.1 19.9 1.6 3.7 100.5 7.2 8.4 16.2 7.4 0.0 4.5 0.1 36.4 17.2 6.4 0.4 8.0 48.1 68.9 20.4 2.0 13.1 6.2 26.2 1.0 13.2 1.9 3.0 20.0 3.6 7.2 24.0 11.1 RAB27B ENSG00000041353 "RAB27B, member RAS oncogene family" O00194 18 54717860-54895516 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 44.1" "Cell type enhanced" "Detected in many" "Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.2;NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017712, HPA019849" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 6500000 "Cluster 48: NK-cells - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Plasma membrane" Cytosol "CAB017712: , HPA019849: AB_1856000" "unprognostic (1.59e-1)" "unprognostic (5.20e-2)" "unprognostic (9.89e-3)" "unprognostic (7.51e-2)" "unprognostic (8.89e-2)" "unprognostic (1.84e-2)" "unprognostic (1.52e-1)" "unprognostic (2.73e-3)" "unprognostic (6.82e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.39e-2)" "unprognostic (1.20e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (5.75e-1)" "unprognostic (1.29e-1)" 0.3 2.6 7.9 1.1 10.2 1.0 11.9 0.0 11.9 3.0 0.0 4.9 5.1 0.8 0.4 14.0 1.1 3.8 0.1 13.3 5.2 0.3 1.3 7.2 0.5 0.0 0.1 0.2 4.1 2.3 1.0 1.1 0.6 20.5 5.3 1.0 14.0 1.0 0.2 15.6 4.9 0.9 0.1 1.7 44.1 4.5 2.6 1.4 0.3 0.5 5.2 6.2 5.2 3.3 7.8 22.4 0.8 0.0 1.5 19.3 0.0 1.7 13.5 1.8 1.3 0.0 8.6 1.3 0.1 3.9 16.7 14.5 0.2 9.0 0.5 0.0 0.5 63.3 5.0 0.0 2.6 3.4 7.0 15.3 46.6 25.5 56.0 21.1 1.2 0.3 0.0 3.9 16.1 7.9 0.2 7.4 0.2 14.0 14.7 0.0 0.0 0.3 4.1 28.9 0.2 10.3 2.2 13.4 0.0 0.1 8.3 0.3 0.3 18.8 0.6 9.8 2.0 0.4 0.0 0.0 165.2 35.6 0.9 0.6 0.0 0.1 2.2 0.0 0.5 0.0 0.7 1.1 0.0 0.0 0.2 1.0 0.2 2.6 0.0 0.0 0.0 1.6 7.9 10.2 0.0 11.9 13.3 5.2 0.0 0.1 0.6 0.1 2.6 3.3 0.3 48.1 37.6 3.3 0.9 25.6 8.6 18.2 8.0 2.4 59.8 25.3 0.5 8.6 36.9 5.5 2.1 6.5 15.0 5.7 1.9 7.2 259.3 30.9 4.4 1.9 4.2 3.4 101.0 41.0 4.5 2.0 178.4 64.0 246.6 0.4 2.5 0.9 0.6 6.7 75.8 31.3 20.3 0.6 2.7 209.9 2.1 38.1 7.2 2.8 2.1 1.4 29.9 98.5 2.6 34.0 18.6 0.4 3.2 78.9 3.0 0.0 15.8 0.4 6.6 0.3 2.2 7.9 1.4 79.2 49.2 2.9 13.9 0.5 7.9 42.2 RAB6A RAB6 ENSG00000175582 "RAB6A, member RAS oncogene family" P20340 11 73675638-73761137 "Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009936, HPA059131" Approved Approved "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "CAB009936: AB_2175466, HPA059131: AB_2683916" "unprognostic (2.84e-1)" "unprognostic (7.18e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (8.18e-5)" "unprognostic (1.79e-1)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (8.67e-3)" "unprognostic (1.16e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (2.24e-4)" "unprognostic (9.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-1)" "unprognostic (4.93e-2)" "unprognostic (2.36e-1)" 71.2 69.8 87.7 53.0 96.5 38.4 50.6 85.4 112.8 64.4 79.3 66.2 71.6 66.9 53.0 100.2 54.0 55.6 99.5 101.8 100.9 75.1 85.3 68.5 45.7 106.0 90.1 64.5 49.0 67.5 36.4 91.4 112.9 64.0 70.6 56.1 47.8 64.9 107.5 55.0 83.4 79.8 80.0 56.9 54.9 36.1 97.4 54.2 98.7 101.7 60.8 78.9 62.4 93.4 86.2 66.3 105.8 68.5 135.9 154.3 141.7 130.4 124.6 111.1 100.8 131.5 146.4 73.2 136.6 174.0 94.9 94.6 68.4 135.3 142.5 84.6 25.6 118.2 68.6 110.9 114.2 78.1 113.1 114.7 246.8 113.5 165.0 124.4 135.9 75.7 71.3 111.5 133.3 99.6 85.7 54.7 42.2 192.0 62.3 64.8 193.9 132.5 135.2 146.6 83.0 70.5 136.1 136.7 290.9 104.7 107.2 71.0 165.0 113.3 56.9 193.5 56.6 71.9 89.5 149.5 46.3 63.2 104.6 227.9 81.8 133.2 84.2 87.6 76.2 56.1 70.3 75.5 62.9 50.7 52.0 61.8 61.9 78.6 88.6 33.7 86.3 111.1 87.7 96.5 85.4 112.8 101.8 100.9 106.0 90.1 112.9 80.0 97.4 93.4 66.3 32.1 51.0 79.7 59.2 83.5 49.4 57.2 88.2 53.9 45.8 30.4 64.2 35.8 42.7 68.0 87.6 109.9 55.3 85.2 43.0 66.0 8.8 51.5 41.3 78.7 52.0 47.5 133.6 49.5 162.3 60.5 52.5 51.2 48.8 83.7 72.5 63.7 65.7 40.4 119.0 61.8 75.3 58.4 85.7 9.5 52.8 58.3 72.9 49.6 74.2 47.7 52.5 130.7 109.4 79.0 61.7 61.7 86.3 57.8 102.7 54.1 47.2 54.2 26.3 47.4 65.5 74.2 53.4 106.5 112.7 173.6 63.8 45.0 50.8 69.8 RAB6B ENSG00000154917 "RAB6B, member RAS oncogene family" Q9NRW1 3 133824235-133895882 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 30.8;Erythroid cells: 79.2;Excitatory neurons: 60.5;Horizontal cells: 67.3;Inhibitory neurons: 54.1" "Cancer enhanced" "Detected in all" "glioma: 18.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 47 "T-cells: 7.3" "Cell line enriched" "Detected in many" 4 "HEL: 226.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017713, HPA059131" Uncertain Approved "Golgi apparatus" NA NA 2200000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus" "CAB017713: , HPA059131: AB_2683916" "unprognostic (2.87e-2)" "unprognostic (6.33e-3)" "unprognostic (4.53e-3)" "prognostic unfavorable (9.01e-4)" "unprognostic (3.61e-1)" "unprognostic (5.14e-2)" "unprognostic (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.97e-6)" "unprognostic (9.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (8.10e-2)" "unprognostic (9.53e-2)" "unprognostic (6.05e-3)" 6.8 11.1 45.7 2.8 72.6 12.0 4.4 0.4 138.0 2.9 0.0 6.8 2.4 3.0 2.1 4.2 16.2 3.2 20.8 71.8 31.3 7.1 0.9 3.1 3.3 74.6 43.1 2.1 4.4 24.9 12.0 1.7 55.7 2.7 2.1 29.4 10.1 5.9 2.7 1.5 2.9 8.4 3.7 5.9 5.5 4.0 21.5 1.4 5.2 2.8 2.0 1.6 2.2 63.1 0.1 3.0 5.8 14.9 10.1 10.3 0.5 3.0 6.3 7.2 0.8 1.6 1.5 0.2 6.3 2.4 21.2 0.4 13.8 0.4 3.6 0.2 8.6 226.6 3.5 0.5 1.2 1.4 8.5 3.1 2.9 1.1 0.2 0.1 2.9 8.3 53.4 0.6 1.1 5.5 0.7 21.3 18.0 10.8 2.2 0.2 0.4 2.3 4.0 1.3 47.2 10.1 4.4 4.2 26.7 22.5 16.8 9.7 3.7 6.5 15.5 3.2 5.4 5.6 1.5 0.5 0.7 0.5 5.6 0.0 0.0 0.0 0.6 0.0 7.3 0.1 0.1 1.7 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.8 45.7 72.6 0.4 138.0 71.8 31.3 74.6 43.1 55.7 3.7 21.5 63.1 2.0 0.0 0.0 25.8 0.2 1.3 2.2 0.5 0.6 10.5 2.0 2.3 30.8 1.5 2.8 1.8 2.1 0.3 0.6 2.2 3.9 3.6 0.1 2.3 0.9 3.5 0.0 79.2 60.5 1.3 0.7 3.7 2.0 1.3 0.0 12.4 7.9 0.1 0.2 67.3 54.1 0.2 0.0 0.6 1.1 0.2 1.8 0.4 1.8 16.9 0.1 10.2 0.0 17.1 9.6 2.5 1.1 6.8 0.1 2.0 0.0 1.5 9.3 21.3 0.0 4.1 13.8 0.9 12.7 0.8 1.4 0.3 1.1 2.2 0.0 0.6 RAB6C WTH3 ENSG00000222014 "RAB6C, member RAS oncogene family" Q9H0N0 2 129979666-129982738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.6;breast: 2.5;parathyroid gland: 3.6" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 10.3;Oligodendrocytes: 3.3" "Group enriched" "Detected in some" 5 "breast cancer: 0.7;prostate cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 2.5;HMC-1: 2.2;REH: 5.4;T-47d: 3.2;U-266/70: 2.1" HPA059131 Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 6: T47d - Mammary gland" "Cluster 43: Cardiomyocytes - Nuclear processes" "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (3.84e-2)" "unprognostic (5.77e-2)" "unprognostic (1.02e-1)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (8.62e-2)" "unprognostic (1.83e-1)" "unprognostic (1.98e-1)" "unprognostic (1.38e-2)" "unprognostic (1.50e-2)" "unprognostic (1.28e-1)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (4.48e-2)" "unprognostic (6.04e-2)" "unprognostic (1.24e-1)" "unprognostic (4.78e-1)" 0.1 0.6 1.4 0.1 2.2 0.0 2.5 0.7 1.9 1.9 0.7 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.2 1.3 1.6 0.1 0.0 0.0 0.0 1.2 1.2 0.1 0.0 3.6 0.2 0.3 1.3 1.7 0.0 0.3 0.0 0.4 0.1 0.0 0.1 0.0 0.7 0.5 0.0 0.9 1.6 0.0 0.1 0.0 0.0 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.4 0.1 0.5 3.2 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.7 1.9 1.3 1.6 1.2 1.2 1.3 0.7 1.6 3.6 0.1 0.0 0.0 0.3 0.1 0.8 0.3 0.3 0.0 0.0 0.9 0.1 10.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.1 1.7 1.0 0.0 0.0 0.7 0.0 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.4 0.0 0.3 0.4 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.7 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.6 1.4 1.4 1.3 0.0 1.1 0.5 0.1 0.1 0.1 0.3 RAB6D "RAB6CL, WTH3DI" ENSG00000233087 "RAB6D, member RAS oncogene family" Q53S08 2 131361111-131364142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "parathyroid gland: 7.4" "Cell type enriched" "Detected in single" 15 "Respiratory ciliated cells: 1.5" "Cancer enhanced" "Detected in some" "prostate cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MOLT-4: 2.2" HPA059131 Uncertain Approved "Golgi apparatus" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (4.19e-2)" "unprognostic (8.54e-2)" "unprognostic (1.16e-1)" "unprognostic (3.03e-2)" "unprognostic (4.08e-1)" "unprognostic (4.79e-2)" "unprognostic (4.41e-2)" "unprognostic (1.01e-1)" "unprognostic (1.87e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-1)" "unprognostic (2.55e-2)" "unprognostic (2.61e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.12e-1)" 0.0 0.2 0.6 0.1 0.5 0.0 0.0 0.0 0.8 0.1 0.0 0.9 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.6 0.9 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 7.4 0.0 0.0 0.5 1.4 0.8 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 1.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.3 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.8 0.6 0.9 0.3 0.2 0.5 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RARRES1 "LXNL, TIG1" ENSG00000118849 "Retinoic acid receptor responder 1" P49788 3 158696892-158732489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 221.9;fallopian tube: 206.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 217.1;Club cells: 621.4;Prostatic glandular cells: 312.9;Urothelial cells: 737.7" "Cancer enhanced" "Detected in all" "urothelial cancer: 93.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 10 "CAPAN-2: 1319.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003892 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "Endoplasmic reticulum" "HPA003892: AB_1856079" "unprognostic (5.76e-3)" "unprognostic (2.13e-1)" "unprognostic (8.85e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (9.29e-4)" "unprognostic (7.09e-2)" "unprognostic (8.93e-2)" "unprognostic (3.86e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.88e-6)" "unprognostic (3.49e-1)" "unprognostic (1.33e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" 221.9 21.3 1.0 65.1 1.5 0.6 44.6 1.5 1.7 74.6 11.3 31.7 5.1 25.9 27.0 11.3 206.4 19.7 81.5 1.5 0.8 25.1 4.2 52.7 18.9 0.6 0.4 60.5 10.0 0.2 27.7 3.5 0.4 78.6 36.2 0.9 165.3 37.2 5.6 8.3 38.5 51.2 0.4 2.7 23.7 4.5 1.0 1.8 20.4 2.8 6.2 92.1 32.2 1.4 19.2 6.9 0.2 1.0 4.0 12.6 0.3 1.8 5.7 1.0 1.4 1.4 1319.3 0.0 1.2 0.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 2.0 0.1 12.0 0.0 0.0 131.3 0.0 0.5 0.0 8.9 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.7 5.8 0.0 0.0 0.0 0.1 0.3 22.9 0.5 1.7 16.7 1.3 0.3 0.0 1.9 2.3 1.3 1.1 0.0 4.6 0.0 0.0 0.0 0.0 1.5 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 1.5 1.5 1.7 1.5 0.8 0.6 0.4 0.4 0.4 1.0 1.4 5.2 0.0 0.6 2.3 0.9 0.5 217.1 92.7 11.4 0.4 99.7 35.6 0.9 11.5 621.4 14.7 0.0 2.9 1.6 59.0 0.0 10.5 29.5 14.4 98.4 18.1 37.5 3.6 14.2 4.7 0.8 101.3 1.1 16.9 29.9 0.3 31.8 6.0 10.8 0.0 10.6 102.3 40.7 1.6 1.7 33.1 10.8 11.0 5.4 1.9 0.0 4.2 0.0 4.5 7.6 2.3 106.1 1.2 1.2 312.9 140.7 19.7 149.3 0.7 0.0 7.7 46.7 3.8 0.7 7.8 0.4 11.4 3.3 0.1 88.3 737.7 RASGEF1A "CG4853, FLJ37817" ENSG00000198915 "RasGEF domain family member 1A" Q8N9B8 10 43194535-43267065 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.6;brain: 19.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 22.1;Inhibitory neurons: 16.3;NK-cells: 8.2;Spermatogonia: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 17.2;SCLC-21H: 15.6;SK-BR-3: 14.1;T-47d: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035593 Enhanced Approved "Golgi apparatus" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA035593: AB_10602083" "prognostic favorable (1.86e-5)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.86e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (5.73e-2)" "unprognostic (8.53e-2)" "unprognostic (9.00e-2)" "unprognostic (2.86e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.11e-7)" "unprognostic (2.88e-2)" "unprognostic (2.32e-1)" "unprognostic (1.89e-2)" "unprognostic (3.83e-2)" 0.8 1.6 18.8 1.3 17.0 14.6 3.3 11.6 19.3 1.7 5.2 0.8 0.9 1.2 0.4 1.1 2.5 2.3 1.5 19.2 14.6 2.6 0.4 1.6 5.3 15.0 15.2 1.2 3.7 4.3 4.4 0.7 13.6 1.4 0.4 1.3 3.4 1.7 0.8 0.8 1.3 1.2 13.1 3.8 0.7 2.3 18.4 1.0 0.8 0.7 3.7 1.2 2.6 17.0 9.7 8.2 0.0 0.1 0.0 0.2 4.8 0.1 0.0 0.0 0.0 0.2 5.2 8.4 8.6 0.8 0.0 0.1 1.3 7.7 0.0 0.0 6.3 0.0 0.1 0.4 3.7 0.0 3.0 2.0 8.7 0.7 0.0 0.0 0.0 0.4 17.2 0.0 0.0 1.9 0.0 0.2 0.8 4.3 0.0 0.0 0.0 0.2 0.6 4.5 15.6 0.0 0.0 14.1 0.1 7.1 15.6 0.1 0.1 0.0 3.5 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 6.1 2.9 0.5 1.1 0.2 0.7 2.2 2.9 2.6 0.2 1.4 9.4 6.3 0.4 5.1 0.0 1.2 18.8 17.0 11.6 19.3 19.2 14.6 15.0 15.2 13.6 13.1 18.4 17.0 0.2 0.0 0.0 3.6 1.1 0.5 0.3 2.4 0.6 2.0 4.3 4.1 2.2 0.0 0.2 3.7 0.0 0.4 6.7 0.2 0.0 0.3 1.3 1.8 0.5 1.0 0.0 0.0 22.1 1.3 1.1 1.0 0.5 2.3 0.0 1.9 1.1 0.1 0.9 1.7 16.3 0.3 0.0 0.9 1.7 0.7 0.0 1.4 0.0 1.0 1.4 0.3 8.2 1.5 1.0 2.1 0.1 0.0 0.7 1.2 0.2 0.6 0.6 0.3 0.0 0.9 0.4 0.7 7.7 0.5 0.3 0.3 5.0 0.5 0.6 0.1 RASGRF1 "CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187" ENSG00000058335 "Ras protein specific guanine nucleotide releasing factor 1" Q13972 15 78959906-79090780 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 26.5;lung: 7.5;retina: 7.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010413, HPA041965" Approved Supported "Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "CAB010413: AB_2238127, HPA041965: AB_10793939" "unprognostic (2.57e-3)" "unprognostic (3.08e-2)" "unprognostic (3.14e-2)" "prognostic favorable (6.14e-6)" "unprognostic (1.90e-1)" "unprognostic (1.15e-3)" "unprognostic (5.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.03e-1)" "unprognostic (4.02e-6)" "unprognostic (2.35e-1)" "unprognostic (8.02e-2)" "unprognostic (3.81e-2)" "unprognostic (8.81e-2)" 0.1 0.1 4.2 1.0 4.1 0.0 0.1 24.4 24.4 0.6 0.0 0.2 0.2 0.4 0.1 0.1 0.4 0.1 0.0 12.2 6.4 0.7 0.0 7.5 1.3 13.9 10.2 0.8 2.3 0.6 1.1 0.2 16.4 0.5 0.2 7.4 0.1 0.2 0.0 0.0 1.4 0.1 8.7 0.6 0.2 0.3 14.9 0.5 0.0 0.0 1.4 0.3 0.1 26.5 8.5 0.1 0.1 0.0 0.0 0.0 7.7 0.0 0.4 0.5 1.2 0.0 1.5 0.4 0.2 0.0 0.6 0.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 10.4 1.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.9 13.0 0.1 0.3 0.8 0.0 0.0 0.1 1.6 0.7 0.0 1.7 0.0 0.0 15.1 0.0 0.3 0.0 3.8 2.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.1 24.4 24.4 12.2 6.4 13.9 10.2 16.4 8.7 14.9 26.5 0.2 3.2 80.6 8.5 4.5 0.6 0.6 0.2 0.0 13.7 0.2 0.1 1.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.2 0.6 0.4 0.5 0.0 0.0 80.9 0.0 2.7 0.3 0.0 1.8 0.0 0.0 0.0 0.0 2.0 25.2 91.2 0.0 0.0 0.3 16.1 0.0 0.0 1.8 3.6 5.6 0.6 1.1 0.0 1.5 121.5 0.3 0.0 0.4 2.1 0.2 0.0 6.8 2.0 2.5 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.8 0.1 1.6 0.0 0.4 RASGRP3 "CalDAG-GEFIII, GRP3, KIAA0846" ENSG00000152689 "RAS guanyl releasing protein 3" Q8IV61 2 33436324-33564750 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.4;skeletal muscle: 42.0" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 186.5;Plasma cells: 64.8;Urothelial cells: 106.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 13.9;memory B-cell: 12.3;naive B-cell: 15.2" "Group enriched" "Detected in many" 16 "B-cells: 15.2;granulocytes: 13.9" "Group enriched" "Detected in many" 7 "Daudi: 88.7;HEL: 92.0;U-266/70: 143.5;U-266/84: 59.1;U-698: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058937 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Golgi apparatus" "HPA058937: AB_2683858" "unprognostic (2.64e-1)" "unprognostic (9.50e-2)" "unprognostic (1.45e-1)" "unprognostic (5.76e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (3.90e-1)" "unprognostic (7.57e-2)" "unprognostic (2.39e-2)" "unprognostic (4.35e-2)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (9.96e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (5.82e-2)" 7.8 2.9 17.7 15.1 35.2 4.8 5.3 29.8 21.6 3.7 10.2 4.7 7.3 2.5 1.1 2.4 2.5 6.5 34.2 15.1 20.2 6.5 5.5 7.7 27.9 37.4 27.1 1.0 3.4 6.8 2.4 11.0 34.6 1.6 6.6 1.0 6.1 2.0 42.0 1.8 4.7 4.7 25.0 14.8 7.4 0.9 30.7 4.2 6.7 17.6 33.6 6.7 1.2 56.4 0.1 0.0 0.0 0.0 0.0 0.5 0.2 1.2 0.7 4.3 12.4 2.3 0.5 88.7 0.4 0.7 1.0 0.1 0.0 0.0 1.1 9.0 0.8 92.0 0.6 0.0 1.3 0.4 12.4 0.1 0.0 0.1 0.2 1.8 5.3 0.8 0.3 4.8 2.0 0.0 0.7 7.2 0.4 0.5 0.1 0.2 4.1 0.1 1.0 5.3 0.6 0.0 0.0 0.3 4.6 0.1 0.1 0.4 1.7 0.3 0.3 0.4 0.8 143.5 59.1 38.7 0.2 0.4 0.3 13.9 0.0 0.0 0.3 0.0 0.4 12.3 0.6 0.6 0.3 15.2 0.9 0.2 0.0 0.3 0.1 0.0 0.8 1.1 17.7 35.2 29.8 21.6 15.1 20.2 37.4 27.1 34.6 25.0 30.7 56.4 41.4 0.0 5.8 2.0 46.7 5.4 31.2 0.9 0.0 1.6 4.8 2.8 50.8 1.5 3.7 5.5 0.0 0.5 3.6 1.1 11.7 21.1 1.6 10.0 3.9 57.9 0.0 7.4 4.9 54.6 1.3 4.4 3.6 31.0 17.8 2.4 60.7 6.0 44.5 0.0 3.5 0.0 2.0 9.4 26.1 0.8 0.9 29.1 40.9 34.7 13.8 0.2 0.0 2.5 186.5 44.8 0.1 1.9 64.8 37.0 0.2 14.3 3.9 1.3 0.0 5.5 4.1 1.4 2.1 0.4 3.7 0.5 8.1 3.8 0.4 106.4 RASSF2 "CENP-34, KIAA0168" ENSG00000101265 "Ras association domain family member 2" P50749 20 4780023-4823608 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 217.0;retina: 162.8" "Cell type enhanced" "Detected in many" "Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3" "Cancer enriched" "Detected in all" 5 "glioma: 48.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051200 Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Golgi apparatus, Plasma membrane, Cytosol" "HPA051200: AB_2681386" "unprognostic (6.51e-2)" "unprognostic (3.67e-3)" "unprognostic (5.31e-2)" "unprognostic (1.47e-2)" "unprognostic (3.15e-1)" "unprognostic (1.46e-3)" "unprognostic (2.80e-1)" "unprognostic (7.01e-2)" "unprognostic (1.38e-2)" "unprognostic (2.41e-2)" "unprognostic (4.93e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (3.51e-2)" "unprognostic (1.35e-1)" "unprognostic (3.49e-1)" "unprognostic (6.46e-2)" 16.4 9.7 76.1 47.1 135.2 91.2 6.9 155.5 113.5 27.9 40.0 8.4 5.3 25.4 22.5 10.0 22.1 15.6 4.2 68.9 94.7 4.0 5.9 25.4 58.6 217.0 148.8 7.0 3.1 1.5 5.0 9.1 186.4 7.3 9.6 162.8 3.0 9.3 1.2 4.2 14.5 38.7 135.8 32.7 7.0 20.6 120.0 19.5 4.7 5.0 73.6 20.7 4.9 197.0 0.1 14.5 34.9 56.8 0.4 0.0 59.2 3.5 10.0 0.6 0.2 3.4 0.1 62.7 5.6 3.1 1.4 0.2 5.1 0.0 0.8 22.7 2.1 41.1 0.0 0.7 0.0 74.7 40.1 0.1 0.0 1.3 0.0 1.3 23.4 7.0 0.2 24.0 0.0 0.1 11.0 96.3 7.8 0.0 1.1 17.1 3.9 23.8 0.0 29.0 0.4 2.8 0.0 1.0 1.7 7.4 0.0 47.0 0.7 1.5 7.4 0.7 4.6 0.3 5.9 37.8 0.3 116.8 0.4 85.6 61.5 101.3 7.7 50.1 14.6 24.3 12.0 10.4 46.8 16.4 7.8 6.5 139.5 8.5 59.9 30.7 11.8 42.1 76.1 135.2 155.5 113.5 68.9 94.7 217.0 148.8 186.4 135.8 120.0 197.0 5.5 0.0 8.7 7.5 49.3 4.7 0.0 0.1 0.0 39.2 4.1 1.7 1.9 1.5 1.9 0.0 27.1 3.0 43.0 0.1 1.9 1.2 6.0 3.2 19.6 18.6 0.0 6.1 1.5 0.9 5.1 10.9 1.1 1.0 54.3 4.5 11.4 1.2 27.1 6.7 1.3 0.7 0.0 87.1 75.8 25.1 33.2 64.6 8.8 26.2 148.5 19.3 7.2 33.7 106.7 0.6 0.0 149.7 14.3 1.2 0.0 0.3 0.1 160.3 0.0 9.4 3.5 0.7 1.0 0.3 2.6 1.4 20.8 0.8 0.0 2.3 RASSF6 ENSG00000169435 "Ras association domain family member 6" Q6ZTQ3 4 73571550-73620631 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.6;stomach 1: 34.9" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 120.3;Gastric mucus-secreting cells: 171.8;Ionocytes: 103.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "memory B-cell: 2.7" "Lineage enriched" "Detected in single" 13 "B-cells: 2.7" "Cell line enhanced" "Detected in some" "Daudi: 76.0;hTERT-HME1: 21.5;RPTEC TERT1: 23.5;RT4: 70.2;U-266/70: 20.2;U-698: 61.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA037712 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 4: Stomach - Digestion" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA037712: AB_2675625" "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (3.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.05e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (6.76e-2)" "unprognostic (3.89e-2)" "unprognostic (5.86e-2)" "unprognostic (2.95e-1)" "unprognostic (8.97e-3)" "unprognostic (5.03e-2)" 0.2 0.1 0.0 4.9 0.0 0.1 8.4 0.0 0.2 2.3 5.0 11.9 9.8 0.5 2.8 1.9 2.7 4.4 0.0 0.1 0.2 6.0 2.2 1.3 5.7 0.0 0.8 1.3 16.6 0.7 0.4 7.4 0.0 5.7 12.7 1.6 3.5 3.7 0.0 5.3 12.3 0.3 0.0 0.2 34.9 0.1 0.7 30.6 5.7 0.4 6.9 9.2 1.8 0.1 0.3 1.9 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.2 12.0 76.0 1.1 0.0 0.3 3.8 0.0 6.0 0.0 1.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 5.8 0.0 21.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 11.1 0.2 0.0 0.1 0.5 23.5 70.2 2.8 0.0 0.2 1.8 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 20.2 0.1 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.8 0.0 0.0 0.7 0.1 0.3 12.8 5.1 0.0 25.0 9.8 38.5 70.5 18.8 0.1 25.1 42.2 1.2 21.5 37.7 7.3 0.0 55.7 0.1 81.1 17.6 18.2 0.3 45.4 2.0 0.8 120.3 0.4 0.3 80.9 23.0 1.7 171.8 22.8 1.3 2.2 0.4 4.0 4.4 0.0 0.1 57.9 103.7 0.3 1.0 0.0 0.0 1.2 1.8 0.0 0.6 18.7 0.0 0.0 0.3 67.1 65.8 0.0 21.3 24.6 30.1 37.8 29.8 0.5 0.0 0.0 1.6 0.0 0.2 11.9 1.4 47.2 3.5 0.7 23.2 60.5 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713340 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 73.9;heart muscle: 25.2;skeletal muscle: 95.3;tongue: 45.3" "Group enriched" "Detected in some" 8 "Excitatory neurons: 5800.8;Inhibitory neurons: 5921.8" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Group enriched" "Detected in many" 10 "basal ganglia: 28.1;cerebral cortex: 73.9;hippocampal formation: 26.6;white matter: 22.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746, HPA075862" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" No No "Cluster 11: Basophils - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: , HPA075862: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 0.3 1.5 3.7 0.4 28.1 0.5 0.1 2.5 73.9 0.6 0.0 0.8 0.2 0.2 3.1 1.1 1.1 0.1 25.2 26.6 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.0 1.1 0.1 0.0 1.7 0.5 5.7 2.2 4.1 95.3 0.3 0.2 0.0 2.7 0.0 0.2 1.1 2.2 0.2 0.1 45.3 0.0 0.4 0.4 22.6 0.1 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.7 0.0 0.0 0.1 1.6 0.0 0.0 0.0 25.9 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.0 0.2 0.2 0.3 0.0 0.7 0.1 0.4 0.2 0.0 0.1 0.2 0.2 0.2 0.0 0.3 0.3 0.2 0.7 0.2 0.1 0.1 0.2 0.0 3.7 28.1 2.5 73.9 26.6 0.0 0.0 0.0 0.0 2.7 2.2 22.6 0.0 0.0 0.5 97.9 0.0 0.0 0.0 0.0 0.0 10.9 0.4 0.0 98.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 6.6 0.3 1.8 0.9 0.0 0.0 5800.8 0.2 0.0 3.5 0.0 0.1 0.0 47.8 0.0 0.0 0.1 0.0 5921.8 0.5 0.0 0.0 0.3 4.9 1.2 0.5 1.8 132.1 0.6 6.6 0.0 597.6 689.4 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.7 2.8 0.0 17.0 1.2 0.6 0.5 0.0 0.0 0.0 0.1 0.7 0.7 0.0 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644336-110839468 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 40.8;pancreas: 20.2" "Cell type enriched" "Detected in many" 8 "Cardiomyocytes: 151.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 6.0;HEL: 5.2;K-562: 5.0;RH-30: 16.2;SH-SY5Y: 15.0;SuSa: 4.9;T-47d: 9.2" "Low region specificity" "Detected in single" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge" Yes No "Cluster 38: Heart - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Golgi apparatus" "Nucleoli, Cytokinetic bridge" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.5 0.1 0.8 0.2 2.6 0.1 2.5 0.4 0.8 1.5 1.8 4.1 0.1 2.9 0.6 5.6 2.6 0.4 40.8 0.8 0.4 0.7 0.1 0.9 0.1 0.8 0.9 2.7 20.2 1.2 1.7 1.6 0.6 1.3 0.4 1.2 7.3 0.7 15.6 1.2 0.8 2.2 0.5 0.1 1.0 0.8 0.8 0.5 1.0 3.8 0.6 1.0 5.5 0.7 0.0 1.6 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.0 2.5 6.0 5.2 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 16.2 0.0 0.0 0.0 0.1 15.0 0.1 0.0 0.6 4.9 9.2 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.4 0.8 0.8 0.4 0.8 0.9 0.6 0.5 0.8 0.7 0.3 0.0 0.0 0.7 0.2 0.1 0.2 0.4 1.2 1.4 0.8 0.5 151.5 0.0 0.1 0.0 2.1 1.6 0.0 0.7 1.9 0.0 0.8 0.5 1.2 1.5 0.0 0.0 14.8 0.2 0.2 3.3 0.0 0.1 0.0 14.6 1.4 0.0 0.1 0.0 15.4 0.7 2.0 0.0 0.0 0.8 4.4 0.0 0.0 17.8 0.0 0.1 0.0 1.5 0.6 0.0 0.1 13.5 1.0 0.0 2.0 1.5 12.4 2.7 6.6 3.7 5.4 0.5 0.8 3.7 0.0 3.1 0.2 1.7 0.2 0.3 RBP2 "CRABP-II, CRBP2, CRBPII, RBPC2" ENSG00000114113 "Retinol binding protein 2" P50120 3 139452884-139480747 "Metabolic proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 294 "intestine: 2713.5" "Cell type enriched" "Detected in some" 26 "Proximal enterocytes: 6095.4" "Group enriched" "Detected in many" 4 "colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CACO-2: 78.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA035866 Enhanced Approved "Golgi apparatus" NA NA 140000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA035866: AB_10672232" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (3.34e-2)" "unprognostic (6.72e-6)" "unprognostic (2.33e-1)" "unprognostic (4.10e-2)" "unprognostic (1.56e-2)" "unprognostic (2.24e-1)" "unprognostic (8.51e-3)" "unprognostic (3.92e-2)" "unprognostic (7.35e-2)" "unprognostic (1.24e-3)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (9.23e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" 0.4 1.1 4.6 1.1 3.2 0.7 0.5 0.3 3.2 0.2 0.0 4.0 2713.5 2.0 0.0 0.2 0.3 1.8 0.2 3.3 5.0 2.6 0.0 7.6 2.2 8.1 9.2 0.3 3.0 0.0 0.1 0.1 3.4 0.4 2.4 2.2 0.1 0.0 0.2 1.1 1886.7 1.0 3.4 0.1 3.6 1.0 9.0 0.0 0.5 0.0 0.0 0.0 0.0 5.3 0.0 0.2 0.2 0.2 0.0 0.0 7.1 0.0 0.0 0.0 0.0 78.8 0.1 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.9 0.1 0.2 0.1 0.1 0.0 11.7 0.0 0.0 4.0 10.1 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 3.2 0.3 3.2 3.3 5.0 8.1 9.2 3.4 3.4 9.0 5.3 0.0 9.6 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 12.9 8.4 0.0 0.0 14.0 0.0 0.6 0.0 0.0 0.0 0.2 1.2 0.0 1.0 6.1 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 185.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.5 0.9 6.1 226.3 0.0 0.0 0.0 6095.4 0.0 0.7 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 142.6 0.1 RBP5 CRBPIII ENSG00000139194 "Retinol binding protein 5" P82980 12 7115736-7128889 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 443.5;liver: 324.2" "Cell type enriched" "Detected in many" 8 "Proximal tubular cells: 3197.2" "Group enriched" "Detected in all" 8 "liver cancer: 70.1;renal cancer: 126.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.0;Hep G2: 13.4;K-562: 26.3" HPA038723 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Vesicles "HPA038723: AB_2676175" "unprognostic (5.70e-3)" "unprognostic (7.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.87e-2)" "unprognostic (1.39e-3)" "unprognostic (2.49e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.04e-1)" "unprognostic (2.65e-1)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-2)" "unprognostic (3.33e-2)" "unprognostic (4.22e-1)" "prognostic favorable (3.68e-4)" 6.4 11.7 0.0 15.0 0.1 1.6 5.1 0.3 0.3 11.2 0.2 8.5 4.6 8.6 3.2 3.8 8.1 5.9 1.4 0.0 0.0 443.5 324.2 3.8 31.2 0.5 0.3 4.9 5.2 1.3 6.2 0.3 0.3 10.0 4.9 0.8 3.7 5.0 0.7 2.4 20.6 5.4 0.0 97.1 5.2 2.2 0.2 14.2 7.9 0.0 21.4 7.4 4.6 0.0 0.9 1.3 0.0 0.3 0.0 0.0 0.2 1.1 0.0 0.0 0.2 1.1 1.2 1.0 0.3 0.0 0.1 1.2 0.1 0.0 0.0 1.6 0.0 6.0 3.9 13.4 0.0 0.2 0.9 0.2 0.0 0.0 0.0 2.4 0.0 0.6 26.3 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.1 1.2 0.0 0.2 1.4 0.9 0.0 0.6 0.5 0.7 0.7 0.6 0.5 2.8 0.4 0.3 0.1 0.0 0.3 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.5 0.3 0.3 0.0 0.2 0.0 4.9 0.0 0.6 0.7 15.2 1.5 0.5 0.1 0.0 1.2 1.3 1.3 0.1 5.7 0.1 80.9 0.0 0.1 0.3 0.1 352.1 0.2 4.1 0.3 1.7 28.8 0.0 0.0 2.1 0.4 0.0 8.2 0.0 0.5 0.0 0.2 8.9 361.1 0.1 5.0 1.1 0.0 0.0 8.1 2.6 6.7 2.5 16.6 0.0 1.9 0.0 1.4 0.0 0.5 0.1 0.2 0.0 0.4 0.1 0.5 0.0 3197.2 0.9 1.7 0.0 0.1 4.3 0.7 0.4 0.2 2.3 0.0 7.3 2.4 0.1 0.3 RC3H1 "KIAA2025, RNF198, roquin, RP5-1198E17.5" ENSG00000135870 "Ring finger and CCCH-type domains 1" Q5TC82 1 173931084-174022357 "Enzymes, Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027428, HPA027434, HPA027448" Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 1: K-562 - Erythropoiesis" "Cluster 44: Endometrium - Transcription" Cytosol "Golgi apparatus, Plasma membrane" "HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683" "unprognostic (6.91e-2)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" "unprognostic (2.33e-2)" "unprognostic (7.73e-2)" "unprognostic (1.61e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" "unprognostic (2.04e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (5.25e-2)" "unprognostic (2.15e-1)" "unprognostic (3.43e-3)" "unprognostic (6.83e-3)" 4.8 3.8 2.6 4.2 4.7 19.6 5.2 16.0 5.1 4.9 11.4 5.2 3.4 4.5 4.0 6.1 4.8 4.0 4.6 3.1 5.8 3.9 5.8 5.9 4.9 3.5 3.5 5.1 4.8 3.9 4.6 4.3 4.0 4.2 4.2 8.0 4.4 3.5 10.6 7.4 5.5 3.7 2.0 6.7 4.6 5.3 4.1 5.0 5.0 10.3 5.6 4.5 5.1 7.2 6.6 9.1 4.9 7.7 9.2 7.1 6.8 4.4 6.3 5.0 4.4 8.4 7.3 9.4 7.7 7.2 3.9 6.2 7.5 6.3 7.0 6.6 1.8 8.1 6.8 7.0 5.6 10.7 9.1 6.8 4.8 7.3 4.9 4.6 7.9 4.5 9.4 5.6 6.2 5.0 6.5 9.6 8.5 6.1 1.0 7.0 8.8 6.9 8.9 12.7 5.9 5.3 8.4 10.7 4.3 8.2 7.2 10.7 11.4 6.5 6.5 5.6 5.8 6.9 7.5 11.8 4.4 4.8 6.7 3.4 1.9 2.7 1.1 1.9 1.2 1.5 1.1 1.3 1.0 1.8 1.5 1.3 6.4 1.4 2.6 0.8 0.9 0.7 2.6 4.7 16.0 5.1 3.1 5.8 3.5 3.5 4.0 2.0 4.1 7.2 39.8 41.7 34.5 32.0 49.4 34.4 17.3 14.1 60.9 35.6 53.6 28.3 25.7 25.8 20.0 23.9 81.3 10.6 70.2 37.4 9.8 25.4 13.3 77.5 45.9 32.0 34.2 30.7 46.8 18.9 8.2 34.9 68.8 82.9 15.8 20.3 34.2 36.3 11.5 38.7 43.5 28.9 16.2 37.2 48.2 8.1 15.8 38.5 30.2 40.3 33.0 22.7 30.9 42.3 68.2 24.8 22.1 10.5 52.2 38.3 25.1 9.8 30.2 47.3 19.7 39.0 31.5 35.8 14.0 66.8 40.9 11.6 41.4 16.1 25.9 38.5 RCBTB2 CHC1L ENSG00000136161 "RCC1 and BTB domain containing protein 2" O95199 13 48488963-48533256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 9 "MOLT-4: 278.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040242 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Golgi apparatus" "HPA040242: AB_10795362" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (8.47e-2)" "unprognostic (9.47e-3)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-1)" "unprognostic (5.40e-3)" "unprognostic (8.28e-3)" "unprognostic (1.20e-1)" "unprognostic (4.85e-2)" "unprognostic (3.60e-1)" "prognostic favorable (2.45e-4)" "unprognostic (1.06e-2)" "unprognostic (8.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.98e-1)" 12.9 11.1 10.0 12.9 11.2 5.2 10.8 11.1 13.9 15.6 17.4 8.9 5.3 15.0 12.3 13.0 12.9 12.3 12.5 9.5 13.2 16.6 9.5 10.5 11.3 11.9 11.7 19.9 6.8 6.6 13.4 17.7 12.5 13.5 8.0 8.3 23.3 19.9 7.0 5.4 7.2 13.7 13.0 17.4 8.8 7.1 10.8 11.8 27.5 10.8 10.7 11.5 12.4 14.4 1.5 1.2 22.0 1.4 17.1 15.1 0.0 6.8 8.4 4.0 3.0 0.8 1.4 4.7 5.0 10.7 2.7 3.1 3.2 2.8 4.6 5.7 4.3 12.2 3.2 1.2 6.6 5.6 7.4 15.6 6.5 5.3 2.6 9.2 12.3 29.8 0.9 7.1 14.6 0.5 278.7 15.6 12.3 0.5 3.7 23.9 2.2 20.3 7.5 3.7 5.1 4.3 5.3 1.1 8.7 9.1 0.5 14.2 10.3 4.6 2.0 1.2 2.7 0.3 0.4 5.7 2.7 12.5 9.1 4.6 39.8 4.6 14.0 28.8 8.7 1.1 11.4 14.2 27.1 1.1 6.6 10.2 55.0 15.5 27.9 0.5 15.5 20.5 10.0 11.2 11.1 13.9 9.5 13.2 11.9 11.7 12.5 13.0 10.8 14.4 23.1 3.2 3.3 9.1 5.5 6.1 11.6 9.5 21.1 1.9 4.9 9.3 16.1 4.3 9.8 5.5 2.1 1.4 20.7 1.3 7.9 1.2 9.0 5.1 6.6 19.7 8.3 6.1 12.3 0.8 1.4 11.6 2.6 5.0 8.8 9.9 24.7 5.2 25.0 1.7 17.0 2.2 2.0 26.6 24.4 8.1 9.3 30.6 8.8 66.5 38.3 33.7 24.7 6.6 13.2 1.3 1.6 14.3 17.4 6.0 0.7 11.2 6.9 4.9 13.1 14.9 14.1 9.6 4.4 12.6 5.7 1.0 24.0 11.9 2.4 6.7 RELN "PRO1598, RL" ENSG00000189056 Reelin P78509 7 103471381-103989658 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein, Hydrolase, Protease, Serine protease" "Disease variant, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 64.4" "Group enriched" "Detected in some" 8 "Hepatic stellate cells: 128.5;Inhibitory neurons: 372.4" "Cancer enhanced" "Detected in many" "liver cancer: 5.7" "Region enriched" "Detected in many" 10 "cerebellum: 64.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.2;PC-3: 8.6;SCLC-21H: 11.1;SH-SY5Y: 13.7;TIME: 33.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 110.0" HPA077891 Approved "Golgi apparatus,Vesicles" "Secreted in brain" NA NA 30000000 "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Vesicles "HPA077891: " "unprognostic (1.42e-1)" "unprognostic (2.93e-3)" "unprognostic (4.31e-2)" "unprognostic (1.29e-4)" "unprognostic (1.30e-1)" "unprognostic (6.95e-2)" "unprognostic (1.85e-1)" "unprognostic (8.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-2)" "unprognostic (3.31e-3)" "unprognostic (3.86e-1)" "unprognostic (2.02e-2)" "unprognostic (1.43e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.06e-2)" 1.3 1.8 2.0 0.6 1.8 0.0 2.7 64.4 3.8 1.5 0.6 0.8 0.2 0.4 0.1 0.8 2.8 0.7 1.7 3.3 6.4 0.4 13.4 0.5 0.4 2.6 4.2 0.4 0.1 0.0 0.5 0.0 6.3 0.6 0.9 2.9 0.8 0.9 0.2 0.6 0.9 0.7 3.9 0.3 0.5 0.7 0.5 0.0 1.7 1.1 0.2 0.7 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 2.1 0.0 0.1 0.0 0.0 4.3 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 1.9 0.0 0.0 0.0 11.1 13.7 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.8 64.4 3.8 3.3 6.4 2.6 4.2 6.3 3.9 0.5 0.5 1.0 0.0 0.0 9.1 0.5 0.6 0.0 0.0 0.6 30.2 0.5 0.4 5.1 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 13.6 0.1 0.0 8.3 0.0 7.0 2.6 1.2 0.1 7.5 0.0 0.1 0.0 0.0 128.5 3.3 0.2 0.0 372.4 0.0 0.0 5.3 2.2 6.1 0.0 0.1 0.0 2.8 0.0 0.2 0.0 3.0 10.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.8 0.7 0.1 0.8 0.0 0.6 0.3 0.4 0.0 0.0 0.0 RER1 ENSG00000157916 "Retention in endoplasmic reticulum sorting receptor 1" O15258 1 2391775-2405442 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037240, HPA051400" Supported Supported "Golgi apparatus" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" "CAB037240: AB_2179604, HPA051400: AB_2681469" "unprognostic (2.90e-2)" "unprognostic (3.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.23e-8)" "unprognostic (1.01e-1)" "unprognostic (5.41e-2)" "unprognostic (1.06e-1)" "unprognostic (3.27e-2)" 100.4 154.2 60.0 89.3 67.6 81.6 97.1 67.0 62.8 93.6 78.3 137.4 114.8 74.4 122.7 176.4 86.1 86.9 75.7 61.1 64.1 106.3 224.8 79.6 94.6 67.0 65.1 92.9 122.3 100.9 82.9 99.0 66.9 94.3 151.4 73.8 101.1 104.2 105.2 101.7 120.0 104.6 65.6 102.2 118.6 107.1 68.5 94.5 85.9 85.1 143.5 101.0 106.5 76.1 203.1 111.0 131.1 146.8 233.7 275.7 100.9 297.1 261.1 254.3 253.2 157.6 299.3 143.9 242.7 297.7 205.1 213.3 152.2 176.7 322.2 180.8 156.1 163.9 247.2 153.0 252.5 181.3 188.6 225.0 176.1 264.3 233.1 175.4 235.8 160.3 197.8 232.6 299.8 141.5 127.2 127.3 87.5 314.1 279.0 146.0 131.9 183.7 227.5 94.3 109.9 126.2 167.9 376.9 242.9 143.7 149.6 127.4 171.8 197.3 114.1 355.9 219.5 223.0 270.2 255.3 209.6 254.8 102.8 239.1 235.5 284.5 195.9 268.2 180.0 169.0 169.8 210.0 221.2 151.7 127.0 155.9 351.3 164.8 275.9 256.1 244.5 309.0 60.0 67.6 67.0 62.8 61.1 64.1 67.0 65.1 66.9 65.6 68.5 76.1 88.7 64.1 50.0 23.5 73.1 53.2 84.4 214.2 50.1 33.6 111.9 123.6 41.6 118.7 131.4 104.8 33.3 233.8 97.5 218.9 66.5 213.4 475.6 89.5 93.5 68.2 36.5 57.2 16.7 258.4 321.8 94.3 71.9 118.8 44.3 76.5 82.1 233.5 217.9 37.0 16.8 158.6 122.1 104.3 73.2 464.0 82.6 99.9 62.2 15.9 126.1 97.0 114.4 19.1 25.8 256.4 195.4 76.0 145.1 142.5 238.7 119.6 136.3 62.6 111.7 60.9 141.6 291.4 145.2 103.4 67.1 467.9 74.3 159.0 162.0 141.0 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077064-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8" "Group enriched" "Detected in some" 4 "Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "midbrain: 53.3;spinal cord: 19.4" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" No NA 2100000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 20.8 1.0 1.3 0.9 0.4 1.1 5.1 5.6 1.0 0.2 3.4 1.4 0.6 0.3 0.4 0.5 0.6 2.2 0.3 5.5 0.9 3.0 0.4 0.6 14.4 27.3 0.4 1.3 31.8 5.3 0.5 12.0 1.8 1.4 4.7 5.1 2.0 5.9 0.9 1.4 1.0 4.8 0.2 2.2 2.7 7.6 1.6 0.8 3.1 0.2 0.6 1.4 5.8 0.1 0.4 0.1 1.7 0.0 0.0 0.1 0.7 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 5.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.6 0.0 42.2 7.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 329.3 0.1 0.0 0.1 0.5 4.1 95.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.0 1.0 0.9 5.1 5.6 0.3 5.5 14.4 27.3 12.0 4.8 7.6 5.8 0.4 0.0 0.5 1.6 0.0 0.3 0.8 0.0 0.0 1.7 6.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 1.5 0.0 0.3 1.1 0.0 0.0 4.2 0.2 2.3 6.8 0.0 0.0 1.3 0.5 0.0 1.2 0.1 79.1 8.6 1.9 26.4 0.0 0.6 1.5 0.3 0.5 0.0 1.0 0.0 0.8 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 1.7 0.0 23.1 1.2 1.1 4.7 0.0 0.6 0.0 0.2 0.3 0.2 0.1 RFC2 "A1, RFC40" ENSG00000049541 "Replication factor C subunit 2" P35250 7 74231499-74254458 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029493 Approved Supported "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus" "HPA029493: AB_10603991" "unprognostic (1.25e-1)" "prognostic favorable (9.91e-4)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (2.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.09e-7)" "unprognostic (2.22e-1)" "unprognostic (6.65e-2)" "unprognostic (3.61e-2)" "unprognostic (2.59e-1)" 12.2 9.5 10.6 13.4 10.9 27.4 15.5 11.4 11.5 12.6 11.1 13.4 9.0 9.6 8.4 18.6 10.1 8.6 10.1 10.5 10.9 14.7 21.2 11.3 23.5 11.7 11.3 11.3 13.3 11.8 7.9 18.4 11.4 11.5 15.0 8.8 12.2 7.6 18.8 20.3 11.2 12.6 11.5 14.2 13.6 10.0 10.7 20.2 9.2 12.2 30.8 11.5 12.6 11.8 74.3 55.6 65.2 64.6 13.1 15.2 29.4 42.5 46.7 85.2 101.4 62.6 67.3 69.2 11.5 30.7 78.7 49.7 53.3 69.2 87.5 49.6 91.5 42.9 76.4 46.7 10.1 64.6 25.3 15.4 15.9 79.8 55.0 18.5 46.0 63.9 89.4 41.9 66.4 87.2 65.1 124.7 74.1 116.3 47.4 95.0 72.0 85.8 45.7 58.1 52.4 65.5 50.7 94.8 34.7 79.2 68.7 58.0 17.4 83.4 54.9 64.6 96.3 25.1 35.1 120.6 42.4 98.4 89.3 33.4 36.7 27.3 18.0 42.3 18.1 31.6 15.5 16.5 31.9 36.8 19.5 14.3 46.4 42.9 40.1 17.1 23.9 29.1 10.6 10.9 11.4 11.5 10.5 10.9 11.7 11.3 11.4 11.5 10.7 11.8 15.4 12.8 11.1 2.6 19.0 23.8 24.3 24.3 19.9 13.2 12.6 17.4 6.1 5.7 16.5 5.5 2.1 68.6 17.5 12.4 5.9 21.0 2.8 8.1 13.3 13.5 4.8 38.3 3.0 19.0 65.0 17.4 10.7 11.5 23.4 25.1 13.6 14.0 37.7 3.3 2.6 13.1 20.3 14.4 28.2 2.5 8.7 18.2 21.4 1.9 26.3 16.1 23.7 1.5 2.2 13.8 6.9 10.9 17.5 11.0 13.2 13.8 8.8 9.5 6.6 14.6 17.5 33.8 44.6 20.1 17.0 46.1 16.9 12.9 19.1 15.3 RFK "FLJ11149, RIFK" ENSG00000135002 "Riboflavin kinase" Q969G6 9 76385526-76394517 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 352.0;Pancreatic endocrine cells: 220.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023259, CAB033887, HPA057163" Approved Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 45: Intestine - Brush border" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357" "unprognostic (1.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-3)" "unprognostic (8.61e-3)" "unprognostic (3.11e-1)" "unprognostic (1.39e-1)" "unprognostic (2.88e-1)" "unprognostic (1.02e-1)" "unprognostic (4.61e-2)" "unprognostic (1.22e-3)" "unprognostic (3.22e-2)" "unprognostic (1.83e-1)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" 11.6 20.6 18.0 14.6 18.4 25.0 11.7 12.6 21.1 11.7 12.5 30.8 33.1 12.8 18.2 12.9 13.6 19.9 16.3 20.6 27.2 27.0 29.2 12.4 11.6 16.9 18.4 11.7 16.4 23.8 12.0 13.2 27.0 13.0 22.9 14.7 11.0 9.9 14.9 5.1 28.2 11.9 14.2 10.2 29.0 16.7 21.6 12.0 19.7 18.7 11.2 13.9 5.9 13.5 21.9 23.2 13.9 18.1 20.5 20.3 41.8 25.2 18.6 17.8 13.9 8.2 13.3 35.3 28.7 18.2 32.3 22.9 19.3 16.5 35.3 10.4 18.0 11.2 30.4 26.2 36.7 37.9 25.6 13.5 29.3 21.4 23.2 19.9 58.3 30.4 30.6 28.7 36.1 20.8 49.3 13.3 18.1 51.2 22.7 26.7 18.3 8.9 82.0 10.6 35.0 12.7 26.9 37.2 22.9 18.1 9.4 20.2 35.9 18.5 33.3 40.1 35.6 30.7 32.3 12.4 30.7 33.3 25.9 5.2 9.8 3.6 5.0 19.9 7.5 5.8 7.3 6.0 11.8 4.4 7.0 6.7 1.4 8.5 21.1 4.3 7.4 9.8 18.0 18.4 12.6 21.1 20.6 27.2 16.9 18.4 27.0 14.2 21.6 13.5 27.3 16.0 9.2 5.9 22.9 45.4 23.8 15.3 22.2 50.4 24.5 20.6 37.9 34.3 20.1 42.3 20.9 54.1 18.4 158.8 60.7 64.9 191.7 37.8 18.5 46.2 28.2 48.8 18.0 189.3 352.0 33.5 33.1 42.3 12.0 18.0 124.2 40.9 33.2 11.8 19.3 23.1 40.7 57.6 26.6 118.1 22.1 29.9 30.2 10.3 25.2 44.7 9.2 7.1 6.5 220.6 68.3 65.1 12.7 33.6 79.9 142.8 27.7 28.7 0.0 23.0 21.7 91.8 64.1 18.8 40.5 123.5 23.1 18.8 33.7 22.6 RFLNA "Cfm2, FAM101A, FLJ44614, RefilinA" ENSG00000178882 "Refilin A" Q6ZTI6 12 123973241-124316024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "stomach 1: 94.7" "Cell type enriched" "Detected in some" 22 "Pancreatic endocrine cells: 113.9" "Cancer enhanced" "Detected in many" "stomach cancer: 19.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTEC/SVTERT24-B: 13.8;HUVEC TERT2: 19.8;LHCN-M2: 34.8;OE19: 37.0;RH-30: 11.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA058911, HPA078021" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 4: Stomach - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm "Golgi apparatus" "HPA058911: AB_2683853, HPA078021: AB_2732368" "unprognostic (1.71e-1)" "unprognostic (6.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (3.15e-2)" "unprognostic (8.78e-4)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.16e-5)" "unprognostic (8.87e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-3)" "unprognostic (1.15e-3)" "unprognostic (1.77e-8)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" 3.4 1.1 3.2 2.2 3.8 0.0 1.8 5.7 3.2 10.2 5.4 15.2 13.9 1.7 0.4 0.6 2.9 0.6 0.7 2.7 3.4 2.4 0.1 1.2 0.2 19.1 4.2 2.9 0.3 0.3 2.1 0.6 19.4 4.3 10.4 0.3 2.2 0.3 5.5 1.3 15.2 0.5 3.9 0.1 94.7 0.2 3.7 0.2 0.1 3.2 0.1 0.5 1.3 3.4 0.0 0.0 2.7 0.0 0.0 0.0 3.5 0.0 0.0 0.4 0.4 1.8 1.3 0.0 0.1 4.9 0.2 0.0 2.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.2 0.8 0.0 13.8 0.1 0.8 19.8 2.1 0.0 0.0 34.8 0.0 0.1 0.0 2.9 37.0 0.0 0.0 11.1 0.2 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.8 5.7 3.2 2.7 3.4 19.1 4.2 19.4 3.9 3.7 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 0.0 0.1 0.5 0.1 0.0 0.0 0.0 2.6 0.1 0.6 0.0 0.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 RFX2 FLJ14226 ENSG00000087903 "Regulatory factor X2" P48378 19 5993164-6199572 "Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 56.9" "Cell type enhanced" "Detected in many" "Astrocytes: 84.2;Early spermatids: 163.7;Late spermatids: 196.2;Respiratory ciliated cells: 103.8;Spermatocytes: 113.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "neutrophil: 23.6" "Lineage enriched" "Detected in many" 9 "granulocytes: 23.6" "Cell line enhanced" "Detected in many" "HMC-1: 19.4;SCLC-21H: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048969 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA048969: AB_2680577" "unprognostic (1.31e-1)" "prognostic favorable (2.80e-4)" "unprognostic (6.72e-2)" "prognostic favorable (2.67e-4)" "unprognostic (1.37e-1)" "unprognostic (4.15e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.86e-2)" "unprognostic (3.84e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" 9.8 2.0 9.0 2.2 8.0 9.5 6.9 12.1 8.1 5.9 35.2 19.4 3.3 16.2 1.2 8.0 20.8 5.0 7.8 10.4 8.7 2.2 1.7 10.5 1.5 15.5 21.2 6.7 4.4 1.8 10.4 0.9 12.7 6.0 1.8 1.3 3.2 2.3 2.0 11.2 8.8 5.3 15.4 2.9 7.0 56.9 12.7 4.2 3.5 0.6 1.6 9.6 6.3 11.7 5.3 3.9 6.2 12.3 3.2 1.9 3.9 3.3 4.3 2.6 4.1 1.8 6.0 5.7 3.4 4.1 5.7 7.6 1.6 6.2 3.6 1.4 0.9 8.8 4.0 1.8 3.6 4.1 19.4 2.2 5.3 5.8 3.0 3.1 4.0 7.7 6.0 0.2 2.6 2.6 7.7 5.5 1.7 6.8 2.6 2.1 3.9 0.6 3.3 9.5 24.2 3.4 3.0 2.4 1.7 0.6 4.2 4.3 6.1 1.1 5.6 4.3 3.3 8.2 2.9 3.3 3.2 14.4 2.3 0.0 2.7 1.1 0.1 0.5 0.0 0.4 0.5 0.3 2.1 0.2 0.5 0.6 23.6 0.7 1.6 0.0 0.1 0.8 9.0 8.0 12.1 8.1 10.4 8.7 15.5 21.2 12.7 15.4 12.7 11.7 12.0 25.6 31.6 84.2 2.6 26.4 33.7 11.5 12.5 3.6 8.5 10.9 7.6 15.7 26.0 3.7 2.1 5.9 2.0 4.1 3.9 5.6 163.7 69.0 9.5 13.2 13.8 6.5 5.2 1.8 8.8 23.0 2.6 4.7 46.2 14.7 12.1 2.8 7.0 0.0 5.5 4.4 2.0 6.2 17.3 196.2 8.1 13.0 7.2 8.4 5.1 5.7 5.2 3.0 1.8 3.5 1.6 4.1 2.4 7.9 4.6 2.1 103.8 3.5 26.3 49.2 11.4 113.2 13.5 6.3 22.0 5.6 5.6 2.6 5.1 22.0 RGL1 RGL ENSG00000143344 "Ral guanine nucleotide dissociation stimulator like 1" Q9NZL6 1 183636085-183928532 "Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 133.5;Excitatory neurons: 176.1;Inhibitory neurons: 141.8;Kupffer cells: 109.1;Oligodendrocytes: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 35.0;HSkMC: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019788 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA019788: AB_1856215" "unprognostic (3.08e-1)" "unprognostic (5.25e-3)" "unprognostic (8.73e-2)" "unprognostic (1.24e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.49e-5)" "prognostic favorable (4.32e-4)" "unprognostic (1.12e-1)" "unprognostic (6.34e-2)" "unprognostic (5.77e-3)" "unprognostic (4.59e-2)" "unprognostic (2.63e-3)" "unprognostic (4.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (2.88e-2)" 24.7 16.8 22.7 19.9 25.3 1.6 17.1 17.3 27.0 18.6 21.5 11.3 8.7 18.0 6.3 10.6 15.2 22.5 17.0 27.1 21.7 28.6 16.2 20.9 22.9 23.7 20.7 19.2 6.8 8.9 9.5 16.1 17.4 13.2 12.8 15.7 7.7 11.6 2.7 8.9 10.6 22.2 21.1 45.4 6.9 14.7 23.9 8.7 9.1 7.7 10.1 18.7 8.9 28.5 0.3 1.5 26.3 4.0 35.0 16.1 26.7 12.4 20.6 5.5 6.8 12.2 0.7 0.3 11.3 8.8 4.3 0.6 1.8 3.1 5.4 0.4 1.9 0.2 2.6 12.6 9.3 0.4 1.5 54.9 0.7 14.0 3.3 26.2 20.8 2.7 0.0 19.6 11.8 0.1 2.9 0.2 9.6 0.9 0.7 23.7 1.7 24.3 1.5 7.5 3.3 7.9 3.9 4.2 2.1 8.5 0.2 0.3 15.3 7.9 3.1 24.7 6.8 2.0 0.5 0.1 8.3 0.3 22.2 0.0 0.8 0.0 0.0 2.1 0.1 0.0 0.3 0.0 0.9 0.0 0.4 0.2 0.0 0.0 0.8 0.0 0.2 0.5 22.7 25.3 17.3 27.0 27.1 21.7 23.7 20.7 17.4 21.1 23.9 28.5 9.4 9.6 12.3 133.5 1.6 8.2 2.2 2.5 5.2 5.1 6.7 4.6 8.7 5.7 9.0 5.5 0.0 5.1 0.6 2.6 5.9 4.0 13.8 7.9 23.2 19.7 0.0 0.4 176.1 0.9 2.6 22.0 3.6 24.1 3.8 11.0 41.4 2.6 43.3 8.4 141.8 0.8 4.1 109.1 50.4 17.6 13.1 43.7 5.4 76.8 1.7 23.0 0.0 38.7 184.3 1.0 0.1 20.7 0.1 3.5 2.8 30.1 14.2 2.0 26.3 1.2 9.7 4.0 2.5 5.8 4.7 5.2 2.2 13.1 0.6 2.9 RGS18 RGS13 ENSG00000150681 "Regulator of G protein signaling 18" Q9NS28 1 192158462-192185815 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.2;lymphoid tissue: 25.4" "Cell type enriched" "Detected in some" 4 "Macrophages: 527.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 353.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 353.1" "Group enriched" "Detected in some" 5 "HEL: 60.2;HL-60: 46.7;NB-4: 43.6;U-937: 39.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA028727, HPA045780" Uncertain Approved "Golgi apparatus" NA NA 340000 "Cluster 2: Granulocytes - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus" "HPA028727: AB_2797219, HPA045780: AB_10962728" "unprognostic (3.09e-2)" "unprognostic (4.32e-2)" "unprognostic (8.66e-2)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-2)" "unprognostic (1.48e-1)" "unprognostic (2.18e-2)" "unprognostic (2.58e-1)" "unprognostic (1.87e-1)" "unprognostic (3.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.30e-3)" "unprognostic (8.21e-3)" "unprognostic (2.81e-4)" "unprognostic (1.73e-2)" "unprognostic (9.91e-2)" 4.3 2.3 0.7 14.1 0.6 13.2 2.3 0.9 0.7 2.4 0.9 2.4 2.9 1.0 0.5 1.9 1.3 5.3 0.8 0.6 1.2 1.0 5.3 4.1 8.4 1.5 1.0 0.8 0.8 0.4 0.3 2.2 1.5 1.1 2.9 0.6 0.7 1.0 0.9 0.4 5.8 2.9 1.3 25.4 1.9 0.4 0.8 4.2 0.8 3.1 4.4 4.8 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 39.9 0.0 195.5 50.7 353.1 0.8 66.7 6.8 0.1 0.8 1.3 51.0 0.2 0.1 0.2 164.8 0.6 82.1 12.0 0.0 94.4 0.7 0.6 0.9 0.7 0.6 1.2 1.5 1.0 1.5 1.3 0.8 1.6 0.3 6.4 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.4 0.0 1.8 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 16.0 0.0 0.0 0.0 0.8 0.0 0.0 24.7 0.0 5.7 1.1 7.3 0.0 0.0 0.0 0.0 124.9 27.3 0.8 0.3 527.4 0.0 15.9 128.3 0.1 28.8 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.3 1.5 0.3 13.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 7.6 0.0 0.1 0.0 RHBDD2 "NPD007, RHBDL7" ENSG00000005486 "Rhomboid domain containing 2" Q6NTF9 7 75842602-75888926 "Enzymes, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 380.1" "Cell type enhanced" "Detected in all" "Late spermatids: 300.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 398.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 165.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045074, HPA051960" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA045074: AB_10965705, HPA051960: AB_2681673" "unprognostic (2.75e-1)" "unprognostic (3.89e-2)" "prognostic unfavorable (3.31e-5)" "unprognostic (9.79e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (2.05e-2)" "unprognostic (1.18e-2)" "unprognostic (2.37e-3)" "unprognostic (1.55e-1)" "unprognostic (2.75e-1)" "unprognostic (5.11e-2)" "unprognostic (1.87e-2)" "prognostic favorable (8.68e-6)" "unprognostic (3.73e-1)" "unprognostic (6.53e-2)" "unprognostic (1.89e-1)" "unprognostic (1.03e-1)" 43.9 232.5 247.5 20.0 248.6 26.9 47.7 169.0 313.0 46.7 224.2 39.4 35.7 36.4 59.3 48.5 47.0 23.2 54.7 255.0 380.1 97.7 99.8 72.0 16.2 216.3 252.8 61.2 56.8 182.8 299.6 16.5 274.5 79.0 16.0 39.1 53.3 94.8 35.0 49.4 44.9 11.8 187.5 50.2 57.6 87.2 321.2 19.9 91.1 11.6 12.5 45.3 43.6 208.3 24.0 80.2 34.5 57.9 16.3 11.5 12.8 12.8 50.6 26.6 27.2 43.6 59.7 7.5 13.0 26.3 59.4 33.7 22.4 17.6 10.3 25.9 46.3 9.0 48.0 41.4 45.0 13.8 61.5 25.0 35.7 31.1 12.3 43.9 20.4 51.2 19.0 51.6 26.9 165.3 26.1 74.9 31.7 41.0 45.1 19.4 22.7 66.8 47.2 42.9 43.3 88.7 59.3 107.8 47.9 23.2 66.3 23.2 20.4 43.5 39.6 29.2 27.9 48.4 18.5 12.9 50.4 20.4 59.9 398.8 62.8 79.0 80.0 66.1 68.9 51.7 89.1 71.7 63.0 50.8 72.5 65.3 104.7 63.6 35.1 49.7 126.8 61.2 247.5 248.6 169.0 313.0 255.0 380.1 216.3 252.8 274.5 187.5 321.2 208.3 20.5 41.7 31.9 16.6 23.7 23.2 46.5 127.6 18.2 34.9 42.3 22.4 8.8 55.8 76.8 86.5 33.3 54.8 20.7 48.3 19.6 94.1 171.2 30.2 12.8 26.9 89.8 10.3 27.0 102.1 41.3 34.7 39.8 16.2 192.7 72.4 57.8 43.1 45.5 18.5 31.9 35.1 128.1 35.9 32.7 300.8 42.6 47.8 60.5 5.6 21.4 68.8 29.9 13.0 11.0 78.1 37.6 52.6 27.9 47.8 52.8 52.5 89.3 35.7 6.6 19.0 26.4 57.3 29.7 27.9 23.7 52.0 61.2 198.1 30.2 50.1 RHOF "ARHF, FLJ20247, RIF" ENSG00000139725 "Ras homolog family member F, filopodia associated" Q9HBH0 12 121777754-121803403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 273.9;Langerhans cells: 224.9;monocytes: 241.2;Pancreatic endocrine cells: 191.7;Paneth cells: 279.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 129.0;HDLM-2: 177.1;PC-3: 147.3;RPTEC TERT1: 127.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045912, HPA076019" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA045912: , HPA076019: AB_2732299" "unprognostic (1.26e-1)" "unprognostic (8.73e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "unprognostic (4.26e-5)" "unprognostic (1.38e-3)" "unprognostic (2.37e-4)" "unprognostic (1.34e-1)" "unprognostic (5.51e-2)" "unprognostic (1.10e-4)" "unprognostic (1.10e-1)" "unprognostic (5.01e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-2)" "unprognostic (7.51e-4)" "unprognostic (1.14e-1)" 6.5 13.3 11.5 26.6 9.9 47.4 5.5 21.6 12.0 14.3 10.6 24.3 31.8 13.2 21.8 11.7 10.0 9.8 15.0 10.4 11.0 16.2 3.9 20.6 41.0 13.0 12.2 8.9 6.1 7.7 5.1 5.7 13.4 9.2 19.3 9.9 11.5 9.8 11.8 9.2 32.3 11.5 8.7 33.3 28.2 9.0 10.6 25.6 14.6 2.8 31.4 9.1 7.3 11.7 58.3 69.2 12.4 15.3 4.4 6.4 5.6 5.3 5.2 2.5 4.4 28.8 129.0 6.3 42.6 6.0 1.4 8.6 23.2 33.7 2.2 177.1 8.0 37.9 47.5 27.7 10.1 38.6 25.8 9.0 7.5 5.4 2.9 23.8 17.6 44.7 5.6 9.9 1.4 41.7 50.7 56.7 10.4 13.6 147.3 26.5 0.7 10.8 127.9 4.9 9.9 9.4 38.5 4.5 2.6 5.6 19.9 15.0 21.4 4.0 40.1 12.5 1.5 12.3 7.6 20.0 5.0 42.9 2.6 23.8 10.9 41.5 97.0 36.5 92.7 55.5 77.2 82.5 31.0 45.2 59.5 73.2 24.4 61.4 69.8 74.3 90.2 43.3 11.5 9.9 21.6 12.0 10.4 11.0 13.0 12.2 13.4 8.7 10.6 11.7 3.1 38.5 10.7 1.0 54.1 8.7 1.9 5.5 3.4 8.1 9.3 3.8 1.5 15.7 11.3 23.9 0.0 2.7 111.8 273.9 41.1 34.0 20.2 16.5 5.6 3.5 6.7 12.2 5.3 55.3 3.9 5.3 50.4 37.1 20.8 13.1 10.0 4.0 14.4 0.0 3.9 28.6 2.0 10.9 224.9 53.8 4.1 40.3 21.4 3.7 241.2 4.7 103.0 1.0 1.2 191.7 279.6 2.2 39.4 3.8 121.6 15.1 13.5 9.7 6.6 2.6 4.5 17.7 2.9 2.5 13.2 5.5 99.2 23.4 17.3 44.3 RHOH "ARHH, TTF" ENSG00000168421 "Ras homolog family member H" Q15669 4 40191053-40246967 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 62.9;lymphoid tissue: 98.2" "Cell type enhanced" "Detected in many" "B-cells: 273.0;dendritic cells: 90.5;granulocytes: 141.8;NK-cells: 64.9;Plasma cells: 183.1;T-cells: 223.6" "Cancer enhanced" "Detected in many" "breast cancer: 4.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 126.3;HMC-1: 92.5;JURKAT: 123.7;MOLT-4: 179.4;U-266/70: 65.5;U-266/84: 56.8;U-698: 116.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030345, HPA061314" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus, Vesicles" "HPA030345: AB_10601607, HPA061314: " "unprognostic (4.00e-2)" "unprognostic (1.83e-4)" "unprognostic (1.24e-2)" "unprognostic (2.22e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-3)" "unprognostic (1.16e-1)" "unprognostic (2.73e-2)" "unprognostic (2.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.07e-2)" "unprognostic (1.38e-1)" "unprognostic (3.31e-6)" "unprognostic (2.96e-1)" "unprognostic (3.91e-2)" "unprognostic (4.46e-2)" "unprognostic (2.44e-2)" 2.2 0.9 0.7 36.4 0.6 62.9 13.2 0.5 0.8 2.9 0.6 6.3 4.8 1.6 0.9 2.9 1.5 6.4 0.7 0.6 0.8 1.2 2.7 5.7 86.0 1.1 1.3 0.9 1.4 0.4 0.7 0.9 0.9 2.7 5.6 0.0 3.9 0.9 0.6 1.2 20.6 1.5 1.0 42.6 8.2 0.7 0.8 98.2 1.8 0.3 85.2 10.6 1.6 1.0 0.2 0.4 0.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 126.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 2.6 0.0 18.8 0.1 0.0 0.0 21.1 92.5 1.5 0.0 0.0 0.0 0.1 0.1 123.7 1.4 1.2 0.0 0.0 179.4 13.3 2.3 0.0 0.4 19.1 0.3 4.3 0.0 0.0 0.1 0.1 0.3 0.8 0.2 0.1 5.7 0.5 0.5 0.0 0.5 0.1 0.2 65.5 56.8 116.3 0.1 4.4 0.1 210.3 1.1 168.7 112.2 0.8 99.3 164.3 176.9 151.1 1.9 212.1 274.3 220.5 8.4 74.2 1.2 26.1 268.4 124.1 0.7 0.6 0.5 0.8 0.6 0.8 1.1 1.3 0.9 1.0 0.8 1.0 2.9 3.2 9.9 0.3 273.0 7.1 1.4 0.3 1.8 0.0 11.1 6.7 1.1 1.5 2.9 0.0 0.0 0.1 90.5 0.3 0.0 0.1 0.6 0.6 0.5 2.3 0.0 23.4 0.3 0.0 0.2 3.6 9.7 1.0 141.8 0.0 1.8 0.2 2.2 0.0 0.3 0.4 0.0 4.4 16.2 0.7 0.0 28.4 56.9 8.4 11.3 0.0 64.9 0.5 0.1 0.0 0.1 0.0 183.1 1.4 0.0 0.4 1.0 0.0 0.0 2.0 2.0 0.3 0.2 0.3 7.0 0.3 223.6 0.1 0.3 2.0 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;parathyroid gland: 24.6;pituitary gland: 32.2" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 75.5;Excitatory neurons: 128.2;Inhibitory neurons: 191.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 28.9;SH-SY5Y: 55.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: AB_2678815" "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.6 14.5 6.3 0.9 11.3 0.2 0.2 0.0 17.5 7.2 17.3 1.5 2.9 2.7 2.5 0.5 7.8 0.9 0.0 25.9 19.2 5.9 0.2 0.4 0.1 1.7 19.6 2.1 2.5 24.6 32.2 0.0 20.6 1.1 1.8 11.2 0.3 1.3 0.2 2.7 2.5 2.4 0.1 1.0 5.9 2.6 0.9 0.3 0.6 3.9 0.1 0.3 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.0 0.4 7.3 0.0 0.0 28.9 55.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 11.3 0.0 17.5 25.9 19.2 1.7 19.6 20.6 0.1 0.9 2.7 0.4 0.0 0.0 5.9 0.0 2.0 0.1 0.0 0.6 19.4 0.0 0.1 1.4 0.0 0.0 0.0 31.3 0.0 0.0 0.4 0.0 0.0 3.8 3.0 1.4 0.4 75.5 0.0 128.2 0.0 0.0 0.7 4.1 6.4 0.0 0.0 0.0 0.0 0.0 10.1 191.4 2.6 6.1 0.0 0.5 2.1 0.9 0.0 0.0 1.0 0.0 3.2 0.0 19.6 5.3 0.1 0.1 0.7 0.0 0.1 0.0 0.1 0.7 14.0 0.0 0.0 0.2 1.7 1.5 0.1 0.6 0.0 0.1 0.0 0.8 0.0 RIN2 RASSF4 ENSG00000132669 "Ras and Rab interactor 2" Q8WYP3 20 19757606-20002457 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 198.5;Microglial cells: 191.1;Oligodendrocyte precursor cells: 296.6;Oligodendrocytes: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "PC-3: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034641 Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol "Nucleoli, Golgi apparatus" "HPA034641: AB_10671230" "unprognostic (8.23e-3)" "unprognostic (8.09e-3)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.12e-2)" "unprognostic (3.86e-2)" "unprognostic (1.61e-2)" "unprognostic (3.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.78e-3)" "unprognostic (2.49e-1)" "unprognostic (6.27e-2)" "prognostic favorable (8.34e-6)" "unprognostic (3.10e-1)" "unprognostic (2.08e-2)" "unprognostic (8.02e-3)" "unprognostic (3.63e-2)" 14.2 6.4 8.7 8.6 13.5 6.1 9.5 9.4 7.1 14.4 14.4 12.5 13.3 14.1 3.9 13.6 11.7 17.8 18.7 9.5 10.8 12.1 5.3 18.3 4.7 14.6 13.2 15.0 6.5 4.6 1.4 19.8 12.8 9.4 12.7 5.5 15.6 13.5 9.4 8.2 14.7 16.2 9.5 16.8 8.8 1.8 12.7 3.0 13.7 13.2 5.3 8.1 3.8 14.0 6.7 22.4 4.1 13.7 23.3 14.2 13.1 5.9 22.8 5.7 3.0 10.0 5.8 0.0 24.0 14.6 10.6 24.7 0.1 33.5 6.3 2.7 0.1 0.0 3.5 0.8 5.4 0.0 0.1 21.7 6.1 10.7 11.9 13.4 30.6 0.0 0.1 0.4 17.0 5.3 0.1 0.4 0.7 3.2 47.1 0.1 13.8 3.4 7.2 9.2 3.5 0.9 5.3 23.7 0.1 4.1 2.0 1.4 33.7 11.4 2.9 8.1 9.2 0.1 0.1 0.0 8.0 0.0 2.0 0.2 1.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 1.0 0.1 0.0 0.4 8.7 13.5 9.4 7.1 9.5 10.8 14.6 13.2 12.8 9.5 12.7 14.0 52.3 64.1 17.5 198.5 1.4 41.9 18.5 30.9 24.5 6.1 25.6 18.4 34.3 14.3 23.7 31.3 8.4 6.8 0.2 30.4 43.0 17.5 1.0 50.0 47.3 52.7 14.4 0.4 5.9 34.5 7.4 33.2 10.7 87.3 0.0 32.4 105.3 4.2 100.2 6.7 82.8 17.2 26.4 60.3 40.3 0.8 19.3 37.7 21.4 191.1 21.4 33.2 1.0 296.6 202.4 26.2 10.5 15.4 0.8 22.3 23.0 50.1 27.1 1.9 0.0 25.4 22.6 0.5 0.8 33.6 54.0 7.1 2.9 43.1 21.9 32.2 RINT1 "FLJ11785, RINT-1" ENSG00000135249 "RAD50 interactor 1" Q6NUQ1 7 105532169-105567677 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019875, HPA031646" Approved Approved "Golgi apparatus" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA019875: AB_1856283, HPA031646: AB_2673975" "unprognostic (1.58e-2)" "unprognostic (3.94e-2)" "unprognostic (9.00e-2)" "unprognostic (1.80e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-2)" "unprognostic (4.68e-3)" "unprognostic (1.33e-2)" "unprognostic (4.96e-3)" "unprognostic (2.41e-1)" "unprognostic (8.72e-2)" "unprognostic (5.35e-2)" "unprognostic (8.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (1.76e-1)" 7.3 6.1 2.8 9.0 3.1 15.2 10.0 6.9 3.7 8.2 5.6 8.1 9.4 8.6 7.2 11.3 8.0 6.7 8.2 3.1 3.1 9.3 10.5 6.7 13.4 2.8 2.7 8.0 11.6 9.7 5.4 8.8 3.1 7.8 9.3 10.3 11.3 6.1 16.7 8.7 7.1 6.4 3.2 8.8 9.7 11.1 2.7 9.9 8.8 13.3 13.7 8.4 5.7 4.1 28.8 23.5 12.1 27.8 18.8 24.9 15.9 27.2 19.2 26.4 29.6 27.4 18.4 31.6 31.3 24.1 29.4 19.0 22.5 21.0 34.7 17.0 25.9 18.3 26.1 18.5 14.5 38.9 17.8 17.9 16.4 28.1 16.3 20.3 29.1 16.3 39.5 23.2 30.3 46.9 29.3 28.6 26.1 23.8 23.1 17.5 20.5 45.4 14.2 23.6 20.5 22.4 28.9 47.7 20.6 20.9 19.4 12.5 20.3 30.2 24.0 83.1 34.8 46.6 59.7 61.4 20.0 31.8 34.6 4.4 3.9 4.4 6.7 5.8 11.6 9.0 9.8 9.2 6.0 7.8 8.6 9.4 0.7 9.1 4.8 4.0 10.5 6.2 2.8 3.1 6.9 3.7 3.1 3.1 2.8 2.7 3.1 3.2 2.7 4.1 6.7 3.2 9.8 10.4 12.4 6.6 9.6 7.7 8.6 5.8 5.9 5.3 10.5 1.5 9.4 3.7 8.4 11.2 13.4 6.0 9.8 8.1 10.8 9.0 6.4 6.8 5.4 4.6 25.6 6.3 10.3 9.4 12.2 5.5 10.1 7.5 4.2 5.1 7.3 6.7 26.0 5.8 10.2 5.6 3.4 6.2 8.7 5.2 5.4 9.4 5.7 7.8 7.2 9.0 18.2 6.7 4.0 9.8 17.9 6.5 5.5 6.8 18.1 8.9 6.6 8.3 8.0 29.2 12.4 8.3 7.7 12.0 10.8 7.5 6.4 8.3 RIOK3 SUDD ENSG00000101782 "RIO kinase 3" O14730 18 23453287-23486603 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 174.3" "Cell type enhanced" "Detected in all" "Distal enterocytes: 338.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001620, HPA024184" Approved Approved "Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "Golgi apparatus, Centriolar satellite" "HPA001620: AB_1079815, HPA024184: AB_1856289" "unprognostic (7.99e-2)" "unprognostic (1.71e-2)" "unprognostic (2.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.05e-1)" "unprognostic (7.48e-2)" "unprognostic (8.98e-3)" "unprognostic (1.01e-1)" "unprognostic (5.10e-2)" "unprognostic (4.20e-1)" "prognostic unfavorable (4.10e-4)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.90e-2)" "unprognostic (1.46e-1)" "unprognostic (5.44e-2)" "unprognostic (1.39e-1)" "unprognostic (2.71e-2)" 23.1 18.5 5.5 20.4 7.1 174.3 19.2 7.9 10.2 17.4 8.3 47.5 51.6 16.7 12.4 65.5 14.8 24.3 32.7 5.9 6.7 29.6 55.6 22.7 22.8 9.3 7.3 15.7 27.6 22.8 5.4 34.9 8.9 20.1 43.5 19.6 23.2 14.5 52.9 33.3 62.5 19.7 7.5 21.5 38.5 36.6 6.9 21.5 22.2 48.8 30.2 25.8 27.0 10.6 41.9 15.7 17.8 25.0 31.8 37.7 28.5 38.9 29.8 27.6 28.4 17.3 47.5 27.6 52.3 43.7 26.9 57.6 25.9 45.4 38.9 29.5 12.0 25.9 26.9 22.2 71.7 74.7 25.8 39.0 91.2 44.1 66.7 36.7 38.4 19.2 39.8 34.7 45.0 19.4 25.8 15.6 17.6 59.0 31.3 31.3 33.2 41.2 39.3 50.0 39.5 28.9 50.1 28.4 37.4 41.0 21.9 45.0 63.7 48.4 10.9 21.2 28.9 66.1 56.0 38.2 31.0 36.7 38.2 50.1 24.5 14.8 15.0 34.6 10.8 14.0 12.3 12.6 19.1 18.5 9.8 11.2 17.2 15.0 39.0 8.6 19.4 20.7 5.5 7.1 7.9 10.2 5.9 6.7 9.3 7.3 8.9 7.5 6.9 10.6 49.7 80.1 57.7 23.2 46.4 120.4 92.4 78.6 113.8 44.1 49.3 35.6 69.1 51.5 81.5 25.8 56.3 43.0 74.6 338.1 25.4 51.0 271.5 130.1 85.5 44.1 62.8 259.8 35.5 52.7 64.6 48.8 93.8 267.2 63.3 40.0 29.6 88.5 41.1 28.6 34.2 119.9 50.8 59.9 51.2 305.8 22.4 85.7 42.7 15.9 80.6 18.3 53.5 34.2 49.5 148.4 210.7 30.1 63.4 118.5 199.5 52.5 72.3 46.4 6.6 43.9 51.6 28.4 10.1 164.2 143.6 88.4 57.3 71.1 77.2 244.4 RIPOR1 "FAM65A, FLJ13725" ENSG00000039523 "RHO family interacting cell polarization regulator 1" Q6ZS17 16 67518418-67546788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 49.2;Endothelial cells: 23.6;Hofbauer cells: 30.0;Pancreatic endocrine cells: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 11.2;eosinophil: 9.3;intermediate monocyte: 15.6;memory B-cell: 15.8;myeloid DC: 10.2;naive B-cell: 9.4;neutrophil: 6.6;non-classical monocyte: 15.1;plasmacytoid DC: 14.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005923 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus, Cytosol" "HPA005923: AB_1078809" "unprognostic (7.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.56e-3)" "unprognostic (3.71e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.38e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.82e-8)" "unprognostic (8.51e-2)" "unprognostic (3.52e-2)" "unprognostic (1.19e-1)" "unprognostic (7.46e-2)" 44.4 28.1 27.6 23.4 30.6 27.2 37.7 26.4 38.6 39.9 7.5 36.0 8.8 45.2 6.0 18.5 36.2 21.5 53.6 33.6 16.3 67.6 16.7 55.8 20.8 26.6 17.1 33.2 30.1 20.6 26.5 29.8 25.4 30.6 7.4 43.8 22.8 20.2 34.9 21.4 32.7 25.2 12.3 61.2 25.9 18.6 21.5 10.8 36.4 22.3 17.5 37.1 30.4 18.6 44.0 36.6 16.1 25.3 40.0 35.7 35.7 45.7 44.9 51.6 43.0 75.7 31.5 6.0 62.4 78.8 26.0 24.4 32.7 41.3 33.2 19.3 17.0 57.9 53.6 17.4 44.7 4.6 28.0 35.5 18.8 69.7 47.1 36.8 55.2 10.2 6.5 6.4 38.7 47.7 13.8 14.4 4.4 8.5 29.1 46.8 29.0 31.2 39.0 22.1 12.1 31.9 85.1 13.8 28.6 15.9 30.2 10.7 96.8 58.3 34.2 49.8 32.2 9.0 6.8 17.8 38.8 11.1 31.7 0.1 11.2 9.3 1.2 15.6 1.8 15.8 1.0 0.5 10.2 9.4 0.7 0.7 6.6 1.7 15.1 14.4 0.8 6.0 27.6 30.6 26.4 38.6 33.6 16.3 26.6 17.1 25.4 12.3 21.5 18.6 49.2 16.0 16.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 12.1 8.8 0.0 0.0 1.8 7.3 0.0 0.8 3.7 0.0 0.0 15.8 0.0 9.3 17.9 23.6 0.0 0.0 0.0 12.5 1.3 6.9 0.0 18.5 10.1 7.9 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 37.0 0.0 0.0 2.3 0.0 0.0 5.8 2.2 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 2.1 2.3 16.6 0.0 0.0 RIT2 "RIBA, RIN" ENSG00000152214 "Ras like without CAAX 2" Q99578 18 42743227-43115691 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 25.9" "Group enriched" "Detected in some" 5 "Excitatory neurons: 225.8;Oligodendrocyte precursor cells: 202.5" "Cancer enriched" "Detected in single" 49 "glioma: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA072174, HPA072526" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Golgi apparatus, Cytosol" "HPA072174: AB_2732195, HPA072526: " "unprognostic (1.37e-2)" "unprognostic (4.15e-1)" "unprognostic (2.14e-1)" 0.0 1.9 9.3 0.1 10.6 0.0 0.0 25.9 16.8 0.1 5.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 13.3 0.0 0.0 0.0 0.0 12.8 9.2 0.0 0.0 0.0 0.5 0.0 17.4 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 8.9 0.0 0.0 0.2 11.6 0.0 0.0 0.0 0.0 0.0 0.2 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 10.6 25.9 16.8 8.8 13.3 12.8 9.2 17.4 8.9 11.6 8.8 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 0.0 225.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 42.5 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 3.7 0.0 1.0 0.0 202.5 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.1 1.4 0.2 0.0 0.0 2.1 0.0 0.5 0.0 0.0 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 42.5" "Group enriched" "Detected in many" 4 "Early spermatids: 270.4;Late spermatids: 163.5;Theca cells: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: AB_2674292, HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favorable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 42.5 3.8 4.1 3.5 3.4 5.3 4.8 4.5 7.7 2.9 12.4 8.4 5.1 9.2 3.4 3.9 6.2 4.4 4.1 2.6 7.8 29.2 11.3 4.6 3.9 2.6 2.8 4.1 3.2 3.0 3.9 2.6 7.2 10.6 4.2 3.7 12.8 5.1 2.9 13.9 5.8 3.0 20.0 4.4 21.7 3.6 5.9 5.4 3.2 2.9 4.3 3.5 3.7 3.3 4.7 2.6 1.8 10.4 11.4 1.5 7.0 9.3 3.6 3.2 1.1 10.9 2.2 2.8 9.9 2.2 3.5 0.8 5.1 4.9 5.0 3.0 3.6 1.6 3.1 5.3 0.0 3.8 16.2 4.6 4.5 0.7 5.4 2.0 1.8 4.4 2.1 6.8 1.3 0.9 4.5 5.1 6.5 3.8 0.0 0.8 0.6 9.0 2.7 2.1 7.5 5.7 0.7 7.3 2.2 1.1 5.9 3.8 4.4 5.1 2.5 2.6 3.8 7.7 4.6 5.4 1.1 4.6 0.0 2.8 0.7 2.0 4.6 3.1 4.1 1.0 1.3 1.8 2.3 1.0 2.2 2.7 3.7 3.5 3.4 0.1 1.4 3.8 3.5 4.8 4.5 4.1 2.6 3.9 2.6 2.6 3.0 3.6 3.7 3.4 28.9 29.6 25.1 6.5 2.4 6.8 16.3 8.6 3.5 1.9 4.2 5.3 11.5 20.0 5.5 2.1 2.1 6.0 20.9 7.9 5.4 270.4 3.7 11.8 4.6 4.8 3.0 33.8 3.8 1.0 9.2 2.6 3.1 15.8 13.1 5.3 15.5 4.7 5.0 24.5 11.4 6.1 6.3 1.7 163.5 9.3 4.8 5.4 19.7 4.4 4.7 6.2 39.2 7.1 2.5 6.1 6.0 1.8 2.2 29.6 6.7 10.2 2.6 6.6 6.4 5.1 9.4 4.8 1.7 2.4 0.8 3.9 77.6 15.2 2.3 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71929018-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favorable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 7.2 9.5 8.8 6.6 8.7 5.8 11.3 8.5 9.2 9.8 9.7 8.1 15.9 8.4 20.0 7.4 11.6 7.8 10.0 8.8 9.0 16.4 11.5 7.6 8.1 8.8 9.1 11.2 10.9 24.3 9.5 11.1 8.8 10.6 10.3 15.7 15.1 13.6 17.2 8.3 13.9 11.8 9.0 6.7 9.2 8.7 9.1 7.7 12.9 14.9 10.4 9.1 7.1 8.7 10.9 22.7 20.5 14.6 19.1 15.2 13.8 16.7 17.7 25.4 26.9 46.0 20.9 9.2 14.9 18.5 26.7 22.1 22.7 21.2 26.7 13.8 13.1 14.0 21.5 21.9 14.3 12.8 11.5 14.8 17.9 28.7 18.2 27.9 46.7 13.5 23.2 8.6 22.7 23.5 9.0 14.1 13.7 43.4 21.9 11.0 44.5 7.9 28.3 18.4 13.7 14.6 22.9 20.4 30.4 20.6 22.5 9.5 32.8 19.0 17.2 11.8 14.6 9.6 10.2 9.4 16.5 8.3 17.1 4.4 2.2 2.2 3.0 2.9 3.5 3.2 2.3 2.4 2.3 1.3 2.7 2.9 1.2 3.2 2.1 3.7 2.1 2.9 8.8 8.7 8.5 9.2 8.8 9.0 8.8 9.1 8.8 9.0 9.1 8.7 9.6 6.4 9.6 12.7 9.4 8.8 11.2 22.8 10.2 16.1 12.1 10.9 9.7 12.8 13.3 20.2 20.9 32.0 17.9 15.2 7.9 26.0 6.3 8.9 10.3 6.5 9.6 13.0 19.3 32.3 26.5 11.8 9.2 10.9 7.0 11.6 8.9 14.4 14.2 10.1 16.9 13.2 26.4 6.6 12.9 3.0 13.1 7.6 10.6 15.0 15.0 19.0 10.3 18.1 19.0 29.0 11.0 12.4 17.1 10.3 31.0 20.9 10.3 21.1 19.7 10.0 14.2 25.1 19.6 6.4 5.8 31.1 10.0 13.4 9.4 9.9 RNF125 FLJ20456 ENSG00000101695 "Ring finger protein 125" Q96EQ8 18 32018825-32073219 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.4" "Cell type enhanced" "Detected in many" "dendritic cells: 169.6;Early spermatids: 90.7;NK-cells: 160.6;Oligodendrocytes: 64.3;T-cells: 114.8" "Cancer enhanced" "Detected in all" "testis cancer: 8.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 51.5;SK-MEL-30: 13.2;U-937: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041514 Uncertain Supported "Nucleoli,Golgi apparatus" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" Nucleoli "HPA041514: AB_10795596" "unprognostic (2.13e-2)" "unprognostic (2.05e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-1)" "unprognostic (5.03e-1)" "unprognostic (4.50e-2)" "unprognostic (2.30e-3)" "unprognostic (6.15e-2)" "unprognostic (4.21e-2)" "unprognostic (3.24e-1)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.99e-1)" "unprognostic (4.12e-1)" "unprognostic (1.82e-1)" "unprognostic (7.07e-3)" 10.2 1.3 2.0 5.2 3.7 18.4 6.3 2.7 2.7 3.9 1.6 5.0 10.5 2.9 0.5 2.5 3.4 3.3 2.6 1.9 2.3 1.0 12.5 4.7 7.0 3.6 3.2 1.4 3.1 1.7 0.3 3.7 3.4 1.8 6.4 0.3 2.2 1.4 2.3 4.9 11.3 3.3 2.6 5.9 3.4 1.0 3.8 5.3 1.4 2.9 4.0 3.0 1.7 6.2 1.2 0.1 0.2 0.4 0.5 0.8 1.0 0.1 0.0 0.0 0.0 0.1 2.5 0.1 1.2 0.1 0.4 0.9 1.6 1.2 0.2 6.6 2.6 0.3 0.4 0.3 0.1 8.9 51.5 1.6 2.4 0.0 2.8 0.3 0.4 2.7 0.1 1.9 0.1 2.0 2.3 8.2 4.2 8.9 1.5 9.2 0.6 0.2 0.5 0.5 0.9 0.3 0.2 0.1 13.2 1.6 1.3 4.2 0.2 0.1 0.7 0.1 0.1 5.9 0.2 0.1 0.6 11.5 6.9 13.3 4.5 4.5 15.0 2.5 9.9 2.5 12.0 12.8 4.2 2.3 9.5 12.3 1.9 15.5 2.8 4.3 13.7 6.9 2.0 3.7 2.7 2.7 1.9 2.3 3.6 3.2 3.4 2.6 3.8 6.2 62.2 3.2 5.8 3.3 16.3 9.8 3.1 1.0 14.2 0.8 5.3 3.7 2.1 4.3 3.8 12.9 0.0 0.4 169.6 24.6 1.9 1.0 90.7 4.9 2.1 28.4 1.2 15.8 2.7 1.8 0.1 5.3 8.6 13.4 18.9 0.2 12.5 25.1 10.5 0.0 3.0 8.3 0.0 19.2 12.6 17.4 2.8 18.4 1.8 30.9 23.8 0.7 160.6 3.5 64.3 1.1 4.5 0.0 49.9 2.7 41.4 4.5 1.7 0.9 0.0 3.2 3.2 0.5 1.8 5.8 6.8 0.8 114.8 0.2 14.7 2.4 RNF157 KIAA1917 ENSG00000141576 "Ring finger protein 157" Q96PX1 17 76142465-76240493 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 86.9;retina: 59.0;skeletal muscle: 73.9;testis: 31.4;tongue: 43.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 114.1;Cone photoreceptor cells: 189.7;Excitatory neurons: 64.6;Horizontal cells: 180.0;Inhibitory neurons: 92.7;Rod photoreceptor cells: 70.9" "Cancer enhanced" "Detected in many" "glioma: 11.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.2;T-cells: 5.8" "Cell line enhanced" "Detected in many" "HDLM-2: 100.9;U-266/70: 50.6;U-266/84: 45.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021854, HPA021991, HPA023922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus" Vesicles "HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202" "unprognostic (4.21e-1)" "unprognostic (4.62e-2)" "unprognostic (1.55e-2)" "unprognostic (2.63e-3)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.07e-3)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-3)" "unprognostic (4.02e-1)" "unprognostic (8.26e-2)" "unprognostic (8.69e-3)" "unprognostic (2.28e-1)" "unprognostic (2.75e-2)" "unprognostic (1.38e-1)" 13.6 3.3 36.4 3.7 39.1 2.2 4.9 34.1 86.9 1.4 9.8 9.8 9.6 1.4 3.4 1.0 1.8 1.3 6.4 56.9 34.5 5.8 2.5 1.4 5.2 59.7 41.9 1.2 3.4 14.6 6.3 1.6 61.1 1.9 7.0 59.0 1.9 1.5 73.9 1.0 10.3 1.8 34.1 3.5 3.9 31.4 51.5 2.8 3.4 43.7 2.7 3.0 1.0 58.1 0.2 7.1 29.3 10.7 8.8 4.4 13.4 0.3 8.9 1.9 1.3 3.3 3.1 0.0 4.2 0.5 6.9 0.2 26.0 0.1 1.6 100.9 8.9 0.0 2.9 4.7 1.7 1.4 10.9 2.4 0.1 3.7 0.1 1.5 0.2 4.7 16.0 0.3 3.6 8.0 4.4 0.8 4.8 5.5 21.1 0.0 0.3 0.1 3.4 3.2 5.1 24.0 5.3 0.1 11.5 6.5 0.7 5.1 0.2 1.9 2.3 14.4 9.6 50.6 45.5 0.1 0.8 0.1 15.1 2.2 0.2 0.3 1.6 0.1 3.4 0.2 3.4 2.7 0.1 0.4 5.8 3.9 1.2 0.7 0.2 0.3 1.3 1.0 36.4 39.1 34.1 86.9 56.9 34.5 59.7 41.9 61.1 34.1 51.5 58.1 2.8 3.2 3.3 33.3 1.5 2.0 0.8 0.2 0.6 114.1 0.8 0.9 9.0 11.5 1.3 1.8 189.7 0.6 5.0 5.3 0.0 1.9 27.8 0.6 3.7 4.4 2.4 5.5 64.6 1.1 0.4 3.1 0.0 1.5 0.0 0.9 0.7 4.3 0.4 180.0 92.7 7.4 0.0 0.8 6.0 29.1 11.5 1.1 1.8 3.7 1.4 35.9 8.2 62.8 35.0 0.1 3.4 13.9 2.1 0.9 19.3 9.1 0.7 70.9 0.0 2.9 1.3 22.7 25.0 0.0 2.3 0.3 15.5 1.3 18.2 1.5 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980310 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;choroid plexus: 12.7" "Cell type enriched" "Detected in some" 4 "Astrocytes: 85.2" "Cancer enhanced" "Detected in many" "glioma: 5.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 81.3;RPTEC TERT1: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 20: HeLa - Mitochondria" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Golgi apparatus" Vesicles "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.1 0.1 12.2 0.1 13.3 8.4 0.6 22.5 17.7 0.8 12.7 0.2 0.2 0.6 1.1 0.3 1.2 0.2 0.3 17.6 12.2 1.1 0.0 3.3 0.2 16.9 17.7 0.3 1.7 5.8 1.8 1.3 16.5 0.4 0.1 8.8 1.3 2.1 0.2 0.4 0.3 0.3 14.2 0.2 0.2 3.7 24.7 1.5 1.3 0.1 0.0 0.3 0.4 12.2 0.2 6.5 12.0 0.0 4.1 5.0 0.7 6.3 8.6 17.0 16.4 0.3 0.1 0.0 0.1 6.8 18.5 0.0 14.3 0.1 30.9 0.0 4.7 0.4 81.3 0.0 0.0 0.1 0.0 2.8 0.0 26.3 0.2 19.5 0.3 3.5 0.5 0.0 11.9 0.2 0.1 2.2 6.9 0.1 23.9 3.8 2.9 1.0 67.3 0.0 14.2 13.7 0.6 0.0 24.8 4.4 0.0 2.4 6.5 20.7 4.4 0.2 14.3 0.0 0.0 0.0 14.1 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 13.3 22.5 17.7 17.6 12.2 16.9 17.7 16.5 14.2 24.7 12.2 0.2 0.0 0.0 85.2 0.1 0.3 0.1 0.0 0.0 19.3 0.2 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 0.4 0.1 0.2 0.0 9.7 8.6 0.0 0.1 0.4 0.0 0.1 0.0 5.4 0.0 0.1 0.1 15.2 1.5 0.1 0.0 0.0 0.3 1.4 0.3 0.0 0.0 5.6 0.0 14.7 0.0 2.5 0.4 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.1 1.3 6.6 0.0 1.3 5.7 3.2 0.0 0.0 0.3 0.3 0.0 0.1 0.1 RNF214 DKFZp547C195 ENSG00000167257 "Ring finger protein 214" Q8ND24 11 117232625-117286454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 20.5" "Group enriched" "Detected in all" 5 "granulocytes: 6.4;T-cells: 20.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039332 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Golgi apparatus, Cytosol" "HPA039332: AB_10671874" "unprognostic (7.36e-2)" "unprognostic (4.91e-2)" "unprognostic (9.90e-2)" "unprognostic (1.66e-2)" "unprognostic (6.34e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.03e-5)" "unprognostic (2.06e-1)" "unprognostic (6.47e-2)" "unprognostic (1.40e-1)" "unprognostic (5.67e-2)" "unprognostic (8.48e-2)" "unprognostic (1.25e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (2.33e-1)" "unprognostic (2.28e-2)" 10.9 11.7 8.9 8.8 10.2 12.4 10.8 10.5 9.9 11.4 6.0 10.8 9.4 11.0 8.5 9.2 9.9 8.9 10.5 7.8 10.1 10.3 13.2 9.1 10.8 9.9 9.4 13.2 21.8 11.5 12.5 11.0 9.6 9.6 9.4 12.2 11.3 10.0 17.9 10.1 10.1 11.2 7.3 11.4 12.7 18.6 10.4 14.4 13.5 13.4 10.6 11.0 9.6 11.9 12.0 14.1 31.7 19.1 15.6 15.6 17.9 19.3 17.5 20.5 21.7 21.6 28.1 16.8 32.7 22.6 19.6 15.7 34.8 16.9 21.1 31.3 10.2 53.3 11.7 16.6 30.5 25.2 19.8 14.4 18.2 25.4 37.6 23.1 25.7 29.0 30.7 17.9 21.1 9.0 20.8 21.0 17.2 20.7 14.0 22.5 21.1 22.4 19.3 17.8 20.5 22.2 22.1 14.8 10.4 24.7 25.1 16.9 24.4 20.7 16.6 11.4 16.3 10.3 7.7 20.2 7.6 20.3 24.3 6.4 2.5 2.7 2.3 2.4 1.4 1.9 7.8 4.0 2.2 1.9 2.2 2.1 1.1 1.2 2.5 2.5 20.5 1.6 8.9 10.2 10.5 9.9 7.8 10.1 9.9 9.4 9.6 7.3 10.4 11.9 19.1 25.6 15.1 23.5 14.8 5.0 9.6 10.6 21.6 23.8 11.1 14.5 12.8 15.7 14.8 5.5 10.4 14.9 10.0 9.0 9.8 13.3 46.8 15.7 26.2 11.9 9.0 14.7 20.9 12.7 13.6 12.9 14.8 15.5 5.1 21.6 7.9 7.1 12.8 13.5 24.7 8.5 10.2 10.6 6.3 20.0 10.2 13.5 8.8 12.2 12.7 14.0 14.4 33.7 24.5 10.6 9.8 12.8 14.9 7.1 10.6 12.1 10.0 37.1 13.1 20.9 19.5 64.6 57.5 15.5 5.1 19.4 17.8 28.2 8.8 7.6 RNF224 ENSG00000233198 "Ring finger protein 224" P0DH78 9 137227502-137229640 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 3.4;pituitary gland: 5.8" "Cell type enhanced" "Detected in single" "Proximal tubular cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.5;HeLa: 4.3;MCF7: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA079078 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Golgi apparatus" "HPA079078: " "unprognostic (2.45e-1)" "unprognostic (2.34e-3)" "unprognostic (7.01e-4)" "unprognostic (6.04e-2)" "unprognostic (5.26e-2)" "unprognostic (1.70e-3)" "unprognostic (3.87e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-3)" "unprognostic (4.57e-2)" "unprognostic (5.24e-2)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "unprognostic (4.95e-2)" "unprognostic (1.27e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 0.2 0.2 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.5 0.0 0.3 0.3 0.2 0.0 3.4 1.4 0.3 0.5 0.1 0.1 2.1 0.0 0.8 0.1 0.8 1.2 0.1 0.8 0.0 5.8 0.0 0.3 1.0 0.0 0.2 1.4 0.0 0.1 0.6 0.5 0.0 0.5 0.2 0.6 1.2 0.5 0.0 0.9 0.0 0.1 0.4 0.9 0.2 0.6 1.0 0.4 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 5.5 0.1 0.2 0.0 0.3 2.7 0.0 0.1 0.0 1.8 0.2 0.0 4.3 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.2 0.4 0.0 9.8 0.1 0.0 0.4 0.7 1.3 0.6 0.2 0.1 0.1 0.6 0.0 1.1 0.5 2.0 0.0 0.7 1.9 0.2 0.2 0.2 0.1 1.1 0.0 0.6 0.2 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.8 1.2 0.3 0.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.9 2.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RNF24 G1L ENSG00000101236 "Ring finger protein 24" Q9Y225 20 3927309-4015558 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.8" "Cell type enhanced" "Detected in all" "Excitatory neurons: 112.5;Inhibitory neurons: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 238.2" "Lineage enriched" "Detected in all" 10 "granulocytes: 238.2" "Cell line enhanced" "Detected in all" "ASC TERT1: 81.7" "Low region specificity" "Detected in all" HPA011900 Approved Supported "Golgi apparatus" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA011900: AB_10671089" "unprognostic (6.61e-2)" "unprognostic (6.56e-2)" "unprognostic (1.72e-1)" "unprognostic (1.17e-2)" "unprognostic (8.79e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (2.65e-1)" "unprognostic (5.87e-2)" "unprognostic (2.66e-2)" "unprognostic (5.19e-3)" "unprognostic (3.42e-1)" "prognostic unfavorable (2.67e-7)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (1.24e-1)" 9.0 7.8 9.5 8.0 9.7 51.8 7.0 4.9 10.9 6.6 0.0 5.7 2.5 5.7 14.9 7.5 5.3 5.9 6.5 10.7 9.5 11.3 2.7 13.9 2.3 7.4 7.6 5.1 4.8 2.5 6.2 3.4 7.6 8.7 3.5 4.7 6.9 6.9 2.1 8.8 4.5 5.3 6.6 12.5 5.7 4.1 8.9 5.4 7.3 3.7 3.8 7.9 5.9 7.2 19.8 9.0 12.9 11.2 48.8 81.7 4.6 16.4 35.4 16.5 23.6 6.0 19.3 4.1 3.5 33.7 25.3 12.9 5.2 18.7 27.4 2.8 3.9 36.4 16.2 4.7 42.1 73.8 13.8 27.6 5.7 43.8 36.8 18.3 15.5 12.6 47.1 9.6 26.9 5.2 11.8 15.1 19.5 18.2 12.6 14.0 10.9 3.3 9.3 10.5 12.1 9.8 44.4 26.3 11.6 18.8 9.6 25.3 23.3 39.8 12.9 27.1 19.7 7.5 7.9 1.4 20.2 24.7 12.7 108.9 23.5 51.3 3.7 8.5 3.0 1.4 7.0 5.4 19.3 4.6 4.2 5.4 238.2 7.5 12.7 0.5 3.4 11.5 9.5 9.7 4.9 10.9 10.7 9.5 7.4 7.6 7.6 6.6 8.9 7.2 6.2 3.2 19.1 34.0 7.8 48.8 36.9 24.1 26.2 18.1 26.9 19.3 2.7 4.3 18.6 49.7 16.7 1.9 9.1 5.7 7.9 33.6 16.3 17.2 37.4 13.9 13.1 43.3 112.5 25.6 6.7 42.4 9.7 31.4 4.5 12.6 17.2 1.2 5.7 38.7 127.2 6.6 10.2 24.7 71.6 22.6 36.7 30.9 39.2 16.9 25.2 10.4 7.2 74.4 21.1 29.2 5.8 60.2 5.9 73.8 2.2 1.8 6.8 9.6 19.7 12.4 32.3 21.4 22.4 12.8 54.4 2.9 17.0 7.4 4.8 75.1 RNPEP APB ENSG00000176393 "Arginyl aminopeptidase" Q9H4A4 1 201982372-202006147 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 201.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 19.8;granulocytes: 22.9;monocytes: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036074, HPA036075, HPA061487" Approved Approved "Golgi apparatus" "Secreted - unknown location" NA NA 7800000 "Cluster 52: Eosinophils - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537" "unprognostic (8.57e-2)" "unprognostic (3.43e-2)" "unprognostic (2.81e-1)" "unprognostic (5.45e-2)" "unprognostic (2.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-3)" "unprognostic (1.80e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-1)" "unprognostic (3.50e-3)" "unprognostic (1.91e-1)" "unprognostic (6.00e-2)" "unprognostic (1.97e-2)" "unprognostic (1.68e-1)" 25.2 31.1 8.0 22.8 8.3 25.2 25.8 8.1 8.5 26.7 16.1 53.6 68.5 25.6 39.0 53.8 40.6 22.3 14.7 8.5 8.7 25.9 32.4 30.5 22.1 9.9 9.1 23.4 34.1 25.4 13.3 27.5 9.1 25.9 57.0 4.2 38.3 27.6 18.8 37.0 58.1 28.1 9.1 33.4 28.5 17.9 10.6 21.7 33.2 12.7 26.5 23.3 28.8 11.8 66.2 71.0 40.8 62.7 65.1 61.3 102.1 49.5 95.6 60.9 67.6 51.8 83.1 14.3 61.8 87.8 38.0 117.4 52.5 97.2 42.4 39.1 67.6 35.5 32.5 48.7 55.1 92.3 121.3 55.9 97.9 54.1 62.0 74.7 110.6 34.8 82.5 21.6 62.1 61.0 12.8 40.2 58.4 105.4 34.4 48.3 57.5 101.6 128.7 61.2 46.9 39.9 122.2 155.9 52.1 78.9 116.6 52.4 79.9 28.9 38.0 28.7 61.3 45.3 39.6 12.9 27.8 77.3 58.1 22.9 14.9 22.1 3.0 25.9 4.1 2.5 3.2 3.4 19.8 4.6 2.8 3.2 11.0 2.9 29.9 7.2 5.4 4.0 8.0 8.3 8.1 8.5 8.5 8.7 9.9 9.1 9.1 9.1 10.6 11.8 26.7 9.6 21.5 8.5 19.7 28.8 40.5 31.2 40.5 15.5 32.8 33.1 12.2 38.6 26.7 25.8 10.4 116.6 21.4 136.6 19.6 71.1 5.4 35.9 17.7 26.1 44.9 19.0 12.7 51.2 91.1 26.1 45.3 21.5 15.2 23.2 27.1 51.4 103.7 11.8 11.1 71.9 14.2 81.0 39.4 4.9 25.4 72.9 24.9 15.0 86.7 12.6 17.5 5.5 8.1 47.8 83.4 23.0 23.6 25.0 201.7 65.8 39.1 8.0 26.3 11.4 28.2 22.7 9.5 53.6 21.6 87.6 17.7 33.2 86.6 34.8 RPGR "COD1, CORDX1, CRD, RP15, RP3" ENSG00000156313 "Retinitis pigmentosa GTPase regulator" Q92834 X 38269163-38327544 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Guanine-nucleotide releasing factor" "Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 146.1;Hepatic stellate cells: 121.7;Respiratory ciliated cells: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 14.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 14.6" "Cell line enhanced" "Detected in many" "HL-60: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001593, HPA073455" Approved Supported "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA001593: AB_1079835, HPA073455: AB_2686603" "unprognostic (3.22e-2)" "unprognostic (1.16e-2)" "unprognostic (5.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.20e-1)" "unprognostic (9.94e-2)" "unprognostic (3.46e-2)" "unprognostic (6.32e-2)" "unprognostic (2.04e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-6)" "unprognostic (1.93e-1)" "unprognostic (7.59e-2)" "unprognostic (8.96e-3)" "unprognostic (1.61e-3)" 19.2 5.7 4.7 4.4 4.6 12.2 16.8 5.2 5.5 10.2 15.5 9.1 3.0 11.6 2.5 5.5 15.0 5.5 9.8 4.6 6.3 6.2 3.7 14.8 3.7 7.6 7.0 6.2 7.5 2.6 32.9 3.7 5.8 6.9 3.6 12.1 5.2 2.6 12.1 6.0 9.4 4.5 6.6 5.1 6.8 8.1 5.3 4.7 9.7 3.7 3.2 8.7 8.2 5.4 4.7 6.0 3.4 3.2 3.6 5.2 2.7 5.8 6.5 4.1 4.8 2.7 2.6 7.1 1.8 3.9 3.4 4.4 4.1 1.8 5.6 7.5 7.9 2.5 2.7 5.5 3.3 31.8 5.8 8.0 2.4 8.7 9.2 1.6 18.9 7.5 3.3 0.0 5.7 1.5 9.1 17.7 8.7 2.9 7.5 6.8 11.7 6.4 3.6 3.0 2.7 5.2 6.4 2.6 7.2 5.1 1.7 5.4 22.4 4.5 8.0 10.7 7.2 1.9 3.9 6.0 10.6 6.1 6.2 1.3 2.6 5.9 1.3 2.4 2.9 1.9 1.5 1.8 2.6 1.5 2.2 1.8 14.6 1.7 2.0 1.8 1.9 1.8 4.7 4.6 5.2 5.5 4.6 6.3 7.6 7.0 5.8 6.6 5.3 5.4 75.2 16.0 32.6 21.2 21.8 7.9 13.5 6.6 7.4 29.5 8.8 8.8 8.0 8.6 18.0 1.8 62.6 5.8 14.0 12.6 3.9 15.3 51.4 146.1 30.4 61.3 17.4 5.5 21.8 8.6 9.5 11.8 9.2 21.0 20.3 73.5 121.7 9.7 7.8 35.3 20.0 13.5 10.2 16.2 8.4 9.1 7.8 14.5 5.4 18.7 15.5 9.4 14.4 9.0 17.1 9.9 8.9 4.5 11.0 10.2 5.0 3.1 119.2 85.7 0.0 23.1 12.9 24.9 25.3 4.8 5.8 8.2 17.2 6.6 8.9 11.2 RPL12 L12 ENSG00000197958 "Ribosomal protein L12" P30050 9 127447674-127451406 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast myoepithelial cells: 16277.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003403 Approved Approved "Golgi apparatus" NA NA 710000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Golgi apparatus" "HPA003403: AB_1856432" "unprognostic (5.89e-3)" "unprognostic (3.27e-1)" "unprognostic (1.08e-1)" "unprognostic (5.75e-3)" "unprognostic (4.93e-2)" "prognostic unfavorable (5.66e-4)" "unprognostic (4.98e-2)" "unprognostic (3.05e-1)" "unprognostic (6.82e-2)" "unprognostic (3.22e-3)" "unprognostic (1.03e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (7.42e-7)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.00e-3)" "unprognostic (4.80e-2)" 1951.8 1231.3 835.3 1038.0 851.8 2761.0 2915.7 839.5 1071.0 1971.7 849.8 1701.0 1014.9 1367.8 2197.8 1898.6 2181.0 1058.6 1075.1 814.9 877.7 1217.9 1183.9 1195.7 2118.1 883.8 861.1 3020.6 2703.8 700.7 888.2 879.2 891.8 1637.0 1384.7 360.7 1784.8 997.7 2166.7 2609.6 1237.2 1202.9 884.9 1349.8 1401.3 339.2 851.4 1696.8 1423.5 1318.1 2422.7 1851.7 1787.9 901.5 1511.6 1359.5 1474.8 2976.3 2773.6 6171.2 2266.6 1317.9 3562.5 2315.3 1802.2 2949.5 1529.4 2855.4 1745.3 2256.0 1161.2 1774.7 1887.1 3068.4 1578.4 1451.5 1731.1 1678.1 1705.9 2724.4 5881.5 2596.8 1735.1 6766.3 6013.6 1628.4 6142.1 4589.1 3178.6 1755.1 2307.8 2371.9 2920.2 5170.1 2464.7 3988.0 2166.2 4448.6 2519.6 2073.6 2828.6 3141.2 3458.6 1497.1 1295.6 1882.9 989.8 3291.6 4287.8 1727.6 2707.1 3536.1 1796.2 866.3 1546.2 1504.9 2645.1 1223.5 1630.1 2951.4 901.8 2447.8 1351.3 354.9 961.6 274.4 997.8 982.9 1845.3 2714.4 1857.1 1366.2 1536.6 2602.0 2177.6 1891.8 114.3 1265.6 973.6 1398.4 1772.9 3151.7 835.3 851.8 839.5 1071.0 814.9 877.7 883.8 861.1 891.8 884.9 851.4 901.5 2021.8 695.5 1593.2 9.1 5219.3 6047.5 4680.5 5696.6 6688.2 186.4 9458.0 16277.6 445.0 2522.1 2427.5 1272.7 85.5 3455.7 2702.3 1424.3 4073.5 2502.6 320.6 1210.9 3910.1 2415.0 2095.3 2939.8 7.4 7126.9 5794.1 2409.3 2320.1 1688.1 1876.4 1940.1 3301.1 2861.4 3348.2 95.9 7.5 4283.6 1810.7 5716.7 5579.1 839.4 5405.5 2945.4 3601.9 13.1 4509.5 782.7 2582.9 5.5 13.4 4166.6 2911.7 2389.9 2741.9 4582.4 3159.4 6003.0 879.7 309.3 986.1 3458.1 2319.6 334.8 584.2 7183.3 6963.2 3724.4 3677.5 3289.4 4446.0 4896.3 RPRD1A "FLJ10656, HsT3101, P15RS" ENSG00000141425 "Regulation of nuclear pre-mRNA domain containing 1A" Q96P16 18 35984387-36067576 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 233.0;Late spermatids: 362.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040602 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA040602: AB_10673137" "unprognostic (2.06e-1)" "unprognostic (9.14e-2)" "unprognostic (1.41e-3)" "unprognostic (2.22e-1)" "unprognostic (9.92e-3)" "unprognostic (2.69e-1)" "unprognostic (2.93e-3)" "unprognostic (1.68e-1)" "unprognostic (2.80e-2)" "unprognostic (3.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (5.50e-3)" "unprognostic (7.95e-2)" "unprognostic (6.78e-3)" "unprognostic (1.49e-1)" "unprognostic (4.30e-1)" 23.3 34.8 40.6 16.4 44.4 11.3 24.7 40.7 59.9 21.1 34.6 29.6 19.0 25.7 115.2 23.6 25.3 18.5 29.1 45.5 43.2 26.7 21.8 19.2 19.5 39.5 40.3 24.1 23.4 26.1 27.8 17.8 40.0 29.6 20.5 41.5 28.3 28.9 54.7 20.9 19.0 21.3 41.4 22.3 21.3 28.0 42.6 19.9 32.1 46.5 19.3 27.6 20.0 44.4 31.6 34.1 57.0 60.8 30.6 35.8 35.5 55.6 54.5 31.7 44.5 9.4 34.2 44.1 57.2 40.7 16.9 51.2 64.1 56.3 44.7 39.2 36.6 46.9 48.9 37.0 53.9 78.9 24.3 27.6 73.7 30.2 85.4 39.8 46.0 51.5 42.8 46.7 41.1 39.3 42.4 33.3 45.9 16.2 24.4 34.7 18.3 70.8 48.4 66.9 99.1 83.4 46.5 25.7 48.3 46.2 35.2 55.9 56.4 33.0 20.6 17.7 46.0 52.5 77.6 45.0 33.6 64.1 33.9 0.7 4.7 2.2 2.9 6.3 4.4 5.0 4.0 3.4 7.8 5.4 5.0 4.0 3.5 7.0 4.2 5.4 2.3 3.3 40.6 44.4 40.7 59.9 45.5 43.2 39.5 40.3 40.0 41.4 42.6 44.4 19.0 32.1 20.7 54.9 40.6 34.4 35.9 23.6 54.7 49.6 29.9 22.2 39.4 17.2 21.0 35.0 31.3 17.1 28.7 13.6 27.4 21.0 233.0 36.3 30.2 23.1 28.8 24.6 105.0 19.9 17.6 19.0 25.0 52.5 13.3 50.7 20.7 29.3 9.8 37.0 91.0 16.7 22.4 20.1 24.2 362.4 22.1 18.8 30.2 58.1 18.1 32.2 18.6 84.9 98.5 20.4 25.2 23.0 33.1 41.5 17.8 26.2 20.3 50.8 13.1 26.1 27.0 39.5 42.2 45.2 38.2 14.6 21.9 51.9 22.2 38.2 RPS12 S12 ENSG00000112306 "Ribosomal protein S12" P25398 6 132814569-132817564 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006124, HPA006365" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 450000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Cytosol "Golgi apparatus, Vesicles" "HPA006124: AB_1856460, HPA006365: AB_2667570" "unprognostic (6.58e-2)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (6.37e-2)" "unprognostic (4.95e-3)" "unprognostic (1.46e-1)" "unprognostic (3.95e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (7.04e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (2.04e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-1)" "unprognostic (5.66e-2)" 2199.7 1325.2 1393.3 1767.2 1454.1 5388.1 3551.2 1388.1 2027.8 2357.3 1375.8 1849.3 1597.8 1747.6 1664.7 2450.9 2149.5 1415.7 1311.3 1347.6 1419.0 1576.6 1443.7 1565.4 3948.0 1445.0 1406.0 4883.9 3660.2 1000.1 871.2 1633.7 1443.1 1696.0 1905.2 608.3 2167.8 1216.4 1965.9 3365.2 1692.7 1357.1 1484.2 2110.3 1718.3 682.0 1446.6 2534.1 1959.6 1376.9 3053.4 2011.6 2108.4 1482.0 1993.8 1568.3 2260.4 3581.3 4521.2 5855.0 2728.8 2502.9 3598.4 2772.7 2665.2 3294.5 1880.3 4497.8 3443.9 3368.1 1338.8 1900.3 2613.1 4373.5 2576.9 2895.0 3346.5 3013.3 1944.0 4743.1 5047.1 8481.4 2221.0 6167.0 7332.7 2340.5 8322.4 4658.3 3754.7 3556.4 5166.0 2858.9 3487.9 4342.3 3620.8 5030.3 2772.9 3420.0 2533.0 3993.0 1799.7 2884.6 3698.6 2185.9 1991.3 1573.0 833.4 5314.3 7184.2 2173.7 2276.5 8489.5 3027.8 1121.1 3111.7 3721.2 4696.8 4153.6 4104.8 3493.8 3635.1 5063.0 1621.7 599.0 1545.5 220.8 2412.5 1426.7 3728.9 4156.1 4210.9 3131.6 1971.7 3564.5 5201.1 4454.7 151.1 2031.9 1170.8 2722.3 2519.7 7450.3 1393.3 1454.1 1388.1 2027.8 1347.6 1419.0 1445.0 1406.0 1443.1 1484.2 1446.6 1482.0 3755.5 1660.2 3063.5 22.9 9470.7 8277.4 8259.7 3758.1 8926.6 531.5 10637.2 15674.0 827.7 3777.4 2693.4 1237.8 179.3 7566.9 6150.1 1808.1 4574.3 4058.0 792.6 1406.5 4602.8 3829.0 2863.4 5499.5 18.9 8085.7 9433.9 3353.4 3537.2 2309.6 1773.2 3890.7 4755.4 5136.7 5871.9 212.0 17.7 6806.4 1116.9 6161.6 5357.0 2335.6 6075.0 4790.9 3938.0 20.6 6667.5 2216.0 5160.7 10.1 25.0 6009.9 4480.8 2990.3 4762.0 10484.3 3517.1 5647.3 792.4 713.1 1617.2 5397.5 3117.8 1035.0 3063.2 11325.5 10512.6 7894.9 7990.4 4517.7 6783.0 9815.1 RPUSD1 "C16orf40, MGC19600, RLUCL" ENSG00000007376 "RNA pseudouridine synthase domain containing 1" Q9UJJ7 16 784974-788397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041144, HPA041938" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Cell Junctions, Cytosol" "HPA041144: AB_10794265, HPA041938: AB_10795601" "unprognostic (1.51e-2)" "unprognostic (1.26e-3)" "unprognostic (2.03e-1)" "unprognostic (4.01e-1)" "unprognostic (2.99e-1)" "unprognostic (9.05e-3)" "unprognostic (1.07e-3)" "unprognostic (3.45e-2)" "unprognostic (1.08e-1)" "unprognostic (3.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (6.25e-2)" "unprognostic (8.07e-3)" "unprognostic (5.44e-2)" "unprognostic (2.95e-1)" "unprognostic (1.41e-1)" 11.8 12.9 12.3 9.7 11.9 13.5 12.0 11.2 21.1 11.0 6.8 14.9 9.8 13.1 3.1 18.7 10.6 4.7 12.0 12.5 10.0 13.0 15.3 9.5 11.3 12.9 10.7 9.2 16.1 4.5 11.2 4.2 10.9 14.6 2.5 2.2 15.2 5.1 11.2 18.1 15.6 3.6 9.7 21.9 17.0 7.2 12.4 8.3 11.0 3.1 5.3 13.1 11.8 11.6 28.2 32.5 7.8 35.7 6.8 7.9 36.2 22.9 13.0 29.4 21.3 76.4 25.8 38.9 24.3 11.1 20.6 47.2 18.1 23.1 5.3 35.7 74.0 19.2 52.1 28.0 10.9 35.8 31.1 11.7 21.9 25.4 6.7 8.7 20.4 22.6 45.7 17.1 10.2 89.2 44.8 37.4 40.0 13.0 55.4 79.0 21.0 80.5 10.9 17.0 40.8 29.4 26.4 42.7 26.1 4.6 22.0 43.9 23.3 29.1 37.9 30.9 33.6 27.2 29.6 45.7 14.1 27.8 24.5 16.5 14.8 13.7 12.7 13.7 12.6 10.2 10.7 14.1 17.0 12.0 10.7 11.1 9.2 13.4 13.6 15.8 14.8 13.1 12.3 11.9 11.2 21.1 12.5 10.0 12.9 10.7 10.9 9.7 12.4 11.6 9.4 3.2 3.3 3.6 12.9 15.9 3.5 13.2 10.8 42.0 12.8 13.3 4.4 5.7 5.2 9.2 2.1 20.5 13.7 23.0 7.9 19.5 0.4 4.7 7.1 8.1 13.2 6.3 6.0 26.9 25.7 6.8 17.9 8.2 0.0 10.9 9.3 5.1 19.6 1.7 4.2 11.5 10.2 5.7 7.0 1.8 6.8 9.0 14.2 1.9 19.2 11.1 23.7 1.5 3.5 29.9 16.6 6.4 19.5 6.3 21.1 10.2 3.4 3.8 13.1 3.6 9.4 3.6 11.4 11.5 16.8 14.6 11.9 13.3 20.7 5.0 RRAD "RAD, REM3" ENSG00000166592 "RRAD, Ras related glycolysis inhibitor and calcium channel regulator" P55042 16 66921679-66925536 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 305.8;skeletal muscle: 769.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 302.0;Endometrial ciliated cells: 477.6;Glandular and luminal cells: 245.5;Respiratory ciliated cells: 214.9;Skeletal myocytes: 179.2;Smooth muscle cells: 232.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HDLM-2: 194.2;U-87 MG: 51.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041755 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 59: Non-specific - Translation" "Cluster 44: HDLM-2 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA041755: AB_2677655" "unprognostic (1.40e-2)" "unprognostic (2.78e-2)" "unprognostic (9.77e-2)" "unprognostic (3.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-3)" "unprognostic (3.46e-2)" "unprognostic (3.33e-2)" "unprognostic (2.04e-2)" "unprognostic (4.80e-3)" 56.5 18.1 4.1 5.5 6.4 4.7 24.4 16.8 14.6 34.6 12.0 16.3 3.4 21.0 1.7 101.2 35.2 11.9 305.8 5.0 5.3 45.0 5.1 52.3 4.0 4.2 6.0 18.8 2.5 1.7 14.4 32.6 4.2 18.4 1.1 2.5 29.4 3.5 769.7 19.9 10.9 6.3 4.9 2.8 13.9 6.7 5.6 1.7 13.7 28.3 3.2 27.4 32.9 6.3 0.1 8.5 0.2 0.1 0.0 0.8 0.3 4.9 0.5 0.8 4.2 2.2 5.9 0.2 4.8 0.3 1.5 0.4 0.2 0.3 0.7 194.2 0.3 0.0 0.3 2.1 8.0 0.0 0.6 2.3 0.9 14.3 0.2 3.3 0.0 0.1 0.2 3.8 0.6 0.2 0.0 0.5 0.7 0.0 0.3 0.6 0.2 0.0 0.9 0.1 0.3 0.6 4.5 0.0 0.0 0.7 0.0 0.5 0.0 0.4 0.5 0.3 0.4 6.2 0.2 0.5 51.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 6.4 16.8 14.6 5.0 5.3 4.2 6.0 4.2 4.9 5.6 6.3 17.0 70.5 150.0 3.3 33.6 9.4 3.7 11.3 4.0 21.4 10.7 15.9 302.0 0.0 18.9 68.0 10.4 4.1 22.5 9.7 23.5 47.4 1.6 477.6 36.7 18.1 10.7 0.0 0.8 3.2 8.2 39.4 10.7 245.5 34.2 26.4 0.7 0.0 1.4 1.7 1.0 7.8 14.2 1.9 36.2 0.7 0.6 24.6 23.2 1.9 0.6 2.4 0.0 0.5 0.6 55.3 5.0 5.3 59.5 30.7 3.4 11.3 214.9 3.2 111.7 179.2 232.6 1.7 5.2 148.1 10.1 5.6 12.4 0.5 6.9 2.6 RRAGA "FIP-1, RAGA" ENSG00000155876 "Ras related GTP binding A" Q7L523 9 19049427-19051025 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Supported Approved "Golgi apparatus,Vesicles" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (6.30e-2)" "unprognostic (4.65e-1)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (6.74e-2)" "unprognostic (2.17e-2)" "unprognostic (2.11e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (3.13e-1)" "unprognostic (2.65e-1)" "unprognostic (1.74e-2)" "unprognostic (4.88e-2)" "unprognostic (2.10e-3)" "unprognostic (1.05e-1)" 79.3 73.7 73.6 39.6 75.1 30.2 72.8 77.5 82.5 67.3 74.6 74.0 38.6 94.8 77.4 62.1 74.7 49.7 87.1 76.7 83.5 67.7 68.3 51.9 46.4 73.5 74.2 83.0 46.7 47.6 68.7 71.0 77.5 58.1 45.6 39.7 53.3 73.8 128.9 72.5 57.1 82.7 80.2 52.9 57.1 40.2 78.1 53.2 57.1 104.5 47.9 70.7 58.0 84.5 115.2 92.7 74.9 78.4 263.8 167.0 51.5 112.7 134.4 96.2 117.7 35.8 34.7 22.6 61.1 190.8 86.7 42.8 64.8 106.6 101.2 97.7 72.8 145.3 122.6 139.0 172.8 20.3 52.7 148.8 101.3 82.2 55.7 132.4 116.1 36.9 33.4 32.1 202.5 72.5 56.2 118.8 41.9 59.5 70.6 43.0 48.8 32.6 147.9 98.8 61.4 76.6 61.9 55.5 60.4 67.5 71.3 54.0 91.0 116.2 44.6 83.6 85.3 22.5 39.4 51.6 127.9 30.8 43.1 155.3 85.6 147.8 74.5 98.0 72.7 49.4 77.1 74.6 81.0 50.4 70.1 69.8 58.9 81.9 109.3 58.2 100.0 107.8 73.6 75.1 77.5 82.5 76.7 83.5 73.5 74.2 77.5 80.2 78.1 84.5 84.3 25.6 27.7 16.0 35.0 61.1 123.7 138.8 50.7 47.8 43.2 57.9 51.8 41.5 63.8 53.3 18.8 130.9 28.1 32.9 105.7 95.9 92.5 74.0 70.6 86.5 17.5 38.1 17.5 61.4 98.6 80.3 28.1 47.2 33.6 38.0 71.4 61.9 64.6 48.8 20.0 29.8 81.4 37.1 33.2 28.3 93.8 39.2 56.9 20.6 51.0 95.4 49.4 21.1 29.6 52.3 44.3 103.0 24.0 50.8 51.4 130.1 75.4 37.0 32.9 65.3 79.1 113.8 22.9 47.7 59.2 121.4 37.3 61.6 34.8 74.8 RRAGB ENSG00000083750 "Ras related GTP binding B" Q5VZM2 X 55717749-55758774 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 72.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (2.01e-1)" "unprognostic (2.82e-3)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.44e-2)" "prognostic favorable (3.31e-5)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (3.64e-6)" "unprognostic (8.89e-3)" "unprognostic (1.56e-2)" "unprognostic (1.31e-2)" "unprognostic (2.71e-3)" "unprognostic (2.74e-2)" "unprognostic (3.35e-2)" "unprognostic (6.21e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" 12.6 14.8 13.1 7.1 13.4 8.2 14.7 11.0 12.9 14.0 9.9 12.3 6.9 18.5 34.7 8.9 20.5 13.0 15.2 13.5 14.2 16.2 8.0 11.1 8.3 11.2 14.0 22.2 8.0 23.1 14.9 11.4 12.5 16.4 9.6 17.1 8.9 18.0 12.0 12.1 8.8 17.3 12.4 11.3 9.6 9.2 15.2 10.2 22.9 15.9 8.7 12.0 10.0 12.5 11.9 8.9 10.0 7.6 34.7 32.2 2.6 10.3 19.0 9.1 12.2 5.2 7.7 3.5 72.6 14.4 7.6 7.5 9.1 5.8 8.4 6.5 12.7 5.2 12.1 10.5 24.6 8.4 8.0 38.4 21.9 6.8 8.8 36.8 12.3 9.3 7.3 8.1 15.3 8.8 4.5 11.7 10.4 3.2 14.4 17.0 11.1 10.0 13.9 15.3 10.0 8.9 14.2 4.4 15.6 25.4 12.9 8.8 6.8 11.2 5.2 10.4 5.6 11.1 16.4 6.7 8.5 18.2 5.0 7.1 4.7 4.1 5.0 6.7 7.5 6.8 6.5 6.9 7.3 10.4 7.4 7.5 1.4 6.5 3.9 4.6 7.5 4.0 13.1 13.4 11.0 12.9 13.5 14.2 11.2 14.0 12.5 12.4 15.2 12.5 14.5 12.8 17.4 22.9 16.0 8.7 15.3 16.1 19.4 20.4 9.7 10.2 16.4 4.3 10.4 18.4 14.6 7.4 6.8 4.9 27.4 9.8 1.8 14.3 16.1 12.7 4.2 11.1 32.4 5.0 5.5 15.6 10.7 11.9 17.1 16.7 5.7 2.6 7.3 20.2 29.6 5.1 8.2 5.4 7.8 2.9 9.9 7.9 5.4 23.4 7.8 27.0 2.1 28.6 38.2 4.3 10.8 15.4 6.4 9.0 7.3 19.3 10.4 25.6 0.0 17.9 16.6 7.7 14.6 11.2 7.7 4.8 11.8 26.9 6.9 6.9 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656068-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 1.8;GAMG: 1.4;HBF TERT88: 2.4;hTEC/SVTERT24-B: 1.7;RH-30: 2.1;U-251 MG: 1.6" "Region enriched" "Detected in single" 9 "hippocampal formation: 2.8" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737" "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 1.0 1.1 0.0 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RUSF1 "C16orf58, FLJ13868" ENSG00000140688 "RUS family member 1" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.8;Cytotrophoblasts: 22.3;Extravillous trophoblasts: 21.0;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 27.1 31.8 19.6 20.0 18.9 21.5 28.8 12.0 21.3 45.4 14.2 29.6 31.3 43.2 20.7 26.5 38.2 23.0 28.5 19.9 19.7 29.5 57.9 25.0 19.8 17.0 16.0 49.6 56.8 46.2 48.4 25.7 18.5 39.1 19.1 22.4 64.8 34.2 9.4 26.9 30.3 25.6 13.8 22.3 39.5 21.4 17.0 18.0 42.0 9.8 15.6 31.8 31.4 17.0 28.6 37.2 22.7 39.7 51.7 34.3 42.3 33.4 56.6 25.5 30.2 11.3 49.1 24.5 69.4 49.8 32.9 39.0 22.9 31.0 11.8 35.8 23.0 24.8 20.6 28.8 74.8 29.4 28.6 41.7 33.1 33.7 68.5 50.2 24.9 38.4 37.3 40.9 25.3 53.9 13.7 19.8 17.8 41.8 24.1 31.1 34.2 74.8 29.3 17.6 24.8 38.2 25.2 65.3 52.8 21.5 56.6 42.9 22.0 44.3 24.7 28.7 22.1 59.0 37.0 18.8 56.7 44.7 62.5 3.1 5.7 7.6 7.8 8.4 7.2 6.7 8.2 7.8 9.7 6.3 7.9 7.0 0.9 9.4 8.1 8.9 9.4 7.2 19.6 18.9 12.0 21.3 19.9 19.7 17.0 16.0 18.5 13.8 17.0 17.0 5.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 22.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 21.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 22.3 0.4 0.0 0.0 0.0 RXRA NR2B1 ENSG00000186350 "Retinoid X receptor alpha" P19793 9 134317098-134440585 "Cancer-related genes, FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 218.9;Kupffer cells: 134.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 19.5" "Group enriched" "Detected in many" 5 "granulocytes: 19.5;monocytes: 12.9" "Cell line enhanced" "Detected in many" "HaCaT: 105.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004565, CAB005352" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Golgi apparatus" "CAB004565: AB_2184877, CAB005352: AB_2184874" "unprognostic (2.68e-1)" "unprognostic (7.94e-2)" "unprognostic (3.67e-2)" "unprognostic (7.22e-2)" "unprognostic (2.07e-2)" "unprognostic (6.69e-2)" "unprognostic (1.52e-1)" "unprognostic (2.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.65e-3)" "prognostic favorable (7.02e-4)" "unprognostic (7.72e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "unprognostic (1.49e-2)" "unprognostic (2.59e-1)" 40.5 22.7 33.5 14.5 36.4 18.9 11.2 25.5 29.4 12.2 16.9 16.6 25.8 13.5 8.7 28.5 16.5 13.6 19.4 27.1 30.2 16.0 32.9 18.8 8.2 32.9 31.3 21.7 25.4 45.1 3.5 14.5 30.8 15.6 10.0 5.4 21.7 17.1 106.5 88.1 28.0 11.1 30.4 25.1 14.7 7.9 42.7 6.0 17.6 51.9 7.6 16.2 8.2 22.6 19.6 36.4 14.7 21.9 42.8 19.1 66.7 14.1 16.1 9.6 6.5 20.7 28.0 0.0 25.8 22.5 15.1 105.5 7.7 32.8 2.9 26.3 7.2 0.1 47.5 30.0 20.4 18.8 4.8 29.0 52.1 11.5 10.6 12.9 12.8 1.6 26.0 1.1 8.7 61.8 1.1 59.5 17.5 63.4 16.9 7.4 30.3 36.7 12.2 64.3 17.2 10.5 37.3 46.9 10.6 7.1 44.9 78.8 16.5 16.2 23.4 17.4 9.7 1.7 0.2 0.4 11.6 33.9 12.7 1.3 8.1 6.6 1.4 12.9 0.2 0.3 0.9 1.0 3.2 0.1 0.2 1.2 19.5 2.2 11.2 0.7 1.2 3.2 33.5 36.4 25.5 29.4 27.1 30.2 32.9 31.3 30.8 30.4 42.7 22.6 32.1 32.1 22.9 36.2 4.6 34.5 16.5 21.1 12.5 6.0 16.7 14.4 38.8 72.9 26.2 9.2 25.0 30.1 11.0 72.3 1.9 13.9 4.3 19.8 16.6 28.9 9.6 30.9 9.1 14.1 29.5 23.7 17.9 17.4 1.3 21.3 71.0 218.9 31.9 33.7 17.6 21.2 10.2 134.2 30.0 18.8 32.3 50.4 12.4 10.3 80.4 36.5 14.4 29.1 6.0 15.9 32.4 21.1 7.4 17.7 55.6 19.9 34.4 19.9 19.7 34.6 30.6 0.9 9.4 34.4 46.9 23.9 12.6 15.5 27.5 32.8 RXYLT1 "HP10481, TMEM5" ENSG00000118600 "Ribitol xylosyltransferase 1" Q9Y2B1 12 63779842-63809562 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Transferase "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 37.2;Endometrial stromal cells: 34.5;Extravillous trophoblasts: 33.8;Syncytiotrophoblasts: 37.1;Theca cells: 45.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064014 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Golgi apparatus" "HPA064014: AB_2685176" "unprognostic (1.19e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (3.58e-1)" "unprognostic (1.33e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.47e-2)" "unprognostic (2.09e-3)" "unprognostic (3.17e-1)" "unprognostic (7.03e-2)" "unprognostic (1.39e-1)" "unprognostic (9.33e-2)" "unprognostic (5.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" 6.6 12.0 6.9 4.9 7.6 4.4 10.8 7.1 8.5 7.1 7.2 6.9 5.7 6.7 15.3 5.6 7.9 5.5 14.3 6.8 7.9 10.9 8.5 5.2 7.4 7.5 7.0 12.0 11.8 15.4 9.0 5.7 7.7 8.4 7.5 9.9 8.3 7.0 10.7 8.3 4.2 6.1 7.5 5.7 5.5 11.8 7.3 7.3 12.8 8.7 7.2 7.4 5.5 9.3 9.6 19.9 14.2 11.7 12.2 16.4 13.5 10.4 18.5 17.7 11.9 6.6 10.1 20.5 17.7 13.4 14.2 9.3 17.5 16.0 22.3 18.5 13.4 11.5 5.1 12.2 18.1 17.6 10.0 14.6 15.6 17.1 22.6 16.8 10.4 16.5 14.0 19.8 27.8 18.3 10.2 8.1 8.1 10.4 20.6 9.0 14.8 13.1 17.8 15.1 30.7 5.9 10.4 9.5 24.5 9.0 20.2 9.9 10.1 14.9 15.2 9.7 15.4 10.6 17.9 15.6 10.9 11.4 20.9 0.8 1.7 1.0 1.9 1.6 3.5 3.0 2.4 2.6 1.7 2.2 2.8 2.6 0.3 3.0 2.2 4.1 4.3 1.2 6.9 7.6 7.1 8.5 6.8 7.9 7.5 7.0 7.7 7.5 7.3 9.3 17.5 9.6 8.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 26.8 26.8 0.0 0.0 10.5 16.5 0.0 24.7 6.9 0.0 37.2 23.1 0.0 28.6 34.5 8.1 0.0 0.0 0.0 30.7 33.8 12.1 0.0 16.6 7.6 15.5 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 8.3 0.0 0.0 0.0 0.0 17.3 0.0 0.0 2.4 0.0 0.0 30.3 13.8 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 37.1 4.8 45.0 0.0 0.0 RYK "D3S3195, JTK5, JTK5A, RYK1" ENSG00000163785 "Receptor like tyrosine kinase" P34925 3 134065303-134250859 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034117, HPA045503, HPA075430" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Cytosol "CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293" "unprognostic (7.84e-2)" "unprognostic (5.82e-2)" "unprognostic (2.22e-2)" "unprognostic (2.34e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.60e-2)" "unprognostic (6.59e-2)" "unprognostic (1.62e-1)" "unprognostic (1.07e-3)" "unprognostic (9.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-1)" "unprognostic (3.43e-1)" "unprognostic (2.85e-2)" 31.8 25.2 15.7 15.7 16.2 17.1 42.8 15.4 19.8 40.2 19.9 34.5 20.1 46.1 40.0 29.6 33.4 24.3 30.3 14.5 15.3 25.4 22.3 25.3 18.9 15.9 15.6 82.1 24.5 29.7 17.0 36.6 15.5 36.3 26.2 15.9 26.9 43.9 25.3 34.7 21.4 40.6 16.3 22.9 23.2 47.0 16.5 21.2 40.9 32.2 20.5 34.7 32.6 16.4 78.8 20.6 63.3 48.7 79.8 84.4 48.8 51.0 117.7 66.4 74.2 65.6 58.8 15.3 82.4 63.1 63.7 71.6 45.5 64.3 94.5 25.9 20.5 40.6 22.4 42.4 62.2 20.0 34.4 56.1 74.0 41.2 82.2 72.5 56.5 26.4 14.5 7.5 66.0 37.6 28.0 25.9 53.4 65.2 24.3 13.7 48.4 32.4 54.5 57.3 31.0 45.6 61.7 44.5 79.1 40.5 55.7 35.8 42.1 54.8 49.6 57.8 41.8 3.1 4.2 8.3 34.8 33.1 39.6 4.6 0.8 1.6 1.1 0.8 1.3 0.6 2.0 1.3 0.3 1.2 1.9 1.5 0.3 1.6 0.8 0.0 0.5 0.5 15.7 16.2 15.4 19.8 14.5 15.3 15.9 15.6 15.5 16.3 16.5 16.4 62.5 12.8 27.9 31.6 20.6 41.3 36.6 26.3 39.3 23.1 45.4 37.2 34.9 18.6 23.7 44.1 29.2 19.4 23.1 15.9 0.0 15.9 16.2 27.6 41.7 31.0 13.9 13.2 69.5 21.1 14.7 41.3 15.8 32.7 17.7 121.2 40.7 24.1 11.3 13.5 59.7 20.9 12.2 18.6 21.6 7.4 33.2 16.1 14.2 65.6 12.8 26.8 13.4 65.9 57.9 21.7 19.7 32.7 12.9 42.8 15.4 10.5 13.9 39.8 46.0 33.8 38.1 24.6 40.9 33.7 38.1 10.8 18.4 50.8 22.2 38.9 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433691-38587564 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 1618.9" "Cell type enhanced" "Detected in many" "Astrocytes: 29.4;Basal squamous epithelial cells: 22.8;Microglial cells: 49.6;Muller glia cells: 50.6;Skeletal myocytes: 41.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.8;myeloid DC: 2.9;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 8 "dendritic cells: 2.9;monocytes: 3.8" "Cell line enhanced" "Detected in some" "A549: 7.7;HaCaT: 18.9;hTCEpi: 7.6;RH-30: 15.3;SiHa: 30.7;U-2 OS: 12.4" "Low region specificity" "Detected in single" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" NA NA 46000 "Cluster 51: Monocytes - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 37: Myocytes - Muscle contraction" "Golgi apparatus, Vesicles" Cytosol "HPA056416: AB_2683121" "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 1.4 2.4 10.3 1.6 8.0 0.3 2.1 8.5 9.3 2.1 1.0 1.2 0.5 0.7 1.3 17.2 1.7 1.1 0.9 7.5 20.5 1.9 0.4 2.6 2.1 8.6 9.7 0.9 0.4 1.9 1.5 1.8 7.7 3.8 0.3 10.6 14.0 1.4 1618.9 13.3 1.3 0.8 2.6 1.7 1.0 8.9 22.6 1.5 1.2 286.6 2.6 1.0 3.3 6.1 0.0 7.7 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.4 0.5 6.3 0.0 0.0 18.9 0.2 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.6 1.7 7.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.5 1.0 0.0 0.0 15.3 1.5 0.8 0.0 0.0 1.5 30.7 0.0 0.0 0.6 0.7 5.9 0.0 0.0 12.4 0.3 0.0 0.4 1.4 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.2 1.8 0.2 0.2 0.1 0.3 2.9 0.3 0.0 0.0 0.0 0.0 3.8 0.0 0.4 0.3 10.3 8.0 8.5 9.3 7.5 20.5 8.6 9.7 7.7 2.6 22.6 6.1 0.3 0.0 1.1 29.4 1.4 11.3 3.8 6.6 22.8 8.9 0.5 7.9 3.6 0.0 1.1 0.0 2.1 0.2 1.2 0.0 5.9 0.1 6.7 0.2 0.9 1.0 0.0 0.4 10.2 0.0 0.4 0.9 0.0 0.5 0.0 0.3 0.7 0.0 8.8 1.7 17.2 0.0 2.0 2.9 15.2 5.9 3.1 6.2 0.0 49.6 1.3 50.6 0.0 13.6 2.0 0.0 0.0 1.9 0.9 0.8 0.0 0.2 0.4 1.8 0.0 41.7 1.2 6.3 7.4 7.5 4.7 0.3 2.6 0.4 0.0 0.7 S100A1 "S100-alpha, S100A" ENSG00000160678 "S100 calcium binding protein A1" P23297 1 153627926-153632039 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 3076.8;skeletal muscle: 3060.2;tongue: 4911.5" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 1848.3" "Group enriched" "Detected in all" 5 "melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "Hep G2: 325.8;SK-MEL-30: 1130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002599, HPA006462" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 290000 "Cluster 10: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Nucleoplasm, Golgi apparatus" "CAB002599: AB_2315307, HPA006462: AB_1079857" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (5.96e-5)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.19e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-3)" "unprognostic (6.83e-3)" "unprognostic (5.22e-1)" "unprognostic (5.04e-3)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.68e-1)" "unprognostic (4.56e-2)" "unprognostic (2.70e-3)" "unprognostic (9.74e-4)" 179.7 8.3 811.3 6.5 898.6 2.3 77.2 851.4 952.4 2.9 643.9 14.5 11.1 4.2 1.0 81.0 41.8 4.9 3076.8 779.4 813.6 194.9 4.5 3.9 5.1 907.6 894.8 2.0 16.8 160.9 54.6 18.1 871.2 29.0 1.2 36.5 622.1 9.3 3060.2 23.0 6.9 1.6 847.7 4.2 23.1 5.9 882.9 9.4 167.9 4911.5 4.0 4.3 2.9 967.6 6.0 3.4 3.9 33.7 0.5 0.2 2.9 7.7 0.2 0.6 0.2 6.6 3.4 3.7 137.7 0.6 2.7 10.3 0.3 0.4 0.0 4.2 3.3 8.2 5.4 325.8 0.4 3.0 2.3 0.7 0.0 0.0 0.1 7.9 0.0 1.5 27.2 3.7 0.1 10.6 1.2 4.9 1.8 4.3 2.6 22.5 3.3 8.0 6.0 12.1 6.1 1.9 3.5 10.6 1130.2 11.1 32.8 16.2 2.7 3.3 2.8 3.0 3.8 6.1 5.7 6.2 2.5 6.2 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 811.3 898.6 851.4 952.4 779.4 813.6 907.6 894.8 871.2 847.7 882.9 967.6 4.3 0.0 0.0 59.4 9.5 9.7 1.2 0.4 1.8 1.1 369.9 354.1 74.4 8.6 0.2 154.5 2.1 1.1 5.9 1.1 162.4 0.9 0.6 90.5 17.3 5.3 1.8 0.0 0.3 3.7 1.9 6.0 0.0 193.3 0.0 0.0 7.9 4.7 199.1 0.0 0.3 3.7 0.0 0.6 3.5 2.2 6.5 15.6 341.5 2.8 0.0 163.5 0.0 2.0 45.8 1.9 0.6 9.1 0.0 1.8 0.9 1848.3 0.2 2.7 0.0 67.0 4.2 3.8 2.8 1.0 2.3 3.4 8.2 2.3 1.8 0.7 S100A3 S100E ENSG00000188015 "S100 calcium binding protein A3" P33764 1 153547329-153549258 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 94.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 15.4;Ductal cells: 21.7;Endometrial stromal cells: 18.4;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 24.2;Skeletal myocytes: 24.7" "Cancer enhanced" "Detected in all" "urothelial cancer: 26.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 3.1;non-classical monocyte: 6.2;plasmacytoid DC: 7.4" "Group enriched" "Detected in many" 11 "dendritic cells: 7.4;monocytes: 6.2" "Cell line enhanced" "Detected in many" "A549: 87.0;HBEC3-KT: 45.7;HeLa: 51.4;U-2197: 47.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 15.8" "HPA042674, HPA056140" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA 240000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 31: Skin - Epidermis development" "Cluster 20: HeLa - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "Golgi apparatus, Plasma membrane" "HPA042674: AB_10796581, HPA056140: AB_2683050" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (4.53e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-1)" "unprognostic (2.08e-1)" "unprognostic (5.34e-3)" "unprognostic (3.97e-3)" "prognostic unfavorable (1.61e-6)" "unprognostic (8.13e-2)" "unprognostic (3.46e-1)" "unprognostic (6.21e-2)" "unprognostic (8.10e-2)" 7.6 1.1 0.9 3.6 1.1 1.8 4.2 0.8 1.3 6.9 0.6 2.8 0.5 3.9 0.2 17.2 3.3 1.7 2.6 0.8 1.4 13.8 0.2 16.6 1.8 1.4 1.6 1.1 0.8 0.1 0.7 2.2 1.2 3.0 1.1 0.0 4.2 1.7 1.0 94.6 1.9 2.1 1.1 0.8 1.4 0.5 2.8 0.4 1.5 1.9 5.1 6.9 9.6 1.4 7.3 87.0 0.1 0.1 8.1 5.2 0.0 6.1 31.4 7.9 12.8 2.6 2.8 0.1 19.0 16.1 10.7 22.2 0.1 45.7 3.7 0.3 0.0 0.3 51.4 15.3 2.2 0.0 0.3 4.1 24.9 17.9 19.9 4.5 1.7 0.0 0.0 0.0 39.8 0.5 0.0 0.0 0.6 0.2 11.5 0.0 5.9 4.7 26.0 18.3 1.2 0.0 5.4 6.1 2.0 24.7 0.2 0.6 8.6 2.9 4.8 47.4 6.3 1.4 1.6 0.2 38.2 0.7 19.1 0.0 0.1 0.0 0.0 3.1 0.2 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.2 7.4 0.1 0.4 0.9 1.1 0.8 1.3 0.8 1.4 1.4 1.6 1.2 1.1 2.8 1.4 2.0 3.2 0.5 0.7 0.0 10.3 2.3 15.4 4.0 0.0 0.3 0.4 0.3 1.5 5.9 0.0 0.0 0.3 0.0 0.0 1.9 21.7 0.0 2.3 18.4 7.4 0.0 1.3 0.0 24.0 4.4 8.4 0.0 1.3 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.1 0.1 4.1 0.4 1.8 0.0 3.6 0.0 0.0 0.0 0.0 24.2 0.0 0.4 0.0 1.5 0.0 0.3 1.1 0.0 0.0 24.7 9.6 0.1 0.0 5.6 6.5 1.5 0.5 1.1 0.0 2.0 S1PR2 "AGR16, DFNB68, EDG5, Gpcr13, H218" ENSG00000267534 "Sphingosine-1-phosphate receptor 2" O95136 19 10221433-10231331 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 92.9;Early spermatids: 92.3;Late spermatids: 184.9;Syncytiotrophoblasts: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 45.0" "Group enriched" "Detected in many" 8 "granulocytes: 45.0;T-cells: 12.4" "Cell line enhanced" "Detected in many" "BEWO: 29.4;Daudi: 54.1;U-266/70: 38.9;U-698: 57.3;WM-115: 38.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014255, HPA014307" Approved Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" "Nuclear speckles" "HPA014255: , HPA014307: AB_1847989" "unprognostic (5.38e-3)" "unprognostic (1.83e-3)" "unprognostic (1.20e-1)" "unprognostic (1.26e-2)" "unprognostic (3.31e-2)" "unprognostic (1.05e-3)" "unprognostic (8.50e-2)" "unprognostic (8.71e-2)" "unprognostic (2.84e-1)" "unprognostic (1.70e-1)" "unprognostic (7.40e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.91e-2)" "unprognostic (4.56e-2)" "unprognostic (3.11e-1)" "unprognostic (8.09e-2)" 7.7 2.5 1.9 6.4 1.8 1.2 5.5 1.7 1.8 10.4 1.9 4.8 1.8 8.3 2.7 3.3 8.4 6.2 6.6 1.6 2.0 3.1 5.6 13.7 10.9 2.8 1.9 5.6 2.9 2.5 3.0 18.5 2.2 6.9 2.4 1.2 4.1 2.3 0.8 5.4 4.8 4.2 2.0 1.9 4.3 13.2 2.1 1.4 3.4 1.3 10.9 8.3 7.0 2.9 3.0 0.4 3.4 6.9 18.2 22.2 29.4 4.4 8.9 1.9 4.1 1.9 1.7 54.1 5.1 8.2 2.3 1.7 1.2 2.1 1.3 5.5 2.7 1.2 1.2 1.3 6.1 1.4 1.1 12.2 1.1 3.8 1.3 5.3 0.2 2.6 1.3 11.1 1.3 2.5 0.6 2.5 3.4 0.9 1.7 3.8 1.4 2.0 1.6 2.5 2.4 4.7 2.5 1.5 3.8 2.6 1.2 1.3 0.4 6.9 2.2 15.9 1.3 38.9 19.6 57.3 2.6 2.7 38.6 45.0 2.8 0.6 7.2 2.4 8.9 0.3 9.2 7.0 2.6 0.5 3.7 3.8 0.7 3.6 1.0 0.4 12.4 2.0 1.9 1.8 1.7 1.8 1.6 2.0 2.8 1.9 2.2 2.0 2.1 2.9 2.0 0.0 1.1 0.3 2.0 0.0 4.6 0.0 1.2 0.6 8.3 4.6 0.6 2.8 0.6 1.8 2.1 92.9 5.4 0.0 0.0 3.6 92.3 8.6 21.5 2.0 2.4 0.0 0.3 3.3 18.1 17.7 0.0 18.1 0.0 2.0 3.9 7.6 13.2 0.0 0.9 0.5 0.0 3.1 0.0 184.9 22.1 7.2 0.0 0.0 4.0 7.1 3.1 6.6 0.5 2.7 0.3 13.2 2.6 4.9 0.0 0.9 0.0 0.5 13.1 2.0 4.6 1.5 1.2 2.0 0.0 68.4 4.2 1.1 0.2 4.1 SACM1L "KIAA0851, SAC1" ENSG00000211456 "SAC1 like phosphatidylinositide phosphatase" Q9NTJ5 3 45689056-45745409 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039573, HPA069869" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 82000 "Cluster 48: NK-cells - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Golgi apparatus" "HPA039573: AB_10674983, HPA069869: AB_2686216" "unprognostic (2.07e-1)" "unprognostic (4.08e-1)" "unprognostic (1.36e-3)" "unprognostic (1.14e-1)" "unprognostic (2.31e-2)" "unprognostic (4.34e-2)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" "unprognostic (8.54e-2)" "unprognostic (1.94e-2)" "unprognostic (1.22e-2)" "unprognostic (6.29e-3)" "prognostic favorable (5.47e-7)" "unprognostic (3.50e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-1)" "unprognostic (1.33e-2)" 23.5 26.3 13.2 26.2 13.8 21.1 22.0 17.1 16.1 22.1 13.6 24.0 23.3 20.6 23.3 20.2 16.9 19.2 16.3 14.0 18.8 38.1 28.2 28.9 26.8 15.5 14.9 16.2 21.8 35.8 10.9 25.0 14.7 24.3 23.6 20.3 22.9 20.6 8.8 18.4 21.6 21.2 14.6 26.2 25.0 14.2 15.9 32.5 43.5 11.4 25.0 22.9 10.8 16.3 31.0 23.0 38.0 22.0 58.8 39.2 29.6 50.1 43.0 36.9 33.1 30.5 21.8 47.8 24.3 39.8 49.8 22.7 50.4 27.0 48.9 34.3 26.8 50.8 38.2 25.7 37.6 78.0 61.5 26.5 41.1 39.9 29.6 29.9 25.6 43.2 57.9 45.7 60.6 14.0 59.5 41.4 40.1 29.6 40.1 17.2 20.0 48.4 41.2 42.7 15.0 36.1 35.5 36.3 44.7 38.0 31.0 64.1 33.7 36.2 21.1 37.0 44.5 25.3 71.7 32.5 45.1 106.8 36.2 10.3 17.1 27.5 24.6 14.2 27.5 11.0 17.8 26.0 27.2 11.9 17.6 23.5 14.1 65.2 13.0 11.1 16.7 27.6 13.2 13.8 17.1 16.1 14.0 18.8 15.5 14.9 14.7 14.6 15.9 16.3 18.4 28.9 37.3 22.5 22.2 19.6 9.1 14.6 22.2 22.8 15.2 12.3 16.6 14.3 15.7 7.3 31.3 22.9 55.4 16.4 19.6 11.1 1.6 15.9 31.9 17.6 12.0 23.4 44.7 10.0 11.2 19.5 17.3 18.5 17.1 17.2 17.2 15.4 24.5 33.7 42.7 9.4 18.3 23.0 18.7 2.9 16.8 22.6 17.8 30.9 25.5 15.8 46.4 40.7 43.6 12.9 20.7 23.0 33.2 14.6 18.5 22.3 14.1 20.7 6.6 15.8 16.6 12.3 12.0 15.7 17.3 18.3 44.5 19.5 13.6 11.6 SAMD12 FLJ39458 ENSG00000177570 "Sterile alpha motif domain containing 12" Q8N8I0 8 118189455-118622112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Excitatory neurons: 537.6;Inhibitory neurons: 531.7;Oligodendrocytes: 1158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 34.6;U-266/70: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024634 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Cytosol" "HPA024634: AB_1856549" "unprognostic (6.96e-2)" "unprognostic (9.35e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (4.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.99e-2)" "unprognostic (1.68e-1)" "unprognostic (3.94e-3)" "unprognostic (2.01e-1)" "prognostic favorable (1.52e-6)" "unprognostic (3.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (6.35e-3)" 0.7 1.4 2.4 1.1 4.9 0.4 3.0 0.7 8.8 2.3 0.0 4.0 3.7 1.1 4.0 4.1 5.3 3.6 6.9 7.5 0.8 5.2 1.6 4.2 0.7 1.4 0.5 0.9 1.9 9.6 3.3 0.1 2.6 3.7 4.7 5.9 2.4 5.0 0.8 0.8 2.0 0.7 0.9 2.6 5.7 1.3 2.1 1.0 10.2 0.1 2.0 4.4 1.1 8.4 10.2 0.7 0.9 0.0 0.0 0.0 2.1 3.4 10.4 7.8 4.3 1.1 12.1 3.4 0.8 8.2 1.6 1.9 2.0 4.7 11.9 0.1 1.1 0.0 5.7 0.0 0.0 0.0 0.2 0.0 2.3 4.6 0.4 2.8 0.2 5.9 0.0 6.0 6.0 2.0 1.6 0.0 0.8 13.2 1.3 0.0 0.0 9.7 5.4 13.5 4.0 0.0 2.8 34.6 0.0 2.1 0.5 0.0 0.0 0.1 3.8 1.4 1.2 14.9 10.2 0.4 1.8 0.0 1.1 0.1 0.0 0.0 0.1 0.0 1.0 1.5 0.8 0.5 0.0 1.0 1.0 0.6 0.1 0.6 0.0 0.3 0.8 0.2 2.4 4.9 0.7 8.8 7.5 0.8 1.4 0.5 2.6 0.9 2.1 8.4 4.7 112.2 95.0 53.5 8.0 1.7 10.1 10.3 13.1 16.8 10.9 5.1 12.1 12.8 57.5 29.5 43.8 0.0 3.3 10.5 19.6 12.9 5.2 12.1 1.5 13.0 14.3 2.1 537.6 12.4 0.1 9.1 26.5 16.4 56.8 4.4 7.5 5.2 0.1 30.3 531.7 11.2 14.2 0.3 0.0 6.1 0.3 6.5 7.2 163.0 0.7 4.5 4.1 122.6 1158.0 13.0 3.5 0.4 16.9 5.0 8.6 17.4 68.0 26.9 0.0 0.5 0.9 0.5 2.4 15.9 1.7 0.0 8.9 4.5 11.9 13.6 SART1 "Ara1, HAF, SNRNP110, Snu66" ENSG00000175467 "Spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP" O43290 11 65961728-65980137 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Allergen, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031188, HPA031189, HPA031190" Supported Enhanced "Nuclear speckles,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" "Golgi apparatus" "HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289" "unprognostic (2.93e-2)" "unprognostic (1.13e-2)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-1)" "unprognostic (6.99e-2)" "unprognostic (2.52e-3)" "unprognostic (8.15e-2)" "unprognostic (8.97e-2)" "unprognostic (2.10e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" 24.6 18.3 15.5 18.3 16.8 41.6 23.1 15.4 17.4 29.2 14.7 26.0 15.6 29.1 8.0 22.7 25.6 8.6 23.2 14.9 16.1 20.4 21.8 22.9 20.3 16.6 16.2 29.2 25.8 11.7 21.4 14.0 15.9 21.7 7.7 8.0 22.2 14.4 38.1 32.0 24.3 10.9 14.6 32.7 24.8 23.5 15.7 20.9 23.5 13.0 13.3 26.2 24.6 17.9 50.4 60.8 27.2 36.8 26.1 20.7 40.8 37.5 27.2 43.8 28.6 44.2 34.3 56.9 42.4 33.8 52.9 48.7 34.6 35.6 22.0 45.8 33.5 65.6 43.6 41.4 39.0 57.4 52.7 26.2 26.4 40.8 36.3 17.4 27.6 42.3 42.2 39.8 25.6 92.6 74.0 83.5 45.7 27.3 55.9 80.8 39.0 60.7 18.4 33.7 30.5 43.0 35.6 37.2 45.5 12.6 41.7 47.0 40.6 54.5 53.0 53.9 54.1 59.6 49.4 48.3 45.0 28.8 47.0 1.4 2.8 8.1 4.3 3.5 3.6 3.9 4.8 4.4 3.6 3.5 3.5 3.9 4.1 2.8 2.0 3.2 5.4 1.8 15.5 16.8 15.4 17.4 14.9 16.1 16.6 16.2 15.9 14.6 15.7 17.9 17.5 6.4 9.1 7.8 27.8 22.7 24.0 12.2 17.6 19.2 12.2 9.1 9.4 21.5 11.3 16.5 10.4 34.1 27.2 30.5 5.9 23.7 9.0 14.2 16.3 19.8 12.5 32.8 5.1 29.3 31.9 17.6 21.9 16.8 32.4 21.8 21.0 15.6 29.4 16.8 4.8 26.5 16.2 22.5 23.6 8.7 37.0 22.9 17.8 6.5 35.7 23.8 34.0 7.1 7.8 26.3 20.1 33.1 31.2 20.5 28.3 18.5 17.5 26.0 32.9 27.6 34.9 26.7 29.7 18.3 21.7 45.3 28.4 15.5 27.5 18.2 SAXO2 "DKFZp666G057, FAM154B" ENSG00000188659 "Stabilizer of axonemal microtubules 2" Q658L1 15 82262810-82284930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 59.9;testis: 21.6" "Group enriched" "Detected in many" 4 "Early spermatids: 90.9;Endometrial ciliated cells: 71.5;Late spermatids: 175.4;Respiratory ciliated cells: 201.9;Spermatocytes: 57.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 10.5;K-562: 10.0;SCLC-21H: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040487, HPA040833" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA040487: AB_10796457, HPA040833: AB_10796561" "unprognostic (3.03e-2)" "unprognostic (3.59e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.98e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-1)" "unprognostic (4.69e-2)" "unprognostic (6.26e-2)" "unprognostic (3.11e-2)" "unprognostic (1.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.71e-2)" "unprognostic (6.20e-2)" "unprognostic (3.87e-2)" 0.9 1.1 2.1 0.3 2.2 0.6 3.2 2.3 2.7 2.3 8.3 1.3 0.7 2.2 17.9 0.6 59.9 1.0 1.3 2.5 2.3 2.7 0.9 8.0 1.2 3.2 5.0 1.7 1.6 4.7 4.9 0.4 2.4 2.6 2.0 6.9 2.8 1.2 1.3 2.1 1.6 0.6 3.1 1.2 2.5 21.6 2.5 2.6 3.5 0.8 1.6 1.3 1.0 3.7 1.4 1.9 1.1 4.1 0.9 1.8 0.5 0.5 0.3 0.8 1.5 0.2 2.3 1.4 1.0 0.0 2.2 10.5 1.8 1.6 1.8 1.0 6.8 0.5 3.4 0.0 0.1 0.3 0.4 1.2 2.2 1.4 1.2 2.3 1.7 2.9 10.0 0.7 1.0 1.0 0.5 0.0 2.7 0.5 0.8 1.4 0.5 0.9 0.8 0.9 7.8 1.2 1.1 0.0 1.5 0.6 4.0 0.4 0.2 2.0 1.1 4.2 0.8 2.1 2.6 0.9 1.9 0.5 1.3 0.0 0.0 3.0 0.5 0.0 0.8 1.3 0.2 1.5 0.1 3.3 0.9 0.4 0.0 2.0 0.1 0.8 0.0 0.3 2.1 2.2 2.3 2.7 2.5 2.3 3.2 5.0 2.4 3.1 2.5 3.7 1.8 0.0 2.7 9.1 1.5 0.0 2.0 0.0 2.8 2.7 4.5 4.1 2.7 1.5 24.1 3.7 4.2 0.5 0.9 0.1 1.9 0.7 90.9 71.5 1.5 0.9 2.4 0.8 21.1 0.5 0.4 1.5 10.2 2.0 1.3 3.7 0.4 0.3 0.1 0.0 16.4 1.9 0.0 0.6 0.0 175.4 2.5 0.5 0.0 3.7 0.0 3.7 0.0 9.0 8.0 0.3 0.1 2.2 1.9 1.5 0.3 4.6 201.9 5.0 6.6 1.0 1.0 57.7 12.7 0.9 0.0 0.3 0.7 3.0 0.5 1.6 SCAMP2 ENSG00000140497 "Secretory carrier membrane protein 2" O15127 15 74843730-74873365 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014699, HPA019194" Approved Supported "Golgi apparatus,Vesicles" NA NA 71000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "HPA014699: AB_1856605, HPA019194: AB_1856604" "unprognostic (1.74e-1)" "unprognostic (1.27e-2)" "unprognostic (2.05e-1)" "unprognostic (5.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.53e-2)" "unprognostic (7.23e-2)" "unprognostic (9.73e-3)" "unprognostic (7.26e-2)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.40e-1)" "unprognostic (1.79e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-2)" 43.1 46.7 27.8 40.3 32.8 51.5 40.7 31.9 31.2 40.5 38.8 76.0 75.7 36.9 36.9 103.4 47.4 35.4 32.4 26.1 29.8 44.9 42.0 49.6 47.9 40.7 30.9 26.5 54.5 85.6 29.4 48.9 36.7 35.5 72.7 4.7 92.7 32.4 34.2 68.3 80.1 33.6 33.6 66.8 64.9 36.2 33.3 33.0 38.3 18.9 53.4 38.1 49.4 35.4 44.7 57.3 24.2 37.6 72.0 37.2 72.0 45.0 56.6 46.9 50.1 83.0 102.6 36.5 57.8 68.1 67.7 157.8 72.3 55.9 19.4 145.8 71.1 92.8 31.2 57.6 54.3 48.0 170.9 48.0 97.6 44.4 32.0 37.0 46.0 42.0 31.3 67.5 33.3 68.1 24.6 55.3 24.1 111.0 36.6 42.6 22.3 126.4 54.0 63.1 24.9 25.0 36.7 64.3 42.4 35.4 88.5 76.3 43.4 40.2 23.9 43.8 53.0 46.1 73.2 37.6 37.8 112.2 30.2 118.3 111.3 90.0 94.1 106.9 76.1 80.8 85.3 95.9 81.8 70.9 69.4 75.8 74.4 83.8 119.3 128.7 105.3 120.8 27.8 32.8 31.9 31.2 26.1 29.8 40.7 30.9 36.7 33.6 33.3 35.4 36.0 73.7 31.7 17.9 49.5 17.5 41.7 40.5 19.4 6.8 28.0 24.8 14.4 24.3 53.1 40.5 2.1 156.9 63.4 116.8 15.6 67.4 132.3 30.8 22.0 36.2 37.3 29.0 7.7 92.8 61.9 37.2 54.0 40.6 79.2 31.3 26.4 27.7 164.7 6.7 6.1 77.5 42.7 78.3 44.5 56.2 32.0 77.0 32.0 21.5 56.9 41.4 63.8 12.1 17.9 96.1 75.5 23.0 73.1 54.0 105.7 48.1 52.6 8.4 26.3 25.6 35.8 47.1 35.3 39.6 22.3 136.4 55.1 40.0 64.2 58.5 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905372-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favorable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 23.2 27.4 31.1 15.5 39.9 11.4 25.4 41.3 33.3 28.1 33.6 23.3 19.8 26.0 17.5 39.9 38.3 19.5 15.5 28.9 33.1 34.4 28.3 25.5 15.6 51.5 42.9 27.1 36.5 15.8 31.8 18.8 47.7 31.7 9.8 7.4 43.9 20.4 13.9 36.3 20.3 12.3 39.7 25.1 26.4 22.0 40.6 8.3 32.7 5.8 9.4 22.0 25.0 53.5 53.6 53.9 25.7 56.8 50.7 31.7 29.6 35.5 33.1 39.3 46.7 44.9 51.1 22.5 32.1 30.7 23.1 63.7 24.7 38.2 14.5 34.8 21.7 15.8 19.0 44.3 65.6 16.9 23.2 48.8 24.2 34.8 21.2 32.9 27.2 25.2 35.7 25.3 23.3 67.8 21.5 31.6 38.8 31.1 18.6 25.9 18.1 34.6 49.8 47.5 33.8 45.0 23.9 49.9 31.4 18.1 50.6 41.5 29.6 44.8 30.5 81.1 35.7 57.8 62.6 21.0 59.1 26.9 30.1 1.7 4.4 1.9 3.9 4.9 2.0 5.1 2.7 2.6 4.8 3.4 1.5 2.9 2.1 5.8 4.5 12.0 2.3 3.7 31.1 39.9 41.3 33.3 28.9 33.1 51.5 42.9 47.7 39.7 40.6 53.5 16.9 9.6 7.3 12.1 22.9 17.1 25.0 20.8 33.0 19.7 40.0 23.5 3.0 21.5 14.1 49.7 75.0 40.0 59.6 53.0 7.9 20.8 0.8 63.2 23.2 17.8 18.7 11.6 8.3 12.5 38.1 18.2 43.3 42.1 17.2 27.8 15.7 13.4 38.0 21.9 8.0 36.1 20.3 20.1 24.9 1.9 21.8 24.2 21.4 5.6 21.0 29.6 33.0 16.6 18.9 16.1 25.3 17.3 16.0 30.0 47.6 10.1 33.2 52.2 0.0 15.8 15.7 19.0 26.1 30.8 20.2 59.0 20.4 26.9 31.1 28.1 SCARF1 "KIAA0149, SREC, SREC1" ENSG00000074660 "Scavenger receptor class F member 1" Q14162 17 1633858-1645744 "Predicted intracellular proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.6" "Cell type enhanced" "Detected in many" "Adipocytes: 65.9;Endothelial cells: 51.3;Hepatic stellate cells: 62.4;Langerhans cells: 37.7;Microglial cells: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 12.1;REH: 11.5;TIME: 37.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035108, HPA072936" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA 2000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "HPA035108: AB_10670289, HPA072936: AB_2686559" "unprognostic (1.94e-1)" "unprognostic (2.84e-1)" "unprognostic (2.53e-3)" "unprognostic (2.88e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.62e-2)" "unprognostic (3.76e-1)" "unprognostic (1.32e-1)" "unprognostic (2.13e-2)" "unprognostic (3.22e-2)" "unprognostic (1.38e-1)" "unprognostic (6.39e-2)" 15.2 5.0 1.5 3.1 1.8 0.4 12.7 1.4 3.4 5.6 1.4 5.2 0.0 6.0 0.9 2.7 6.5 2.2 11.8 1.6 1.8 7.5 7.5 16.3 2.1 2.7 1.7 2.6 3.1 0.1 3.8 4.3 2.2 4.6 1.2 0.2 4.2 0.0 5.3 3.1 5.4 1.2 1.7 25.6 4.2 1.6 1.7 0.5 18.8 1.9 1.0 5.6 4.6 2.8 0.0 0.1 0.3 0.3 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.3 12.1 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 11.5 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.3 37.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 1.5 1.8 1.4 3.4 1.6 1.8 2.7 1.7 2.2 1.7 1.7 2.8 65.9 22.4 17.6 6.5 0.6 3.4 0.4 0.7 1.2 1.2 0.8 0.9 3.5 0.0 2.9 3.7 4.2 0.4 2.0 4.9 1.9 0.4 0.3 0.5 0.9 51.3 0.0 3.4 5.4 0.2 0.2 2.5 4.1 1.1 3.8 0.3 62.4 2.3 9.0 0.0 3.5 4.4 0.0 15.7 37.7 0.4 1.2 10.1 3.6 26.2 4.8 0.7 0.0 0.5 1.1 0.3 1.2 1.2 0.0 0.7 3.0 0.2 3.0 2.0 0.0 2.1 3.0 0.5 0.6 0.3 2.7 1.2 1.0 1.3 2.2 0.8 SCG2 "CHGC, SgII, SN" ENSG00000171951 "Secretogranin II" P13521 2 223596940-223602361 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 360.1;brain: 426.2;pituitary gland: 269.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 212.4;Enteroendocrine cells: 283.4;Inhibitory neurons: 109.9;Ionocytes: 138.4" "Group enriched" "Detected in many" 8 "glioma: 70.0;pancreatic cancer: 52.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 53.3;HSkMC: 45.9;hTERT-RPE1: 46.5;SCLC-21H: 47.6;SH-SY5Y: 20.7;WM-115: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011893, HPA075062" Enhanced Supported Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 330000 "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Golgi apparatus" Vesicles "HPA011893: AB_1856656, HPA075062: AB_2732277" "unprognostic (2.93e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-3)" "unprognostic (6.82e-4)" "unprognostic (2.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.77e-3)" "unprognostic (6.73e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "prognostic favorable (5.58e-4)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.01e-10)" "unprognostic (2.47e-3)" "unprognostic (4.02e-1)" "unprognostic (1.57e-2)" "unprognostic (1.90e-3)" 9.2 360.1 49.2 30.2 78.4 0.4 0.5 17.1 54.7 1.5 2.2 10.6 47.7 3.5 0.4 0.6 0.2 4.0 1.7 21.7 426.2 0.6 0.2 3.3 0.4 118.3 195.4 6.1 28.3 0.5 269.0 1.1 250.9 3.5 13.0 40.6 0.3 1.2 0.3 1.0 21.3 12.8 77.4 0.2 17.9 0.2 130.7 0.1 6.4 0.8 0.1 0.8 1.3 30.3 0.0 3.1 10.3 8.5 2.3 53.3 0.2 0.5 2.0 4.0 10.1 0.4 1.0 0.0 0.9 0.7 6.2 0.2 0.2 0.0 5.0 0.1 0.5 0.0 0.6 0.0 0.5 0.7 4.6 45.9 0.2 5.8 2.0 46.5 0.0 0.0 0.2 0.4 5.1 0.3 0.0 0.2 7.3 0.1 0.2 0.0 0.3 0.3 0.9 0.1 47.6 20.7 0.0 0.5 2.5 1.6 0.0 0.1 0.1 5.4 2.2 0.2 3.6 0.1 0.0 0.3 1.6 0.1 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 78.4 17.1 54.7 21.7 426.2 118.3 195.4 250.9 77.4 130.7 30.3 0.0 6.4 0.0 12.7 0.0 0.0 0.4 2.8 0.0 212.4 0.0 0.0 0.1 0.0 1.3 0.0 2.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.2 6.7 283.4 0.0 27.7 0.2 0.0 2.3 0.0 0.1 0.0 0.0 0.7 0.0 0.1 8.4 109.9 14.7 138.4 0.3 0.3 0.0 0.6 0.0 1.8 3.7 0.0 11.6 0.0 34.2 8.2 14.8 6.2 0.4 0.0 2.1 0.1 0.1 0.7 14.6 0.0 1.8 1.7 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.5 0.8 SCLY SCL ENSG00000132330 "Selenocysteine lyase" Q96I15 2 238060924-238099413 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 39.1" "Group enriched" "Detected in many" 13 "Early spermatids: 90.6;Late spermatids: 156.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020190, HPA055760" Uncertain Enhanced "Golgi apparatus" NA NA 300000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA020190: , HPA055760: AB_2682910" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (8.65e-5)" "unprognostic (8.96e-2)" "unprognostic (9.85e-3)" "unprognostic (1.14e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-2)" "unprognostic (8.38e-2)" "unprognostic (3.98e-3)" "unprognostic (1.03e-2)" "unprognostic (1.02e-3)" "unprognostic (3.73e-1)" "unprognostic (4.37e-2)" "unprognostic (2.50e-3)" "unprognostic (1.98e-1)" 5.1 4.3 7.2 5.3 9.4 5.0 4.9 9.4 9.3 6.8 6.4 7.3 8.5 8.1 5.6 5.9 6.3 3.8 8.1 6.8 8.2 12.9 39.1 4.7 5.7 9.2 8.8 6.3 22.8 6.1 5.0 2.0 9.4 5.9 3.2 4.6 4.4 4.1 6.4 3.5 8.6 3.9 7.3 7.2 5.8 16.8 8.3 5.9 7.2 3.5 4.3 7.8 5.1 10.4 11.1 19.1 11.9 31.1 9.0 6.4 23.2 11.2 5.6 11.3 14.3 11.6 8.0 18.9 3.3 5.9 35.4 16.4 44.1 21.5 10.9 21.2 41.8 21.1 24.0 37.6 16.7 17.6 18.2 7.1 11.6 21.3 22.0 5.1 21.0 26.1 38.0 5.1 11.7 16.9 17.9 33.0 36.4 16.0 15.6 22.0 23.3 18.2 11.3 3.6 13.1 28.9 12.0 19.4 20.6 8.2 6.3 26.5 8.5 16.3 11.8 24.2 23.7 14.2 13.3 9.3 11.3 37.0 14.4 1.1 3.2 4.0 2.6 2.3 2.0 2.6 3.1 4.4 3.3 1.6 2.3 2.6 0.5 2.9 3.5 0.6 3.2 2.8 7.2 9.4 9.4 9.3 6.8 8.2 9.2 8.8 9.4 7.3 8.3 10.4 2.2 0.0 0.0 0.0 4.6 1.7 2.4 1.9 5.7 5.4 1.7 1.9 2.6 1.5 1.2 0.0 8.4 1.4 3.4 1.9 3.9 5.3 90.6 1.7 3.4 2.4 2.4 9.4 0.0 3.7 2.1 1.9 5.1 2.6 0.0 3.5 1.8 3.3 4.0 6.7 0.0 3.3 8.2 0.9 3.2 156.3 3.1 2.1 1.8 0.0 2.7 2.6 2.1 0.0 0.0 3.0 5.0 0.0 4.9 1.9 3.9 2.7 1.9 6.9 0.0 1.9 3.2 6.2 5.6 3.4 1.6 0.7 4.4 2.2 4.8 1.8 SCOC "HRIHFB2072, SCOCO, UNC-69" ENSG00000153130 "Short coiled-coil protein" Q9UIL1 4 140257286-140385728 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 320.8;Early spermatids: 537.1;Proximal tubular cells: 311.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061198, HPA070321" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 22000 "Cluster 44: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA061198: AB_2684449, HPA070321: AB_2686252" "unprognostic (2.27e-2)" "unprognostic (2.26e-2)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (7.34e-3)" "unprognostic (1.37e-3)" "unprognostic (8.99e-3)" "unprognostic (1.13e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-1)" "unprognostic (4.03e-1)" "prognostic favorable (4.82e-12)" "unprognostic (2.98e-2)" "unprognostic (1.32e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-2)" 44.8 66.8 81.8 27.7 84.5 14.7 69.4 87.4 114.6 42.6 72.0 43.9 45.4 48.0 79.5 54.1 44.7 39.7 103.6 85.1 109.1 101.6 74.3 35.9 29.7 91.3 96.8 42.6 51.3 94.1 43.2 48.3 103.1 59.9 49.8 74.5 49.2 47.1 40.8 29.9 37.1 50.9 91.4 27.9 53.7 33.8 95.2 29.3 67.4 59.3 32.8 38.9 19.4 105.6 53.9 38.1 92.6 49.9 80.6 109.3 67.4 85.5 78.0 64.6 71.8 24.4 81.0 22.0 75.5 83.9 60.6 22.6 57.3 113.6 95.7 79.1 40.4 33.5 18.8 59.7 70.1 70.2 40.5 72.5 155.9 59.0 63.1 124.1 87.1 63.8 53.0 60.0 116.3 36.5 94.7 42.5 30.2 47.6 57.1 54.0 39.1 32.1 197.1 52.9 68.4 70.4 57.0 84.5 97.0 81.7 63.4 41.9 68.0 104.4 60.5 86.9 83.1 94.4 193.4 64.9 118.2 32.2 102.3 47.8 16.5 23.0 27.5 23.0 35.1 36.8 32.3 27.3 21.4 30.3 46.8 36.4 9.7 36.9 23.1 26.7 33.2 37.0 81.8 84.5 87.4 114.6 85.1 109.1 91.3 96.8 103.1 91.4 95.2 105.6 63.2 48.1 47.2 15.3 34.4 61.1 69.7 74.1 78.6 135.0 84.9 96.0 140.3 62.9 51.8 126.9 22.9 139.9 31.3 63.4 320.8 99.2 537.1 67.5 52.4 54.4 37.8 34.7 33.8 112.8 82.2 58.3 66.8 58.4 36.8 32.0 51.4 65.0 47.6 171.6 37.1 42.7 114.0 23.0 27.9 91.2 60.0 34.5 138.7 17.8 36.7 205.6 22.6 20.6 42.9 92.9 37.0 66.2 30.8 91.7 46.8 311.1 54.9 71.0 46.0 40.8 64.5 60.7 56.1 83.8 56.7 88.9 36.3 39.6 46.1 56.0 SCPEP1 RISC ENSG00000121064 "Serine carboxypeptidase 1" Q9HB40 17 56978129-57006768 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 300.9" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 456.2;Club cells: 304.9;Respiratory ciliated cells: 397.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 319.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 389.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039102, HPA057200" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA039102: AB_10673605, HPA057200: AB_2683365" "unprognostic (5.83e-3)" "unprognostic (7.43e-3)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (9.26e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (1.00e-3)" "unprognostic (1.68e-1)" "unprognostic (1.70e-1)" "unprognostic (3.56e-3)" "unprognostic (1.40e-1)" "unprognostic (3.25e-1)" "unprognostic (7.28e-2)" "unprognostic (8.89e-2)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" 64.1 121.5 25.7 32.6 26.4 75.8 91.0 27.3 42.9 69.8 34.5 46.9 31.4 37.5 73.1 54.8 48.5 71.2 60.1 27.2 30.9 88.6 32.0 95.1 48.7 30.1 29.5 53.6 17.0 300.9 28.7 20.8 30.6 61.6 33.7 8.1 90.0 102.9 15.8 46.3 40.3 60.9 28.7 44.8 54.2 14.3 28.4 14.6 135.1 32.5 60.6 71.1 51.1 33.6 48.3 20.9 49.4 41.4 389.3 85.6 26.0 23.3 119.6 41.9 77.8 13.7 33.3 63.3 126.4 55.9 65.8 44.0 22.0 105.4 46.8 82.0 36.1 19.8 28.2 8.7 89.1 39.1 190.1 103.7 45.0 52.0 43.0 37.5 72.3 24.3 5.1 257.9 59.1 20.3 19.9 100.4 20.4 15.2 39.3 24.2 53.8 41.4 9.3 143.7 13.8 33.8 56.3 45.6 33.3 57.1 19.1 104.1 34.1 118.3 29.9 68.8 26.5 250.5 187.2 35.9 88.1 28.5 34.4 2.1 228.5 319.0 11.8 137.1 8.0 56.0 8.2 8.3 105.7 55.1 11.3 12.3 34.8 23.7 141.0 18.0 10.2 118.7 25.7 26.4 27.3 42.9 27.2 30.9 30.1 29.5 30.6 28.7 28.4 33.6 48.8 44.8 61.8 25.1 52.7 23.7 208.6 456.2 37.5 12.7 52.4 110.7 32.5 10.0 304.9 95.6 16.7 9.9 20.5 2.0 19.6 22.2 1.0 51.5 24.5 27.1 24.4 21.2 37.2 6.8 19.4 115.4 4.6 13.6 8.2 4.3 62.8 15.7 160.5 10.1 24.9 5.0 126.1 135.0 33.7 3.4 64.3 110.2 24.9 20.6 142.2 18.9 25.7 21.1 20.7 4.8 1.6 68.1 39.0 74.1 62.4 29.7 397.8 17.0 52.6 28.1 63.2 4.4 12.3 38.1 19.9 11.1 18.8 67.1 8.0 122.6 SCRN2 ENSG00000141295 "Secernin 2" Q96FV2 17 47837692-47841289 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 149.7;Proximal tubular cells: 332.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022934, HPA023434" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA 370000 "Cluster 44: Non-specific - Transcription" "Cluster 7: Kidney - Transmembrane transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Golgi apparatus" "HPA022934: AB_1856638, HPA023434: AB_1856639" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.86e-1)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (1.73e-1)" "prognostic favorable (3.86e-4)" "unprognostic (4.63e-2)" "unprognostic (3.25e-2)" "unprognostic (5.77e-2)" "unprognostic (1.28e-3)" "unprognostic (8.72e-2)" "unprognostic (3.43e-2)" "unprognostic (5.28e-3)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "prognostic favorable (5.83e-4)" 81.2 22.9 18.9 11.1 19.4 13.4 48.9 18.8 22.3 28.2 22.0 23.8 43.8 24.5 11.5 19.2 26.5 12.0 31.9 18.5 20.6 68.6 37.2 17.4 12.9 19.9 19.6 25.4 26.4 25.4 31.5 12.9 18.8 28.5 10.4 6.5 33.8 19.7 38.1 22.1 36.7 10.2 20.1 34.0 21.5 10.6 19.4 12.0 39.9 25.0 10.1 22.2 23.3 20.1 28.0 43.8 12.1 11.0 33.7 25.7 36.6 13.7 27.6 20.6 21.0 32.5 33.2 15.3 27.5 7.1 11.0 14.7 3.9 24.6 6.9 37.6 29.7 15.5 33.8 29.2 12.0 7.9 12.7 25.7 18.1 12.8 9.8 31.5 23.5 35.6 5.4 18.2 28.9 25.4 24.6 12.8 6.0 12.1 17.5 32.7 9.0 62.4 16.9 12.9 8.9 37.6 8.0 17.3 17.8 8.3 37.9 14.5 10.7 18.2 20.8 5.6 6.6 70.2 9.8 7.7 52.1 13.2 4.2 24.5 19.9 43.4 24.6 21.1 24.1 24.8 20.4 24.2 25.7 25.3 31.7 17.8 5.4 29.3 10.8 30.1 23.0 16.5 18.9 19.4 18.8 22.3 18.5 20.6 19.9 19.6 18.8 20.1 19.4 20.1 21.9 38.5 29.9 15.0 18.7 15.7 31.5 41.8 20.5 12.0 24.5 25.7 19.3 15.7 35.9 16.5 10.4 43.1 12.4 33.2 74.3 27.7 3.9 16.9 10.0 24.6 22.3 7.2 12.4 61.0 9.3 25.7 17.3 12.4 16.5 22.1 24.3 26.7 22.7 20.2 10.5 33.6 48.8 11.1 13.7 2.8 33.2 12.8 42.7 7.5 13.9 28.8 26.8 11.1 6.0 33.3 36.5 16.6 30.9 14.1 149.7 332.7 40.9 16.8 6.6 19.1 16.0 5.2 16.7 21.9 11.5 33.8 21.6 23.9 40.7 27.0 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 410.9" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 515.9;Pancreatic endocrine cells: 476.4;Suprabasal keratinocytes: 472.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 512.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 320000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 15: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favorable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favorable (2.67e-4)" "unprognostic (7.42e-2)" 68.0 73.1 90.3 26.3 116.8 10.1 113.1 90.2 120.7 53.0 68.5 102.6 37.8 53.0 11.8 124.3 76.6 72.2 65.9 66.4 90.2 166.9 410.9 168.3 9.8 120.5 127.8 26.3 90.3 34.7 43.2 27.3 95.4 53.0 62.6 35.1 103.7 45.9 101.5 190.4 42.4 53.8 89.9 32.3 140.1 47.1 151.9 8.2 51.1 35.4 35.2 124.7 68.7 71.4 162.1 20.7 11.1 0.8 269.2 164.3 474.4 201.5 273.0 222.9 158.6 242.7 400.0 0.2 88.1 255.4 224.5 203.1 8.2 512.2 269.0 46.7 7.4 4.9 15.8 95.8 292.4 1.0 8.2 223.1 336.5 92.4 223.2 123.3 29.9 3.7 8.2 0.5 130.5 159.9 0.2 14.2 20.4 139.9 63.1 0.3 99.7 0.6 367.7 211.7 4.3 15.6 277.2 169.4 51.4 125.2 123.1 9.7 56.4 169.4 141.4 17.3 131.8 8.5 6.7 0.7 266.2 16.4 103.2 1.5 1.6 0.4 0.7 0.6 2.1 0.3 2.0 0.8 1.5 0.3 0.4 0.5 0.8 0.7 0.6 1.4 4.4 0.7 90.3 116.8 90.2 120.7 66.4 90.2 120.5 127.8 95.4 89.9 151.9 71.4 21.9 291.7 391.2 106.7 3.8 373.7 322.2 352.8 75.1 14.5 208.8 90.6 59.3 245.9 218.4 189.4 12.5 38.9 7.8 174.3 64.6 296.0 1.2 116.6 20.8 16.0 55.1 7.4 0.2 515.9 230.0 43.0 170.7 179.0 13.9 10.8 11.4 260.6 18.8 0.0 0.3 131.9 160.7 19.3 106.0 3.8 4.1 39.5 76.5 5.6 33.0 10.0 0.0 3.5 1.8 476.4 121.7 5.3 2.1 284.2 59.0 153.8 178.6 23.6 0.0 34.9 33.5 1.8 2.5 170.9 472.8 67.5 16.8 3.2 90.7 423.9 SDCBP2 "SITAC18, ST-2" ENSG00000125775 "Syndecan binding protein 2" Q9H190 20 1309909-1329139 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 141.8;intestine: 136.9;stomach 1: 101.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 782.5;Pancreatic endocrine cells: 755.4;Paneth cells: 948.5;Proximal enterocytes: 470.3;Urothelial cells: 641.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.6;OE19: 57.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005804, HPA064490" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm "Golgi apparatus, Cytosol" "HPA005804: , HPA064490: AB_2732713" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (2.37e-1)" "unprognostic (5.85e-2)" "unprognostic (2.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.01e-1)" "unprognostic (3.78e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.17e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.37e-4)" 7.3 3.4 19.9 10.1 20.7 0.7 6.9 16.3 24.3 25.8 15.2 85.8 136.9 5.7 9.0 141.8 4.3 41.8 4.6 19.6 20.2 16.0 18.1 20.9 1.3 17.2 17.9 3.5 15.2 2.5 3.9 3.3 17.4 6.5 55.5 1.0 29.8 2.5 2.8 62.9 133.0 3.6 16.9 3.1 101.8 5.6 20.3 1.5 14.6 1.4 13.7 38.2 49.9 18.0 10.9 0.5 1.4 0.5 5.8 5.1 0.9 3.2 6.3 2.8 2.7 2.3 18.6 1.1 2.1 1.2 2.0 8.2 0.5 15.5 1.4 0.4 1.0 0.9 0.6 1.5 5.8 1.1 1.2 1.8 10.8 2.2 2.2 6.0 9.6 2.0 1.5 0.7 1.1 2.6 1.7 3.0 1.3 57.3 0.7 1.6 0.7 2.2 1.2 14.4 2.4 1.9 1.5 9.3 3.6 0.6 0.4 0.9 6.5 1.5 0.6 2.8 1.2 2.8 2.7 1.1 0.7 4.1 0.9 0.1 0.8 1.9 0.9 0.3 0.7 0.2 1.2 0.9 1.0 0.4 1.0 1.8 0.8 0.9 0.6 0.7 2.3 0.7 19.9 20.7 16.3 24.3 19.6 20.2 17.2 17.9 17.4 16.9 20.3 18.0 15.6 16.0 4.2 0.0 4.1 55.7 112.0 198.1 3.4 1.0 4.9 4.8 0.8 72.9 172.6 16.5 0.0 1.8 1.0 782.5 27.4 114.5 17.1 25.8 11.7 14.1 35.9 0.0 0.0 209.7 1.1 4.6 201.8 85.4 8.9 1.0 7.1 5.1 0.9 1.7 0.0 150.8 156.6 1.9 6.4 1.9 1.5 1.8 8.8 0.0 2.3 1.0 2.1 0.0 0.0 755.4 948.5 0.0 0.7 107.0 470.3 1.8 89.6 0.9 0.0 1.7 9.9 5.0 7.6 31.1 95.6 1.6 3.5 2.0 109.2 641.9 SDE2 "C1orf55, FLJ35382" ENSG00000143751 "SDE2 telomere maintenance homolog" Q6IQ49 1 225982702-225999343 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028467, HPA031255, HPA031256" Approved Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" "Nuclear speckles" "Golgi apparatus, Plasma membrane, Cytosol" "HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568" "unprognostic (9.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.10e-1)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (9.59e-2)" "unprognostic (2.68e-1)" "unprognostic (3.63e-2)" "unprognostic (1.84e-2)" "unprognostic (3.34e-2)" "unprognostic (9.01e-2)" "unprognostic (1.41e-3)" "unprognostic (3.90e-2)" "unprognostic (3.51e-1)" "unprognostic (3.98e-2)" "unprognostic (3.84e-2)" 17.4 8.5 5.5 11.3 7.0 32.9 11.8 6.4 6.6 9.0 4.8 8.3 9.0 11.8 7.8 9.6 7.4 10.5 7.7 4.9 6.0 9.2 14.6 9.2 12.4 6.9 6.6 10.2 9.6 11.1 4.4 11.8 6.6 9.8 9.1 5.1 6.7 7.3 12.7 10.8 9.0 9.8 6.6 10.4 7.7 8.3 6.1 22.8 12.5 9.6 10.6 11.6 7.8 8.4 13.1 9.3 14.9 15.9 10.2 11.3 18.5 13.7 12.9 18.4 14.0 13.7 14.7 19.2 20.9 11.6 7.2 16.5 18.9 11.9 22.2 14.7 15.3 21.1 7.9 12.7 18.6 21.0 24.6 12.5 16.9 19.6 24.6 10.3 12.8 22.6 39.3 22.6 13.7 3.8 29.5 16.6 20.8 20.2 9.8 24.4 19.1 24.9 11.1 9.2 13.3 22.0 15.6 16.9 26.3 11.9 16.6 25.4 12.7 15.6 11.0 20.3 30.4 13.4 10.3 23.4 16.1 12.9 31.5 21.8 6.3 5.9 8.0 6.4 10.8 8.0 8.1 7.8 7.1 7.0 8.1 7.7 18.5 13.5 7.9 8.1 6.7 6.9 5.5 7.0 6.4 6.6 4.9 6.0 6.9 6.6 6.6 6.6 6.1 8.4 36.0 28.9 22.6 4.2 39.9 43.6 17.2 11.2 29.0 6.2 19.8 13.6 9.4 2.8 20.1 9.2 0.0 9.6 29.3 14.3 15.6 6.5 72.8 24.8 15.1 24.8 17.4 56.2 4.7 7.1 10.2 17.8 13.3 35.9 35.5 9.7 12.8 20.6 11.1 15.2 5.0 10.8 16.2 16.4 28.8 20.4 9.9 27.0 19.6 1.9 7.4 12.6 10.3 4.5 8.6 9.7 9.4 6.4 26.6 14.2 9.5 12.7 12.7 8.9 6.6 28.8 23.9 23.9 14.4 26.5 59.1 14.2 23.2 21.0 9.9 18.2 SDF4 Cab45 ENSG00000078808 "Stromal cell derived factor 4" Q9BRK5 1 1216909-1232067 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 406.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011249, HPA011895, CAB015227" Supported Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 2600000 "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "CAB015227: , HPA011249: AB_2668468, HPA011895: " "unprognostic (1.98e-1)" "prognostic unfavorable (5.89e-4)" "unprognostic (3.63e-1)" "unprognostic (2.38e-3)" "unprognostic (5.88e-2)" "unprognostic (7.95e-3)" "unprognostic (3.73e-3)" "unprognostic (1.06e-1)" "unprognostic (2.01e-1)" "unprognostic (8.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.07e-1)" "unprognostic (8.39e-3)" "unprognostic (1.09e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.04e-2)" 86.5 91.8 44.2 78.8 47.8 56.2 80.2 47.2 65.3 84.4 72.5 95.9 117.1 91.8 43.9 66.3 74.6 66.2 134.6 45.5 44.8 89.6 160.7 82.0 53.4 53.2 46.1 85.4 104.6 61.5 78.5 73.3 47.0 76.9 60.4 25.7 83.5 52.2 78.9 72.9 116.8 58.2 43.5 78.0 93.6 71.7 50.5 34.6 81.8 47.7 39.6 82.2 71.6 45.9 139.7 123.7 67.1 214.0 320.0 160.4 80.5 266.1 241.4 191.2 159.4 147.0 236.2 87.8 201.8 258.0 137.4 140.4 77.5 117.1 58.2 147.9 133.0 153.6 185.7 207.8 147.4 156.7 199.2 199.0 59.5 144.6 81.2 186.5 155.9 57.3 129.2 225.0 95.7 101.1 77.8 158.9 61.7 158.0 167.1 85.8 86.5 234.4 127.2 66.4 243.3 86.7 177.2 208.2 182.8 59.0 108.0 176.7 198.8 196.2 107.0 149.5 154.2 138.9 141.2 144.6 222.9 289.7 87.1 14.4 21.5 30.8 19.3 14.6 14.6 13.5 27.6 28.4 21.9 16.8 16.0 14.1 16.9 26.8 23.2 14.0 25.1 11.8 44.2 47.8 47.2 65.3 45.5 44.8 53.2 46.1 47.0 43.5 50.5 45.9 92.9 22.4 19.2 18.6 62.5 119.8 74.0 24.6 46.7 34.5 51.2 47.6 35.7 68.6 28.9 49.7 18.8 124.1 68.4 240.0 11.7 79.0 39.1 49.0 76.2 77.8 65.5 32.8 21.1 71.4 284.4 117.1 81.1 60.8 36.2 61.4 76.4 117.1 122.4 38.7 23.5 174.9 30.5 73.7 154.8 36.8 95.4 62.8 167.2 13.1 50.8 64.9 111.2 13.6 17.5 73.0 213.5 76.0 202.5 101.5 406.2 57.7 18.4 40.0 59.2 69.8 75.1 101.7 63.5 53.2 114.2 168.0 73.4 88.7 181.0 71.1 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716460 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nuclear membrane" "Golgi apparatus" "HPA047533: AB_2680078" "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favorable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.95e-4)" "unprognostic (7.89e-2)" 142.9 138.1 66.2 83.4 69.4 172.2 136.2 69.0 80.4 147.1 76.6 110.8 82.9 111.0 202.5 81.6 103.6 97.5 98.4 63.7 72.6 137.2 152.3 107.9 112.6 74.1 67.2 168.6 139.4 114.6 84.5 115.1 73.9 82.0 124.9 37.0 95.9 87.5 154.3 70.5 86.4 96.3 72.4 86.2 95.3 61.5 69.4 93.2 177.5 147.4 98.2 137.3 94.0 75.3 201.7 320.7 286.7 425.4 368.5 462.8 225.4 310.1 356.5 241.9 291.2 347.1 443.0 99.0 198.8 370.3 277.2 408.3 409.1 243.4 255.5 267.1 239.4 279.4 358.8 324.9 311.7 213.4 281.2 315.8 305.0 169.1 285.1 366.0 337.9 116.7 295.8 244.3 315.1 363.1 89.2 345.8 282.1 266.2 135.4 101.6 368.4 302.9 472.6 424.4 131.2 300.8 257.3 239.5 598.5 407.0 248.5 416.6 254.3 240.0 181.0 209.8 361.9 224.4 509.6 150.0 226.4 331.7 180.6 83.5 161.1 89.7 95.1 173.7 95.0 101.0 114.8 104.7 165.8 90.0 95.1 98.0 111.6 134.3 184.8 160.9 168.8 200.8 66.2 69.4 69.0 80.4 63.7 72.6 74.1 67.2 73.9 72.4 69.4 75.3 261.1 89.8 99.1 25.8 131.8 107.1 179.4 356.6 90.5 30.0 163.7 202.6 68.2 228.8 188.0 128.8 22.9 309.1 171.9 111.1 238.7 258.8 46.3 118.5 268.0 217.2 157.4 101.7 21.2 247.3 655.3 206.0 120.8 184.1 218.4 191.0 197.7 165.5 363.3 20.2 22.8 218.7 168.9 386.7 337.2 100.6 299.5 337.3 158.3 24.4 396.7 110.5 204.9 26.7 38.3 183.4 136.3 166.3 197.9 185.7 142.7 350.9 99.3 38.2 170.9 173.5 225.5 233.5 169.6 135.2 119.9 305.8 153.4 237.6 210.7 242.2 SEC11C "SEC11L3, SPC21, SPCS4C" ENSG00000166562 "SEC11 homolog C, signal peptidase complex subunit" Q9BY50 18 59139866-59158832 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ionocytes: 685.6;Muller glia cells: 544.7;Plasma cells: 1164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 523.5;Karpas-707: 546.2;RPMI-8226: 1150.0;U-266/70: 587.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026816, HPA047533" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane" "Golgi apparatus" "HPA026816: AB_10602089, HPA047533: AB_2680078" "unprognostic (1.47e-2)" "unprognostic (2.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.44e-2)" "unprognostic (3.13e-3)" "unprognostic (4.48e-3)" "unprognostic (2.95e-1)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.80e-2)" "unprognostic (1.72e-1)" "unprognostic (6.25e-2)" "unprognostic (3.83e-2)" "unprognostic (4.63e-2)" "unprognostic (2.58e-1)" "unprognostic (1.15e-1)" 24.6 76.7 110.0 86.5 117.5 63.1 81.8 122.9 140.5 57.8 94.4 92.3 126.7 40.1 284.6 42.5 41.4 47.3 30.0 112.9 146.4 70.2 219.0 62.7 104.2 137.3 130.2 29.9 374.0 153.9 155.2 28.4 136.8 225.7 78.2 108.1 397.3 62.3 15.7 29.7 97.8 30.1 123.7 81.4 138.5 28.1 113.5 53.0 163.7 20.0 117.8 59.4 21.2 135.8 82.4 100.0 52.9 74.1 31.9 6.8 64.7 72.4 62.9 89.9 55.2 78.3 42.5 176.8 109.9 46.6 67.6 82.8 84.7 59.0 58.4 523.5 113.8 58.5 69.3 242.3 99.3 199.4 87.6 20.4 140.7 56.2 161.1 20.2 33.7 78.4 67.4 546.2 34.6 100.0 79.0 79.2 48.1 140.4 60.5 72.8 50.0 1150.0 67.5 76.1 223.2 90.5 43.1 162.5 252.8 29.9 76.0 148.5 24.7 98.5 45.4 36.5 86.9 587.3 434.4 176.0 99.4 131.8 124.5 76.4 70.7 57.9 146.1 97.6 187.6 197.8 150.4 142.5 78.8 127.9 77.7 105.4 12.2 108.3 108.8 299.6 223.7 222.1 110.0 117.5 122.9 140.5 112.9 146.4 137.3 130.2 136.8 123.7 113.5 135.8 64.8 28.9 120.7 19.2 295.9 32.6 49.3 92.4 12.5 63.6 120.0 128.3 59.3 144.4 102.5 60.7 50.1 70.8 148.7 76.3 88.0 164.4 45.4 58.7 34.2 60.3 339.3 43.8 12.2 263.1 109.1 29.2 60.6 147.1 47.5 21.5 56.4 224.7 112.9 50.5 13.3 223.1 685.6 37.1 56.9 18.8 12.5 63.9 256.1 10.3 46.4 544.7 96.8 17.1 31.2 148.9 78.4 23.0 1164.8 380.9 99.3 118.8 81.3 89.3 6.6 23.1 70.6 110.2 81.5 35.5 45.5 149.7 92.3 40.1 88.3 79.2 SEC14L5 "KIAA0420, PRELID4B" ENSG00000103184 "SEC14 like lipid binding 5" O43304 16 4958330-5019157 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 78.7" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 85.5;Excitatory neurons: 67.0;Oligodendrocytes: 189.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.5;RPMI-8226: 1.6;SCLC-21H: 2.5;T-47d: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041492, HPA041825" Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Cytosol" "HPA041492: AB_10794519, HPA041825: AB_10794526" "unprognostic (1.90e-3)" "unprognostic (4.08e-2)" "unprognostic (5.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (5.68e-2)" "unprognostic (7.33e-3)" "unprognostic (8.71e-4)" "unprognostic (6.87e-2)" "unprognostic (1.56e-4)" "unprognostic (1.01e-3)" "unprognostic (7.12e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" 0.4 0.5 12.5 0.3 43.6 0.4 0.3 25.9 29.8 0.9 0.0 0.5 0.3 0.1 0.2 0.6 0.7 0.2 5.1 15.4 17.8 0.2 0.1 0.2 0.3 33.4 35.9 0.4 0.6 0.0 2.2 0.3 29.9 0.4 0.6 3.9 0.6 0.2 5.6 1.0 0.2 0.1 22.9 0.3 1.4 0.4 31.5 0.4 0.1 10.9 0.5 0.2 0.4 78.7 0.0 0.1 0.1 0.1 0.2 1.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.3 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.3 0.1 0.0 0.1 1.6 0.0 0.0 2.5 0.0 0.1 0.1 0.1 0.2 1.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 12.5 43.6 25.9 29.8 15.4 17.8 33.4 35.9 29.9 22.9 31.5 78.7 0.2 0.0 0.0 2.3 0.0 0.3 0.1 0.0 0.0 4.1 0.2 0.1 9.1 1.5 0.1 0.0 85.5 1.1 1.3 0.3 0.0 0.1 1.6 1.0 0.1 0.3 0.0 0.0 67.0 0.2 0.1 0.6 0.0 0.1 0.0 1.5 0.4 0.3 0.3 5.0 7.1 0.6 4.1 0.0 0.3 0.5 0.3 2.0 0.0 1.9 0.5 0.0 0.0 3.5 189.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.7 0.2 0.1 0.3 0.0 0.1 0.3 0.0 0.1 0.6 0.0 SEC16A "KIAA0310, p250, Sec16L" ENSG00000148396 "SEC16 homolog A, endoplasmic reticulum export factor" O15027 9 136440096-136483759 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005684 Supported Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 48000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "Endoplasmic reticulum" "HPA005684: AB_1079189" "unprognostic (1.24e-3)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.84e-2)" "unprognostic (3.48e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-3)" "unprognostic (4.75e-1)" "prognostic favorable (4.47e-4)" "unprognostic (5.57e-3)" "unprognostic (2.64e-1)" "unprognostic (2.47e-2)" "unprognostic (1.41e-1)" 16.8 18.2 6.4 16.6 6.7 35.3 17.1 8.0 9.4 16.6 19.3 17.3 14.9 17.9 9.0 17.9 16.4 12.4 14.5 7.0 5.2 14.3 37.9 19.4 16.9 4.4 4.9 16.2 29.2 14.0 24.3 10.8 3.5 18.7 10.5 9.2 25.8 13.1 23.5 19.7 19.1 10.7 2.4 20.7 27.2 17.6 5.2 17.4 15.3 11.9 12.3 15.9 14.5 5.0 26.5 57.7 28.5 47.2 29.6 30.3 33.6 32.1 27.9 23.4 17.8 41.9 22.1 26.4 22.1 39.2 28.8 71.3 31.8 46.2 12.7 56.2 20.7 26.9 55.1 33.7 28.6 46.2 45.8 32.8 32.5 32.7 38.1 18.9 32.2 34.5 34.1 35.6 25.0 114.3 31.2 24.9 25.1 79.0 40.4 44.3 35.2 45.0 23.8 35.0 40.0 26.6 41.6 62.2 19.8 13.8 63.6 35.9 47.0 37.6 28.1 30.8 25.2 16.9 27.7 33.4 29.2 20.6 38.3 1.7 2.8 1.2 2.5 3.1 2.7 2.3 2.6 3.0 1.6 1.4 1.6 2.8 2.0 1.5 3.4 2.6 1.9 2.4 6.4 6.7 8.0 9.4 7.0 5.2 4.4 4.9 3.5 2.4 5.2 5.0 20.0 25.6 41.7 16.6 16.4 24.9 15.3 18.4 10.8 20.2 38.7 30.6 11.5 12.8 23.6 12.9 25.0 8.1 17.5 30.1 7.9 14.2 5.1 26.9 19.5 18.2 40.7 12.0 27.4 16.4 11.8 16.0 46.9 38.2 23.5 25.4 17.9 62.2 16.5 33.7 19.2 65.5 20.3 23.4 19.5 6.0 13.1 22.3 14.2 17.8 19.5 13.0 11.3 9.5 14.7 22.8 14.7 16.6 25.1 26.3 22.3 10.1 34.7 17.1 13.1 20.5 16.6 24.4 16.1 17.2 26.9 15.1 17.8 15.8 22.8 22.1 SEC22C "MGC13261, MGC5373, SEC22L3" ENSG00000093183 "SEC22 homolog C, vesicle trafficking protein" Q9BRL7 3 42547969-42601080 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031242 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA031242: " "unprognostic (1.68e-1)" "unprognostic (4.86e-2)" "unprognostic (1.01e-1)" "unprognostic (2.67e-1)" "unprognostic (9.37e-3)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.15e-1)" "unprognostic (3.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.35e-7)" "unprognostic (2.59e-1)" "unprognostic (3.30e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-3)" 35.7 23.4 37.3 14.1 40.8 36.5 33.2 39.1 46.8 28.2 33.8 31.1 31.9 29.8 27.4 17.2 27.2 18.9 24.3 34.1 38.0 26.2 16.4 33.1 19.0 41.4 40.3 29.3 29.6 26.4 26.6 19.3 42.0 37.3 15.6 25.6 23.3 25.9 22.2 19.4 32.6 26.3 37.5 20.4 28.3 27.5 39.2 18.2 24.2 26.1 16.4 25.7 23.1 48.1 24.0 22.2 35.9 30.5 72.4 68.1 7.6 43.8 46.7 46.1 47.9 15.5 37.9 24.5 17.6 50.1 28.2 12.6 24.1 39.8 40.7 32.8 28.5 41.7 40.0 21.0 55.4 19.2 39.5 38.3 53.1 51.4 62.5 46.5 51.1 38.7 37.0 46.5 45.8 16.6 27.1 22.3 19.8 16.0 31.9 11.7 21.4 22.9 40.6 21.1 18.5 27.8 30.9 28.0 34.5 26.5 48.4 20.9 42.9 35.1 27.8 63.8 43.1 36.8 55.6 23.5 41.7 26.6 34.0 11.7 11.5 22.0 13.2 9.0 19.6 11.5 17.6 16.3 10.8 9.4 14.9 13.2 7.1 10.2 9.3 11.3 16.3 10.1 37.3 40.8 39.1 46.8 34.1 38.0 41.4 40.3 42.0 37.5 39.2 48.1 31.4 25.6 27.6 27.1 23.2 15.0 18.3 25.3 25.0 16.6 31.6 29.6 18.8 24.3 17.2 11.0 29.2 20.5 28.1 1.9 41.1 29.7 61.2 17.5 19.5 30.5 9.0 48.2 18.9 32.9 20.3 31.8 21.9 12.7 49.4 25.1 32.2 14.5 31.3 26.9 18.4 4.9 32.6 19.0 14.4 15.0 32.6 17.6 40.9 21.5 35.5 39.2 24.7 12.5 44.1 28.8 1.0 42.9 23.0 24.0 36.9 29.6 19.4 39.9 39.5 26.6 31.1 96.9 49.8 11.3 10.2 10.5 34.6 20.3 6.6 9.4 SELENOP "SELP, SeP, SEPP, SEPP1" ENSG00000250722 "Selenoprotein P" P49908 5 42799880-42887392 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "intestine: 2087.6;liver: 6268.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 448.7;Alveolar cells type 2: 529.3;Granulosa cells: 458.1;Hofbauer cells: 858.5;Macrophages: 373.3;Proximal tubular cells: 1044.7" "Cancer enriched" "Detected in all" 4 "liver cancer: 116.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "Hep G2: 567.4;HSkMC: 451.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036287 Approved Uncertain "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 2220000000 1800000000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Golgi apparatus" "HPA036287: AB_10794618" "unprognostic (7.96e-2)" "unprognostic (2.10e-1)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (6.67e-2)" "unprognostic (6.37e-2)" "unprognostic (9.22e-2)" "unprognostic (2.19e-2)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.97e-6)" "unprognostic (1.35e-2)" "unprognostic (4.19e-2)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" 719.1 424.3 164.8 179.9 345.6 40.1 617.5 386.0 290.0 460.0 145.5 644.0 620.0 335.8 459.7 240.7 376.5 670.5 237.2 156.3 231.3 853.7 6268.1 512.0 552.4 519.4 316.4 701.2 229.0 246.0 108.3 973.0 490.3 214.2 714.2 59.2 170.8 374.1 156.4 171.8 2087.6 233.2 310.3 948.8 257.0 87.8 284.7 170.4 147.0 265.6 177.4 414.3 213.1 524.3 0.7 1.7 7.7 1.0 43.6 12.2 7.3 4.1 10.9 0.0 0.0 12.5 65.3 2.0 36.3 1.5 1.4 1.7 0.2 0.1 0.0 2.4 52.7 3.1 0.2 567.4 25.9 3.2 0.4 451.1 0.7 0.0 0.1 1.9 0.1 1.5 6.4 12.9 23.5 1.3 1.1 6.4 30.6 17.0 0.9 1.3 2.0 100.8 12.5 8.0 2.2 2.7 2.7 16.7 1.6 54.6 125.4 0.7 0.7 3.2 1.7 5.2 1.0 8.4 1.5 2.0 1.7 5.9 1.5 0.1 0.1 0.5 0.5 0.1 0.6 0.4 0.3 0.3 0.3 0.5 0.4 0.4 0.5 0.6 0.2 0.9 0.3 0.3 164.8 345.6 386.0 290.0 156.3 231.3 519.4 316.4 490.3 310.3 284.7 524.3 312.7 448.7 529.3 0.0 15.2 0.0 0.0 0.0 0.0 0.0 312.0 271.1 0.0 0.0 102.1 125.0 0.0 223.4 9.4 0.0 197.6 73.4 0.0 83.8 231.0 75.8 0.0 0.0 0.0 52.8 17.5 358.7 0.0 116.1 26.5 458.1 0.0 0.0 858.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 373.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 4.9 0.0 0.0 1044.7 52.5 0.0 0.0 0.0 133.1 0.0 0.0 0.0 0.0 112.9 10.0 361.8 0.0 0.0 SEMA3C "SEMAE, SemE" ENSG00000075223 "Semaphorin 3C" Q99985 7 80742538-80922359 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 92.2;Breast myoepithelial cells: 93.5;Fibroblasts: 109.6;Ionocytes: 91.6;Oligodendrocytes: 223.7;Respiratory ciliated cells: 103.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 9 "basophil: 49.6" "Lineage enriched" "Detected in many" 9 "granulocytes: 49.6" "Cell line enhanced" "Detected in many" "GAMG: 252.7;RT4: 238.3;T-47d: 267.0;U-2197: 349.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042418 Approved "Golgi apparatus,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 13000 "Cluster 46: Basophils - DNA binding" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Cytosol" "Plasma membrane" "HPA042418: AB_10797389" "unprognostic (1.93e-2)" "unprognostic (2.54e-3)" "unprognostic (4.94e-1)" "unprognostic (9.86e-2)" "unprognostic (6.74e-2)" "prognostic unfavorable (5.72e-5)" "unprognostic (9.28e-3)" "unprognostic (1.91e-3)" "unprognostic (1.39e-2)" "unprognostic (9.01e-2)" "prognostic unfavorable (4.08e-5)" "unprognostic (2.07e-2)" "unprognostic (1.55e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-2)" 53.8 9.5 4.9 12.7 8.1 0.8 57.3 9.1 5.5 53.0 2.6 38.4 10.6 42.7 23.1 20.5 15.4 30.0 22.1 11.0 12.7 10.0 1.3 18.4 1.0 15.0 8.0 48.5 2.6 0.8 3.7 6.0 17.5 66.6 31.3 1.0 27.3 42.3 19.3 17.9 14.1 44.4 10.0 22.2 20.6 12.9 8.4 1.4 1.8 34.3 1.1 69.8 14.4 12.8 6.6 77.0 156.4 0.6 35.2 82.5 0.3 51.8 59.7 25.9 32.5 12.4 144.7 0.0 2.1 17.7 252.7 31.2 0.7 47.0 42.4 0.1 15.8 9.9 63.6 0.7 41.3 0.7 0.2 36.1 32.3 63.6 62.0 220.2 0.5 0.0 0.5 0.1 46.4 113.7 0.2 0.3 1.4 22.2 12.2 0.1 75.5 1.2 142.9 238.3 0.8 82.4 145.7 38.9 9.5 66.3 267.0 0.2 125.2 140.1 64.2 349.2 93.9 1.2 0.0 0.1 52.8 0.0 142.3 49.6 5.7 0.9 0.0 2.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 2.6 0.0 1.9 3.3 0.0 1.7 4.9 8.1 9.1 5.5 11.0 12.7 15.0 8.0 17.5 10.0 8.4 12.8 7.4 9.6 8.9 3.3 0.3 26.4 41.8 92.2 10.8 0.3 15.8 93.5 38.2 1.5 39.8 7.3 6.2 0.5 1.7 56.1 1.9 3.8 0.5 20.3 11.9 7.7 6.0 4.6 41.7 6.6 1.3 109.6 17.9 34.4 5.1 13.2 1.1 0.0 8.8 0.0 16.7 15.7 91.6 3.1 14.9 2.3 7.8 9.0 55.2 20.6 8.3 1.5 1.0 3.0 223.7 68.2 12.4 52.3 0.0 53.7 12.5 0.4 103.0 0.6 0.0 38.8 17.3 0.7 2.7 3.0 18.9 0.3 1.5 9.9 30.4 70.0 SEMA3D "coll-2, Sema-Z2" ENSG00000153993 "Semaphorin 3D" O95025 7 84995553-85186855 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 47.8;thyroid gland: 45.4" "Cell type enhanced" "Detected in many" "Early spermatids: 157.4;Leydig cells: 52.5;Peritubular cells: 62.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 28.4;HaCaT: 28.7;TIME: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037522 Uncertain Approved "Golgi apparatus,Plasma membrane" "Secreted in other tissues" NA NA 120000 "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "Plasma membrane" "HPA037522: AB_10672494" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.51e-1)" "unprognostic (7.58e-3)" "unprognostic (4.02e-3)" "unprognostic (9.94e-2)" "unprognostic (5.62e-2)" "unprognostic (1.63e-1)" "unprognostic (9.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (5.25e-3)" 3.2 2.9 5.9 1.0 1.9 0.0 5.9 0.8 4.6 5.6 0.0 2.8 1.8 2.4 2.6 1.7 5.1 1.7 2.2 6.2 4.7 3.8 1.0 3.6 3.3 2.3 8.9 1.9 0.7 0.2 0.5 0.7 2.2 8.3 3.4 2.2 4.3 1.9 0.0 2.4 3.3 1.4 3.0 47.8 3.3 3.8 3.2 0.3 45.4 0.9 1.4 3.1 0.7 3.2 0.0 0.0 12.1 0.0 0.0 0.0 0.5 7.6 8.2 8.8 4.2 0.0 0.0 0.0 2.2 28.4 0.2 28.7 3.1 0.0 5.8 0.0 5.8 0.0 3.1 0.0 0.1 0.0 0.0 0.1 0.0 1.5 7.2 10.1 13.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.6 7.5 2.1 8.9 6.8 2.8 0.0 0.1 1.1 0.0 0.0 0.4 13.8 0.4 0.0 44.2 0.0 2.7 0.4 0.0 5.4 3.4 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 1.9 0.8 4.6 6.2 4.7 2.3 8.9 2.2 3.0 3.2 3.2 2.8 0.0 3.3 18.3 1.8 3.6 2.4 0.1 0.0 2.6 0.8 8.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 157.4 1.6 0.3 14.8 26.5 0.0 12.3 0.2 0.0 15.3 0.0 4.3 2.5 0.2 2.9 0.0 1.3 1.7 5.1 0.7 2.0 0.0 5.7 23.3 52.5 0.5 12.4 19.7 0.0 1.9 0.0 3.0 0.9 0.0 0.0 62.4 0.0 5.8 1.9 4.7 0.8 4.1 0.0 0.7 2.0 0.7 0.8 0.1 2.4 0.0 0.5 11.2 1.0 0.4 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774228 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 38.5;placenta: 43.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Horizontal cells: 79.1;Inhibitory neurons: 319.5;Oligodendrocytes: 140.1" "Cancer enriched" "Detected in many" 4 "glioma: 8.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 14.9;SCLC-21H: 13.3;SH-SY5Y: 12.1;SuSa: 14.2;U-266/70: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 1100000 "Cluster 45: Intestine - Brush border" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.5 1.5 11.3 3.9 27.9 0.4 5.0 11.1 21.3 5.8 0.0 10.6 21.8 1.6 2.5 1.7 4.9 4.0 9.4 9.8 16.3 15.1 3.1 8.9 2.1 17.2 31.1 26.7 16.1 10.6 5.5 43.1 23.1 4.5 12.7 15.8 4.5 8.4 20.9 3.0 38.5 3.3 12.0 2.5 3.0 2.6 20.5 2.7 5.8 6.0 0.6 3.1 10.0 28.8 0.0 0.0 2.5 0.0 1.5 1.2 0.2 0.6 14.9 0.4 0.0 0.3 0.1 2.2 0.0 4.0 0.0 7.6 3.4 1.1 0.1 1.1 1.7 0.0 5.0 0.0 4.0 0.0 0.2 1.1 8.3 0.0 0.5 0.0 1.0 5.7 0.1 3.4 0.4 0.8 2.8 0.7 4.6 0.0 0.0 1.6 0.1 2.4 1.1 1.1 13.3 12.1 0.1 1.0 4.3 14.2 0.5 0.0 0.0 6.9 0.3 0.2 0.0 10.0 0.0 2.3 1.8 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.3 27.9 11.1 21.3 9.8 16.3 17.2 31.1 23.1 12.0 20.5 28.8 13.9 51.3 1.5 72.8 0.2 2.0 4.0 1.4 1.2 6.2 0.5 10.7 10.0 4.3 2.1 11.0 114.7 19.7 0.1 40.6 5.9 1.0 0.2 0.5 2.3 10.1 17.4 0.0 120.7 0.2 1.8 10.8 0.0 0.3 3.8 71.0 5.0 0.9 2.6 79.1 319.5 5.4 0.0 0.0 1.9 1.2 23.3 1.0 8.8 15.9 0.0 9.3 0.0 43.2 140.1 0.3 8.5 13.5 0.0 1.2 53.5 0.2 0.1 2.3 0.0 9.3 13.9 0.8 6.3 0.3 1.1 4.7 0.2 3.4 15.1 1.6 SERPINE2 "GDN, nexin, PI7, PN1, PNI" ENSG00000135919 "Serpin family E member 2" P07093 2 223975045-224039318 "Plasma proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "placenta: 1091.9" "Cell type enriched" "Detected in many" 8 "Granulosa cells: 4466.0" "Cancer enriched" "Detected in all" 9 "melanoma: 271.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 12.9;naive CD8 T-cell: 6.8;NK-cell: 23.2" "Group enriched" "Detected in many" 15 "NK-cells: 23.2;T-cells: 12.9" "Cell line enhanced" "Detected in many" "BJ: 1492.9;fHDF/TERT166: 6425.1;SK-MEL-30: 2966.9;WM-115: 2183.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000277 Approved "Golgi apparatus" "Secreted in female reproductive system" NA NA 910000 "Cluster 48: NK-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "HPA000277: " "unprognostic (1.73e-1)" "unprognostic (7.08e-3)" "unprognostic (8.49e-2)" "unprognostic (7.78e-3)" "unprognostic (2.57e-3)" "unprognostic (5.57e-2)" "unprognostic (1.49e-2)" "unprognostic (7.43e-3)" "unprognostic (4.41e-1)" "unprognostic (7.12e-2)" "unprognostic (7.56e-3)" "unprognostic (2.40e-1)" "unprognostic (1.97e-3)" "unprognostic (1.23e-2)" "unprognostic (1.31e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.48e-5)" 28.0 19.8 120.3 75.7 125.9 6.5 14.3 128.6 158.7 28.1 71.1 22.7 28.2 17.4 5.6 36.2 20.8 46.0 100.0 115.9 145.9 39.3 10.8 14.5 30.9 158.1 152.6 145.6 8.5 3.4 8.7 1091.9 134.4 26.4 21.8 5.4 12.6 7.5 6.6 11.2 27.0 119.6 141.1 30.9 8.9 57.6 146.4 17.0 26.1 10.8 44.0 146.9 27.6 132.0 3.1 83.8 29.4 32.6 1172.5 438.7 4.4 1492.9 851.5 118.1 112.7 4.8 7.0 0.4 32.5 6425.1 188.0 5.0 3.5 102.5 101.0 0.6 26.8 16.6 49.9 22.7 57.7 12.8 1.5 128.3 68.5 342.0 505.6 304.6 9.0 5.4 0.5 1.9 412.1 4.5 2.3 3.9 56.2 31.8 92.3 10.3 25.2 64.5 1100.2 97.5 43.0 7.1 284.4 0.5 2966.9 385.2 1.2 6.4 1056.5 692.5 96.6 214.4 72.7 6.3 13.3 0.8 443.5 11.1 2183.6 0.0 0.0 0.0 0.7 0.0 0.5 0.8 0.6 0.6 0.0 1.2 12.9 6.8 0.5 23.2 0.0 0.2 0.7 2.7 120.3 125.9 128.6 158.7 115.9 145.9 158.1 152.6 134.4 141.1 146.4 132.0 13.5 0.0 1.1 233.1 3.1 23.3 16.0 132.2 351.7 5.3 7.9 8.5 5.3 0.0 4.6 7.3 0.0 106.1 11.3 19.5 11.7 13.0 2.6 5.3 17.7 20.9 24.0 23.1 86.1 33.2 524.3 556.7 5.6 5.9 2.5 4466.0 23.2 0.0 45.5 0.0 11.4 4.7 0.0 0.8 26.9 9.9 401.4 9.7 142.3 23.4 3.5 2.5 2.1 199.6 13.5 22.1 14.9 98.9 5.6 27.2 2.0 146.2 1.7 3.5 13.1 5.2 146.6 4.2 70.9 34.8 14.5 133.9 10.7 18.9 3.1 7.2 SERTAD1 "SEI1, TRIP-Br1" ENSG00000197019 "SERTA domain containing 1" Q9UHV2 19 40421589-40425992 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 480.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063323 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" Nucleoplasm "HPA063323: AB_2684984" "unprognostic (2.23e-2)" "unprognostic (4.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.55e-1)" "unprognostic (3.44e-3)" "unprognostic (1.01e-2)" "unprognostic (3.82e-2)" "unprognostic (1.62e-1)" "unprognostic (5.21e-2)" "unprognostic (1.28e-1)" "unprognostic (9.46e-2)" "unprognostic (9.43e-2)" "unprognostic (1.74e-1)" "unprognostic (3.08e-3)" 27.1 9.3 8.1 7.3 7.8 28.7 10.7 9.4 12.1 9.1 8.5 12.0 6.7 11.3 2.1 18.8 15.2 12.7 21.2 9.0 7.5 21.9 14.1 22.3 5.8 8.7 7.9 6.9 15.1 4.4 8.9 6.6 8.7 11.1 3.0 0.9 8.4 4.2 15.1 15.5 10.8 7.1 8.4 10.0 18.8 3.8 9.7 5.5 11.6 13.2 3.5 11.0 11.9 8.7 18.5 21.4 3.0 7.4 8.3 5.9 8.0 29.0 8.7 15.4 15.1 9.5 14.6 3.6 13.4 9.8 4.4 7.4 2.4 26.2 4.7 10.1 5.1 3.2 5.0 8.3 9.4 1.1 11.0 9.6 15.8 16.8 3.1 7.4 8.7 3.1 6.8 5.6 14.1 27.7 1.7 5.6 2.3 13.2 14.2 2.2 4.8 9.3 8.2 12.8 0.9 1.4 15.3 14.0 14.5 3.4 14.0 3.1 16.2 15.2 17.2 12.3 19.8 8.1 3.6 4.8 21.3 4.8 7.2 22.5 21.9 15.0 9.7 19.8 5.8 13.3 9.5 9.3 26.1 12.7 10.9 7.8 17.5 15.9 19.4 23.8 14.2 13.6 8.1 7.8 9.4 12.1 9.0 7.5 8.7 7.9 8.7 8.4 9.7 8.7 480.2 73.7 52.3 2.3 138.2 126.2 196.5 83.4 243.6 5.0 221.4 299.7 83.2 32.9 51.5 31.3 0.0 46.0 203.8 246.0 23.5 62.6 1.4 100.0 72.1 156.1 106.1 6.1 1.1 61.7 72.8 159.7 169.7 126.7 132.9 27.9 86.7 12.8 53.9 3.3 0.6 152.3 46.8 28.9 98.3 4.2 16.4 102.6 94.3 4.7 30.0 17.9 6.2 1.5 0.8 91.6 300.8 10.9 69.7 130.9 158.9 18.5 31.7 2.4 39.5 292.5 201.5 1.7 5.4 174.7 130.4 130.2 150.4 24.2 102.0 111.9 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 116.6;Oligodendrocyte precursor cells: 133.2;Oligodendrocytes: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "gdT-cell: 2.1;memory B-cell: 4.4;naive B-cell: 6.6" "Group enriched" "Detected in many" 4 "B-cells: 6.6;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" Yes No 170000 "Cluster 19: B-cells - Humoral immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: AB_2686713" "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 43.2 63.4 19.9 9.4 21.6 0.4 36.5 22.1 31.6 45.1 20.9 51.6 8.0 43.2 27.1 13.3 40.7 27.6 38.9 19.6 21.0 19.5 14.4 30.5 16.7 23.2 20.6 92.2 21.5 10.9 30.9 52.7 22.4 18.0 12.8 16.8 21.1 31.6 8.5 8.2 19.2 41.8 21.9 25.1 23.8 18.5 20.4 12.8 23.9 19.8 7.2 35.6 34.6 26.7 13.5 42.5 39.6 61.8 63.7 110.8 7.1 51.3 92.3 40.7 60.4 24.9 78.0 12.8 70.4 86.5 83.7 9.4 60.0 21.6 49.1 2.2 32.7 1.4 36.9 28.3 44.0 4.3 0.0 95.5 31.1 64.8 79.3 104.9 30.8 0.0 0.1 93.7 43.5 42.6 0.0 0.0 32.8 8.0 29.0 19.8 51.0 25.8 78.6 13.6 26.2 20.8 0.0 52.2 65.1 44.2 17.6 0.8 0.0 131.1 45.1 11.8 81.7 50.8 67.9 14.8 51.4 0.2 74.2 0.7 0.0 0.1 2.1 0.0 0.8 4.4 0.6 1.0 0.0 6.6 0.2 0.7 0.3 1.0 0.1 0.2 0.2 0.3 19.9 21.6 22.1 31.6 19.6 21.0 23.2 20.6 22.4 21.9 20.4 26.7 39.2 70.5 33.3 66.9 6.1 5.0 18.4 16.8 1.8 18.6 9.7 44.4 18.6 30.0 28.3 20.2 4.2 90.2 1.4 0.0 5.9 42.5 1.6 4.0 17.1 18.8 1.2 0.4 85.2 4.3 26.1 116.6 1.5 6.6 2.5 37.3 58.2 11.2 6.3 20.2 68.5 0.1 12.2 2.5 7.3 3.7 75.5 1.4 51.6 15.9 0.0 31.5 0.0 133.2 116.3 2.1 0.0 58.3 2.6 5.5 0.0 14.1 13.7 30.3 85.5 68.0 60.7 17.1 13.0 0.9 4.0 82.8 2.7 44.0 0.0 2.2 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" Q86VZ5 10 50305586-50625163 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.1;Microglial cells: 229.5;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 422.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favorable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 15.8 19.3 19.8 10.7 27.4 24.0 14.5 21.5 20.3 16.9 33.9 10.1 13.5 11.9 19.9 15.3 16.6 15.4 13.2 17.2 23.0 20.2 27.9 21.9 14.9 29.5 24.1 18.6 13.3 52.9 6.4 24.6 28.5 19.5 11.7 20.2 18.0 16.8 9.9 25.3 16.0 15.8 23.6 11.7 14.3 11.3 23.4 12.0 24.7 10.5 14.5 20.9 13.1 41.3 30.2 14.0 4.0 9.0 14.2 18.6 18.8 19.6 19.7 13.5 12.6 11.7 30.3 22.1 11.3 25.9 12.2 18.7 9.5 20.6 14.0 19.4 10.2 32.7 17.9 9.0 16.5 7.5 7.6 12.1 23.6 18.0 21.7 8.7 19.3 7.9 62.6 32.2 14.6 12.7 3.3 4.2 9.2 13.7 13.7 5.5 18.4 8.8 19.7 31.2 6.2 4.9 14.4 14.2 7.5 11.3 21.4 2.7 27.1 14.6 17.8 14.1 14.6 11.0 9.5 6.3 18.2 12.0 12.1 3.4 9.3 28.4 4.6 4.9 10.3 7.0 6.2 6.8 5.2 6.5 8.2 5.4 16.7 10.1 4.0 3.2 15.6 6.3 19.8 27.4 21.5 20.3 17.2 23.0 29.5 24.1 28.5 23.6 23.4 41.3 17.1 44.8 40.0 106.7 19.9 54.4 28.9 15.6 23.9 20.1 15.8 8.9 26.3 10.0 30.0 29.5 4.2 10.9 15.6 6.2 15.6 17.6 17.0 20.9 10.5 19.6 14.9 32.0 153.1 21.6 7.7 19.8 30.5 32.4 20.8 12.1 17.9 16.0 29.0 5.0 117.2 11.1 4.1 46.5 17.6 30.6 16.1 34.5 12.4 229.5 12.4 17.4 10.3 313.1 422.0 10.7 6.4 10.5 13.7 32.3 18.4 9.3 25.1 36.4 0.0 20.5 27.1 12.8 2.3 18.7 83.4 4.9 20.0 11.8 12.4 25.4 SGSM3 "DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3" ENSG00000100359 "Small G protein signaling modulator 3" Q96HU1 22 40370591-40410289 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Gastric mucus-secreting cells: 176.4;Intestinal goblet cells: 135.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048980 Approved Supported "Golgi apparatus" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA048980: AB_2680585" "unprognostic (4.63e-2)" "unprognostic (7.51e-3)" "unprognostic (3.02e-2)" "prognostic favorable (4.47e-5)" "unprognostic (1.81e-1)" "unprognostic (6.83e-3)" "unprognostic (5.70e-3)" "unprognostic (7.53e-2)" "unprognostic (3.57e-1)" "unprognostic (5.67e-2)" "unprognostic (1.71e-3)" "unprognostic (1.93e-1)" "unprognostic (2.97e-1)" "unprognostic (4.08e-3)" "unprognostic (2.10e-1)" "unprognostic (1.63e-1)" "unprognostic (5.98e-3)" 24.8 42.6 34.6 26.1 34.8 19.3 29.4 27.3 43.6 37.3 32.6 46.6 32.8 31.9 14.5 49.2 37.1 28.7 37.0 33.2 33.3 36.4 37.3 33.8 32.9 36.5 34.3 30.8 107.7 24.7 55.0 21.9 34.8 62.6 24.3 11.0 70.1 25.9 34.2 36.7 46.1 17.4 27.6 51.5 91.4 39.8 33.6 27.5 48.7 23.4 28.3 33.1 35.6 31.9 37.8 21.1 30.6 34.1 33.2 18.1 43.4 35.0 22.9 26.0 33.7 12.0 30.9 23.3 23.7 37.9 15.6 30.0 29.2 42.9 10.4 58.4 68.8 15.9 56.9 11.3 31.6 23.1 33.1 30.2 29.5 29.1 17.4 29.2 46.0 48.6 19.8 31.4 19.4 60.5 32.1 23.5 20.5 75.8 14.0 59.3 19.3 51.1 26.8 33.0 18.8 24.2 38.6 55.4 27.5 24.2 46.3 38.9 40.2 8.8 31.8 23.4 20.6 47.1 23.2 31.0 37.4 19.0 22.9 1.1 14.6 16.3 18.7 15.7 15.6 17.7 11.5 14.9 18.9 22.3 13.8 11.3 3.3 35.4 11.9 31.6 11.7 15.8 34.6 34.8 27.3 43.6 33.2 33.3 36.5 34.3 34.8 27.6 33.6 31.9 5.3 3.2 10.3 14.0 32.8 11.5 32.4 33.1 14.8 57.0 12.1 7.1 8.3 27.1 42.1 7.3 18.8 42.8 23.9 46.4 1.9 20.2 17.5 5.1 3.8 14.3 31.3 18.1 27.1 45.3 54.3 14.0 176.4 6.7 15.9 3.1 21.8 24.0 24.2 26.9 34.6 135.3 50.8 17.2 8.3 31.7 22.7 11.8 16.0 13.1 21.6 13.4 30.9 15.6 15.1 21.3 40.6 19.2 30.5 46.1 36.2 4.4 60.2 34.0 39.5 14.4 13.8 83.5 44.4 19.8 10.4 45.6 16.7 3.3 47.7 60.0 SH3BP2 "CRBM, RES4-23" ENSG00000087266 "SH3 domain binding protein 2" P78314 4 2793071-2841098 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036789, HPA036790" Approved Approved "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA036789: , HPA036790: AB_10671712" "unprognostic (7.86e-2)" "unprognostic (3.45e-1)" "unprognostic (9.83e-2)" "prognostic unfavorable (5.42e-6)" "prognostic unfavorable (9.52e-4)" "prognostic favorable (1.57e-5)" "unprognostic (6.58e-2)" "unprognostic (3.16e-2)" "unprognostic (3.17e-2)" "unprognostic (6.41e-3)" "unprognostic (3.35e-2)" "unprognostic (3.30e-2)" "unprognostic (3.24e-3)" "unprognostic (1.78e-2)" "unprognostic (5.32e-1)" "unprognostic (1.78e-1)" "prognostic favorable (2.67e-4)" 15.3 6.8 17.2 30.0 20.6 48.2 7.9 20.1 16.6 7.0 6.8 12.3 11.4 6.8 9.8 7.1 8.9 8.7 6.7 14.4 22.3 13.1 12.1 17.0 23.2 34.0 30.5 5.8 9.6 4.8 5.0 12.8 25.2 5.3 9.1 5.2 10.4 8.3 16.9 39.7 16.0 10.5 21.5 43.9 16.7 5.2 36.1 8.4 4.7 4.8 13.3 12.3 9.7 14.8 11.2 5.2 7.4 8.7 4.6 14.6 7.2 16.8 13.0 11.1 10.9 6.9 31.6 18.0 20.5 14.2 9.7 5.6 0.3 10.5 7.5 12.2 6.8 41.4 15.2 6.1 17.1 15.4 29.1 27.7 10.5 7.1 5.9 11.8 25.7 13.7 2.5 37.2 15.0 9.6 2.7 24.3 13.3 21.6 13.3 0.6 7.4 9.9 20.1 16.1 25.4 16.4 12.8 10.7 10.3 6.8 15.7 30.8 35.4 12.1 8.9 4.2 13.8 19.5 10.6 4.3 14.1 40.2 14.4 4.1 21.0 13.6 13.8 36.5 8.2 3.0 3.8 8.8 15.9 6.9 1.9 5.0 33.8 8.3 44.6 6.7 6.9 12.1 17.2 20.6 20.1 16.6 14.4 22.3 34.0 30.5 25.2 21.5 36.1 14.8 27.6 3.2 5.8 40.5 19.5 38.1 10.0 35.3 8.6 0.8 19.8 10.0 8.3 7.2 25.3 40.5 0.0 1.3 43.7 42.5 3.9 6.3 8.5 9.7 11.0 31.3 10.2 14.9 0.4 22.0 1.2 11.3 18.3 22.0 9.5 11.6 33.9 59.0 49.3 0.0 2.7 14.2 30.5 81.5 63.3 10.8 13.7 71.9 19.6 18.7 48.9 23.7 57.7 2.5 0.5 25.3 27.1 10.1 18.1 16.1 23.7 43.7 12.3 6.4 39.5 5.2 16.0 1.9 3.7 18.6 83.4 4.2 22.0 25.5 15.4 20.1 SH3BP5L KIAA1720 ENSG00000175137 "SH3 binding domain protein 5 like" Q7L8J4 1 248810446-248825915 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 7.7;eosinophil: 4.1;neutrophil: 4.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038067, HPA038068" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA038067: AB_2675814, HPA038068: AB_10670651" "unprognostic (2.48e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (4.41e-1)" "unprognostic (2.78e-1)" "unprognostic (2.27e-3)" "unprognostic (1.99e-3)" "unprognostic (5.84e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (1.50e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-2)" "unprognostic (4.66e-2)" 9.6 10.5 18.0 10.1 18.7 9.0 7.7 17.3 21.0 8.8 13.9 12.2 13.5 10.5 7.8 15.8 10.0 8.0 14.1 19.4 15.8 9.5 10.5 9.2 11.3 17.0 16.7 8.6 10.0 12.0 5.9 11.4 16.9 9.1 7.3 5.3 11.9 11.6 30.6 18.4 12.4 9.9 15.8 12.3 9.9 9.5 17.1 13.8 8.1 17.8 10.2 9.0 9.1 18.3 23.2 14.7 18.5 21.2 25.7 17.1 24.6 51.1 17.4 29.2 21.8 14.3 20.0 11.6 29.7 44.1 7.3 24.6 17.9 22.1 15.0 25.4 6.3 18.6 16.4 11.9 15.8 20.4 21.9 14.4 23.4 33.0 12.9 20.7 19.6 21.4 33.0 12.0 20.2 7.9 19.7 16.5 32.4 25.5 36.9 21.9 13.0 23.5 20.5 10.6 21.1 29.2 15.6 19.3 17.9 14.0 21.0 42.4 27.5 36.9 15.7 14.7 80.2 30.5 34.3 10.5 26.8 23.5 15.4 7.7 1.2 4.1 0.7 0.8 0.7 0.6 1.0 0.6 1.1 0.6 0.3 0.3 4.6 0.3 0.3 0.4 0.2 0.8 18.0 18.7 17.3 21.0 19.4 15.8 17.0 16.7 16.9 15.8 17.1 18.3 5.2 0.0 2.0 5.9 4.3 4.6 2.1 2.9 4.0 8.3 6.1 5.0 9.4 1.5 2.3 11.0 0.0 9.6 4.7 15.1 1.9 8.8 1.3 10.5 5.4 6.0 7.7 6.9 6.5 6.0 5.2 4.9 7.7 6.1 0.0 9.0 6.1 10.0 6.0 8.4 5.7 8.4 2.0 5.3 4.5 1.0 4.4 5.6 3.6 3.7 7.1 4.7 6.2 6.0 6.4 10.6 8.1 5.7 5.4 3.0 13.8 9.2 5.1 3.5 0.0 3.7 5.8 8.8 7.0 7.0 4.7 11.4 6.3 5.4 7.3 3.3 SHARPIN "DKFZP434N1923, SIPL1" ENSG00000179526 "SHANK associated RH domain interactor" Q9H0F6 8 144098633-144108124 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 391.4;Late spermatids: 1255.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024825, HPA044453" Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA024825: , HPA044453: AB_10962490" "unprognostic (4.91e-2)" "unprognostic (3.47e-2)" "unprognostic (1.35e-2)" "unprognostic (7.88e-2)" "unprognostic (3.32e-2)" "unprognostic (9.54e-2)" "unprognostic (1.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.13e-3)" "unprognostic (5.44e-2)" "unprognostic (7.91e-2)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.24e-1)" "unprognostic (1.00e-1)" 29.9 39.2 38.5 16.5 39.9 32.6 27.2 39.1 52.2 29.9 35.7 37.7 20.7 29.4 11.2 29.9 28.8 19.4 44.4 36.0 39.2 36.7 39.1 27.1 21.8 41.7 39.7 27.4 35.1 28.7 26.7 17.2 39.9 33.8 12.7 8.9 33.8 22.2 49.4 27.1 26.3 17.3 37.7 33.4 34.2 94.7 39.8 19.6 29.1 39.7 13.9 31.2 26.4 38.7 26.9 43.5 20.4 17.9 34.2 35.1 22.5 23.5 29.5 34.0 32.9 24.9 42.0 12.0 38.5 30.6 17.1 28.4 10.8 42.2 8.2 33.0 23.3 31.4 40.1 29.9 61.6 11.6 23.1 40.4 59.4 28.3 30.8 37.6 36.8 36.6 18.2 27.3 30.2 43.8 35.2 26.6 9.3 53.6 124.2 23.6 16.7 39.4 35.2 28.3 20.3 30.7 45.0 62.1 41.5 14.3 69.4 35.8 34.0 26.5 38.9 32.5 32.4 30.0 25.4 16.3 38.3 25.9 23.5 22.6 33.5 53.5 29.9 41.2 32.4 23.3 28.5 38.3 30.0 21.8 23.5 24.7 17.5 33.9 34.8 42.7 34.1 22.4 38.5 39.9 39.1 52.2 36.0 39.2 41.7 39.7 39.9 37.7 39.8 38.7 56.3 9.6 18.1 10.4 39.4 24.0 32.9 37.0 26.2 27.1 43.5 44.4 20.9 31.5 26.1 35.0 4.2 56.7 44.4 87.2 119.3 53.8 391.4 28.3 26.8 38.9 35.4 88.0 8.0 49.5 52.6 35.9 52.0 24.4 13.3 35.1 36.4 37.2 59.0 48.8 9.5 45.6 44.7 42.1 32.9 1255.3 49.0 33.0 46.2 15.0 57.7 45.4 59.8 9.0 14.3 95.2 81.3 43.6 31.2 36.1 83.1 86.4 20.6 28.9 52.6 26.8 44.2 181.7 67.9 33.5 32.4 43.1 38.8 37.4 59.0 33.9 SHLD1 "C20orf196, FLJ25067, RINN3" ENSG00000171984 "Shieldin complex subunit 1" Q8IYI0 20 5750393-5864395 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;dendritic cells: 13.1;Distal tubular cells: 19.6;Exocrine glandular cells: 14.2;Hofbauer cells: 17.0;Pancreatic endocrine cells: 11.7;Proximal tubular cells: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 55.7;U-698: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040749 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum, Golgi apparatus, Vesicles" "HPA040749: AB_10673093" "unprognostic (2.03e-1)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "unprognostic (4.20e-3)" "unprognostic (6.15e-2)" "unprognostic (1.66e-1)" "unprognostic (1.72e-3)" "unprognostic (6.66e-2)" "unprognostic (9.04e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-2)" "unprognostic (7.59e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "prognostic favorable (4.05e-5)" 4.0 9.7 5.0 6.2 5.8 16.7 5.3 7.2 6.1 5.1 4.6 5.1 9.1 3.8 5.3 5.4 3.9 4.4 8.6 4.9 5.8 6.7 3.0 4.8 14.3 5.6 5.3 5.1 5.2 2.4 6.0 3.0 6.3 6.3 4.9 4.0 8.4 3.7 12.0 4.1 7.1 2.6 4.6 9.9 4.7 3.1 5.4 13.3 6.6 7.7 12.1 4.5 4.7 6.4 9.2 9.6 4.6 2.3 2.8 2.8 2.3 2.5 4.5 3.1 4.3 4.5 9.4 33.3 6.3 2.5 2.5 4.1 2.8 6.1 3.6 10.3 3.4 12.9 1.4 18.2 6.2 16.2 5.7 3.3 7.2 4.7 3.1 3.0 6.4 8.7 17.8 13.9 5.9 3.5 20.4 55.7 6.3 10.3 5.2 16.5 7.1 15.1 5.0 4.5 8.2 7.4 4.6 4.7 10.0 2.6 3.9 13.2 4.3 3.6 5.4 3.5 5.4 8.7 16.6 45.8 1.8 13.9 6.4 21.7 12.4 22.5 21.3 14.8 16.4 27.7 25.2 21.5 12.7 33.1 22.9 17.2 4.9 23.5 16.9 15.1 31.5 13.0 5.0 5.8 7.2 6.1 4.9 5.8 5.6 5.3 6.3 4.6 5.4 6.4 9.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 6.4 8.6 0.0 0.0 0.0 12.9 0.0 7.5 13.1 0.0 19.6 7.9 0.0 6.4 4.4 2.8 0.0 0.0 0.0 14.2 7.5 1.7 0.0 5.2 0.0 7.3 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 11.7 0.0 0.0 2.3 0.0 0.0 11.7 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 5.9 6.4 5.0 0.0 0.0 SIGLEC11 ENSG00000161640 "Sialic acid binding Ig like lectin 11" Q96RL6 19 49948985-49961172 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 23.1;ovary: 65.5" "Group enriched" "Detected in some" 7 "Granulosa cells: 196.9;Theca cells: 192.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 1.4;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 6 "granulocytes: 1.4;monocytes: 1.3" "Cell line enriched" "Detected in single" 16 "HEL: 10.1" "HPA052132, HPA060278" Approved Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Nucleoplasm "HPA052132: , HPA060278: AB_2684240" "unprognostic (1.07e-1)" "unprognostic (2.85e-3)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (3.35e-2)" "unprognostic (9.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.20e-1)" "unprognostic (8.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.95e-3)" "unprognostic (5.38e-2)" 1.1 7.3 0.5 1.8 0.8 0.4 0.4 0.4 0.7 0.3 0.6 0.5 0.8 0.3 0.2 0.1 0.9 0.3 0.4 0.6 0.6 0.4 1.7 1.7 0.6 1.4 1.0 65.5 2.7 0.1 0.2 1.8 1.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 1.0 1.2 0.8 23.1 4.7 1.5 1.6 0.1 0.2 0.1 0.0 0.6 0.2 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 10.1 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.3 1.4 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.2 1.3 0.1 0.0 0.1 0.5 0.8 0.4 0.7 0.6 0.6 1.4 1.0 1.3 0.8 1.6 1.4 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 19.6 0.0 0.6 0.2 0.3 1.0 0.0 0.0 0.0 1.1 0.1 4.3 0.0 0.3 0.0 196.9 5.3 0.6 7.9 0.0 0.0 0.0 0.0 26.8 0.2 0.1 0.0 6.1 0.0 5.6 1.3 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.2 7.5 1.7 0.7 0.0 0.1 0.1 0.2 192.3 0.0 0.0 SIGLEC15 "CD33L3, HsT1361" ENSG00000197046 "Sialic acid binding Ig like lectin 15" Q6ZMC9 18 45825675-45844094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 1.7;intestine: 3.0;urinary bladder: 1.4" "Cell type enhanced" "Detected in some" "Breast glandular cells: 3.6;Hofbauer cells: 10.1;Macrophages: 3.7;Pancreatic endocrine cells: 3.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 3.0;myeloid DC: 1.0" "Group enriched" "Detected in many" 21 "dendritic cells: 1.0;monocytes: 3.0" "Cell line enriched" "Detected in some" 5 "U-87 MG: 124.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053509 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 14: B-cells - Humoral immune response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Golgi apparatus" "HPA053509: " "unprognostic (3.89e-3)" "unprognostic (1.87e-2)" "unprognostic (1.77e-1)" "unprognostic (7.18e-3)" "unprognostic (2.27e-1)" "unprognostic (8.07e-2)" "unprognostic (5.91e-2)" "unprognostic (2.71e-1)" "unprognostic (9.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-2)" "unprognostic (7.65e-2)" "unprognostic (6.55e-2)" "unprognostic (1.42e-1)" "unprognostic (6.06e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.14e-5)" 0.0 0.4 0.1 0.3 0.4 0.0 1.7 0.6 0.3 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.0 1.0 1.3 0.0 0.0 0.2 0.0 0.0 0.6 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.9 0.3 1.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 2.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.4 10.9 2.1 0.3 0.0 22.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 5.5 0.0 0.1 1.3 0.0 0.0 0.0 124.2 2.9 0.2 0.0 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.4 0.6 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.0 1.0 3.6 0.9 0.8 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.5 0.4 0.2 1.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.7 0.0 0.0 2.2 0.4 10.1 1.7 0.1 0.2 0.0 1.6 2.5 0.0 0.0 3.7 0.0 0.0 1.6 0.0 1.0 0.0 0.0 3.5 0.1 0.0 0.0 1.1 1.2 0.1 0.0 1.0 0.0 1.5 0.4 1.2 0.1 0.0 0.3 0.0 0.3 0.0 0.1 2.8 SIPA1 SPA1 ENSG00000213445 "Signal-induced proliferation-associated 1" Q96FS4 11 65638101-65650918 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 95.6" "Cell type enhanced" "Detected in many" "dendritic cells: 82.5;NK-cells: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020833, HPA039867" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 2: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoli "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB020833: , HPA039867: AB_2676716" "unprognostic (6.10e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (1.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.09e-1)" "unprognostic (3.30e-2)" "unprognostic (6.44e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.60e-1)" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-1)" 21.6 17.2 16.4 48.7 15.5 53.8 16.2 14.1 16.8 20.6 10.3 24.0 12.5 20.9 3.4 14.3 19.5 16.0 25.7 15.8 13.2 17.0 15.0 37.0 60.7 22.3 16.0 13.1 8.4 3.5 7.5 19.4 19.5 17.1 6.0 0.9 14.1 10.0 10.0 8.1 37.8 12.0 19.5 95.6 15.9 4.7 24.5 21.3 14.9 6.4 32.5 18.8 15.3 21.0 1.6 13.3 9.1 20.1 5.4 11.1 21.7 14.9 12.7 11.7 11.3 3.9 14.5 21.3 33.2 7.6 0.4 7.8 3.4 5.1 3.9 22.7 8.1 52.6 20.7 7.4 9.6 21.5 21.5 11.4 2.3 16.2 2.1 11.5 34.4 21.8 30.3 9.2 5.8 5.8 8.6 36.1 6.4 5.4 12.3 38.8 5.1 19.3 4.4 0.8 3.4 20.9 7.5 12.6 31.7 8.5 9.6 32.5 49.2 14.2 28.7 15.2 3.0 14.1 12.2 48.4 19.5 33.0 42.0 3.2 3.3 9.3 5.8 3.9 4.1 4.1 2.8 3.7 2.3 4.7 2.0 3.1 11.1 4.7 4.8 2.1 3.0 3.0 16.4 15.5 14.1 16.8 15.8 13.2 22.3 16.0 19.5 19.5 24.5 21.0 22.5 6.4 5.2 7.5 59.0 6.8 24.7 23.2 17.6 2.1 24.8 26.5 7.2 21.5 19.2 23.9 0.0 10.1 82.5 16.5 37.2 19.8 3.0 8.3 6.8 26.8 21.0 31.6 0.1 14.5 19.6 12.2 11.2 14.9 7.0 37.1 42.8 22.0 38.4 5.0 0.2 12.8 30.5 44.4 11.4 9.8 8.1 40.2 10.6 14.0 23.7 7.6 88.6 0.5 4.0 27.2 12.7 13.2 29.6 29.0 39.0 20.7 6.0 1.8 13.1 7.4 20.9 0.8 13.8 14.4 11.1 13.5 50.4 30.9 14.3 31.9 SIPA1L2 "KIAA1389, SPAR2" ENSG00000116991 "Signal induced proliferation associated 1 like 2" Q9P2F8 1 232397965-232630571 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024181, HPA027224" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus" No NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear membrane, Nuclear bodies" "Golgi apparatus" "HPA024181: AB_1856886, HPA027224: AB_2672165" "unprognostic (2.34e-2)" "unprognostic (9.67e-2)" "unprognostic (8.02e-2)" "unprognostic (1.71e-3)" "unprognostic (2.98e-1)" "unprognostic (5.68e-2)" "unprognostic (5.57e-3)" "unprognostic (7.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.80e-2)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (3.36e-2)" "unprognostic (2.75e-1)" "unprognostic (5.84e-3)" "unprognostic (3.45e-3)" 12.1 3.3 8.5 6.4 7.2 5.4 9.2 9.6 11.7 10.0 0.5 19.4 3.9 4.4 2.8 20.3 4.5 8.5 31.3 9.6 16.0 7.7 6.4 16.2 3.0 44.0 21.7 11.9 3.6 4.4 8.1 18.3 44.6 8.1 18.9 14.7 8.7 4.7 7.1 9.0 9.2 7.4 14.4 9.6 5.7 7.2 18.7 2.4 8.0 9.5 3.3 12.5 14.9 9.0 0.0 7.5 69.7 0.2 0.6 0.0 29.3 1.2 2.5 3.1 2.2 2.9 0.1 5.9 13.3 26.4 2.9 1.7 13.8 2.3 2.9 0.0 12.8 0.0 7.0 0.0 5.9 1.0 7.2 3.8 9.1 0.6 6.2 0.0 15.7 25.4 0.0 0.1 1.6 3.5 7.4 0.7 53.9 0.2 10.2 0.0 0.0 3.4 8.1 11.5 3.5 11.9 23.8 0.8 9.5 15.8 1.4 0.6 5.6 8.1 0.0 17.8 2.9 6.5 0.0 0.0 10.0 6.2 46.1 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.6 0.3 0.3 0.0 0.1 8.5 7.2 9.6 11.7 9.6 16.0 44.0 21.7 44.6 14.4 18.7 9.0 53.7 6.4 1.8 22.9 0.8 8.8 9.8 8.7 15.4 23.5 10.7 8.6 62.6 12.8 10.4 3.7 52.1 4.9 4.4 29.9 0.0 7.1 11.7 19.0 21.4 22.7 7.2 0.4 80.2 0.5 7.1 15.2 5.1 47.5 1.3 16.0 1.8 3.8 10.0 5.0 95.9 29.5 14.2 16.6 7.2 9.8 0.9 19.5 14.2 183.6 6.3 12.7 1.0 104.0 21.0 1.4 39.9 1.9 0.5 13.2 9.1 0.4 7.7 35.7 0.0 21.8 23.9 6.9 24.0 45.8 7.4 14.8 2.0 11.9 23.4 23.0 SIPA1L3 "KIAA0545, SPAR3" ENSG00000105738 "Signal induced proliferation associated 1 like 3" O60292 19 37907208-38208369 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 93.7;Inhibitory neurons: 87.3;Oligodendrocyte precursor cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A549: 59.6" "Low region specificity" "Detected in all" "HPA042072, HPA045480, HPA074988" Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 10: Brain - Neuronal signaling" "Cluster 18: U-2197 - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: " "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.86e-1)" "unprognostic (5.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-2)" "unprognostic (1.31e-2)" "unprognostic (5.48e-2)" "unprognostic (3.11e-1)" "unprognostic (6.05e-2)" "unprognostic (3.15e-1)" "unprognostic (5.43e-2)" "unprognostic (9.26e-3)" "unprognostic (6.45e-2)" "unprognostic (4.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.96e-2)" 2.2 3.0 6.0 6.6 3.0 2.9 5.1 10.4 16.2 4.8 2.6 10.6 18.4 3.3 1.3 4.9 4.8 3.9 6.2 28.9 2.0 6.4 3.4 5.7 6.8 4.2 4.1 2.9 9.7 3.3 3.2 1.4 3.5 5.3 7.0 5.0 8.4 3.5 6.5 11.1 18.1 1.8 1.6 7.3 9.1 4.3 5.6 3.8 10.0 7.3 5.5 4.3 3.6 5.5 34.4 59.6 7.3 9.3 4.3 4.3 4.9 14.5 12.2 9.4 8.8 20.6 19.5 19.5 12.2 12.4 7.9 7.6 6.7 27.1 10.4 6.7 3.3 5.3 5.5 6.5 8.3 3.7 5.5 3.3 14.1 17.5 37.3 13.9 10.8 5.6 3.9 4.1 16.6 10.6 5.0 5.1 6.0 27.2 15.8 10.8 5.9 2.9 20.7 29.1 17.3 9.3 16.0 27.1 2.2 3.9 18.0 3.5 23.2 15.6 5.5 48.4 22.6 5.4 10.0 6.6 20.1 4.9 20.6 0.1 0.1 0.4 0.1 0.2 0.0 1.1 0.1 0.2 0.1 1.5 0.1 0.5 0.1 0.3 1.5 0.3 0.1 0.1 6.0 3.0 10.4 16.2 28.9 2.0 4.2 4.1 3.5 1.6 5.6 5.5 4.8 6.4 10.1 41.4 24.5 12.0 5.2 10.4 6.2 21.9 22.6 12.1 5.2 22.8 10.8 23.9 14.6 2.1 9.3 93.7 3.9 7.2 4.5 19.8 4.8 5.4 25.2 10.8 61.1 15.3 1.4 3.7 40.2 16.5 2.5 4.8 6.4 23.5 3.5 33.7 87.3 46.3 20.3 5.1 13.9 9.2 2.1 8.3 5.4 50.6 7.1 3.0 5.2 99.5 58.7 13.4 38.7 1.9 12.8 6.6 50.0 21.1 19.1 5.7 6.6 4.5 3.6 1.7 5.1 8.9 16.1 0.8 5.1 1.7 30.4 5.6 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646196 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.5;lymphoid tissue: 18.3" "Cell type enhanced" "Detected in some" "dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4" "Group enriched" "Detected in many" 8 "dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4" "Group enriched" "Detected in some" 7 "HEL: 91.2;JURKAT: 51.8" "Not detected" "Not detected" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Cluster 48: NK-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 36: HEL - Hemostasis" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: AB_2682246, HPA058217: AB_2683641" "unprognostic (4.16e-3)" "prognostic favorable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 1.3 0.6 0.4 5.7 0.6 12.5 0.8 1.6 0.7 0.8 0.3 1.7 2.7 1.0 0.5 0.7 0.9 2.4 0.7 0.4 0.2 0.5 1.5 4.1 10.4 0.7 0.4 0.4 0.4 0.1 0.4 0.6 0.8 0.7 1.7 0.5 1.4 0.5 0.6 0.7 3.1 0.5 0.3 8.0 2.6 0.5 0.6 18.3 0.7 0.2 9.0 2.2 0.6 1.1 0.0 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 91.2 0.6 3.4 0.0 2.5 0.3 0.1 0.1 0.0 0.0 0.0 0.1 51.8 0.1 0.2 0.0 0.2 10.9 7.6 0.1 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 2.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.1 7.6 0.1 3.0 0.4 3.8 28.8 0.7 24.1 0.4 23.8 27.1 0.4 0.3 21.8 30.5 4.8 39.2 0.1 48.5 33.4 26.5 0.4 0.6 1.6 0.7 0.4 0.2 0.7 0.4 0.8 0.3 0.6 1.1 0.6 0.0 3.9 0.0 1.6 0.4 0.1 0.0 0.0 0.3 0.5 0.3 0.3 0.0 0.7 0.0 0.0 0.1 97.0 0.6 0.0 0.2 1.1 0.4 0.4 0.4 0.0 8.2 2.2 0.0 0.2 0.5 4.1 0.6 1.3 0.0 0.7 0.1 0.2 0.0 1.7 0.0 0.0 1.6 0.4 0.0 0.3 21.8 0.0 1.9 1.2 0.4 44.3 1.5 1.4 0.3 0.1 0.0 25.8 0.1 0.0 0.1 0.0 0.9 0.0 0.3 0.4 0.0 0.2 0.2 0.1 0.1 59.2 0.0 0.2 0.3 SLC16A13 MCT13 ENSG00000174327 "Solute carrier family 16 member 13" Q7RTY0 17 7036015-7040117 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 22.8;GAMG: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065245 Supported "Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA065245: AB_2685443" "unprognostic (5.61e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (1.78e-1)" "unprognostic (2.22e-3)" "unprognostic (9.53e-2)" "unprognostic (1.62e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.44e-2)" "unprognostic (7.31e-3)" "unprognostic (9.70e-3)" "unprognostic (3.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.14e-1)" 1.4 1.0 1.1 2.1 0.8 0.4 1.4 1.8 1.1 1.8 1.0 2.2 9.2 0.8 1.3 5.3 1.8 3.7 1.6 0.9 1.0 6.8 36.1 2.4 2.8 1.2 1.2 0.5 1.2 2.9 0.8 1.5 1.0 1.4 1.6 0.3 3.3 0.8 0.4 5.3 5.5 0.9 0.9 3.5 1.9 0.5 1.0 1.8 3.3 0.2 2.5 1.2 2.6 0.8 13.1 22.8 5.3 3.2 3.2 1.8 2.2 1.3 3.3 2.9 6.5 7.4 14.3 8.3 2.2 2.1 26.2 20.1 4.1 7.0 1.2 10.3 2.9 3.4 1.8 18.0 3.6 1.2 7.6 2.1 7.8 4.3 3.5 3.9 11.9 7.4 4.0 2.3 3.1 6.5 5.1 2.1 2.2 6.6 1.8 2.4 1.8 1.4 2.7 3.6 0.2 1.4 4.0 2.2 1.8 7.8 6.1 1.8 4.5 1.8 4.1 3.0 1.9 4.0 8.9 0.5 5.4 3.0 0.8 0.0 0.8 1.0 1.2 0.8 0.9 1.1 1.0 1.5 0.8 2.5 1.1 1.1 0.9 1.2 0.9 1.1 1.2 0.5 1.1 0.8 1.8 1.1 0.9 1.0 1.2 1.2 1.0 0.9 1.0 0.8 2.3 0.0 1.5 0.7 5.1 0.5 0.9 1.3 4.0 0.4 1.6 0.9 0.4 1.5 0.8 5.5 0.0 1.9 2.4 1.1 0.0 1.0 0.0 0.5 0.5 2.8 0.0 0.4 1.8 0.2 0.4 0.6 4.1 0.7 3.8 1.1 2.2 8.2 0.5 3.3 1.1 1.2 2.0 0.6 3.1 0.0 0.9 1.6 0.0 1.0 1.4 0.9 6.2 0.5 0.0 0.5 0.1 0.0 2.9 0.9 2.4 1.9 1.4 0.5 0.0 0.3 1.1 0.0 0.0 7.4 1.6 2.5 4.7 0.5 1.0 1.0 SLC17A1 "NAPI-1, NPT1" ENSG00000124568 "Solute carrier family 17 member 1" Q14916 6 25782915-25832052 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 49 "kidney: 169.3;liver: 49.4" "Cell type enhanced" "Detected in some" "Early spermatids: 13.5;Hepatocytes: 10.3;Proximal tubular cells: 49.2" "Group enriched" "Detected in some" 150 "liver cancer: 7.6;renal cancer: 19.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 647 "RPTEC TERT1: 64.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050513 Approved "Golgi apparatus" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA050513: AB_2681152" "unprognostic (6.98e-2)" "unprognostic (2.99e-1)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-3)" "unprognostic (1.32e-1)" "unprognostic (2.37e-1)" "unprognostic (4.74e-1)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 169.3 49.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 SLC18B1 "C6orf192, dJ55C23.6" ENSG00000146409 "Solute carrier family 18 member B1" Q6NT16 6 132769370-132813339 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 93.4;Hofbauer cells: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029747 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 1: K-562 - Erythropoiesis" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" Cytosol "HPA029747: AB_10600797" "unprognostic (1.84e-2)" "unprognostic (3.94e-1)" "unprognostic (4.22e-2)" "unprognostic (2.85e-1)" "unprognostic (2.41e-2)" "prognostic favorable (3.55e-4)" "prognostic unfavorable (7.90e-4)" "unprognostic (1.53e-1)" "unprognostic (2.39e-1)" "unprognostic (4.09e-1)" "unprognostic (6.97e-3)" "unprognostic (1.13e-1)" "prognostic favorable (9.24e-4)" "unprognostic (7.20e-3)" "unprognostic (1.08e-1)" "unprognostic (2.08e-2)" "unprognostic (7.88e-2)" 9.9 8.9 21.0 6.3 21.6 4.6 9.7 22.5 28.0 9.4 23.1 9.7 14.5 6.4 5.8 13.6 9.8 11.9 3.9 21.2 22.2 12.7 7.6 5.7 7.7 21.6 22.3 6.9 9.9 12.9 8.3 15.7 21.0 5.4 10.1 2.6 13.1 4.5 3.2 9.5 10.5 5.9 22.8 8.3 16.1 2.0 25.1 7.9 10.2 3.5 8.1 11.1 7.2 22.8 6.8 6.5 10.0 0.0 1.5 3.2 5.7 2.5 7.2 4.4 13.4 14.9 13.8 0.2 9.2 1.5 7.9 17.3 13.4 15.4 3.3 10.3 27.6 3.6 11.3 16.8 7.5 3.0 0.3 9.3 13.7 7.2 14.5 7.3 13.6 20.7 40.4 2.5 3.8 9.4 10.5 0.3 14.1 15.8 8.7 15.7 11.7 11.8 36.6 11.4 21.2 0.0 12.9 25.2 20.1 6.0 8.9 0.1 6.0 1.9 5.3 2.1 5.7 8.5 0.5 0.4 11.5 0.1 1.7 0.0 14.4 0.8 4.3 3.2 8.1 6.6 6.5 6.0 19.9 9.7 9.5 6.6 0.8 3.4 0.3 15.5 11.9 8.1 21.0 21.6 22.5 28.0 21.2 22.2 21.6 22.3 21.0 22.8 25.1 22.8 10.4 0.0 6.5 93.4 15.2 10.1 10.3 30.4 22.8 5.5 13.0 7.4 3.1 40.0 20.6 27.6 2.1 53.1 8.2 5.4 9.8 32.0 0.2 12.6 4.8 7.8 16.3 49.1 32.2 15.1 19.3 7.8 20.4 5.8 0.0 5.8 18.2 15.6 65.6 0.0 25.3 11.9 32.6 21.5 9.0 0.5 6.8 26.7 14.2 27.2 11.4 9.3 5.2 51.3 4.4 14.6 6.0 4.5 6.6 8.8 7.2 6.4 27.9 3.5 0.0 8.6 4.8 0.3 0.5 25.5 10.9 28.5 7.3 21.7 15.3 13.2 SLC20A1 "Glvr-1, GLVR1, PiT-1" ENSG00000144136 "Solute carrier family 20 member 1" Q8WUM9 2 112645939-112663825 "Metabolic proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Phosphate transport, Symport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 353.3;Paneth cells: 261.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 522.4;U-87 MG: 507.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019279, HPA035834" Approved Approved "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB019279: , HPA035834: AB_2674809" "unprognostic (1.81e-1)" "unprognostic (2.18e-1)" "unprognostic (5.38e-2)" "unprognostic (4.03e-3)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.50e-2)" "unprognostic (3.38e-2)" "unprognostic (2.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.43e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.44e-5)" "unprognostic (6.85e-2)" "unprognostic (1.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-3)" 36.1 11.7 16.2 33.2 24.3 74.6 15.6 27.8 26.3 11.8 25.0 53.6 14.4 13.7 8.4 15.0 14.5 26.4 21.8 20.7 19.8 22.1 49.0 29.2 37.1 25.5 20.7 9.2 30.7 10.4 15.9 29.7 25.2 13.3 21.9 52.3 12.8 9.3 19.7 14.5 28.4 15.0 18.6 29.5 20.2 15.7 24.5 27.2 15.9 7.5 27.5 40.8 13.3 21.2 69.0 55.5 71.1 57.8 52.9 128.8 54.4 181.6 215.3 79.1 102.2 85.0 164.9 124.0 97.5 67.7 305.0 70.5 78.8 138.0 114.8 68.5 80.4 105.5 57.1 81.3 78.2 61.2 178.9 66.0 53.8 279.1 193.9 522.4 102.2 52.9 199.5 126.3 346.7 26.8 83.9 235.9 119.3 31.8 147.6 77.8 63.5 34.9 114.5 312.8 64.4 60.8 91.7 54.9 127.9 31.4 56.0 42.9 223.6 143.5 94.7 50.8 142.4 52.1 143.7 102.2 507.2 57.9 178.3 13.4 33.5 30.1 52.8 59.8 59.4 8.3 22.2 38.4 25.4 5.0 17.5 27.6 14.7 50.2 37.2 41.8 14.6 33.9 16.2 24.3 27.8 26.3 20.7 19.8 25.5 20.7 25.2 18.6 24.5 21.2 61.7 12.8 25.9 42.4 40.3 112.8 59.1 38.7 104.7 60.0 41.9 31.6 49.6 32.9 35.3 9.2 210.6 44.7 119.1 353.3 13.7 18.1 1.5 86.0 34.3 48.2 35.7 53.2 47.3 14.0 13.5 61.5 96.4 167.8 25.3 20.6 41.0 58.1 28.2 20.2 27.2 85.8 32.6 58.5 86.2 3.3 3.7 80.5 26.6 19.7 42.8 31.8 66.9 18.6 26.1 26.9 261.6 4.9 59.8 34.0 156.3 5.2 59.6 84.6 0.0 36.9 25.9 8.5 18.7 119.5 61.8 74.3 70.4 19.0 96.5 90.3 SLC23A2 "KIAA0238, SLC23A1, SVCT2, YSPL2" ENSG00000089057 "Solute carrier family 23 member 2" Q9UGH3 20 4852356-5010293 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 99.3;choroid plexus: 88.4;retina: 107.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 236.8;Cone photoreceptor cells: 114.7;Excitatory neurons: 102.8;Inhibitory neurons: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052825, HPA059314" Approved Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 56: Bipolar cells - Visual perception" Vesicles "Golgi apparatus" "HPA052825: AB_2681965, HPA059314: AB_2683975" "unprognostic (3.83e-1)" "unprognostic (1.08e-2)" "unprognostic (1.95e-3)" "unprognostic (1.64e-3)" "unprognostic (8.05e-2)" "unprognostic (2.09e-1)" "prognostic favorable (3.35e-4)" "unprognostic (6.22e-3)" "unprognostic (2.08e-1)" "unprognostic (6.36e-3)" "prognostic favorable (7.14e-5)" "unprognostic (1.57e-1)" "unprognostic (1.60e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.08e-5)" 10.2 99.3 26.3 8.2 27.2 7.8 9.4 24.1 26.0 13.5 88.4 9.4 6.4 12.9 8.7 6.1 15.9 10.1 8.3 28.5 26.7 13.0 57.0 12.1 10.2 28.1 32.0 38.5 10.0 17.7 23.3 8.1 29.5 12.5 6.1 107.2 5.9 10.3 3.3 11.4 12.5 10.0 25.6 20.9 9.4 11.4 34.6 8.2 25.0 4.5 9.9 18.9 8.9 33.1 21.2 24.5 32.2 12.2 22.2 12.4 40.9 8.9 12.1 10.3 9.6 12.7 23.6 9.6 9.4 12.4 29.1 20.1 9.1 24.2 19.2 6.0 16.2 13.3 4.3 48.0 12.5 18.9 7.6 10.6 13.8 25.8 15.4 21.5 15.2 15.5 9.3 7.9 13.7 7.9 20.7 10.5 11.4 16.9 14.9 19.0 21.2 14.3 5.6 34.2 10.7 12.0 17.0 17.7 63.3 11.4 9.8 10.9 13.1 23.0 10.7 27.8 17.4 11.2 22.2 25.5 8.1 11.2 36.8 0.0 1.1 0.1 1.1 0.7 1.0 1.8 0.8 0.8 1.5 1.0 0.8 0.8 1.2 0.3 0.9 2.4 0.5 0.9 26.3 27.2 24.1 26.0 28.5 26.7 28.1 32.0 29.5 25.6 34.6 33.1 9.3 6.4 7.2 50.3 14.5 7.4 4.5 7.0 12.5 236.8 8.3 7.4 7.9 15.7 9.4 14.7 114.7 4.9 12.6 0.8 0.0 5.0 4.6 2.8 10.1 13.0 7.2 8.6 102.8 5.5 6.6 14.2 3.6 1.9 8.2 13.5 17.5 71.3 10.6 85.8 117.4 1.9 0.0 30.2 7.5 9.3 20.2 16.3 16.0 60.0 8.8 24.8 7.2 77.4 78.3 3.4 6.7 29.3 11.9 8.2 0.6 1.3 7.8 71.5 13.1 12.6 12.2 0.6 8.0 5.5 6.1 4.0 8.2 65.6 2.8 14.7 SLC24A3 ENSG00000185052 "Solute carrier family 24 member 3" Q9HC58 20 19212642-19722926 "Metabolic proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.7" "Group enriched" "Detected in many" 9 "Astrocytes: 134.5;Inhibitory neurons: 327.0;Oligodendrocyte precursor cells: 375.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 39 "basophil: 5.8;eosinophil: 1.8" "Lineage enriched" "Detected in single" 58 "granulocytes: 5.8" "Cell line enriched" "Detected in some" 4 "HMC-1: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043400, HPA045497" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Cytosol "HPA043400: AB_2678462, HPA045497: AB_2679349" "unprognostic (8.74e-2)" "unprognostic (1.13e-2)" "unprognostic (1.16e-1)" "unprognostic (1.41e-1)" "unprognostic (7.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.04e-2)" "unprognostic (3.25e-2)" "unprognostic (1.05e-1)" "unprognostic (5.40e-2)" "unprognostic (1.21e-3)" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (6.08e-4)" "unprognostic (7.36e-3)" 10.4 3.1 16.2 4.0 11.7 1.4 4.9 13.3 56.1 17.8 2.7 10.8 3.8 28.3 24.3 20.6 20.0 13.0 1.1 81.7 18.6 1.1 0.7 5.5 1.0 13.6 19.2 14.6 0.7 7.5 1.2 3.0 9.1 10.9 5.4 7.3 4.7 17.5 40.9 7.0 5.0 29.1 10.3 2.4 3.8 1.5 34.8 1.9 3.0 16.9 2.7 8.6 8.9 5.4 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.8 13.3 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 18.2 0.0 0.0 0.7 0.0 75.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 8.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 9.0 0.0 0.6 17.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.2 11.7 13.3 56.1 81.7 18.6 13.6 19.2 9.1 10.3 34.8 5.4 0.2 3.2 1.1 134.5 0.1 1.1 1.1 0.4 0.0 19.1 5.0 2.3 0.4 0.0 1.3 1.8 0.0 8.5 0.1 0.3 0.0 0.1 17.0 1.2 29.8 0.4 7.7 3.4 11.8 0.0 0.3 1.9 0.0 1.6 26.6 0.1 0.4 0.0 0.6 1.7 327.0 4.1 0.0 0.0 0.7 18.3 3.7 1.1 0.0 12.2 0.0 3.1 0.0 375.5 2.4 0.2 2.8 4.1 0.4 0.8 0.4 0.0 0.0 2.2 0.0 2.7 3.0 0.5 0.8 2.9 4.1 3.4 0.4 0.1 0.7 3.8 SLC26A11 ENSG00000181045 "Solute carrier family 26 member 11" Q86WA9 17 80219699-80253500 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 58.4;Rod photoreceptor cells: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029893 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 39: CACO-2 - Unknown function" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" Nucleoplasm "HPA029893: AB_10600809" "unprognostic (5.86e-2)" "unprognostic (6.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (3.80e-2)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.82e-6)" "unprognostic (2.05e-2)" "unprognostic (3.54e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.43e-5)" "unprognostic (2.86e-1)" "unprognostic (3.50e-1)" "unprognostic (9.54e-3)" "unprognostic (8.40e-2)" "unprognostic (8.69e-2)" "unprognostic (7.32e-2)" 12.2 36.5 27.4 8.9 24.8 16.4 11.8 14.1 23.2 16.3 21.9 12.1 7.2 11.6 8.9 7.5 13.5 7.6 7.1 21.1 45.5 19.1 10.2 18.8 14.1 27.8 33.3 22.5 10.6 11.8 35.1 9.0 30.1 16.8 4.1 11.6 11.3 9.2 5.9 13.0 11.2 6.0 17.7 22.6 10.0 4.8 42.2 3.4 24.8 3.6 5.6 11.6 12.1 17.4 0.7 12.4 14.3 11.1 7.1 5.2 16.1 6.7 8.4 15.6 9.4 13.6 2.5 0.1 13.1 7.4 11.3 4.4 8.0 5.2 6.1 15.7 14.4 0.0 17.5 13.5 18.6 0.0 2.2 9.5 8.4 7.5 3.4 1.4 13.3 2.7 6.4 16.8 9.3 11.6 0.6 0.3 6.5 3.5 11.7 0.5 1.6 5.7 14.2 13.6 5.4 16.9 6.8 17.0 18.3 22.0 20.4 0.3 9.9 11.8 6.9 10.4 0.9 17.8 7.4 1.8 6.2 0.0 10.1 0.0 1.0 0.0 0.7 0.4 1.1 0.2 1.2 1.0 0.6 0.1 1.9 0.8 0.0 0.0 0.1 0.0 1.7 0.9 27.4 24.8 14.1 23.2 21.1 45.5 27.8 33.3 30.1 17.7 42.2 17.4 8.8 6.4 13.4 22.2 3.9 4.6 8.9 5.0 5.2 27.2 9.6 9.9 2.5 5.7 5.6 12.9 58.4 14.5 5.6 3.2 1.9 7.5 0.6 7.1 7.0 12.4 10.2 2.7 13.4 6.0 8.8 8.1 3.6 11.6 1.3 15.4 8.2 2.2 15.2 3.3 17.2 3.2 8.2 11.4 10.5 0.7 17.1 15.1 3.6 12.2 4.2 22.8 5.2 12.1 13.3 3.4 3.9 12.4 2.2 9.0 7.0 6.0 4.4 40.8 32.9 6.4 7.7 0.2 5.3 2.4 4.7 26.0 8.2 16.4 2.6 5.3 SLC29A3 "ENT3, FLJ11160" ENSG00000198246 "Solute carrier family 29 member 3" Q9BZD2 10 71319259-71381423 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 31.8;Hep G2: 35.9;RT4: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046085, HPA054976, HPA057905" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Vesicles" "HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550" "unprognostic (1.73e-1)" "unprognostic (2.38e-3)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (1.28e-1)" "unprognostic (4.71e-1)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (3.37e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.16e-4)" "unprognostic (3.43e-3)" 4.7 2.6 3.1 4.1 3.9 1.1 4.8 3.7 3.7 7.3 2.7 4.4 2.1 6.8 2.5 2.2 5.8 4.4 2.4 3.0 3.6 2.5 9.4 6.7 7.1 4.7 3.7 9.7 5.2 3.5 1.7 11.2 4.2 5.1 3.5 0.3 4.9 2.9 1.4 2.6 3.7 5.1 4.2 6.5 6.1 3.7 4.4 3.7 3.8 0.6 3.8 9.8 4.4 5.0 2.1 12.3 1.8 7.8 6.8 5.3 31.8 2.3 2.2 0.7 0.4 13.8 8.8 7.4 6.4 4.7 3.2 18.3 5.7 2.9 0.1 5.6 5.6 2.2 1.0 35.9 3.3 1.8 4.5 5.2 12.9 0.3 0.6 1.5 3.2 8.5 6.5 6.8 0.9 19.1 4.2 3.8 4.2 19.2 4.5 5.7 0.6 5.9 2.3 29.5 8.5 9.6 6.4 20.3 1.7 5.2 3.2 4.0 5.2 0.2 3.8 2.3 0.1 1.8 3.1 4.0 7.6 24.0 1.3 4.2 19.3 2.2 5.4 15.3 4.6 4.9 4.5 5.1 29.1 1.9 3.5 5.0 1.5 9.4 10.3 20.2 5.5 9.5 3.1 3.9 3.7 3.7 3.0 3.6 4.7 3.7 4.2 4.2 4.4 5.0 2.0 3.2 1.1 2.0 3.1 0.3 1.5 4.0 1.8 2.3 2.7 3.8 0.8 1.5 3.8 0.0 0.0 46.1 6.3 2.6 0.0 6.1 3.6 1.8 3.2 1.8 1.8 4.2 2.4 8.9 45.3 4.7 7.1 2.4 2.5 10.2 3.3 5.4 34.7 0.0 1.3 2.5 8.2 11.8 4.4 15.2 2.8 10.9 1.8 16.9 8.5 3.0 3.1 2.5 2.7 7.9 13.1 1.5 6.0 3.2 0.1 2.0 2.6 0.4 0.0 0.2 2.5 0.6 5.0 0.7 0.0 31.7 2.9 10.0 2.5 1.7 SLC30A5 "FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1" ENSG00000145740 "Solute carrier family 30 member 5" Q8TAD4 5 69093949-69131069 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035373 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" "Golgi apparatus" Nucleoplasm "HPA035373: AB_10794630" "unprognostic (9.81e-3)" "unprognostic (3.33e-1)" "unprognostic (2.82e-2)" "unprognostic (8.16e-2)" "unprognostic (1.65e-1)" "unprognostic (3.88e-2)" "unprognostic (1.16e-3)" "unprognostic (2.47e-2)" "unprognostic (4.65e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (2.92e-1)" "unprognostic (1.49e-1)" "unprognostic (2.53e-2)" "unprognostic (2.07e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" 25.8 25.6 9.8 21.0 10.3 19.6 30.3 11.7 15.9 29.7 17.4 26.9 24.7 25.6 38.2 19.3 24.3 24.0 24.1 9.7 10.6 29.1 29.0 21.1 24.7 10.1 11.4 22.3 33.0 35.9 24.0 27.4 10.2 29.4 24.7 18.5 30.8 24.0 16.4 27.1 23.6 22.8 9.7 21.9 26.3 16.4 10.9 20.8 37.5 16.5 23.7 23.6 19.7 12.1 37.4 29.9 26.3 46.2 69.1 53.2 82.5 58.8 53.6 36.4 55.1 26.0 45.7 50.2 70.6 41.4 63.7 38.8 38.6 46.1 61.5 60.2 43.5 55.7 35.0 43.2 55.0 34.8 58.3 35.7 57.1 38.3 46.5 50.1 36.6 34.2 34.9 57.0 46.1 46.9 46.4 71.6 29.4 25.3 33.3 35.5 33.2 89.9 53.6 34.5 46.0 36.8 47.4 45.0 84.5 36.0 43.7 76.2 33.3 23.2 29.5 58.7 58.2 49.5 67.5 37.9 46.6 62.3 58.9 11.9 5.1 8.5 4.1 5.3 4.4 6.9 6.4 6.2 6.3 4.3 5.9 4.8 4.1 4.0 5.5 9.6 4.9 2.8 9.8 10.3 11.7 15.9 9.7 10.6 10.1 11.4 10.2 9.7 10.9 12.1 17.3 19.2 21.5 14.7 26.9 18.7 27.9 27.5 19.9 15.3 28.5 20.6 29.2 18.6 23.2 25.8 22.9 42.0 35.3 19.9 29.4 22.0 6.9 28.8 35.8 19.3 13.2 29.9 29.6 27.1 80.4 24.8 34.7 23.7 41.3 15.4 21.8 19.8 22.3 8.4 30.6 27.9 32.6 17.2 18.4 9.9 24.2 16.8 14.2 19.7 21.2 14.9 15.5 22.1 23.3 19.0 16.7 22.2 51.8 34.7 16.9 21.3 27.7 24.7 26.3 17.5 21.4 11.0 14.9 26.6 21.5 51.6 23.4 20.9 23.2 28.6 SLC30A6 "FLJ31101, ZNT6" ENSG00000152683 "Solute carrier family 30 member 6" Q6NXT4 2 32165841-32224379 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055032, HPA057328" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 1: Thyroid gland - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA055032: AB_2682677, HPA057328: AB_2683411" "unprognostic (5.61e-2)" "unprognostic (9.11e-3)" "unprognostic (1.05e-3)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.58e-6)" "unprognostic (2.98e-1)" "unprognostic (9.47e-2)" "unprognostic (1.88e-1)" "unprognostic (3.30e-3)" "unprognostic (7.05e-2)" "unprognostic (3.06e-2)" "unprognostic (3.51e-1)" "unprognostic (3.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" 10.3 8.9 4.0 8.5 4.8 4.2 10.1 5.2 4.8 10.1 5.1 10.0 8.6 9.2 7.5 8.8 8.0 9.0 7.6 4.0 4.5 11.7 11.2 8.4 9.8 5.0 4.4 9.0 10.4 11.3 4.3 12.1 4.9 8.8 10.0 6.0 7.7 7.8 7.8 8.0 8.4 9.4 4.8 7.8 9.2 6.2 4.4 9.4 11.8 7.6 10.3 9.9 5.6 6.2 27.7 20.3 20.5 18.0 25.4 22.6 22.7 25.3 25.0 20.4 18.5 15.8 25.4 13.1 16.4 20.4 23.4 17.0 24.7 17.4 25.8 26.6 13.7 28.6 10.9 20.3 16.3 30.4 16.9 17.0 26.7 27.4 21.8 20.7 16.6 9.2 24.6 17.2 23.6 10.2 16.1 13.9 31.0 30.8 10.6 14.2 24.7 19.3 22.5 23.9 15.3 23.3 19.9 21.2 20.4 19.0 11.7 13.6 14.3 25.9 14.3 17.2 30.3 23.1 43.5 19.2 23.0 23.4 26.6 12.8 2.4 1.9 2.5 2.0 3.5 3.0 2.3 2.8 2.9 2.7 3.4 3.2 2.4 7.0 2.3 2.0 4.6 2.0 4.0 4.8 5.2 4.8 4.0 4.5 5.0 4.4 4.9 4.8 4.4 6.2 8.6 9.6 9.9 19.9 14.9 9.1 5.3 14.9 13.6 4.5 9.0 5.7 4.1 8.6 8.3 7.3 6.2 19.8 8.4 9.5 5.9 7.5 2.8 7.4 10.1 10.9 3.6 13.2 29.2 8.7 14.7 9.5 11.7 10.5 3.8 12.9 11.4 15.3 10.7 1.7 31.0 7.9 14.2 8.8 9.3 1.0 6.5 6.6 8.8 10.3 7.7 7.5 12.3 27.2 37.2 9.8 7.0 7.9 20.0 8.7 9.1 8.3 10.0 7.1 13.1 7.3 7.3 12.3 9.4 13.6 6.3 27.5 9.5 9.0 9.0 5.2 SLC30A7 "ZNT7, ZnTL2" ENSG00000162695 "Solute carrier family 30 member 7" Q8NEW0 1 100896076-100981757 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018034 Uncertain Supported "Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA018034: AB_1857089" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (8.05e-3)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "unprognostic (3.18e-1)" "unprognostic (2.89e-3)" "unprognostic (1.24e-1)" "unprognostic (1.61e-1)" "unprognostic (1.11e-3)" "unprognostic (2.78e-2)" "unprognostic (1.95e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" "unprognostic (3.37e-1)" 6.8 6.8 2.5 7.2 3.0 6.7 6.5 3.7 3.5 7.2 6.6 5.9 6.6 4.7 7.8 5.0 4.6 6.7 4.2 2.5 3.0 5.3 10.2 9.3 7.5 2.9 3.1 4.5 8.0 6.8 5.7 8.7 3.0 5.9 7.1 4.7 8.6 3.6 2.6 6.1 6.1 4.4 2.7 7.1 7.6 3.0 3.2 7.0 6.9 2.1 7.0 7.8 5.3 3.9 11.3 5.2 6.1 12.5 16.5 14.9 16.2 8.5 17.0 7.3 9.4 5.3 7.7 5.0 17.2 14.1 4.9 10.7 6.5 11.1 12.7 6.4 4.7 8.5 8.4 11.4 19.5 11.7 7.6 17.3 8.4 12.9 18.9 10.9 15.3 8.4 4.9 15.9 12.5 4.4 9.4 8.1 7.7 5.6 5.5 4.2 10.8 5.8 10.6 10.0 3.3 7.4 11.4 15.8 12.2 5.3 6.7 8.1 17.9 18.2 6.3 19.9 13.7 14.0 5.7 4.6 23.1 11.1 5.7 8.3 5.8 4.2 5.2 6.6 4.9 2.7 5.3 4.8 3.9 2.5 5.5 5.7 2.7 3.5 8.7 3.9 4.3 3.1 2.5 3.0 3.7 3.5 2.5 3.0 2.9 3.1 3.0 2.7 3.2 3.9 28.3 32.1 21.6 32.3 26.3 57.4 19.7 22.8 21.1 10.1 25.8 13.2 6.1 20.0 22.1 23.9 6.2 32.6 24.5 24.1 1.9 24.1 0.9 14.9 27.0 34.5 22.8 11.6 44.8 26.4 24.3 29.1 29.0 29.4 37.4 16.3 33.5 44.6 22.1 5.0 39.6 38.3 14.2 37.0 39.1 1.1 17.1 28.5 32.0 34.7 29.6 6.5 28.8 52.8 59.2 36.0 27.9 16.6 48.1 46.0 20.7 15.7 23.5 13.7 6.6 30.2 20.9 11.4 9.2 19.3 63.9 41.7 28.8 34.8 24.3 32.7 SLC35A2 "UGALT, UGAT, UGT, UGT1, UGT2, UGTL" ENSG00000102100 "Solute carrier family 35 member A2" P78381 X 48903180-48911958 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036087 Approved Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" "HPA036087: AB_10604093" "prognostic unfavorable (3.16e-4)" "unprognostic (3.34e-1)" "unprognostic (4.88e-3)" "unprognostic (1.11e-1)" "unprognostic (8.15e-3)" "unprognostic (4.25e-3)" "prognostic unfavorable (9.64e-5)" "unprognostic (3.47e-1)" "unprognostic (2.50e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-3)" "unprognostic (9.58e-2)" "unprognostic (3.16e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" 15.8 20.5 13.7 12.7 14.3 15.9 14.9 14.3 14.8 18.7 19.4 29.3 17.3 13.1 28.4 24.7 32.6 15.2 15.0 14.5 15.8 19.8 31.8 18.2 11.4 14.6 15.0 9.3 30.0 24.7 21.3 19.9 15.4 17.1 28.2 3.1 23.8 14.8 14.0 21.9 18.0 11.7 14.4 14.7 25.0 7.1 15.9 11.8 15.4 7.2 14.7 19.8 15.4 15.9 48.8 55.2 18.8 27.3 36.5 31.6 29.7 49.7 54.1 51.3 59.9 64.0 84.5 18.8 22.2 54.2 64.4 67.0 51.7 40.0 39.7 27.9 34.0 20.5 33.1 49.6 47.8 38.7 40.9 35.7 69.9 48.6 39.8 28.9 30.6 25.9 38.7 29.8 37.6 47.1 20.5 35.0 39.7 55.3 67.7 22.3 35.5 61.1 44.4 39.1 21.8 36.1 52.9 54.5 28.7 35.1 80.8 30.7 28.2 30.3 30.6 55.4 27.5 45.1 32.8 19.6 38.4 34.1 40.3 18.1 22.3 40.0 15.3 23.4 15.8 10.7 12.6 13.9 27.7 9.9 8.3 14.6 24.2 13.8 17.5 27.7 13.1 11.9 13.7 14.3 14.3 14.8 14.5 15.8 14.6 15.0 15.4 14.4 15.9 15.9 16.2 9.6 17.0 3.3 13.1 14.1 11.7 29.0 2.8 4.5 26.5 10.9 5.2 10.0 23.5 16.5 0.0 31.0 15.6 24.1 3.9 27.4 3.3 24.2 12.0 13.5 12.7 19.0 2.6 32.3 30.6 14.0 18.8 16.8 2.5 8.0 11.0 15.6 23.4 6.7 2.5 31.5 28.5 10.1 14.5 1.3 9.9 12.3 10.6 4.7 21.9 9.4 8.2 4.5 4.4 27.1 19.7 10.9 19.3 18.7 17.8 10.5 50.5 5.7 6.6 9.7 19.4 10.3 6.8 10.9 17.5 48.0 13.8 12.2 21.7 23.4 SLC35A5 FLJ20730 ENSG00000138459 "Solute carrier family 35 member A5" Q9BS91 3 112561709-112585579 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035519, HPA057964" Uncertain Approved "Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA035519: AB_10601487, HPA057964: AB_2683566" "unprognostic (7.89e-2)" "unprognostic (2.33e-1)" "unprognostic (7.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (7.09e-2)" "unprognostic (1.45e-1)" "unprognostic (4.78e-2)" "unprognostic (8.60e-3)" "unprognostic (2.60e-1)" "unprognostic (8.21e-2)" "unprognostic (3.51e-1)" "prognostic favorable (4.10e-5)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (8.05e-2)" "unprognostic (3.42e-1)" 15.5 19.3 18.2 13.4 23.9 5.7 14.8 22.4 26.9 15.5 18.4 15.6 16.7 15.6 16.0 14.3 14.6 15.4 9.7 18.1 21.4 20.2 21.0 14.7 15.7 24.0 21.7 17.9 9.5 17.2 9.1 18.4 24.3 16.0 16.1 21.7 11.4 13.9 6.1 9.2 18.3 15.9 23.2 14.2 14.5 18.8 21.2 12.7 26.1 10.2 15.3 12.6 8.3 30.0 20.4 18.4 31.2 18.8 39.3 37.4 18.0 33.2 23.7 27.5 31.5 13.6 22.8 18.1 27.4 28.8 31.3 25.3 22.4 15.6 34.6 14.2 11.1 23.2 15.9 11.4 33.6 20.7 21.5 31.8 30.9 24.3 14.9 34.8 25.1 13.8 13.5 22.1 38.7 7.2 16.2 13.1 20.8 24.0 19.2 14.4 11.4 19.7 34.2 14.9 18.3 24.1 21.3 10.4 38.0 20.9 14.2 13.9 28.3 40.3 21.8 8.6 15.7 15.7 24.4 32.2 29.9 17.2 30.8 14.8 16.4 21.0 10.9 25.9 10.3 14.7 10.2 8.6 19.7 13.6 13.6 11.2 14.6 7.3 27.4 9.4 11.2 10.8 18.2 23.9 22.4 26.9 18.1 21.4 24.0 21.7 24.3 23.2 21.2 30.0 9.9 3.2 10.1 13.1 12.5 6.4 8.3 9.9 11.4 12.8 8.5 6.5 5.5 7.2 12.6 14.7 0.0 36.1 12.5 16.4 9.8 7.8 156.8 9.2 9.1 12.9 7.7 9.2 15.0 7.7 25.6 14.0 10.7 10.0 14.0 9.0 19.6 13.1 17.9 37.0 15.2 11.8 20.3 23.2 9.2 23.5 17.1 13.0 26.6 5.6 14.0 20.3 9.2 23.1 36.6 8.1 13.1 17.3 14.3 8.5 25.8 14.8 10.4 16.9 26.3 9.6 10.6 14.9 15.7 8.9 6.7 29.8 10.7 14.6 10.0 6.5 SLC35C1 "FLJ11320, FUCT1" ENSG00000181830 "Solute carrier family 35 member C1" Q96A29 11 45804072-45813016 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 84.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064001 Enhanced Supported "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA064001: AB_2685171" "unprognostic (2.62e-2)" "unprognostic (5.16e-2)" "unprognostic (7.82e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (8.22e-2)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "unprognostic (4.09e-2)" "unprognostic (2.73e-1)" "unprognostic (7.68e-2)" "unprognostic (1.83e-3)" "unprognostic (2.18e-1)" "prognostic favorable (3.64e-4)" "unprognostic (2.30e-2)" 28.2 7.3 6.6 10.7 6.3 2.4 19.8 7.0 7.0 9.6 6.1 19.8 24.4 8.8 2.3 41.5 7.3 12.2 9.0 6.2 7.2 7.0 84.5 10.2 6.6 8.2 7.9 6.3 13.4 5.6 10.4 15.0 7.7 9.9 14.3 1.6 26.1 5.9 6.8 5.1 24.1 9.9 6.5 8.4 18.5 5.2 8.8 4.5 6.6 6.9 10.0 13.8 14.9 6.3 10.3 25.8 6.3 16.3 19.9 19.8 19.5 22.1 20.1 13.3 14.4 10.7 15.2 10.4 9.9 27.3 19.4 26.0 13.4 13.6 6.5 24.8 14.5 5.9 20.4 20.6 42.6 11.4 16.2 23.8 16.3 9.2 11.1 16.2 17.6 10.3 13.3 13.8 14.4 21.8 5.9 9.0 27.5 39.9 34.6 7.2 10.5 21.5 15.1 25.4 6.0 8.6 16.6 16.3 9.5 6.6 13.7 6.0 25.7 25.0 14.7 46.1 15.6 9.8 26.9 4.9 18.5 14.4 14.2 9.7 11.6 12.5 11.0 11.9 12.3 5.0 18.0 14.7 9.6 3.7 9.3 8.0 1.8 5.6 8.7 8.2 13.0 10.1 6.6 6.3 7.0 7.0 6.2 7.2 8.2 7.9 7.7 6.5 8.8 6.3 5.5 0.0 11.2 2.6 6.2 3.6 8.9 12.7 3.4 1.9 11.1 3.0 50.6 22.8 26.7 5.5 2.1 13.8 6.4 54.6 0.0 18.4 4.9 7.3 6.7 10.6 9.6 3.6 2.0 41.9 14.0 10.5 23.4 11.4 2.5 5.2 6.8 42.2 14.7 3.3 2.1 40.6 4.1 9.3 4.8 6.0 6.5 6.3 1.8 2.8 9.5 2.8 7.2 1.0 2.1 50.6 54.0 5.7 13.6 11.8 58.0 4.7 11.4 1.1 0.0 3.6 9.7 4.0 4.3 12.7 2.4 15.3 6.5 5.7 26.4 20.1 SLC35C2 "bA394O2.1, C20orf5, CGI-15, OVCOV1" ENSG00000080189 "Solute carrier family 35 member C2" Q9NQQ7 20 46345980-46364458 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027011 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" Nucleoplasm "HPA027011: AB_2672082" "unprognostic (7.25e-2)" "unprognostic (1.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.27e-2)" "unprognostic (1.06e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (9.31e-2)" "unprognostic (7.15e-2)" "unprognostic (1.18e-2)" "unprognostic (3.88e-1)" 23.2 36.3 23.1 17.2 22.3 27.1 23.2 21.3 25.2 26.4 22.6 23.9 21.3 23.1 17.4 31.8 23.2 18.2 17.2 21.8 20.6 27.7 38.3 22.8 24.0 22.6 23.1 25.5 34.9 14.9 20.3 18.2 22.3 31.2 10.1 11.3 30.3 14.0 18.3 32.7 26.4 10.4 21.2 33.6 27.7 25.0 23.4 14.4 29.2 8.2 13.4 22.4 25.6 22.8 35.9 45.1 17.5 15.0 23.9 23.2 36.3 17.6 33.7 19.7 22.6 60.9 54.6 22.5 63.2 19.9 24.7 49.0 9.3 40.5 6.7 19.6 32.5 20.2 29.5 49.0 46.6 27.6 23.6 33.6 51.0 27.4 29.8 20.8 15.2 23.7 33.3 41.5 14.2 85.0 19.8 40.7 24.3 34.1 36.7 18.9 19.7 45.3 25.8 35.1 28.1 39.6 16.4 87.1 60.9 10.4 56.0 47.8 15.7 53.2 33.7 27.5 32.0 55.6 51.5 25.2 58.0 29.7 23.9 42.7 37.9 48.0 37.5 39.9 35.4 29.7 39.0 38.8 42.4 27.9 44.5 40.3 33.5 33.4 30.8 72.9 41.1 44.1 23.1 22.3 21.3 25.2 21.8 20.6 22.6 23.1 22.3 21.2 23.4 22.8 17.0 16.0 19.1 24.5 27.6 14.4 29.0 35.5 29.0 41.3 32.4 25.4 6.7 21.5 29.2 27.6 41.7 89.5 32.6 26.9 13.7 41.3 5.9 12.8 13.0 18.4 21.0 12.4 13.6 61.8 49.2 24.0 26.0 13.9 14.7 20.3 31.8 27.5 38.7 18.5 13.6 35.1 26.4 22.8 8.2 6.7 19.3 23.6 21.4 14.0 36.4 23.4 34.0 11.1 14.2 35.0 26.9 19.2 28.8 50.0 34.8 18.3 18.7 33.6 19.7 20.1 19.0 16.1 23.6 24.8 16.6 79.2 25.9 24.8 30.2 33.1 SLC35D2 "SQV7L, UGTrel8" ENSG00000130958 "Solute carrier family 35 member D2" Q76EJ3 9 96313444-96383711 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 117.2;Proximal enterocytes: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 103.8;Hep G2: 132.3" HPA064047 Approved Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA064047: AB_2685182" "unprognostic (3.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.16e-2)" "unprognostic (3.17e-1)" "unprognostic (8.86e-3)" "unprognostic (4.25e-3)" "unprognostic (2.24e-2)" "unprognostic (4.12e-1)" "unprognostic (5.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-2)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.44e-1)" 14.7 8.8 13.5 14.4 20.6 11.4 16.4 17.8 20.6 16.5 12.3 49.1 65.1 14.9 12.1 13.7 14.6 20.6 12.2 14.3 16.0 32.1 56.4 19.2 12.4 25.5 19.7 17.3 31.4 16.4 7.2 25.5 22.1 14.2 46.4 4.3 13.0 11.0 3.9 9.4 65.8 13.9 16.6 10.0 43.1 7.2 20.1 7.5 29.5 6.9 11.7 17.2 13.1 27.8 33.2 27.6 15.8 30.2 20.3 37.3 27.9 14.7 30.2 21.6 17.5 60.4 103.8 0.6 24.5 13.5 49.9 47.6 22.2 21.8 18.7 16.4 16.8 11.3 9.8 132.3 32.5 0.1 0.0 32.2 27.6 16.3 48.7 51.0 46.7 0.0 22.3 0.4 23.7 27.2 0.3 0.1 13.2 67.5 28.5 0.1 0.0 0.0 54.4 21.3 5.5 35.9 11.9 24.8 68.5 53.3 16.4 24.7 41.3 14.5 16.2 21.2 13.8 0.0 0.9 0.1 30.2 0.1 20.4 1.2 0.9 0.6 1.3 1.1 1.6 0.7 2.1 2.9 1.2 0.9 0.7 1.4 0.1 1.8 2.1 0.2 3.9 0.5 13.5 20.6 17.8 20.6 14.3 16.0 25.5 19.7 22.1 16.6 20.1 27.8 14.5 9.6 11.0 12.1 4.3 5.2 8.9 2.1 1.8 1.1 15.1 13.1 7.2 27.1 4.6 12.9 2.1 28.1 12.9 61.7 11.7 8.1 0.2 21.0 14.0 12.6 9.6 1.3 0.8 24.5 45.1 9.5 20.4 31.6 4.5 20.0 13.2 43.2 20.5 1.7 1.1 42.0 4.1 23.0 9.7 0.6 10.8 17.7 17.8 20.6 8.9 10.2 7.2 11.1 117.2 25.4 43.5 6.0 6.3 15.5 67.0 23.6 6.7 3.6 13.1 6.8 11.2 1.4 4.4 8.6 5.4 26.5 14.6 7.0 34.9 17.9 SLC35E1 FLJ14251 ENSG00000127526 "Solute carrier family 35 member E1" Q96K37 19 16549831-16572415 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016570, HPA062214" Approved Enhanced "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA016570: AB_2190214, HPA062214: AB_2684713" "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.92e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.35e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (9.07e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (2.54e-1)" "unprognostic (3.75e-2)" 10.7 9.8 5.9 5.6 4.8 8.0 9.6 3.7 6.6 9.6 6.3 9.2 6.6 8.5 5.9 11.5 7.4 6.1 10.1 5.6 4.7 7.8 11.4 9.1 7.1 4.8 5.9 8.8 22.3 15.2 11.2 7.2 5.0 11.7 6.1 7.4 15.4 10.0 20.5 11.9 7.7 6.8 3.6 6.7 15.3 4.1 9.1 8.5 9.2 14.0 8.1 10.1 8.7 4.5 26.2 10.4 6.9 16.2 25.2 19.8 16.4 17.8 20.3 15.1 18.2 11.8 18.7 13.6 30.2 29.3 14.9 17.6 19.7 21.5 15.2 15.8 29.5 11.9 11.6 14.4 21.1 19.6 14.5 16.5 24.2 17.0 24.5 19.2 14.8 16.0 19.9 17.3 19.4 25.3 15.3 9.3 8.1 24.8 34.6 14.9 10.6 16.6 15.7 16.1 11.9 11.9 12.3 19.6 11.5 8.3 14.7 9.9 15.3 19.5 9.6 26.9 21.2 23.6 26.9 15.1 29.3 21.4 12.6 1.8 1.3 3.2 1.3 0.9 1.8 2.2 1.4 1.3 1.0 0.8 1.0 0.8 1.3 1.8 2.0 1.1 1.8 1.1 5.9 4.8 3.7 6.6 5.6 4.7 4.8 5.9 5.0 3.6 9.1 4.5 21.7 38.5 42.5 6.8 14.9 21.9 15.3 22.1 5.7 28.8 34.1 21.5 16.1 22.8 31.3 29.5 35.5 14.4 43.3 25.2 0.0 20.4 3.6 26.6 20.1 20.2 18.5 13.7 13.9 36.8 29.8 14.8 13.3 50.8 8.2 21.2 22.9 26.9 17.4 30.3 13.9 29.7 8.2 21.1 28.0 4.2 17.1 23.3 8.8 10.3 22.8 19.4 17.5 9.0 6.2 41.7 13.1 21.1 29.3 30.9 22.1 7.0 24.0 29.4 6.6 30.1 14.3 10.2 14.3 13.6 25.9 32.6 29.4 16.2 20.4 28.4 SLC35F2 FLJ13018 ENSG00000110660 "Solute carrier family 35 member F2" Q8IXU6 11 107790991-107928293 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 37.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.0;Basal prostatic cells: 34.5;Suprabasal keratinocytes: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 188.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048185, HPA060150" Enhanced Approved "Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA048185: AB_2680304, HPA060150: " "unprognostic (7.73e-2)" "unprognostic (3.28e-3)" "unprognostic (8.37e-3)" "unprognostic (5.77e-2)" "unprognostic (1.38e-3)" "unprognostic (3.07e-2)" "unprognostic (7.26e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (6.22e-2)" "unprognostic (8.20e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (1.24e-1)" "unprognostic (4.10e-2)" "unprognostic (1.34e-1)" "unprognostic (7.33e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" 4.1 1.2 3.3 7.2 3.9 5.1 5.5 2.3 3.6 16.3 3.2 17.9 19.0 6.3 11.6 12.2 13.5 5.1 3.5 3.8 4.2 10.0 0.5 5.7 7.9 3.5 3.4 5.0 5.4 6.0 3.4 3.2 3.3 22.3 20.4 12.7 37.4 6.1 1.1 20.5 17.8 4.6 4.3 4.0 7.0 4.5 3.5 5.5 7.2 1.5 13.9 7.9 9.5 3.6 30.8 19.8 2.3 30.1 15.2 22.6 29.0 6.8 3.9 17.3 22.7 84.2 31.4 51.2 67.7 20.1 94.1 63.1 37.3 60.5 34.2 40.3 34.8 28.5 18.1 34.1 24.8 65.0 14.2 15.7 36.9 58.3 123.1 53.2 91.7 38.3 74.0 20.7 13.0 17.0 28.3 69.7 20.5 67.5 188.4 57.7 23.9 68.9 100.1 26.7 46.6 20.1 21.9 54.8 14.8 24.7 38.1 15.2 68.0 33.4 53.9 0.8 73.5 54.6 62.5 53.9 21.4 22.0 22.4 0.3 0.2 0.0 3.1 0.1 8.2 10.6 5.3 5.4 6.9 6.5 1.9 2.7 0.6 3.7 0.0 0.3 13.5 1.8 3.3 3.9 2.3 3.6 3.8 4.2 3.5 3.4 3.3 4.3 3.5 3.6 2.7 9.6 1.5 2.0 10.3 46.0 34.5 6.4 14.8 1.1 3.7 2.3 0.6 7.2 9.6 3.7 12.5 0.9 2.5 21.5 3.9 9.5 0.3 13.6 2.8 13.7 6.0 1.7 3.9 8.2 19.1 8.3 6.1 22.9 2.5 5.0 0.7 0.0 4.8 0.0 4.4 10.1 4.1 0.3 15.0 1.0 0.9 3.6 23.2 6.5 3.7 1.2 1.0 4.0 0.4 25.9 10.0 2.6 23.6 20.6 15.1 6.4 0.1 8.0 6.6 2.8 3.1 0.3 7.5 8.6 50.3 4.5 5.7 4.9 24.7 16.6 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904676-234324511 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.7" "Group enriched" "Detected in some" 6 "Excitatory neurons: 485.2;Inhibitory neurons: 216.1;Oligodendrocyte precursor cells: 190.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 35 "plasmacytoid DC: 3.5" "Lineage enriched" "Detected in single" 35 "dendritic cells: 3.5" "Cell line enriched" "Detected in some" 7 "HDLM-2: 111.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" Nucleoli "HPA051327: AB_2681443, HPA061582: AB_2684563" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.0 1.1 6.9 0.3 17.7 0.1 2.5 9.5 15.5 0.3 0.0 0.4 0.1 0.3 0.7 0.5 0.4 0.1 0.0 5.4 0.7 0.7 0.0 0.2 0.8 1.6 0.3 0.1 3.5 1.4 2.6 0.0 1.9 0.5 0.1 0.3 2.5 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.7 0.2 2.5 2.3 0.5 0.1 0.5 0.0 0.5 9.5 3.0 7.9 1.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 14.9 0.0 0.0 0.1 0.2 0.6 0.1 7.7 0.0 111.9 0.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.1 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 9.0 0.0 0.0 0.0 7.7 0.0 4.2 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.9 17.7 9.5 15.5 5.4 0.7 1.6 0.3 1.9 0.2 2.5 9.5 0.1 0.0 0.0 8.5 0.9 0.4 2.4 0.3 10.8 2.1 3.0 8.9 0.7 0.0 0.1 0.0 0.0 0.0 9.5 0.0 3.9 1.4 0.7 5.9 1.6 0.1 1.8 0.0 485.2 3.4 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 216.1 0.1 26.4 0.0 0.0 0.9 0.0 0.6 0.0 9.4 0.9 0.0 0.0 190.5 45.4 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.5 0.0 0.8 0.1 0.6 1.5 0.8 0.1 0.0 0.4 0.0 0.0 0.2 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144174-93197991 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 5.8 7.4 4.2 9.3 4.6 19.4 4.6 8.1 5.8 5.1 6.2 5.4 2.0 7.1 2.1 5.3 4.8 5.7 6.0 4.0 8.5 9.4 7.8 6.0 5.3 7.2 6.9 5.7 5.7 6.5 7.7 6.2 7.7 4.9 6.4 15.3 3.7 5.9 2.4 4.1 3.1 8.1 5.5 4.1 4.3 4.3 6.1 7.3 8.8 2.3 6.7 6.9 3.6 7.0 10.4 18.2 36.5 7.3 12.7 25.6 20.5 17.6 29.2 25.6 31.0 14.6 33.1 12.5 9.9 16.5 13.3 12.5 11.4 6.5 23.4 21.1 13.3 14.5 35.3 9.8 10.0 36.6 20.6 12.4 20.0 14.9 9.2 12.0 14.0 17.6 1.3 0.2 26.5 2.6 16.3 27.4 14.8 4.0 18.4 7.2 21.7 5.1 8.7 15.1 33.6 43.8 25.7 9.9 6.4 26.4 18.0 10.6 15.7 48.0 14.8 28.6 26.0 5.1 10.9 0.0 10.9 15.0 25.4 0.1 4.9 5.3 0.8 2.6 1.0 0.9 0.6 1.0 1.9 1.0 1.5 1.0 1.5 0.5 1.7 0.7 0.5 1.1 4.2 4.6 8.1 5.8 4.0 8.5 7.2 6.9 7.7 5.5 6.1 7.0 11.9 12.8 11.5 35.9 29.5 30.7 43.2 9.7 25.6 21.2 10.3 8.0 11.5 20.0 7.1 20.2 22.9 10.7 13.6 3.1 35.2 24.4 9.9 15.5 19.2 18.5 27.6 5.5 66.8 43.6 25.8 21.9 18.8 5.7 4.5 29.0 13.2 9.1 13.6 26.9 71.0 19.6 10.2 52.3 47.1 4.2 18.0 50.1 21.4 27.2 42.8 20.7 13.4 45.2 59.4 33.2 6.3 15.4 22.1 70.4 0.4 16.2 20.8 24.2 6.6 18.0 18.1 7.3 3.3 11.8 32.0 16.3 15.7 20.6 4.3 30.6 SLC38A10 "MGC15523, PP1744" ENSG00000157637 "Solute carrier family 38 member 10" Q9HBR0 17 81244811-81295547 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021374, HPA023161, HPA024631" Enhanced Enhanced "Golgi apparatus" NA NA 70000000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860" "unprognostic (2.18e-2)" "unprognostic (1.54e-1)" "unprognostic (7.40e-2)" "unprognostic (3.00e-3)" "unprognostic (2.06e-2)" "unprognostic (1.69e-1)" "unprognostic (2.12e-1)" "unprognostic (2.63e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "prognostic favorable (2.92e-4)" "unprognostic (8.39e-2)" "prognostic unfavorable (5.34e-7)" "unprognostic (6.55e-2)" "unprognostic (3.15e-1)" "unprognostic (1.31e-1)" "unprognostic (2.45e-1)" 37.6 37.0 12.7 23.4 14.0 30.8 31.2 12.7 16.1 33.0 14.7 31.7 31.8 35.3 17.3 24.0 31.7 25.8 36.8 10.5 13.8 31.6 75.2 31.4 21.4 21.5 14.9 37.7 91.4 15.6 62.1 24.6 15.7 34.2 9.5 4.4 51.1 20.8 20.0 25.2 34.7 15.4 13.3 43.8 38.8 30.5 16.6 12.9 41.3 6.3 10.6 37.6 26.8 19.4 45.2 77.5 13.3 70.2 49.8 23.3 77.6 53.7 48.2 32.5 38.2 36.1 73.0 34.4 59.2 37.3 36.0 53.0 13.5 27.1 12.0 34.7 40.0 34.6 28.5 61.2 44.4 34.1 78.4 40.7 19.7 29.2 18.9 26.2 62.2 24.5 26.3 51.3 24.6 56.5 21.0 59.4 12.9 41.3 37.6 33.8 27.8 34.8 22.2 42.3 25.7 65.7 43.2 26.9 59.2 18.3 38.1 70.0 61.9 52.2 29.9 38.9 29.4 44.6 21.4 20.0 30.9 51.8 54.5 12.7 10.6 18.6 7.4 11.9 8.7 6.2 7.1 9.1 6.2 7.0 4.8 5.4 8.0 4.6 15.9 9.8 5.6 9.5 12.7 14.0 12.7 16.1 10.5 13.8 21.5 14.9 15.7 13.3 16.6 19.4 24.4 25.6 35.6 25.8 28.6 8.3 12.3 21.9 13.6 10.9 25.3 18.0 19.3 31.5 24.6 11.0 18.8 61.0 29.8 66.4 5.9 31.9 25.4 17.3 13.7 22.4 45.0 22.3 12.3 26.9 62.4 35.9 44.9 32.8 15.2 64.6 27.5 79.2 49.3 25.2 14.3 58.8 12.2 40.6 15.1 75.6 32.9 35.7 14.2 28.1 29.1 27.7 23.7 9.0 20.5 25.1 53.1 27.4 96.5 16.0 59.1 23.9 21.4 9.1 32.9 17.0 21.2 19.7 22.8 11.8 7.2 62.5 25.0 39.9 48.2 11.4 SLC39A14 "KIAA0062, NET34, ZIP14" ENSG00000104635 "Solute carrier family 39 member 14" Q15043 8 22367278-22434129 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease variant, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 551.3;pancreas: 252.7" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 266.7;Hepatocytes: 611.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ hTERT+: 321.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016508, HPA056732" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" NA NA 1100000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 85: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 15: Hepatocytes - Hemostasis" "Endoplasmic reticulum, Golgi apparatus, Plasma membrane" "HPA016508: AB_1857148, HPA056732: " "unprognostic (1.67e-1)" "unprognostic (6.67e-3)" "prognostic favorable (5.00e-5)" "unprognostic (9.83e-3)" "unprognostic (9.21e-3)" "unprognostic (8.99e-3)" "unprognostic (1.99e-1)" "unprognostic (2.91e-2)" "unprognostic (4.95e-2)" "unprognostic (5.66e-2)" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.79e-7)" "unprognostic (4.88e-2)" "unprognostic (8.73e-2)" "unprognostic (1.63e-2)" "unprognostic (1.11e-3)" 63.5 72.4 13.0 35.5 11.0 1.4 39.8 11.9 13.1 17.3 39.7 48.2 142.2 30.2 6.2 11.6 25.9 32.0 76.7 14.5 22.9 30.8 551.3 23.9 7.6 43.0 30.4 27.7 252.7 12.9 21.5 19.0 25.7 22.3 50.3 18.6 21.8 18.7 43.0 20.0 84.9 33.0 13.3 8.1 80.5 26.5 25.3 6.0 87.7 17.4 6.9 56.0 14.5 14.8 51.8 68.3 18.4 37.6 65.1 54.7 40.1 72.8 321.0 111.3 173.5 226.9 47.9 51.1 39.9 86.1 288.9 55.6 92.8 91.1 181.9 53.1 49.2 40.8 51.0 230.7 154.3 28.5 43.2 58.4 72.6 198.0 136.9 56.3 50.5 36.5 36.2 51.2 57.3 24.0 43.4 18.2 113.4 81.9 49.8 60.1 34.9 110.8 40.8 22.3 31.3 48.7 74.3 31.3 151.4 39.7 25.1 39.4 28.0 137.3 69.2 87.4 75.7 29.2 28.7 66.9 194.3 37.7 81.9 0.0 0.4 2.1 6.7 0.1 7.2 4.0 3.8 5.0 1.5 1.9 4.3 5.9 0.1 2.7 0.1 0.7 3.4 3.4 13.0 11.0 11.9 13.1 14.5 22.9 43.0 30.4 25.7 13.3 25.3 14.8 12.4 3.2 7.7 11.4 9.1 33.3 11.5 10.8 18.8 7.8 20.3 16.6 66.6 41.5 3.8 7.3 2.1 0.4 3.6 91.6 1.9 47.6 0.5 136.1 58.3 32.2 33.4 10.5 26.2 74.7 2.7 58.8 47.9 266.7 0.0 20.8 29.6 611.4 1.8 48.8 24.6 60.6 6.1 15.4 25.8 3.2 23.9 2.9 44.4 6.5 2.7 5.2 2.1 9.0 3.9 47.3 39.1 41.8 13.5 26.5 75.6 24.6 1.1 8.2 0.0 47.1 32.2 0.7 3.0 4.1 21.0 0.5 7.4 14.7 43.5 9.4 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515780 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 128.6;pancreas: 233.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2" "Cancer enhanced" "Detected in all" "liver cancer: 45.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 62.7;NB-4: 74.3;U-937: 70.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favorable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (7.30e-2)" 13.9 10.7 3.6 4.7 4.2 35.7 11.1 2.7 5.0 13.1 2.7 15.7 8.7 12.6 10.3 4.4 13.5 18.2 8.6 3.6 2.8 7.3 128.6 9.9 7.4 3.8 3.2 20.3 233.2 1.8 4.4 6.3 3.5 12.8 9.4 1.3 13.8 6.2 17.1 18.8 9.2 8.7 2.7 8.5 30.4 3.4 3.4 2.1 12.7 9.1 6.6 16.2 9.9 3.9 1.1 1.7 1.8 20.3 25.7 18.8 0.2 10.4 13.8 3.0 7.6 6.5 2.8 59.5 2.7 7.9 3.9 1.0 18.1 1.2 3.7 2.8 4.6 30.9 0.5 62.7 33.7 54.3 7.2 23.8 4.4 5.2 23.2 7.3 13.4 34.7 43.9 10.7 3.8 2.3 0.5 74.3 6.6 27.0 13.6 51.0 9.8 27.2 0.5 0.1 23.5 3.6 1.9 0.3 23.8 0.5 1.6 27.3 5.5 3.1 7.1 26.2 1.7 12.1 4.3 35.3 1.5 70.6 4.2 11.1 6.2 0.7 10.9 2.4 9.2 2.9 4.9 7.7 8.4 1.5 4.9 6.9 0.5 7.5 0.2 1.9 9.5 5.5 3.6 4.2 2.7 5.0 3.6 2.8 3.8 3.2 3.5 2.7 3.4 3.9 4.4 0.0 7.3 1.6 3.3 7.0 1.6 0.0 3.4 5.7 1.8 2.4 6.8 47.1 0.6 0.0 0.0 0.2 3.6 3.1 3.9 3.4 21.5 5.3 6.0 4.7 6.0 82.9 3.5 35.4 0.4 10.9 4.6 13.4 3.8 1.3 15.4 138.2 7.4 0.0 1.4 8.8 0.0 8.1 2.9 14.8 15.5 3.2 5.4 5.6 1.3 0.2 5.2 4.0 0.6 11.1 2.9 7.9 6.2 3.2 0.3 0.1 0.7 0.4 6.6 6.4 7.7 0.7 1.5 0.3 3.7 0.1 6.4 2.9 9.0 0.9 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043261-32113029 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 528.1" "Cell type enriched" "Detected in many" 6 "Proximal enterocytes: 768.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "OE19: 34.2" "Region enriched" "Detected in single" 26 "cerebellum: 7.6" "Low region specificity" "Detected in many" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 4.2 0.1 0.0 9.7 0.2 0.1 12.3 0.0 10.7 528.1 0.5 3.5 5.1 1.1 26.9 75.2 0.1 0.0 6.6 1.7 2.1 0.3 0.1 0.0 0.0 1.6 0.3 1.0 0.0 0.1 3.0 9.7 0.2 19.0 2.4 0.3 13.5 302.4 0.7 0.0 2.9 7.2 2.3 0.5 0.1 0.0 0.0 4.0 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 34.2 0.0 0.0 0.0 2.1 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.2 0.1 0.0 0.0 0.3 0.2 0.6 1.7 4.2 0.0 0.0 11.6 6.5 115.2 115.8 8.2 0.0 0.0 0.0 0.2 19.8 0.0 3.0 38.4 2.4 1.4 1.0 25.4 0.0 0.4 1.4 0.0 1.4 5.6 10.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 34.1 0.0 0.0 0.0 71.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 32.6 1.5 0.0 17.6 768.7 6.4 2.0 0.0 0.0 0.0 0.7 10.1 4.2 2.0 5.5 0.0 0.1 0.1 41.2 6.7 SLC6A16 NTT5 ENSG00000063127 "Solute carrier family 6 member 16" Q9GZN6 19 49289638-49325215 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 94.2" "Group enriched" "Detected in many" 8 "Early spermatids: 125.9;Late spermatids: 46.8;Spermatocytes: 153.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 18.2;SuSa: 9.9" "Not detected" "Not detected" HPA076812 Supported "Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA076812: AB_2686816" "unprognostic (1.98e-1)" "unprognostic (7.15e-3)" "unprognostic (6.39e-3)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.83e-3)" "unprognostic (7.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.55e-3)" "unprognostic (1.63e-1)" "unprognostic (3.23e-2)" "unprognostic (3.31e-1)" "unprognostic (2.10e-1)" "unprognostic (8.93e-2)" "unprognostic (4.18e-2)" 4.5 2.0 2.8 2.9 2.2 4.5 3.2 1.2 2.1 4.6 17.9 3.8 1.2 4.0 2.4 1.7 5.8 2.3 2.5 2.2 1.8 8.5 10.0 4.9 7.3 5.0 4.9 7.0 6.9 0.9 1.6 3.2 4.3 5.0 1.1 5.0 1.5 2.9 1.0 2.2 3.7 1.8 2.9 4.7 3.5 94.2 2.5 2.3 3.2 0.5 5.5 3.6 3.4 2.1 0.0 7.3 18.2 6.5 0.3 2.8 3.3 0.9 1.5 0.6 2.0 0.2 0.6 8.5 1.1 0.8 0.3 0.3 2.0 0.3 2.2 1.3 2.1 0.7 0.7 1.7 1.4 0.6 3.0 2.8 1.1 1.4 1.0 5.2 1.6 1.5 1.7 1.1 2.4 1.6 0.5 0.3 6.4 0.3 0.9 0.3 4.4 1.6 1.0 0.0 0.2 0.4 2.9 0.1 0.6 9.9 2.9 0.3 9.3 1.4 6.7 4.2 0.0 4.0 4.6 7.5 0.1 2.0 0.4 0.2 0.3 2.6 1.6 1.2 1.5 4.5 0.5 1.6 0.4 2.2 1.4 0.9 1.9 1.8 2.1 1.1 0.9 1.3 2.8 2.2 1.2 2.1 2.2 1.8 5.0 4.9 4.3 2.9 2.5 2.1 4.4 0.0 1.1 3.6 5.8 1.5 0.9 0.4 2.2 8.6 1.7 1.7 1.5 2.8 0.1 1.8 2.1 0.0 1.7 0.1 11.7 0.8 125.9 2.3 1.6 3.9 0.0 0.0 4.1 0.6 0.0 1.7 0.0 1.5 1.3 0.3 2.2 5.5 0.9 0.0 8.1 0.1 0.0 1.4 1.8 46.8 3.7 0.8 5.4 12.2 1.2 0.5 5.2 2.5 1.7 0.2 0.0 3.4 1.5 0.5 0.0 0.3 11.3 1.2 0.0 1.7 4.9 153.5 8.3 0.3 1.3 0.0 1.1 1.8 0.1 0.3 SLC6A4 "5-HTT, HTT, OCD1, SERT1" ENSG00000108576 "Solute carrier family 6 member 4" P31645 17 30194319-30236002 "FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 232.0" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Group enriched" "Detected in some" 11 "midbrain: 232.0;pons: 86.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4" "Region enriched" "Detected in some" 4 "midbrain: 58.4" "Group enriched" "Detected in some" 7 "midbrain: 38.9;pons: 29.1" "HPA054723, HPA071354, HPA074728" Supported Supported Supported "Golgi apparatus,Vesicles" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Vesicles" "HPA054723: , HPA071354: , HPA074728: AB_2686708" "unprognostic (7.45e-2)" "unprognostic (7.13e-2)" "unprognostic (2.26e-1)" "unprognostic (3.72e-4)" "unprognostic (2.07e-1)" "unprognostic (8.42e-3)" "unprognostic (2.73e-2)" "unprognostic (3.39e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-3)" "unprognostic (2.70e-3)" "unprognostic (1.16e-1)" "unprognostic (8.78e-2)" "unprognostic (4.98e-2)" "unprognostic (1.76e-1)" "unprognostic (4.05e-2)" "unprognostic (7.18e-2)" 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.5 10.3 0.0 0.0 2.8 1.7 0.0 0.9 0.1 0.2 0.2 0.0 28.8 0.1 14.8 232.0 0.1 1.4 0.2 0.0 18.4 86.1 0.1 0.1 0.1 0.7 0.2 0.1 0.5 40.3 0.0 0.0 0.1 0.9 0.3 0.2 0.0 0.5 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 10.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.1 0.2 14.8 232.0 86.1 0.0 0.2 0.2 1.1 16.0 5.0 0.3 0.0 0.1 0.4 0.1 17.1 1.2 0.1 0.0 1.0 0.0 1.9 1.8 0.0 125.4 1.5 0.2 0.0 0.0 2.8 0.2 0.6 3.2 0.0 0.0 0.9 0.0 8.6 1.3 0.0 0.5 2.5 0.2 2.2 0.3 9.5 0.0 0.6 2.3 0.0 1.0 1.2 2.2 0.3 5.9 0.0 0.0 0.1 0.5 2.1 0.5 0.5 0.4 0.0 0.4 0.1 0.3 100.9 0.4 0.7 0.8 0.0 1.3 0.5 0.5 0.9 4.8 0.3 106.4 0.5 0.2 4.1 0.3 SLC6A9 GLYT1 ENSG00000196517 "Solute carrier family 6 member 9" P48067 1 43991500-44031467 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.4;skin 1: 46.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.7;Distal enterocytes: 17.8;Erythroid cells: 33.1;Ionocytes: 20.3" "Cancer enhanced" "Detected in all" "glioma: 18.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 62.3;hTCEpi: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013977 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Nucleoplasm "HPA013977: AB_1849835" "unprognostic (2.73e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (5.98e-2)" "unprognostic (6.83e-3)" "unprognostic (3.06e-2)" "unprognostic (9.72e-2)" "unprognostic (1.85e-2)" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (5.93e-4)" "unprognostic (5.36e-3)" "unprognostic (1.59e-1)" "unprognostic (2.53e-1)" "unprognostic (1.20e-2)" 3.9 31.0 21.7 4.9 45.5 10.8 4.6 53.2 24.2 12.1 6.3 11.0 2.3 7.4 1.1 23.1 9.5 4.8 2.1 16.1 31.3 4.3 2.3 11.6 1.1 66.3 43.5 2.9 8.2 2.8 1.7 1.4 63.6 3.9 6.3 17.2 11.5 5.5 1.1 46.6 6.0 9.1 45.6 1.9 7.4 1.1 45.9 1.4 5.3 0.6 4.3 12.3 25.1 72.4 19.7 13.7 7.1 18.0 11.2 3.7 15.6 14.7 41.0 24.3 30.1 4.8 7.5 0.3 1.6 42.9 0.0 62.3 11.0 12.5 5.0 0.1 1.8 17.1 33.9 5.8 50.3 3.8 0.7 11.3 106.6 11.9 28.5 15.3 0.6 12.3 13.0 48.5 1.0 10.4 2.9 0.1 5.4 7.4 19.1 2.2 0.0 22.9 2.3 2.2 4.4 4.2 7.4 35.3 7.0 1.7 9.1 10.3 0.2 2.8 11.0 2.4 8.0 53.1 39.2 4.4 9.2 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 45.5 53.2 24.2 16.1 31.3 66.3 43.5 63.6 45.6 45.9 72.4 1.5 0.0 2.0 5.9 1.1 7.5 0.9 3.2 8.0 30.7 2.2 0.9 0.7 4.3 2.2 1.8 16.7 0.5 0.5 17.8 0.0 3.7 5.9 4.8 0.4 0.7 0.0 33.1 2.2 8.9 1.0 0.9 1.5 2.7 0.0 0.0 0.0 0.3 0.3 1.7 1.5 2.7 20.3 0.0 1.0 0.8 1.5 0.1 3.6 0.0 1.0 1.2 0.0 3.0 16.4 4.2 3.0 1.5 1.3 2.0 9.1 1.1 12.5 11.1 6.6 0.1 10.0 0.1 0.4 8.9 12.9 0.5 0.3 1.2 2.6 3.2 SLPI "ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4" ENSG00000124107 "Secretory leukocyte peptidase inhibitor" P03973 20 45252239-45254564 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 27919.2;salivary gland: 14140.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 4134.5;Basal respiratory cells: 18759.4;Club cells: 20435.8;Respiratory ciliated cells: 8096.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 79 "neutrophil: 321.8" "Lineage enriched" "Detected in many" 79 "granulocytes: 321.8" "Cell line enhanced" "Detected in many" "EFO-21: 1719.5;hTCEpi: 2037.1;OE19: 767.9;SiHa: 622.1;THP-1: 531.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002303, HPA027774" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 26400000 9600000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "CAB002303: AB_564008, HPA027774: AB_10602405" "unprognostic (2.31e-2)" "unprognostic (3.07e-1)" "unprognostic (3.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.16e-2)" "unprognostic (9.98e-2)" "unprognostic (2.90e-1)" "unprognostic (3.23e-1)" "unprognostic (1.83e-3)" "unprognostic (4.01e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (6.91e-5)" "unprognostic (1.53e-1)" "unprognostic (2.15e-1)" "unprognostic (8.81e-2)" "unprognostic (8.31e-2)" 259.4 13.8 4.1 70.8 4.3 353.5 306.7 5.0 22.5 27919.2 28.9 97.8 4.5 107.1 16.5 1372.7 714.2 294.7 68.4 4.5 4.8 382.6 268.0 1181.7 2.0 5.6 5.5 11.5 36.1 5.5 470.2 8.3 5.5 112.6 106.7 0.6 14140.1 2946.3 599.9 272.4 19.9 14.0 4.8 22.5 154.7 28.1 10.4 47.7 30.4 51.5 215.8 226.6 685.3 4.8 4.9 19.4 0.0 0.3 0.2 0.0 1.1 0.1 0.0 0.1 0.0 1.5 318.7 0.9 1719.5 0.2 23.9 132.8 0.0 64.1 0.0 8.6 0.3 0.3 227.1 0.2 326.4 0.5 1.0 8.8 2037.1 0.1 134.0 0.0 0.2 0.0 0.2 0.3 0.0 0.4 0.4 24.4 0.4 767.9 120.1 0.6 0.7 0.1 355.5 14.6 0.3 0.0 622.1 131.4 1.8 0.4 2.8 531.8 0.3 0.4 8.5 1.2 1.1 1.2 9.7 6.1 0.0 33.0 0.5 3.6 0.9 0.4 0.1 3.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 321.8 0.0 4.0 0.0 0.0 7.9 4.1 4.3 5.0 22.5 4.5 4.8 5.6 5.5 5.5 4.8 10.4 4.8 6.3 1807.7 4134.5 0.3 5.4 100.7 1330.7 18759.4 2.2 0.0 594.2 607.6 3.9 1609.9 20435.8 3428.2 0.0 2.3 10.1 225.8 0.0 407.5 381.6 632.0 170.7 43.3 200.2 18.7 0.0 258.9 1.2 326.0 193.7 1398.8 77.0 0.0 15.7 508.5 6.8 0.0 0.0 74.7 2616.3 8.5 73.3 69.8 25.4 27.1 39.2 0.0 5.3 0.0 0.0 1.0 0.1 901.6 370.3 0.0 1.3 1289.4 2.7 3.4 8096.4 0.0 0.0 8.6 971.2 1.8 1.8 347.3 138.9 2.1 29.5 0.0 224.5 3338.5 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702236-66782849 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 30.1;lung: 27.9" "Cell type enhanced" "Detected in many" "Endothelial cells: 25.1;Hepatic stellate cells: 91.4;Microglial cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 29.8;HaCaT: 18.2;HeLa: 28.6;U-2197: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 20: HeLa - Mitochondria" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: AB_2684637" "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favorable (5.45e-5)" 9.5 2.6 5.2 1.6 4.9 0.1 7.6 4.9 4.3 6.8 8.6 3.7 1.9 6.2 0.6 2.1 5.4 1.4 30.1 3.4 4.1 8.9 6.7 27.9 0.5 7.6 5.4 5.9 2.7 1.1 3.4 7.4 5.8 7.0 1.1 0.9 2.1 3.5 1.6 2.4 3.9 0.9 4.4 2.6 5.5 1.8 6.8 0.4 15.5 1.5 0.2 8.0 5.7 4.6 1.3 10.2 1.6 3.5 6.0 1.6 9.4 7.2 0.1 1.1 0.1 2.0 4.6 0.7 29.8 6.1 0.9 18.2 2.2 0.0 0.2 2.3 8.4 16.1 28.6 1.7 0.7 0.1 1.2 2.0 0.0 0.1 0.0 3.4 1.3 5.1 1.4 1.0 0.5 2.0 0.1 4.4 3.0 10.5 3.8 0.0 1.8 2.2 3.4 8.1 3.6 1.6 3.9 4.3 0.8 5.9 1.4 2.9 6.2 4.3 5.5 17.6 1.4 0.5 1.8 0.3 3.1 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.9 4.9 4.3 3.4 4.1 7.6 5.4 5.8 4.4 6.8 4.6 19.8 12.8 6.0 5.2 0.9 0.8 1.2 2.1 0.6 0.6 0.9 1.1 4.9 4.3 3.0 1.8 2.1 0.8 0.1 4.3 3.9 4.7 3.4 8.3 5.5 25.1 0.0 0.0 0.3 5.8 0.9 4.9 5.1 6.5 4.5 5.9 91.4 4.0 1.7 0.0 0.3 2.1 0.0 10.0 0.3 1.4 2.8 1.2 0.0 57.1 0.7 10.2 0.0 0.5 0.4 8.4 1.5 8.2 0.0 1.3 2.1 1.9 0.1 0.6 0.0 0.9 1.5 0.2 3.2 0.4 0.1 0.8 0.4 0.1 5.5 0.4 SMAP1 "FLJ13159, SMAP-1" ENSG00000112305 "Small ArfGAP 1" Q8IYB5 6 70667776-70862011 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 325.7;Late spermatids: 281.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030574 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 34: Spermatids - Unknown function" "Plasma membrane, Cytosol" "Golgi apparatus" "HPA030574: AB_10601589" "unprognostic (1.55e-1)" "unprognostic (2.66e-3)" "unprognostic (1.01e-3)" "unprognostic (2.98e-3)" "unprognostic (7.06e-2)" "unprognostic (2.90e-2)" "unprognostic (1.66e-3)" "unprognostic (3.46e-1)" "unprognostic (6.50e-2)" "unprognostic (3.75e-2)" "unprognostic (7.80e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-1)" "unprognostic (4.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.85e-1)" "unprognostic (1.22e-1)" 17.0 12.8 24.4 16.1 27.8 18.6 13.6 19.5 44.8 15.2 13.3 27.5 26.8 14.1 18.0 28.4 10.2 17.4 23.1 27.6 24.3 14.1 16.6 14.9 15.4 22.7 25.3 11.1 37.2 28.5 8.6 16.1 23.7 17.6 28.3 24.8 18.0 15.2 32.9 20.4 26.7 19.7 20.1 13.7 20.9 30.9 24.4 24.8 21.1 20.1 22.4 18.1 16.1 29.2 60.3 18.6 28.5 35.3 26.0 33.9 46.4 26.6 29.5 21.4 20.9 27.9 17.4 31.4 28.1 32.0 30.5 18.5 27.4 28.1 35.5 36.3 39.4 34.7 16.5 23.6 17.2 25.5 28.0 22.3 31.3 24.2 29.2 39.6 34.2 16.1 33.8 36.9 33.8 35.0 19.2 31.4 21.3 30.9 21.9 36.0 107.9 51.8 38.1 36.0 40.7 28.7 16.9 23.3 17.1 24.2 31.0 37.3 33.6 17.2 29.7 11.4 23.5 34.3 32.9 16.0 13.0 29.4 24.2 35.0 16.4 18.4 18.2 18.3 20.7 14.8 24.3 21.0 14.0 12.7 12.1 15.7 22.6 25.6 20.0 13.7 25.3 23.4 24.4 27.8 19.5 44.8 27.6 24.3 22.7 25.3 23.7 20.1 24.4 29.2 45.0 38.5 39.4 58.1 39.3 66.9 37.7 66.9 33.0 51.8 39.6 47.2 38.8 52.9 46.0 38.6 37.5 26.2 47.6 111.3 54.8 78.9 325.7 26.1 46.8 43.2 41.9 28.8 120.1 151.0 48.8 40.3 64.7 52.1 48.2 42.9 58.5 41.3 56.6 55.5 104.3 82.3 61.1 61.2 59.8 281.1 50.7 53.0 32.0 60.0 64.1 69.7 64.9 115.6 72.7 108.2 99.5 67.0 51.8 76.3 92.6 69.6 21.1 38.6 65.7 36.3 53.3 105.2 84.2 89.3 77.3 31.7 64.9 44.1 75.8 51.6 SMCO1 "C3orf43, DKFZp313B0440, FLJ41923" ENSG00000214097 "Single-pass membrane protein with coiled-coil domains 1" Q147U7 3 196506879-196515346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "heart muscle: 41.5;skeletal muscle: 149.2;tongue: 107.0" "Cell type enriched" "Detected in some" 34 "Cardiomyocytes: 89.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061937 Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" "Endoplasmic reticulum" "HPA061937: AB_2684642" "unprognostic (4.86e-2)" "unprognostic (1.62e-1)" "unprognostic (1.51e-2)" "unprognostic (6.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-2)" "unprognostic (2.95e-1)" "unprognostic (2.72e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-3)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.6 2.4 0.0 0.0 41.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.7 0.0 149.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 107.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11093834-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 75.1;Syncytiotrophoblasts: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 15: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: AB_2685539" "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 4.7 4.6 15.4 3.4 16.1 2.9 3.4 21.4 23.8 4.3 5.6 4.1 3.6 5.0 3.4 4.8 2.9 4.1 6.6 16.7 18.0 4.3 9.7 3.5 3.0 17.6 16.7 4.1 3.0 6.4 4.1 12.7 19.3 4.6 3.6 17.1 3.7 4.8 11.5 4.9 3.1 5.2 15.8 2.9 3.1 3.4 20.0 3.4 3.0 14.2 3.0 4.9 3.7 19.4 9.9 8.3 12.6 10.6 12.7 14.4 13.2 26.7 11.3 13.4 14.9 11.1 3.1 12.1 35.9 8.6 13.3 8.6 26.3 9.3 24.0 7.1 19.1 12.7 9.1 8.8 16.9 23.8 2.9 17.4 25.5 13.7 18.0 10.6 14.4 11.0 18.3 5.0 25.7 5.4 10.1 14.0 5.9 6.5 7.1 13.5 23.1 17.2 8.2 7.6 29.4 16.3 5.6 18.2 32.4 17.2 4.6 9.9 20.7 20.3 15.0 8.6 18.1 9.5 33.0 17.1 4.8 9.9 31.8 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.0 15.4 16.1 21.4 23.8 16.7 18.0 17.6 16.7 19.3 15.8 20.0 19.4 14.3 12.8 1.5 12.4 9.1 75.1 17.1 13.7 10.8 16.4 10.6 10.3 12.7 12.8 5.2 11.0 20.9 29.3 14.4 5.7 3.9 5.2 10.3 11.8 15.6 11.4 3.6 11.8 26.8 7.4 36.6 11.9 6.1 12.0 10.8 4.2 7.9 25.6 13.5 30.3 31.4 8.1 10.2 8.1 29.4 4.3 2.8 12.0 16.0 10.3 6.3 7.6 7.2 18.6 28.0 10.5 3.1 4.1 14.6 18.8 5.8 7.8 4.6 15.2 0.0 7.7 9.8 16.8 24.8 12.7 39.5 65.1 12.9 10.4 8.7 16.2 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 125.0;Distal tubular cells: 92.0;Endometrial ciliated cells: 69.4;Erythroid cells: 142.5;Glandular and luminal cells: 67.6;Urothelial cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 56 "plasmacytoid DC: 207.6" "Lineage enriched" "Detected in many" 56 "dendritic cells: 207.6" "Cell line enhanced" "Detected in some" "HEL: 2.3;MCF7: 10.5;OE19: 2.8;SK-BR-3: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles "Golgi apparatus" "HPA065332: AB_2685471, HPA071268: AB_2686377" "unprognostic (6.97e-2)" "prognostic favorable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favorable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 1.3 0.6 4.5 1.9 8.5 11.4 1.5 8.5 6.4 8.4 10.7 10.5 9.6 1.2 0.8 27.4 7.4 4.4 12.2 5.0 5.6 28.4 1.4 3.1 1.1 11.2 8.8 2.7 2.5 3.4 2.4 1.9 9.6 4.2 2.6 0.7 7.8 1.9 0.5 14.3 15.2 0.5 7.2 4.8 10.1 2.2 7.8 0.6 15.9 0.3 3.6 6.1 14.6 16.4 1.8 1.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.4 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 10.5 0.1 0.0 0.0 2.8 0.1 0.3 0.3 0.0 0.0 2.0 0.8 0.0 0.0 4.5 0.0 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.5 0.5 1.1 0.3 0.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.1 0.0 207.6 0.0 13.7 4.5 8.5 8.5 6.4 5.0 5.6 11.2 8.8 9.6 7.2 7.8 16.4 0.7 9.6 7.0 0.7 1.6 1.1 7.3 4.8 0.6 1.5 1.2 0.9 25.1 10.0 13.9 125.0 2.1 3.1 51.9 48.4 92.0 2.9 0.1 69.4 10.1 1.8 14.4 142.5 0.0 0.5 5.8 2.3 26.0 67.6 0.0 0.3 1.8 0.2 0.7 0.0 0.0 16.1 44.7 0.6 0.9 0.3 0.6 17.0 7.2 0.0 1.2 3.3 1.0 0.0 17.9 10.7 54.2 1.5 0.9 7.4 15.5 0.9 48.0 2.1 0.0 1.4 3.1 0.4 0.5 10.0 8.4 32.8 0.8 0.3 2.3 90.6 SMIM7 "C19orf42, MGC2747" ENSG00000214046 "Small integral membrane protein 7" Q9BQ49 19 16630751-16660442 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043127 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "HPA043127: AB_10806378" "unprognostic (6.61e-2)" "unprognostic (1.61e-2)" "unprognostic (1.90e-1)" "unprognostic (3.71e-2)" "unprognostic (2.52e-1)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "unprognostic (1.79e-2)" "unprognostic (6.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-1)" "unprognostic (1.76e-3)" "unprognostic (8.29e-3)" "unprognostic (2.94e-1)" "unprognostic (2.29e-1)" "unprognostic (8.38e-2)" "unprognostic (7.64e-2)" 41.6 39.5 39.6 24.8 41.8 19.9 47.2 41.4 48.5 36.7 39.8 34.1 34.4 32.5 72.9 30.0 36.9 30.5 35.8 37.8 41.3 52.7 66.7 33.5 33.7 42.9 41.1 32.2 47.7 54.1 16.1 34.7 42.2 46.5 42.0 18.6 52.3 39.3 18.7 32.1 25.4 36.4 43.0 26.7 38.2 21.0 41.7 29.3 50.0 21.0 34.0 32.8 17.9 44.2 60.6 52.1 48.7 42.3 74.4 64.4 48.9 50.4 69.4 70.7 68.8 45.2 111.8 44.4 67.7 69.3 50.5 48.0 44.5 69.8 86.7 38.1 34.4 42.4 34.9 48.5 43.3 64.2 46.5 49.3 49.8 51.5 52.9 43.0 68.9 40.3 59.9 53.7 81.6 120.2 42.4 55.1 45.2 121.5 77.4 41.3 32.9 43.4 83.4 66.3 26.0 48.2 37.8 41.0 51.2 26.8 59.9 80.5 41.5 55.4 35.7 130.3 83.2 46.4 72.6 56.0 56.3 75.6 71.2 47.5 73.3 38.3 37.1 65.8 35.3 49.6 38.0 37.0 58.8 44.3 37.0 33.6 31.0 42.8 78.3 79.2 44.9 45.3 39.6 41.8 41.4 48.5 37.8 41.3 42.9 41.1 42.2 43.0 41.7 44.2 63.5 67.3 64.5 29.0 75.5 34.2 62.8 114.3 70.6 70.1 69.0 84.6 38.5 57.2 68.8 57.0 95.9 144.1 68.5 67.6 129.1 85.2 18.4 58.2 60.8 61.5 73.0 54.7 35.3 86.3 105.2 74.9 57.1 51.5 50.1 42.3 66.0 85.7 115.6 63.9 32.1 78.3 77.3 77.2 43.9 21.6 88.9 64.6 48.0 21.5 102.4 101.3 98.9 21.6 44.8 87.6 87.0 83.1 76.5 77.6 85.1 140.0 54.6 121.4 72.3 42.3 64.8 84.0 81.0 74.7 35.8 156.4 54.7 66.7 62.7 57.7 SMPDL3B ASML3B ENSG00000130768 "Sphingomyelin phosphodiesterase acid like 3B" Q92485 1 27935000-27959157 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.1;pancreas: 49.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.1;Ductal cells: 31.5;Paneth cells: 47.5;Proximal enterocytes: 37.4;Undifferentiated cells: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 6 "eosinophil: 3.3;myeloid DC: 1.3;neutrophil: 1.8" "Group enriched" "Detected in many" 7 "dendritic cells: 1.3;granulocytes: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 46.0;CAPAN-2: 35.3;NTERA-2: 27.6;RPMI-8226: 30.1;SK-BR-3: 45.9;T-47d: 33.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA030561 Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 400000 "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Golgi apparatus" "HPA030561: AB_10604095" "unprognostic (1.22e-2)" "unprognostic (4.45e-1)" "unprognostic (4.58e-3)" "unprognostic (3.83e-2)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.50e-1)" "unprognostic (2.68e-1)" "unprognostic (3.95e-1)" "unprognostic (6.02e-2)" "unprognostic (1.64e-1)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (2.40e-1)" "unprognostic (1.48e-1)" "unprognostic (4.40e-2)" "unprognostic (3.09e-3)" 1.5 0.3 0.5 2.2 0.6 2.0 5.7 2.5 0.6 2.8 2.0 22.2 24.1 1.9 15.8 1.1 7.0 2.2 0.3 1.1 0.7 5.2 0.4 6.6 1.2 0.4 0.4 0.2 49.4 7.9 1.0 0.3 0.5 3.6 23.6 0.1 12.5 0.5 0.0 0.9 14.2 1.0 0.6 1.7 16.5 0.7 0.8 0.5 13.9 0.0 3.1 2.2 0.4 0.6 5.4 2.5 0.0 0.3 0.0 0.0 46.0 0.0 1.1 0.6 3.4 12.1 35.3 1.7 8.3 0.0 0.7 5.9 3.8 3.2 0.5 0.0 23.6 7.9 0.5 3.0 0.0 2.6 0.0 0.2 2.9 7.0 0.4 1.0 1.0 0.3 1.0 0.4 0.0 19.5 0.1 0.8 27.6 4.1 4.3 0.5 0.2 30.1 24.6 9.5 23.4 0.5 0.0 45.9 1.3 4.7 33.3 1.4 0.0 0.0 7.6 0.1 0.0 0.3 12.9 0.6 0.8 0.0 0.1 0.1 0.1 3.3 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.2 0.1 0.0 1.8 0.3 0.0 0.0 0.0 0.1 0.5 0.6 2.5 0.6 1.1 0.7 0.4 0.4 0.5 0.6 0.8 0.6 0.1 9.6 17.9 0.0 2.3 0.1 2.7 4.0 0.0 0.0 15.0 6.5 0.4 1.5 13.8 9.2 0.0 2.5 0.5 38.1 0.0 31.5 0.4 2.2 0.3 1.1 20.4 1.3 0.8 23.3 0.2 0.2 18.3 5.6 0.0 2.0 0.4 0.0 0.3 0.0 0.1 21.6 10.2 0.0 0.4 0.2 0.0 0.9 0.0 1.0 0.0 0.0 0.0 1.0 0.0 21.7 47.5 0.0 16.6 3.7 37.4 8.7 2.7 0.0 0.0 0.0 0.8 0.0 0.2 0.6 0.1 7.7 0.8 0.1 31.2 3.0 SMYD4 "KIAA1936, ZMYND21" ENSG00000186532 "SET and MYND domain containing 4" Q8IYR2 17 1779485-1830634 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030059 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA030059: AB_2191728" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (2.47e-1)" "unprognostic (4.23e-2)" "unprognostic (1.13e-2)" "unprognostic (3.66e-2)" "unprognostic (4.03e-2)" "unprognostic (1.04e-1)" "unprognostic (1.79e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-3)" "unprognostic (9.26e-3)" "unprognostic (3.63e-2)" "unprognostic (1.33e-2)" "unprognostic (7.35e-2)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" 7.4 6.6 4.1 6.0 3.6 3.4 7.3 8.0 4.5 7.9 3.7 7.5 7.0 6.5 5.0 3.9 7.3 3.6 7.0 3.5 3.5 3.7 4.9 5.6 6.8 3.7 3.2 9.5 6.7 3.6 6.6 4.7 4.0 6.5 4.8 7.6 7.3 5.6 13.7 6.6 7.4 5.9 2.2 6.3 4.9 5.8 4.3 6.2 5.7 10.2 6.5 7.2 6.2 5.6 7.4 13.7 13.5 9.6 9.0 6.1 15.7 11.9 6.7 12.3 12.5 22.0 6.2 19.7 7.8 4.8 8.3 14.2 12.9 7.7 15.3 5.7 13.1 7.2 15.9 6.0 4.5 7.4 6.8 4.4 6.8 12.7 11.1 6.3 6.2 16.6 7.6 7.5 9.7 4.6 13.6 5.3 6.2 8.7 6.6 16.7 6.9 5.0 4.9 8.8 5.5 7.6 11.0 4.5 11.1 10.9 6.7 4.5 5.9 12.0 6.1 10.0 10.4 5.2 7.5 7.1 6.8 6.4 11.9 12.0 2.4 2.3 5.1 3.0 4.3 4.0 3.0 3.3 1.5 2.7 3.4 5.0 1.3 3.1 2.4 4.5 3.5 2.1 4.1 3.6 8.0 4.5 3.5 3.5 3.7 3.2 4.0 2.2 4.3 5.6 22.9 6.4 27.8 6.5 12.9 5.0 9.3 11.9 14.8 19.3 6.9 8.4 6.3 14.3 14.0 7.3 33.3 9.7 16.5 6.9 1.9 5.7 20.2 3.7 8.9 10.9 3.6 9.7 11.7 3.3 10.9 14.2 4.1 3.5 7.6 14.7 17.2 6.7 12.9 26.9 12.1 5.2 12.2 23.3 9.2 5.9 27.1 17.4 5.4 13.1 16.4 7.9 43.3 4.5 7.1 4.2 2.0 24.8 10.1 7.2 23.3 2.9 17.8 19.9 46.0 43.6 23.9 12.6 14.8 5.1 6.7 8.1 12.1 6.1 6.4 3.5 SNAPIN "BLOC1S7, BORCS3, SNAPAP" ENSG00000143553 "SNAP associated protein" O95295 1 153658703-153661852 "Predicted intracellular proteins, Transporters" "Exocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046974 Approved Approved "Nucleoli,Golgi apparatus" NA NA 20000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" Nucleoli "HPA046974: AB_10962506" "unprognostic (3.65e-1)" "unprognostic (1.67e-1)" "unprognostic (1.47e-1)" "unprognostic (5.66e-2)" "unprognostic (1.75e-1)" "unprognostic (2.06e-1)" "unprognostic (1.64e-3)" "unprognostic (1.54e-1)" "unprognostic (4.86e-2)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.31e-1)" "unprognostic (4.73e-1)" "unprognostic (1.31e-3)" "unprognostic (4.89e-2)" 34.6 50.8 41.5 18.5 42.9 13.1 30.3 44.3 43.0 23.9 38.7 35.7 12.8 30.7 34.1 35.1 27.5 21.7 63.7 39.9 43.5 37.8 32.1 21.0 27.4 43.1 42.3 24.0 17.5 41.2 16.4 19.0 42.9 24.4 20.2 25.1 22.1 29.4 91.5 27.9 23.2 30.4 44.5 30.9 26.3 19.2 43.0 30.6 25.5 77.0 31.9 31.1 23.5 45.1 50.8 60.6 51.5 31.0 63.2 42.7 32.4 41.7 46.1 57.8 43.9 43.9 39.3 35.8 82.6 42.9 29.0 65.6 42.5 54.4 40.9 49.3 57.4 39.6 41.3 21.1 65.4 39.3 24.4 50.5 41.1 43.6 49.0 61.0 54.8 41.7 34.7 27.8 59.5 82.7 46.0 23.9 27.5 78.6 64.7 42.9 44.1 96.8 65.0 47.6 38.9 67.8 48.0 55.0 57.8 50.3 84.0 43.5 48.4 27.2 40.5 54.4 40.0 65.6 77.4 56.0 51.4 24.9 36.1 106.2 146.9 139.7 86.8 154.1 100.6 130.1 88.2 88.9 153.5 119.6 96.9 87.9 30.4 118.1 126.8 115.6 136.3 146.6 41.5 42.9 44.3 43.0 39.9 43.5 43.1 42.3 42.9 44.5 43.0 45.1 41.7 19.2 16.6 7.2 31.6 20.6 35.1 88.7 35.9 14.2 39.1 44.4 39.8 40.0 45.3 29.5 8.4 64.4 35.9 18.0 74.3 71.4 9.6 31.5 24.2 34.9 13.8 33.6 5.9 65.2 49.5 31.2 16.3 25.6 30.4 31.9 40.7 35.1 90.2 21.9 6.5 20.0 40.7 48.3 21.8 26.6 30.7 34.7 26.6 4.7 76.5 84.8 59.8 8.0 14.4 53.5 25.5 49.7 23.8 34.7 26.6 76.7 40.9 21.7 46.0 25.3 39.7 29.3 42.6 45.5 23.4 73.7 26.9 44.2 24.6 36.2 SNTB2 "D16S2531E, EST25263, SNT2B2, SNT3, SNTL" ENSG00000168807 "Syntrophin beta 2" Q13425 16 69187129-69309052 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 151.4;Muller glia cells: 214.1;Rod photoreceptor cells: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SiHa: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001394 Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA001394: AB_1080170" "unprognostic (4.86e-1)" "unprognostic (3.26e-2)" "unprognostic (2.77e-2)" "unprognostic (8.07e-3)" "unprognostic (6.46e-2)" "unprognostic (9.68e-2)" "unprognostic (1.89e-2)" "unprognostic (5.50e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-2)" "unprognostic (3.64e-2)" "unprognostic (5.77e-3)" "unprognostic (1.71e-2)" "unprognostic (7.43e-2)" "unprognostic (1.73e-2)" "unprognostic (1.88e-1)" 11.0 5.0 3.3 5.2 3.9 2.7 8.8 1.0 6.7 11.0 10.1 6.7 3.7 10.4 5.1 7.0 8.7 7.1 5.3 4.6 0.8 6.7 3.8 8.6 5.6 2.5 0.9 6.2 4.1 12.4 4.0 5.2 0.9 8.2 5.3 21.6 5.2 5.5 5.7 8.5 6.0 8.7 0.6 5.7 6.1 7.1 1.5 5.8 10.5 3.8 4.9 8.7 8.7 3.7 7.2 10.9 7.4 5.8 26.6 35.6 9.1 13.9 19.3 10.7 11.8 10.7 6.5 9.0 8.3 16.2 5.6 12.9 10.0 6.8 13.9 4.0 5.5 4.0 11.1 9.2 8.8 0.3 5.9 25.6 4.9 17.6 7.1 11.1 32.4 2.5 2.3 13.8 13.1 8.2 3.0 1.4 5.0 4.2 8.6 18.1 6.5 16.8 5.7 10.9 2.8 6.1 42.6 6.0 4.4 5.5 7.1 0.5 25.4 20.0 9.6 14.2 13.0 3.1 5.2 10.0 12.8 1.4 9.3 0.4 0.2 0.3 0.9 0.3 0.9 0.2 0.4 0.5 0.2 0.2 0.2 1.1 0.9 0.7 0.3 0.1 0.5 0.3 3.3 3.9 1.0 6.7 4.6 0.8 2.5 0.9 0.9 0.6 1.5 3.7 55.9 19.2 11.7 36.6 9.0 38.0 28.0 17.1 70.0 33.2 19.0 25.0 9.2 10.0 10.4 27.6 41.7 9.5 33.7 29.0 3.9 9.7 25.9 20.6 61.3 81.4 10.3 4.8 151.4 24.1 7.9 53.1 20.9 28.7 1.3 15.8 126.7 11.1 6.9 5.0 62.6 16.6 8.2 33.1 29.3 27.5 59.0 12.9 30.2 33.7 8.6 214.1 47.4 30.7 27.9 16.3 32.8 65.1 20.7 40.9 12.7 34.5 10.0 136.7 6.6 26.0 35.6 27.9 15.4 30.7 38.8 3.7 32.8 20.2 19.6 28.7 SNX29 "FLJ12363, RUNDC2A" ENSG00000048471 "Sorting nexin 29" Q8TEQ0 16 11976734-12574287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 354.5;Late spermatids: 430.7;Microglial cells: 169.6;Oligodendrocytes: 241.6;Rod photoreceptor cells: 256.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "naive B-cell: 22.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008889, HPA062810" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "Nucleoli, Cytosol" "HPA008889: AB_1079856, HPA062810: " "unprognostic (2.50e-1)" "unprognostic (4.12e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (9.82e-3)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" "unprognostic (6.08e-2)" "prognostic favorable (1.38e-7)" "unprognostic (3.85e-3)" "unprognostic (4.54e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.03e-4)" 8.6 3.5 7.4 8.2 18.8 9.5 6.2 13.6 11.8 6.6 7.4 5.3 2.3 5.8 2.6 8.2 8.4 4.8 4.5 7.5 9.9 19.0 2.3 6.8 13.0 17.0 15.6 10.2 3.5 22.5 7.1 8.0 18.3 3.5 3.4 23.8 5.6 4.8 6.0 6.9 4.6 5.7 11.4 9.0 4.3 8.5 17.9 21.0 6.5 5.7 16.0 6.3 5.0 26.7 5.0 2.9 4.4 3.5 25.4 20.8 5.7 10.7 29.1 4.3 4.7 0.6 5.7 18.7 13.9 16.6 2.8 4.2 2.9 6.8 6.2 7.2 3.0 2.5 2.5 6.4 4.9 2.7 6.6 19.1 4.4 6.3 2.8 6.5 7.6 6.1 3.9 5.2 4.4 6.7 5.0 3.1 2.4 3.2 2.6 11.3 5.6 15.2 19.3 4.6 5.2 4.4 12.2 7.2 2.5 3.8 4.1 3.2 11.7 7.6 3.0 5.8 2.1 29.5 24.4 11.5 14.1 2.8 4.9 3.8 6.9 1.6 2.0 4.5 2.5 10.6 4.3 2.7 2.5 22.3 5.2 3.6 2.5 1.3 2.3 7.4 4.0 1.9 7.4 18.8 13.6 11.8 7.5 9.9 17.0 15.6 18.3 11.4 17.9 26.7 14.4 12.8 22.9 71.2 61.0 15.3 6.5 5.3 19.9 63.9 8.5 7.4 9.7 4.3 10.8 16.5 354.5 18.6 26.9 4.4 21.5 4.6 124.0 35.3 27.8 13.8 13.1 6.1 59.0 2.9 5.0 20.8 14.8 62.6 42.5 15.2 17.9 4.8 28.7 92.5 54.6 4.6 8.2 29.3 39.6 430.7 21.5 36.7 12.4 169.6 24.3 23.1 16.5 51.8 241.6 7.7 4.3 15.4 23.9 3.6 3.3 42.6 27.2 256.1 6.6 20.8 14.2 20.0 10.8 21.9 15.5 17.1 15.4 14.1 4.0 5.5 SNX31 MGC39715 ENSG00000174226 "Sorting nexin 31" Q8N9S9 8 100572889-100663415 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 6.5;urinary bladder: 16.4" "Cell type enriched" "Detected in some" 4 "Early spermatids: 81.8" "Cancer enriched" "Detected in many" 22 "urothelial cancer: 24.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 49 "RT4: 80.7" "Region enriched" "Detected in single" 5 "thalamus: 2.6" "Not detected" "Not detected" "HPA024284, HPA053466" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" Cytosol "HPA024284: AB_1853894, HPA053466: AB_2682161" "unprognostic (1.39e-1)" "unprognostic (3.83e-2)" "unprognostic (7.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.20e-5)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.69e-1)" "unprognostic (7.79e-3)" "unprognostic (1.66e-1)" "prognostic favorable (1.47e-4)" "unprognostic (2.54e-1)" "unprognostic (4.05e-2)" 0.6 0.1 1.0 0.0 1.2 0.2 0.4 0.8 3.1 0.4 0.6 0.3 0.0 0.3 0.2 6.5 0.3 1.1 1.7 1.0 1.1 0.2 0.5 0.1 0.4 0.0 0.0 0.4 0.3 0.3 0.2 0.0 0.0 1.4 0.1 0.2 1.2 0.2 0.6 0.6 0.1 0.5 0.4 0.1 0.7 4.0 0.7 0.3 0.5 0.5 3.6 16.4 1.7 1.5 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.0 0.0 0.0 80.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.0 1.2 0.8 3.1 1.0 1.1 0.0 0.0 0.0 0.4 0.7 1.5 0.5 0.0 0.0 6.2 0.1 0.4 3.3 0.2 9.6 0.0 0.2 0.6 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.9 0.0 81.8 0.2 0.1 0.4 0.0 0.0 12.8 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 19.7 0.6 0.2 0.0 1.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 1.2 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.3 3.7 0.3 0.5 9.7 0.4 0.0 0.1 0.0 0.0 6.0 SORT1 "Gp95, NT3" ENSG00000134243 "Sortilin 1" Q99523 1 109309568-109397918 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Osteogenesis, Transport" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 285.6" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 447.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 9.2;non-classical monocyte: 10.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006889, CAB011498" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 7170000 110000 "Cluster 51: Monocytes - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Cytosol" "Plasma membrane" "CAB011498: AB_2192606, HPA006889: AB_1080056" "unprognostic (2.10e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.74e-6)" "unprognostic (4.12e-1)" "unprognostic (9.41e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (3.34e-3)" "unprognostic (4.27e-2)" "unprognostic (9.44e-2)" "unprognostic (2.42e-2)" "unprognostic (1.28e-2)" "unprognostic (1.23e-3)" "unprognostic (1.45e-2)" "unprognostic (2.15e-1)" "unprognostic (3.95e-1)" "unprognostic (4.46e-3)" 48.2 11.3 71.0 12.0 168.3 21.4 25.1 124.3 114.2 17.7 21.5 29.5 22.1 24.7 139.8 41.5 27.5 17.8 64.7 131.8 90.0 38.7 6.5 37.4 2.8 151.9 133.8 6.1 17.5 46.5 11.3 44.8 153.1 18.3 26.9 40.0 25.2 44.0 85.0 19.0 21.9 27.8 102.8 10.2 18.2 43.5 118.0 6.4 42.7 71.8 10.3 16.9 18.0 285.6 38.8 15.3 37.5 45.8 107.0 21.2 107.3 28.2 44.9 27.2 29.0 39.8 14.0 0.3 35.2 11.9 19.9 9.4 44.7 22.3 38.9 1.1 21.2 10.7 23.5 43.1 41.8 0.2 33.5 53.2 3.6 33.3 7.3 72.6 4.2 31.7 81.3 4.0 38.7 41.1 27.9 0.8 14.1 17.5 6.3 30.7 87.9 18.9 52.0 27.8 38.3 21.8 16.6 109.3 120.6 53.1 46.1 6.7 1.1 5.8 21.7 1.0 47.6 37.0 32.2 0.3 9.8 0.3 24.3 0.0 7.1 2.5 0.0 9.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.4 10.8 1.6 0.0 2.0 71.0 168.3 124.3 114.2 131.8 90.0 151.9 133.8 153.1 102.8 118.0 285.6 10.6 38.5 47.9 54.5 1.9 1.3 4.7 6.7 1.2 14.9 27.5 14.2 98.9 27.1 20.3 75.4 35.5 30.6 3.2 70.2 5.9 23.9 65.1 33.2 5.2 15.9 16.8 4.0 87.9 23.7 30.2 9.8 16.8 34.9 7.6 10.4 7.9 22.1 30.1 13.5 56.7 27.7 6.1 38.7 9.9 79.7 8.7 34.6 21.4 78.7 37.7 21.7 0.0 48.7 447.8 25.6 23.2 49.7 1.5 7.1 64.0 13.1 29.6 50.7 32.9 25.1 53.6 46.3 21.6 9.3 1.8 36.8 2.1 1.8 28.3 10.8 SOSTDC1 "DAND7, DKFZp564D206, USAG1" ENSG00000171243 "Sclerostin domain containing 1" Q6X4U4 7 16461481-16530580 "Predicted secreted proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 111.3;stomach 1: 60.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 68.5;Distal tubular cells: 29.4;Gastric mucus-secreting cells: 76.5;Horizontal cells: 30.3;Ionocytes: 128.1;Melanocytes: 32.0" "Cancer enhanced" "Detected in many" "renal cancer: 25.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;EFO-21: 12.7;HEL: 4.8;NTERA-2: 4.9;RPTEC TERT1: 23.5" "Group enriched" "Detected in many" 5 "basal ganglia: 9.2;hippocampal formation: 18.4;pons and medulla: 15.1;thalamus: 11.9" "Low region specificity" "Detected in many" HPA042856 Uncertain "Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" "Nucleoli, Nucleoli rim, Vesicles" "HPA042856: " "unprognostic (2.08e-2)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.17e-3)" "unprognostic (5.59e-3)" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (1.41e-2)" "prognostic favorable (8.69e-4)" "unprognostic (2.59e-1)" "unprognostic (2.62e-1)" "prognostic favorable (3.22e-5)" "unprognostic (7.01e-2)" "unprognostic (1.23e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (8.72e-4)" 0.2 0.5 1.3 0.9 2.7 0.1 17.9 1.7 3.4 2.6 111.3 10.9 11.6 4.7 0.3 3.7 5.0 0.3 3.1 3.7 0.3 22.3 0.0 39.2 0.1 0.7 0.9 1.1 0.6 0.6 2.4 0.0 0.1 1.8 15.0 3.0 15.6 3.5 0.1 16.8 8.6 1.1 0.2 0.1 60.4 1.9 2.2 0.1 8.6 0.9 3.9 1.4 3.5 1.8 0.0 0.0 7.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 12.7 0.0 0.0 0.3 0.4 0.0 0.0 0.1 2.6 4.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.3 0.1 0.0 0.1 0.7 0.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.7 1.7 3.4 3.7 0.3 0.7 0.9 0.1 0.2 2.2 1.8 0.4 0.0 0.0 0.0 0.2 5.6 4.3 2.1 9.1 0.6 68.5 17.8 3.8 0.0 2.0 14.7 0.0 0.0 0.4 1.2 29.4 0.0 19.7 1.0 0.1 2.9 2.4 0.0 0.0 0.0 0.0 3.9 76.5 1.5 0.0 0.0 0.4 0.1 0.0 30.3 0.0 0.2 128.1 0.0 1.2 13.0 7.2 0.4 32.0 0.0 0.0 14.2 0.0 0.0 0.0 0.4 2.2 2.6 0.4 1.1 0.0 21.8 0.0 0.7 0.0 0.1 0.3 3.4 1.2 14.1 7.2 0.0 0.9 0.0 2.3 1.5 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box transcription factor 15" O60248 17 7588178-7590094 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 87.4;skin 1: 48.2" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 209.2;Basal squamous epithelial cells: 447.3;Squamous epithelial cells: 388.1;Suprabasal keratinocytes: 169.9" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 6.7;non-classical monocyte: 10.6" "Lineage enriched" "Detected in many" 5 "monocytes: 10.6" "Group enriched" "Detected in many" 8 "A-431: 130.6;HaCaT: 142.1;HBEC3-KT: 57.8;hTCEpi: 56.6" "Not detected" "Not detected" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Yes NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: AB_2685802, HPA074049: AB_2686656" "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 2.2 0.9 15.0 0.8 14.6 2.7 3.4 17.4 23.3 21.1 11.8 12.4 0.7 8.2 1.7 87.4 11.0 1.0 8.6 14.5 15.3 1.7 1.3 1.5 0.5 14.3 15.0 15.3 1.0 0.2 7.9 0.3 14.1 12.1 0.5 5.0 14.6 7.1 2.3 48.2 3.5 1.3 14.5 1.1 4.7 2.6 14.7 1.0 2.3 1.8 2.8 10.4 32.7 15.0 130.6 3.2 1.8 1.0 0.1 0.3 9.6 1.4 0.5 1.1 1.7 2.5 0.8 0.4 1.2 0.1 0.4 142.1 0.1 57.8 0.4 3.3 3.9 0.5 1.7 0.5 0.2 0.3 2.6 0.0 56.6 0.7 11.9 3.6 0.0 2.6 2.9 0.8 0.2 0.9 0.6 1.5 3.6 0.3 0.7 1.6 1.8 1.0 2.7 0.7 0.8 2.2 1.5 0.5 0.7 5.5 1.1 1.0 1.6 1.3 2.3 1.6 4.4 0.9 1.5 1.6 4.4 1.7 3.2 0.1 2.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 10.6 1.0 0.0 0.4 15.0 14.6 17.4 23.3 14.5 15.3 14.3 15.0 14.1 14.5 14.7 15.0 0.8 0.0 0.0 2.6 0.1 209.2 51.8 72.7 447.3 13.6 6.3 13.0 4.7 0.0 20.6 1.8 14.6 1.7 0.7 0.5 1.9 0.1 0.2 0.4 4.9 3.1 1.2 0.0 8.1 0.5 2.0 10.4 0.0 0.4 0.0 1.3 1.4 0.0 0.4 10.1 7.7 0.4 10.2 1.2 19.3 1.1 31.4 0.9 26.6 1.0 1.2 50.0 0.0 4.0 2.4 0.5 0.1 36.9 4.9 21.2 0.3 0.2 16.2 9.4 32.9 7.8 7.1 0.7 10.9 388.1 169.9 1.1 1.1 0.6 0.8 73.8 SOX7 ENSG00000171056 "SRY-box transcription factor 7" Q9BT81 8 10723768-10730511 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 42.4" "Cell type enhanced" "Detected in many" "Adipocytes: 115.4;Basal keratinocytes: 61.2;Basal prostatic cells: 67.6;Basal squamous epithelial cells: 148.5;Endothelial cells: 115.1;Squamous epithelial cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 11.8;hTCEpi: 21.3;HUVEC TERT2: 25.2;TIME: 6.8" "Low region specificity" "Detected in many" HPA009065 Approved Approved "Nuclear speckles,Golgi apparatus" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (1.21e-1)" "unprognostic (1.08e-1)" "unprognostic (1.15e-3)" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.74e-2)" "unprognostic (7.26e-2)" "unprognostic (7.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.71e-3)" "unprognostic (2.45e-3)" "unprognostic (2.38e-1)" "unprognostic (5.41e-3)" "unprognostic (4.84e-3)" 22.6 3.8 2.5 1.0 2.3 0.1 11.9 1.9 2.6 27.0 1.4 4.2 0.1 4.3 1.1 26.8 4.5 3.6 18.5 2.1 1.8 5.1 4.3 23.2 1.7 2.6 2.2 1.5 2.6 1.0 5.6 17.3 2.5 5.4 1.1 0.4 10.5 2.7 9.8 20.2 3.6 2.3 2.5 2.4 3.7 0.7 2.7 1.5 7.6 6.4 1.9 4.6 42.4 2.0 5.8 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.3 0.6 11.8 3.4 4.2 0.1 0.1 0.4 0.1 0.3 0.1 0.0 0.2 0.2 0.1 21.3 0.0 4.3 0.0 25.2 0.0 0.6 0.3 0.0 0.2 0.2 0.2 1.6 0.9 3.2 1.2 0.0 0.0 0.0 2.1 0.6 3.4 2.2 0.0 0.0 1.4 0.0 0.1 6.8 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.3 1.9 2.6 2.1 1.8 2.6 2.2 2.5 2.5 2.7 2.0 115.4 0.0 11.5 0.3 1.1 61.2 67.6 24.5 148.5 1.2 5.2 4.7 4.8 1.5 6.3 0.0 4.2 4.3 0.1 0.2 0.0 0.2 0.2 14.9 1.9 115.1 0.0 0.0 4.6 0.2 0.8 4.7 0.0 22.9 3.8 0.5 48.5 4.9 0.7 0.0 2.9 0.2 10.2 1.9 8.7 0.1 0.9 0.9 3.6 10.3 0.3 0.5 0.0 1.5 0.8 0.5 0.0 0.4 1.2 17.8 0.1 0.6 3.2 2.2 0.0 8.5 4.4 2.4 1.6 98.9 40.6 12.4 1.8 1.2 0.4 26.6 SPAG11A "EDDM2A, HE2" ENSG00000178287 "Sperm associated antigen 11A" Q6PDA7 8 7847876-7868867 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11461 "epididymis: 4564.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 5.7;RPMI-8226: 1.7" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4564.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG11B "EDDM2B, EP2, EP2C, EP2D, HE2" ENSG00000164871 "Sperm associated antigen 11B" Q08648 8 7442684-7463674 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1636 "epididymis: 864.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 864.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SPATA25 "C20orf165, dJ337O18.8, TSG23" ENSG00000149634 "Spermatogenesis associated 25" Q9BR10 20 45886489-45887635 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 304.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 6.7;HeLa: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA041386 Approved "Golgi apparatus" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 39: CACO-2 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA041386: AB_2677446" "unprognostic (1.88e-1)" "unprognostic (2.66e-1)" "unprognostic (1.60e-1)" "unprognostic (4.92e-3)" "unprognostic (2.36e-1)" "unprognostic (1.84e-2)" "unprognostic (2.75e-3)" "unprognostic (1.57e-2)" "unprognostic (2.57e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (1.67e-2)" "unprognostic (3.14e-1)" "unprognostic (5.07e-2)" "unprognostic (2.62e-1)" "unprognostic (5.93e-5)" "unprognostic (1.12e-1)" 3.0 1.8 1.9 1.8 3.2 0.6 1.6 4.2 2.4 2.4 3.3 2.6 4.5 3.2 2.3 2.2 2.8 2.1 3.2 1.7 1.7 5.5 5.2 1.1 1.5 2.3 2.2 6.5 2.3 2.5 1.6 1.7 1.9 2.1 2.2 4.3 2.5 3.1 9.9 2.6 3.3 3.6 1.5 1.8 1.6 24.0 2.5 6.8 2.9 3.4 1.1 3.1 2.1 2.8 0.6 2.1 1.5 1.7 2.3 1.4 1.7 0.4 1.8 0.9 0.3 6.7 3.7 1.2 0.5 0.8 1.9 2.8 0.8 0.5 0.3 0.4 1.4 0.6 6.2 4.4 1.7 0.1 1.0 3.2 1.0 0.4 0.5 2.4 0.6 2.0 0.9 1.6 0.7 1.4 0.8 0.0 0.9 0.6 1.1 1.6 1.0 0.8 0.1 0.9 2.9 1.6 1.9 1.3 1.9 0.6 2.2 1.6 0.5 1.1 1.2 0.8 0.6 1.4 0.9 0.3 1.5 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.2 4.2 2.4 1.7 1.7 2.3 2.2 1.9 1.5 2.5 2.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 304.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 58.3 2.1 0.1 0.0 1.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 1.1 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 SPATA6 "FLJ10007, SRF-1, SRF1" ENSG00000132122 "Spermatogenesis associated 6" Q9NWH7 1 48295373-48472208 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.1" "Group enriched" "Detected in many" 5 "Early spermatids: 1475.4;Late spermatids: 4697.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 5.9" "Group enriched" "Detected in many" 4 "granulocytes: 3.6;monocytes: 5.9" "Cell line enhanced" "Detected in many" "AN3-CA: 12.9;ASC TERT1: 20.9;HSkMC: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028234 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" Nucleoplasm "HPA028234: AB_2672532" "unprognostic (1.36e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (2.87e-2)" "unprognostic (3.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.77e-2)" "unprognostic (4.69e-3)" "unprognostic (2.40e-2)" "unprognostic (2.61e-2)" "unprognostic (8.41e-2)" "unprognostic (6.50e-2)" "unprognostic (3.41e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (7.89e-2)" "unprognostic (5.71e-3)" 6.0 8.1 6.2 2.0 9.7 1.0 7.2 6.9 6.4 7.8 7.2 5.2 2.7 5.8 6.1 3.4 15.3 4.9 4.4 5.9 8.0 6.1 1.7 5.9 2.2 8.6 8.5 8.9 4.6 10.6 8.6 4.7 8.6 5.4 3.9 13.3 6.3 7.4 1.7 4.4 3.3 4.4 7.3 3.7 6.7 50.1 9.6 3.2 9.5 3.7 1.6 6.0 6.3 11.9 0.2 1.2 11.6 12.9 10.5 20.9 1.6 1.3 4.9 0.9 0.8 0.1 0.8 0.0 0.7 2.1 6.1 0.3 0.9 2.9 0.8 0.9 1.6 0.1 0.5 0.6 2.2 0.0 0.8 15.0 2.2 1.9 0.7 6.3 4.7 1.8 0.1 0.0 4.9 0.4 0.1 0.2 4.9 0.9 1.2 3.7 0.0 1.1 7.1 2.0 2.8 6.3 4.8 0.4 11.3 9.5 2.8 0.7 1.4 1.7 1.7 2.7 1.9 0.0 0.0 0.0 7.0 0.1 7.7 0.0 1.2 3.6 0.0 2.8 0.0 0.1 0.2 0.0 1.1 0.0 0.4 0.3 0.1 0.2 5.9 0.5 0.0 0.5 6.2 9.7 6.9 6.4 5.9 8.0 8.6 8.5 8.6 7.3 9.6 11.9 14.8 3.2 10.0 151.8 2.0 5.6 16.7 6.4 9.1 17.0 13.1 19.9 3.5 28.6 12.5 16.5 45.9 0.4 5.1 3.9 17.6 8.9 1475.4 77.3 18.9 10.5 9.6 2.1 43.9 10.2 0.6 29.8 35.2 9.0 16.5 5.0 16.1 2.4 5.1 32.0 35.0 5.7 12.2 17.9 9.2 4697.2 36.7 14.9 19.6 68.4 10.5 23.4 3.1 563.5 341.6 4.5 3.8 25.2 2.0 6.2 3.4 10.3 67.3 45.7 19.7 47.5 14.7 110.5 23.8 6.7 5.3 0.3 1.6 11.5 5.7 9.7 SPCS1 "HSPC033, SPC1, SPC12, YJR010C-A" ENSG00000114902 "Signal peptidase complex subunit 1" Q9Y6A9 3 52704955-52711148 "Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046091, HPA055273" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 16: U-266 - Nucleosome" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA046091: AB_10959614, HPA055273: AB_2682768" "unprognostic (5.47e-2)" "unprognostic (4.04e-1)" "prognostic favorable (9.28e-4)" "unprognostic (5.93e-2)" "unprognostic (6.88e-2)" "unprognostic (1.10e-2)" "unprognostic (3.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (5.56e-2)" "unprognostic (3.89e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.90e-4)" "unprognostic (5.96e-2)" "unprognostic (1.80e-1)" "unprognostic (3.58e-1)" "unprognostic (3.09e-2)" 95.3 154.7 75.1 64.1 76.6 61.3 100.5 80.7 101.1 97.4 88.7 110.1 94.8 101.0 110.8 117.0 92.1 48.4 119.7 75.4 83.9 137.3 172.8 87.8 71.2 82.3 80.5 91.1 231.2 89.5 141.1 59.4 82.1 96.3 84.7 124.6 145.2 79.1 142.2 109.0 103.9 53.0 81.7 105.6 151.1 153.2 81.4 66.6 113.2 49.7 87.1 103.0 94.7 84.9 114.6 102.2 113.4 139.3 164.9 134.4 157.2 157.6 144.5 139.4 128.4 108.1 171.0 114.6 65.7 145.4 142.5 110.2 109.9 142.5 149.1 154.3 115.8 138.6 169.2 164.6 175.1 213.3 229.1 104.7 190.5 148.5 174.4 130.5 117.4 147.5 118.8 418.0 151.8 105.5 168.8 207.2 195.8 317.2 203.9 67.9 95.7 608.6 232.7 148.3 73.6 157.4 148.7 178.1 224.2 102.4 188.1 248.1 106.2 127.3 119.1 226.3 192.1 406.2 654.1 169.8 196.5 209.4 169.8 292.7 129.9 258.2 131.1 137.0 155.1 202.0 158.5 144.2 143.9 149.3 146.8 152.1 100.1 119.6 152.5 620.5 177.1 253.8 75.1 76.6 80.7 101.1 75.4 83.9 82.3 80.5 82.1 81.7 81.4 84.9 172.5 64.1 104.2 23.8 282.3 156.5 227.9 470.7 136.1 465.4 289.0 351.0 148.7 221.6 283.6 310.8 118.9 373.5 488.1 195.2 361.9 353.8 597.8 286.4 180.8 157.6 167.7 143.9 27.1 339.4 399.8 181.9 119.8 181.5 211.6 138.7 131.4 301.8 311.0 102.6 34.4 291.3 325.5 202.9 189.9 1177.6 216.3 192.5 380.6 13.1 321.9 296.9 213.1 21.1 53.2 274.8 274.1 191.8 888.8 295.0 405.5 665.1 374.1 251.3 164.3 152.6 335.5 746.4 504.5 195.8 184.4 351.2 220.8 283.6 267.7 285.3 SPEM2 C17orf74 ENSG00000184560 "SPEM family member 2" Q0P670 17 7425616-7427568 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 571 "testis: 128.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023649 Uncertain Approved "Golgi apparatus" NA NA "Cluster 36: Testis - Spermatogenesis" "Golgi apparatus" "HPA023649: AB_1845606" "unprognostic (3.00e-1)" "unprognostic (3.88e-1)" "unprognostic (1.12e-4)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 128.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPINK4 "MGC133107, PEC-60" ENSG00000122711 "Serine peptidase inhibitor Kazal type 4" O60575 9 33218365-33248567 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 980.5" "Cell type enriched" "Detected in some" 14 "Intestinal goblet cells: 8017.1" "Group enriched" "Detected in many" 20 "colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "basophil: 1.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.8" "Group enriched" "Detected in some" 12 "HMC-1: 175.7;OE19: 480.7" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Low region specificity" "Detected in single" HPA007286 Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Secreted to digestive system" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Vesicles" Nucleoplasm "HPA007286: AB_1080083" "unprognostic (3.49e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.85e-5)" "unprognostic (3.09e-4)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.66e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-1)" "unprognostic (3.25e-1)" "unprognostic (2.42e-3)" 1.4 0.6 0.0 84.2 0.0 0.6 0.1 0.7 0.3 0.0 0.1 639.5 263.4 1.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.1 0.1 0.0 0.9 2.1 0.9 0.0 0.1 0.0 980.5 92.1 0.1 0.5 0.2 0.1 638.1 42.2 0.0 0.2 1.4 0.3 0.0 0.1 0.0 0.0 0.0 17.4 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.0 0.0 3.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 11.7 27.8 1.1 0.0 0.0 175.7 0.0 0.0 0.0 0.4 0.5 0.0 0.1 4.1 0.3 0.0 3.9 0.4 2.3 0.0 480.7 0.4 0.0 0.0 0.2 0.0 0.5 0.4 1.4 15.2 3.1 0.0 0.1 14.2 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.3 0.1 1.4 0.3 0.0 1.8 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.3 0.0 0.0 0.0 21.7 0.1 0.0 0.0 0.0 0.0 5.5 12.5 0.1 0.0 56.5 0.0 0.2 1.0 0.1 0.0 0.6 88.2 0.0 0.0 0.0 0.0 0.0 43.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8017.1 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.5 0.1 0.1 106.8 0.0 0.1 0.2 541.4 0.0 0.0 129.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.1 191.5 0.2 SPNS1 "HSpin1, LAT, nrs, PP2030, SLC62A1, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 26.8 30.8 17.0 19.3 17.4 37.0 24.8 17.1 26.3 27.7 18.6 32.5 22.4 30.9 6.6 25.9 23.0 18.0 27.5 16.9 15.7 32.1 33.9 31.5 20.1 19.1 16.6 22.0 24.4 20.8 21.1 19.8 17.2 26.5 10.0 6.5 24.4 14.9 25.0 35.7 27.8 15.1 15.8 33.9 28.2 20.3 19.8 20.8 27.8 14.9 10.5 30.5 25.2 18.3 25.9 59.6 22.2 51.9 41.5 22.8 62.9 28.2 28.9 46.1 40.9 55.0 60.4 16.4 67.8 25.5 38.2 53.3 36.4 31.2 16.4 19.0 61.6 23.8 57.1 69.3 70.4 26.7 49.2 38.4 40.9 49.7 21.0 26.8 42.9 30.0 54.4 28.7 23.4 68.8 29.3 75.8 52.6 20.8 39.1 36.7 26.7 73.6 24.9 24.8 39.5 51.3 20.1 59.3 44.9 18.5 59.2 31.9 36.6 37.3 28.2 52.7 22.0 43.2 36.7 15.6 47.7 40.4 30.8 13.4 32.8 13.5 9.9 42.1 8.3 5.7 9.8 13.0 27.6 4.3 10.0 6.8 5.6 7.7 28.8 11.5 12.1 18.1 17.0 17.4 17.1 26.3 16.9 15.7 19.1 16.6 17.2 15.8 19.8 18.3 24.4 6.4 7.2 8.8 14.9 21.3 21.3 29.8 14.8 31.0 17.2 15.7 0.3 20.0 20.1 20.2 29.2 63.3 26.5 10.5 13.7 58.1 2.1 15.3 19.2 24.1 12.2 21.8 10.2 45.7 72.3 24.6 16.8 18.9 22.7 40.9 19.2 14.3 98.7 26.9 10.3 13.8 46.8 45.6 28.4 3.7 22.7 61.8 33.8 15.0 32.7 28.5 24.7 7.1 8.6 37.3 16.0 16.6 18.6 14.4 41.5 18.2 26.2 38.6 6.6 17.4 23.8 24.8 33.5 16.4 22.7 87.3 20.7 37.8 20.0 19.4 SPP1 "BNSP, BSPI, ETA-1, OPN" ENSG00000118785 "Secreted phosphoprotein 1" P10451 4 87975650-87983426 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Biomineralization, Cell adhesion" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 2424.4;kidney: 3587.6;placenta: 2791.9" "Cell type enriched" "Detected in many" 8 "Hofbauer cells: 60702.5" "Group enriched" "Detected in all" 4 "glioma: 1690.9;renal cancer: 1385.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "neutrophil: 24.8" "Lineage enriched" "Detected in single" 249 "granulocytes: 24.8" "Cell line enhanced" "Detected in many" "EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3" "Region enhanced" "Detected in all" "pons and medulla: 316.8" "Low region specificity" "Detected in all" "HPA027540, HPA027541" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 114000000 73000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" "HPA027540: AB_10600222, HPA027541: AB_10601446" "unprognostic (4.74e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.13e-3)" "unprognostic (2.04e-1)" "unprognostic (2.31e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.84e-6)" "unprognostic (2.46e-3)" "unprognostic (7.86e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (4.31e-2)" "unprognostic (2.55e-1)" "unprognostic (7.19e-2)" "unprognostic (1.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.63e-2)" 113.1 24.4 276.0 59.5 490.3 1.0 70.2 652.0 736.4 27.5 265.0 44.9 9.5 131.2 9.8 4.8 52.8 2424.4 37.0 301.6 417.1 3587.6 35.6 18.8 9.1 813.2 645.3 9.9 292.0 19.2 20.6 2791.9 781.8 15.7 7.6 745.5 88.7 22.1 16.0 2.7 14.4 38.3 472.6 9.2 11.0 11.7 633.1 8.4 8.3 0.4 5.7 25.0 6.0 855.0 2.2 144.0 19.1 1.1 0.0 0.2 0.3 5.6 4.4 1.4 9.1 0.6 0.2 0.2 4825.8 2.3 371.5 1.4 0.0 0.0 3.1 11.2 0.0 0.0 1.8 2469.7 0.3 6.8 5.1 0.5 0.3 34.9 0.1 118.8 4.2 0.2 0.1 10.8 1.3 0.2 1.2 21.3 227.5 0.3 0.0 2.4 0.5 1189.8 10348.3 1.8 1.1 0.9 0.3 0.8 339.1 441.9 0.5 5.2 0.3 11.5 27.1 0.4 25.8 0.9 7.9 13.9 436.3 1.1 457.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 276.0 490.3 652.0 736.4 301.6 417.1 813.2 645.3 781.8 472.6 633.1 855.0 35.7 3.2 4.7 5.2 34.0 1.5 5.2 0.1 1.2 46.6 1767.7 22.4 17.9 1584.2 0.3 2183.1 27.1 335.6 6.9 0.0 1003.7 7273.8 0.1 61.2 25.2 367.9 0.0 2.7 1.4 71.7 294.5 48.9 0.0 154.2 0.0 1.7 5.7 5.0 60702.5 785.7 9.9 0.0 0.0 57.4 7.7 1.0 0.9 247.7 1.8 99.3 69.2 3862.9 0.0 4.5 532.1 215.4 0.0 0.0 0.1 0.4 0.0 5594.0 1.6 169.7 0.0 0.9 21.6 0.5 0.2 1.1 1.0 667.8 30.0 0.4 0.0 9.9 SPRY1 hSPRY1 ENSG00000164056 "Sprouty RTK signaling antagonist 1" O43609 4 123396795-123403760 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 238.1" "Cell type enhanced" "Detected in many" "Adipocytes: 771.3;Endothelial cells: 352.8;Fibroblasts: 222.3;Leydig cells: 448.0;Skeletal myocytes: 245.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 61.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 95.4;AN3-CA: 194.1;ASC diff: 76.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013538, HPA051369, HPA070554" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Cytosol" Nucleoplasm "CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.06e-1)" "unprognostic (7.15e-2)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (9.43e-2)" "unprognostic (6.99e-2)" "unprognostic (4.32e-1)" "unprognostic (4.06e-1)" "unprognostic (3.11e-2)" "unprognostic (8.77e-3)" "unprognostic (1.21e-3)" "unprognostic (4.48e-2)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" 238.1 38.4 6.5 22.3 7.9 22.7 154.3 7.6 9.0 71.9 26.6 46.6 15.7 40.9 24.1 42.5 81.2 83.8 73.1 7.5 8.4 35.6 21.5 58.3 13.0 5.5 5.4 30.0 31.8 37.4 27.3 49.6 5.8 52.0 27.5 19.0 45.2 24.7 49.9 79.8 25.2 57.7 5.6 17.0 35.1 10.2 7.6 29.2 92.7 49.9 10.1 74.4 71.0 6.0 6.3 1.8 95.4 194.1 76.5 51.6 6.4 0.4 4.9 0.3 2.0 5.8 10.3 0.0 42.4 2.9 0.4 1.2 2.6 4.6 0.7 0.1 10.0 2.2 0.0 31.0 21.7 14.2 0.1 21.1 2.5 0.7 2.1 10.5 8.1 2.2 1.7 1.9 4.7 0.7 16.4 34.8 22.8 22.6 32.0 7.1 10.3 0.2 13.2 14.5 14.5 12.3 0.1 19.4 19.6 10.1 1.9 0.0 20.2 1.2 0.2 0.4 2.9 1.0 0.1 0.2 1.4 2.6 3.2 0.1 0.4 6.5 1.1 0.2 33.1 29.8 4.0 9.2 0.1 61.2 5.7 6.4 0.4 14.2 0.1 1.7 0.0 2.0 6.5 7.9 7.6 9.0 7.5 8.4 5.5 5.4 5.8 5.6 7.6 6.0 771.3 28.9 28.3 14.4 16.2 49.6 17.3 37.3 68.9 86.2 22.8 69.6 16.9 32.9 20.6 27.6 33.3 12.7 21.6 10.4 80.3 5.0 2.5 45.9 41.9 352.8 26.5 5.7 5.0 10.9 1.7 222.3 8.2 67.4 9.5 0.2 166.3 5.9 10.1 6.7 2.2 15.0 14.2 15.3 37.9 10.5 448.0 17.1 46.2 5.6 0.7 158.3 0.0 7.5 0.3 7.0 6.3 57.9 6.1 16.8 8.1 38.7 11.7 84.5 151.2 245.0 81.6 6.2 9.6 37.0 43.3 3.1 57.3 1.8 17.9 13.5 SPRY4 ENSG00000187678 "Sprouty RTK signaling antagonist 4" Q9C004 5 142310427-142326455 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 39.5;Alveolar cells type 2: 49.0;Endothelial cells: 32.8;Hepatic stellate cells: 37.1;Oligodendrocyte precursor cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 100.2;WM-115: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008086, HPA055471, HPA072661" Enhanced Approved "Golgi apparatus,Cytosol" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" Cytosol "CAB008086: AB_2195454, HPA055471: AB_2682825, HPA072661: AB_2732207" "unprognostic (9.54e-3)" "prognostic unfavorable (7.12e-4)" "unprognostic (2.18e-1)" "unprognostic (1.16e-1)" "unprognostic (8.70e-2)" "unprognostic (3.23e-2)" "unprognostic (3.98e-3)" "unprognostic (1.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.48e-1)" "unprognostic (9.89e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (6.29e-3)" "unprognostic (3.63e-2)" "unprognostic (4.59e-2)" "unprognostic (8.21e-2)" 30.6 18.9 8.4 4.8 8.4 0.0 14.3 6.6 9.9 4.9 13.1 9.3 6.4 6.6 1.5 3.2 7.4 8.1 19.7 8.7 9.4 22.1 12.4 26.8 2.7 9.5 8.2 2.6 4.6 7.0 20.1 13.8 8.5 9.1 5.2 4.3 4.4 4.7 5.1 3.9 7.8 6.2 6.4 8.7 8.7 1.8 8.4 2.0 19.5 6.5 1.4 8.1 4.0 6.3 3.0 5.0 48.4 100.2 29.0 20.7 12.7 35.9 12.0 5.7 6.0 5.2 5.1 0.0 25.0 9.2 6.1 2.4 0.0 10.6 7.2 0.1 0.0 0.2 0.0 22.9 9.5 0.0 0.2 16.7 0.2 15.8 8.6 9.3 5.5 0.1 11.7 0.1 21.9 4.3 0.0 14.0 21.5 16.8 31.3 1.1 6.8 1.3 17.7 32.2 0.6 14.1 0.7 4.7 42.5 14.1 0.4 2.1 8.3 12.6 0.2 2.5 32.4 0.1 1.7 0.2 19.4 0.1 139.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 8.4 6.6 9.9 8.7 9.4 9.5 8.2 8.5 6.4 8.4 6.3 39.5 6.4 49.0 6.8 0.2 1.7 3.8 1.7 17.1 9.1 7.6 10.2 3.2 1.5 1.1 3.7 0.0 1.0 0.9 7.3 0.0 2.0 0.8 10.1 4.6 32.8 13.8 0.0 11.2 0.4 2.1 12.4 6.1 17.1 3.8 0.5 37.1 3.2 0.3 0.0 17.1 7.3 0.0 2.6 1.2 1.7 0.3 0.5 7.2 22.5 0.0 1.6 0.0 96.5 0.8 5.1 2.5 0.4 0.1 4.3 5.6 1.2 0.6 0.6 19.7 17.1 24.3 0.1 1.0 3.5 0.3 3.4 1.4 1.3 7.6 1.8 SPSB4 SSB-4 ENSG00000175093 "SplA/ryanodine receptor domain and SOCS box containing 4" Q96A44 3 141051347-141148611 "Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 2.9;pancreas: 7.0;pituitary gland: 3.0;testis: 2.9" "Group enriched" "Detected in some" 4 "Early spermatids: 23.6;Late spermatids: 11.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 22.1" "Group enriched" "Detected in some" 5 "glioma: 4.6;testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.5;NTERA-2: 3.5;RH-30: 4.2;SH-SY5Y: 3.6;U-2 OS: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062793 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA062793: AB_2732689" "unprognostic (5.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.12e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.72e-4)" "unprognostic (7.49e-2)" "unprognostic (6.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-3)" "unprognostic (2.30e-2)" "unprognostic (2.46e-4)" "unprognostic (9.80e-3)" 0.3 0.3 0.5 0.0 0.9 0.0 0.1 0.8 1.2 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 2.0 0.3 0.0 0.4 0.0 2.8 2.1 0.0 7.0 0.2 3.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 1.5 1.1 0.0 2.9 1.1 0.2 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 12.5 0.2 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.9 0.0 3.5 0.0 0.0 0.0 4.2 0.6 0.0 0.0 1.1 3.6 0.0 0.0 0.0 2.0 0.2 0.3 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.8 1.2 0.3 2.0 2.8 2.1 1.6 1.5 1.1 0.9 0.4 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.6 0.0 0.1 0.1 0.0 0.0 2.8 0.5 0.0 3.2 0.0 0.0 0.0 0.4 0.4 0.1 0.2 0.0 5.6 0.0 0.0 5.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.3 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.4 22.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SPTBN1 ENSG00000115306 "Spectrin beta, non-erythrocytic 1" Q01082 2 54456317-54671446 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 615.4;Peritubular cells: 663.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012685, HPA013149" Supported Approved "Golgi apparatus" NA Yes 1500000 "Cluster 39: Non-specific - mRNA processing" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "HPA012685: AB_1857433, HPA013149: AB_1857434" "unprognostic (2.72e-1)" "unprognostic (4.44e-3)" "unprognostic (3.00e-2)" "unprognostic (3.25e-1)" "unprognostic (4.09e-2)" "unprognostic (7.95e-2)" "unprognostic (9.24e-2)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (1.67e-1)" "unprognostic (2.26e-2)" "unprognostic (7.25e-2)" "prognostic favorable (2.59e-5)" "unprognostic (2.31e-1)" "unprognostic (2.73e-1)" "unprognostic (1.68e-3)" "unprognostic (5.18e-3)" 187.3 70.9 210.6 34.7 205.1 37.6 78.7 97.4 166.1 54.1 94.2 62.8 32.7 52.0 36.3 41.7 56.2 69.2 135.9 156.2 99.7 65.3 83.8 131.6 28.9 141.2 154.4 73.2 45.5 129.2 27.8 97.4 120.4 43.8 52.4 56.0 55.1 74.4 54.0 39.4 46.8 59.9 134.8 58.7 55.6 32.6 214.6 29.3 72.8 87.2 30.0 45.6 38.6 163.6 96.5 150.5 60.4 57.2 234.7 158.8 74.8 40.2 82.3 63.7 61.4 101.7 66.6 0.4 112.1 142.0 55.1 110.9 85.1 128.0 66.0 0.8 35.6 43.7 118.4 166.2 97.7 59.7 24.4 62.3 64.8 193.8 119.7 77.6 151.6 95.1 50.0 64.0 86.1 21.6 105.0 14.5 66.3 129.6 70.2 116.2 95.0 37.2 92.2 120.6 36.3 113.3 121.5 39.5 88.1 58.9 19.6 9.9 235.2 89.9 79.0 110.2 58.2 62.8 42.8 32.7 98.1 17.7 163.7 2.3 0.4 2.8 3.7 0.0 3.9 3.7 3.4 3.6 1.3 3.5 5.0 3.6 0.6 5.2 0.0 1.1 3.2 3.1 210.6 205.1 97.4 166.1 156.2 99.7 141.2 154.4 120.4 134.8 214.6 163.6 615.4 407.1 124.6 233.4 45.7 83.1 50.0 64.7 42.7 94.4 60.8 58.0 262.9 144.4 100.6 145.3 73.0 28.3 31.7 343.6 7.9 223.7 12.1 140.4 80.3 426.4 83.1 21.5 231.3 121.9 42.0 271.6 139.7 115.7 35.4 68.2 228.5 184.6 14.2 141.3 195.4 135.5 77.3 17.7 47.0 31.5 503.2 16.6 147.7 294.2 9.7 131.9 36.0 154.8 283.1 243.3 109.9 663.5 76.3 75.6 142.8 44.1 187.3 93.6 164.3 340.3 171.9 54.7 53.3 79.7 68.2 11.1 49.2 56.6 151.9 88.1 SRCAP "DOMO1, EAF1, KIAA0309, SWR1" ENSG00000080603 "Snf2 related CREBBP activator protein" Q6ZRS2 16 30698209-30741409 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 186.4;Club cells: 145.6;Ionocytes: 179.0;Respiratory ciliated cells: 118.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA028929 Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA028929: AB_10601265" "unprognostic (1.26e-1)" "unprognostic (1.35e-1)" "unprognostic (5.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (8.59e-2)" "unprognostic (2.34e-2)" "unprognostic (3.77e-1)" "unprognostic (6.45e-2)" "unprognostic (4.36e-2)" "unprognostic (8.57e-2)" "unprognostic (1.16e-2)" "unprognostic (2.09e-1)" "unprognostic (4.11e-2)" "unprognostic (7.71e-2)" "unprognostic (1.07e-1)" 15.4 11.9 3.6 18.9 4.8 30.1 10.1 7.1 4.2 12.8 1.7 13.2 15.7 15.5 6.4 13.5 14.2 10.9 12.1 2.9 3.4 9.6 7.1 11.6 15.3 5.9 4.3 16.9 19.4 20.2 9.5 12.6 3.5 12.6 11.2 12.5 18.0 13.1 24.5 16.2 16.1 15.0 0.8 18.7 16.0 20.6 7.7 20.2 14.0 19.4 13.6 11.3 9.9 6.8 29.5 60.1 36.9 35.9 28.3 19.5 37.7 24.0 21.1 26.2 20.7 27.8 21.9 65.9 29.7 30.5 16.9 27.8 37.7 27.5 21.9 42.2 88.1 42.5 56.2 24.3 11.4 49.8 48.0 20.8 13.2 40.3 29.0 12.8 27.8 21.7 65.4 36.5 19.7 34.5 42.2 17.4 37.6 10.8 27.7 57.7 28.7 36.4 7.5 34.2 34.5 36.5 26.6 31.0 8.4 12.2 35.4 26.0 44.1 37.0 26.5 21.0 31.6 39.8 36.7 45.9 29.7 23.2 28.9 0.3 0.7 2.9 0.8 1.2 0.6 0.7 0.4 0.9 0.5 1.0 0.5 0.4 2.2 0.6 0.3 0.9 0.9 0.7 3.6 4.8 7.1 4.2 2.9 3.4 5.9 4.3 3.5 0.8 7.7 6.8 3.0 3.2 3.7 8.8 9.8 24.6 1.9 186.4 13.1 7.5 3.3 1.8 2.4 4.3 145.6 1.8 8.4 2.3 5.3 54.3 0.0 1.4 1.2 4.6 3.0 3.4 11.3 7.6 8.6 3.1 1.4 4.2 19.9 4.7 2.5 3.0 2.2 3.0 2.3 8.4 8.6 17.7 179.0 1.9 14.3 0.9 2.8 3.4 10.6 8.4 3.0 1.7 6.2 4.5 10.6 1.9 39.1 1.2 11.1 3.1 3.1 0.6 118.3 5.8 0.0 5.0 14.3 5.6 6.0 7.8 58.2 2.5 8.9 2.0 25.6 3.1 SREBF1 "bHLHd1, SREBP-1c, SREBP1, SREBP1a" ENSG00000072310 "Sterol regulatory element binding transcription factor 1" P36956 17 17810399-17837011 "Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 219.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "RPMI-8226: 202.5;SK-BR-3: 178.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005406, HPA043343, HPA043878" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 30: Mammary glandular cells - Lactation" "Nucleoplasm, Golgi apparatus, Cytosol" "CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710" "unprognostic (9.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-2)" "prognostic favorable (2.66e-4)" "unprognostic (4.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (3.14e-2)" "unprognostic (9.02e-3)" "prognostic favorable (9.05e-4)" "unprognostic (3.12e-1)" "unprognostic (9.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (7.65e-2)" "unprognostic (2.36e-3)" 42.2 219.2 26.8 7.9 41.5 20.1 46.5 20.4 37.2 51.5 9.4 37.7 28.7 23.4 8.9 68.7 42.7 14.0 27.4 20.0 25.9 24.7 128.5 26.4 9.1 30.1 29.7 41.4 17.0 8.4 37.0 7.8 24.2 37.2 6.7 3.9 89.5 16.7 34.5 47.8 34.0 5.6 23.4 17.2 25.2 35.4 35.8 14.4 27.0 2.9 6.3 32.5 48.8 41.7 54.1 122.5 12.0 85.2 24.9 55.8 23.5 18.5 60.0 16.4 39.2 23.3 104.2 33.5 17.2 14.8 14.5 144.0 16.7 47.2 4.0 21.1 7.2 16.8 86.4 19.1 36.1 2.5 29.6 42.0 19.6 21.8 12.5 12.2 17.6 64.9 36.8 105.8 2.5 118.7 46.9 26.1 17.8 38.3 23.1 32.6 10.8 202.5 9.0 23.1 16.3 70.5 24.4 178.7 48.0 8.9 62.0 32.6 21.5 8.2 40.5 19.5 12.5 32.2 3.1 15.5 48.9 24.6 45.2 0.0 0.3 0.1 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.4 0.6 1.3 0.1 0.1 0.1 0.0 0.2 26.8 41.5 20.4 37.2 20.0 25.9 30.1 29.7 24.2 23.4 35.8 41.7 6.1 6.4 26.0 66.9 11.9 9.3 12.0 29.2 14.8 24.5 58.0 30.6 9.4 18.6 29.7 20.2 29.2 4.5 11.4 44.5 1.9 16.5 2.7 30.9 37.2 10.5 29.9 24.8 12.8 23.5 15.7 24.7 31.1 31.9 14.7 13.2 12.8 72.2 12.1 58.9 11.3 30.8 24.4 14.0 13.3 4.9 29.8 15.1 8.8 15.0 11.0 51.7 1.0 10.6 56.7 16.7 20.8 10.9 8.4 19.0 33.2 6.6 32.1 31.6 13.1 15.6 12.9 11.4 4.9 40.2 18.3 19.8 13.4 27.5 41.1 25.2 SRGN "PPG, PRG, PRG1" ENSG00000122862 Serglycin P10124 10 69088103-69104805 "Plasma proteins, Predicted secreted proteins" "Apoptosis, Biomineralization" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 8096.7" "Cell type enhanced" "Detected in many" "dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 5714.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 5714.1" "Cell line enhanced" "Detected in many" "HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000759 Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 100000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA000759: AB_1079675" "unprognostic (3.61e-2)" "unprognostic (1.62e-2)" "unprognostic (2.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (4.50e-2)" "unprognostic (1.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.63e-1)" "unprognostic (8.22e-2)" "unprognostic (5.80e-2)" "unprognostic (9.82e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.65e-1)" "unprognostic (2.32e-2)" "unprognostic (4.07e-2)" "unprognostic (4.08e-2)" 404.6 114.9 48.8 799.8 50.5 8096.7 136.4 55.5 99.6 93.2 70.1 101.8 77.9 63.5 25.9 91.0 96.8 316.4 111.9 48.2 67.8 98.3 239.4 347.3 437.2 82.4 59.3 30.7 68.4 131.6 62.1 355.6 67.8 58.9 118.9 15.5 40.1 57.4 37.5 18.9 111.4 219.4 65.5 362.8 95.0 18.3 64.7 228.9 72.7 117.1 314.6 508.3 46.1 71.0 5.3 43.0 0.2 0.4 768.1 749.7 1.2 94.9 63.9 235.1 283.5 0.1 18.2 9.1 117.4 4.1 134.4 1.1 0.0 20.6 799.9 535.7 0.4 87.1 29.8 0.3 312.7 4442.1 914.9 306.8 1.1 641.5 39.2 223.8 1227.8 13.3 82.5 419.9 1239.9 0.2 18.7 2549.7 0.7 0.1 84.6 2.4 2.3 446.7 0.6 6.0 0.3 0.8 2.3 0.6 16.0 0.0 2.2 4346.8 2609.1 187.9 12.9 3.8 20.1 486.4 508.4 57.3 112.2 3546.9 1.2 2349.8 1105.3 2730.6 474.9 774.6 313.4 73.5 228.5 362.8 583.0 39.0 125.5 268.4 5714.1 962.8 693.6 631.9 392.6 1590.5 48.8 50.5 55.5 99.6 48.2 67.8 82.4 59.3 67.8 65.5 64.7 71.0 1081.4 112.2 198.1 0.7 592.0 175.9 12.5 38.3 8.6 1.1 16.0 28.2 21.2 21.5 57.5 33.1 0.0 10.2 2922.2 2.9 0.0 4.2 4.1 4.6 15.0 566.8 1.8 277.8 0.2 9.8 10.2 87.9 70.3 6.6 2343.1 0.4 636.1 22.1 847.1 0.0 0.5 1.7 0.0 1789.9 6618.2 8.4 7.5 3639.1 556.7 80.6 3188.2 1.4 1292.5 0.0 0.2 1.3 1.2 18.0 1740.9 12.2 0.3 4.7 45.6 5.0 72.3 22.8 97.5 0.9 2.2 8.7 141.8 14.2 2235.9 1.2 5.5 18.1 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643786 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 61.1;intestine: 195.9;stomach 1: 64.9" "Cell type enriched" "Detected in many" 5 "Intestinal goblet cells: 801.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4" "Lineage enriched" "Detected in single" 32 "T-cells: 8.9" "Group enriched" "Detected in some" 4 "K-562: 65.5;OE19: 107.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 3500000 "Cluster 20: T-cells - T-cell receptor" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favorable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.9 0.1 6.0 12.6 5.6 2.8 2.0 5.7 9.2 61.1 4.5 155.3 62.5 5.1 3.9 24.4 3.8 18.3 3.4 5.5 6.0 0.4 0.1 5.7 1.2 6.1 6.0 0.8 0.7 0.1 0.0 2.1 6.4 6.9 195.9 1.0 26.3 0.5 1.4 0.9 75.8 5.4 5.8 14.6 64.9 3.1 6.1 0.2 0.3 0.9 2.3 3.1 4.5 5.6 0.2 2.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.4 0.2 11.9 0.0 0.0 12.4 0.0 2.9 0.0 0.0 0.0 19.5 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 65.5 0.0 0.0 0.0 0.2 0.2 0.0 107.5 0.4 0.0 0.0 0.4 0.1 0.7 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.9 0.1 0.0 0.0 3.4 0.0 0.2 0.0 0.0 0.0 1.3 0.9 6.0 5.6 5.7 9.2 5.5 6.0 6.1 6.0 6.4 5.8 6.1 5.6 8.6 16.0 7.5 0.7 0.3 0.1 5.7 90.2 12.0 0.1 0.1 0.0 2.0 17.2 143.4 0.0 0.0 0.3 0.0 133.3 0.0 1.4 0.3 85.1 7.6 27.2 33.0 6.7 0.4 18.2 0.1 1.3 65.7 77.6 0.0 0.3 8.6 0.0 0.3 0.0 0.3 801.0 50.8 0.0 0.0 0.9 1.5 1.1 0.0 18.7 0.0 0.0 0.0 1.5 0.3 42.8 76.1 0.0 0.0 2.4 51.6 0.0 117.4 1.2 0.0 0.3 5.3 0.4 0.1 12.8 0.1 0.1 1.8 63.3 123.1 24.5 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917041 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.0" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 67.8;Erythroid cells: 112.2;Plasma cells: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 9 "plasmacytoid DC: 233.9" "Lineage enriched" "Detected in all" 9 "dendritic cells: 233.9" "Cell line enhanced" "Detected in many" "HDLM-2: 105.3;RPMI-8226: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 25: RPMI-8226 - Immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus" Nucleoplasm "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 20.9 16.9 11.2 10.6 10.4 40.0 16.6 11.9 15.2 18.1 12.7 18.6 14.9 18.5 6.3 15.2 19.3 8.6 34.2 11.5 9.9 20.5 9.0 27.7 14.0 10.6 9.8 25.1 72.0 7.4 20.8 5.3 9.6 13.6 6.6 1.0 11.8 15.3 24.4 9.7 19.4 7.5 10.4 37.2 15.1 5.4 10.2 5.9 11.3 10.2 9.4 17.9 14.7 9.7 9.5 15.9 4.1 20.1 27.4 20.8 3.0 16.3 17.6 16.2 9.4 9.1 17.0 60.2 24.0 20.2 22.8 23.0 8.2 17.2 2.7 105.3 7.2 19.3 48.8 34.2 33.3 1.6 19.1 25.6 18.0 14.4 12.9 13.1 43.2 11.4 14.0 38.9 7.8 4.4 3.8 2.2 4.6 30.7 38.9 18.3 10.5 149.6 16.5 0.5 33.8 7.8 23.6 49.8 3.0 1.3 10.3 12.2 31.3 13.1 15.2 41.3 25.8 63.5 35.0 18.8 26.2 8.4 1.9 3.7 9.0 0.3 11.1 8.0 12.3 25.1 6.9 13.3 11.3 18.6 8.6 11.9 1.1 18.9 14.5 233.9 13.3 10.2 11.2 10.4 11.9 15.2 11.5 9.9 10.6 9.8 9.6 10.4 10.2 9.7 15.0 9.6 26.5 2.3 35.5 2.2 12.2 21.1 8.6 3.1 5.2 4.8 12.2 10.0 9.9 1.8 0.0 1.1 48.1 27.0 1.9 16.1 0.2 2.5 13.8 14.8 67.8 112.2 3.7 14.1 15.6 10.7 6.6 2.6 8.2 7.1 12.1 1.9 23.0 0.0 4.9 16.6 8.2 13.3 10.0 0.6 17.4 9.2 7.2 1.9 11.2 15.0 11.3 2.0 1.0 9.3 9.1 42.9 93.9 12.8 17.1 20.6 5.1 1.9 13.1 9.2 10.9 0.3 1.5 9.3 3.1 4.5 10.2 34.0 13.0 10.6 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393881-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.4;heart muscle: 3.9" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 2.9;Cardiomyocytes: 4.3;Inhibitory neurons: 3.5;Muller glia cells: 2.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 25.8;LHCN-M2: 7.7;RH-30: 11.7;RPMI-8226: 8.9;SH-SY5Y: 5.0;WM-115: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.0 0.3 0.6 0.0 0.6 0.0 0.4 0.6 2.2 0.8 0.0 0.1 0.0 0.4 0.8 0.0 0.0 0.2 3.9 1.5 1.2 0.1 0.0 0.0 0.0 8.4 1.9 0.0 0.0 0.0 0.2 0.0 8.2 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.4 1.8 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.2 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.2 0.0 4.1 0.0 0.0 0.0 11.7 8.9 0.0 0.0 0.6 5.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 4.2 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 2.2 1.5 1.2 8.4 1.9 8.2 0.1 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 1.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57352557-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.7;pituitary gland: 8.1;retina: 7.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" No NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA063398: AB_2685004, HPA066783: AB_2685721" "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.0 4.3 8.0 0.0 21.7 0.0 0.0 6.7 15.6 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.9 0.0 12.5 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 8.1 0.0 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 9.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 21.7 6.7 15.6 12.5 14.5 0.0 0.0 0.0 0.0 2.1 4.9 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 1.6 5.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 63.9 56.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 4.7 0.0 1.2 0.0 22.1 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ST8SIA4 "PST, PST1, SIAT8D" ENSG00000113532 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4" Q92187 5 100806933-100903282 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.0" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 73.3;Kupffer cells: 92.4;Langerhans cells: 149.3;Microglial cells: 101.2;monocytes: 97.5;Plasma cells: 73.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 91.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 41.1;HDLM-2: 69.3;Karpas-707: 57.2;NB-4: 27.9;RPMI-8226: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051126, HPA053995" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA 980000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA051126: AB_2681352, HPA053995: AB_2682336" "unprognostic (2.25e-1)" "unprognostic (2.04e-2)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.14e-1)" "unprognostic (6.45e-3)" "unprognostic (1.91e-1)" "unprognostic (5.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.49e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (7.80e-7)" "unprognostic (6.07e-2)" "unprognostic (4.38e-2)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" 5.8 1.9 2.2 14.0 2.4 7.6 2.2 1.6 2.4 1.9 2.5 3.3 3.2 1.6 0.5 1.1 1.8 5.0 2.3 1.8 4.5 0.7 2.6 5.7 12.3 4.8 3.6 0.5 0.8 1.0 0.6 11.1 5.2 1.3 4.2 0.6 1.2 0.8 0.8 0.8 4.5 2.8 2.7 11.8 3.0 0.4 4.3 9.5 2.0 1.7 10.3 5.5 1.1 4.5 0.0 6.1 41.1 0.0 2.6 3.9 1.0 0.0 0.0 0.0 0.3 0.0 0.0 3.3 0.1 0.0 1.0 0.1 1.0 0.1 0.1 69.3 0.0 2.5 0.4 0.0 0.0 13.0 5.0 3.2 0.0 0.1 0.1 5.3 7.7 10.1 0.0 57.2 2.4 0.6 18.6 27.9 0.3 0.0 0.3 10.3 0.7 44.8 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.2 0.0 11.6 2.7 0.4 0.2 0.0 0.6 18.6 20.3 3.9 1.0 15.8 5.1 58.0 18.5 22.9 13.1 21.7 9.9 11.1 8.7 11.1 12.2 9.9 5.4 10.1 91.7 10.6 24.0 3.7 17.4 12.2 2.2 2.4 1.6 2.4 1.8 4.5 4.8 3.6 5.2 2.7 4.3 4.5 35.8 6.4 14.1 1.6 49.7 8.3 0.4 2.1 2.2 0.6 0.9 0.9 2.3 1.5 10.1 0.0 0.0 9.4 44.0 0.0 1.9 0.2 0.2 0.9 1.6 28.4 0.0 8.2 6.8 0.0 42.4 5.0 1.1 0.3 24.1 0.1 7.1 0.1 22.6 0.0 73.3 0.2 4.1 92.4 149.3 0.7 0.0 57.5 14.2 101.2 97.5 3.2 34.0 4.5 1.6 0.0 0.0 0.4 73.8 0.2 0.0 0.3 16.6 0.9 13.1 1.2 3.7 0.5 0.8 0.4 5.5 19.2 37.7 0.7 0.0 0.5 STK26 "MASK, MST4" ENSG00000134602 "Serine/threonine kinase 26" Q9P289 X 132023302-132075943 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 70.0;epididymis: 56.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 140.1;U-937: 144.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059921 Approved Uncertain "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Yes No 360000 "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA059921: AB_2684163" "unprognostic (6.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-3)" "unprognostic (4.42e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (1.42e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (4.76e-2)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" 6.0 2.5 1.0 15.2 2.7 70.0 6.0 1.7 1.3 6.8 2.5 11.5 9.6 46.6 56.3 13.1 7.4 5.6 1.4 0.7 1.5 3.5 5.2 7.2 26.2 0.8 0.8 2.1 3.7 23.5 5.0 25.2 0.7 20.0 11.6 0.2 7.3 35.8 0.9 7.8 6.9 38.1 0.6 13.2 12.2 2.2 3.8 41.3 3.7 1.2 23.5 11.8 7.4 0.7 32.9 11.3 1.3 0.0 5.2 4.9 72.0 1.0 4.0 0.5 0.6 30.1 29.0 44.6 19.4 7.3 22.1 36.5 80.8 51.1 0.0 39.1 66.6 64.6 25.9 28.4 4.7 135.3 5.1 6.9 30.0 0.1 33.7 15.1 14.2 60.0 29.2 40.4 12.2 29.0 140.1 124.9 64.4 22.0 4.3 99.9 39.7 57.9 32.6 51.8 26.6 29.6 19.2 17.0 0.9 54.9 22.0 35.4 0.3 12.8 13.7 39.0 47.9 31.0 52.0 49.8 11.7 144.8 6.5 59.1 9.5 31.6 22.8 12.4 22.4 14.5 15.2 19.6 11.3 12.6 19.7 20.6 18.2 41.0 22.7 4.2 7.2 20.4 1.0 2.7 1.7 1.3 0.7 1.5 0.8 0.8 0.7 0.6 3.8 0.7 0.9 22.4 15.6 0.0 24.7 0.0 36.4 0.0 6.8 0.0 5.9 10.9 1.3 5.7 8.1 11.0 0.0 55.2 42.7 6.5 3.9 4.5 0.6 7.4 1.8 1.7 1.2 12.8 2.0 7.1 34.7 9.6 15.3 17.9 11.4 0.5 1.4 4.4 11.8 0.0 1.4 4.8 0.0 8.8 0.0 0.4 3.4 17.3 0.0 2.8 13.5 0.0 53.5 0.0 0.2 10.9 4.0 2.2 14.5 33.6 1.9 1.5 6.6 0.0 6.6 6.7 3.6 1.8 2.5 16.1 0.0 59.1 27.4 0.6 6.5 18.2 STMN3 SCLIP ENSG00000197457 "Stathmin 3" Q9NZ72 20 63639705-63657682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 291.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 108.5;Granulosa cells: 254.2;Horizontal cells: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 5 "T-cells: 6.2" "Cell line enhanced" "Detected in many" "AN3-CA: 125.1;MOLT-4: 142.0;REH: 143.8;SCLC-21H: 192.5;SH-SY5Y: 146.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012947 Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 14: REH - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Cytosol "HPA012947: AB_1857606" "unprognostic (7.59e-2)" "unprognostic (4.36e-1)" "unprognostic (5.28e-2)" "unprognostic (2.33e-1)" "unprognostic (3.60e-2)" "unprognostic (6.30e-2)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.65e-3)" "unprognostic (7.52e-2)" "unprognostic (2.52e-3)" "unprognostic (2.73e-2)" "unprognostic (9.87e-2)" "unprognostic (4.08e-2)" "unprognostic (9.08e-3)" 23.4 49.7 188.4 21.3 197.6 11.4 20.0 112.5 291.7 29.2 16.6 26.5 5.5 30.0 5.0 11.6 27.9 10.9 17.1 215.0 162.0 24.8 3.7 23.6 25.8 259.6 158.1 50.5 16.4 17.5 102.2 10.0 266.1 24.3 5.2 38.8 11.7 12.7 4.3 20.2 24.8 14.7 100.8 48.2 15.1 9.0 159.3 43.5 63.9 3.7 12.4 21.9 19.0 179.9 10.4 11.6 74.4 125.1 1.9 7.3 5.1 12.0 0.4 35.8 16.8 73.6 13.7 0.5 36.3 4.6 2.0 68.6 52.2 1.3 11.1 5.2 14.0 5.1 17.0 27.6 9.9 3.9 42.0 15.3 0.3 11.5 2.9 1.5 1.3 34.4 98.8 2.2 9.6 11.7 142.0 17.7 76.5 2.4 81.7 143.8 12.1 58.0 60.9 2.0 192.5 146.6 5.7 3.4 14.9 5.9 2.1 25.9 1.9 0.8 20.4 0.8 2.6 4.9 10.4 3.6 2.1 14.3 48.8 1.1 0.0 1.1 2.5 0.1 2.7 0.2 5.2 4.5 0.1 0.6 6.2 5.3 0.1 0.0 0.1 1.1 0.9 2.0 188.4 197.6 112.5 291.7 215.0 162.0 259.6 158.1 266.1 100.8 159.3 179.9 5.8 6.4 2.5 16.3 17.1 8.2 6.9 11.9 8.6 108.5 4.7 14.7 2.3 4.3 3.2 3.7 52.1 11.7 13.4 1.1 13.7 4.0 10.0 1.6 17.9 7.8 37.2 4.6 56.9 2.5 4.0 25.4 2.0 2.7 4.5 254.2 6.8 0.0 2.3 109.4 67.1 0.6 4.1 2.2 7.6 18.8 30.1 3.5 7.2 7.5 4.6 37.2 16.5 21.1 11.3 2.2 0.1 35.7 5.3 4.5 0.1 5.0 0.8 44.5 13.1 3.0 20.9 3.3 6.7 1.6 4.3 8.8 28.6 51.0 0.6 2.7 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 333.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 45.6;Horizontal cells: 92.5;Oligodendrocyte precursor cells: 27.6;Oligodendrocytes: 217.4" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 86.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 65: Brain - Ion transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 0.3 10.2 128.0 0.2 147.2 0.1 0.2 154.9 333.3 0.5 66.3 4.3 0.6 0.4 0.9 0.1 0.3 0.2 0.1 148.1 150.9 0.1 0.1 0.1 0.0 185.1 152.3 0.2 0.1 0.0 1.1 0.0 184.4 0.5 1.4 21.4 0.1 0.2 0.2 0.4 1.6 0.6 151.1 0.0 0.9 0.6 150.9 0.0 0.1 0.0 0.0 0.6 0.6 265.7 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 86.8 3.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.0 147.2 154.9 333.3 148.1 150.9 185.1 152.3 184.4 151.1 150.9 265.7 0.1 0.0 0.0 4.6 0.0 0.4 0.1 0.0 0.0 45.6 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 21.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 92.5 18.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.6 0.0 9.7 0.0 27.6 217.4 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 13.4 0.0 0.0 0.2 0.8 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 STX10 "hsyn10, SYN10" ENSG00000104915 "Syntaxin 10" O60499 19 13144058-13150383 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035303, HPA056439" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Vesicles" "HPA035303: AB_10671932, HPA056439: AB_2683135" "unprognostic (1.72e-2)" "unprognostic (2.26e-2)" "unprognostic (1.62e-2)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (1.21e-2)" "unprognostic (2.54e-3)" "prognostic favorable (8.26e-4)" "unprognostic (4.09e-1)" "unprognostic (3.66e-2)" "unprognostic (4.57e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.69e-7)" "unprognostic (2.39e-3)" "unprognostic (7.95e-2)" "unprognostic (2.23e-1)" "unprognostic (2.98e-2)" 45.3 58.7 42.1 35.6 44.3 72.3 47.1 45.3 52.3 65.5 47.0 57.2 47.7 48.7 17.1 80.7 49.6 29.5 56.1 42.2 41.7 60.9 78.8 66.9 42.5 44.6 43.3 50.7 48.3 27.9 49.1 17.0 43.1 49.9 19.8 11.6 52.0 20.4 35.8 68.2 60.7 20.9 40.7 87.0 60.3 17.7 43.6 35.3 56.6 16.6 28.2 51.4 55.4 48.5 99.9 68.8 51.8 138.1 51.5 52.8 17.2 55.4 49.4 46.1 48.4 31.8 88.3 66.5 80.5 66.8 33.7 76.3 44.9 67.0 26.6 113.4 86.0 60.8 154.4 66.5 38.2 71.4 63.2 54.3 55.3 57.4 37.2 62.8 58.1 85.9 32.9 34.6 31.8 87.2 105.6 125.2 55.2 51.3 112.5 117.3 54.1 96.6 44.4 47.2 60.0 121.3 57.9 66.2 127.6 14.9 45.1 67.9 58.4 75.3 38.7 145.9 77.5 78.1 75.2 57.0 98.0 172.8 59.8 41.5 162.3 120.4 48.1 128.4 40.7 39.9 41.4 48.7 119.1 40.3 36.3 37.3 267.6 32.1 151.5 31.2 51.4 80.7 42.1 44.3 45.3 52.3 42.2 41.7 44.6 43.3 43.1 40.7 43.6 48.5 31.6 16.0 21.6 13.1 29.9 35.4 34.5 52.0 31.3 21.3 43.0 37.5 12.6 30.0 53.6 20.2 6.2 17.7 32.2 54.3 27.4 42.5 1.0 23.9 28.3 31.3 16.3 33.2 16.6 56.1 26.2 27.6 40.8 24.7 53.8 33.7 31.1 18.8 82.4 13.5 11.8 48.0 46.8 86.7 45.8 3.0 25.1 62.0 48.0 7.5 86.1 21.4 48.4 11.1 14.0 57.0 53.8 31.2 25.3 19.9 77.9 28.3 38.2 17.1 26.3 21.2 31.0 9.0 16.2 38.6 43.2 19.4 39.1 23.6 55.5 38.4 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773219-27824443 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: AB_2682778" "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 64.2 30.1 38.1 26.6 39.0 10.8 37.0 40.8 45.6 28.8 25.4 30.7 36.3 30.9 62.9 39.2 23.9 39.8 20.9 37.3 41.7 35.2 29.1 50.0 25.6 42.0 45.3 22.1 30.3 46.5 26.6 33.3 43.6 30.7 32.5 43.2 26.9 32.1 21.4 27.0 32.8 35.9 42.2 30.5 65.5 13.4 38.4 17.3 94.7 27.1 22.2 39.1 23.4 44.6 23.2 10.9 28.8 19.0 53.9 65.0 14.8 47.9 70.3 43.1 48.5 13.5 29.5 25.2 49.6 64.6 18.5 19.0 19.2 23.9 42.9 22.2 22.8 14.4 12.0 13.7 42.2 16.1 29.0 61.3 28.7 60.6 34.5 35.3 70.3 14.3 19.1 24.6 47.7 8.5 13.7 12.3 12.1 34.3 15.3 8.7 23.1 15.5 38.1 37.5 32.3 17.6 22.4 19.3 35.2 23.3 13.1 14.0 76.2 21.9 12.5 50.0 16.6 14.5 11.2 14.3 35.1 24.1 31.2 24.6 35.7 13.7 6.1 39.4 10.6 13.6 7.3 9.7 25.2 10.8 8.1 6.8 16.5 9.2 40.6 12.4 7.9 17.4 38.1 39.0 40.8 45.6 37.3 41.7 42.0 45.3 43.6 42.2 38.4 44.6 93.0 54.5 36.3 25.1 43.6 109.4 97.2 30.7 51.2 46.2 42.0 25.7 18.9 30.0 40.8 57.0 31.3 30.0 28.3 82.8 37.2 51.9 2.0 34.7 33.1 71.1 41.3 17.7 70.9 58.4 33.5 53.2 108.6 49.4 22.8 26.7 47.8 20.4 50.6 26.9 65.7 29.5 14.2 91.4 77.7 4.2 36.1 62.3 53.4 56.2 41.3 67.9 36.0 34.7 59.1 68.4 58.6 47.4 33.9 74.9 51.3 69.7 27.4 51.2 39.5 45.7 57.5 20.0 20.1 69.9 99.2 78.0 31.6 54.0 29.9 99.9 STX5 "SED5, STX5A" ENSG00000162236 "Syntaxin 5" Q13190 11 62806860-62832051 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001358 Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" Nucleoplasm "HPA001358: AB_1080119" "unprognostic (3.51e-2)" "unprognostic (4.23e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-3)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-2)" "unprognostic (3.30e-1)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (1.67e-2)" "unprognostic (3.42e-2)" "unprognostic (2.79e-1)" "unprognostic (2.86e-2)" "unprognostic (8.22e-3)" 34.2 31.8 31.2 22.2 32.1 41.9 34.4 35.3 39.0 42.0 34.6 27.5 22.7 30.6 42.6 34.9 33.1 25.0 27.2 31.3 32.1 38.3 51.0 32.7 25.1 34.2 31.8 42.2 51.1 27.0 29.6 27.4 31.7 43.6 22.4 18.8 51.8 26.9 27.7 41.4 28.4 23.9 31.3 35.5 36.0 29.0 32.9 30.4 37.9 20.2 31.6 28.4 34.2 33.5 40.9 25.4 34.5 29.9 44.6 50.2 31.0 39.2 54.9 64.7 52.0 18.8 39.0 26.0 35.9 55.9 37.8 41.7 29.7 37.2 47.8 60.4 28.3 23.0 33.0 39.2 55.3 26.9 33.5 40.7 41.6 58.6 70.3 50.5 31.9 37.0 21.0 71.7 34.5 48.4 36.5 43.8 11.3 36.2 36.8 37.1 32.3 70.2 28.8 20.7 26.3 21.6 31.4 49.4 63.6 25.7 54.4 35.9 36.8 46.8 24.6 54.6 25.1 64.2 38.1 27.4 38.0 18.7 29.6 11.7 11.4 36.2 10.4 14.1 9.3 11.0 8.1 10.1 10.4 11.3 7.5 7.6 17.8 13.1 12.7 12.9 13.0 6.6 31.2 32.1 35.3 39.0 31.3 32.1 34.2 31.8 31.7 31.3 32.9 33.5 30.3 22.4 29.3 12.7 64.1 67.2 79.5 37.9 13.6 21.0 38.0 27.9 5.6 20.0 27.6 11.0 27.1 55.3 57.6 29.8 29.4 45.7 113.1 28.2 28.6 33.1 32.9 23.5 16.0 59.6 75.1 39.5 23.9 34.0 52.7 25.2 30.0 24.4 46.5 18.5 15.4 54.8 22.4 39.5 53.5 143.7 39.1 33.2 46.2 12.2 51.6 30.3 44.3 10.1 16.6 44.1 36.0 25.2 47.2 61.2 44.8 32.6 20.7 18.6 32.9 34.1 33.6 32.2 30.1 19.8 64.2 177.6 40.4 28.0 26.2 75.5 STX6 ENSG00000135823 "Syntaxin 6" O43752 1 180972712-181023121 "Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038557, HPA038558" Approved Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" Nucleoplasm "HPA038557: AB_2676082, HPA038558: AB_10672716" "unprognostic (1.11e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.09e-3)" "unprognostic (2.23e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.12e-1)" "unprognostic (6.12e-2)" "unprognostic (4.48e-3)" "unprognostic (4.18e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.93e-8)" "unprognostic (2.59e-1)" "unprognostic (1.59e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" 9.5 7.4 13.7 11.2 14.9 2.7 9.2 15.9 17.9 9.5 11.6 7.9 7.5 8.2 7.7 17.5 7.4 7.1 5.8 15.6 13.5 8.7 4.8 11.3 10.9 13.8 13.7 8.2 4.1 7.4 4.5 11.5 12.6 7.2 8.1 8.1 8.0 6.7 4.0 12.8 7.6 8.7 13.2 9.3 7.9 5.6 14.1 17.2 11.4 4.9 14.1 14.2 11.2 16.6 16.9 18.6 18.0 24.1 18.5 21.7 30.3 21.2 27.3 16.4 13.9 17.4 16.5 17.0 28.7 23.4 10.2 29.4 16.5 37.4 19.0 12.3 12.1 11.4 14.2 17.2 18.4 16.4 14.1 19.9 33.6 27.6 28.3 29.3 33.6 15.7 21.3 11.8 22.0 24.2 15.9 15.4 28.2 21.0 9.2 13.7 22.0 24.7 19.6 41.7 25.5 27.0 22.2 42.3 23.9 30.7 25.8 14.9 28.0 22.4 11.8 21.2 17.3 19.8 11.8 12.3 11.0 15.8 13.5 2.6 1.6 2.1 0.7 1.3 0.8 0.7 1.1 1.1 2.2 0.7 1.4 0.9 1.4 0.2 1.1 0.7 1.4 0.6 13.7 14.9 15.9 17.9 15.6 13.5 13.8 13.7 12.6 13.2 14.1 16.6 13.9 16.0 18.6 32.3 11.8 48.9 21.3 19.0 41.5 12.8 16.0 11.7 6.4 2.8 13.7 18.4 6.2 25.7 15.8 10.5 11.7 10.7 8.9 19.4 16.6 23.0 23.4 16.0 54.7 9.8 24.9 12.7 19.4 22.7 12.0 12.7 14.6 4.8 26.4 8.4 38.0 11.1 16.2 26.1 28.0 11.8 8.4 31.9 7.2 23.4 25.2 6.7 15.5 50.3 30.7 14.9 13.9 13.2 10.0 22.2 10.2 11.5 13.3 11.4 6.6 8.2 12.2 5.6 15.4 47.8 37.6 20.5 14.0 16.4 10.6 22.8 SULT1B1 ST1B2 ENSG00000173597 "Sulfotransferase family 1B member 1" O43704 4 69721167-69787961 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 99.4;stomach 1: 44.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4" "Group enriched" "Detected in some" 11 "colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 10.7;neutrophil: 32.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 32.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002107 Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Nucleoplasm "HPA002107: AB_2666542" "unprognostic (9.58e-2)" "unprognostic (4.05e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (2.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (4.77e-2)" "unprognostic (5.14e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-1)" "unprognostic (1.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-2)" "unprognostic (6.93e-2)" "unprognostic (5.46e-2)" 3.0 0.7 2.3 10.7 4.3 5.5 2.1 8.0 6.8 1.5 2.5 69.9 99.4 2.0 2.4 2.0 1.5 1.5 1.9 3.2 1.8 1.9 23.8 2.5 4.2 0.9 0.9 3.0 0.8 0.9 0.1 1.3 2.0 2.5 62.2 3.9 0.8 1.4 1.2 1.3 95.3 5.1 0.3 9.7 44.9 1.2 2.0 3.0 2.7 2.3 7.5 1.6 0.9 5.6 0.7 0.6 0.8 0.8 1.8 1.9 1.2 0.8 0.4 0.3 0.3 0.7 0.7 1.3 0.7 0.8 1.0 1.1 0.1 0.2 0.7 1.5 1.0 1.0 1.2 0.5 2.7 1.3 1.3 12.3 0.2 0.3 0.5 1.1 110.9 1.6 0.6 2.5 1.0 0.7 0.6 1.0 0.8 26.3 0.4 0.6 3.7 0.8 0.2 1.8 1.3 0.8 0.5 0.3 0.5 0.7 1.6 0.6 36.2 1.0 1.7 31.5 0.6 1.9 1.0 0.6 0.4 3.3 1.3 10.7 4.8 1.4 1.0 2.7 0.3 0.1 1.5 0.4 2.7 0.2 4.9 2.5 32.0 2.9 3.4 0.2 0.9 2.6 2.3 4.3 8.0 6.8 3.2 1.8 0.9 0.9 2.0 0.3 2.0 5.6 1.3 19.2 20.8 0.3 0.9 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 8.4 0.0 0.0 0.0 4.9 298.2 0.0 0.3 0.1 1.2 0.1 2.2 33.7 2.7 0.1 4.4 0.2 1.8 61.7 0.2 16.4 0.2 2.9 45.1 0.3 0.0 0.1 42.6 0.0 24.9 1.8 0.0 0.0 9.4 0.0 3.7 15.4 0.0 11.3 0.0 0.1 18.2 153.4 0.0 1.0 0.2 234.3 1.5 12.8 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.3 6.7 0.1 76.4 0.1 SUN3 "MGC33329, SUNC1" ENSG00000164744 "Sad1 and UNC84 domain containing 3" Q8TAQ9 7 47987148-48029119 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 41.6" "Cell type enriched" "Detected in some" 7 "Early spermatids: 582.2" "Cancer enriched" "Detected in single" 4 "testis cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 7.0;U-2 OS: 20.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA008344, HPA076890" Enhanced Approved "Golgi apparatus" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 9: U-2 OS - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA008344: AB_1857656, HPA076890: " "unprognostic (5.11e-2)" "unprognostic (4.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-4)" "unprognostic (2.31e-2)" "unprognostic (5.62e-2)" "unprognostic (1.35e-2)" "unprognostic (2.24e-2)" "unprognostic (1.59e-5)" "unprognostic (4.88e-1)" "unprognostic (1.47e-1)" "unprognostic (2.65e-1)" "unprognostic (1.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.48e-1)" "unprognostic (2.58e-1)" 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 3.1 0.1 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 1.3 20.6 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.1 1.9 0.0 582.2 0.1 0.0 0.1 0.0 0.0 3.6 0.0 25.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 3.4 0.0 0.0 0.0 0.0 79.3 2.1 0.3 0.0 1.0 0.1 0.0 0.0 1.0 0.4 0.2 0.1 1.5 0.1 0.0 0.0 0.6 0.0 0.0 6.6 0.0 0.2 19.1 7.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 SURF4 "ERV29, FLJ22993, MGC102753" ENSG00000148248 "Surfeit 4" O15260 9 133361450-133376166 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 325.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064613 Approved Supported "Nuclear membrane,Endoplasmic reticulum,Golgi apparatus,Cytosol" NA Yes 65000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane, Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA064613: AB_2685299" "prognostic unfavorable (5.85e-4)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.47e-5)" "prognostic unfavorable (8.11e-4)" "unprognostic (1.10e-3)" "unprognostic (3.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.30e-3)" "unprognostic (1.23e-1)" "unprognostic (9.76e-3)" "unprognostic (7.58e-3)" "unprognostic (1.25e-1)" "unprognostic (2.29e-1)" "unprognostic (4.29e-3)" 97.0 106.4 20.3 38.8 22.5 66.5 76.5 22.1 23.4 70.5 27.9 72.1 79.2 78.5 40.6 77.6 71.1 39.0 74.1 21.5 22.3 67.1 223.8 84.2 29.6 23.6 22.2 61.0 150.4 35.4 88.6 55.4 22.2 69.2 37.9 14.0 86.4 39.5 60.1 63.2 82.2 43.4 22.9 59.6 88.5 49.4 25.8 27.8 68.2 23.3 31.4 62.7 59.4 25.9 59.8 96.4 65.3 90.3 134.8 140.2 127.4 184.1 178.4 127.0 124.7 145.9 84.8 41.1 70.6 254.2 122.9 152.7 75.7 94.4 97.0 86.5 46.3 72.1 87.1 156.5 156.2 124.8 94.1 150.4 85.8 109.3 120.2 101.6 118.6 62.9 89.0 109.8 164.5 131.8 60.1 115.4 72.7 162.8 96.2 41.2 89.9 156.5 100.4 56.3 53.8 65.5 136.4 100.4 95.2 61.5 106.6 75.8 127.5 179.4 64.5 137.3 119.6 56.1 86.4 46.4 166.7 66.6 137.5 43.9 40.8 36.2 51.9 32.8 56.9 15.1 36.3 48.4 32.9 12.1 22.0 34.6 28.4 29.4 31.7 38.9 46.9 68.8 20.3 22.5 22.1 23.4 21.5 22.3 23.6 22.2 22.2 22.9 25.8 25.9 53.5 44.8 48.1 18.9 43.0 60.8 65.8 72.5 46.1 21.9 55.5 43.2 42.6 31.5 47.5 35.0 39.6 167.9 80.4 106.9 19.6 95.7 38.6 28.6 72.8 54.8 75.2 31.1 23.2 118.1 254.4 84.8 78.5 67.7 24.7 49.5 47.5 207.3 85.9 33.7 15.6 107.9 30.5 52.3 50.5 19.7 68.3 50.8 40.9 17.8 53.7 53.3 52.5 22.6 23.8 115.1 65.5 53.0 114.8 106.8 151.3 48.5 23.2 26.9 78.9 51.9 80.6 84.4 47.3 46.1 62.4 325.2 90.5 81.8 81.2 84.2 SUSD5 KIAA0527 ENSG00000173705 "Sushi domain containing 5" O60279 3 33150043-33218810 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Excitatory neurons: 15.4;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 61.3;Sertoli cells: 32.9;Smooth muscle cells: 29.0" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 31.1;HUVEC TERT2: 78.5;LHCN-M2: 30.4;TIME: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052788 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA 17000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus, Vesicles" "HPA052788: AB_2681948" "unprognostic (1.81e-1)" "unprognostic (1.52e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-3)" "unprognostic (1.39e-3)" "unprognostic (4.05e-2)" "unprognostic (3.72e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-3)" "unprognostic (6.45e-2)" "unprognostic (8.46e-2)" "unprognostic (1.89e-2)" 4.6 1.4 2.9 0.9 3.0 0.1 1.9 2.2 4.6 6.3 4.4 1.7 0.8 4.6 2.2 1.3 5.2 5.5 1.5 3.1 4.4 1.5 0.5 1.7 2.3 3.4 3.4 3.8 0.6 1.0 0.8 0.2 3.4 1.3 1.2 0.6 0.7 6.3 1.6 1.9 1.9 4.8 3.8 2.5 1.8 2.1 4.7 0.1 3.2 3.3 5.3 1.5 2.4 3.5 0.0 1.1 1.2 0.7 1.7 0.2 0.1 9.6 3.4 31.1 10.5 0.1 0.0 0.0 8.8 2.5 9.5 0.1 13.7 4.5 12.9 0.3 15.3 0.0 2.0 0.0 0.2 0.1 0.1 1.3 2.4 19.9 3.9 15.2 78.5 0.0 0.0 0.1 30.4 0.0 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.0 1.0 0.1 0.1 2.5 0.7 1.8 1.9 31.3 0.0 14.4 1.2 4.7 0.0 0.7 0.0 0.3 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.9 3.0 2.2 4.6 3.1 4.4 3.4 3.4 3.4 3.8 4.7 3.5 0.1 0.0 0.0 0.3 0.0 1.0 0.1 0.0 0.0 1.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 2.2 0.5 0.0 0.0 15.4 0.0 0.1 1.4 0.0 0.9 0.0 0.2 0.4 0.0 0.0 3.3 10.5 0.0 0.0 2.1 2.0 0.3 0.0 0.1 1.8 0.0 0.0 0.5 0.0 61.3 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 32.9 3.6 29.0 0.1 2.6 0.1 1.0 0.0 0.2 0.1 0.0 0.1 SYAP1 "FLJ14495, PRO3113" ENSG00000169895 "Synapse associated protein 1" Q96A49 X 16719612-16765340 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000175, HPA000882, HPA048047" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 13000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 18: U-2197 - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240" "unprognostic (4.66e-2)" "unprognostic (2.99e-2)" "unprognostic (1.25e-2)" "unprognostic (5.44e-2)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (9.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.82e-1)" "unprognostic (1.62e-2)" "unprognostic (1.95e-1)" "unprognostic (3.95e-3)" "unprognostic (1.14e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-3)" 15.3 25.1 5.8 11.2 6.5 25.5 12.4 7.1 7.8 13.1 11.8 14.6 17.4 9.2 8.7 11.3 11.1 13.2 9.5 6.8 7.4 16.0 29.4 9.1 10.3 7.1 6.7 10.9 11.8 15.5 7.6 8.7 7.0 12.8 13.0 7.8 10.7 8.0 12.6 10.3 15.6 9.9 6.6 7.1 13.2 6.4 7.7 7.9 11.5 7.6 10.7 10.8 8.3 8.8 29.2 24.1 17.0 32.0 22.6 25.6 7.8 22.7 16.2 18.6 18.4 22.8 23.5 22.6 32.4 22.3 37.9 16.9 21.0 29.7 24.7 14.8 41.9 9.0 25.4 21.9 16.2 15.5 13.4 17.6 13.7 32.2 27.1 21.5 26.0 6.9 19.8 12.2 25.4 34.2 8.4 16.6 19.9 16.1 26.3 9.1 21.5 22.8 27.8 18.9 17.3 21.3 42.2 29.7 23.1 22.0 39.5 13.8 20.6 23.7 12.5 48.7 18.6 13.4 12.2 26.1 23.3 7.7 19.8 7.4 7.2 9.3 9.9 7.9 8.1 9.0 8.4 9.2 7.8 7.0 8.3 8.7 12.0 10.1 11.4 6.5 10.5 6.5 5.8 6.5 7.1 7.8 6.8 7.4 7.1 6.7 7.0 6.6 7.7 8.8 60.4 64.1 75.6 14.4 96.0 64.1 107.0 69.5 37.0 20.2 116.0 78.2 74.3 88.6 92.2 79.1 22.9 66.5 273.8 164.3 111.6 119.6 214.8 219.3 84.7 53.3 106.1 45.9 13.9 132.1 83.3 65.5 72.4 176.3 210.0 38.3 71.4 216.0 49.5 23.5 16.0 107.4 63.1 70.8 241.0 296.2 42.3 171.5 67.6 8.4 55.7 49.4 64.9 11.6 26.9 183.6 159.2 54.5 185.5 80.3 148.3 164.3 169.7 21.5 59.2 56.9 68.1 15.3 21.5 42.0 52.6 150.5 156.6 48.5 118.6 104.4 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562919 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 46 "testis: 142.1" "Cell type enhanced" "Detected in many" "Early spermatids: 497.2;Late spermatids: 99.0;Spermatocytes: 508.0;Spermatogonia: 182.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.0;Karpas-707: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 74: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: AB_2797234" "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 1.1 1.7 0.5 1.7 0.3 1.1 1.7 3.0 0.4 1.5 0.7 0.2 0.0 1.6 0.5 1.2 1.0 0.3 1.7 1.8 2.8 1.8 0.6 0.5 1.9 2.0 0.0 0.4 0.6 1.3 0.3 2.1 0.4 0.1 1.3 0.5 0.1 0.1 0.5 0.2 0.0 1.6 0.2 0.4 142.1 1.8 0.8 1.7 0.0 0.3 0.5 0.2 1.8 0.2 0.4 0.1 0.1 0.3 0.3 0.2 0.3 0.0 0.1 0.0 0.0 5.0 0.2 1.7 0.0 1.0 0.0 0.5 0.5 0.0 0.0 0.2 0.0 0.4 0.0 2.1 0.0 0.9 1.3 1.1 0.2 0.8 0.2 0.0 1.0 0.0 4.1 0.2 1.8 0.0 0.0 0.2 2.1 0.0 0.0 0.0 2.3 0.6 1.5 0.4 1.3 0.0 1.2 0.9 0.2 1.2 1.0 0.0 0.4 0.4 0.0 0.0 1.0 0.2 0.7 0.5 0.1 0.1 0.0 0.7 0.8 0.0 0.6 0.1 0.0 0.0 0.0 1.1 0.2 0.0 0.1 4.3 0.0 0.5 0.0 0.0 0.1 1.7 1.7 1.7 3.0 1.7 1.8 1.9 2.0 2.1 1.6 1.8 1.8 0.3 0.0 0.0 0.0 0.1 0.1 0.4 3.7 2.8 0.8 5.6 5.6 0.5 2.8 2.1 1.8 0.0 5.9 0.1 0.4 3.9 1.7 497.2 2.7 0.4 0.7 0.0 0.0 0.1 0.6 3.2 0.2 0.0 2.0 0.0 0.0 0.7 3.2 1.7 0.0 0.1 0.1 4.1 1.2 0.0 99.0 10.8 0.8 0.0 0.0 2.9 1.2 0.0 0.0 0.2 0.9 0.1 7.2 0.0 0.6 0.4 7.6 4.7 0.8 46.0 0.0 0.7 508.0 182.4 0.8 0.1 3.7 0.1 0.0 0.2 0.8 SYDE1 "7h3, FLJ13511, SYD1" ENSG00000105137 "Synapse defective Rho GTPase homolog 1" Q6ZW31 19 15107401-15114985 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 140.3;Peritubular cells: 42.2;Sertoli cells: 85.5;Syncytiotrophoblasts: 134.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 107.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013328 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Golgi apparatus, Cytosol" "HPA013328: AB_1848705" "unprognostic (9.99e-2)" "unprognostic (3.73e-2)" "unprognostic (8.17e-3)" "unprognostic (1.65e-2)" "unprognostic (6.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-2)" "unprognostic (2.46e-2)" "unprognostic (2.96e-1)" "unprognostic (5.01e-3)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (5.63e-7)" "unprognostic (1.82e-2)" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.27e-4)" 23.3 12.6 7.8 5.7 8.0 0.0 17.6 7.4 7.8 27.6 15.7 28.6 3.8 32.9 4.6 6.6 23.2 5.7 20.8 6.9 7.2 16.3 4.9 18.1 3.5 9.7 8.0 23.5 6.0 2.5 6.7 15.4 7.9 18.2 2.5 1.4 6.1 11.5 5.4 8.6 11.7 10.8 7.8 12.9 13.5 4.7 8.5 0.9 12.4 3.8 1.4 23.9 18.8 7.3 11.2 17.4 9.0 23.9 19.9 18.2 7.1 46.9 33.7 44.4 37.5 4.1 7.0 0.0 30.3 46.5 15.2 7.0 7.0 8.1 24.6 0.3 8.0 1.6 34.2 7.6 37.7 0.1 0.1 32.1 5.9 26.6 12.0 26.8 8.2 0.0 0.0 0.1 33.6 5.9 0.0 0.0 14.7 0.3 17.3 0.0 22.4 0.2 11.1 1.8 0.3 17.8 25.9 15.9 31.6 8.7 1.9 1.2 17.5 107.3 32.8 49.6 50.4 0.1 0.3 0.2 29.3 0.1 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 8.0 7.4 7.8 6.9 7.2 9.7 8.0 7.9 7.8 8.5 7.3 18.6 3.2 1.1 3.6 0.2 2.4 0.8 1.2 1.8 0.3 0.9 3.2 4.1 1.5 0.8 1.8 0.0 7.6 0.0 0.0 0.0 4.7 10.0 0.7 13.6 15.2 0.0 0.0 0.0 0.4 140.3 16.2 0.0 0.5 0.0 12.8 20.0 0.3 3.4 1.7 0.0 0.0 0.0 1.0 2.7 19.3 29.5 0.6 14.2 6.5 0.0 20.0 0.0 1.0 0.2 1.7 0.0 42.2 0.0 0.5 0.0 6.1 0.1 0.8 85.5 10.7 30.8 3.1 0.6 0.3 2.6 134.5 0.4 7.5 0.0 0.2 SYDE2 FLJ13815 ENSG00000097096 "Synapse defective Rho GTPase homolog 2" Q5VT97 1 85156889-85201016 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 51.3;Cone photoreceptor cells: 54.2;Rod photoreceptor cells: 145.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 14.6;SK-BR-3: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027138, HPA058378" Uncertain Approved "Nucleoli,Nucleoli rim,Golgi apparatus" No No "Cluster 77: Retina - Visual perception" "Cluster 28: BEWO - Transcription regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoli, Nucleoli rim, Golgi apparatus" "HPA027138: AB_1857686, HPA058378: AB_2683696" "unprognostic (1.68e-1)" "unprognostic (8.90e-2)" "unprognostic (2.34e-2)" "unprognostic (3.43e-3)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (3.84e-3)" "unprognostic (6.47e-3)" "unprognostic (4.39e-2)" "unprognostic (1.85e-1)" "unprognostic (3.88e-2)" "unprognostic (4.05e-1)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (7.51e-2)" "unprognostic (6.69e-2)" 1.1 0.6 0.8 0.9 0.6 0.5 2.0 0.1 1.2 0.8 4.2 4.5 1.5 1.5 0.7 1.1 0.8 2.2 3.2 1.8 0.5 2.5 3.6 3.3 0.3 0.6 0.6 1.6 1.8 4.3 0.7 2.6 0.3 1.3 1.4 7.6 1.9 1.3 0.4 0.7 1.5 2.2 0.6 0.5 1.8 1.6 0.8 0.4 2.5 1.6 0.3 1.9 0.6 0.3 2.1 0.6 0.6 0.8 2.2 0.6 14.6 2.3 1.4 1.4 2.1 4.0 0.7 0.0 0.8 1.5 2.7 3.9 7.3 1.0 2.1 0.9 2.0 1.9 1.7 1.4 2.6 1.2 0.4 1.0 1.2 1.0 0.9 0.9 0.3 1.3 2.4 0.0 1.0 2.9 1.2 0.2 3.7 1.6 0.9 0.0 3.9 0.5 1.0 5.2 0.1 0.0 1.6 8.0 2.4 3.3 1.8 1.6 0.3 1.7 3.8 0.0 2.3 0.0 0.3 0.8 0.2 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.1 1.2 1.8 0.5 0.6 0.6 0.3 0.6 0.8 0.3 3.1 51.3 12.4 9.4 1.1 8.3 8.0 1.7 8.0 6.8 10.0 6.5 24.4 4.3 6.9 1.8 54.2 10.8 0.5 2.5 7.9 1.9 3.1 11.0 2.9 2.1 19.2 3.0 12.6 4.7 4.7 7.8 3.6 5.2 1.3 4.4 3.6 8.4 1.5 0.0 5.2 4.1 2.0 0.3 4.0 1.6 2.1 0.7 19.6 1.9 1.7 9.4 1.0 5.5 0.2 3.6 1.3 2.6 0.7 6.9 8.1 5.8 14.0 145.4 0.0 6.3 5.2 16.6 9.0 8.5 4.5 2.6 3.3 6.6 4.5 4.5 SYNC "SYNC1, SYNCOILIN" ENSG00000162520 "Syncoilin, intermediate filament protein" Q9H7C4 1 32679906-32703596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 106.8;smooth muscle: 54.1;tongue: 73.4" "Cell type enhanced" "Detected in many" "Horizontal cells: 74.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 121.0;U-138 MG: 113.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA028311, HPA063549" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" "Golgi apparatus, Vesicles" "HPA028311: AB_2672554, HPA063549: " "unprognostic (3.99e-1)" "unprognostic (6.04e-3)" "unprognostic (2.02e-2)" "unprognostic (7.60e-3)" "unprognostic (1.99e-2)" "unprognostic (5.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.71e-1)" "unprognostic (1.32e-4)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (8.15e-4)" 10.5 8.5 6.4 15.6 6.1 0.7 5.4 6.7 6.6 9.7 6.1 11.6 6.5 10.9 4.9 17.9 7.4 9.5 17.3 5.8 7.9 2.4 2.2 10.5 6.4 8.3 8.7 3.7 2.6 4.7 0.7 2.5 7.9 13.1 8.7 0.4 9.6 14.6 106.8 2.5 7.3 54.1 9.0 6.2 9.0 9.7 7.4 1.1 4.5 73.4 1.7 12.3 2.9 8.2 8.7 7.0 11.2 19.3 19.4 30.5 6.6 41.9 81.5 28.7 19.6 1.2 24.8 23.9 13.0 121.0 43.4 5.8 1.0 0.7 16.2 12.4 0.8 26.1 22.6 18.0 16.4 33.0 12.0 46.6 2.9 31.6 1.1 86.1 9.0 17.2 19.6 26.2 24.3 4.2 32.0 8.9 5.9 11.2 9.6 34.5 36.5 12.7 32.6 14.2 18.1 1.7 57.1 17.6 21.7 22.2 16.0 10.4 14.4 113.0 19.4 69.4 18.8 11.4 21.1 30.2 39.0 10.4 98.3 5.9 7.7 6.1 6.1 9.6 8.1 6.9 6.9 6.4 9.7 5.2 6.2 7.0 0.9 9.1 9.5 12.3 7.9 12.0 6.4 6.1 6.7 6.6 5.8 7.9 8.3 8.7 7.9 9.0 7.4 8.2 10.6 9.6 9.8 15.7 15.1 22.0 14.2 14.5 8.0 50.2 20.6 7.0 1.0 20.0 14.1 9.2 39.6 9.4 20.7 8.3 5.9 11.7 11.2 12.9 25.0 13.1 7.3 16.0 12.2 5.4 9.3 17.1 0.5 16.3 22.2 12.4 22.9 19.1 5.4 74.0 13.2 8.4 8.2 17.7 23.2 14.8 41.7 7.3 33.8 7.5 11.4 20.0 34.0 15.1 11.6 7.9 7.9 64.3 5.7 16.0 10.7 10.1 6.0 53.9 19.7 16.6 12.8 32.8 36.0 7.2 22.3 5.1 15.3 9.4 12.6 9.4 SYNGR2 ENSG00000108639 "Synaptogyrin 2" O43760 17 78168581-78173527 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 434.8;monocytes: 836.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 672.3;OE19: 547.9;SK-BR-3: 630.6;T-47d: 502.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014742 Approved Approved "Golgi apparatus" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 59: Non-specific - Translation" "Cluster 2: Karpas-707 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Golgi apparatus" "HPA014742: AB_2669079" "unprognostic (2.19e-2)" "unprognostic (1.05e-3)" "unprognostic (2.84e-1)" "unprognostic (6.77e-3)" "unprognostic (9.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-3)" "unprognostic (4.98e-2)" "unprognostic (1.26e-2)" "unprognostic (1.20e-2)" "unprognostic (9.44e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (4.74e-2)" "unprognostic (5.21e-2)" "unprognostic (3.51e-2)" "unprognostic (1.78e-2)" 92.9 59.7 50.9 99.4 74.0 112.9 105.5 75.1 63.5 59.2 53.5 118.0 86.4 56.7 22.6 133.8 75.5 70.7 150.1 51.5 61.2 113.0 101.0 158.1 143.9 88.1 70.7 45.3 188.9 52.9 91.2 61.7 86.0 130.7 71.1 2.8 184.8 45.6 369.9 161.4 125.4 33.2 67.3 148.1 141.7 31.8 68.0 68.2 68.7 122.6 112.6 92.0 87.9 92.5 172.5 334.5 9.0 73.9 3.2 1.1 52.5 58.6 60.2 55.0 31.4 200.9 173.6 136.9 123.2 33.5 47.8 245.5 39.9 95.0 16.2 97.2 177.2 47.0 46.9 140.8 76.1 77.3 356.5 3.4 105.1 17.5 47.2 77.9 118.7 50.4 193.9 672.3 5.3 337.4 77.3 79.6 24.4 547.9 140.1 44.3 19.2 391.4 166.7 155.5 53.8 60.2 48.6 630.6 60.3 31.7 502.8 122.2 31.7 1.1 54.2 28.1 77.8 280.7 109.7 79.8 39.7 52.8 9.5 694.4 656.1 237.9 173.6 944.7 202.1 970.0 231.0 200.2 907.6 972.1 204.6 168.6 282.5 219.8 1139.9 530.1 314.6 837.0 50.9 74.0 75.1 63.5 51.5 61.2 88.1 70.7 86.0 67.3 68.0 92.5 56.1 128.2 113.4 3.3 226.6 124.1 136.1 170.9 79.1 3.3 126.5 84.1 63.0 68.6 153.2 171.0 6.2 169.7 63.1 125.2 9.8 313.6 3.6 41.2 9.6 83.5 72.6 70.2 2.4 434.8 59.1 27.9 104.5 89.7 103.0 25.3 56.4 46.9 255.5 5.0 1.2 327.6 193.3 137.9 330.6 4.9 22.1 150.3 74.7 16.9 836.7 5.1 24.7 2.5 31.3 286.5 160.9 17.0 159.2 282.4 77.5 36.2 63.4 3.9 39.5 26.0 46.2 13.4 12.3 120.1 163.4 179.5 58.8 11.4 212.8 216.8 SYNGR4 ENSG00000105467 "Synaptogyrin 4" O95473 19 48364367-48376377 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 54.4" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 159.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 9.8;SCLC-21H: 24.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030075, HPA059286" Enhanced Approved "Golgi apparatus" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA030075: AB_10610559, HPA059286: AB_2683965" "unprognostic (1.58e-2)" "unprognostic (3.44e-2)" "unprognostic (3.18e-2)" "unprognostic (9.49e-4)" "unprognostic (2.51e-2)" "unprognostic (7.10e-2)" "unprognostic (2.52e-3)" "unprognostic (3.72e-3)" "unprognostic (2.87e-2)" "unprognostic (6.19e-2)" "unprognostic (6.69e-2)" "unprognostic (2.41e-2)" "unprognostic (2.02e-7)" "unprognostic (1.06e-2)" "unprognostic (1.74e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" 0.0 0.0 0.4 0.0 0.4 0.1 0.0 3.0 1.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 0.4 0.5 0.0 1.0 3.9 0.3 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.0 54.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 9.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.5 3.2 0.5 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.1 3.6 0.1 0.3 0.5 0.2 0.0 0.7 1.8 0.7 0.0 2.8 0.0 0.0 24.1 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.0 0.8 0.0 0.0 3.2 1.1 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 3.0 1.0 0.8 0.6 0.4 0.5 0.4 0.4 0.4 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 32.6 0.0 0.1 0.1 9.1 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.0 24.6 0.9 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 6.6 0.0 0.0 159.5 33.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 SYT15 CHR10SYT ENSG00000204176 "Synaptotagmin 15" Q9BQS2 10 46578217-46594173 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 54.5;Alveolar cells type 2: 49.5;Endothelial cells: 20.4;Hepatic stellate cells: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-BR-3: 14.6" "HPA036971, HPA036972, HPA064559" Uncertain Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (1.64e-2)" "unprognostic (9.28e-3)" "unprognostic (1.54e-1)" "unprognostic (6.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.02e-2)" "unprognostic (1.49e-2)" "unprognostic (3.19e-4)" "unprognostic (4.03e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "unprognostic (1.15e-3)" 3.7 2.3 3.5 3.4 3.8 0.8 3.2 1.9 9.3 4.5 0.0 1.6 1.8 2.9 3.9 3.3 4.5 2.7 4.1 7.6 1.8 2.1 1.4 9.6 5.4 6.9 1.7 2.6 4.8 2.3 0.9 5.1 6.7 2.5 2.1 3.4 3.6 3.5 2.2 11.6 1.5 3.7 0.2 3.5 1.2 1.5 4.3 1.8 2.6 4.1 4.0 2.9 3.4 3.9 2.8 2.9 1.5 0.7 1.7 1.6 2.1 2.9 5.3 2.2 2.5 6.8 5.2 0.6 2.2 2.5 2.1 9.4 0.0 0.8 2.9 1.4 3.2 1.7 2.8 4.5 4.4 3.0 2.1 3.2 0.9 1.4 4.2 2.7 1.2 2.2 0.7 1.7 1.0 4.6 1.5 4.7 1.2 0.5 1.2 1.9 0.0 1.9 3.3 1.3 0.9 1.4 2.4 14.6 1.3 1.4 4.3 1.3 3.8 0.8 3.3 2.0 2.1 2.6 2.9 2.3 1.8 1.9 0.6 0.0 0.6 0.3 0.7 1.4 0.6 0.4 0.6 0.3 0.6 0.2 0.4 0.5 0.0 0.5 1.1 0.4 0.1 0.3 3.5 3.8 1.9 9.3 7.6 1.8 6.9 1.7 6.7 0.2 4.3 3.9 8.0 54.5 49.5 0.7 0.3 6.1 2.2 2.0 0.6 2.2 2.8 1.5 3.6 0.0 3.0 1.8 2.1 1.1 0.6 0.9 1.9 2.0 0.4 0.8 1.2 20.4 1.2 2.7 0.7 5.8 1.4 2.7 0.0 1.0 2.5 1.1 26.4 1.5 0.1 0.0 0.8 1.6 0.0 2.2 3.5 0.6 3.7 0.6 3.6 1.9 0.5 0.6 1.0 1.0 1.1 4.5 0.9 3.8 0.4 5.6 1.1 2.5 1.5 1.8 6.6 3.6 2.7 1.3 1.4 0.5 5.5 1.2 0.8 0.4 1.4 2.4 SYTL2 "CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2" ENSG00000137501 "Synaptotagmin like 2" Q9HCH5 11 85694224-85811159 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 74.2;stomach 1: 127.7" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 14.0;MAIT T-cell: 23.7" "Lineage enriched" "Detected in many" 5 "T-cells: 23.7" "Cell line enhanced" "Detected in many" "MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039651 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Golgi apparatus" "Plasma membrane" "HPA039651: AB_10795153" "unprognostic (8.07e-3)" "unprognostic (6.72e-3)" "prognostic favorable (2.67e-4)" "unprognostic (9.34e-4)" "unprognostic (6.60e-3)" "unprognostic (2.19e-4)" "unprognostic (2.24e-2)" "unprognostic (5.37e-2)" "unprognostic (5.56e-2)" "unprognostic (5.45e-2)" "unprognostic (1.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.85e-2)" "unprognostic (4.03e-1)" "unprognostic (1.87e-2)" "unprognostic (9.72e-2)" "prognostic favorable (9.07e-4)" 16.7 9.6 19.3 12.9 24.6 3.3 16.0 8.7 35.7 10.7 11.9 51.7 21.6 9.1 16.3 17.0 7.6 27.8 8.4 29.0 25.1 20.2 6.9 14.8 11.1 26.4 14.0 4.8 2.7 6.4 6.1 18.2 17.9 13.6 74.2 13.3 8.9 9.8 5.1 6.8 25.0 10.2 15.6 10.4 127.7 5.1 13.8 7.1 4.7 2.7 6.8 50.9 7.4 29.1 3.5 8.0 12.2 1.0 2.8 15.4 0.2 30.3 39.4 26.3 59.2 34.7 4.5 0.7 11.1 21.3 38.0 22.3 0.8 2.7 34.5 2.4 0.2 0.0 0.2 0.3 1.8 2.7 0.5 19.6 3.8 56.8 0.8 6.2 0.2 1.0 0.4 0.4 33.6 91.1 0.1 0.9 20.6 148.1 13.6 1.3 175.8 0.1 124.2 46.8 0.3 0.6 6.7 5.4 3.0 10.2 0.6 0.5 0.1 40.8 15.6 25.9 1.5 0.2 0.0 16.1 41.9 0.5 25.7 0.0 0.0 0.0 14.0 0.0 23.7 0.0 2.8 8.4 0.0 0.1 2.3 4.1 0.0 4.6 0.1 1.0 1.1 2.6 19.3 24.6 8.7 35.7 29.0 25.1 26.4 14.0 17.9 15.6 13.8 29.1 7.5 22.4 32.5 15.3 3.0 3.6 11.7 15.8 1.8 10.4 45.4 14.0 2.3 8.6 62.1 68.0 8.4 0.7 45.6 115.2 0.0 9.1 1.2 8.0 2.2 6.4 19.2 4.0 103.9 16.9 0.4 11.5 382.2 2.3 130.8 0.8 5.0 0.5 0.5 1.7 23.2 185.9 2.0 5.9 5.0 0.9 1.8 4.6 10.6 20.6 1.6 14.0 63.8 35.7 91.9 16.5 40.6 30.1 31.6 30.7 16.3 8.6 138.4 8.1 32.9 42.1 59.8 3.6 2.6 2.2 5.7 0.4 50.1 2.3 36.7 60.9 TAF11 "TAF2I, TAFII28" ENSG00000064995 "TATA-box binding protein associated factor 11" Q15544 6 34877462-34888071 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029326, HPA049127" Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Golgi apparatus" "HPA029326: AB_2672999, HPA049127: AB_2680645" "unprognostic (4.02e-2)" "unprognostic (5.36e-3)" "unprognostic (7.41e-2)" "unprognostic (5.18e-3)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (2.56e-3)" "unprognostic (1.45e-2)" "unprognostic (1.68e-3)" "prognostic favorable (5.87e-4)" "unprognostic (2.91e-1)" "unprognostic (6.77e-3)" "unprognostic (1.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.87e-2)" "unprognostic (4.92e-1)" "unprognostic (3.32e-1)" 23.2 27.9 21.3 19.5 22.4 47.1 23.0 24.8 26.5 23.9 22.0 27.8 19.3 22.6 18.4 25.8 25.1 15.5 29.5 21.4 21.0 27.5 28.5 25.5 27.1 22.0 21.7 27.9 27.2 16.7 19.8 22.6 22.0 26.2 20.6 24.8 20.9 16.9 32.6 29.0 26.5 20.7 21.1 33.8 25.1 33.4 22.3 23.7 24.4 21.6 25.4 24.9 23.1 25.6 37.2 15.4 50.2 91.4 29.5 30.8 44.5 29.5 23.1 47.2 44.8 35.9 23.0 49.5 37.8 27.3 23.1 23.4 61.5 25.1 37.7 30.3 49.6 55.7 30.7 58.8 41.3 74.9 38.6 35.8 41.2 32.2 25.2 28.8 57.6 55.0 89.0 38.1 22.6 65.6 48.1 63.4 45.9 74.3 26.0 51.6 44.9 39.7 34.4 23.0 60.6 55.3 33.9 37.9 68.6 41.5 59.4 88.6 34.6 33.3 44.6 20.1 36.9 35.2 90.5 72.4 12.2 86.3 49.9 43.6 27.8 24.5 14.3 25.8 13.8 13.8 14.9 15.4 24.1 17.1 17.4 15.6 17.5 17.6 21.7 21.5 21.4 15.9 21.3 22.4 24.8 26.5 21.4 21.0 22.0 21.7 22.0 21.1 22.3 25.6 49.9 28.9 19.5 18.3 44.9 46.0 31.4 36.1 24.5 29.0 55.1 44.3 24.0 25.8 31.3 42.3 12.5 71.9 50.4 33.5 64.6 47.9 6.6 37.4 49.7 43.8 39.5 39.5 20.8 63.2 68.9 33.5 29.6 47.7 22.2 57.8 61.1 58.8 44.2 32.0 23.7 38.4 50.8 52.2 32.2 10.6 33.8 36.5 24.9 13.1 48.5 37.8 48.4 16.6 33.6 50.8 51.2 37.2 44.0 32.9 43.5 48.9 17.1 32.9 32.9 34.0 35.5 130.9 71.2 36.3 58.4 76.8 44.3 38.2 40.6 31.2 TAF7 "TAF2F, TAFII55" ENSG00000178913 "TATA-box binding protein associated factor 7" Q15545 5 141260225-141320784 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006429 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Golgi apparatus" "HPA006429: AB_1080196" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "unprognostic (4.79e-2)" "unprognostic (4.28e-2)" "unprognostic (8.17e-2)" "unprognostic (1.15e-3)" "unprognostic (1.66e-1)" "unprognostic (5.78e-2)" "unprognostic (6.75e-2)" "unprognostic (9.43e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.88e-1)" "unprognostic (2.85e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-2)" 58.0 62.9 54.7 53.8 56.1 79.7 76.7 63.6 69.2 57.4 63.0 53.4 44.6 73.8 82.1 48.9 73.6 42.7 103.1 56.4 57.5 63.9 66.6 55.7 79.5 55.2 55.5 104.1 52.8 43.4 62.5 60.9 56.8 67.6 56.4 92.0 56.6 57.0 142.9 56.2 59.5 63.0 60.3 69.8 51.8 76.0 57.0 119.6 60.7 130.8 88.8 51.0 43.8 70.7 82.4 67.4 150.3 110.7 131.2 120.9 93.7 104.9 93.0 145.4 141.4 95.3 90.2 220.1 204.6 107.3 157.5 68.7 95.9 97.4 146.0 96.8 106.6 39.8 80.1 79.8 119.4 55.2 80.2 111.1 141.9 56.8 99.9 114.6 106.5 98.7 85.8 167.3 141.7 103.3 124.7 133.1 54.4 103.7 24.4 156.7 200.7 162.4 107.5 109.0 120.0 137.1 85.6 121.7 118.1 114.5 174.1 178.2 98.5 20.5 69.9 67.6 129.2 45.0 195.3 198.9 89.3 126.8 83.6 183.7 35.9 161.5 53.1 44.5 69.1 58.2 62.6 60.2 50.2 54.7 84.9 72.3 104.2 89.1 55.2 55.5 57.7 70.6 54.7 56.1 63.6 69.2 56.4 57.5 55.2 55.5 56.8 60.3 57.0 70.7 142.3 86.6 68.7 0.0 146.0 120.4 353.0 96.4 67.7 132.7 78.9 72.8 168.4 77.2 92.8 82.8 95.9 94.8 147.4 123.7 82.2 113.7 50.8 92.9 115.7 112.6 84.2 52.6 0.0 76.0 73.3 127.3 70.3 90.8 155.1 70.0 96.0 70.9 51.0 121.1 0.0 110.2 69.2 52.5 92.3 36.8 146.9 86.3 112.1 0.0 94.6 141.4 132.8 0.0 0.0 123.7 150.4 129.1 68.0 243.3 120.0 77.3 107.2 101.4 164.3 175.2 135.8 124.7 141.1 75.7 170.5 141.3 161.5 111.9 106.8 245.9 TANGO6 "FLJ12688, KIAA1746, TMCO7" ENSG00000103047 "Transport and golgi organization 6 homolog" Q9C0B7 16 68843531-69085182 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 110.2;Excitatory neurons: 45.4;Inhibitory neurons: 57.4;Late spermatids: 50.5;Oligodendrocyte precursor cells: 38.7;Oligodendrocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041312 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" Cytosol "HPA041312: AB_10796342" "unprognostic (8.55e-2)" "unprognostic (6.64e-2)" "unprognostic (4.66e-2)" "unprognostic (1.94e-2)" "unprognostic (3.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.50e-1)" "unprognostic (1.86e-1)" "unprognostic (2.22e-1)" "unprognostic (9.82e-3)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.20e-4)" "unprognostic (1.55e-2)" "unprognostic (1.73e-1)" "unprognostic (1.45e-3)" "unprognostic (6.02e-2)" 5.1 3.0 2.8 4.5 3.8 3.4 4.6 3.5 3.4 4.8 4.9 3.9 2.4 4.3 1.9 3.6 3.8 2.8 3.2 2.6 3.6 5.7 12.9 3.6 4.9 2.7 3.1 4.2 3.2 6.0 2.5 3.4 2.8 4.0 3.1 4.2 3.2 4.2 8.8 4.2 3.1 4.8 2.4 4.5 4.1 4.3 3.5 4.7 3.3 5.7 4.6 5.5 4.2 3.9 7.1 14.3 4.6 9.9 7.6 8.6 3.3 9.5 7.7 11.5 9.3 9.1 5.7 15.8 5.1 13.2 6.0 5.8 10.6 12.8 14.0 3.8 6.3 3.0 5.4 8.5 6.3 8.0 7.2 6.6 6.7 16.3 14.7 4.7 11.2 7.6 10.6 2.7 10.7 7.1 8.3 6.4 10.2 6.9 7.6 8.9 6.8 17.8 8.4 3.9 4.8 5.6 23.3 1.3 6.3 5.5 4.6 8.9 6.5 10.9 3.9 11.2 6.8 4.9 4.5 10.7 6.9 3.0 7.4 0.0 3.8 2.0 3.4 6.6 3.5 2.7 3.3 3.5 4.8 2.4 2.0 3.3 0.2 2.0 6.2 1.3 4.9 3.1 2.8 3.8 3.5 3.4 2.6 3.6 2.7 3.1 2.8 2.4 3.5 3.9 5.1 0.0 4.2 23.5 5.4 5.2 9.5 5.0 2.8 8.8 1.5 1.8 3.8 5.7 2.2 7.3 10.4 5.6 3.1 2.1 0.0 2.2 110.2 1.5 3.5 4.8 0.0 7.8 45.4 3.3 2.7 4.0 6.1 3.0 1.3 3.7 3.9 12.3 4.7 5.0 57.4 1.8 4.1 7.6 3.5 50.5 5.6 4.2 5.4 25.3 3.5 3.3 4.1 38.7 51.3 2.7 4.4 3.4 2.9 3.7 1.1 6.0 0.5 10.5 0.0 3.9 3.4 5.7 4.7 4.0 3.0 2.5 7.0 3.2 2.2 9.2 TATDN3 ENSG00000203705 "TatD DNase domain containing 3" Q17R31 1 212791828-212816830 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032092 Approved Approved "Nucleoplasm,Golgi apparatus,Focal adhesion sites" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Golgi apparatus, Focal adhesion sites" "HPA032092: AB_10671086" "unprognostic (9.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.80e-1)" "unprognostic (3.88e-2)" "unprognostic (3.34e-3)" "unprognostic (5.02e-3)" "prognostic favorable (1.59e-4)" "unprognostic (1.93e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-3)" "unprognostic (2.96e-3)" 13.0 11.3 10.1 10.4 12.4 12.2 10.0 10.1 12.7 6.5 9.3 8.3 6.1 7.1 13.3 7.3 7.7 7.4 19.3 10.6 12.4 16.6 10.3 8.0 12.2 12.2 10.5 8.6 9.4 18.2 8.2 7.3 12.4 6.9 7.7 17.7 8.5 6.9 29.9 6.3 7.2 7.7 10.5 11.1 11.1 10.0 10.4 11.2 11.7 24.1 10.3 8.2 5.5 15.8 12.2 11.9 10.3 15.1 16.7 26.0 23.5 12.9 14.3 10.8 13.1 3.1 17.2 27.4 12.3 12.4 6.0 7.6 13.0 18.2 11.5 17.1 17.0 13.4 10.3 6.3 19.0 33.3 16.3 20.6 12.8 14.3 37.3 11.2 16.1 37.7 28.2 21.7 11.7 5.9 28.4 10.9 13.9 14.9 7.6 16.0 19.3 49.4 11.3 6.3 21.6 18.5 14.5 25.1 30.6 19.2 26.6 19.6 10.1 7.9 10.3 16.4 13.0 19.4 32.9 44.9 20.6 26.8 12.0 26.1 37.2 60.2 12.7 59.3 11.5 39.7 15.8 15.4 45.6 31.0 12.5 14.9 42.8 13.8 64.4 74.6 16.1 22.9 10.1 12.4 10.1 12.7 10.6 12.4 12.2 10.5 12.4 10.5 10.4 15.8 9.1 6.4 16.2 17.3 18.5 4.5 8.1 14.2 3.4 16.1 8.5 8.3 36.6 8.6 8.0 3.7 18.8 14.3 39.7 3.4 41.1 18.1 12.2 10.8 7.6 8.9 10.2 6.5 35.1 16.5 17.5 10.0 6.1 7.8 7.0 10.8 5.3 7.0 18.8 15.2 43.9 5.1 12.2 27.6 8.3 4.0 5.3 20.4 14.2 17.8 31.0 17.8 8.2 23.1 53.6 12.0 6.2 4.9 9.3 6.2 7.3 26.4 12.5 29.6 6.6 8.8 9.2 24.2 17.9 6.6 4.4 9.3 11.1 11.0 5.2 7.0 TBC1D14 KIAA1322 ENSG00000132405 "TBC1 domain family member 14" Q9P2M4 4 6909242-7033118 "Plasma proteins, Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 197.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036930, HPA067398" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 3: HMC-1 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" Nucleoplasm "HPA036930: AB_10670155, HPA067398: AB_2685833" "unprognostic (3.05e-2)" "unprognostic (7.48e-3)" "unprognostic (4.80e-3)" "unprognostic (8.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.78e-3)" "unprognostic (9.63e-2)" "unprognostic (5.25e-2)" "unprognostic (9.71e-2)" "unprognostic (7.65e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" "prognostic favorable (5.28e-10)" "unprognostic (1.56e-1)" "unprognostic (3.50e-1)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" 26.3 42.1 42.7 31.5 41.9 15.9 27.6 38.7 43.9 19.4 50.2 26.4 22.8 20.9 22.9 34.0 23.5 17.0 30.4 42.9 44.9 44.5 27.4 24.4 29.8 49.3 45.6 28.7 19.5 41.9 27.1 23.8 44.8 24.5 26.3 18.5 31.7 20.2 51.6 49.5 26.0 22.9 45.7 34.9 58.5 30.0 48.7 40.1 19.2 41.3 26.9 19.8 22.2 44.2 34.5 36.8 40.4 45.5 32.8 27.4 24.5 27.0 29.3 24.7 21.1 38.3 69.8 54.9 15.6 32.5 62.8 24.5 68.4 61.7 30.0 15.5 22.2 91.8 23.8 40.4 22.7 42.0 197.9 21.3 85.8 23.4 38.3 31.5 23.5 51.2 88.6 19.3 30.2 22.3 64.9 42.5 54.9 41.1 40.8 80.2 53.2 59.9 36.8 23.9 61.6 44.0 22.4 24.1 84.3 31.2 33.3 39.4 23.7 27.2 20.5 24.0 40.3 36.7 91.6 55.7 25.4 53.2 26.6 2.6 13.2 5.6 8.6 8.2 13.1 8.1 9.3 9.3 10.7 8.3 6.9 6.6 40.6 8.6 3.9 11.5 11.9 10.8 42.7 41.9 38.7 43.9 42.9 44.9 49.3 45.6 44.8 45.7 48.7 44.2 8.4 6.4 17.7 22.5 15.5 9.1 7.0 15.8 15.9 10.2 21.1 16.3 4.6 10.0 14.8 14.7 14.6 12.5 16.3 17.7 19.6 11.5 68.0 12.3 10.3 7.8 6.6 7.2 25.6 10.2 7.1 9.5 14.8 11.9 7.6 18.9 8.2 24.4 26.0 25.2 25.1 15.7 10.2 33.6 8.7 41.0 7.2 27.8 19.6 27.2 24.4 13.4 16.5 51.8 27.0 11.8 14.2 8.6 15.4 12.9 12.8 19.8 10.7 6.6 0.0 12.7 7.1 17.7 18.0 19.8 11.9 16.4 16.3 12.5 19.9 10.1 TBC1D22A C22orf4 ENSG00000054611 "TBC1 domain family member 22A" Q8WUA7 22 46762617-47175699 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 252.9;Oligodendrocytes: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001173 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA001173: AB_1080212" "unprognostic (1.62e-1)" "unprognostic (5.90e-3)" "unprognostic (1.10e-1)" "unprognostic (4.79e-3)" "unprognostic (3.65e-2)" "unprognostic (7.07e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (5.95e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.69e-1)" "unprognostic (9.17e-2)" "unprognostic (4.68e-2)" "unprognostic (4.93e-2)" "unprognostic (4.14e-1)" "unprognostic (1.09e-1)" "unprognostic (2.39e-1)" 13.4 12.3 10.5 14.4 9.9 10.4 11.8 9.0 10.5 11.8 7.9 12.5 14.9 10.5 6.8 18.1 12.1 9.3 12.9 10.4 9.2 13.3 11.0 12.7 19.4 11.3 11.5 9.8 14.7 12.0 11.2 12.0 10.7 9.3 9.5 4.9 14.1 7.8 17.9 17.6 15.0 7.6 9.8 19.1 14.8 7.3 11.0 14.7 12.3 11.3 18.4 11.0 12.3 11.4 19.1 13.0 8.1 9.9 11.6 16.1 9.9 12.8 17.2 14.3 15.3 14.8 14.5 16.6 13.9 19.5 8.9 20.7 7.0 20.0 9.9 7.2 19.6 9.5 11.1 28.6 17.7 20.9 7.4 18.9 23.0 9.8 13.6 17.2 23.7 10.4 6.2 17.4 13.1 9.8 9.3 10.7 8.0 17.9 14.6 11.8 9.5 17.9 16.7 9.7 6.6 12.3 11.8 4.5 20.1 10.0 10.5 13.7 19.5 10.9 15.3 11.5 8.2 11.5 3.9 10.5 27.0 10.6 6.9 2.5 10.7 6.3 6.4 15.5 6.0 11.6 5.9 6.1 12.5 13.0 3.9 4.3 15.5 5.5 18.6 6.1 10.2 6.6 10.5 9.9 9.0 10.5 10.4 9.2 11.3 11.5 10.7 9.8 11.0 11.4 20.3 25.6 18.3 81.0 47.0 6.4 12.1 21.1 21.6 18.6 9.9 7.9 8.6 14.3 20.2 7.3 18.8 24.4 22.7 27.9 11.7 25.8 13.9 20.1 14.2 19.0 3.6 13.5 82.0 23.5 19.6 12.2 39.3 14.5 17.1 13.3 23.2 7.9 33.1 21.9 94.2 16.2 18.3 23.0 16.7 3.5 9.9 32.7 10.6 252.9 39.4 13.7 29.9 76.9 113.2 30.2 25.2 11.7 28.8 10.5 39.4 19.8 15.0 27.3 13.1 12.3 11.8 7.9 10.5 18.5 8.0 29.0 22.7 12.7 18.4 11.8 TBC1D23 FLJ11046 ENSG00000036054 "TBC1 domain family member 23" Q9NUY8 3 100260992-100325251 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038151, HPA038152" Approved Enhanced "Golgi apparatus" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA038151: AB_10672405, HPA038152: AB_10672620" "unprognostic (9.23e-3)" "unprognostic (6.01e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (1.79e-2)" "unprognostic (6.18e-2)" "unprognostic (7.87e-3)" "unprognostic (6.16e-2)" "unprognostic (7.92e-2)" "unprognostic (2.02e-2)" "unprognostic (2.98e-3)" "unprognostic (3.66e-3)" "unprognostic (1.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.51e-1)" "unprognostic (5.64e-2)" "unprognostic (2.32e-1)" 15.1 17.4 4.8 12.7 7.0 23.0 14.8 10.8 6.7 13.5 5.0 15.1 17.9 14.3 10.2 16.2 9.3 13.9 14.3 5.9 6.4 17.1 22.7 12.6 12.5 6.6 5.4 16.2 18.2 17.9 5.1 21.6 7.1 11.7 15.5 16.8 15.2 9.9 17.2 13.5 18.4 14.1 7.0 12.5 15.2 17.1 6.7 14.4 14.1 15.3 15.5 15.6 8.2 10.9 72.9 15.0 17.4 9.8 34.4 44.3 17.5 40.4 45.7 46.6 53.6 28.6 13.3 18.3 20.6 46.9 26.0 25.5 64.5 29.4 72.4 9.0 15.1 49.9 16.6 19.3 33.9 23.2 39.1 35.9 23.7 23.3 38.1 39.0 25.2 14.1 41.0 26.8 30.1 16.3 17.9 11.4 20.3 26.2 27.8 14.8 37.9 21.6 27.3 16.3 24.8 13.5 23.4 18.4 29.8 22.7 19.6 22.0 24.1 32.9 30.9 15.5 26.9 25.6 28.1 31.8 42.1 21.2 27.4 27.8 17.8 22.7 12.2 20.5 12.4 12.0 11.7 10.7 18.7 12.7 10.3 10.9 10.2 21.8 24.8 8.2 17.4 17.4 4.8 7.0 10.8 6.7 5.9 6.4 6.6 5.4 7.1 7.0 6.7 10.9 24.0 41.7 12.6 19.6 24.5 31.5 18.6 14.8 16.5 18.6 17.9 11.7 26.1 11.5 20.5 12.9 14.6 20.1 19.1 24.8 31.3 26.8 46.8 17.5 28.4 22.5 7.2 54.1 50.9 29.5 19.3 31.9 13.7 31.7 29.8 19.0 13.9 19.0 13.9 35.3 42.4 17.5 18.3 17.1 20.2 44.2 20.5 21.9 24.9 48.7 14.0 18.7 12.3 41.7 56.4 36.1 16.9 14.3 34.5 22.3 21.1 19.9 19.3 30.2 13.1 27.6 25.9 20.8 15.2 20.4 38.8 65.8 21.1 21.8 14.3 30.2 TBC1D5 KIAA0210 ENSG00000131374 "TBC1 domain family member 5" Q92609 3 17157162-18444817 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035125, HPA035126" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "Golgi apparatus" "HPA035125: AB_2674479, HPA035126: AB_10670696" "unprognostic (1.87e-1)" "unprognostic (3.57e-1)" "unprognostic (2.86e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (4.30e-3)" "unprognostic (3.07e-2)" "unprognostic (3.31e-1)" "unprognostic (3.56e-2)" "unprognostic (6.27e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "prognostic favorable (1.75e-7)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (5.72e-2)" "unprognostic (7.07e-2)" 17.9 17.4 13.7 17.0 21.1 25.2 18.6 18.2 15.5 20.1 6.0 13.5 10.8 17.6 12.1 16.8 22.5 19.2 15.8 13.8 16.1 19.9 14.7 18.0 23.1 21.9 17.7 28.1 18.3 25.7 8.5 17.5 22.8 14.0 13.9 10.9 14.1 16.4 9.3 14.0 13.8 18.3 18.3 24.0 13.8 18.9 16.0 20.3 30.0 11.3 23.2 14.8 10.1 29.9 26.3 28.8 23.2 22.0 45.0 65.5 25.4 27.6 39.7 17.7 15.3 14.0 23.2 48.5 29.1 56.3 27.1 8.0 20.6 33.6 36.6 43.0 7.9 46.6 11.1 16.5 28.8 45.7 39.0 42.6 39.3 38.5 23.2 39.8 40.9 28.3 29.6 43.6 43.5 17.6 22.5 10.5 19.1 16.8 30.0 48.9 29.6 34.7 26.3 20.0 8.8 41.0 52.5 12.2 18.6 21.7 34.6 37.6 44.7 48.7 21.6 25.6 30.4 25.2 36.6 46.7 37.5 42.3 46.5 11.7 8.1 11.9 5.8 6.5 7.5 10.3 4.4 4.2 9.2 11.3 3.2 3.8 10.4 4.3 6.3 5.8 5.2 4.8 13.7 21.1 18.2 15.5 13.8 16.1 21.9 17.7 22.8 18.3 16.0 29.9 40.4 16.0 35.0 226.6 56.0 18.4 20.0 15.8 42.7 20.3 23.0 19.9 18.6 25.8 27.8 14.7 10.4 17.1 28.9 9.2 5.9 17.7 64.1 19.6 28.9 30.7 13.1 31.3 333.2 9.9 16.7 32.5 20.4 28.2 18.9 31.5 34.6 19.9 21.4 35.3 350.5 13.4 10.2 35.6 22.9 40.2 30.7 34.9 14.2 324.2 23.2 26.6 32.0 341.8 565.6 12.3 9.1 30.5 20.7 9.8 13.7 15.9 16.3 22.3 6.6 34.0 20.4 20.7 25.5 28.4 17.0 8.2 30.0 35.5 14.5 17.6 TCP11L1 FLJ11336 ENSG00000176148 "T-complex 11 like 1" Q9NUJ3 11 33039417-33105943 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005769 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 10: Brain - Neuronal signaling" "Cluster 20: HeLa - Mitochondria" "Cluster 3: Monocytes - Immune response regulation" Cytosol "Golgi apparatus" "HPA005769: AB_2202398" "unprognostic (5.22e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (3.73e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "unprognostic (6.99e-2)" "unprognostic (9.10e-2)" "unprognostic (1.42e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (9.50e-3)" 6.3 5.0 5.6 5.5 7.9 7.4 4.5 0.7 7.3 4.8 0.0 6.9 6.1 5.0 3.3 4.9 4.0 8.1 4.7 9.6 7.4 5.9 4.0 4.6 4.9 4.9 8.9 5.3 5.7 4.0 5.0 7.0 8.3 5.0 7.2 6.0 4.9 7.0 3.0 5.4 8.9 8.7 1.0 5.4 4.2 5.6 3.1 7.6 3.2 4.1 5.7 5.8 4.5 7.5 11.9 21.3 10.7 10.2 18.3 20.3 7.2 16.9 14.4 12.8 17.3 11.0 5.6 12.3 4.6 33.1 19.0 18.7 14.5 13.2 18.2 16.1 13.0 8.3 23.1 8.1 12.0 8.2 10.8 16.4 16.2 13.2 25.0 14.6 12.8 17.4 5.2 14.3 32.4 17.6 8.1 3.2 8.0 8.8 8.2 9.4 22.4 2.2 11.6 4.6 9.1 18.3 43.3 27.5 7.9 13.5 7.0 3.4 20.0 22.7 32.5 25.7 18.1 17.5 19.7 13.9 16.5 4.0 18.1 18.6 6.1 8.8 3.4 3.9 3.4 2.1 1.8 3.8 5.9 2.8 1.8 2.4 3.6 4.8 1.1 11.1 5.9 3.5 5.6 7.9 0.7 7.3 9.6 7.4 4.9 8.9 8.3 1.0 3.1 7.5 4.9 9.6 1.1 12.7 5.0 2.3 10.7 4.2 12.0 5.6 1.7 2.0 3.1 2.8 1.8 0.0 4.2 3.8 4.6 3.5 1.9 4.6 11.6 1.8 4.4 4.5 1.8 2.1 22.5 4.0 19.2 6.3 3.1 2.3 4.5 2.4 4.2 1.6 6.8 8.4 23.7 1.2 2.0 5.7 5.2 6.3 1.8 6.9 0.0 18.7 20.2 1.6 8.2 23.1 29.6 5.7 1.6 2.6 11.6 8.9 13.3 5.0 0.7 5.7 0.0 7.0 6.4 10.4 5.4 6.1 2.6 4.7 6.7 2.8 1.4 3.9 TCTN2 "C12orf38, FLJ12975, JBTS24, MKS8, TECT2" ENSG00000168778 "Tectonic family member 2" Q96GX1 12 123671110-123708399 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 27.6;Respiratory ciliated cells: 32.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039900 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus, Vesicles" "HPA039900: AB_10673366" "unprognostic (3.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-2)" "unprognostic (1.63e-3)" "unprognostic (1.32e-1)" "unprognostic (3.09e-3)" "unprognostic (3.14e-2)" "unprognostic (7.05e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-3)" "unprognostic (2.23e-1)" "unprognostic (1.69e-1)" "unprognostic (2.79e-1)" "unprognostic (2.46e-1)" "unprognostic (7.86e-2)" "unprognostic (2.68e-1)" 5.3 4.4 5.5 2.6 6.4 1.9 7.2 5.8 5.3 10.0 30.4 5.7 2.1 11.0 11.0 3.4 28.5 6.4 4.8 4.9 9.5 10.0 1.4 8.3 3.3 8.4 11.5 14.7 6.9 14.1 16.3 4.6 6.5 9.6 4.0 17.6 9.1 8.6 1.7 8.3 3.8 6.0 7.1 4.1 5.4 11.1 8.7 2.5 12.4 2.1 3.0 5.2 6.7 4.1 14.9 15.1 10.7 15.6 15.0 16.5 13.1 5.4 10.9 11.5 8.7 7.9 14.5 0.5 9.2 8.9 10.0 19.6 6.2 4.9 11.2 2.5 7.6 1.2 10.6 7.2 5.0 3.7 4.8 8.0 8.8 16.3 4.8 34.9 15.7 5.1 7.1 0.3 7.1 7.9 4.5 7.4 6.8 5.9 9.1 4.0 10.8 1.5 13.7 11.1 6.5 8.3 18.2 6.0 8.4 11.0 25.5 5.6 9.8 16.0 8.2 14.7 7.1 4.3 8.9 1.4 20.9 0.4 9.7 1.7 0.2 1.2 1.9 0.6 2.7 1.9 2.2 2.0 0.4 2.1 2.4 2.4 0.3 0.8 0.5 2.5 1.4 0.2 5.5 6.4 5.8 5.3 4.9 9.5 8.4 11.5 6.5 7.1 8.7 4.1 2.7 3.2 5.3 6.5 1.8 4.1 2.3 2.6 1.2 4.4 4.8 2.3 3.8 5.7 3.9 7.3 12.5 2.8 2.1 1.2 0.0 2.9 6.1 27.6 5.0 1.7 1.2 2.5 10.4 2.1 3.0 4.6 2.6 4.3 3.8 5.0 2.9 0.4 1.3 0.0 14.4 1.8 2.0 0.3 1.2 2.8 2.5 1.0 5.4 2.8 1.4 4.6 1.0 2.5 1.3 2.0 0.8 4.9 1.1 1.4 0.2 1.9 32.1 14.5 0.0 6.0 2.7 11.5 10.9 0.6 2.3 1.1 2.4 2.3 3.0 1.0 TDRD3 FLJ21007 ENSG00000083544 "Tudor domain containing 3" Q9H7E2 13 60396457-60573878 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 169.1;granulocytes: 152.3;Inhibitory neurons: 128.9;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 168.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034925, HPA067153" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 80: Striated muscle - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Golgi apparatus, Cytosol" "CAB034925: AB_2240523, HPA067153: AB_2732759" "unprognostic (8.52e-2)" "unprognostic (3.19e-1)" "unprognostic (2.23e-1)" "prognostic favorable (2.77e-4)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (7.37e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (6.18e-3)" "unprognostic (9.62e-2)" "unprognostic (9.95e-2)" "unprognostic (3.68e-2)" "unprognostic (4.40e-2)" "unprognostic (1.27e-3)" 8.8 8.2 14.2 6.8 18.7 5.8 12.0 18.2 16.4 10.6 12.7 9.9 9.5 10.8 9.9 10.4 9.8 9.2 10.7 11.8 16.0 11.4 9.4 12.5 9.1 17.1 15.5 14.0 14.1 10.9 7.7 6.0 16.6 8.0 11.1 10.9 9.3 7.4 16.7 11.3 8.7 9.2 16.0 8.7 11.2 12.3 17.9 11.9 12.0 18.5 9.2 8.1 7.7 21.2 6.7 7.3 15.3 36.7 5.9 13.3 9.5 7.6 8.4 8.7 5.6 4.9 10.9 16.0 3.0 11.1 7.4 8.9 12.6 11.0 9.4 12.5 10.1 30.4 13.7 9.4 12.0 21.3 15.4 8.9 15.4 5.1 15.1 17.9 12.0 13.3 6.7 9.7 9.5 7.4 19.5 11.4 11.7 24.4 5.5 10.1 7.5 11.0 12.0 8.8 13.8 16.4 10.9 13.2 27.9 10.9 6.8 9.3 10.2 5.4 5.6 6.1 8.5 18.8 17.7 13.7 5.0 11.0 16.7 0.3 1.4 1.6 3.2 2.2 2.3 2.2 3.7 3.7 2.1 1.4 3.0 3.8 0.1 2.1 1.7 4.6 4.5 1.3 14.2 18.7 18.2 16.4 11.8 16.0 17.1 15.5 16.6 16.0 17.9 21.2 24.5 22.4 30.0 169.1 13.8 7.9 9.6 9.3 14.8 30.9 10.8 10.2 44.4 11.5 18.2 11.0 54.2 8.8 18.7 11.5 21.5 13.4 20.9 18.8 24.4 15.9 17.4 7.2 101.1 17.8 10.6 18.5 18.3 15.7 152.3 26.1 11.7 8.8 6.9 20.2 128.9 12.8 12.2 9.5 7.8 24.4 19.0 22.2 19.6 69.3 12.2 12.7 20.6 142.7 168.7 10.6 19.2 18.4 14.6 7.1 12.4 12.3 22.8 30.6 6.6 32.9 12.9 38.9 21.6 14.1 6.7 6.7 20.9 30.6 14.0 8.0 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 66.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 6: Brain - Smell perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: AB_2676320, HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 1.6 5.2 4.9 5.5 6.8 4.7 4.1 7.8 4.3 0.5 5.5 5.1 3.8 1.0 6.8 4.6 1.8 4.3 5.8 3.0 4.0 5.4 4.9 5.4 7.0 3.5 2.5 3.0 1.0 5.3 1.6 4.2 4.2 1.6 0.5 4.3 2.3 2.3 8.2 5.4 1.0 3.1 6.8 5.9 4.9 3.6 4.5 5.7 0.5 3.1 3.9 4.5 5.3 17.2 38.9 9.2 13.5 0.8 1.5 24.5 13.4 5.0 15.9 14.7 14.0 31.2 25.6 27.2 2.2 6.2 43.5 3.2 14.0 3.0 29.0 16.0 6.5 22.8 13.3 0.6 12.9 17.9 0.3 4.6 10.6 3.5 2.0 6.4 23.2 10.5 31.2 2.5 66.7 26.9 29.6 11.9 14.6 41.8 21.9 13.8 17.9 4.5 14.3 25.7 15.5 13.7 15.8 9.8 2.0 26.0 12.6 7.8 10.9 18.4 33.4 22.4 17.8 8.2 15.7 13.9 14.8 18.0 0.0 0.5 0.6 0.5 0.9 0.4 0.1 0.8 1.4 0.7 0.3 0.6 0.1 0.1 0.0 0.8 2.4 0.6 0.2 5.2 5.5 4.1 7.8 5.8 3.0 7.0 3.5 4.2 3.1 3.6 5.3 4.8 3.2 2.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.9 5.3 0.0 0.0 0.6 1.8 0.0 8.0 10.1 0.0 3.9 11.6 0.0 12.0 3.0 4.0 0.0 0.0 0.0 12.7 26.6 3.4 0.0 7.2 0.0 8.1 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 11.9 0.0 0.0 0.0 0.0 14.7 0.0 0.0 4.7 0.0 0.0 2.0 3.6 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.0 4.2 2.5 0.0 0.0 TENT4A "LAK-1, PAPD7, POLK, POLS, TRF4, TRF4-1" ENSG00000112941 "Terminal nucleotidyltransferase 4A" Q5XG87 5 6713432-6757044 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 19.3;Breast glandular cells: 13.4;Breast myoepithelial cells: 13.2;dendritic cells: 12.3;Endometrial stromal cells: 15.4;Glandular and luminal cells: 14.0;Granulosa cells: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045487, HPA046742" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA045487: AB_2679346, HPA046742: AB_2679781" "unprognostic (1.45e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-3)" "unprognostic (7.57e-2)" "unprognostic (1.30e-2)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.62e-1)" "unprognostic (9.78e-2)" "unprognostic (3.10e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.99e-5)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.60e-2)" "prognostic favorable (8.55e-4)" 13.1 8.1 8.4 9.5 8.6 27.6 11.0 16.6 10.1 12.5 5.7 10.0 8.7 11.1 6.4 10.7 11.5 10.0 8.5 8.7 8.1 9.6 20.5 12.8 13.0 6.5 6.5 15.6 12.0 10.0 11.1 9.1 7.0 11.1 7.2 12.5 8.2 8.8 9.3 15.7 12.4 12.2 6.0 13.7 9.6 10.1 7.9 14.6 10.2 12.1 10.4 10.1 11.8 8.9 31.7 20.9 25.4 31.6 17.7 15.6 37.0 21.0 25.7 25.1 28.2 21.9 17.3 23.1 16.1 25.5 28.5 22.9 20.7 16.4 23.1 26.1 14.0 12.0 72.5 12.4 11.0 18.0 17.3 10.7 13.8 28.7 18.4 18.6 15.0 16.9 16.3 29.8 20.8 17.6 24.4 25.3 13.6 9.7 16.6 21.8 21.2 6.0 10.5 17.5 25.1 19.3 50.7 24.1 14.5 13.4 14.5 9.9 13.6 30.6 32.7 27.2 29.8 28.6 12.6 20.4 19.6 16.4 19.2 0.0 0.2 0.2 0.6 0.1 0.6 0.5 0.4 0.4 0.3 0.4 0.5 0.5 0.1 0.1 0.2 1.1 0.6 0.2 8.4 8.6 16.6 10.1 8.7 8.1 6.5 6.5 7.0 6.0 7.9 8.9 19.3 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 13.4 13.2 0.0 0.0 0.0 5.5 0.0 5.3 12.3 0.0 1.9 4.9 0.0 10.7 15.4 4.8 0.0 0.0 0.0 4.4 4.0 4.0 0.0 14.0 0.0 14.5 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 4.2 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 5.6 4.8 10.7 0.0 0.0 TEPSIN "C17orf56, ENTHD2, FLJ31528" ENSG00000167302 "TEPSIN adaptor related protein complex 4 accessory protein" Q96N21 17 81228277-81239091 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Cytotrophoblasts: 9.9;Syncytiotrophoblasts: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063410 Approved "Nuclear membrane,Nuclear speckles,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear membrane, Nuclear speckles, Golgi apparatus" "HPA063410: AB_2685008" "unprognostic (6.90e-3)" "unprognostic (1.03e-2)" "unprognostic (4.26e-2)" "unprognostic (3.64e-2)" "unprognostic (1.00e-1)" "prognostic favorable (9.96e-4)" "unprognostic (1.16e-2)" "unprognostic (4.85e-2)" "unprognostic (8.52e-2)" "unprognostic (2.29e-1)" "prognostic favorable (6.95e-4)" "unprognostic (4.99e-2)" "prognostic unfavorable (7.31e-8)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (3.58e-1)" "unprognostic (3.16e-3)" 11.4 12.1 8.3 7.4 8.5 13.0 11.3 8.4 12.8 12.9 9.1 14.2 10.8 11.2 4.0 13.3 11.5 4.3 10.2 8.3 8.1 16.6 17.7 12.0 11.0 9.4 8.5 9.3 15.8 3.3 11.4 5.3 8.9 15.3 4.0 1.6 12.0 3.0 10.0 14.6 19.7 4.4 8.3 28.6 15.6 13.3 9.1 10.3 16.0 3.2 5.8 13.5 11.8 8.8 9.5 14.2 5.1 8.6 3.5 5.7 10.0 8.2 4.7 8.5 7.6 9.1 6.8 6.9 4.5 5.5 8.0 11.8 5.3 7.3 3.8 4.1 18.7 5.7 8.1 13.0 5.4 6.0 12.8 3.4 9.1 3.8 4.2 5.9 13.4 9.7 6.7 6.7 5.3 8.4 11.2 15.7 5.7 7.5 11.6 6.9 7.1 7.4 3.3 6.1 6.7 8.5 9.7 11.1 11.5 9.9 9.1 11.3 8.0 11.2 6.6 8.5 8.3 9.4 6.5 5.5 8.3 5.3 5.7 2.4 1.2 4.0 0.8 1.6 0.5 1.2 0.5 0.6 1.3 1.8 0.3 0.4 2.1 0.4 1.0 1.4 0.8 0.8 8.3 8.5 8.4 12.8 8.3 8.1 9.4 8.5 8.9 8.3 9.1 8.8 8.6 9.6 5.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 6.9 7.1 0.0 0.0 1.3 1.8 0.0 9.9 8.8 0.0 0.0 4.7 0.0 3.2 5.8 3.0 0.0 0.0 0.0 5.3 7.2 2.5 0.0 6.2 6.3 8.6 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 6.0 0.0 0.0 3.3 0.0 0.0 2.3 2.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 10.5 3.9 5.1 0.0 0.0 TEX26 "C13orf26, MGC40178" ENSG00000175664 "Testis expressed 26" Q8N6G2 13 30932656-30975500 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 21.5" "Group enriched" "Detected in some" 19 "Early spermatids: 847.1;Late spermatids: 1640.3" "Cancer enriched" "Detected in single" 7 "glioma: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA079709 Approved "Golgi apparatus" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA079709: " "unprognostic (2.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (1.53e-2)" "unprognostic (9.27e-2)" 0.1 0.4 1.2 0.0 1.3 0.0 0.0 0.9 1.2 0.8 4.6 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 1.1 4.5 0.0 0.1 0.2 0.0 2.3 2.3 0.0 0.0 0.0 1.3 0.0 2.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 21.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.9 1.2 1.1 4.5 2.3 2.3 2.1 2.0 4.6 1.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 28.6 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 847.1 19.0 0.1 0.4 0.0 0.0 4.3 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.0 1.1 0.0 6.1 0.0 0.0 1640.3 8.7 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 7.9 0.0 0.0 0.0 0.0 65.4 0.0 0.0 1.1 1.1 15.5 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TFAP2D TFAP2BL1 ENSG00000008197 "Transcription factor AP-2 delta" Q7Z6R9 6 50713526-50773033 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "brain: 6.3" "Cell type enhanced" "Detected in single" "Horizontal cells: 1.7" "Cancer enriched" "Detected in single" 10 "lung cancer: 0.5" "Region enriched" "Detected in some" 5 "midbrain: 6.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Region enriched" "Detected in many" 4 "midbrain: 11.8" "Region enriched" "Detected in some" 6 "midbrain: 9.4" HPA048962 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Golgi apparatus, Vesicles" "HPA048962: AB_2680573" 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.3 0.2 0.0 0.0 6.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFR2 "HFE3, TFRC2" ENSG00000106327 "Transferrin receptor 2" Q9UP52 7 100620416-100642779 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 346.1" "Group enriched" "Detected in some" 13 "Erythroid cells: 152.8;Hepatocytes: 455.7" "Cancer enriched" "Detected in many" 70 "liver cancer: 136.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "basophil: 2.5;eosinophil: 1.9" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Group enriched" "Detected in some" 11 "HEL: 69.7;HMC-1: 92.7;K-562: 65.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016255, HPA017171, HPA073125" Enhanced Approved "Golgi apparatus" NA NA 410000 "Cluster 46: Basophils - DNA binding" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "CAB016255: AB_628395, HPA017171: , HPA073125: " "unprognostic (4.18e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" "unprognostic (4.13e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.29e-2)" "unprognostic (4.49e-2)" "unprognostic (9.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.90e-1)" "unprognostic (1.18e-9)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" 0.0 0.1 0.0 0.0 0.0 22.5 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 346.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.7 0.0 7.2 0.0 1.6 92.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 65.8 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 2.1 0.3 0.9 0.4 0.0 8.5 0.3 0.6 1.2 10.0 0.8 0.0 8.4 0.1 1.7 0.1 0.0 0.4 5.8 0.1 0.6 1.2 0.0 152.8 5.4 0.2 1.1 0.5 1.5 0.2 0.0 0.2 7.1 455.7 0.3 21.9 5.4 0.3 0.0 8.6 1.7 8.4 0.0 0.4 0.0 1.0 0.2 0.4 6.2 1.5 0.7 0.1 0.1 0.0 0.4 0.6 0.1 0.1 0.3 1.9 0.0 0.4 0.7 0.7 2.9 0.2 0.6 0.1 2.6 0.1 0.6 0.5 TGFB1 "CED, DPD1, TGFB, TGFbeta" ENSG00000105329 "Transforming growth factor beta 1" 19 41301587-41353922 "Human disease related genes, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 438.3;Extravillous trophoblasts: 452.1;Macrophages: 188.8;NK-cells: 223.5;T-cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000361, HPA073356" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 1290000 "Cluster 52: Eosinophils - Transcription" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" Cytosol "CAB000361: AB_2201910, HPA073356: " "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (3.29e-2)" "unprognostic (4.90e-2)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (8.51e-3)" "unprognostic (5.63e-3)" "unprognostic (2.47e-2)" "unprognostic (5.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.65e-3)" "unprognostic (2.79e-2)" "unprognostic (6.39e-2)" "unprognostic (4.86e-3)" 39.8 28.6 10.8 39.7 10.7 82.9 25.4 11.8 9.4 53.2 9.5 31.0 14.4 45.9 7.4 52.2 27.7 18.1 35.8 9.5 15.5 35.8 14.7 63.4 34.0 24.5 14.9 17.4 14.3 11.5 18.0 32.1 17.6 31.6 8.4 0.6 21.2 19.8 8.1 29.3 37.8 21.8 18.4 88.9 20.1 8.1 19.4 16.7 20.2 8.3 25.7 44.1 45.3 17.7 57.7 87.6 3.4 0.3 41.7 35.3 10.0 81.9 64.4 25.2 15.4 40.4 30.1 57.0 88.6 110.5 26.8 30.1 17.8 54.6 11.1 76.6 17.9 199.0 18.0 50.4 47.7 54.9 119.6 45.0 17.5 50.5 32.7 138.7 135.2 21.1 108.0 116.8 27.9 42.1 43.1 79.6 9.4 12.0 52.7 44.4 13.1 85.4 46.8 20.3 0.3 6.5 23.9 0.1 15.1 32.5 1.9 36.3 170.3 96.4 77.2 20.7 91.2 74.4 31.7 36.3 90.3 106.4 16.4 1.1 0.8 3.9 0.7 1.2 0.6 0.2 0.3 0.4 0.5 0.3 0.2 0.3 2.4 0.3 0.8 0.9 0.3 0.9 10.8 10.7 11.8 9.4 9.5 15.5 24.5 14.9 17.6 18.4 19.4 17.7 55.0 0.0 0.0 3.3 120.6 44.4 36.5 64.8 38.7 0.2 14.4 9.7 2.3 4.3 17.2 16.5 0.0 5.4 438.3 1.4 0.0 12.8 1.0 5.7 18.2 63.1 0.0 28.0 1.6 17.1 452.1 34.3 14.3 5.0 64.9 20.0 71.4 2.7 141.2 0.0 2.1 1.4 22.4 136.1 158.6 1.8 12.2 188.8 23.2 30.0 105.8 0.3 223.5 0.0 0.6 45.1 16.4 18.0 156.5 32.9 0.4 9.0 9.7 0.7 39.5 13.9 78.6 3.1 8.0 40.3 18.9 55.7 221.9 4.1 0.8 31.1 TGOLN2 "TGN38, TGN46, TGN48, TGN51, TTGN2" ENSG00000152291 "Trans-golgi network protein 2" O43493 2 85318020-85328296 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011489, HPA012609, HPA012723" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA 12000000 "Cluster 14: Monocytes - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Nucleoplasm "CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975" "unprognostic (3.03e-2)" "unprognostic (1.82e-2)" "unprognostic (2.35e-1)" "unprognostic (4.39e-2)" "unprognostic (3.90e-2)" "unprognostic (2.66e-1)" "unprognostic (5.50e-3)" "unprognostic (2.49e-1)" "unprognostic (2.98e-1)" "unprognostic (1.52e-2)" "unprognostic (5.19e-2)" "unprognostic (2.72e-2)" "unprognostic (6.30e-2)" "unprognostic (2.83e-2)" "unprognostic (3.22e-2)" "unprognostic (2.04e-2)" "unprognostic (5.37e-2)" 70.0 67.5 37.5 82.6 42.1 129.9 58.3 38.5 44.0 63.5 32.2 85.8 110.6 62.0 60.9 41.1 65.1 75.7 63.5 39.6 45.3 120.8 136.5 86.8 73.9 45.5 43.4 61.3 56.0 67.1 26.9 76.6 44.9 66.9 102.3 31.8 59.8 62.5 34.7 40.1 111.9 74.0 40.4 83.2 74.8 37.1 45.1 65.2 91.3 46.2 66.1 61.4 41.0 50.0 46.5 116.4 51.8 68.6 124.0 129.0 120.7 144.1 172.2 98.5 78.5 100.6 142.2 60.6 108.3 207.1 132.9 76.4 37.8 71.9 161.8 96.5 36.7 87.2 41.3 113.3 67.1 173.0 189.5 96.2 45.2 125.5 76.1 152.1 144.4 49.5 50.9 94.1 147.1 43.9 54.0 86.3 46.0 109.3 47.5 55.4 193.1 45.6 104.8 73.2 47.4 40.5 127.2 95.5 83.6 61.7 50.7 77.0 155.7 205.5 73.9 158.6 173.5 58.7 81.9 58.1 152.3 131.1 137.3 62.6 78.0 68.5 32.4 73.3 25.0 25.0 23.8 22.4 41.5 24.4 24.3 23.6 96.3 25.1 103.5 15.9 20.9 75.6 37.5 42.1 38.5 44.0 39.6 45.3 45.5 43.4 44.9 40.4 45.1 50.0 104.4 102.5 96.4 22.5 89.7 38.2 57.1 72.5 43.9 53.3 89.2 56.4 64.3 150.2 84.2 180.3 39.6 59.4 116.9 216.1 9.8 92.7 6.0 86.3 89.5 91.7 89.5 39.5 29.5 93.2 80.9 87.5 64.7 105.7 158.8 70.5 86.7 245.0 113.0 208.6 37.9 99.0 52.9 187.1 85.3 7.8 49.4 145.6 60.5 33.7 126.9 47.8 95.8 25.1 50.6 101.6 121.8 69.2 74.0 62.8 211.2 82.8 111.4 36.5 65.7 85.0 65.8 36.1 37.1 32.6 34.9 44.6 91.1 61.9 100.3 70.8 THAP10 ENSG00000129028 "THAP domain containing 10" Q9P2Z0 15 70881342-70892433 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 17.5;Early spermatids: 12.6;Spermatocytes: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 7 "monocytes: 4.2" "Cell line enhanced" "Detected in many" "U-2197: 40.4" "HPA041416, HPA073220" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 18: U-2197 - ECM organization" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Golgi apparatus, Cytosol" "HPA041416: AB_10795592, HPA073220: " "unprognostic (1.00e-1)" "unprognostic (3.51e-1)" "unprognostic (5.42e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-1)" "unprognostic (6.15e-2)" "unprognostic (6.25e-2)" "unprognostic (2.16e-2)" "unprognostic (2.99e-2)" "unprognostic (6.47e-2)" "unprognostic (1.55e-3)" "unprognostic (3.71e-2)" "prognostic favorable (3.05e-5)" "unprognostic (1.25e-2)" "unprognostic (2.12e-2)" "unprognostic (7.46e-2)" "unprognostic (9.44e-3)" 1.7 2.2 4.6 1.3 5.2 0.1 1.9 6.1 7.3 2.4 2.4 2.2 2.3 2.1 1.8 1.9 3.2 1.5 4.7 3.9 5.2 3.0 2.1 1.8 1.0 5.1 5.4 3.7 1.9 5.1 1.7 1.8 5.2 3.0 1.9 10.8 1.8 3.1 2.3 1.3 1.2 2.0 5.0 0.9 2.9 3.4 6.3 0.9 3.6 2.3 0.9 2.6 1.4 5.9 7.3 12.6 7.7 9.8 4.1 5.0 0.1 13.5 6.1 11.4 13.5 2.0 9.5 0.0 8.2 3.8 14.3 11.3 16.2 3.7 10.2 0.0 8.3 2.6 6.2 0.9 2.0 0.7 5.2 1.6 5.1 6.5 6.2 7.9 5.8 0.0 0.9 0.0 8.3 5.7 0.0 2.9 11.2 5.2 5.3 0.0 9.9 0.3 5.1 5.9 8.6 8.9 9.3 3.9 6.5 7.5 4.6 6.3 4.3 7.9 5.6 40.4 9.6 3.4 4.3 0.0 5.0 0.9 11.6 0.0 0.3 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.6 0.1 0.0 0.1 0.0 0.4 4.2 0.0 0.2 0.1 4.6 5.2 6.1 7.3 3.9 5.2 5.1 5.4 5.2 5.0 6.3 5.9 3.5 0.0 0.5 0.0 0.5 1.8 4.1 2.4 1.2 17.5 2.0 2.0 6.1 1.5 2.0 11.0 0.0 0.2 0.0 2.5 9.8 3.0 12.6 5.5 1.9 2.7 3.0 0.4 3.0 1.1 0.3 2.4 1.1 1.1 0.0 2.1 1.4 1.8 1.3 1.7 4.0 1.5 8.2 0.6 1.0 7.8 2.5 0.7 0.0 0.0 0.1 5.2 0.0 1.0 4.7 0.8 5.3 4.9 1.2 2.2 0.6 6.8 5.4 4.6 0.0 1.5 2.9 19.3 2.7 2.6 1.4 0.1 0.2 1.8 2.9 4.2 THAP2 DKFZP564I0422 ENSG00000173451 "THAP domain containing 2" Q9H0W7 12 71664301-71680644 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 367.4;Late spermatids: 183.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039790 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" Nucleoplasm "HPA039790: AB_10795157" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" "unprognostic (5.55e-2)" "unprognostic (2.90e-2)" "unprognostic (1.80e-2)" "unprognostic (1.51e-4)" "unprognostic (1.24e-4)" "unprognostic (7.00e-2)" "unprognostic (1.02e-1)" "unprognostic (7.20e-2)" "unprognostic (3.73e-3)" "unprognostic (6.83e-2)" "unprognostic (3.13e-2)" "unprognostic (7.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (4.80e-2)" 16.1 26.1 5.7 9.1 7.1 14.8 4.2 11.6 9.2 4.8 3.1 4.1 5.7 6.3 17.0 6.5 4.6 8.6 5.2 5.5 6.3 5.6 4.4 4.7 7.9 6.7 6.0 8.6 3.8 3.4 11.1 6.8 6.6 4.7 5.7 11.3 4.7 4.1 5.0 5.7 4.3 4.4 6.9 5.1 6.4 18.2 5.7 5.4 4.6 5.7 7.1 28.2 4.1 10.8 3.9 4.9 11.2 8.6 8.2 7.2 5.6 6.0 5.5 5.7 4.8 5.1 5.1 2.7 4.0 4.0 6.9 6.8 10.9 3.4 7.4 11.5 6.0 7.8 8.6 8.0 7.4 4.8 3.4 5.1 15.1 5.4 12.0 11.9 9.0 13.2 5.7 5.6 7.9 1.3 3.9 4.7 5.7 7.9 8.2 5.5 3.8 13.3 7.1 6.0 7.9 12.4 6.6 3.8 5.8 7.8 7.1 5.4 4.0 5.9 2.8 5.1 4.1 6.9 9.4 6.2 3.4 5.7 3.6 1.4 2.2 2.2 3.7 3.0 6.0 4.1 5.1 3.6 3.0 4.8 8.1 5.5 1.9 6.4 3.7 1.4 5.5 2.1 5.7 7.1 11.6 9.2 5.5 6.3 6.7 6.0 6.6 6.9 5.7 10.8 15.1 0.0 11.0 11.1 36.2 19.6 27.7 13.7 20.5 11.5 9.9 13.6 12.4 4.3 7.9 3.7 4.2 4.0 24.4 8.1 9.8 7.7 367.4 12.2 13.5 10.6 5.4 3.4 14.8 5.4 7.3 47.1 12.8 20.2 58.3 9.4 6.1 4.3 12.3 13.5 20.8 8.1 2.0 11.3 93.2 183.7 11.5 75.2 78.2 5.6 9.9 10.2 9.2 14.1 24.3 7.0 9.4 5.7 44.3 16.7 15.6 19.2 10.5 7.5 0.0 22.2 64.1 26.1 7.2 44.8 29.5 3.0 20.0 6.7 9.5 25.7 TIMP1 "CLGI, EPO, TIMP" ENSG00000102265 "TIMP metallopeptidase inhibitor 1" P01033 X 47582408-47586789 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 2277.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 2325.3;Hepatic stellate cells: 2681.5;Langerhans cells: 2307.7;Leydig cells: 1776.0;Macrophages: 1705.0;Peritubular cells: 1561.7;Smooth muscle cells: 2043.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 3225.4;ASC TERT1: 4323.2;fHDF/TERT166: 2762.5;HSkMC: 2960.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022360, HPA053417" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 127000000 520000000 "Cluster 7: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "CAB022360: , HPA053417: AB_2682142" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.09e-4)" "unprognostic (4.68e-2)" "unprognostic (1.81e-2)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" "unprognostic (8.24e-3)" "unprognostic (9.12e-3)" "unprognostic (9.69e-2)" "unprognostic (9.10e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (2.90e-11)" "unprognostic (1.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (2.66e-1)" 1043.9 895.8 110.6 1713.4 110.5 122.2 253.0 114.1 329.6 630.5 160.0 228.0 68.3 342.1 237.4 130.8 570.2 1220.1 995.3 113.5 119.9 469.6 458.6 1221.2 150.4 132.9 125.2 820.8 170.1 224.1 510.7 589.3 130.1 749.1 204.0 25.9 518.6 412.7 61.8 132.4 180.0 741.1 118.9 239.9 208.9 267.7 286.5 80.3 340.0 78.9 119.7 2277.2 303.3 115.6 194.7 295.9 150.4 1850.9 3225.4 4323.2 36.4 2079.0 1728.4 632.5 514.0 118.9 360.1 1.8 269.6 2762.5 355.3 187.2 82.9 896.0 394.8 387.0 193.8 204.1 191.7 174.9 2097.2 136.6 2440.9 2960.8 227.7 1951.9 410.1 743.6 292.1 0.7 315.8 142.9 1088.6 343.1 2.5 518.0 166.8 229.8 647.9 2.5 318.3 173.8 1038.8 120.4 2.5 8.6 1243.6 8.2 276.9 277.6 15.3 257.6 284.8 943.7 1012.1 1108.3 206.3 58.8 135.0 7.4 2688.9 322.6 634.2 331.9 488.4 8.3 139.4 853.2 137.8 21.9 224.6 122.9 511.4 10.1 73.0 65.4 504.5 88.4 817.9 15.0 104.0 431.4 110.6 110.5 114.1 329.6 113.5 119.9 132.9 125.2 130.1 118.9 286.5 115.6 145.9 109.0 170.1 6.2 57.5 231.2 591.5 937.3 132.6 25.4 147.8 133.2 22.5 374.6 355.5 132.4 0.0 25.2 59.3 53.6 0.0 538.6 21.6 34.7 511.9 772.1 277.2 102.7 0.4 411.3 280.1 2325.3 53.5 66.7 491.4 163.7 2681.5 345.1 329.7 0.0 0.4 73.0 297.0 741.4 2307.7 86.9 1776.0 1705.0 512.3 6.5 289.0 141.7 73.2 8.5 0.6 802.1 42.4 1561.7 257.4 741.4 1.1 12.9 109.1 8.4 690.2 304.1 2043.5 52.8 10.6 25.8 174.7 45.0 126.5 231.9 50.5 513.7 TIMP3 SFD ENSG00000100234 "TIMP metallopeptidase inhibitor 3" P35625 22 32801705-32863041 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Sensory transduction, Vision" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1663.5;Fibroblasts: 967.5;Leydig cells: 1398.6;Peritubular cells: 1934.1;Sertoli cells: 2327.1;Smooth muscle cells: 1116.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 502.6;BJ: 1173.0;BJ hTERT+: 514.7;fHDF/TERT166: 1073.7;WM-115: 893.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068391 Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 700000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "Golgi apparatus" "HPA068391: " "unprognostic (4.98e-2)" "unprognostic (1.77e-3)" "unprognostic (1.60e-1)" "unprognostic (8.53e-4)" "unprognostic (1.67e-2)" "unprognostic (1.05e-2)" "unprognostic (7.01e-2)" "unprognostic (3.22e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (1.90e-5)" "unprognostic (3.92e-1)" "unprognostic (1.95e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.66e-3)" "unprognostic (1.44e-2)" "unprognostic (2.55e-3)" "unprognostic (3.11e-2)" 805.5 288.7 71.7 41.4 74.9 1.1 556.9 68.7 72.6 376.1 221.0 190.4 30.5 393.3 230.4 168.1 373.9 153.5 532.8 64.3 79.2 248.0 92.0 625.1 69.5 83.2 86.7 116.2 81.1 139.5 139.1 999.5 76.0 178.8 81.2 31.7 178.7 341.1 128.1 170.3 122.1 379.6 70.3 187.2 152.1 64.1 106.2 41.1 340.1 325.9 28.8 197.4 261.1 59.5 19.6 0.0 16.9 2.7 502.6 280.6 1.0 1173.0 514.7 94.1 110.8 20.5 0.3 0.1 28.1 1073.7 3.6 18.3 3.2 48.4 135.0 0.1 14.3 147.4 23.5 52.4 197.4 0.1 59.7 47.4 120.4 166.9 9.5 3.4 0.0 0.0 0.1 0.9 44.6 1.2 0.4 5.0 2.5 0.0 0.8 0.1 3.4 0.4 2.1 97.0 12.5 16.8 24.1 0.5 322.9 266.6 0.7 1.3 0.0 7.9 25.2 245.9 19.1 0.2 0.4 0.4 232.3 0.2 893.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 71.7 74.9 68.7 72.6 64.3 79.2 83.2 86.7 76.0 70.3 106.2 59.5 1663.5 365.4 35.9 101.9 5.3 77.4 766.2 49.5 10.2 4.0 31.2 177.2 279.9 14.3 22.2 51.5 4.2 492.2 4.6 0.3 3.9 2.5 14.9 27.9 747.6 677.3 1.8 35.3 26.1 0.7 433.7 967.5 21.4 23.9 89.2 11.4 743.9 102.0 109.2 3.3 15.7 0.0 24.4 39.3 95.0 57.7 1398.6 28.6 76.5 116.2 0.7 146.6 0.0 52.3 0.8 0.9 0.0 1934.1 9.5 159.5 0.0 15.5 8.5 5.5 2327.1 339.2 1116.6 6.2 7.0 14.3 56.4 809.0 21.5 4.8 0.7 163.4 TJAP1 "PILT, TJP4" ENSG00000137221 "Tight junction associated protein 1" Q5JTD0 6 43477523-43506556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Oligodendrocytes: 117.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030164, HPA030165, HPA030166" Supported Enhanced "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 35: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858" "unprognostic (5.05e-3)" "unprognostic (2.82e-2)" "unprognostic (6.89e-3)" "unprognostic (1.03e-3)" "unprognostic (3.09e-2)" "unprognostic (4.50e-3)" "prognostic unfavorable (9.02e-6)" "unprognostic (4.27e-2)" "unprognostic (4.76e-2)" "unprognostic (1.43e-1)" "unprognostic (5.53e-3)" "unprognostic (1.61e-3)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (5.15e-3)" "unprognostic (7.51e-3)" 24.4 32.1 25.5 17.3 36.6 18.5 24.4 28.2 32.8 31.8 23.5 30.1 20.3 31.1 10.1 16.7 28.8 13.4 24.8 26.3 29.3 21.8 25.9 21.7 20.6 34.0 33.3 37.2 33.2 13.2 24.5 14.9 31.2 31.3 9.2 11.3 24.0 14.5 44.1 19.7 25.9 15.1 25.7 32.2 26.0 20.3 35.1 17.1 30.4 16.7 14.9 28.7 23.5 49.4 40.6 15.7 27.1 40.7 21.5 20.1 30.0 25.1 26.8 26.2 28.4 23.8 17.2 22.4 18.6 23.3 25.0 35.0 22.9 30.0 16.8 38.7 35.2 28.5 30.8 26.3 25.8 29.2 39.6 23.0 39.7 32.6 28.6 20.7 17.4 28.6 24.9 41.2 23.5 22.5 28.7 48.3 23.7 69.0 23.9 34.2 17.8 24.0 16.3 22.1 17.8 24.7 21.4 13.0 33.5 16.7 23.2 56.7 15.3 34.9 26.9 29.3 37.9 30.0 26.9 40.0 15.3 33.1 30.2 13.6 7.1 5.7 7.1 8.2 9.2 6.3 5.8 6.2 5.4 6.7 6.5 7.2 4.0 5.5 7.5 5.7 3.5 7.1 25.5 36.6 28.2 32.8 26.3 29.3 34.0 33.3 31.2 25.7 35.1 49.4 10.9 12.8 10.3 12.1 10.3 7.5 14.7 9.3 13.6 11.1 9.9 13.0 7.7 10.0 6.3 12.9 29.2 21.3 7.3 7.2 3.9 10.0 1.4 7.3 10.6 10.5 11.4 7.8 11.6 8.4 18.6 10.6 8.6 9.8 14.7 21.9 8.2 8.3 9.8 8.4 9.4 8.5 14.2 7.7 8.7 2.2 10.5 9.1 5.4 14.0 8.3 10.0 6.2 19.6 117.1 9.5 7.2 12.8 10.2 14.9 7.9 6.2 5.9 15.2 6.6 9.5 10.0 14.1 14.8 4.9 3.7 18.7 9.8 10.6 7.0 9.0 TLR4 "ARMD10, CD284, hToll, TLR-4" ENSG00000136869 "Toll like receptor 4" O00206 9 117704175-117724735 "CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Age-related macular degeneration, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 86.8" "Group enriched" "Detected in many" 33 "dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6" "Cell line enhanced" "Detected in many" "Karpas-707: 60.0;TIME: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004025, HPA049174" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 2: Karpas-707 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" "Golgi apparatus" "CAB004025: , HPA049174: AB_2680662" "unprognostic (1.60e-1)" "unprognostic (8.34e-2)" "unprognostic (7.22e-2)" "prognostic favorable (6.29e-4)" "unprognostic (3.39e-1)" "unprognostic (7.48e-2)" "unprognostic (8.68e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (5.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.63e-2)" "prognostic unfavorable (3.79e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-2)" 31.1 11.0 12.4 25.7 15.7 22.3 12.0 11.7 8.3 6.5 1.7 6.7 4.3 5.6 1.2 4.8 4.8 10.8 8.4 10.3 17.8 6.8 16.7 16.2 13.1 12.3 14.0 6.0 2.6 2.5 2.1 23.9 12.4 4.6 7.3 2.9 6.0 3.2 3.1 3.5 5.8 10.8 14.9 32.6 4.4 1.5 14.2 3.5 5.5 12.0 7.7 13.3 2.7 10.1 0.0 0.0 25.5 0.0 11.1 23.0 0.1 10.2 17.9 2.5 1.5 0.0 2.6 3.6 0.5 26.7 7.5 0.1 0.0 2.2 3.7 0.0 0.0 5.7 5.1 0.4 8.1 19.1 0.1 14.2 0.0 5.4 0.7 22.5 31.4 0.0 0.0 60.0 29.2 0.0 0.0 2.9 3.1 2.4 1.2 0.0 28.0 19.8 0.9 28.9 0.0 0.1 6.4 0.0 1.0 2.2 0.0 10.4 43.5 1.4 18.4 0.1 4.8 0.0 0.0 0.0 0.9 19.1 15.2 64.0 64.9 21.5 0.1 57.5 0.0 1.7 0.1 0.0 22.4 0.5 0.0 0.0 86.8 0.1 65.6 0.9 0.0 25.5 12.4 15.7 11.7 8.3 10.3 17.8 12.3 14.0 12.4 14.9 14.2 10.1 38.6 0.0 5.0 50.9 2.3 0.8 0.3 0.1 0.6 0.2 3.5 1.0 2.9 2.8 2.9 0.0 0.0 0.3 0.1 1.6 0.0 0.1 0.1 3.5 29.2 31.6 0.0 1.3 0.2 0.2 0.2 11.5 1.5 6.8 15.8 1.2 62.8 1.9 38.2 0.0 0.2 2.0 0.0 106.0 8.6 0.4 0.0 64.5 1.8 26.2 54.0 8.8 2.1 7.5 0.3 0.5 6.1 0.0 0.1 0.1 0.0 0.4 3.7 1.3 6.6 5.5 4.5 0.1 0.3 0.3 0.0 0.8 0.9 3.1 1.2 3.3 TLR5 "FLJ10052, MGC126430, MGC126431, SLEB1, TIL3" ENSG00000187554 "Toll like receptor 5" O60602 1 223109404-223143248 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 20.2" "Cell type enhanced" "Detected in many" "Club cells: 23.3;Glandular and luminal cells: 25.6;Kupffer cells: 29.5;Microglial cells: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "classical monocyte: 30.8;intermediate monocyte: 28.1;myeloid DC: 23.4;neutrophil: 25.3;non-classical monocyte: 12.4" "Group enriched" "Detected in many" 11 "dendritic cells: 23.4;granulocytes: 25.3;monocytes: 30.8" "Cell line enhanced" "Detected in some" "A-431: 2.1;HaCaT: 3.2;OE19: 1.8;SK-BR-3: 2.0;T-47d: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB009013 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB009013: AB_2240732" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-2)" "unprognostic (3.81e-2)" "unprognostic (3.09e-2)" "unprognostic (6.83e-2)" "unprognostic (1.49e-2)" "unprognostic (2.71e-1)" "unprognostic (4.23e-3)" "unprognostic (1.46e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.06e-3)" "unprognostic (5.60e-2)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" 3.5 1.9 2.6 4.7 2.2 0.5 8.6 2.5 2.4 6.0 2.3 2.0 1.6 2.1 2.6 4.9 5.1 4.5 1.7 2.3 2.7 4.1 1.6 6.2 4.3 3.7 3.5 20.2 4.0 4.4 0.7 3.4 3.6 3.3 2.1 0.7 10.3 2.4 1.4 2.0 2.1 2.6 3.1 2.9 4.1 1.8 3.4 2.5 1.9 1.6 5.0 4.0 2.4 5.0 2.1 0.2 0.3 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.0 3.2 0.0 0.2 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.2 0.1 0.8 0.4 0.0 0.0 0.3 0.5 0.1 1.1 1.8 0.0 0.0 0.0 0.1 0.9 0.4 0.8 0.3 0.6 2.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.3 0.2 0.0 30.8 0.4 0.2 28.1 0.4 0.2 1.5 0.4 23.4 0.1 2.3 0.7 25.3 0.4 12.4 0.3 1.2 10.9 2.6 2.2 2.5 2.4 2.3 2.7 3.7 3.5 3.6 3.1 3.4 5.0 1.0 3.2 17.0 0.0 0.2 0.5 5.8 18.9 4.6 0.1 10.6 5.3 1.7 14.3 23.3 22.0 2.1 1.5 0.3 0.4 3.9 5.9 4.6 13.6 2.0 2.1 1.2 0.0 0.5 3.8 0.3 7.7 3.1 25.6 2.5 4.6 0.7 0.7 18.1 0.0 1.0 0.6 6.1 29.5 3.1 5.7 9.3 22.4 3.6 23.4 14.4 1.4 0.0 1.5 0.1 2.4 0.1 8.6 0.1 3.0 0.5 0.1 11.0 0.2 0.0 4.2 4.1 5.4 5.5 15.9 1.6 0.8 1.7 4.1 1.5 6.3 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189149-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.27e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 28.0 35.2 7.5 10.5 7.6 3.7 25.6 7.9 7.9 29.2 18.2 23.9 12.7 31.1 31.3 25.4 27.9 17.5 21.7 7.4 7.7 25.1 34.6 26.7 7.7 8.8 9.4 24.8 46.8 36.6 20.0 18.1 8.4 23.4 15.5 5.9 35.6 21.3 19.5 24.2 21.4 18.1 8.5 19.4 29.4 20.2 8.3 8.3 30.7 11.1 12.4 23.8 23.6 8.4 22.0 45.1 17.7 18.0 59.4 40.4 22.4 37.6 55.4 53.7 60.5 19.1 49.0 12.5 25.2 50.3 30.7 50.5 14.9 29.7 39.3 18.4 15.4 9.4 21.3 56.2 41.8 18.5 22.8 41.3 56.1 36.9 50.5 42.3 32.3 7.9 11.2 30.7 43.6 51.2 12.1 15.7 8.4 62.1 39.2 15.6 22.1 24.7 42.5 37.9 16.3 18.6 39.0 44.3 24.5 16.8 28.8 14.1 26.0 47.5 21.2 23.1 28.1 31.0 25.5 7.4 18.1 11.5 39.5 33.4 20.5 25.0 14.1 18.1 15.3 15.0 14.6 12.6 23.4 16.3 13.0 12.9 28.3 23.1 18.5 39.2 17.2 13.5 7.5 7.6 7.9 7.9 7.4 7.7 8.8 9.4 8.4 8.5 8.3 8.4 5.5 16.0 5.3 8.8 11.2 3.3 6.1 7.3 18.8 4.4 6.1 5.0 1.5 7.2 7.6 1.8 14.6 9.8 5.0 4.0 0.0 8.2 13.9 5.2 7.4 8.7 1.8 5.5 6.6 4.9 10.4 14.9 13.7 6.3 2.5 5.3 5.0 4.8 4.1 0.0 7.1 3.5 6.1 2.5 4.5 6.2 5.3 5.6 1.8 4.7 5.3 5.4 4.1 9.0 7.3 5.3 6.1 4.5 54.3 7.7 3.5 3.0 30.0 7.6 6.6 10.1 7.4 7.0 5.4 19.5 4.7 11.9 9.1 5.7 4.1 3.8 TM9SF3 SMBP ENSG00000077147 "Transmembrane 9 superfamily member 3" Q9HD45 10 96518110-96587452 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039609 Approved Approved "Golgi apparatus,Vesicles" NA NA 240000 "Cluster 46: Basophils - DNA binding" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "Golgi apparatus" "HPA039609: AB_10673535" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (1.43e-2)" "unprognostic (5.11e-2)" "unprognostic (4.95e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-2)" "unprognostic (3.09e-2)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (4.14e-3)" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (8.28e-3)" "unprognostic (6.18e-2)" 57.0 53.4 28.5 54.6 33.0 36.7 58.4 33.2 34.8 65.3 34.9 111.8 116.9 62.5 69.2 57.5 46.0 89.9 39.7 27.7 34.4 68.0 75.0 43.2 42.0 33.8 31.2 62.9 73.3 70.1 22.5 67.8 35.2 91.7 94.5 43.4 83.2 56.4 26.6 38.5 112.4 50.8 35.7 41.8 183.5 34.6 30.7 44.7 87.4 41.1 44.9 72.8 34.8 43.6 146.8 97.2 106.5 149.3 151.4 112.4 127.7 197.8 146.7 84.0 67.5 116.4 281.6 107.3 107.0 175.8 105.5 135.3 97.6 108.1 156.8 121.3 83.6 95.3 81.8 92.0 114.5 197.7 107.2 105.0 108.6 118.6 203.7 253.2 94.7 96.4 97.0 119.9 132.2 66.4 77.1 76.2 68.9 237.9 59.6 94.6 134.4 84.8 120.1 106.8 49.6 110.3 104.1 98.6 103.0 126.2 171.0 73.7 165.3 103.5 87.1 104.6 183.1 123.7 152.3 98.4 140.9 134.9 73.5 5.7 2.2 3.8 3.5 2.3 4.0 2.1 3.6 3.9 2.7 1.5 2.7 3.6 2.4 3.9 2.4 7.1 4.0 1.3 28.5 33.0 33.2 34.8 27.7 34.4 33.8 31.2 35.2 35.7 30.7 43.6 115.7 51.3 43.0 43.1 53.2 116.8 118.8 63.2 51.8 57.8 103.1 73.0 65.0 121.5 88.2 141.6 56.3 77.5 89.5 238.7 21.5 80.7 27.6 93.0 162.0 99.8 123.9 68.8 59.9 146.1 97.6 98.7 212.0 192.2 40.6 75.0 78.9 126.9 60.0 58.9 64.0 368.3 69.2 85.6 125.3 12.8 93.2 73.5 103.2 49.6 56.8 58.1 54.6 69.9 79.2 132.1 140.6 82.4 88.9 196.1 141.5 59.3 65.9 54.7 65.7 89.2 121.0 45.8 38.4 73.2 120.6 140.9 63.0 74.5 246.7 156.2 TMBIM4 "CGI-119, GAAP, LFG4, S1R, ZPRO" ENSG00000155957 "Transmembrane BAX inhibitor motif containing 4" Q9HC24 12 66135846-66170072 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA077642 Supported "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA077642: AB_2686849" "unprognostic (5.41e-2)" "unprognostic (1.27e-1)" "unprognostic (3.19e-1)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (5.62e-2)" "unprognostic (7.18e-3)" "unprognostic (8.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.33e-2)" "unprognostic (3.36e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.68e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-3)" 79.7 88.6 28.0 75.3 34.3 61.5 81.4 34.0 29.7 67.3 47.6 90.5 59.5 61.0 68.6 62.6 65.8 70.1 70.8 27.1 35.6 94.0 109.6 76.7 74.5 38.5 32.1 56.7 103.5 104.7 40.1 74.2 39.1 72.8 70.2 39.7 89.3 73.7 46.7 52.2 69.8 58.5 34.7 74.4 93.3 85.1 31.0 63.1 97.9 61.5 56.0 80.0 42.9 41.5 49.1 62.4 39.7 72.8 131.4 122.7 41.9 74.4 129.1 56.7 45.8 32.8 78.7 45.6 86.3 105.2 42.6 78.9 20.1 65.7 36.6 74.5 27.3 87.7 30.0 38.6 66.6 106.9 109.2 86.9 92.8 27.7 31.1 79.0 87.2 51.8 65.9 160.3 94.3 79.5 41.1 37.5 47.4 76.1 63.3 21.5 26.5 50.8 126.8 80.3 20.1 47.6 84.5 154.5 102.3 34.2 146.3 146.7 106.0 69.1 25.9 50.5 44.8 82.7 48.5 32.2 94.8 103.7 84.1 420.7 372.7 371.6 136.0 381.4 137.9 205.9 139.7 139.4 256.2 196.6 157.9 139.1 662.3 135.3 434.3 171.7 159.8 483.9 28.0 34.3 34.0 29.7 27.1 35.6 38.5 32.1 39.1 34.7 31.0 41.5 232.8 150.6 147.2 34.0 131.3 0.0 64.1 0.0 84.2 47.8 202.2 152.1 37.0 0.0 66.2 244.6 45.9 137.0 128.2 191.4 103.7 213.8 330.6 116.2 96.4 114.5 74.7 32.0 15.8 338.1 116.9 140.7 85.1 105.8 179.0 72.7 0.0 0.0 210.7 45.4 25.2 172.4 0.0 0.0 0.0 143.8 104.4 193.2 0.0 62.8 205.5 114.1 123.6 42.7 77.0 202.9 176.9 91.0 126.8 87.9 128.9 214.5 99.1 65.9 59.2 67.8 75.7 391.0 40.8 112.5 0.0 130.8 99.3 142.7 182.2 62.8 TMC8 "EVER2, EVIN2" ENSG00000167895 "Transmembrane channel like 8" Q8IU68 17 78130770-78142968 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0" "Cell type enhanced" "Detected in many" "B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047387, HPA054429" Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA047387: , HPA054429: AB_2682485" "unprognostic (8.54e-3)" "prognostic favorable (8.45e-6)" "unprognostic (1.32e-1)" "unprognostic (2.33e-3)" "unprognostic (3.59e-1)" "prognostic favorable (4.19e-5)" "unprognostic (6.38e-3)" "unprognostic (6.47e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-1)" "unprognostic (6.06e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.24e-2)" "unprognostic (1.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" 7.8 3.0 3.6 56.0 4.4 91.8 3.7 3.7 5.1 3.7 3.5 8.2 10.3 2.5 0.7 4.8 4.0 7.4 2.7 3.6 4.8 5.2 7.1 18.4 100.5 5.8 4.7 1.3 2.0 0.5 2.2 3.9 5.6 4.9 4.5 0.1 5.8 1.3 1.8 3.6 54.6 2.4 5.0 117.0 10.4 1.2 7.8 60.1 6.4 0.9 46.7 6.4 5.0 7.2 0.5 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.3 46.3 2.0 0.0 0.1 3.4 0.0 0.1 0.0 0.0 0.1 16.4 0.1 0.8 0.0 63.0 119.9 0.0 0.0 0.0 0.0 0.0 0.0 22.1 4.0 103.9 0.0 1.3 20.9 2.8 0.2 3.5 0.5 1.4 0.3 66.6 0.0 0.2 0.0 0.1 0.0 2.2 0.6 0.1 6.9 12.7 0.1 0.0 0.1 0.1 0.0 49.3 2.0 4.6 0.1 51.9 0.1 2.6 2.0 6.6 13.4 3.4 9.7 5.5 10.8 13.3 2.3 4.8 9.4 8.6 3.3 7.5 7.9 2.1 6.5 5.5 3.6 4.4 3.7 5.1 3.6 4.8 5.8 4.7 5.6 5.0 7.8 7.2 3.6 3.2 10.2 1.0 44.9 5.4 10.4 4.9 4.6 0.2 1.2 1.5 1.9 1.5 6.5 0.0 0.0 0.4 52.3 3.7 0.0 1.0 0.7 1.0 0.6 3.2 1.2 17.1 0.4 1.3 1.4 2.3 2.0 1.8 41.2 0.1 5.7 0.5 30.5 0.0 0.4 1.4 14.2 28.2 44.6 0.5 0.0 22.0 7.2 24.4 30.2 0.2 85.5 1.0 2.7 0.6 3.6 0.4 20.2 2.9 0.9 0.4 2.1 0.2 0.0 0.3 2.0 0.4 0.6 8.4 4.5 0.5 68.6 2.7 7.0 10.7 TMED10 "p23, P24(DELTA), p24d1, p24delta1, TMP21" ENSG00000170348 "Transmembrane p24 trafficking protein 10" P49755 14 75131469-75176612 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034442, CAB037251, HPA047139, HPA050539" Enhanced Supported "Golgi apparatus" NA NA 220000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163" "unprognostic (2.00e-1)" "unprognostic (1.73e-2)" "unprognostic (2.02e-1)" "unprognostic (2.51e-3)" "unprognostic (4.06e-1)" "unprognostic (1.17e-3)" "unprognostic (5.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (1.01e-2)" "unprognostic (1.27e-2)" "unprognostic (1.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.06e-2)" 68.0 70.3 51.8 55.2 55.8 18.0 93.2 52.6 60.7 137.9 61.2 77.0 62.3 92.6 133.1 59.9 100.6 69.2 82.3 49.5 66.1 62.7 126.9 68.0 61.0 65.8 54.3 99.7 131.9 91.4 53.6 76.3 63.2 91.0 82.3 48.8 130.7 85.9 73.7 56.0 58.8 78.9 57.5 54.6 78.3 40.0 58.2 73.7 146.0 61.0 65.9 66.9 59.7 69.6 93.3 52.2 85.5 142.5 197.5 183.7 110.9 96.5 159.5 99.5 111.2 51.8 161.2 82.5 80.6 167.5 56.8 90.8 80.4 140.6 160.5 43.7 36.2 50.5 31.1 79.2 167.1 101.7 50.2 135.1 221.5 77.0 220.1 196.0 176.9 91.7 44.6 177.8 145.0 104.6 71.0 80.7 51.9 145.2 55.8 70.6 55.3 116.6 119.7 94.8 82.9 87.1 89.0 147.0 175.9 81.0 138.3 163.3 122.3 97.0 62.9 65.9 50.7 98.9 99.3 91.3 177.0 88.3 95.8 107.4 46.4 28.9 60.8 39.4 93.8 39.7 58.7 59.3 62.9 30.3 51.9 55.9 20.4 101.8 42.6 70.9 38.2 91.4 51.8 55.8 52.6 60.7 49.5 66.1 65.8 54.3 63.2 57.5 58.2 69.6 80.8 64.1 106.3 32.0 141.8 114.2 180.4 488.1 107.0 55.6 182.5 130.6 155.3 187.3 279.9 200.5 27.1 181.0 186.7 186.2 62.6 319.1 14.5 147.7 177.5 107.3 140.7 75.5 26.9 385.7 609.9 164.4 145.8 172.0 100.1 170.9 123.1 339.7 255.0 77.4 30.0 276.2 272.6 159.4 166.3 31.5 179.3 151.6 297.1 38.4 129.5 137.9 130.7 50.8 84.2 225.8 148.9 209.9 538.8 218.7 120.3 138.9 304.8 63.1 78.9 112.7 132.2 317.7 116.5 151.7 135.1 309.2 122.1 145.8 161.9 207.7 TMED3 "C15orf22, p24B, p24g4, p24gamma4" ENSG00000166557 "Transmembrane p24 trafficking protein 3" Q9Y3Q3 15 79311112-79427432 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 409.4" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049314, HPA076949" Enhanced Supported "Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA049314: AB_2680708, HPA076949: AB_2686820" "prognostic unfavorable (7.71e-4)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (8.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.03e-3)" "unprognostic (2.42e-2)" "unprognostic (2.49e-1)" "unprognostic (4.85e-1)" "unprognostic (9.06e-2)" "unprognostic (8.09e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.16e-1)" "unprognostic (2.88e-1)" "unprognostic (2.50e-1)" "unprognostic (1.52e-1)" 25.9 26.2 19.6 23.1 19.2 37.0 66.4 21.5 20.5 56.6 30.6 49.9 25.4 38.3 138.7 132.3 38.7 37.8 41.9 20.8 31.9 34.7 12.4 30.9 26.0 22.4 22.0 30.9 246.7 54.9 89.6 42.4 26.5 60.0 55.4 11.3 409.4 54.6 4.6 106.8 26.6 37.3 21.6 32.4 73.1 35.0 22.6 23.1 76.3 7.2 37.8 48.7 75.1 25.1 68.1 169.0 31.9 63.6 220.3 167.5 69.0 153.0 206.7 103.3 126.9 141.4 123.3 31.5 117.3 236.0 135.9 124.5 95.7 98.5 53.0 62.7 145.6 104.5 143.0 110.3 131.5 112.2 200.4 126.5 144.4 59.6 86.9 123.5 120.8 105.9 47.1 0.6 101.4 144.3 32.1 106.0 45.7 251.6 92.2 39.1 47.4 158.9 94.2 51.4 99.4 48.8 80.6 162.1 159.3 103.5 141.5 81.7 98.5 85.2 75.7 2.2 111.4 61.7 78.8 44.1 109.8 180.7 103.1 74.9 69.8 95.1 58.1 85.3 62.7 75.5 57.2 63.9 106.7 63.6 71.4 69.1 6.0 61.4 95.7 109.1 73.1 92.2 19.6 19.2 21.5 20.5 20.8 31.9 22.4 22.0 26.5 21.6 22.6 25.1 9.9 28.9 43.6 6.8 41.2 95.8 109.4 125.6 64.9 14.9 153.8 132.8 16.9 55.8 108.5 57.0 8.4 167.8 40.7 67.7 23.5 143.4 48.9 31.6 39.6 31.7 83.9 33.7 10.0 250.5 294.5 68.1 54.6 70.4 47.0 44.0 65.7 6.4 100.5 13.5 10.2 219.3 87.5 52.7 54.4 118.6 49.7 49.2 85.4 9.4 60.0 38.0 44.3 17.1 12.9 173.3 79.9 27.4 71.1 165.2 43.9 28.9 37.7 17.0 19.7 25.6 57.0 51.1 60.3 104.7 121.8 172.4 30.4 64.6 126.4 200.1 TMEM104 "FLJ00021, FLJ20255" ENSG00000109066 "Transmembrane protein 104" Q8NE00 17 74776499-74839753 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044330 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Golgi apparatus" "HPA044330: AB_10960543" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (5.95e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (7.46e-2)" "unprognostic (2.86e-2)" "unprognostic (4.75e-1)" "prognostic favorable (1.97e-5)" "unprognostic (8.14e-2)" "unprognostic (6.17e-2)" "unprognostic (8.46e-2)" "unprognostic (7.95e-2)" "unprognostic (2.82e-3)" "unprognostic (1.00e-2)" 6.5 10.7 7.0 5.6 9.1 8.4 5.3 9.2 7.9 3.9 5.6 5.0 3.5 4.7 3.8 6.6 4.2 3.4 7.2 6.5 6.8 7.7 14.9 7.8 4.5 10.4 9.3 3.8 8.1 8.1 9.9 5.0 9.8 5.5 2.9 2.0 7.5 3.8 5.4 5.2 5.3 4.2 8.2 7.0 6.1 8.4 9.3 4.2 7.8 3.8 4.4 5.1 4.2 10.8 10.8 26.0 13.4 15.4 18.9 11.7 8.1 18.2 18.1 22.8 25.1 21.1 11.2 5.6 5.8 20.9 23.4 12.0 13.8 10.2 12.0 4.2 19.5 14.1 10.5 15.0 13.8 23.5 12.6 9.3 10.9 23.1 5.0 6.8 16.5 13.6 8.4 8.5 15.6 10.3 14.1 9.3 7.5 14.2 20.6 8.7 21.3 9.4 9.9 9.3 11.4 15.1 10.1 12.9 13.6 10.0 16.5 35.8 13.2 48.0 12.1 18.4 24.0 5.9 5.5 6.5 18.5 24.0 18.6 1.4 5.0 3.7 4.7 4.1 2.4 3.3 4.5 4.4 5.3 0.8 3.7 2.6 2.1 2.8 4.6 5.5 5.0 3.6 7.0 9.1 9.2 7.9 6.5 6.8 10.4 9.3 9.8 8.2 9.3 10.8 2.3 6.4 5.8 7.8 2.2 2.5 1.1 3.4 0.6 2.7 5.6 3.3 49.5 8.6 4.6 5.5 2.1 4.1 5.2 6.0 0.0 5.0 3.0 3.3 2.7 4.8 8.3 1.7 5.6 5.6 4.3 4.6 5.6 6.4 1.3 3.2 2.9 14.2 13.3 0.0 4.4 4.7 4.1 7.3 3.8 3.5 2.8 9.5 0.0 4.7 4.7 4.1 3.1 4.0 11.1 6.2 3.4 2.2 8.2 2.5 3.4 1.9 2.0 3.1 0.0 3.3 4.2 4.4 3.8 2.8 2.3 3.8 4.3 2.5 3.6 1.6 TMEM115 PL6 ENSG00000126062 "Transmembrane protein 115" Q12893 3 50354750-50359521 "Plasma proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006319, HPA015497" Supported Supported "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "CAB006319: AB_425880, HPA015497: AB_1858076" "unprognostic (1.62e-2)" "unprognostic (2.37e-1)" "unprognostic (1.59e-2)" "unprognostic (1.65e-3)" "unprognostic (2.32e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.00e-2)" "unprognostic (6.00e-2)" "unprognostic (2.05e-2)" "unprognostic (1.75e-3)" "unprognostic (2.65e-2)" "prognostic favorable (1.04e-7)" "unprognostic (4.88e-3)" "unprognostic (3.00e-1)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" 29.4 34.3 23.5 12.0 24.4 11.7 28.6 24.6 26.5 25.2 26.9 29.5 23.4 33.3 17.6 27.2 26.3 15.6 31.9 23.3 23.1 28.9 32.3 26.6 11.3 25.7 24.1 25.4 29.9 32.0 20.3 22.8 24.7 30.7 12.8 6.7 29.1 20.6 27.1 42.6 27.1 17.0 23.2 24.3 31.2 17.0 24.4 10.8 34.6 18.2 9.6 28.0 25.6 24.0 26.6 31.9 20.4 33.6 56.9 45.2 26.4 40.3 59.3 50.2 38.3 24.0 30.4 12.9 33.1 53.1 46.2 27.8 24.7 32.7 14.1 23.9 42.9 19.5 27.8 32.9 79.7 21.4 27.2 68.4 41.6 41.5 30.1 43.3 38.6 15.7 21.3 21.7 37.9 24.5 14.8 33.8 36.4 17.4 49.9 7.2 16.3 28.8 38.3 24.7 22.7 48.7 24.5 26.9 34.5 17.8 22.3 22.4 40.4 45.3 22.8 48.1 42.9 32.0 19.9 7.3 41.6 23.3 30.5 52.5 27.9 41.4 26.5 25.1 17.5 18.2 17.5 21.2 23.2 18.5 18.7 18.2 37.9 27.3 24.5 26.1 24.1 23.8 23.5 24.4 24.6 26.5 23.3 23.1 25.7 24.1 24.7 23.2 24.4 24.0 24.0 16.0 12.4 4.2 14.3 30.2 19.7 26.1 29.6 17.1 25.3 24.9 7.0 25.8 15.8 11.0 6.2 58.8 15.9 39.9 3.9 44.7 1.1 17.9 17.2 22.9 15.7 18.5 2.9 26.5 42.2 31.5 20.4 16.3 11.4 23.6 26.0 19.5 36.3 18.5 3.7 26.6 28.5 11.4 12.4 1.2 29.2 15.5 10.6 2.8 20.4 25.7 13.4 6.6 4.4 35.6 32.5 25.2 18.8 33.8 43.9 26.9 14.3 15.1 26.3 19.3 26.5 17.0 8.0 17.5 34.9 92.8 14.3 36.4 24.9 25.6 TMEM123 "KCT3, PORIMIN" ENSG00000152558 "Transmembrane protein 123" Q8N131 11 102396332-102470384 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 988.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026001, HPA062862" Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 32: Non-specific - Translation" "Golgi apparatus" "Vesicles, Cytosol" "CAB026001: , HPA062862: AB_2732691" "unprognostic (2.64e-1)" "unprognostic (8.39e-2)" "unprognostic (4.18e-3)" "unprognostic (1.40e-1)" "unprognostic (7.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.08e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.67e-1)" "unprognostic (1.38e-2)" "unprognostic (8.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-2)" "unprognostic (3.65e-2)" 56.0 80.2 53.0 120.2 60.3 225.1 153.3 56.7 68.2 114.9 67.0 120.0 63.5 174.7 47.8 100.1 91.7 99.6 71.2 48.0 61.0 93.2 393.7 119.2 196.4 71.2 68.6 86.8 82.5 70.7 15.8 98.5 65.1 105.2 97.1 9.2 224.0 104.1 20.4 95.6 78.8 130.6 61.3 111.2 125.5 73.3 61.5 238.6 312.3 49.7 142.9 146.8 70.7 89.8 220.5 195.8 186.9 174.8 233.5 185.6 135.8 169.7 352.0 324.4 358.1 247.9 988.1 370.2 423.9 387.9 234.5 228.3 212.3 272.9 339.4 228.4 82.5 192.0 67.8 352.3 207.5 404.1 137.4 219.1 280.7 240.1 352.3 433.9 361.8 187.8 134.3 0.9 257.7 71.8 353.0 135.4 115.8 340.3 181.1 214.7 532.0 359.3 291.3 207.9 90.7 110.5 201.8 267.6 109.9 197.2 161.3 154.0 451.9 211.3 249.4 190.5 126.6 139.4 84.3 366.6 62.0 432.7 143.2 159.7 113.3 207.0 102.6 121.8 155.3 70.1 158.8 123.8 126.1 95.3 208.6 181.7 72.4 223.9 111.0 33.7 183.8 248.7 53.0 60.3 56.7 68.2 48.0 61.0 71.2 68.6 65.1 61.3 61.5 89.8 93.3 125.0 78.1 33.0 179.3 160.3 257.1 307.3 157.6 0.7 144.9 118.4 53.9 143.0 202.8 163.7 0.0 45.8 91.8 48.2 80.3 153.7 41.3 141.1 47.6 140.0 90.5 68.3 1.0 118.8 41.1 82.2 88.2 161.4 58.9 126.6 271.3 317.6 107.1 1.7 2.2 163.1 160.7 249.6 419.9 23.6 94.1 189.8 161.9 63.7 229.4 4.7 83.4 25.6 114.0 127.8 55.1 93.3 117.8 324.2 31.0 52.9 257.0 1.1 65.7 181.9 80.2 23.1 74.9 146.3 177.2 30.4 164.8 109.4 146.3 270.2 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.1;brain: 141.0;pituitary gland: 100.3;testis: 37.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 51.2;Excitatory neurons: 43.8;Inhibitory neurons: 53.9" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.7;EFO-21: 6.4;GAMG: 6.9;hTERT-RPE1: 11.0;NTERA-2: 3.8;SH-SY5Y: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Uncertain Supported "Golgi apparatus" NA NA 9400 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 0.5 37.1 63.7 1.5 64.2 0.6 1.2 0.0 116.6 3.2 0.0 3.9 0.8 1.1 9.4 1.6 1.0 1.8 0.6 67.3 141.0 3.4 0.1 6.2 2.3 11.6 8.2 0.9 0.8 2.7 100.3 0.5 17.0 2.4 1.2 17.9 0.4 6.7 2.0 0.4 1.5 0.8 7.2 0.7 1.4 37.4 55.7 1.8 0.5 0.1 0.3 0.9 4.9 42.4 0.0 0.6 0.0 0.0 0.2 0.0 0.3 2.9 6.7 0.5 0.4 0.1 0.1 0.1 6.4 1.7 6.9 0.1 0.0 0.0 0.1 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 11.0 0.3 0.2 0.1 0.4 0.3 0.5 0.1 0.2 3.8 0.0 0.2 0.1 0.0 0.6 0.0 0.1 0.4 7.8 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.2 0.1 0.4 0.4 0.2 0.8 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 1.6 0.3 0.2 0.2 0.1 0.1 63.7 64.2 0.0 116.6 67.3 141.0 11.6 8.2 17.0 7.2 55.7 42.4 0.1 0.0 0.0 2.6 0.0 0.4 0.4 0.1 0.0 51.2 0.3 0.4 1.0 1.5 2.0 1.8 2.1 0.1 1.5 0.1 0.0 0.0 1.6 0.1 0.2 0.5 0.0 0.0 43.8 0.2 0.1 2.1 0.0 0.2 0.0 0.5 0.7 0.0 0.1 0.0 53.9 0.0 2.0 0.0 1.2 2.7 0.9 0.3 0.0 3.7 0.0 1.7 0.0 11.6 4.2 0.0 0.0 6.8 0.0 0.3 0.2 0.1 0.3 4.3 0.0 0.6 0.8 0.6 0.6 0.0 0.3 0.3 0.2 0.0 0.1 0.2 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5" "Cancer enriched" "Detected in some" 4 "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 170000 "Cluster 40: NK-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: AB_2686286" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.3 0.1 4.6 0.0 3.0 0.0 0.1 6.1 6.4 0.4 0.0 0.1 1.2 0.1 0.0 0.1 0.1 0.1 0.5 2.6 6.2 3.6 0.4 0.1 0.1 17.9 5.1 0.2 0.0 0.0 0.1 0.1 10.2 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.7 0.1 8.7 0.3 0.1 1.9 6.5 0.0 0.2 0.0 0.1 0.1 0.2 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 4.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 4.6 3.0 6.1 6.4 2.6 6.2 17.9 5.1 10.2 8.7 6.5 11.1 0.1 0.0 0.0 2.6 0.1 0.3 0.0 0.0 0.0 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 6.4 0.0 0.0 1.9 0.7 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 0.2 0.5 1.2 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TMEM165 "GDT1, TMPT27, TPARL" ENSG00000134851 "Transmembrane protein 165" Q9HC07 4 55395957-55453397 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 1021.6;Urothelial cells: 601.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038299, HPA062424" Supported Enhanced "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA038299: AB_10675793, HPA062424: AB_2732682" "unprognostic (2.53e-2)" "unprognostic (1.08e-3)" "unprognostic (3.46e-3)" "unprognostic (7.07e-3)" "unprognostic (5.97e-2)" "unprognostic (9.84e-2)" "prognostic unfavorable (2.08e-5)" "unprognostic (1.41e-1)" "unprognostic (1.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.55e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.18e-8)" "unprognostic (9.05e-2)" "unprognostic (8.96e-2)" "unprognostic (2.72e-1)" "unprognostic (2.18e-2)" 53.4 61.3 39.2 42.6 75.1 11.3 35.2 62.0 70.8 45.9 36.0 32.4 32.0 34.0 31.1 55.8 31.6 46.0 37.3 40.8 51.1 41.6 19.3 52.7 32.6 84.8 72.0 22.3 40.1 32.3 24.0 60.5 78.9 37.8 33.3 15.0 40.4 30.6 17.1 26.2 27.9 40.0 54.5 37.0 39.2 13.7 65.8 24.0 37.8 17.2 42.5 78.8 42.7 117.4 74.6 30.4 47.1 50.2 143.5 105.4 50.0 138.6 212.7 98.0 106.7 34.2 108.3 76.9 98.3 85.9 56.2 53.8 50.0 56.8 98.9 43.8 46.4 66.0 50.1 66.6 89.1 92.1 75.1 109.1 72.7 55.9 37.3 82.4 113.2 25.6 112.8 47.8 116.5 54.5 73.0 76.5 51.7 97.8 70.6 52.0 35.5 42.1 148.6 70.2 48.3 64.7 69.8 261.0 85.8 46.3 41.2 65.3 98.3 83.1 49.6 37.0 102.5 44.4 38.5 48.3 98.9 77.2 67.9 23.7 40.4 26.0 15.2 35.7 17.0 19.0 14.3 17.8 36.5 11.5 12.1 14.4 28.6 18.1 35.9 28.4 18.3 30.2 39.2 75.1 62.0 70.8 40.8 51.1 84.8 72.0 78.9 54.5 65.8 117.4 119.6 54.5 52.4 42.7 87.9 245.1 277.8 295.0 147.4 50.6 85.8 42.7 32.2 71.4 214.9 79.1 81.3 112.5 97.7 42.4 17.6 171.1 32.1 123.6 99.1 108.0 50.4 79.1 58.2 163.5 157.2 110.4 76.0 173.8 21.0 57.6 113.8 18.4 105.7 28.6 71.5 69.4 77.3 97.9 145.7 24.7 58.7 109.5 88.9 59.0 117.5 53.2 123.6 71.4 1021.6 248.0 48.6 63.6 117.1 239.3 51.3 50.0 125.2 91.9 98.6 92.2 129.0 37.8 24.6 169.4 268.8 80.6 81.6 90.6 61.6 601.6 TMEM168 DKFZp564C012,FLJ13576 ENSG00000146802 "Transmembrane protein 168" Q9H0V1 7 112762377-112790423 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020389, HPA077143" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Cytosol "HPA020389: AB_1858101, HPA077143: " "unprognostic (1.54e-1)" "unprognostic (2.23e-1)" "unprognostic (2.55e-1)" "unprognostic (4.92e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-2)" "unprognostic (2.30e-3)" "prognostic favorable (4.07e-6)" "unprognostic (1.60e-3)" "unprognostic (8.73e-2)" "unprognostic (3.07e-3)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.47e-1)" "unprognostic (1.84e-1)" "unprognostic (4.89e-3)" "unprognostic (3.30e-2)" 12.9 10.6 6.0 12.5 7.6 6.7 15.6 7.5 7.1 11.6 9.5 22.4 13.7 13.2 17.9 14.1 10.7 12.2 13.9 5.8 6.8 12.8 8.4 12.1 11.3 8.1 6.6 12.1 6.7 28.6 8.3 14.4 8.2 16.3 24.6 20.2 20.6 13.4 9.4 26.7 14.8 15.3 7.8 12.3 12.6 10.2 6.7 13.5 17.7 9.4 11.2 10.9 12.9 10.1 16.0 13.2 12.2 10.9 20.4 41.5 17.2 17.3 16.2 6.4 5.6 17.0 16.4 16.9 11.4 17.2 14.6 16.8 12.5 15.1 16.5 26.8 12.9 14.7 16.8 9.7 13.7 16.4 17.9 20.3 38.6 7.3 10.9 6.0 18.9 13.6 19.9 15.0 23.3 25.2 14.2 10.3 9.9 16.7 10.2 9.5 6.1 24.9 16.0 29.9 9.2 18.2 23.3 30.6 14.0 14.9 17.5 14.4 27.0 30.5 15.5 14.5 22.6 25.4 23.1 18.9 19.7 14.7 40.0 21.2 14.9 11.6 12.1 12.6 14.4 10.9 12.9 11.8 16.0 13.2 18.6 13.0 8.4 13.5 13.2 11.1 13.0 9.5 6.0 7.6 7.5 7.1 5.8 6.8 8.1 6.6 8.2 7.8 6.7 10.1 17.4 12.8 22.3 43.1 18.6 31.1 19.1 12.0 27.3 31.5 16.4 14.4 18.1 10.0 18.9 33.1 27.1 35.5 14.3 16.9 0.0 5.9 2.9 9.2 22.1 17.3 20.5 14.1 29.9 9.1 8.9 17.6 18.3 11.8 12.0 19.2 18.5 12.6 8.9 16.8 32.6 34.8 16.2 13.5 9.3 1.9 18.3 10.9 24.9 41.2 10.8 16.3 15.5 70.9 71.5 6.1 17.0 14.7 10.2 21.6 15.5 6.0 7.1 29.6 6.6 19.4 16.7 18.1 13.3 24.8 26.0 14.2 13.8 21.1 30.5 14.5 TMEM176B "LR8, MS4B2" ENSG00000106565 "Transmembrane protein 176B" Q3YBM2 7 150791285-150801360 "Predicted membrane proteins, Transporters" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 1656.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 1171.9;monocytes: 502.3;Paneth cells: 762.4;Proximal enterocytes: 922.5;Proximal tubular cells: 976.5" "Cancer enhanced" "Detected in all" "liver cancer: 537.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 865.5;intermediate monocyte: 586.0" "Lineage enriched" "Detected in many" 5 "monocytes: 865.5" "Group enriched" "Detected in some" 17 "HSkMC: 642.7;THP-1: 215.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047509 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA047509: AB_2680072" "unprognostic (5.21e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-2)" "unprognostic (8.27e-2)" "unprognostic (3.35e-2)" "unprognostic (6.96e-2)" "unprognostic (7.23e-2)" "unprognostic (2.74e-2)" "unprognostic (5.31e-2)" "unprognostic (1.47e-1)" "unprognostic (5.72e-3)" "unprognostic (7.50e-2)" "unprognostic (3.11e-3)" "unprognostic (5.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.05e-2)" 120.9 49.5 48.5 190.8 50.1 13.5 77.8 50.7 65.8 74.5 43.0 251.8 167.7 25.9 25.7 50.4 81.5 197.3 208.5 45.4 58.0 356.5 1656.5 95.6 177.5 69.2 60.1 143.1 53.6 7.3 22.7 115.0 64.5 48.9 244.9 34.1 42.5 28.3 11.0 34.7 286.6 99.0 65.0 87.0 94.5 11.1 52.2 26.1 33.6 36.1 93.7 158.6 92.4 73.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 2.2 25.7 0.4 0.8 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.8 0.4 0.0 0.0 0.6 0.8 0.2 642.7 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.7 0.1 0.9 0.5 0.1 0.0 0.1 1.0 11.8 0.1 0.0 1.9 1.4 0.6 0.3 0.2 0.2 0.0 215.7 0.0 0.0 3.2 0.5 0.2 0.4 0.2 0.6 0.0 0.3 0.0 5.3 865.5 50.5 2.3 586.0 3.4 2.5 0.6 0.7 164.3 0.6 0.7 0.4 8.6 0.6 309.3 7.7 0.6 498.5 48.5 50.1 50.7 65.8 45.4 58.0 69.2 60.1 64.5 65.0 52.2 73.2 22.2 3.2 9.3 14.4 16.9 12.6 0.5 0.9 5.7 156.9 52.2 74.0 73.7 190.1 14.4 375.2 2.1 0.9 2.8 419.4 166.3 95.1 18.5 6.1 14.5 19.8 128.1 13.5 0.1 34.0 1.0 243.7 14.8 2.1 54.4 61.9 22.9 1171.9 92.5 6.7 0.6 252.1 46.8 98.5 44.4 12.2 43.5 190.0 16.0 8.4 502.3 87.3 1.0 7.5 0.1 65.4 762.4 3.4 1.5 2.5 922.5 976.5 11.3 17.9 0.0 6.7 34.0 4.0 3.8 1.8 15.6 2.7 9.1 0.4 263.7 2.8 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040189 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 24: Non-specific - Transcription regulation" Vesicles "Golgi apparatus" "HPA040189: AB_10793959" "unprognostic (1.93e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 14.6 12.4 16.6 12.2 17.0 9.1 18.7 9.7 17.5 27.3 8.3 22.7 24.6 15.2 9.0 13.1 12.7 16.5 10.3 17.6 17.5 7.9 14.9 13.3 9.4 13.3 15.1 10.3 34.3 13.4 11.8 15.0 14.1 20.0 24.8 10.5 52.3 20.9 10.2 16.1 28.5 17.4 12.9 14.3 35.7 21.3 22.3 6.3 21.3 8.7 8.2 20.6 13.4 14.9 22.1 12.6 17.5 27.0 45.1 41.1 33.4 49.1 28.6 25.1 28.4 21.5 26.5 9.3 24.7 41.0 53.5 32.0 26.1 32.4 39.6 13.7 18.7 17.3 18.9 45.6 36.8 21.9 15.8 34.3 31.2 27.9 37.6 37.6 40.7 13.1 33.4 11.3 41.4 13.3 9.7 27.1 13.6 43.8 15.9 9.3 20.1 10.6 23.9 17.1 51.3 35.3 36.0 33.3 24.2 23.9 12.7 30.4 39.1 25.7 17.4 43.1 43.0 6.6 4.9 10.0 31.0 26.8 25.1 5.7 1.1 3.0 2.2 1.1 1.7 0.4 1.2 1.8 0.8 0.4 1.1 1.5 0.7 2.0 1.9 1.0 1.3 0.8 16.6 17.0 9.7 17.5 17.6 17.5 13.3 15.1 14.1 12.9 22.3 14.9 26.7 12.8 33.1 19.9 9.4 20.4 15.6 20.5 17.6 15.6 30.0 18.8 14.2 27.1 23.1 16.5 18.8 8.8 46.0 47.2 3.9 23.3 4.2 16.8 27.7 27.5 44.3 21.5 61.1 32.7 12.5 16.6 49.5 40.5 11.4 36.8 21.0 22.5 10.2 20.2 66.3 35.9 18.3 15.3 16.4 6.7 13.1 14.7 14.2 28.1 13.3 6.0 51.5 43.2 61.7 35.3 25.7 17.7 26.6 37.5 39.4 4.6 25.8 14.6 6.6 12.7 17.8 13.1 22.7 23.6 21.0 5.2 27.0 24.2 30.5 37.1 TMEM184B "C22orf5, DKFZP586A1024, FM08, HS5O6A" ENSG00000198792 "Transmembrane protein 184B" Q9Y519 22 38219291-38273010 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 86.8;Oligodendrocytes: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 197.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024076 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus, Cytosol" Nucleoplasm "HPA024076: AB_1858106" "unprognostic (1.52e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-1)" "unprognostic (8.96e-2)" "unprognostic (3.82e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.94e-6)" "unprognostic (1.14e-2)" "unprognostic (5.18e-2)" "unprognostic (4.52e-2)" "unprognostic (9.20e-2)" "unprognostic (1.77e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.96e-1)" 28.6 21.9 49.5 14.0 52.3 5.8 24.9 54.5 59.6 18.6 22.1 21.0 16.9 19.4 7.2 17.3 17.1 14.5 35.7 49.6 48.2 25.9 11.4 35.9 8.4 56.8 56.0 16.2 18.4 18.9 34.3 38.4 54.8 18.8 10.8 15.2 22.6 14.4 28.7 16.0 17.6 14.0 52.9 22.0 22.4 7.5 56.7 6.2 26.1 17.4 8.2 18.4 16.5 66.9 55.8 47.5 27.5 21.9 53.6 42.6 63.4 58.8 82.9 46.9 41.5 35.1 25.2 10.6 44.9 87.6 42.4 67.2 24.9 57.8 31.6 37.9 45.0 20.9 34.0 29.5 56.3 16.6 28.0 36.1 50.2 55.4 61.5 48.5 59.5 15.9 13.5 36.2 41.5 31.6 10.6 14.1 22.4 41.2 43.4 18.1 24.8 10.6 34.8 60.6 59.3 10.5 44.2 63.6 32.0 31.7 35.2 12.0 89.2 47.7 48.4 42.5 36.2 74.5 197.9 8.5 69.2 12.1 42.0 14.2 3.3 4.7 5.3 2.3 4.6 1.4 2.9 4.0 4.5 1.1 2.1 2.5 10.9 6.2 1.6 7.0 1.0 3.2 49.5 52.3 54.5 59.6 49.6 48.2 56.8 56.0 54.8 52.9 56.7 66.9 43.4 6.4 14.8 86.8 7.5 12.4 19.8 22.3 17.6 16.4 15.9 10.5 17.1 8.6 18.7 14.7 2.1 35.0 17.8 12.5 3.9 17.3 5.6 17.4 15.5 34.6 25.9 4.6 42.6 22.2 48.3 17.4 13.3 33.8 2.5 15.3 18.2 4.4 14.7 15.2 40.7 19.7 12.2 8.5 19.7 2.4 11.8 8.4 14.2 22.5 12.2 44.4 23.7 42.3 93.1 28.3 9.8 13.5 35.6 32.9 11.1 4.3 15.9 9.0 19.7 15.3 27.0 3.3 6.1 5.3 9.7 78.4 9.3 10.2 10.1 37.0 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719315-19773617 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 10.4;retina: 21.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 116.4;Endometrial stromal cells: 90.9;Excitatory neurons: 45.1;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 127.6" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 4.8;ASC TERT1: 4.5" "Low region specificity" "Detected in many" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 77: Retina - Visual perception" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 56: Bipolar cells - Visual perception" "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.3 1.3 2.6 0.0 4.4 0.0 0.0 0.0 4.1 0.4 0.0 0.1 0.0 1.4 0.4 0.0 0.3 0.0 0.0 2.7 10.4 0.0 0.0 0.0 0.0 3.6 6.7 0.0 1.1 0.0 3.7 0.0 3.3 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.7 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 4.8 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 4.4 0.0 4.1 2.7 10.4 3.6 6.7 3.3 1.9 7.1 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 116.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 90.9 0.4 0.0 0.0 45.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 3.3 23.9 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 1.9 0.0 2.6 0.0 127.6 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TMEM214 FLJ20254 ENSG00000119777 "Transmembrane protein 214" Q6NUQ4 2 27032910-27041694 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034551 Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum, Golgi apparatus, Cytosol" "HPA034551: AB_10602481" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (3.10e-1)" "unprognostic (4.12e-3)" "unprognostic (1.90e-2)" "unprognostic (2.42e-2)" "prognostic unfavorable (4.96e-4)" "unprognostic (1.96e-1)" "unprognostic (3.70e-1)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.74e-2)" "prognostic unfavorable (2.39e-10)" "unprognostic (1.54e-2)" "unprognostic (1.97e-2)" "unprognostic (2.04e-1)" "unprognostic (2.92e-2)" 45.8 39.0 14.7 30.8 15.8 23.1 43.2 15.3 17.3 45.0 28.7 38.3 30.5 43.7 66.2 31.5 37.5 30.7 36.7 14.8 17.0 30.0 46.5 37.7 25.1 19.1 18.7 41.4 79.9 56.0 60.4 45.8 18.3 37.9 41.7 8.8 83.6 44.4 35.7 37.8 33.6 45.1 15.6 37.4 40.8 19.5 17.8 21.7 42.3 21.3 34.4 36.7 33.9 14.9 82.4 53.5 32.2 68.2 102.8 103.7 69.4 105.9 142.4 76.0 85.2 53.0 67.3 37.6 52.4 156.6 59.7 57.6 39.3 74.9 61.0 36.3 44.1 49.9 41.4 109.8 128.1 45.7 82.5 90.4 52.7 66.8 112.0 58.6 83.5 24.3 46.0 75.3 85.9 59.6 23.3 34.1 23.1 110.0 42.8 31.3 58.5 91.0 57.1 57.0 27.8 32.3 49.4 83.3 38.2 31.0 45.9 27.0 72.4 55.2 52.8 57.0 60.4 100.9 73.3 59.2 71.1 56.8 77.9 5.7 3.5 2.8 3.9 3.8 5.0 2.5 3.0 2.8 2.8 2.8 1.5 2.1 0.6 5.6 2.2 5.0 2.6 2.5 14.7 15.8 15.3 17.3 14.8 17.0 19.1 18.7 18.3 15.6 17.8 14.9 15.8 3.2 20.1 3.9 18.5 7.6 9.6 10.4 3.4 9.3 19.8 11.0 8.2 21.5 15.0 14.7 10.4 43.6 15.0 37.5 1.9 24.7 6.4 11.3 25.4 17.5 17.9 18.5 4.8 34.6 62.9 26.9 33.1 23.8 14.5 17.0 32.5 28.9 27.3 6.7 4.4 37.6 10.2 18.9 12.8 7.8 32.6 11.7 5.4 6.5 14.6 6.9 14.4 4.0 3.8 21.7 22.3 20.3 63.0 20.8 25.4 10.4 11.0 8.4 26.3 11.6 19.6 24.4 12.7 8.4 9.2 71.7 12.0 17.6 27.6 15.8 TMEM241 "C18orf45, FLJ44259, MGC11386" ENSG00000134490 "Transmembrane protein 241" Q24JQ0 18 23197144-23437961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 70.8;Oligodendrocyte precursor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "NK-cell: 6.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029489, HPA059922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" Vesicles "HPA029489: AB_2673067, HPA059922: AB_2684164" "unprognostic (1.44e-3)" "unprognostic (1.92e-1)" "unprognostic (7.80e-2)" "unprognostic (1.02e-2)" "unprognostic (1.37e-1)" "unprognostic (6.48e-2)" "unprognostic (1.15e-4)" "unprognostic (7.07e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.81e-3)" "unprognostic (9.53e-3)" "unprognostic (1.15e-1)" "unprognostic (1.42e-1)" "unprognostic (2.95e-1)" "unprognostic (4.93e-1)" "prognostic unfavorable (5.80e-4)" 2.1 0.6 0.7 1.8 0.9 1.1 2.3 0.0 1.7 1.8 0.7 1.7 1.5 2.0 1.6 1.7 1.7 1.6 1.5 1.5 0.2 1.1 1.7 1.4 1.4 0.1 0.1 1.6 1.3 2.4 1.1 2.3 0.0 0.9 2.2 0.3 1.2 0.9 1.0 0.8 1.1 2.9 0.0 1.5 1.4 0.6 0.2 1.0 2.2 0.9 1.5 1.6 1.0 1.1 3.2 4.5 1.2 4.1 5.5 5.3 3.5 1.6 1.9 1.9 3.8 1.3 7.6 13.1 3.4 2.7 6.6 6.0 2.9 7.8 5.3 1.4 1.5 2.4 4.5 3.7 3.3 2.7 2.1 5.3 6.5 6.3 6.6 4.1 6.6 6.3 5.5 4.1 5.3 4.6 2.6 0.5 1.8 10.6 2.9 1.9 5.8 11.2 2.6 1.9 4.6 4.3 7.1 3.2 4.2 4.3 4.0 0.8 3.0 10.3 2.4 3.6 3.9 8.4 8.1 5.3 5.1 8.4 7.2 1.2 0.5 0.0 0.9 2.2 1.3 1.3 0.2 0.9 2.0 2.2 0.8 1.2 0.0 6.0 0.8 0.7 1.2 1.1 0.7 0.9 0.0 1.7 1.5 0.2 0.1 0.1 0.0 0.0 0.2 1.1 3.7 0.0 6.9 4.9 3.5 2.8 3.3 3.9 4.0 1.0 16.1 7.9 1.4 1.5 5.2 3.7 4.2 8.3 4.7 1.8 0.0 2.3 0.0 2.4 4.6 2.5 1.2 3.8 70.8 2.2 8.7 3.9 7.1 3.2 2.5 4.2 3.3 3.8 3.1 10.1 16.0 4.0 6.1 0.6 2.9 0.3 1.8 2.4 1.8 11.2 1.4 1.0 5.2 21.6 9.9 3.0 3.1 1.2 5.7 4.6 2.0 3.3 8.3 1.3 0.0 4.2 3.0 1.4 5.5 6.2 4.4 4.7 2.1 4.2 2.3 2.9 TMEM25 FLJ14399 ENSG00000149582 "Transmembrane protein 25" Q86YD3 11 118531041-118547280 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA012163, HPA051562" Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 6900000 "Cluster 48: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus, Vesicles" "HPA012163: AB_1858112, HPA051562: AB_2681535" "unprognostic (1.53e-2)" "unprognostic (7.18e-2)" "unprognostic (2.43e-1)" "unprognostic (6.69e-2)" "unprognostic (3.61e-1)" "unprognostic (6.50e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (1.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.66e-2)" "unprognostic (8.19e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.15e-1)" "unprognostic (2.51e-1)" "unprognostic (1.26e-1)" "unprognostic (7.01e-2)" 6.9 25.3 35.0 3.8 36.0 2.2 14.6 33.9 44.3 14.9 32.2 16.0 46.0 15.3 25.7 11.1 13.7 8.9 8.9 37.5 36.7 18.6 23.1 9.9 4.8 32.1 30.3 23.4 17.6 23.3 29.5 6.0 32.0 15.7 3.7 22.3 21.0 18.3 18.5 8.7 35.2 10.8 31.5 5.3 13.3 6.5 35.1 5.1 15.9 9.9 5.3 14.4 11.6 35.1 3.4 0.7 5.8 9.5 6.0 0.9 5.6 5.2 9.9 4.9 9.8 27.1 18.8 0.3 20.1 5.3 10.9 14.8 0.0 18.3 4.4 11.9 11.1 0.5 5.4 6.0 16.0 0.3 0.5 7.3 10.9 5.3 0.9 35.9 7.2 13.7 2.6 11.7 4.9 4.1 6.0 0.5 4.9 0.1 12.8 8.1 4.2 12.3 25.3 0.3 17.0 11.5 5.1 33.7 0.1 8.7 43.8 0.6 2.5 2.1 10.6 0.4 1.6 11.7 8.3 3.1 0.4 0.2 0.2 0.7 0.2 0.2 5.1 0.2 7.1 4.0 7.3 2.9 0.5 2.6 10.0 5.4 0.4 7.4 0.2 3.4 6.0 3.5 35.0 36.0 33.9 44.3 37.5 36.7 32.1 30.3 32.0 31.5 35.1 35.1 5.1 6.4 3.9 11.1 6.2 5.7 10.7 14.7 13.1 27.7 27.7 30.6 6.1 14.3 9.3 16.5 29.2 37.1 4.8 0.9 11.7 16.6 2.8 4.1 5.0 6.4 11.4 5.2 20.1 6.4 16.9 8.7 2.6 5.5 8.9 18.0 3.6 9.6 2.9 11.8 22.0 7.8 10.2 0.0 1.9 5.5 23.3 1.1 7.2 2.8 3.4 28.8 5.2 8.5 6.5 5.0 5.5 23.3 5.5 5.5 149.1 25.6 7.4 41.1 0.0 12.1 7.5 3.9 5.2 4.0 3.7 16.3 4.7 15.3 15.0 5.7 TMEM251 "C14orf109, DKFZP564F1123" ENSG00000153485 "Transmembrane protein 251" Q8N6I4 14 93184951-93188463 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 113.5;Hofbauer cells: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048559 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 4: Macrophages - Innate immune response" "Cell Junctions" "Golgi apparatus" "HPA048559: AB_2680441" "unprognostic (1.21e-2)" "unprognostic (4.56e-2)" "unprognostic (4.61e-3)" "unprognostic (3.37e-2)" "unprognostic (2.14e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (6.14e-7)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (9.99e-3)" "unprognostic (5.80e-3)" "unprognostic (1.58e-1)" "prognostic favorable (1.10e-4)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (7.47e-2)" "unprognostic (6.17e-2)" 16.6 22.9 7.3 6.4 7.8 2.7 16.9 7.9 10.0 15.5 8.2 22.9 10.3 14.2 16.5 13.1 14.7 6.7 25.6 7.6 7.6 33.2 17.2 17.1 8.0 7.7 7.8 14.2 21.2 10.3 19.8 6.9 7.8 25.7 12.5 20.7 19.6 9.2 30.6 13.7 18.1 6.8 7.4 15.9 21.8 8.4 8.1 8.6 17.6 12.4 6.9 17.2 12.8 9.0 11.0 12.1 15.3 16.1 17.2 7.3 9.4 7.9 8.2 12.7 16.2 7.8 11.1 12.1 12.9 7.9 15.9 15.9 17.8 12.6 17.7 9.3 13.4 10.9 8.8 18.3 15.2 16.0 14.7 9.3 14.6 10.0 16.2 6.8 12.2 13.5 9.3 12.0 11.6 52.5 10.2 12.8 8.3 28.0 11.6 4.7 16.0 11.3 16.6 23.6 12.9 13.4 11.7 6.0 36.9 12.4 17.7 11.4 5.0 6.1 10.8 14.6 9.4 9.3 16.0 11.8 11.4 6.1 9.1 6.8 9.7 13.6 3.9 9.4 2.9 4.7 4.6 4.4 8.0 5.5 5.2 5.9 10.5 5.3 13.0 7.3 4.1 4.2 7.3 7.8 7.9 10.0 7.6 7.6 7.7 7.8 7.8 7.4 8.1 9.0 13.4 3.2 14.4 5.2 22.4 23.2 37.9 33.6 13.1 14.8 41.1 39.1 22.5 32.9 22.0 31.3 27.1 36.6 16.5 44.8 113.5 30.3 1.8 33.1 16.3 11.9 15.0 11.3 5.9 26.6 21.1 16.6 20.9 35.7 17.2 15.2 8.9 19.2 110.1 13.5 7.8 36.1 26.4 28.4 20.0 2.3 11.8 39.6 32.0 2.8 16.2 34.8 12.3 5.0 13.8 17.7 23.8 10.9 13.1 43.3 31.7 69.6 17.2 30.6 39.5 13.9 23.2 4.5 17.8 18.1 31.1 27.4 16.1 17.6 30.9 36.4 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 200.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: AB_2683905, HPA059790: AB_2684125" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 9.0 27.2 9.6 5.4 9.3 11.0 10.2 9.7 11.0 10.0 8.9 7.9 26.4 8.7 11.2 23.6 9.2 7.6 9.9 9.0 9.4 14.7 20.5 10.6 7.4 9.4 11.6 14.1 9.7 8.7 5.7 8.4 9.2 10.2 8.9 7.5 12.0 8.3 9.8 19.9 24.1 7.4 9.8 12.5 10.3 9.3 12.1 7.8 7.0 16.4 12.6 10.8 14.6 10.9 43.6 15.4 10.1 12.5 15.6 16.8 29.6 16.3 14.3 20.2 14.6 40.5 16.7 13.4 30.5 15.3 28.5 29.4 28.1 17.5 20.4 22.6 25.8 23.3 8.6 41.2 17.5 25.3 12.5 15.7 25.6 18.3 20.9 12.7 15.6 16.8 42.1 32.4 13.0 16.8 15.6 14.5 16.8 34.1 24.1 15.5 15.6 24.6 17.4 31.4 10.1 13.1 14.1 35.8 25.7 14.4 42.8 19.6 11.4 11.9 15.0 25.2 34.5 47.2 78.0 26.5 18.2 15.1 14.6 14.0 8.2 7.2 16.3 9.4 21.0 17.5 16.7 18.1 9.3 15.6 18.2 19.8 2.8 12.2 12.2 21.7 15.3 9.2 9.6 9.3 9.7 11.0 9.0 9.4 9.4 11.6 9.2 9.8 12.1 10.9 12.1 9.6 30.5 7.2 16.7 53.0 42.8 29.5 50.7 22.4 38.2 20.6 12.6 24.3 24.9 20.2 18.8 27.5 18.3 23.3 7.9 33.4 0.7 17.7 14.5 19.8 18.6 16.4 8.1 56.0 23.5 18.0 36.2 38.0 8.8 50.2 17.2 40.9 19.6 16.8 9.8 28.3 16.2 14.2 17.3 2.8 14.3 12.5 8.8 2.8 65.9 11.4 11.3 20.1 7.6 50.3 17.0 13.5 20.9 64.2 200.8 23.2 9.6 28.6 19.7 16.8 16.5 22.1 14.3 113.0 84.7 46.0 18.5 82.6 45.6 93.4 TMEM53 "FLJ22353, NET4" ENSG00000126106 "Transmembrane protein 53" Q6P2H8 1 44635238-44674481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 59.5" "Cell type enriched" "Detected in many" 5 "Late spermatids: 999.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "plasmacytoid DC: 99.4" "Lineage enriched" "Detected in all" 4 "dendritic cells: 99.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021134 Approved Approved "Golgi apparatus,Focal adhesion sites" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "Focal adhesion sites" "HPA021134: AB_2205162" "unprognostic (5.28e-2)" "unprognostic (2.60e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-2)" "unprognostic (3.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (2.88e-2)" "unprognostic (2.19e-2)" "prognostic favorable (6.96e-4)" "unprognostic (3.00e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.02e-5)" "unprognostic (1.15e-3)" "unprognostic (1.84e-2)" "unprognostic (4.07e-2)" "unprognostic (2.29e-2)" 12.8 12.0 5.7 4.4 9.2 6.7 12.1 6.8 8.3 6.8 6.3 14.2 16.4 8.9 6.8 6.0 7.0 6.2 13.9 5.7 7.2 18.3 59.5 10.5 4.0 8.5 8.5 10.6 8.3 6.3 10.1 3.9 8.5 7.2 6.9 7.1 7.2 3.3 7.6 6.6 14.6 4.2 5.8 6.3 10.1 34.9 8.8 3.3 7.9 3.7 2.1 7.5 6.1 15.4 12.9 14.7 13.0 9.6 16.6 12.5 15.6 3.8 11.1 7.2 10.5 4.7 39.9 4.1 11.8 3.6 27.4 11.5 3.6 7.8 3.8 6.5 9.2 4.7 6.0 22.7 16.5 3.7 16.6 14.8 11.9 14.4 3.1 7.9 4.0 9.1 2.0 5.1 4.3 7.7 4.5 11.2 7.6 9.9 8.5 6.8 1.8 40.0 21.6 13.4 9.0 8.7 4.1 15.7 21.3 9.3 4.8 9.9 1.7 5.3 8.8 7.5 4.7 3.7 4.7 2.3 13.6 9.6 6.3 14.1 12.9 6.3 7.3 23.1 6.3 13.9 7.4 6.3 6.6 14.8 3.5 4.5 1.4 7.8 16.2 99.4 8.1 7.6 5.7 9.2 6.8 8.3 5.7 7.2 8.5 8.5 8.5 5.8 8.8 15.4 10.9 6.4 12.0 8.1 3.5 1.7 9.5 24.2 1.8 6.9 9.0 7.6 35.5 10.0 20.4 20.2 4.2 14.5 9.5 53.1 45.0 18.6 188.3 14.0 4.6 8.5 14.4 10.1 2.9 25.7 15.5 6.9 8.2 5.7 6.3 8.6 10.0 93.0 34.3 18.5 3.6 22.6 44.7 12.6 0.7 999.9 9.0 14.0 8.8 1.9 3.8 17.1 5.2 3.0 4.8 17.5 51.3 12.4 2.6 8.9 74.3 45.9 32.8 13.8 26.3 3.7 10.6 15.6 13.2 3.9 2.3 9.3 3.7 8.3 18.0 12.7 TMEM74 "FLJ30668, NET36" ENSG00000164841 "Transmembrane protein 74" Q96NL1 8 108606850-108787594 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.2" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 4.6;Bipolar cells: 4.7;Cone photoreceptor cells: 6.2;Excitatory neurons: 5.1;Muller glia cells: 3.3;Rod photoreceptor cells: 8.3;Spermatogonia: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.7;JURKAT: 1.5;NTERA-2: 2.1;RH-30: 1.5;SCLC-21H: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015672, HPA076461" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus, Cytosol" "HPA015672: AB_1858132, HPA076461: " "unprognostic (8.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.25e-2)" "unprognostic (6.33e-2)" "unprognostic (2.05e-1)" "unprognostic (4.18e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-2)" "unprognostic (2.01e-2)" "unprognostic (3.97e-2)" "unprognostic (3.75e-4)" "unprognostic (8.77e-2)" "unprognostic (6.36e-2)" "unprognostic (5.95e-2)" "unprognostic (1.46e-3)" 0.3 0.2 1.8 0.1 2.2 0.0 0.2 4.7 2.4 0.2 1.4 1.3 0.0 0.1 0.0 0.5 0.1 0.1 1.3 3.7 3.0 0.1 0.8 0.1 0.0 3.8 1.7 0.1 0.5 0.0 0.4 0.0 3.5 0.1 0.1 2.5 0.2 0.1 0.8 0.3 0.2 0.4 6.1 0.1 0.3 0.3 1.6 0.3 0.1 0.2 0.1 0.2 0.4 8.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 1.7 0.7 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 1.5 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.7 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.2 4.7 2.4 3.7 3.0 3.8 1.7 3.5 6.1 1.6 8.2 0.4 0.0 0.0 2.0 0.0 0.9 0.7 0.0 4.6 4.7 0.2 0.6 0.8 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.3 1.8 0.0 5.1 0.2 0.8 0.7 0.0 0.1 0.0 0.5 0.0 0.7 0.1 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 8.3 0.0 0.8 0.9 0.2 4.1 2.0 0.6 0.1 0.1 0.1 0.0 0.0 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 27.6" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 15.6;Horizontal cells: 18.5;Inhibitory neurons: 16.3;Paneth cells: 15.6;Proximal enterocytes: 21.1;Sertoli cells: 19.7;Smooth muscle cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 7.3;Hep G2: 9.2;K-562: 16.8;Karpas-707: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favorable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 5.8 2.0 17.5 1.0 16.2 0.2 4.9 10.3 19.4 1.9 8.8 4.0 18.2 2.0 0.8 4.0 7.4 3.9 11.2 13.5 16.6 4.5 4.7 27.6 2.0 19.8 13.2 1.0 2.0 7.1 10.1 17.2 18.2 3.1 1.8 3.9 6.3 15.7 5.1 9.8 23.1 2.0 10.8 2.8 4.1 4.1 17.8 0.3 4.1 2.2 1.2 1.2 2.0 11.5 0.0 4.4 2.5 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.3 0.6 0.1 0.9 0.0 2.7 0.3 3.4 0.4 0.1 0.0 4.2 1.1 0.0 9.2 0.0 0.0 1.2 0.0 0.9 0.0 0.1 0.1 0.1 0.6 16.8 7.1 0.0 0.0 0.1 0.0 3.0 1.2 0.3 0.0 0.2 0.0 0.7 0.6 0.5 1.9 0.1 0.0 0.1 0.9 0.0 0.0 1.7 0.0 2.9 0.0 0.1 2.7 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 16.2 10.3 19.4 13.5 16.6 19.8 13.2 18.2 10.8 17.8 11.5 3.7 0.0 0.0 0.7 0.1 0.3 0.7 0.9 0.6 10.5 2.2 1.0 2.3 0.0 0.2 0.0 0.0 0.2 0.2 1.0 0.0 0.5 1.0 0.2 0.1 3.3 15.6 0.0 9.7 0.2 1.8 0.8 2.6 0.1 0.0 0.5 4.6 0.8 0.0 18.5 16.3 9.9 2.0 0.6 0.7 0.7 0.0 1.4 1.8 1.9 1.0 0.5 0.0 0.0 1.1 0.9 15.6 0.0 0.1 0.7 21.1 0.6 1.2 4.0 19.7 0.4 13.3 0.2 2.7 0.2 0.9 1.4 0.2 0.3 3.9 0.3 TMEM80 FLJ38216 ENSG00000177042 "Transmembrane protein 80" Q96HE8 11 695428-705028 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 82.2;Spermatogonia: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059592, HPA067046" Uncertain Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA059592: AB_2684076, HPA067046: AB_2685769" "unprognostic (1.48e-1)" "unprognostic (6.55e-3)" "unprognostic (1.70e-2)" "unprognostic (2.64e-2)" "unprognostic (2.71e-3)" "unprognostic (1.68e-3)" "unprognostic (4.36e-2)" "unprognostic (5.39e-3)" "unprognostic (3.85e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-3)" "unprognostic (1.03e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (3.27e-1)" "unprognostic (4.23e-3)" 21.0 23.0 18.4 14.7 18.2 6.5 23.8 19.5 22.0 30.5 17.3 30.2 23.7 27.8 24.8 42.5 30.1 8.4 15.3 19.3 16.5 36.0 20.2 17.5 21.2 21.2 18.1 29.7 29.7 17.8 34.3 8.7 19.0 29.9 17.5 9.1 31.5 19.4 19.7 31.0 31.1 12.7 18.9 34.3 30.8 24.8 19.0 19.7 47.6 11.8 21.3 27.8 30.6 19.9 37.8 17.5 11.0 14.3 23.6 11.1 19.0 8.5 4.7 8.9 9.6 23.9 42.0 16.0 7.3 13.2 15.8 26.8 16.2 9.7 6.3 11.0 41.7 9.7 19.0 14.5 13.9 12.8 16.8 25.7 19.9 4.0 6.2 17.5 10.5 18.9 12.1 17.7 11.4 12.2 16.8 8.7 10.4 29.9 8.4 12.2 7.6 31.5 12.7 5.7 31.1 9.8 12.8 23.5 12.3 7.3 18.2 11.9 15.0 14.9 7.8 3.4 6.4 8.4 3.2 14.8 15.6 15.9 6.5 8.3 26.5 35.4 21.0 25.9 18.4 26.7 15.7 16.0 21.8 30.1 22.3 20.0 12.8 21.4 32.0 22.0 21.4 20.7 18.4 18.2 19.5 22.0 19.3 16.5 21.2 18.1 19.0 18.9 19.0 19.9 15.1 6.4 20.7 13.7 24.0 15.3 15.9 25.6 17.6 22.7 31.7 36.8 19.3 15.7 20.2 20.2 8.4 33.9 19.4 15.4 11.7 13.0 9.2 17.1 15.8 14.4 12.1 8.6 13.9 17.1 9.8 20.8 9.7 19.9 7.0 15.9 12.8 6.2 17.6 55.5 13.1 22.7 28.5 13.2 13.6 9.5 42.6 12.7 12.4 11.2 19.7 23.2 26.8 16.6 16.7 10.6 10.3 28.6 11.5 12.3 22.1 8.1 19.4 9.1 32.9 23.4 21.2 82.2 87.2 13.7 17.2 15.2 16.7 21.6 19.5 12.3 TMEM86A FLJ90119 ENSG00000151117 "Transmembrane protein 86A" Q8N2M4 11 18693122-18704785 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 17.6" "Cell type enhanced" "Detected in many" "Hofbauer cells: 40.6;Theca cells: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057119 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Golgi apparatus" "HPA057119: AB_2683342" "unprognostic (1.25e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-3)" "unprognostic (1.89e-1)" "unprognostic (2.53e-1)" "unprognostic (1.10e-1)" "unprognostic (4.05e-2)" "unprognostic (2.94e-1)" "unprognostic (3.73e-1)" "unprognostic (1.74e-1)" "unprognostic (8.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "unprognostic (7.92e-2)" "unprognostic (4.20e-1)" "unprognostic (3.24e-1)" 2.8 2.7 2.6 2.2 2.2 0.3 3.2 2.1 2.8 2.3 3.8 1.5 1.4 2.2 1.0 2.3 2.6 4.0 2.9 2.1 2.6 9.5 2.6 3.5 4.7 3.1 2.7 7.1 3.4 5.4 2.2 4.3 2.5 1.6 1.8 5.7 2.7 1.4 2.9 17.6 2.0 1.9 2.7 4.9 2.1 2.3 4.0 1.6 2.1 2.5 2.5 2.3 3.6 4.5 0.0 0.2 0.6 3.1 2.7 0.0 0.1 0.6 0.5 0.5 0.5 0.0 0.4 0.0 1.2 0.6 3.0 0.3 0.2 0.1 0.3 0.2 1.9 0.2 0.1 0.0 2.1 0.0 2.8 3.8 1.2 0.1 0.2 0.7 1.7 1.8 0.6 0.0 1.3 1.7 0.0 0.0 0.2 0.5 1.6 0.0 5.1 0.0 17.5 3.8 1.0 1.3 1.0 3.2 1.4 1.1 3.9 0.4 1.9 0.5 0.2 0.1 0.1 3.2 2.7 0.0 1.1 0.0 1.1 0.0 1.9 0.1 0.2 1.4 0.5 0.0 0.2 0.4 3.4 0.1 0.4 0.8 0.0 0.1 0.5 2.0 0.5 0.8 2.6 2.2 2.1 2.8 2.1 2.6 3.1 2.7 2.5 2.7 4.0 4.5 1.9 0.0 0.0 0.3 0.0 0.1 0.8 0.4 0.0 5.2 3.5 1.8 2.2 0.0 0.7 11.0 8.4 0.5 1.4 0.6 7.9 7.8 12.2 1.1 1.9 2.1 3.5 0.0 0.5 8.0 0.3 1.7 1.1 1.0 0.0 3.0 3.9 1.6 40.6 0.0 0.8 0.8 0.0 12.7 0.8 12.1 2.1 8.3 0.0 3.7 2.3 2.6 0.0 2.0 0.1 7.4 0.1 1.9 0.4 0.6 0.0 8.3 0.4 4.8 6.6 0.4 1.2 7.8 2.6 0.2 0.3 2.3 0.7 17.4 0.2 0.4 TMEM87A DKFZP564G2022 ENSG00000103978 "Transmembrane protein 87A" Q8NBN3 15 42210447-42273584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018104, HPA018189" Enhanced Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA018104: AB_1858135, HPA018189: AB_2205198" "unprognostic (7.07e-2)" "unprognostic (1.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.05e-2)" "unprognostic (2.49e-1)" "unprognostic (6.39e-3)" "unprognostic (1.19e-2)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-3)" "unprognostic (1.38e-1)" "unprognostic (3.41e-2)" "unprognostic (7.90e-2)" "unprognostic (2.19e-1)" "unprognostic (5.49e-3)" "unprognostic (3.63e-1)" 31.8 26.3 23.7 26.1 37.7 88.2 97.7 32.0 29.5 40.2 17.7 56.5 26.6 38.6 49.3 48.2 45.3 32.4 19.7 23.5 26.3 27.1 24.5 72.8 25.4 36.7 29.4 35.4 34.9 47.9 14.2 42.7 38.7 79.8 60.9 26.1 64.7 36.6 24.9 50.2 26.9 38.0 32.5 23.1 38.6 33.0 28.8 24.8 75.9 22.2 30.9 42.0 34.3 59.1 41.0 20.5 30.5 27.0 58.5 50.3 47.7 55.1 82.0 53.5 52.0 29.8 87.5 17.4 52.9 59.9 60.5 104.0 28.3 51.2 42.8 46.8 25.0 35.6 51.5 33.5 63.4 65.6 48.3 52.3 112.1 39.5 65.3 50.6 41.9 30.1 39.4 67.4 51.7 26.3 21.3 38.8 25.7 60.8 29.3 33.5 46.6 36.8 34.5 127.4 33.7 41.2 53.1 70.1 49.9 24.0 27.4 62.4 41.3 104.4 25.5 68.1 82.6 46.8 95.0 36.5 40.1 47.9 66.8 58.3 26.9 31.2 29.0 32.3 33.3 27.6 35.6 34.0 24.4 24.4 33.6 33.5 15.2 42.4 34.7 22.4 42.2 26.0 23.7 37.7 32.0 29.5 23.5 26.3 36.7 29.4 38.7 32.5 28.8 59.1 66.2 125.0 264.0 46.0 48.9 68.6 90.2 78.8 58.1 31.2 148.7 105.9 13.9 45.8 98.0 49.7 50.1 78.1 57.5 77.7 1.9 63.7 5.6 57.0 67.0 54.6 32.2 34.5 41.7 64.2 72.7 64.0 50.0 124.7 59.5 42.9 51.0 34.4 41.6 20.2 48.2 74.1 67.1 39.2 37.0 7.9 41.0 41.3 62.2 45.0 60.1 61.8 52.5 74.4 177.5 56.1 62.4 53.8 47.6 118.5 36.6 15.5 86.4 63.0 85.5 77.0 59.0 59.4 61.4 79.1 65.5 110.4 54.8 53.3 76.9 105.6 TMEM87B FLJ14681 ENSG00000153214 "Transmembrane protein 87B" Q96K49 2 112055269-112119318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 89.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035183 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus, Vesicles" "HPA035183: AB_10600829" "unprognostic (3.19e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.28e-4)" "prognostic unfavorable (4.72e-4)" "unprognostic (4.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.07e-2)" "unprognostic (2.87e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.32e-1)" "unprognostic (5.35e-2)" "unprognostic (1.05e-1)" "unprognostic (3.25e-3)" 10.5 12.2 6.8 14.7 6.6 7.9 20.1 6.1 8.0 12.9 6.9 28.4 28.6 11.0 18.5 10.5 8.4 12.1 5.0 5.9 7.1 7.9 7.4 11.7 15.4 7.5 10.0 6.0 11.3 12.9 9.2 15.1 8.0 30.7 27.8 6.9 15.4 15.9 3.1 13.7 30.5 13.4 7.1 15.5 22.8 5.0 8.3 9.7 15.0 4.2 14.6 17.1 9.0 6.9 21.7 6.4 5.9 25.8 24.9 32.6 21.4 35.5 46.8 21.9 26.7 16.6 28.6 20.9 18.2 47.3 30.2 34.9 3.8 21.6 28.7 12.8 4.1 27.5 4.6 15.2 24.7 19.6 28.9 22.3 25.9 28.0 22.0 21.4 23.6 9.6 16.9 13.1 31.8 13.7 9.3 10.8 4.8 35.0 16.4 7.6 8.9 17.0 20.3 30.2 4.6 6.4 15.4 38.6 34.6 15.5 20.4 14.7 26.6 22.3 6.8 17.6 7.8 10.6 18.1 12.9 25.9 10.1 16.3 5.4 3.0 2.6 3.2 5.2 5.6 5.9 6.9 4.4 2.7 4.9 6.2 3.6 1.8 3.5 6.7 2.7 7.4 3.6 6.8 6.6 6.1 8.0 5.9 7.1 7.5 10.0 8.0 7.1 8.3 6.9 18.3 28.9 13.9 18.9 23.3 12.2 14.5 20.9 39.9 5.0 32.9 14.4 4.6 20.0 21.6 18.4 2.1 15.9 12.3 59.5 0.0 42.9 18.7 14.4 26.5 19.9 17.4 6.3 18.4 89.3 25.5 17.5 46.4 24.9 13.3 14.5 35.7 10.1 21.7 6.7 16.4 53.6 12.2 37.7 10.9 24.5 9.9 22.7 3.6 30.0 20.9 4.0 6.2 21.6 23.1 69.7 47.1 3.0 21.6 28.9 44.9 4.7 17.9 7.9 0.0 5.4 17.2 4.9 5.6 29.9 12.8 29.1 20.5 11.8 38.2 23.9 TMF1 "ARA160, TMF" ENSG00000144747 "TATA element modulatory factor 1" P82094 3 69019827-69052339 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 508.1;Late spermatids: 544.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008729 Approved Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA008729: AB_1080310" "unprognostic (2.71e-1)" "unprognostic (2.11e-2)" "unprognostic (8.02e-3)" "unprognostic (7.19e-2)" "unprognostic (2.74e-1)" "unprognostic (6.75e-3)" "unprognostic (6.73e-3)" "unprognostic (1.79e-1)" "unprognostic (4.62e-2)" "unprognostic (2.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.83e-2)" "unprognostic (1.50e-1)" "unprognostic (1.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.51e-2)" "unprognostic (1.01e-1)" 10.3 10.6 4.4 14.0 5.2 26.2 14.1 6.2 5.5 13.3 12.3 12.5 12.9 14.8 14.1 11.5 12.9 14.1 9.2 4.3 5.3 12.6 11.0 12.0 16.0 5.3 5.1 12.6 13.6 15.6 9.9 16.5 5.2 14.5 14.2 12.5 17.4 10.3 9.8 9.7 14.8 11.6 5.1 12.8 14.0 19.4 5.4 9.6 20.9 8.3 14.8 13.5 7.9 6.1 19.5 8.3 7.8 7.9 20.7 26.4 17.5 24.6 23.6 16.1 19.2 11.9 14.1 7.4 3.9 25.1 11.3 10.5 10.2 10.8 26.4 14.3 7.6 14.4 11.0 14.1 18.5 16.3 19.7 15.6 17.0 21.4 19.3 17.1 17.5 6.0 8.8 11.8 21.2 11.1 9.5 14.1 6.8 12.3 4.4 7.8 9.9 10.4 21.0 15.4 5.4 8.3 20.2 14.2 15.4 10.4 10.7 19.4 23.1 15.8 6.7 27.9 14.8 13.2 13.6 7.2 24.1 16.6 13.1 4.8 2.4 5.1 3.1 2.0 2.1 2.6 2.8 2.7 2.1 3.1 2.9 2.6 5.3 2.7 3.4 2.4 3.1 1.6 4.4 5.2 6.2 5.5 4.3 5.3 5.3 5.1 5.2 5.1 5.4 6.1 49.2 64.1 78.9 21.9 84.7 37.5 37.6 41.7 39.3 43.4 46.2 35.8 36.9 38.6 86.4 42.3 37.5 39.6 108.4 48.8 15.6 52.4 508.1 150.4 92.8 43.1 55.6 45.0 32.2 56.2 58.7 70.0 54.6 86.2 74.7 51.7 29.3 19.7 28.4 35.3 38.4 61.6 38.7 31.8 54.4 544.8 51.0 55.1 35.6 32.8 66.7 41.5 59.8 36.2 40.9 50.6 40.8 62.1 129.3 64.8 49.4 25.1 200.5 52.1 32.9 62.8 56.8 116.2 39.3 30.6 39.5 80.6 94.5 54.5 38.5 85.7 TMPRSS11E "DESC1, TMPRSS11E2" ENSG00000087128 "Transmembrane serine protease 11E" Q9UL52 4 68447463-68497604 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix: 89.5;esophagus: 220.2;salivary gland: 56.7;vagina: 156.3" "Cell type enriched" "Detected in some" 14 "Ionocytes: 476.0" "Group enriched" "Detected in many" 6 "cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.5;OE19: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043816, HPA051062" Enhanced Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA043816: , HPA051062: AB_2681329" "unprognostic (2.53e-1)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" "unprognostic (9.14e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (2.22e-1)" "unprognostic (9.70e-3)" "unprognostic (2.16e-1)" "unprognostic (3.74e-2)" "unprognostic (4.03e-2)" "unprognostic (8.39e-2)" "unprognostic (1.27e-1)" "unprognostic (3.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 89.5 0.0 0.0 0.0 0.0 18.2 220.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.2 0.0 0.0 56.7 0.7 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 24.5 6.5 156.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 12.9 0.7 0.0 0.0 0.5 0.3 0.3 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 476.0 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.2 6.6 0.3 1.1 0.7 0.0 0.0 32.6 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103121476-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 277.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 48.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "RT4: 785.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: AB_2673552" "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.10e-4)" "prognostic favorable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favorable (7.17e-5)" 119.9 76.8 9.0 103.6 11.5 106.8 78.4 6.7 12.2 53.8 12.1 39.8 38.0 50.9 6.6 88.3 57.1 102.2 48.3 8.0 9.7 67.7 61.6 142.4 87.4 17.1 10.4 16.9 33.6 66.8 16.6 48.4 16.2 73.6 26.8 1.6 84.0 14.9 35.0 53.3 52.5 24.8 13.6 147.9 37.4 37.1 21.4 39.5 36.8 32.5 80.3 277.5 74.6 16.1 34.7 156.3 1.1 0.6 10.1 45.9 54.5 9.7 43.2 26.4 8.9 1.6 148.7 0.3 120.3 48.5 142.5 104.2 11.6 0.0 11.9 6.1 0.6 15.4 120.0 0.7 19.2 7.7 20.0 17.8 1.6 8.4 0.1 10.5 14.2 7.7 15.5 35.3 3.6 3.4 0.4 11.6 9.7 19.6 13.4 6.8 18.9 24.9 80.8 785.1 1.3 2.3 150.2 52.4 1.9 5.6 83.8 50.4 28.4 5.1 13.5 30.3 31.5 31.4 2.4 0.9 38.1 34.0 16.1 5.9 16.8 9.0 0.1 18.6 0.1 0.1 0.1 0.0 9.4 0.2 0.1 0.1 48.4 0.2 15.0 0.5 0.0 4.5 9.0 11.5 6.7 12.2 8.0 9.7 17.1 10.4 16.2 13.6 21.4 16.1 45.8 0.0 25.1 2.3 8.2 28.3 41.8 295.5 6.8 1.1 24.2 11.4 14.1 51.5 126.1 27.6 0.0 1.2 1.3 1.0 0.0 160.9 36.8 92.4 122.2 47.1 17.3 1.7 2.5 44.7 61.2 123.3 5.6 172.8 33.7 4.5 18.9 8.0 54.1 0.0 5.7 0.3 85.5 151.2 198.7 48.8 8.4 163.3 30.2 25.3 351.9 5.9 5.2 1.0 0.9 122.1 18.3 2.2 11.7 186.0 0.7 14.4 121.5 0.7 19.7 104.9 39.7 2.1 4.6 20.7 33.4 4.8 8.3 1.1 1.9 138.6 TNFSF9 "4-1BB-L, 4-1BBL" ENSG00000125657 "TNF superfamily member 9" P41273 19 6531026-6535924 "Plasma proteins, Predicted intracellular proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 9.8;esophagus: 9.8;vagina: 9.5" "Cell type enhanced" "Detected in many" "B-cells: 57.5;dendritic cells: 51.6;Gastric mucus-secreting cells: 23.0;Macrophages: 22.5;T-cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 85.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA059857 Approved "Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA059857: AB_2684144" "unprognostic (2.21e-1)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "unprognostic (7.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-1)" "unprognostic (2.93e-2)" "unprognostic (2.41e-3)" "unprognostic (4.88e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (8.07e-3)" 1.8 0.6 3.5 1.0 3.0 3.7 0.8 3.7 7.6 9.8 2.3 1.2 0.3 0.3 0.3 9.8 1.1 1.0 0.6 3.9 3.3 0.9 0.4 4.9 1.1 3.6 2.9 0.5 0.3 0.5 0.3 0.9 3.4 0.3 1.8 0.3 1.5 0.1 0.7 1.4 1.2 0.4 3.1 2.2 0.6 3.3 3.1 0.5 0.4 0.3 0.7 0.7 9.5 6.3 10.7 13.4 0.2 4.8 2.5 6.0 0.4 1.5 4.8 3.6 17.1 0.3 18.0 11.3 6.8 3.0 0.0 19.2 5.4 2.3 0.9 0.0 2.6 1.8 18.4 4.4 0.4 0.3 85.8 1.0 10.1 20.1 5.5 2.6 0.6 1.6 10.9 0.2 1.3 1.5 0.9 1.8 1.8 0.7 9.5 1.2 0.0 2.8 22.9 0.4 0.0 0.0 29.8 1.7 5.0 0.6 1.2 16.4 6.2 0.0 9.6 26.0 0.0 26.9 10.2 20.9 10.2 5.9 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.5 3.0 3.7 7.6 3.9 3.3 3.6 2.9 3.4 3.1 3.1 6.3 11.3 0.0 4.5 0.0 57.5 2.7 0.3 4.3 6.2 0.2 4.0 3.8 8.1 0.0 1.6 0.0 0.0 0.1 51.6 4.3 0.0 0.3 0.1 5.7 3.9 6.8 14.2 0.0 2.2 0.2 0.0 12.6 23.0 9.2 8.9 0.6 1.8 0.0 4.5 0.0 2.5 3.4 2.0 1.9 15.9 0.0 0.0 22.5 3.6 0.0 1.6 0.8 0.0 1.5 2.9 0.8 4.9 0.0 17.2 0.9 0.2 0.1 0.9 0.2 0.0 2.5 7.5 0.1 0.4 12.7 1.3 0.1 31.5 0.9 5.7 0.3 TNNT1 "ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS" ENSG00000105048 "Troponin T1, slow skeletal type" P13805 19 55132698-55149206 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 29 "skeletal muscle: 21567.3;tongue: 13372.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 61.2;Basal squamous epithelial cells: 47.8;Cardiomyocytes: 51.5;Skeletal myocytes: 192.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "eosinophil: 211.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 211.5" "Cell line enhanced" "Detected in many" "HMC-1: 829.4;RH-30: 638.8" "Region enriched" "Detected in many" 5 "thalamus: 125.0" "Region enhanced" "Detected in all" "thalamus: 23.1" "CAB015168, HPA058448" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 79000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Golgi apparatus, Cytosol" "CAB015168: AB_2206426, HPA058448: AB_2683720" "unprognostic (1.88e-1)" "unprognostic (7.23e-2)" "prognostic unfavorable (4.66e-4)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.47e-3)" "unprognostic (3.92e-3)" "unprognostic (1.35e-3)" "unprognostic (1.03e-3)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.23e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.91e-2)" "unprognostic (4.01e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-2)" 5.7 1.2 42.1 0.4 45.7 3.3 5.0 44.3 55.4 1.9 36.4 2.7 1.0 1.1 1.0 593.5 8.4 1.0 256.7 43.9 38.9 1.3 2.5 8.3 0.4 36.7 41.4 1.5 2.5 2.3 8.5 6.0 38.5 200.4 0.6 0.6 171.2 0.4 21567.3 48.5 2.0 0.4 35.6 1.9 1.9 10.6 40.8 3.4 3.8 13372.6 2.0 1.7 5.8 40.8 178.4 102.3 1.0 22.4 0.0 1.7 33.3 8.0 30.1 11.1 32.7 37.9 115.8 2.6 66.5 3.2 88.8 88.5 24.0 76.0 9.4 11.8 192.2 33.6 11.8 6.7 3.7 2.7 829.4 36.6 121.3 3.4 127.0 125.7 0.5 35.1 171.7 158.6 10.3 168.0 3.4 0.3 21.4 45.0 202.1 113.9 638.8 21.2 26.5 5.8 6.6 49.3 10.7 1.3 57.9 8.5 106.3 102.7 2.9 163.6 238.9 6.5 12.4 1.2 7.0 8.8 171.8 26.4 50.9 2.4 39.4 211.5 0.3 21.7 0.3 0.2 0.3 0.3 37.4 0.4 0.3 0.4 1.9 0.6 10.2 0.9 0.1 12.2 42.1 45.7 44.3 55.4 43.9 38.9 36.7 41.4 38.5 35.6 40.8 40.8 0.0 0.0 0.0 0.7 0.3 61.2 0.6 25.1 47.8 4.5 0.5 5.3 51.5 0.0 2.8 0.0 0.0 2.2 0.0 0.5 0.0 2.1 2.1 9.7 0.3 2.6 2.4 2.7 0.4 0.0 18.0 18.8 0.0 3.4 0.0 22.1 1.4 0.0 12.9 0.0 0.7 0.3 0.0 13.2 3.8 10.7 0.3 8.9 3.6 0.0 25.8 0.7 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.7 0.0 192.0 3.5 4.3 34.1 2.5 30.4 3.6 1.6 1.2 0.8 0.2 TNRC6A "CAGH26, GW182, KIAA1460, TNRC6" ENSG00000090905 "Trinucleotide repeat containing adaptor 6A" Q8NDV7 16 24610209-24827632 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 289.3;Excitatory neurons: 283.8;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 265.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015305, HPA017869" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA015305: AB_1850454, HPA017869: AB_1850456" "unprognostic (2.64e-1)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (1.10e-3)" "unprognostic (1.62e-1)" "unprognostic (3.22e-3)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (7.44e-3)" "unprognostic (2.63e-3)" "unprognostic (1.78e-1)" "unprognostic (9.18e-2)" "unprognostic (5.77e-2)" "unprognostic (2.31e-1)" "unprognostic (3.35e-2)" 17.2 21.0 5.0 6.4 3.6 6.0 14.9 10.8 7.1 17.8 6.1 17.8 5.5 23.5 11.5 11.3 17.7 6.4 11.1 3.4 6.6 10.3 13.0 12.8 7.1 6.1 4.8 20.6 19.2 13.2 22.8 6.6 6.1 14.6 6.4 7.0 14.9 8.0 14.0 13.1 15.3 8.1 2.2 9.9 15.2 6.6 7.0 8.6 17.8 6.9 7.4 13.0 13.4 7.4 10.1 13.8 16.0 8.7 13.6 17.7 9.1 16.9 13.6 12.0 13.1 10.2 8.2 10.2 7.1 17.0 12.4 11.2 20.1 14.2 18.0 10.4 10.4 10.2 16.7 14.1 11.7 10.5 6.9 18.0 7.3 15.8 10.2 14.8 16.7 6.6 15.7 6.2 15.8 11.9 8.8 6.9 23.1 4.9 6.8 17.1 12.4 9.1 9.1 9.3 7.7 10.8 11.8 7.2 6.6 12.1 8.4 6.8 15.5 15.3 10.5 7.6 12.0 13.7 11.6 16.5 14.3 6.4 11.3 0.5 0.5 0.4 0.5 0.3 0.4 1.1 0.5 0.5 0.2 1.0 0.7 0.5 0.3 0.6 0.3 1.0 0.5 0.3 5.0 3.6 10.8 7.1 3.4 6.6 6.1 4.8 6.1 2.2 7.0 7.4 51.2 38.5 60.0 289.3 45.5 34.9 17.8 21.9 39.9 97.1 42.8 41.0 75.3 51.5 32.3 46.0 118.9 22.4 49.9 38.3 17.6 23.6 17.2 38.7 65.5 45.5 55.9 34.9 283.8 24.5 15.1 50.5 33.6 42.8 39.3 76.5 60.3 115.3 21.2 176.7 414.6 36.3 22.4 56.2 26.5 11.3 69.0 28.7 30.2 138.7 36.1 42.0 50.4 265.4 234.2 28.5 36.1 81.3 44.7 26.0 42.8 19.2 29.8 81.7 19.7 52.8 60.9 41.2 30.6 38.1 28.7 8.2 39.0 36.5 35.8 17.4 TOM1L2 ENSG00000175662 "Target of myb1 like 2 membrane trafficking protein" Q6ZVM7 17 17843511-17972422 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 180.5;Cone photoreceptor cells: 158.4;Oligodendrocytes: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 104.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022541, HPA023304" Enhanced Approved "Golgi apparatus,Intermediate filaments" NA NA 73000 "Cluster 6: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 9: Photoreceptor cells - Phototransduction" "Intermediate filaments" "Golgi apparatus" "HPA022541: AB_1858182, HPA023304: AB_1858183" "unprognostic (2.32e-1)" "unprognostic (7.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.25e-2)" "prognostic favorable (1.24e-4)" "unprognostic (2.22e-1)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "prognostic unfavorable (2.58e-4)" "prognostic favorable (1.92e-4)" "unprognostic (3.19e-2)" "prognostic favorable (6.21e-9)" "unprognostic (7.11e-2)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (4.51e-2)" 20.7 30.5 64.0 9.5 62.7 6.1 20.3 52.7 70.0 31.9 21.3 44.2 14.0 33.2 11.0 64.4 26.6 13.0 141.0 66.0 56.4 31.3 13.9 23.2 7.7 91.5 80.3 32.9 19.7 40.3 42.2 9.0 95.3 37.3 13.8 50.2 21.3 28.7 67.1 59.7 20.9 23.3 49.7 16.6 34.9 39.4 74.6 8.8 48.5 55.4 12.9 31.4 35.1 72.7 27.1 29.0 8.2 6.2 19.1 19.3 14.2 43.3 20.1 22.9 19.3 28.2 17.6 5.0 52.9 40.8 13.3 104.3 6.8 24.1 14.0 7.2 12.7 8.0 28.0 6.0 12.2 2.0 5.2 22.9 16.6 20.5 15.2 19.6 23.3 7.3 3.0 6.9 30.3 27.1 3.6 4.6 1.5 34.4 19.5 4.7 20.7 12.0 32.4 48.1 8.7 8.4 19.5 25.2 15.3 55.9 13.4 3.6 31.8 21.9 6.5 46.0 16.8 6.1 5.1 2.3 26.4 2.7 55.2 10.0 3.3 4.8 2.8 1.0 2.0 1.6 2.6 2.4 1.6 2.2 4.3 3.2 12.8 1.4 3.3 1.9 1.3 1.7 64.0 62.7 52.7 70.0 66.0 56.4 91.5 80.3 95.3 49.7 74.6 72.7 10.1 32.1 17.0 180.5 9.5 10.8 14.6 13.9 7.4 74.5 20.9 14.1 73.7 15.7 16.6 11.0 158.4 8.5 10.2 43.3 5.9 12.2 30.8 14.1 9.4 12.4 20.4 4.8 63.2 8.7 17.4 12.7 13.3 15.7 2.5 28.1 16.4 13.4 9.2 95.9 74.2 19.2 18.3 8.5 7.6 64.2 26.4 6.4 12.4 35.6 11.8 28.1 10.3 66.9 123.2 16.1 41.0 25.6 8.4 39.1 22.4 11.1 22.9 78.3 19.7 18.0 13.0 16.7 12.1 37.2 17.2 32.2 10.0 30.8 15.4 64.5 TP53I11 PIG11 ENSG00000175274 "Tumor protein p53 inducible protein 11" O14683 11 44885903-44951306 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 461.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 41.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 133.9;SCLC-21H: 357.9;T-47d: 209.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059727, HPA061276" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum, Golgi apparatus" "HPA059727: AB_2684113, HPA061276: AB_2684461" "prognostic unfavorable (7.33e-5)" "unprognostic (1.87e-1)" "unprognostic (4.03e-2)" "unprognostic (3.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (6.55e-2)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.65e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" 77.8 18.6 41.1 20.4 17.8 29.6 63.7 40.5 27.5 32.8 19.7 43.4 20.2 36.0 4.9 24.5 45.5 24.7 71.7 24.7 27.6 27.9 10.5 45.7 12.7 16.9 30.2 20.0 37.7 5.6 20.3 23.9 24.1 47.8 27.5 2.2 42.7 11.7 15.0 30.3 38.8 32.8 19.5 61.2 29.9 16.2 18.3 9.1 41.0 10.3 12.3 29.2 32.0 13.4 0.0 82.0 27.3 38.2 28.0 2.2 0.5 23.9 46.3 8.5 10.7 5.1 0.5 14.3 20.5 6.9 21.7 14.5 14.6 0.5 2.8 28.0 12.3 1.3 0.8 0.0 52.5 0.8 101.1 118.0 1.9 11.5 4.9 2.0 29.6 31.6 2.2 0.1 11.3 73.0 1.4 133.9 48.9 53.4 26.9 60.3 16.1 7.2 0.0 5.2 357.9 13.0 44.2 96.8 0.1 33.9 209.9 7.5 6.8 55.8 39.3 87.3 0.1 0.5 0.5 0.3 0.1 7.8 16.1 0.0 5.9 0.0 5.2 5.8 7.0 8.0 1.0 5.1 4.7 8.4 0.0 1.7 41.2 8.1 21.2 25.3 0.9 4.8 41.1 17.8 40.5 27.5 24.7 27.6 16.9 30.2 24.1 19.5 18.3 13.4 52.2 22.4 30.9 0.3 13.2 10.8 36.9 12.9 13.6 1.7 29.5 22.7 10.3 24.3 23.7 42.3 0.0 57.8 8.7 31.0 1.9 32.0 96.5 9.0 6.3 45.1 36.0 3.2 2.7 21.3 22.0 15.0 23.0 9.7 0.0 7.8 76.8 1.6 35.7 0.0 10.2 30.1 38.7 7.5 20.3 461.2 12.2 9.3 10.6 5.6 11.5 0.8 0.0 0.0 0.5 28.5 16.0 7.5 2.1 28.6 17.7 0.1 14.5 0.8 13.1 1.4 22.4 3.4 6.3 4.4 4.4 68.3 8.7 5.1 54.0 45.7 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652516-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 8.0;fallopian tube: 6.7;skin 1: 6.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 13.0;Basal squamous epithelial cells: 16.5;Early spermatids: 21.8;Endometrial ciliated cells: 31.0;Late spermatids: 15.7;Respiratory ciliated cells: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 15.0;RH-30: 11.6;SCLC-21H: 18.0;U-698: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 27: Brain & Skin - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971" "unprognostic (5.71e-3)" "prognostic favorable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favorable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favorable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.0 0.0 0.7 0.7 0.5 0.5 0.8 4.2 0.5 1.4 8.0 0.2 0.0 0.1 0.1 3.7 6.7 0.0 0.1 0.8 0.7 0.1 0.2 0.9 1.0 2.4 2.9 0.1 0.8 0.1 0.3 0.0 1.4 2.6 0.1 0.2 2.9 0.3 0.2 6.6 0.2 0.0 1.4 0.7 0.3 0.7 0.7 1.6 0.2 0.0 1.4 0.1 2.9 1.0 2.6 0.1 0.3 7.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.9 4.0 2.6 2.0 0.0 0.9 4.3 2.7 0.9 0.0 0.8 8.7 0.2 3.9 2.6 0.0 0.0 2.9 0.0 1.7 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.8 1.9 15.0 2.0 0.5 0.0 0.1 0.0 11.6 0.1 0.3 3.8 18.0 8.4 0.4 0.0 0.8 0.0 10.9 9.2 0.0 2.9 7.5 0.0 5.8 3.3 0.7 18.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 4.2 0.5 0.8 0.7 2.4 2.9 1.4 1.4 0.7 1.0 0.0 0.0 1.5 0.0 1.2 3.1 3.8 13.0 16.5 0.5 0.2 2.5 1.5 0.0 7.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 21.8 31.0 0.3 0.3 2.4 3.2 0.1 0.2 0.4 0.4 0.0 0.7 0.0 0.1 0.4 0.2 0.3 0.0 0.1 0.5 2.0 0.0 1.3 15.7 0.6 0.1 1.8 0.0 0.0 0.2 0.0 2.5 0.1 0.2 0.0 0.0 6.8 0.2 0.0 0.1 35.8 0.1 0.0 0.0 2.6 0.1 0.4 1.6 2.3 0.3 0.4 0.1 0.3 0.2 TPD52 "D52, hD52, N8L" ENSG00000076554 "Tumor protein D52" P55327 8 80034745-80231232 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 187.6" "Cell type enhanced" "Detected in many" "Ionocytes: 476.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 50.5" "Group enriched" "Detected in many" 5 "B-cells: 50.5;NK-cells: 15.1;T-cells: 22.0" "Cell line enhanced" "Detected in many" "Karpas-707: 252.6;SK-BR-3: 572.5" "HPA028427, HPA062167" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 310000 "Cluster 43: B-cells - Humoral immune response" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" Cytosol "Golgi apparatus" "HPA028427: AB_10610561, HPA062167: AB_2684704" "prognostic unfavorable (1.11e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-2)" "unprognostic (3.77e-3)" "unprognostic (8.24e-2)" "unprognostic (3.75e-1)" "unprognostic (7.99e-3)" "unprognostic (6.47e-2)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.77e-6)" "unprognostic (2.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (1.70e-2)" 5.4 9.2 34.9 28.4 40.2 8.9 75.9 34.2 69.4 19.6 36.6 117.7 98.9 9.9 56.2 34.9 15.3 31.1 11.7 42.9 35.4 46.5 30.7 19.8 44.0 33.2 37.1 2.4 41.8 27.4 34.3 22.9 36.3 104.8 129.7 187.6 80.7 18.3 8.6 46.9 100.3 10.4 32.8 16.0 84.1 5.2 53.3 15.5 64.5 9.8 56.2 20.9 20.2 48.1 131.8 34.9 1.6 23.0 0.0 0.0 51.7 8.6 12.9 34.7 17.1 18.0 37.4 189.9 45.2 0.8 25.5 52.5 52.7 36.3 24.6 23.8 44.2 26.8 46.9 29.4 0.2 8.6 0.7 0.0 25.2 0.1 12.2 21.6 2.0 128.9 0.4 252.6 0.1 43.6 42.6 39.4 11.7 148.8 86.0 0.3 0.7 122.0 60.7 31.6 64.9 44.1 40.1 572.5 110.7 51.0 55.9 34.2 2.1 0.0 35.2 0.6 30.8 94.1 87.1 155.2 22.5 0.2 2.6 0.6 0.1 5.5 12.7 0.1 22.0 50.5 12.4 11.1 2.5 44.7 8.1 9.3 0.5 15.1 0.1 5.2 9.1 8.3 34.9 40.2 34.2 69.4 42.9 35.4 33.2 37.1 36.3 32.8 53.3 48.1 17.3 44.8 67.8 10.4 133.6 80.7 89.6 83.4 51.2 171.1 105.6 54.2 22.2 82.9 78.1 66.2 118.9 98.9 28.6 230.9 170.2 112.8 20.6 25.2 8.4 26.2 169.9 11.6 85.4 79.6 116.9 6.7 97.3 72.8 1.3 15.3 25.7 40.6 13.1 32.0 53.9 331.9 476.0 14.6 24.2 13.0 1.2 10.8 104.9 37.5 91.2 50.3 60.8 69.9 181.0 79.7 317.5 1.5 270.5 214.4 132.3 135.3 21.4 232.2 0.0 49.6 8.3 1.6 18.2 91.4 124.6 231.2 51.3 0.3 247.1 135.4 TPST1 TANGO13A ENSG00000169902 "Tyrosylprotein sulfotransferase 1" O60507 7 66205317-66420543 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 76.5;Excitatory neurons: 101.9;Inhibitory neurons: 107.1;Spermatocytes: 97.1" "Cancer enhanced" "Detected in all" "glioma: 36.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 52.2;neutrophil: 35.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047415, HPA061837" Approved Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA047415: AB_10964056, HPA061837: AB_2732672" "unprognostic (7.46e-2)" "unprognostic (1.45e-1)" "unprognostic (8.62e-2)" "unprognostic (3.43e-2)" "unprognostic (3.52e-2)" "unprognostic (1.78e-3)" "unprognostic (5.71e-2)" "unprognostic (8.21e-2)" "unprognostic (3.59e-1)" "unprognostic (9.25e-3)" "unprognostic (4.12e-2)" "unprognostic (4.98e-1)" "prognostic unfavorable (8.16e-6)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.48e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.73e-5)" 16.9 15.8 22.1 10.8 20.5 6.0 13.4 18.4 21.6 35.4 12.3 11.1 3.2 21.8 14.3 10.8 11.2 38.1 8.5 19.4 36.7 23.1 46.0 11.5 5.9 37.2 25.0 13.5 7.8 11.0 19.5 26.4 24.7 15.1 8.0 5.2 6.8 16.4 2.7 8.2 8.7 16.2 22.9 12.0 10.9 23.0 33.8 2.1 11.3 5.6 5.3 36.8 22.1 22.5 12.1 6.5 16.5 22.4 52.7 42.0 5.7 22.3 49.8 25.7 37.1 21.9 6.6 1.4 17.7 45.1 38.9 8.9 16.2 24.8 33.3 3.5 9.3 2.3 15.1 16.5 62.3 1.8 1.9 59.5 19.0 50.2 22.1 27.8 32.7 2.9 1.0 10.2 40.2 6.2 0.1 3.1 15.5 0.4 9.6 7.8 14.6 11.4 27.3 11.5 10.4 44.5 27.8 2.1 62.2 32.4 8.6 4.7 62.3 33.1 21.3 24.2 40.6 9.2 13.3 4.7 29.6 6.8 48.2 52.2 2.3 23.9 0.8 0.1 0.8 6.1 0.5 0.6 0.3 14.0 2.2 4.1 35.2 8.8 0.0 0.0 0.0 1.9 22.1 20.5 18.4 21.6 19.4 36.7 37.2 25.0 24.7 22.9 33.8 22.5 33.8 0.0 8.9 38.8 11.5 10.8 7.7 24.4 33.6 8.5 4.0 13.3 1.6 5.7 9.6 31.3 2.1 1.8 3.8 0.2 9.8 23.0 11.2 13.3 76.5 17.9 7.7 1.3 101.9 47.6 4.3 58.5 12.2 9.7 4.5 12.2 10.0 34.1 16.2 6.7 107.1 0.8 8.2 8.9 8.9 11.6 48.1 6.2 14.2 32.8 15.8 5.0 1.0 61.3 38.8 23.7 0.1 37.2 7.1 5.3 0.0 3.2 19.5 3.6 6.6 16.4 21.6 97.1 41.3 15.1 7.5 3.8 2.8 12.6 0.7 7.7 TRAF3IP2 "ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522" ENSG00000056972 "TRAF3 interacting protein 2" O43734 6 111555381-111606906 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Inflammatory response, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 149.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA036352 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" Vesicles "HPA036352: AB_10672085" "unprognostic (1.94e-1)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-1)" "prognostic favorable (4.73e-5)" "unprognostic (2.81e-2)" "unprognostic (3.03e-2)" "unprognostic (1.01e-2)" "unprognostic (9.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.13e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (5.16e-5)" "unprognostic (1.11e-1)" "unprognostic (4.88e-1)" "unprognostic (2.34e-2)" "unprognostic (1.31e-1)" 19.7 16.3 24.8 19.5 24.8 32.4 19.9 24.3 29.4 24.9 23.7 34.0 28.6 36.2 47.2 26.5 34.7 14.2 8.3 24.4 26.0 9.3 8.6 17.5 16.3 27.2 28.2 13.9 21.6 13.6 9.3 14.2 25.6 19.2 26.4 5.9 25.3 30.8 11.4 35.0 25.1 22.1 21.7 6.8 35.5 3.0 28.7 21.0 14.8 14.8 22.5 26.5 18.1 22.9 32.2 11.0 6.8 15.7 35.9 39.0 15.6 39.8 62.2 9.9 14.1 8.7 14.1 6.2 13.2 33.5 35.5 58.2 8.0 86.2 18.4 43.2 11.6 12.7 10.6 11.9 13.9 6.9 22.6 47.1 57.5 29.9 110.1 24.9 20.0 15.2 13.6 1.9 13.2 22.0 51.2 19.4 9.0 30.6 8.8 53.3 12.4 2.7 29.5 52.4 27.3 6.9 12.1 71.8 47.8 12.7 31.6 18.0 9.2 19.2 7.6 149.7 35.5 0.8 12.4 16.8 45.8 10.8 50.1 25.8 2.5 5.3 3.8 0.8 12.7 6.4 7.6 5.6 2.6 8.6 7.6 7.4 3.5 5.7 0.3 0.8 17.9 3.1 24.8 24.8 24.3 29.4 24.4 26.0 27.2 28.2 25.6 21.7 28.7 22.9 24.7 3.2 13.8 26.1 10.8 30.1 61.5 46.3 11.4 7.5 8.3 8.6 4.9 7.2 21.6 3.7 12.5 19.3 3.8 30.0 5.9 35.4 0.1 20.9 14.5 18.3 13.2 5.2 5.9 31.9 28.8 14.4 18.3 32.7 20.2 7.7 3.9 5.5 6.0 6.7 10.8 16.9 16.2 1.3 10.7 0.5 7.2 5.8 12.4 7.5 6.2 14.2 8.2 19.6 6.6 20.2 26.3 7.5 4.5 42.9 18.5 5.9 18.3 5.5 0.0 14.7 10.5 0.8 2.1 16.2 24.6 20.9 7.9 4.6 21.9 45.0 TRAPPC12 "CGI-87, TTC-15, TTC15" ENSG00000171853 "Trafficking protein particle complex 12" Q8WVT3 2 3379675-3485094 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 96.6" "Cell type enhanced" "Detected in all" "Early spermatids: 293.9;Late spermatids: 504.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034799, HPA043196" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA034799: AB_10600920, HPA043196: " "prognostic favorable (1.80e-5)" "unprognostic (9.21e-2)" "unprognostic (1.01e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-2)" "unprognostic (1.32e-2)" "unprognostic (1.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.27e-1)" "prognostic favorable (9.15e-4)" "unprognostic (3.23e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.53e-1)" "unprognostic (7.18e-2)" 21.7 26.0 13.9 10.9 14.4 10.1 21.8 15.0 23.3 20.2 13.5 27.9 10.1 23.7 6.3 23.0 22.2 10.4 46.7 14.8 15.9 22.6 28.0 17.1 16.0 15.9 14.1 21.4 26.2 18.4 26.7 6.6 17.1 20.6 4.7 9.1 25.8 10.0 45.8 35.7 21.2 5.2 14.6 22.1 28.4 96.6 14.8 15.7 24.7 6.4 5.0 26.1 18.9 15.5 16.4 28.0 9.1 10.4 19.9 24.5 23.9 26.6 6.5 7.6 4.2 17.5 13.6 18.8 28.6 9.0 6.7 20.8 10.5 11.9 3.1 22.8 39.5 16.2 8.1 60.8 9.0 20.4 28.0 18.1 9.0 8.5 21.2 5.8 6.7 21.5 25.5 10.0 13.5 22.5 20.6 34.9 22.1 7.3 39.4 15.4 12.4 15.3 8.1 13.5 23.2 37.8 10.6 11.8 18.5 4.0 13.9 16.3 17.2 18.6 10.6 18.7 23.6 28.5 22.4 15.0 21.8 15.9 10.5 0.7 1.0 3.8 0.8 2.5 2.0 0.5 1.3 2.2 1.4 0.5 0.8 1.0 1.0 0.9 3.6 4.3 2.5 0.8 13.9 14.4 15.0 23.3 14.8 15.9 15.9 14.1 17.1 14.6 14.8 15.5 18.8 9.6 12.8 59.4 20.7 11.5 16.2 15.1 14.2 31.8 13.7 16.0 68.4 21.5 11.2 12.9 33.3 21.3 16.9 17.1 58.7 21.7 293.9 20.3 16.4 18.5 3.5 19.1 56.2 18.0 15.2 23.7 23.0 14.5 5.7 22.3 11.0 16.0 25.9 26.9 62.5 17.7 14.2 17.9 10.0 504.5 26.4 20.7 16.0 30.0 28.5 42.6 15.5 52.3 56.4 23.9 11.9 24.0 19.6 16.0 20.3 30.0 19.4 42.0 26.3 20.9 21.7 125.2 26.3 18.8 17.8 17.6 14.4 33.8 15.7 12.2 TRAPPC3 BET3 ENSG00000054116 "Trafficking protein particle complex 3" O43617 1 36136570-36156053 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028408 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" Cytosol "Golgi apparatus" "HPA028408: AB_10601826" "unprognostic (3.54e-3)" "unprognostic (1.17e-1)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (7.39e-3)" "unprognostic (1.15e-1)" "unprognostic (7.12e-3)" "unprognostic (7.38e-2)" "unprognostic (2.94e-1)" "unprognostic (9.25e-3)" "unprognostic (2.61e-2)" "unprognostic (9.47e-2)" "unprognostic (2.10e-3)" "unprognostic (6.53e-2)" 43.7 74.7 42.5 31.2 43.0 28.8 46.6 47.0 50.7 38.5 53.7 57.0 33.6 41.1 60.7 61.6 37.0 32.6 51.1 43.1 44.9 55.3 51.2 36.4 38.3 48.0 45.1 28.2 46.0 54.4 47.0 37.8 47.2 39.2 42.5 39.9 46.4 45.4 48.9 51.5 38.5 49.9 48.3 41.6 48.2 53.1 46.3 51.3 59.9 44.6 54.4 46.2 41.2 48.9 95.7 65.6 44.9 70.2 114.2 91.4 87.9 85.2 109.0 100.0 97.0 55.9 90.0 40.4 79.0 95.0 79.6 68.8 69.9 114.1 113.8 79.8 103.7 75.8 77.2 81.7 132.6 80.0 76.7 78.3 98.5 93.8 91.5 103.6 126.7 101.2 93.2 67.0 122.0 71.4 95.6 74.6 60.5 79.5 93.7 65.8 63.8 90.9 128.4 76.1 67.8 49.7 69.2 78.5 140.1 115.2 50.2 59.6 95.6 59.1 66.7 116.0 116.3 80.1 87.0 67.3 100.7 88.7 60.5 161.9 130.2 148.7 85.0 142.5 89.4 93.6 100.4 90.4 132.6 89.0 96.0 86.9 134.3 95.8 116.3 109.4 135.4 155.3 42.5 43.0 47.0 50.7 43.1 44.9 48.0 45.1 47.2 48.3 46.3 48.9 41.9 25.6 27.6 12.1 45.6 101.1 111.5 152.1 52.3 41.8 97.8 78.5 57.8 55.8 75.7 38.6 16.7 145.7 43.0 55.1 170.2 157.0 286.1 51.8 38.3 59.1 48.3 63.3 15.4 188.5 146.0 52.1 29.0 55.6 45.7 40.5 33.2 49.8 145.0 53.8 16.9 51.2 132.2 56.1 74.7 131.0 42.9 60.6 96.0 10.3 104.4 68.0 61.8 8.5 17.9 178.4 72.1 51.9 80.7 196.9 73.3 115.9 49.2 30.7 32.9 37.4 69.2 172.5 89.4 63.4 123.6 191.4 50.4 50.3 54.3 134.1 TRAPPC3L "bA259P20.2, BET3L, FLJ11180" ENSG00000173626 "Trafficking protein particle complex 3 like" Q5T215 6 116494989-116545684 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.1" "Cell type enhanced" "Detected in some" "Adipocytes: 1.6;Early spermatids: 1.8;Endothelial cells: 1.5;Hepatic stellate cells: 6.1;Kupffer cells: 4.2;Macrophages: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA060912 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 6: Brain - Smell perception" "Cluster 2: Karpas-707 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Vesicles" "HPA060912: " "unprognostic (1.34e-1)" "unprognostic (7.24e-2)" "unprognostic (1.93e-2)" "unprognostic (2.91e-1)" "unprognostic (5.25e-2)" "unprognostic (1.15e-2)" "unprognostic (8.98e-2)" "unprognostic (9.09e-4)" "unprognostic (8.41e-2)" "unprognostic (3.23e-2)" "unprognostic (1.96e-1)" "unprognostic (2.91e-3)" "unprognostic (2.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "unprognostic (8.11e-2)" "unprognostic (7.47e-3)" 0.7 0.7 1.6 0.8 1.7 3.7 1.0 8.1 5.0 0.4 0.3 0.7 1.0 1.2 1.8 0.7 0.5 1.1 0.9 2.3 0.0 0.7 1.4 1.2 1.7 0.6 0.1 1.0 0.7 3.0 0.0 3.9 1.6 0.7 0.5 4.2 1.2 0.7 1.2 2.3 1.0 0.4 0.1 4.7 1.1 1.5 0.7 0.5 1.8 0.2 0.6 0.5 0.0 3.9 0.8 0.4 1.0 1.5 0.3 1.0 1.1 0.5 0.5 0.4 0.5 0.5 0.7 1.3 0.6 0.2 0.8 1.0 0.3 0.6 0.5 0.6 0.6 1.4 1.9 0.6 0.5 0.9 0.6 0.4 0.3 0.2 0.3 1.5 0.8 1.0 0.8 6.6 0.3 1.5 0.9 1.0 0.9 0.3 0.6 0.8 0.7 2.2 0.7 1.3 1.0 0.7 0.8 0.4 0.5 1.2 0.7 0.8 1.0 1.2 0.9 1.2 0.6 1.2 0.8 0.8 0.8 0.9 0.7 0.6 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.3 0.1 2.8 1.6 1.7 8.1 5.0 2.3 0.0 0.6 0.1 1.6 0.1 0.7 3.9 1.6 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.5 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 6.1 0.1 1.1 0.0 0.1 0.0 0.0 4.2 0.0 0.4 0.3 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 TRAPPC9 "IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120" ENSG00000167632 "Trafficking protein particle complex 9" Q96Q05 8 139727725-140458579 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 89.5;Excitatory neurons: 121.8;Inhibitory neurons: 136.3;Late spermatids: 119.0;Microglial cells: 105.9;Oligodendrocyte precursor cells: 93.5;Oligodendrocytes: 170.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026579 Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA026579: AB_1854459" "unprognostic (1.82e-2)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.14e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.76e-2)" "unprognostic (2.31e-1)" "prognostic favorable (5.11e-6)" "unprognostic (2.09e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.62e-1)" 8.6 13.4 10.3 6.9 11.0 11.1 8.9 10.7 12.7 10.3 12.5 11.1 8.0 11.3 5.1 12.3 12.2 5.8 15.0 10.8 10.3 13.8 11.6 9.5 8.0 13.1 14.1 10.5 11.9 27.4 20.7 7.2 13.9 11.7 6.0 14.2 11.6 8.3 33.5 11.4 10.9 7.2 10.2 11.3 12.5 9.0 11.9 11.3 12.9 17.6 6.8 11.1 10.8 13.0 9.6 16.6 7.4 20.8 15.5 9.0 4.9 6.0 9.9 3.1 5.0 6.2 11.2 11.6 14.0 11.9 4.7 12.2 10.0 9.4 3.4 16.8 6.1 18.6 9.8 6.2 11.2 4.7 14.5 8.9 9.3 2.5 7.9 11.1 12.9 13.1 6.7 10.1 5.1 27.0 29.2 6.2 2.3 31.3 14.0 12.2 2.7 19.4 11.6 11.6 19.1 10.6 9.8 4.7 10.6 7.6 15.3 6.8 7.7 4.6 7.9 10.8 4.9 14.1 10.9 7.8 9.6 10.1 7.4 15.4 3.5 2.9 4.2 3.3 4.6 2.7 2.9 3.3 3.5 4.4 2.8 3.6 5.0 4.9 3.4 4.2 2.1 3.5 10.3 11.0 10.7 12.7 10.8 10.3 13.1 14.1 13.9 10.2 11.9 13.0 5.1 3.2 8.3 89.5 9.6 2.3 4.7 3.1 5.7 14.2 5.5 4.1 13.9 5.7 5.3 11.0 20.9 10.9 5.4 15.2 9.8 6.5 47.9 8.4 3.7 6.5 30.5 3.4 121.8 6.2 4.4 5.3 29.6 10.2 8.8 7.9 4.6 9.2 7.5 28.6 136.3 14.4 10.2 10.5 3.7 119.0 5.9 10.3 10.6 105.9 5.3 13.6 11.3 93.5 170.6 5.1 6.6 7.9 11.0 3.7 13.4 19.9 15.7 13.7 6.6 9.0 5.3 3.6 6.6 8.7 3.0 14.6 10.5 8.6 12.0 5.4 TREM1 "CD354, TREM-1" ENSG00000124731 "Triggering receptor expressed on myeloid cells 1" Q9NP99 6 41267926-41286682 "CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 96.0;lung: 65.3;lymphoid tissue: 44.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 26.1;Hofbauer cells: 25.1;Kupffer cells: 35.5;Langerhans cells: 21.5;Late spermatids: 20.6;Macrophages: 104.2;monocytes: 19.9" "Cancer enhanced" "Detected in many" "lung cancer: 9.6" "Region enhanced" "Detected in some" "cerebral cortex: 8.5" "Immune cell enriched" "Detected in many" 7 "neutrophil: 615.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 615.1" "Group enriched" "Detected in some" 4 "SuSa: 6.2;U-87 MG: 24.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005563, HPA053612" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA005563: AB_1858259, HPA053612: " "unprognostic (6.41e-2)" "unprognostic (1.47e-3)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (6.07e-3)" "unprognostic (2.97e-2)" "unprognostic (5.73e-5)" "unprognostic (1.29e-1)" "unprognostic (1.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.24e-3)" "unprognostic (7.65e-2)" "unprognostic (3.18e-7)" "unprognostic (6.32e-3)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (7.26e-2)" 20.4 1.4 0.4 44.1 0.4 96.0 1.2 0.4 8.5 0.8 2.3 0.9 0.4 2.2 0.0 1.5 3.9 9.9 3.8 0.4 0.6 1.1 6.9 65.3 0.4 0.9 0.7 0.5 3.9 1.1 2.4 7.7 1.9 0.7 0.3 0.6 1.2 0.5 0.5 0.2 1.0 8.4 0.6 11.1 0.8 0.3 2.6 3.1 0.7 2.6 1.3 12.6 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 1.6 0.0 0.1 82.7 2.3 0.0 20.7 0.1 0.6 0.1 0.0 32.8 1.5 0.2 0.0 615.1 0.2 10.1 0.7 0.0 32.5 0.4 0.4 0.4 8.5 0.4 0.6 0.9 0.7 1.9 0.6 2.6 0.9 0.0 6.4 26.1 0.0 1.8 0.4 0.4 5.4 0.0 0.0 0.1 0.1 0.3 2.8 12.4 0.0 0.0 0.4 0.3 0.1 0.0 0.3 12.1 0.3 1.8 3.8 0.0 0.0 0.0 0.2 1.1 2.5 1.1 0.1 6.3 0.0 0.7 0.5 25.1 0.0 0.0 0.0 2.0 35.5 21.5 20.6 0.0 104.2 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.2 0.0 0.3 13.3 0.1 0.0 0.8 2.8 0.0 0.1 0.0 0.1 14.6 2.0 0.0 0.0 0.1 TREML1 "dJ238O23.3, TLT1" ENSG00000161911 "Triggering receptor expressed on myeloid cells like 1" Q86YW5 6 41149342-41154337 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.7;brain: 4.5;lymphoid tissue: 7.3" "Group enriched" "Detected in some" 7 "Macrophages: 75.6;monocytes: 28.3" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "basophil: 92.4" "Lineage enriched" "Detected in many" 49 "granulocytes: 92.4" "Cell line enriched" "Detected in single" 170 "HEL: 66.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016700, HPA017860" Enhanced Uncertain "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA 43000000 "Cluster 34: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "Nuclear speckles, Cytosol" "Golgi apparatus, Plasma membrane" "HPA016700: AB_1858262, HPA017860: AB_1858261" "unprognostic (6.70e-2)" "unprognostic (3.50e-3)" "unprognostic (1.15e-3)" "unprognostic (1.62e-1)" "unprognostic (3.48e-2)" "unprognostic (4.53e-5)" "unprognostic (1.10e-2)" "unprognostic (2.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.12e-3)" "unprognostic (2.34e-2)" "unprognostic (7.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.36e-1)" "unprognostic (8.38e-2)" "unprognostic (7.51e-2)" "unprognostic (3.41e-2)" 0.9 1.0 1.7 2.7 2.1 8.7 0.5 2.2 4.5 0.3 1.3 0.3 0.0 0.1 0.4 0.1 0.4 0.9 0.3 1.9 2.5 0.2 0.3 2.1 5.4 3.3 2.4 0.1 0.4 0.2 0.4 0.5 2.8 0.2 0.9 0.2 0.4 0.3 0.1 0.3 0.4 0.2 2.5 7.3 0.2 0.1 3.6 4.1 0.3 0.5 4.8 0.4 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.4 1.7 2.8 0.2 1.8 0.4 0.2 0.1 0.0 0.7 0.3 0.5 0.0 10.7 0.0 0.3 0.9 0.0 110.6 1.7 2.1 2.2 4.5 1.9 2.5 3.3 2.4 2.8 2.5 3.6 3.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.0 3.9 0.0 0.0 0.0 0.0 1.6 2.7 0.0 0.0 75.6 0.0 6.5 28.3 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 TRIM22 "GPSTAF50, RNF94, STAF50" ENSG00000132274 "Tripartite motif containing 22" Q8IYM9 11 5689697-5737089 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 135.9;dendritic cells: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003307, HPA003575" Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA003307: AB_1080381, HPA003575: AB_1080378" "unprognostic (1.47e-2)" "unprognostic (5.27e-3)" "unprognostic (4.00e-2)" "unprognostic (4.21e-3)" "unprognostic (2.21e-1)" "unprognostic (1.21e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (1.86e-3)" "unprognostic (2.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" "unprognostic (1.15e-1)" "unprognostic (9.16e-2)" 54.0 21.3 13.1 101.3 18.8 90.3 50.7 16.3 23.7 42.7 25.5 36.0 25.2 50.6 70.2 37.1 49.3 78.6 22.6 14.7 16.5 21.2 72.5 83.4 139.0 17.9 16.7 60.3 17.2 8.0 12.6 21.5 16.7 43.3 53.4 11.0 65.4 52.6 13.4 18.1 53.4 52.1 17.7 143.1 39.5 15.4 12.8 101.2 21.7 40.6 120.7 61.6 22.6 29.3 2.8 1.2 13.9 2.4 88.6 174.6 5.0 53.3 93.9 89.8 209.9 1.7 8.6 111.9 13.0 80.2 20.6 10.5 34.0 56.4 10.7 2.0 0.0 6.4 5.6 1.4 107.8 18.2 11.4 190.6 54.3 18.7 9.6 124.5 128.7 1.0 2.3 4.7 111.6 1.5 54.1 16.9 40.3 0.5 4.9 62.6 3.4 2.3 51.1 14.9 1.4 2.7 4.5 4.5 2.1 56.8 4.5 17.9 153.6 56.4 29.8 2.5 2.4 4.9 4.4 11.2 67.7 28.9 7.2 108.7 118.5 79.6 109.0 143.3 145.9 149.4 118.4 117.2 138.7 158.2 106.5 102.7 103.1 61.3 181.1 177.0 197.9 181.9 13.1 18.8 16.3 23.7 14.7 16.5 17.9 16.7 16.7 17.7 12.8 29.3 54.4 67.3 57.7 2.0 135.9 12.6 17.0 42.5 56.3 0.5 17.7 14.0 6.0 7.2 60.5 29.5 0.0 1.5 113.9 4.7 5.9 11.2 0.3 16.1 27.0 40.5 4.2 16.8 4.9 8.0 4.7 36.2 20.9 23.8 17.7 5.4 33.5 4.3 18.7 1.7 0.3 9.0 30.5 87.1 46.6 2.0 36.1 67.8 5.4 52.5 59.0 6.4 83.4 1.0 0.5 5.4 6.3 30.1 18.8 9.9 4.4 3.3 52.5 1.0 13.1 35.1 24.4 0.6 0.3 14.1 8.7 2.3 89.3 13.0 5.0 18.8 TRIM55 "MURF-2, RNF29" ENSG00000147573 "Tripartite motif containing 55" Q9BYV6 8 66126896-66175485 "Predicted intracellular proteins, Predicted membrane proteins" "Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 61.8;liver: 37.9;skeletal muscle: 29.6;tongue: 33.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 108.9;Endometrial ciliated cells: 64.7;Hepatocytes: 30.4;Skeletal myocytes: 31.0;Spermatocytes: 23.8" "Group enriched" "Detected in some" 10 "liver cancer: 12.3;renal cancer: 5.8" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "LHCN-M2: 426.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038793, HPA053691" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 39: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" Cytosol "HPA038793: AB_10673289, HPA053691: AB_2682231" "unprognostic (5.44e-3)" "unprognostic (1.25e-2)" "unprognostic (5.93e-3)" "unprognostic (4.07e-2)" "unprognostic (6.83e-3)" "unprognostic (3.77e-3)" "unprognostic (8.31e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.50e-1)" "unprognostic (5.18e-2)" "unprognostic (2.10e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-2)" "unprognostic (1.77e-3)" 1.4 0.0 0.1 0.1 0.0 0.0 0.2 1.5 0.1 0.3 0.0 0.0 0.1 0.1 3.5 0.8 5.3 0.1 61.8 0.0 0.0 4.8 37.9 0.2 0.0 0.1 0.6 0.0 0.2 0.2 0.4 0.0 0.3 0.7 0.1 0.0 1.3 0.2 29.6 0.4 0.1 0.1 0.0 0.1 0.0 7.3 0.0 0.2 0.3 33.7 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 7.2 0.1 0.3 0.1 0.0 0.4 0.5 0.6 0.0 60.5 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 4.2 426.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.7 1.5 27.6 0.0 2.4 0.0 0.0 0.1 0.0 91.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.6 0.0 0.1 2.8 0.0 0.0 0.1 0.0 108.9 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.8 64.7 0.2 1.2 0.0 0.0 0.2 0.0 0.1 3.8 0.0 3.5 0.0 0.0 0.7 30.4 0.1 0.0 1.5 0.0 0.0 1.3 0.0 6.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 7.4 15.4 0.0 6.6 31.0 2.9 23.8 1.2 0.0 0.0 3.8 0.3 0.0 0.0 0.3 TRIP11 "CEV14, GMAP-210, GMAP210, Trip230" ENSG00000100815 "Thyroid hormone receptor interactor 11" Q15643 14 91965991-92040896 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002570, HPA070684" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA002570: AB_1078995, HPA070684: AB_2686295" "unprognostic (1.65e-1)" "unprognostic (2.81e-2)" "unprognostic (7.14e-2)" "unprognostic (1.12e-1)" "unprognostic (6.89e-2)" "unprognostic (1.39e-1)" "unprognostic (3.49e-3)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.21e-1)" "prognostic favorable (1.78e-6)" "unprognostic (1.78e-1)" "unprognostic (5.08e-1)" "unprognostic (7.74e-2)" "unprognostic (5.55e-2)" 10.4 10.5 4.7 8.6 8.8 7.6 10.5 10.8 7.4 11.6 13.5 10.1 10.4 9.7 6.7 12.1 7.7 10.1 10.6 3.5 5.4 13.5 12.9 8.0 9.4 6.2 7.3 11.0 25.5 19.2 4.8 11.6 6.8 9.6 9.8 10.6 11.0 8.5 11.8 8.9 7.9 10.2 6.2 8.6 15.3 13.6 6.5 11.2 16.7 15.6 11.4 10.4 5.8 10.7 22.8 22.5 14.4 15.2 24.8 38.1 21.8 35.3 27.0 17.1 19.5 13.8 36.0 15.8 25.3 31.3 13.3 29.1 19.1 17.1 37.0 24.1 5.8 17.9 20.4 13.1 18.9 21.2 17.1 14.7 20.4 30.3 25.8 18.9 27.8 8.7 11.9 17.8 27.0 31.7 12.2 5.2 6.6 22.1 16.0 14.8 27.5 8.0 15.3 36.5 10.5 9.5 28.5 16.6 11.0 14.5 36.2 10.5 36.9 19.8 13.8 20.8 16.1 15.7 25.9 14.2 23.2 11.7 25.3 9.3 9.7 20.2 13.9 9.0 13.6 13.0 14.7 13.1 7.9 23.7 14.2 14.9 9.6 14.8 16.1 14.3 14.5 4.3 4.7 8.8 10.8 7.4 3.5 5.4 6.2 7.3 6.8 6.2 6.5 10.7 66.8 54.5 79.8 57.5 32.5 16.6 30.7 31.7 21.6 61.1 39.9 40.0 115.7 34.3 54.0 38.6 73.0 44.2 41.4 29.8 17.6 72.5 13.6 58.2 81.2 53.9 32.2 30.7 58.1 46.2 32.0 51.7 39.8 56.5 37.9 68.7 32.9 37.5 24.4 43.7 74.7 40.4 32.6 25.7 11.2 14.7 62.1 30.4 7.2 51.5 41.6 56.5 47.4 66.9 92.4 44.7 29.5 54.2 26.3 39.0 31.6 23.4 56.4 70.4 59.2 76.6 50.4 105.0 65.8 19.5 17.0 72.5 30.2 79.8 32.9 35.1 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 9.4;skin 1: 4.1" "Group enriched" "Detected in some" 7 "Bipolar cells: 627.4;Melanocytes: 158.3" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 112 "SK-MEL-30: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 56: Bipolar cells - Visual perception" "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: AB_2669090, HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 9.4 0.1 0.0 0.0 4.1 0.0 0.0 0.5 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.1 0.2 0.2 0.4 0.3 0.5 0.3 0.5 0.0 0.0 0.0 0.7 0.0 4.2 0.0 0.0 0.0 627.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 50.5 0.1 0.1 1.7 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 13.5 0.8 0.0 0.0 0.0 1.0 6.3 0.0 0.0 158.3 0.0 0.0 11.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 22.2 0.0 0.1 0.1 10.1 4.4 1.8 1.0 1.0 0.0 0.0 0.0 0.1 TRRAP "PAF400, TR-AP, Tra1" ENSG00000196367 "Transformation/transcription domain associated protein" Q9Y4A5 7 98877933-99050831 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Autism spectrum disorder, Cancer-related genes, Deafness, Disease variant, Mental retardation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054376 Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Golgi apparatus" "HPA054376: AB_2682467" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (2.21e-1)" "unprognostic (4.35e-2)" "unprognostic (2.02e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (8.77e-4)" "unprognostic (1.40e-2)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "unprognostic (9.45e-2)" "unprognostic (7.02e-2)" "unprognostic (2.21e-3)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (2.96e-1)" 6.0 8.1 3.4 7.4 3.5 11.1 6.2 10.3 3.7 8.3 5.9 7.7 5.3 8.6 3.5 6.8 8.4 4.9 6.8 3.1 2.6 6.2 6.7 7.0 9.3 1.4 2.2 10.9 8.3 10.3 14.0 6.1 1.9 7.1 5.0 7.5 7.1 5.2 7.6 11.2 8.4 6.2 0.6 8.5 7.1 11.0 2.8 15.8 8.8 7.3 8.7 7.3 7.0 5.0 24.0 27.2 27.7 23.4 12.9 13.8 13.7 10.3 13.6 15.8 15.1 21.2 10.3 32.8 15.9 19.1 30.3 12.2 29.1 14.0 17.7 19.2 28.3 20.2 20.3 11.7 9.4 36.9 14.3 12.6 8.0 25.8 21.7 10.9 20.5 29.2 35.4 59.8 14.8 44.0 45.0 13.5 21.1 14.1 16.6 32.7 16.0 25.2 7.7 26.6 21.6 27.1 26.1 16.6 8.4 22.7 8.5 15.7 22.0 21.1 30.6 28.3 24.2 24.7 30.2 47.8 14.9 18.3 21.3 2.8 0.3 0.2 0.5 0.2 0.9 0.6 0.8 0.4 0.3 0.8 0.6 0.6 1.0 0.5 0.3 1.0 0.7 0.1 3.4 3.5 10.3 3.7 3.1 2.6 1.4 2.2 1.9 0.6 2.8 5.0 12.8 16.0 14.2 30.3 16.4 15.8 4.2 8.2 13.1 15.2 13.7 10.0 10.9 5.7 9.4 14.7 27.1 8.9 15.0 7.9 0.0 7.7 3.6 16.6 20.1 11.1 12.6 12.4 43.7 6.5 5.2 11.1 11.2 24.1 5.7 26.5 8.6 11.0 8.0 21.9 45.5 10.4 8.2 10.4 7.4 5.4 8.7 12.3 8.8 29.0 9.8 6.1 6.2 36.7 42.4 8.3 5.8 8.6 25.3 7.6 6.2 5.2 8.3 9.2 0.0 12.8 12.4 14.8 8.4 18.5 21.3 10.9 17.1 12.1 10.1 7.5 TSC22D3 "DIP, DSIPI, GILZ, hDIP, TSC-22R" ENSG00000157514 "TSC22 domain family member 3" Q99576 X 107713221-107777342 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 1234.8;dendritic cells: 1146.4;Plasma cells: 2348.5;T-cells: 1479.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 380.5;ASC TERT1: 259.7;HHSteC: 628.0;hTCEpi: 572.7;Karpas-707: 364.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001916, CAB034364" Approved Approved "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "Nuclear speckles, Golgi apparatus" "CAB034364: AB_2272198, HPA001916: AB_2666504" "unprognostic (3.67e-2)" "unprognostic (3.90e-3)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.43e-4)" "unprognostic (3.49e-2)" "unprognostic (3.21e-2)" "unprognostic (3.73e-3)" "unprognostic (4.40e-2)" "unprognostic (9.42e-2)" "unprognostic (5.32e-2)" "unprognostic (3.25e-1)" "unprognostic (7.47e-2)" "unprognostic (6.38e-2)" "unprognostic (1.37e-3)" "unprognostic (6.41e-2)" "unprognostic (4.14e-1)" "unprognostic (9.64e-2)" 536.4 240.5 90.3 394.8 93.5 433.3 447.3 101.0 105.0 396.4 104.1 290.2 87.2 269.3 72.0 300.4 369.8 167.1 331.9 81.3 102.9 194.9 177.4 522.6 281.0 99.6 97.2 371.1 113.8 55.7 136.2 163.8 98.9 404.4 183.6 22.5 333.4 160.5 729.3 493.6 426.3 178.7 92.8 408.2 390.4 43.8 99.3 203.2 313.0 187.8 338.2 508.2 486.9 91.3 10.9 18.2 9.3 25.7 380.5 259.7 3.7 16.9 14.1 7.8 8.6 0.1 35.8 23.4 40.1 13.7 5.5 53.5 19.1 54.2 3.3 7.0 9.0 11.5 76.9 1.0 628.0 2.5 37.7 238.8 572.7 6.1 158.7 78.8 29.3 2.5 3.6 364.1 67.2 37.8 0.7 40.5 16.3 11.5 11.7 1.2 23.5 51.3 26.1 7.3 2.4 20.3 16.6 89.2 128.8 16.9 17.0 52.4 44.1 23.6 7.1 4.8 3.4 79.6 37.8 11.2 12.0 46.7 6.7 668.9 417.2 1653.1 649.7 524.1 484.2 584.0 740.6 641.5 399.5 559.6 686.3 643.0 2396.6 968.4 851.8 81.4 1080.9 1624.1 90.3 93.5 101.0 105.0 81.3 102.9 99.6 97.2 98.9 92.8 99.3 91.3 423.5 64.1 164.7 10.4 1234.8 110.0 82.8 129.7 435.4 52.0 97.0 47.5 31.8 70.1 106.9 47.8 0.0 3.2 1146.4 26.2 232.8 28.3 28.8 24.2 40.9 171.7 64.2 481.5 13.1 22.2 140.5 454.2 200.3 29.7 353.2 15.3 247.0 95.6 121.3 62.2 12.9 32.9 83.4 396.3 191.8 41.2 230.5 539.1 437.6 16.9 126.0 8.9 234.8 37.7 23.7 22.7 19.6 319.7 2348.5 106.5 58.6 48.6 61.0 19.1 433.9 245.4 248.3 24.1 15.3 182.6 79.1 9.9 1479.6 89.6 33.0 42.2 TSHZ2 "C20orf17, OVC10-2, TSH2, ZABC2, ZNF218" ENSG00000182463 "Teashirt zinc finger homeobox 2" Q9NRE2 20 52972358-53495330 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 395.6;Leydig cells: 468.2;Peritubular cells: 803.8;Theca cells: 396.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 3.0;T-reg: 2.4" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "AN3-CA: 26.7;ASC diff: 11.3;HeLa: 23.6;SiHa: 15.3;U-2197: 13.7" "Low region specificity" "Detected in all" HPA038123 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 89: Fibroblasts - ECM organization" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA038123: AB_10670657" "unprognostic (9.24e-3)" "unprognostic (1.58e-1)" "unprognostic (9.35e-2)" "unprognostic (1.13e-1)" "unprognostic (1.21e-4)" "unprognostic (3.30e-1)" "unprognostic (4.30e-1)" "unprognostic (1.28e-1)" "unprognostic (2.16e-1)" "unprognostic (3.23e-2)" "unprognostic (3.33e-1)" "unprognostic (3.14e-2)" "unprognostic (9.88e-8)" "unprognostic (6.26e-2)" "unprognostic (3.81e-2)" "unprognostic (3.37e-7)" "unprognostic (2.97e-3)" 21.5 14.8 3.4 4.5 4.7 0.2 10.6 2.9 4.3 9.0 0.0 7.3 2.3 6.8 16.5 8.2 8.7 12.4 3.7 5.7 8.9 3.3 12.6 2.9 3.9 5.9 8.2 18.4 3.5 5.4 2.7 1.3 5.5 5.4 2.0 1.7 12.9 13.6 1.6 5.9 2.8 8.8 10.3 5.1 6.1 4.8 8.1 2.0 5.3 2.6 3.4 7.6 5.7 7.5 0.0 0.0 1.8 26.7 11.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 6.8 0.0 0.1 0.0 0.1 0.0 5.2 1.4 0.0 23.6 0.0 0.3 0.0 0.6 4.1 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.7 4.4 15.3 0.1 0.0 0.7 0.0 0.0 0.0 0.1 2.6 13.7 0.0 0.1 0.3 0.0 2.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.1 0.0 0.4 3.0 0.2 0.6 0.1 0.0 0.1 2.4 0.5 3.4 4.7 2.9 4.3 5.7 8.9 5.9 8.2 5.5 10.3 8.1 7.5 171.4 0.0 0.6 32.7 7.0 45.4 19.9 43.8 37.0 6.7 24.4 161.5 2.8 54.3 41.6 36.8 2.1 1.3 1.3 0.1 0.0 52.2 11.1 32.7 144.4 125.7 6.6 0.0 188.2 9.8 0.5 93.3 3.1 68.9 1.3 395.6 11.7 92.1 1.2 0.0 58.1 1.9 18.3 1.3 16.6 20.3 468.2 2.8 12.4 104.9 1.9 39.0 1.0 23.6 4.9 6.8 2.7 803.8 16.0 27.5 0.8 0.4 19.9 1.9 39.5 10.9 48.2 2.6 1.8 43.9 40.5 0.8 24.2 396.9 2.6 8.2 TSLP ENSG00000145777 "Thymic stromal lymphopoietin" Q969D9 5 111070062-111078026 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.5;urinary bladder: 12.0" "Group enriched" "Detected in many" 4 "Basal respiratory cells: 108.1;Basal squamous epithelial cells: 338.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.0;HHSteC: 17.1;hTCEpi: 10.3;hTEC/SVTERT24-B: 18.9;hTERT-HME1: 12.5;hTERT-RPE1: 38.6;U-87 MG: 14.1" "Not detected" "Not detected" HPA056350 Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 38400 "Cluster 85: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Vesicles" "HPA056350: " "unprognostic (6.47e-4)" "unprognostic (3.26e-1)" "unprognostic (6.57e-2)" "unprognostic (1.93e-1)" "unprognostic (5.03e-2)" "unprognostic (7.72e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-2)" "unprognostic (5.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-1)" "unprognostic (1.88e-1)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (2.76e-1)" "unprognostic (1.74e-3)" 1.6 0.7 0.3 1.3 0.3 0.0 1.5 0.3 0.5 1.4 0.2 1.1 0.7 0.8 0.3 3.8 0.6 8.8 4.3 0.3 0.3 1.2 11.5 1.9 0.4 0.4 0.3 0.3 0.3 0.4 0.4 0.1 0.4 6.2 0.9 0.0 1.2 4.0 1.4 0.8 1.0 0.6 0.3 0.4 1.2 4.8 1.1 0.2 2.7 1.4 0.5 12.0 1.9 0.4 0.0 0.0 0.0 1.8 2.3 15.0 0.0 0.0 2.3 0.4 2.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 1.5 0.5 0.8 0.0 2.4 2.8 0.1 0.0 17.1 0.5 0.0 0.3 10.3 18.9 12.5 38.6 0.0 6.6 0.3 0.0 3.2 0.0 2.5 0.0 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.9 0.0 0.0 4.1 0.0 0.0 14.1 0.3 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.3 0.4 0.3 0.4 0.3 1.1 0.4 6.2 0.0 3.1 0.3 0.1 55.8 26.6 108.1 338.6 0.0 6.5 8.0 7.4 0.0 35.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 38.5 0.1 0.9 10.5 0.0 0.0 0.0 0.0 0.1 10.0 0.0 0.1 0.0 0.9 7.9 9.4 0.2 0.0 0.0 0.0 24.4 1.2 5.0 26.3 0.6 0.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 24.7 0.2 1.6 3.5 0.0 0.0 6.9 3.8 0.4 0.9 38.0 25.1 0.0 0.8 1.9 0.1 3.1 TSNAX "C3PO, TRAX" ENSG00000116918 "Translin associated factor X" Q99598 1 231528541-231566524 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 194.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024613, HPA031054, HPA031055, CAB034263" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 36000 "Cluster 10: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Golgi apparatus, Cytosol" "CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314" "unprognostic (6.28e-3)" "unprognostic (5.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.12e-1)" "unprognostic (5.55e-2)" "unprognostic (2.27e-1)" "unprognostic (2.96e-2)" "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-3)" "unprognostic (4.51e-2)" "unprognostic (1.91e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-2)" "unprognostic (6.52e-3)" "unprognostic (2.70e-2)" 22.7 31.9 12.2 20.2 12.8 15.1 25.4 11.5 15.1 19.5 17.8 18.4 17.7 21.5 22.8 19.4 18.0 18.7 26.2 13.2 15.2 31.7 26.0 20.8 26.4 11.9 12.7 18.3 16.3 40.0 17.0 20.4 12.3 22.8 19.6 19.9 18.1 20.5 50.5 21.8 17.3 20.7 13.4 28.5 17.7 20.9 13.2 26.6 29.8 40.7 25.7 19.9 14.9 13.7 30.3 24.1 36.7 29.7 27.1 32.6 41.4 33.1 50.9 42.2 36.0 21.4 40.8 42.3 55.0 38.0 15.7 31.9 29.3 31.4 53.9 38.4 51.7 40.7 23.9 28.6 35.8 67.8 82.1 40.4 32.4 40.9 32.3 26.4 30.7 31.6 66.6 28.8 58.0 12.9 44.0 32.9 53.4 26.5 28.3 42.8 39.8 56.8 46.9 33.9 34.1 65.7 35.3 43.3 116.8 14.5 63.2 113.0 28.9 28.3 26.3 57.6 61.0 48.2 68.9 46.4 46.8 52.0 79.7 194.4 34.8 85.6 30.6 40.2 30.3 28.5 33.5 30.6 33.2 28.3 34.6 34.0 37.7 51.9 55.7 22.3 39.4 33.6 12.2 12.8 11.5 15.1 13.2 15.2 11.9 12.7 12.3 13.4 13.2 13.7 48.3 28.9 41.3 0.0 25.5 43.8 21.4 42.4 8.6 59.2 27.2 20.1 24.1 40.0 25.3 42.3 29.2 44.4 36.9 21.8 54.8 30.6 12.6 23.6 20.5 46.1 28.9 59.5 0.0 31.1 51.5 28.1 11.7 19.3 77.3 26.2 31.8 32.8 49.5 65.6 0.0 28.2 38.7 62.2 35.0 9.4 33.5 40.5 26.6 0.0 51.7 72.0 37.0 0.0 0.0 26.5 21.8 36.1 13.4 17.3 22.4 45.8 31.9 47.1 39.5 34.4 30.2 40.8 65.4 13.0 51.4 36.3 30.5 46.8 25.6 14.9 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 705.9;Muller glia cells: 508.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2" "Group enriched" "Detected in all" 5 "B-cells: 488.1;dendritic cells: 313.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 333.8 143.9 257.2 87.3 248.9 33.3 143.3 253.4 292.4 138.2 288.7 364.2 342.1 130.9 432.8 78.4 249.8 186.2 108.8 247.8 296.3 211.3 87.4 202.1 88.0 250.0 267.7 148.1 140.2 283.4 189.7 111.6 260.2 96.2 386.3 418.6 152.2 187.3 429.1 78.3 349.2 128.3 266.7 84.8 221.2 84.8 282.5 71.6 200.3 374.4 106.9 170.1 67.4 281.3 130.6 347.6 282.8 179.3 484.7 295.8 93.3 203.7 220.2 245.1 265.7 213.5 264.7 126.9 294.8 211.6 234.0 289.0 271.2 139.5 182.9 143.4 410.4 91.0 252.5 204.4 234.5 118.4 64.3 280.9 165.5 135.8 120.1 372.6 304.8 83.1 98.0 109.2 243.3 49.5 105.7 112.1 200.5 414.7 152.4 130.8 351.0 135.3 408.0 73.0 255.0 282.1 139.8 116.9 393.7 269.3 125.0 220.8 292.1 225.7 88.4 138.0 290.7 237.4 346.6 67.1 200.1 173.5 131.9 8.8 51.3 10.4 32.6 69.6 34.1 481.0 16.5 23.9 99.2 488.1 42.6 39.3 4.8 60.3 77.1 313.2 4.6 95.2 257.2 248.9 253.4 292.4 247.8 296.3 250.0 267.7 260.2 266.7 282.5 281.3 76.1 112.2 213.4 69.5 83.8 34.7 77.5 114.6 36.5 247.7 43.6 32.3 98.2 108.7 169.0 68.0 183.5 89.9 41.3 705.9 25.4 250.2 28.5 86.1 63.4 57.6 91.3 19.4 47.8 354.0 35.6 90.8 85.1 41.7 23.4 88.6 53.6 29.5 65.4 127.9 54.3 290.4 97.6 58.0 27.5 57.9 64.3 38.2 72.9 29.0 35.1 508.9 36.0 116.6 32.7 245.1 410.7 51.6 81.2 220.1 364.3 65.5 201.7 185.1 26.3 44.8 189.0 108.0 64.6 34.2 34.2 75.9 19.4 149.5 205.2 381.4 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750219 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enriched" "Detected in all" 4 "glioma: 54.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" Yes No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 5: Muller glia cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: AB_2683447" "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favorable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 24.5 29.7 9.0 11.2 10.8 5.5 23.1 10.8 15.6 26.2 11.8 20.5 16.4 26.2 13.2 20.4 25.8 20.9 26.7 9.5 10.3 26.7 20.9 22.8 11.8 11.2 10.2 25.6 25.2 32.7 24.4 12.5 11.0 22.1 10.7 29.7 25.6 13.5 21.0 18.6 18.5 8.4 11.1 20.8 23.0 8.0 9.9 9.8 30.2 21.2 8.7 21.0 20.1 13.0 9.5 23.4 21.1 5.4 44.3 24.0 13.5 15.8 11.7 4.6 5.1 16.7 46.4 7.6 32.7 29.0 9.4 17.5 5.7 26.7 10.7 23.1 15.4 10.7 18.7 6.6 45.2 10.6 17.9 29.6 30.2 13.7 30.3 22.1 14.6 4.6 7.5 19.9 19.6 19.4 9.2 5.9 4.3 18.3 7.0 10.5 139.8 20.0 15.7 19.0 6.6 16.7 15.6 21.3 10.5 4.5 41.1 15.8 27.6 11.3 9.5 5.6 7.4 28.9 8.1 4.1 32.7 6.3 19.2 25.4 26.3 16.4 35.8 28.6 34.8 31.1 28.5 30.7 27.6 31.0 28.3 26.2 5.8 35.4 42.0 58.3 22.1 33.0 9.0 10.8 10.8 15.6 9.5 10.3 11.2 10.2 11.0 11.1 9.9 13.0 37.1 48.1 32.4 8.1 23.8 11.2 46.4 37.4 22.2 43.2 32.0 27.4 5.1 20.0 31.4 31.3 41.7 20.9 29.8 19.9 9.8 37.6 1.2 18.5 32.5 26.7 26.5 8.2 9.1 39.0 15.2 31.7 11.7 20.4 45.0 28.9 22.1 21.6 22.4 21.9 9.1 21.6 32.6 18.0 16.4 1.8 25.7 24.2 32.0 8.4 21.6 62.7 35.0 11.1 13.3 37.6 20.3 17.3 18.4 30.5 30.6 18.1 27.9 60.4 19.7 22.3 31.9 9.2 7.7 16.1 12.6 24.5 20.4 35.3 19.4 31.8 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 128.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 68.7;Extravillous trophoblasts: 105.1;Syncytiotrophoblasts: 80.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 96.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 213.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.1" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 25.4 12.9 11.0 7.1 12.1 0.6 25.0 96.6 13.5 29.6 9.7 18.0 7.9 32.3 11.5 15.4 23.2 35.2 128.8 6.9 12.6 45.8 54.8 35.8 5.4 12.3 13.0 35.3 13.1 28.1 8.6 58.7 14.5 27.6 6.2 14.8 18.0 24.4 16.8 27.9 12.3 23.6 8.6 20.6 13.4 5.1 17.1 19.1 18.4 12.4 7.1 18.4 22.3 7.6 1.5 12.7 20.1 16.1 19.2 15.5 48.3 26.7 82.3 20.1 26.1 30.6 11.6 0.8 23.9 14.6 19.7 3.1 9.5 9.6 11.8 5.0 9.3 36.3 8.5 20.6 42.2 0.2 3.0 17.7 7.4 40.4 16.9 50.4 55.7 1.1 1.0 1.1 17.6 16.7 0.0 0.8 25.5 7.8 7.4 9.9 213.0 3.1 61.7 7.4 36.8 22.6 18.8 36.6 16.4 45.9 13.7 0.2 27.2 8.5 28.8 14.8 25.7 0.2 0.6 0.3 20.3 0.5 10.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 1.2 11.0 12.1 96.6 13.5 6.9 12.6 12.3 13.0 14.5 8.6 17.1 7.6 60.1 0.0 4.1 10.4 0.8 19.2 13.3 22.4 13.1 68.7 19.8 9.0 50.1 11.5 6.5 12.9 2.1 53.1 0.2 1.7 5.9 21.1 3.0 2.3 24.9 43.1 6.0 5.3 16.8 9.1 105.1 22.2 2.0 5.7 0.0 13.0 41.0 36.7 6.2 33.7 45.5 2.3 2.0 3.2 3.5 4.1 17.4 7.1 12.4 30.9 0.8 4.0 0.0 9.0 2.0 9.9 0.6 17.3 1.4 13.8 2.4 22.4 2.5 4.7 19.7 1.4 20.9 1.3 3.4 9.7 11.9 80.7 1.5 6.4 2.5 10.5 TSPYL5 KIAA1750 ENSG00000180543 "TSPY like 5" Q86VY4 8 97273488-97277928 "Predicted intracellular proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.7" "Group enriched" "Detected in many" 8 "Early spermatids: 172.9;Late spermatids: 419.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 34.9;K-562: 30.5;SCLC-21H: 60.8;SH-SY5Y: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031347 Enhanced Approved "Golgi apparatus,Cytosol" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Golgi apparatus" "HPA031347: AB_10601454" "prognostic favorable (1.21e-4)" "unprognostic (5.13e-2)" "unprognostic (4.90e-2)" "unprognostic (1.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.06e-1)" "unprognostic (1.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "unprognostic (3.46e-2)" "unprognostic (1.25e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.40e-5)" "unprognostic (3.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.31e-2)" "unprognostic (3.13e-1)" 6.0 8.6 11.1 4.3 12.6 1.2 12.1 6.7 11.4 11.4 0.8 9.7 1.8 15.2 15.5 4.5 12.4 6.6 12.4 10.0 17.6 10.0 1.7 7.2 6.2 10.3 8.6 25.2 8.7 8.1 11.8 4.3 12.5 15.3 3.2 11.3 9.7 18.3 12.9 4.1 4.1 14.3 7.6 7.3 8.4 44.7 14.4 7.4 8.3 10.5 7.3 9.7 4.6 8.7 0.0 15.9 0.0 0.0 0.4 0.4 0.1 12.4 0.0 12.2 7.9 0.0 0.5 0.0 16.8 14.8 0.0 4.4 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 19.4 0.0 17.2 0.0 0.0 0.2 34.9 30.5 0.0 0.5 23.4 0.0 0.0 0.0 0.0 0.2 23.1 0.0 0.1 10.2 0.1 60.8 47.1 0.0 4.1 0.0 8.2 0.0 1.9 0.0 0.0 26.2 0.1 0.0 14.4 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.3 0.2 0.1 0.0 0.2 0.0 0.5 0.2 0.0 11.1 12.6 6.7 11.4 10.0 17.6 10.3 8.6 12.5 7.6 14.4 8.7 7.5 6.4 4.1 0.0 5.5 2.3 4.5 0.7 6.8 12.5 9.9 8.8 16.3 2.8 2.1 9.2 20.9 0.2 2.6 0.0 5.9 5.8 172.9 6.4 13.7 9.8 2.4 3.4 0.0 3.5 0.1 12.1 10.2 2.6 0.0 19.2 6.4 0.8 6.3 8.4 0.0 0.3 2.0 5.0 5.9 419.0 24.5 4.6 7.2 0.0 2.2 13.1 0.0 0.0 0.0 3.7 0.0 21.1 0.8 7.8 0.0 1.4 4.1 12.2 6.6 12.4 9.3 35.5 31.0 5.6 1.6 0.1 1.3 9.9 0.3 4.1 TSR3 "C16orf42, MGC24381" ENSG00000007520 "TSR3 ribosome maturation factor" Q9UJK0 16 1349240-1351878 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040760, HPA046265" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Golgi apparatus" "HPA040760: AB_2677122, HPA046265: AB_10963942" "unprognostic (4.04e-1)" "unprognostic (2.00e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (4.74e-2)" "unprognostic (4.44e-1)" "unprognostic (1.40e-2)" "unprognostic (1.12e-2)" "unprognostic (5.36e-2)" "unprognostic (3.81e-2)" "unprognostic (6.07e-2)" "unprognostic (8.32e-2)" "unprognostic (3.92e-2)" "unprognostic (9.72e-2)" "unprognostic (3.72e-1)" "unprognostic (2.82e-1)" "unprognostic (1.14e-1)" 44.0 47.6 47.7 18.9 50.4 17.4 40.4 47.9 54.6 35.5 43.3 60.7 25.6 38.6 11.1 51.2 33.5 12.6 72.8 46.1 44.5 51.8 58.3 34.4 20.4 52.7 50.0 32.2 57.2 18.5 35.0 15.2 46.8 42.6 9.0 8.3 42.6 19.8 86.8 46.5 38.3 11.6 48.7 43.0 49.1 30.5 49.6 15.9 35.0 27.9 11.7 48.9 38.1 47.7 60.0 65.2 26.6 35.7 30.8 37.3 44.7 54.3 23.8 38.1 35.3 72.7 59.6 37.8 70.8 36.7 40.5 61.6 24.2 45.2 13.1 73.8 110.8 16.7 56.3 58.2 56.0 36.2 31.8 39.5 63.8 34.3 33.0 29.5 41.7 60.2 54.1 32.6 31.8 107.4 53.6 61.1 44.6 34.4 78.0 93.5 32.3 103.0 33.5 23.7 41.9 53.9 41.9 52.3 73.0 20.8 50.3 44.8 45.9 63.0 67.3 54.2 67.4 67.8 49.2 51.3 31.9 43.5 43.6 13.8 4.0 12.0 4.7 3.6 5.9 7.4 5.9 4.4 3.4 10.0 6.2 5.7 10.4 2.6 3.9 5.2 4.8 1.7 47.7 50.4 47.9 54.6 46.1 44.5 52.7 50.0 46.8 48.7 49.6 47.7 45.2 19.2 16.2 3.3 33.7 28.2 44.9 7.4 18.8 27.1 54.3 48.9 9.4 44.3 12.1 25.8 12.5 48.6 37.8 43.1 103.7 36.5 3.5 30.7 30.9 30.7 24.0 32.4 4.3 46.6 48.7 28.5 18.3 26.9 8.2 45.0 33.9 54.1 48.8 18.5 5.2 35.3 10.2 42.4 26.7 4.9 28.0 38.0 48.0 1.9 34.6 53.9 49.4 3.5 9.2 38.5 32.6 32.0 47.3 53.8 41.5 125.6 11.1 33.6 6.6 27.7 40.4 15.7 39.7 50.3 41.5 29.8 34.7 38.4 35.7 49.2 TTC33 OSRF ENSG00000113638 "Tetratricopeptide repeat domain 33" Q6PID6 5 40512333-40755963 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038252, HPA038253" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 20: HeLa - Mitochondria" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Golgi apparatus, Vesicles" "HPA038252: AB_10674551, HPA038253: AB_10671739" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.04e-3)" "unprognostic (3.01e-2)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.83e-4)" "unprognostic (8.50e-2)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (4.28e-3)" 6.9 5.9 6.6 3.3 7.2 0.8 5.7 10.0 9.7 5.8 5.3 6.3 4.3 6.2 4.7 4.2 5.6 4.6 6.3 7.5 6.6 7.5 7.7 5.1 4.3 6.3 6.5 6.7 4.8 8.9 4.4 4.1 6.3 5.9 4.2 11.6 5.3 5.6 15.5 3.8 4.8 5.0 5.6 4.6 5.2 4.5 7.3 6.7 6.0 14.8 4.1 5.4 5.2 6.9 3.6 3.2 6.1 6.8 5.0 7.1 2.9 4.7 5.6 4.8 5.1 1.7 3.5 11.0 2.8 4.3 5.2 1.6 5.2 2.7 8.5 10.3 4.9 2.4 13.5 4.3 5.5 6.5 3.1 4.4 5.6 4.8 5.0 8.4 7.2 7.3 5.8 8.3 6.4 1.0 12.5 9.3 1.9 2.8 3.5 11.1 11.5 7.9 8.2 2.1 4.5 6.2 11.0 6.4 8.1 5.0 4.3 8.7 5.5 5.5 4.6 4.3 4.6 6.0 6.7 5.8 5.1 10.1 4.9 7.1 1.8 3.2 2.0 4.4 2.2 2.1 2.3 2.1 1.9 2.2 2.5 2.2 2.5 2.3 6.6 1.0 2.2 1.9 6.6 7.2 10.0 9.7 7.5 6.6 6.3 6.5 6.3 5.6 7.3 6.9 12.9 16.0 7.4 9.8 13.1 14.4 5.6 8.6 11.4 12.3 8.6 6.0 18.2 7.2 6.2 7.3 6.2 5.9 8.8 6.9 19.6 8.2 22.4 9.1 11.5 11.0 3.0 9.5 23.7 6.3 4.2 12.6 6.1 6.8 12.7 8.9 13.9 9.4 5.1 5.0 27.5 8.0 10.2 7.5 15.4 8.4 14.0 7.5 10.6 15.9 14.3 19.2 2.1 23.6 35.1 8.0 8.4 13.9 11.8 6.8 6.8 12.6 13.7 23.5 13.1 9.9 13.4 28.1 22.1 6.3 18.3 2.6 14.6 5.0 6.2 4.5 TTPAL "C20orf121, dJ179M20.3" ENSG00000124120 "Alpha tocopherol transfer protein like" Q9BTX7 20 44475874-44494603 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 28.7" "Cell type enhanced" "Detected in all" "Hepatocytes: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 91.0;HSkMC: 78.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046957, HPA066532" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus, Cytosol" "HPA046957: AB_10959741, HPA066532: AB_2685686" "unprognostic (8.71e-2)" "unprognostic (3.05e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (3.47e-5)" "unprognostic (1.69e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (2.32e-1)" "unprognostic (5.06e-2)" "unprognostic (4.50e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (8.09e-5)" "unprognostic (2.09e-2)" "unprognostic (2.88e-1)" "unprognostic (2.24e-2)" "unprognostic (7.93e-2)" 8.2 4.4 5.4 5.7 5.5 9.0 5.2 4.7 5.4 6.1 7.1 3.6 3.5 5.0 4.7 5.5 4.9 4.0 2.8 6.3 7.3 4.1 28.7 3.3 8.4 5.2 6.3 4.1 6.4 7.2 7.0 2.8 8.1 4.6 4.0 2.9 5.0 4.3 2.7 12.5 4.0 5.4 3.2 4.6 4.0 3.0 5.2 6.2 7.6 1.7 7.9 5.0 5.3 4.3 21.1 10.8 8.2 14.6 91.0 35.3 8.2 22.4 31.1 21.3 18.1 40.1 12.5 13.1 18.8 20.9 38.8 20.4 10.5 35.2 22.9 13.6 4.8 6.2 11.6 11.8 25.2 9.3 14.1 78.5 22.6 20.9 35.0 10.1 7.3 11.0 8.0 13.4 17.2 24.2 9.1 5.9 9.8 11.4 18.0 2.8 8.8 7.1 8.3 15.0 18.2 8.6 31.1 13.5 14.0 10.1 14.8 6.0 7.5 47.2 18.8 14.2 19.5 19.8 14.5 14.0 22.8 6.6 14.1 0.6 1.1 1.8 4.0 2.2 4.4 3.6 3.6 4.2 1.1 3.8 3.0 4.7 2.6 5.7 2.3 2.0 3.8 2.3 5.4 5.5 4.7 5.4 6.3 7.3 5.2 6.3 8.1 3.2 5.2 4.3 3.9 9.6 11.4 6.2 15.7 6.4 17.2 9.5 1.8 24.4 8.0 5.8 5.3 18.6 10.3 22.0 25.0 7.4 19.8 8.7 1.9 10.2 4.9 8.4 30.5 7.5 9.5 38.9 8.3 9.4 8.6 13.8 2.6 9.3 9.5 8.3 8.2 60.7 4.9 18.5 9.1 5.3 2.0 17.6 6.5 10.3 18.6 6.9 3.6 2.8 8.4 11.5 30.9 8.5 7.1 13.3 9.3 11.3 8.6 14.3 11.0 4.7 8.4 20.3 6.6 16.3 10.1 9.6 11.4 6.1 20.0 10.9 17.9 12.3 9.5 10.9 TTR "CTS, CTS1, HsT2651, PALB" ENSG00000118271 Transthyretin P02766 18 31557009-31598833 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Transport "Hormone, Thyroid hormone" "Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "choroid plexus: 142023.1" "Cell type enriched" "Detected in many" 30 "Hepatocytes: 23659.3" "Group enriched" "Detected in many" 28 "liver cancer: 928.2;pancreatic cancer: 666.0" "Group enriched" "Detected in all" 7 "cerebellum: 621.7;hippocampal formation: 1730.9;thalamus: 688.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 160.1;EFO-21: 39.6;Hep G2: 249.0;U-2 OS: 57.0" "Group enriched" "Detected in all" 5 "basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4" "Region enhanced" "Detected in all" "medulla oblongata: 1381.8" "CAB002517, HPA002550, CAB062567, CAB073406" Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 345000000000 99000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419" "unprognostic (6.79e-3)" "unprognostic (3.38e-2)" "unprognostic (4.10e-1)" "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (8.15e-2)" "unprognostic (3.74e-2)" "unprognostic (9.66e-3)" "unprognostic (8.72e-2)" "unprognostic (1.23e-2)" "unprognostic (8.35e-3)" "unprognostic (5.26e-1)" "unprognostic (3.52e-2)" 4.2 0.6 148.5 0.5 56.7 9.6 0.4 621.7 83.7 2.0 142023.1 6.0 14.9 1.3 0.9 2.2 0.8 51.2 2.9 1730.9 37.3 18.4 21288.1 0.8 2.4 106.5 86.0 1.1 1785.1 186.8 6.0 2.7 27.1 1.6 4.5 80.1 1.8 0.4 1.1 15.6 6.8 0.3 12.3 3.8 49.8 2.3 688.2 1.1 1.3 0.0 0.1 2.3 0.6 133.9 1.6 0.4 0.6 0.5 0.8 0.1 1.0 0.8 0.3 0.0 0.0 160.1 0.0 2.9 39.6 0.5 0.6 0.4 0.0 0.3 0.0 5.9 0.8 5.2 1.8 249.0 0.4 11.2 1.0 0.1 0.1 0.1 0.0 0.7 0.0 0.3 2.8 0.4 0.0 0.5 0.4 0.7 0.6 4.5 0.3 0.3 7.4 0.2 0.3 1.6 0.9 1.1 5.8 0.0 0.2 1.7 0.6 0.2 1.7 2.4 57.0 0.5 4.3 1.0 2.6 17.6 0.7 4.3 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 148.5 56.7 621.7 83.7 1730.9 37.3 106.5 86.0 27.1 12.3 688.2 133.9 0.0 0.0 0.0 0.0 15.1 0.5 0.0 0.0 0.0 144.8 0.0 0.0 1.8 779.2 0.0 5.5 162.6 0.3 0.0 1.5 5.9 3.1 6.8 0.5 0.5 14.1 356.2 192.5 0.0 2.0 3.6 0.7 13.3 0.0 0.0 0.2 192.4 23659.3 2.4 26.9 0.1 19.6 0.0 313.7 0.0 8.7 0.3 1.2 0.0 0.0 0.0 24.9 0.0 0.0 0.0 130.5 5.2 0.0 0.0 0.2 1.3 26.9 0.0 56.0 0.0 0.0 0.3 3.3 1.1 0.0 0.1 4.0 10.9 0.0 1.7 0.0 TVP23B "CGI-148, FAM18B, FAM18B1, YDR084C" ENSG00000171928 "Trans-golgi network vesicle protein 23 homolog B" Q9NYZ1 17 18781111-18806714 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019585, HPA065603" Uncertain Supported "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA019585: AB_1848385, HPA065603: AB_2685517" "unprognostic (1.91e-1)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (9.32e-3)" "unprognostic (1.13e-2)" "unprognostic (8.51e-2)" "unprognostic (2.37e-1)" "unprognostic (3.32e-2)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (2.30e-1)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (3.54e-1)" "unprognostic (5.27e-1)" "unprognostic (7.78e-2)" "unprognostic (8.55e-2)" 26.4 43.2 11.1 20.0 11.7 19.9 30.3 12.8 15.1 38.2 23.3 25.8 29.9 26.5 40.4 52.3 34.5 30.4 22.8 10.6 13.5 31.0 44.0 20.8 25.4 12.3 13.0 30.1 33.6 47.8 32.7 29.6 13.0 33.5 31.2 32.1 34.3 24.4 17.3 19.3 23.8 21.7 13.1 17.4 40.5 34.9 12.4 20.4 46.9 16.2 31.4 32.7 34.2 13.3 55.0 63.8 23.6 26.2 68.8 60.9 56.1 93.5 75.0 42.8 54.6 37.6 38.7 17.9 33.9 60.3 42.6 74.1 19.2 40.2 63.2 44.3 39.7 17.0 47.1 46.3 48.0 13.0 35.6 31.6 95.7 46.0 67.7 78.7 36.0 12.6 14.0 13.1 62.9 27.6 17.2 18.3 11.0 99.2 25.6 17.4 52.1 23.1 52.7 36.0 13.4 29.9 49.8 32.4 60.4 129.0 46.9 19.7 41.6 32.7 28.1 69.8 57.5 25.9 31.7 9.5 50.2 22.2 68.2 54.4 20.4 44.6 29.7 27.4 40.5 32.1 33.0 32.1 17.3 26.9 34.8 34.8 24.2 32.3 27.1 27.9 26.3 32.1 11.1 11.7 12.8 15.1 10.6 13.5 12.3 13.0 13.0 13.1 12.4 13.3 10.0 12.8 13.2 9.4 29.4 25.2 28.1 70.4 54.7 8.6 16.5 9.7 4.2 10.0 42.4 9.2 10.4 13.3 15.7 8.5 11.7 13.9 8.6 21.7 16.1 12.9 6.1 17.2 8.1 11.6 30.3 19.1 40.2 16.2 22.2 7.1 11.0 10.3 10.0 1.7 8.8 14.6 44.7 10.3 10.7 4.2 16.8 16.0 26.6 11.2 9.1 9.1 17.5 14.1 12.8 16.5 10.7 17.0 62.1 28.5 12.0 14.0 60.0 11.1 13.1 9.0 17.0 50.8 43.0 65.5 30.5 26.1 23.7 8.9 8.6 32.4 TVP23C "FAM18B2, MGC8763" ENSG00000175106 "Trans-golgi network vesicle protein 23 homolog C" Q96ET8 17 15502264-15563595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA019585, HPA065603" Uncertain Supported "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Golgi apparatus" "HPA019585: AB_1848385, HPA065603: AB_2685517" "unprognostic (2.87e-3)" "unprognostic (5.35e-3)" "unprognostic (1.01e-1)" "unprognostic (8.39e-3)" "unprognostic (1.33e-3)" "unprognostic (3.00e-1)" "unprognostic (6.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-3)" "unprognostic (3.43e-1)" "unprognostic (8.09e-5)" "unprognostic (2.42e-2)" "unprognostic (1.61e-1)" "unprognostic (3.50e-1)" "unprognostic (2.45e-2)" 3.8 6.6 4.2 2.3 3.5 10.9 4.5 6.9 3.9 7.4 8.0 3.3 2.1 4.6 3.3 5.9 4.2 2.4 4.1 3.1 4.7 6.4 3.9 4.6 2.8 5.5 5.2 8.8 5.2 3.7 10.1 4.0 3.9 6.4 2.1 4.1 6.0 2.0 3.0 4.5 3.8 2.2 3.0 4.7 3.8 5.2 5.2 1.9 6.8 1.5 2.4 3.9 5.7 6.5 8.3 7.3 2.7 3.9 3.5 1.8 4.2 6.9 11.6 12.1 14.2 9.3 3.3 0.0 3.7 5.8 6.6 3.5 8.4 5.2 8.6 5.2 4.5 5.5 6.7 13.2 3.2 2.0 5.0 2.4 2.0 12.2 7.2 10.2 11.1 2.9 6.7 3.5 5.3 2.7 3.5 5.6 3.0 3.3 2.5 0.6 0.3 0.4 3.3 4.8 0.9 2.3 8.7 1.0 1.8 11.3 4.8 1.1 7.9 2.0 2.8 2.9 2.2 2.2 2.1 0.0 2.3 0.0 1.8 11.3 1.8 8.4 3.3 4.1 4.5 6.4 4.5 5.0 3.0 4.6 5.5 5.1 2.9 5.0 2.9 3.3 4.7 4.3 4.2 3.5 6.9 3.9 3.1 4.7 5.5 5.2 3.9 3.0 5.2 6.5 3.5 3.2 8.2 0.0 2.9 4.0 5.4 4.3 4.6 5.9 4.2 2.7 17.2 0.0 7.0 0.0 14.6 5.9 5.5 3.8 1.9 2.9 1.3 6.6 4.4 5.8 1.8 3.0 0.0 0.6 11.7 5.6 6.6 6.5 2.5 6.2 1.8 0.7 3.2 6.7 0.0 4.0 6.1 1.9 3.3 0.9 3.4 2.3 1.8 0.0 2.4 2.6 4.1 0.0 0.0 1.6 2.9 2.2 9.2 5.2 4.3 0.8 4.3 10.5 0.0 3.3 5.6 10.0 7.9 5.5 2.8 5.5 4.7 7.2 4.9 7.0 TVP23C-CDRT4 FAM18B2-CDRT4 ENSG00000259024 "TVP23C-CDRT4 readthrough" 17 15436021-15563561 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 10 "Astrocytes: 16.0;Excitatory neurons: 18.0;Inhibitory neurons: 23.9;Microglial cells: 21.5;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 29.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 35.1" HPA065603 Approved "Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA065603: AB_2685517" "unprognostic (3.95e-3)" "unprognostic (1.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.59e-1)" "unprognostic (8.67e-3)" "unprognostic (9.05e-2)" "unprognostic (4.71e-2)" "unprognostic (9.40e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-1)" "unprognostic (2.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.57e-1)" "unprognostic (2.07e-1)" "unprognostic (2.08e-1)" 3.1 6.0 1.3 1.6 1.4 1.4 2.2 1.4 2.4 5.4 2.7 2.4 3.5 3.3 6.0 3.2 5.9 2.2 2.1 1.0 2.0 3.2 1.3 1.8 1.8 1.9 2.0 5.7 4.9 5.3 5.0 3.1 2.5 3.6 2.5 8.4 5.1 4.4 1.4 2.0 3.9 2.1 1.8 1.8 3.1 0.1 1.5 2.3 5.8 1.2 2.9 2.1 2.4 2.4 6.3 4.8 3.8 7.0 3.5 4.3 9.1 3.9 15.8 7.0 8.2 5.2 1.1 0.0 8.2 8.5 2.6 5.5 4.3 3.5 6.7 7.4 3.8 2.3 3.6 9.5 8.3 3.0 6.4 3.0 1.6 4.1 16.8 18.4 6.6 3.9 3.4 3.0 2.2 2.6 4.4 6.6 2.9 4.6 3.3 0.7 0.0 0.0 3.8 4.0 2.3 5.6 4.0 0.8 2.1 35.1 3.1 1.8 2.8 0.3 2.7 1.9 2.7 6.4 3.6 0.0 0.7 0.0 1.0 5.3 0.4 5.1 2.8 0.2 3.1 1.2 2.3 2.6 1.1 0.7 1.4 1.7 0.1 3.3 0.2 1.3 2.3 1.1 1.3 1.4 1.4 2.4 1.0 2.0 1.9 2.0 2.5 1.8 1.5 2.4 0.3 0.0 2.0 16.0 0.1 0.0 0.1 0.0 1.2 0.4 0.2 0.3 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.1 0.0 0.5 0.1 0.4 0.1 0.0 0.0 0.0 18.0 0.0 0.4 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.5 0.0 0.0 0.0 29.1 29.5 0.0 0.0 0.0 0.9 0.3 0.0 0.1 2.2 0.2 0.0 0.0 0.1 1.0 0.5 0.4 0.0 0.3 0.5 0.2 0.0 0.3 TXNDC15 "2310047H23Rik, C5orf14, FLJ22625" ENSG00000113621 "Thioredoxin domain containing 15" Q96J42 5 134874371-134901635 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 203.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015483 Approved Approved "Golgi apparatus" NA NA 49000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA015483: AB_1845722" "unprognostic (1.56e-1)" "unprognostic (1.22e-2)" "unprognostic (2.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.68e-2)" "unprognostic (9.71e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (2.36e-1)" "unprognostic (4.37e-1)" "unprognostic (1.41e-3)" "unprognostic (1.50e-1)" 34.1 44.7 20.3 34.9 23.2 8.9 33.9 22.8 23.2 42.5 39.1 37.3 23.7 35.0 56.1 22.3 29.5 32.5 35.8 20.8 24.2 29.0 33.7 30.5 25.4 25.9 21.6 31.4 49.7 43.7 42.9 37.1 21.6 38.2 26.2 36.5 46.8 44.0 41.9 19.1 21.7 43.7 21.5 35.9 32.3 18.8 21.8 20.3 59.9 30.4 31.1 35.9 24.7 23.8 28.8 77.8 47.8 76.9 75.8 102.7 5.5 117.7 135.1 42.3 93.7 56.8 38.5 38.1 64.3 108.6 78.8 21.0 33.0 48.6 38.6 81.5 36.6 20.0 46.7 46.1 58.7 13.6 51.2 61.7 39.6 56.0 35.2 70.6 65.8 18.0 10.1 106.8 65.6 36.5 20.8 30.7 21.4 31.3 31.7 30.0 58.1 117.7 35.5 29.4 27.7 35.6 70.3 19.4 63.9 22.7 27.3 19.8 83.0 62.5 35.3 62.0 42.7 70.7 120.3 31.8 93.0 28.5 41.3 32.7 34.3 19.8 31.0 33.7 32.7 32.3 25.2 32.8 31.0 23.8 20.8 24.5 9.3 29.5 33.8 30.1 29.8 32.7 20.3 23.2 22.8 23.2 20.8 24.2 25.9 21.6 21.6 21.5 21.8 23.8 47.8 60.9 31.9 11.8 49.9 25.4 30.5 41.5 22.8 37.6 25.1 29.0 36.4 27.1 36.3 23.9 20.9 32.4 31.9 10.0 13.7 33.5 4.2 12.1 49.4 38.7 12.6 6.7 13.7 33.1 54.3 65.7 12.8 19.2 30.4 33.1 45.3 29.7 33.9 63.9 19.7 17.0 44.7 31.3 32.3 6.7 63.3 27.3 69.4 19.7 39.2 43.0 29.9 19.6 20.1 19.2 14.0 45.5 203.2 25.1 17.4 28.3 26.7 36.6 46.0 45.2 44.1 36.5 61.6 17.4 23.4 30.0 36.3 45.1 13.3 21.5 TYMP "ECGF1, MNGIE" ENSG00000025708 "Thymidine phosphorylase" P19971 22 50525752-50530032 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Glycosyltransferase, Growth factor, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1" "Group enriched" "Detected in all" 10 "dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6" "Not detected" "Not detected" "HPA000530, HPA001072, CAB002518" Enhanced Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 11000000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Nuclear bodies, Golgi apparatus" Cytosol "CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274" "unprognostic (7.02e-3)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "prognostic favorable (4.34e-5)" "unprognostic (7.60e-2)" "unprognostic (1.16e-2)" "unprognostic (2.40e-1)" "unprognostic (7.17e-2)" "unprognostic (4.64e-2)" "unprognostic (1.33e-1)" "unprognostic (3.31e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (3.50e-8)" "unprognostic (1.32e-1)" "unprognostic (4.02e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" 46.8 19.5 6.1 77.7 6.0 22.0 37.9 7.1 7.9 32.2 12.7 20.4 26.1 7.8 0.5 58.5 30.0 7.2 26.7 6.4 8.6 38.2 82.0 63.4 31.5 22.1 18.3 4.0 13.8 4.5 8.8 15.4 15.9 21.0 3.6 0.0 40.0 5.6 10.7 24.5 32.5 9.1 10.9 86.1 31.2 3.0 18.0 15.6 25.4 1.6 15.3 22.9 27.0 12.2 27.0 2.5 0.4 0.8 1.8 2.2 5.1 3.7 0.5 6.1 17.4 0.1 40.0 1.8 4.1 5.8 1.3 21.0 0.2 1.0 0.0 9.0 16.5 1.8 3.9 3.5 95.2 1.3 26.9 4.7 4.6 5.4 0.0 0.1 0.1 0.5 2.8 68.6 0.9 1.9 1.5 9.9 0.6 1.9 9.1 5.7 0.4 35.1 0.3 1.2 0.7 5.6 22.9 17.3 6.5 0.2 4.2 13.8 6.7 0.8 4.7 1.5 1.5 68.6 15.9 5.7 1.9 1.5 1.6 19.5 135.8 74.9 2.0 98.4 1.2 6.7 2.9 1.2 39.5 6.9 1.6 1.3 114.1 9.5 77.1 9.3 3.1 10.1 6.1 6.0 7.1 7.9 6.4 8.6 22.1 18.3 15.9 10.9 18.0 12.2 122.6 12.8 29.0 0.3 122.9 58.5 57.4 169.9 53.5 3.4 101.5 90.8 3.2 50.1 88.6 33.1 4.2 17.2 65.8 154.8 29.4 340.2 2.2 55.7 56.0 55.7 16.8 19.6 0.3 643.9 300.8 81.9 38.7 59.2 53.4 3.0 38.2 93.0 477.4 0.0 0.4 50.2 24.4 371.8 409.4 8.7 5.0 561.7 113.8 4.7 2174.6 2.9 71.1 0.5 0.2 364.0 86.4 1.9 102.1 109.8 214.5 105.1 78.0 6.6 26.3 93.3 62.4 1.5 8.0 71.7 56.7 33.5 62.5 3.7 51.1 76.0 UBAC1 "GBDR1, KPC2, UBADC1" ENSG00000130560 "UBA domain containing 1" Q9BSL1 9 135932969-135961373 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 301.3;tongue: 171.0" "Cell type enhanced" "Detected in all" "Erythroid cells: 290.9;Late spermatids: 197.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 246.4;K-562: 316.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005651 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 87000 "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Plasma membrane, Cytosol" "Golgi apparatus" "HPA005651: AB_1858489" "unprognostic (8.41e-2)" "prognostic favorable (4.34e-6)" "unprognostic (2.10e-1)" "unprognostic (9.15e-2)" "unprognostic (4.11e-1)" "unprognostic (3.85e-2)" "unprognostic (7.68e-3)" "unprognostic (2.85e-1)" "unprognostic (4.37e-2)" "unprognostic (3.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.20e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.95e-3)" "unprognostic (9.46e-2)" "unprognostic (3.16e-2)" "unprognostic (5.78e-2)" 23.1 20.7 42.2 14.7 44.8 82.5 20.7 43.0 43.0 23.8 41.4 38.6 24.3 22.0 12.9 37.4 22.8 12.0 72.0 40.4 42.2 23.5 24.9 19.8 15.7 43.2 42.7 20.9 17.1 27.1 23.5 22.8 41.8 24.7 18.4 15.2 27.8 20.6 301.3 53.2 23.3 16.3 43.7 21.0 23.0 43.1 44.0 17.7 18.0 171.0 16.5 28.3 27.0 41.0 37.4 42.7 29.7 43.4 22.0 25.6 55.7 32.0 27.1 38.9 31.2 59.7 46.3 44.8 30.1 26.4 46.1 124.4 41.9 37.0 17.5 246.4 39.6 37.4 79.0 33.8 22.9 49.2 34.4 24.2 47.7 24.6 23.8 26.0 32.8 41.4 316.6 35.5 31.2 76.9 40.4 50.5 70.5 87.4 71.8 45.1 55.8 59.3 28.0 23.7 46.0 50.6 46.3 41.4 33.5 26.3 34.9 52.5 26.8 22.0 33.0 26.5 40.2 20.5 41.1 53.9 40.7 43.9 30.6 6.5 17.6 8.7 4.8 28.4 5.1 4.9 5.4 3.2 15.6 2.8 2.8 3.3 3.7 4.0 33.4 1.6 4.5 7.0 42.2 44.8 43.0 43.0 40.4 42.2 43.2 42.7 41.8 43.7 44.0 41.0 42.8 16.0 10.0 18.6 14.5 40.7 38.8 41.8 43.3 38.3 29.6 36.2 85.7 11.5 24.5 27.6 31.3 148.6 20.7 45.5 93.9 16.3 101.6 82.9 33.7 27.5 16.8 290.9 17.3 22.9 32.7 22.5 21.9 21.3 7.0 28.6 20.3 32.7 75.2 13.5 23.6 37.4 28.5 34.3 30.3 197.4 19.6 41.8 35.6 9.4 46.0 60.7 13.4 9.0 14.1 22.6 42.3 22.6 24.6 23.1 47.9 35.6 96.0 44.1 19.7 42.8 27.4 57.7 54.9 73.2 64.8 60.5 16.5 25.7 55.6 39.4 UBASH3A "CLIP4, STS-2, TULA" ENSG00000160185 "Ubiquitin associated and SH3 domain containing A" P57075 21 42403447-42447684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 18.9" "Cell type enhanced" "Detected in some" "dendritic cells: 5.9;Erythroid cells: 3.8;T-cells: 20.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9" "Lineage enriched" "Detected in many" 12 "T-cells: 32.2" "Group enriched" "Detected in some" 7 "HEL: 23.0;JURKAT: 39.0;MOLT-4: 47.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035367 Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" Nucleoplasm "Golgi apparatus" "HPA035367: AB_2732466" "unprognostic (5.14e-4)" "unprognostic (3.91e-4)" "unprognostic (1.57e-2)" "unprognostic (4.10e-5)" "unprognostic (4.33e-2)" "unprognostic (1.85e-6)" "unprognostic (5.54e-4)" "unprognostic (1.46e-3)" "unprognostic (6.17e-4)" "unprognostic (2.47e-3)" "unprognostic (1.94e-2)" "unprognostic (1.81e-1)" "unprognostic (2.37e-6)" "unprognostic (1.65e-1)" "unprognostic (7.96e-2)" "unprognostic (3.24e-2)" "unprognostic (4.17e-2)" 0.4 0.6 0.0 5.2 0.0 2.5 0.2 0.0 0.1 0.5 0.1 0.8 1.6 0.5 0.0 0.4 0.4 2.0 0.4 0.0 0.1 0.4 0.7 1.7 11.1 0.2 0.0 0.3 0.1 0.0 0.1 0.2 0.1 0.4 0.9 0.0 0.9 0.1 0.2 0.3 2.4 0.1 0.1 4.4 1.9 0.1 0.0 18.9 0.5 0.1 5.1 1.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 23.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 39.0 4.4 0.0 0.0 0.0 47.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 12.9 0.0 22.9 0.1 28.2 24.8 0.0 0.0 32.2 24.0 0.5 2.5 0.1 0.1 27.9 10.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.5 0.0 0.8 0.4 0.0 0.8 0.0 0.0 0.2 0.3 1.0 0.0 0.8 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 3.8 0.0 0.0 0.0 0.4 1.1 0.5 1.3 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.1 0.6 0.0 0.3 0.0 20.5 0.0 0.0 0.0 UBXN6 "UBXD1, UBXDC2" ENSG00000167671 "UBX domain protein 6" Q9BZV1 19 4444999-4457794 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 1342.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040906, HPA041313, HPA061872" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Cytosol" "HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.50e-2)" "prognostic favorable (5.68e-5)" "unprognostic (1.67e-1)" "unprognostic (2.65e-3)" "unprognostic (1.83e-2)" "unprognostic (1.41e-2)" "unprognostic (1.09e-1)" "unprognostic (3.48e-1)" "prognostic favorable (6.95e-4)" "unprognostic (3.93e-2)" "prognostic favorable (2.78e-5)" "unprognostic (4.61e-2)" "unprognostic (2.67e-1)" "unprognostic (1.43e-1)" "unprognostic (1.79e-1)" 99.7 188.7 60.5 35.0 60.9 85.8 89.4 53.3 91.6 94.9 64.0 93.6 49.2 94.5 21.1 89.7 89.1 33.7 116.1 72.3 53.1 118.4 122.2 72.0 35.2 64.0 64.8 115.2 100.3 64.7 146.1 34.8 64.1 93.8 14.1 23.8 86.1 50.7 216.6 113.8 67.7 23.2 52.9 77.8 88.5 174.8 55.1 26.9 111.8 84.3 18.1 91.8 85.3 57.5 71.7 49.4 23.3 50.6 57.7 70.6 35.1 71.3 84.3 50.9 54.1 30.8 58.8 31.8 63.5 70.8 26.3 40.8 18.2 54.8 18.6 56.3 39.4 26.4 53.5 41.4 94.5 33.6 51.1 65.2 70.4 40.1 38.7 62.3 62.9 42.7 55.6 83.6 38.3 45.4 67.2 56.8 37.6 27.4 42.9 30.4 33.3 76.0 48.3 43.9 67.1 97.3 40.1 40.9 116.7 10.8 48.5 54.4 76.8 67.4 51.4 145.0 47.7 186.6 80.7 33.2 128.7 62.5 61.4 6.4 6.6 10.4 3.8 8.0 6.2 5.3 4.5 5.2 6.7 6.0 5.3 4.2 6.7 2.7 4.9 10.2 5.5 4.9 60.5 60.9 53.3 91.6 72.3 53.1 64.0 64.8 64.1 52.9 55.1 57.5 26.7 41.7 30.1 13.7 25.1 37.2 44.9 26.7 15.9 37.2 36.3 25.1 47.2 64.3 21.2 44.1 27.1 54.5 31.9 105.0 80.3 58.1 297.0 29.1 35.6 30.5 46.8 172.0 14.4 65.0 43.1 39.0 28.5 32.2 34.3 50.0 47.5 61.6 54.8 13.5 11.9 66.2 20.3 52.8 35.9 1342.0 100.0 37.5 53.4 1.9 49.0 60.1 25.7 5.5 10.3 65.6 90.1 73.0 16.4 50.9 136.9 112.2 21.4 35.2 72.3 38.8 29.5 139.9 68.9 20.4 41.1 79.6 18.5 41.4 58.4 48.5 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035021-36071358 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.5;lymphoid tissue: 14.7;skin 1: 10.3" "Group enriched" "Detected in some" 4 "Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0" "Low region specificity" "Detected in many" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 14: REH - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.0 0.8 0.0 0.0 0.0 6.5 1.1 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 2.6 0.6 0.0 0.0 1.0 1.1 0.0 0.0 0.1 0.9 0.2 1.2 0.4 0.0 0.1 0.1 0.0 0.1 10.3 0.0 0.0 0.1 1.2 0.1 2.9 0.6 14.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.8 0.0 0.1 0.0 0.0 0.3 0.4 0.0 1.3 0.0 0.5 6.8 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 12.4 0.0 5.3 0.0 0.0 29.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 7.2 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.0 1.1 1.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 1.1 8.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 UNC13B "hmunc13, Munc13-2, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Alveolar cells type 2: 80.7;Cone photoreceptor cells: 95.9;Excitatory neurons: 60.4;Microglial cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Yes No "Cluster 77: Retina - Visual perception" "Cluster 21: OE19 - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: AB_2684742" "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favorable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favorable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favorable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favorable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 12.6 12.8 10.5 5.6 13.3 1.0 10.3 6.6 14.5 12.5 15.7 22.2 11.6 10.1 7.7 17.5 10.4 11.5 13.6 11.4 7.2 21.8 12.8 38.9 1.8 8.3 9.5 7.3 21.3 15.0 11.5 6.0 7.8 22.6 25.0 41.2 17.8 23.3 24.2 12.3 13.4 11.9 7.3 4.7 17.9 15.6 10.6 3.0 12.2 10.4 5.0 10.2 12.7 9.0 9.8 12.8 13.9 22.6 26.3 14.6 11.8 15.7 7.1 11.4 15.3 10.7 4.5 0.0 7.0 20.6 20.1 4.7 35.4 18.2 14.5 0.0 11.3 5.9 36.6 13.9 12.7 2.2 6.4 11.6 14.0 18.0 18.5 18.2 37.3 15.8 13.5 8.1 13.5 7.5 2.1 0.2 12.6 30.2 13.3 0.1 8.6 3.4 15.5 12.6 14.9 15.7 11.0 6.8 11.4 23.0 11.6 7.5 34.5 7.8 7.2 12.3 12.2 12.7 16.2 0.0 8.5 18.4 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 13.3 6.6 14.5 11.4 7.2 8.3 9.5 7.8 7.3 10.6 9.0 6.7 57.7 80.7 28.7 0.8 3.1 1.1 2.1 3.4 42.3 7.3 4.4 11.4 18.6 16.7 9.2 95.9 3.7 0.1 24.4 3.9 6.0 6.9 8.2 5.1 8.5 24.6 1.7 60.4 12.2 2.1 4.8 16.3 13.9 2.5 8.7 5.7 12.5 4.9 6.7 17.7 31.9 0.0 2.4 3.0 12.3 2.1 3.7 7.2 73.1 0.1 5.7 0.0 42.3 36.7 7.8 11.9 3.0 4.2 11.7 10.5 7.8 10.0 40.8 6.6 8.4 6.5 8.7 7.5 14.3 7.4 2.9 1.0 5.7 19.5 5.7 USO1 "p115, TAP, VDP" ENSG00000138768 "USO1 vesicle transport factor" O60763 4 75724577-75814286 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 219.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010108, HPA038282, HPA038283" Supported Supported "Nucleoli fibrillar center,Golgi apparatus" NA NA 170000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "Nucleoli fibrillar center" "CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929" "unprognostic (9.45e-3)" "unprognostic (3.12e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-3)" "unprognostic (6.29e-2)" "unprognostic (2.11e-1)" "unprognostic (2.03e-1)" "unprognostic (3.24e-2)" "unprognostic (9.18e-2)" "unprognostic (7.95e-3)" "unprognostic (4.01e-1)" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-2)" 35.0 38.7 13.1 32.3 14.7 13.0 39.0 15.6 19.0 44.3 26.1 33.9 35.6 32.3 64.2 50.1 30.1 32.0 57.4 14.9 16.1 38.7 76.8 30.4 32.5 16.7 14.4 56.9 57.5 37.7 31.5 43.7 16.4 39.9 36.9 39.2 54.7 37.5 219.2 36.2 33.7 35.7 14.9 26.3 40.8 43.1 15.6 30.7 53.4 138.7 39.7 40.2 27.6 19.2 46.8 36.0 49.5 66.7 118.6 155.8 45.5 106.2 129.4 57.2 69.2 36.2 70.4 60.6 64.0 98.0 49.2 52.8 74.9 66.5 85.6 67.2 29.3 41.8 31.4 76.3 93.0 55.8 46.2 89.2 80.6 59.8 116.4 110.6 87.1 41.7 73.7 67.9 85.8 30.9 55.4 29.5 67.9 98.2 21.3 36.3 47.2 49.2 85.5 53.1 39.4 38.3 39.1 82.4 67.3 73.6 60.6 45.1 67.4 52.2 32.2 95.8 40.7 63.6 36.6 29.5 77.6 33.1 63.2 21.9 13.1 11.9 16.4 18.7 22.2 9.8 13.6 15.7 16.8 11.2 13.9 13.8 8.1 22.2 26.9 13.4 15.1 13.7 13.1 14.7 15.6 19.0 14.9 16.1 16.7 14.4 16.4 14.9 15.6 19.2 34.5 60.9 84.5 59.1 43.2 38.0 52.8 59.6 51.2 33.3 35.0 28.4 126.9 28.6 71.7 25.8 43.8 47.9 32.6 32.0 35.2 38.4 11.1 35.7 57.5 36.4 40.1 20.8 70.9 48.6 49.0 62.7 61.2 55.0 48.8 126.2 32.9 62.0 42.8 26.9 68.7 63.7 40.7 38.0 35.1 10.9 78.6 41.3 28.4 60.9 54.8 32.8 45.3 77.4 113.7 48.5 33.4 68.4 106.9 78.2 44.3 50.4 66.4 51.2 39.5 54.0 50.5 73.8 68.2 58.7 40.3 90.6 37.8 36.3 41.9 63.8 USP32 "NY-REN-60, USP10" ENSG00000170832 "Ubiquitin specific peptidase 32" Q8NFA0 17 60177327-60422470 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 102.1" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 241.8;Inhibitory neurons: 113.1;Oligodendrocytes: 268.9;Rod photoreceptor cells: 136.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 59.2" "Group enriched" "Detected in all" 10 "dendritic cells: 59.2;granulocytes: 29.4" "Cell line enhanced" "Detected in all" "MCF7: 171.4" "Low region specificity" "Detected in all" HPA044365 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" Cytosol "HPA044365: AB_2678914" "unprognostic (4.10e-2)" "unprognostic (3.38e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.90e-3)" "unprognostic (2.33e-2)" "unprognostic (2.24e-1)" "unprognostic (3.93e-1)" "unprognostic (6.49e-2)" "unprognostic (2.78e-1)" "unprognostic (2.82e-1)" "unprognostic (1.97e-1)" "unprognostic (7.23e-2)" "unprognostic (8.35e-2)" "unprognostic (4.16e-2)" 16.1 21.8 13.6 15.0 27.8 32.1 14.1 23.2 23.6 12.4 25.2 13.0 9.5 10.3 6.8 21.7 10.7 11.8 17.4 14.3 22.8 20.2 26.6 20.7 10.5 22.2 25.0 10.0 12.5 19.2 11.9 13.2 24.8 10.8 11.4 58.8 12.9 11.2 40.8 21.0 10.5 13.7 18.1 18.5 12.2 102.1 22.3 14.4 20.6 29.2 11.6 13.1 14.7 44.4 32.6 38.2 19.0 30.8 44.8 45.3 17.2 26.4 41.9 34.5 45.8 18.6 20.0 19.4 21.5 50.0 56.1 16.3 33.1 36.9 61.5 16.8 13.9 39.7 31.8 19.5 44.1 31.7 33.6 39.6 24.6 49.9 45.2 33.5 38.6 24.4 42.9 17.1 41.1 171.4 32.3 21.3 21.7 29.6 18.8 15.8 51.6 11.5 33.1 24.5 13.1 19.1 22.9 6.0 33.8 32.1 27.4 41.3 32.6 49.7 54.9 33.1 23.5 16.2 37.4 19.6 24.6 23.6 33.4 14.5 4.3 16.5 2.0 3.7 1.4 3.0 1.4 1.7 8.5 2.2 1.0 1.9 29.4 1.3 4.6 59.2 2.6 2.1 13.6 27.8 23.2 23.6 14.3 22.8 22.2 25.0 24.8 18.1 22.3 44.4 8.0 6.4 16.4 58.8 12.5 26.9 13.3 5.8 11.4 17.3 9.2 7.6 8.2 10.0 10.1 5.5 241.8 5.1 12.6 8.5 3.9 11.3 95.0 9.0 9.9 9.8 8.3 44.2 92.3 7.5 8.4 12.6 15.8 11.6 11.4 18.5 12.5 12.0 18.5 13.5 113.1 5.6 6.1 29.7 41.3 33.3 13.1 25.1 5.4 101.2 28.0 10.4 24.7 70.4 268.9 9.6 11.4 5.7 8.3 10.3 7.4 4.6 7.0 136.4 26.3 11.9 9.1 92.7 14.9 11.2 21.9 4.9 10.9 8.5 5.5 8.2 USP33 "KIAA1097, VDU1" ENSG00000077254 "Ubiquitin specific peptidase 33" Q8TEY7 1 77695987-77759852 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005719 Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 36: HEL - Hemostasis" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Golgi apparatus" "HPA005719: AB_10601708" "unprognostic (2.31e-3)" "unprognostic (2.73e-2)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (9.19e-3)" "unprognostic (1.88e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.59e-1)" "unprognostic (5.36e-3)" "unprognostic (4.89e-2)" "unprognostic (5.76e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-2)" 40.7 31.2 31.5 24.6 40.4 34.5 34.3 52.0 49.7 24.2 37.3 24.3 25.4 28.0 26.8 21.6 22.5 26.3 21.7 35.4 31.8 31.1 25.4 26.2 28.1 28.6 24.9 29.3 19.5 35.0 20.9 28.0 30.8 28.8 25.2 49.1 25.2 22.9 18.0 24.3 26.9 24.1 22.3 26.0 24.4 25.4 28.6 27.1 30.4 20.7 26.0 22.9 20.0 55.5 42.4 18.8 64.1 44.2 90.0 78.3 54.8 45.3 42.9 54.0 60.1 25.4 35.5 31.4 41.2 44.3 88.2 32.1 47.4 31.1 65.7 28.8 36.6 111.1 44.6 22.2 56.0 37.8 26.8 58.3 23.9 52.4 37.9 51.9 48.7 28.0 43.9 26.3 41.2 16.1 34.9 38.0 62.2 32.6 37.2 33.0 67.7 22.2 51.0 41.1 53.8 41.2 31.9 41.5 64.2 54.3 23.1 41.2 41.2 49.4 34.4 50.1 43.2 21.0 28.4 30.4 37.3 44.5 25.4 67.3 22.5 31.8 21.0 22.6 21.7 20.5 20.6 21.7 17.5 22.3 24.5 21.9 30.5 19.2 30.1 18.4 20.7 16.7 31.5 40.4 52.0 49.7 35.4 31.8 28.6 24.9 30.8 22.3 28.6 55.5 40.2 44.8 40.9 66.3 35.1 17.2 18.8 21.2 32.5 56.7 25.7 22.1 39.9 22.8 25.5 35.0 58.4 25.1 48.8 35.9 9.8 20.8 4.3 54.8 37.8 31.8 35.5 50.9 149.3 15.4 19.0 39.6 43.3 54.6 23.4 43.1 28.2 23.1 19.0 62.2 159.0 28.6 22.4 30.8 20.7 5.5 35.8 35.1 23.2 75.9 38.7 31.4 37.0 98.0 138.5 19.6 27.8 32.0 42.4 22.9 33.2 25.6 37.3 44.5 19.7 34.9 35.6 39.8 30.1 28.4 16.3 11.9 41.0 39.2 24.8 21.8 USP8 "HumORF8, KIAA0055, SPG59, UBPY" ENSG00000138592 "Ubiquitin specific peptidase 8" P40818 15 50424380-50514421 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050215 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 18: U-2197 - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Cytosol "HPA050215: AB_2681054" "unprognostic (5.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "unprognostic (9.58e-2)" "unprognostic (2.35e-2)" "unprognostic (2.91e-1)" "unprognostic (1.42e-1)" "unprognostic (3.96e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.94e-1)" "unprognostic (3.99e-2)" "prognostic favorable (1.29e-5)" "unprognostic (4.89e-2)" "unprognostic (1.13e-1)" "unprognostic (3.79e-1)" "unprognostic (1.58e-1)" 20.3 18.8 11.5 21.1 11.0 27.6 19.6 14.4 13.3 20.5 18.1 21.5 26.7 19.1 10.4 20.7 18.5 16.4 15.1 9.1 14.6 27.0 28.1 19.5 19.0 14.1 13.1 19.9 17.4 45.1 10.6 20.3 12.5 17.0 20.8 22.2 19.8 17.2 17.6 14.2 24.4 18.4 11.5 18.7 22.5 32.0 13.6 20.9 25.4 22.7 24.3 20.0 12.6 13.2 30.6 35.8 23.7 41.1 32.3 44.3 31.0 45.7 43.9 35.7 40.4 19.5 17.7 28.8 35.0 43.5 46.6 57.8 28.8 28.3 39.9 27.2 19.3 52.9 31.9 27.3 35.9 34.3 34.4 32.4 36.2 26.0 55.8 37.0 36.3 23.3 28.4 36.8 32.9 45.9 26.6 12.0 28.5 32.6 17.1 24.1 39.1 45.8 29.5 61.3 29.1 23.8 42.5 55.9 57.4 48.9 35.8 36.9 45.0 41.1 24.1 122.7 52.7 28.5 69.8 32.4 30.6 65.6 40.1 114.6 27.7 50.1 21.4 26.1 22.1 37.3 22.9 23.3 22.7 34.3 24.0 21.2 47.9 22.1 35.0 20.5 20.0 16.0 11.5 11.0 14.4 13.3 9.1 14.6 14.1 13.1 12.5 11.5 13.6 13.2 63.5 96.1 130.8 36.2 101.8 28.9 40.7 47.3 35.9 54.5 41.7 40.0 69.8 51.5 72.7 47.8 68.8 59.0 92.7 79.5 25.4 53.7 153.7 91.5 79.7 53.8 53.3 36.8 41.0 51.3 45.4 55.8 58.1 65.6 86.7 48.5 51.0 56.6 45.4 33.7 44.3 68.7 36.7 73.2 38.2 28.4 53.7 77.6 40.9 46.9 85.3 45.5 72.1 34.7 46.1 57.3 58.2 61.7 87.1 51.0 88.9 49.9 114.9 74.2 46.0 108.2 56.2 140.5 54.8 39.6 41.5 105.2 72.6 77.1 64.8 55.3 VAMP4 ENSG00000117533 "Vesicle associated membrane protein 4" O75379 1 171700160-171742074 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050418 Enhanced Approved "Golgi apparatus" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA050418: AB_2681121" "unprognostic (9.38e-2)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (9.66e-2)" "unprognostic (6.97e-2)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (5.10e-2)" "unprognostic (3.14e-2)" "unprognostic (2.87e-1)" "unprognostic (4.80e-2)" "prognostic unfavorable (5.43e-6)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-2)" "unprognostic (1.15e-1)" 10.9 12.0 11.2 8.6 11.3 5.2 8.8 14.1 13.5 8.9 8.0 8.2 7.9 8.5 7.4 8.4 7.7 8.1 7.7 11.5 13.8 8.1 8.2 10.3 10.9 13.4 13.6 7.0 9.9 12.7 15.2 10.1 13.6 7.3 7.1 10.0 10.5 7.0 6.3 10.0 8.1 7.4 13.3 10.1 8.5 11.7 14.3 7.1 11.4 6.1 8.4 7.3 8.3 12.8 9.5 3.3 8.1 6.6 12.1 14.0 5.2 16.8 13.7 4.1 5.2 2.6 12.2 6.1 14.9 13.5 6.2 6.2 3.3 5.8 5.9 10.9 5.4 5.0 4.1 2.2 7.3 4.4 4.1 6.9 10.0 5.2 9.6 11.9 7.6 8.1 12.4 7.1 8.9 3.1 10.6 6.2 3.9 18.1 12.9 8.7 6.3 15.6 8.6 3.0 5.1 9.6 8.6 8.8 7.3 8.9 12.0 8.1 8.9 12.7 4.3 18.3 16.2 25.8 23.4 8.4 19.6 3.9 10.4 11.0 8.8 11.9 8.6 7.6 11.9 8.2 11.3 9.9 4.5 6.6 7.8 8.6 3.4 9.5 7.8 6.4 11.3 8.8 11.2 11.3 14.1 13.5 11.5 13.8 13.4 13.6 13.6 13.3 14.3 12.8 22.3 22.4 9.3 18.3 21.4 15.4 13.8 18.0 26.7 12.3 12.9 9.7 11.6 10.0 14.8 3.7 22.9 10.8 18.2 9.7 15.6 7.5 35.1 7.8 8.4 20.3 10.2 30.9 23.5 7.7 13.4 20.4 6.6 8.9 24.7 8.9 18.2 11.8 14.8 10.1 24.1 12.3 16.2 15.4 12.1 38.6 9.3 20.1 12.4 19.7 17.1 17.0 25.7 18.6 23.0 10.0 14.9 13.2 20.8 19.7 13.4 13.7 11.4 9.4 19.7 15.2 15.0 42.7 20.2 16.1 17.3 13.4 23.1 8.5 7.4 17.5 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 873.4;NB-4: 1362.5;U-937: 912.8" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 220000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 74.0 34.7 26.9 148.4 28.2 299.7 225.1 28.7 53.8 121.8 51.6 250.6 229.9 30.6 144.5 303.1 166.1 119.2 24.6 26.5 29.9 280.1 247.4 266.5 212.4 35.6 31.6 10.4 182.5 270.3 33.7 265.7 34.3 107.7 300.9 4.4 322.5 90.4 24.3 210.2 252.1 71.4 31.9 175.9 228.4 23.4 35.5 173.5 126.0 27.3 311.7 198.0 150.0 36.5 255.0 33.2 2.6 2.3 2.4 1.4 241.6 0.7 0.3 0.2 0.3 191.2 225.2 56.8 174.4 1.2 17.9 175.2 2.4 451.6 0.6 232.3 173.7 290.3 104.4 220.7 3.3 873.4 287.1 2.3 317.5 0.3 72.3 1.2 58.2 1.2 214.9 11.6 103.8 363.9 0.8 1362.5 3.2 315.9 26.0 5.2 8.9 381.7 516.9 384.3 8.4 2.9 120.9 628.3 19.4 126.3 231.4 665.4 113.9 0.3 15.3 2.9 2.7 3.0 151.1 340.0 2.6 912.8 1.1 601.3 868.6 328.4 469.3 740.3 455.6 519.3 537.0 463.3 787.3 508.3 423.2 442.0 52.4 556.3 460.0 2135.6 665.3 1536.0 26.9 28.2 28.7 53.8 26.5 29.9 35.6 31.6 34.3 31.9 35.5 36.5 39.4 371.8 283.2 1.3 147.7 259.1 303.3 800.9 164.4 1.2 289.7 251.7 6.3 356.0 662.1 366.0 0.0 980.8 447.1 832.3 765.0 630.7 28.0 231.3 22.8 46.1 129.1 147.4 0.1 730.0 460.4 35.6 188.6 212.9 269.4 3.3 163.1 314.8 1191.1 0.0 0.1 391.8 545.3 1000.4 488.7 49.1 9.3 537.2 352.2 2.8 686.1 7.9 375.9 0.0 0.5 865.5 843.2 7.5 103.0 302.7 1184.0 1046.8 600.5 2.0 46.0 21.4 56.5 48.0 8.3 239.8 329.7 877.8 219.5 13.8 299.4 602.0 VGF "SCG7, SgVII" ENSG00000128564 "VGF nerve growth factor inducible" O15240 7 101162509-101165569 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 1407.4" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 128.3;Horizontal cells: 225.4" "Cancer enriched" "Detected in many" 6 "melanoma: 236.3" "Region enriched" "Detected in all" 6 "hypothalamus: 1407.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055177, HPA072505" Enhanced Enhanced "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1270000 3100000 "Cluster 73: Brain - Neuropeptide signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus, Vesicles" "HPA055177: AB_2682728, HPA072505: AB_2686528" "unprognostic (3.04e-2)" "unprognostic (3.45e-1)" "unprognostic (3.19e-3)" "prognostic unfavorable (4.25e-4)" "prognostic unfavorable (3.31e-4)" "unprognostic (1.51e-2)" "unprognostic (2.86e-2)" "unprognostic (1.66e-3)" "unprognostic (2.25e-2)" "unprognostic (8.77e-2)" "unprognostic (3.84e-3)" "unprognostic (3.70e-3)" "unprognostic (9.82e-3)" "unprognostic (3.79e-1)" "unprognostic (7.23e-2)" "unprognostic (4.36e-3)" "unprognostic (2.21e-1)" 2.1 3.1 23.7 0.8 24.8 0.1 0.1 5.5 174.6 0.0 0.0 0.5 0.1 0.7 0.0 0.0 0.0 0.0 0.1 22.7 1407.4 3.6 0.0 0.1 0.0 235.4 69.9 0.1 16.1 0.0 117.0 0.0 158.8 0.1 0.0 2.2 0.0 0.0 0.0 0.8 0.3 0.2 16.6 0.1 1.9 0.9 48.7 0.0 0.6 0.0 0.0 0.0 0.1 27.3 2.2 1.1 1.1 9.5 0.0 0.0 10.3 0.9 0.0 0.0 0.0 2.4 0.9 0.1 3.1 0.0 1.4 1.4 0.5 0.1 0.0 1.0 0.7 0.3 0.0 0.9 0.1 0.6 4.4 0.1 0.2 0.2 0.7 0.0 0.0 0.1 3.7 2.3 0.0 23.4 0.1 2.4 17.6 1.0 2.3 0.8 0.0 0.1 0.3 0.1 14.1 172.0 0.3 0.9 511.5 1.1 0.4 0.3 0.0 0.4 85.9 0.0 2.0 0.1 0.8 4.7 13.5 0.4 141.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 24.8 5.5 174.6 22.7 1407.4 235.4 69.9 158.8 16.6 48.7 27.3 1.7 0.0 0.0 3.6 0.9 1.5 1.0 0.0 1.2 22.0 0.9 0.6 2.9 0.0 0.0 0.0 0.0 1.5 1.0 1.3 29.4 0.3 0.1 0.4 0.4 0.9 128.3 0.0 22.7 0.0 8.4 0.3 3.1 0.5 0.0 1.4 0.0 0.0 0.6 225.4 37.7 4.5 0.0 0.0 0.4 0.6 0.6 0.7 0.0 11.2 0.0 2.1 0.0 4.0 4.8 5.9 2.8 0.0 0.9 4.3 2.7 1.2 0.0 5.0 0.0 0.1 0.8 0.2 4.3 0.6 2.3 1.4 0.5 5.4 2.3 0.6 VPS51 "ANG2, ANG3, C11orf2, C11orf3, FFR" ENSG00000149823 "VPS51 subunit of GARP complex" Q9UID3 11 65089324-65111862 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039650, HPA061447" Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 50: Non-specific - Ribosome" "Cluster 25: RPMI-8226 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus, Vesicles" Nucleoli "HPA039650: AB_10673147, HPA061447: AB_2684521" "unprognostic (2.36e-2)" "unprognostic (7.58e-2)" "unprognostic (8.35e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-2)" "unprognostic (1.64e-1)" "unprognostic (9.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "prognostic favorable (2.41e-9)" "unprognostic (7.77e-3)" "unprognostic (4.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.18e-1)" 48.5 37.8 19.0 34.9 23.1 60.9 46.6 22.0 30.7 45.6 20.4 55.4 52.9 54.4 7.3 42.5 46.1 20.3 45.3 22.5 15.5 33.7 36.2 34.2 48.6 18.5 18.6 83.8 120.3 37.4 28.6 22.2 20.2 38.1 25.1 20.3 65.5 27.7 84.2 71.2 49.7 22.7 14.3 40.9 70.3 28.4 17.2 46.7 39.7 42.9 32.5 45.2 38.1 21.5 71.8 74.5 35.7 44.4 15.5 38.5 72.1 27.5 53.2 52.6 38.8 55.2 88.7 118.0 76.1 51.4 27.3 60.0 37.9 59.3 19.2 69.6 62.1 72.5 72.6 55.1 51.3 77.1 65.0 66.8 39.9 39.0 32.1 41.6 58.4 55.0 73.6 82.9 21.7 95.1 105.8 83.0 59.8 30.7 61.5 67.5 17.5 150.7 36.2 76.2 61.5 87.8 20.7 110.9 71.8 21.0 93.7 39.1 48.1 35.2 32.0 45.4 39.7 115.7 92.2 68.9 39.9 28.0 26.3 10.6 15.0 15.4 17.9 15.8 21.2 22.4 25.2 27.1 22.1 21.2 23.3 20.7 8.0 30.6 16.0 19.1 17.7 18.3 19.0 23.1 22.0 30.7 22.5 15.5 18.5 18.6 20.2 14.3 17.2 21.5 49.8 19.2 47.7 18.9 77.3 49.1 66.3 46.0 58.6 64.7 76.5 67.8 5.8 44.3 27.8 31.3 29.2 78.4 73.7 156.5 62.6 49.2 77.5 25.6 35.0 46.5 95.8 50.5 21.8 120.5 79.4 38.8 45.9 34.4 37.5 47.3 55.3 52.5 45.5 67.3 24.1 110.0 32.6 54.0 30.6 222.4 53.4 36.1 49.8 15.9 71.3 65.9 89.6 21.6 28.0 51.2 144.4 54.5 66.4 45.1 158.7 75.9 16.1 52.5 26.3 49.3 44.4 40.3 31.4 52.3 54.8 115.3 64.0 61.5 170.5 51.0 VPS53 "FLJ10979, HCCS1" ENSG00000141252 "VPS53 subunit of GARP complex" Q5VIR6 17 508503-721717 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 270.0;Late spermatids: 203.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022988, HPA024446" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" Cytosol "HPA022988: AB_1848679, HPA024446: AB_1848680" "unprognostic (8.62e-3)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.39e-2)" "unprognostic (9.08e-3)" "unprognostic (3.12e-1)" "unprognostic (9.67e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.53e-2)" "unprognostic (1.82e-2)" "unprognostic (1.89e-2)" "unprognostic (2.81e-1)" "unprognostic (4.82e-2)" "unprognostic (1.31e-1)" 4.3 4.7 7.0 3.0 5.9 20.5 4.6 21.4 10.3 5.2 2.8 4.5 3.7 4.4 3.4 9.0 4.0 3.6 4.3 8.2 3.3 4.0 4.5 5.1 4.9 3.0 3.9 5.3 4.5 6.4 6.0 4.6 4.2 4.6 5.9 8.1 4.7 5.0 7.0 7.1 4.0 6.1 0.9 4.5 5.0 14.6 4.0 4.9 7.6 5.1 5.2 4.1 4.8 9.4 12.9 26.5 7.6 8.3 12.4 9.5 5.5 6.4 9.4 15.8 15.4 12.6 5.8 7.8 5.9 19.9 10.0 10.9 16.5 13.9 23.1 6.7 11.4 5.0 17.2 8.1 6.1 6.6 9.2 11.1 7.8 14.7 9.8 6.4 11.7 9.7 9.1 9.1 14.9 8.9 4.3 5.1 6.2 5.6 6.9 10.5 3.9 5.2 8.0 10.4 7.6 6.1 12.4 4.3 5.4 7.5 6.5 3.5 7.9 6.8 5.4 12.5 7.0 4.3 3.3 4.8 11.5 5.2 8.6 8.1 1.9 4.4 2.4 2.3 1.8 2.1 2.2 1.7 1.1 3.0 2.3 1.9 6.1 1.9 5.6 3.0 1.9 0.9 7.0 5.9 21.4 10.3 8.2 3.3 3.0 3.9 4.2 0.9 4.0 9.4 16.0 12.8 25.9 54.5 19.3 25.5 16.5 11.6 19.9 53.3 19.6 9.3 17.4 14.3 21.5 40.5 70.9 10.5 19.9 24.9 1.9 16.7 270.0 23.9 22.2 18.7 24.6 5.0 109.3 18.3 7.9 18.5 26.5 28.1 24.1 18.2 15.7 17.7 21.4 63.9 103.6 27.4 4.1 20.6 19.4 203.9 18.6 21.0 10.6 39.4 27.5 18.3 37.0 48.2 62.5 25.3 15.5 23.0 20.6 18.7 21.0 10.6 24.3 52.2 6.6 31.1 20.7 46.0 35.3 24.6 38.8 8.9 26.8 17.2 22.0 19.6 VPS54 "HCC8, PPP1R164" ENSG00000143952 "VPS54 subunit of GARP complex" Q9P1Q0 2 63892146-64019428 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 81.8;Microglial cells: 76.8;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 108.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055894, HPA067981, HPA070582" Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Nucleoplasm "HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282" "unprognostic (1.35e-1)" "unprognostic (3.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.46e-1)" "unprognostic (3.37e-1)" "unprognostic (9.47e-3)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.16e-1)" "unprognostic (4.62e-2)" "unprognostic (1.82e-1)" "prognostic favorable (2.03e-4)" "unprognostic (3.20e-1)" "unprognostic (8.38e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (1.57e-1)" "unprognostic (4.91e-2)" 11.7 11.5 8.1 10.6 9.7 15.0 14.5 13.5 9.6 13.5 10.9 11.6 13.0 14.4 12.3 10.8 12.4 10.4 8.4 7.8 8.5 16.0 14.4 13.1 11.1 8.8 8.7 14.6 17.0 28.3 13.0 13.5 8.9 17.4 13.4 17.3 36.8 12.8 9.3 10.9 12.2 12.8 8.5 12.9 14.4 13.4 8.5 13.2 17.7 9.9 11.2 10.9 9.8 11.0 23.3 11.9 22.5 17.4 15.7 17.1 16.6 14.3 21.4 15.0 14.9 22.0 14.9 15.8 10.5 20.1 22.3 10.7 22.1 12.9 27.1 23.0 15.9 14.7 10.0 38.9 15.0 10.3 6.2 16.3 19.8 10.5 22.7 18.0 23.0 11.3 16.6 13.4 19.4 10.1 10.9 11.5 13.8 22.9 9.1 10.8 21.8 9.0 17.1 13.1 13.1 19.6 12.8 16.3 17.8 17.3 11.9 20.6 16.8 19.3 15.3 11.8 23.9 30.8 8.7 20.4 14.3 20.5 16.4 1.0 0.7 0.3 0.5 0.6 0.5 0.6 0.4 0.5 0.4 0.7 0.6 0.5 0.6 0.7 0.5 0.6 0.9 0.2 8.1 9.7 13.5 9.6 7.8 8.5 8.8 8.7 8.9 8.5 8.5 11.0 16.6 16.0 22.3 62.7 5.2 11.1 8.7 6.4 3.4 20.9 11.8 9.8 14.3 15.7 14.2 1.8 12.5 6.5 6.4 11.1 1.9 6.8 53.9 9.3 16.6 13.4 13.2 2.1 71.6 13.2 6.8 11.8 15.8 11.0 2.5 15.2 10.8 15.4 8.1 23.5 81.8 17.4 2.0 9.8 9.3 37.4 18.6 12.2 5.4 76.8 9.6 9.4 3.1 105.6 108.9 11.3 12.8 12.4 7.7 17.3 11.6 9.9 10.6 16.2 19.7 13.4 12.8 14.9 8.3 9.4 10.4 5.5 7.5 15.9 12.9 13.8 VTI1A "MVti1, Vti1-rp2" ENSG00000151532 "Vesicle transport through interaction with t-SNAREs 1A" Q96AJ9 10 112446998-112818744 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 135.2;Excitatory neurons: 244.7;Inhibitory neurons: 199.5;Late spermatids: 102.8;Microglial cells: 195.8;Oligodendrocyte precursor cells: 172.4;Oligodendrocytes: 218.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054108 Supported Supported "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Vesicles" "HPA054108: AB_2682382" "unprognostic (9.81e-2)" "unprognostic (6.42e-2)" "unprognostic (4.49e-2)" "unprognostic (1.50e-1)" "unprognostic (1.66e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.50e-5)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic favorable (7.27e-5)" "unprognostic (3.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-3)" "unprognostic (2.61e-1)" 6.6 4.7 3.7 7.0 3.7 13.8 4.7 2.3 4.7 3.5 1.1 6.4 7.2 3.8 4.9 7.3 3.2 4.6 5.8 4.8 2.6 6.8 4.7 5.1 7.7 2.8 3.7 3.1 3.9 7.5 2.6 4.0 3.5 4.7 7.5 4.2 5.2 4.8 7.4 5.9 7.2 5.7 1.8 5.6 5.5 4.5 4.3 8.6 6.3 6.1 9.4 5.2 4.4 4.6 13.5 11.2 10.1 14.1 15.5 13.4 6.1 14.1 17.4 11.0 12.2 12.7 13.6 14.0 5.3 16.0 9.3 15.6 8.8 11.2 14.9 18.0 8.1 11.9 8.1 13.3 11.0 16.8 16.8 10.4 13.9 12.6 25.9 12.4 11.9 14.1 11.3 16.9 14.8 9.5 13.3 12.8 4.4 10.5 6.5 13.9 14.6 6.2 11.5 11.9 4.6 9.0 10.0 8.6 9.5 8.4 7.8 9.3 17.0 8.7 7.4 10.8 15.8 7.4 11.0 15.9 14.2 15.3 8.6 9.2 7.0 9.6 5.4 9.3 5.1 5.5 4.5 4.4 5.2 4.6 4.3 4.4 11.4 5.7 8.7 4.9 7.2 4.6 3.7 3.7 2.3 4.7 4.8 2.6 2.8 3.7 3.5 1.8 4.3 4.6 13.5 12.8 10.3 135.2 33.1 11.2 14.5 8.8 13.6 16.5 7.8 4.6 14.0 7.2 11.6 5.5 43.8 7.6 31.5 17.0 7.9 15.4 42.9 11.4 15.5 13.6 18.5 18.1 244.7 25.0 12.3 12.9 21.9 17.0 19.6 10.2 8.9 8.1 18.8 21.9 199.5 10.7 14.2 17.0 27.0 102.8 6.8 20.9 12.4 195.8 19.0 6.0 25.7 172.4 218.6 29.7 12.2 5.7 23.9 12.6 17.2 9.4 11.7 20.7 0.0 13.5 14.1 11.1 9.2 17.0 16.3 14.4 25.4 9.7 12.1 19.7 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647085-67674820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206" "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favorable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 53.8 26.9 55.5 20.4 56.8 22.3 39.8 54.4 102.1 22.7 49.8 42.9 28.3 18.4 53.5 44.3 18.5 28.7 60.1 56.6 58.1 53.0 41.6 26.8 23.8 55.1 56.6 21.0 44.0 23.9 17.1 21.3 56.8 22.3 35.2 23.0 30.1 13.6 46.5 31.0 24.1 22.4 56.0 26.5 40.0 30.8 56.3 12.1 34.0 28.2 27.0 33.3 23.4 56.9 111.7 54.8 31.4 18.1 61.9 37.2 45.4 48.1 30.5 23.8 23.7 27.3 38.5 32.9 40.2 54.5 27.5 30.6 36.8 36.6 37.7 34.3 22.6 33.4 32.5 34.8 26.6 20.9 22.9 36.3 39.6 25.6 26.1 60.5 27.2 23.1 22.2 25.4 34.5 131.1 26.6 77.7 20.3 76.6 88.0 31.8 35.6 12.2 35.1 65.0 17.4 35.5 33.8 45.5 71.4 23.7 41.9 58.0 38.5 62.6 93.8 51.4 45.6 23.8 27.8 53.2 52.9 38.9 29.0 88.8 61.5 143.8 49.4 80.4 42.4 49.0 43.1 51.1 59.6 43.0 40.5 50.3 27.2 56.4 70.2 38.6 60.2 58.3 55.5 56.8 54.4 102.1 56.6 58.1 55.1 56.6 56.8 56.0 56.3 56.9 47.6 25.6 35.0 13.1 48.7 42.3 61.4 91.7 33.0 23.2 82.2 65.4 30.5 67.2 64.4 66.2 22.9 107.4 47.5 138.2 217.2 109.1 141.7 58.5 43.2 51.5 46.6 102.7 15.8 131.4 167.9 51.6 40.8 49.5 64.0 43.6 73.9 95.3 131.4 15.2 18.2 96.0 50.8 99.8 49.2 493.5 41.7 80.9 71.2 11.2 121.6 65.4 78.2 13.6 17.1 130.7 119.4 39.9 51.0 120.5 165.4 268.6 55.3 44.8 19.7 36.5 58.2 104.5 57.2 58.2 52.8 125.9 46.8 35.5 91.9 124.6 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 40.7;brain: 16.4" "Group enriched" "Detected in some" 7 "Enteroendocrine cells: 112.4;Excitatory neurons: 39.2;Inhibitory neurons: 29.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9;pancreatic cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 31.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 22.9" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507" "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.0 40.7 7.8 0.0 1.7 0.1 0.0 0.7 16.4 0.5 0.0 0.4 1.8 0.2 0.1 0.0 1.3 0.0 0.0 6.5 0.7 0.2 0.0 0.1 0.0 7.4 0.5 0.4 5.6 1.4 8.3 0.0 5.0 0.5 0.3 0.2 0.6 2.4 0.0 0.0 1.1 0.0 0.0 0.0 2.8 1.0 2.6 0.0 0.3 0.0 0.0 0.1 0.1 2.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.9 0.3 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.7 0.4 0.3 0.0 0.0 31.7 2.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.1 0.1 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 1.7 0.7 16.4 6.5 0.7 7.4 0.5 5.0 0.0 2.6 2.0 0.4 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 7.6 0.1 0.1 112.4 0.0 39.2 0.2 0.0 0.0 6.1 0.8 0.0 0.2 1.1 0.0 0.2 3.3 29.2 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 1.7 0.2 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 WDFY1 "FENS-1, KIAA1435, WDF1, ZFYVE17" ENSG00000085449 "WD repeat and FYVE domain containing 1" Q8IWB7 2 223855716-223945357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050603, HPA079597" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Vesicles" "HPA050603: AB_2681188, HPA079597: " "unprognostic (2.49e-1)" "unprognostic (1.24e-1)" "unprognostic (2.94e-1)" "unprognostic (7.62e-2)" "unprognostic (8.24e-2)" "unprognostic (5.31e-2)" "unprognostic (2.63e-2)" "unprognostic (7.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.29e-2)" "unprognostic (1.23e-3)" "unprognostic (1.36e-1)" "unprognostic (3.81e-3)" "unprognostic (3.94e-1)" "unprognostic (2.98e-1)" "unprognostic (3.04e-1)" "unprognostic (7.55e-2)" 18.6 13.2 9.3 18.0 9.5 48.5 14.4 9.3 12.0 20.5 11.2 20.4 15.6 22.6 19.8 14.4 20.5 17.5 11.7 9.2 10.7 14.8 18.0 18.4 23.3 11.0 10.2 20.2 14.1 19.8 8.7 27.4 11.4 16.2 20.1 15.9 13.5 12.8 11.4 13.5 15.9 19.6 9.7 21.2 19.8 10.9 10.5 15.9 22.1 12.6 18.9 17.9 13.7 11.1 27.9 19.3 34.9 27.2 46.4 44.0 43.7 34.7 48.3 37.5 30.4 81.4 25.0 7.7 30.8 60.6 47.3 19.2 18.7 52.3 40.4 15.6 15.8 19.2 31.9 59.2 36.4 15.2 15.8 39.0 37.9 46.3 71.0 62.4 63.9 16.2 34.3 23.4 44.4 26.8 6.5 11.1 34.5 20.7 16.6 25.3 44.8 8.6 28.4 47.7 29.6 15.7 20.7 19.2 90.9 41.6 12.5 38.1 70.9 74.9 25.7 13.5 18.0 28.8 4.6 21.4 36.3 32.9 26.2 4.4 21.5 8.1 13.7 29.0 16.6 14.1 9.7 13.5 14.8 11.7 10.0 9.5 10.3 24.0 25.7 3.0 9.7 17.6 9.3 9.5 9.3 12.0 9.2 10.7 11.0 10.2 11.4 9.7 10.5 11.1 40.0 16.0 9.3 22.5 22.0 12.5 14.5 19.9 17.1 14.0 11.8 7.6 7.7 12.8 24.4 16.5 8.4 22.6 25.5 36.4 9.8 12.9 0.8 23.2 30.7 34.1 10.3 11.2 28.7 17.2 11.2 21.4 29.6 36.5 17.7 12.5 16.8 25.7 17.9 28.6 28.1 15.2 8.2 26.3 17.2 2.4 14.6 24.4 35.6 27.2 25.6 13.9 24.7 33.7 39.8 18.0 24.4 23.7 21.8 16.6 16.0 14.4 29.9 10.9 6.6 13.1 26.7 3.8 8.8 24.4 15.5 19.0 21.1 15.0 21.8 28.7 WDR41 FLJ10904 ENSG00000164253 "WD repeat domain 41" Q9HAD4 5 77425970-77620611 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043124 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Golgi apparatus, Cytosol" "HPA043124: AB_10793990" "unprognostic (1.81e-1)" "unprognostic (9.42e-2)" "unprognostic (2.52e-3)" "unprognostic (9.69e-2)" "unprognostic (1.52e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.28e-3)" "unprognostic (1.43e-1)" "unprognostic (1.68e-2)" "unprognostic (2.30e-3)" "unprognostic (1.49e-1)" "unprognostic (4.15e-3)" "unprognostic (6.11e-2)" "unprognostic (4.90e-1)" "unprognostic (1.85e-1)" "unprognostic (2.90e-3)" 16.3 9.4 13.5 13.7 15.1 19.3 15.7 13.3 18.3 13.4 8.5 12.8 8.9 10.9 12.3 19.6 16.6 11.7 17.1 13.8 13.7 12.9 14.8 14.0 15.2 15.0 13.6 7.6 21.0 13.8 6.9 11.4 14.8 11.3 13.1 20.6 12.1 10.9 21.4 12.1 8.8 19.1 12.4 11.8 11.3 27.6 14.0 11.7 22.4 21.0 17.2 14.8 10.8 17.0 17.7 29.8 42.6 62.1 41.9 60.1 32.2 55.5 59.6 26.3 47.5 28.1 28.7 54.1 24.6 53.1 44.4 22.3 31.6 77.8 27.6 65.5 37.1 21.6 32.0 24.7 63.7 46.1 50.0 38.5 96.1 30.1 63.1 28.3 42.0 29.6 21.7 56.8 42.2 39.1 24.7 29.7 15.4 17.8 11.7 58.1 56.1 38.7 27.9 14.8 23.5 29.7 48.2 31.0 47.9 49.9 29.4 57.8 38.2 34.3 28.0 19.1 41.3 51.3 44.8 96.7 48.1 20.7 59.4 25.4 28.5 50.1 11.3 33.8 10.9 19.0 6.5 10.2 51.0 13.3 4.4 8.0 13.7 31.8 38.5 23.2 5.8 16.5 13.5 15.1 13.3 18.3 13.8 13.7 15.0 13.6 14.8 12.4 14.0 17.0 10.2 38.5 12.3 63.3 12.6 12.0 25.2 31.0 14.2 34.8 11.6 12.3 17.3 12.8 16.5 18.4 20.9 8.8 16.4 4.4 37.2 22.7 178.8 17.7 25.6 11.3 6.0 13.5 41.3 20.9 25.5 23.7 9.2 8.3 15.8 11.7 8.9 11.5 26.3 23.5 46.7 8.5 14.2 20.2 29.5 87.5 9.6 23.9 17.8 36.5 16.4 14.9 15.5 56.8 78.9 15.2 7.4 8.2 25.6 26.8 5.0 18.7 17.0 19.2 6.6 12.7 22.3 56.4 44.5 23.9 14.2 6.3 11.4 35.5 10.9 28.0 WDR44 "DKFZp686L20145, RAB11BP, RPH11, SYM-4" ENSG00000131725 "WD repeat domain 44" Q5JSH3 X 118346073-118449961 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038084, HPA046719" Approved Supported "Golgi apparatus" NA NA 1800000 "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA038084: AB_10675626, HPA046719: AB_2679772" "unprognostic (1.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (2.40e-1)" "unprognostic (1.04e-1)" "unprognostic (4.56e-1)" "unprognostic (1.52e-1)" "unprognostic (6.09e-2)" "unprognostic (1.91e-1)" "unprognostic (1.88e-2)" "unprognostic (1.46e-1)" "unprognostic (1.08e-1)" "unprognostic (4.98e-2)" "unprognostic (5.52e-2)" 8.4 7.3 6.6 8.2 8.9 6.0 6.3 7.9 7.6 8.0 2.5 6.8 8.3 7.8 6.7 11.3 5.8 11.8 8.3 7.1 6.9 6.0 12.8 7.9 9.4 6.0 6.5 7.6 6.7 10.1 5.2 7.2 6.1 7.5 6.2 8.4 5.6 10.5 9.7 5.1 7.7 10.4 5.7 8.1 8.6 9.8 7.2 10.6 6.9 8.9 9.2 10.0 6.9 10.1 16.4 9.4 10.0 5.8 16.7 13.6 5.5 25.2 17.6 17.9 25.2 6.4 18.4 4.6 14.4 18.1 15.1 12.6 19.7 12.0 20.6 18.6 8.8 18.5 23.3 4.2 11.5 11.7 12.4 8.1 12.6 17.0 11.4 18.2 16.1 8.5 14.8 15.8 17.3 8.0 9.2 6.9 18.1 12.3 15.1 7.2 8.6 7.2 14.6 10.3 4.3 6.7 23.9 8.3 7.9 17.7 7.4 8.3 20.5 13.3 5.1 18.2 14.4 5.9 10.0 6.5 11.2 13.7 9.1 8.0 3.2 7.3 5.4 4.9 5.5 3.6 4.4 5.4 5.1 3.2 5.1 5.6 2.0 7.2 5.5 3.7 7.1 4.0 6.6 8.9 7.9 7.6 7.1 6.9 6.0 6.5 6.1 5.7 7.2 10.1 14.3 22.4 15.0 18.3 11.0 14.8 7.2 6.3 9.1 8.9 7.6 6.3 11.4 10.0 6.2 12.9 10.4 2.3 9.9 9.6 1.9 5.2 0.4 10.9 10.8 12.0 1.2 5.0 35.2 5.3 2.2 11.1 14.3 17.8 8.8 9.8 5.7 16.7 8.6 1.7 41.2 5.2 4.1 13.6 17.7 1.3 7.2 17.2 7.2 40.3 10.3 7.5 11.3 35.2 89.6 11.0 5.8 11.3 12.1 10.2 6.2 4.2 9.1 7.0 26.3 9.3 11.1 17.5 17.6 12.3 9.2 1.2 14.7 5.7 4.6 7.4 WDR45B "WDR45L, WIPI3" ENSG00000141580 "WD repeat domain 45B" Q5MNZ6 17 82614562-82648553 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 462.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017886 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" Cytosol "HPA017886: AB_1858810" "unprognostic (1.91e-1)" "unprognostic (7.77e-2)" "unprognostic (5.13e-2)" "unprognostic (3.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.88e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (1.22e-2)" "unprognostic (4.41e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.93e-3)" "unprognostic (8.89e-2)" "unprognostic (4.27e-2)" "unprognostic (1.02e-1)" 39.4 44.5 50.7 22.4 56.1 58.7 37.6 52.4 50.4 35.6 41.4 33.6 30.8 37.9 30.1 59.3 43.6 36.8 37.0 48.9 50.9 37.3 32.4 32.9 23.3 53.0 51.7 50.1 46.1 46.2 36.8 25.5 50.7 37.5 25.9 30.9 46.6 28.5 24.4 46.9 34.4 27.5 54.3 28.6 39.9 50.0 54.6 23.8 32.1 26.8 25.8 39.8 40.1 60.3 100.5 65.1 56.0 54.6 53.8 44.4 63.0 71.1 77.7 106.4 93.5 78.7 53.8 27.9 44.8 64.2 76.9 52.4 52.8 58.5 101.4 18.6 93.7 55.4 40.5 67.8 64.1 42.8 42.8 50.9 61.7 62.1 57.3 52.1 88.2 38.0 41.6 27.8 63.0 66.8 31.3 37.6 72.3 86.8 78.2 36.6 92.0 28.1 65.0 99.3 68.3 100.9 66.9 74.7 90.7 67.6 86.9 39.2 63.6 120.0 94.4 81.5 135.8 66.5 29.7 40.5 76.8 42.9 87.0 34.2 27.5 33.9 16.4 27.6 16.6 13.4 12.5 13.7 22.2 12.8 10.9 10.5 21.9 13.9 22.8 10.9 11.3 19.3 50.7 56.1 52.4 50.4 48.9 50.9 53.0 51.7 50.7 54.3 54.6 60.3 62.1 32.1 47.3 17.0 51.5 59.9 48.6 71.5 48.3 39.7 76.3 54.0 21.2 60.1 84.4 42.3 12.5 54.4 49.6 85.6 88.0 128.8 152.7 145.2 72.5 56.1 47.4 14.5 16.9 137.7 77.3 44.9 43.3 177.1 73.5 32.7 47.2 71.5 45.8 45.4 20.0 68.0 67.1 62.0 42.5 462.7 57.2 72.8 56.9 15.9 57.8 66.2 44.3 13.0 24.6 157.6 55.4 48.2 24.8 72.8 58.3 71.5 91.1 34.9 32.9 44.6 53.2 94.5 171.6 53.8 72.5 108.1 46.7 37.0 68.3 101.0 WDR77 "MEP50, p44" ENSG00000116455 "WD repeat domain 77" Q9BQA1 1 111439890-111449256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 104.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026437, HPA026448, HPA027271" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 18000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004" "unprognostic (1.84e-1)" "unprognostic (7.01e-2)" "unprognostic (6.26e-3)" "unprognostic (1.19e-3)" "unprognostic (1.12e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.06e-6)" "unprognostic (5.14e-1)" "unprognostic (3.88e-3)" "prognostic favorable (7.88e-4)" "unprognostic (6.16e-2)" "unprognostic (1.72e-3)" "unprognostic (1.63e-2)" "unprognostic (8.13e-2)" "unprognostic (1.92e-1)" "unprognostic (6.17e-2)" "unprognostic (1.23e-2)" 16.5 23.5 13.5 18.2 13.6 10.3 14.1 13.0 13.5 14.2 13.3 17.0 14.9 20.1 17.7 27.3 104.9 12.4 29.6 15.1 14.6 19.5 22.7 13.8 28.4 14.1 15.2 12.6 17.5 18.2 14.2 18.5 14.2 17.4 24.1 11.4 19.4 14.7 42.2 13.6 16.3 19.2 13.4 22.5 21.2 14.1 15.1 20.5 13.6 32.9 36.2 24.6 16.7 14.1 70.0 58.6 56.0 46.2 32.5 19.6 76.6 51.8 27.6 76.4 50.1 86.0 25.5 118.8 48.6 44.0 49.1 49.4 101.2 96.9 91.1 46.9 80.0 70.9 67.4 125.2 36.9 71.7 114.6 23.8 68.6 75.4 47.6 20.5 51.7 51.9 96.3 30.1 74.5 86.0 94.0 38.8 109.7 64.5 99.4 92.2 88.2 44.9 68.9 118.7 45.6 33.4 45.5 54.7 42.3 70.6 45.1 50.5 38.7 42.3 86.4 82.6 111.1 25.4 34.1 106.3 54.6 81.1 126.5 17.6 24.6 6.6 27.5 38.2 31.2 53.6 30.0 31.5 54.5 42.3 31.2 29.4 3.6 58.5 35.6 34.1 27.8 27.1 13.5 13.6 13.0 13.5 15.1 14.6 14.1 15.2 14.2 13.4 15.1 14.1 11.1 12.8 11.4 8.1 29.6 20.8 27.9 34.8 10.8 11.5 13.2 11.7 22.2 10.0 17.7 18.4 25.0 56.1 19.4 7.0 25.4 30.6 4.8 42.1 18.2 15.3 15.7 18.1 6.0 13.6 57.0 12.9 26.5 40.9 15.8 21.2 8.2 15.6 47.4 8.4 7.2 14.4 20.3 20.3 8.0 4.1 7.5 18.9 5.4 7.5 16.0 9.7 13.4 7.1 5.8 22.1 7.8 9.1 20.1 28.2 8.8 29.3 34.2 9.2 13.1 10.6 18.3 22.3 24.8 26.1 18.5 45.6 15.3 36.0 22.5 23.5 WDR88 PQWD ENSG00000166359 "WD repeat domain 88" Q6ZMY6 19 33132090-33175799 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 8.9" "Group enriched" "Detected in some" 5 "Early spermatids: 31.3;Late spermatids: 15.9;Spermatocytes: 24.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041916, HPA050336" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA041916: AB_10804121, HPA050336: AB_2681093" "unprognostic (1.02e-1)" "unprognostic (9.40e-2)" "unprognostic (3.12e-1)" "unprognostic (1.33e-4)" "unprognostic (5.14e-2)" "unprognostic (7.98e-2)" "unprognostic (8.44e-2)" "unprognostic (2.01e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-4)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (2.28e-1)" "unprognostic (1.63e-1)" "unprognostic (2.43e-2)" "unprognostic (6.67e-2)" 0.2 0.4 0.4 0.9 0.9 0.9 0.1 0.9 0.8 0.1 0.0 0.1 0.6 0.3 0.0 0.6 0.2 0.5 0.9 0.6 0.2 0.3 0.1 0.2 1.2 0.3 0.2 0.7 0.8 0.0 0.2 0.2 0.3 0.3 0.0 1.5 0.8 0.0 0.2 0.7 0.7 0.0 0.2 0.6 0.3 8.9 0.4 0.0 1.0 0.0 0.0 0.2 0.0 0.4 0.5 1.1 0.7 1.3 0.3 0.0 1.0 0.4 0.0 0.1 0.0 0.5 1.1 1.3 0.6 0.0 0.8 0.4 0.0 0.1 0.0 2.8 0.4 1.3 1.0 0.2 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.9 1.4 0.0 1.7 0.5 0.6 0.5 0.4 0.4 1.1 0.4 0.2 0.0 0.6 1.9 1.9 1.3 0.6 0.3 0.9 1.6 1.0 0.7 0.3 1.0 0.6 0.2 1.2 0.9 0.7 0.2 2.1 0.5 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.4 0.9 0.9 0.8 0.6 0.2 0.3 0.2 0.3 0.2 0.4 0.4 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 15.9 0.3 0.0 0.0 1.9 0.0 0.0 0.0 2.5 4.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WDTC1 "ADP, DCAF9, KIAA1037" ENSG00000142784 "WD and tetratricopeptide repeats 1" Q8N5D0 1 27234632-27308636 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028177, HPA028180, HPA028182" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles "Golgi apparatus" "HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204" "unprognostic (3.18e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.69e-2)" "unprognostic (8.28e-2)" "unprognostic (3.31e-2)" "unprognostic (2.00e-3)" "unprognostic (1.25e-2)" "unprognostic (9.44e-2)" "unprognostic (2.44e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-3)" "unprognostic (1.73e-1)" "prognostic favorable (8.84e-8)" "unprognostic (1.28e-1)" "unprognostic (9.33e-2)" "unprognostic (3.01e-2)" "unprognostic (2.51e-2)" 16.5 24.4 25.4 10.5 22.3 14.7 17.5 20.2 25.4 18.9 12.7 24.7 12.9 19.7 7.0 18.0 19.9 10.5 35.9 21.8 20.0 19.9 18.7 16.9 14.4 25.3 21.0 19.0 22.1 47.7 16.9 10.6 24.4 19.3 9.5 33.5 20.1 15.1 63.0 24.8 18.0 12.0 19.4 17.7 23.2 37.6 23.5 19.8 18.4 54.4 12.7 19.8 18.5 21.1 19.8 8.6 13.5 1.3 18.9 15.8 5.6 12.0 20.1 12.7 15.5 2.9 19.3 17.0 14.0 24.0 9.3 10.1 13.0 18.4 11.0 23.2 22.0 17.7 8.9 7.9 17.0 9.0 22.4 15.1 29.6 15.8 14.4 22.9 17.4 5.4 18.2 17.2 13.6 11.1 14.6 21.6 6.3 13.0 18.1 7.3 10.1 18.7 15.2 4.2 19.7 16.9 15.7 6.6 14.4 10.1 9.8 15.5 15.2 10.3 6.2 14.5 5.9 24.7 14.2 8.1 20.8 17.3 12.5 0.1 0.2 2.7 1.4 0.3 0.5 0.6 0.3 0.6 0.7 0.4 0.2 0.6 2.1 0.4 0.2 0.5 0.4 0.5 25.4 22.3 20.2 25.4 21.8 20.0 25.3 21.0 24.4 19.4 23.5 21.1 10.8 9.6 10.7 19.6 13.8 12.9 10.3 8.4 16.5 31.4 18.5 14.5 15.6 14.3 7.6 31.3 54.2 14.2 14.3 17.3 9.8 15.1 29.8 15.3 8.2 10.1 16.7 32.8 22.4 14.1 4.8 10.6 16.3 13.2 1.3 15.4 18.5 16.6 13.0 21.9 21.2 16.9 6.1 21.0 11.3 66.2 17.1 15.8 10.6 19.7 18.9 15.8 28.8 16.6 22.2 16.0 10.1 16.6 12.3 17.2 26.6 19.1 18.4 70.0 6.6 17.1 10.3 30.9 6.6 13.0 17.3 16.4 13.3 14.1 15.0 16.8 WIPI1 "ATG18, ATG18A, FLJ10055, WIPI49" ENSG00000070540 "WD repeat domain, phosphoinositide interacting 1" Q5MNZ9 17 68420948-68457513 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 127.2" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 165.7;Syncytiotrophoblasts: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 114.1;eosinophil: 223.6" "Lineage enriched" "Detected in all" 9 "granulocytes: 223.6" "Cell line enhanced" "Detected in many" "ASC diff: 224.3;HHSteC: 216.7;HSkMC: 180.8;SK-MEL-30: 183.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007493, CAB037230" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB037230: AB_1841265, HPA007493: AB_1848642" "unprognostic (2.83e-2)" "unprognostic (7.85e-2)" "unprognostic (1.05e-3)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-2)" "unprognostic (3.97e-3)" "unprognostic (1.78e-2)" "prognostic favorable (3.11e-4)" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (3.06e-1)" "unprognostic (6.32e-3)" "unprognostic (6.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (1.89e-3)" 31.3 18.8 11.2 14.1 11.2 26.6 30.5 12.5 15.1 33.1 19.1 36.4 12.8 15.3 14.4 14.8 12.6 23.3 78.4 10.6 12.9 33.3 18.7 26.2 8.7 12.5 12.0 11.2 29.8 25.2 17.8 62.4 12.5 17.4 38.5 8.2 55.0 18.3 127.2 21.9 14.8 18.8 11.4 12.5 29.3 9.6 15.5 5.9 21.1 97.5 16.7 22.0 14.4 11.9 4.9 9.8 8.6 12.5 224.3 167.2 49.0 36.3 163.5 13.7 43.6 7.2 7.3 3.0 16.0 74.2 47.9 3.7 3.3 22.1 23.9 4.4 4.6 34.7 3.2 42.6 216.7 2.4 48.5 180.8 39.5 54.2 72.0 44.2 61.3 5.3 2.5 82.0 41.1 29.9 0.5 7.1 1.8 12.7 15.0 0.4 30.3 35.7 20.2 16.7 2.4 11.4 7.7 103.8 183.4 44.4 54.8 9.5 61.2 65.4 10.1 31.0 8.6 78.2 92.0 10.5 98.9 16.5 29.7 114.1 18.4 223.6 11.9 22.7 5.3 4.4 3.1 11.7 9.0 1.4 0.2 5.6 39.0 10.7 24.7 6.3 2.7 15.0 11.2 11.2 12.5 15.1 10.6 12.9 12.5 12.0 12.5 11.4 15.5 11.9 26.2 9.6 11.5 12.7 13.3 7.8 11.9 45.6 0.6 15.0 24.1 8.9 7.3 28.6 48.5 16.5 2.1 44.0 18.3 30.2 31.3 31.2 6.3 26.3 19.9 17.2 12.0 56.6 9.4 57.2 165.7 41.2 25.5 40.0 7.0 12.3 33.9 11.7 35.6 10.1 8.2 67.6 44.7 18.2 14.5 5.2 46.3 37.1 42.7 20.6 34.2 10.6 20.6 6.0 12.2 28.8 20.1 42.2 83.3 55.3 8.5 71.8 49.6 15.7 26.3 10.1 24.1 5.0 5.1 3.3 6.8 125.1 13.6 27.8 28.2 36.7 WNT10B "SHFM6, WNT-12" ENSG00000169884 "Wnt family member 10B" O00744 12 48965340-48971735 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 17.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 7.3;Extravillous trophoblasts: 21.7;Fibroblasts: 4.8;Inhibitory neurons: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 7.3;T-47d: 8.2;U-266/84: 7.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA055048, HPA062539" Enhanced Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 16: U-266 - Nucleosome" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA055048: AB_2682683, HPA062539: AB_2684793" "unprognostic (1.13e-1)" "unprognostic (2.14e-2)" "unprognostic (5.73e-4)" "unprognostic (2.27e-2)" "unprognostic (3.09e-2)" "unprognostic (3.33e-2)" "unprognostic (6.08e-2)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.14e-1)" "unprognostic (4.99e-3)" "unprognostic (3.05e-2)" "unprognostic (5.39e-6)" "unprognostic (4.29e-2)" "unprognostic (3.74e-2)" "unprognostic (4.50e-1)" "unprognostic (1.25e-1)" 1.5 0.2 13.1 1.5 14.9 1.2 0.6 4.2 17.9 0.8 3.2 1.4 1.4 0.3 1.5 1.4 1.0 0.5 1.5 15.3 7.3 0.4 0.4 1.1 1.7 8.6 7.6 0.2 0.3 0.1 2.4 0.3 8.2 0.8 0.7 0.1 0.9 0.6 0.7 3.4 4.3 0.1 5.1 4.1 1.1 3.3 10.4 1.9 1.0 0.4 1.5 1.3 1.0 9.8 1.9 1.2 0.0 1.7 0.0 0.0 4.6 1.3 2.4 0.5 0.1 3.6 4.0 0.0 0.3 0.2 1.5 2.2 4.8 0.3 0.2 1.1 6.3 2.1 1.7 0.1 0.0 0.7 2.9 0.0 0.4 0.1 2.1 4.1 0.0 1.5 7.3 0.3 0.7 2.4 0.1 2.5 0.0 1.3 2.5 0.0 0.6 2.2 0.0 0.4 0.1 0.0 0.3 0.1 0.6 2.2 8.2 2.7 0.0 2.5 4.9 0.4 0.6 2.6 7.8 0.0 1.0 5.4 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.1 14.9 4.2 17.9 15.3 7.3 8.6 7.6 8.2 5.1 10.4 9.8 0.2 0.0 0.0 0.7 0.2 0.4 0.0 0.0 1.8 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.8 0.2 0.1 0.0 0.0 0.0 7.3 0.0 21.7 4.8 0.0 0.1 0.0 0.0 0.7 0.0 0.3 0.0 4.7 0.2 0.0 0.0 1.2 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.7 3.0 0.9 1.3 1.4 1.6 0.0 0.0 0.1 WSCD1 KIAA0523 ENSG00000179314 "WSC domain containing 1" Q658N2 17 6057807-6124427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5" "Cell type enhanced" "Detected in many" "Early spermatids: 73.4;Late spermatids: 99.6;Oligodendrocyte precursor cells: 110.1" "Cancer enriched" "Detected in many" 4 "glioma: 18.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 40.0;HUVEC TERT2: 24.7;OE19: 26.4;PC-3: 24.8;RH-30: 50.5;SCLC-21H: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015919 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "Golgi apparatus" "HPA015919: AB_2216211" "unprognostic (1.50e-1)" "unprognostic (7.10e-2)" "unprognostic (5.32e-2)" "unprognostic (1.15e-2)" "unprognostic (2.61e-1)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-1)" "unprognostic (3.46e-4)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" 2.2 2.2 19.7 1.0 21.7 0.0 1.8 29.5 19.8 1.1 6.8 6.8 3.4 1.2 0.2 0.6 1.0 0.9 2.0 18.1 19.1 5.9 0.5 1.4 1.3 29.4 23.8 0.5 1.5 0.9 3.5 4.8 24.9 0.6 3.8 5.7 1.2 0.7 11.4 1.3 4.3 1.3 22.2 13.6 1.3 11.2 22.9 1.1 0.9 3.8 0.9 0.8 0.8 26.7 0.0 5.8 40.0 3.2 0.2 0.0 2.1 4.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 10.0 0.3 0.0 0.0 13.6 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.5 0.0 24.7 0.1 0.0 0.9 1.2 0.8 0.0 0.0 13.3 26.4 24.8 0.0 50.5 1.6 8.4 2.1 15.5 0.0 0.2 0.0 0.0 4.1 0.0 0.3 0.1 0.0 1.4 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 21.7 29.5 19.8 18.1 19.1 29.4 23.8 24.9 22.2 22.9 26.7 7.7 0.0 0.0 11.8 0.1 0.4 0.0 0.0 0.6 24.1 0.2 0.1 3.8 0.0 0.0 1.8 0.0 0.7 0.1 22.4 1.9 0.3 73.4 0.1 0.0 5.9 0.0 0.0 2.7 0.2 0.1 0.2 0.0 0.0 0.0 0.7 10.0 0.4 1.2 1.7 12.5 3.3 0.0 0.8 0.4 99.6 0.6 0.0 1.8 4.7 0.0 9.8 0.0 110.1 20.6 0.2 6.5 0.0 0.0 0.0 21.5 1.4 0.0 3.5 0.0 6.0 0.7 0.4 3.3 0.1 0.6 0.0 0.3 0.1 5.8 0.1 WWC1 "KIAA0869, KIBRA, PPP1R168" ENSG00000113645 "WW and C2 domain containing 1" Q8IX03 5 168291645-168472303 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 142.3" "Cell type enhanced" "Detected in many" "Astrocytes: 162.2;Cone photoreceptor cells: 91.8;Endometrial ciliated cells: 81.8;Glandular and luminal cells: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 120.2;RPTEC TERT1: 260.4;SK-BR-3: 136.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038016, HPA038017" Approved Approved "Golgi apparatus" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA038016: AB_10697091, HPA038017: AB_10669513" "unprognostic (3.60e-1)" "unprognostic (2.24e-2)" "unprognostic (1.08e-1)" "unprognostic (9.92e-2)" "unprognostic (1.51e-1)" "unprognostic (6.77e-3)" "unprognostic (2.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.31e-2)" "unprognostic (7.38e-2)" "prognostic favorable (1.95e-8)" "unprognostic (2.81e-3)" "unprognostic (1.80e-1)" "unprognostic (2.77e-1)" "unprognostic (1.50e-1)" 7.8 0.6 41.8 2.9 43.3 0.1 21.2 41.0 39.7 6.0 50.4 6.4 24.3 2.8 6.8 22.9 17.2 8.7 1.6 40.3 41.3 73.3 38.1 20.2 3.0 56.8 47.0 0.8 28.3 23.5 7.8 10.2 43.6 16.4 6.1 17.8 142.3 11.8 0.0 19.9 20.2 1.1 46.6 0.7 22.9 1.7 54.3 1.3 29.7 0.0 6.9 9.3 10.1 38.6 50.6 56.4 9.2 0.4 0.0 0.0 96.8 3.7 0.9 17.1 15.3 120.2 73.6 0.0 58.6 1.2 47.4 35.0 18.9 46.1 20.1 0.1 18.6 0.0 28.6 29.9 0.9 4.4 0.0 6.0 13.9 32.3 28.5 13.2 0.0 3.0 0.0 7.2 1.3 56.4 0.0 0.1 13.3 60.8 8.2 0.0 0.4 29.1 260.4 68.8 30.7 11.4 66.5 136.4 17.1 11.6 67.8 4.3 0.0 3.0 34.2 0.4 36.9 0.8 0.4 0.2 3.4 0.1 8.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 41.8 43.3 41.0 39.7 40.3 41.3 56.8 47.0 43.6 46.6 54.3 38.6 0.3 64.1 72.3 162.2 1.3 11.9 14.7 6.0 1.8 1.4 35.7 25.7 1.8 34.3 42.1 58.8 91.8 11.6 0.6 17.9 13.7 44.9 0.4 81.8 10.8 1.3 7.8 0.0 50.1 40.5 2.3 5.3 15.3 149.2 1.3 5.6 1.1 16.9 1.3 0.0 27.9 7.8 6.1 0.6 1.1 0.1 1.2 4.2 10.6 8.4 1.1 18.1 0.0 17.6 1.9 73.1 10.9 0.7 0.1 38.8 18.9 61.8 36.7 9.1 0.0 0.2 5.6 0.3 5.0 7.3 13.9 18.2 2.1 2.5 12.2 16.5 WWOX "FOR, SDR41C1, WOX1" ENSG00000186153 "WW domain containing oxidoreductase" Q9NZC7 16 78099430-79212667 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" Oxidoreductase "Disease variant, Epilepsy, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Astrocytes: 927.8;Excitatory neurons: 270.5;Inhibitory neurons: 540.9;Microglial cells: 471.2;Oligodendrocyte precursor cells: 914.9;Oligodendrocytes: 793.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 85.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050992 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Cytosol "HPA050992: AB_2681299" "prognostic unfavorable (9.07e-5)" "unprognostic (1.14e-2)" "unprognostic (1.92e-1)" "unprognostic (9.27e-2)" "unprognostic (2.32e-1)" "unprognostic (1.81e-1)" "unprognostic (6.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.65e-1)" "unprognostic (3.61e-3)" "unprognostic (4.33e-2)" "unprognostic (3.50e-2)" "prognostic favorable (4.49e-5)" "unprognostic (3.75e-1)" "unprognostic (1.78e-1)" "unprognostic (2.36e-2)" "unprognostic (1.77e-1)" 8.6 6.3 18.6 4.0 23.9 4.2 7.4 24.0 20.3 8.6 21.2 5.2 5.3 8.2 10.1 7.7 9.0 7.4 5.2 18.8 22.5 12.7 12.0 5.3 4.6 24.0 22.4 7.6 8.3 12.1 9.8 5.3 25.3 7.7 3.2 6.9 8.5 6.4 3.3 7.1 4.5 5.1 22.0 4.7 6.0 9.3 21.0 9.0 21.8 2.1 6.0 6.7 7.1 30.0 11.1 9.5 9.2 7.7 11.0 5.3 11.1 1.6 3.2 3.7 3.2 7.0 9.6 19.5 8.6 1.5 5.2 10.0 5.1 1.3 2.6 11.0 26.8 6.0 1.9 15.7 7.5 16.7 3.4 5.9 3.8 2.3 2.4 0.9 4.4 25.9 9.2 4.2 2.6 85.7 27.7 21.9 8.6 5.9 5.7 32.2 3.9 19.1 5.3 3.9 17.6 10.0 7.1 11.9 4.0 9.3 12.8 12.0 1.6 2.7 10.4 2.2 6.4 0.0 18.3 41.2 10.4 8.4 4.6 7.0 9.1 2.1 11.4 7.9 13.4 9.3 8.2 9.1 7.7 6.6 8.4 8.3 0.7 9.1 5.8 14.5 13.5 6.0 18.6 23.9 24.0 20.3 18.8 22.5 24.0 22.4 25.3 22.0 21.0 30.0 12.0 6.4 6.9 927.8 9.0 9.2 21.2 8.0 19.4 7.4 12.1 16.1 8.8 17.2 13.3 14.7 4.2 25.7 10.9 4.5 33.2 12.4 43.1 18.2 13.9 9.5 9.6 13.3 270.5 10.3 11.9 12.0 9.2 7.6 12.7 18.7 13.2 18.9 9.2 5.0 540.9 5.1 0.0 5.6 5.7 38.2 14.0 7.7 5.4 471.2 5.9 46.3 9.2 914.9 793.5 4.5 5.9 17.7 18.4 11.5 8.7 28.3 18.7 12.2 6.6 10.3 11.8 19.7 17.9 13.3 6.8 17.4 9.9 12.1 6.8 13.0 WWP1 "AIP5, DKFZP434D2111" ENSG00000123124 "WW domain containing E3 ubiquitin protein ligase 1" Q9H0M0 8 86342547-86478420 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 171.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023180 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Golgi apparatus, Plasma membrane" "HPA023180: AB_10602587" "unprognostic (3.89e-1)" "unprognostic (6.63e-2)" "unprognostic (3.81e-2)" "unprognostic (7.91e-2)" "unprognostic (3.70e-1)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.24e-2)" "unprognostic (1.83e-1)" "unprognostic (9.43e-3)" "unprognostic (3.09e-3)" "unprognostic (1.48e-1)" "prognostic favorable (5.45e-5)" "unprognostic (2.35e-1)" "unprognostic (4.63e-1)" "unprognostic (3.19e-3)" "unprognostic (1.01e-1)" 33.6 22.1 16.3 25.8 21.5 18.2 40.6 19.6 16.3 23.6 24.3 26.9 26.3 23.0 24.6 33.1 18.5 45.3 50.8 14.3 20.7 40.9 111.7 27.2 39.0 18.3 19.0 24.7 28.0 116.3 9.8 36.9 19.7 33.4 33.1 43.2 25.9 25.6 171.4 40.8 28.1 24.6 18.1 45.7 34.3 29.5 19.5 22.7 32.6 122.2 30.6 33.7 15.8 23.1 59.8 27.1 18.3 13.1 23.0 22.4 16.3 21.0 22.5 16.5 19.5 18.9 35.3 24.9 14.0 36.5 22.9 49.3 26.4 34.1 28.5 31.6 21.0 28.7 24.4 44.7 16.8 11.7 14.0 20.5 42.5 18.2 33.3 25.3 74.1 29.0 14.3 28.7 28.4 29.6 27.7 8.1 11.2 82.6 30.0 18.0 21.4 22.5 37.3 44.5 5.5 12.9 21.2 104.7 23.0 39.8 31.3 10.8 84.4 23.9 28.7 26.3 10.7 33.9 22.0 25.7 29.9 1.6 19.0 6.2 2.1 3.9 5.2 1.9 4.6 2.7 6.4 5.3 1.5 2.4 7.5 4.7 1.3 2.4 2.2 1.9 6.5 2.0 16.3 21.5 19.6 16.3 14.3 20.7 18.3 19.0 19.7 18.1 19.5 23.1 51.2 25.6 22.6 29.0 13.0 35.8 26.9 15.4 26.7 28.8 41.7 23.5 82.7 44.3 19.2 29.5 58.4 28.3 19.5 23.7 43.0 20.5 42.1 22.6 20.1 32.3 23.6 3.0 55.3 37.6 3.3 27.6 35.2 35.5 3.8 18.0 62.4 88.8 55.9 40.4 134.6 25.3 14.2 95.2 28.1 12.7 32.3 43.0 30.2 61.8 18.6 23.3 18.6 60.3 103.8 45.1 16.0 36.5 18.5 45.1 15.8 45.7 17.2 52.6 6.6 18.8 16.6 12.4 21.2 28.8 39.5 23.0 32.0 25.1 19.7 38.3 XKR8 FLJ10307 ENSG00000158156 "XK related 8" Q9H6D3 1 27959588-27968093 "Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "eosinophil: 202.8;neutrophil: 101.6" "Lineage enriched" "Detected in all" 13 "granulocytes: 202.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049984, HPA053529" Uncertain Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" "HPA049984: AB_2680982, HPA053529: AB_2682179" "prognostic favorable (8.63e-4)" "unprognostic (2.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-3)" "unprognostic (1.97e-2)" "unprognostic (1.38e-2)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (7.87e-2)" "unprognostic (8.41e-2)" "unprognostic (1.83e-3)" "unprognostic (6.29e-2)" "unprognostic (8.55e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-2)" 5.8 4.4 17.7 8.6 18.0 22.7 6.6 18.7 19.1 6.2 18.5 6.0 7.0 5.7 8.1 5.3 7.7 6.7 8.1 18.3 19.3 6.8 15.3 7.4 8.8 18.9 18.6 9.1 14.0 9.7 4.5 15.2 18.0 6.3 6.1 5.4 10.3 8.0 6.2 5.6 6.0 9.3 17.9 9.4 9.0 6.3 19.1 6.9 6.5 11.7 7.4 7.0 4.7 17.9 10.9 8.6 12.4 13.4 10.5 15.5 13.5 8.8 17.1 19.5 18.7 18.2 7.6 4.1 9.1 21.1 14.5 4.6 19.0 9.5 9.8 15.0 18.2 13.8 5.2 15.4 15.7 6.8 4.7 16.9 18.8 21.8 15.2 19.7 19.3 12.5 21.6 8.9 14.1 10.0 8.5 19.7 40.3 9.1 12.6 15.1 4.0 8.8 15.6 6.3 2.9 4.1 3.8 9.6 6.2 21.7 6.2 16.8 8.0 11.4 10.2 23.9 8.0 13.1 13.6 6.5 29.3 9.2 8.7 20.3 11.9 202.8 15.1 11.9 14.8 7.6 15.7 14.1 13.0 7.1 14.4 13.5 101.6 14.0 10.2 6.3 14.8 11.2 17.7 18.0 18.7 19.1 18.3 19.3 18.9 18.6 18.0 17.9 19.1 17.9 4.4 3.2 1.1 2.6 8.8 1.9 3.8 3.5 1.8 4.5 5.2 3.4 3.3 5.7 4.4 3.7 0.0 62.0 15.5 4.7 3.9 7.8 0.5 1.8 2.9 6.8 1.8 2.1 2.2 11.4 15.8 6.1 5.6 2.4 1.3 5.2 8.6 5.6 14.0 3.3 2.2 6.1 2.0 6.6 3.7 0.9 3.4 8.0 1.8 1.0 21.1 14.0 16.5 3.5 5.5 7.2 2.8 3.8 14.0 5.1 7.2 4.5 1.7 1.3 6.6 5.1 4.0 0.6 7.8 2.2 3.0 22.4 9.1 4.4 5.2 4.1 YIF1A "54TM, FinGER7, YIF1, YIF1P" ENSG00000174851 "Yip1 interacting factor homolog A, membrane trafficking protein" O95070 11 66284580-66289145 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014840, HPA076194" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "HPA014840: AB_2217189, HPA076194: " "unprognostic (9.35e-2)" "unprognostic (7.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (4.38e-3)" "unprognostic (2.25e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (2.13e-1)" "unprognostic (6.39e-3)" "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.03e-1)" "unprognostic (2.64e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (8.70e-4)" 49.2 54.7 33.4 28.4 36.0 16.7 47.5 38.5 41.4 42.7 42.4 50.8 56.5 53.5 34.5 50.9 45.7 25.5 57.8 33.5 35.6 50.9 149.5 44.9 22.9 38.9 36.1 42.1 86.0 40.6 74.1 34.5 38.2 47.3 37.7 12.3 51.1 29.6 96.2 43.0 47.4 41.1 38.5 35.9 56.1 36.4 35.6 21.6 49.9 59.3 24.7 45.4 40.6 41.9 80.7 131.3 39.4 72.6 130.0 138.7 73.8 114.4 122.3 95.5 94.3 126.0 95.5 67.9 111.5 161.4 107.8 119.9 60.7 107.9 75.6 77.7 72.0 42.5 93.3 158.7 147.4 59.3 61.5 97.4 144.4 98.6 158.9 76.6 91.3 67.0 80.7 114.8 84.3 199.3 71.3 64.4 40.3 147.4 136.6 54.9 61.2 203.9 81.9 70.9 58.5 57.9 62.5 106.7 103.4 49.6 155.5 43.5 81.0 80.8 69.0 165.3 54.1 78.1 86.0 63.0 125.4 56.2 90.2 19.4 95.6 20.6 71.3 141.4 78.4 95.9 60.6 67.2 116.4 82.4 48.0 55.3 9.4 51.2 140.0 141.6 54.9 99.8 33.4 36.0 38.5 41.4 33.5 35.6 38.9 36.1 38.2 38.5 35.6 41.9 63.4 38.5 48.0 6.2 52.2 36.1 88.1 170.4 38.1 27.1 84.4 92.7 34.5 82.9 115.5 46.0 22.9 114.3 42.6 66.8 64.6 137.9 28.1 42.1 84.8 53.6 87.4 21.0 1.9 149.4 248.5 90.4 55.0 42.8 29.9 38.8 49.2 172.0 105.4 26.9 3.9 140.9 116.0 38.4 44.9 48.6 75.5 45.0 72.9 8.4 40.8 73.7 28.8 10.1 10.4 132.1 93.3 82.4 92.4 195.2 202.2 135.2 101.4 34.0 39.5 60.8 150.0 61.0 56.8 63.3 46.3 154.3 36.5 88.1 107.2 112.1 YIF1B FinGER8 ENSG00000167645 "Yip1 interacting factor homolog B, membrane trafficking protein" Q5BJH7 19 38303558-38317273 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039328, HPA055257, HPA062675" Approved Approved "Golgi apparatus,Vesicles" NA NA 37000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 10: Non-specific - Unknown function" Vesicles "Golgi apparatus" "HPA039328: AB_2676445, HPA055257: AB_2682762, HPA062675: AB_2684830" "unprognostic (2.51e-1)" "unprognostic (3.34e-1)" "unprognostic (1.38e-1)" "unprognostic (6.81e-2)" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.53e-5)" "unprognostic (1.37e-1)" "unprognostic (1.45e-2)" "unprognostic (5.53e-2)" "prognostic favorable (1.88e-4)" "unprognostic (4.57e-2)" "unprognostic (2.40e-2)" "unprognostic (3.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.64e-1)" "unprognostic (3.94e-3)" 30.1 30.7 29.3 33.0 32.4 69.1 26.7 37.0 38.3 33.5 29.0 26.6 20.4 24.1 10.9 33.2 25.6 16.5 40.6 30.2 32.6 27.2 58.3 35.7 32.1 36.3 30.9 26.7 27.1 16.9 29.1 23.5 38.6 23.7 16.1 13.6 30.2 12.5 35.0 26.0 24.0 18.1 33.4 47.7 22.0 23.1 34.0 20.9 19.8 26.7 20.9 26.8 25.6 38.5 43.7 108.9 48.3 57.5 68.4 63.5 37.8 103.2 79.0 75.7 110.7 53.5 32.6 75.7 44.4 121.1 81.5 27.4 85.9 54.6 28.7 81.1 43.3 117.0 48.2 56.5 94.8 82.4 132.9 52.3 47.9 78.0 33.8 76.1 71.3 99.4 152.9 205.3 68.5 46.0 87.6 98.9 37.0 74.9 33.7 89.0 58.6 117.9 48.9 40.6 34.8 58.1 34.5 76.7 55.4 37.2 29.9 163.2 68.8 74.6 73.2 108.4 83.9 76.4 122.1 51.8 96.1 150.5 54.6 81.9 155.7 179.0 60.8 119.4 54.4 49.3 57.3 54.8 300.3 42.7 46.7 47.5 42.8 44.0 70.8 127.0 59.0 120.2 29.3 32.4 37.0 38.3 30.2 32.6 36.3 30.9 38.6 33.4 34.0 38.5 27.4 0.0 5.5 5.5 22.8 17.7 19.4 25.8 18.2 12.2 22.6 18.7 4.7 18.6 14.2 22.0 12.5 44.7 17.0 16.0 0.0 39.4 6.3 17.5 18.2 23.9 14.4 33.2 7.3 27.7 52.9 23.8 16.3 18.6 22.9 43.4 37.1 30.5 94.4 11.8 7.4 24.7 32.6 42.3 37.4 8.5 9.0 53.3 35.6 3.7 34.4 20.8 16.5 4.0 12.7 15.5 13.5 9.1 69.4 14.8 8.1 16.1 20.7 15.5 6.6 11.1 40.3 20.6 31.9 30.7 20.0 27.6 18.8 26.2 25.9 19.5 YIPF1 "DJ167A19.1, FinGER1" ENSG00000058799 "Yip1 domain family member 1" Q9Y548 1 53851719-53889798 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.0;Syncytiotrophoblasts: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014716, HPA073931" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA014716: AB_1847686, HPA073931: " "unprognostic (4.94e-2)" "unprognostic (4.50e-1)" "unprognostic (6.37e-2)" "unprognostic (2.06e-2)" "unprognostic (3.93e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.96e-1)" "unprognostic (6.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-1)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.38e-1)" "unprognostic (5.39e-3)" "unprognostic (6.35e-1)" 7.1 9.2 5.3 6.2 5.6 5.7 8.5 5.8 15.2 6.7 6.9 7.9 6.9 4.1 7.6 9.0 6.3 5.5 6.6 5.9 6.3 11.1 13.5 7.7 7.1 6.7 5.8 7.0 6.8 7.0 6.2 9.7 6.8 11.3 9.2 7.2 11.7 4.8 14.6 9.4 6.9 6.0 6.2 8.2 8.7 7.2 6.0 8.8 22.1 10.4 10.7 7.7 7.1 6.4 11.0 6.4 10.1 7.1 11.9 13.1 9.0 7.7 12.0 14.0 18.3 7.1 3.3 3.8 12.9 9.2 21.6 13.2 12.9 17.0 14.4 27.4 10.3 8.9 6.4 11.6 15.9 10.0 8.1 13.3 15.8 11.3 13.5 12.0 15.0 13.2 9.6 10.0 14.0 9.2 10.8 14.2 7.7 12.7 10.4 6.6 9.3 15.4 11.5 5.8 4.5 5.6 7.4 13.8 35.4 31.0 21.4 11.1 7.1 5.7 5.8 10.4 6.8 20.1 24.7 7.0 9.3 8.1 5.0 19.1 18.4 20.2 11.8 16.5 11.0 10.4 10.0 12.1 16.6 13.8 9.5 9.2 38.3 11.0 23.3 11.5 24.3 16.5 5.3 5.6 5.8 15.2 5.9 6.3 6.7 5.8 6.8 6.2 6.0 6.4 11.6 6.4 12.6 9.8 9.0 8.5 17.6 19.2 9.6 6.6 20.0 12.4 9.6 24.3 24.0 9.2 0.0 80.0 8.5 14.6 11.7 28.3 30.5 11.4 10.9 10.9 9.6 12.2 9.8 32.6 28.4 9.9 9.7 14.7 9.5 6.3 11.7 20.8 39.7 10.1 8.2 27.5 30.5 19.4 7.7 54.9 5.9 18.9 10.6 11.2 20.2 16.5 21.6 8.5 11.5 32.5 10.8 9.4 28.1 33.2 12.3 17.7 19.7 6.5 0.0 5.6 17.7 22.2 20.9 12.3 10.9 129.6 10.8 17.7 10.8 29.0 YIPF2 "FinGER2, MGC3262" ENSG00000130733 "Yip1 domain family member 2" Q9BWQ6 19 10922185-10928681 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019902 Approved Approved "Golgi apparatus,Mitochondria" No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus, Mitochondria" "HPA019902: AB_1858925" "unprognostic (1.27e-1)" "unprognostic (8.56e-2)" "unprognostic (2.90e-3)" "unprognostic (8.38e-2)" "unprognostic (3.66e-1)" "unprognostic (3.96e-1)" "unprognostic (1.93e-1)" "unprognostic (7.65e-2)" "unprognostic (4.30e-2)" "unprognostic (5.62e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.92e-2)" "unprognostic (5.99e-2)" "unprognostic (2.00e-2)" 29.5 43.5 18.1 15.9 18.7 29.6 34.1 20.5 26.6 41.7 30.7 34.7 31.8 38.1 26.8 51.0 35.2 30.3 31.6 19.4 20.3 45.1 56.1 32.8 16.8 22.4 19.6 39.6 114.3 33.4 108.2 38.9 21.0 40.3 15.8 6.5 105.7 23.6 24.8 33.8 29.9 14.2 18.2 27.7 39.2 76.8 19.4 14.3 47.5 10.3 11.2 32.6 39.6 20.4 64.9 22.3 17.5 25.4 40.0 38.9 30.1 48.9 71.6 36.6 52.9 68.1 51.6 12.8 80.2 56.2 16.7 49.8 11.9 47.6 9.5 41.7 43.2 24.2 27.3 39.1 62.1 42.5 49.3 35.7 33.6 24.7 35.4 47.7 26.2 31.1 31.6 69.2 22.9 109.4 27.4 42.7 29.4 44.3 55.2 22.8 14.1 65.3 33.0 30.2 45.4 22.2 35.2 56.4 48.8 15.3 51.7 60.1 39.1 41.6 15.3 60.2 36.7 96.7 42.5 24.2 65.1 72.9 43.9 39.2 18.8 9.3 13.3 21.3 10.4 16.3 10.4 12.3 22.3 9.5 9.3 13.3 3.1 12.1 19.4 34.1 12.6 10.4 18.1 18.7 20.5 26.6 19.4 20.3 22.4 19.6 21.0 18.2 19.4 20.4 20.5 16.0 21.2 2.6 16.0 6.8 41.6 22.4 17.1 19.4 46.9 37.8 0.5 27.1 27.3 35.0 16.7 109.5 20.6 31.9 27.4 69.3 131.1 23.0 20.1 19.2 43.3 17.2 6.4 80.7 114.1 36.0 33.6 29.3 21.6 22.5 22.5 23.0 38.7 18.5 6.7 69.4 14.2 15.3 5.2 34.6 35.1 20.5 5.4 5.6 21.1 23.8 16.5 3.5 3.3 50.3 47.7 25.6 55.4 51.6 52.5 27.0 26.1 16.4 6.6 20.0 21.9 159.1 16.6 22.6 7.0 174.3 13.9 27.9 50.6 50.0 YIPF3 "C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1" ENSG00000137207 "Yip1 domain family member 3" Q9GZM5 6 43511832-43516985 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 494.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014859, HPA063699" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" Nucleoplasm "HPA014859: AB_1845729, HPA063699: AB_2685095" "unprognostic (2.82e-2)" "unprognostic (1.29e-1)" "unprognostic (2.29e-2)" "unprognostic (4.71e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (3.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.70e-3)" "unprognostic (1.70e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.94e-2)" "unprognostic (3.55e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" 72.3 120.2 78.9 43.3 79.9 46.4 70.0 79.5 92.0 74.0 102.6 74.3 65.2 72.1 100.5 80.3 69.7 63.3 87.6 80.2 78.9 78.2 105.4 68.9 42.6 80.5 79.2 75.6 152.0 110.0 91.9 77.8 81.2 76.3 62.1 49.8 118.6 61.1 82.8 70.0 66.1 57.5 78.3 67.2 106.1 48.0 81.6 46.0 74.3 83.4 46.5 69.1 67.3 80.8 95.0 66.2 95.3 185.4 208.3 168.5 56.1 111.9 174.6 91.8 115.7 79.1 67.6 37.8 84.4 208.6 78.4 93.4 71.0 110.2 59.4 69.9 95.7 61.2 91.8 153.2 163.2 64.7 85.9 169.0 141.2 77.9 78.3 154.4 141.1 61.1 67.8 88.2 111.5 146.9 47.5 82.3 49.7 494.4 71.1 42.6 43.0 103.2 164.3 101.4 76.7 109.0 50.3 66.9 122.2 72.8 111.4 133.5 133.5 103.1 53.4 57.0 78.8 102.5 88.8 74.3 73.2 53.5 71.5 147.2 84.8 128.7 60.0 82.2 52.3 46.1 53.7 54.1 78.7 48.5 42.7 48.5 316.0 65.5 83.2 70.3 79.8 78.2 78.9 79.9 79.5 92.0 80.2 78.9 80.5 79.2 81.2 78.3 81.6 80.8 77.8 35.3 33.6 12.7 41.4 40.7 63.8 121.7 63.2 54.6 62.8 49.4 31.7 82.9 86.5 55.2 37.5 192.2 41.1 109.7 49.0 149.6 38.1 63.5 60.5 78.9 107.1 42.1 12.1 101.8 209.5 78.2 59.7 67.9 40.6 77.9 74.6 71.0 99.3 58.9 14.7 117.6 101.7 49.1 31.2 79.0 69.9 49.6 65.8 14.0 72.4 115.0 42.2 15.1 17.7 117.5 108.8 67.0 111.6 71.4 129.1 74.9 51.2 63.5 32.9 45.5 64.4 44.0 40.8 52.8 35.5 264.1 34.9 101.9 80.0 81.6 YIPF4 "FinGER4, MGC11061" ENSG00000119820 "Yip1 domain family member 4" Q9BSR8 2 32277904-32316594 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "brain: 129.1;choroid plexus: 65.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017884 Supported Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "Vesicles, Plasma membrane" "HPA017884: AB_1853855" "unprognostic (5.61e-3)" "unprognostic (8.50e-2)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (3.05e-1)" "unprognostic (7.64e-2)" "unprognostic (3.45e-2)" "unprognostic (3.61e-2)" "unprognostic (3.69e-1)" "unprognostic (8.70e-2)" "unprognostic (4.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (6.11e-2)" 7.0 6.2 69.9 5.5 66.9 2.5 8.4 69.6 129.1 6.1 65.6 6.9 5.8 6.9 7.2 5.0 5.0 4.5 7.4 71.7 68.8 7.7 9.2 5.6 5.9 69.3 67.7 6.6 14.8 6.5 5.2 5.9 71.9 6.6 6.2 13.1 7.4 5.6 8.0 7.0 5.8 6.5 66.8 6.9 6.4 4.2 67.3 7.9 10.1 6.0 5.1 5.3 5.1 75.4 8.9 4.4 8.6 7.7 9.8 12.4 4.5 7.5 7.5 7.7 5.0 5.9 6.6 4.7 5.1 8.2 7.4 6.8 9.2 6.6 10.0 7.6 14.3 7.6 9.8 10.7 11.5 10.2 6.2 8.7 12.4 6.9 11.0 10.6 6.6 5.2 10.7 9.6 8.5 5.8 8.0 10.6 7.0 9.6 7.5 5.5 12.7 8.9 8.4 3.8 9.6 9.2 6.4 6.4 11.7 5.5 3.5 8.6 7.4 10.1 4.8 7.1 7.2 14.2 19.1 5.8 15.9 9.7 5.7 14.9 5.4 5.7 4.4 5.1 3.7 4.6 4.4 4.1 4.6 4.0 4.5 4.0 14.9 6.4 5.1 5.4 4.6 4.7 69.9 66.9 69.6 129.1 71.7 68.8 69.3 67.7 71.9 66.8 67.3 75.4 61.4 93.0 69.8 13.1 68.5 51.4 56.9 59.5 50.7 113.8 63.3 28.2 88.0 60.1 58.3 42.3 106.3 68.4 81.3 68.8 33.2 45.3 34.7 39.5 57.9 59.0 57.1 86.9 18.8 39.3 69.9 66.6 28.1 40.1 40.0 56.3 67.8 80.9 48.3 101.0 20.1 70.2 50.8 81.7 60.7 21.0 86.6 58.0 81.8 21.5 85.1 53.1 114.4 22.1 31.8 41.8 66.8 74.9 62.6 78.5 62.7 60.1 62.2 122.2 78.9 71.9 66.2 160.2 59.6 41.1 65.9 192.8 60.7 65.4 46.8 74.7 YIPF5 "FinGER5, SMAP-5" ENSG00000145817 "Yip1 domain family member 5" Q969M3 5 144158162-144170714 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 236.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042338, HPA073622" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum, Golgi apparatus, Vesicles" Nucleoplasm "HPA042338: AB_2677953, HPA073622: AB_2686618" "prognostic unfavorable (7.83e-5)" "unprognostic (1.13e-3)" "unprognostic (1.95e-2)" "unprognostic (8.35e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.12e-5)" "prognostic unfavorable (3.26e-5)" "unprognostic (2.89e-2)" "unprognostic (1.99e-1)" "unprognostic (3.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.69e-1)" "unprognostic (1.24e-2)" "unprognostic (5.11e-2)" "unprognostic (6.49e-2)" 22.2 20.4 8.3 17.7 9.8 21.0 24.1 9.8 11.0 24.7 16.3 25.8 30.5 20.2 21.2 28.6 20.3 21.4 18.1 9.5 12.5 25.4 31.7 20.3 18.9 9.7 10.3 20.6 32.0 25.7 17.0 30.2 11.5 18.3 26.0 20.6 26.2 19.2 9.3 17.7 27.3 28.5 10.3 15.5 22.7 20.9 10.3 16.1 22.6 14.5 23.9 24.0 14.3 12.0 43.2 28.2 36.0 28.6 84.4 90.5 32.9 143.6 96.9 63.2 101.5 45.3 44.0 23.5 67.3 156.9 72.5 38.7 34.7 70.5 84.8 32.9 30.2 17.4 44.9 46.7 68.0 39.3 27.7 69.1 64.3 56.8 46.3 108.9 61.0 25.6 18.8 38.5 86.4 22.5 19.4 22.2 23.3 27.5 30.7 20.3 53.4 39.3 39.4 37.7 24.4 30.0 49.7 26.4 66.5 36.2 54.9 25.5 236.7 74.0 35.8 72.5 57.2 34.7 61.8 29.9 70.7 36.9 55.2 48.9 34.5 48.7 47.2 47.4 53.1 37.9 47.1 52.4 41.2 36.4 49.0 46.3 26.0 41.0 44.7 45.0 62.8 40.6 8.3 9.8 9.8 11.0 9.5 12.5 9.7 10.3 11.5 10.3 10.3 12.0 43.5 38.5 27.4 8.5 35.6 29.4 24.5 49.4 26.2 40.6 33.4 29.6 21.8 31.5 35.9 20.2 33.3 56.7 40.5 33.0 31.3 43.7 14.9 31.4 49.8 44.1 14.8 20.0 19.7 68.3 77.1 51.9 33.6 31.2 36.8 34.1 30.4 34.7 36.5 33.7 16.9 50.1 22.4 34.0 24.4 7.3 35.4 28.7 30.2 6.5 38.3 54.9 27.8 13.6 16.2 60.5 35.5 33.8 70.0 23.4 56.0 36.1 50.6 53.8 39.5 31.8 45.4 83.9 56.0 33.4 26.0 67.5 42.0 41.1 27.4 24.5 ZADH2 MGC45594 ENSG00000180011 "Zinc binding alcohol dehydrogenase domain containing 2" Q8N4Q0 18 75195113-75209139 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021468, HPA053646" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 33: Fibroblasts - ECM organization" Vesicles "Nucleoplasm, Golgi apparatus" "HPA021468: AB_1858932, HPA053646: AB_2682216" "unprognostic (3.22e-2)" "unprognostic (1.03e-2)" "unprognostic (7.14e-2)" "unprognostic (1.13e-1)" "unprognostic (4.79e-1)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (1.49e-1)" "unprognostic (3.62e-3)" "unprognostic (1.42e-1)" "unprognostic (3.05e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.02e-6)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.23e-1)" 17.7 12.9 15.6 11.8 17.8 20.7 22.2 19.2 22.0 18.8 14.0 26.3 19.0 15.5 24.8 20.0 17.9 15.8 34.3 17.0 12.9 24.2 32.5 16.3 19.3 16.8 13.9 23.9 26.6 24.7 21.5 36.6 18.3 17.1 28.7 30.6 23.8 18.2 44.9 22.0 26.0 15.2 16.5 16.1 21.3 7.0 15.5 23.3 27.8 40.7 20.6 16.6 16.9 16.8 21.7 14.1 14.8 30.4 22.6 29.0 16.3 38.5 44.6 14.8 18.5 8.7 30.0 15.2 6.0 38.3 17.4 28.7 18.5 32.6 10.4 94.6 27.1 34.1 32.7 17.0 16.0 58.0 33.2 32.2 31.9 11.9 27.2 27.5 30.9 35.2 18.6 54.0 28.6 25.5 14.6 28.6 3.8 20.9 31.9 31.0 23.7 50.2 28.9 36.2 27.2 22.4 21.4 21.7 24.5 10.4 21.8 28.4 27.7 28.9 22.0 9.2 12.4 8.8 41.2 10.5 19.1 49.5 23.8 1.7 3.4 8.9 3.2 2.9 2.3 2.1 2.6 2.9 2.3 1.5 1.4 2.2 1.7 1.7 3.8 1.7 3.2 1.8 15.6 17.8 19.2 22.0 17.0 12.9 16.8 13.9 18.3 16.5 15.5 16.8 41.5 35.3 17.9 12.4 7.5 9.7 18.7 13.9 9.6 59.0 15.3 10.8 56.3 20.0 12.5 27.6 6.2 8.4 15.9 24.8 19.6 12.3 0.5 8.5 39.0 24.1 23.4 9.9 16.6 21.1 8.1 26.4 12.8 11.1 7.0 42.6 23.6 25.0 16.4 25.2 14.1 25.1 14.2 20.2 19.1 2.1 36.7 18.3 12.4 12.2 23.9 21.3 13.4 20.6 14.9 15.5 21.9 63.2 6.2 18.5 35.2 19.0 8.1 40.9 19.7 25.5 12.3 0.4 4.9 23.7 11.1 6.7 11.0 73.0 27.2 20.9 ZBBX FLJ23049 ENSG00000169064 "Zinc finger B-box domain containing" A8MT70 3 167239843-167407874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 13.5;choroid plexus: 28.9;fallopian tube: 23.2;testis: 35.9" "Cell type enhanced" "Detected in some" "Early spermatids: 423.4;Endometrial ciliated cells: 107.4;Excitatory neurons: 80.1;Late spermatids: 232.4;Respiratory ciliated cells: 226.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036327, HPA036328" Enhanced Approved "Golgi apparatus" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA036327: AB_10672240, HPA036328: AB_2675063" "unprognostic (2.68e-3)" "unprognostic (4.49e-2)" "unprognostic (6.94e-2)" "unprognostic (3.99e-1)" "unprognostic (4.08e-2)" "unprognostic (7.61e-2)" "unprognostic (1.24e-1)" "unprognostic (1.75e-3)" "unprognostic (1.29e-1)" "unprognostic (2.30e-3)" "unprognostic (1.15e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" 0.0 0.2 3.7 0.0 2.6 0.0 0.0 0.7 1.5 0.7 28.9 0.0 0.0 0.8 0.1 0.0 23.2 0.0 0.0 2.4 2.7 0.2 0.0 3.5 0.0 13.5 11.1 0.0 0.0 0.3 2.0 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 35.9 3.5 0.1 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.6 0.7 1.5 2.4 2.7 13.5 11.1 6.6 10.5 3.5 6.1 0.0 0.0 1.1 7.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 25.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 423.4 107.4 0.6 0.6 0.0 0.0 80.1 0.0 0.0 0.5 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 23.8 0.0 6.1 0.0 0.0 232.4 1.5 0.4 0.0 1.9 0.0 0.0 0.0 4.5 1.1 0.1 0.0 1.5 0.0 0.1 0.0 0.2 226.2 0.0 0.0 0.0 1.2 37.4 11.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 ZBED5 Buster1 ENSG00000236287 "Zinc finger BED-type containing 5" Q49AG3 11 10812074-10858796 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048472, HPA050994" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA048472: AB_2680408, HPA050994: AB_2681300" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (4.72e-2)" "unprognostic (3.40e-1)" "unprognostic (9.05e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (5.69e-2)" "unprognostic (4.61e-2)" "unprognostic (2.23e-2)" "unprognostic (2.25e-2)" "unprognostic (3.27e-2)" "unprognostic (8.77e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic favorable (3.87e-4)" 26.4 22.0 16.9 36.6 22.5 34.1 32.7 35.3 20.0 39.4 23.3 33.1 25.6 45.6 35.7 26.4 38.5 25.8 32.5 16.8 18.0 33.1 15.7 31.5 57.1 20.1 18.5 45.1 28.8 35.0 30.5 27.9 21.1 36.3 29.9 50.8 29.6 21.9 33.3 51.4 36.5 28.9 19.5 42.9 28.5 21.3 18.7 49.7 40.1 29.1 45.4 30.7 31.7 32.7 46.8 36.7 63.1 41.2 33.8 52.0 32.7 37.4 38.2 24.8 24.5 27.0 99.6 50.7 27.5 28.0 34.5 56.8 39.8 39.3 33.1 49.8 35.5 13.4 89.3 15.6 27.5 42.3 17.1 36.0 55.3 18.8 41.0 44.3 31.0 25.3 35.0 56.0 36.0 23.6 41.9 46.2 34.1 33.3 47.8 62.8 34.3 27.4 29.2 64.6 30.9 54.4 38.4 49.1 30.6 35.3 46.8 23.1 31.1 53.2 38.4 35.9 26.6 27.9 36.8 39.8 46.0 29.5 41.2 1.1 8.7 8.0 11.0 9.6 14.3 20.6 13.1 14.1 12.2 21.2 17.0 17.2 7.3 17.8 11.6 15.8 12.3 8.5 16.9 22.5 35.3 20.0 16.8 18.0 20.1 18.5 21.1 19.5 18.7 32.7 17.1 57.7 33.0 32.0 44.6 34.7 46.1 25.0 34.7 32.8 15.9 11.8 38.8 20.0 39.4 22.0 29.2 17.1 13.6 12.3 23.5 22.2 6.9 13.9 29.4 22.7 27.6 8.8 18.1 16.2 8.5 27.3 15.3 14.0 8.8 25.8 20.7 6.2 12.1 28.6 22.3 15.6 26.4 15.7 19.8 7.9 27.4 19.3 16.0 16.9 18.1 21.6 14.4 25.6 40.9 18.3 13.1 27.4 26.6 25.3 12.5 14.5 42.7 35.8 19.7 41.2 25.2 43.4 22.2 25.9 35.7 12.4 22.6 18.7 16.7 28.5 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.7" "Group enriched" "Detected in many" 4 "Early spermatids: 27.2;Spermatocytes: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.7;hTCEpi: 4.4;K-562: 8.3;U-266/84: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.1 0.5 0.8 0.1 0.6 0.1 0.9 1.6 0.8 0.8 0.1 0.4 0.2 0.6 3.1 0.2 1.2 0.2 0.3 0.6 0.6 0.8 1.2 0.5 0.1 0.2 0.3 1.6 0.8 0.9 0.7 0.6 0.3 1.4 0.5 1.5 0.7 1.9 0.0 0.2 0.2 0.3 0.1 0.0 0.3 8.7 0.4 0.4 1.7 0.0 0.1 0.2 0.3 0.4 1.1 1.2 1.2 0.0 0.0 0.0 1.3 0.2 0.0 0.2 0.7 0.0 0.7 0.0 4.7 0.1 2.4 0.6 0.0 1.3 0.2 0.0 3.0 0.2 0.8 1.1 0.7 0.0 0.0 0.6 4.4 0.1 2.1 0.7 0.0 0.0 8.3 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.6 0.4 0.5 0.0 1.3 1.3 1.2 2.8 0.0 1.2 0.0 1.6 0.0 0.3 0.0 0.0 1.3 0.0 0.8 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.6 1.6 0.8 0.6 0.6 0.2 0.3 0.3 0.1 0.4 0.4 0.0 0.0 3.2 0.3 0.2 0.0 0.9 0.0 2.2 1.6 1.5 0.8 1.9 2.8 0.6 0.0 2.1 2.8 0.0 1.0 1.9 1.7 27.2 1.1 0.3 0.3 1.2 0.0 5.2 1.3 1.5 0.3 0.0 1.1 0.0 1.7 0.0 1.9 0.4 0.0 5.7 1.4 0.0 0.0 0.0 5.4 2.5 0.1 0.0 0.0 0.1 1.1 0.0 1.0 0.2 0.4 0.8 0.0 0.0 0.9 0.5 0.6 0.7 1.5 0.0 0.2 0.2 24.9 3.5 1.3 0.0 1.0 0.0 0.2 1.2 0.6 ZBTB5 KIAA0354 ENSG00000168795 "Zinc finger and BTB domain containing 5" O15062 9 37438102-37465450 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021521 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA021521: AB_2670736" "unprognostic (2.36e-2)" "unprognostic (2.78e-2)" "unprognostic (5.22e-2)" "unprognostic (6.35e-2)" "unprognostic (1.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.96e-3)" "unprognostic (5.81e-2)" "unprognostic (3.95e-2)" "unprognostic (1.43e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" "unprognostic (1.27e-3)" "unprognostic (5.73e-3)" "unprognostic (2.30e-1)" "unprognostic (2.77e-3)" "unprognostic (1.80e-1)" 4.9 6.2 4.9 5.6 5.8 13.6 7.4 5.9 5.0 6.3 5.0 6.1 6.3 6.3 7.7 17.8 5.9 5.4 5.5 4.7 5.0 7.4 12.9 7.9 9.0 5.7 5.3 8.4 8.4 7.6 4.7 6.2 5.5 7.2 5.8 9.2 7.8 6.7 5.2 11.9 7.2 5.3 5.0 7.2 7.2 8.8 5.2 9.5 10.3 7.2 12.1 5.6 9.3 7.8 9.3 10.5 26.6 16.6 6.7 4.7 11.4 7.5 5.8 9.0 7.4 7.8 6.7 18.8 7.9 5.6 6.6 11.1 17.5 6.2 6.9 13.9 9.1 6.9 28.7 9.1 6.5 8.6 5.8 4.5 15.5 4.5 9.5 10.2 10.2 14.8 16.6 15.6 6.8 5.9 18.2 6.3 6.8 10.0 5.3 16.3 12.8 7.2 8.7 8.2 12.2 21.9 7.3 11.7 5.8 13.3 18.7 8.3 7.0 6.3 17.3 3.7 7.2 8.3 9.8 16.3 5.8 7.3 6.8 0.1 0.4 0.0 0.6 0.2 0.7 0.9 0.5 0.5 0.8 0.7 0.8 0.9 0.0 0.3 0.0 0.2 0.5 0.3 4.9 5.8 5.9 5.0 4.7 5.0 5.7 5.3 5.5 5.0 5.2 7.8 4.0 16.0 6.5 12.7 5.1 14.3 8.8 5.0 11.4 2.0 8.4 6.6 3.2 7.2 9.3 1.8 6.2 3.9 3.7 6.5 0.0 4.0 2.2 7.3 4.2 5.6 8.4 2.1 8.9 3.2 2.2 4.2 5.1 7.3 1.3 6.6 3.6 8.6 2.4 13.5 9.1 5.2 4.1 1.9 4.8 5.3 4.1 3.4 3.6 10.3 3.7 3.3 1.0 13.6 15.5 4.1 3.7 3.8 4.2 12.6 3.1 3.5 6.0 5.1 0.0 5.4 4.0 7.5 7.9 17.9 18.2 5.7 2.7 4.4 5.1 8.2 ZC3H12B "CXorf32, MCPIP2" ENSG00000102053 "Zinc finger CCCH-type containing 12B" Q5HYM0 X 65366638-65507887 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 30 "Astrocytes: 90.4;Excitatory neurons: 232.1;Inhibitory neurons: 219.8;Microglial cells: 128.4;Oligodendrocyte precursor cells: 253.8;Oligodendrocytes: 258.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA000836 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Endoplasmic reticulum" "Golgi apparatus, Vesicles" "HPA000836: AB_2217374" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (1.38e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (7.44e-3)" "unprognostic (7.86e-3)" "unprognostic (5.46e-2)" "unprognostic (3.32e-1)" "unprognostic (5.76e-2)" "unprognostic (1.12e-3)" "unprognostic (1.28e-1)" "unprognostic (2.61e-1)" "unprognostic (1.11e-2)" "unprognostic (5.08e-2)" "unprognostic (1.45e-2)" "unprognostic (1.71e-2)" 0.6 0.5 2.4 0.4 2.7 0.2 0.5 2.1 2.7 1.3 0.8 1.3 0.6 1.3 0.5 0.3 1.3 0.6 0.6 2.7 1.6 0.7 0.5 0.5 0.5 1.1 1.4 1.7 0.4 1.6 2.2 0.0 0.9 1.1 0.6 1.9 0.6 1.1 0.2 0.3 0.9 0.9 1.3 0.4 0.8 0.2 2.1 0.9 1.0 0.3 0.3 1.0 0.9 2.3 0.1 0.2 2.1 0.3 0.0 0.0 0.2 0.5 1.1 0.0 0.3 0.2 0.2 0.3 0.1 0.6 0.0 0.3 0.5 0.0 0.0 0.3 1.5 0.7 1.2 0.3 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.4 0.0 1.7 0.4 1.7 0.0 0.0 0.9 0.2 0.8 1.2 0.4 1.0 0.1 0.4 0.0 0.1 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.4 0.7 0.2 0.3 0.4 0.7 1.3 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 2.4 2.7 2.1 2.7 2.7 1.6 1.1 1.4 0.9 1.3 2.1 2.3 0.2 6.4 0.5 90.4 1.3 0.0 0.5 0.0 1.2 2.7 0.1 0.6 0.6 0.0 0.0 0.0 2.1 0.0 0.1 0.7 0.0 0.2 0.2 0.7 1.3 0.5 4.2 0.0 232.1 0.2 0.2 1.4 0.0 0.1 0.0 0.6 0.7 0.7 0.1 1.7 219.8 1.3 0.0 0.0 0.3 0.2 2.5 0.0 0.0 128.4 0.1 1.0 0.0 253.8 258.0 0.2 0.6 4.1 0.3 0.3 1.0 0.4 0.0 1.5 0.0 2.1 1.1 0.0 0.1 0.1 0.4 0.0 0.4 0.5 1.0 0.1 ZC3H12C "KIAA1726, MCPIP3" ENSG00000149289 "Zinc finger CCCH-type containing 12C" Q9C0D7 11 110093392-110171841 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 102.2;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 56.1;Suprabasal keratinocytes: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 36 "basophil: 5.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 5.9" "Cell line enhanced" "Detected in many" "HSkMC: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038836, HPA038837" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Nuclear membrane, Golgi apparatus" "HPA038836: AB_2676229, HPA038837: AB_10675953" "unprognostic (1.22e-1)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (6.96e-3)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "unprognostic (8.91e-3)" "unprognostic (1.30e-2)" "unprognostic (3.20e-1)" "unprognostic (2.34e-2)" "unprognostic (8.90e-2)" "prognostic favorable (9.90e-6)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (8.03e-2)" "unprognostic (1.11e-1)" 4.6 4.2 4.0 2.4 6.7 3.2 2.5 6.5 3.9 4.0 2.7 4.6 1.7 3.7 1.7 3.2 3.2 4.7 4.4 4.2 4.9 3.4 4.0 4.0 1.5 6.8 5.6 6.7 3.5 4.7 3.2 2.6 5.5 3.5 3.7 4.1 2.3 3.3 10.5 5.9 2.6 4.4 4.1 1.8 2.4 3.4 5.4 1.5 8.1 13.2 1.4 5.4 2.1 6.5 6.1 3.6 14.0 0.0 6.4 14.8 2.7 2.3 15.7 4.1 6.8 4.6 5.6 0.1 8.7 7.1 10.3 5.8 2.8 8.5 8.1 23.2 2.0 9.7 4.5 1.7 7.2 0.0 4.4 23.8 8.0 7.2 11.7 8.1 5.8 0.0 0.9 1.3 8.6 0.9 0.0 0.0 2.2 0.1 12.7 0.0 4.9 0.6 4.6 12.4 6.4 11.5 5.6 0.4 10.5 2.7 3.5 3.6 9.8 9.1 4.4 4.8 5.2 0.5 0.0 0.0 5.5 1.7 10.8 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 6.7 6.5 3.9 4.2 4.9 6.8 5.6 5.5 4.1 5.4 6.5 21.1 35.3 8.6 102.2 1.1 47.4 4.8 19.1 7.4 8.8 3.5 5.0 15.5 2.8 9.1 5.5 4.2 1.5 0.2 17.0 0.0 6.1 10.6 8.6 6.7 14.9 8.9 2.1 23.8 3.5 0.5 8.9 5.6 14.1 0.0 5.2 13.6 6.4 10.9 15.2 50.0 8.1 0.0 5.7 39.3 11.8 9.6 9.9 23.2 26.2 3.9 5.6 0.0 52.3 56.1 3.4 15.2 8.2 0.6 21.0 5.7 6.6 8.9 2.7 0.0 9.1 5.7 4.6 0.8 3.2 66.5 0.8 1.1 5.6 8.0 7.8 ZC3H6 "FLJ41410, FLJ45877, KIAA2035, ZC3HDC6" ENSG00000188177 "Zinc finger CCCH-type containing 6" P61129 2 112275597-112340063 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036019, HPA036020, HPA076065" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus" "HPA036019: AB_10673228, HPA036020: AB_2674904, HPA076065: AB_2732300" "unprognostic (1.05e-2)" "unprognostic (3.01e-1)" "unprognostic (2.77e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-3)" "unprognostic (1.83e-1)" "unprognostic (3.99e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.68e-1)" "unprognostic (4.41e-2)" "unprognostic (6.42e-3)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (6.45e-2)" 3.9 2.5 3.1 1.8 4.4 1.7 3.3 5.5 4.1 3.2 0.0 3.0 1.4 2.9 3.4 1.8 3.6 1.8 2.9 2.6 3.1 2.1 1.8 2.4 2.9 3.1 3.3 6.1 2.3 3.0 3.4 1.7 3.0 2.4 1.7 9.4 2.8 2.1 5.8 4.4 2.6 1.8 2.9 3.1 2.2 2.9 3.0 3.8 3.7 5.7 2.6 2.9 2.9 5.4 1.1 0.4 2.3 2.2 2.1 4.1 0.7 1.2 1.9 0.7 1.5 0.2 1.4 1.7 0.9 0.7 2.0 0.6 0.7 0.3 1.0 2.0 0.2 0.3 0.5 0.0 1.9 0.4 0.4 1.6 3.3 0.8 5.5 3.4 1.2 2.2 0.4 3.0 1.7 1.0 1.0 0.6 1.5 0.7 0.5 0.6 0.1 1.6 1.0 0.2 1.7 2.3 1.1 0.6 1.2 1.2 0.7 0.6 1.8 1.1 0.1 1.3 0.5 3.1 0.9 1.5 2.2 1.1 3.0 0.5 0.6 0.8 0.9 0.4 1.0 1.3 1.3 1.0 0.6 1.7 1.4 1.2 1.2 0.6 1.3 1.0 1.2 0.4 3.1 4.4 5.5 4.1 2.6 3.1 3.1 3.3 3.0 2.9 3.0 5.4 33.3 38.5 32.0 33.3 24.4 17.3 30.0 12.1 33.0 69.3 31.9 33.4 68.7 20.0 20.6 22.0 54.2 21.1 17.5 7.8 29.4 13.1 16.8 39.3 16.0 27.7 16.2 14.5 46.7 14.8 7.3 31.7 7.7 16.2 26.6 41.2 25.7 16.7 12.4 114.4 62.2 13.5 6.1 19.5 14.2 12.4 46.3 16.2 5.4 29.0 21.1 47.6 30.9 43.7 114.4 16.0 10.4 36.1 12.2 30.7 12.1 22.3 30.6 89.5 32.9 50.8 31.0 75.2 46.4 13.7 18.5 7.9 28.6 26.9 12.9 20.6 ZC3HAV1 "ARTD13, FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2" ENSG00000105939 "Zinc finger CCCH-type containing, antiviral 1" Q7Z2W4 7 139043515-139132122 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 85.9" "Cell type enhanced" "Detected in many" "dendritic cells: 194.8;Glandular and luminal cells: 359.9;T-cells: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047818, HPA059096" Approved Supported "Golgi apparatus,Cytosol" NA NA 24000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Golgi apparatus" "HPA047818: AB_10962642, HPA059096: AB_2683903" "unprognostic (1.68e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-1)" "unprognostic (1.51e-2)" "unprognostic (3.92e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (8.77e-7)" "unprognostic (5.40e-2)" "unprognostic (3.08e-1)" "unprognostic (2.55e-2)" "unprognostic (3.72e-1)" "unprognostic (5.41e-2)" "unprognostic (3.31e-3)" "prognostic favorable (6.86e-4)" "unprognostic (6.47e-2)" "unprognostic (1.99e-1)" "unprognostic (7.84e-2)" 13.5 12.7 8.7 19.1 8.9 85.9 11.1 8.1 15.2 8.6 12.2 12.9 9.7 8.6 10.3 12.9 9.7 11.4 6.4 8.1 13.6 11.1 11.0 16.1 24.0 12.3 11.5 10.9 7.3 9.2 6.2 9.3 12.3 9.5 13.7 2.5 14.3 9.1 3.2 13.1 13.9 13.8 12.7 21.0 10.4 6.5 14.9 24.0 10.6 5.6 23.8 11.9 8.7 12.4 25.1 29.5 4.1 24.7 37.4 35.9 17.6 27.5 21.2 46.9 47.7 21.6 31.4 21.9 25.2 43.9 40.6 27.6 33.2 32.6 26.3 37.2 12.2 43.8 29.7 26.9 21.8 51.1 38.6 37.0 20.3 53.3 11.8 17.4 35.3 32.1 37.6 23.5 20.1 23.3 41.9 59.0 16.6 18.6 17.6 48.5 14.6 21.0 32.0 31.0 7.5 15.4 43.1 29.2 37.8 9.3 17.4 30.9 45.3 9.9 14.3 27.6 23.1 17.9 20.2 49.9 22.4 47.0 24.0 78.7 19.6 30.8 43.0 26.0 56.0 32.2 61.9 53.1 15.2 35.3 59.0 58.6 52.5 38.7 30.6 17.7 58.8 30.6 8.7 8.9 8.1 15.2 8.1 13.6 12.3 11.5 12.3 12.7 14.9 12.4 150.3 25.6 41.1 8.1 119.4 28.7 21.7 17.5 62.6 2.8 70.8 44.8 6.2 21.5 21.1 53.3 4.2 12.6 194.8 57.0 9.8 20.2 2.8 185.9 77.7 74.5 53.2 64.4 0.8 21.2 23.1 68.1 60.6 359.9 32.3 41.6 49.2 36.1 35.1 0.0 3.0 42.2 8.2 43.9 150.0 1.9 18.6 84.4 39.2 33.7 57.1 13.9 88.6 27.6 1.0 23.8 33.8 26.7 104.2 41.5 28.0 36.4 29.9 1.3 13.1 79.5 53.6 1.0 1.1 61.7 22.3 2.3 222.3 41.3 35.8 28.0 ZCCHC4 "FLJ23024, HSPC052, ZGRF4" ENSG00000168228 "Zinc finger CCHC-type containing 4" Q9H5U6 4 25312774-25370383 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 19.6;Oligodendrocytes: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035575, HPA035576" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 59: Non-specific - Transcription" "Nuclear speckles, Golgi apparatus" "HPA035575: AB_2674682, HPA035576: AB_10671516" "unprognostic (5.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.06e-2)" "unprognostic (1.87e-2)" "unprognostic (5.84e-2)" "unprognostic (2.80e-3)" "unprognostic (1.71e-1)" "unprognostic (3.00e-1)" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (1.85e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.59e-2)" "unprognostic (1.07e-2)" 4.5 3.6 2.8 3.5 3.6 3.8 5.0 3.7 3.5 4.3 3.5 3.9 3.8 5.2 4.0 3.3 4.3 3.3 4.6 2.7 3.0 3.8 3.5 3.6 5.2 3.3 3.1 6.1 3.4 6.0 2.7 3.3 3.4 3.9 4.0 4.8 3.9 3.9 7.4 4.3 4.0 3.7 3.0 4.4 3.4 4.4 3.3 4.8 4.5 5.5 4.5 4.1 3.6 4.3 4.5 2.8 9.1 4.2 6.9 8.8 8.1 11.4 12.1 13.1 15.0 4.4 11.9 7.5 3.1 7.0 12.9 3.5 8.9 8.3 18.2 1.8 4.8 7.0 5.8 7.4 8.8 11.6 4.9 7.0 9.2 12.5 9.8 7.8 6.3 11.4 12.7 3.6 11.3 3.4 12.0 15.2 12.5 7.4 6.0 8.0 13.9 4.6 7.1 4.7 8.4 5.8 4.9 4.1 7.4 8.8 6.0 6.9 5.0 11.0 4.6 7.2 15.7 7.2 9.6 11.0 11.8 11.0 10.8 1.4 1.9 0.6 3.0 2.4 4.4 3.5 3.9 3.8 2.8 3.6 3.7 4.1 1.1 4.4 2.3 2.1 4.3 2.3 2.8 3.6 3.7 3.5 2.7 3.0 3.3 3.1 3.4 3.0 3.3 4.3 5.9 0.0 5.8 12.1 7.6 3.7 4.0 4.3 6.8 3.7 3.0 2.9 6.4 1.5 5.5 0.0 2.1 5.9 4.2 2.1 3.9 3.8 1.5 5.5 5.1 4.6 2.4 2.1 10.7 2.3 4.5 4.8 3.1 3.9 1.3 6.4 2.2 3.1 5.1 3.3 15.5 3.6 6.1 4.4 2.2 0.5 4.1 3.3 3.6 5.6 2.6 5.5 5.2 19.6 23.6 2.9 3.9 5.3 3.7 2.7 5.7 4.5 8.2 5.2 0.0 5.2 5.7 9.0 9.1 4.9 3.4 3.7 5.4 4.0 4.4 2.5 ZCWPW1 "DKFZp434N0510, FLJ10057, ZCW1" ENSG00000078487 "Zinc finger CW-type and PWWP domain containing 1" Q9H0M4 7 100400826-100428992 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 42.4" "Group enriched" "Detected in many" 12 "Spermatocytes: 996.6;Spermatogonia: 361.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 15.6;hTERT-HME1: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020911 Approved "Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA020911: AB_1858990" "unprognostic (1.86e-2)" "prognostic favorable (1.99e-4)" "unprognostic (1.92e-3)" "unprognostic (6.74e-2)" "unprognostic (2.58e-2)" "unprognostic (8.46e-3)" "unprognostic (1.99e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "prognostic favorable (1.93e-4)" "unprognostic (2.43e-3)" "unprognostic (1.72e-2)" "unprognostic (2.84e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-2)" "prognostic favorable (5.26e-4)" 3.7 2.6 6.3 2.5 7.5 2.9 4.4 9.0 9.0 2.8 5.2 3.5 1.2 4.0 4.5 2.4 5.0 2.9 4.0 6.3 6.9 3.5 6.0 2.6 3.8 7.7 7.0 6.2 2.2 4.4 2.1 1.9 7.4 3.1 1.9 3.2 2.1 3.8 3.9 4.5 2.6 2.9 7.0 4.1 2.5 42.4 7.1 2.8 5.1 4.6 3.7 3.8 2.3 8.3 5.8 2.6 1.3 2.2 7.2 5.7 0.8 2.9 3.3 2.4 3.1 1.0 1.8 15.6 11.5 2.2 5.5 1.5 1.3 0.9 3.8 1.2 1.1 4.8 0.6 0.8 2.3 2.0 2.9 3.2 6.1 1.9 13.8 1.2 0.2 3.1 3.4 4.6 2.3 5.4 1.6 4.4 0.5 2.9 0.7 3.6 1.0 1.0 2.1 1.3 4.2 1.8 7.4 2.0 4.7 1.1 3.0 3.2 0.3 6.3 2.5 5.4 1.0 1.6 2.1 7.0 2.4 5.2 5.5 3.6 1.6 15.9 2.1 3.2 3.4 14.6 2.7 3.0 1.9 12.8 4.5 3.3 5.5 3.3 9.6 3.6 1.6 2.1 6.3 7.5 9.0 9.0 6.3 6.9 7.7 7.0 7.4 7.0 7.1 8.3 7.5 0.0 7.4 14.4 13.1 8.0 10.3 5.2 12.5 10.9 9.3 11.8 7.3 0.0 8.5 5.5 2.1 1.3 7.5 2.1 11.7 5.8 36.1 11.3 5.2 5.3 2.4 1.7 6.7 3.6 0.7 7.6 12.8 4.0 21.0 8.6 5.7 9.7 3.4 5.0 9.1 3.3 0.0 9.5 7.6 52.5 16.4 5.8 1.8 2.8 4.0 13.6 8.2 5.0 20.7 3.8 4.6 7.9 2.9 5.5 4.6 12.5 23.0 5.2 46.0 11.0 4.6 996.6 361.4 4.2 4.5 1.4 6.4 5.4 3.9 5.9 ZDHHC13 "FLJ10852, FLJ10941, HIP14L" ENSG00000177054 "Zinc finger DHHC-type palmitoyltransferase 13" Q8IUH4 11 19117099-19176422 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 120.5;Urothelial cells: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 136.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016759, HPA018791" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Vesicles "Golgi apparatus" "HPA016759: AB_1858993, HPA018791: AB_1858992" "unprognostic (1.43e-2)" "unprognostic (4.00e-3)" "unprognostic (1.08e-1)" "unprognostic (1.11e-3)" "unprognostic (2.95e-2)" "unprognostic (1.34e-2)" "unprognostic (1.55e-2)" "unprognostic (1.57e-1)" "unprognostic (3.57e-3)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (2.16e-1)" "unprognostic (6.95e-3)" "unprognostic (1.15e-1)" "unprognostic (7.93e-2)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" 4.8 5.7 5.2 7.8 5.2 9.7 8.9 6.6 7.1 9.3 6.6 16.9 11.2 6.7 5.1 37.2 12.9 8.7 9.1 5.4 5.7 9.2 2.2 6.1 9.6 5.5 5.0 5.3 11.2 14.9 11.7 6.2 5.8 8.2 18.2 16.1 10.2 5.4 1.6 18.8 11.3 6.1 5.3 5.7 18.5 14.4 5.0 11.7 8.7 2.9 22.4 22.4 15.4 5.2 41.6 19.3 18.0 15.5 6.3 7.2 17.3 19.4 17.8 21.3 24.4 11.7 9.7 21.1 13.1 16.3 47.9 61.3 26.0 12.8 23.3 26.4 22.6 11.1 12.6 9.7 14.6 15.2 18.5 8.3 14.7 9.0 12.5 19.9 136.8 28.9 10.7 10.3 22.1 13.5 19.6 12.2 15.1 38.7 17.6 21.3 25.0 5.0 21.9 27.0 31.3 23.0 23.2 28.0 10.7 17.3 13.2 17.6 39.6 18.9 13.2 29.2 15.8 8.7 28.5 19.2 22.6 15.5 33.6 11.6 4.7 32.7 8.5 7.9 7.8 8.7 6.6 9.6 5.9 5.5 6.2 8.3 6.0 6.3 6.4 5.6 9.4 4.6 5.2 5.2 6.6 7.1 5.4 5.7 5.5 5.0 5.8 5.3 5.0 5.2 8.1 9.6 10.7 28.7 9.6 24.2 22.3 27.2 14.2 12.0 7.5 4.8 34.1 12.8 41.3 16.5 10.4 8.7 10.6 20.1 5.9 25.1 120.5 21.5 6.6 11.3 15.6 11.6 27.2 19.2 18.8 9.2 24.5 30.8 12.0 16.2 12.8 0.9 6.1 16.8 34.9 24.7 36.7 6.8 8.3 46.6 7.8 6.2 3.6 9.4 20.8 52.8 18.6 19.6 20.9 20.4 16.4 2.2 10.4 47.4 15.5 3.5 57.0 8.8 0.0 5.4 7.4 58.1 31.7 21.3 36.2 6.3 11.4 7.7 21.4 103.0 ZDHHC17 "HIP14, HYPH, KIAA0946" ENSG00000186908 "Zinc finger DHHC-type palmitoyltransferase 17" Q8IUH5 12 76764103-76853696 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 102.2;Inhibitory neurons: 95.1;Oligodendrocytes: 115.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 17.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016807, HPA058674" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 12: NES - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus, Vesicles" "HPA016807: AB_1858999, HPA058674: AB_2732626" "unprognostic (1.06e-1)" "unprognostic (2.26e-2)" "unprognostic (2.63e-2)" "unprognostic (3.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-3)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.56e-3)" "unprognostic (5.42e-2)" "prognostic unfavorable (7.11e-5)" "unprognostic (1.77e-2)" "unprognostic (2.69e-1)" "unprognostic (2.98e-1)" "unprognostic (1.71e-2)" 15.6 14.1 18.6 12.1 20.4 23.7 16.1 23.1 25.9 15.8 11.8 13.7 7.5 21.7 12.3 8.0 12.8 10.5 12.5 19.8 18.9 11.0 9.8 10.6 14.8 18.2 18.6 20.1 10.2 12.7 11.0 16.4 18.9 14.1 10.1 31.0 8.1 12.8 11.8 10.2 10.3 14.6 19.2 14.4 8.5 12.8 19.4 14.9 11.8 14.2 11.4 11.7 11.7 27.8 8.2 9.5 30.1 15.4 17.6 18.5 14.6 16.2 13.4 10.5 9.2 7.8 5.8 11.2 9.5 15.9 10.5 7.5 12.1 10.1 16.2 9.5 12.6 16.4 13.1 12.0 11.9 16.5 13.9 17.6 10.3 10.0 14.7 35.2 12.2 15.2 18.0 5.2 13.8 7.6 12.0 21.9 22.1 3.6 11.3 16.1 10.7 12.3 12.0 12.3 11.7 20.1 17.8 6.4 10.7 25.7 14.4 16.3 16.9 14.3 11.0 8.8 9.3 8.1 8.5 11.9 5.4 7.6 15.0 6.2 2.3 5.7 3.6 2.4 2.9 2.5 2.9 2.6 2.8 3.9 3.0 2.5 5.9 2.0 2.5 17.1 1.3 1.5 18.6 20.4 23.1 25.9 19.8 18.9 18.2 18.6 18.9 19.2 19.4 27.8 33.4 32.1 18.3 75.7 20.1 7.1 10.4 9.8 12.5 54.6 9.9 10.7 21.3 12.8 15.5 12.9 39.6 20.3 74.1 5.0 0.0 8.0 11.3 11.8 23.8 24.8 19.2 12.0 102.2 4.7 10.2 21.2 7.1 10.1 41.2 20.7 20.3 10.6 8.8 28.6 95.1 7.5 8.2 12.3 19.4 13.7 20.2 14.9 5.4 54.4 14.9 26.1 18.6 88.4 115.8 6.8 4.5 21.1 13.5 10.2 8.4 5.5 18.0 38.1 0.0 32.3 22.0 17.7 22.6 9.5 5.5 5.6 18.1 19.6 6.2 5.5 ZDHHC21 "DHHC21, DNZ1, HSPC097" ENSG00000175893 "Zinc finger DHHC-type palmitoyltransferase 21" Q8IVQ6 9 14611071-14693432 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 219.4;Inhibitory neurons: 201.6;Oligodendrocyte precursor cells: 268.9;Oligodendrocytes: 158.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065254 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 36: HEL - Hemostasis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Cytosol" "HPA065254: AB_2685446" "unprognostic (2.95e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-2)" "unprognostic (2.01e-1)" "unprognostic (4.19e-2)" "unprognostic (2.58e-2)" "unprognostic (2.81e-2)" "unprognostic (1.13e-2)" "unprognostic (2.18e-2)" "unprognostic (8.37e-2)" "unprognostic (9.79e-3)" "unprognostic (3.97e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (8.87e-2)" "prognostic favorable (9.28e-6)" 3.7 5.7 4.7 4.6 5.8 2.5 6.2 12.7 6.7 6.2 2.2 4.7 6.8 4.9 6.1 8.5 4.5 3.5 5.1 6.0 4.5 4.9 2.6 5.2 6.6 3.4 3.3 5.2 4.7 4.8 6.5 4.2 3.7 5.2 5.2 10.6 4.6 3.7 4.5 8.7 7.2 4.1 3.4 5.5 4.3 4.1 3.5 2.6 6.1 3.4 6.1 4.2 6.7 4.7 7.1 3.6 6.9 4.6 1.1 1.2 5.3 8.9 2.7 3.1 3.5 1.8 3.3 7.0 2.1 6.2 3.9 4.5 4.8 2.9 4.4 14.1 3.7 29.9 8.3 3.5 3.6 5.3 9.5 2.3 6.6 3.6 2.3 5.7 18.4 2.8 2.5 0.8 5.5 3.9 1.2 5.1 4.8 3.0 6.7 0.0 3.3 3.5 9.6 7.8 4.2 11.3 4.1 5.0 2.8 5.3 6.3 8.6 13.2 2.2 3.3 2.2 8.3 2.8 5.6 0.0 4.6 0.3 2.3 0.2 0.1 0.0 0.4 0.3 0.4 2.0 0.4 0.4 0.0 1.4 0.3 0.4 0.0 1.1 0.2 0.5 0.6 0.2 4.7 5.8 12.7 6.7 6.0 4.5 3.4 3.3 3.7 3.4 3.5 4.7 18.0 22.4 24.1 132.9 46.6 9.6 9.3 8.1 13.1 45.1 23.0 14.1 23.2 24.3 18.2 44.1 43.8 8.8 27.7 31.9 5.9 16.0 5.3 18.1 23.5 18.4 15.6 7.2 219.4 17.9 7.1 14.0 26.5 24.6 10.8 36.7 32.9 10.1 11.1 37.0 201.6 14.6 10.2 15.5 8.2 7.7 19.3 11.8 1.8 107.7 17.7 65.7 41.2 268.9 158.2 35.9 14.1 31.2 20.8 12.4 46.7 11.3 12.7 49.4 6.6 19.7 15.3 22.3 26.6 24.4 20.0 7.7 14.4 10.5 13.9 16.1 ZDHHC3 "DHHC3, GODZ, ZNF373" ENSG00000163812 "Zinc finger DHHC-type palmitoyltransferase 3" Q9NYG2 3 44915257-44976185 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 570.7;Late spermatids: 1564.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012465, HPA016616" Approved Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "CAB012465: , HPA016616: AB_1859004" "unprognostic (2.80e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.43e-4)" "unprognostic (3.10e-2)" "unprognostic (2.47e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.20e-2)" "unprognostic (1.04e-1)" "unprognostic (6.37e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "prognostic favorable (1.81e-8)" "unprognostic (2.64e-1)" "unprognostic (1.49e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-2)" 50.1 48.6 23.0 25.7 21.5 82.8 36.3 27.9 22.9 42.2 25.8 70.6 44.1 35.4 24.5 58.0 27.5 32.0 36.3 25.8 21.1 40.3 32.3 41.9 21.9 28.7 25.1 28.9 22.2 46.0 13.4 28.7 29.8 35.6 64.6 16.6 33.3 40.1 43.7 70.0 58.1 36.3 25.8 29.6 55.3 80.8 27.0 26.9 38.6 52.8 33.3 53.6 42.5 25.3 62.5 53.3 41.0 49.1 219.2 100.5 46.8 58.8 80.7 78.3 66.5 61.0 85.1 58.7 31.4 107.9 52.8 80.7 68.4 104.3 74.6 61.7 29.3 55.9 57.9 45.7 50.6 136.3 43.0 92.5 111.6 73.6 67.2 59.8 79.6 63.8 73.8 51.3 78.1 42.9 46.2 73.6 60.7 155.9 96.7 29.9 40.6 47.0 66.7 176.7 14.6 52.8 70.3 70.5 36.4 70.4 57.4 88.2 78.0 55.4 55.2 60.2 66.3 32.2 66.6 59.6 55.2 198.9 39.4 53.7 24.5 32.6 14.6 12.3 13.3 10.7 11.0 16.1 26.8 12.6 10.2 14.4 25.4 14.5 17.5 15.3 17.1 13.6 23.0 21.5 27.9 22.9 25.8 21.1 28.7 25.1 29.8 25.8 27.0 25.3 41.5 41.7 82.1 7.5 17.8 48.2 42.1 40.8 48.9 9.8 24.4 20.8 29.2 24.3 27.1 53.3 6.2 47.7 23.4 105.6 72.4 46.6 570.7 18.8 31.2 34.1 35.9 68.8 15.7 79.0 59.4 26.4 69.3 26.6 19.0 21.5 35.7 29.4 49.5 15.2 15.6 78.2 38.7 34.0 26.7 1564.3 51.9 37.4 24.9 18.7 35.6 25.1 34.0 15.1 11.2 115.8 73.1 44.8 26.2 73.7 112.9 30.1 20.9 10.6 19.7 15.6 31.9 104.5 45.3 70.5 60.2 101.7 25.0 26.1 72.8 128.9 ZDHHC7 "DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370" ENSG00000153786 "Zinc finger DHHC-type palmitoyltransferase 7" Q9NXF8 16 84974175-85011535 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019215, HPA059054, HPA059642" Uncertain Supported "Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus" "HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093" "unprognostic (9.77e-2)" "unprognostic (2.12e-1)" "unprognostic (6.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (8.76e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.41e-2)" "unprognostic (5.78e-2)" "unprognostic (2.21e-2)" "unprognostic (7.79e-3)" "unprognostic (8.04e-2)" "prognostic favorable (1.12e-5)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.45e-1)" "unprognostic (5.42e-2)" 33.0 28.1 19.0 24.7 18.8 64.2 26.8 21.4 18.6 40.0 27.1 42.5 27.1 36.8 12.8 27.6 27.7 31.2 31.2 19.1 19.8 35.4 30.0 37.2 26.5 20.1 21.0 27.7 26.9 35.5 19.6 33.4 20.3 32.8 32.4 10.3 24.1 20.0 56.5 31.8 33.5 30.0 19.1 35.4 44.7 14.1 23.5 16.1 25.5 58.4 23.5 37.4 33.1 19.6 63.8 55.0 28.5 34.5 123.1 92.3 38.9 57.4 110.8 88.4 43.7 58.3 72.4 29.1 32.7 93.5 29.0 65.6 37.1 76.1 110.9 16.4 29.7 21.0 22.0 66.5 51.5 40.0 21.2 76.7 85.4 72.5 41.5 56.0 46.1 26.7 68.9 9.7 56.8 75.8 27.0 38.1 44.3 53.2 39.5 33.6 26.2 15.7 86.4 82.5 24.2 29.8 74.3 40.9 36.1 43.0 77.6 24.0 67.9 53.1 39.9 49.8 34.3 33.5 51.0 65.5 50.1 29.1 43.0 7.5 9.7 8.3 2.1 8.2 2.6 1.4 2.0 1.7 6.3 2.2 1.5 2.2 6.4 1.4 7.2 4.3 0.5 3.6 19.0 18.8 21.4 18.6 19.1 19.8 20.1 21.0 20.3 19.1 23.5 19.6 13.3 32.1 25.2 12.1 10.8 13.3 21.5 25.4 17.1 9.2 16.2 13.2 22.5 12.8 17.9 16.5 6.2 18.5 15.7 37.7 1.9 14.1 9.7 15.5 20.1 12.2 12.6 11.6 16.4 15.6 24.9 23.0 28.5 29.1 3.8 14.3 15.0 11.6 28.1 15.2 16.2 29.4 14.2 46.8 26.7 10.9 17.4 36.2 16.0 19.7 42.9 5.9 21.6 13.6 14.7 30.0 33.9 21.1 15.2 26.2 22.1 9.5 32.6 6.7 13.1 13.7 14.9 8.3 13.0 20.1 12.8 16.1 13.4 6.8 34.7 35.3 ZDHHC9 "CGI-89, CXorf11, DHHC9, ZDHHC10, ZNF379, ZNF380" ENSG00000188706 "Zinc finger DHHC-type palmitoyltransferase 9" Q9Y397 X 129803288-129843909 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 66.0;Oligodendrocytes: 118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031814 Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 45: Intestine - Brush border" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA031814: AB_10610700" "prognostic unfavorable (9.77e-5)" "prognostic unfavorable (4.64e-5)" "unprognostic (2.83e-2)" "unprognostic (7.53e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (4.01e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-1)" "unprognostic (3.49e-2)" "unprognostic (9.70e-3)" "unprognostic (4.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-2)" "unprognostic (4.11e-2)" 28.2 12.0 39.2 10.2 66.6 5.4 24.3 46.5 52.5 19.1 23.3 22.0 31.6 11.8 11.7 15.6 12.1 15.3 15.5 39.2 49.0 37.1 40.1 26.7 3.3 60.5 58.2 11.2 25.9 25.2 11.4 17.2 52.5 18.8 24.9 6.0 21.1 11.3 13.4 35.3 34.0 15.3 44.8 3.9 19.5 4.1 57.8 3.6 13.8 11.3 6.6 23.8 14.5 78.6 45.9 23.8 33.2 67.5 112.4 87.7 27.0 44.3 50.6 20.9 26.0 37.6 58.4 1.6 73.7 47.6 54.0 30.4 38.0 44.6 30.0 2.6 23.7 9.2 24.0 50.1 44.4 6.1 15.7 96.0 71.1 34.0 50.1 36.5 39.9 15.0 10.1 17.6 34.0 40.0 8.8 11.4 18.0 102.3 40.4 8.2 21.4 27.1 30.1 25.2 26.3 22.0 12.7 64.7 20.5 38.9 27.6 10.1 32.8 21.1 7.3 50.0 36.3 16.5 12.7 5.5 37.9 25.1 10.8 0.0 2.2 1.8 3.0 2.0 3.7 2.7 3.6 2.9 2.4 1.5 4.5 2.6 0.0 2.5 5.2 5.1 1.8 2.1 39.2 66.6 46.5 52.5 39.2 49.0 60.5 58.2 52.5 44.8 57.8 78.6 66.0 22.4 28.6 4.6 2.8 18.6 12.4 12.8 13.1 9.1 16.8 15.1 4.6 17.2 15.9 46.0 2.1 5.6 2.7 20.1 3.9 18.6 1.8 23.8 16.9 16.6 18.0 4.2 10.5 19.8 19.1 32.7 18.3 59.7 2.5 11.5 7.9 43.7 4.9 1.7 11.8 23.2 10.2 3.5 12.2 2.0 12.2 3.9 10.6 7.5 0.3 1.5 1.0 9.5 118.2 33.5 14.6 7.5 7.7 39.1 51.0 25.8 7.2 2.8 0.0 9.5 11.1 8.4 8.7 16.9 19.2 10.3 5.1 7.5 27.2 22.1 ZFAND4 "ANUBL1, FLJ40185" ENSG00000172671 "Zinc finger AN1-type containing 4" Q86XD8 10 45615500-45672780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 37.4" "Group enriched" "Detected in many" 6 "Early spermatids: 414.6;Late spermatids: 689.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "Daudi: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057543, HPA074103" Enhanced Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 83: Testis - Spermatogenesis" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA057543: AB_2683461, HPA074103: " "unprognostic (1.57e-1)" "unprognostic (1.53e-2)" "unprognostic (6.90e-2)" "unprognostic (3.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.46e-3)" "unprognostic (2.55e-1)" "unprognostic (3.16e-1)" "unprognostic (8.85e-5)" "unprognostic (3.23e-1)" "unprognostic (9.15e-3)" "unprognostic (1.18e-1)" "unprognostic (6.19e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-3)" 2.2 3.3 1.8 2.0 1.9 2.2 3.0 4.0 2.1 2.6 1.9 2.1 2.1 2.4 1.5 1.6 2.7 1.4 2.5 1.5 2.4 2.1 3.8 2.2 4.9 2.3 2.4 2.4 2.4 1.4 3.0 1.2 2.3 2.6 2.2 2.2 2.3 1.7 2.2 3.2 2.0 1.8 2.1 2.5 1.9 37.4 2.3 3.2 3.4 1.6 4.7 2.1 2.2 2.4 1.0 0.7 1.4 2.1 3.2 2.5 0.0 1.4 2.4 1.3 1.4 0.0 1.0 34.6 1.7 0.9 1.9 0.3 1.1 0.9 1.6 5.6 1.7 1.0 1.1 0.8 2.4 0.0 6.8 2.2 1.7 0.5 1.3 1.0 1.2 4.5 0.9 5.8 1.5 0.1 3.3 0.7 1.4 1.1 0.9 0.5 1.1 0.0 1.1 0.9 2.7 1.8 1.1 1.3 1.1 1.5 2.9 1.9 1.1 0.5 2.5 2.1 1.7 4.6 8.2 0.0 1.0 3.4 0.6 0.3 0.2 0.0 0.4 0.1 0.5 0.4 0.3 0.3 0.1 0.3 0.3 0.4 0.0 0.7 0.4 0.1 0.3 0.1 1.8 1.9 4.0 2.1 1.5 2.4 2.3 2.4 2.3 2.1 2.3 2.4 2.5 6.4 3.1 22.5 7.6 0.8 3.3 1.0 5.7 7.9 4.0 2.2 3.9 4.3 0.7 1.8 27.1 0.3 7.1 3.7 1.9 1.1 414.6 6.5 3.4 2.8 1.8 5.7 3.3 1.8 0.4 3.1 4.6 1.8 2.5 3.0 3.3 5.6 2.2 3.3 23.2 2.5 0.0 2.5 1.0 689.8 6.5 2.3 3.6 13.1 2.2 4.1 1.0 47.3 39.7 1.3 0.5 3.0 10.3 3.9 1.6 3.7 8.9 8.7 6.6 4.5 2.2 86.3 13.5 3.2 2.3 0.1 7.0 4.0 2.7 1.9 ZFPL1 "D11S750, MCG4" ENSG00000162300 "Zinc finger protein like 1" O95159 11 65084210-65088398 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014909, HPA017347" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA014909: AB_1859055, HPA017347: AB_1859056" "unprognostic (2.03e-1)" "unprognostic (5.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.12e-6)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (3.63e-1)" "unprognostic (7.34e-2)" "prognostic favorable (2.73e-5)" "unprognostic (1.88e-1)" "unprognostic (1.44e-1)" "unprognostic (4.34e-2)" "unprognostic (6.94e-2)" 30.8 32.5 23.0 11.5 25.7 29.3 29.3 24.9 29.8 29.5 22.6 30.4 17.9 31.4 18.7 30.0 27.8 10.0 30.7 22.4 23.9 27.9 32.6 21.4 11.9 25.1 24.5 29.3 32.0 15.6 40.5 12.8 24.0 31.5 9.1 7.6 30.8 16.8 37.8 35.2 28.1 12.7 23.8 25.4 30.4 27.5 25.2 11.0 27.1 20.4 8.3 31.1 26.5 26.3 60.3 41.1 25.4 26.5 22.3 31.5 40.5 26.0 33.8 31.8 25.2 27.5 40.9 19.5 51.2 39.5 31.0 30.8 15.0 34.4 11.1 27.7 25.0 20.0 29.3 54.3 48.0 14.8 27.0 29.7 45.2 24.0 40.6 20.2 31.2 30.4 24.3 29.4 23.9 83.1 25.6 35.8 17.2 19.9 35.7 23.3 14.5 53.7 25.0 27.9 27.6 22.3 21.5 41.8 63.5 12.1 61.7 25.4 30.1 21.2 35.0 47.2 21.4 19.4 21.0 24.0 33.2 14.6 41.2 77.1 19.7 42.2 15.1 21.4 16.3 18.0 14.0 15.9 20.0 20.1 15.3 13.8 27.3 23.8 21.2 19.6 26.1 12.0 23.0 25.7 24.9 29.8 22.4 23.9 25.1 24.5 24.0 23.8 25.2 26.3 22.6 12.8 18.4 6.8 16.1 11.0 29.6 45.0 19.4 20.4 27.4 27.1 4.4 21.5 35.3 12.9 4.2 49.9 19.0 49.6 58.7 39.4 18.6 24.1 17.9 17.9 22.8 14.5 6.4 47.9 47.1 19.4 25.0 29.6 9.5 30.0 16.4 20.7 32.1 23.5 6.1 40.1 32.6 15.7 11.9 47.0 20.5 12.8 17.8 3.7 25.0 39.2 18.6 5.0 23.7 44.0 44.4 20.3 29.5 29.8 55.0 32.6 25.8 19.5 19.7 17.5 27.5 35.7 18.3 24.4 12.5 68.3 13.6 17.0 37.5 36.1 ZKSCAN2 "FLJ23199, ZNF694, ZSCAN34" ENSG00000155592 "Zinc finger with KRAB and SCAN domains 2" Q63HK3 16 25236001-25257845 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 16.0;Cone photoreceptor cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049141 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus" "HPA049141: AB_2680652" "unprognostic (2.71e-1)" "unprognostic (4.99e-2)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.26e-1)" "unprognostic (5.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.14e-2)" "unprognostic (8.28e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.70e-6)" "unprognostic (2.33e-1)" "unprognostic (2.29e-1)" "unprognostic (1.97e-1)" "unprognostic (4.03e-2)" 1.2 1.3 2.2 0.9 2.0 1.9 1.7 2.0 1.9 2.1 0.7 1.3 0.6 2.3 1.2 0.6 1.7 1.0 1.9 2.1 2.6 1.5 1.6 1.2 1.2 2.0 2.2 3.8 1.1 2.9 1.6 1.6 2.3 1.6 1.0 4.1 1.2 1.7 3.2 0.6 1.0 1.9 1.8 1.1 1.1 4.2 3.0 2.4 2.1 4.6 1.1 1.2 0.9 2.4 2.0 1.9 8.6 5.4 3.4 3.2 3.5 2.1 3.2 3.1 3.0 5.0 1.4 6.5 2.2 2.5 3.4 1.4 5.8 2.8 3.7 3.6 3.9 3.8 3.4 7.7 4.5 3.1 1.9 4.3 3.3 2.9 4.9 3.2 2.4 4.6 7.0 3.1 2.9 2.0 7.7 3.3 4.7 0.7 1.8 9.0 6.3 1.4 2.5 2.8 6.8 6.8 2.6 2.3 2.3 4.1 2.8 5.0 2.4 5.0 3.3 2.0 3.3 4.1 3.6 7.5 1.7 2.5 3.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.4 0.0 0.2 0.0 0.1 2.2 2.0 2.0 1.9 2.1 2.6 2.0 2.2 2.3 1.8 3.0 2.4 1.2 16.0 2.3 4.2 2.4 0.8 2.7 1.3 0.6 7.4 2.0 1.9 3.8 0.0 0.6 1.8 14.6 3.4 1.5 1.1 0.0 1.6 4.4 2.4 3.9 2.1 4.9 0.4 3.3 0.9 2.1 2.5 0.5 2.9 1.3 7.2 0.7 3.2 1.6 6.7 4.9 1.7 2.0 2.4 1.5 2.1 5.0 1.3 1.8 2.8 1.7 4.1 2.1 1.5 4.1 2.2 0.8 3.8 4.1 2.5 1.1 1.4 2.3 8.9 0.0 3.6 1.9 11.4 8.2 1.0 0.6 4.1 1.5 3.9 1.3 1.4 ZMYM5 "MYM, ZNF198L1, ZNF237" ENSG00000132950 "Zinc finger MYM-type containing 5" Q9UJ78 13 19823482-19863649 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015544, HPA020879" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Golgi apparatus" "HPA015544: , HPA020879: AB_2670524" "unprognostic (4.14e-1)" "unprognostic (3.05e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (9.35e-2)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 7.0 7.8 2.6 7.1 3.6 12.2 7.9 3.5 3.4 6.7 3.9 5.9 6.2 7.6 8.6 7.6 5.4 9.2 5.4 2.2 2.9 6.6 6.9 6.7 10.3 3.9 3.2 6.7 5.4 5.5 4.8 7.1 3.5 8.2 6.2 9.0 5.7 5.5 6.2 7.8 6.6 6.9 2.9 7.5 7.3 23.4 3.3 10.1 8.6 7.7 8.9 7.2 5.8 5.0 8.5 4.4 9.6 7.7 6.5 10.3 3.6 7.8 12.2 12.5 10.3 10.6 16.5 11.8 8.4 11.2 15.5 7.9 7.1 9.3 14.0 9.5 5.7 22.1 7.9 7.4 21.0 15.9 11.4 12.5 11.0 6.8 12.7 12.8 12.7 7.6 9.0 10.0 12.0 21.4 11.9 16.4 5.2 11.0 6.4 13.2 12.3 4.6 10.5 9.4 9.0 8.2 10.1 8.2 27.4 10.2 12.7 13.7 10.6 6.8 5.1 9.2 5.8 15.9 7.7 17.6 6.8 6.9 11.2 16.1 5.4 8.6 8.7 5.2 9.3 9.9 9.9 8.5 5.7 8.6 7.7 8.2 10.7 8.0 7.4 7.8 8.9 4.2 2.6 3.6 3.5 3.4 2.2 2.9 3.9 3.2 3.5 2.9 3.3 5.0 34.1 28.9 17.3 33.0 35.7 24.3 20.8 20.3 43.9 29.7 27.4 26.8 16.2 22.8 18.9 11.0 18.8 17.9 32.4 10.7 7.9 15.5 16.0 24.0 24.0 21.3 27.6 22.3 36.2 10.5 9.6 24.4 19.9 25.4 33.6 19.6 15.0 7.9 11.4 28.6 35.8 11.9 24.4 12.9 24.0 20.8 22.7 23.9 21.4 26.2 17.0 15.2 16.5 30.7 52.9 14.2 16.9 18.4 20.7 16.8 10.7 11.2 10.4 30.3 32.9 27.2 24.7 92.7 51.1 56.5 21.7 8.3 38.3 15.5 11.4 32.9 ZMYND19 MIZIP ENSG00000165724 "Zinc finger MYND-type containing 19" Q96E35 9 137582081-137590512 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "retina: 287.8" "Group enriched" "Detected in many" 14 "Cone photoreceptor cells: 244.0;Rod photoreceptor cells: 680.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020642, HPA050761" Supported Approved "Golgi apparatus,Vesicles" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "HPA020642: AB_1859078, HPA050761: AB_2681228" "unprognostic (2.30e-2)" "unprognostic (9.62e-3)" "unprognostic (3.45e-2)" "unprognostic (7.99e-2)" "unprognostic (2.66e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.18e-1)" "unprognostic (2.48e-1)" "unprognostic (1.35e-1)" "unprognostic (9.33e-2)" "unprognostic (1.99e-2)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (4.30e-2)" "unprognostic (1.62e-1)" "unprognostic (1.72e-1)" 11.9 16.5 19.6 9.4 19.9 9.1 11.9 18.8 23.9 14.2 18.6 12.4 8.8 11.2 5.0 26.5 11.4 7.2 14.1 20.0 19.5 12.9 21.1 12.0 11.9 18.7 19.2 12.9 16.1 8.0 16.9 8.5 19.7 16.5 5.7 287.8 15.9 7.1 14.2 27.7 12.4 6.8 18.9 15.1 22.2 49.5 19.4 9.5 10.8 8.8 9.4 13.3 16.6 19.8 28.9 44.7 41.8 45.5 22.1 21.3 42.1 38.8 25.8 41.7 31.8 53.1 28.7 51.7 43.6 25.8 40.2 71.7 51.3 38.9 13.2 33.8 49.7 26.9 86.1 41.8 34.4 58.4 33.9 16.8 58.7 38.0 37.1 18.4 22.3 40.5 66.3 22.2 25.6 97.2 68.4 88.7 60.7 86.4 61.9 73.8 36.8 79.6 25.7 24.2 60.1 39.4 37.4 79.4 35.4 18.5 53.7 89.9 21.3 51.1 38.9 76.8 63.8 21.4 54.9 56.8 31.6 44.8 35.9 0.0 0.3 0.3 0.5 1.6 1.2 0.8 0.3 0.2 0.3 0.3 0.5 0.4 0.0 0.1 0.2 0.9 1.0 0.1 19.6 19.9 18.8 23.9 20.0 19.5 18.7 19.2 19.7 18.9 19.4 19.8 6.1 9.6 7.2 3.6 4.0 17.5 5.6 3.2 5.2 23.6 14.9 19.2 6.2 2.8 2.4 1.8 244.0 5.2 6.8 5.3 0.0 3.2 4.5 6.5 12.8 5.6 2.4 6.9 4.1 3.6 6.8 6.3 10.7 8.1 1.3 10.6 3.9 7.6 4.4 11.8 4.0 8.8 6.1 3.2 5.7 4.4 2.8 3.6 5.4 1.9 2.2 31.6 5.2 2.0 2.1 4.2 4.6 3.0 10.9 10.2 1.9 3.1 1.3 680.0 0.0 6.9 6.7 27.8 28.7 4.5 22.9 4.5 4.6 8.5 7.8 7.1 ZMYND8 "PRKCBP1, RACK7" ENSG00000101040 "Zinc finger MYND-type containing 8" Q9ULU4 20 47209214-47356889 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020949 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Golgi apparatus" "HPA020949: AB_1857223" "prognostic unfavorable (2.56e-4)" "unprognostic (5.09e-2)" "unprognostic (5.84e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.62e-4)" "unprognostic (2.10e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (8.64e-2)" "unprognostic (3.62e-1)" "prognostic unfavorable (7.06e-5)" "unprognostic (3.59e-2)" "unprognostic (7.50e-2)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" 13.1 32.7 25.4 10.5 21.3 26.0 14.7 26.2 36.2 11.9 47.8 14.1 11.0 9.8 33.3 16.0 15.9 12.3 12.5 35.5 29.5 18.5 10.9 11.1 12.8 30.5 22.9 13.6 12.3 11.6 25.9 11.8 33.0 11.8 14.5 20.1 14.6 14.6 15.3 19.9 16.2 8.7 9.4 18.3 20.0 14.2 25.2 14.6 11.0 11.0 12.8 14.5 14.9 37.3 27.6 17.2 90.5 36.6 15.2 21.3 59.4 21.7 17.8 22.3 22.8 107.7 26.0 26.5 34.4 16.3 27.1 18.7 39.4 96.0 33.3 11.4 14.9 110.4 6.3 95.9 55.4 11.9 55.9 20.9 43.4 24.8 94.1 40.4 61.0 9.5 90.6 17.7 41.0 32.1 4.4 45.4 85.9 20.3 24.3 55.8 15.0 22.9 30.4 49.6 38.0 14.3 10.3 32.4 44.4 70.3 17.0 22.6 143.6 23.9 16.6 23.3 20.2 12.5 25.2 23.2 80.8 18.3 80.3 34.8 7.4 10.4 8.7 7.5 8.7 15.3 8.8 9.0 4.7 18.3 11.4 11.8 19.8 16.3 6.8 16.5 9.3 4.3 25.4 21.3 26.2 36.2 35.5 29.5 30.5 22.9 33.0 9.4 25.2 37.3 48.2 44.8 78.5 94.0 36.6 8.8 32.2 44.6 15.9 108.1 29.3 20.7 23.7 28.6 74.3 90.1 160.6 23.1 36.2 64.0 15.6 36.5 13.6 111.3 29.8 31.7 56.3 112.9 153.8 28.7 42.0 24.2 41.8 124.4 32.2 44.8 30.7 16.1 21.9 85.8 113.5 49.2 42.7 48.8 12.8 21.9 27.7 31.8 10.6 49.6 25.0 24.4 40.2 89.0 138.7 47.1 42.3 26.7 29.7 23.9 56.8 12.0 82.3 50.0 32.9 33.4 27.5 6.3 29.9 19.2 8.4 66.5 34.2 39.3 32.1 24.2 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Sertoli cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA003264, HPA074818" Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies, Golgi apparatus, Vesicles" "HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 9.0 6.1 8.6 11.4 10.1 18.6 9.6 17.3 9.9 10.0 10.8 9.7 9.5 10.5 14.4 9.8 10.1 8.4 9.3 7.9 9.3 8.6 9.6 9.1 15.7 9.9 8.8 13.7 7.7 7.9 7.1 10.4 11.2 8.7 9.9 16.1 8.9 8.0 17.3 10.2 8.2 9.5 9.8 11.1 7.7 16.9 9.0 18.9 14.6 11.5 14.1 11.2 8.4 14.9 20.0 18.8 23.4 15.2 18.9 17.4 21.5 21.8 17.3 16.4 17.9 26.7 24.3 19.6 9.7 17.7 14.0 22.5 23.1 17.3 24.5 20.0 27.7 18.5 27.7 18.7 15.6 25.9 17.8 15.3 20.4 22.2 19.4 21.4 16.3 17.9 20.5 23.3 18.3 17.1 24.1 10.6 26.3 23.0 19.9 21.4 21.2 12.3 14.7 24.0 16.1 15.8 24.0 16.0 14.3 20.6 14.9 14.6 15.6 21.4 15.3 15.1 19.6 11.5 21.6 33.4 13.8 14.8 12.5 39.1 24.6 57.3 28.0 24.9 25.0 23.0 24.6 22.9 20.9 18.2 22.8 19.6 45.1 19.4 28.2 10.1 29.7 19.6 8.6 10.1 17.3 9.9 7.9 9.3 9.9 8.8 11.2 9.8 9.0 14.9 17.9 6.4 12.1 6.2 14.7 26.6 34.1 12.1 17.6 9.3 8.7 13.2 15.5 7.2 10.3 5.5 8.4 10.0 17.1 10.1 3.9 12.5 20.3 18.7 14.9 13.0 6.6 25.4 8.1 11.5 16.2 14.5 9.7 16.3 14.0 7.7 6.8 7.6 9.9 5.0 7.4 6.9 14.2 8.3 22.0 10.0 11.8 15.8 10.6 12.2 16.3 15.5 17.5 7.5 9.8 14.1 7.7 6.8 15.4 20.1 6.3 7.7 15.0 14.3 59.2 18.3 16.7 50.5 21.3 12.8 23.4 18.3 18.1 7.3 7.9 26.9 ZNF148 "BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148" ENSG00000163848 "Zinc finger protein 148" Q9UQR1 3 125225669-125375325 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001656, CAB017486" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Golgi apparatus" "CAB017486: AB_794260, HPA001656: AB_1079995" "unprognostic (2.40e-1)" "unprognostic (1.12e-2)" "unprognostic (5.03e-2)" "unprognostic (3.94e-2)" "unprognostic (5.94e-3)" "unprognostic (5.66e-2)" "unprognostic (1.24e-2)" "unprognostic (2.36e-1)" "unprognostic (1.69e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (3.63e-2)" "unprognostic (2.72e-1)" 8.9 7.5 5.6 9.4 8.9 7.9 12.1 12.9 7.8 12.6 0.0 10.8 7.6 13.9 10.2 10.3 12.4 9.5 15.5 4.5 16.4 12.9 11.7 10.3 12.3 4.2 6.5 17.4 9.5 15.8 4.7 9.7 4.2 11.1 11.5 13.1 10.0 11.1 11.1 5.8 8.9 13.7 2.3 11.9 9.8 10.5 14.5 16.9 30.0 12.0 14.4 10.6 6.1 8.3 30.6 19.8 21.1 18.9 18.4 19.7 16.0 27.2 31.5 29.9 28.4 19.1 16.6 24.4 18.5 40.3 24.1 24.4 23.2 20.5 42.4 10.9 8.9 30.1 23.3 9.8 13.6 20.9 29.1 16.1 21.0 28.0 29.4 19.7 20.7 17.7 15.0 20.2 22.3 23.9 26.1 7.7 13.6 20.6 16.8 18.6 23.2 13.9 17.1 33.6 18.2 15.3 36.2 18.2 29.7 11.7 22.7 20.8 26.6 22.6 24.1 28.5 17.5 17.4 21.5 36.6 16.9 13.1 21.3 4.4 15.3 32.0 21.8 14.5 22.5 24.5 19.2 20.9 13.0 22.2 27.9 22.0 51.4 33.2 23.4 11.3 19.6 20.1 5.6 8.9 12.9 7.8 4.5 16.4 4.2 6.5 4.2 2.3 14.5 8.3 54.7 93.0 41.3 92.7 56.7 35.6 26.0 36.2 48.9 68.0 37.0 35.7 75.2 24.3 43.0 33.1 39.6 28.7 53.7 34.7 25.4 37.5 82.0 28.8 54.3 51.6 47.9 32.0 166.7 37.4 24.3 44.5 31.1 38.1 50.6 75.7 37.9 41.0 31.1 75.7 170.3 34.4 26.4 37.1 21.2 135.2 48.1 41.2 17.8 143.4 50.1 45.7 59.8 154.3 151.4 33.7 25.6 59.0 35.8 36.6 28.2 43.9 27.5 39.4 32.9 63.4 60.7 24.4 24.2 32.5 38.4 31.6 52.0 42.0 33.6 35.6 ZNF18 "HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38" ENSG00000154957 "Zinc finger protein 18" P17022 17 11977439-11997475 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 23.0;Late spermatids: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006144 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA006144: AB_1080683" "unprognostic (2.99e-3)" "prognostic favorable (6.32e-4)" "unprognostic (2.32e-1)" "unprognostic (2.50e-2)" "unprognostic (4.91e-2)" "unprognostic (2.72e-3)" "unprognostic (2.28e-2)" "unprognostic (5.93e-3)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "prognostic favorable (5.12e-6)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (1.52e-2)" "unprognostic (9.31e-2)" "unprognostic (3.34e-2)" "unprognostic (3.53e-3)" 7.2 5.7 7.9 5.8 8.6 13.7 6.1 7.7 11.2 6.7 7.4 6.0 5.0 5.3 6.3 7.5 5.7 5.5 5.9 7.9 8.3 5.8 12.4 5.1 8.8 8.4 8.0 5.7 6.0 4.3 7.7 4.0 8.8 8.4 6.7 4.9 5.2 5.1 7.3 9.7 6.6 5.8 7.6 10.2 5.3 14.1 8.1 8.5 6.2 4.6 8.0 6.3 6.6 9.8 3.0 6.1 6.4 9.7 11.9 10.5 3.4 4.3 7.5 5.5 5.9 2.9 5.0 10.3 6.3 4.7 4.8 6.1 5.4 6.8 5.9 7.8 4.5 6.1 6.9 4.0 8.4 3.4 7.8 8.7 10.8 4.2 7.6 6.3 8.4 12.0 3.6 4.7 7.6 3.1 11.5 6.9 4.8 10.9 2.8 9.4 6.5 4.6 8.0 3.6 2.5 5.4 7.3 3.6 5.9 37.2 5.1 3.2 6.7 6.5 3.2 2.9 3.3 5.2 4.1 5.1 7.5 7.9 7.8 10.5 5.9 6.9 10.3 5.9 9.6 9.0 9.3 9.7 5.8 7.2 10.0 10.3 19.1 7.7 8.2 8.6 11.1 6.1 7.9 8.6 7.7 11.2 7.9 8.3 8.4 8.0 8.8 7.6 8.1 9.8 2.5 0.0 2.0 10.1 3.8 2.0 1.7 4.2 4.6 2.0 2.0 1.4 1.6 2.8 2.1 1.8 2.1 2.4 3.5 2.5 1.9 3.1 23.0 1.8 2.8 1.9 1.2 5.2 7.4 0.9 2.2 2.7 2.0 1.8 2.5 5.1 2.5 3.7 4.3 1.7 8.4 4.2 6.1 3.8 1.8 27.3 3.4 3.2 1.8 8.4 3.4 2.0 5.2 7.5 9.3 2.1 5.0 3.4 2.3 1.6 3.9 3.1 2.5 1.2 0.0 2.5 2.3 9.6 4.9 5.0 2.3 1.5 4.7 2.8 3.1 1.1 ZNF208 "PMIDP, ZNF95" ENSG00000160321 "Zinc finger protein 208" O43345 19 21932958-22010949 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Late spermatids: 14.1;Oligodendrocytes: 26.3" "Group enriched" "Detected in some" 4 "ovarian cancer: 0.6;testis cancer: 1.9;thyroid cancer: 0.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 9.3;NTERA-2: 33.1;SuSa: 6.9;U-266/84: 11.2" HPA077100 Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Cytosol "HPA077100: " "unprognostic (4.06e-3)" "unprognostic (2.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.75e-1)" "unprognostic (7.46e-2)" "unprognostic (1.66e-1)" "unprognostic (2.87e-1)" "unprognostic (6.23e-2)" "unprognostic (1.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.29e-2)" "unprognostic (1.66e-1)" "unprognostic (4.94e-2)" "unprognostic (7.21e-3)" "unprognostic (1.70e-1)" "unprognostic (1.47e-2)" "unprognostic (2.73e-3)" 4.2 1.1 4.0 1.9 6.5 1.5 3.4 2.8 4.5 4.0 2.4 4.9 1.4 6.6 4.6 2.2 4.9 3.5 11.4 6.0 7.0 4.6 0.7 1.3 2.8 8.9 7.3 3.4 2.6 13.3 7.1 2.7 8.7 3.5 1.5 2.4 2.8 3.2 0.9 4.0 2.2 6.0 3.0 2.7 1.7 8.6 6.2 0.5 7.9 1.3 1.7 3.2 2.6 6.9 0.4 0.3 0.5 1.1 0.0 0.2 1.5 0.3 0.1 0.2 0.1 1.8 0.6 0.6 0.3 0.3 9.3 0.7 1.2 0.2 0.4 0.2 0.2 0.6 1.5 0.8 0.0 0.4 0.2 1.0 0.3 0.0 0.2 0.7 0.4 0.4 0.5 1.6 0.0 0.5 0.4 0.6 33.1 0.0 1.1 0.2 0.0 1.9 1.1 1.8 0.8 1.6 0.2 0.8 0.3 6.9 0.9 0.8 0.0 0.5 0.3 1.9 0.1 1.0 11.2 0.2 0.1 0.4 0.7 2.4 0.6 0.7 0.8 0.4 0.4 1.3 1.5 0.5 0.3 1.6 0.6 0.9 2.6 1.0 0.3 1.6 1.5 0.3 4.0 6.5 2.8 4.5 6.0 7.0 8.9 7.3 8.7 3.0 6.2 6.9 6.7 0.0 0.0 11.4 4.3 0.0 1.0 0.0 0.6 6.6 4.2 2.5 11.4 0.0 1.3 5.5 0.0 6.8 0.5 0.0 3.9 6.6 15.4 0.2 3.7 3.4 0.0 1.3 11.5 0.2 3.1 5.9 0.5 0.1 0.0 2.7 1.1 0.5 0.7 3.3 1.7 0.0 0.0 0.0 0.7 14.1 1.5 0.2 0.0 9.4 0.0 0.8 1.0 11.1 26.3 0.7 0.0 1.2 0.4 1.2 0.0 2.6 0.0 0.4 0.0 2.5 1.7 8.7 6.2 0.9 0.3 5.3 2.2 0.3 0.0 2.0 ZNF25 "FLJ31890, KOX19, Zfp9" ENSG00000175395 "Zinc finger protein 25" P17030 10 37949573-37976647 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 46.7;Inhibitory neurons: 44.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030190 Uncertain Approved "Nucleoplasm,Golgi apparatus" No No "Cluster 14: Monocytes - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA030190: AB_10602687" "unprognostic (9.42e-2)" "unprognostic (6.18e-2)" "unprognostic (5.64e-2)" "unprognostic (2.93e-1)" "unprognostic (4.67e-2)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (3.85e-3)" "unprognostic (1.15e-1)" "unprognostic (5.32e-2)" "unprognostic (1.40e-3)" "unprognostic (1.45e-1)" "unprognostic (2.01e-3)" "unprognostic (1.21e-2)" "unprognostic (1.29e-1)" "unprognostic (9.30e-3)" "unprognostic (2.61e-1)" 10.2 10.1 12.3 3.5 12.5 2.6 8.2 12.5 19.1 9.7 4.1 12.3 2.2 9.9 6.1 5.4 9.2 6.1 10.0 12.5 15.9 5.7 3.0 6.4 4.8 11.9 10.9 11.1 5.4 7.6 14.3 4.7 12.4 7.3 4.4 10.6 4.6 8.9 22.3 4.8 5.3 8.9 9.8 6.5 5.8 4.7 14.6 4.6 6.0 21.5 4.3 8.8 7.1 12.6 1.6 3.0 3.3 6.7 12.1 9.2 0.6 3.6 4.9 2.8 4.2 0.5 2.3 3.1 1.0 6.4 1.0 0.4 0.9 1.5 4.5 7.3 1.6 5.0 0.0 1.0 7.7 3.3 3.1 6.5 6.6 3.1 3.6 11.1 4.9 4.0 0.4 2.3 6.9 1.0 1.1 2.6 0.6 0.6 2.2 1.2 3.7 0.6 3.3 0.6 1.2 7.6 1.2 0.2 4.7 1.2 2.9 5.3 7.1 4.3 0.8 7.1 2.2 2.8 1.4 1.3 8.2 6.3 2.9 1.3 1.5 3.4 1.6 2.5 1.7 1.0 1.4 1.3 1.9 1.3 1.8 1.5 0.2 1.0 5.2 0.3 1.2 1.2 12.3 12.5 12.5 19.1 12.5 15.9 11.9 10.9 12.4 9.8 14.6 12.6 10.0 3.2 3.2 17.9 4.8 3.4 2.5 2.5 3.4 17.3 3.8 3.6 23.6 4.3 2.9 7.3 6.2 1.2 3.5 1.0 1.9 2.0 27.9 2.4 7.0 7.6 0.0 2.1 46.7 2.5 0.5 10.6 4.1 2.7 8.2 8.2 10.4 2.9 5.7 16.8 44.6 1.2 4.1 13.2 6.8 41.9 12.2 9.5 3.6 14.0 8.1 13.7 5.2 38.2 36.7 1.8 0.3 16.1 1.5 2.6 1.3 3.1 8.1 7.1 0.0 11.4 10.4 4.4 6.4 2.4 4.0 0.3 5.2 4.8 0.8 1.3 ZNF280D "FLJ20086, SUHW4, ZNF634" ENSG00000137871 "Zinc finger protein 280D" Q6N043 15 56630176-56734086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 176.6;Oligodendrocyte precursor cells: 200.1;Oligodendrocytes: 293.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030233 Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Cytosol" "Golgi apparatus, Centrosome" "HPA030233: AB_10602590" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.55e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-2)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.15e-2)" "unprognostic (3.63e-1)" "unprognostic (7.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (1.98e-1)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "unprognostic (7.72e-2)" 11.3 11.4 3.4 8.7 3.9 23.1 15.4 9.0 4.6 18.0 4.8 10.2 7.5 20.1 8.1 8.4 12.4 9.6 9.2 3.6 3.8 10.3 13.2 10.1 10.0 3.1 3.0 23.7 13.7 11.1 4.5 11.5 3.6 10.6 11.5 12.4 10.5 9.9 12.6 6.6 9.5 15.1 4.0 10.3 10.3 7.8 3.5 35.9 11.5 11.6 9.9 10.9 8.5 9.8 13.4 7.4 13.6 20.9 13.3 18.7 9.9 20.2 14.3 8.2 9.3 5.4 13.6 22.7 8.4 14.5 7.9 10.0 6.7 5.3 9.9 11.6 4.1 2.4 12.5 8.2 13.3 20.4 6.6 12.8 7.6 5.6 8.0 20.6 18.3 23.0 11.9 25.7 13.0 9.6 14.4 2.3 0.0 15.6 5.8 4.3 22.2 16.1 10.1 15.4 11.2 20.0 16.9 10.5 6.7 0.7 11.4 19.9 16.2 12.1 18.2 11.3 16.1 13.2 21.6 0.0 13.7 31.0 13.2 7.8 2.6 3.5 2.1 2.2 2.0 3.4 1.9 1.7 3.6 3.2 2.0 2.4 0.4 1.8 2.0 3.6 1.9 1.0 3.4 3.9 9.0 4.6 3.6 3.8 3.1 3.0 3.6 4.0 3.5 9.8 32.4 9.6 18.9 176.6 31.1 11.1 18.3 12.9 42.7 79.8 20.5 20.7 37.9 22.8 14.6 3.7 83.4 23.0 25.5 12.2 7.9 12.0 18.3 14.3 33.0 36.5 32.3 27.5 107.2 14.0 21.5 37.5 26.0 14.2 17.7 37.8 34.2 31.1 36.6 69.0 151.3 25.7 16.2 35.6 18.1 49.5 33.2 22.9 16.0 91.8 27.0 24.9 28.8 200.1 293.3 10.5 10.4 21.1 41.4 21.1 26.8 14.2 12.8 84.5 6.6 47.4 30.8 49.4 33.8 26.8 13.9 13.3 21.4 27.7 22.2 16.3 ZNF287 "ZKSCAN13, ZSCAN45" ENSG00000141040 "Zinc finger protein 287" Q9HBT7 17 16546954-16569204 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029290 Uncertain Approved "Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA029290: AB_10603465" "unprognostic (4.74e-2)" "unprognostic (1.77e-2)" "unprognostic (2.88e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.99e-2)" "unprognostic (4.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.78e-3)" "unprognostic (1.19e-1)" "prognostic favorable (5.28e-5)" "unprognostic (5.69e-3)" "unprognostic (5.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.87e-1)" 2.4 3.3 1.3 2.0 2.1 0.7 3.2 4.2 2.0 3.1 0.4 1.9 0.8 2.7 4.0 1.9 2.8 2.1 4.9 1.6 1.4 2.8 0.3 2.3 2.6 1.0 1.4 4.2 2.1 6.7 3.5 1.5 1.4 3.1 1.9 5.0 1.7 3.6 3.0 3.1 1.5 3.0 1.4 2.5 2.4 2.7 1.4 2.6 3.7 4.4 2.9 2.3 1.6 2.5 3.9 7.0 6.1 6.4 4.0 7.8 1.5 3.2 5.7 6.0 7.5 1.3 2.8 1.7 3.5 5.2 4.1 6.1 3.7 5.7 7.3 2.7 3.1 0.0 0.5 0.0 5.0 0.0 5.6 5.8 3.8 2.6 3.8 5.8 3.7 7.9 0.4 0.0 8.9 3.5 5.5 0.2 1.3 3.3 3.3 0.0 6.8 0.2 3.5 1.9 3.5 5.8 10.2 1.3 4.1 16.5 4.8 0.6 3.0 3.8 2.0 5.0 4.3 3.1 2.4 0.0 5.5 0.0 4.7 0.1 0.6 0.5 8.0 0.7 6.8 10.9 8.6 8.1 2.9 7.7 9.3 9.4 0.1 6.7 3.1 1.8 7.0 4.4 1.3 2.1 4.2 2.0 1.6 1.4 1.0 1.4 1.4 1.4 1.4 2.5 2.3 3.2 1.7 4.6 4.2 0.6 1.5 6.0 2.2 3.7 1.4 1.8 10.0 1.5 4.9 0.0 4.2 0.2 3.3 0.1 5.9 5.2 3.0 1.8 2.3 3.8 2.4 0.4 7.2 9.1 0.7 4.0 2.0 0.9 7.0 3.5 1.8 0.1 1.3 16.8 8.4 0.6 0.0 1.0 0.9 2.9 2.1 1.1 0.0 1.0 1.0 3.8 4.1 8.0 9.2 4.6 0.2 3.4 0.8 0.6 0.1 2.3 7.2 3.7 6.6 2.6 3.1 12.6 5.9 1.7 1.4 0.0 4.3 6.3 0.9 0.7 ZNF326 "FLJ20403, ZAN75, Zfp326, ZIRD" ENSG00000162664 "Zinc finger protein 326" Q5BKZ1 1 89995110-90035533 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 52.6" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 373.2;Rod photoreceptor cells: 458.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028450, HPA028461, HPA028466" Supported Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 79: Retina - Phototransduction" "Cluster 20: HeLa - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Golgi apparatus, Vesicles" "HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677" "prognostic favorable (9.46e-4)" "unprognostic (2.45e-1)" "unprognostic (7.25e-3)" "unprognostic (1.09e-1)" "unprognostic (5.28e-3)" "unprognostic (1.67e-2)" "unprognostic (8.61e-3)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-2)" "unprognostic (3.66e-2)" "unprognostic (1.33e-2)" "unprognostic (2.62e-2)" "unprognostic (8.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "prognostic favorable (2.84e-4)" 11.0 9.5 5.9 5.5 7.2 21.0 11.1 8.9 6.7 13.5 6.8 12.8 8.8 12.5 7.4 15.3 11.0 5.3 10.4 7.1 5.2 12.2 12.8 8.5 6.9 7.3 6.5 17.2 17.0 4.5 10.3 6.2 7.3 9.3 8.5 52.6 13.4 3.9 9.8 10.2 12.6 5.0 6.7 8.0 10.3 6.9 5.8 5.3 10.9 2.4 6.0 9.6 12.4 10.2 9.2 6.9 17.9 7.1 6.1 4.3 16.4 11.1 4.5 6.6 5.0 7.2 8.1 13.3 5.7 5.6 6.3 9.5 10.8 7.2 8.8 5.9 7.2 10.6 14.3 7.0 2.4 12.6 6.1 4.3 4.3 6.8 5.7 8.5 4.6 7.8 11.7 5.8 7.1 4.0 13.3 9.6 11.2 6.1 8.0 11.1 11.1 3.0 6.2 15.5 11.3 10.9 10.1 10.6 5.0 10.2 7.8 4.2 8.0 9.3 7.7 8.3 8.4 7.2 3.8 8.8 2.7 10.1 5.3 1.0 1.1 1.2 0.9 1.4 0.8 0.9 0.8 0.9 0.7 1.5 0.8 1.0 0.8 2.0 1.5 1.7 0.6 0.4 5.9 7.2 8.9 6.7 7.1 5.2 7.3 6.5 7.3 6.7 5.8 10.2 43.0 22.4 50.9 48.0 40.5 65.1 61.5 43.3 37.0 140.8 35.3 39.0 39.2 28.6 43.4 23.9 373.2 46.4 46.7 81.6 19.6 54.2 5.1 45.0 50.3 43.5 70.3 66.9 29.1 54.8 85.3 35.6 35.2 48.9 51.8 68.4 29.6 35.1 26.1 69.0 35.1 47.8 38.7 19.4 38.2 7.3 43.2 34.0 39.2 28.1 40.9 57.0 28.8 58.8 61.3 47.7 70.6 33.8 33.0 53.8 61.0 19.6 44.6 458.4 26.3 45.0 53.6 58.5 35.8 53.2 45.3 49.4 31.6 71.0 50.0 82.0 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36636618-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Alveolar cells type 2: 23.8;Early spermatids: 43.5;granulocytes: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 2.2 3.6 3.5 2.0 3.4 3.0 3.0 6.2 5.2 2.0 1.7 2.2 0.5 3.3 2.5 2.1 3.0 2.0 2.3 3.5 3.4 2.7 2.0 2.0 3.2 2.3 2.6 4.4 1.3 3.2 3.0 3.4 2.6 2.8 1.9 6.6 1.6 2.2 2.2 3.0 1.9 3.2 2.4 3.5 2.5 3.7 3.5 2.5 4.1 2.1 3.2 2.0 2.0 3.7 2.9 4.7 3.5 4.8 2.6 4.9 2.4 2.9 3.0 4.2 5.8 0.8 1.4 0.4 6.2 3.8 4.2 0.6 2.5 3.0 4.6 5.6 3.4 4.9 0.7 1.9 4.1 3.7 5.5 3.5 5.6 1.5 4.3 5.6 2.6 2.4 0.2 0.5 4.3 2.7 6.1 1.7 2.3 0.4 2.1 0.4 3.6 1.0 1.8 6.3 4.6 6.1 0.3 2.1 3.8 3.5 2.2 1.5 3.2 2.5 3.4 2.1 3.7 7.6 12.2 1.6 0.0 0.8 3.6 0.8 0.5 0.5 1.3 1.1 1.7 1.5 2.1 2.8 1.2 2.0 1.6 1.3 0.1 1.4 0.2 0.5 2.0 0.9 3.5 3.4 6.2 5.2 3.5 3.4 2.3 2.6 2.6 2.4 3.5 3.7 2.3 28.9 23.8 8.1 4.1 3.3 2.0 2.3 4.6 5.4 4.7 2.5 2.2 7.2 12.9 3.7 0.0 2.5 2.6 0.9 1.9 1.7 43.5 4.6 2.9 5.2 3.0 0.8 16.3 0.9 2.9 6.2 1.5 4.6 33.5 3.1 2.9 1.2 1.7 3.3 14.0 1.1 0.0 2.5 3.2 8.3 0.9 3.2 0.0 4.7 0.9 1.6 1.0 9.0 12.4 0.8 0.5 1.9 1.2 2.3 0.8 1.8 9.9 3.6 0.0 4.9 3.9 10.2 4.0 3.1 3.4 2.9 6.1 1.9 1.3 1.8 ZNF526 "KIAA1951, MGC4267" ENSG00000167625 "Zinc finger protein 526" Q8TF50 19 42220312-42228201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 33.3;granulocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023070, HPA056609" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA023070: AB_2671057, HPA056609: AB_2683189" "unprognostic (2.04e-1)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (9.09e-3)" "unprognostic (1.79e-1)" "unprognostic (8.84e-2)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (2.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (2.30e-1)" 3.4 2.5 2.1 2.8 2.3 3.8 3.1 4.3 2.6 3.9 2.0 3.3 3.3 3.6 2.3 3.1 3.5 1.9 2.8 2.0 2.1 2.3 2.8 2.6 4.0 2.4 2.2 4.5 3.5 3.9 3.0 3.0 2.3 3.3 2.1 2.0 4.6 3.3 5.1 5.2 3.1 2.4 1.6 3.6 3.1 3.5 2.4 4.2 2.8 4.0 3.6 3.5 3.4 3.4 7.8 24.8 7.1 6.4 8.0 7.7 6.2 8.9 8.2 9.2 10.1 13.0 5.5 12.6 6.3 9.5 4.2 5.7 7.7 9.7 5.7 7.5 9.2 12.6 12.0 12.5 7.5 8.1 7.8 7.6 7.7 9.2 9.6 5.7 5.8 6.7 12.3 7.8 5.9 10.8 8.2 5.2 4.7 6.8 8.7 9.4 8.7 5.7 4.2 14.0 7.3 6.4 10.2 10.1 7.2 5.4 4.1 14.4 7.8 11.3 7.7 4.8 11.2 9.3 5.9 8.5 7.5 7.8 9.5 1.8 3.6 1.4 4.5 3.6 6.9 4.7 3.5 4.1 2.8 4.4 4.2 5.3 0.7 3.4 5.3 4.2 3.9 3.3 2.1 2.3 4.3 2.6 2.0 2.1 2.4 2.2 2.3 1.6 2.4 3.4 3.0 22.4 33.3 2.0 6.9 5.5 4.4 2.8 4.0 7.4 3.1 2.4 3.2 0.0 17.1 3.7 14.6 8.0 3.2 5.7 3.9 4.1 5.8 1.7 4.0 7.1 13.8 9.5 1.4 3.0 8.3 7.4 4.6 2.3 25.2 4.9 3.6 2.6 4.6 6.7 1.5 4.2 2.0 6.8 1.8 6.3 7.2 7.0 0.0 1.9 5.8 4.1 11.3 1.0 1.4 2.9 2.8 3.0 6.1 4.6 7.8 2.8 9.2 9.6 0.0 5.7 3.6 9.9 10.1 1.9 5.1 10.3 6.7 3.7 5.7 2.6 ZNF527 KIAA1829 ENSG00000189164 "Zinc finger protein 527" Q8NB42 19 37371061-37393066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037740, HPA037741" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Golgi apparatus" "HPA037740: AB_10672284, HPA037741: AB_2675642" "unprognostic (4.36e-2)" "unprognostic (5.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-2)" "unprognostic (1.30e-2)" "unprognostic (9.26e-2)" "unprognostic (8.70e-3)" "unprognostic (6.47e-3)" "unprognostic (1.91e-1)" "unprognostic (6.05e-4)" "unprognostic (8.34e-3)" "unprognostic (8.92e-2)" "unprognostic (6.83e-2)" "unprognostic (1.44e-2)" "unprognostic (1.52e-3)" "unprognostic (3.17e-4)" 2.0 2.1 1.9 1.3 1.8 2.5 2.0 2.1 2.4 2.8 1.6 2.5 0.8 2.2 1.7 1.5 2.2 1.3 2.3 1.7 2.1 2.2 1.7 1.5 2.1 1.9 1.6 3.3 1.7 2.7 2.3 1.2 2.0 2.3 1.5 3.2 1.9 1.7 2.3 1.7 1.7 1.9 1.5 1.9 1.7 2.4 1.9 2.5 2.5 3.0 1.5 2.3 2.3 2.3 2.3 2.3 2.1 2.8 1.6 3.3 0.8 2.2 2.2 1.9 2.6 2.1 0.6 2.1 2.6 2.1 1.4 0.9 3.1 1.9 2.5 4.9 1.4 1.7 2.8 0.2 2.3 4.1 2.5 2.6 2.7 2.1 3.6 2.3 2.0 3.4 0.9 1.5 2.4 0.8 2.7 2.2 1.6 2.6 1.0 3.4 2.6 1.7 1.7 2.3 4.1 1.8 3.4 1.0 1.5 1.8 2.3 3.6 3.6 2.0 2.7 2.5 2.4 4.0 5.4 6.4 0.1 3.1 1.7 2.2 1.0 3.4 3.3 1.4 2.9 3.5 2.1 3.0 1.3 2.8 3.0 3.7 1.0 2.4 0.9 1.5 2.3 2.3 1.9 1.8 2.1 2.4 1.7 2.1 1.9 1.6 2.0 1.5 1.9 2.3 2.6 9.6 4.8 5.2 2.5 2.7 1.9 3.3 3.4 6.1 2.4 1.8 8.7 1.5 3.5 0.0 12.5 2.3 5.8 1.2 3.9 1.9 1.3 2.0 2.9 3.0 1.2 2.5 5.8 1.5 1.3 3.5 1.1 2.4 1.3 4.5 2.2 1.9 1.7 6.7 6.9 1.9 4.1 0.8 1.3 0.8 2.5 2.0 0.0 2.8 1.7 3.8 6.2 6.6 7.0 0.5 0.6 1.5 1.8 1.9 1.4 2.4 4.0 10.2 0.0 4.1 3.7 5.3 2.7 2.0 1.6 2.1 4.6 3.3 1.9 1.3 ZNF532 FLJ10697 ENSG00000074657 "Zinc finger protein 532" Q9HCE3 18 58862600-58986480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 90.1;Excitatory neurons: 86.9;Inhibitory neurons: 90.9;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 178.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 118.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015322 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "Golgi apparatus" "HPA015322: AB_2304947" "unprognostic (3.43e-1)" "unprognostic (4.36e-2)" "unprognostic (1.41e-3)" "prognostic unfavorable (6.46e-5)" "unprognostic (4.24e-1)" "unprognostic (5.84e-2)" "unprognostic (1.50e-3)" "unprognostic (7.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.09e-3)" "unprognostic (1.90e-1)" "unprognostic (7.60e-3)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "unprognostic (5.53e-2)" "prognostic unfavorable (5.76e-4)" 24.0 12.5 33.5 15.7 53.1 1.4 17.9 73.9 39.8 30.3 12.4 25.9 7.2 65.1 20.1 22.3 26.2 24.5 36.0 34.3 45.0 14.1 4.2 19.9 14.2 55.2 44.2 52.8 6.8 16.3 15.7 26.4 56.6 48.0 13.3 25.7 15.8 34.1 61.1 16.5 12.0 41.4 33.8 17.0 12.8 24.2 46.1 11.9 24.7 49.8 17.4 23.0 21.3 84.8 21.3 30.0 118.8 63.4 18.5 42.2 5.8 37.6 35.2 26.0 23.4 10.2 23.0 26.5 28.3 47.2 12.9 34.1 1.0 29.7 26.7 19.5 25.0 0.0 51.8 0.6 24.5 0.2 0.2 33.1 54.5 27.2 49.5 34.4 28.8 0.0 0.3 31.9 30.8 0.0 0.2 0.3 63.0 1.0 19.9 0.6 31.6 4.2 18.1 2.8 27.1 70.3 24.2 2.6 40.8 78.8 30.3 17.3 22.0 70.7 50.1 0.5 30.7 0.4 21.7 7.3 24.0 0.0 55.2 0.0 0.3 0.0 0.4 1.1 0.1 3.7 0.2 0.2 0.7 1.6 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.4 33.5 53.1 73.9 39.8 34.3 45.0 55.2 44.2 56.6 33.8 46.1 84.8 16.6 12.8 12.2 90.1 13.2 10.6 12.5 8.0 12.0 28.8 9.3 8.8 17.0 5.7 10.1 1.8 27.1 2.0 1.4 0.3 0.0 4.9 4.9 8.3 48.3 24.2 4.2 0.0 86.9 0.5 2.7 17.9 3.1 10.0 0.0 15.8 14.6 0.1 4.4 35.3 90.9 0.2 4.1 9.1 14.3 3.5 11.5 9.2 8.8 53.4 5.2 22.1 0.0 130.2 178.2 6.0 1.4 18.0 8.6 33.5 0.0 1.6 8.8 9.7 13.1 15.5 24.2 5.5 17.2 8.9 9.2 3.4 4.3 5.0 0.3 11.9 ZNF564 MGC26914 ENSG00000249709 "Zinc finger protein 564" Q8TBZ8 19 12525373-12551542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 13.1;Oligodendrocyte precursor cells: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043998 Uncertain Approved "Golgi apparatus" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA043998: AB_10969446" "unprognostic (3.85e-2)" "unprognostic (1.40e-3)" "unprognostic (4.61e-2)" "unprognostic (2.67e-2)" "unprognostic (2.05e-2)" "unprognostic (4.26e-3)" "unprognostic (4.25e-1)" "unprognostic (2.53e-2)" "unprognostic (1.76e-3)" "unprognostic (8.69e-2)" "unprognostic (3.94e-2)" "unprognostic (5.24e-3)" "unprognostic (1.26e-5)" "unprognostic (5.77e-3)" "unprognostic (3.07e-1)" "unprognostic (4.51e-3)" "unprognostic (1.83e-2)" 4.7 3.5 4.2 3.7 5.4 4.4 7.4 11.8 6.2 5.5 3.0 7.4 6.3 6.7 6.1 3.0 6.5 3.4 5.1 5.0 3.6 7.7 5.7 4.3 6.9 5.5 4.2 6.0 3.7 7.6 3.1 5.0 5.2 6.3 7.3 7.1 4.8 6.0 6.2 5.3 7.1 4.3 3.5 6.9 6.7 3.0 4.4 7.5 7.9 8.0 7.5 5.3 4.2 9.2 4.3 1.2 4.9 6.2 7.4 5.5 6.0 4.3 6.0 5.3 7.0 3.2 2.7 5.3 5.8 3.9 3.2 4.9 2.5 4.1 5.6 4.3 4.1 3.7 3.9 6.7 5.4 6.6 6.8 5.5 10.3 2.5 6.3 5.5 4.5 5.5 7.8 2.2 6.6 5.7 5.4 3.9 5.0 4.8 5.5 3.2 5.4 4.4 5.9 6.9 3.4 3.0 5.2 2.9 6.2 7.2 4.5 11.4 4.6 8.0 2.5 5.0 3.3 7.6 9.2 4.2 2.4 4.4 3.4 15.2 7.3 18.6 11.9 10.1 11.0 14.7 10.2 10.9 9.4 11.1 11.5 10.6 13.7 11.3 13.1 7.3 9.3 7.1 4.2 5.4 11.8 6.2 5.0 3.6 5.5 4.2 5.2 3.5 4.4 9.2 1.8 0.0 1.5 6.5 6.9 0.0 0.9 0.8 2.8 2.1 1.0 1.1 0.5 5.7 1.5 0.0 4.2 1.3 3.6 1.5 3.9 1.2 0.1 2.0 1.7 1.8 0.0 4.0 8.4 0.7 0.9 1.5 7.7 1.6 0.0 4.9 2.5 1.1 1.1 0.0 8.6 1.0 0.0 1.6 0.4 0.3 0.6 1.4 1.8 13.1 2.0 2.4 5.2 11.1 8.8 1.6 1.0 0.7 5.9 1.7 2.0 0.8 6.3 4.4 0.0 2.2 1.3 1.2 2.3 1.1 0.0 1.2 4.0 1.4 0.9 1.5 ZNF569 "FLJ32053, ZAP1, Zfp74" ENSG00000196437 "Zinc finger protein 569" Q5MCW4 19 37411155-37469275 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 137.7;Late spermatids: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052994 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA052994: AB_2682007" "unprognostic (1.40e-1)" "unprognostic (3.37e-1)" "unprognostic (4.95e-2)" "unprognostic (2.18e-2)" "unprognostic (5.44e-2)" "unprognostic (4.79e-2)" "unprognostic (2.95e-2)" "unprognostic (4.00e-1)" "unprognostic (5.08e-2)" "unprognostic (6.50e-3)" "unprognostic (4.01e-3)" "unprognostic (9.41e-2)" "unprognostic (9.70e-2)" "unprognostic (3.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.91e-2)" "unprognostic (1.37e-1)" 3.3 4.1 4.0 2.8 4.1 4.6 3.5 7.2 4.5 3.3 4.0 2.2 1.7 3.8 4.7 2.2 3.3 2.3 4.3 3.3 5.9 3.5 3.3 2.5 4.0 3.6 4.8 5.6 1.8 4.5 3.3 3.0 4.2 2.9 1.8 13.7 2.3 2.8 4.4 3.2 1.8 3.4 3.6 3.4 2.3 10.9 5.8 5.1 5.6 4.7 3.2 2.2 1.8 6.5 3.3 6.2 7.6 12.2 6.0 5.5 3.7 5.9 3.4 6.1 6.5 2.3 1.5 4.0 8.4 4.5 6.0 1.2 8.4 2.0 6.6 9.0 5.1 10.3 1.8 3.8 3.6 1.9 4.0 3.8 1.4 6.3 0.2 6.3 5.2 11.7 3.3 0.8 8.7 2.0 12.0 4.1 8.0 0.2 4.4 8.1 9.6 4.1 4.4 3.3 6.4 9.8 0.2 1.3 3.4 7.1 5.3 8.1 5.3 4.9 10.1 3.9 9.6 10.2 18.6 15.0 0.2 4.2 7.8 3.7 1.8 5.9 6.4 2.6 5.5 4.6 5.7 6.1 2.2 5.4 8.0 6.5 1.8 4.8 3.3 2.4 6.1 2.4 4.0 4.1 7.2 4.5 3.3 5.9 3.6 4.8 4.2 3.6 5.8 6.5 5.1 0.0 1.7 14.0 7.8 1.7 1.7 2.0 2.8 16.1 3.5 4.2 16.3 0.0 5.2 1.8 31.3 3.2 8.1 0.5 1.9 1.5 137.7 5.1 3.9 6.5 0.0 2.1 14.5 2.0 4.0 4.0 1.5 2.3 2.5 5.3 5.3 2.5 2.9 3.3 17.4 0.4 0.0 3.8 3.9 41.8 4.7 4.0 0.0 8.4 3.0 9.3 8.2 20.6 23.4 1.6 0.4 7.5 2.4 0.9 1.0 4.7 5.3 30.2 0.0 6.9 6.3 32.3 13.1 3.4 2.0 0.8 9.1 4.2 0.7 0.9 ZNF576 MGC2508 ENSG00000124444 "Zinc finger protein 576" Q9H609 19 43596392-43601157 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050064 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA050064: AB_2681003" "unprognostic (1.28e-2)" "unprognostic (8.69e-3)" "unprognostic (1.12e-1)" "unprognostic (1.84e-3)" "unprognostic (2.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.60e-1)" "unprognostic (7.42e-3)" "unprognostic (2.42e-2)" "unprognostic (6.65e-3)" "unprognostic (8.66e-2)" "unprognostic (1.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (1.34e-3)" 10.3 13.9 10.3 7.1 11.2 3.4 10.5 12.5 12.5 10.7 6.0 12.4 9.4 11.4 4.8 11.1 9.8 7.9 11.7 10.1 9.8 12.0 18.7 6.8 8.4 11.3 11.5 11.8 9.4 8.7 15.0 5.1 11.3 15.1 4.8 5.3 10.7 6.8 14.0 9.0 9.7 5.5 9.9 9.3 10.2 13.6 12.1 7.6 9.1 10.7 5.2 11.9 10.1 11.2 21.9 24.9 9.1 11.6 11.7 10.5 8.1 17.8 11.6 17.5 19.4 12.2 16.2 14.3 19.7 13.4 10.2 8.6 13.0 12.6 4.7 15.6 22.3 10.5 16.7 15.4 9.9 14.2 18.8 9.1 15.4 15.3 6.0 8.7 12.6 12.3 13.3 18.0 13.2 21.4 20.0 6.3 6.4 18.0 21.0 16.7 8.0 14.1 10.5 19.2 16.7 10.5 11.7 23.3 9.3 6.5 11.0 16.2 13.2 23.3 13.1 10.5 26.5 9.4 11.4 10.0 20.1 16.4 20.6 10.5 15.2 16.2 17.2 15.4 15.5 28.2 17.2 14.6 15.9 18.6 18.5 14.6 8.5 19.3 15.6 25.4 18.9 11.5 10.3 11.2 12.5 12.5 10.1 9.8 11.3 11.5 11.3 9.9 12.1 11.2 12.7 6.4 7.3 1.3 11.3 10.6 8.7 17.1 11.4 23.2 15.1 20.1 13.1 10.0 12.7 14.7 31.3 13.7 11.0 16.8 21.5 18.9 34.2 8.6 12.5 13.5 11.4 8.6 3.4 18.9 20.3 13.4 6.6 7.9 9.5 42.0 14.6 20.3 15.4 23.5 3.1 11.9 6.1 6.3 9.2 96.2 13.4 6.6 19.6 0.0 11.1 24.8 12.3 4.0 3.7 19.3 13.0 15.4 9.6 18.0 30.6 32.4 10.7 33.4 6.6 11.3 11.3 28.4 19.4 11.8 12.4 5.7 8.7 14.7 16.0 10.9 ZNF622 "MGC17552, MGC2485, ZPR9" ENSG00000173545 "Zinc finger protein 622" Q969S3 5 16451519-16465800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036514, HPA036515" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA036514: AB_2675167, HPA036515: AB_10672224" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.00e-2)" "unprognostic (6.53e-2)" "unprognostic (8.24e-3)" "unprognostic (4.71e-3)" "unprognostic (1.06e-1)" "unprognostic (1.71e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (8.69e-2)" "unprognostic (5.93e-2)" "unprognostic (2.19e-1)" "unprognostic (7.42e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" 19.5 13.5 20.3 13.8 21.4 36.0 18.4 17.2 21.8 16.7 14.4 21.5 16.9 17.8 17.2 17.9 15.3 12.1 56.9 18.1 19.6 14.6 22.0 16.6 17.8 18.7 20.7 15.6 54.3 15.6 15.1 16.9 20.3 15.5 20.7 10.8 18.3 12.7 41.7 25.6 20.3 12.5 19.1 15.5 22.4 20.5 19.4 16.0 15.5 25.2 15.7 17.5 17.0 22.1 25.7 55.2 16.9 35.2 40.4 34.3 61.4 45.2 33.9 36.0 45.6 66.0 23.2 30.0 59.6 36.0 48.4 33.3 27.5 35.3 28.9 40.6 37.3 27.4 92.8 47.7 58.1 53.8 31.5 53.3 43.7 33.6 31.5 28.0 25.6 17.6 37.6 28.9 40.1 43.2 28.4 52.3 30.0 24.2 53.8 22.1 20.6 25.8 33.6 38.0 23.4 26.2 63.1 46.8 78.2 29.4 26.0 41.1 35.3 40.0 30.5 39.3 29.1 41.3 39.7 41.9 34.9 45.8 28.5 89.3 65.6 88.6 73.8 71.3 77.8 85.4 73.7 82.0 73.3 81.9 84.2 70.3 87.9 67.9 79.6 59.2 85.0 82.6 20.3 21.4 17.2 21.8 18.1 19.6 18.7 20.7 20.3 19.1 19.4 22.1 14.8 22.4 24.2 2.9 33.2 60.7 43.1 48.6 34.1 22.8 19.8 16.4 73.8 24.3 34.4 14.7 10.4 64.0 39.5 77.5 27.4 55.2 111.5 35.0 36.8 22.3 98.7 20.0 7.6 66.7 57.2 34.1 31.1 71.3 52.0 13.3 15.0 25.1 50.0 16.8 7.9 60.6 48.8 19.3 35.1 62.8 18.0 29.7 33.8 4.7 43.3 22.6 37.0 6.6 9.0 51.2 127.1 19.9 26.6 28.3 84.5 39.2 29.7 19.3 19.7 31.7 46.9 63.2 37.8 21.8 43.2 40.6 41.6 20.5 55.5 33.5 ZNF629 "KIAA0326, ZNF65" ENSG00000102870 "Zinc finger protein 629" Q9UEG4 16 30778456-30787205 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019550, HPA056051" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Golgi apparatus" "HPA019550: AB_1859386, HPA056051: AB_2683020" "unprognostic (1.03e-2)" "unprognostic (2.15e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (3.17e-1)" "unprognostic (6.38e-2)" "unprognostic (6.14e-2)" "unprognostic (2.98e-2)" "unprognostic (3.15e-1)" "unprognostic (6.24e-2)" "unprognostic (4.87e-3)" "unprognostic (2.66e-2)" "prognostic favorable (4.57e-10)" "unprognostic (8.41e-2)" "unprognostic (1.96e-1)" "unprognostic (5.71e-2)" "unprognostic (9.70e-2)" 5.6 9.0 5.6 3.0 6.0 4.1 5.7 7.1 5.9 6.5 4.3 6.8 5.5 8.0 4.3 5.1 6.6 3.6 12.6 5.9 6.1 7.8 4.3 5.3 1.9 6.2 6.7 6.8 5.9 15.0 6.6 3.6 5.6 6.3 4.5 7.8 6.5 6.0 9.7 8.6 5.3 6.8 5.0 4.0 7.3 4.1 7.0 3.9 5.9 9.6 2.3 6.5 5.1 5.5 9.8 15.8 23.9 18.5 11.5 10.6 3.6 10.8 15.6 16.6 14.0 9.7 8.8 1.8 10.2 17.6 5.2 11.4 11.7 14.3 11.0 0.4 17.6 13.6 14.0 10.2 12.3 4.8 8.0 17.7 10.5 10.3 8.6 13.0 8.9 0.8 20.2 0.4 14.6 20.8 7.2 6.3 12.6 4.7 6.4 24.3 18.4 0.8 13.9 15.9 22.6 25.3 10.5 19.4 2.6 7.8 14.6 17.4 10.8 15.5 10.1 10.6 8.3 0.3 0.1 0.5 10.2 11.9 5.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.3 0.1 0.6 0.0 0.1 5.6 6.0 7.1 5.9 5.9 6.1 6.2 6.7 5.6 5.0 7.0 5.5 4.9 19.2 9.4 5.9 2.6 1.9 3.4 4.3 5.7 16.7 4.2 3.4 28.3 4.3 6.5 9.2 4.2 1.3 1.6 5.4 1.9 8.7 1.7 5.1 9.5 8.0 11.5 4.6 2.4 8.0 0.6 5.3 7.1 5.3 2.5 10.7 8.2 4.7 4.4 16.8 3.7 7.9 6.1 5.2 3.0 4.7 9.3 2.6 1.8 1.0 7.7 13.4 1.0 4.5 3.4 10.9 5.0 4.5 3.0 4.8 5.1 4.3 5.9 12.4 0.0 6.7 5.6 4.6 1.5 3.8 1.8 0.5 1.4 8.3 9.0 3.8 ZNF682 BC39498_3 ENSG00000197124 "Zinc finger protein 682" O95780 19 19997058-20039505 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 22.2" "Cancer enhanced" "Detected in many" "testis cancer: 7.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 14.4;AN3-CA: 21.8" HPA055998 Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA055998: AB_2683002" "unprognostic (8.96e-2)" "unprognostic (3.93e-2)" "unprognostic (4.78e-2)" "unprognostic (1.10e-1)" "unprognostic (6.16e-2)" "unprognostic (6.95e-3)" "unprognostic (1.69e-2)" "unprognostic (1.71e-2)" "unprognostic (6.44e-2)" "unprognostic (1.24e-3)" "unprognostic (7.70e-4)" "unprognostic (1.77e-3)" "unprognostic (4.06e-7)" "unprognostic (2.07e-1)" "unprognostic (2.10e-1)" "unprognostic (1.19e-1)" "prognostic favorable (3.51e-4)" 2.0 2.5 4.0 2.4 4.5 2.1 3.4 4.5 7.2 2.7 1.9 2.4 1.5 2.4 3.5 3.3 3.0 2.2 6.2 4.5 5.2 5.1 4.1 3.7 3.9 4.3 4.4 2.0 3.0 3.0 4.1 3.0 4.4 4.8 2.5 3.2 1.8 4.0 3.4 6.5 2.9 1.3 3.6 4.0 3.0 3.3 4.1 3.1 8.0 1.6 4.5 3.5 3.1 6.0 0.0 0.0 14.4 21.8 1.1 1.5 0.6 3.1 1.4 5.1 8.1 2.5 3.1 0.1 5.2 4.4 1.5 2.6 5.9 0.5 5.7 0.0 6.3 0.0 0.1 1.6 2.0 0.0 5.1 2.1 1.7 2.8 0.0 0.8 0.0 5.7 0.0 0.1 3.9 4.3 8.7 1.3 7.9 0.0 1.9 5.3 7.5 0.1 2.7 9.7 7.9 8.5 0.0 2.8 0.0 7.8 5.4 2.9 0.0 7.5 1.2 12.7 5.4 0.0 9.0 1.4 0.0 0.0 2.4 7.1 0.4 0.9 2.5 0.5 1.8 4.1 3.7 2.0 1.5 2.7 4.0 4.1 1.5 1.4 0.7 1.3 4.2 1.3 4.0 4.5 4.5 7.2 4.5 5.2 4.3 4.4 4.4 3.6 4.1 6.0 5.2 9.6 15.1 7.2 7.0 3.4 2.1 0.6 5.2 5.4 4.6 5.2 10.3 4.3 4.6 3.7 0.0 6.8 8.2 2.7 5.9 4.0 1.8 1.8 2.9 4.4 1.2 4.4 9.8 7.5 6.8 3.5 2.6 3.0 2.5 5.9 5.0 3.0 2.9 3.3 10.1 2.8 0.0 3.5 2.7 0.9 1.8 2.3 1.8 6.5 0.6 4.0 5.2 6.6 22.2 4.8 1.2 4.5 3.1 1.5 1.7 3.8 1.5 2.3 0.0 3.1 3.4 4.3 4.2 3.7 3.4 2.5 6.9 9.2 2.1 2.5 ZNF75D "D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28" ENSG00000186376 "Zinc finger protein 75D" P51815 X 135248920-135344109 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Early spermatids: 202.9;Late spermatids: 378.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004705 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA004705: AB_1080749" "unprognostic (1.56e-3)" "unprognostic (7.96e-3)" "unprognostic (3.07e-1)" "unprognostic (5.12e-2)" "unprognostic (1.30e-1)" "unprognostic (3.00e-2)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "prognostic favorable (7.42e-5)" 6.3 14.5 4.8 5.6 4.9 6.9 6.3 4.7 5.3 7.1 5.6 6.7 4.8 6.2 7.5 5.2 7.0 4.7 5.5 4.6 5.6 8.4 11.0 6.7 8.4 5.2 4.9 6.8 9.8 7.1 6.9 5.0 5.4 10.2 5.5 6.7 6.4 5.9 5.1 6.8 8.2 4.9 4.9 13.9 7.5 2.2 5.2 8.6 9.3 3.9 7.2 6.0 5.8 5.3 3.3 4.3 4.6 7.4 7.7 9.3 7.0 5.5 7.5 4.4 9.4 2.6 4.1 3.5 7.9 4.7 8.5 4.5 15.2 2.5 4.2 3.3 4.0 2.4 8.6 3.5 3.3 4.1 6.6 4.6 5.9 2.7 3.4 5.5 4.6 4.4 2.1 5.4 3.9 8.0 5.0 7.5 2.2 6.7 5.8 4.7 4.6 3.1 5.0 4.5 1.5 5.2 3.1 5.2 0.9 4.9 1.8 5.9 4.8 4.2 1.0 7.1 5.3 2.7 4.1 2.5 2.6 4.5 2.7 2.7 1.0 2.0 2.3 0.8 2.1 1.4 2.5 2.7 0.9 1.6 3.1 2.8 1.1 2.8 0.8 0.8 3.4 1.5 4.8 4.9 4.7 5.3 4.6 5.6 5.2 4.9 5.4 4.9 5.2 5.3 6.4 6.4 12.9 23.5 7.5 1.8 1.3 1.4 2.8 4.9 3.9 2.0 4.7 1.5 5.0 0.0 6.2 2.4 8.4 3.7 1.9 2.0 202.9 9.2 4.8 7.1 1.8 0.8 18.5 4.0 1.5 4.2 6.1 4.9 6.3 4.9 5.7 5.3 2.4 5.0 21.8 5.0 6.1 2.9 1.6 378.3 6.5 3.8 0.0 28.1 3.9 4.1 6.2 18.6 21.4 3.1 2.8 3.4 5.0 2.3 3.3 3.7 5.1 5.1 0.0 3.4 3.5 7.6 3.1 3.4 1.4 1.8 7.1 10.2 3.6 2.3 ZNF90 HTF9 ENSG00000213988 "Zinc finger protein 90" Q03938 19 20077994-20127076 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 217.1;Langerhans cells: 329.2;Smooth muscle cells: 451.1;Suprabasal keratinocytes: 280.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 10.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 9.5;NB-4: 7.9;NTERA-2: 17.0;SuSa: 10.5;U-2197: 7.0" HPA003227 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Golgi apparatus" "HPA003227: AB_1859471" "unprognostic (4.52e-2)" "unprognostic (2.64e-3)" "unprognostic (3.93e-1)" "unprognostic (2.45e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-2)" "unprognostic (7.34e-3)" "unprognostic (4.95e-1)" "unprognostic (4.44e-3)" "unprognostic (2.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-4)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (9.10e-2)" "unprognostic (2.60e-2)" 0.3 0.2 0.1 0.6 0.3 0.6 0.5 1.0 0.2 0.8 0.2 0.5 0.2 0.9 0.6 0.4 0.8 0.3 0.3 0.1 0.2 0.5 0.1 0.7 1.2 0.3 0.2 1.5 0.9 1.8 0.3 1.2 0.3 0.6 0.7 0.0 0.3 1.4 0.2 1.1 0.6 0.6 0.1 0.5 0.8 0.6 0.3 0.8 1.9 0.0 0.8 1.0 0.7 0.4 0.0 0.0 3.7 9.5 0.0 0.0 0.0 0.9 0.3 3.3 4.0 3.2 2.3 1.3 1.7 0.6 2.5 1.1 0.0 0.5 5.7 0.0 0.9 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 3.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.8 7.9 17.0 0.0 0.0 0.0 3.1 0.4 2.3 3.3 0.0 3.9 0.0 1.4 0.2 10.5 1.8 0.0 0.0 1.0 0.0 7.0 3.7 0.0 1.5 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.2 0.1 0.2 0.3 0.2 0.3 0.1 0.3 0.4 2.2 6.4 8.4 1.0 31.7 217.1 112.5 32.7 2.8 0.6 7.8 6.6 1.9 50.1 16.7 7.3 2.1 87.5 25.1 4.8 17.6 2.3 8.2 1.9 4.9 28.8 8.5 26.7 0.5 2.0 99.1 27.6 1.5 4.5 1.3 9.3 54.3 57.1 47.8 0.0 0.7 16.9 14.2 107.1 329.2 24.2 60.9 14.9 124.5 5.6 34.6 2.2 44.3 1.5 2.9 1.2 12.3 34.6 1.8 87.8 8.4 14.0 8.6 2.5 19.7 45.2 451.1 8.6 16.7 1.9 280.3 81.5 40.1 16.0 19.0 66.4 ZNRF3 "BK747E2.3, FLJ22057, KIAA1133, RNF203" ENSG00000183579 "Zinc and ring finger 3" Q9ULT6 22 28883572-29057488 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Astrocytes: 504.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036702, HPA036703" Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Golgi apparatus" "HPA036702: , HPA036703: AB_10672227" "unprognostic (1.07e-1)" "unprognostic (2.13e-3)" "unprognostic (7.48e-3)" "unprognostic (5.72e-2)" "unprognostic (6.81e-2)" "unprognostic (1.36e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-2)" "unprognostic (5.18e-2)" "unprognostic (3.94e-1)" "unprognostic (9.55e-5)" "unprognostic (6.49e-2)" "unprognostic (1.02e-1)" "unprognostic (3.70e-2)" "unprognostic (2.55e-2)" 2.8 7.1 11.3 1.3 11.2 0.3 2.6 8.1 13.8 4.4 1.0 3.9 3.0 5.1 13.4 3.4 4.8 2.1 2.6 12.1 5.5 8.2 6.6 4.3 0.5 13.2 9.2 5.9 3.3 8.7 2.7 5.0 4.2 7.2 3.4 1.1 7.5 7.7 3.8 5.3 2.7 4.6 5.1 1.2 4.4 5.0 13.6 1.3 4.1 1.9 0.6 3.2 3.3 6.2 5.8 13.7 12.5 3.5 2.3 2.6 23.7 3.5 1.7 2.7 2.6 20.8 3.2 0.1 5.4 1.8 4.9 9.8 8.7 5.5 3.3 7.8 8.9 2.3 2.5 46.1 2.0 6.9 2.3 2.7 5.0 4.3 4.3 2.3 2.4 4.1 5.0 3.2 3.9 5.6 0.2 3.5 4.6 7.3 5.4 6.9 8.2 5.3 11.6 8.5 20.6 7.6 6.2 6.1 3.5 3.8 4.1 3.1 2.3 10.3 8.8 8.2 5.8 4.3 6.3 8.1 4.4 3.9 5.5 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 11.3 11.2 8.1 13.8 12.1 5.5 13.2 9.2 4.2 5.1 13.6 6.2 4.2 12.8 23.6 504.1 0.3 12.6 5.2 4.9 15.9 3.7 5.7 9.5 7.5 8.6 5.3 12.9 0.0 28.1 0.5 2.1 1.9 5.0 12.7 8.0 8.0 5.8 8.4 4.0 62.9 2.5 2.5 5.8 5.6 15.5 0.0 5.4 2.2 17.6 3.5 1.7 37.4 9.4 0.0 1.0 3.1 15.0 10.8 0.8 0.0 82.4 0.0 6.0 0.0 54.8 34.4 3.7 2.1 12.8 0.6 9.6 2.4 11.6 4.9 3.9 0.0 16.0 6.6 4.6 3.2 7.8 7.5 7.7 0.7 14.5 12.9 2.8 ZYG11B "FLJ13456, ZYG11" ENSG00000162378 "Zyg-11 family member B, cell cycle regulator" Q9C0D3 1 52726453-52827336 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 78.9;tongue: 62.0" "Cell type enhanced" "Detected in all" "Hepatocytes: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028156 Uncertain Approved "Golgi apparatus,Intermediate filaments" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus, Intermediate filaments" "HPA028156: AB_10602360" "unprognostic (2.54e-1)" "unprognostic (2.02e-1)" "prognostic favorable (5.42e-6)" "unprognostic (1.58e-2)" "unprognostic (4.44e-2)" "unprognostic (3.04e-3)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (4.84e-3)" "unprognostic (5.06e-2)" "unprognostic (2.76e-1)" "unprognostic (6.08e-2)" "prognostic favorable (9.80e-7)" "unprognostic (2.22e-1)" "unprognostic (3.37e-1)" "unprognostic (1.13e-1)" "unprognostic (9.57e-2)" 9.4 8.4 13.5 5.5 14.5 7.6 7.2 15.9 14.0 9.1 3.5 9.9 4.3 10.8 5.9 9.5 6.8 6.6 17.1 13.7 16.0 12.9 18.6 7.6 5.1 8.5 9.7 10.8 5.1 10.0 4.6 7.1 11.1 9.4 7.5 13.4 6.3 8.6 78.9 6.3 4.6 12.5 8.0 5.6 5.0 8.6 16.3 6.9 12.8 62.0 5.4 7.7 5.7 10.3 10.8 9.9 12.1 15.1 21.7 18.5 10.0 11.7 15.3 9.4 8.7 8.4 3.5 10.2 11.1 23.6 12.6 5.5 14.1 10.6 14.9 7.9 8.6 13.1 10.4 5.3 11.5 9.9 7.7 13.5 11.2 13.4 9.4 13.1 16.6 2.3 12.0 2.1 17.2 4.4 3.9 6.4 12.3 5.4 10.0 6.7 22.4 9.3 9.6 17.2 5.5 10.9 20.6 12.8 10.6 15.2 7.7 7.8 19.1 14.4 8.2 14.3 7.4 8.6 10.8 7.4 9.8 6.6 9.5 0.3 0.7 0.9 0.5 0.3 0.6 0.6 0.7 0.4 0.7 0.5 1.1 0.8 1.7 0.6 0.6 0.4 1.0 0.3 13.5 14.5 15.9 14.0 13.7 16.0 8.5 9.7 11.1 8.0 16.3 10.3 26.8 25.6 28.8 29.0 13.4 11.3 10.5 12.1 10.2 49.5 13.6 11.9 88.3 20.0 14.0 14.7 20.9 24.6 6.9 37.2 7.9 12.2 5.7 13.2 40.9 22.1 10.2 9.0 72.4 11.1 12.0 26.3 12.2 18.6 8.2 32.0 32.5 107.7 20.6 97.6 82.6 11.4 14.2 37.5 11.8 7.9 24.5 21.5 21.4 36.5 21.9 21.6 4.1 46.3 52.0 16.3 17.9 30.9 11.6 26.0 14.0 30.0 11.1 24.4 26.3 35.7 25.9 11.4 23.7 17.3 14.6 34.8 9.7 19.5 15.5 19.0